Citrus Sinensis ID: 046907
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 345 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 0.959 | 0.516 | 0.632 | 1e-128 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.739 | 0.203 | 0.362 | 2e-38 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.823 | 0.243 | 0.321 | 5e-38 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.814 | 0.791 | 0.317 | 6e-38 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.753 | 0.249 | 0.349 | 8e-38 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.820 | 0.243 | 0.326 | 2e-37 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.773 | 0.259 | 0.346 | 2e-37 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.823 | 0.235 | 0.327 | 3e-37 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.823 | 0.235 | 0.327 | 3e-37 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.739 | 0.231 | 0.357 | 6e-37 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 457 bits (1175), Expect = e-128, Method: Compositional matrix adjust.
Identities = 225/356 (63%), Positives = 265/356 (74%), Gaps = 25/356 (7%)
Query: 2 CVCSFFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGC 61
+ F KL + A+R + PGP+IFSPLIKKA+DLAFLE + LASLE IG GGC
Sbjct: 299 TISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGC 358
Query: 62 GEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121
GEV+KAELPG NG++I++KK++ PP DA L +EDS LNKKMRQI +
Sbjct: 359 GEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQI-------------R 405
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHR 170
SEINTVG IRHRNL PLLAHV+RP+CH L IL DV G +EL W ARH+
Sbjct: 406 SEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHK 465
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
IALG+A GLEYLHM H PRIIHRDL P NVLLDDD+EARIS FG A+A+PDA THITTS+
Sbjct: 466 IALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSH 525
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289
V GTV YIAPE+ Q T+KCDIY FG +L LV+GKLPSD+FFQHT+EMS +KWMRN+
Sbjct: 526 VAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNI 585
Query: 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
+ SENP AID KL+ G +EQMLLVLKIAC+CTL+DP +RPNSKDVR MLSQI+H
Sbjct: 586 ITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 159 bits (403), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 112/309 (36%), Positives = 160/309 (51%), Gaps = 54/309 (17%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
IGSGG G+VYKAEL +NG I++KKI + +D ++ NK +
Sbjct: 954 IGSGGSGKVYKAEL--KNGETIAVKKI----------LWKDDLMSNKSFNR--------- 992
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVT-RPDCHLLYIL--------------NDVSQGR 160
E+ T+G IRHR+L L+ + + + D L I N+ ++ +
Sbjct: 993 -------EVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKK 1045
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L W R +IALGLA G+EYLH P I+HRD+ NVLLD +IEA + FG A+ +
Sbjct: 1046 EVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILT 1105
Query: 221 DAHTHITTSNVV--GTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277
+ T SN + G+ YIAPEY L TEK D+Y G +L +V GK+P++ F
Sbjct: 1106 GNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEE 1165
Query: 278 NEMSFVKWMRNVM----ASENPKRAIDSKLVG-NGCEEQMLL-VLKIACFCTLEDPNERP 331
+M V+W+ V+ SE ++ IDS+L CEE+ VL+IA CT P ERP
Sbjct: 1166 TDM--VRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERP 1223
Query: 332 NSKDVRRML 340
+S+ L
Sbjct: 1224 SSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 107/333 (32%), Positives = 167/333 (50%), Gaps = 49/333 (14%)
Query: 29 AIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMD 88
A F ++K LE G ++ +GSGG GEVYKA+L ++G +++IKK++
Sbjct: 838 ATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQL--RDGSVVAIKKLI----- 890
Query: 89 AAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH 148
+ + R+ +E+ T+G+I+HRNL PLL + +
Sbjct: 891 ----------------------RITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEER 928
Query: 149 LLY-----------ILNDVS--QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195
LL +L++ S +G L+W AR +IA+G A GL +LH P IIHRD+
Sbjct: 929 LLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDM 988
Query: 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
NVLLD+D EAR+S FG AR + TH++ S + GT Y+ PEY Q T K D+Y
Sbjct: 989 KSSNVLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVY 1048
Query: 256 -FGALLAGLVMGKLPSD--KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEE-Q 311
+G +L L+ GK P D +F + N V W + + + +D +LV + + +
Sbjct: 1049 SYGVILLELLSGKKPIDPGEFGEDNN---LVGWAKQLYREKRGAEILDPELVTDKSGDVE 1105
Query: 312 MLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344
+ LKIA C + P +RP + M +++
Sbjct: 1106 LFHYLKIASQCLDDRPFKRPTMIQLMAMFKEMK 1138
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 103/324 (31%), Positives = 164/324 (50%), Gaps = 43/324 (13%)
Query: 32 SPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAA 91
S L+ F++K L++ + +GSGG G VY+
Sbjct: 57 SQLLNSVSSDMFMKKTHKLSNKDILGSGGFGTVYRL------------------------ 92
Query: 92 LIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY 151
+I++ + K++ + SE + R E+ + I+HRN+ L + T P +LL
Sbjct: 93 VIDDSTTFAVKRLNRGTSE-----RDRGFHRELEAMADIKHRNIVTLHGYFTSPHYNLLI 147
Query: 152 I-------LNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204
L+ GR+ LDW +R+RIA+G A G+ YLH P IIHRD+ N+LLD
Sbjct: 148 YELMPNGSLDSFLHGRKALDWASRYRIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDH 207
Query: 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263
++EAR+S FG A + TH++T V GT Y+APEY T K D+Y FG +L L
Sbjct: 208 NMEARVSDFGLATLMEPDKTHVSTF-VAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLEL 266
Query: 264 VMGKLPS-DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCE--EQMLLVLKIAC 320
+ G+ P+ D+FF+ ++ V W++ V+ + + ID++L G+ + E+M V IA
Sbjct: 267 LTGRKPTDDEFFEEGTKL--VTWVKGVVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAM 324
Query: 321 FCTLEDPNERPNSKDVRRMLSQIQ 344
C +P RP +V ++L I+
Sbjct: 325 MCLEPEPAIRPAMTEVVKLLEYIK 348
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 107/306 (34%), Positives = 163/306 (53%), Gaps = 46/306 (15%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G G VYKAE+P NG +I++KK+ G + N K+R+ +S +L
Sbjct: 725 LGMGSTGTVYKAEMP--NGEIIAVKKLWGKNKE------------NGKIRRRKSGVL--- 767
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRREL----- 163
+E++ +G +RHRN+ LL T DC +L L+D+ G +
Sbjct: 768 ------AEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAA 821
Query: 164 DWLARHRIALGLACGLEYLHMHHC-PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+W A ++IA+G+A G+ YLH H C P I+HRDL P N+LLD D EAR++ FG A+ I
Sbjct: 822 EWTALYQIAIGVAQGICYLH-HDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI--- 877
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
T + S V G+ YIAPEY L + +K DIY +G +L ++ GK + F N S
Sbjct: 878 QTDESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGN--S 935
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCE---EQMLLVLKIACFCTLEDPNERPNSKDVRR 338
V W+R+ + ++ + K +G C E+M +L+IA CT P +RP +DV
Sbjct: 936 IVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLL 995
Query: 339 MLSQIQ 344
+L + +
Sbjct: 996 ILQEAK 1001
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 108/331 (32%), Positives = 163/331 (49%), Gaps = 48/331 (14%)
Query: 29 AIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMD 88
A F ++K LE G ++ IGSGG G+VYKA+L +G +++IKK++
Sbjct: 837 ATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKL--ADGSVVAIKKLI----- 889
Query: 89 AAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH 148
+ + R+ +E+ T+G+I+HRNL PLL + +
Sbjct: 890 ----------------------QVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEER 927
Query: 149 LLY-----------ILND-VSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196
LL +L++ +G LDW AR +IA+G A GL +LH P IIHRD+
Sbjct: 928 LLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMK 987
Query: 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY- 255
NVLLD D AR+S FG AR + TH++ S + GT Y+ PEY Q T K D+Y
Sbjct: 988 SSNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYS 1047
Query: 256 FGALLAGLVMGKLPSD--KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEE-QM 312
+G +L L+ GK P D +F + N V W + + + +D +LV + + ++
Sbjct: 1048 YGVILLELLSGKKPIDPEEFGEDNN---LVGWAKQLYREKRGAEILDPELVTDKSGDVEL 1104
Query: 313 LLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
L LKIA C + P +RP V M ++
Sbjct: 1105 LHYLKIASQCLDDRPFKRPTMIQVMTMFKEL 1135
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (394), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 105/303 (34%), Positives = 160/303 (52%), Gaps = 36/303 (11%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
IG G G VYKAE+ + +++KK+ P I+
Sbjct: 720 IGMGAIGIVYKAEVMRRPLLTVAVKKLWRSP---------------SPQNDIEDHHQEED 764
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTR-----------PDCHLLYILNDVSQGRRELD 164
+ I E+N +G +RHRN+ +L +V P+ +L L+ + D
Sbjct: 765 EEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRD 824
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
WL+R+ +A+G+ GL YLH P IIHRD+ N+LLD ++EARI+ FG A+ + H
Sbjct: 825 WLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMM--LHK 882
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+ T S V G+ YIAPEY L + EK DIY G +L LV GK+P D F+ + + V
Sbjct: 883 NETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFE--DSIDVV 940
Query: 284 KWM-RNVMASENPKRAIDSKLVGNGCE---EQMLLVLKIACFCTLEDPNERPNSKDVRRM 339
+W+ R V +E+ + ID+ + G+ C+ E+MLL L+IA CT + P +RP+ +DV M
Sbjct: 941 EWIRRKVKKNESLEEVIDASIAGD-CKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITM 999
Query: 340 LSQ 342
L++
Sbjct: 1000 LAE 1002
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 108/330 (32%), Positives = 166/330 (50%), Gaps = 46/330 (13%)
Query: 29 AIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMD 88
A F ++K LE G + +GSGG G+VYKA+L ++G +++IKK++
Sbjct: 867 AAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLI----- 919
Query: 89 AAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH 148
+ + R+ +E+ T+G+I+HRNL PLL + +
Sbjct: 920 ----------------------HVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 957
Query: 149 LLYI-------LNDVSQGRRE----LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197
LL L DV R++ L+W AR +IA+G A GL +LH + P IIHRD+
Sbjct: 958 LLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKS 1017
Query: 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256
NVLLD+++EAR+S FG AR + TH++ S + GT Y+ PEY Q + K D+Y +
Sbjct: 1018 SNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSY 1077
Query: 257 GALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGN--GCEEQMLL 314
G +L L+ GK P+D N + V W++ + A D +L+ E ++L
Sbjct: 1078 GVVLLELLTGKQPTDSADFGDNNL--VGWVK-LHAKGKITDVFDRELLKEDASIEIELLQ 1134
Query: 315 VLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344
LK+AC C + +RP V M +IQ
Sbjct: 1135 HLKVACACLDDRHWKRPTMIQVMAMFKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (393), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 108/330 (32%), Positives = 166/330 (50%), Gaps = 46/330 (13%)
Query: 29 AIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMD 88
A F ++K LE G + +GSGG G+VYKA+L ++G +++IKK++
Sbjct: 867 AAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQL--KDGSVVAIKKLI----- 919
Query: 89 AAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH 148
+ + R+ +E+ T+G+I+HRNL PLL + +
Sbjct: 920 ----------------------HVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEER 957
Query: 149 LLYI-------LNDVSQGRRE----LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197
LL L DV R++ L+W AR +IA+G A GL +LH + P IIHRD+
Sbjct: 958 LLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKS 1017
Query: 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256
NVLLD+++EAR+S FG AR + TH++ S + GT Y+ PEY Q + K D+Y +
Sbjct: 1018 SNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSY 1077
Query: 257 GALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGN--GCEEQMLL 314
G +L L+ GK P+D N + V W++ + A D +L+ E ++L
Sbjct: 1078 GVVLLELLTGKQPTDSADFGDNNL--VGWVK-LHAKGKITDVFDRELLKEDASIEIELLQ 1134
Query: 315 VLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344
LK+AC C + +RP V M +IQ
Sbjct: 1135 HLKVACACLDDRHWKRPTMIQVMAMFKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 154 bits (390), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 108/302 (35%), Positives = 157/302 (51%), Gaps = 47/302 (15%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G CG VYKAE+ G G +I++KK LN + S+
Sbjct: 805 LGRGACGTVYKAEMSG--GEVIAVKK------------------LNSRGEGASSD----- 839
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY--------ILNDVSQGRRE--LDW 165
++EI+T+G+IRHRN+ L + +LL + + +G + LDW
Sbjct: 840 --NSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDW 897
Query: 166 LARHRIALGLACGLEYLHMHHC-PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
AR+RIALG A GL YLH H C P+I+HRD+ N+LLD+ +A + FG A+ I +++
Sbjct: 898 NARYRIALGAAEGLCYLH-HDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYS 956
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+ S V G+ YIAPEY + +TEKCDIY FG +L L+ GK P Q + V
Sbjct: 957 K-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD---LV 1012
Query: 284 KWMRNVMASENPK-RAIDSKLVGNG--CEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340
W+R + + P D++L N +M LVLKIA FCT P RP ++V M+
Sbjct: 1013 NWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
Query: 341 SQ 342
++
Sbjct: 1073 TE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 345 | ||||||
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 0.959 | 0.525 | 0.688 | 1e-137 | |
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.927 | 0.505 | 0.708 | 1e-136 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 0.942 | 0.518 | 0.687 | 1e-135 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 0.942 | 0.511 | 0.673 | 1e-131 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 0.927 | 0.505 | 0.666 | 1e-128 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 0.942 | 0.515 | 0.659 | 1e-127 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 0.959 | 0.516 | 0.632 | 1e-126 | |
| 297822929 | 641 | hypothetical protein ARALYDRAFT_482113 [ | 0.959 | 0.516 | 0.629 | 1e-125 | |
| 16648755 | 641 | At2g31880/F20M17.8 [Arabidopsis thaliana | 0.959 | 0.516 | 0.629 | 1e-125 | |
| 225456834 | 632 | PREDICTED: leucine-rich repeat receptor- | 0.953 | 0.520 | 0.662 | 1e-124 |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 493 bits (1269), Expect = e-137, Method: Compositional matrix adjust.
Identities = 245/356 (68%), Positives = 277/356 (77%), Gaps = 25/356 (7%)
Query: 2 CVCSFFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGC 61
C+ K+ LAAV+ GRD GPAIFSPLIK+A+DLAFLEK GLA+LE IG GGC
Sbjct: 288 CLSGLVFSLLFKIVLAAVKGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGC 347
Query: 62 GEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121
GEVYKAELPG NG+MI+IKKI+ PP DAA L EEDS LL+KK MRQIQ
Sbjct: 348 GEVYKAELPGSNGKMIAIKKIIQPPKDAAELTEEDSKLLHKK-------------MRQIQ 394
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-----------LNDVSQGRRELDWLARHR 170
SEINTVG IRHRNL PLLAHV+RPDCH L LN V++GRRELDWLARHR
Sbjct: 395 SEINTVGHIRHRNLLPLLAHVSRPDCHYLVYELMKNGSLQDALNHVTEGRRELDWLARHR 454
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
IA+G+A GLEYLH+ H PRIIHRDL P NVLLDD +EARI+ FG A+A+PDA THITTSN
Sbjct: 455 IAVGVASGLEYLHLSHSPRIIHRDLKPANVLLDDSMEARIADFGLAKAMPDAQTHITTSN 514
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289
V GTV YIAPEY Q L T+KCDIY FG +L LVMGKLPSD+FFQ+T EMS VKWMRN+
Sbjct: 515 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNI 574
Query: 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
M SENP++AID KL+GNG EEQMLLVLKIACFCT++DP +RPNSKDVR MLSQI+H
Sbjct: 575 MTSENPRQAIDPKLMGNGLEEQMLLVLKIACFCTIDDPKQRPNSKDVRCMLSQIKH 630
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1261), Expect = e-136, Method: Compositional matrix adjust.
Identities = 245/346 (70%), Positives = 277/346 (80%), Gaps = 26/346 (7%)
Query: 13 KLFLAAVRRVGRDPGPAIFSP-LIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPG 71
KL LA +R G+D GPAIFSP LIKKA++LAFLEK+ GL++LE IG GGCGEVYKAELPG
Sbjct: 301 KLILATIRGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEVYKAELPG 360
Query: 72 QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131
NG+MI+IKKIV PP DAA L EED+ LLNKKMRQ I+SEINTVGQIR
Sbjct: 361 SNGKMIAIKKIVQPPRDAAELTEEDTKLLNKKMRQ-------------IRSEINTVGQIR 407
Query: 132 HRNLHPLLAHVTRPDCH-LLY----------ILNDVSQGRRELDWLARHRIALGLACGLE 180
HRNL PLLAHV+RPDCH L+Y IL+DV QG+RELDWLARHRIA+G+A GLE
Sbjct: 408 HRNLLPLLAHVSRPDCHCLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLE 467
Query: 181 YLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAP 240
YLH H PRIIHRDL P NVLLDDD+EARI+ FG A+A+PDA+TH+TTSNV GTV YIAP
Sbjct: 468 YLHTSHSPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAP 527
Query: 241 EYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAI 299
EY Q L T+KCDIY FG LL LVMGKLPSD+FFQ T EMS VKWMRN+M SENP +AI
Sbjct: 528 EYHQTLKFTDKCDIYSFGVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAI 587
Query: 300 DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
D K+ GNG EEQMLLVLKIACFCTL+DP +RPNSKD+R MLSQI+H
Sbjct: 588 DPKMNGNGFEEQMLLVLKIACFCTLDDPRQRPNSKDIRCMLSQIKH 633
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1253), Expect = e-135, Method: Compositional matrix adjust.
Identities = 242/352 (68%), Positives = 277/352 (78%), Gaps = 27/352 (7%)
Query: 6 FFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVY 65
F L F K+ LAAV+ GRD GPAIFSPLIKKA+DLAFLEK GLA+LE IG GGCGEV+
Sbjct: 291 FSLLF--KIVLAAVKGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVF 348
Query: 66 KAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125
KAELPG NG+MI++KKI+ PP DAA L EEDS +LNKKMRQI QSEIN
Sbjct: 349 KAELPGSNGKMIAVKKIIQPPKDAAELSEEDSKVLNKKMRQI-------------QSEIN 395
Query: 126 TVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHRIALG 174
TVG IRHRNL PLLAHV+RPDCH L +LN V++G+RELDWLARH+IA+G
Sbjct: 396 TVGHIRHRNLLPLLAHVSRPDCHYLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVG 455
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A GLEYLH+ H P+IIHRDL P NVLLDDD+EARI+ FG A+A+PDA THITTSNV GT
Sbjct: 456 VASGLEYLHLSHSPQIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGT 515
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASE 293
V YIAPEY Q L TEKCDIY FG +L LVMGKLPSD FFQ T E+S VKWMRN+M SE
Sbjct: 516 VGYIAPEYHQTLKFTEKCDIYSFGVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISE 575
Query: 294 NPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
NP +AID KL+G+G EEQMLLVLKIACFCT++DP +RP+SKDVR MLSQI+H
Sbjct: 576 NPSQAIDPKLIGHGLEEQMLLVLKIACFCTIDDPKQRPSSKDVRCMLSQIKH 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1220), Expect = e-131, Method: Compositional matrix adjust.
Identities = 237/352 (67%), Positives = 273/352 (77%), Gaps = 27/352 (7%)
Query: 6 FFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVY 65
F L F KL LA ++ GR GP I+SPLIKKA+DLAFLEK+ G+ASLE IG GGCGEVY
Sbjct: 300 FSLMF--KLALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEVY 357
Query: 66 KAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125
KAELPG NG+MI+IKKIV PP D A L EEDS +LNKKMRQI +SEIN
Sbjct: 358 KAELPGSNGKMIAIKKIVQPPKDGAELAEEDSKVLNKKMRQI-------------RSEIN 404
Query: 126 TVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHRIALG 174
TVGQIRHRNL PLLAHV+RP+CH L L+ V +G ELDWL+RH+I+LG
Sbjct: 405 TVGQIRHRNLLPLLAHVSRPECHYLVYEFMKNGSLQDTLSKVERGESELDWLSRHKISLG 464
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A GLEYLHM+H PRIIHRDL P N+LLDDD+EARI+ FG A+A+PD THITTSNV GT
Sbjct: 465 VAAGLEYLHMNHNPRIIHRDLKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGT 524
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASE 293
V YIAPEY Q+L T+KCDIY +G +L LV+GKLPSD FFQHT EMS VKWMR ++SE
Sbjct: 525 VGYIAPEYHQILKFTDKCDIYSYGVILGVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSE 584
Query: 294 NPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
NPK AI+SKL+GNG EEQMLLVLKIACFCT++DP ERPNSKDVR MLSQI+H
Sbjct: 585 NPKEAINSKLLGNGYEEQMLLVLKIACFCTMDDPKERPNSKDVRCMLSQIKH 636
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1194), Expect = e-128, Method: Compositional matrix adjust.
Identities = 230/345 (66%), Positives = 268/345 (77%), Gaps = 25/345 (7%)
Query: 13 KLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQ 72
KL + VR+ D I+SPLIKKA+DLAFLEK+ G+ASLE IG GGCGEVY+AELPG
Sbjct: 302 KLVMFFVRKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEVYRAELPGS 361
Query: 73 NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132
NG++I+IKKI+ PPMDAA L EED+ LNKKMRQ++ SEI +GQIRH
Sbjct: 362 NGKIIAIKKILQPPMDAAELAEEDTKALNKKMRQVK-------------SEIQILGQIRH 408
Query: 133 RNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHRIALGLACGLEY 181
RNL PLLAH+ RPDCH L IL V++G RELDWL RHRIA+G+A GLEY
Sbjct: 409 RNLLPLLAHMPRPDCHYLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEY 468
Query: 182 LHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPE 241
LH++H IIHRDL P NVLLDDD+EARI+ FG A+A+PDAHTH+TTSNV GTV YIAPE
Sbjct: 469 LHINHSQCIIHRDLKPANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPE 528
Query: 242 YLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAID 300
Y Q L T+KCDIY FG +LA LV+GKLPSD+FFQHT EMS VKW+RNVM SE+PKRAID
Sbjct: 529 YHQTLKFTDKCDIYSFGVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAID 588
Query: 301 SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
KL+G+G EEQMLLVLKIACFCTLE+P ERPNSKDVR ML+QI+H
Sbjct: 589 PKLIGSGFEEQMLLVLKIACFCTLENPKERPNSKDVRCMLTQIKH 633
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1187), Expect = e-127, Method: Compositional matrix adjust.
Identities = 232/352 (65%), Positives = 270/352 (76%), Gaps = 27/352 (7%)
Query: 6 FFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVY 65
F L F KL LA ++ GR GP I+SPLIKKA+DLAFLEK+ G+ASLE IG GGCGEVY
Sbjct: 295 FSLMF--KLALALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVY 352
Query: 66 KAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125
KAELPG NG+MI+IKKI+ PP + A L EEDS +LNKKMRQI +SEI
Sbjct: 353 KAELPGSNGKMIAIKKIIQPPKEGAELAEEDSKVLNKKMRQI-------------RSEIT 399
Query: 126 TVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHRIALG 174
TVGQIRHRNL PLLAHV+RP CH L L+ V G ELDWL+RH+IALG
Sbjct: 400 TVGQIRHRNLLPLLAHVSRPGCHYLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALG 459
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A GLEYLH++H PRIIHRDL P N+LLDDD+EARI+ FG A+A+PD THITTSNV GT
Sbjct: 460 VAAGLEYLHLNHNPRIIHRDLKPANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGT 519
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASE 293
V YIAPEY Q+L T+KCDIY FG +L LV+GKLPS +FFQHT EMS VKWMR +++SE
Sbjct: 520 VGYIAPEYHQILKFTDKCDIYSFGVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSE 579
Query: 294 NPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
NPK AID+KL+GNG E+QMLLVLKIACFCT++DP ERPNSKDV MLSQI+H
Sbjct: 580 NPKEAIDTKLLGNGYEDQMLLVLKIACFCTMDDPKERPNSKDVWCMLSQIKH 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1175), Expect = e-126, Method: Compositional matrix adjust.
Identities = 225/356 (63%), Positives = 265/356 (74%), Gaps = 25/356 (7%)
Query: 2 CVCSFFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGC 61
+ F KL + A+R + PGP+IFSPLIKKA+DLAFLE + LASLE IG GGC
Sbjct: 299 TISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGC 358
Query: 62 GEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121
GEV+KAELPG NG++I++KK++ PP DA L +EDS LNKKMRQI +
Sbjct: 359 GEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQI-------------R 405
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHR 170
SEINTVG IRHRNL PLLAHV+RP+CH L IL DV G +EL W ARH+
Sbjct: 406 SEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHK 465
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
IALG+A GLEYLHM H PRIIHRDL P NVLLDDD+EARIS FG A+A+PDA THITTS+
Sbjct: 466 IALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSH 525
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289
V GTV YIAPE+ Q T+KCDIY FG +L LV+GKLPSD+FFQHT+EMS +KWMRN+
Sbjct: 526 VAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNI 585
Query: 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
+ SENP AID KL+ G +EQMLLVLKIAC+CTL+DP +RPNSKDVR MLSQI+H
Sbjct: 586 ITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 455 bits (1171), Expect = e-125, Method: Compositional matrix adjust.
Identities = 224/356 (62%), Positives = 264/356 (74%), Gaps = 25/356 (7%)
Query: 2 CVCSFFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGC 61
+ F KL + A+R G+ GP+IFSPLIKKA+DLAFLE + LASLE IG GGC
Sbjct: 299 TISGFVFSVLFKLIIQAIRGSGKPSGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGC 358
Query: 62 GEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121
GEV+KAELPG NG++I++KK++ PP DA L +EDS +NKKMRQI+
Sbjct: 359 GEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFMNKKMRQIR------------- 405
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHR 170
SEI+TVGQIRHRNL PLLAHV+RP+CH L IL DV G +EL W ARH+
Sbjct: 406 SEISTVGQIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHK 465
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
IALG+A GLEYLHM H PRIIHRDL P NVLLDDD+EARIS FG A+ +PDA THITTSN
Sbjct: 466 IALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKVMPDAVTHITTSN 525
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289
V GTV YIAPE+ Q T KCDIY FG +L LV+GKLPSD+FFQHT+EMS +KWMRN+
Sbjct: 526 VAGTVGYIAPEFYQTHKFTAKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNI 585
Query: 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
+ SENP AID KL+ G +EQMLLVLKIAC+CTL+DP +RPNSKDVR MLSQI+H
Sbjct: 586 ITSENPSLAIDPKLMEQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16648755|gb|AAL25569.1| At2g31880/F20M17.8 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1168), Expect = e-125, Method: Compositional matrix adjust.
Identities = 224/356 (62%), Positives = 264/356 (74%), Gaps = 25/356 (7%)
Query: 2 CVCSFFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGC 61
+ F KL + A+R + PGP+IFSPLIKKA+DLAFLE + LASLE IG GGC
Sbjct: 299 TISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGC 358
Query: 62 GEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121
GEV+KAELPG NG++I++KK++ PP DA L +EDS LNKKMRQI +
Sbjct: 359 GEVFKAELPGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQI-------------R 405
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHR 170
SEINTVG IRHRNL PLLAHV+RP+CH L IL DV G +EL W ARH+
Sbjct: 406 SEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHK 465
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
IALG+A GLEYLHM H PRIIHRD P NVLLDDD+EARIS FG A+A+PDA THITTS+
Sbjct: 466 IALGIAAGLEYLHMDHNPRIIHRDSKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSH 525
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289
V GTV YIAPE+ Q T+KCDIY FG +L LV+GKLPSD+FFQHT+EMS +KWMRN+
Sbjct: 526 VAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNI 585
Query: 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
+ SENP AID KL+ G +EQMLLVLKIAC+CTL+DP +RPNSKDVR MLSQI+H
Sbjct: 586 ITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456834|ref|XP_002276125.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 452 bits (1162), Expect = e-124, Method: Compositional matrix adjust.
Identities = 236/356 (66%), Positives = 267/356 (75%), Gaps = 27/356 (7%)
Query: 2 CVCSFFLFFYPKLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGC 61
C+ K L VR G++ GPAIFSPLIKKA+DLAFLEK GLASLE IG GGC
Sbjct: 292 CISGLVFSVLFKALLVLVRGGGKESGPAIFSPLIKKAEDLAFLEKDDGLASLEIIGKGGC 351
Query: 62 GEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121
GEVY+AELPG G++I+IKKIV PP DAA L EEDS LLNKKMRQ I+
Sbjct: 352 GEVYRAELPG--GKLIAIKKIVQPPKDAAELAEEDSKLLNKKMRQ-------------IR 396
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLY-----------ILNDVSQGRRELDWLARHR 170
SEI TVG IRHRNL PLLAHV+RP+CH L +L VS+G RELDWLARHR
Sbjct: 397 SEIQTVGNIRHRNLLPLLAHVSRPNCHYLVYEFMKNGSLQDMLTQVSEGTRELDWLARHR 456
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
+ALG+A GLEYLHM H PRIIHRDL P N+LLDDD+EARI+ FG A+A+PDA+TH+TTSN
Sbjct: 457 VALGVAAGLEYLHMSHSPRIIHRDLKPGNILLDDDMEARIADFGLAKAVPDANTHVTTSN 516
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289
V GTV YIAPEY Q L T+KCDIY FG LL LV+GKLPSD FFQHT EMS VKWM N+
Sbjct: 517 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLGVLVVGKLPSDDFFQHTAEMSLVKWMANI 576
Query: 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
S++P RAID KL+GNG EEQMLLVLKIACFCT++D RPNSKDVR MLSQI+H
Sbjct: 577 RTSDDPSRAIDRKLMGNGFEEQMLLVLKIACFCTVDDAKIRPNSKDVRTMLSQIKH 632
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 345 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 0.927 | 0.499 | 0.623 | 1.5e-106 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.643 | 0.198 | 0.360 | 9.3e-35 | |
| TAIR|locus:2203000 | 355 | AT1G78530 [Arabidopsis thalian | 0.657 | 0.639 | 0.345 | 1e-34 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.628 | 0.368 | 0.391 | 5e-34 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.678 | 0.395 | 0.352 | 9.9e-34 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.710 | 0.210 | 0.327 | 2.6e-33 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.628 | 0.197 | 0.371 | 8.9e-33 | |
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.640 | 0.365 | 0.373 | 1.4e-32 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.649 | 0.316 | 0.355 | 2.7e-32 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.707 | 0.204 | 0.322 | 1.4e-31 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1054 (376.1 bits), Expect = 1.5e-106, P = 1.5e-106
Identities = 215/345 (62%), Positives = 255/345 (73%)
Query: 13 KLFLAAVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQ 72
KL + A+R + PGP+IFSPLIKKA+DLAFLE + LASLE IG GGCGEV+KAELPG
Sbjct: 310 KLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGS 369
Query: 73 NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132
NG++I++KK++ PP DA L +EDS LNKKMRQI+SE INTVG IRH
Sbjct: 370 NGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSE-------------INTVGHIRH 416
Query: 133 RNLHPLLAHVTRPDCH-LLY----------ILNDVSQGRRELDWLARHRIALGLACGLEY 181
RNL PLLAHV+RP+CH L+Y IL DV G +EL W ARH+IALG+A GLEY
Sbjct: 417 RNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEY 476
Query: 182 LHMHHCPRIIHRXXXXXXXXXXXXIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPE 241
LHM H PRIIHR +EARIS FG A+A+PDA THITTS+V GTV YIAPE
Sbjct: 477 LHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPE 536
Query: 242 YLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAID 300
+ Q T+KCDIY FG +L LV+GKLPSD+FFQHT+EMS +KWMRN++ SENP AID
Sbjct: 537 FYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAID 596
Query: 301 SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
KL+ G +EQMLLVLKIAC+CTL+DP +RPNSKDVR MLSQI+H
Sbjct: 597 PKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 334 (122.6 bits), Expect = 9.3e-35, Sum P(2) = 9.3e-35
Identities = 88/244 (36%), Positives = 129/244 (52%)
Query: 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LNDVSQGRRE----LDWL 166
R+ +E+ T+G+I+HRNL PLL + + LL Y+ L DV R++ L+W
Sbjct: 846 REFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWE 905
Query: 167 ARHRIALGLACGLEYLHMHHC-PRIIHRXXXXXXXXXXXXIEARISGFGFARAIPDAHTH 225
AR +IA+G A GL +LH H+C P IIHR +EAR+S FG AR + TH
Sbjct: 906 ARRKIAVGAARGLAFLH-HNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTH 964
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK--FFQHTNEMSF 282
++ S + GT Y+ PEY Q T K D+Y +G +L L+ GK P+D F + N + +
Sbjct: 965 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLELLTGKPPTDSADFGEDNNLVGW 1024
Query: 283 VKWMRNVMASENPKRAIDSKLVGN--GCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340
VK + ++ D +L+ E ++L LKIAC C + P+ RP V M
Sbjct: 1025 VKQHTKLKITD----VFDPELLKEDPSVELELLEHLKIACACLDDRPSRRPTMLKVMAMF 1080
Query: 341 SQIQ 344
+IQ
Sbjct: 1081 KEIQ 1084
|
|
| TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 336 (123.3 bits), Expect = 1.0e-34, Sum P(2) = 1.0e-34
Identities = 84/243 (34%), Positives = 129/243 (53%)
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDWL 166
+++ R E+ + I+HRN+ L + T P +LL L+ GR+ LDW
Sbjct: 110 SERDRGFHRELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLHGRKALDWA 169
Query: 167 ARHRIALGLACGLEYLHMHHC-PRIIHRXXXXXXXXXXXXIEARISGFGFARAIPDAHTH 225
+R+RIA+G A G+ YLH H C P IIHR +EAR+S FG A + TH
Sbjct: 170 SRYRIAVGAARGISYLH-HDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTH 228
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD-KFFQHTNEMSFV 283
++T V GT Y+APEY T K D+Y FG +L L+ G+ P+D +FF+ ++ V
Sbjct: 229 VSTF-VAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKL--V 285
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEE--QMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
W++ V+ + + ID++L G+ +E +M V IA C +P RP +V ++L
Sbjct: 286 TWVKGVVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLE 345
Query: 342 QIQ 344
I+
Sbjct: 346 YIK 348
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 334 (122.6 bits), Expect = 5.0e-34, Sum P(2) = 5.0e-34
Identities = 92/235 (39%), Positives = 123/235 (52%)
Query: 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LNDVSQGRRE-LDWLARH 169
R + E+ +G I+HR L L + P LL Y+ L++ R E LDW +R
Sbjct: 343 RFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRV 402
Query: 170 RIALGLACGLEYLHMHHC-PRIIHRXXXXXXXXXXXXIEARISGFGFARAIPDAHTHITT 228
I +G A GL YLH H C PRIIHR +EAR+S FG A+ + D +HITT
Sbjct: 403 NIIIGAAKGLAYLH-HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 461
Query: 229 SNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMR 287
V GT Y+APEY+Q TEK D+Y FG L+ ++ GKLP+D F + V W+
Sbjct: 462 I-VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKG-FNIVGWL- 518
Query: 288 NVMASEN-PKRAIDSKLVGNGCEEQML-LVLKIACFCTLEDPNERPNSKDVRRML 340
N + SEN K +D L G E + L +L IA C P+ERP V ++L
Sbjct: 519 NFLISENRAKEIVD--LSCEGVERESLDALLSIATKCVSSSPDERPTMHRVVQLL 571
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 325 (119.5 bits), Expect = 9.9e-34, Sum P(2) = 9.9e-34
Identities = 88/250 (35%), Positives = 128/250 (51%)
Query: 103 KMRQIQSEMLLNKKM-RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LN 154
K+ ++ + LN+ R + E+ +G I+HR L L + P LL Y+ L+
Sbjct: 329 KVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLD 388
Query: 155 DVSQGRR--ELDWLARHRIALGLACGLEYLHMHHC-PRIIHRXXXXXXXXXXXXIEARIS 211
+ R +LDW +R I +G A GL YLH H C PRIIHR +EAR+S
Sbjct: 389 EALHVERGEQLDWDSRVNIIIGAAKGLSYLH-HDCSPRIIHRDIKSSNILLDGNLEARVS 447
Query: 212 GFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270
FG A+ + D +HITT V GT Y+APEY+Q TEK D+Y FG L+ ++ GK P+
Sbjct: 448 DFGLAKLLEDEESHITTI-VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPT 506
Query: 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER 330
D F ++ V W++ +++ + P+ +D G E L L IA C P ER
Sbjct: 507 DASFIEKG-LNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDAL-LSIATQCVSPSPEER 564
Query: 331 PNSKDVRRML 340
P V ++L
Sbjct: 565 PTMHRVVQLL 574
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 313 (115.2 bits), Expect = 2.6e-33, Sum P(2) = 2.6e-33
Identities = 88/269 (32%), Positives = 135/269 (50%)
Query: 91 ALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL 150
A + + S++ KK+ Q+ + R+ +E+ T+G+I+HRNL PLL + + LL
Sbjct: 875 AKLADGSVVAIKKLIQVTGQ-----GDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLL 929
Query: 151 -Y----------ILND-VSQGRRELDWLARHRIALGLACGLEYLHMHHC-PRIIHRXXXX 197
Y +L++ +G LDW AR +IA+G A GL +LH H C P IIHR
Sbjct: 930 VYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLH-HSCIPHIIHRDMKS 988
Query: 198 XXXXXXXXIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256
AR+S FG AR + TH++ S + GT Y+ PEY Q T K D+Y +
Sbjct: 989 SNVLLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSY 1048
Query: 257 GALLAGLVMGKLPSD-KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEE-QMLL 314
G +L L+ GK P D + F N + V W + + + +D +LV + + ++L
Sbjct: 1049 GVILLELLSGKKPIDPEEFGEDNNL--VGWAKQLYREKRGAEILDPELVTDKSGDVELLH 1106
Query: 315 VLKIACFCTLEDPNERPNSKDVRRMLSQI 343
LKIA C + P +RP V M ++
Sbjct: 1107 YLKIASQCLDDRPFKRPTMIQVMTMFKEL 1135
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 323 (118.8 bits), Expect = 8.9e-33, Sum P(2) = 8.9e-33
Identities = 88/237 (37%), Positives = 128/237 (54%)
Query: 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LND-VSQGRRE--LDWLARHR 170
++EI+T+G+IRHRN+ L + +LL Y+ L + + +G + LDW AR+R
Sbjct: 843 RAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYR 902
Query: 171 IALGLACGLEYLHMHHC-PRIIHRXXXXXXXXXXXXIEARISGFGFARAIPDAHTHITTS 229
IALG A GL YLH H C P+I+HR +A + FG A+ I +++ + S
Sbjct: 903 IALGAAEGLCYLH-HDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK-SMS 960
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRN 288
V G+ YIAPEY + +TEKCDIY FG +L L+ GK P Q + V W+R
Sbjct: 961 AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD---LVNWVRR 1017
Query: 289 VMASENPK-RAIDSKLVGNGCE--EQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342
+ + P D++L N +M LVLKIA FCT P RP ++V M+++
Sbjct: 1018 SIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
|
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 336 (123.3 bits), Expect = 1.4e-32, Sum P(2) = 1.4e-32
Identities = 89/238 (37%), Positives = 122/238 (51%)
Query: 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LNDVSQGRRE----LDWL 166
R + E+ +G ++H NL L + P LL Y+ L+D+ R + L+W
Sbjct: 351 RVFEREVEILGSVKHINLVNLRGYCRLPSSRLLIYDYLTLGSLDDLLHERAQEDGLLNWN 410
Query: 167 ARHRIALGLACGLEYLHMHHC-PRIIHRXXXXXXXXXXXXIEARISGFGFARAIPDAHTH 225
AR +IALG A GL YLH H C P+I+HR +E R+S FG A+ + D H
Sbjct: 411 ARLKIALGSARGLAYLH-HDCSPKIVHRDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAH 469
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
+TT V GT Y+APEYLQ TEK D+Y FG LL LV GK P+D F ++ V
Sbjct: 470 VTTV-VAGTFGYLAPEYLQNGRATEKSDVYSFGVLLLELVTGKRPTDPIFVKRG-LNVVG 527
Query: 285 WMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342
WM V+ + ID + EE + +L+IA CT +P RP V ++L Q
Sbjct: 528 WMNTVLKENRLEDVIDKRCTDVD-EESVEALLEIAERCTDANPENRPAMNQVAQLLEQ 584
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 323 (118.8 bits), Expect = 2.7e-32, Sum P(2) = 2.7e-32
Identities = 85/239 (35%), Positives = 121/239 (50%)
Query: 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILN-DVS---QGRRE-LDWLARH 169
R+ ++E+ T+ +I HR+L ++ H D LL Y+ N D+ G + LDW R
Sbjct: 416 REFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEKSVLDWATRV 475
Query: 170 RIALGLACGLEYLHMHHCPRIIHRXXXXXXXXXXXXIEARISGFGFARAIPDAHTHITTS 229
+IA G A GL YLH PRIIHR +AR+S FG AR D +THITT
Sbjct: 476 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITT- 534
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRN 288
V+GT Y+APEY LTEK D++ FG +L L+ G+ P D Q + S V+W R
Sbjct: 535 RVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTS-QPLGDESLVEWARP 593
Query: 289 VMA----SENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
+++ +E D KL GN E +M +++ A C +RP + R +
Sbjct: 594 LISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESL 652
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 308 (113.5 bits), Expect = 1.4e-31, Sum P(2) = 1.4e-31
Identities = 87/270 (32%), Positives = 135/270 (50%)
Query: 91 ALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL 150
A++++ S + KK+ + + R+ +E+ T+G+I+HRNL PLL + D LL
Sbjct: 900 AILKDGSAVAIKKLIHVSGQ-----GDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLL 954
Query: 151 -Y----------ILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHC-PRIIHRXXXXX 198
Y +L+D + +L+W R +IA+G A GL +LH H+C P IIHR
Sbjct: 955 VYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLH-HNCSPHIIHRDMKSS 1013
Query: 199 XXXXXXXIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FG 257
+EAR+S FG AR + TH++ S + GT Y+ PEY Q + K D+Y +G
Sbjct: 1014 NVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYG 1073
Query: 258 ALLAGLVMGKLPSDK-FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGN--GCEEQMLL 314
+L L+ GK P+D F N + +VK + S+ D +L+ E ++L
Sbjct: 1074 VVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLRISD----VFDPELMKEDPALEIELLQ 1129
Query: 315 VLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344
LK+A C + RP V M +IQ
Sbjct: 1130 HLKVAVACLDDRAWRRPTMVQVMAMFKEIQ 1159
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00150657 | hypothetical protein (630 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 345 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-27 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-25 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-24 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-19 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-19 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.001 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.001 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.001 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.002 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.002 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.002 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.003 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 77/298 (25%), Positives = 117/298 (39%), Gaps = 61/298 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEK+G G G+VY A R K+V A+ K +++ +
Sbjct: 4 LEKLGEGSFGKVYLA-------RDKKTGKLV-------AI---------KVIKKKK---- 36
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRREL 163
+ K +I EI + +++H N+ L D LY+ L D+ + R L
Sbjct: 37 IKKDRERILREIKILKKLKHPNIVRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRL 94
Query: 164 D-WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
AR + LEYLH I+HRDL P N+LLD+D +++ FG AR +
Sbjct: 95 SEDEARF-YLRQILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQL--- 147
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
+ VGT EY+APE L + DI+ G +L L+ GK P F +
Sbjct: 148 DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP---FPGDDQLLE 204
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339
K + P S E L+ K DP +R +++ +
Sbjct: 205 LFKKIGKPKPPFPPPEWDIS-------PEAKDLIRK--LLVK--DPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 43/216 (19%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G GG G VY A + G+ ++IK I + +
Sbjct: 1 LGEGGFGTVYLARD-KKTGKKVAIKII--------------------------KKEDSSS 33
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LND-VSQGRRELDWLA 167
+ ++ EI + ++ H N+ L + L + L D + + +L
Sbjct: 34 LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDE 93
Query: 168 RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTHI 226
RI L + GLEYLH + IIHRDL P N+LLD D+ + +++ FG ++ + +
Sbjct: 94 ILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-- 148
Query: 227 TTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALL 260
+VGT Y+APE L +EK DI+ G +L
Sbjct: 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-24
Identities = 83/295 (28%), Positives = 137/295 (46%), Gaps = 55/295 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L K+GSG G VYKA+ G G+++++K + K R +S+
Sbjct: 4 LRKLGSGSFGTVYKAKHKG-TGKIVAVKIL--------------------KKRSEKSKKD 42
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-- 170
+ + EI + ++ H N+ L+ D LY++ + +G D+L+R
Sbjct: 43 -----QTARREIRILRRLSHPNIVRLIDAFEDKD--HLYLVMEYCEGGDLFDYLSRGGPL 95
Query: 171 -------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
IAL + GLEYLH + IIHRDL P N+LLD++ +I+ FG A+ + +
Sbjct: 96 SEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS 152
Query: 224 THITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
+ +TT VGT Y+APE L K D++ G +L L+ GK P F N +
Sbjct: 153 SSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILD 206
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336
++ +R ++ D +G EE L+ K DP++RP ++++
Sbjct: 207 QLQLIRRILGPPLE---FDEPKWSSGSEEAKDLIKKCLNK----DPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 64/298 (21%), Positives = 110/298 (36%), Gaps = 72/298 (24%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E +G G G VY A G ++++K ++
Sbjct: 6 ELLGRGSFGSVYLALDKD-TGELMAVK-------------------------SVELSGDS 39
Query: 114 NKKMRQIQSEINTVGQIRHRNL-HPLLAHVTRPDCHLLYILNDVSQG------------- 159
+++ ++ EI + ++H N+ + L L VS G
Sbjct: 40 EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP 99
Query: 160 ----RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
R+ R + GL YLH + I+HRD+ N+L+D D +++ FG
Sbjct: 100 EPVIRK----YTRQ-----ILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGC 147
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274
A+ + D T T +V GT ++APE ++ DI+ G + + GK P +
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP---WS 204
Query: 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332
+ N M+ + + + E P I L E+ L+ C DP +RP
Sbjct: 205 ELGNPMAAL--YKIGSSGEPP--EIPEHLS-----EEAKDFLR-KCLRR--DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 90.6 bits (223), Expect = 3e-20
Identities = 64/292 (21%), Positives = 109/292 (37%), Gaps = 34/292 (11%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L K+G G GEVY A +++++K + + +K++ + E+
Sbjct: 5 LRKLGEGSFGEVYLARDR----KLVALKVL-----------AKKLESKSKEVERFLREIQ 49
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIA 172
+ + + + + L+ D L L + L I
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYV--DGGSLEDLLKKIGRKGPLSESEALFIL 107
Query: 173 LGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTH----IT 227
+ LEYLH IIHRD+ P N+LLD D ++ FG A+ +PD +
Sbjct: 108 AQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164
Query: 228 TSNVVGTVEYIAPEYLQMLTL---TEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
S VGT Y+APE L L+L + DI+ G L L+ G P + + +
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335
K + + + + + + L+ K +DP R +S
Sbjct: 225 KIILE-LPTPSLASPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 21/261 (8%)
Query: 92 LIEEDSMLLNKKMRQIQSEM-LLNKKMRQIQS----EINTVGQIRHRNLHPLLAHVTRPD 146
+I + K + I++ M + K++ + S EI +G+++H N+ L+
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEK 756
Query: 147 CHLL---YIL-NDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202
L YI ++S+ R L W R +IA+G+A L +LH P ++ +L+P +++
Sbjct: 757 GAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816
Query: 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLA 261
D E + + +S Y+APE + +TEK DIY FG +L
Sbjct: 817 DGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILI 869
Query: 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGC--EEQMLLVLKIA 319
L+ GK P+D F + S V+W R + + ID + G+ + +++ V+ +A
Sbjct: 870 ELLTGKSPADAEFG-VHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA 927
Query: 320 CFCTLEDPNERPNSKDVRRML 340
CT DP RP + DV + L
Sbjct: 928 LHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 6e-19
Identities = 64/307 (20%), Positives = 114/307 (37%), Gaps = 66/307 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+K+G G GEVYK +L K G + A K ++ E
Sbjct: 1 KKLGEGAFGEVYKGKL----------KGKDGKTTEVAV----------KTLK----EDAS 36
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL------------------ND 155
++ + E + ++ H N+ LL T + LY++
Sbjct: 37 EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE--PLYLVLEYMEGGDLLDYLRKSRPVF 94
Query: 156 VSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
S + L A+ +A G+EYL +HRDL N L+ +D+ +IS FG
Sbjct: 95 PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKF---VHRDLAARNCLVGEDLVVKISDFGL 151
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSDKF 273
+R + D + + + ++APE L+ T K D++ FG LL + +G P
Sbjct: 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-- 209
Query: 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333
+S + + + + C +++ ++ C DP +RP
Sbjct: 210 -----GLSNEEVLEYLRKGYRLPKPE-------YCPDEL---YELMLSCWQLDPEDRPTF 254
Query: 334 KDVRRML 340
++ L
Sbjct: 255 SELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 8e-19
Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 43/221 (19%)
Query: 53 LEKIGSGGCGEVYKAEL---PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+K+G G GEVYK L +++K + + Q
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ------------------QI 45
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDV--SQGR 160
E L E + ++ H N+ LL T + ++ + L D
Sbjct: 46 EEFL--------REARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP 97
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
+EL AL +A G+EYL + IHRDL N L+ +++ +IS FG +R +
Sbjct: 98 KELSLSDLLSFALQIARGMEYLESKNF---IHRDLAARNCLVGENLVVKISDFGLSRDLY 154
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
D + + ++APE L+ T K D++ FG LL
Sbjct: 155 D-DDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-19
Identities = 66/234 (28%), Positives = 98/234 (41%), Gaps = 59/234 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEKIG GG GEVYKA + G+ ++IK + L K
Sbjct: 5 LEKIGKGGFGEVYKA-RHKRTGKEVAIKV----------------IKLESK--------- 38
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI---------LNDVSQG 159
+K +I +EI + + +H N+ V +L L+I L D+ +
Sbjct: 39 --EKKEKIINEIQILKKCKHPNI------VKYYGSYLKKDELWIVMEFCSGGSLKDLLKS 90
Query: 160 R-RELD--WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+ L +A + L GLEYLH + IIHRD+ N+LL D E ++ FG +
Sbjct: 91 TNQTLTESQIAY--VCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLS 145
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ D + +VGT ++APE + K DI+ G L GK P
Sbjct: 146 AQLSDT---KARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 1e-18
Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 53 LEKIGSGGCGEVYKAEL---PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+K+G G GEVYK L +++K L + +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVK-----------------TLKEGASEEERE 46
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI-----LNDVSQGRR 161
E L E + + ++ H N+ LL T+ + + Y+ L+ + +
Sbjct: 47 EFL---------EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE 97
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+L ++AL +A G+EYL + +HRDL N L+ +++ +IS FG +R I +
Sbjct: 98 KLTLKDLLQMALQIAKGMEYLESKNF---VHRDLAARNCLVTENLVVKISDFGLSRDIYE 154
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ ++++APE L+ T K D++ FG LL
Sbjct: 155 DDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 1e-18
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 42/220 (19%)
Query: 53 LEKIGSGGCGEVYKAEL---PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+K+G G GEVYK +L G+ +++K L Q
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK-----------------TLKEDASEQQIE 46
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRE 162
E L E + ++ H N+ LL T + + + L + R
Sbjct: 47 EFL---------REARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP 97
Query: 163 -LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
L AL +A G+EYL + IHRDL N L+ +++ +IS FG +R + D
Sbjct: 98 KLSLSDLLSFALQIARGMEYLESKNF---IHRDLAARNCLVGENLVVKISDFGLSRDLYD 154
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + + ++APE L+ T K D++ FG LL
Sbjct: 155 DDYYRKRGGKL-PIRWMAPESLKEGKFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 2e-18
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 9/109 (8%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ LEYLH II+RDL P N+LLD D +++ FG A+ + + T GT
Sbjct: 102 IVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
EY+APE L + D + G LL ++ GK P F+ + +
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP---FYAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
GL+YLH IIHRD+ P N+L++ E +I+ FG ++ + + T + VGTV Y
Sbjct: 111 GLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFVGTVTY 166
Query: 238 IAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPK 296
++PE +Q + + DI+ G L +GK P F + SF + M+ + P
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFP----FLPPGQPSFFELMQAICDGPPP- 221
Query: 297 RAIDSKLVGNGCEEQMLLVLK--IACFCTLEDPNERP 331
L + + I+ C +DP +RP
Sbjct: 222 -----SLPAEEFSPEF----RDFISA-CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 83/312 (26%), Positives = 126/312 (40%), Gaps = 63/312 (20%)
Query: 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKI-VGPPMDAAALIEEDSMLLNKKMRQI 107
A LE +GSG G VYK ++++K+I V P E D K + I
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERD-----KSIGDI 55
Query: 108 QSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA 167
SE+ + K+ Q+RH N+ + + T + LYI+ D+ +G L
Sbjct: 56 VSEVTIIKE------------QLRHPNI--VRYYKTFLENDRLYIVMDLIEGAP----LG 97
Query: 168 RH-----------------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210
H I + + L YLH RI+HRDL P N++L +D + I
Sbjct: 98 EHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTI 155
Query: 211 SGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ FG A+ ++VVGT+ Y PE ++ EK D++ FG +L + + P
Sbjct: 156 TDFGLAK---QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329
F TN +S + V A P L E + V+ C D
Sbjct: 213 ----FYSTNMLSLA--TKIVEAVYEP-------LPEGMYSEDVTDVIT---SCLTPDAEA 256
Query: 330 RPNSKDVRRMLS 341
RP+ V M+S
Sbjct: 257 RPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 57/230 (24%), Positives = 88/230 (38%), Gaps = 51/230 (22%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ IG G G VYK L + G ++IK+I L K ++S
Sbjct: 6 DLIGRGAFGVVYKG-LNLETGDFVAIKQIS---------------LEKIKEEALKS---- 45
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR----- 168
I EI+ + ++H N+ + + D L IL G L +
Sbjct: 46 ------IMQEIDLLKNLKHPNIVKYIGSIETSD-SLYIILEYAENGS-----LRQIIKKF 93
Query: 169 HRIALGLAC--------GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L GL YLH +IHRD+ N+L D +++ FG A +
Sbjct: 94 GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN 150
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
D + VVGT ++APE ++M + DI+ G + L+ G P
Sbjct: 151 DVSKDDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 48/242 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LE IG G G V K R S KI+ ++I +
Sbjct: 5 LETIGKGSFGTVRKV-------RRKSDGKILV-------------------WKEIDYGNM 38
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL----------NDVSQGRRE 162
K+ +Q+ SE+N + +++H N+ + LYI+ + + ++E
Sbjct: 39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE 98
Query: 163 LDWLARH---RIALGLACGLEYLH--MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
++ RI L L H ++HRDL P N+ LD + ++ FG A+
Sbjct: 99 RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
+ H VGT Y++PE L ++ EK DI+ G L+ L P F
Sbjct: 159 ILG--HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTA 212
Query: 277 TN 278
N
Sbjct: 213 RN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 71/288 (24%), Positives = 114/288 (39%), Gaps = 52/288 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDA---AALIEEDSML--LNKKMRQI 107
L KIG G G V+K + + R+ ++K+I M+ I+E +L L+
Sbjct: 5 LNKIGKGSFGVVFKV-VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 108 QSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA 167
E L+K I E G +LH LL Q R L
Sbjct: 64 YYESFLDKGKLNIVMEYAENG-----DLHKLLK----------------MQRGRPLPEDQ 102
Query: 168 RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT 227
R + + GL +LH +I+HRD+ +N+ LD +I G A+ + D
Sbjct: 103 VWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159
Query: 228 TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV-KW 285
T +VGT Y++PE + EK D++ G +L GK P F N+ + + K
Sbjct: 160 T--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP----FDANNQGALILKI 213
Query: 286 MRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333
+R V V +Q+ ++ C +D +RP++
Sbjct: 214 IRGVF-----------PPVSQMYSQQLAQLIDQ---CLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 73/318 (22%), Positives = 118/318 (37%), Gaps = 91/318 (28%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ IG G V A+ + +IK +L+K RQ+ E
Sbjct: 7 KIIGEGSFSTVVLAKEKE-TNKEYAIK------------------ILDK--RQLIKE--- 42
Query: 114 NKKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-- 170
KK++ ++ E + ++ H + L + L ++L G EL R
Sbjct: 43 -KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN-LYFVLEYAPNG--ELLQYIRKYGS 98
Query: 171 --------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD- 221
A + LEYLH IIHRDL P N+LLD D+ +I+ FG A+ +
Sbjct: 99 LDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155
Query: 222 -----------------AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263
++ VGT EY++PE L + D++ G ++ +
Sbjct: 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215
Query: 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASE------NPKRAIDSKLVGNGCEEQMLLVLK 317
+ GK P F+ +NE + ++ E P A D L+ + LLVL
Sbjct: 216 LTGKPP----FRGSNEY---LTFQKILKLEYSFPPNFPPDAKD--LI------EKLLVL- 259
Query: 318 IACFCTLEDPNERPNSKD 335
DP +R +
Sbjct: 260 --------DPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 52/240 (21%)
Query: 53 LEKIGSGGCGEVYKAE-LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
+E IG G VY A LP N ++IK+I + + Q+ +
Sbjct: 6 IEVIGVGATAVVYAAICLP--NNEKVAIKRI--------------------DLEKCQTSV 43
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRI 171
++R+ E+ + Q H N+ + + + L+++ G LD + +
Sbjct: 44 ---DELRK---EVQAMSQCNHPNV--VKYYTSFVVGDELWLVMPYLSGGSLLD-IMKSSY 94
Query: 172 ALG------LAC-------GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
G +A GLEYLH + IHRD+ N+LL +D +I+ FG + +
Sbjct: 95 PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSAS 151
Query: 219 IPDA--HTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFF 274
+ D T VGT ++APE ++ + K DI+ FG L G P K+
Sbjct: 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 33/208 (15%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E IG G G V + E GQ + +IK V A A +EE ++ M ++ + L
Sbjct: 12 EIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAV-----MTKLHHKNL- 61
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIAL 173
+ +G I H L+ ++ +++ + L+ L ++GR + + + +L
Sbjct: 62 ----------VRLLGVILHNGLYIVMELMSKGN--LVNFLR--TRGRALVSVIQLLQFSL 107
Query: 174 GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVG 233
+A G+EYL +++HRDL N+L+ +D A++S FG AR N
Sbjct: 108 DVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKL 159
Query: 234 TVEYIAPEYLQMLTLTEKCDIY-FGALL 260
V++ APE L+ + K D++ +G LL
Sbjct: 160 PVKWTAPEALKHKKFSSKSDVWSYGVLL 187
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 73/323 (22%), Positives = 129/323 (39%), Gaps = 84/323 (26%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +IG G G+VYKA + G ++++KKI M+ E++ I +
Sbjct: 4 IAQIGEGTYGQVYKAR-NKKTGELVALKKI---RMEN----EKEGF-------PITA--- 45
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT---RPDCHLL--YILNDVSQGRRELDWLA 167
+R EI + ++RH N+ L VT + +++ Y+ +D L L
Sbjct: 46 ----IR----EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHD-------LTGLL 90
Query: 168 RHR-----------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
L GL+YLH + I+HRD+ N+L+++D +++ FG A
Sbjct: 91 DSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA 147
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFF 274
R ++ T+ V+ T+ Y PE L T + D++ G +LA L +GK F
Sbjct: 148 RPYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK----PIF 202
Query: 275 QHTNEM---------------------SFVKWMRNVMASENPKRAIDSKLVGNGCEEQML 313
Q + E+ S + W N+ + KR + +
Sbjct: 203 QGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALD 262
Query: 314 LVLKIACFCTLEDPNERPNSKDV 336
L+ K+ DP +R ++
Sbjct: 263 LLDKLLTL----DPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L KIG G G VYKA G +++IKKI L E + +R+I+ +L
Sbjct: 4 LGKIGEGTYGVVYKAR-DKLTGEIVAIKKI--------KLRFESEGIPKTALREIK--LL 52
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRP-DCHLLYILND-----VSQGRRELDWL 166
++ H N+ LL D +L++ D + + R+ L
Sbjct: 53 K---------------ELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--L 95
Query: 167 ARHRIA---LGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI---P 220
I L GL + H H I+HRDL P N+L++ + +++ FG AR+
Sbjct: 96 PESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152
Query: 221 DAHTHITTSNVVGTVEYIAPEYL-QMLTLTEKCDIY-FGALLAGLVMGK 267
+TH V T Y APE L + DI+ G + A L+ +
Sbjct: 153 RPYTH-----YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 48/233 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
KIG G G+VY A + G ++++K+I D +
Sbjct: 5 GNKIGGGTFGKVYTA-VNLDTGELMAVKEIRIQDNDPKTI-------------------- 43
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLA-HVTRPDCHLLYI---------LNDVSQGRRE 162
++I E+ + ++H NL V R +YI L ++ + R
Sbjct: 44 -----KEIADEMKVLELLKHPNLVKYYGVEVHREK---VYIFMEYCSGGTLEELLEHGRI 95
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
LD L L GL YLH H I+HRD+ P N+ LD + ++ FG A + +
Sbjct: 96 LDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152
Query: 223 HTHITTS--NVVGTVEYIAPEYLQMLTLTEK---CDIY-FGALLAGLVMGKLP 269
T + ++ GT Y+APE + DI+ G ++ + GK P
Sbjct: 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 68/304 (22%), Positives = 122/304 (40%), Gaps = 66/304 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
K+GSG GEV++ +N ++IK +++ D +L
Sbjct: 11 ERKLGSGYFGEVWEGLW--KNRVRVAIK-----------ILKSDDLL------------- 44
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPD-----------CHLLYILNDVSQGRR 161
K + Q E+ + ++RH++L L A + + LL L +G+
Sbjct: 45 ---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ- 99
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
L + +A +A G+ YL + IHRDL N+L+ +D+ +++ FG AR I +
Sbjct: 100 VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNE 279
+S+ ++ APE T + K D++ FG LL + G++P N
Sbjct: 157 --DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM---NNH 211
Query: 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339
+ + K C Q + + + C+ +P +RP+ K +R
Sbjct: 212 EVYDQITAGYRMPCPAK-----------C-PQEIYKIMLECWAA--EPEDRPSFKALREE 257
Query: 340 LSQI 343
L I
Sbjct: 258 LDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 40/215 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV------GPPMDAAALIEEDSMLLNKKMRQ 106
L +IG G G VYKA GR +++KK+ G P+ + + E ++L +Q
Sbjct: 4 LAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLSEEGIPL---STLREIALL-----KQ 54
Query: 107 IQSEMLLN-KKMRQIQSEINTVGQIRHRNLHPLLA--HVTRPDCHL-LYILNDVSQG--R 160
++S N ++ + G R L L HV D L Y+ G
Sbjct: 55 LESFEHPNIVRLLDV-----CHGPRTDRELKLTLVFEHV---DQDLATYLSKCPKPGLPP 106
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
+ L R L G+++LH H RI+HRDL P N+L+ D + +I+ FG AR I
Sbjct: 107 ETIKDLMRQ-----LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR-IY 157
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
+T+ VV T+ Y APE L + D++
Sbjct: 158 SFEMALTS--VVVTLWYRAPEVLLQSSYATPVDMW 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 55/235 (23%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+LEKIG G GEVYKA G+ ++IKK+ L + I +
Sbjct: 21 YKNLEKIGEGASGEVYKAT-DRATGKEVAIKKMR---------------LRKQNKELIIN 64
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYILNDVSQGRRELDW 165
E+L+ K + H N+ V D +L L+++ + G D
Sbjct: 65 EILIMKDCK-------------HPNI------VDYYDSYLVGDELWVVMEYMDGGSLTDI 105
Query: 166 LARHRIAL-----GLAC-----GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
+ ++ + + C GLEYLH + IHRD+ N+LL D +++ FGF
Sbjct: 106 ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGF 162
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
A + + + VVGT ++APE ++ K DI+ G + + G+ P
Sbjct: 163 AAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 22/141 (15%)
Query: 116 KMRQIQ---SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-ARHRI 171
+++Q Q +E + ++ H + L T D LY+L + G +L R
Sbjct: 41 RLKQEQHVHNEKRVLKEVSHPFIIRLFW--TEHDQRFLYMLMEYVPGGELFSYLRNSGRF 98
Query: 172 ALGLA--------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ C LEYLH I++RDL P N+LLD + +++ FGFA+ + D
Sbjct: 99 SNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153
Query: 224 THITTSNVVGTVEYIAPEYLQ 244
T + GT EY+APE +Q
Sbjct: 154 ---RTWTLCGTPEYLAPEVIQ 171
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 40/99 (40%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A + CGLE LH RI++RDL P N+LLDD RIS G A +P+ T
Sbjct: 108 AAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGR 161
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
VGTV Y+APE ++ T D + G LL ++ G+ P
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 7e-12
Identities = 42/141 (29%), Positives = 63/141 (44%), Gaps = 22/141 (15%)
Query: 116 KMRQIQ---SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR-HRI 171
K++Q++ +E + IRH L L LY++ + G L + R
Sbjct: 41 KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRF 98
Query: 172 ALGLAC--------GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+A LEYLH I++RDL P N+LLD D +I+ FGFA+ +
Sbjct: 99 PEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-- 153
Query: 224 THITTSNVVGTVEYIAPEYLQ 244
T + GT EY+APE +
Sbjct: 154 ---RTYTLCGTPEYLAPEIIL 171
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 51/215 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAA--ALIEEDSMLLNKKMRQIQSE 110
LEK+G G G VYKA + + G++++IK + P++ +I+E S+ ++Q S
Sbjct: 8 LEKLGEGSYGSVYKA-IHKETGQVVAIKVV---PVEEDLQEIIKEISI-----LKQCDSP 58
Query: 111 MLLN-------KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL 163
++ I E G + ++ I N
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSV----------------SDIMKITNKT------- 95
Query: 164 DWLARHRIALGLAC---GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L IA L GLEYLH + + IHRD+ N+LL+++ +A+++ FG + +
Sbjct: 96 --LTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQL- 149
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
T + V+GT ++APE +Q + K DI+
Sbjct: 150 -TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 41/103 (39%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A L CGLE L RI++RDL P N+LLDD RIS G A IP+ T
Sbjct: 108 AAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGR 161
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273
VGTV Y+APE + T D + G L+ ++ G+ P K
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (157), Expect = 1e-11
Identities = 66/204 (32%), Positives = 94/204 (46%), Gaps = 50/204 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEK+G G G VYKA + G ++++KKI +D EE+ I S L
Sbjct: 4 LEKLGEGTYGVVYKARDK-KTGEIVALKKI---RLD----NEEEG---------IPSTAL 46
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLL--YILNDVSQGRRELDWLARH 169
EI+ + +++H N+ LL T +L+ Y D+ ++ LD
Sbjct: 47 ---------REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDL---KKYLDKRPGP 94
Query: 170 -------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IP 220
I L GL Y H H RI+HRDL P N+L++ D +++ FG ARA IP
Sbjct: 95 LSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151
Query: 221 -DAHTHITTSNVVGTVEYIAPEYL 243
+TH VV T+ Y APE L
Sbjct: 152 LRTYTH----EVV-TLWYRAPEIL 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 64/314 (20%), Positives = 113/314 (35%), Gaps = 90/314 (28%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+++IG G G+VY +G++ +K+I + M +
Sbjct: 5 IKQIGKGSFGKVYLVR-RKSDGKLYVLKEI---DL--------------SNMSE------ 40
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRRE- 162
K+ +E+ + ++ H N+ L I L+ + +++
Sbjct: 41 --KEREDALNEVKILKKLNHPNIIKYYESFEEKGK--LCIVMEYADGGDLSQKIKKQKKE 96
Query: 163 ---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
LDW + L L+YLH I+HRD+ P N+ L + ++ F
Sbjct: 97 GKPFPEEQILDWFVQ------LCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDF 147
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272
G ++ + + T VVGT Y++PE Q K DI+ G +L L K P
Sbjct: 148 GISKVL--SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--- 202
Query: 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSK-------LVGNGCEEQMLLVLKIACFCTLE 325
F+ N + ++ + P I S+ LV +L
Sbjct: 203 -FEGENLLEL---ALKILKGQYPP--IPSQYSSELRNLV-----SSLLQK---------- 241
Query: 326 DPNERPNSKDVRRM 339
DP ERP+ + +
Sbjct: 242 DPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 41/99 (41%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A + CGLE LH RI++RDL P N+LLDD RIS G A IP+ T
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGR 161
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
VGTV Y+APE ++ T D + G L+ ++ GK P
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 36/96 (37%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ CGLE+LH RI++RDL P NVLLDD RIS G A + GT
Sbjct: 104 IICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGT 157
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
Y+APE LQ D + G L ++ G+ P
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 57/221 (25%), Positives = 86/221 (38%), Gaps = 45/221 (20%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIK-KIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+K+G G G V + E G++I + K + K+ I + L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS----------------DKLSDIMDDFL 44
Query: 113 LNKKMRQIQSEINTVGQIRHRNL---------HPLLAHVTR--PDCHLLYILNDVSQGRR 161
E + + H NL HPL+ VT P LL L + G
Sbjct: 45 ---------KEAAIMHSLDHENLIRLYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHF 94
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+ L A+ +A G+ YL IHRDL N+LL D + +I FG RA+P
Sbjct: 95 LISTL--CDYAVQIANGMRYLESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQ 149
Query: 222 AHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
H + ++ + APE L+ T + D++ FG L
Sbjct: 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQ 106
KG L IGSG G VY + +G ++++K++ P + A++ + SML
Sbjct: 4 KGAL-----IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSML------- 50
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL--- 163
+ EI + +++H N+ L D HL L V G
Sbjct: 51 -----------DALAREIALLKELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLN 98
Query: 164 ------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ L R+ + L GL YLH IIHRD+ N+L+D+ +IS FG ++
Sbjct: 99 NYGAFEETLVRNFVRQILK-GLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154
Query: 218 AIPDAHTHITTSN-----VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ +A++ T +N + G+V ++APE ++ + T K DI+ G L+ ++ GK P
Sbjct: 155 KL-EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 60/229 (26%), Positives = 96/229 (41%), Gaps = 37/229 (16%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E IG G G VY A L G M+++K++ P A + + + +
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIA----GRHD----SRQKDMVKAL-- 55
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVS----------QGRREL 163
+SEI T+ + H N+ L T + ++ L V GR E
Sbjct: 56 -------RSEIETLKDLDHLNIVQYLGFETTEEYLSIF-LEYVPGGSIGSCLRTYGRFEE 107
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
L R L GL YLH I+HRDL N+L+D D +IS FG ++ D +
Sbjct: 108 Q-LVRFFTEQVLE-GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIY 162
Query: 224 THITTSNVVGTVEYIAPE--YLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ ++ G+V ++APE + + K DI+ G ++ + G+ P
Sbjct: 163 DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 32/68 (47%), Positives = 39/68 (57%), Gaps = 5/68 (7%)
Query: 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVE 236
GLE+LH RII+RDL P NVLLD+D RIS G A + D + T GT
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPG 162
Query: 237 YIAPEYLQ 244
++APE LQ
Sbjct: 163 FMAPELLQ 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 27/70 (38%), Positives = 35/70 (50%), Gaps = 6/70 (8%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ LEYLH IIHRD+ P N+LLD+ I+ F A + +TS GT
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GT 162
Query: 235 VEYIAPEYLQ 244
Y+APE L
Sbjct: 163 PGYMAPEVLC 172
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 32/159 (20%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A + CGLE LH + ++RDL P N+LLDD RIS G A IP+ +
Sbjct: 108 AAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGR 161
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP------------SDKFFQHTN 278
VGTV Y+APE L T D + G L+ ++ G+ P D+ T
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
Query: 279 EMSFVKWMR------NVMASENPKRAIDSKLVGNGCEEQ 311
E+ K+ ++ +++PK+ + GC+E+
Sbjct: 222 EVYSAKFSEEAKSICKMLLTKDPKQRL-------GCQEE 253
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 44/201 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L KIG G G V+K + G++++IKK V E+D ++ +R
Sbjct: 6 LSKIGEGSYGVVFKCR-NRETGQIVAIKKFVES--------EDDPVIKKIALR------- 49
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRP-DCHLLY------ILNDVSQGRRELDW 165
EI + Q++H NL L+ R HL++ +LN++ + R +
Sbjct: 50 ----------EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPE 99
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI---PDA 222
+I + + H H+C IHRD+ P N+L+ + ++ FGFAR + D
Sbjct: 100 HLIKKIIWQTLQAVNFCHKHNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 223 HTHITTSNVVGTVEYIAPEYL 243
+T + V T Y APE L
Sbjct: 157 YT-----DYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 50/198 (25%), Positives = 74/198 (37%), Gaps = 37/198 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +G G G V K G +++IKK E+D + +R
Sbjct: 6 LGVVGEGAYGVVLKCR-NKATGEIVAIKKFKE--------SEDDEDVKKTALR------- 49
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPD-CHLLY------ILNDVSQGRRELDW 165
E+ + Q+RH N+ L R +L++ +L + L
Sbjct: 50 ----------EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPP 99
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
A L + Y H H IIHRD+ P N+L+ + ++ FGFARA+
Sbjct: 100 DAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 226 ITTSNVVGTVEYIAPEYL 243
T V T Y APE L
Sbjct: 157 PLTDYVA-TRWYRAPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 47/203 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+EKIG G G VYKA G ++++KKI +D ++E +
Sbjct: 5 VEKIGEGTYGVVYKAR-NKLTGEVVALKKI---RLDT------------------ETEGV 42
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG-RRELDWLARHRI 171
+ +R EI+ + ++ H N+ LL V + L + + Q ++ +D I
Sbjct: 43 PSTAIR----EISLLKELNHPNIVKLL-DVIHTENKLYLVFEFLHQDLKKFMDASPLSGI 97
Query: 172 ALGLA--------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IP- 220
L L GL + H H R++HRDL P N+L++ + +++ FG ARA +P
Sbjct: 98 PLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154
Query: 221 DAHTHITTSNVVGTVEYIAPEYL 243
+TH VV T+ Y APE L
Sbjct: 155 RTYTH----EVV-TLWYRAPEIL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 61/232 (26%), Positives = 93/232 (40%), Gaps = 49/232 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LE++G G G+VYK EL G N R+ + + L E + ++ RQ
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAI------KTLKENAEPKVQQEFRQ------ 57
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR--PDCHLLYILN---------------- 154
E + ++H N+ LL T+ P C L L
Sbjct: 58 ----------EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSD 107
Query: 155 -----DVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR 209
+ LD IA+ +A G+EYL HH +HRDL N L+ + + +
Sbjct: 108 VGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVK 164
Query: 210 ISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
IS FG +R I A + S + V ++ PE + T + DI+ FG +L
Sbjct: 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 53/219 (24%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
IG G G+V + GQ +++K + A A + E S++
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK---VAVKCLKDDSTAAQAFLAEASVMT------------- 55
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-ARHRIA 172
+RH NL LL V + L + +++G +D+L +R R
Sbjct: 56 ---------------TLRHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSL-VDYLRSRGRAV 98
Query: 173 LGLAC----------GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ LA G+EYL +HRDL NVL+ +D+ A++S FG A+ +A
Sbjct: 99 ITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EA 152
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + V++ APE L+ + K D++ FG LL
Sbjct: 153 SQGQDSGKL--PVKWTAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 37/199 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKI-VGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
+K+G G VYKA + GR+++IKKI +G +A I ++ R+I
Sbjct: 5 GKKLGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGINFTAL------REI---- 53
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLL--YILNDVSQ--GRRELDWL 166
K ++++ +H N+ LL + + +L+ ++ D+ + + +
Sbjct: 54 ---KLLQEL----------KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLT 100
Query: 167 ARH--RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
L GLEYLH + I+HRDL P N+L+ D +++ FG AR+ +
Sbjct: 101 PADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157
Query: 225 HITTSNVVGTVEYIAPEYL 243
+T VV T Y APE L
Sbjct: 158 KMTH-QVV-TRWYRAPELL 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 47/226 (20%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G GG G V ++ +N R ++K + K R I
Sbjct: 1 LGVGGFGRVELVKVKSKN-RTFALKCV--------------------KKRHIVE----TG 35
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-----------D 164
+ I SE + + H + L + T D +Y+L + G EL +
Sbjct: 36 QQEHIFSEKEILEECNHPFIVKL--YRTFKDKKYIYMLMEYCLGG-ELWTILRDRGLFDE 92
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ AR IA + EYLH II+RDL P N+LLD + ++ FGFA+ +
Sbjct: 93 YTARFYIA-CVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
T GT EY+APE + D + G LL L+ G+ P
Sbjct: 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 20/180 (11%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
+IA+ + GL YL+ H RI+HRD+ P N+L++ + ++ FG + + ++
Sbjct: 107 KIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IAD 160
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP----SDKFFQHTNEMSFVK 284
VGT Y++PE +Q T K D++ G + L +GK P + + M +
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220
Query: 285 WMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344
++ ++ P +L + E + + C L+DP ERP + + M IQ
Sbjct: 221 LLQQIVQEPPP------RLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLCAMPPFIQ 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 38/99 (38%), Positives = 52/99 (52%), Gaps = 12/99 (12%)
Query: 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIA 239
EYLH II+RDL P N+LLD+ +++ FGFA+ +PD T + GT EY+A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLA 183
Query: 240 PEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277
PE +Q + D + G LL + G P FF T
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP---FFDDT 219
|
Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 45/227 (19%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
IGSG G V A + + GR ++IKKI + + +D + + +R+I LL
Sbjct: 8 IGSGAYGVVCSA-VDKRTGRKVAIKKI--------SNVFDDLIDAKRILREI---KLLR- 54
Query: 116 KMRQIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYI--------LNDVSQGRRELD 164
+RH N L +L + D + +YI L+ V + + L
Sbjct: 55 -------------HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT 101
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI--PDA 222
+ GL+YLH + +IHRDL P N+L++ + + +I FG AR + +
Sbjct: 102 DDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
Query: 223 HTHITTSNVVGTVEYIAPE-YLQMLTLTEKCDIY-FGALLAGLVMGK 267
T VV T Y APE L T+ DI+ G + A L+ K
Sbjct: 159 EKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 104 MRQIQSEMLLNKK-MRQIQSEINT-VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG-- 159
++ +Q + +L KK + I +E N + ++H L L D L ++L+ V+ G
Sbjct: 25 VKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-KLYFVLDYVNGGEL 83
Query: 160 ----RRELDWL-ARHRI-ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
+RE + R R A +A L YLH II+RDL P N+LLD ++ F
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDF 140
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272
G + TTS GT EY+APE L+ D + GA+L ++ G P
Sbjct: 141 GLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP--- 195
Query: 273 FF-QHTNEM 280
F+ + T EM
Sbjct: 196 FYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVE 236
CGL++LH II+RDL NVLLD D +I+ FG + + + S GT +
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPD 161
Query: 237 YIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
YIAPE L+ E D + FG LL +++G+ P
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/79 (41%), Positives = 44/79 (55%), Gaps = 9/79 (11%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI---PDAHTHITTSNV 231
L GL+Y+H +IHRDL P N+L+++D E RI FG AR + P H + T
Sbjct: 116 LLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY- 171
Query: 232 VGTVEYIAPEYLQMLTLTE 250
V T Y APE +L+L E
Sbjct: 172 VATRWYRAPEL--LLSLPE 188
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 45/205 (21%)
Query: 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMR 105
+KG E +GSG G VY+ L +G ++K E S+ + +
Sbjct: 3 RKG-----ELLGSGSFGSVYEG-LNLDDGDFFAVK--------------EVSLADDGQTG 42
Query: 106 QIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-LNDVSQGR---- 160
Q + ++Q++ EI + +++H N+ L D LYI L V G
Sbjct: 43 Q--------EAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN--LYIFLELVPGGSLAKL 92
Query: 161 -RELDWLARHRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
++ I L + GLEYLH + +HRD+ N+L+D + +++ FG A
Sbjct: 93 LKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMA 149
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPE 241
+ + + G+ ++APE
Sbjct: 150 KQV---VEFSFAKSFKGSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 42/231 (18%)
Query: 52 SLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
+L +G G G V K + + G++++IKK + E+D M+ KK+
Sbjct: 5 NLGLVGEGSYGMVMKCK-HKETGQIVAIKKFLES--------EDDKMV--KKI------- 46
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPD-CHLLY------ILNDVSQGRRELD 164
MR EI + Q+RH NL L+ R +L++ +L+D+ + LD
Sbjct: 47 ----AMR----EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD 98
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ + G+E+ H H+ IIHRD+ P N+L+ ++ FGFAR + A
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAP 153
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEK-CDIY-FGALLAGLVMGK--LPSD 271
++ V T Y APE L T + DI+ G L+ ++ G+ P D
Sbjct: 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 44/218 (20%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
EKIG G G+VYK L G + + PP ++E +L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILK------------- 47
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIAL 173
Q H N+ L+ +YI+ ++ G L +L + + L
Sbjct: 48 ---------------QYDHPNIVKLIGVCV--QKQPIYIVMELVPGGSLLTFLRKKKNRL 90
Query: 174 GL----------ACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ A G+EYL +C IHRDL N L+ ++ +IS FG +R
Sbjct: 91 TVKKLLQMSLDAAAGMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
++ +++ APE L T + D++ +G LL
Sbjct: 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ CGL++LH II+RDL NV+LD D +I+ FG + + S GT
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGT 159
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+YIAPE LQ L T D + FG LL +++G+ P
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 46/240 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+++GSG G V A L + G ++IKK+ R QSE+
Sbjct: 20 LKQVGSGAYGTVCSA-LDRRTGAKVAIKKL---------------------YRPFQSELF 57
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL-----LYIL-----NDVSQGRRE 162
+ R E+ + ++H N+ LL V PD L Y++ D+ + +
Sbjct: 58 AKRAYR----ELRLLKHMKHENVIGLL-DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK- 111
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ L+ RI + L+ L H IIHRDL P N+ +++D E +I FG AR
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----- 166
Query: 223 HTHITTSNVVGTVEYIAPEY-LQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
T + V T Y APE L + T+ DI+ G ++A ++ GK P K H +++
Sbjct: 167 QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQL 225
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 35/195 (17%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L + +IGSG G VYK + GR+ ++K I G ED++
Sbjct: 76 LERVNRIGSGAGGTVYKV-IHRPTGRLYALKVIYGN--------HEDTVR---------- 116
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNL---HPLLAHVTRPDCHLLYILNDVSQGRRELDWL 166
RQI EI + + H N+ H + H L ++ +G D
Sbjct: 117 --------RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ 168
Query: 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI 226
+A + G+ YLH H I+HRD+ P N+L++ +I+ FG +R + A T
Sbjct: 169 FLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMD 223
Query: 227 TTSNVVGTVEYIAPE 241
++ VGT+ Y++PE
Sbjct: 224 PCNSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 11/103 (10%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD--AHTHIT 227
+IA+ + GL YLH H +IIHRD+ P N+L++ + ++ FG + + + A T
Sbjct: 104 KIAVAVLKGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-- 159
Query: 228 TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
VGT Y+APE +Q + K DI+ G L L G+ P
Sbjct: 160 ----VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 55/216 (25%), Positives = 82/216 (37%), Gaps = 62/216 (28%)
Query: 55 KIGSGGCGEVYKAE-LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
IG G G VYKA+ G++G+ +IKK G + S R E+ L
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGI----SQ---SACR----EIAL 55
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPL----LAHVTRPDCHLLYILNDVSQGRRELDWLA-- 167
+ +++H N+ L L H + +Y+L D + E D
Sbjct: 56 LR-------------ELKHENVVSLVEVFLEHADK----SVYLLFDYA----EHDLWQII 94
Query: 168 -RHRIALG--------------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR--- 209
HR A + G+ YLH + ++HRDL P N+L+ + R
Sbjct: 95 KFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVV 151
Query: 210 -ISGFGFARAIPDAHTHITTSN-VVGTVEYIAPEYL 243
I G AR + + VV T+ Y APE L
Sbjct: 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 39/235 (16%)
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDV-----------SQGRRELDWLARHR 170
+E + + Q+RH NL LL V + LYI+ + S+GR L +
Sbjct: 48 AEASVMTQLRHSNLVQLLG-VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
+L + +EYL ++ +HRDL NVL+ +D A++S FG + +A + T
Sbjct: 107 FSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGK 160
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSDKFFQHTNEMSFVKWMRN 288
+ V++ APE L+ + K D++ FG LL + G++P + +++
Sbjct: 161 L--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----------LKD 207
Query: 289 VMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
V+ +D+ +GC + V+K C D RP+ +R L I
Sbjct: 208 VVPRVEKGYKMDAP---DGCPPVVYDVMKQ---CWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 46/229 (20%)
Query: 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
SL+++GSG G V A + + G ++IKK+ P QSE
Sbjct: 18 TSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKLSRP---------------------FQSE 55
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRP-------DCHLL--YILNDVSQGR- 160
+ + R E+ + ++H N+ LL T D +L+ Y+ D+ +
Sbjct: 56 IFAKRAYR----ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG 111
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L + + CGL+Y+H IIHRDL P N+ +++D E +I FG AR
Sbjct: 112 HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--- 165
Query: 221 DAHTHITTSNVVGTVEYIAPEY-LQMLTLTEKCDIY-FGALLAGLVMGK 267
H + V T Y APE L + + DI+ G ++A ++ GK
Sbjct: 166 --HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 39/99 (39%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
+ L L GL+YLH + IIHRDL N+LL D +I+ FG AR + T
Sbjct: 113 LMLQLLRGLQYLH-ENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPK 168
Query: 231 VVGTVEYIAPEYL-QMLTLTEKCDIY-FGALLAGLVMGK 267
VV T+ Y APE L T T D++ G +LA L+ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-09
Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 67/304 (22%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L ++K+G+G GEV+ ++IK + M A + E ++
Sbjct: 8 LKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSLKQGSMSPEAFLAEANL----------- 54
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH 169
M+Q+Q H L L A VT+ +YI+ + + +D+L
Sbjct: 55 -------MKQLQ----------HPRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTP 94
Query: 170 R-----------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+A +A G+ ++ + IHRDL N+L+ + + +I+ FG AR
Sbjct: 95 EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARL 151
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQH 276
I D + +++ APE + T T K D++ FG LL +V G++P
Sbjct: 152 IEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG---- 206
Query: 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336
M N +N +R N C E++ ++++ C E P ERP + +
Sbjct: 207 ---------MTNPEVIQNLERGYRMPRPDN-CPEELYELMRL---CWKEKPEERPTFEYL 253
Query: 337 RRML 340
R +L
Sbjct: 254 RSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 34/96 (35%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
LA L++LH II+RDL P N+LLD++ +++ FG ++ D + GT
Sbjct: 107 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGT 161
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
VEY+APE + T+ D + FG L+ ++ G LP
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 53/235 (22%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRM-ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
L K+G+G GEV+ NG +++K + M A ++E
Sbjct: 8 LKLERKLGAGQFGEVWMGTW---NGTTKVAVKTLKPGTMSPEAFLQE------------- 51
Query: 109 SEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR 168
+ ++RH L L A + + +YI+ + LD+L
Sbjct: 52 ---------------AQIMKKLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKS 94
Query: 169 HR-----------IALGLACGLEYLH-MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+A +A G+ YL ++ IHRDL N+L+ +++ +I+ FG A
Sbjct: 95 GEGKKLRLPQLVDMAAQIAEGMAYLESRNY----IHRDLAARNILVGENLVCKIADFGLA 150
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
R I D + +++ APE T K D++ FG LL +V G++P
Sbjct: 151 RLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 79/300 (26%), Positives = 124/300 (41%), Gaps = 75/300 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LE IG G GEVYKA + + ++++IK I D +EE
Sbjct: 6 LECIGKGSFGEVYKA-IDKRTNQVVAIKVI-----D----LEEAE--------------- 40
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR------PDCHLLYILNDVSQGRRELDWL 166
++ IQ EI + Q R ++T+ L +I+ + G LD L
Sbjct: 41 --DEIEDIQQEIQFLSQCRS-------PYITKYYGSFLKGSKL-WIIMEYCGGGSCLDLL 90
Query: 167 ARHR--------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+ I + GLEYLH IHRD+ N+LL ++ + +++ FG +
Sbjct: 91 KPGKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQ 147
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277
+ T + VGT ++APE ++ EK DI+ G L G+ P
Sbjct: 148 L--TSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP-------- 197
Query: 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLK--IACFCTLEDPNERPNSKD 335
+S + MR V+ PK S L GN + K ++ C +DP ERP++K+
Sbjct: 198 --LSDLHPMR-VL-FLIPKNNPPS-LEGNKFSKP----FKDFVSL-CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 163 LDWLARHRIALG--------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
D+L +H++ L + G+ YLH H IHRDL NVLLD+D +I FG
Sbjct: 96 RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFG 152
Query: 215 FARAIPDAHTHITTS-NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
A+A+P+ H + + V + A E L+ + D++ FG L
Sbjct: 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 56 IGSGGCGEVYKAELPGQN----GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
+G G G+V +AE G + + +++ A ++++++ +K + + SEM
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTV---------AVKMLKDNAT--DKDLADLISEM 68
Query: 112 LLNKKMRQIQSEINTVGQIRHR-------------NLHPLLAHVTRPDCHLLYILNDVSQ 158
L K + + ++ IN +G NL L P + + V +
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+L + A +A G+EYL C IHRDL NVL+ +D +I+ FG AR
Sbjct: 129 E--QLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ D + TSN V+++APE L T + D++ FG L+
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 70/255 (27%), Positives = 108/255 (42%), Gaps = 55/255 (21%)
Query: 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKI-----VGPPMDAAALIEEDSMLL 100
K LEK+G G VYK + NG+++++K I G P A I E S+L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVIRLQEEEGTPFTA---IREASLLK 58
Query: 101 NKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL------HPLLAHVTRPDCHLLYILN 154
K + ++L + + + V + H +L HP H P+ L++
Sbjct: 59 GLK----HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH---PENVKLFLFQ 111
Query: 155 DVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
L GL Y+H + I+HRDL P N+L+ D E +++ FG
Sbjct: 112 --------------------LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFG 148
Query: 215 FARA--IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKC-DIY-FGALLAGLVMG--KL 268
ARA +P +HT+ SN V T+ Y P+ L T C D++ G + ++ G
Sbjct: 149 LARAKSVP-SHTY---SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
Query: 269 PSDKFFQHTNEMSFV 283
P K Q E F+
Sbjct: 205 PGMKDIQDQLERIFL 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 22/217 (10%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G G+V AE G I K P A ++++D+ +K + + SEM + K
Sbjct: 20 LGEGCFGQVVMAEAIG-----IDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMK 72
Query: 116 KMRQIQSEINTVGQIRHRN-LHPLLAHVTRPDCH----------LLYILNDVSQGRRELD 164
+ + ++ IN +G L+ L+ + ++ + + Y + +L
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ A +A G+EYL C IHRDL NVL+ +D +I+ FG AR + +
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY 189
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ T+N V+++APE L T + D++ FG LL
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 72/313 (23%), Positives = 122/313 (38%), Gaps = 67/313 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+E++G G++YK L P MD A L+ K ++ I +
Sbjct: 10 MEELGECAFGKIYKGHL-------------YLPGMDHAQLVAI------KTLKDINNP-- 48
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR--PDCHLLYILN---------------D 155
++ + Q E + + ++ H N+ LL VT+ P C L LN D
Sbjct: 49 --QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSD 106
Query: 156 VSQGRRE-------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
V E LD IA+ +A G+EYL H +H+DL N+L+ + +
Sbjct: 107 VGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHV 163
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
+IS G +R I A + + + ++ PE + + DI+ FG +L +
Sbjct: 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFG 223
Query: 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327
L F + + V+ + + SE+ C +M ++ C E P
Sbjct: 224 LQPYYGFSNQEVIEMVRKRQLLPCSED-------------CPPRMYSLMT---ECWQEGP 267
Query: 328 NERPNSKDVRRML 340
+ RP KD+ L
Sbjct: 268 SRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 36/105 (34%), Positives = 51/105 (48%), Gaps = 18/105 (17%)
Query: 150 LYILNDVSQGRRELDW-----------LARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198
LY++ D G EL W A+ IA L LE+LH + I++RDL P
Sbjct: 71 LYLVTDYMSGG-ELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKYD---IVYRDLKPE 125
Query: 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL 243
N+LLD + FG ++ + + TT+ GT EY+APE L
Sbjct: 126 NILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 47/218 (21%)
Query: 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114
K+G G GEVY+ + + +++K + +ED+M + + ++
Sbjct: 13 KLGGGQYGEVYEG-VWKKYSLTVAVKTL-----------KEDTMEVEEFLK--------- 51
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTR-----------PDCHLLYILNDVSQGRREL 163
E + +I+H NL LL TR +LL L + R+E+
Sbjct: 52 --------EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEV 101
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ + +A ++ +EYL + IHRDL N L+ ++ +++ FG +R +
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-D 157
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
T+ + +++ APE L + K D++ FG LL
Sbjct: 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ CG+ LH+H I++RD+ P NVLLDD R+S G A + D T + GT
Sbjct: 104 ITCGI--LHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGT 157
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
Y+APE L+ + D + G + +V G+ P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 63/294 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ I G G VY A KK A ++++ M+ ++ +++E
Sbjct: 1 LKPISKGAFGSVYLA------------KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE-- 46
Query: 113 LNKKMRQIQSEINTVGQIRHR-----NLHPLLAHVTRPDCH-LLYILNDVSQGRRELDWL 166
+ + IQ E V ++ + L+ ++ ++ DC L+ L G DW
Sbjct: 47 --RAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-----GGLPEDW- 98
Query: 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI 226
A+ IA + G+E LH IIHRD+ P N+L+D +++ FG +R +
Sbjct: 99 AKQYIA-EVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------L 148
Query: 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP-----SDKFFQHTNEM 280
VGT +Y+APE + + + D + G ++ + G P D F +
Sbjct: 149 ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-LS 207
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334
+ W V +P+ A+D L+ ++ C DP +R +
Sbjct: 208 RRINWPEEVKEFCSPE-AVD-------------LINRLLCM----DPAKRLGAN 243
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++K+G+G GEV+ N +++K + M A +EE ++
Sbjct: 11 VKKLGAGQFGEVWMGYY--NNSTKVAVKTLKPGTMSVQAFLEEANL-------------- 54
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---ARH 169
M+ +Q H L L A VT+ + +YI+ + LD+L
Sbjct: 55 ----MKTLQ----------HDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGG 98
Query: 170 RIAL--------GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
++ L +A G+ Y+ + IHRDL NVL+ + + +I+ FG AR I D
Sbjct: 99 KVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
+ + +++ APE + + T K D++ FG LL +V GK+P
Sbjct: 156 -NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 57/238 (23%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML-LN 114
IG GG GEVY G+M ++K L K+++ Q E L LN
Sbjct: 2 IGRGGFGEVYGCR-KADTGKMYAMK-----------------CLDKKRIKMKQGETLALN 43
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVT----RPDCHLLYILNDVSQGRRELDW-LARH 169
++ I + + G P + +T PD L +IL+ ++ G +L + L++H
Sbjct: 44 ER---IMLSLVSTGDC------PFIVCMTYAFHTPD-KLCFILDLMNGG--DLHYHLSQH 91
Query: 170 RI---------ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
+ A + GLE++H +++RDL P N+LLD+ RIS G A
Sbjct: 92 GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIYF--GALLAGLVMGKLPSDKFFQH 276
H + VGT Y+APE LQ T + +F G +L L+ G P F QH
Sbjct: 149 KKKPHAS----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP---FRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 37/212 (17%)
Query: 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114
+IG G G+V+KA GR +++K++ E+ M L+ +R++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLST-IREVAV----- 54
Query: 115 KKMRQIQS----------EINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL 163
+R +++ ++ TV + R L + HV D L L+ V +
Sbjct: 55 --LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPT 109
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ + + L GL++LH H R++HRDL P N+L+ + +++ FG AR
Sbjct: 110 ETI--KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--- 161
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
+ ++VV T+ Y APE L + D++
Sbjct: 162 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLW 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 70/303 (23%), Positives = 128/303 (42%), Gaps = 52/303 (17%)
Query: 55 KIGSGGCGEVYKAEL----PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
++G G G+V+ AE P ++ ++++K + P + A +K Q ++E
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA------------RKDFQREAE 59
Query: 111 MLLNKKMRQIQSEINTVGQ----------IRHRNLHPLL-AHVTRPDCHLLYILNDVSQG 159
+L N + I G ++H +L+ L AH PD +L + Q
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH--GPDAMIL-VDGQPRQA 116
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+ EL IA +A G+ YL H +HRDL N L+ ++ +I FG +R +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDV 173
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL-VMGKLPSDKFFQHT 277
+ + + + ++ PE + T + D++ FG +L + GK P +FQ +
Sbjct: 174 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLS 230
Query: 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337
N V+ R ++ V C ++ V I C +P +R N K++
Sbjct: 231 NTE--------VIECITQGRVLERPRV---CPKE---VYDIMLGCWQREPQQRLNIKEIY 276
Query: 338 RML 340
++L
Sbjct: 277 KIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 52/241 (21%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G G+V+ AEL G N + +IK +++D +L++ + E K
Sbjct: 3 LGKGSFGKVFLAELKGTN-QFFAIK-----------ALKKDVVLMDDDVECTMVE----K 46
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVT---RPDCHLLYILNDVSQGRRELDWLARHRIA 172
++ + E HP L H+ + +L +++ ++ G + H+
Sbjct: 47 RVLSLAWE------------HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD 94
Query: 173 LGLA--------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDA 222
L A CGL++LH I++RDL N+LLD D +I+ FG + + DA
Sbjct: 95 LPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
T GT +YIAPE L D + FG LL +++G+ P F H E
Sbjct: 152 K----TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEEL 204
Query: 282 F 282
F
Sbjct: 205 F 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 31/83 (37%), Positives = 43/83 (51%), Gaps = 10/83 (12%)
Query: 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA------RAIP 220
AR IA + LEYLH + IIHRDL P N+L+D + +++ FG + R I
Sbjct: 95 ARIYIAEIVLA-LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN 150
Query: 221 DAHTHITTSNVVGTVEYIAPEYL 243
+VGT +YIAPE +
Sbjct: 151 LNDDEKEDKRIVGTPDYIAPEVI 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 53/176 (30%), Positives = 75/176 (42%), Gaps = 21/176 (11%)
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNL-HPLLA--HVTRPDCHLLYILNDVSQGRREL 163
+Q + +L KK Q+ I + +NL HP L H + LY + D G
Sbjct: 28 LQKKTILKKKE---QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELF 84
Query: 164 DWLARHR---------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
L R R A +A + YLH + II+RDL P N+LLD ++ FG
Sbjct: 85 FHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141
Query: 215 FARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ TTS GT EY+APE L+ D + GA+L ++ G P
Sbjct: 142 LCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 4/79 (5%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT-TSNVVGTVE 236
G+EYLH + I+HRD+ N+L D ++ FG ++ + + T +V GT
Sbjct: 116 GVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 237 YIAPEYLQMLTLTEKCDIY 255
+++PE + K D++
Sbjct: 173 WMSPEVISGEGYGRKADVW 191
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 75/316 (23%), Positives = 125/316 (39%), Gaps = 60/316 (18%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L + +G G G+V KAE + + A ++++D+ K + + S
Sbjct: 14 LTLGKPLGEGAFGQVVKAEA-------VGLDNPNETSTVAVKMLKDDAT--EKDLSDLVS 64
Query: 110 EMLLNKKMRQIQSEINTVGQ-------------IRHRNLHPLLAHVTRPDCHLLYILNDV 156
EM + K + + ++ IN +G H NL L P +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 157 SQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+ L A +A G+E+L C IHRDL NVL+ +D +I+ FG A
Sbjct: 125 PEETLTQKDLVS--FAYQVARGMEFLASKKC---IHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL------AGLVMGKLP 269
R I + T+N V+++APE L T + D++ FG LL G +P
Sbjct: 180 RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239
Query: 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329
++ F K ++ E P+ C +++ ++ C E P++
Sbjct: 240 VEELF---------KLLKEGYRMEKPQN----------CTQELYHLM---RDCWHEVPSQ 277
Query: 330 RPNSK----DVRRMLS 341
RP K D+ RML+
Sbjct: 278 RPTFKQLVEDLDRMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 57/191 (29%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 104 MRQIQSEMLLNKKM-RQIQSEINTVGQIRHRNL-HPLLA--HVTRPDCHLLYILNDVSQG 159
++ +Q + +L KK + I SE N + +N+ HP L H + LY + D G
Sbjct: 25 VKVLQKKAILKKKEEKHIMSERNVL----LKNVKHPFLVGLHFSFQTADKLYFVLDYING 80
Query: 160 RRELDWLARHRI---------ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210
L R R A +A L YLH + I++RDL P N+LLD +
Sbjct: 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVL 137
Query: 211 SGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ FG + + + TTS GT EY+APE L D + GA+L ++ G P
Sbjct: 138 TDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
Query: 270 SDKFFQHTNEM 280
+ ++T EM
Sbjct: 196 F--YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 39/199 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +IG G G V+KA + G +++KK+ L + I ++ L
Sbjct: 5 LGRIGEGAHGIVFKA-KDRETGETVALKKV----------------ALRRLEGGIPNQAL 47
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQGRRELD----- 164
EI + +H + LL +L Y+ +D+S+ R+ +
Sbjct: 48 ---------REIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPE 98
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ L G+ Y+H + I+HRDL P N+L+ D +I+ FG AR +
Sbjct: 99 AQVK-SYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEE 153
Query: 225 HITTSNVVGTVEYIAPEYL 243
S+ V T Y APE L
Sbjct: 154 PRLYSHQVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV------GPPMDAAALIEEDSMLLNKKMRQ 106
LEKIG G G+VYKA G+++++KK G P A + E S+L Q
Sbjct: 6 LEKIGEGTYGKVYKAR-DKNTGKLVALKKTRLEMDEEGIPPTA---LREISLL------Q 55
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL 166
+ SE + ++ ++ G+ +L+ L+ D N GR L
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKP---SLY-LVFEYLDSDLKKFMDSNGRGPGR-PLPAK 110
Query: 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA-RISGFGFARA--IP-DA 222
L G+ + H H ++HRDL P N+L+D +I+ G RA IP +
Sbjct: 111 TIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 223 HTHITTSNVVGTVEYIAPEYL 243
+TH +V T+ Y APE L
Sbjct: 168 YTH----EIV-TLWYRAPEVL 183
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 38/100 (38%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
GL+Y+H IIHRDL P NV +++D E RI FG AR D T V T Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----GYVATRWY 181
Query: 238 IAPE-YLQMLTLTEKCDIY-FGALLAGLVMGK--LPSDKF 273
APE L + + DI+ G ++A L+ GK P + +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 50/219 (22%)
Query: 54 EKIGSGGCGEVYKAEL--PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
E IG+G GEV + L PG+ ++IK + +
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE----------------------- 46
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR- 170
K+ R SE + +GQ H N+ L VT+ ++ I + G LD R
Sbjct: 47 ---KQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMIITEFMENG--ALDSFLRQND 100
Query: 171 -----IAL-----GLACGLEYL-HMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
I L G+A G++YL M++ +HRDL N+L++ ++ ++S FG +R +
Sbjct: 101 GQFTVIQLVGMLRGIAAGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRFL 156
Query: 220 PDAHTHITTSNVVG---TVEYIAPEYLQMLTLTEKCDIY 255
D + T ++ +G + + APE + T D++
Sbjct: 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVW 195
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 40/124 (32%), Positives = 60/124 (48%), Gaps = 12/124 (9%)
Query: 158 QGRRELDWLARHRI-ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
Q R+ D R R A + L +LH H +I+RDL N+LLD + +++ FG
Sbjct: 88 QRSRKFD-EPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMC 143
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275
+ +TT+ GT +YIAPE LQ L D + G L+ ++ G+ P F+
Sbjct: 144 KE--GILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP----FE 197
Query: 276 HTNE 279
NE
Sbjct: 198 ADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LE+IG G GEV+K + + ++++IK I + + + E+
Sbjct: 9 LERIGKGSFGEVFKG-IDNRTQQVVAIKII--------------------DLEEAEDEI- 46
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA----- 167
IQ EI + Q + + L+I+ + G LD L
Sbjct: 47 -----EDIQQEITVLSQCDSPYVTKYYGSYLKGT--KLWIIMEYLGGGSALDLLRAGPFD 99
Query: 168 RHRIALGLA---CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+IA L GL+YLH + IHRD+ NVLL + + +++ FG A + D T
Sbjct: 100 EFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--T 154
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270
I + VGT ++APE +Q K DI+ G L G+ P+
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 29/69 (42%), Positives = 41/69 (59%), Gaps = 11/69 (15%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IP-DAHTHITTSNVVGT 234
G+ Y H H R++HRDL P N+L+D + +++ FG ARA +P +TH VV T
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH----EVV-T 162
Query: 235 VEYIAPEYL 243
+ Y APE L
Sbjct: 163 LWYRAPEIL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 55/233 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L K+G+G GEV+ E N +++K + MD + E ++
Sbjct: 11 LRKLGAGQFGEVW--EGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIM------------- 55
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-- 170
KK +RH L L A T + +YI+ ++ + L++L
Sbjct: 56 --KK-------------LRHPKLIQLYAVCTLEEP--IYIVTELMKYGSLLEYLQGGAGR 98
Query: 171 ---------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+A +A G+ YL + IHRDL NVL+ ++ +++ FG AR I +
Sbjct: 99 ALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155
Query: 222 AHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
I + G +++ APE + K D++ FG LL +V G++P
Sbjct: 156 ---DIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 11/94 (11%)
Query: 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVE 236
CG+++LH IIHRDL P N+++ D +I FG AR A T + V T
Sbjct: 129 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRY 182
Query: 237 YIAPEYLQMLTLTEKCDIY-----FGALLAGLVM 265
Y APE + + E DI+ G ++ G V+
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVL 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT----HITTSNVV 232
CGL+Y+H ++HRDL P N+L++ D E +I FG AR + +T V
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT--EYV 170
Query: 233 GTVEYIAPE-YLQMLTLTEKCDIY-FGALLAGLVMGK 267
T Y APE L + T+ D++ G +LA L+ K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 53/183 (28%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 104 MRQIQSEMLLNKK-MRQIQSEINTVGQIRHRNL-HPLLA--HVTRPDCHLLYILNDVSQG 159
++ +Q +++LN+K + I +E N + +N+ HP L H + LY + D G
Sbjct: 25 VKVLQKKIVLNRKEQKHIMAERNVL----LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80
Query: 160 RRELDWLARHR---------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210
L R R A +A L YLH I++RDL P N+LLD +
Sbjct: 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVL 137
Query: 211 SGFGFAR---AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG 266
+ FG + A D TT+ GT EY+APE ++ D + GA+L ++ G
Sbjct: 138 TDFGLCKEGIAQSD-----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
Query: 267 KLP 269
P
Sbjct: 193 LPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 59/232 (25%), Positives = 92/232 (39%), Gaps = 41/232 (17%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
LEKIG G GEV+K + + ++++IK I + + +
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII--------------------DLEEAED 44
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-------E 162
E+ IQ EI + Q + + D L I+ + G
Sbjct: 45 EI------EDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYLGGGSALDLLEPGP 97
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
LD I + GL+YLH + IHRD+ NVLL + E +++ FG A + D
Sbjct: 98 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD- 153
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273
T I + VGT ++APE ++ K DI+ G L G+ P +
Sbjct: 154 -TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 43/187 (22%), Positives = 68/187 (36%), Gaps = 54/187 (28%)
Query: 115 KKMRQIQSEINTVGQIRH-RNLHPLLAHVTRP----------DCHLLYILNDVSQGRREL 163
K +R+ S++ QI H R +LA P D LY++ + G +
Sbjct: 32 KVLRK--SDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89
Query: 164 DWLARHRI---------ALGLACGLEYLH-MHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
+ L R + L L+ +H + IHRD+ P N+L+D D +++ F
Sbjct: 90 NLLIRKDVFPEETARFYIAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADF 145
Query: 214 GFARAIPDAHTHITTSN---------------------------VVGTVEYIAPEYLQML 246
G + + A N VGT +YIAPE L+
Sbjct: 146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205
Query: 247 TLTEKCD 253
+CD
Sbjct: 206 PYGLECD 212
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL----ARH-------RI 171
E + ++RH L PL A V+ +YI+ + LD+L ++ +
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM 107
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A +A G+ Y+ + IHRDL N+L+ D++ +I+ FG AR I D + +
Sbjct: 108 AAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGA 163
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNV 289
+++ APE T K D++ FG LL LV G++P M N
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-------------YPGMVNR 210
Query: 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340
E +R GC E + ++K+ C +DP+ERP + ++ L
Sbjct: 211 EVLEQVERGYRMP-CPQGCPESLHELMKL---CWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT--- 234
G+ YL + IHRDL N L+DD ++S FG +R + D T+S VG+
Sbjct: 112 GMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSS--VGSKFP 164
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSDKF 273
V + PE L + K D++ FG L+ + +GK+P ++F
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 36/107 (33%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ CG+++LH IIHRDL P N+++ D +I FG AR A T+ + V T
Sbjct: 132 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---ACTNFMMTPYVVT 185
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
Y APE + + E DI+ G ++ LV G + FQ T+ +
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 21/180 (11%)
Query: 146 DCHLLYILNDVSQGRRELDWLARHR-------IALGLACGLEYLHMHHCPRIIHRDLNPV 198
D LY++ + G L L R+ LA + +H H +HRD+ P
Sbjct: 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE 131
Query: 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK------C 252
NVL+D +++ FG A + A+ + + VGT +YIAPE L + K C
Sbjct: 132 NVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190
Query: 253 DIY-FGALLAGLVMGKLP-----SDKFFQHT-NEMSFVKWMRNVMASENPKRAIDSKLVG 305
D + G + ++ G+ P S K + + N F+K+ + S + I S L G
Sbjct: 191 DWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCG 250
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 68/305 (22%), Positives = 123/305 (40%), Gaps = 67/305 (21%)
Query: 56 IGSGGCGEVYKA--ELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
IG+G GEV++ ++PG+ ++IK + E
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL------KPGYTE------------------- 47
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR--- 170
K+ + SE + +GQ H N+ L VT+ + I + G LD R
Sbjct: 48 -KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-PAMIITEYMENG--ALDKYLRDHDGE 103
Query: 171 --------IALGLACGLEYL-HMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+ G+A G++YL M++ +HRDL N+L++ ++E ++S FG +R + D
Sbjct: 104 FSSYQLVGMLRGIAAGMKYLSDMNY----VHRDLAARNILVNSNLECKVSDFGLSRVLED 159
Query: 222 -AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIYFGALLAGLVM--GKLPSDKFFQHTN 278
TTS + + APE + T D++ ++ VM G+ P ++ +N
Sbjct: 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP---YWDMSN 216
Query: 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
VM + N + + + C V ++ C +D RP D+
Sbjct: 217 H--------EVMKAINDGFRLPAPM---DCPSA---VYQLMLQCWQQDRARRPRFVDIVN 262
Query: 339 MLSQI 343
+L ++
Sbjct: 263 LLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 8/101 (7%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
+IA + GL YLH +IIHRD+ P N+LL + ++ FG + + ++
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAG 161
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
GT Y+APE +Q + D++ G L + + P
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 39/247 (15%)
Query: 50 LASLEKIGSGGCGEVYKAEL----PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMR 105
+ ++G G G+V+ E P + ++++K + + A +D
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFER------ 57
Query: 106 QIQSEMLLNKKMRQIQSEINTVGQ----------IRHRNLHPLL-AHVTRPDCHLLYILN 154
++E+L N + I + + H +L+ L +H PD L
Sbjct: 58 --EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSH--GPDAAFL-KSP 112
Query: 155 DVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
D G L L +IA+ +A G+ YL H +HRDL N L+ D+ +I FG
Sbjct: 113 DSPMGELTLSQL--LQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFG 167
Query: 215 FARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL-VMGKLPSDK 272
+R + + + + + ++ PE + T + D++ FG +L + GK P
Sbjct: 168 MSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--- 224
Query: 273 FFQHTNE 279
++ +NE
Sbjct: 225 WYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 39/122 (31%), Positives = 59/122 (48%), Gaps = 17/122 (13%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTSNVV 232
+ GL++LH II+RDL NVLLD + +I+ FG + + TTS
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 233 GTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP-----SDKFFQH--TNEMSFVK 284
GT +YIAPE L D + G LL ++ G+ P D+ FQ +E+ + +
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR 217
Query: 285 WM 286
W+
Sbjct: 218 WL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 51/231 (22%)
Query: 52 SLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
+L +GSG G+V A GR ++IKK+ R QS +
Sbjct: 19 NLSPVGSGAYGQVCSAFDTK-TGRKVAIKKL---------------------SRPFQSAI 56
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL-----LYI--------LNDVSQ 158
+ R E+ + + H N+ LL V P L +Y+ LN++ +
Sbjct: 57 HAKRTYR----ELRLLKHMDHENVIGLL-DVFTPASSLEDFQDVYLVTHLMGADLNNIVK 111
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
++ D + + + GL+Y+H IIHRDL P N+ +++D E +I FG AR
Sbjct: 112 CQKLSDDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR- 166
Query: 219 IPDAHTHITTSNVVGTVEYIAPE-YLQMLTLTEKCDIY-FGALLAGLVMGK 267
HT + V T Y APE L + + DI+ G ++A L+ GK
Sbjct: 167 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 33/126 (26%), Positives = 54/126 (42%), Gaps = 8/126 (6%)
Query: 145 PDCHLLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204
P L ++ + R+ + RI + L GL+ LH +I+HRDL N+LL
Sbjct: 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVA 138
Query: 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263
+ +I G ++ + +GT Y+APE + + K DI+ G LL +
Sbjct: 139 NDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEM 194
Query: 264 VMGKLP 269
P
Sbjct: 195 ATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 48/204 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQN---GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+EKIG G G VYK G+N G+++++KKI L E+ + + +R
Sbjct: 5 IEKIGEGTYGVVYK----GRNKKTGQIVAMKKI--------RLESEEEGVPSTAIR---- 48
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG-RRELDWLAR 168
EI+ + +++H N+ L V + L I +S ++ LD L +
Sbjct: 49 -------------EISLLKELQHPNIVCLQ-DVLMQESRLYLIFEFLSMDLKKYLDSLPK 94
Query: 169 HRIALGLACGLEYLH-------MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--I 219
+ + YL+ H R++HRDL P N+L+D+ +++ FG ARA I
Sbjct: 95 GQ-YMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153
Query: 220 PDAHTHITTSNVVGTVEYIAPEYL 243
P + T VV T+ Y APE L
Sbjct: 154 P---VRVYTHEVV-TLWYRAPEVL 173
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
++++ + GL YL H +I+HRD+ P N+L++ E ++ FG + + D+ +
Sbjct: 107 KVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ VGT Y++PE LQ + + DI+ G L L +G+ P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 34/92 (36%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
GL+Y+H IIHRDL P N+ +++D E +I FG AR HT + V T Y
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWY 183
Query: 238 IAPE-YLQMLTLTEKCDIY-FGALLAGLVMGK 267
APE L + + DI+ G ++A L+ G+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 30/101 (29%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
++++ + GL YL H +I+HRD+ P N+L++ E ++ FG + + D+ +
Sbjct: 107 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ VGT Y++PE LQ + + DI+ G L + +G+ P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A +A G+EYL C IHRDL NVL+ +D +I+ FG AR I + T+N
Sbjct: 146 AYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
V+++APE L T + D++ FG LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
+I++ + GL YL H +I+HRD+ P N+L++ E ++ FG + + D+ +
Sbjct: 103 KISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ VGT Y++PE LQ T + DI+ G L + +G+ P
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 42/121 (34%), Positives = 57/121 (47%), Gaps = 13/121 (10%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
GLE++H +++RDL P N+LLD+ RIS G A H + VGT Y
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 238 IAPEYLQMLTLTEKCDIYF--GALLAGLVMGKLPSDKFFQH-TNEMSFVKWMRNVMASEN 294
+APE LQ + +F G +L L+ G P F QH T + + M MA E
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHEIDRMTLTMAVEL 218
Query: 295 P 295
P
Sbjct: 219 P 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 4/87 (4%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A G+EYL C IHRDL NVL+ ++ +I+ FG AR + + + T+N
Sbjct: 146 VARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALL 260
V+++APE L T + D++ FG L+
Sbjct: 203 VKWMAPEALFDRVYTHQSDVWSFGVLM 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 46/227 (20%)
Query: 50 LASLEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQ 106
L ++++G G G+V L G +++K LN
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS------------------LNHSGE- 46
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH-LLYILNDVSQGRRELDW 165
+ + EI + + H N+ +P L I+ + G D+
Sbjct: 47 -------EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR-DY 98
Query: 166 LARHRIALGL----------ACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
L RHR + L G++YL IHRDL N+L++ + +IS FG
Sbjct: 99 LQRHRDQINLKRLLLFSSQICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGL 155
Query: 216 ARAIPDAHTHITTSNVVGT-VEYIAPEYLQMLTLTEKCDIY-FGALL 260
A+ +P+ + + + + APE L+ + D++ FG L
Sbjct: 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 43/229 (18%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
LE+IG G GEVYK + + +++IK I + + +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKII--------------------DLEEAED 44
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR- 168
E+ IQ EI + Q + + L+I+ + G LD L
Sbjct: 45 EI------EDIQQEITVLSQCDSPYITRYYGSYLKGT--KLWIIMEYLGGGSALDLLKPG 96
Query: 169 -------HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
I + GL+YLH R IHRD+ NVLL + + +++ FG A + D
Sbjct: 97 PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
T I + VGT ++APE ++ K DI+ G L G+ P
Sbjct: 154 --TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 26/81 (32%), Positives = 41/81 (50%), Gaps = 6/81 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
GL++LH + I+HRDL P N+L+ + +++ FG AR + + VV T
Sbjct: 117 FLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVT 170
Query: 235 VEYIAPEYLQMLTLTEKCDIY 255
+ Y APE L T D++
Sbjct: 171 LWYRAPEVLLQSTYATPVDMW 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 58/221 (26%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+++IGSG G+VYKA G +++IK I +E
Sbjct: 8 IQRIGSGTYGDVYKARDI-ATGELVAIKVI---------KLEPGDDF------------- 44
Query: 113 LNKKMRQIQSEINTVGQIRHRNL-HPLLAHVTRPDCHLLYI---------LNDVSQGRRE 162
IQ EI+ + + RH N+ +++ R L+I L D+ Q R
Sbjct: 45 -----EIIQQEISMLKECRHPNIVAYFGSYLRR---DKLWIVMEYCGGGSLQDIYQVTRG 96
Query: 163 LDWLARHRIALGLAC-----GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
L+ +IA C GL YLH IHRD+ N+LL +D + +++ FG +
Sbjct: 97 P--LSELQIAY--VCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSA 149
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDIY 255
+ T + +GT ++APE + KCDI+
Sbjct: 150 QL--TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIW 188
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 57/220 (25%), Positives = 87/220 (39%), Gaps = 47/220 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIK--KIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
E+IG G GEV+ L N +++K + PP A ++E +L
Sbjct: 1 ERIGRGNFGEVFSGRLRADN-TPVAVKSCRETLPPDLKAKFLQEARIL------------ 47
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH-- 169
Q H N+ L+ T+ +YI+ ++ QG L +L
Sbjct: 48 ----------------KQYSHPNIVRLIGVCTQK--QPIYIVMELVQGGDFLTFLRTEGP 89
Query: 170 --------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
++ A G+EYL HC IHRDL N L+ + +IS FG +R D
Sbjct: 90 RLKVKELIQMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEED 146
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
T V++ APE L + + D++ FG LL
Sbjct: 147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-07
Identities = 53/192 (27%), Positives = 90/192 (46%), Gaps = 25/192 (13%)
Query: 104 MRQIQSEMLLNK-KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE 162
M+ ++ E+++ K ++ +E + RH L L D L +++ V+ G E
Sbjct: 25 MKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-RLCFVMEYVNGG--E 81
Query: 163 LDW-LARHRI---------ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISG 212
L + L+R R+ + L+YLH +I++RDL N++LD D +I+
Sbjct: 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITD 138
Query: 213 FGFAR-AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270
FG + I DA T T GT EY+APE L+ D + G ++ ++ G+LP
Sbjct: 139 FGLCKEGITDAATMKT---FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP- 194
Query: 271 DKFFQHTNEMSF 282
F+ +E F
Sbjct: 195 --FYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 43/136 (31%), Positives = 65/136 (47%), Gaps = 23/136 (16%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
GL+Y+H ++HRDL P N+L++++ + +I FG AR I D + V T Y
Sbjct: 120 GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQ----MTGYVSTRYY 171
Query: 238 IAPEYLQMLT---LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV--------KW 285
APE MLT + DI+ G + A ++ GK P H N+ S +
Sbjct: 172 RAPEI--MLTWQKYDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPDD 228
Query: 286 MRNVMASENPKRAIDS 301
+ N + SEN R + S
Sbjct: 229 VINTICSENTLRFVQS 244
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 26/199 (13%)
Query: 82 IVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAH 141
IV DA I E ++ + K R Q++ + R E+ + + H+N+ LL +
Sbjct: 39 IVCAAYDA---ILERNVAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIGLL-N 90
Query: 142 VTRPDCHL-----LYILNDVSQG------RRELDWLARHRIALGLACGLEYLHMHHCPRI 190
V P L +YI+ ++ + ELD + + CG+++LH I
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGI 147
Query: 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250
IHRDL P N+++ D +I FG AR A T + V T Y APE + + E
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKE 204
Query: 251 KCDIY-FGALLAGLVMGKL 268
DI+ G ++ ++ G +
Sbjct: 205 NVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 6e-07
Identities = 34/95 (35%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245
H II+RDL NVLLD + +++ FG + TTS GT +YIAPE LQ
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 246 LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
+ D + G LL ++ G P F+ NE
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP----FEAENE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 62/258 (24%), Positives = 99/258 (38%), Gaps = 67/258 (25%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLN------------KK 103
+G G G+V KA G++++IKK+ ++ + + +D L+ K
Sbjct: 17 LGEGTYGKVEKAY-DTLTGKIVAIKKV--KIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 104 MRQIQSEMLLNKKMRQIQSE-INTVGQIRHRNLHPLLAHVTR-----PDCHLLYILNDVS 157
M +I+ E ++ ++ + IN V I +L ++ R C LL ILN
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILN--- 130
Query: 158 QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
GL LH + +HRDL+P N+ ++ +I+ FG AR
Sbjct: 131 --------------------GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167
Query: 218 A-------------IPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAG 262
TS VV T+ Y APE L D++ G + A
Sbjct: 168 RYGYPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226
Query: 263 LVMGKLPSDKFFQHTNEM 280
L+ GK F NE+
Sbjct: 227 LLTGK----PLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A +A GL +LH II+RDL NV+LD + +I+ FG + + +TT
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP-----SDKFFQHTNE 279
GT +YIAPE + + D + FG LL ++ G+ P D+ FQ E
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 46/203 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+EKIG G G VYKA N I++KKI L +ED + + +R
Sbjct: 7 VEKIGEGTYGVVYKARDRVTN-ETIALKKI--------RLEQEDEGVPSTAIR------- 50
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQGRRELDWLAR- 168
EI+ + +++H N+ L V L Y+ D+ + A+
Sbjct: 51 ----------EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN 100
Query: 169 HRIA----LGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA-RISGFGFARA--IP- 220
R+ + G+ Y H H R++HRDL P N+L+D A +++ FG ARA IP
Sbjct: 101 PRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157
Query: 221 DAHTHITTSNVVGTVEYIAPEYL 243
TH VV T+ Y APE L
Sbjct: 158 RTFTH----EVV-TLWYRAPEIL 175
|
Length = 294 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 78/311 (25%), Positives = 121/311 (38%), Gaps = 78/311 (25%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L L+++GSG G V+ + G+ ++IK I M IEE
Sbjct: 6 LTFLKELGSGQFGVVHLGKWRGK--IDVAIKMIREGAMSEDDFIEE-------------- 49
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVT--RPDCHLLYILNDVSQGRRELDWLA 167
K M ++ H NL L T RP ++I+ + L++L
Sbjct: 50 ----AKVMMKLS----------HPNLVQLYGVCTKQRP----IFIVTEYMANGCLLNYLR 91
Query: 168 RHRIALGLA---------C-GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ LG C +EYL + IHRDL N L+ +D ++S FG AR
Sbjct: 92 ERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR 148
Query: 218 AIPDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALLAGL-VMGKLPSDK 272
+ D T+S GT V++ PE + K D++ FG L+ + GK+P ++
Sbjct: 149 YVLD--DQYTSS--QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
Query: 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332
F +N V+ + PK A V I C E P +RP
Sbjct: 205 F---SN-SEVVESVSAGYRLYRPKLAPTE-------------VYTIMYSCWHEKPEDRPA 247
Query: 333 SKDVRRMLSQI 343
+++LSQ+
Sbjct: 248 ---FKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 8e-07
Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 20/160 (12%)
Query: 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR---HRIAL------ 173
E N + ++H L L A VT+ +YI+ + LD+L + L
Sbjct: 51 EANVMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 174 --GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
+A G+ ++ + IHRDL N+L+ + +I+ FG AR I D + +
Sbjct: 108 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGA 163
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLP 269
+++ APE + + T K D++ FG LL +V G++P
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQ--- 106
L ++K+G+G GEV+ G +++K + M + +EE ++ KK+R
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNT--KVAVKTLKPGTMSPESFLEEAQIM--KKLRHDKL 63
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL 166
+Q +++++ I +E + G LL L D +L L
Sbjct: 64 VQLYAVVSEEPIYIVTEYMSKGS-------------------LLDFLKDGEGRALKLPNL 104
Query: 167 ARHRIALGLACGLEYLH-MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
+A +A G+ Y+ M++ IHRDL N+L+ D + +I+ FG AR I D + +
Sbjct: 105 VD--MAAQVAAGMAYIERMNY----IHRDLRSANILVGDGLVCKIADFGLARLIED-NEY 157
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
+++ APE T K D++ FG LL LV G++P
Sbjct: 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 59/207 (28%)
Query: 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
L +IG G G VY A + +++IKK M + K QS
Sbjct: 18 TDLREIGHGSFGAVYFAR-DVRTNEVVAIKK----------------MSYSGK----QS- 55
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---------YILNDVS---- 157
N+K + I E+ + Q+RH N + C+L Y L S
Sbjct: 56 ---NEKWQDIIKEVRFLQQLRHPNT------IEYKGCYLREHTAWLVMEYCLGSASDILE 106
Query: 158 ---QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
+ +E++ A I G GL YLH H IHRD+ N+LL + +++ FG
Sbjct: 107 VHKKPLQEVEIAA---ICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160
Query: 215 FARAIPDAHTHITTSNVVGTVEYIAPE 241
A + A++ VGT ++APE
Sbjct: 161 SASLVSPANS------FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 10/113 (8%)
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
ELD + + CG+++LH IIHRDL P N+++ D +I FG AR
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--- 168
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIYFGALLAGLVMGKLPSDKFF 274
A T + V T Y APE + + E DI+ G +MG++ K
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWS----VGCIMGEMVRHKIL 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 79/316 (25%), Positives = 134/316 (42%), Gaps = 71/316 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L KIG G EV KA+ + G+ +IK + +E+ + L R+IQ+
Sbjct: 4 LGKIGEGTFSEVLKAQ-SRKTGKYYAIKCM----KKHFKSLEQVNNL-----REIQA--- 50
Query: 113 LNKKMRQIQSEINTVG--QIRHRNLHPLLAHVTRPDCHLLYI-LNDVSQGRRELDWLARH 169
+R++ N + ++ LA V L+ + L ++ +GR+ L
Sbjct: 51 ----LRRLSPHPNILRLIEVLFDRKTGRLALV----FELMDMNLYELIKGRKRP--LPEK 100
Query: 170 RIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI 226
R+ L L+ HMH I HRD+ P N+L+ DDI +++ FG R I ++
Sbjct: 101 RVKSYMYQLLKSLD--HMHRN-GIFHRDIKPENILIKDDI-LKLADFGSCRGI---YSKP 153
Query: 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIYFGALL----AGLVMGKLPSDK-FFQHTNEMS 281
+ + T Y APE L LT D Y+G + G V ++ S F TNE+
Sbjct: 154 PYTEYISTRWYRAPECL--LT-----DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206
Query: 282 FVKWMRNVMASENPK--------RAID-----------SKLVGNGCEEQMLLVLKIACFC 322
+ + +V+ + + + R ++ KL+ N E + L+ K+ +
Sbjct: 207 QIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAY- 265
Query: 323 TLEDPNERPNSKDVRR 338
DP+ER +K R
Sbjct: 266 ---DPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 64/213 (30%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+E IG G G+VYKA + G++++IK MD EE+
Sbjct: 11 VEVIGEGTYGKVYKARHK-KTGQLVAIKI-----MDIIEDEEEE---------------- 48
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLA----------HVTRPDCHLLYILN-------- 154
I+ E N +R + HP +A D L ++
Sbjct: 49 -------IKEEYNI---LRKYSNHPNIATFYGAFIKKNPPGNDD-QLWLVMELCGGGSVT 97
Query: 155 DVSQGRREL------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
D+ +G R+ +W+A I GL YLH + +IHRD+ N+LL + E
Sbjct: 98 DLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEV 152
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPE 241
++ FG + + T + +GT ++APE
Sbjct: 153 KLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 182 LHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPE 241
+H H +HRD+ P NVLLD + R++ FG + T + +S VGT +YI+PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173
Query: 242 YLQ-----MLTLTEKCDIY-FGALLAGLVMGKLP 269
LQ M +CD + G + ++ G+ P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI-PDAHTHITTSNVVGTVE 236
GL+YLH I+HRD+ P N+L++ + +I FG AR PD H+T V T
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQY 169
Query: 237 YIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKL 268
Y APE L T DI+ G + A L+ ++
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 55 KIGSGGCGEVYKAE----LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
++G G G+V+ AE LP Q+ ++++K + A + ++ LL + Q Q
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT--VLQHQHI 69
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQGRRELDWLARH 169
+ + + + +RH +L+ L +H PD +L DV+ G+ L +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSH--GPDAKILAGGEDVAPGQLTLGQMLA- 126
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
IA +A G+ YL H +HRDL N L+ + +I FG +R I +
Sbjct: 127 -IASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + ++ PE + T + DI+ FG +L
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTS 229
A +A GL +LH II+RDL NV+LD + +I+ FG + TT
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTR 159
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271
GT +YIAPE + + D + FG LL ++ G+ P D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 47/202 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G+G G V A ++ ++IK+ E+ ++ K++ + SE
Sbjct: 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRF-----------EKSKIIKQKQVDHVFSE-- 81
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLA--HVTRPDCHLLYILNDVSQGRRELDWLARHR 170
R+I + IN HP + + D LY++ + G +L R++
Sbjct: 82 -----RKILNYIN----------HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK 126
Query: 171 ---------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
A + EYL + I++RDL P N+LLD D +++ FGFA+ +
Sbjct: 127 RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-- 181
Query: 222 AHTHITTSNVVGTVEYIAPEYL 243
T + GT EYIAPE L
Sbjct: 182 ---DTRTYTLCGTPEYIAPEIL 200
|
Length = 340 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
R + +A G+++L +C IHRD+ NVLL D A+I FG AR I + ++
Sbjct: 216 RFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
N V+++APE + T + D++ +G LL
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 8/107 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
L C LE LH + +I+RDL P N+LLD + FG + + T+ GT
Sbjct: 102 LLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGT 156
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
EY+APE L T+ D + G LL ++ G P + ++ NEM
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF--YDENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 11/94 (11%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTSNVVGTV 235
G+ + H + R++HRDL P N+L++ E +++ FG ARA IP T SN V T+
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN----TFSNEVVTL 164
Query: 236 EYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGK 267
Y AP+ L T + DI+ G ++A ++ G+
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 9/98 (9%)
Query: 176 AC---GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVV 232
AC GL+YLH + +I++RDL N+LLD + +I+ FG + TS
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTSTFC 162
Query: 233 GTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
GT E++APE L + T D + G L+ +++G+ P
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 40/179 (22%), Positives = 71/179 (39%), Gaps = 41/179 (22%)
Query: 104 MRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLA--------HVTRP-----DCHLL 150
+++I + + ++ +Q EI T Q++H N+ P + +V P C L
Sbjct: 30 VKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89
Query: 151 YILNDVSQGRRELDWLARHRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207
+ +G EL IA + L+Y+H IHR + ++LL D +
Sbjct: 90 -LKTHFPEGLPEL------AIAFILKDVLNALDYIHSKGF---IHRSVKASHILLSGDGK 139
Query: 208 ARISGF---------GFARAIPDAHTHITTSNVVGTVEYIAPEYLQ--MLTLTEKCDIY 255
+SG G + + + N + +++PE LQ + EK DIY
Sbjct: 140 VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN----LPWLSPEVLQQNLQGYNEKSDIY 194
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 31/91 (34%), Positives = 41/91 (45%), Gaps = 16/91 (17%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR---AIPDAHTHITTSNVVGT 234
GL YLH RIIHRD+ N+ ++D + I G A+ P + GT
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL------GLAGT 219
Query: 235 VEYIAPEYLQMLTLTEKCDIYFGALLAGLVM 265
VE APE L K DI+ AG+V+
Sbjct: 220 VETNAPEVLARDKYNSKADIWS----AGIVL 246
|
Length = 357 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 51/236 (21%), Positives = 88/236 (37%), Gaps = 44/236 (18%)
Query: 51 ASLEKI---GSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQI 107
LEKI GSG G VYK + P + + +L + +
Sbjct: 7 TELEKIKVLGSGAFGTVYKG--------------VWIPEGEKVKIPVAIKVLREETSPKA 52
Query: 108 QSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA 167
E+L E + + H ++ LL L+ L + G LD++
Sbjct: 53 NKEIL---------DEAYVMASVDHPHVVRLLGICLSSQVQLITQL--MPLGCL-LDYVR 100
Query: 168 RHRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
H+ +G +A G+ YL R++HRDL NVL+ +I+ FG A+
Sbjct: 101 NHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSD 271
+ ++++A E + T K D++ +G + L+ G P +
Sbjct: 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 14/98 (14%)
Query: 171 IALGL--ACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD-----AH 223
I GL A G+EYL + +HRDL N +LD+ +++ FG AR I D H
Sbjct: 101 IGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
H + V+++A E LQ T K D++ FG LL
Sbjct: 158 NH---TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 28/90 (31%), Positives = 41/90 (45%), Gaps = 15/90 (16%)
Query: 174 GLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAH----THI 226
LAC H I+HRDL P N+++ A++ FG +P +
Sbjct: 91 ALACA-------HNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 227 T-TSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
T T+ V+GT Y APE L+ +T D+Y
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 47/230 (20%), Positives = 90/230 (39%), Gaps = 74/230 (32%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++ +G G G V+ L G G++ ++K ++++ M+ K++++ +E
Sbjct: 6 IKLLGKGDVGRVFLVRLKG-TGKLFALK-----------VLDKKEMIKRNKVKRVLTE-- 51
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLA---HVTRPDCHL-----------LYILNDVSQ 158
++I + ++ HP L + + +L L+ L
Sbjct: 52 -----QEILATLD----------HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP 96
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD------------- 205
G+ + +AR A + LEYLH I++RDL P N+LL +
Sbjct: 97 GKCLSEEVARFYAA-EVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152
Query: 206 ------IEARISGFGFARAIPDAHTHIT--------TSNVVGTVEYIAPE 241
++ G R+ ++ T +++ VGT EYIAPE
Sbjct: 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 27/68 (39%), Positives = 39/68 (57%), Gaps = 9/68 (13%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTSNVVGTV 235
GL Y H R++HRDL P N+L+ + E +++ FG ARA +P + T SN V T+
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SK-TYSNEVVTL 167
Query: 236 EYIAPEYL 243
Y P+ L
Sbjct: 168 WYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 35/148 (23%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILND-----VSQGRRELDWLARHRIAL 173
+E + +GQ H N+ L VT+ ++ Y+ N + + + +
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR 113
Query: 174 GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVG 233
G+A G++YL + +HRDL N+L++ ++ ++S FG +R + D+ TT
Sbjct: 114 GIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 234 TVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + APE + T D++ FG ++
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVM 198
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 46/208 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L KIG G GEV+KA + +++++KK+ ++ N+K E
Sbjct: 17 LAKIGQGTFGEVFKAR-HKKTKQIVALKKV---------------LMENEK------EGF 54
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLL----AHVT-----RPDCHLLYILND------VS 157
+R EI + ++H N+ L+ T + +L++ + +S
Sbjct: 55 PITALR----EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS 110
Query: 158 QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ ++ L GL Y+H + +I+HRD+ N+L+ D +++ FG AR
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
Query: 218 A--IPDAHTHITTSNVVGTVEYIAPEYL 243
A + +N V T+ Y PE L
Sbjct: 168 AFSLSKNSKPNRYTNRVVTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 11/106 (10%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR-AIPDAHTHITTSNVVGTVEY 237
L YLH +++RDL N++LD D +I+ FG + I D T GT EY
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEY 161
Query: 238 IAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
+APE L+ D + G ++ ++ G+LP F+ +E F
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A ++ GL +LH II+RDL NV+LD + +I+ FG + +TT
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTF 161
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP-----SDKFFQHTNE 279
GT +YIAPE + + D + +G LL ++ G+ P D+ FQ E
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR-AIPDAHTHITTSNVVGTVEY 237
LEYLH +++RD+ N++LD D +I+ FG + I D T T GT EY
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEY 161
Query: 238 IAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
+APE L+ D + G ++ ++ G+LP F+ +E F
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR-AIPDAHTHITTSNVVG 233
+ L+YLH +++RDL N++LD D +I+ FG + I D T T G
Sbjct: 104 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCG 158
Query: 234 TVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
T EY+APE L+ D + G ++ ++ G+LP F+ +E F
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 38/147 (25%), Positives = 55/147 (37%), Gaps = 48/147 (32%)
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA--------- 216
LAR IA L C +E +H IHRD+ P N+L+D D +++ FG
Sbjct: 102 LARFYIA-ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 217 ---------------------------------RAIPDAHTHITTSNVVGTVEYIAPEYL 243
R H ++VGT YIAPE L
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ-HQRCLAHSLVGTPNYIAPEVL 216
Query: 244 QMLTLTEKCDIY-FGALLAGLVMGKLP 269
T+ CD + G +L +++G+ P
Sbjct: 217 LRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 63/307 (20%), Positives = 117/307 (38%), Gaps = 64/307 (20%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKK---MRQIQSE 110
+KIG G EVY+A + LL++K ++++Q
Sbjct: 8 KKIGRGQFSEVYRA-----------------------------TCLLDRKPVALKKVQIF 38
Query: 111 MLLNKKMRQ-IQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQGRRELDWLAR 168
+++ K RQ EI+ + Q+ H N+ L + + + +++ L D + + + +
Sbjct: 39 EMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK 98
Query: 169 HR----------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+ + L +E++H R++HRD+ P NV + ++ G R
Sbjct: 99 QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277
T ++VGT Y++PE + K DI+ G LL M L S +
Sbjct: 156 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL--YEMAALQSPFYGDKM 211
Query: 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337
N S + + P KL ++ C DP++RP+ V
Sbjct: 212 NLFSLCQKIEQCDYPPLPTEHYSEKL------------RELVSMCIYPDPDQRPDIGYVH 259
Query: 338 RMLSQIQ 344
++ Q+
Sbjct: 260 QIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 47/225 (20%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 53 LEKIGSGGCGEVYKAEL----PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
+E++G G+VYK L PG+ + ++IK L ++ L ++ +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIK----------TLKDKAEGPLREEFKH-- 57
Query: 109 SEMLLNKKMRQ--IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL----------NDV 156
E ++ +++ I + V + + L + ++ + D H ++ +D
Sbjct: 58 -EAMMRSRLQHPNIVCLLGVV--TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 157 SQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+ L+ I +A G+E+L HH ++H+DL NVL+ D + +IS G
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLF 171
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
R + A + N + + +++PE + + DI+ +G +L
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 49/194 (25%), Positives = 87/194 (44%), Gaps = 36/194 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNK-KMRQIQSEM 111
++++GSG G+VYKA G + ++K I P D +LI+++ ++ + K I +
Sbjct: 14 IQRVGSGTYGDVYKAR-NLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 112 --LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRP--DCHLLYILNDVSQGRRELDWLA 167
L+++ I E G ++ + HVT P + + Y+ + QG
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQD------IYHVTGPLSELQIAYVCRETLQG-------- 118
Query: 168 RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT 227
L YLH +HRD+ N+LL D+ + +++ FG A I T
Sbjct: 119 -----------LAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAK 162
Query: 228 TSNVVGTVEYIAPE 241
+ +GT ++APE
Sbjct: 163 RKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 30/88 (34%), Positives = 44/88 (50%), Gaps = 4/88 (4%)
Query: 183 HMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEY 242
H+H II+RDL P N+LLD +++ FG + H T GT+EY+APE
Sbjct: 115 HLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKE--SIHEGTVTHTFCGTIEYMAPEI 171
Query: 243 LQMLTLTEKCDIY-FGALLAGLVMGKLP 269
L + D + GAL+ ++ G P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 33/99 (33%), Positives = 47/99 (47%), Gaps = 9/99 (9%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
R A + L+ LH I+ RDLNP N+LLDD +++ F + D+
Sbjct: 89 RWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE 145
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
N+ Y APE + TE CD + GA+L L+ GK
Sbjct: 146 NM-----YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 25/66 (37%), Positives = 36/66 (54%), Gaps = 5/66 (7%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
GL+Y+H ++HRDL P N+LL+ + + +I FG AR + +T V T Y
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRWY 174
Query: 238 IAPEYL 243
APE L
Sbjct: 175 RAPELL 180
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIE-ARISGFGFARAIPDAHTHITTSN-----V 231
GL YLH + +IIHRD+ N+L+D + RI+ FG A + T + +
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQL 168
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+GT+ ++APE L+ CD++ G ++ + K P
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 42/177 (23%), Positives = 81/177 (45%), Gaps = 19/177 (10%)
Query: 99 LLNKKMRQIQS--EMLLNKKMRQIQSEI----NTVGQIRHRNLHPLLAHVTRPDCHLLYI 152
L K ++++ + L + + + E + + Q+ H + L+ V + + +L +
Sbjct: 16 YLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCKGEPLMLVM 74
Query: 153 -------LNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD 205
L + RRE+ +A +A G+ YL H +HRDL NVLL +
Sbjct: 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNR 131
Query: 206 IEARISGFGFARAI-PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+A+IS FG +RA+ + + T+ +++ APE + + K D++ +G L
Sbjct: 132 HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 28/100 (28%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A+ +ACG+ YLH +IH+D+ N ++D++++ +I+ +R + H N
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLP 269
V+++A E L + D++ FG LL L+ +G+ P
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 33/100 (33%), Positives = 45/100 (45%), Gaps = 17/100 (17%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
G+ +LH + I+HRDL N+LL++ +I FG AR T VV T+ Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQLVV-TLWY 172
Query: 238 IAPEYLQML---TLTEKCDIY-----FGALLAG--LVMGK 267
APE L L + D++ F LL L GK
Sbjct: 173 RAPELL--LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 53/215 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV------GPPMDAAALIEEDSMLLNKKMRQ 106
L K+G G GEVYKA + GR++++KKI+ G P+ A I+ L + +
Sbjct: 13 LGKLGEGTFGEVYKAR-QIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVP 71
Query: 107 IQSEMLLNK--KMRQIQSEINTVGQIRHRNLHPLL----AHVTRPD--CHLLYILNDVSQ 158
+ +M + + K ++ + + V +L LL +T C++L +L
Sbjct: 72 L-IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE---- 126
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
G+ YLH I+HRD+ N+L+D+ +I+ FG AR
Sbjct: 127 -------------------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 219 I----------PDAHTHITTSNVVGTVEYIAPEYL 243
T T+ VV T Y PE L
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELL 198
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 22/56 (39%), Positives = 34/56 (60%), Gaps = 7/56 (12%)
Query: 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN-VVGTVEYIAPEYLQ 244
IHRDL P N L+D +++ FG ++ I +T +N VVG+ +Y+APE L+
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSVVGSPDYMAPEVLR 171
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI 238
LE+LH + +IHRD+ N+LL D +++ FGF I + +T +VGT ++
Sbjct: 128 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 182
Query: 239 APEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
APE + K DI+ G + +V G+ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 4/87 (4%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A G+ +L +C IHRDL NVLL +I FG AR I + ++ N
Sbjct: 150 VAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALL 260
V+++APE + T + D++ +G LL
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 10/95 (10%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVE 236
GL+Y+H ++HRDL P N+LL+ + + +I FG AR H H + V T
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 237 YIAPEYLQMLT---LTEKCDIY-FGALLAGLVMGK 267
Y APE ML T+ DI+ G +LA ++ +
Sbjct: 175 YRAPEI--MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
G++YL +++HRDL NVL+ + + +IS FG +R + + +++ S V++
Sbjct: 139 GMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKW 195
Query: 238 IAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSDKFFQHTNEMSFVKWMRNVMASENP 295
+A E L T + D++ FG LL +V +G P + +K + EN
Sbjct: 196 MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLKTGYRMERPEN- 253
Query: 296 KRAIDSKLVGNGCEEQML-LVLKIACFCTLEDPNERPN----SKDVRRML 340
C E+M L+L C ++P++RP SK++ +M+
Sbjct: 254 ------------CSEEMYNLMLT----CWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 29/167 (17%)
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
+AR +A + ++ +H H +HRD+ P N+L+D + R++ FG + + T
Sbjct: 103 MARFYLA-EMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT- 157
Query: 226 ITTSNVVGTVEYIAPEYLQMLT-----LTEKCDIY-FGALLAGLVMGKLP---------S 270
+ +S VGT +YI+PE LQ + +CD + G + ++ G+ P
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
Query: 271 DKFFQHTNEMSFVKWMRNVMASENPKRAI-------DSKLVGNGCEE 310
K H F + +V SE+ K I + +L NG E+
Sbjct: 218 GKIMNHKERFQFPAQVTDV--SEDAKDLIRRLICSREHRLGQNGIED 262
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 47/219 (21%)
Query: 52 SLEK-IGSGGCGEVY--KAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
+EK IG+G GEV + +LPG+ ++IK + +
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-------------------- 46
Query: 109 SEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR 168
K+ R SE + +GQ H N+ L VT+ + I+ + + +L +
Sbjct: 47 ------KQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRK 98
Query: 169 HR-----IAL-----GLACGLEYLH-MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
H I L G+A G++YL M + +HRDL N+L++ ++ ++S FG +R
Sbjct: 99 HDGQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSR 154
Query: 218 AIP-DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
+ D TT + + APE + T D++
Sbjct: 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 26/65 (40%), Positives = 36/65 (55%), Gaps = 4/65 (6%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR-AIPDAHTHITTSNVVGTVE 236
L+Y+H + + HRDL P N+L + D + +I FG AR A D T I ++ V T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 237 YIAPE 241
Y APE
Sbjct: 172 YRAPE 176
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI---PDAHTHITTSNVVGTVEYIAPEY 242
H +IHRDL P N+LL+ D +++ FG AR++ + + ++ V T Y APE
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 243 LQMLTL-TEKCDIY-FGALLAGLVMGK 267
L T T+ D++ G +L +++GK
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 27/68 (39%), Positives = 39/68 (57%), Gaps = 9/68 (13%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTSNVVGTV 235
GL Y H +I+HRDL P N+L+++ E +++ FG ARA +P T SN V T+
Sbjct: 115 GLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK----TYSNEVVTL 167
Query: 236 EYIAPEYL 243
Y P+ L
Sbjct: 168 WYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI 238
L+ L H ++IHRD+ N+LL D +++ FGF I + +T +VGT ++
Sbjct: 125 LQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 182
Query: 239 APEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
APE + K DI+ G + +V G+ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 21/190 (11%)
Query: 63 EVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122
E+ K G G++ ++K+ G D L +M + +K +Q K + ++
Sbjct: 3 ELLKVLGTGAYGKVFLVRKVTGH--DTGKLY---AMKVLQKAALVQKA----KTVEHTRT 53
Query: 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG-------RRELDWLARHRIALG- 174
E N + +R L + + + L IL+ VS G +R+ R G
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ LE+LH I++RD+ N+LLD + ++ FG ++ T S GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGT 169
Query: 235 VEYIAPEYLQ 244
+EY+APE ++
Sbjct: 170 IEYMAPEIIR 179
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-----------I 171
E + ++RH L L A V+ +YI+ + LD+L +
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
A +A G+ Y+ + +HRDL N+L+ +++ +++ FG AR I D + +
Sbjct: 108 AAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGA 163
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
+++ APE T K D++ FG LL L G++P
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 3/92 (3%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI 238
L+ L H ++IHRD+ N+LL D +++ FGF I + S +VGT ++
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWM 183
Query: 239 APEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
APE + K DI+ G + ++ G+ P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 29/77 (37%), Positives = 43/77 (55%), Gaps = 6/77 (7%)
Query: 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHI 226
H + L L L L+ H +++HRDL P N+L+++ E +++ FG ARA IP
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---- 159
Query: 227 TTSNVVGTVEYIAPEYL 243
T SN V T+ Y P+ L
Sbjct: 160 TYSNEVVTLWYRPPDIL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 48/228 (21%)
Query: 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQI 107
G +KIG G VYKA +GR++++KK+ QI
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKV-----------------------QI 37
Query: 108 QSEMLLNKKMRQ--IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILN-----DVSQ-- 158
EM+ + K RQ ++ EI+ + Q+ H N+ LA + L +L D+S+
Sbjct: 38 -FEMM-DAKARQDCLK-EIDLLKQLDHPNVIKYLASFIE-NNELNIVLELADAGDLSRMI 93
Query: 159 -----GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
+R + + + L LE++H RI+HRD+ P NV + ++
Sbjct: 94 KHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDL 150
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
G R T ++VGT Y++PE + K DI+ G LL
Sbjct: 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 44/182 (24%)
Query: 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
LEKIG G G V+KA+ + ++++K++ L ++D + + +R
Sbjct: 3 EKLEKIGEGTYGTVFKAK-NRETHEIVALKRV--------RLDDDDEGVPSSALR----- 48
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILN----------DVSQGR 160
EI + +++H+N+ L V D L + D G
Sbjct: 49 ------------EICLLKELKHKNI-VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNG- 94
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA-- 218
++D L GL + H H+ ++HRDL P N+L++ + E +++ FG ARA
Sbjct: 95 -DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
Query: 219 IP 220
IP
Sbjct: 151 IP 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 43/177 (24%), Positives = 69/177 (38%), Gaps = 29/177 (16%)
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
IA+ L YL +IIHRD+ P N+LLD + ++ FG + + D+ I +
Sbjct: 112 IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---IAKTR 166
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIY--------FGALLAGLVMGKLPSDKFFQHTNEMSF 282
G Y+APE + D Y G L + GK P K+ S
Sbjct: 167 DAGCRPYMAPERID----PSARDGYDVRSDVWSLGITLYEVATGKFPYPKW------NSV 216
Query: 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339
+ V+ + P + + E V I C ++D ++RP K++
Sbjct: 217 FDQLTQVVKGDPPILSNSEER-----EFSPSFVNFIN-LCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 27/61 (44%), Positives = 35/61 (57%), Gaps = 5/61 (8%)
Query: 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFA-RAIPDAHTHITTSNV-VGTVEYIAPEYL 243
H +HRD+ P NVLLD + R++ FG R + D SNV VGT +YI+PE L
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---TVQSNVAVGTPDYISPEIL 175
Query: 244 Q 244
Q
Sbjct: 176 Q 176
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 182 LHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVV-----GTVE 236
+H H +IHRD+ N+LL + ++ FGF++ T S+ V GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-----MYAATVSDDVGRTFCGTPY 210
Query: 237 YIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271
Y+APE + ++K D++ G LL L+ K P D
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 8/102 (7%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
+ A +A G++YL + IHRDL NVL+ +++ ++I+ FG +R + + T
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRG-EEVYVKKTMG 178
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLP 269
+ V ++A E L T K D++ FG LL +V +G P
Sbjct: 179 RL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 7/108 (6%)
Query: 154 NDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
+D S+G LD L+ +A G+E+L +C +HRDL NVLL +I F
Sbjct: 228 DDGSEGLTTLDLLS---FTYQVARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDF 281
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
G AR I +++ + V+++APE + T D++ +G LL
Sbjct: 282 GLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 41/176 (23%), Positives = 76/176 (43%), Gaps = 24/176 (13%)
Query: 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITT 228
++A +A G+ YL +HRDL N ++ +D+ +I FG R I + +
Sbjct: 122 IQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 229 SNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE--MSFVKW 285
+ V ++APE L+ T K D++ FG +L M L + +NE + FV
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL--WEMATLAEQPYQGLSNEEVLKFVI- 235
Query: 286 MRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
+ + P+ C +++L ++++ C +P RP ++ L
Sbjct: 236 DGGHL--DLPE----------NCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 33/125 (26%), Positives = 58/125 (46%), Gaps = 18/125 (14%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
L +LH H ++IHRDL N+LL D + +++ FG + + T +GT +
Sbjct: 115 ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYW 169
Query: 238 IAPEYLQMLTLTE-----KCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMA 291
+APE + T + K DI+ G L L + P +E++ ++ + ++
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH-------HELNPMRVLLKILK 222
Query: 292 SENPK 296
SE P
Sbjct: 223 SEPPT 227
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 31/108 (28%), Positives = 47/108 (43%), Gaps = 20/108 (18%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI---------- 219
I + +EY+H ++HRDL P N+LL E I +G A
Sbjct: 117 SIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 220 -----PDAHTHITT-SNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
++ +T +VGT +Y+APE L + +E DIY G +L
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 3/92 (3%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI 238
L+ L H ++IHRD+ NVLL D +++ FGF I + +T +VGT ++
Sbjct: 125 LQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWM 182
Query: 239 APEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
APE + K DI+ G + +V G+ P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 63/262 (24%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L + KIG G G V A GR +++KK M L K+ R+
Sbjct: 21 LDNFVKIGEGSTGIVCIAT-DKSTGRQVAVKK----------------MDLRKQQRR--- 60
Query: 110 EMLLNKK--MRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYILNDVSQGRREL 163
E+L N+ MR Q H N+ V +L L+++ + +G
Sbjct: 61 ELLFNEVVIMRDYQ----------HPNI------VEMYSSYLVGDELWVVMEFLEGGALT 104
Query: 164 DWLARHRI------ALGLAC--GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
D + R+ + LA L +LH +IHRD+ ++LL D ++S FGF
Sbjct: 105 DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF 161
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274
+ ++VGT ++APE + L + DI+ G ++ +V G+ P +F
Sbjct: 162 CAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP---YF 216
Query: 275 QHTNEMSFVKWMRNVMASENPK 296
NE ++ M+ + + PK
Sbjct: 217 ---NE-PPLQAMKRIRDNLPPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 15/138 (10%)
Query: 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----LNDV-----SQGRREL---DW 165
+ E ++H NL L T +LL + L D+ S + EL D
Sbjct: 40 MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP 99
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
R+A +A GL +LH ++ IH DL N LL D+ +I +G + +
Sbjct: 100 TTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156
Query: 226 ITTSNVVGTVEYIAPEYL 243
+T + + +IAPE +
Sbjct: 157 VTPDQLWVPLRWIAPELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A G+E+L C IHRDL N+LL ++ +I FG AR I ++ +
Sbjct: 183 VARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALL 260
++++APE + T + D++ FG LL
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLL 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 26/75 (34%), Positives = 38/75 (50%), Gaps = 4/75 (5%)
Query: 182 LHMHHCPRIIHRDLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAP 240
LH H I+HRDL N+LLD + +I FG ++ + + VVGT YI+P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISP 170
Query: 241 EYLQMLTLTEKCDIY 255
E + +K DI+
Sbjct: 171 ELCEGKPYNQKSDIW 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 52/238 (21%)
Query: 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKM 104
+ + L S KIG G G V A G+ +++KK M L K+
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIAT-EKHTGKQVAVKK----------------MDLRKQQ 61
Query: 105 RQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD 164
R+ E+L N E+ + H N+ + D L+++ + +G D
Sbjct: 62 RR---ELLFN--------EVVIMRDYHHENVVDMYNSYLVGD--ELWVVMEFLEGGALTD 108
Query: 165 WLARHR--------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF- 215
+ R + L + L YLH +IHRD+ ++LL D ++S FGF
Sbjct: 109 IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC 165
Query: 216 ---ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
++ +P ++VGT ++APE + L + DI+ G ++ ++ G+ P
Sbjct: 166 AQVSKEVP------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 27/85 (31%), Positives = 46/85 (54%), Gaps = 5/85 (5%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI-PDAHTHITTSNVVGTVE 236
G++YL + +HRDL NVLL A+IS FG ++A+ D + + ++ V+
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 237 YIAPEYLQMLTLTEKCDIY-FGALL 260
+ APE + + K D++ FG L+
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 94 EEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL 153
E+DS+++ K ++ L K+ R +EI + ++H N+ H D + L I
Sbjct: 23 EDDSLVVWK---EVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM--DDNTLLIE 77
Query: 154 NDVSQGRRELDWLARHRIAL-----------GLACGLEYLHMHHCPRIIHRDLNPVNVLL 202
+ + G D + R + L + + Y+H I+HRD+ +N+ L
Sbjct: 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFL 134
Query: 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIYFGALLAG 262
++ FG ++ + ++ T VVGT Y++PE Q + K DI+ AL G
Sbjct: 135 TKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIW--AL--G 188
Query: 263 LVMGKLPS-DKFFQHTNEMSFV 283
V+ +L + + F TN ++ V
Sbjct: 189 CVLYELLTLKRTFDATNPLNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 10/96 (10%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI 238
L YL H +IHRD+ P N+LLD ++ FG + + D+ + G Y+
Sbjct: 127 LHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYM 181
Query: 239 APEYLQMLTLTEKCDI-----YFGALLAGLVMGKLP 269
APE + K DI G L L G+ P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 4/87 (4%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A G+ +L +C IHRDL N+LL +I FG AR I + ++ N
Sbjct: 223 VAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALL 260
V+++APE + T + D++ +G LL
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILL 306
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
+ + +A G+EYL IHRDL N +L +D+ ++ FG ++ I +
Sbjct: 117 KFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FG 257
V++IA E L T K D++ FG
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFG 202
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 51/204 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV-----GPPMDAAALIEEDSMLLNKKMRQI 107
LEK+G G VYK + NG+++++K I G P A I E S+L K
Sbjct: 10 LEKLGEGSYATVYKG-ISRINGQLVALKVISMKTEEGVPFTA---IREASLLKGLK---- 61
Query: 108 QSEMLLNKKMRQIQSEINTVGQIRHRNL------HPLLAHVTRPDCHLLYILNDVSQGRR 161
+ ++L + + + V + H +L HP H P L++
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH---PYNVRLFMFQ------- 111
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--I 219
L GL Y+H H I+HRDL P N+L+ E +++ FG ARA I
Sbjct: 112 -------------LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155
Query: 220 PDAHTHITTSNVVGTVEYIAPEYL 243
P T S+ V T+ Y P+ L
Sbjct: 156 PSQ----TYSSEVVTLWYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 21/152 (13%)
Query: 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH----------RI 171
SE + Q H N+ L+ T+ +YI+ ++ G L +L + +
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF 98
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
AL A G+ YL +C IHRDL N L+ ++ +IS FG +R D I +S+
Sbjct: 99 ALDAAAGMAYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSRQEDDG---IYSSSG 152
Query: 232 VGT--VEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ +++ APE L + + D++ +G LL
Sbjct: 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A G+E+L C IHRDL N+LL ++ +I FG AR I ++ +
Sbjct: 188 VAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALL 260
++++APE + T + D++ FG LL
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLL 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 9e-05
Identities = 58/243 (23%), Positives = 96/243 (39%), Gaps = 56/243 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++++G G G VY A + G +++IKK M E+ M +R+++S
Sbjct: 4 IKQLGDGTFGSVYLARNK-ETGELVAIKK-----MKKKFYSWEECM----NLREVKSLRK 53
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG------RRELDWL 166
LN+ H N+ L V R + L ++ + R+
Sbjct: 54 LNE----------------HPNIVKLK-EVFRENDELYFVFEYMEGNLYQLMKDRKGKPF 96
Query: 167 ARHRIA---LGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ I + GL ++H H HRDL P N+L+ +I+ FG AR I
Sbjct: 97 SESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKC-----DIY-FGALLAGLVMGKLPSDKFFQHT 277
+ ++ V T Y APE L L DI+ G ++A L + P F +
Sbjct: 154 PY---TDYVSTRWYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR-P---LFPGS 202
Query: 278 NEM 280
+E+
Sbjct: 203 SEI 205
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 24/67 (35%), Positives = 38/67 (56%), Gaps = 5/67 (7%)
Query: 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250
IHRD+ P N+LLD +++ FG + DA+ + VGT +YI+PE L+ ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLK----SQ 218
Query: 251 KCDIYFG 257
D Y+G
Sbjct: 219 GGDGYYG 225
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 7/82 (8%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI 238
LE L H +IIHRDL NVLL D + +++ FG + + T + +GT ++
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWM 177
Query: 239 APEYLQMLTLTE-----KCDIY 255
APE + T+ + K DI+
Sbjct: 178 APEVVMCETMKDTPYDYKADIW 199
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV 231
+ +A G+E+L C IHRDL N+LL ++ +I FG AR I ++ +
Sbjct: 179 SFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
++++APE + T + D++ FG LL
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 43/180 (23%), Positives = 70/180 (38%), Gaps = 23/180 (12%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
R+A +A GL +LH IH DL N L D+ +I +G A +IT
Sbjct: 104 RMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160
Query: 230 NVVGTVEYIAPEY-------LQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
+ ++APE L T+K +I+ G + + + ++E
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM--WELFTAADQPYPDLSDEQV 218
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
+ +R + PK +D K E FC L DP RP +++V +L+
Sbjct: 219 LKQVVRE-QDIKLPKPQLDLKYSDRWYEVMQ--------FCWL-DPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 49/207 (23%), Positives = 75/207 (36%), Gaps = 69/207 (33%)
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA--------- 216
LAR IA L C +E +H IHRD+ P N+L+D D +++ FG
Sbjct: 102 LARFYIA-ELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 217 ------------------------------------RAIPDAHTHITTSNVVGTVEYIAP 240
R H ++VGT YIAP
Sbjct: 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217
Query: 241 EYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT---NEMSFVKWMRNV----MAS 292
E L T+ CD + G +L +++G+ P F T +M + W ++ A
Sbjct: 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPP---FLAQTPLETQMKVINWQTSLHIPPQAK 274
Query: 293 ENPK---------RAIDSKLVGNGCEE 310
+P+ R + +L NG +E
Sbjct: 275 LSPEASDLIIKLCRGPEDRLGKNGADE 301
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 26/68 (38%), Positives = 39/68 (57%), Gaps = 9/68 (13%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTSNVVGTV 235
GL Y H +++HRDL P N+L+++ E +++ FG ARA +P T SN V T+
Sbjct: 116 GLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK----TYSNEVVTL 168
Query: 236 EYIAPEYL 243
Y P+ L
Sbjct: 169 WYRPPDVL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 43/166 (25%), Positives = 67/166 (40%), Gaps = 23/166 (13%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
G+EYL + IHRDL N L+ ++S FG R + D + ++S V++
Sbjct: 112 GMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKW 167
Query: 238 IAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENP 295
PE + K D++ FG L+ + GK+P F+ + V+ M S
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP----FEKKSNYEVVE-----MISRG- 217
Query: 296 KRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
R KL E M C E P RP ++ R ++
Sbjct: 218 FRLYRPKLASMTVYEVMYS-------CWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 48/217 (22%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 46 KKGGLASLEKIGSGGCGEVYKAEL----PGQNGRMISIKKIVGPPMDAAALIEEDSMLLN 101
K+ + ++G G G+V+ AE P Q+ ++++K + +A ++ LL
Sbjct: 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLT 62
Query: 102 KKMRQIQSEMLLNKKMRQIQSE--INTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQ 158
+Q E ++ ++ + I ++H +L+ L AH PD L+ N +
Sbjct: 63 ----NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH--GPDAVLMAEGNRPA- 115
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
EL IA +A G+ YL H +HRDL N L+ +++ +I FG +R
Sbjct: 116 ---ELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRD 169
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
+ + + + + ++ PE + T + D++
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 206
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
DW+A I + GL +LH H +IHRD+ NVLL ++ E ++ FG + +
Sbjct: 121 DWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--R 173
Query: 224 THITTSNVVGTVEYIAPEYL 243
T + +GT ++APE +
Sbjct: 174 TVGRRNTFIGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 13/107 (12%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
RI + GL++L H IIHRD+ P NVL++ + + ++ FG + + + + +
Sbjct: 106 RITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKT 160
Query: 230 NVVGTVEYIAPEYL------QMLTLTEKCDIY-FGALLAGLVMGKLP 269
N +G Y+APE + Q T T + D++ G + + +G+ P
Sbjct: 161 N-IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 29/158 (18%)
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------------- 159
++ + + E + Q++H N+ D LLYI+ +G
Sbjct: 41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG-LLYIVMGFCEGGDLYHKLKEQKGKLL 99
Query: 160 --RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ ++W + +A L+YLH H I+HRDL NV L ++ G AR
Sbjct: 100 PENQVVEWFVQ------IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR 150
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
+ + S ++GT Y++PE K D++
Sbjct: 151 VLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVW 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 50/201 (24%), Positives = 79/201 (39%), Gaps = 41/201 (20%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+ L +IG G G VY A +N +++IKK+ S
Sbjct: 17 FSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMS------------------------YS 51
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQ----GRRE 162
N+K + I E+ + ++RH N R L Y L S ++
Sbjct: 52 GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP 111
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
L + + G GL YLH H+ +IHRD+ N+LL + ++ FG A + A
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 223 HTHITTSNVVGTVEYIAPEYL 243
+ VGT ++APE +
Sbjct: 169 NX------FVGTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 183 HMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEY 242
H+H R++HRD+ N+ L + + ++ FG AR + + T VGT Y+ PE
Sbjct: 115 HIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEI 171
Query: 243 LQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ + K DI+ G +L L K P
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 47/186 (25%), Positives = 82/186 (44%), Gaps = 21/186 (11%)
Query: 102 KKMRQIQSEMLLNKKMRQIQSEINTVGQIRH----RNLHPLLAHVT---RPDCHLLYILN 154
KK +I + ++ K++ +I+ V +H + HP L + + + L +++
Sbjct: 17 KKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 76
Query: 155 DVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI 206
V+ G +R+L + ++ L YLH II+RDL NVLLD +
Sbjct: 77 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEG 133
Query: 207 EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM 265
+++ +G + TTS GT YIAPE L+ D + G L+ ++
Sbjct: 134 HIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
Query: 266 GKLPSD 271
G+ P D
Sbjct: 192 GRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 5/92 (5%)
Query: 182 LHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR-AIPDAHTHITTSNVVGTVEYIAP 240
L+ H II+RDL NVLLD + +++ +G + I TTS GT YIAP
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAP 165
Query: 241 EYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271
E L+ D + G L+ ++ G+ P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 28/108 (25%), Positives = 52/108 (48%), Gaps = 8/108 (7%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
RIA+ + GL YL +I+HRD+ P N+L++ + ++ FG + + ++
Sbjct: 99 RIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAK 151
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
VGT Y+APE + D++ G L +G+ P + ++
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 38/221 (17%)
Query: 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114
KIG G G V A + +G+++++KK M L K+ R+ E+L N
Sbjct: 27 KIGEGSTGIVCIATVK-SSGKLVAVKK----------------MDLRKQQRR---ELLFN 66
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR---- 170
E+ + +H N+ + D L+++ + +G D + R
Sbjct: 67 --------EVVIMRDYQHENVVEMYNSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEE 116
Query: 171 -IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
IA L+ L + H +IHRD+ ++LL D ++S FGF +
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RK 174
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
++VGT ++APE + L + DI+ G ++ +V G+ P
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 47/187 (25%), Positives = 79/187 (42%), Gaps = 21/187 (11%)
Query: 63 EVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122
E+ K G G++ ++K+ G D+ L +M + KK +Q K ++
Sbjct: 3 ELLKVLGTGAYGKVFLVRKVSG--HDSGKLY---AMKVLKKATIVQKA----KTTEHTRT 53
Query: 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-------IALG- 174
E + IR L + + D L IL+ ++ G R R I G
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ LE+LH II+RD+ N+LLD + ++ FG ++ + S GT
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169
Query: 235 VEYIAPE 241
+EY+AP+
Sbjct: 170 IEYMAPD 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
L G+ Y+H RI+HRDL N+ L +++ +I FG +R + + TT GT
Sbjct: 115 LLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGT 168
Query: 235 VEYIAPEYLQMLTLTEKCDIY 255
Y++PE L+ K DI+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIW 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 31/111 (27%), Positives = 49/111 (44%), Gaps = 15/111 (13%)
Query: 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245
H +IHRD+ P N+LLD +++ FG + D + VGT +YI+PE L+
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKS 217
Query: 246 LT----LTEKCDIY-FGALLAGLVMGKLP---------SDKFFQHTNEMSF 282
+CD + G L +++G P K H N ++F
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF 268
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 36/194 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKI-VGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
+++IGSG G+VYKA G + +IK I + P D A + +E M+ + K I +
Sbjct: 14 IQRIGSGTYGDVYKAR-NVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 112 --LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRP--DCHLLYILNDVSQGRRELDWLA 167
L + I E G ++ + HVT P + + Y+ + QG
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQD------IYHVTGPLSESQIAYVSRETLQG-------- 118
Query: 168 RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT 227
L YLH +HRD+ N+LL D+ +++ FG + I T
Sbjct: 119 -----------LYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQI--TATIAK 162
Query: 228 TSNVVGTVEYIAPE 241
+ +GT ++APE
Sbjct: 163 RKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 30/102 (29%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
A +A G++YL + IHRDL N+L+ ++ A+I+ FG +R + + T
Sbjct: 116 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMG 171
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLP 269
+ V ++A E L T D++ +G LL +V +G P
Sbjct: 172 RL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD-IEARISGFGFARAIPD 221
L W + I+LGL H+H +I+HRD+ N+ L + + A++ FG AR + D
Sbjct: 104 LSWFVQ--ISLGLK------HIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+ T VGT Y++PE Q K DI+ G +L L K P
Sbjct: 155 SMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 3/91 (3%)
Query: 182 LHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPE 241
L+ H II+RDL NVLLD D +++ +G + TTS GT YIAPE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPE 166
Query: 242 YLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271
L+ D + G L+ ++ G+ P D
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 15/111 (13%)
Query: 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245
H IHRD+ P N+LLD +++ FG + + + VGT +YI+PE L+
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 246 LT----LTEKCDIY-FGALLAGLVMGKLP---------SDKFFQHTNEMSF 282
+CD + G L +++G P K H N ++F
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 268
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 13/103 (12%)
Query: 163 LDWLARHRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISG 212
LD + +HR +L +A G+ YL H R++HR+L N+LL D +I+
Sbjct: 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152
Query: 213 FGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
FG A + S ++++A E + T + D++
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVW 195
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTH--ITTSNVVGT 234
GL+Y+H ++HRDL P NV ++ +D+ +I FG AR + ++H + +V T
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-T 181
Query: 235 VEYIAPE-YLQMLTLTEKCDIY-FGALLAGLVMGK 267
Y +P L T+ D++ G + A ++ GK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A G+E+L +C +HRDL NVL+ + +I FG AR I +I+ +
Sbjct: 248 VANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALL 260
++++APE + T D++ FG LL
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILL 331
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 30/155 (19%)
Query: 102 KKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---------YI 152
KKM + N+K + I E+ + Q++H N + C+L Y
Sbjct: 52 KKMSYSGKQT--NEKWQDIIKEVKFLQQLKHPNT------IEYKGCYLKEHTAWLVMEYC 103
Query: 153 LNDVSQ----GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
L S ++ L + I G GL YLH H+ +IHRD+ N+LL + +
Sbjct: 104 LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQV 160
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL 243
+++ FG A A++ VGT ++APE +
Sbjct: 161 KLADFGSASKSSPANS------FVGTPYWMAPEVI 189
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 55/245 (22%), Positives = 92/245 (37%), Gaps = 38/245 (15%)
Query: 104 MRQIQSEMLLNKKMRQ-IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE 162
++++Q L++ K R EI+ + Q+ H N+ A D L +L G +
Sbjct: 32 LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAG--D 88
Query: 163 LDWLARH--------------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
L + +H + + L LE++H R++HRD+ P NV +
Sbjct: 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV 145
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
++ G R T ++VGT Y++PE + K DI+ G LL M
Sbjct: 146 KLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL--YEMAA 201
Query: 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327
L S + N S K + P +L ++ C DP
Sbjct: 202 LQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL------------RQLVNMCINPDP 249
Query: 328 NERPN 332
+RP+
Sbjct: 250 EKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 34/130 (26%), Positives = 51/130 (39%), Gaps = 37/130 (28%)
Query: 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAH--------THITTSN------------ 230
IHRD+ P N+LLD ++S FG + AH TH S+
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 231 -------------VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
VGT +YIAPE + CD + G ++ +++G P F
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP---FCSE 239
Query: 277 TNEMSFVKWM 286
T + ++ K M
Sbjct: 240 TPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 47/231 (20%), Positives = 95/231 (41%), Gaps = 47/231 (20%)
Query: 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
L + +G G GEV+ A+ G ++++L K +++ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKG------------------IEEEGGETLVLVKALQKTK 47
Query: 109 SEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH---LLYI-LND------VSQ 158
E L ++ R E++ ++ H+N+ LL + H L Y L D ++
Sbjct: 48 DENLQSEFRR----ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATK 103
Query: 159 GRRE------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISG 212
+ E L + + +A G+++L R +HRDL N L+ E ++S
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160
Query: 213 FGFARAI--PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
++ + + + N + + ++APE +Q + K D++ FG L+
Sbjct: 161 LSLSKDVYNSEYYKL---RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 39/176 (22%), Positives = 73/176 (41%), Gaps = 22/176 (12%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
R + +A G+EYL + IHRDL N +L++++ ++ FG ++ I +
Sbjct: 117 RFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSDKFFQHTNEMSFVKWMR 287
V+++A E L T D++ FG + ++ G+ P + ++
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP----YAGVENSEIYNYL- 228
Query: 288 NVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
+ K+ D C E V ++ C C +P RP+ + +R L I
Sbjct: 229 --IKGNRLKQPPD-------CLED---VYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 8e-04
Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 9/73 (12%)
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
I G GL YLH H+ +IHRD+ N+LL + + +++ FG A A++
Sbjct: 130 ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------ 180
Query: 231 VVGTVEYIAPEYL 243
VGT ++APE +
Sbjct: 181 FVGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 23/80 (28%), Positives = 42/80 (52%), Gaps = 1/80 (1%)
Query: 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245
H +++HRDL N+ L ++ FGF++ D+ + S+ GT Y+APE +
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 246 LTLTEKCDIY-FGALLAGLV 264
++K D++ G +L L+
Sbjct: 246 KRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 23/72 (31%), Positives = 40/72 (55%), Gaps = 5/72 (6%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
+IA+ + LEYLH +IHRD+ P NVL++ + + ++ FG + + D+ + +
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 230 NVVGTVEYIAPE 241
G Y+APE
Sbjct: 162 IDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 8/119 (6%)
Query: 152 ILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARIS 211
+ + VSQ R L +IA L+ L H +IHRD+ ++LL D ++S
Sbjct: 105 LTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLS 159
Query: 212 GFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
FGF I + ++VGT ++APE + + DI+ G ++ +V G+ P
Sbjct: 160 DFGFCAQI--SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 23/161 (14%)
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD-WLARHRIA 172
+K+ R +E T+GQ H N+ L +TR + ++ + +S G LD +L +H
Sbjct: 47 DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT-MMIVTEYMSNG--ALDSFLRKHEGQ 103
Query: 173 L----------GLACGLEYL-HMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
L GLA G++YL M + +H+ L VL++ D+ +ISGF R D
Sbjct: 104 LVAGQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR--RLQED 157
Query: 222 AHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
I TT + V + APE +Q + D++ FG ++
Sbjct: 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVM 198
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVV----G 233
G+ YLH ++C ++HRD+ NV+L + ++ FG AR + H T SN++ G
Sbjct: 114 GVAYLH-NNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 234 TVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
T ++APE + K DI+ G + + GK P
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 33/98 (33%), Positives = 43/98 (43%), Gaps = 13/98 (13%)
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
I L L YLH IIHRD+ N+ LD+ A + FG A + H T
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQ 243
Query: 231 V---VGTVEYIAPEYLQMLTLTEKCDIYFGALLAGLVM 265
GT+E +PE L + K DI+ AGLV+
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWS----AGLVL 277
|
Length = 392 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 22/66 (33%), Positives = 37/66 (56%), Gaps = 5/66 (7%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
GL +LH H ++IHRD+ NVLL ++ E ++ FG + + T + +GT +
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYW 177
Query: 238 IAPEYL 243
+APE +
Sbjct: 178 MAPEVI 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 43/198 (21%), Positives = 77/198 (38%), Gaps = 30/198 (15%)
Query: 75 RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRN 134
+ + +KKI A L++ +++I + K+ + + E+ + ++H N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 135 LHPLLAHVTRPDCHLLYILNDVSQG-----------------RRELDWLARHRIALGLAC 177
+ LYI+ D +G + LDW + I L L
Sbjct: 61 IVQYQESFEENGN--LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLALK- 115
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
H+H +I+HRD+ N+ L D ++ FG AR + T +GT Y
Sbjct: 116 -----HVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYY 167
Query: 238 IAPEYLQMLTLTEKCDIY 255
++PE + K DI+
Sbjct: 168 LSPEICENRPYNNKSDIW 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 33/130 (25%), Positives = 51/130 (39%), Gaps = 37/130 (28%)
Query: 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAH-------------THITTSNV------ 231
IHRD+ P N+LLD ++S FG + AH + T N+
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 232 --------------VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
VGT +YIAPE + CD + G ++ +++G P F
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP---FCSE 239
Query: 277 TNEMSFVKWM 286
T + ++ K M
Sbjct: 240 TPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 25/92 (27%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTS 229
++A +A G+ YL+ + + +HRDL N ++ +D +I FG R I + +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 230 NVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ V +++PE L+ T D++ FG +L
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 20/118 (16%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--------IPDAHTHITT-- 228
LEYLH + I+HRDL P N+L+ +++ FG ++ + + H T
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 229 ---SNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
V GT EYIAPE + + D + G +L ++G +P FF T E F
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP---FFGDTPEELF 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 22/77 (28%), Positives = 38/77 (49%), Gaps = 5/77 (6%)
Query: 166 LARHRIALG-LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ R+ + + L++LH II+RD+ N+LLD + ++ FG ++
Sbjct: 104 ESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 225 HITTSNVVGTVEYIAPE 241
S GT+EY+APE
Sbjct: 161 ERAYS-FCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 24/65 (36%), Positives = 39/65 (60%), Gaps = 6/65 (9%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVE 236
GL+YLH + +I+HRD+ NVL++ +IS FG ++ + A + T GT++
Sbjct: 120 GLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQ 174
Query: 237 YIAPE 241
Y+APE
Sbjct: 175 YMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 20/65 (30%), Positives = 36/65 (55%), Gaps = 1/65 (1%)
Query: 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI 238
++ +H H I+HRD+ P N+L+ + ++ FGFAR + + ++ + V T Y
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYR 168
Query: 239 APEYL 243
+PE L
Sbjct: 169 SPELL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 38/175 (21%), Positives = 82/175 (46%), Gaps = 28/175 (16%)
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
IA +A G+ YL +HRDL N L+ +++ +I+ FG +R I A + + N
Sbjct: 135 IAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDIYFGALLAGLVMGKLPS---DKFFQHTNEMSFVKWMR 287
+ ++ PE + T + D++ A G+V+ ++ S ++ +E + ++R
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVW--AY--GVVLWEIFSYGMQPYYGMAHE-EVIYYVR 246
Query: 288 --NVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340
NV++ + C ++ ++++ C + P++RP+ + R+L
Sbjct: 247 DGNVLSCP------------DNCPLELYNLMRL---CWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 17/43 (39%), Positives = 28/43 (65%), Gaps = 3/43 (6%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+A L+YLH H IIHRDL P N+L+ ++ +++ FG ++
Sbjct: 113 VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 10/90 (11%)
Query: 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN 230
I G GL++LH + RIIHRD+ N+LL + ++ FG + + TS
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 231 VVGTVEYIAPEYLQM-----LTLTEKCDIY 255
VGT ++APE + + +CD++
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVW 217
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 345 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.23 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.13 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.99 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.93 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.74 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.72 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.7 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.69 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.35 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.29 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.16 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.99 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.91 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.89 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.83 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.2 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.03 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.92 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.83 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.78 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.26 | |
| PLN02236 | 344 | choline kinase | 94.68 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.23 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.17 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.1 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.87 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.83 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.69 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 93.17 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.78 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 90.19 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 89.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 89.3 | |
| PTZ00384 | 383 | choline kinase; Provisional | 88.87 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 88.1 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 87.87 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 87.31 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 85.83 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 85.58 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=340.72 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=202.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++++.+..||+|+.|+||+++++ .+++.+|+|.+.... .....+++.+|+++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~--------------------------~~~~~~Qi~rEl~i 130 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNI--------------------------DPALQKQILRELEI 130 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEc-CCCeEEEEEeecccC--------------------------CHHHHHHHHHHHHH
Confidence 347888999999999999999975 689999999994321 13457889999999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHM-HHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~-~~~~~iiH~dlk 196 (345)
++..+||+||.+||.|..++. .+.++||||++|++ +++....+++.++++||.|||+ ++ |+|||||
T Consensus 131 l~~~~spyIV~~ygaF~~~~~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIK 206 (364)
T KOG0581|consen 131 LRSCQSPYIVGFYGAFYSNGE-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIK 206 (364)
T ss_pred HhhCCCCCeeeEeEEEEeCCc-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCC
Confidence 999999999999999998885 69999999999876 4555567899999999999996 66 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|+|++..|.+||||||++..+-++ ..++++||..|||||.+++..|+.++||| ||++++|+++|++||...
T Consensus 207 PsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-- 280 (364)
T KOG0581|consen 207 PSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-- 280 (364)
T ss_pred HHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--
Confidence 99999999999999999999877554 34679999999999999999999999999 999999999999998654
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.+..+...+.|. ++.+. ...++..++..||+.||.+|||+.++++
T Consensus 281 ~~~~~~~~~Ll~~Iv~~ppP~------lP~~~---fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 281 NPPYLDIFELLCAIVDEPPPR------LPEGE---FSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCHHHHHHHHhcCCCCC------CCccc---CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 223344445554444333321 22222 2334677788899999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=330.19 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=202.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|+++++||+|+||+||++... .+|+.+|.|.+.- ++...+..+....|+.
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f-------------------------~~md~k~rq~~v~Ei~ 70 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQF-------------------------GMMDAKARQDCVKEIS 70 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcch-------------------------hhccHHHHHHHHHHHH
Confidence 4458999999999999999999854 6899999999853 2333566888999999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCC-CCeE
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHC-PRII 191 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~-~~ii 191 (345)
+|++|+|||||+++++...++...++++||+|+.|++ +++..+++++.|++.||.++|+... +.++
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 9999999999999996655555678999999988654 6777888999999999999999431 2499
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||||||.||+++.+|.+|++|||+++.+.+... ...+.+||+.||+||.+.+.+|+.++||| +||++|||..-.+||
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999998865432 34568999999999999999999999999 999999999999995
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
.+.+..++.+.|.....++.|. .-...++..+|..|+..||+.||+...+++.+.
T Consensus 229 ----~g~n~~~L~~KI~qgd~~~~p~------------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 229 ----YGDNLLSLCKKIEQGDYPPLPD------------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----ccccHHHHHHHHHcCCCCCCcH------------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 3345555555555443222221 223345677778899999999998555555443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=345.44 Aligned_cols=255 Identities=30% Similarity=0.443 Sum_probs=205.3
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCCCce-eEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRM-ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
..++.++.+++.+...||+|+||+||+|.|+ |.. ||||.+.....+. ...+
T Consensus 33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~-------------------------~~~~ 84 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDD-------------------------ESRK 84 (362)
T ss_pred ccceecChHHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcCh-------------------------HHHH
Confidence 3556778888899999999999999999996 445 9999997654432 1267
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
.|.+|+.+|++++|||||+++|++..+.. .+.+++||+++|++ +++..+.+++.||+.|+.|||+.+
T Consensus 85 ~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~- 162 (362)
T KOG0192|consen 85 AFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG- 162 (362)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 89999999999999999999999988763 68999999998754 566667889999999999999997
Q ss_pred CCeEecCCCCCCeeecCCC-CeEEeccccceecCCCCcceeccCcccCcccccccccc--ccccCccchhh-HHHHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDI-EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ--MLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~--~~~~~~~~Dvw-lG~vl~el 263 (345)
+||||||||+|+|++.++ ++||+|||+++...... ...+...||..|||||++. ..+++.++||| ||+++|||
T Consensus 163 -~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 163 -PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL 239 (362)
T ss_pred -CeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence 399999999999999997 99999999998765432 1233478999999999999 55899999999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHH-HHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWM-RNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
+||..||.+... ......+ ....+...+ .++...+..+|..||+.||+.||++.+++..|+.
T Consensus 240 ~t~~~Pf~~~~~----~~~~~~v~~~~~Rp~~p-------------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~ 302 (362)
T KOG0192|consen 240 LTGEIPFEDLAP----VQVASAVVVGGLRPPIP-------------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES 302 (362)
T ss_pred HHCCCCCCCCCH----HHHHHHHHhcCCCCCCC-------------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence 999999755322 2222222 122222211 2244458888889999999999999999999997
Q ss_pred hh
Q 046907 343 IQ 344 (345)
Q Consensus 343 l~ 344 (345)
+.
T Consensus 303 ~~ 304 (362)
T KOG0192|consen 303 IM 304 (362)
T ss_pred HH
Confidence 63
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=351.93 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=212.7
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
.-.|..+.+.+.+++.||+|-||+||.|+|+ ....||+|.++....+ .+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~~m~----------------------------~~~ 247 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEGSMS----------------------------PEA 247 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEeccccC----------------------------hhH
Confidence 3457888889999999999999999999996 3447999999765333 456
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH-----------HHHHHHHHHHHHHHHhhcCCC
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA-----------RHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~-----------~~~i~~~i~~~l~~lh~~~~~ 188 (345)
|.+|+++|++|+|+|||++++++..++ .+++|+||+..|+++++++ ...++.|||+|++||.+++
T Consensus 248 f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~-- 323 (468)
T KOG0197|consen 248 FLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN-- 323 (468)
T ss_pred HHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--
Confidence 779999999999999999999999876 6999999999887766654 4679999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
+|||||.++|||++.+..+||+|||+|+...+...... ....-+..|+|||.+....++.+|||| ||++||||+| |
T Consensus 324 -~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 324 -YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred -ccchhhhhhheeeccCceEEEcccccccccCCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence 99999999999999999999999999996655443322 233447889999999999999999999 9999999999 8
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..|| ......+.++.+.++.+.+.|.. |+..+.++|..||+.+|++|||++.+...|+.+.
T Consensus 402 ~~py----~~msn~ev~~~le~GyRlp~P~~-------------CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 402 RVPY----PGMSNEEVLELLERGYRLPRPEG-------------CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCC----CCCCHHHHHHHHhccCcCCCCCC-------------CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 9994 44566777788877777666543 3334778999999999999999999999998874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.83 Aligned_cols=276 Identities=32% Similarity=0.553 Sum_probs=230.0
Q ss_pred hhhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 36 KKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 36 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
....-.++..++++|.-...||+|+||.||+|... +|..||||++...... .
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~--------------------------~ 114 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQ--------------------------G 114 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCc--------------------------c
Confidence 33455667889999999999999999999999985 6689999988653211 0
Q ss_pred HHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhh
Q 046907 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHM 184 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~ 184 (345)
..+|.+|+.++.+++|||+|+++|+|.+.+. ..++|.||+.+|+ .++|..+.+|+.++|+||.|||+
T Consensus 115 -~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~ 192 (361)
T KOG1187|consen 115 -EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHE 192 (361)
T ss_pred -hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHcc
Confidence 3449999999999999999999999998874 5788889988753 46899999999999999999999
Q ss_pred cCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCc-ccCccccccccccccccCccchhh-HHHHHHH
Q 046907 185 HHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV-VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAG 262 (345)
Q Consensus 185 ~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~e 262 (345)
...++|+|||||++|||+|.++++||+|||+|+.......+.. .. .||.+|+|||+...+..+.++||| ||+++.|
T Consensus 193 ~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~--~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllE 270 (361)
T KOG1187|consen 193 GCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVS--TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLE 270 (361)
T ss_pred CCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccccee--eecCCCCccCChhhhccCCcCcccccccchHHHHH
Confidence 9877899999999999999999999999999966543111111 12 799999999999988899999999 9999999
Q ss_pred HHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcccccccc-CCCcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 263 LVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLV-GNGCE-EQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 263 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
++||+.|.+... ......+..|............++|+++. ..... ++...+..++..|++.+|.+||+|.+|++.|
T Consensus 271 litgr~~~d~~~-~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 271 LITGRKAVDQSR-PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHhCCcccCCCC-CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 999998865422 23344478888777777788888999987 44443 6888899999999999999999999999999
Q ss_pred hhhh
Q 046907 341 SQIQ 344 (345)
Q Consensus 341 ~~l~ 344 (345)
+.+.
T Consensus 350 ~~~~ 353 (361)
T KOG1187|consen 350 EGIL 353 (361)
T ss_pred Hhhc
Confidence 7764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=332.12 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=199.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.+.|.+.+.||+|+||.|-+|. ..++|+.||||++........... ........+|++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~-e~~tgk~vAiKIi~krk~~~~s~~--------------------~~~~~~v~~Eie 228 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAY-EKKTGKQVAIKIINKRKSTGCSRA--------------------IAKTRDVQNEIE 228 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEE-EcccCcEEEeeeeehhhccccccc--------------------ccchhhhHHHHH
Confidence 56688889999999999999997 457999999999976443322110 112334679999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH---------HHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA---------RHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~---------~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|++++|||||++++++..++ ..|+|+||++||.+++..- ...++.|++.|+.|||++| |+|||||
T Consensus 229 ILkkL~HP~IV~~~d~f~~~d--s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiK 303 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPD--SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIK 303 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCC--ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCC
Confidence 999999999999999999988 6799999999998876553 3469999999999999999 9999999
Q ss_pred CCCeeecCC---CCeEEeccccceecCCCCcceeccCcccCcccccccccccccc---Cccchhh-HHHHHHHHHhCCCC
Q 046907 197 PVNVLLDDD---IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 197 ~~nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~---~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|+|||+..+ ..+||+|||+|+..+.. ....+.+||+.|.|||++.+... ..+.|+| +||++|-+++|.+|
T Consensus 304 PeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 304 PENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 999999865 78999999999976533 24577999999999999977653 3478999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|.+.+.. ..+.+.+..+.....+ ....+..++.++||.++|..||++|||++++++
T Consensus 381 FS~~~~~---~sl~eQI~~G~y~f~p----------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 381 FSEEYTD---PSLKEQILKGRYAFGP----------LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccccCC---ccHHHHHhcCcccccC----------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 8665443 2244444433322211 223445566889999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=321.59 Aligned_cols=241 Identities=26% Similarity=0.402 Sum_probs=189.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+.+.||+|+||+||+|+++ .++..||||.+.... ++.+..+-+..|+.
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~-~~~~~VAIK~i~~~~-------------------------l~~k~~e~L~~Ei~ 61 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHK-KSGTEVAIKCIAKKK-------------------------LNKKLVELLLSEIK 61 (429)
T ss_pred ccccceehhhccCcceEEEEEeEec-cCCceEEeeeehhhc-------------------------cCHHHHHHHHHHHH
Confidence 5679999999999999999999976 567999999995321 12455777889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|+.++|||||.+++++..++ ++++|||||.||++ +++.....++.|++.|+++||+++ |+|||||
T Consensus 62 iLkel~H~nIV~l~d~~~~~~--~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLK 136 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDD--FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLK 136 (429)
T ss_pred HHHhcCCcceeeEEEEEecCC--eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCC
Confidence 999999999999999999888 89999999999876 455556689999999999999999 9999999
Q ss_pred CCCeeecCC------CCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 197 PVNVLLDDD------IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 197 ~~nil~~~~------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|+|||++.. ..+||+|||+|+.+.... ...+.+|++.|||||++....|+.|+|+| .|+++|+|++|+.|
T Consensus 137 PQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 137 PQNILLSTTARNDTSPVLKIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred cceEEeccCCCCCCCceEEecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC
Confidence 999999864 568999999999887543 34568999999999999999999999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
|+ .....++..+++......... .........+++...++.+|.+|-++.+
T Consensus 214 f~----a~t~~eL~~~~~k~~~~~~~~-----------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 214 FD----AETPKELLLYIKKGNEIVPVL-----------PAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred cc----ccCHHHHHHHHhccccccCch-----------hhhccCchhhhhhHHHhcCccccCchHH
Confidence 54 334455555444333221110 0111111345555566667777765543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=312.08 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=205.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.|+.+.++|+|+||+||+|+.+ .+|..||||.+....-+ ....+-.++|++.|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd-------------------------~~VkKIAlREIrmL 55 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDD-------------------------PVVKKIALREIRML 55 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-CcccEEEEEeeccCCcc-------------------------HHHHHHHHHHHHHH
Confidence 46889999999999999999954 78999999999643322 22355678999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++|||+|.++.+|.... .+++|+|||+. ...++.....+++.|++.|+.|||+++ ++||||||+
T Consensus 56 KqLkH~NLVnLiEVFrrkr--klhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPE 130 (396)
T KOG0593|consen 56 KQLKHENLVNLIEVFRRKR--KLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPE 130 (396)
T ss_pred HhcccchHHHHHHHHHhcc--eeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChh
Confidence 9999999999999998776 68888898864 344677778899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
|||++.++.+|+||||.|+.+..... ..+.++.|..|.|||.+.+ -.|+...||| .||++.||++|.+.|++
T Consensus 131 NILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG---- 204 (396)
T KOG0593|consen 131 NILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG---- 204 (396)
T ss_pred heEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC----
Confidence 99999999999999999998864322 3345788999999999988 5699999999 99999999999999654
Q ss_pred cchhhHHHHHHHHhhhcCCCc--c---------------ccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKR--A---------------IDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~--~---------------~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.++.+.+..|+..++.-.+.. + -.++..+.-++....-+++++..|++.||++|++.++++.
T Consensus 205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 205 RSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 466666666766665443321 0 1111222234455557899999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=333.35 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=199.1
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
..|..++.||+|+|+.||.++. ..+|+.||+|++... ........+...+|+++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~-~~tge~~A~KvVpk~------------------------~l~k~~~reKv~~EIeIH 72 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARD-LDTGEVVAVKVVPKK------------------------LLKKPKQREKVLNEIEIH 72 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEE-cCCCcEEEEEEeehH------------------------HhcCcchHHHHHHHHHHH
Confidence 6899999999999999999995 358999999999532 122245688889999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.|+|||||+++++|++.+ .+|++.|+|..+++ +++..+..++.||+.||.|||+.+ |+|||||..
T Consensus 73 r~L~HpnIV~f~~~FEDs~--nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLG 147 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSN--NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLG 147 (592)
T ss_pred HhcCCCcEEeeeeEeecCC--ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchh
Confidence 9999999999999999887 79999999988765 556667789999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|++++++.++||+|||+|..+...+. .-.+.+||+.|.|||++.....+..+||| +||++|-|+.|++||+. .
T Consensus 148 NlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet----k 221 (592)
T KOG0575|consen 148 NLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET----K 221 (592)
T ss_pred heeecCcCcEEecccceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc----c
Confidence 99999999999999999998875433 23458999999999999999999999999 99999999999999643 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+-.+....++.....-+ ........+||..+|+.||.+|||+++|+.
T Consensus 222 ~vkety~~Ik~~~Y~~P--------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 TVKETYNKIKLNEYSMP--------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hHHHHHHHHHhcCcccc--------------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33333334433322111 122233678888999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.22 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=208.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.-++|.++++||.|+||.||+|+ ...+|+.||||.++....+-. -..-++|+.
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~-~~~~~~~VAIK~MK~Kf~s~e--------------------------e~~nLREvk 60 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAK-SKETGELVAIKKMKKKFYSWE--------------------------ECMNLREVK 60 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEee-ecCCCceeeHHHHHhhhccHH--------------------------HHHHHHHHH
Confidence 44689999999999999999999 457899999999965443322 122367999
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.|++|+ |||||++.+.+.+.+. .+++|+||++. +.+++...+..|+.||++||.|+|.+| +.|||+
T Consensus 61 sL~kln~hpniikL~Evi~d~~~-~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDl 136 (538)
T KOG0661|consen 61 SLRKLNPHPNIIKLKEVIRDNDR-ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDL 136 (538)
T ss_pred HHHhcCCCCcchhhHHHhhccCc-eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccC
Confidence 999998 9999999999887775 89999999864 567899999999999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+|||+.....+||+|||+|+...+.. ..+.++.|..|.|||++... .|+.+.|+| +||+++|+.+-++.
T Consensus 137 KPENiLi~~~~~iKiaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL---- 209 (538)
T KOG0661|consen 137 KPENILISGNDVIKIADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL---- 209 (538)
T ss_pred ChhheEecccceeEecccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc----
Confidence 9999999988899999999999876544 34568999999999988654 589999999 99999999999988
Q ss_pred ccccchhhHHHHHHHHhhhcCCCcccc------------ccc----cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAID------------SKL----VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~----~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
|++.++.+....|-.+++.+....... +.. .....+.+..+..++|.+|+.+||++||||.+++
T Consensus 210 FPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 210 FPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred CCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 555677777777777776655432211 000 1112234666788899999999999999999998
Q ss_pred HH
Q 046907 338 RM 339 (345)
Q Consensus 338 ~~ 339 (345)
+.
T Consensus 290 ~~ 291 (538)
T KOG0661|consen 290 QH 291 (538)
T ss_pred cC
Confidence 63
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=312.82 Aligned_cols=237 Identities=24% Similarity=0.358 Sum_probs=189.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|+++++||+|+||+|+.++.+ .+++.+|+|.++.. .....+..+....|..
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~------------------------~iv~~~e~~~~~~Er~ 77 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKK------------------------KIVEKKEVRHTKAERN 77 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhh------------------------HhhhhhhHHHHHHHHH
Confidence 5679999999999999999999954 78999999999531 1222456788899999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH---------HHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---------ARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~---------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|.+++||.||++...|+++. .+|++.+|+.||.++..+ .+.-++..|+.||.|||+.+ |+|||||
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~--kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlK 152 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEE--KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLK 152 (357)
T ss_pred HHHhCCCCcEeeeEEecccCC--eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCC
Confidence 999999999999999888876 799999999998764444 45568899999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|||+|.+|.++|+|||+++..-... ..+.+++||+.|||||++.+.+|+..+|+| +|+++|||++|.+||..
T Consensus 153 PENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~--- 227 (357)
T KOG0598|consen 153 PENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA--- 227 (357)
T ss_pred HHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---
Confidence 999999999999999999998643322 245668999999999999999999999999 99999999999999643
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
.+ ......+......+. .+.. ......+++...++.||++|.
T Consensus 228 -~~---~~~~~~~I~~~k~~~-------~p~~---ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 228 -ED---VKKMYDKILKGKLPL-------PPGY---LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -cc---HHHHHHHHhcCcCCC-------CCcc---CCHHHHHHHHHHhccCHHHhc
Confidence 22 222333333222110 0011 112366788889999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=333.12 Aligned_cols=267 Identities=22% Similarity=0.325 Sum_probs=209.9
Q ss_pred cccchhhhhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHH
Q 046907 30 IFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109 (345)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (345)
.....+.+....+|.+..+.+.++..||+|+||+||+|+|.+ .||||.++-....
T Consensus 374 ~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt--------------------- 428 (678)
T KOG0193|consen 374 SGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPT--------------------- 428 (678)
T ss_pred ccccccCCccccccccCHHHhhccceeccccccceeeccccc----ceEEEEEecCCCC---------------------
Confidence 334444455667899999999999999999999999999964 4999999755443
Q ss_pred HHHHHHHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCH----------HHHHHHHHHHHHHH
Q 046907 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDW----------LARHRIALGLACGL 179 (345)
Q Consensus 110 ~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~----------~~~~~i~~~i~~~l 179 (345)
....+.|.+|+..+++-+|.||+-+.|++..++ +.+++.+|+|.++... .....|+.|+++|+
T Consensus 429 ----~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM 501 (678)
T KOG0193|consen 429 ----PEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGM 501 (678)
T ss_pred ----HHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhh
Confidence 345889999999999999999999999999887 4899999999876443 34567999999999
Q ss_pred HHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc---cccCccchhh-
Q 046907 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM---LTLTEKCDIY- 255 (345)
Q Consensus 180 ~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~---~~~~~~~Dvw- 255 (345)
.|||.++ |||||||..||++.+++.|||+|||++..-....-........|+..|||||+++. .+|+..+|||
T Consensus 502 ~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYa 578 (678)
T KOG0193|consen 502 DYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYA 578 (678)
T ss_pred hhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhh
Confidence 9999998 99999999999999999999999999975433222222345678999999999964 3689999999
Q ss_pred HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 256 FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 256 lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
||+|+|||++|..||. ..+..+++..+-.++..+. ......++..++.+|+..||..++++||.+.+
T Consensus 579 FGiV~YELltg~lPys----i~~~dqIifmVGrG~l~pd---------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~ 645 (678)
T KOG0193|consen 579 FGIVWYELLTGELPYS----IQNRDQIIFMVGRGYLMPD---------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQ 645 (678)
T ss_pred hhHHHHHHHhCcCCcC----CCChhheEEEecccccCcc---------chhhhccCHHHHHHHHHHHHhcCcccCccHHH
Confidence 9999999999999964 2222222221111111111 11234556667888888899999999999999
Q ss_pred HHHHHhhhh
Q 046907 336 VRRMLSQIQ 344 (345)
Q Consensus 336 ll~~L~~l~ 344 (345)
|+..|+.+.
T Consensus 646 il~~l~~l~ 654 (678)
T KOG0193|consen 646 LLSKLEELL 654 (678)
T ss_pred HHHHHHHhh
Confidence 999888764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.52 Aligned_cols=263 Identities=24% Similarity=0.348 Sum_probs=204.6
Q ss_pred hhhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 36 KKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 36 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
.......|..+.++|++..+||.|..+.||+|++. .+++.||||++.- +.. +.
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~-p~~e~VAIK~inL-------------------------Ekc-~~ 66 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCI-PTNEVVAIKIINL-------------------------EKC-NN 66 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeec-ccCCEEEEEEeeh-------------------------hhh-hh
Confidence 34456678889999999999999999999999986 4679999999942 222 22
Q ss_pred HHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCC-----------HHHHHHHHHHHHHHHHHHhh
Q 046907 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD-----------WLARHRIALGLACGLEYLHM 184 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~-----------~~~~~~i~~~i~~~l~~lh~ 184 (345)
..+.+.+|+..++.++||||++++..|..+. .+|+||.|+.+|+.++ +..+..++.++++||.|||.
T Consensus 67 ~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~ 144 (516)
T KOG0582|consen 67 DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ 144 (516)
T ss_pred hHHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh
Confidence 3788999999999999999999999998887 7999999999987654 44456799999999999999
Q ss_pred cCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCccee--ccCcccCccccccccccc--cccCccchhh-HHHH
Q 046907 185 HHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT--TSNVVGTVEYIAPEYLQM--LTLTEKCDIY-FGAL 259 (345)
Q Consensus 185 ~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~gt~~~~aPE~~~~--~~~~~~~Dvw-lG~v 259 (345)
+| .||||||+.|||++.+|.+||+|||.+..+.+.+.... .++++||+.|||||++.. ..|+.|+||| ||++
T Consensus 145 ~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGIT 221 (516)
T KOG0582|consen 145 NG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGIT 221 (516)
T ss_pred cC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHH
Confidence 99 99999999999999999999999999887755443222 266899999999999643 3589999999 9999
Q ss_pred HHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 260 LAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 260 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..|+.+|..||..+-+ .+.+...+....+... -..+..+........+.+++..||+.||.+|||++++++
T Consensus 222 A~ELA~G~aPf~k~pP-------mkvLl~tLqn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 222 ACELAHGHAPFSKYPP-------MKVLLLTLQNDPPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHHhcCCCCcccCCh-------HHHHHHHhcCCCCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 9999999999765433 1222222222222111 011111122223346888888899999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=319.63 Aligned_cols=259 Identities=24% Similarity=0.296 Sum_probs=209.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+.|+.+++||+|.||.||+|+ +..+|+.||+|.+.-.-.. .....-..+||.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr-~~~tgkivALKKvr~d~~~-------------------------~~~~~t~~REI~ 168 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKAR-DLETGKIVALKKVRFDNEK-------------------------EGFPITAIREIK 168 (560)
T ss_pred chHHHHHHHHhcCcchhheeEee-ecccCcEEEEEEeecccCC-------------------------CcchHHHHHHHH
Confidence 45689999999999999999999 4578999999999643221 223455678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
||++|+||||+++.+...+.....+|+|++|++. +-.++..++..++.|++.||+|||+++ |+|||||
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK 245 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIK 245 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeecccc
Confidence 9999999999999999998866689999999975 335788899999999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
.+|||+|.+|.+||+|||+|+........ ..++.+-|..|.|||.+.|.. |+.+.|+| .|||+.||++|++. +
T Consensus 246 ~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI----~ 320 (560)
T KOG0600|consen 246 GSNILIDNNGVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI----L 320 (560)
T ss_pred ccceEEcCCCCEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC----c
Confidence 99999999999999999999977554332 245567799999999999875 99999999 99999999999999 5
Q ss_pred cccchhhHHHHHHHHhhhcCCCcccccccc---------------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLV---------------GNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++..+.+.+..|.+..+.+......-.+++ .+.........++|+..+|..||.+|.||.++++
T Consensus 321 ~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 321 QGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 666778888888888776654321111111 0111122345677888899999999999998875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=291.99 Aligned_cols=255 Identities=24% Similarity=0.293 Sum_probs=210.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|...++||+|.||+||+|+. ..+|+.||||.++..... ........+|++.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d-~~t~~~VAIKKIkl~~~k-------------------------dGi~~talREIK~L 55 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARD-TETGKRVAIKKIKLGNAK-------------------------DGINRTALREIKLL 55 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEe-cCCCcEEEEEEeeccccc-------------------------cCccHHHHHHHHHH
Confidence 4788999999999999999995 468999999999754222 11245678999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+.+.+.|-..+ .+.++.||++. ...++..++..++.++++|+.|||++. |+|||+||.
T Consensus 56 qel~h~nIi~LiD~F~~~~--~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPn 130 (318)
T KOG0659|consen 56 QELKHPNIIELIDVFPHKS--NLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPN 130 (318)
T ss_pred HHccCcchhhhhhhccCCC--ceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCcc
Confidence 9999999999999988776 57788888864 345777888999999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
|+|++.+|.+||+|||+|+..+....... ..+-|..|.|||.+-|.. |+...|+| .||++.||+.|.+- +++
T Consensus 131 NLLis~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~----fpG 204 (318)
T KOG0659|consen 131 NLLISSDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF----FPG 204 (318)
T ss_pred ceEEcCCCcEEeecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC----CCC
Confidence 99999999999999999998876543222 236799999999998875 89999999 99999999988876 667
Q ss_pred cchhhHHHHHHHHhhhcCCCccccc--------------cccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDS--------------KLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
+++.+.+..+....+.+.+....+- .......+.+..+.++|+..+|..||.+|+|+.|+++.
T Consensus 205 ~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 205 DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 7888888999988888776543221 11222456667778999999999999999999998763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=317.21 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=194.9
Q ss_pred HHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
|....++|++.+.||+|+||.||+|++. ..++..||+|.+..... .....
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~ 55 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--------------------------ASEHK 55 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--------------------------hHHHH
Confidence 5567789999999999999999999752 23467899999864211 12245
Q ss_pred HHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCCC---------------------------------
Q 046907 119 QIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD--------------------------------- 164 (345)
Q Consensus 119 ~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~--------------------------------- 164 (345)
.+.+|+.++..+ +||||+++++++..++ ..++++++|+++|++.+
T Consensus 56 ~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (338)
T cd05102 56 ALMSELKILIHIGNHLNVVNLLGACTKPN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134 (338)
T ss_pred HHHHHHHHHHHhccCcceeeEEeEecCCC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccc
Confidence 688899999999 8999999999887654 35788899998876533
Q ss_pred --------------------------------------HHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCC
Q 046907 165 --------------------------------------WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI 206 (345)
Q Consensus 165 --------------------------------------~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~ 206 (345)
+.....++.|++.||.|||+.+ ++||||||+|||++.++
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~ 211 (338)
T cd05102 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENN 211 (338)
T ss_pred cccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCC
Confidence 3344568899999999999998 99999999999999999
Q ss_pred CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHH
Q 046907 207 EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVK 284 (345)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~ 284 (345)
.+||+|||+++...............++..|+|||++.+..++.++||| ||+++|||++ |..||..... ......
T Consensus 212 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---~~~~~~ 288 (338)
T cd05102 212 VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---NEEFCQ 288 (338)
T ss_pred cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHH
Confidence 9999999999765432222222334567889999999988899999999 9999999997 9999754221 112222
Q ss_pred HHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 285 WMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.+.... .+. . +......+.+++..||+.||++|||+.++++.|+++.
T Consensus 289 ~~~~~~---~~~------~----~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 289 RLKDGT---RMR------A----PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHhcCC---CCC------C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222111 110 0 1112235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.56 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=208.7
Q ss_pred HhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
...+++..+.+.||+|+||+||+|+..+ .+...||||.++.... ......
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--------------------------~~~~~d 535 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--------------------------NQARQD 535 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--------------------------HHHHHH
Confidence 3466788889999999999999998642 3456899999964321 235788
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------------------CCHHHHHHHHHHHH
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------------------LDWLARHRIALGLA 176 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------------------l~~~~~~~i~~~i~ 176 (345)
|.+|++++..++|||||+++|.|..++ .++++.||+..|++ ++..+...||.|||
T Consensus 536 F~REaeLla~l~H~nIVrLlGVC~~~~--P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIA 613 (774)
T KOG1026|consen 536 FRREAELLAELQHPNIVRLLGVCREGD--PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIA 613 (774)
T ss_pred HHHHHHHHHhccCCCeEEEEEEEccCC--eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHH
Confidence 999999999999999999999999887 68888898876432 66777889999999
Q ss_pred HHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-
Q 046907 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY- 255 (345)
Q Consensus 177 ~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw- 255 (345)
.|+.||-++. ++||||.++|+|+.++..|||+|||+++..=..+++....+..-+++|||||.+..+.++++||||
T Consensus 614 aGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs 690 (774)
T KOG1026|consen 614 AGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWS 690 (774)
T ss_pred HHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhh
Confidence 9999999998 999999999999999999999999999876555444333334447899999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 256 FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 256 lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
||++|||+++ |..||.+ ....+.++.++...-.+ .+.+++.++.+||..||+.+|.+||+++
T Consensus 691 ~GVvLWEIFsyG~QPy~g----lSn~EVIe~i~~g~lL~-------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 691 FGVVLWEIFSYGKQPYYG----LSNQEVIECIRAGQLLS-------------CPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred hhhhhhhhhccccCcccc----cchHHHHHHHHcCCccc-------------CCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 9999999998 9999644 34566667776554333 3345566789999999999999999999
Q ss_pred HHHHHHhhh
Q 046907 335 DVRRMLSQI 343 (345)
Q Consensus 335 ~ll~~L~~l 343 (345)
||-.+|+..
T Consensus 754 eI~~~L~~~ 762 (774)
T KOG1026|consen 754 EIHSRLQAW 762 (774)
T ss_pred HHHHHHHHH
Confidence 999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=314.21 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=199.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|.+++.||.|+|+.|++|+.+ .+++.||||++... .....++...+..|-.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~------------------------~Iike~KvkYV~~Ek~ 125 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKR------------------------YIIKEKKVKYVTREKE 125 (604)
T ss_pred ChhhcchhheeccccceeEEEeeec-CCCceeeHhhhhHH------------------------HHHhhcccchhhHHHH
Confidence 5569999999999999999999954 68999999998421 1122455777888999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH---------HHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA---------RHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~---------~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+|.+| .||.|++|+-.|.++. .+|++.+|+++|.+++++. ...++.+|+.||+|||+.| ||||||
T Consensus 126 ~l~~L~~hPgivkLy~TFQD~~--sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDl 200 (604)
T KOG0592|consen 126 ALTQLSGHPGIVKLYFTFQDEE--SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDL 200 (604)
T ss_pred HHHHhhCCCCeEEEEEEeeccc--ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccC
Confidence 99999 8999999998888765 7999999999998866554 4569999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcc-----------eeccCcccCccccccccccccccCccchhh-HHHHHHHH
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTH-----------ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-----------~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el 263 (345)
||+|||+|.++.++|+|||.|+.++..... .....++||..|.+||++.+...+..+|+| |||++|.|
T Consensus 201 KPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQm 280 (604)
T KOG0592|consen 201 KPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQM 280 (604)
T ss_pred ChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHH
Confidence 999999999999999999999988643221 112458999999999999999999999999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.|.+|| ...++....+.|......-.+ +.+ ..+.+|+...|-.||.+|+|+.+|.+
T Consensus 281 laG~PPF----ra~NeyliFqkI~~l~y~fp~----------~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 281 LAGQPPF----RAANEYLIFQKIQALDYEFPE----------GFP----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred hcCCCCC----ccccHHHHHHHHHHhcccCCC----------CCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence 9999995 444666666655555432211 112 33667888889999999999988765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=315.29 Aligned_cols=240 Identities=23% Similarity=0.415 Sum_probs=200.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|-+.+.||+|+||.||+|+ ++.+.+.||+|.+.+.... .++...+.+|++++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~K~gr~-------------------------~k~l~~l~~ev~i~ 55 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGR-RKYTIQVVAIKFIDKSGRN-------------------------EKELKNLRQEVRIL 55 (808)
T ss_pred cchhHHHHhcCCccceeeecc-cccceeEEEEEEehhcCCc-------------------------hHHHHHHHHHHHHH
Confidence 579999999999999999998 5678999999999654433 34577789999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+.++|||||.++++|++.. .+++|.||+.| ...+++..+..++.|+++||.|||+.+ |+|||+||.|
T Consensus 56 r~lkHpniv~m~esfEt~~--~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqn 130 (808)
T KOG0597|consen 56 RSLKHPNIVEMLESFETSA--HLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQN 130 (808)
T ss_pred HhcCCcchhhHHHhhcccc--eEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcce
Confidence 9999999999999999887 68888898876 345788888999999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
||++..+.+|+||||+|+..+.... ......||+.|||||...+.+|+..+|.| +||++||+++|.+|| +.
T Consensus 131 iLl~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF---~a--- 202 (808)
T KOG0597|consen 131 ILLEKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF---YA--- 202 (808)
T ss_pred eeecCCCceeechhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc---hH---
Confidence 9999999999999999998765433 33457899999999999999999999999 999999999999996 22
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.++...++.+..++... +++....+..++...++.||.+|.|..+++.
T Consensus 203 -~si~~Lv~~I~~d~v~~-----------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 203 -RSITQLVKSILKDPVKP-----------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -HHHHHHHHHHhcCCCCC-----------cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 23444444444333221 1234445777888899999999999988864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=336.51 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=203.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCce----eEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRM----ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+.+..++.+.||+|+||+||+|++....|.. ||||.+..... ..+...|+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--------------------------~~~~~~Fl 743 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--------------------------EQEVSDFL 743 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--------------------------HHHHHHHH
Confidence 4778888999999999999999998666653 89999864322 23478899
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH----------------HHHHHHHHHHHHHHHHhhc
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL----------------ARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~----------------~~~~i~~~i~~~l~~lh~~ 185 (345)
+|+.+|++++|||||+++|++.... ..+++.|||.+|++++++ +...++.|+|+|+.||+++
T Consensus 744 ~Ea~~m~~f~HpNiv~liGv~l~~~--~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~ 821 (1025)
T KOG1095|consen 744 KEALLMSKFDHPNIVSLIGVCLDSG--PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK 821 (1025)
T ss_pred HHHHHHhcCCCcceeeEEEeecCCC--CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC
Confidence 9999999999999999999999854 688899999998775554 4457999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
+ +|||||.++|||++....+||+|||+|+.+-+..+........-+..|||||.+....++.++||| ||+++||++
T Consensus 822 ~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 822 H---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred C---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 9 999999999999999999999999999955444433332222345789999999999999999999 999999999
Q ss_pred h-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 265 M-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 265 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
| |..| |+..+..+.........+.+.| +.|+..+.++|.+||+.+|++||++..|++++..+
T Consensus 899 slG~~P----Y~~~~n~~v~~~~~~ggRL~~P-------------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 899 SLGATP----YPSRSNFEVLLDVLEGGRLDPP-------------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred hCCCCC----CCCcchHHHHHHHHhCCccCCC-------------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 9 8999 4445556665544433333333 23344467999999999999999999999988876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=303.16 Aligned_cols=247 Identities=21% Similarity=0.350 Sum_probs=189.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
..++..++.||+|+||.||++... ++|...|||.+.... ....+.+.+|+.+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~-~~g~~~AvK~v~~~~---------------------------~~~~~~l~~Ei~i 67 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNK-KTGELMAVKSVELED---------------------------SPTSESLEREIRI 67 (313)
T ss_pred cchhhhhccccCccceEEEEEEec-CCCcceeeeeeeccc---------------------------chhHHHHHHHHHH
Confidence 457889999999999999999864 469999999985331 1115678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
|++++|||||+++|.........+++++||+++|+ .++...+.++..|+++||.|||+++ ++|||||
T Consensus 68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK 144 (313)
T KOG0198|consen 68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIK 144 (313)
T ss_pred HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcc
Confidence 99999999999999744433256889999998753 4678888899999999999999999 9999999
Q ss_pred CCCeeecC-CCCeEEeccccceecCCC-CcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDD-DIEARISGFGFARAIPDA-HTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~-~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|||++. ++.+||+|||++...... ..........||+.|||||++.... ...++||| +||++.||+||..||..
T Consensus 145 ~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 145 PANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 99999999 799999999999866531 1111233578999999999999633 34599999 99999999999999876
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
+ ......+.........+ ..++.......+++..|++.||++||||.++++.
T Consensus 225 ~------~~~~~~~~~ig~~~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 225 F------FEEAEALLLIGREDSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred h------cchHHHHHHHhccCCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 4 11222222222221111 1122233345667777999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=305.55 Aligned_cols=262 Identities=24% Similarity=0.337 Sum_probs=202.2
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
...-++|.++..||+|.||.|-+|+ +..+++.||||++.......++.+....... --..+...+|
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar-~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~-------------~~~~ekv~~E 158 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLAR-DEVDGKLYAIKILPKKELRRQYGFPRQPAMK-------------LMPIEKVRRE 158 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEe-ecCCCcEEEEEeechhhhhhhcccccccccc-------------cCcHHHHHHH
Confidence 3456799999999999999999998 4568999999999765554443222111000 0124578899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.+|++++|||||+++.+..++....+|+|.+||..|.. ++.....+++.+++.||+|||.++ |+|||
T Consensus 159 IailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRD 235 (576)
T KOG0585|consen 159 IAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRD 235 (576)
T ss_pred HHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccc
Confidence 999999999999999999999999999999999987542 677888999999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCC---cceeccCcccCccccccccccccc----cCccchhh-HHHHHHHHHhC
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAH---THITTSNVVGTVEYIAPEYLQMLT----LTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~~~aPE~~~~~~----~~~~~Dvw-lG~vl~el~tg 266 (345)
|||+|+|++.+|++||+|||++....... ........+||+.|+|||.+.++. .+.+.||| +|++||.|+.|
T Consensus 236 IKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG 315 (576)
T KOG0585|consen 236 IKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFG 315 (576)
T ss_pred cchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhc
Confidence 99999999999999999999998763321 111223478999999999998733 35789999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..||- + .....+...|.+ . .+.-+..++....+.+||..+|+.||++|.+..+|..
T Consensus 316 ~~PF~---~-~~~~~l~~KIvn---~---------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 316 QLPFF---D-DFELELFDKIVN---D---------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cCCcc---c-chHHHHHHHHhc---C---------cccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 99963 2 222233222221 1 1111223355667889999999999999999988754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=310.58 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=199.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
....|....+||+|+.|.||.++ ...++..||||++.... ....+-+.+|+.
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~-~~~~~~~VaiK~m~l~~---------------------------Q~~keLilnEi~ 322 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVAR-KISTKQEVAIKRMDLRK---------------------------QPKKELLLNEIL 322 (550)
T ss_pred hhhhhcchhhhccccccceeeee-eccCCceEEEEEEEecc---------------------------CCchhhhHHHHH
Confidence 45578889999999999999998 45689999999995432 223566788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+|+..+|+|||.+++.+...+ .+|++|||++||.+ +++.++..++..+++||.|||.++ |+|||||.
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~d--eLWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKS 397 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGD--ELWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKS 397 (550)
T ss_pred HHHhccchHHHHHHHHhcccc--eeEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeecccc
Confidence 999999999999999888775 69999999999876 456678899999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.+||+|||++..+..... ...+.+||++|||||++....|+++.||| ||++..||+.|++|| +.
T Consensus 398 DnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY---ln- 471 (550)
T KOG0578|consen 398 DNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY---LN- 471 (550)
T ss_pred ceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc---cC-
Confidence 999999999999999999988765443 34568999999999999999999999999 999999999999995 22
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++....+..|........ .........+.+++.+||+.|+++|+++.++|+
T Consensus 472 E~PlrAlyLIa~ng~P~l-----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 472 ENPLRALYLIATNGTPKL-----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CChHHHHHHHhhcCCCCc-----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 233333444433321111 112233345788888899999999999999986
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=289.52 Aligned_cols=260 Identities=21% Similarity=0.250 Sum_probs=207.1
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
.+.-+.|+.+..|++|+||.||+|+. .++++.||+|+++...... ...-.-++|
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakd-k~t~eIVALKr~kmekek~-------------------------GFPItsLRE 125 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKD-KKTDEIVALKRLKMEKEKE-------------------------GFPITSLRE 125 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEecc-CCcceeEEeeecccccccC-------------------------CCcchhHHH
Confidence 44567899999999999999999994 5789999999997543211 112334689
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.+|.+.+|||||.+-.+....+...+|++|+|++. +..+....+..++.|+++|+.|||..+ |+|||
T Consensus 126 IniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRD 202 (419)
T KOG0663|consen 126 INILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRD 202 (419)
T ss_pred HHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecc
Confidence 999999999999999999988887789999999975 345667778889999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||++|+|++..|.+||+|||+|+..++... ..+..+-|..|.|||.+.+.+ |+++.|+| +|||+.||+++.+.
T Consensus 203 LK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl--- 277 (419)
T KOG0663|consen 203 LKTSNLLLSHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL--- 277 (419)
T ss_pred cchhheeeccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC---
Confidence 999999999999999999999999876532 334566799999999999876 89999999 99999999999998
Q ss_pred cccccchhhHHHHHHHHhhhcCCCcccc---c------cccC-------CCcHH--HHHHHHHHHhhccCCCCCCCCCHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAID---S------KLVG-------NGCEE--QMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~-------~~~~~--~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
+++..+.+.+..|...++.+....... . +... ..... ..+.-++|+...+..||.+|.|++
T Consensus 278 -f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 278 -FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred -CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence 555677777788877776554321100 0 0000 00011 225567888889999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
+.++
T Consensus 357 ~~L~ 360 (419)
T KOG0663|consen 357 DGLK 360 (419)
T ss_pred Hhhc
Confidence 9875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=304.38 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=195.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
....|..++.||+|+||.||+|.. ..+++.||+|++.-... ......+.+|+.
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d-~~t~k~vAiKii~Le~~--------------------------~deIediqqei~ 63 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAID-NKTKKVVAIKIIDLEEA--------------------------EDEIEDIQQEIS 63 (467)
T ss_pred cccccccchhccccccceeeeeee-ccccceEEEEEechhhc--------------------------chhhHHHHHHHH
Confidence 445788889999999999999985 46899999999953221 234677889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH---------HHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA---------RHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~---------~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|..++++||.++|+.+..+. .++++|+|+.||+.++.++ ..-++.++..|+.|+|..+ .+|||+|
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~--~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIK 138 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGT--KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIK 138 (467)
T ss_pred HHHhcCcchHHhhhhheeecc--cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eeccccc
Confidence 999999999999999888776 7999999999987654443 3447889999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+.|||+..+|.+|++|||++..+..... ...+++||++|||||++....|+.++||| +|++.+||.+|.+|+.+..+
T Consensus 139 aanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 139 AANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred ccceeEeccCcEEEEecceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 9999999999999999999988766543 23679999999999999988999999999 99999999999999876555
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
+.....+ .+..+|.+.+ .++ ..+.++|..||+.||+.||+|.++++.
T Consensus 217 mrvlflI-------------pk~~PP~L~~-~~S---~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 217 MRVLFLI-------------PKSAPPRLDG-DFS---PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ceEEEec-------------cCCCCCcccc-ccC---HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2211111 1111122222 222 236677777999999999999999863
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.63 Aligned_cols=242 Identities=22% Similarity=0.337 Sum_probs=190.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|+++..||+|+||.||+|+ +..+|+.+|+|+++. +++........+..|-.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLar-Kk~Tg~iyAmK~LkK------------------------S~M~~~~Qv~hV~aERd 193 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLAR-KKDTGEIYAMKILKK------------------------SEMLKKNQVEHVRAERD 193 (550)
T ss_pred CcccchhheeeccccceeEEEEE-EccCCcEEeeecccH------------------------HHHHhhhhHHHHHHHHH
Confidence 66799999999999999999999 557999999999963 44455666888889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|...++|+||++|..|.+.+ ++|++|||++||+. |+.....-++.+.+-|+..+|..| ++|||||
T Consensus 194 iL~~~ds~~vVKLyYsFQD~~--~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIK 268 (550)
T KOG0605|consen 194 ILAEVDSPWVVKLYYSFQDKE--YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIK 268 (550)
T ss_pred HhhhcCCCcEEEEEEEecCCC--eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCC
Confidence 999999999999999998777 89999999999864 455556678889999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCC-----------------------cc----------------------eeccCc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAH-----------------------TH----------------------ITTSNV 231 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~-----------------------~~----------------------~~~~~~ 231 (345)
|+|+|+|..|++||+|||++..+...+ .. ......
T Consensus 269 PdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~St 348 (550)
T KOG0605|consen 269 PDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYST 348 (550)
T ss_pred hhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcc
Confidence 999999999999999999986432100 00 001236
Q ss_pred ccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHH
Q 046907 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEE 310 (345)
Q Consensus 232 ~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (345)
+|||-|||||++.+..|+..+|+| +|||+|||+.|.+||....+......+..|-.....+... +
T Consensus 349 VGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~ 414 (550)
T KOG0605|consen 349 VGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------D 414 (550)
T ss_pred cCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------c
Confidence 899999999999999999999999 9999999999999975443333333333333222211111 1
Q ss_pred HHHHHHHHHhhccCCCCCCCCC
Q 046907 311 QMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 311 ~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
...+..+||+.|+. ||++|..
T Consensus 415 ~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 415 LSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred ccHHHHHHHHHHhc-CHHHhcC
Confidence 11346778888887 9999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=312.83 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=203.6
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEecCCCC---ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNG---RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
..-.|+..-++..+.++||+|+||+||+|+++..++ ..||||..+.... ....
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~------------------------~~~~ 203 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE------------------------LTKE 203 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc------------------------ccHH
Confidence 344588888899999999999999999999875444 2389999875211 1134
Q ss_pred HHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhc
Q 046907 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
...++++|++++++++|||||++||++.... .+++++|++.||++ ++..+..+++.+.+.||+|||++
T Consensus 204 ~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k 281 (474)
T KOG0194|consen 204 QIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK 281 (474)
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC--ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC
Confidence 5888999999999999999999999888776 69999999999865 44556678999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
+ ++||||.++|||++.++.+||+|||+++....... ......-+..|+|||.+....++.++||| ||+++||++
T Consensus 282 ~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 282 N---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred C---CcchhHhHHHheecCCCeEEeCccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 8 99999999999999999999999999876431111 11122346899999999999999999999 999999999
Q ss_pred h-CCCCCcccccccchhhHHHHH-HHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 265 M-GKLPSDKFFQHTNEMSFVKWM-RNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 265 t-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
+ |..||.+ ....+....+ ....+.+.+. ..+..+..++.+||..+|++||||.++.+.|+.
T Consensus 357 ~~g~~Py~g----~~~~~v~~kI~~~~~r~~~~~-------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 357 ENGAEPYPG----MKNYEVKAKIVKNGYRMPIPS-------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred ccCCCCCCC----CCHHHHHHHHHhcCccCCCCC-------------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 8 7889544 3344555555 3333322221 223346677778999999999999999999998
Q ss_pred hh
Q 046907 343 IQ 344 (345)
Q Consensus 343 l~ 344 (345)
+.
T Consensus 420 ~~ 421 (474)
T KOG0194|consen 420 LE 421 (474)
T ss_pred HH
Confidence 74
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.93 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=191.2
Q ss_pred cCCcccccccccCcceeeEEEEecC---------------CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPG---------------QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (345)
.++|.+.+.||+|+||.||+|.++. .++..||+|.+.....
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------------ 59 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN------------------------ 59 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC------------------------
Confidence 4689999999999999999998632 2345799999864321
Q ss_pred HHHHHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC----------------------------
Q 046907 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------------------------- 163 (345)
Q Consensus 112 ~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------------------------- 163 (345)
......+.+|+.++.+++||||+++++++...+ ..++++||+.++++.
T Consensus 60 --~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (304)
T cd05096 60 --KNARNDFLKEVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAI 135 (304)
T ss_pred --HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCC--ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccc
Confidence 122556889999999999999999999998766 588999999876543
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccc
Q 046907 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL 243 (345)
Q Consensus 164 ~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~ 243 (345)
++....+++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+
T Consensus 136 ~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 136 SYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 33456689999999999999998 999999999999999999999999999865443322223345567889999999
Q ss_pred cccccCccchhh-HHHHHHHHHh--CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHh
Q 046907 244 QMLTLTEKCDIY-FGALLAGLVM--GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIAC 320 (345)
Q Consensus 244 ~~~~~~~~~Dvw-lG~vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 320 (345)
.+..++.++||| ||+++|||++ +..||... ........+........... . ...++.+...+.++|.
T Consensus 213 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~li~ 282 (304)
T cd05096 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL----TDEQVIENAGEFFRDQGRQV-Y-----LFRPPPCPQGLYELML 282 (304)
T ss_pred hcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC----CHHHHHHHHHHHhhhccccc-c-----ccCCCCCCHHHHHHHH
Confidence 888899999999 9999999987 55675432 22223222222221111100 0 0011123345789999
Q ss_pred hccCCCCCCCCCHHHHHHHHhh
Q 046907 321 FCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 321 ~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
+||+.||++|||+.+|.+.|++
T Consensus 283 ~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 283 QCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHccCCchhCcCHHHHHHHHhC
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=308.08 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=194.7
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
.|....++|++.+.||+|+||.||+|++. ..++..||||.+..... ....
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--------------------------~~~~ 82 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--------------------------LTER 82 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--------------------------cHHH
Confidence 45556779999999999999999999752 23567899999864321 1124
Q ss_pred HHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCC---------------------------------
Q 046907 118 RQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL--------------------------------- 163 (345)
Q Consensus 118 ~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l--------------------------------- 163 (345)
..+.+|+.++..+ +||||+++++++...+ ..++++||+++|++.
T Consensus 83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (375)
T cd05104 83 EALMSELKVLSYLGNHINIVNLLGACTVGG--PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREM 160 (375)
T ss_pred HHHHHHHHHHHHhcCCcceeeeeeeeccCC--cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcc
Confidence 5678899999999 8999999999988776 578899998876543
Q ss_pred ---------------------------------------------------CHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 164 ---------------------------------------------------DWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 164 ---------------------------------------------------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
++....+++.|++.||.|||+.+ ++|
T Consensus 161 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH 237 (375)
T cd05104 161 SCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIH 237 (375)
T ss_pred cchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 34445678999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
|||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||| ||+++|||++ |..||
T Consensus 238 ~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~ 317 (375)
T cd05104 238 RDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317 (375)
T ss_pred cCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999866443221122234456789999999998999999999 9999999998 88887
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.... ........+........+ . .....+.+++.+||+.||++|||+.+|++.|++.
T Consensus 318 ~~~~---~~~~~~~~~~~~~~~~~~----------~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 318 PGMP---VDSKFYKMIKEGYRMLSP----------E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCC---chHHHHHHHHhCccCCCC----------C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 5422 222333333322111111 1 1123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=281.52 Aligned_cols=232 Identities=23% Similarity=0.328 Sum_probs=186.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.-++|+.+..||.|+||.|.+++.+ .+|.-+|+|++.... ....+..+...+|..
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~------------------------vVklKQveH~~nEk~ 96 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQK------------------------VVKLKQVEHTHNEKR 96 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEc-cCCceeehhhcCHHH------------------------HHHHHHHHHHhhHHH
Confidence 4568999999999999999999965 579999999995321 112345777889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHH---------HHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR---------HRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~---------~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|+.+.||+++++++.+.+.+ .++++|+|.+||.+++++.. .-++.+|+.||+|||+.+ |++||+|
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~--~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLK 171 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNS--NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLK 171 (355)
T ss_pred HHhhccCceeEEEEEeeccCC--eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCC
Confidence 999999999999999887766 89999999999988777654 459999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|+|+|.+|.+||+|||.|+.+... +.+.+||+.|+|||.++..+++.++|+| ||+++|||+.|.+|| +.
T Consensus 172 PENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF---~~ 243 (355)
T KOG0616|consen 172 PENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPF---YD 243 (355)
T ss_pred hHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCC---cC
Confidence 99999999999999999999987543 4568999999999999999999999999 999999999999996 33
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCC
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER 330 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 330 (345)
... ...-+.|.... .. .++-....+.+|+...++.|-.+|
T Consensus 244 ~~~-~~iY~KI~~~~---v~-----------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 244 DNP-IQIYEKILEGK---VK-----------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCh-HHHHHHHHhCc---cc-----------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 222 33222222111 10 001111135677777888888888
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=305.63 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=193.8
Q ss_pred HHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
|....++|++.+.||+|+||.||+|++. ..++..||+|.+...... ....
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~ 86 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--------------------------DERE 86 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--------------------------HHHH
Confidence 4456678999999999999999999853 223568999999643211 2245
Q ss_pred HHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCC----------------------------------
Q 046907 119 QIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------------------------------- 163 (345)
Q Consensus 119 ~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------------------------------- 163 (345)
.+.+|+.+++.+ +||||+++++++...+ .++++++|+.++++.
T Consensus 87 ~~~~E~~il~~l~~h~nIv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 87 ALMSELKILSHLGQHKNIVNLLGACTHGG--PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred HHHHHHHHHHhhccCCceeeEeeEecCCC--CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 678899999999 8999999999988776 688899998776543
Q ss_pred ---------------------------------------------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 164 ---------------------------------------------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 164 ---------------------------------------------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++....+++.|++.||.|||+.+ ++||||||+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~ 241 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAAR 241 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchh
Confidence 33445679999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~ 276 (345)
||+++.++.++|+|||++.............+..++..|+|||++.+..++.++||| +|+++|||++ |..||.....
T Consensus 242 Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~- 320 (374)
T cd05106 242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV- 320 (374)
T ss_pred eEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-
Confidence 999999999999999999765433222222233456789999999888899999999 9999999997 9999754322
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.......+........+ .. ....+.+++..||+.||++|||+.+|++.|+++-
T Consensus 321 --~~~~~~~~~~~~~~~~~----------~~---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 321 --NSKFYKMVKRGYQMSRP----------DF---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred --cHHHHHHHHcccCccCC----------CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 11222222211111000 01 1234778889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=282.80 Aligned_cols=245 Identities=19% Similarity=0.282 Sum_probs=195.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.++||+|.|+.|+++. ++.+|..+|+|.+.... .+....+.+.+|++
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~-~~~tg~~fa~kiin~~k-------------------------~~~~~~e~l~rEar 62 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKK-------------------------LSARDFQKLEREAR 62 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHH-hccchHHHHHHHhhhhh-------------------------hccccHHHHHHHHH
Confidence 35689999999999999999997 56789999999985322 22345788899999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
|.+.|+||||+++++.+.++. +.++++++++|+.+. ++.....+..||+++|.|+|.++ |+|||+|
T Consensus 63 IC~~LqHP~IvrL~~ti~~~~--~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvk 137 (355)
T KOG0033|consen 63 ICRKLQHPNIVRLHDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLK 137 (355)
T ss_pred HHHhcCCCcEeehhhhhcccc--eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCC
Confidence 999999999999999988776 789999999998763 44455678999999999999999 9999999
Q ss_pred CCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|+++.. ..-+|++|||+|..+++. .....+.||+.|||||++...+|+..+||| .|++||-++.|.+||-+
T Consensus 138 P~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 138 PENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred hhheeeeeccCCCceeecccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 99999963 346899999999988733 245668999999999999999999999999 99999999999999633
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.....+-+.|......-.+ ...+.......+|+.+||..||.+|.|+.|.++
T Consensus 215 ----~~~~rlye~I~~g~yd~~~----------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 215 ----EDQHRLYEQIKAGAYDYPS----------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----ccHHHHHHHHhccccCCCC----------cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2333344444433322211 122222334667888899999999999998874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=308.28 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=208.4
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|+-++.+..+.++||-|-||+||.|.|+ +-...||||.++... -...+|+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWK-kyslTvAVKtLKEDt----------------------------MeveEFL 311 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT----------------------------MEVEEFL 311 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeee-ccceeeehhhhhhcc----------------------------hhHHHHH
Confidence 47888889999999999999999999997 467889999996432 2378899
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHH-----------HHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR-----------HRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~-----------~~i~~~i~~~l~~lh~~~~~~i 190 (345)
.|+.+|+.++|||+|+++|+|..+. ..|++.||+..|++++++.. ..|+.||.+|+.||..+. +
T Consensus 312 kEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---F 386 (1157)
T KOG4278|consen 312 KEAAVMKEIKHPNLVQLLGVCTHEP--PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---F 386 (1157)
T ss_pred HHHHHHHhhcCccHHHHhhhhccCC--CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---h
Confidence 9999999999999999999998776 68999999999999888854 469999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
|||||.++|||+.++..+|++|||+++.+....+. ......=++.|+|||.+....++.++||| ||++|||+.| |..
T Consensus 387 IHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMs 465 (1157)
T KOG4278|consen 387 IHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMS 465 (1157)
T ss_pred hhhhhhhhhccccccceEEeeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999988654332 11222336789999999999999999999 9999999998 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||++ .+-.+.-..+.+..+...+ ..|+..+.+||..||+++|.+||+++|+-+.++.|.
T Consensus 466 PYPG----idlSqVY~LLEkgyRM~~P-------------eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 466 PYPG----IDLSQVYGLLEKGYRMDGP-------------EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCC----ccHHHHHHHHhccccccCC-------------CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 9654 3334444444444443333 233345788999999999999999999999999873
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=309.67 Aligned_cols=244 Identities=24% Similarity=0.384 Sum_probs=193.2
Q ss_pred hhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHH
Q 046907 37 KAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKK 116 (345)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (345)
+..+-.|++..+...-++-||+|+-|.||+|++ .++.||||.++
T Consensus 113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl---~netVAVKKV~--------------------------------- 156 (904)
T KOG4721|consen 113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRL---HNETVAVKKVR--------------------------------- 156 (904)
T ss_pred hhhhhhccCCHHHhhhhhhhccCcccceeeeec---cCceehhHHHh---------------------------------
Confidence 334455777777666688899999999999997 57889999883
Q ss_pred HHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH---------HHHHHHHHHHHHHHHhhcCC
Q 046907 117 MRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA---------RHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 117 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~---------~~~i~~~i~~~l~~lh~~~~ 187 (345)
+.-..+|+-|++|+||||+.|.|+|.... .++++||||..|.+...++ ...+..+|+.|+.|||...
T Consensus 157 -elkETdIKHLRkLkH~NII~FkGVCtqsP--cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK- 232 (904)
T KOG4721|consen 157 -ELKETDIKHLRKLKHPNIITFKGVCTQSP--CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK- 232 (904)
T ss_pred -hhhhhhHHHHHhccCcceeeEeeeecCCc--eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh-
Confidence 22345789999999999999999998765 7999999999887654443 3468889999999999998
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg 266 (345)
|||||||.-||||..+..+||+|||.++...+.. ....+.||..|||||++...+.+.+.||| ||+|||||+||
T Consensus 233 --IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~ 307 (904)
T KOG4721|consen 233 --IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG 307 (904)
T ss_pred --HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc
Confidence 9999999999999999999999999998765542 23458999999999999999999999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
..||.+-... ..|.. .+...+. -..++.+++.+.-||.+||+..|.+||++.+++..|+
T Consensus 308 EiPYkdVdss-------AIIwG-VGsNsL~--------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 308 EIPYKDVDSS-------AIIWG-VGSNSLH--------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred CCCccccchh-------eeEEe-ccCCccc--------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9997543221 11110 1111111 1223444455666777799999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=293.21 Aligned_cols=245 Identities=19% Similarity=0.238 Sum_probs=190.0
Q ss_pred Ccccc--cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASL--EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 49 ~~~~~--~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
+++.. ..||+|++|.||+|.+ +|+.||||.+....... ....+.+.+|+.+
T Consensus 19 ~i~~~~~~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~------------------------~~~~~~~~~E~~~ 71 (283)
T PHA02988 19 DIDKYTSVLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGH------------------------KVLIDITENEIKN 71 (283)
T ss_pred HcCCCCCeEEeeCCceEEEEEEE---CCEEEEEEecccccccc------------------------HHHHHHHHHHHHH
Confidence 44444 6799999999999997 68899999986432111 1225678899999
Q ss_pred HhhccCCCccceeEEEec--CCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecC
Q 046907 127 VGQIRHRNLHPLLAHVTR--PDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMH-HCPRIIHRD 194 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH~d 194 (345)
+++++||||+++++++.. ++...+++++||+.+|++ +++....+++.|++.|+.|||+. + ++|||
T Consensus 72 l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrd 148 (283)
T PHA02988 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKN 148 (283)
T ss_pred HHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCc
Confidence 999999999999999876 444568899999998754 45666788999999999999985 6 88999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc--cccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM--LTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~--~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|||+|++++.++.+|++|||++....... ....|+..|+|||.+.+ ..++.++||| ||+++|||++|..||.
T Consensus 149 lkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 149 LTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred CChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654321 23568899999999976 5789999999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.. ...+....+.... ..+. .+..+...+.+++.+||+.||++|||+.++++.|+.++
T Consensus 224 ~~----~~~~~~~~i~~~~--~~~~----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 224 NL----TTKEIYDLIINKN--NSLK----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CC----CHHHHHHHHHhcC--CCCC----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 32 2222222221111 1110 01122345788999999999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=288.88 Aligned_cols=260 Identities=23% Similarity=0.342 Sum_probs=199.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
....|..++.||+|+||.|..+..+ .+|+.||||.+...... ....++..+|+.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~-------------------------~~~akRtlRElk 73 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFEN-------------------------QIDAKRTLRELK 73 (359)
T ss_pred ccceecccccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhc-------------------------hHHHHHHHHHHH
Confidence 4557777899999999999999854 68899999999643322 345788999999
Q ss_pred HHhhccCCCccceeEEEec---CCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTR---PDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~---~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+|+.++|+||+.+++.+.. ++..-+|+++++++. +..++......+++|++.||.|+|+.+ ++|||
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRD 150 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRD 150 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccc
Confidence 9999999999999999876 233457999998854 333677778889999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|||+|++++.+..+||+|||+|+...........+.++-|..|.|||.+.. ..|+.+.||| .||++.||++|++.|+
T Consensus 151 LKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp- 229 (359)
T KOG0660|consen 151 LKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP- 229 (359)
T ss_pred cchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC-
Confidence 999999999999999999999998754322233466888999999998854 4699999999 9999999999999954
Q ss_pred cccccchhhHHHHHHHHhhhcCCCcc-----------------ccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRA-----------------IDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
+.+..+....+....+.+..... .++.......+......++|+.++|..||.+|+|++|
T Consensus 230 ---G~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e 306 (359)
T KOG0660|consen 230 ---GKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE 306 (359)
T ss_pred ---CCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 44555555555555444322110 0000001112233334677888899999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 307 AL~ 309 (359)
T KOG0660|consen 307 ALA 309 (359)
T ss_pred Hhc
Confidence 875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=299.81 Aligned_cols=245 Identities=25% Similarity=0.334 Sum_probs=190.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+.|.+++.||+|+||.|+.|+.. .+++.||+|.+........ . ....+.+.+|+.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~---------------------~-~~~~~~i~rEi~ 71 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSK---------------------S-QKLDELIKREIS 71 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhccccc---------------------c-cccchhhHHHHH
Confidence 5679999999999999999999854 5789999997754211100 0 012334458999
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++ ||||++++.++.++. .+++++||+.||.+ +.+....+++.|+++|+.|||+.+ |+||||
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~--~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDL 146 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPT--KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDL 146 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCC--eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCC
Confidence 999998 999999999999988 49999999999755 444556789999999999999999 999999
Q ss_pred CCCCeeecCC-CCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cC-ccchhh-HHHHHHHHHhCCCCCc
Q 046907 196 NPVNVLLDDD-IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LT-EKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 196 k~~nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~-~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||+|+|++.+ +++||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||| +|++||.|++|..||+
T Consensus 147 K~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 147 KPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred CHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 9999999998 999999999998763 1122346689999999999999987 75 789999 9999999999999976
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
+ .+.......+.... ..- + .... ...+..|+.+|++.||.+|+|+.+++
T Consensus 225 d----~~~~~l~~ki~~~~---~~~---p-----~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 225 D----SNVPNLYRKIRKGE---FKI---P-----SYLL--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred C----ccHHHHHHHHhcCC---ccC---C-----CCcC--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 5 22222222222221 110 0 0110 23477888899999999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=286.92 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=192.5
Q ss_pred hcCCcccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+.++|++.+.||+|+||.||+|+++. ..+..||+|.+..... ......+.+|
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--------------------------~~~~~~~~~e 56 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--------------------------DKQRRGFLAE 56 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--------------------------HHHHHHHHHH
Confidence 56789999999999999999998642 3467899999865321 1224568899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.++++++||||+++++++..++ .+++++||++++.+ +++.....++.|++.||.|||+.+ ++||
T Consensus 57 ~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~ 131 (266)
T cd05064 57 ALTLGQFDHSNIVRLEGVITRGN--TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHK 131 (266)
T ss_pred HHHHhcCCCCCcCeEEEEEecCC--CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 99999999999999999988765 68899999987543 566677889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~ 271 (345)
||||+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++||| +|+++||+++ |..||.
T Consensus 132 dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~ 210 (266)
T cd05064 132 GLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred cccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence 9999999999999999999998765422111 111223456789999999998999999999 9999999775 999964
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.. ........+......+ .+......+.+++..||+.+|++|||+.+|++.|+++
T Consensus 211 ~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 211 DM----SGQDVIKAVEDGFRLP-------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred cC----CHHHHHHHHHCCCCCC-------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 32 2233333332211111 1122334577888999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=304.43 Aligned_cols=240 Identities=24% Similarity=0.280 Sum_probs=196.8
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
...-++|.++++||+|+||+|+++..+ .+++.+|||.+++... ...++.+..+.|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK~~I------------------------l~~d~Ve~~~~E 418 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKKGDI------------------------LQRDEVESLMCE 418 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEc-CCCcEEEEEEeeccce------------------------eccccHHHHHHH
Confidence 346679999999999999999999976 5788999999975432 224457777888
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.+|+... +||.+++++..|.+++ .++++|||+.||.. ++.....-++..++.||.|||+++ ||+||
T Consensus 419 krI~~la~~HPFL~~L~~~fQT~~--~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRD 493 (694)
T KOG0694|consen 419 KRIFELANRHPFLVNLFSCFQTKE--HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRD 493 (694)
T ss_pred HHHHHHhccCCeEeecccccccCC--eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeee
Confidence 8888777 5999999999999988 89999999999863 566677779999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||.+|||+|..|.+||+|||+++..-..+ ..+++++||+.|||||++++..|+.+.|+| ||+++|||+.|..||
T Consensus 494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF--- 568 (694)
T KOG0694|consen 494 LKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF--- 568 (694)
T ss_pred cchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC---
Confidence 99999999999999999999998643222 256789999999999999999999999999 999999999999995
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
.++++.++...|.... .. ++.....+..++|...+..+|++|..+
T Consensus 569 -~gddEee~FdsI~~d~---~~-----------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 569 -PGDDEEEVFDSIVNDE---VR-----------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCHHHHHHHHhcCC---CC-----------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 4456666655554321 11 111223346678888999999999865
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.85 Aligned_cols=244 Identities=21% Similarity=0.326 Sum_probs=202.9
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|..++++|+|+||.++.++++ .+++.+++|.+.-...+. ...+...+|+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t~-------------------------~~r~~A~~E~~l 56 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLTE-------------------------PERRSAIQEMDL 56 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhc-cCCceEEEEEEeccccCc-------------------------hhhHHHHHHHHH
Confidence 468999999999999999999854 578899999997654442 335578899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++++|||||.+++.|..++ .+++++|+|++||++ ++..++.+++.|++.|+.|||+.. |+||||
T Consensus 57 is~~~hP~iv~y~ds~~~~~-~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDl 132 (426)
T KOG0589|consen 57 LSKLLHPNIVEYKDSFEEDG-QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDL 132 (426)
T ss_pred HHhccCCCeeeeccchhcCC-ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccc
Confidence 99999999999999998776 369999999999754 667777889999999999999887 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+.||+++.+..++++|||+|+.++.... ...+.+||+.||+||.+.+.+|+.++||| +||++|||++-+.+|.
T Consensus 133 K~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~--- 207 (426)
T KOG0589|consen 133 KCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK--- 207 (426)
T ss_pred hhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC---
Confidence 99999999999999999999998876531 34568999999999999999999999999 9999999999999953
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
..+...+...+......+.+ ......+..+|..|++.+|..||++.+++..
T Consensus 208 -a~~m~~Li~ki~~~~~~Plp-------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 208 -ASNMSELILKINRGLYSPLP-------------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -ccchHHHHHHHhhccCCCCC-------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33444555555444422222 2333457788889999999999999999865
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.45 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=193.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|.-.+++|+|+||.||.|... .+++.||||....... .--+|+.+|+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~-e~~~~vAIKKv~~d~r-------------------------------~knrEl~im~ 72 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLR-ETEEEVAIKKVLQDKR-------------------------------YKNRELQIMR 72 (364)
T ss_pred EEEeeEEEeecccceEEEEEEc-CCCceeEEEEecCCCC-------------------------------cCcHHHHHHH
Confidence 5777899999999999999986 4589999999975432 2236999999
Q ss_pred hccCCCccceeEEEecCCcc---eeeeeccccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 129 QIRHRNLHPLLAHVTRPDCH---LLYILNDVSQG------------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~---~l~~~~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+++|||||++.-+|...... ++.+++||++. +..++...+.-+..|+.+||.|||+.+ |+||
T Consensus 73 ~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHR 149 (364)
T KOG0658|consen 73 KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHR 149 (364)
T ss_pred hcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccC
Confidence 99999999999888765433 56678888864 455667777889999999999999998 9999
Q ss_pred CCCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCC
Q 046907 194 DLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 194 dlk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||||.|+|+|. .+.+||||||.|+.+...... .++..|..|.|||.+.|.. |+.+.||| .|||+.||+-|.+-|
T Consensus 150 DIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF 226 (364)
T KOG0658|consen 150 DIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF 226 (364)
T ss_pred CCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence 99999999995 489999999999988665543 4478899999999998875 99999999 999999999999995
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccc--c--------ccccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAI--D--------SKLVGN-----GCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~-----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
++ .+..+.+..+-+..+.+....+. . +.+... .......+..+++.++++.+|.+|.++.+
T Consensus 227 pG----~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~ 302 (364)
T KOG0658|consen 227 PG----DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE 302 (364)
T ss_pred CC----CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence 43 45555555555555444332210 0 111110 12233445778899999999999999998
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
++.
T Consensus 303 ~l~ 305 (364)
T KOG0658|consen 303 ALA 305 (364)
T ss_pred Hhc
Confidence 874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=313.93 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=208.6
Q ss_pred HHhhcCCcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
.+++.+...+.++||.|.||+|++|+++ ++....||||.++..... +....|
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--------------------------kqrrdF 677 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--------------------------KQRRDF 677 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--------------------------HHHhhh
Confidence 4678888999999999999999999975 334568999999876543 347889
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC----------CHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL----------DWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l----------~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+.|+.||-+++||||++|-|+..... .++++.|||++|.+- .+.+...|+..|+.|+.||-+.+ .
T Consensus 678 L~EAsIMGQFdHPNIIrLEGVVTks~--PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---Y 752 (996)
T KOG0196|consen 678 LSEASIMGQFDHPNIIRLEGVVTKSK--PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---Y 752 (996)
T ss_pred hhhhhhcccCCCCcEEEEEEEEecCc--eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---c
Confidence 99999999999999999999887665 789999999998764 44455679999999999999999 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCC-cceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAH-THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GK 267 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~ 267 (345)
+||||.++|||++.+..+|++|||+++.+.+.. ....+....-+.+|+|||.+...+++.++||| ||+++||+++ |+
T Consensus 753 VHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 753 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred hhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 999999999999999999999999999875543 21122222335789999999999999999999 9999999876 99
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.|| -+....+..+-+....+.+.| .+|+..+..||.+|||.|-..||++.+|+..|+++
T Consensus 833 RPY----WdmSNQdVIkaIe~gyRLPpP-------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 833 RPY----WDMSNQDVIKAIEQGYRLPPP-------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred Ccc----cccchHHHHHHHHhccCCCCC-------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 994 333455666666666655444 24455688999999999999999999999999987
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.19 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=195.5
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
.|..+.++|.+++.||+|+||.||+|++.+ .++..||||.+..... ....
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--------------------------~~~~ 84 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--------------------------SSEK 84 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--------------------------hHHH
Confidence 355578899999999999999999998632 2345799999854321 1224
Q ss_pred HHHHHHHHHHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCCC---------------------------------
Q 046907 118 RQIQSEINTVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRREL--------------------------------- 163 (345)
Q Consensus 118 ~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l--------------------------------- 163 (345)
+.+.+|+.+++++. ||||+++++++...+ .+++++||+.++++.
T Consensus 85 ~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (400)
T cd05105 85 QALMSELKIMTHLGPHLNIVNLLGACTKSG--PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADES 162 (400)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCC--ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccc
Confidence 56889999999995 999999999997765 688899999876543
Q ss_pred ------------------------------------------------------------------------CHHHHHHH
Q 046907 164 ------------------------------------------------------------------------DWLARHRI 171 (345)
Q Consensus 164 ------------------------------------------------------------------------~~~~~~~i 171 (345)
++.....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~ 242 (400)
T cd05105 163 TRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSF 242 (400)
T ss_pred ccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHH
Confidence 33344678
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 172 ~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+.|++.||.|||+.+ ++|+||||+||+++.++.+|++|||++................++..|+|||.+.+..++.+
T Consensus 243 ~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 319 (400)
T cd05105 243 TYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL 319 (400)
T ss_pred HHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch
Confidence 999999999999998 99999999999999999999999999986543322222233456788999999998889999
Q ss_pred chhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 252 CDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 252 ~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
+||| ||+++|||++ |..||..... .......+.... .+. ........+.+++.+||+.||++
T Consensus 320 ~DiwSlGvil~ellt~g~~P~~~~~~---~~~~~~~~~~~~---~~~----------~~~~~~~~l~~li~~cl~~dP~~ 383 (400)
T cd05105 320 SDVWSYGILLWEIFSLGGTPYPGMIV---DSTFYNKIKSGY---RMA----------KPDHATQEVYDIMVKCWNSEPEK 383 (400)
T ss_pred hhHHHHHHHHHHHHHCCCCCCcccch---hHHHHHHHhcCC---CCC----------CCccCCHHHHHHHHHHCccCHhH
Confidence 9999 9999999997 8999754321 111222221111 110 11123345788999999999999
Q ss_pred CCCHHHHHHHHhhhh
Q 046907 330 RPNSKDVRRMLSQIQ 344 (345)
Q Consensus 330 Rpt~~~ll~~L~~l~ 344 (345)
|||+.+|.+.|+++.
T Consensus 384 RPt~~~l~~~l~~l~ 398 (400)
T cd05105 384 RPSFLHLSDIVESLL 398 (400)
T ss_pred CcCHHHHHHHHHHHc
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=288.60 Aligned_cols=255 Identities=18% Similarity=0.238 Sum_probs=190.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+++ .++..||+|.+...... ......+.+|+.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~-------------------------~~~~~~~~~E~~~l 54 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEEN-------------------------EEVKETTLRELKML 54 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEeccccc-------------------------ccchhhHHHHHHHH
Confidence 47999999999999999999964 57899999998643211 12245667899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+..++ .+++++||++++ ..++...+..++.|++.||.|||+.+ ++||||||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~ 129 (287)
T cd07848 55 RTLKQENIVELKEAFRRRG--KLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPE 129 (287)
T ss_pred HhCCCccccchhhhEecCC--EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999999999999887765 789999999765 23566677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.+||+|||++........ .......|+..|+|||++.+..++.++|+| +|+++|||++|..||....
T Consensus 130 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~--- 205 (287)
T cd07848 130 NLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES--- 205 (287)
T ss_pred HEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC---
Confidence 99999999999999999987543221 122345789999999999988899999999 9999999999999975422
Q ss_pred chhhHHHHHHHHhhhc------------CCCccccccccC------CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASE------------NPKRAIDSKLVG------NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~------~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+....+....... .......+.... .........+.+++..||+.||++|||++++++
T Consensus 206 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 206 -EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred -HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111111111000 000000000000 001112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=294.80 Aligned_cols=256 Identities=22% Similarity=0.341 Sum_probs=194.0
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
|....++|++.+.||+|+||.||+|++.+ .+++.||+|.+..... .....
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--------------------------~~~~~ 55 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--------------------------ASEYK 55 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--------------------------HHHHH
Confidence 44566799999999999999999997432 3468899999864221 11245
Q ss_pred HHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-----------------------------------
Q 046907 119 QIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------------------------------- 162 (345)
Q Consensus 119 ~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------------------------------- 162 (345)
.+..|+.++.++ +||||+++++++..++ ..++++++|++++++
T Consensus 56 ~~~~E~~~~~~l~~h~niv~~~~~~~~~~-~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (337)
T cd05054 56 ALMTELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134 (337)
T ss_pred HHHHHHHHHHhhccCcchhheeeeEecCC-CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccc
Confidence 567899999999 8999999999887654 367778888876533
Q ss_pred -----------------------------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCC
Q 046907 163 -----------------------------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207 (345)
Q Consensus 163 -----------------------------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~ 207 (345)
+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~ 211 (337)
T cd05054 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNV 211 (337)
T ss_pred cCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCc
Confidence 355556789999999999999998 999999999999999999
Q ss_pred eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHH
Q 046907 208 ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKW 285 (345)
Q Consensus 208 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~ 285 (345)
++|+|||++..+.............++..|+|||++.+..++.++||| +|+++|||++ |..||..... ...+...
T Consensus 212 vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~---~~~~~~~ 288 (337)
T cd05054 212 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---DEEFCRR 288 (337)
T ss_pred EEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc---cHHHHHH
Confidence 999999999876433322223345567789999999999999999999 9999999998 9999754221 1122222
Q ss_pred HHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 286 MRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
+........ .......+.+++.+||+.+|++||++.+|++.|+.+-
T Consensus 289 ~~~~~~~~~-------------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 289 LKEGTRMRA-------------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HhccCCCCC-------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221111100 0112234788899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=295.53 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=187.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|+.++.||+|+||.||+|++. .+++.||||.+..... ......+.+|+.
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~E~~ 124 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHE--------------------------DTVRRQICREIE 124 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCc--------------------------HHHHHHHHHHHH
Confidence 4568899999999999999999864 5789999999854321 122456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
+++.++||||+++++++..++ .+++++||+.++.+ .+......++.|++.||.|||+.+ ++||||||+||
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 199 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNG--EIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNL 199 (353)
T ss_pred HHHhCCCCCcceeeeEeccCC--eEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHE
Confidence 999999999999999987766 68899999988764 345566789999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-----ccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-----TLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-----~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|++.++.+||+|||++........ ......||..|+|||.+... ..+.++||| ||+++|||++|..||...
T Consensus 200 ll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~- 276 (353)
T PLN00034 200 LINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG- 276 (353)
T ss_pred EEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC-
Confidence 999999999999999986543221 12346789999999988532 234689999 999999999999997521
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
........+........+ .........+.++|.+||+.||++|||+.++++.
T Consensus 277 ---~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 277 ---RQGDWASLMCAICMSQPP----------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCccHHHHHHHHhccCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222222211111111 0111223457889999999999999999999863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=288.53 Aligned_cols=256 Identities=21% Similarity=0.291 Sum_probs=185.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
.+|++.+.||+|+||.||+|+....++..||+|.+........ ....+.+|+.++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-------------------------~~~~~~~e~~~l 55 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-------------------------MPLSTIREVAVL 55 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-------------------------chHHHHHHHHHH
Confidence 4799999999999999999986545678999999864322211 122334556655
Q ss_pred hh---ccCCCccceeEEEecC---CcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 128 GQ---IRHRNLHPLLAHVTRP---DCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 128 ~~---l~hpniv~l~~~~~~~---~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+. ++||||+++++++... ....++++++++.+. ..+++..+..++.|++.||.|||+.+ ++
T Consensus 56 ~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ii 132 (290)
T cd07862 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VV 132 (290)
T ss_pred HhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 55 4799999999988532 234678899988652 23566778899999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||||||+||+++.++.+||+|||++....... ......||..|+|||.+.+..++.++||| +|+++|||++|..||
T Consensus 133 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f 209 (290)
T cd07862 133 HRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209 (290)
T ss_pred eCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc
Confidence 99999999999999999999999997654321 22346789999999999888899999999 999999999999996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCc----------cccccc---cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKR----------AIDSKL---VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
... ...+....+......+.+.. ...... .....++....+.+++.+||+.||++|||+.+++
T Consensus 210 ~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 210 RGS----SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCC----CHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 542 22333333332221111100 000000 0001112334567899999999999999999998
Q ss_pred H
Q 046907 338 R 338 (345)
Q Consensus 338 ~ 338 (345)
+
T Consensus 286 ~ 286 (290)
T cd07862 286 S 286 (290)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=290.94 Aligned_cols=192 Identities=23% Similarity=0.380 Sum_probs=162.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+++.. .+|..+|+|.+..... ......+.+|+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~--------------------------~~~~~~~~~E~~ 55 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIK--------------------------PAIRNQIIRELQ 55 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccC--------------------------HHHHHHHHHHHH
Confidence 3579999999999999999999864 5789999999854211 123567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++++||||+++++++..++ .++++++|++++++ ++......++.|++.||.|||+.+ .++|||||
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlk 131 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVK 131 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECC--EEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCC
Confidence 999999999999999988776 68899999988755 445556789999999999999863 39999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+||+++.++.++|+|||++...... ......|+..|+|||.+.+..++.++||| +|+++|||++|..||..
T Consensus 132 p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 132 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred hhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999998765332 12345789999999999998899999999 99999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=283.26 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=194.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|++. .++..||||.+....... .+....+.+|+.++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~------------------------~~~~~~~~~e~~~l 56 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMD------------------------AKARQDCVKEIDLL 56 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCC------------------------HHHHHHHHHHHHHH
Confidence 58999999999999999999864 578999999875422111 23356678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.++||||+++++.+..++ ..++++++++++++ ++......++.|++.||.|||+.+ ++|+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 131 (267)
T cd08228 57 KQLNHPNVIKYLDSFIEDN--ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRD 131 (267)
T ss_pred HhCCCcceeeeeeeEEECC--eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCC
Confidence 9999999999999888776 67888899887644 344556789999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+|+||+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|||++|..||...
T Consensus 132 l~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 132 IKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 999999999999999999999886643321 12335688899999999888889999999 999999999999996431
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.. ........+... ..+. .........+.++|.+||+.+|++||++.++++.|++++
T Consensus 210 ~~--~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 210 KM--NLFSLCQKIEQC---DYPP---------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred cc--cHHHHHHHHhcC---CCCC---------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11 111222222111 1110 011223355889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=287.88 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=185.8
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|+..+.||+|+||.||+|... .+|+.||+|.+...... .......+.+|+.+++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~------------------------~~~~~~~~~~E~~il~ 55 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIK------------------------KRKGEAMALNEKRILE 55 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhh------------------------hhhhHHHHHHHHHHHH
Confidence 4788999999999999999864 57999999998532111 0122345778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++|+||+++++.+..++ .++++++++.++++ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 56 ~l~~~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp 130 (285)
T cd05631 56 KVNSRFVVSLAYAYETKD--ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKP 130 (285)
T ss_pred hcCCCcEEEEEEEEccCC--eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCH
Confidence 999999999999888776 68899999987654 455667789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++|+|||++....... ......||..|+|||++.+..++.++||| +|+++|||++|..||......
T Consensus 131 ~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 131 ENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred HHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 99999999999999999998754322 12345789999999999998999999999 999999999999997543221
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
. ....+......... .........+.+++..||+.||++||+ ++++++
T Consensus 208 ~----~~~~~~~~~~~~~~----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 208 V----KREEVDRRVKEDQE----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred h----hHHHHHHHhhcccc----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1 11111111111100 011112234778899999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=298.03 Aligned_cols=253 Identities=19% Similarity=0.204 Sum_probs=184.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|... .+++.||+|... ...+.+|+.
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~---------------------------------~~~~~~E~~ 135 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQ---------------------------------RGGTATEAH 135 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechh---------------------------------hhhhHHHHH
Confidence 4568999999999999999999854 678999999752 234568999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++ ..+++++++.+ ...+++.....++.|++.||.|||+.+ |+||||||
T Consensus 136 il~~l~HpnIv~~~~~~~~~~--~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP 210 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNK--FTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKA 210 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECC--eeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 999999999999999988766 56677776643 234667778899999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++||| +|+++|||++|..||-.....
T Consensus 211 ~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~ 289 (391)
T PHA03212 211 ENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGL 289 (391)
T ss_pred HhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccc
Confidence 999999999999999999865332211 122346799999999999998999999999 999999999999885321111
Q ss_pred c---chhhHHHHHHHHhhhcCCCcccc----------------ccccC-----CCcHHHHHHHHHHHhhccCCCCCCCCC
Q 046907 277 T---NEMSFVKWMRNVMASENPKRAID----------------SKLVG-----NGCEEQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 277 ~---~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~-----~~~~~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
. ........+.............+ ..... .........+.+++.+||+.||++|||
T Consensus 290 ~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt 369 (391)
T PHA03212 290 DGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS 369 (391)
T ss_pred cccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC
Confidence 1 11111111211111100000000 00000 001123456888999999999999999
Q ss_pred HHHHHH
Q 046907 333 SKDVRR 338 (345)
Q Consensus 333 ~~~ll~ 338 (345)
+.++++
T Consensus 370 a~elL~ 375 (391)
T PHA03212 370 AEALLD 375 (391)
T ss_pred HHHHhc
Confidence 999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=287.95 Aligned_cols=256 Identities=21% Similarity=0.278 Sum_probs=187.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||+|.+...... .....+.+|+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~--------------------------~~~~~~~~E~~ 55 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEE--------------------------GTPFTAIREAS 55 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEecccccc--------------------------ccchhHHHHHH
Confidence 3578999999999999999999864 57899999998543211 11334567999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++|+.++ ..++...+..++.|++.||.|||+.+ ++|||||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlk 130 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLK 130 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCC--eEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 999999999999999988765 788999998642 23566677889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++........ ......||..|+|||.+.+. .++.++||| +|+++|+|++|..||....
T Consensus 131 p~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 131 PQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred HHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999999999875432211 22345789999999998754 478899999 9999999999999976432
Q ss_pred cccchhhHHHHHHHHhhhcCCCc--------ccccc-c--cCC-CcH------HHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKR--------AIDSK-L--VGN-GCE------EQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-~--~~~-~~~------~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+.......+......+.... ...+. . ... ... .....+.+++..||+.||++|||+.++
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~ 285 (303)
T cd07869 209 ---DIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA 285 (303)
T ss_pred ---cHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH
Confidence 22222222222211111000 00000 0 000 000 012346789999999999999999999
Q ss_pred HH
Q 046907 337 RR 338 (345)
Q Consensus 337 l~ 338 (345)
++
T Consensus 286 l~ 287 (303)
T cd07869 286 LS 287 (303)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=287.07 Aligned_cols=255 Identities=19% Similarity=0.256 Sum_probs=188.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+-++|++.+.||+|+||.||+|+.+ .++..||+|.+...... .....+.+|+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~E~~ 55 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEE--------------------------GAPCTAIREVS 55 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccC--------------------------CcchhHHHHHH
Confidence 3468999999999999999999854 57899999998542211 11334568999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ ..+++++++++ +..++......++.|++.||.|||+.+ ++|||||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlk 130 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTER--CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLK 130 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCC--eEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999987765 68889998875 223566677889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++........ ......|+..|+|||.+.+ ..++.++||| +|+++|+|++|..||...
T Consensus 131 p~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~- 207 (288)
T cd07871 131 PQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS- 207 (288)
T ss_pred HHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC-
Confidence 9999999999999999999976533221 1234578999999999865 4588999999 999999999999997432
Q ss_pred cccchhhHHHHHHHHhhhcCCCc------------cccccccC----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKR------------AIDSKLVG----NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~----~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+......+.... ...+.... ...+.....+.+++.+||+.||.+|||++|+++
T Consensus 208 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 208 ---TVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ---CHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 22233333322222111100 00000000 000112345678999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=286.20 Aligned_cols=249 Identities=28% Similarity=0.406 Sum_probs=192.4
Q ss_pred cCCcccccccccCcceeeEEEEecCC----CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQ----NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
.++|++.+.||+|+||.||+|..... +...||+|.+..... ......+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--------------------------~~~~~~~~~ 57 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--------------------------PKVQQEFRQ 57 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--------------------------HHHHHHHHH
Confidence 45899999999999999999986432 236799999854321 122456788
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHHHHHHHH
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRIALGLAC 177 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i~~~i~~ 177 (345)
|+.+++.++||||+++++++...+ ..+++++++.++++ ++......++.|++.
T Consensus 58 ei~~l~~l~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 135 (283)
T cd05048 58 EAELMSDLQHPNIVCLLGVCTKEQ--PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135 (283)
T ss_pred HHHHHHhcCCcccceEEEEEcCCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHH
Confidence 999999999999999999887665 57888898877654 334455689999999
Q ss_pred HHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-H
Q 046907 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256 (345)
Q Consensus 178 ~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-l 256 (345)
||.|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||| |
T Consensus 136 al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 136 GMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred HHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 999999998 999999999999999999999999999865433322223345668889999999888899999999 9
Q ss_pred HHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 257 GALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 257 G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
|+++|||++ |..||... ...+....+.... .+ ..+......+.+++.+||+.||++||++.+
T Consensus 213 G~il~el~~~g~~p~~~~----~~~~~~~~i~~~~---~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~ 275 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGF----SNQEVIEMIRSRQ---LL----------PCPEDCPARVYALMIECWNEIPARRPRFKD 275 (283)
T ss_pred HHHHHHHHcCCCCCCCCC----CHHHHHHHHHcCC---cC----------CCcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999998 99996442 2223332222111 11 112233456889999999999999999999
Q ss_pred HHHHHhhh
Q 046907 336 VRRMLSQI 343 (345)
Q Consensus 336 ll~~L~~l 343 (345)
|++.|+++
T Consensus 276 i~~~l~~~ 283 (283)
T cd05048 276 IHTRLRSW 283 (283)
T ss_pred HHHHHhcC
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=289.49 Aligned_cols=249 Identities=19% Similarity=0.303 Sum_probs=189.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCc----eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGR----MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
...+|+..+.||+|+||.||+|++.. ++. .||+|.+..... .....++.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~ 57 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS--------------------------PKANKEIL 57 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccCC--------------------------HHHHHHHH
Confidence 34579999999999999999998752 333 489999853211 12345678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..+. .+++++++.+|.+ +++.....++.|++.||.|||+.+ ++
T Consensus 58 ~e~~~l~~l~h~niv~~~g~~~~~~---~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ii 131 (316)
T cd05108 58 DEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LV 131 (316)
T ss_pred HHHHHHHhCCCCCCCeEEEEEcCCC---ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---ee
Confidence 8999999999999999999887654 5567777777654 445556789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||| ||+++|||++ |..|
T Consensus 132 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p 211 (316)
T cd05108 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211 (316)
T ss_pred ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999876543322222333456789999999998999999999 9999999998 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ...+....+......+.+ +.+...+.+++..||+.+|++|||+.+++..|..+.
T Consensus 212 ~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 212 YDGI----PASEISSILEKGERLPQP-------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCC----CHHHHHHHHhCCCCCCCC-------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 6532 222332222221111110 111234778899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=295.13 Aligned_cols=257 Identities=24% Similarity=0.333 Sum_probs=186.1
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|+.. .+|..||||.+...... .....++.+|+.+++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~~l~ 54 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEH-------------------------VSDATRILREIKLLR 54 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhcc-------------------------chhHHHHHHHHHHHH
Confidence 5889999999999999999854 57899999998532111 122456788999999
Q ss_pred hccCCCccceeEEEecCCc---ceeeeeccccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDC---HLLYILNDVSQGR--------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++||||+++++++...+. ..++++++++.+. ..+++.....++.|+++||.|||+.+ ++||||||
T Consensus 55 ~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp 131 (338)
T cd07859 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKP 131 (338)
T ss_pred hCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 9999999999998765432 3478999999652 23566677889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCC-cceeccCcccCccccccccccc--cccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAH-THITTSNVVGTVEYIAPEYLQM--LTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~~~aPE~~~~--~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+|||++.++.+||+|||++....... .........||..|+|||++.+ ..++.++||| +|+++|||++|..||...
T Consensus 132 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 132 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred HHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999997543221 1112234678999999999876 5688999999 999999999999997542
Q ss_pred ccccchhhHHHHHHHHhhhcCCCc-----------c---ccccc---cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKR-----------A---IDSKL---VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~~~---~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+.......+......+.... . +.... .....+.....+.+++..||+.||++|||++++
T Consensus 212 ----~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~ 287 (338)
T cd07859 212 ----NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287 (338)
T ss_pred ----ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH
Confidence 22222222222111110000 0 00000 000011122346789999999999999999999
Q ss_pred HH
Q 046907 337 RR 338 (345)
Q Consensus 337 l~ 338 (345)
++
T Consensus 288 l~ 289 (338)
T cd07859 288 LA 289 (338)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=286.25 Aligned_cols=265 Identities=20% Similarity=0.244 Sum_probs=192.5
Q ss_pred Cc-ccccccccCcceeeEEEEec---CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GL-ASLEKIGSGGCGEVYKAELP---GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 49 ~~-~~~~~iG~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
+| ++.+.||+|+||.||+++++ ..++..||+|.+..... ......+.+|+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~E~ 57 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--------------------------QQNTSGWKKEI 57 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--------------------------hHHHHHHHHHH
Confidence 44 89999999999999887643 34688999999864321 11245677899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
.++++++||||+++++++...+...++++++++.++.+ +++..+..++.|++.||.|||+.+ ++|+|||
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlk 134 (283)
T cd05080 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLA 134 (283)
T ss_pred HHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccC
Confidence 99999999999999998877666678999999987654 566777889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCccee-ccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.++++|||++........... .....++..|+|||.+.+..++.++||| +|+++|||++|..||....
T Consensus 135 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 135 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred hheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999999999986643221111 1223456779999999888899999999 9999999999999974322
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
... ....................+..............+.+++..||+.+|++|||++++++.|+++.
T Consensus 215 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 215 KKF--EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred chh--hhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 100 00000000000000000000000001111223456888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=301.35 Aligned_cols=242 Identities=24% Similarity=0.321 Sum_probs=198.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.-+-|++++.||.|+.|.|-+|++ ..||...|||.+...... .......+.+|+-
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh-~~TGqlaaiKii~k~~~~------------------------s~s~~~~IerEIv 64 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKH-AETGQLAAIKIIPKRSEL------------------------SSSQPAGIEREIV 64 (786)
T ss_pred cccceeccccccCCCCceehhhhc-ccccceeEEEeecccccc------------------------ccccccchhhhhH
Confidence 346789999999999999999994 579999999999643211 1233678899999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH---------HHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---------ARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~---------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|+.+.|||++++|+.+.+.. .+|++.||+++|.+++++ ...+++.||+.|+.|||..+ |+|||+|
T Consensus 65 iMkLi~HpnVl~LydVwe~~~--~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLK 139 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQ--HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLK 139 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCc--eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCC
Confidence 999999999999999998776 799999999998876655 55789999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+|+|+|..+++||+|||+|..-.... ...+.||++.|.|||++.|.+| +.++||| +|+|||-|++|..||+
T Consensus 140 pENlLLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--- 213 (786)
T KOG0588|consen 140 PENLLLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--- 213 (786)
T ss_pred chhhhhhcccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---
Confidence 999999999999999999998654433 3456899999999999999998 5689999 9999999999999964
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.+-..++..+..+.... | .....+..+|+..++..||++|.|++||++
T Consensus 214 -DdNir~LLlKV~~G~f~M-P-------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 214 -DDNIRVLLLKVQRGVFEM-P-------------SNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -CccHHHHHHHHHcCcccC-C-------------CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 344445555444443221 1 122234678888899999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=292.33 Aligned_cols=240 Identities=24% Similarity=0.320 Sum_probs=187.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+++ .+++.||+|.+.... .........+.+|+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~------------------------~~~~~~~~~~~~E~~ 70 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKRE------------------------ILKMKQVQHVAQEKS 70 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHH------------------------HhhhhhHHHHHHHHH
Confidence 3468999999999999999999965 578999999985311 011233567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++.+..++ .++++++++.++.+ ++......++.|++.||.|||+.+ ++|||||
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlk 145 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDEN--RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLK 145 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCC--EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCC
Confidence 999999999999999988776 78999999988754 344556678999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|||++.++.+||+|||++....... ....||+.|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 146 p~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~--- 217 (329)
T PTZ00263 146 PENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD--- 217 (329)
T ss_pred HHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC---
Confidence 999999999999999999998664322 235789999999999998899999999 99999999999999743
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
.........+.. .... . . .. ....+.+++..||+.||.+||+ +.++++
T Consensus 218 -~~~~~~~~~i~~---~~~~---~----p-~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 218 -DTPFRIYEKILA---GRLK---F----P-NW---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -CCHHHHHHHHhc---CCcC---C----C-CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 122222222211 1100 0 0 01 1124678999999999999997 576653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=292.33 Aligned_cols=247 Identities=19% Similarity=0.262 Sum_probs=190.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|++. .++..||+|.+.... .........+..|+.++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~------------------------~~~~~~~~~~~~e~~~l 55 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSL------------------------LFKLNEVRHVLTERDIL 55 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHH------------------------HhhhhHHHHHHHHHHHH
Confidence 47999999999999999999964 578999999985211 00122356788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
..++||||+++++.+..++ .+++++||++++++ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~~~h~~iv~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~ 130 (333)
T cd05600 56 TTTKSEWLVKLLYAFQDDE--YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPE 130 (333)
T ss_pred HhCCCCCCccEEEEEEcCC--EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH
Confidence 9999999999999988766 78999999988654 455566779999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.+||+|||++..... ......||+.|+|||.+.+..++.++||| +|+++|||++|..||...
T Consensus 131 Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~---- 201 (333)
T cd05600 131 NFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS---- 201 (333)
T ss_pred HEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC----
Confidence 99999999999999999876533 22346789999999999998999999999 999999999999997532
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
...+....+.............+ ........+.+++..||+.+|.+||++.++++.
T Consensus 202 ~~~~~~~~i~~~~~~~~~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 202 TPNETWENLKYWKETLQRPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CHHHHHHHHHhccccccCCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 22222222221110000000000 001223457788889999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.87 Aligned_cols=250 Identities=19% Similarity=0.336 Sum_probs=193.6
Q ss_pred hcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+..+|.+.+.||+|+||.||++... ..++..+|+|.+.... ......+.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---------------------------~~~~~~~~ 55 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------------------------DNARKDFH 55 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---------------------------HHHHHHHH
Confidence 5678999999999999999999742 2346679999885421 22355688
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------------------CCHHHHHHHHHHHHHHH
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------------------LDWLARHRIALGLACGL 179 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------------------l~~~~~~~i~~~i~~~l 179 (345)
+|+.++++++||||+++++++...+ .++++++++.++.+ +++.....++.|++.||
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL 133 (288)
T cd05093 56 REAELLTNLQHEHIVKFYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGM 133 (288)
T ss_pred HHHHHHHhCCCCCcceEEEEEecCC--ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHH
Confidence 8999999999999999999988765 67889998876543 56777888999999999
Q ss_pred HHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHH
Q 046907 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258 (345)
Q Consensus 180 ~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~ 258 (345)
.|||+.+ ++||||||+||+++.++.++++|||++................++..|+|||.+.+..++.++|+| ||+
T Consensus 134 ~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 210 (288)
T cd05093 134 VYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210 (288)
T ss_pred HHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHH
Confidence 9999998 999999999999999999999999999765433222222334557789999999988899999999 999
Q ss_pred HHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 259 LLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 259 vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
++|+|++ |..||... ........+.... ... .. . .....+.+++.+||+.||.+|||+.++.
T Consensus 211 il~~l~t~g~~p~~~~----~~~~~~~~i~~~~---~~~------~~-~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 211 VLWEIFTYGKQPWYQL----SNNEVIECITQGR---VLQ------RP-R---TCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHHHHHhCCCCCCCCC----CHHHHHHHHHcCC---cCC------CC-C---CCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 9999998 89996432 2222222222211 110 00 0 1123478899999999999999999999
Q ss_pred HHHhhhh
Q 046907 338 RMLSQIQ 344 (345)
Q Consensus 338 ~~L~~l~ 344 (345)
+.|+++.
T Consensus 274 ~~l~~~~ 280 (288)
T cd05093 274 SLLQNLA 280 (288)
T ss_pred HHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.85 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=188.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+.||+|+||.||+++++ ++..+|+|.+...... ...+.+|+.
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~~~----------------------------~~~~~~e~~ 51 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGAMS----------------------------EEDFIEEAK 51 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCCcc----------------------------HHHHHHHHH
Confidence 3467999999999999999999875 5668999987533211 345778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++++++||||+++++++..++ .++++++|++++.+ +++.....++.|++.||.|||+.+ ++|+||
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 126 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQK--PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDL 126 (256)
T ss_pred HHHHCCCCCceeEEEEEccCC--CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 999999999999999887765 68899999987543 455667789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~ 273 (345)
+|+|++++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+| +|+++|||++ |..||..
T Consensus 127 ~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~- 204 (256)
T cd05114 127 AARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK- 204 (256)
T ss_pred CcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-
Confidence 999999999999999999998765432211 11223456789999999988899999999 9999999999 8999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
....+....+........ +. . ....+.+++.+||+.+|++||++.++++.|.
T Consensus 205 ---~~~~~~~~~i~~~~~~~~------~~----~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 205 ---KSNYEVVEMISRGFRLYR------PK----L---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCHHHHHHHHHCCCCCCC------CC----C---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 233333333332211111 11 1 1235789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=285.32 Aligned_cols=240 Identities=21% Similarity=0.342 Sum_probs=197.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.-+|++.+.||+|.||.|-+|+. ...|+.||||.++...... ..+.-.+.+|++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e-~~sgR~VAiKsIrKdkIkd------------------------eqDlvhIRREIeI 106 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYE-HKSGREVAIKSIRKDKIKD------------------------EQDLVHIRREIEI 106 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhh-ccCCcEeehhhhhhhhccc------------------------HHHHHHHHHHHHH
Confidence 34899999999999999999974 3579999999996432211 3457788999999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.|+||||+.+|.+|.+.+ .++++|||..+|.+. +......++.||.+|+.|||.++ ++|||||.
T Consensus 107 MSsLNHPhII~IyEVFENkd--KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKL 181 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKD--KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKL 181 (668)
T ss_pred HhhcCCCceeehhhhhcCCc--eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccch
Confidence 99999999999999998777 799999999988764 44456789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+|||+|.++++||+|||++..+.+.. ...+++|++.|.+||.+.|.+| ++..|.| +|++||-++.|..||+++
T Consensus 182 ENILLD~N~NiKIADFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-- 256 (668)
T KOG0611|consen 182 ENILLDQNNNIKIADFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-- 256 (668)
T ss_pred hheeecCCCCeeeeccchhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--
Confidence 99999999999999999997765443 3466999999999999999997 5789999 999999999999997553
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+...++..|..+.+.+... +.....||.|+|..||+.|.|+.+|..
T Consensus 257 --Dhk~lvrQIs~GaYrEP~~---------------PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 257 --DHKRLVRQISRGAYREPET---------------PSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred --hHHHHHHHhhcccccCCCC---------------CchHHHHHHHHHhcCcccchhHHHHhh
Confidence 4444544444443322221 112668999999999999999999864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.32 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=191.8
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+..+|.+.+.||+|+||.||+|.++ .+++.||+|.+.... .....+.+|+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~~----------------------------~~~~~~~~e~ 53 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT----------------------------MEVEEFLKEA 53 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecCCc----------------------------hHHHHHHHHH
Confidence 45668999999999999999999875 568899999985321 1245677899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.+++.++||||+++++++..++ .+++++++++++.+ +++.....++.|+++||.|||+.+ ++|+
T Consensus 54 ~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~ 128 (263)
T cd05052 54 AVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHR 128 (263)
T ss_pred HHHHhCCCCChhheEEEEcCCC--CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeec
Confidence 9999999999999999887766 57888888876543 455666789999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~ 271 (345)
||||+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++||| ||+++|||++ |..||.
T Consensus 129 dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred ccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999766443211 11223345689999999988899999999 9999999998 899964
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.. ...+....+....... ........+.+++.+||+.||++|||+.++++.|+++
T Consensus 208 ~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 208 GI----DLSQVYELLEKGYRME-------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC----CHHHHHHHHHCCCCCC-------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 32 2222222222111110 1111234578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=282.06 Aligned_cols=242 Identities=26% Similarity=0.478 Sum_probs=183.5
Q ss_pred ccccccccCcceeeEEEEec---CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 51 ASLEKIGSGGCGEVYKAELP---GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
.+.+.||.|+||.||+|+++ ...+..|+||.+..... .+....+.+|++.+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~--------------------------~~~~~~~~~e~~~l 55 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS--------------------------EEEEEEFLNEIQIL 55 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS--------------------------HHHHHHHHHHHHHH
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc--------------------------cccceeeeeccccc
Confidence 35688999999999999987 22367899999954221 22367788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++||||+++++++...+ .+++++|++.++. .+++..+.+++.|++.||.|||+.+ ++|++|+
T Consensus 56 ~~l~h~ni~~~~g~~~~~~--~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~ 130 (259)
T PF07714_consen 56 RKLRHPNIVKLYGFCIENE--PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLS 130 (259)
T ss_dssp HTHSBTTBE-EEEEEESSS--SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred ccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc
Confidence 9999999999999999554 4888889887643 4677788899999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~ 274 (345)
++||+++.++.+||+|||++................+...|+|||.+.+..++.++||| ||+++||+++ |..||...
T Consensus 131 ~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~- 209 (259)
T PF07714_consen 131 PSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY- 209 (259)
T ss_dssp GGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 99999999999999999999877433332333445677899999999998899999999 9999999999 78885432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
...+....+........+ ..+...+.++|..||+.||++|||+.+|++.|
T Consensus 210 ---~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 ---DNEEIIEKLKQGQRLPIP-------------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---CHHHHHHHHHTTEETTSB-------------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ccccccccccccccceec-------------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 444444444333322111 11233477899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=278.88 Aligned_cols=258 Identities=23% Similarity=0.279 Sum_probs=201.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
...|+.+++||+|+||+||+|+.+ .+|..||+|.+.-...... ......+|+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG-------------------------~P~taiREisl 63 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEG-------------------------VPSTAIREISL 63 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccC-------------------------CCchhhHHHHH
Confidence 457889999999999999999954 6899999999976543211 24456789999
Q ss_pred HhhccCCC-ccceeEEEecCC----cceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 127 VGQIRHRN-LHPLLAHVTRPD----CHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 127 l~~l~hpn-iv~l~~~~~~~~----~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
++.++|+| ||.+++++.+.+ ...+++++++++.. ..++...+..++.|++.||+|||+++
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--- 140 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--- 140 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 99999999 999999998766 23577788877541 24555678899999999999999999
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|+||||||.|+|++.+|.+|++|||+|+...-... ..+..++|..|.|||++.+. .|+...|+| +||++.||+++.
T Consensus 141 IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~ 218 (323)
T KOG0594|consen 141 ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR 218 (323)
T ss_pred eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence 99999999999999999999999999996653221 23457889999999999988 589999999 999999999988
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccc--------cc---ccc-C----CCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAI--------DS---KLV-G----NGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~---~~~-~----~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
..| ++..+.+....+....+.+...... .. ... + ...+....+..+++.+|++.+|.+|.
T Consensus 219 ~LF----pG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~ 294 (323)
T KOG0594|consen 219 PLF----PGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI 294 (323)
T ss_pred CCC----CCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc
Confidence 884 4456677777777777666443211 10 000 0 00111113678899999999999999
Q ss_pred CHHHHHHH
Q 046907 332 NSKDVRRM 339 (345)
Q Consensus 332 t~~~ll~~ 339 (345)
|+..+++.
T Consensus 295 Sa~~al~h 302 (323)
T KOG0594|consen 295 SAKGALTH 302 (323)
T ss_pred CHHHHhcC
Confidence 99998875
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=283.93 Aligned_cols=252 Identities=17% Similarity=0.297 Sum_probs=190.6
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
|....++|++.+.||+|+||.||+|.+++ .++..||+|.+..... .....
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--------------------------~~~~~ 54 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--------------------------MRERI 54 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--------------------------HHHHH
Confidence 34567889999999999999999998642 2457899998743211 11245
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC-------------------CHHHHHHHHHHHHHHH
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-------------------DWLARHRIALGLACGL 179 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l-------------------~~~~~~~i~~~i~~~l 179 (345)
.+.+|+.+++.++||||+++++++...+ ..++++++++++++. ++.....++.|++.||
T Consensus 55 ~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (277)
T cd05062 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132 (277)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCC--CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHH
Confidence 6788999999999999999999887665 678899998876543 3344567899999999
Q ss_pred HHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHH
Q 046907 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258 (345)
Q Consensus 180 ~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~ 258 (345)
.|||+.+ ++|+||||+||+++.++.++++|||++................++..|+|||.+.+..++.++||| ||+
T Consensus 133 ~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05062 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209 (277)
T ss_pred HHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHH
Confidence 9999998 999999999999999999999999998765433222122234557889999999988899999999 999
Q ss_pred HHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 259 LLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 259 vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
++|||++ |..||.. .........+........ .......+.+++.+||+.||++|||+.+++
T Consensus 210 ~l~el~~~~~~p~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 210 VLWEIATLAEQPYQG----MSNEQVLRFVMEGGLLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred HHHHHHcCCCCCCCC----CCHHHHHHHHHcCCcCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999999 6888643 222333332221110000 011223578899999999999999999999
Q ss_pred HHHhh
Q 046907 338 RMLSQ 342 (345)
Q Consensus 338 ~~L~~ 342 (345)
+.|++
T Consensus 273 ~~l~~ 277 (277)
T cd05062 273 SSIKE 277 (277)
T ss_pred HHhhC
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.29 Aligned_cols=243 Identities=15% Similarity=0.202 Sum_probs=188.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
...|.+.+.||+|++|.||+|......+..||+|.+.... ......+.+|+.+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---------------------------~~~~~~~~~E~~~ 118 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---------------------------ERQAAYARSELHC 118 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---------------------------HHHHHHHHHHHHH
Confidence 3459999999999999999998543337788999764321 1224456789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
++.++||||+++++++..++ .+++++||+.++++ ++......++.|++.||.|||+.+ ++||
T Consensus 119 l~~l~Hpniv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHr 193 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDD--KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHR 193 (478)
T ss_pred HHhCCCCCEeEEEEEEEECC--EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEEC
Confidence 99999999999999998776 78999999998765 344455679999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||| +|+++|||++|..||..
T Consensus 194 Dlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred CcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543222223456799999999999998899999999 99999999999999743
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+.. ..... ........+.++|..||+.||++||++.+++.
T Consensus 274 ----~~~~~~~~~~~~---~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 274 ----PSQREIMQQVLY---GKYDP----------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----CCHHHHHHHHHh---CCCCC----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 222222222211 11110 00112234788999999999999999999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.10 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=191.3
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++.+.||+|+||.||+|+.. .+|+.||||.+.....+ ......+.+|+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~-------------------------~~~~~~~~~Ei 82 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMS-------------------------EADKNRAQAEV 82 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCC-------------------------HHHHHHHHHHH
Confidence 35679999999999999999999854 57999999998643222 22355677899
Q ss_pred HHHhhccCCCccceeEEEecCCc------ceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhc
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDC------HLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~------~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
.++..++|+||+++++.+...+. ..++++++|+.++++ ++......++.|++.||.|||+.
T Consensus 83 ~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~ 162 (496)
T PTZ00283 83 CCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162 (496)
T ss_pred HHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99999999999999887654321 246789999988765 34445567999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
+ ++||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||| +|+++|||+
T Consensus 163 ~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl 239 (496)
T PTZ00283 163 H---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239 (496)
T ss_pred C---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 8 999999999999999999999999999876443222233456899999999999998999999999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
+|..||.. .........+......+ .++.....+.+++..||+.||.+||++.++++.
T Consensus 240 tG~~Pf~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 240 TLKRPFDG----ENMEEVMHKTLAGRYDP-------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HCCCCCCC----CCHHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 99999743 22222222221111110 111122347788999999999999999998763
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.88 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=192.2
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|+++++||+|+||.||+|... ++..||+|.+.... ...+.+.+|
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~----------------------------~~~~~~~~e 51 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT----------------------------MSVQAFLEE 51 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc----------------------------hhHHHHHHH
Confidence 456779999999999999999999864 56789999875421 124567889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+.+++.++||||+++++.+...+ ..+++++++.++++ +++..+..++.|++.||.|||+.+ ++|
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H 126 (261)
T cd05072 52 ANLMKTLQHDKLVRLYAVVTKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIH 126 (261)
T ss_pred HHHHHhCCCCCeeeEEEEEcCCC--CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 99999999999999999887665 57899999887654 344556779999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
+||||+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+| +|+++|+|++ |..||
T Consensus 127 ~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred cccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 999999999999999999999999876443221 12234456789999999888889999999 9999999998 99997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
... ........+......+. .......+.+++.+||+.+|++||+++++.+.|+++
T Consensus 206 ~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 206 PGM----SNSDVMSALQRGYRMPR-------------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCC----CHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 532 22233333322211100 011223477899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=291.87 Aligned_cols=241 Identities=22% Similarity=0.268 Sum_probs=188.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+++...+..||+|.+.... .........+.+|+.
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~------------------------~~~~~~~~~~~~E~~ 83 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK------------------------IIKQKQVDHVFSERK 83 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH------------------------hhhhhhHHHHHHHHH
Confidence 56689999999999999999998765456789999984211 111233567788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++|+.++.+ ++......++.|++.||.|||+.+ ++|||||
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~--~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLk 158 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDES--YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLK 158 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCC
Confidence 999999999999999998776 78999999988754 444556789999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|+| +|+++|||++|..||...
T Consensus 159 p~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-- 231 (340)
T PTZ00426 159 PENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN-- 231 (340)
T ss_pred HHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC--
Confidence 99999999999999999999865432 2346789999999999988899999999 999999999999997432
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
........+.. .... + + .. ....+.+++.+||+.||++|+ ++.++++
T Consensus 232 --~~~~~~~~i~~---~~~~---~----p-~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 232 --EPLLIYQKILE---GIIY---F----P-KF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --CHHHHHHHHhc---CCCC---C----C-CC---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 22222222211 1100 0 0 11 112367888999999999995 7888765
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=301.60 Aligned_cols=253 Identities=20% Similarity=0.308 Sum_probs=206.2
Q ss_pred hhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCc--eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 37 KAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGR--MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
...+..-++..++..+.++||+|+||+|++|.|....|+ .||||.+.......
T Consensus 99 p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~------------------------- 153 (1039)
T KOG0199|consen 99 PSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA------------------------- 153 (1039)
T ss_pred cCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------------------------
Confidence 344444466777889999999999999999999765554 68999997654331
Q ss_pred HHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHH-----------HHHHHHHHHHHHHHh
Q 046907 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR-----------HRIALGLACGLEYLH 183 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~-----------~~i~~~i~~~l~~lh 183 (345)
.+..|.+|+.+|.+|+|||++++||...++ -+.+|+|+++.|++++.+.. ..++.||+.|+.||.
T Consensus 154 -~mddflrEas~M~~L~H~hliRLyGvVl~q---p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe 229 (1039)
T KOG0199|consen 154 -IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE 229 (1039)
T ss_pred -hHHHHHHHHHHHHhccCcceeEEeeeeccc---hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh
Confidence 478899999999999999999999998875 48899999999988766644 469999999999999
Q ss_pred hcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCccee-ccCcccCccccccccccccccCccchhh-HHHHHH
Q 046907 184 MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLA 261 (345)
Q Consensus 184 ~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~ 261 (345)
+++ +|||||.++|+|+...-.+||+|||+.+.++....... .....-..-|.|||.+....++.++||| ||+++|
T Consensus 230 skr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiW 306 (1039)
T KOG0199|consen 230 SKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIW 306 (1039)
T ss_pred hhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHH
Confidence 999 99999999999999988999999999999877654433 2233445679999999999999999999 999999
Q ss_pred HHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 262 GLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 262 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||+| |+-||.+. ...++++.+....+.+ .++.|.+++.++|..||..+|.+|||+.+|.+
T Consensus 307 EMFtyGEePW~G~----~g~qIL~~iD~~erLp-------------RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 307 EMFTYGEEPWVGC----RGIQILKNIDAGERLP-------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred hhhccCCCCCCCC----CHHHHHHhccccccCC-------------CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 9998 89998764 3445555444333222 23456677889999999999999999999973
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=278.24 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=193.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+.++|++.+.||+|+||.||+|+++.. +...||+|.+..... ......+..|
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--------------------------~~~~~~~~~e 55 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--------------------------DKQRLDFLTE 55 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--------------------------hHHHHHHHHH
Confidence 356899999999999999999997532 356899998854321 1224567889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.++++++||||+++++++...+ ..+++++++.+++ .+++....+++.|++.|+.|||+.+ ++|+
T Consensus 56 ~~~l~~l~h~~i~~~~~~~~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~ 130 (266)
T cd05033 56 ASIMGQFDHPNIIRLEGVVTKSR--PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHR 130 (266)
T ss_pred HHHHHhCCCCCcceEeEEEecCC--ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999887665 5788999988754 3566677889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~ 271 (345)
|+||+||+++.++.++++|||++................++..|+|||.+.+..++.++||| +|+++|+|++ |..||.
T Consensus 131 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 131 DLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred CCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999999876522222222233456789999999988899999999 9999999998 999964
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.. ........+......+. .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 211 ~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 211 DM----SNQDVIKAVEDGYRLPP-------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC----CHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 32 22233333322111111 112234578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=302.16 Aligned_cols=251 Identities=18% Similarity=0.237 Sum_probs=182.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|... .++..||||.+... .....+|+.
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~-------------------------------~~~~~~Ei~ 111 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQD-------------------------------PQYKNRELL 111 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecC-------------------------------cchHHHHHH
Confidence 3468999999999999999999864 57899999988432 112236899
Q ss_pred HHhhccCCCccceeEEEecC------CcceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRP------DCHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~------~~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
+++.++||||+++++++... ...+++++++|++++ ..++......++.|++.||.|||+.+
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~- 190 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF- 190 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 99999999999999877542 223577899998753 23566677789999999999999998
Q ss_pred CCeEecCCCCCCeeecCCC-CeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDI-EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~ 264 (345)
++||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+. .++.++||| +|+++|||+
T Consensus 191 --IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell 265 (440)
T PTZ00036 191 --ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265 (440)
T ss_pred --EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999654 79999999998654322 12346789999999998764 589999999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCC---------------ccccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPK---------------RAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
+|.+||.+. ...+....+......+... ......+....+......+.+|+.+||+.||.+
T Consensus 266 tG~~pf~~~----~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~ 341 (440)
T PTZ00036 266 LGYPIFSGQ----SSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLK 341 (440)
T ss_pred hCCCCCCCC----ChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhH
Confidence 999997532 2222222222221111100 000000000011112346788999999999999
Q ss_pred CCCHHHHHH
Q 046907 330 RPNSKDVRR 338 (345)
Q Consensus 330 Rpt~~~ll~ 338 (345)
|||+.++++
T Consensus 342 R~ta~e~l~ 350 (440)
T PTZ00036 342 RLNPIEALA 350 (440)
T ss_pred CcCHHHHhC
Confidence 999999874
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=278.47 Aligned_cols=249 Identities=21% Similarity=0.314 Sum_probs=189.9
Q ss_pred cccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
|++.+.||+|+||.||+|++... .+..||+|.+...... ......+.+|+..+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~e~~~l 55 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-------------------------YSEIEEFLSEAACM 55 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-------------------------HHHHHHHHHHHHHH
Confidence 67889999999999999986432 3578999998643222 22356688899999
Q ss_pred hhccCCCccceeEEEecCCc----ceeeeeccccCCCCC---------------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGRRE---------------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~~~---------------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+.++||||+++++++..... ...+++++|+.++++ +++.....++.|++.||.|||+.+
T Consensus 56 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~-- 133 (273)
T cd05035 56 KDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN-- 133 (273)
T ss_pred HhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999998765442 246788888876543 566667789999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++|+|+||+||+++.++.+|++|||+++...............++..|+|||.+.+..++.++||| +|+++|||++ |
T Consensus 134 -i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 134 -FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred -eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876443222122223446789999999888899999999 9999999999 8
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
..||.. .........+.... .+. .+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 213 ~~p~~~----~~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 213 QTPYPG----VENHEIYDYLRHGN---RLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC----CCHHHHHHHHHcCC---CCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 888643 22223333332211 110 1112334588899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.64 Aligned_cols=238 Identities=24% Similarity=0.355 Sum_probs=186.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+.. .+++.||+|.+..... ...+....+.+|+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~E~~~l 55 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEV------------------------IRLKQEQHVHNEKRVL 55 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHH------------------------hhhHHHHHHHHHHHHH
Confidence 47999999999999999999864 5789999999853111 0122356678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ .++++++|+.++++ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 130 (291)
T cd05612 56 KEVSHPFIIRLFWTEHDQR--FLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPE 130 (291)
T ss_pred HhCCCCcHhhhHhhhccCC--eEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHH
Confidence 9999999999999887665 78999999988754 445556789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.+||+|||++...... .....||+.|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 131 NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~---- 201 (291)
T cd05612 131 NILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD---- 201 (291)
T ss_pred HeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----
Confidence 999999999999999998765432 1235789999999999998899999999 999999999999997432
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
........+... ... + . ......+.+++..||+.||.+||+ +.++++
T Consensus 202 ~~~~~~~~i~~~---~~~---~----~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 202 NPFGIYEKILAG---KLE---F----P----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CHHHHHHHHHhC---CcC---C----C----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 222222222111 100 0 0 011234778999999999999995 888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=288.25 Aligned_cols=235 Identities=20% Similarity=0.303 Sum_probs=181.8
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
+.||+|+||.||+|+.+ .+|+.||+|.+..... ........+.+|+.+++.++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~e~~~l~~l~hp 55 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVI------------------------IAKDEVAHTLTESRVLQNTRHP 55 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hhhHHHHHHHHHHHHHHhCCCC
Confidence 46999999999999854 5799999999852110 0123356677899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~ 204 (345)
||+++++.+..++ .++++++|+.++.+ +++.....++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 56 ~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~ 130 (323)
T cd05571 56 FLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDK 130 (323)
T ss_pred CCCCEEEEEEcCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECC
Confidence 9999999988776 78999999988754 455566789999999999999999 999999999999999
Q ss_pred CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHH
Q 046907 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283 (345)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~ 283 (345)
++.+||+|||+++....... ......||+.|+|||.+.+..++.++||| +|+++|||++|..||.. .+.....
T Consensus 131 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~----~~~~~~~ 204 (323)
T cd05571 131 DGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLF 204 (323)
T ss_pred CCCEEEeeCCCCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC----CCHHHHH
Confidence 99999999999875322211 22346799999999999998999999999 99999999999999743 2222222
Q ss_pred HHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
..+.. .. . .. +......+.+++.+||+.||++|| ++.++++
T Consensus 205 ~~~~~---~~-~------~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 205 ELILM---EE-I------RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHc---CC-C------CC----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 22211 11 0 00 111223477888999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=268.22 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=199.0
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
...++.++|.+.+.||.|+|+.||+++ .-.+++.||+|++.... .+..+..+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~-~~s~~~~YAlKkI~c~~---------------------------~~~~e~~~ 66 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVK-GLSTGHLYALKKILCHS---------------------------QEDIEEAL 66 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeec-ccCcccchhhheeeccc---------------------------hHHHHHHH
Confidence 345688899999999999999999998 45789999999996543 34577889
Q ss_pred HHHHHHhhccCCCccceeEEEecC---CcceeeeeccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhc
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRP---DCHLLYILNDVSQGR-------------RELDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~---~~~~l~~~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
+|++..++++|||+++++++...+ .....|++..|...| +.+++.+...++.++++||.+||+.
T Consensus 67 rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~ 146 (302)
T KOG2345|consen 67 REIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK 146 (302)
T ss_pred HHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc
Confidence 999999999999999999876433 334567777766554 4467777888999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC----C---cceeccCcccCcccccccccc---ccccCccchhh
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA----H---THITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY 255 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~----~---~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw 255 (345)
. ++.+||||||.|||+...+.+++.|||.+....-. . ..+.......|..|.|||.+. +.-.++++|||
T Consensus 147 ~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIW 225 (302)
T KOG2345|consen 147 E-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIW 225 (302)
T ss_pred C-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchh
Confidence 7 57999999999999999999999999988754311 0 112234467799999999985 44468899999
Q ss_pred -HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 256 -FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 256 -lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
+||++|.|+.|..||+..++. ++.-..+ ...+.+.-+..+...+.+.+++.+|++.||.+||++.
T Consensus 226 SLGCtLYa~mf~~sPfe~~~~~-GgSlaLA-------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~ 291 (302)
T KOG2345|consen 226 SLGCTLYAMMFGESPFERIYQQ-GGSLALA-------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIP 291 (302)
T ss_pred hhhHHHHHHHHcCCcchHHhhc-CCeEEEe-------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHH
Confidence 999999999999998765441 1111111 1111111111222455688899999999999999999
Q ss_pred HHHHHHhhh
Q 046907 335 DVRRMLSQI 343 (345)
Q Consensus 335 ~ll~~L~~l 343 (345)
+++..++.+
T Consensus 292 ~ll~~~d~L 300 (302)
T KOG2345|consen 292 ELLSKLDDL 300 (302)
T ss_pred HHHHHHHhh
Confidence 999999876
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.94 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=190.5
Q ss_pred cCCcccccccccCcceeeEEEEec---CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELP---GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
.++|++.+.||+|+||.||+|++. ..++..+|+|.+..... ......+.+|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--------------------------~~~~~~~~~E 57 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--------------------------PQQWGEFQQE 57 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--------------------------HHHHHHHHHH
Confidence 468999999999999999999852 23568899999864221 1224567889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------------------------CCHHHHHHHHHHHHH
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------------------------LDWLARHRIALGLAC 177 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------------------------l~~~~~~~i~~~i~~ 177 (345)
+.+++.++||||+++++++..++ ..+++++++.++++ +++.....++.|++.
T Consensus 58 ~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 135 (283)
T cd05090 58 ASLMAELHHPNIVCLLGVVTQEQ--PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135 (283)
T ss_pred HHHHhhCCCCCeeeEEEEEecCC--ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence 99999999999999999987766 67889998877543 344455679999999
Q ss_pred HHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-H
Q 046907 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256 (345)
Q Consensus 178 ~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-l 256 (345)
||.|||+.+ ++|+|+||+||+++.++.++++|||++................++..|+|||.+.+..++.++|+| |
T Consensus 136 al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 136 GMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred HHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 999999998 999999999999999999999999999765433222222344567789999999888899999999 9
Q ss_pred HHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 257 GALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 257 G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
|+++|||++ |..||... ........+......+ .+......+.+++.+||+.||++||++.+
T Consensus 213 G~il~el~~~g~~p~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 275 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGF----SNQEVIEMVRKRQLLP-------------CSEDCPPRMYSLMTECWQEGPSRRPRFKD 275 (283)
T ss_pred HHHHHHHHcCCCCCCCCC----CHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 999999998 88896432 2233333332211111 11112234778889999999999999999
Q ss_pred HHHHHhh
Q 046907 336 VRRMLSQ 342 (345)
Q Consensus 336 ll~~L~~ 342 (345)
|++.|..
T Consensus 276 i~~~l~~ 282 (283)
T cd05090 276 IHTRLRS 282 (283)
T ss_pred HHHHhhc
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=289.57 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=192.0
Q ss_pred HHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
|....++|++.+.||+|+||.||+|++. ..+++.||||.+..... .....
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~ 55 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------------------------HSEHR 55 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--------------------------hHHHH
Confidence 4445679999999999999999999753 23578999999864221 12245
Q ss_pred HHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCC----------------------------------
Q 046907 119 QIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------------------------------- 163 (345)
Q Consensus 119 ~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------------------------------- 163 (345)
.+.+|+.++.++ +||||+++++++...+ ..++++++|++++++.
T Consensus 56 ~~~~E~~~l~~l~~h~niv~~~~~~~~~~-~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (343)
T cd05103 56 ALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134 (343)
T ss_pred HHHHHHHHHHhccCCccHhhhcceeecCC-CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhh
Confidence 678899999999 7899999999887654 3577888998876542
Q ss_pred ------------------------------------------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 046907 164 ------------------------------------------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 164 ------------------------------------------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil 201 (345)
++....+++.|+++||.|||+.+ ++||||||+||+
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 211 (343)
T cd05103 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 211 (343)
T ss_pred hhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEE
Confidence 33445678999999999999998 999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccch
Q 046907 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNE 279 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~ 279 (345)
++.++.++++|||++................++..|+|||.+.+..++.++|+| ||+++|+|++ |..||..... .
T Consensus 212 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~ 288 (343)
T cd05103 212 LSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---D 288 (343)
T ss_pred EcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---c
Confidence 999999999999998765332221122234456789999999888899999999 9999999997 8999754221 1
Q ss_pred hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
......+........+ .. ....+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 289 ~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 289 EEFCRRLKEGTRMRAP----------DY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHhccCCCCCC----------CC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1222222111111100 01 1124788899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=277.22 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=191.4
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+.+.++|++.+.||+|++|.||+|.++ ++..||+|.+..... ..+.+.+|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~~----------------------------~~~~~~~e 51 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTM----------------------------DPKDFLAE 51 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCcc----------------------------cHHHHHHH
Confidence 346678999999999999999999864 567899999864321 13456789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+.++++++||||+++++++...+ .++++++++.+++ .+++.....++.|++.|+.+||+.+ ++|
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H 126 (261)
T cd05068 52 AQIMKKLRHPKLIQLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126 (261)
T ss_pred HHHHHHCCCCCccceeEEEecCC--CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 99999999999999999887766 5788888886543 3566677899999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
+||||+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|+| ||+++|||++ |..||
T Consensus 127 ~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 205 (261)
T cd05068 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205 (261)
T ss_pred ccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999876532211 11122334579999999988899999999 9999999999 99996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
... ........+......+ ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 206 ~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 206 PGM----TNAEVLQQVDQGYRMP-------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCC----CHHHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 432 2223333222211110 0111234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.32 Aligned_cols=249 Identities=20% Similarity=0.341 Sum_probs=192.3
Q ss_pred hcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|.+.+.||+|+||.||+|++.. .++..||+|.+..... .+....+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~ 56 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--------------------------NDARKDFE 56 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--------------------------HHHHHHHH
Confidence 35679999999999999999998642 2467899999854321 12256788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------------------CCHHHHHHHHHHHHHH
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------------------LDWLARHRIALGLACG 178 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------------------l~~~~~~~i~~~i~~~ 178 (345)
+|++++++++||||+++++++...+ ..+++++++.++++ +++.....++.|++.|
T Consensus 57 ~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~ 134 (280)
T cd05049 57 REAELLTNFQHENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG 134 (280)
T ss_pred HHHHHHHhcCCCCchheeeEEecCC--CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999999988775 68889999876543 3455667899999999
Q ss_pred HHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HH
Q 046907 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FG 257 (345)
Q Consensus 179 l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG 257 (345)
+.|||+.+ ++|+||||+||+++.++.++++|||++................++..|+|||.+.+..++.++||| +|
T Consensus 135 l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 211 (280)
T cd05049 135 MVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 211 (280)
T ss_pred HHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHH
Confidence 99999998 999999999999999999999999998765333222222334567889999999998999999999 99
Q ss_pred HHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 258 ALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 258 ~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+++|||++ |..||... ........+........ .......+.+++..||+.||++|||+.++
T Consensus 212 ~il~e~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 274 (280)
T cd05049 212 VVLWEIFTYGKQPWYGL----SNEEVIECITQGRLLQR-------------PRTCPSEVYDIMLGCWKRDPQQRINIKDI 274 (280)
T ss_pred HHHHHHHhcCCCCCCCC----CHHHHHHHHHcCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99999998 99996432 22333333331111110 11123457889999999999999999999
Q ss_pred HHHHhh
Q 046907 337 RRMLSQ 342 (345)
Q Consensus 337 l~~L~~ 342 (345)
++.|++
T Consensus 275 l~~l~~ 280 (280)
T cd05049 275 HERLQK 280 (280)
T ss_pred HHHhhC
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=277.24 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=186.6
Q ss_pred cccccccccCcceeeEEEEecCCCC--ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNG--RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
|.+.+.||+|+||.||+|++.. ++ ..+|+|.+.....+ ......+..|+.++
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~-~~~~~~~a~k~~~~~~~~-------------------------~~~~~~~~~E~~~l 54 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQ-DDSILKVAVKTMKIAICT-------------------------RSEMEDFLSEAVCM 54 (272)
T ss_pred CccccccCcccCceEEEeEEcc-CCCeeeEEEEecccCcCC-------------------------HHHHHHHHHHHHHH
Confidence 4577899999999999998753 33 36999988643211 23366788899999
Q ss_pred hhccCCCccceeEEEecCC----cceeeeeccccCCCCC---------------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGRRE---------------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~~~---------------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+.++||||+++++.+.... ....+++++|+.++++ +++.....++.|++.||.|||+.+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-- 132 (272)
T cd05075 55 KEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS-- 132 (272)
T ss_pred HhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999775322 2246778888876543 455667789999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++||||||+||+++.++.++|+|||++................++..|+|||...+..++.++|+| +|+++|||++ |
T Consensus 133 -i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 133 -FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred -eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876443221112223456789999999988899999999 9999999999 7
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
..||.. .........+.... ... ..+.....+.+++.+||+.||++|||+.+|++.|+++
T Consensus 212 ~~p~~~----~~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 212 QTPYPG----VENSEIYDYLRQGN---RLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCC----CCHHHHHHHHHcCC---CCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 888643 22233333332211 110 0112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=286.47 Aligned_cols=192 Identities=23% Similarity=0.391 Sum_probs=161.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||++++. .++..+|+|.+..... ......+.+|++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~--------------------------~~~~~~~~~E~~ 55 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIK--------------------------PAIRNQIIRELQ 55 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccC--------------------------HHHHHHHHHHHH
Confidence 4579999999999999999999864 5788999998854211 122456789999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++|+.++++ ++......++.|++.||.|||+.+ .++|+|||
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlk 131 (333)
T cd06650 56 VLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVK 131 (333)
T ss_pred HHHHCCCCcccceeEEEEECC--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCC
Confidence 999999999999999998876 78899999988765 344455689999999999999852 39999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+||+++.++.+||+|||++...... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||..
T Consensus 132 p~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 132 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999998754322 12345789999999999988899999999 99999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=295.82 Aligned_cols=251 Identities=16% Similarity=0.279 Sum_probs=198.0
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCC---CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQ---NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
+.+++...+.+.||.|-||.||.|.+... ..-.||||.-+..+.. .+.+.|
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--------------------------d~tekf 438 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--------------------------DDTEKF 438 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--------------------------hhHHHH
Confidence 33555566678999999999999997422 2346888987664432 347789
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+.|+.++++++|||||+++|+|.+.. +|++||+++.|.+ ++......++.|++.||.|||+.. +
T Consensus 439 lqEa~iMrnfdHphIikLIGv~~e~P---~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---f 512 (974)
T KOG4257|consen 439 LQEASIMRNFDHPHIIKLIGVCVEQP---MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---F 512 (974)
T ss_pred HHHHHHHHhCCCcchhheeeeeeccc---eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---h
Confidence 99999999999999999999998775 8999999987765 444455679999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
+||||.++|||+.....+|++|||+++.+.+....... ...-+..|||||.+.-..++.++||| ||+++||+++ |..
T Consensus 513 VHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvk 591 (974)
T KOG4257|consen 513 VHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVK 591 (974)
T ss_pred hhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999998776554332 33446789999999999999999999 9999999987 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||.+-.+. +..-.+.++.+.+ .++.|+..+..||.+||.++|.+||++.++...|+.+.
T Consensus 592 PfqgvkNs----DVI~~iEnGeRlP-------------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 592 PFQGVKNS----DVIGHIENGERLP-------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred cccccccc----ceEEEecCCCCCC-------------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 97543321 1222222222222 23344445779999999999999999999999998774
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=281.25 Aligned_cols=250 Identities=20% Similarity=0.349 Sum_probs=193.4
Q ss_pred hcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
...+|.+.+.||+|+||.||+|++.. .++..+++|.+.... ......+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---------------------------~~~~~~~~ 55 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---------------------------LAARKDFQ 55 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---------------------------HHHHHHHH
Confidence 34579999999999999999998532 245679999985432 12245677
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHHHHHHH
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRIALGLA 176 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i~~~i~ 176 (345)
+|+.++++++||||+++++++...+ ..++++++++++++ +++..+..++.|++
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 133 (291)
T cd05094 56 REAELLTNLQHEHIVKFYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 133 (291)
T ss_pred HHHHHHhcCCCCCcceEEEEEccCC--ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHH
Confidence 8999999999999999999988765 67889999876543 45667788999999
Q ss_pred HHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-
Q 046907 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY- 255 (345)
Q Consensus 177 ~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw- 255 (345)
.|+.|||+++ ++|+||||+||+++.++.++++|||++................++..|+|||.+.+..++.++|||
T Consensus 134 ~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 210 (291)
T cd05094 134 SGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 210 (291)
T ss_pred HHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHH
Confidence 9999999998 999999999999999999999999999765443222222345667889999999988899999999
Q ss_pred HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 256 FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 256 lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
+|+++|||++ |..||... ........+....... ........+.+++.+||+.||++|||+.
T Consensus 211 lG~il~el~t~g~~p~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 273 (291)
T cd05094 211 FGVILWEIFTYGKQPWFQL----SNTEVIECITQGRVLE-------------RPRVCPKEVYDIMLGCWQREPQQRLNIK 273 (291)
T ss_pred HHHHHHHHHhCCCCCCCCC----CHHHHHHHHhCCCCCC-------------CCccCCHHHHHHHHHHcccChhhCcCHH
Confidence 9999999999 99996432 2222322222111110 0111234578999999999999999999
Q ss_pred HHHHHHhhhh
Q 046907 335 DVRRMLSQIQ 344 (345)
Q Consensus 335 ~ll~~L~~l~ 344 (345)
++++.|+++.
T Consensus 274 ~v~~~l~~~~ 283 (291)
T cd05094 274 EIYKILHALG 283 (291)
T ss_pred HHHHHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=281.66 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=190.2
Q ss_pred hcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+.++|.+.+.||+|+||.||+|++.. .++..||+|.+..... ......+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~ 56 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--------------------------GPLREEFK 56 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--------------------------HHHHHHHH
Confidence 34578999999999999999998642 2467899999864321 12245678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC-------------------------CCCHHHHHHHHHHHH
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-------------------------ELDWLARHRIALGLA 176 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-------------------------~l~~~~~~~i~~~i~ 176 (345)
.|+.++..++||||+++++++..++ .++++++++.++. .+++.....++.|++
T Consensus 57 ~e~~~~~~l~h~~iv~~~~~~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~ 134 (283)
T cd05091 57 HEAMMRSRLQHPNIVCLLGVVTKEQ--PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIA 134 (283)
T ss_pred HHHHHHhcCCCCCcCeEEEEEcCCC--ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHH
Confidence 8999999999999999999988776 4667777765543 245556678999999
Q ss_pred HHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-
Q 046907 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY- 255 (345)
Q Consensus 177 ~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw- 255 (345)
.||.|+|+.+ ++||||||+||+++.++.+|++|||+++...............+++.|+|||.+.+..++.++|||
T Consensus 135 ~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05091 135 AGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS 211 (283)
T ss_pred HHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHH
Confidence 9999999998 999999999999999999999999998866443322223344567899999999888899999999
Q ss_pred HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 256 FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 256 lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
+|+++|||++ |..||... ...+....+....... ...++...+.+++..||+.+|++||++.
T Consensus 212 lG~~l~el~~~g~~p~~~~----~~~~~~~~i~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~RP~~~ 274 (283)
T cd05091 212 YGVVLWEVFSYGLQPYCGY----SNQDVIEMIRNRQVLP-------------CPDDCPAWVYTLMLECWNEFPSRRPRFK 274 (283)
T ss_pred HHHHHHHHHcCCCCCCCCC----CHHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence 9999999998 88886432 2233333332221111 1122334577899999999999999999
Q ss_pred HHHHHHhh
Q 046907 335 DVRRMLSQ 342 (345)
Q Consensus 335 ~ll~~L~~ 342 (345)
+|++.|+.
T Consensus 275 ~i~~~l~~ 282 (283)
T cd05091 275 DIHSRLRT 282 (283)
T ss_pred HHHHHhhC
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=281.55 Aligned_cols=252 Identities=19% Similarity=0.314 Sum_probs=193.9
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
|....++|++.+.||+|+||.||+|.++. .++..||+|.+..... .....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--------------------------~~~~~ 54 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--------------------------MRERI 54 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--------------------------HHHHH
Confidence 34567899999999999999999998642 2357899999854321 12245
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC-------------------CHHHHHHHHHHHHHHH
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-------------------DWLARHRIALGLACGL 179 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l-------------------~~~~~~~i~~~i~~~l 179 (345)
.+.+|+.+++.++||||+++++++...+ ..++++++++++++. ++.....++.|++.||
T Consensus 55 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 132 (277)
T cd05032 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132 (277)
T ss_pred HHHHHHHHHHhCCCCceeEEEEEEcCCC--CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHH
Confidence 6778999999999999999999988765 678899998776543 3445677999999999
Q ss_pred HHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHH
Q 046907 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258 (345)
Q Consensus 180 ~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~ 258 (345)
.|||+.+ ++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++||| ||+
T Consensus 133 ~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (277)
T cd05032 133 AYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209 (277)
T ss_pred HHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHH
Confidence 9999998 999999999999999999999999998765443322222344567899999999888899999999 999
Q ss_pred HHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 259 LLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 259 vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
++||+++ |..||.. ....+....+........+ ......+.+++..||+.+|++|||+.+++
T Consensus 210 il~el~t~g~~p~~~----~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 210 VLWEMATLAEQPYQG----LSNEEVLKFVIDGGHLDLP-------------ENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred HHHHhhccCCCCCcc----CCHHHHHHHHhcCCCCCCC-------------CCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 9999998 8989643 2333333333311111111 11134578899999999999999999999
Q ss_pred HHHhh
Q 046907 338 RMLSQ 342 (345)
Q Consensus 338 ~~L~~ 342 (345)
+.|++
T Consensus 273 ~~l~~ 277 (277)
T cd05032 273 SSLKD 277 (277)
T ss_pred HHhcC
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.42 Aligned_cols=247 Identities=26% Similarity=0.338 Sum_probs=197.9
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+++.||+|+||.|.+|. +..+++.||||++++. .....+...|+.+|.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~-d~~T~e~VAIKIiKN~----------------------------k~f~~Q~~~Ei~iL~ 237 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAY-DHKTGEIVAIKIIKNK----------------------------KRFLRQAQIEIRILE 237 (586)
T ss_pred EEEEEEEecccccceeEEEE-ecCCCcEEEEEeeccC----------------------------hHHHHHHHHHHHHHH
Confidence 78889999999999999996 5579999999999875 334667778999999
Q ss_pred hcc-CC-----CccceeEEEecCCcceeeeeccccCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 129 QIR-HR-----NLHPLLAHVTRPDCHLLYILNDVSQG----------RRELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 129 ~l~-hp-----niv~l~~~~~~~~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
.|+ |. |+|+++++|...+ +++++.|+++. -..++...+..++.|++.||..||+.+ |||
T Consensus 238 ~ln~~d~~~~~n~Vrm~d~F~fr~--HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIH 312 (586)
T KOG0667|consen 238 LLNKHDPDDKYNIVRMLDYFYFRN--HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIH 312 (586)
T ss_pred HHhccCCCCCeeEEEeeecccccc--ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 996 33 8999999999888 78888777753 234777888899999999999999998 999
Q ss_pred cCCCCCCeeecC--CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 193 RDLNPVNVLLDD--DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 193 ~dlk~~nil~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||||+|||+.. ...+||+|||.|....... .+++-+..|.|||++.|.+|+.+.||| ||||+.||++|.+.
T Consensus 313 cDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 313 CDLKPENILLKDPKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred ccCChhheeeccCCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 999999999973 3489999999998765432 257789999999999999999999999 99999999999766
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCc---------cccc--------------------------------cccC---
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKR---------AIDS--------------------------------KLVG--- 305 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~--------------------------------~~~~--- 305 (345)
|++.++.+.+..|....+.+...- .++. ...+
T Consensus 388 ----fpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~ 463 (586)
T KOG0667|consen 388 ----FPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGS 463 (586)
T ss_pred ----cCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCC
Confidence 666788888888877776443210 0000 0000
Q ss_pred ----CCcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 306 ----NGCE-EQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 306 ----~~~~-~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.... ..-..+.+++..|+++||..|+|+.++++
T Consensus 464 ~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 464 RSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred cccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0111 33456899999999999999999998875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.28 Aligned_cols=300 Identities=23% Similarity=0.324 Sum_probs=213.1
Q ss_pred hHHHHHHHHHHHHHHHhcCCCCCC---cc--cchhhhhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEe
Q 046907 6 FFLFFYPKLFLAAVRRVGRDPGPA---IF--SPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIK 80 (345)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK 80 (345)
+++.+.+..|+.+++||....... ++ .+......+ +.+....++++.||+|.||+||+|.+ +++.||||
T Consensus 166 ~l~~lvi~~~~~~r~~k~~~~~~e~~~~p~~d~~~~~ssp---l~~l~pl~l~eli~~Grfg~V~KaqL---~~~~VAVK 239 (534)
T KOG3653|consen 166 LLAALVILAFLGYRQRKNAREEIEPVLIPLEDSGPAPSSP---LLELDPLQLLELIGRGRFGCVWKAQL---DNRLVAVK 239 (534)
T ss_pred HHHHHHHHHHHHHHHhhcccccCccCcccCCCCCCCCCcc---cccCCchhhHHHhhcCccceeehhhc---cCceeEEE
Confidence 334444556667777777664221 11 111111111 34577899999999999999999997 56899999
Q ss_pred eecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh--ccCCCccceeEEEecCC--cceeeeeccc
Q 046907 81 KIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ--IRHRNLHPLLAHVTRPD--CHLLYILNDV 156 (345)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~--~~~l~~~~~~ 156 (345)
++. ....+.|..|-+|.+. |+|+||++|++.-.... ..-+++|++|
T Consensus 240 ifp------------------------------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 240 IFP------------------------------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred ecC------------------------------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 994 3457778888888775 58999999998765443 3457889999
Q ss_pred cCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCC------CCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 046907 157 SQGRRE--------LDWLARHRIALGLACGLEYLHMHHC------PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222 (345)
Q Consensus 157 ~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~------~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~ 222 (345)
.+.|++ .+|....+++..++.||.|||+... ++|+|||+|++|||+..++++.|+|||+|..+...
T Consensus 290 h~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 290 HPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG 369 (534)
T ss_pred ccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence 998876 4555667899999999999998753 57999999999999999999999999999988766
Q ss_pred CcceeccCcccCccccccccccccc-cC-----ccchhh-HHHHHHHHHhCCCCC--------ccccc-ccchhhHHHHH
Q 046907 223 HTHITTSNVVGTVEYIAPEYLQMLT-LT-----EKCDIY-FGALLAGLVMGKLPS--------DKFFQ-HTNEMSFVKWM 286 (345)
Q Consensus 223 ~~~~~~~~~~gt~~~~aPE~~~~~~-~~-----~~~Dvw-lG~vl~el~tg~~p~--------~~~~~-~~~~~~~~~~~ 286 (345)
.......+.+||.+|||||++.+.. +. .+.||| +|.|+|||+++..-. ...|. .-+......-+
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 5555556689999999999997753 22 479999 999999999864322 11121 11111122222
Q ss_pred HHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 287 RNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
+........++.+...+.. -.....+.+.+..||..||+.|.|+.=+-+++.++.
T Consensus 450 q~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 450 QELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 2222222222222211111 145667889999999999999999998888888764
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=278.06 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=189.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCc----eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGR----MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|++++.||+|+||.||+|++.. ++. .||+|.+..... ......+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~~--------------------------~~~~~~~~ 57 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENTS--------------------------PKANKEIL 57 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCCC--------------------------HHHHHHHH
Confidence 56789999999999999999998753 343 489999864321 12245677
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++.... .++++++++++.+ +++.....++.|++.||.|||+.+ ++
T Consensus 58 ~e~~~l~~~~~~~i~~~~~~~~~~~---~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ii 131 (279)
T cd05109 58 DEAYVMAGVGSPYVCRLLGICLTST---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LV 131 (279)
T ss_pred HHHHHHHhcCCCCCceEEEEEcCCC---cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 8999999999999999999887543 5677777776543 455566789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||| ||+++|||++ |..|
T Consensus 132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 211 (279)
T cd05109 132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999876543222222233456789999999988899999999 9999999998 8999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ........+......+. .......+.+++..||+.||++||++.++++.|+.+.
T Consensus 212 ~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 212 YDGI----PAREIPDLLEKGERLPQ-------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCC----CHHHHHHHHHCCCcCCC-------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 6432 22233333322211111 1112335778899999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=292.63 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=196.6
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
.+..|....++|.+.+.||+|+||.||+|++++ ..+..||+|.+......
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-------------------------- 81 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-------------------------- 81 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--------------------------
Confidence 344578888899999999999999999999753 24578999999643211
Q ss_pred HHHHHHHHHHHHHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCCCC-----------------------------
Q 046907 115 KKMRQIQSEINTVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD----------------------------- 164 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~----------------------------- 164 (345)
.....+.+|+.++.++. ||||+++++.+..++ .++++++|+.+|++.+
T Consensus 82 ~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~--~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (401)
T cd05107 82 SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG--PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGST 159 (401)
T ss_pred hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC--CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccc
Confidence 12346788999999997 999999999988766 6888999988765433
Q ss_pred ------------------------------------------------------------------------------HH
Q 046907 165 ------------------------------------------------------------------------------WL 166 (345)
Q Consensus 165 ------------------------------------------------------------------------------~~ 166 (345)
+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 239 (401)
T cd05107 160 PLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYM 239 (401)
T ss_pred cccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHH
Confidence 33
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc
Q 046907 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML 246 (345)
Q Consensus 167 ~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~ 246 (345)
...+++.|++.||.|||+.+ ++||||||+|||++.++.++++|||++................++..|+|||.+.+.
T Consensus 240 ~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 316 (401)
T cd05107 240 DLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN 316 (401)
T ss_pred HHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence 44568899999999999998 999999999999999999999999999765332211122334678889999999988
Q ss_pred ccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccC
Q 046907 247 TLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTL 324 (345)
Q Consensus 247 ~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~ 324 (345)
.++.++||| ||+++|||++ |..||.... ........+....... .+......+.+++..||+
T Consensus 317 ~~~~~~DvwslGvil~e~l~~g~~P~~~~~---~~~~~~~~~~~~~~~~-------------~p~~~~~~l~~li~~cl~ 380 (401)
T cd05107 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELP---MNEQFYNAIKRGYRMA-------------KPAHASDEIYEIMQKCWE 380 (401)
T ss_pred CCCcHhHHHHHHHHHHHHHHcCCCCCCCCC---chHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcC
Confidence 899999999 9999999998 888964321 1111222222111110 011123457888899999
Q ss_pred CCCCCCCCHHHHHHHHhhhh
Q 046907 325 EDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 325 ~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.+|.+||++.+|++.|+++-
T Consensus 381 ~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 381 EKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CChhHCcCHHHHHHHHHHHh
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=262.42 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=195.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.-++|++++.||+|.||.||.|+.+ +++..||+|+++. ++........++.+|++
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarek-ks~~IvalKVlfK------------------------sqi~~~~v~~qlrREiE 74 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFK------------------------SQILKTQVEHQLRREIE 74 (281)
T ss_pred chhhccccccccCCccccEeEeeec-cCCcEEEEeeeeH------------------------HHHHHhcchhhhhheeE
Confidence 4568999999999999999999975 6899999999963 22333556778899999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH-----------HHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-----------ARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~-----------~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
|-+.|+||||+++|++|.+.. -+|++.||.++|.++..+ ....+..|++.|+.|+|..+ ++|||
T Consensus 75 Iqs~L~hpnilrlY~~fhd~~--riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRd 149 (281)
T KOG0580|consen 75 IQSHLRHPNILRLYGYFHDSK--RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRD 149 (281)
T ss_pred eecccCCccHHhhhhheeccc--eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCC
Confidence 999999999999999999876 799999999887765444 34579999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+|+|++..+.+|++|||-+.....+ ...+.+||.-|.+||...+...+...|+| +|++.||++.|.+||+..
T Consensus 150 iKpenlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 150 IKPENLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred CCHHHhccCCCCCeeccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 9999999999999999999998765422 23568999999999999999999999999 999999999999996532
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+.-..+.+..... + +.......++|..|+..+|.+|.+..+++.
T Consensus 226 ----~~~etYkrI~k~~~~~-p-------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 226 ----SHSETYKRIRKVDLKF-P-------------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----hhHHHHHHHHHccccC-C-------------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 2333333333322111 0 111223678888899999999999999875
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.28 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=186.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCc----eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGR----MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
.++|++++.||+|+||.||+|++. .++. .+++|.+..... ......+..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~~~~~~~~k~~~~~~~--------------------------~~~~~~~~~ 58 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWI-PEGDSIKIPVAIKTIQDRSG--------------------------RQTFQEITD 58 (279)
T ss_pred HhhceeccccCccCCcceEEEEEc-CCCCceeeEEEEeecccccc--------------------------hHHHHHHHH
Confidence 468999999999999999999974 2344 477777642110 123456778
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+..+..++||||+++++++..+ ..+++++++.++++ +++.....++.|++.||.|||+.+ ++|
T Consensus 59 ~~~~l~~l~h~~iv~~~~~~~~~---~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH 132 (279)
T cd05111 59 HMLAMGSLDHAYIVRLLGICPGA---SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVH 132 (279)
T ss_pred HHHHHhcCCCCCcceEEEEECCC---ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---Eec
Confidence 88899999999999999987543 35677888877654 345566789999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
+||||+||+++.++.+|++|||+++...............++..|+|||.+.+..++.++||| ||+++||+++ |..||
T Consensus 133 ~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 133 RNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred cccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999866433222223345667889999999988899999999 9999999998 99996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
... ........+........+ .. +...+.+++..||..||++|||+.++++.|..+.
T Consensus 213 ~~~----~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 213 AGM----RPHEVPDLLEKGERLAQP----------QI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCC----CHHHHHHHHHCCCcCCCC----------CC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 432 222222333221111100 11 1234677888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=289.01 Aligned_cols=258 Identities=23% Similarity=0.293 Sum_probs=190.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|.. ..+++.||+|.+.....+ ......+.+|+.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 68 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQN-------------------------QTHAKRAYRELV 68 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEe-cCCCceEEEEEeCCcccC-------------------------hHHHHHHHHHHH
Confidence 457999999999999999999984 457899999998643221 123456678999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCCCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGRR------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++..... ..+++++++++++. .++......++.|++.||.|||+.+ ++||||
T Consensus 69 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDi 145 (355)
T cd07874 69 LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 145 (355)
T ss_pred HHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999998865432 35789999997642 2456667789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+||+++.++.+||+|||+++...... ......||..|+|||.+.+..++.++||| +|+++|+|++|..||....
T Consensus 146 kp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 146 KPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997654322 22346789999999999998899999999 9999999999999975321
Q ss_pred cccchhhHHHHHHHHhhhcC------------------C--Ccccccc-----c---cCCCcHHHHHHHHHHHhhccCCC
Q 046907 275 QHTNEMSFVKWMRNVMASEN------------------P--KRAIDSK-----L---VGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~------------------~--~~~~~~~-----~---~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
.......+......+. + .....+. . ...........+.+++.+||+.|
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 298 (355)
T cd07874 223 ----YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298 (355)
T ss_pred ----HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCC
Confidence 1111111111110000 0 0000000 0 00011112345789999999999
Q ss_pred CCCCCCHHHHHHH
Q 046907 327 PNERPNSKDVRRM 339 (345)
Q Consensus 327 p~~Rpt~~~ll~~ 339 (345)
|++|||+.++++.
T Consensus 299 P~~Rps~~ell~h 311 (355)
T cd07874 299 PAKRISVDEALQH 311 (355)
T ss_pred chhcCCHHHHhcC
Confidence 9999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=289.10 Aligned_cols=195 Identities=27% Similarity=0.397 Sum_probs=161.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+|..||+|.+.....+ ......+.+|+.
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~~ 72 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQN-------------------------QTHAKRAYRELV 72 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccc-------------------------hhHHHHHHHHHH
Confidence 4579999999999999999999854 57899999998543211 123456778999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCCCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGRR------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+. ..++++++++.++. .++......++.|++.||.|||+.+ ++||||
T Consensus 73 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDl 149 (359)
T cd07876 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149 (359)
T ss_pred HHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999998865542 24789999987642 2456667789999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||+||+++.++.+||+|||++....... ......||..|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 150 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 150 KPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999987543221 22345789999999999998999999999 99999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=276.88 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=193.3
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++.+.||.|+||.||+|++. .+..+|+|.+.... ......+..|+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~~---------------------------~~~~~~~~~e~ 53 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSDD---------------------------LLKQQDFQKEV 53 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccccc---------------------------hhhHHHHHHHH
Confidence 45668999999999999999999975 48899999986432 12245677899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.+++.++||||+++++++...+ ..++++++++++.+ +++....+++.|++.||.|||+.+ ++|+
T Consensus 54 ~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~ 128 (261)
T cd05148 54 QALKRLRHKHLISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHR 128 (261)
T ss_pred HHHhcCCCcchhheeeeEecCC--CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 9999999999999999988776 57889998877543 566677889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~ 271 (345)
|++|+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+| +|+++|+|++ |..||.
T Consensus 129 dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred ccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999766433211 1234557789999999888899999999 9999999998 899964
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.. ...+....+......+ ........+.++|.+||+.||.+|||+.++++.|+++
T Consensus 207 ~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 207 GM----NNHEVYDQITAGYRMP-------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cC----CHHHHHHHHHhCCcCC-------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 32 2223333222211111 1112234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=280.73 Aligned_cols=253 Identities=18% Similarity=0.303 Sum_probs=192.5
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
|..+.++|++.+.||+|+||.||+|.++. ..+..||+|.+..... .....
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~ 54 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--------------------------LRERI 54 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--------------------------HHHHH
Confidence 55678899999999999999999997542 2356899998753211 11234
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH-------------------HHHHHHHHHHHHH
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-------------------ARHRIALGLACGL 179 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~-------------------~~~~i~~~i~~~l 179 (345)
.+.+|+.+++.++||||+++++++..++ ..+++++|+.++++.++. ....++.|++.||
T Consensus 55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCC--CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 5778999999999999999999887665 678999999877664443 3456899999999
Q ss_pred HHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHH
Q 046907 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258 (345)
Q Consensus 180 ~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~ 258 (345)
.|||+.+ ++||||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+| +|+
T Consensus 133 ~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~ 209 (288)
T cd05061 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 209 (288)
T ss_pred HHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHH
Confidence 9999998 999999999999999999999999998765433221122233457789999999988899999999 999
Q ss_pred HHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 259 LLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 259 vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
++|||++ |..||.. .........+... ..+. ........+.+++.+||+.||++|||+.+++
T Consensus 210 ~l~el~~~~~~p~~~----~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 272 (288)
T cd05061 210 VLWEITSLAEQPYQG----LSNEQVLKFVMDG---GYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272 (288)
T ss_pred HHHHHHhCCCCCCCC----CCHHHHHHHHHcC---CCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999998 7888643 2222333322211 1110 0111224588999999999999999999999
Q ss_pred HHHhhh
Q 046907 338 RMLSQI 343 (345)
Q Consensus 338 ~~L~~l 343 (345)
+.|++.
T Consensus 273 ~~l~~~ 278 (288)
T cd05061 273 NLLKDD 278 (288)
T ss_pred HHHHhh
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=290.47 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=206.4
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
..++.+.+.++||+|-||+|.+|... .+..||||+++.... ......|.+|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~--------------------------~~~r~~F~kEI 586 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDAT--------------------------KNARNDFLKEI 586 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccc--------------------------hhHHHHHHHHH
Confidence 35667788999999999999999974 468999999975432 22368899999
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH-----------HHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA-----------RHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~-----------~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
++|.+++|||||.+++.|..++ .+++++||+++|.+-+++. ..+|+.||++|+.||.+.. ++||
T Consensus 587 kiLsqLkhPNIveLvGVC~~De--PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHr 661 (807)
T KOG1094|consen 587 KILSRLKHPNIVELLGVCVQDD--PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHR 661 (807)
T ss_pred HHHhccCCCCeeEEEeeeecCC--chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhc
Confidence 9999999999999999999887 6899999999987644443 3479999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh--CCCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM--GKLPS 270 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t--g~~p~ 270 (345)
|+.++|||++.++++||+|||+++.+-....+......+-+.+|||||.+.-++++.++|+| ||+++||+++ ...||
T Consensus 662 d~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py 741 (807)
T KOG1094|consen 662 DLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPY 741 (807)
T ss_pred cccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCch
Confidence 99999999999999999999999977655555555556778999999999999999999999 9999999875 78896
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
... .+.+..+..-.....+..... ...++-+...+.++|..||..|-++||+++++..-|.+.
T Consensus 742 ~~l----t~e~vven~~~~~~~~~~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 742 SQL----TDEQVVENAGEFFRDQGRQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhh----hHHHHHHhhhhhcCCCCccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 543 334444444444433332221 122344555677999999999999999999999988765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=301.11 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=197.0
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....-++++.+.|.+|+|+.||.|+.. ..|..||+|++.... ....+.+.+|
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~-~~~~~~AlKrm~~~d---------------------------e~~L~~v~~E 84 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDV-KGGKKYALKRMYVND---------------------------EEALNAVKRE 84 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEec-CCCceeeeeeeecCC---------------------------HHHHHHHHHH
Confidence 445668888999999999999999965 345999999997653 2346778899
Q ss_pred HHHHhhcc-CCCccceeEE-Eec---CC-cceeeeeccccCCCCCC-----------CHHHHHHHHHHHHHHHHHHhhcC
Q 046907 124 INTVGQIR-HRNLHPLLAH-VTR---PD-CHLLYILNDVSQGRREL-----------DWLARHRIALGLACGLEYLHMHH 186 (345)
Q Consensus 124 ~~~l~~l~-hpniv~l~~~-~~~---~~-~~~l~~~~~~~~~~~~l-----------~~~~~~~i~~~i~~~l~~lh~~~ 186 (345)
+.+|++|+ |||||.+++. ... .+ ..-++++||||.+|+++ ++..+++|+.|+++|+.+||...
T Consensus 85 I~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~ 164 (738)
T KOG1989|consen 85 IDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK 164 (738)
T ss_pred HHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC
Confidence 99999996 9999999993 322 22 23468899999987664 45567799999999999999997
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC-cc------eeccCcccCccccccccc---cccccCccchhh-
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH-TH------ITTSNVVGTVEYIAPEYL---QMLTLTEKCDIY- 255 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~-~~------~~~~~~~gt~~~~aPE~~---~~~~~~~~~Dvw- 255 (345)
+++||||||.+|+|++.++..||||||.+....... .. ........|+.|+|||.+ .+.++++|+|||
T Consensus 165 -pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA 243 (738)
T KOG1989|consen 165 -PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA 243 (738)
T ss_pred -CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence 679999999999999999999999999886432211 10 011234668999999988 677899999999
Q ss_pred HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 256 FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 256 lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
+||+||-|+....||++.-. ..++..+..-+..+.+...|.+||..||+.||++||++-+
T Consensus 244 LGclLYkLCy~t~PFe~sg~--------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 244 LGCLLYKLCYFTTPFEESGK--------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HHHHHHHHHHhCCCcCcCcc--------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 99999999999999864211 1111111111223567777899999999999999999999
Q ss_pred HHHHHhhhh
Q 046907 336 VRRMLSQIQ 344 (345)
Q Consensus 336 ll~~L~~l~ 344 (345)
|+..+-+|+
T Consensus 304 v~~~~~~l~ 312 (738)
T KOG1989|consen 304 VLEEIFELA 312 (738)
T ss_pred HHHHHHHHh
Confidence 999988775
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=276.02 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=193.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|++. .++..+|||.+...... ..+....+.+|+.++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~------------------------~~~~~~~~~~e~~~l 56 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLM------------------------DAKARADCIKEIDLL 56 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhh------------------------hHHHHHHHHHHHHHH
Confidence 57999999999999999999864 57899999987532111 123356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.++||||+++++.+..++ ..+++++++.++.+ +++.....++.|++.||.|||+.+ ++|+|
T Consensus 57 ~~~~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 131 (267)
T cd08229 57 KQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRD 131 (267)
T ss_pred HHccCCchhhhhheeEeCC--eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 9999999999999988766 67888888876543 455666789999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+|+||+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 132 l~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 132 IKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999999999999999876543221 12335688999999999888899999999 999999999999997431
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
. .........+... ..+ ... .......+.+++.+||+.||++|||+.+|+++++++.
T Consensus 210 ~--~~~~~~~~~~~~~---~~~------~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 210 K--MNLYSLCKKIEQC---DYP------PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred c--chHHHHhhhhhcC---CCC------CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 1111222222111 110 000 1123345788889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=274.52 Aligned_cols=243 Identities=23% Similarity=0.351 Sum_probs=188.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|.+++.||+|+||.||+|++. .+..+|+|.+...... ...+.+|+.
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~~~----------------------------~~~~~~e~~ 51 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS----------------------------EDEFIEEAK 51 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCccc----------------------------HHHHHHHHH
Confidence 3468999999999999999999875 4557999998643211 345778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++++++||||+++++++...+ .++++++++.++. .+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 126 (256)
T cd05113 52 VMMKLSHEKLVQLYGVCTKQR--PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDL 126 (256)
T ss_pred HHhcCCCCCeeeEEEEEccCC--CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 999999999999999987665 5788889887642 3566777899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~ 273 (345)
||+||+++.++.+|++|||.++........ ......++..|+|||.+.+..++.++||| ||+++|+|++ |..||...
T Consensus 127 ~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 127 AARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred CcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 999999999999999999998765443221 11223456789999999888899999999 9999999998 99996432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
+.......+........+ ......+.+++.+||+.||++|||+.+|++.|+
T Consensus 206 ----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 206 ----NNSETVEKVSQGLRLYRP-------------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CHHHHHHHHhcCCCCCCC-------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 222233333222111111 011245788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=276.94 Aligned_cols=247 Identities=21% Similarity=0.351 Sum_probs=191.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+.. .++..||+|.+..... ......+.+|+.++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~--------------------------~~~~~~~~~E~~~l 53 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDIT--------------------------VELQKQIMSELEIL 53 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCC--------------------------hHHHHHHHHHHHHH
Confidence 47899999999999999999854 5789999999854311 12245688899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-----CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
++++||||+++++.+..++ ..++++++++++.+ ++......++.|++.||.|||+.+ ++|+||||+||++
T Consensus 54 ~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill 128 (279)
T cd06619 54 YKCDSPYIIGFYGAFFVEN--RISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLV 128 (279)
T ss_pred HhCCCCCeeeEEEEEEECC--EEEEEEecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEE
Confidence 9999999999999998876 57789999988754 456677889999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhh
Q 046907 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~ 281 (345)
+.++.++|+|||++...... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...........
T Consensus 129 ~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 204 (279)
T cd06619 129 NTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204 (279)
T ss_pred CCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence 99999999999999765432 12345789999999999988899999999 99999999999999865443222221
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
......... ..... ..... .....+.+++..||+.+|++||+++++++.
T Consensus 205 ~~~~~~~~~-~~~~~-----~~~~~---~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 205 PLQLLQCIV-DEDPP-----VLPVG---QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred hHHHHHHHh-ccCCC-----CCCCC---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111 11111 01011 112347788999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=280.29 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=196.0
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKK 116 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (345)
.+|..+.++|++.+.||+|+||.||++.+.. .....+|+|.+..... .+.
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--------------------------~~~ 58 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--------------------------EKD 58 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--------------------------HHH
Confidence 3566678899999999999999999998642 2347899999864321 122
Q ss_pred HHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHH
Q 046907 117 MRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHR 170 (345)
Q Consensus 117 ~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~ 170 (345)
...+.+|+.++.++ +||||+++++++..++ .++++++|+.++++ +++....+
T Consensus 59 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 136 (293)
T cd05053 59 LSDLVSEMEMMKMIGKHKNIINLLGVCTQEG--PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC--CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHH
Confidence 45677899999999 8999999999887765 57888888876543 44555678
Q ss_pred HHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc
Q 046907 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250 (345)
Q Consensus 171 i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~ 250 (345)
++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.
T Consensus 137 i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 213 (293)
T cd05053 137 FAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH 213 (293)
T ss_pred HHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc
Confidence 9999999999999998 9999999999999999999999999998765433222223344567899999998888999
Q ss_pred cchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 251 KCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 251 ~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
++||| ||+++||+++ |..||... ...+....+.... .+. ........+.+++.+||+.||+
T Consensus 214 ~~Di~slG~il~el~~~g~~p~~~~----~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~ 276 (293)
T cd05053 214 QSDVWSFGVLLWEIFTLGGSPYPGI----PVEELFKLLKEGY---RME----------KPQNCTQELYHLMRDCWHEVPS 276 (293)
T ss_pred ccceeehhhHHHHHhcCCCCCCCCC----CHHHHHHHHHcCC---cCC----------CCCCCCHHHHHHHHHHcccCcc
Confidence 99999 9999999997 88896432 2222222222111 110 1112234578899999999999
Q ss_pred CCCCHHHHHHHHhhhh
Q 046907 329 ERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 329 ~Rpt~~~ll~~L~~l~ 344 (345)
+|||+.++++.|+++-
T Consensus 277 ~Rps~~eil~~l~~~~ 292 (293)
T cd05053 277 QRPTFKQLVEDLDRML 292 (293)
T ss_pred cCcCHHHHHHHHHHhh
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=281.48 Aligned_cols=255 Identities=19% Similarity=0.293 Sum_probs=188.0
Q ss_pred cCCcccccccccCcceeeEEEEec---------------CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELP---------------GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (345)
.++|++.+.||+|+||.||++++. ..++..+|+|.+.....
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~------------------------ 59 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN------------------------ 59 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC------------------------
Confidence 457999999999999999998643 12345799999864311
Q ss_pred HHHHHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC--------------------CHHHHHHH
Q 046907 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL--------------------DWLARHRI 171 (345)
Q Consensus 112 ~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l--------------------~~~~~~~i 171 (345)
......+.+|+.+++.++||||+++++++..++ ..+++++++.++++. ++....++
T Consensus 60 --~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (296)
T cd05095 60 --KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD--PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFM 135 (296)
T ss_pred --HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHH
Confidence 123567889999999999999999999988776 578899998876543 33457789
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 172 ~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++................++..|+|||...+..++.+
T Consensus 136 ~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 136 ATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred HHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch
Confidence 999999999999998 99999999999999999999999999876543322112223445678999999888889999
Q ss_pred chhh-HHHHHHHHHh--CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 252 CDIY-FGALLAGLVM--GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 252 ~Dvw-lG~vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
+|+| ||+++|||++ |..||.... ..+................ ..+ ....+...+.+++.+||+.||+
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~~p~ 282 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLS----DEQVIENTGEFFRDQGRQV-YLP-----KPALCPDSLYKLMLSCWRRNAK 282 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccC----hHHHHHHHHHHHhhccccc-cCC-----CCCCCCHHHHHHHHHHcCCCcc
Confidence 9999 9999999998 678864322 2222221111111110000 000 0111224578899999999999
Q ss_pred CCCCHHHHHHHHhh
Q 046907 329 ERPNSKDVRRMLSQ 342 (345)
Q Consensus 329 ~Rpt~~~ll~~L~~ 342 (345)
+|||+.+|.+.|++
T Consensus 283 ~Rp~~~~i~~~l~~ 296 (296)
T cd05095 283 ERPSFQEIHATLLE 296 (296)
T ss_pred cCCCHHHHHHHHhC
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=276.52 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=190.1
Q ss_pred hcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+..+|.+.++||+|+||.||+++.. ..++..+|+|.+.... ......+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---------------------------~~~~~~~~ 55 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------------------------ESARQDFQ 55 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---------------------------HHHHHHHH
Confidence 4678999999999999999999742 2356789999875321 22356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC------------------------CCHHHHHHHHHHHHH
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------------------LDWLARHRIALGLAC 177 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------------------l~~~~~~~i~~~i~~ 177 (345)
+|+.+++.++||||+++++++...+ ..+++++++.++.+ +++..+..++.|++.
T Consensus 56 ~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 133 (280)
T cd05092 56 REAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIAS 133 (280)
T ss_pred HHHHHHhcCCCCCCceEEEEEecCC--ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHH
Confidence 8999999999999999999887765 57888888876532 566677889999999
Q ss_pred HHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-H
Q 046907 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256 (345)
Q Consensus 178 ~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-l 256 (345)
|+.|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||| |
T Consensus 134 al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05092 134 GMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210 (280)
T ss_pred HHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence 999999998 999999999999999999999999998765432221222334457789999999988899999999 9
Q ss_pred HHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 257 GALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 257 G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
|+++|||++ |..||... ........+........+ ......+.+++.+||+.||.+||++.+
T Consensus 211 G~il~el~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 211 GVVLWEIFTYGKQPWYQL----SNTEAIECITQGRELERP-------------RTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHHHHHHHcCCCCCCccC----CHHHHHHHHHcCccCCCC-------------CCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999999998 89996432 222222222211111100 112234778999999999999999999
Q ss_pred HHHHHhh
Q 046907 336 VRRMLSQ 342 (345)
Q Consensus 336 ll~~L~~ 342 (345)
|++.|+.
T Consensus 274 l~~~l~~ 280 (280)
T cd05092 274 IHSRLQA 280 (280)
T ss_pred HHHHHhC
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=283.33 Aligned_cols=232 Identities=24% Similarity=0.338 Sum_probs=177.7
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||+|+||.||+|+.. .+++.||+|.+.... .........+..|+.++..++||||
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~------------------------~~~~~~~~~~~~E~~~l~~l~h~~i 55 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAH------------------------IVSRSEVTHTLAERTVLAQVNCPFI 55 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHH------------------------hhhhhHHHHHHHHHHHHHhCCCCcE
Confidence 799999999999864 578899999985211 0012335667889999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCC
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI 206 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~ 206 (345)
+++++.+..++ .++++++|+.++.+ +++.....++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 56 v~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~ 130 (312)
T cd05585 56 VPLKFSFQSPE--KLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQG 130 (312)
T ss_pred eceeeEEecCC--eEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCC
Confidence 99999888765 78899999988755 455566789999999999999998 99999999999999999
Q ss_pred CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHH
Q 046907 207 EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKW 285 (345)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~ 285 (345)
.++|+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||... .....
T Consensus 131 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~----~~~~~--- 201 (312)
T cd05585 131 HIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE----NVNEM--- 201 (312)
T ss_pred cEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC----CHHHH---
Confidence 999999999875422211 22346799999999999998999999999 999999999999997532 22222
Q ss_pred HHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 046907 286 MRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN---SKDVR 337 (345)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt---~~~ll 337 (345)
.......... ........+.+++..||+.||++||+ +.+++
T Consensus 202 ~~~~~~~~~~-----------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 202 YRKILQEPLR-----------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHcCCCC-----------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 1222211110 00112234678889999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=278.14 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=189.5
Q ss_pred CcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
+|++.+.||+|+||.||+|+... .....+|+|.+..... ......+.+|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--------------------------~~~~~~~~~E~ 54 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--------------------------SSELRDLLSEF 54 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--------------------------HHHHHHHHHHH
Confidence 58899999999999999998532 1235799998854321 12246688899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------------------------------CCHHHHHHH
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------------------------------LDWLARHRI 171 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------------------------------l~~~~~~~i 171 (345)
.+++.++||||+++++.+...+ ..+++++++.++.+ +++.....+
T Consensus 55 ~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 132 (290)
T cd05045 55 NLLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132 (290)
T ss_pred HHHhhCCCCCEeeEEEEEecCC--CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHH
Confidence 9999999999999999887766 46778888876544 344555789
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 172 ~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.+
T Consensus 133 ~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 209 (290)
T cd05045 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ 209 (290)
T ss_pred HHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH
Confidence 999999999999998 99999999999999999999999999876533322222223455678999999988889999
Q ss_pred chhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 252 CDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 252 ~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
+||| ||+++|||++ |..||... ....+.+.+........ .......+.+++.+||+.+|++
T Consensus 210 ~Di~slG~~l~el~t~g~~p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~i~~cl~~~P~~ 272 (290)
T cd05045 210 SDVWSFGVLLWEIVTLGGNPYPGI----APERLFNLLKTGYRMER-------------PENCSEEMYNLMLTCWKQEPDK 272 (290)
T ss_pred hHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHHHHhCCCCCCC-------------CCCCCHHHHHHHHHHccCCccc
Confidence 9999 9999999998 99997432 33333333332211111 1112235778999999999999
Q ss_pred CCCHHHHHHHHhhhh
Q 046907 330 RPNSKDVRRMLSQIQ 344 (345)
Q Consensus 330 Rpt~~~ll~~L~~l~ 344 (345)
||++.++++.|+++-
T Consensus 273 Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 273 RPTFADISKELEKMM 287 (290)
T ss_pred CCCHHHHHHHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.78 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=195.0
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
.|....++|.+.+.||+|+||.||+|++. ..++..||+|.+..... ....
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~ 82 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--------------------------SSER 82 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--------------------------hHHH
Confidence 45556678999999999999999999752 23466899999864321 1224
Q ss_pred HHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhc
Q 046907 118 RQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 118 ~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
..+.+|+.+++++ +||||+++++.+...+ .++++++++.++++ +++.....++.|++.||.|||+.
T Consensus 83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 160 (302)
T cd05055 83 EALMSELKIMSHLGNHENIVNLLGACTIGG--PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160 (302)
T ss_pred HHHHHHHHHHHhccCCCCcceEEEEEecCC--ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 5678899999999 8999999999887766 68899999876543 56667788999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
+ ++|+|+||+||+++.++.++++|||++................++..|+|||.+.+..++.++||| +|+++|+|+
T Consensus 161 ~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~ 237 (302)
T cd05055 161 N---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237 (302)
T ss_pred C---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHH
Confidence 8 999999999999999999999999999865433222222334567889999999988899999999 999999999
Q ss_pred h-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 265 M-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 265 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+ |..||..... ...+...+....... ........+.+++..||+.+|++|||+.++++.|+++
T Consensus 238 t~g~~p~~~~~~---~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 238 SLGSNPYPGMPV---DSKFYKLIKEGYRMA-------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred hCCCCCcCCCCc---hHHHHHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 8 9999654221 112222221111000 0011123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=288.82 Aligned_cols=257 Identities=22% Similarity=0.290 Sum_probs=189.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|... .+++.||||.+.....+ ......+.+|+.
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 75 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQN-------------------------QTHAKRAYRELV 75 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccC-------------------------chhHHHHHHHHH
Confidence 4578999999999999999999853 57889999998643211 122456678999
Q ss_pred HHhhccCCCccceeEEEecCC----cceeeeeccccCCCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGRR------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+ ...++++++++.++. .++......++.|++.||.|||+.+ ++||||
T Consensus 76 ~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dl 152 (364)
T cd07875 76 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 152 (364)
T ss_pred HHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCC
Confidence 999999999999999876543 235789999997642 2456667789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+||+++.++.+||+|||+++...... ......||..|+|||++.+..++.++||| +|+++|+|++|..||....
T Consensus 153 kp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 153 KPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997654322 22346789999999999998999999999 9999999999999975422
Q ss_pred cccchhhHHHHHHHHhhhcCC------------------C-ccc-----ccc----ccCCCcHHHHHHHHHHHhhccCCC
Q 046907 275 QHTNEMSFVKWMRNVMASENP------------------K-RAI-----DSK----LVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~------------------~-~~~-----~~~----~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
.......+......+.+ . ... .+. ............+.+++.+||+.|
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 305 (364)
T cd07875 230 ----HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305 (364)
T ss_pred ----HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcC
Confidence 11111111111111000 0 000 000 000001112345789999999999
Q ss_pred CCCCCCHHHHHH
Q 046907 327 PNERPNSKDVRR 338 (345)
Q Consensus 327 p~~Rpt~~~ll~ 338 (345)
|.+|||+.++++
T Consensus 306 P~~R~t~~e~L~ 317 (364)
T cd07875 306 ASKRISVDEALQ 317 (364)
T ss_pred cccCCCHHHHhc
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=280.26 Aligned_cols=256 Identities=19% Similarity=0.302 Sum_probs=188.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCC-------------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ-------------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (345)
..++|++.+.||+|+||.||+|+..+. ....||+|.+.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------------- 57 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT------------------------- 57 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-------------------------
Confidence 346899999999999999999975321 123589999864311
Q ss_pred HHHHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------------------CCHHHHHHH
Q 046907 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------------------LDWLARHRI 171 (345)
Q Consensus 113 ~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------------------l~~~~~~~i 171 (345)
......+.+|++++++++|||++++++++...+ .+++++|++.++++ +++.....+
T Consensus 58 -~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i 134 (295)
T cd05097 58 -KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD--PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYM 134 (295)
T ss_pred -HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC--ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHH
Confidence 122456889999999999999999999987765 67899999987654 344556779
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 172 ~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+.|++.||.|||+.+ ++|+||||+||+++.++.+|++|||++................++..|+|||.+.+..++.+
T Consensus 135 ~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 211 (295)
T cd05097 135 AVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211 (295)
T ss_pred HHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch
Confidence 999999999999998 99999999999999999999999999876543322222233455778999999988889999
Q ss_pred chhh-HHHHHHHHHh--CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 252 CDIY-FGALLAGLVM--GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 252 ~Dvw-lG~vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
+|+| ||+++|+|++ +..||... ........+......... ... ....+.....+.+++.+||+.||+
T Consensus 212 ~DvwSlG~~l~el~~~~~~~p~~~~----~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 212 SDVWAFGVTLWEMFTLCKEQPYSLL----SDEQVIENTGEFFRNQGR-QIY-----LSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCccc----ChHHHHHHHHHhhhhccc-ccc-----CCCCCCCCHHHHHHHHHHcCCCch
Confidence 9999 9999999998 56675432 222222222111111000 000 000111223588999999999999
Q ss_pred CCCCHHHHHHHHhh
Q 046907 329 ERPNSKDVRRMLSQ 342 (345)
Q Consensus 329 ~Rpt~~~ll~~L~~ 342 (345)
+|||+++|++.|++
T Consensus 282 ~RPs~~~i~~~l~~ 295 (295)
T cd05097 282 DRPTFNKIHHFLRE 295 (295)
T ss_pred hCcCHHHHHHHHhC
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.71 Aligned_cols=241 Identities=19% Similarity=0.281 Sum_probs=184.8
Q ss_pred ccccCcceeeEEEEec-CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 55 KIGSGGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
+||+|+||.||+|.++ ..++..+|+|.+.....+ ....+.+..|+.+++.++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-------------------------~~~~~~~~~e~~~l~~l~h~ 56 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-------------------------PALKDELLREANVMQQLDNP 56 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-------------------------HHHHHHHHHHHHHHHhCCCC
Confidence 6899999999999764 335789999998643222 22356788899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~ 204 (345)
||+++++++..+ ..++++++++++.+ ++......++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 57 ~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~ 130 (257)
T cd05116 57 YIVRMIGICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVT 130 (257)
T ss_pred CcceEEEEEcCC---CcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcC
Confidence 999999987543 35778888887644 455667889999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecCCCCcce-eccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhh
Q 046907 205 DIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMS 281 (345)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~ 281 (345)
++.++++|||++.......... ......++..|+|||.+....++.++|+| ||+++|||++ |..||... ....
T Consensus 131 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~----~~~~ 206 (257)
T cd05116 131 QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM----KGNE 206 (257)
T ss_pred CCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC----CHHH
Confidence 9999999999998764432211 11223446789999999888889999999 9999999998 99997532 2333
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
....+......+. + ......+.++|.+||+.||++||++++|.+.|++.
T Consensus 207 ~~~~i~~~~~~~~---------~----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 207 VTQMIESGERMEC---------P----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHCCCCCCC---------C----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 4343332211111 1 11223477899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=282.39 Aligned_cols=239 Identities=24% Similarity=0.311 Sum_probs=181.0
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH--
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV-- 127 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-- 127 (345)
|++++.||+|+||.||+|+++ .++..||||.+...... .......+..|+.++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~l~~e~~~~~~ 55 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDII------------------------ARDEVESLMCEKRIFET 55 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hhhHHHHHHHHHHHHHh
Confidence 678999999999999999865 57899999998532110 012234555565554
Q ss_pred -hhccCCCccceeEEEecCCcceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 -GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 -~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++...+ .+++++||+.++. .+++.....++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~--~~~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~ 130 (324)
T cd05589 56 ANSERHPFLVNLFACFQTED--HVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLD 130 (324)
T ss_pred ccccCCCChhceeeEEEcCC--EEEEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHH
Confidence 5678999999999988776 7899999998864 3677778889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.+||+|||++....... .......|++.|+|||.+.+..++.++|+| +|+++|||++|..||...
T Consensus 131 Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~---- 204 (324)
T cd05589 131 NLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD---- 204 (324)
T ss_pred HeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC----
Confidence 9999999999999999986532221 122446799999999999998899999999 999999999999997432
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
........+... ... . . ......+.+++.+||+.||.+|| ++.++++
T Consensus 205 ~~~~~~~~i~~~---~~~---~----p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 205 DEEEVFDSIVND---EVR---Y----P----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CHHHHHHHHHhC---CCC---C----C----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 222222222211 110 0 0 11123467889999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=281.69 Aligned_cols=188 Identities=27% Similarity=0.378 Sum_probs=152.5
Q ss_pred ccccccCcceeeEEEEecC-CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 53 LEKIGSGGCGEVYKAELPG-QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
..+||+|+||.||+|+.+. .++..||+|.+..... ...+.+|+.++++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----------------------------~~~~~~E~~~l~~l~ 56 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----------------------------SMSACREIALLRELK 56 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----------------------------cHHHHHHHHHHHhcC
Confidence 4689999999999998642 3678999999854321 223567999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGR-----------------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
||||+++++++.......++++++++.+. ..++...+..++.|++.||.|||+.+ ++|||
T Consensus 57 h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrD 133 (317)
T cd07868 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRD 133 (317)
T ss_pred CCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCC
Confidence 99999999998776666788999887642 13566677889999999999999998 99999
Q ss_pred CCCCCeee----cCCCCeEEeccccceecCCCCc-ceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCC
Q 046907 195 LNPVNVLL----DDDIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 195 lk~~nil~----~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|||+|||+ +.++.+||+|||++........ ........||+.|+|||++.+. .++.++||| +|+++|+|++|.
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 213 (317)
T cd07868 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred CCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999 4567899999999986643221 1122346789999999999774 478999999 999999999999
Q ss_pred CCCcc
Q 046907 268 LPSDK 272 (345)
Q Consensus 268 ~p~~~ 272 (345)
+||..
T Consensus 214 ~~f~~ 218 (317)
T cd07868 214 PIFHC 218 (317)
T ss_pred CCccC
Confidence 99853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=279.94 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=194.7
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecC------CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPG------QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
.|....++|.+.+.||+|+||.||+|++.. .++..||+|.+..... ..
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--------------------------~~ 62 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--------------------------EK 62 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--------------------------hH
Confidence 355677899999999999999999997521 2355799998853211 22
Q ss_pred HHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHH
Q 046907 116 KMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARH 169 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~ 169 (345)
....+.+|+.+++.+ +||||+++++++...+ .++++++|+.++++ +++....
T Consensus 63 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05101 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140 (304)
T ss_pred HHHHHHHHHHHHHhhccCCCchheeEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHH
Confidence 356678899999999 8999999999988765 67889999887643 3444567
Q ss_pred HHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccC
Q 046907 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLT 249 (345)
Q Consensus 170 ~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~ 249 (345)
.++.|++.||.|||+.+ ++||||||+||+++.++.++++|||++................++..|+|||.+.+..++
T Consensus 141 ~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (304)
T cd05101 141 SCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217 (304)
T ss_pred HHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC
Confidence 78999999999999998 999999999999999999999999999876543322222334566789999999888899
Q ss_pred ccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCC
Q 046907 250 EKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp 327 (345)
.++||| ||+++|++++ |..||.. .........+... .... ........+.+++..||+.+|
T Consensus 218 ~~~Di~slG~~l~el~~~g~~p~~~----~~~~~~~~~~~~~---~~~~----------~~~~~~~~~~~li~~cl~~~p 280 (304)
T cd05101 218 HQSDVWSFGVLMWEIFTLGGSPYPG----IPVEELFKLLKEG---HRMD----------KPANCTNELYMMMRDCWHAIP 280 (304)
T ss_pred chhhHHHHHHHHHHHHcCCCCCccc----CCHHHHHHHHHcC---CcCC----------CCCCCCHHHHHHHHHHcccCh
Confidence 999999 9999999998 7788532 2222333322211 1110 011223457788999999999
Q ss_pred CCCCCHHHHHHHHhhhh
Q 046907 328 NERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 328 ~~Rpt~~~ll~~L~~l~ 344 (345)
.+|||+.++++.|+++.
T Consensus 281 ~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 281 SHRPTFKQLVEDLDRIL 297 (304)
T ss_pred hhCCCHHHHHHHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=275.89 Aligned_cols=259 Identities=19% Similarity=0.286 Sum_probs=191.0
Q ss_pred cCCcccccccccCcceeeEEEEec---CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELP---GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..+|++.+.||+|+||.||+|+++ ..++..||+|.+.... ......+.+|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---------------------------~~~~~~~~~e 55 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---------------------------AEHLRDFERE 55 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---------------------------HHHHHHHHHH
Confidence 458999999999999999999853 3468899999985432 1235667889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.+++.++||||+++++++...+...++++++|++++++ +++.....++.|++.||.|||+.+ ++|+
T Consensus 56 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~ 132 (284)
T cd05081 56 IEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHR 132 (284)
T ss_pred HHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 999999999999999998876665678999999987544 455566789999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcce-eccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+| +|+++|||++|..|+.
T Consensus 133 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 133 DLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 999999999999999999999998664332211 11122345569999999988899999999 9999999999876643
Q ss_pred ccccc-----cch---hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 272 KFFQH-----TNE---MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 272 ~~~~~-----~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
..... ... ......+......... ..........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 213 SPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcchhhhhhcccccccccchHHHHHHHhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 21100 000 0000001111100000 001112234588899999999999999999999999987
Q ss_pred h
Q 046907 344 Q 344 (345)
Q Consensus 344 ~ 344 (345)
+
T Consensus 284 ~ 284 (284)
T cd05081 284 R 284 (284)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=284.42 Aligned_cols=235 Identities=21% Similarity=0.325 Sum_probs=181.3
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
+.||+|+||.||+++.+ .+|..||+|.+..... ........+.+|+.+++.++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~------------------------~~~~~~~~~~~E~~~l~~l~hp 55 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVI------------------------IAKDEVAHTLTESRVLKNTRHP 55 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hhhhHHHHHHHHHHHHHhCCCC
Confidence 46899999999999854 5799999999853211 0123356778899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~ 204 (345)
||+++++.+..++ .+++++||+.++.+ +++.....++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 56 ~iv~~~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~ 130 (328)
T cd05593 56 FLTSLKYSFQTKD--RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDK 130 (328)
T ss_pred CCcceEEEEEcCC--EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECC
Confidence 9999999888776 78999999988754 455667789999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHH
Q 046907 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283 (345)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~ 283 (345)
++.+||+|||++....... .......||+.|+|||.+.+..++.++||| +|+++|+|++|..||.. .......
T Consensus 131 ~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~----~~~~~~~ 204 (328)
T cd05593 131 DGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLF 204 (328)
T ss_pred CCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC----CCHHHHH
Confidence 9999999999987532211 122346799999999999988899999999 99999999999999743 1222222
Q ss_pred HHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
..+. .... ..+ ......+.+++.+||+.||++|| ++.++++
T Consensus 205 ~~~~---~~~~-------~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 205 ELIL---MEDI-------KFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHhc---cCCc-------cCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 2211 1110 001 11123467888899999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=291.01 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=181.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.|++++.||+|+||.||+|+.. .++..||+|.+.... .........+..|+.++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~------------------------~~~~~~~~~~~~E~~il 55 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKD------------------------VLNRNQVAHVKAERDIL 55 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHH------------------------hhhhHHHHHHHHHHHHH
Confidence 46899999999999999999864 579999999985311 11123456788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+..++ .+++++||++++.+ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~l~h~~iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~ 130 (381)
T cd05626 56 AEADNEWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPD 130 (381)
T ss_pred HhcCCCCeeeeEEEEecCC--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHH
Confidence 9999999999999998766 78999999988765 445556678999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCc---------------------------------------------ceeccCccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHT---------------------------------------------HITTSNVVG 233 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------------~~~~~~~~g 233 (345)
|||++.++.+||+|||++........ ........|
T Consensus 131 Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (381)
T cd05626 131 NILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVG 210 (381)
T ss_pred HEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccC
Confidence 99999999999999998754311000 000123579
Q ss_pred CccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHH
Q 046907 234 TVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQM 312 (345)
Q Consensus 234 t~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (345)
|+.|+|||.+.+..++.++||| +|+++|||++|..||.... .......+.... .... .+. .....+
T Consensus 211 t~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~--~~~~--~~~--~~~~s~--- 277 (381)
T cd05626 211 TPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT----PTETQLKVINWE--NTLH--IPP--QVKLSP--- 277 (381)
T ss_pred CccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCC----HHHHHHHHHccc--cccC--CCC--CCCCCH---
Confidence 9999999999988899999999 9999999999999975422 111111111100 0000 000 001122
Q ss_pred HHHHHHHhh--ccCCCCCCCCCHHHHHH
Q 046907 313 LLVLKIACF--CTLEDPNERPNSKDVRR 338 (345)
Q Consensus 313 ~~l~~li~~--Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.+++.+ |+..+|..||++.++++
T Consensus 278 -~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 278 -EAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred -HHHHHHHHHccCcccccCCCCHHHHhc
Confidence 23445544 66777778999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=275.53 Aligned_cols=253 Identities=18% Similarity=0.322 Sum_probs=194.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecCC---CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQ---NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.+.++|++.+.||+|+||.||+|.+... .+..|++|.+..... ......+.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~--------------------------~~~~~~~~ 56 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS--------------------------EIQVTLLL 56 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC--------------------------HHHHHHHH
Confidence 3577999999999999999999997532 268899998864321 22356678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC-----------------CCCHHHHHHHHHHHHHHHHHHhh
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------------ELDWLARHRIALGLACGLEYLHM 184 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lh~ 184 (345)
+|+.++++++||||+++++++...+ ...+++++++.++. .+++.....++.|++.||.|||+
T Consensus 57 ~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 135 (280)
T cd05043 57 QESCLLYGLSHQNILPILHVCIEDG-EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135 (280)
T ss_pred HHHHHHHhCCCCCCCeEEEEEecCC-CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 8999999999999999999877643 24566666665433 35566677899999999999999
Q ss_pred cCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHH
Q 046907 185 HHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 185 ~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el 263 (345)
.+ ++|+||||+||+++.++.+|++|||+++.+.............++..|+|||.+.+..++.++||| +|+++||+
T Consensus 136 ~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el 212 (280)
T cd05043 136 RG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212 (280)
T ss_pred CC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence 98 999999999999999999999999999866443332222334567789999999888899999999 99999999
Q ss_pred Hh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 264 VM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 264 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
++ |..||.. .+..+....+........ ...+...+.+++.+||+.||++|||+.++++.|++
T Consensus 213 ~~~g~~p~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 213 MTLGQTPYVE----IDPFEMAAYLKDGYRLAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred hcCCCCCcCc----CCHHHHHHHHHcCCCCCC-------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 99 9999643 233334333332211110 11122357889999999999999999999999998
Q ss_pred hh
Q 046907 343 IQ 344 (345)
Q Consensus 343 l~ 344 (345)
+.
T Consensus 276 ~~ 277 (280)
T cd05043 276 FH 277 (280)
T ss_pred HH
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=288.25 Aligned_cols=256 Identities=20% Similarity=0.330 Sum_probs=187.6
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++++.||+|+||.||+|+.. .+|+.||+|.+.....+ .....++.+|+.+++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~~l~ 54 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQN-------------------------LVSCKRVFRELKMLC 54 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccc-------------------------hHHHHHHHHHHHHHH
Confidence 5889999999999999999853 57999999998532211 122456788999999
Q ss_pred hccCCCccceeEEEecCCc---ceeeeeccccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDC---HLLYILNDVSQGR--------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++++..++. ..++++++++.+. ..++......++.|++.||.|||+.+ ++||||||
T Consensus 55 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp 131 (372)
T cd07853 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKP 131 (372)
T ss_pred hCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCh
Confidence 9999999999999876641 2578888888652 34677778899999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+|||++.++.+||+|||++......... ......++..|+|||.+.+.. ++.++||| +|+++|||++|..||...
T Consensus 132 ~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-- 208 (372)
T cd07853 132 GNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ-- 208 (372)
T ss_pred HHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC--
Confidence 9999999999999999999765332211 223356789999999998754 78899999 999999999999997542
Q ss_pred ccchhhHHHHHHHHhhhcCCCc---------------cccccc---cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKR---------------AIDSKL---VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~---~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
+.......+......+.... ...+.. ...........+.+++..||+.||++|||+.+++
T Consensus 209 --~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 209 --SPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred --CHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 22222222222211111000 000000 0001111234577899999999999999999998
Q ss_pred H
Q 046907 338 R 338 (345)
Q Consensus 338 ~ 338 (345)
+
T Consensus 287 ~ 287 (372)
T cd07853 287 A 287 (372)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=277.80 Aligned_cols=256 Identities=18% Similarity=0.311 Sum_probs=191.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCC---------------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ---------------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (345)
+.++|++.+.||+|+||.||+|+.... .+..||+|.+.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~----------------------- 59 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS----------------------- 59 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-----------------------
Confidence 356899999999999999999986422 234689999864321
Q ss_pred HHHHHHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC--------------------CCCHHHHHH
Q 046907 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR--------------------ELDWLARHR 170 (345)
Q Consensus 111 ~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~--------------------~l~~~~~~~ 170 (345)
......+.+|++++++++||||+++++++..++ ..+++++++.+++ .+++.....
T Consensus 60 ---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (296)
T cd05051 60 ---DNAREDFLKEVKILSRLSDPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLY 134 (296)
T ss_pred ---HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHH
Confidence 123567889999999999999999999988765 6778888887652 356667788
Q ss_pred HHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc
Q 046907 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250 (345)
Q Consensus 171 i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~ 250 (345)
++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||++................++..|+|||.+.+..++.
T Consensus 135 ~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 211 (296)
T cd05051 135 MATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT 211 (296)
T ss_pred HHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCc
Confidence 9999999999999998 9999999999999999999999999987654433222233455678899999998888999
Q ss_pred cchhh-HHHHHHHHHh--CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCC
Q 046907 251 KCDIY-FGALLAGLVM--GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 251 ~~Dvw-lG~vl~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp 327 (345)
++||| ||+++|||++ +..||... ...................... ...+.....+.+++.+||+.||
T Consensus 212 ~~Dv~slG~~l~el~~~~~~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 212 KSDVWAFGVTLWEILTLCREQPYEHL----TDQQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred cchhhhhHHHHHHHHhcCCCCCCCCc----ChHHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccCh
Confidence 99999 9999999998 67775432 2222222222221111111000 1111223468899999999999
Q ss_pred CCCCCHHHHHHHHhh
Q 046907 328 NERPNSKDVRRMLSQ 342 (345)
Q Consensus 328 ~~Rpt~~~ll~~L~~ 342 (345)
++|||+.+|++.|++
T Consensus 282 ~~Rpt~~el~~~L~~ 296 (296)
T cd05051 282 EDRPTFREIHLFLQR 296 (296)
T ss_pred hcCCCHHHHHHHhcC
Confidence 999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=291.80 Aligned_cols=254 Identities=19% Similarity=0.220 Sum_probs=183.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
..+|.+.+.||+|+||.||+|++. .++..||||... ...+.+|+.+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~---------------------------------~~~~~~E~~i 213 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW---------------------------------YASSVHEARL 213 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc---------------------------------ccCHHHHHHH
Confidence 458999999999999999999865 568899999642 2234579999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++++|||||++++++...+ ..+++++++.+ ...+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 214 L~~L~HpnIv~l~~~~~~~~--~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP 288 (461)
T PHA03211 214 LRRLSHPAVLALLDVRVVGG--LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKT 288 (461)
T ss_pred HHHCCCCCCCcEEEEEEECC--EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCH
Confidence 99999999999999888766 45666665543 234677888899999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc-
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ- 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~- 275 (345)
+|||++.++.++|+|||+++...............||..|+|||++.+..++.++||| ||+++|||++|..|+-....
T Consensus 289 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~ 368 (461)
T PHA03211 289 ENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRG 368 (461)
T ss_pred HHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcc
Confidence 9999999999999999999765433222122345799999999999998999999999 99999999998765321111
Q ss_pred ---ccchhhHHHHHHHHhhhcC-CCcccc----------------ccccCCCcH---HHHHHHHHHHhhccCCCCCCCCC
Q 046907 276 ---HTNEMSFVKWMRNVMASEN-PKRAID----------------SKLVGNGCE---EQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 276 ---~~~~~~~~~~~~~~~~~~~-~~~~~~----------------~~~~~~~~~---~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
.....++...+........ ...... +........ .....+.+|+..||+.||.+|||
T Consensus 369 ~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs 448 (461)
T PHA03211 369 DERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS 448 (461)
T ss_pred cccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC
Confidence 1112223333332211100 000000 000000000 11235778999999999999999
Q ss_pred HHHHHHH
Q 046907 333 SKDVRRM 339 (345)
Q Consensus 333 ~~~ll~~ 339 (345)
+.|+++.
T Consensus 449 a~elL~h 455 (461)
T PHA03211 449 AAELLRL 455 (461)
T ss_pred HHHHhhC
Confidence 9999863
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=282.37 Aligned_cols=235 Identities=21% Similarity=0.311 Sum_probs=180.7
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
+.||+|+||.||+++.+ .+|..||+|.+..... ........+.+|+.+++.++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~~E~~~l~~l~hp 55 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI------------------------IAKDEVAHTVTESRVLQNTRHP 55 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hhhHHHHHHHHHHHHHHhCCCC
Confidence 46899999999999854 5799999999853110 0122355677899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~ 204 (345)
||+++++.+..++ .+++++||++++.+ +++.....++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 56 ~i~~~~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~ 130 (323)
T cd05595 56 FLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDK 130 (323)
T ss_pred CCcceeeEEecCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcC
Confidence 9999999988776 78999999988754 566677789999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHH
Q 046907 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283 (345)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~ 283 (345)
++.+||+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|||++|..||... +.....
T Consensus 131 ~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~----~~~~~~ 204 (323)
T cd05595 131 DGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ----DHERLF 204 (323)
T ss_pred CCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC----CHHHHH
Confidence 99999999999875322211 22346789999999999988899999999 999999999999996432 222222
Q ss_pred HHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
..+.. .. . +.. ......+.+++..||+.||++|| ++.++++
T Consensus 205 ~~~~~---~~-~------~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 205 ELILM---EE-I------RFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHhc---CC-C------CCC----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 21111 10 0 000 11123467888899999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=279.60 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=198.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-..+.++.+.||+|.||+||+|+|+ |+.||||++.+. +-..+.+|.+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr------------------------------dE~SWfrEtE 255 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR------------------------------DERSWFRETE 255 (513)
T ss_pred hhheeEEEEEecCccccceeecccc---CCceEEEEeccc------------------------------chhhhhhHHH
Confidence 3457888999999999999999994 889999999642 3455667777
Q ss_pred HHhh--ccCCCccceeEEEecCCc--ceeeeeccccCCCCCCCHHHH--------HHHHHHHHHHHHHHhhc-----CCC
Q 046907 126 TVGQ--IRHRNLHPLLAHVTRPDC--HLLYILNDVSQGRRELDWLAR--------HRIALGLACGLEYLHMH-----HCP 188 (345)
Q Consensus 126 ~l~~--l~hpniv~l~~~~~~~~~--~~l~~~~~~~~~~~~l~~~~~--------~~i~~~i~~~l~~lh~~-----~~~ 188 (345)
|.+. |+|+||+.|++.-..+++ ..++++.+|.+.|++.+++.+ .+++..+++||.|||.. |.+
T Consensus 256 IYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKP 335 (513)
T KOG2052|consen 256 IYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKP 335 (513)
T ss_pred HHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCc
Confidence 7765 599999999986554443 347999999999999887754 58999999999999964 457
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCC--cceeccCcccCcccccccccccccc------Cccchhh-HHHH
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH--THITTSNVVGTVEYIAPEYLQMLTL------TEKCDIY-FGAL 259 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~~~aPE~~~~~~~------~~~~Dvw-lG~v 259 (345)
.|.|||||+.|||+..++.+.|+|+|+|....+.. .....+..+||-+|||||++..... -..+||| ||.|
T Consensus 336 aIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 336 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred hhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 89999999999999999999999999998765432 2234567899999999999976432 1469999 9999
Q ss_pred HHHHHhC----------CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 260 LAGLVMG----------KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 260 l~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
+||+..+ ..||.+..+.+. ..+-+++..=.....+.++.++ ...+++..+.++|..||..||..
T Consensus 416 lWEiarRc~~ggi~eey~~Pyyd~Vp~DP---s~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~a 489 (513)
T KOG2052|consen 416 LWEIARRCESGGIVEEYQLPYYDVVPSDP---SFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAA 489 (513)
T ss_pred HHHHHHHhhcCCEehhhcCCcccCCCCCC---CHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchh
Confidence 9998743 246544333221 2222333332333333333332 34577888999999999999999
Q ss_pred CCCHHHHHHHHhhhh
Q 046907 330 RPNSKDVRRMLSQIQ 344 (345)
Q Consensus 330 Rpt~~~ll~~L~~l~ 344 (345)
|-|+=-+.+.|.++.
T Consensus 490 RltALriKKtl~~l~ 504 (513)
T KOG2052|consen 490 RLTALRIKKTLAKLS 504 (513)
T ss_pred hhHHHHHHHHHHHHh
Confidence 999999999998875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=290.16 Aligned_cols=246 Identities=19% Similarity=0.306 Sum_probs=184.1
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.. .+|+.||||.+.... .........+.+|+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------------------------~~~~~~~~~~~~E~~il 55 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSE------------------------MLEKEQVAHVRAERDIL 55 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHH------------------------hhhhhHHHHHHHHHHHH
Confidence 47999999999999999999964 578999999995211 01123356677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ .+++++||+.++.+ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~l~h~~iv~~~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~ 130 (364)
T cd05599 56 AEADNPWVVKLYYSFQDEN--YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPD 130 (364)
T ss_pred HhCCCCCCcceEEEEEcCC--eEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHH
Confidence 9999999999999998776 78999999987644 456667789999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcce------------------------------------eccCcccCcccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHI------------------------------------TTSNVVGTVEYIAPEY 242 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------------------~~~~~~gt~~~~aPE~ 242 (345)
|||++.++.++|+|||++.......... .....+||+.|+|||+
T Consensus 131 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 210 (364)
T cd05599 131 NLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210 (364)
T ss_pred HeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHH
Confidence 9999999999999999987543211000 0112469999999999
Q ss_pred ccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhh
Q 046907 243 LQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACF 321 (345)
Q Consensus 243 ~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 321 (345)
+.+..++.++||| +||++|||++|..||... ........+... .... ..+. . ......+.+++..
T Consensus 211 ~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~----~~~~~~~~i~~~---~~~~-~~~~----~--~~~s~~~~~li~~ 276 (364)
T cd05599 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD----NPQETYRKIINW---KETL-QFPD----E--VPLSPEAKDLIKR 276 (364)
T ss_pred HcCCCCCCeeeeecchhHHHHhhcCCCCCCCC----CHHHHHHHHHcC---CCcc-CCCC----C--CCCCHHHHHHHHH
Confidence 9988899999999 999999999999997532 222221111111 0000 0000 0 0112235677777
Q ss_pred ccCCCCCCCCC---HHHHHH
Q 046907 322 CTLEDPNERPN---SKDVRR 338 (345)
Q Consensus 322 Cl~~dp~~Rpt---~~~ll~ 338 (345)
|+. +|.+|++ +.++++
T Consensus 277 ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 277 LCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred Hcc-CHhhcCCCCCHHHHhc
Confidence 886 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=271.93 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=194.6
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|... .+|+.||+|.+....... ......+.+|+.++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------------------~~~~~~~~~ei~~l 56 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMD------------------------AKARQDCLKEIDLL 56 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccc------------------------hhhHHHHHHHHHHH
Confidence 58999999999999999999864 579999999885322111 12356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
++++|+|++++++.+...+ ..+++++|++++++ ++...+..++.+++.|+.|||+.+ ++|+|
T Consensus 57 ~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 131 (267)
T cd08224 57 KQLDHPNVIKYLASFIENN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRD 131 (267)
T ss_pred HhCCCCCeeeeeeeeecCC--eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 9999999999999988765 67889999887544 455667789999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+|+||+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 132 l~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 132 IKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cChhhEEECCCCcEEEeccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 999999999999999999999876543221 11235678899999999988899999999 999999999999996421
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
. .........+......+.+ .+.....+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 210 ~--~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 210 K--MNLYSLCKKIEKCDYPPLP------------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C--ccHHHHHhhhhcCCCCCCC------------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 1111122221111111100 1123345788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=290.00 Aligned_cols=238 Identities=27% Similarity=0.395 Sum_probs=191.8
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
-|+=++.||.|+||.||-|+. ..+.+.||||.+... ..+...+.+.+.+|+..|+
T Consensus 27 lf~dLrEIGHGSFGAVYfArd-~~n~evVAIKKMsyS------------------------GKQs~EKWqDIlKEVrFL~ 81 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYS------------------------GKQSNEKWQDILKEVRFLR 81 (948)
T ss_pred HHHHHHHhcCCccceeEEeec-cCccceeeeeecccc------------------------ccccHHHHHHHHHHHHHHH
Confidence 577789999999999999985 468999999998532 1222566889999999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+++|||+|.+.|.|..+. ..|+||+||-|. ..+....+..|+.+.+.||.|||+.+ .||||||+.|
T Consensus 82 ~l~HPntieYkgCyLre~--TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGN 156 (948)
T KOG0577|consen 82 QLRHPNTIEYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGN 156 (948)
T ss_pred hccCCCcccccceeeccc--hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccc
Confidence 999999999999887654 679999999774 23556667789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
||++..|.||++|||.|.... +.++++||++|||||++. .+.|+-++||| +|+++.|+...++|. |+
T Consensus 157 ILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl---Fn 227 (948)
T KOG0577|consen 157 ILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL---FN 227 (948)
T ss_pred eEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc---cC
Confidence 999999999999999987643 346699999999999994 45689999999 999999999999993 44
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+-++.+.+|..... |.+..+..++++. .++..||+.-|.+|||.++++.
T Consensus 228 -MNAMSALYHIAQNes---------PtLqs~eWS~~F~---~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 228 -MNAMSALYHIAQNES---------PTLQSNEWSDYFR---NFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -chHHHHHHHHHhcCC---------CCCCCchhHHHHH---HHHHHHHhhCcccCCcHHHHhh
Confidence 344555555543332 2223344455554 5555699999999999998875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.21 Aligned_cols=247 Identities=18% Similarity=0.263 Sum_probs=183.8
Q ss_pred CcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
+|++++.||+|+||.||+++.. ..+++.||+|.+...... ........+..|+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-----------------------~~~~~~~~~~~e~~~ 57 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-----------------------QKAKTVEHTRTERNV 57 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-----------------------hhhhHHHHHHHHHHH
Confidence 5889999999999999999753 236899999998521100 012235567789999
Q ss_pred Hhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+..+ +||||+++++++..++ .++++++|+.++.+ ++......++.|++.||.|||+.+ ++|||||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlk 132 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEA--KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIK 132 (332)
T ss_pred HHhccCCCCcccEEEEEecCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCC
Confidence 9999 5999999999887766 68899999988654 455566789999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+|||++.++.+||+|||++......... ......||..|+|||.+.+.. ++.++||| +|+++|||++|..||....
T Consensus 133 p~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 133 LENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred HHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 99999999999999999998764332211 223467999999999998754 78899999 9999999999999975432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.......+...+ ..... .. .......+.+++.+||+.||++|| ++.++++
T Consensus 212 ~~~~~~~~~~~~---~~~~~-------~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 212 ERNTQSEVSRRI---LKCDP-------PF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCHHHHHHHH---hcCCC-------CC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 222222222211 11110 00 111223467888999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=272.35 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=191.0
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|....++|+++++||+|+||.||+|..+ ++..||+|.+...... ...+.+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~~~----------------------------~~~~~~ 50 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMS----------------------------PEAFLA 50 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCCCc----------------------------HHHHHH
Confidence 3456789999999999999999999864 6788999998643221 345778
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
|+.+++.++||||+++++++... ..+++++++.++.+ +++.....++.|++.||.|||+.+ ++
T Consensus 51 E~~~l~~l~h~~i~~~~~~~~~~---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~ 124 (260)
T cd05067 51 EANLMKQLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YI 124 (260)
T ss_pred HHHHHHhcCCcCeeeEEEEEccC---CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---ee
Confidence 99999999999999999976433 47888888877544 455566789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|+||||+|++++.++.++++|||++......... ......++..|+|||.+.+..++.++|+| ||+++||+++ |..|
T Consensus 125 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p 203 (260)
T cd05067 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203 (260)
T ss_pred cccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999776532211 11234567789999999888899999999 9999999999 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
|... ........+......+. .......+.+++.+||+.+|++|||++++++.|+.+
T Consensus 204 ~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 204 YPGM----TNPEVIQNLERGYRMPR-------------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCC----ChHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 7532 22223222222111111 111223588899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=272.99 Aligned_cols=245 Identities=24% Similarity=0.395 Sum_probs=189.4
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|.++ ++..+|+|.+...... ...+.+|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~~----------------------------~~~~~~E 51 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMS----------------------------PESFLEE 51 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCCC----------------------------HHHHHHH
Confidence 345678999999999999999999864 5677999998653221 2347789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+.++++++|||++++++++... ..+++++++.++.+ +++..+..++.|++.||.|||+.+ ++|
T Consensus 52 ~~~l~~l~~~~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H 125 (260)
T cd05070 52 AQIMKKLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIH 125 (260)
T ss_pred HHHHHhcCCCceEEEEeEECCC---CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999987533 36788888876533 566677899999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
+|+||+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+| ||+++|+|++ |..||
T Consensus 126 ~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~ 204 (260)
T cd05070 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred CCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999865433211 11223456789999999888899999999 9999999999 88896
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
... ...+....+......+ ........+.+++.+||+.+|++|||++++.+.|++
T Consensus 205 ~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 205 PGM----NNREVLEQVERGYRMP-------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCC----CHHHHHHHHHcCCCCC-------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 432 2223333332211110 111223458889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=269.98 Aligned_cols=240 Identities=25% Similarity=0.336 Sum_probs=181.6
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
+.||+|+||.||+|++. .+++.+|+|.+..... ......+.+|+.++++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~ 53 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLP--------------------------PDLKAKFLQEARILKQYSHP 53 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCC--------------------------HHHHHHHHHHHHHHHhCCCC
Confidence 47999999999999864 4789999998753211 12345678899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
||+++++++...+ .+++++|++.++++ +++.....++.|++.||.|||+.+ ++|+|+||+||+++
T Consensus 54 ~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~ 128 (252)
T cd05084 54 NIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVT 128 (252)
T ss_pred CcceEEEEEcCCC--CeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEc
Confidence 9999999988765 67888898877543 456666789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhh
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMS 281 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~ 281 (345)
.++.++++|||++................++..|+|||.+.+..++.++|+| +|+++|||++ |..||... ....
T Consensus 129 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~----~~~~ 204 (252)
T cd05084 129 EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL----SNQQ 204 (252)
T ss_pred CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc----CHHH
Confidence 9999999999998765432111111112234579999999988899999999 9999999998 88886432 2222
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
....+...... .........+.+++.+||+.+|++|||+.++++.|++
T Consensus 205 ~~~~~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 205 TREAIEQGVRL-------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHcCCCC-------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 22222211110 0111223457889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=284.26 Aligned_cols=195 Identities=24% Similarity=0.376 Sum_probs=161.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.. .+++.||+|.+.... .........+..|+.++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~------------------------~~~~~~~~~~~~E~~il 55 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKAD------------------------MLEKEQVGHIRAERDIL 55 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHH------------------------HHHhhHHHHHHHHHHHH
Confidence 57999999999999999999854 578999999985311 11123356778899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
..++||||+++++.+...+ .+++++||++++.+ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~~~~~~iv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~ 130 (363)
T cd05628 56 VEADSLWVVKMFYSFQDKL--NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPD 130 (363)
T ss_pred HhCCCCCcceEEEEEecCC--eEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHH
Confidence 9999999999999988766 78999999988654 455567789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcc---------------------------------eeccCcccCccccccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTH---------------------------------ITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~~~aPE~~~~ 245 (345)
|||++.++.+||+|||++......... ......+||+.|+|||.+.+
T Consensus 131 NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 210 (363)
T cd05628 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ 210 (363)
T ss_pred HeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC
Confidence 999999999999999998754321100 00123579999999999999
Q ss_pred cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 246 LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 246 ~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
..++.++||| +|+++|||++|..||..
T Consensus 211 ~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred CCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 8999999999 99999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=279.80 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=192.1
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCC------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQ------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKK 116 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (345)
|....++|.+.+.||+|+||.||++++.+. ++..+|+|.+..... ...
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--------------------------~~~ 66 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--------------------------EKD 66 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--------------------------hHH
Confidence 444567899999999999999999986421 235799999864311 122
Q ss_pred HHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHH
Q 046907 117 MRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHR 170 (345)
Q Consensus 117 ~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~ 170 (345)
...+..|+.+++++ +||||+++++++...+ ..+++++++.++++ +++....+
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 144 (307)
T cd05098 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144 (307)
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHH
Confidence 45677899999999 7999999999988776 67889999877533 45566778
Q ss_pred HHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc
Q 046907 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250 (345)
Q Consensus 171 i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~ 250 (345)
++.|++.||.|||+.+ ++|+||||+||+++.++.++++|||.+................++..|+|||.+.+..++.
T Consensus 145 ~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (307)
T cd05098 145 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221 (307)
T ss_pred HHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc
Confidence 9999999999999998 9999999999999999999999999987654322111122233456899999999888999
Q ss_pred cchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 251 KCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 251 ~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
++|+| +|+++|||++ |..||.. ....+....+.... .. +.+......+.+++..||+.+|.
T Consensus 222 ~~DvwslG~~l~el~~~g~~p~~~----~~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~~l~~~p~ 284 (307)
T cd05098 222 QSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGH---RM----------DKPSNCTNELYMMMRDCWHAVPS 284 (307)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCc----CCHHHHHHHHHcCC---CC----------CCCCcCCHHHHHHHHHHcccChh
Confidence 99999 9999999998 8888632 22223333222111 11 01112234577889999999999
Q ss_pred CCCCHHHHHHHHhhhh
Q 046907 329 ERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 329 ~Rpt~~~ll~~L~~l~ 344 (345)
+|||+.++++.|+++.
T Consensus 285 ~Rps~~evl~~l~~~~ 300 (307)
T cd05098 285 QRPTFKQLVEDLDRIL 300 (307)
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=276.56 Aligned_cols=243 Identities=27% Similarity=0.352 Sum_probs=185.8
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|++.+.||+|+||.||++... .+++.||+|.+....... ......+.+|+.+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~~E~~~l~ 55 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKK------------------------RKGEAMALNEKQILE 55 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhh------------------------hhhHHHHHHHHHHHH
Confidence 4888999999999999999854 578999999985321110 112455678999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++.+..++ .++++++|+.++.+ +++.....++.|++.||.|||+.+ ++|+||||
T Consensus 56 ~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp 130 (285)
T cd05605 56 KVNSRFVVSLAYAYETKD--ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKP 130 (285)
T ss_pred hcCCCCEeeeeeeecCCC--eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCH
Confidence 999999999999887766 78999999987543 455667789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||| +|+++|||++|..||...
T Consensus 131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~--- 204 (285)
T cd05605 131 ENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR--- 204 (285)
T ss_pred HHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC---
Confidence 99999999999999999987654322 12335789999999999988899999999 999999999999997542
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
......+.+......... .........+.+++..||+.||++|| +++++++
T Consensus 205 -~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 205 -KEKVKREEVERRVKEDQE----------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -chhhHHHHHHHHhhhccc----------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 221111112111111110 01112233477899999999999999 7888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=287.04 Aligned_cols=246 Identities=20% Similarity=0.326 Sum_probs=187.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|.+.+.||+|+||.||+|+.. .+|+.||+|.+..... ........+..|+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~e~~~l 55 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDM------------------------IKRNQIAHVRAERDIL 55 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHH------------------------hhccHHHHHHHHHHHH
Confidence 47999999999999999999864 5799999999853110 0123356678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
..++||||+++++.+..++ .++++++|+.++.+ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~ 130 (350)
T cd05573 56 ADADSPWIVKLYYSFQDEE--HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPD 130 (350)
T ss_pred HhcCCCCccchhhheecCC--eEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 9999999999999888766 78999999987644 555666789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCC---------------------------cceeccCcccCccccccccccccccCcc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAH---------------------------THITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~---------------------------~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
||+++.++.++|+|||++....... .........||+.|+|||.+.+..++.+
T Consensus 131 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 210 (350)
T cd05573 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE 210 (350)
T ss_pred HeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc
Confidence 9999999999999999997654332 0012234678999999999999899999
Q ss_pred chhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCC
Q 046907 252 CDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER 330 (345)
Q Consensus 252 ~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 330 (345)
+||| +|+++|||++|..||.... .......+......... +. .......+.+++..|++ ||.+|
T Consensus 211 ~DiwSlG~il~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~~~----p~------~~~~~~~~~~li~~ll~-dp~~R 275 (350)
T cd05573 211 CDWWSLGVILYEMLYGFPPFYSDT----LQETYNKIINWKESLRF----PP------DPPVSPEAIDLICRLLC-DPEDR 275 (350)
T ss_pred eeeEecchhhhhhccCCCCCCCCC----HHHHHHHHhccCCcccC----CC------CCCCCHHHHHHHHHHcc-Chhhc
Confidence 9999 9999999999999975432 11111111110000000 00 00022347788888997 99999
Q ss_pred CC-HHHHHH
Q 046907 331 PN-SKDVRR 338 (345)
Q Consensus 331 pt-~~~ll~ 338 (345)
|+ +.++++
T Consensus 276 ~~s~~~ll~ 284 (350)
T cd05573 276 LGSFEEIKS 284 (350)
T ss_pred CCCHHHHhc
Confidence 99 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=275.37 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=190.5
Q ss_pred hcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+.++|++...||+|+||.||+|++++ .++..||+|.+..... ......+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--------------------------~~~~~~~~ 56 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------------------------ADMQADFQ 56 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--------------------------HHHHHHHH
Confidence 46789999999999999999998642 3678999999854211 12245688
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------------CCHHHHHH
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------------LDWLARHR 170 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------------l~~~~~~~ 170 (345)
+|+.++++++||||+++++++..++ .+++++++++++.+ +++..+..
T Consensus 57 ~ei~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 134 (288)
T cd05050 57 REAALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLC 134 (288)
T ss_pred HHHHHHHhcCCCchheEEEEEcCCC--ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHH
Confidence 8999999999999999999887665 57889998877543 34455678
Q ss_pred HHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc
Q 046907 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250 (345)
Q Consensus 171 i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~ 250 (345)
++.|++.||.|||+.+ ++||||||+||+++.++.++++|||++................++..|+|||.+.+..++.
T Consensus 135 ~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 211 (288)
T cd05050 135 IAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT 211 (288)
T ss_pred HHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc
Confidence 9999999999999998 9999999999999999999999999987654332211222334567799999999888999
Q ss_pred cchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 251 KCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 251 ~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
++||| ||+++|||++ |..||... ...+....+.... .+ ...+.....+.+++.+||+.+|+
T Consensus 212 ~~Dv~slG~il~el~~~~~~p~~~~----~~~~~~~~~~~~~---~~----------~~~~~~~~~l~~li~~~l~~~p~ 274 (288)
T cd05050 212 ESDVWAYGVVLWEIFSYGMQPYYGM----AHEEVIYYVRDGN---VL----------SCPDNCPLELYNLMRLCWSKLPS 274 (288)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCC---CC----------CCCCCCCHHHHHHHHHHcccCcc
Confidence 99999 9999999997 88886332 2222222222111 11 01112234588899999999999
Q ss_pred CCCCHHHHHHHHhh
Q 046907 329 ERPNSKDVRRMLSQ 342 (345)
Q Consensus 329 ~Rpt~~~ll~~L~~ 342 (345)
+|||+.|+++.|++
T Consensus 275 ~Rpt~~el~~~l~~ 288 (288)
T cd05050 275 DRPSFASINRILQR 288 (288)
T ss_pred cCCCHHHHHHHhhC
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=285.70 Aligned_cols=250 Identities=18% Similarity=0.252 Sum_probs=188.0
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|+.. .++..||+|.+.... .........+.+|
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~------------------------~~~~~~~~~~~~e 93 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFE------------------------MIKRSDSAFFWEE 93 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHH------------------------hhhhhhHHHHHHH
Confidence 346679999999999999999999864 578999999984211 0012234557789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+.+++.++||||+++++++..++ .++++++|++++++ ++......++.|++.||.|||+.+ ++||||
T Consensus 94 ~~il~~~~h~~iv~~~~~~~~~~--~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDL 168 (370)
T cd05596 94 RDIMAHANSEWIVQLHYAFQDDK--YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDV 168 (370)
T ss_pred HHHHHhCCCCCcceEEEEEecCC--EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 99999999999999999888766 79999999988755 344556678999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc----ccCccchhh-HHHHHHHHHhCCCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML----TLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~----~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||+|||++.++.+||+|||++........ .......||+.|+|||.+.+. .++.++||| +|+++|||++|..||
T Consensus 169 kp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 169 KPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred CHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 99999999999999999999976543221 122346799999999998654 378899999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE--RPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--Rpt~~~ll~ 338 (345)
... +.......+.. ...... .+ ........+.+++..||+.+|.+ |||+.++++
T Consensus 248 ~~~----~~~~~~~~i~~---~~~~~~-~~------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 248 YAD----SLVGTYSKIMD---HKNSLT-FP------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCC----CHHHHHHHHHc---CCCcCC-CC------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 432 22222222211 110000 00 00112235678889999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=271.07 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=188.5
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|..+.++|++.+.||+|+||.||+|.. .|..+|+|.+... ...+.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~-----------------------------~~~~~~~~ 48 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND-----------------------------ATAQAFLA 48 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCC-----------------------------chHHHHHH
Confidence 345667999999999999999999985 5788999998532 11345778
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
|+.++++++|||++++++++...+ ..+++++++++++.+ +++.....++.|++.||.|||+.+ ++
T Consensus 49 e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 124 (256)
T cd05082 49 EASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124 (256)
T ss_pred HHHHHHhCCCCCeeeEEEEEEcCC-CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 999999999999999999765443 357889999887543 445566789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|+||||+||+++.++.+|++|||++....... ....++..|+|||.+.+..++.++||| +|+++|+|++ |..|
T Consensus 125 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p 199 (256)
T cd05082 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199 (256)
T ss_pred ccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987543321 223456789999999988899999999 9999999998 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
|.. ....+....+..... + . ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 200 ~~~----~~~~~~~~~~~~~~~---~------~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 200 YPR----IPLKDVVPRVEKGYK---M------D----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCC----CCHHHHHHHHhcCCC---C------C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 643 222233322222111 0 0 1112233577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=278.23 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=192.5
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecC------CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPG------QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
.|....++|.+.+.||+|+||.||+|+..+ .....+|+|.+..... ..
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--------------------------~~ 59 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--------------------------DK 59 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--------------------------hH
Confidence 345566799999999999999999997531 2356799999864321 12
Q ss_pred HHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHH
Q 046907 116 KMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARH 169 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~ 169 (345)
....+..|+.+++.+ +||||+++++++...+ .++++++++.++.+ +++....
T Consensus 60 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 137 (314)
T cd05099 60 DLADLISEMELMKLIGKHKNIINLLGVCTQEG--PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137 (314)
T ss_pred HHHHHHHHHHHHHhccCCCCeeeEEEEEccCC--ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHH
Confidence 245677899999999 6999999999887665 57888998877543 4555667
Q ss_pred HHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccC
Q 046907 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLT 249 (345)
Q Consensus 170 ~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~ 249 (345)
+++.|++.||.|||+.+ ++|+||||+||+++.++.+|++|||+++...............++..|+|||.+.+..++
T Consensus 138 ~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (314)
T cd05099 138 SCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT 214 (314)
T ss_pred HHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC
Confidence 89999999999999998 999999999999999999999999999865432221112223345679999999888899
Q ss_pred ccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCC
Q 046907 250 EKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp 327 (345)
.++||| ||+++|+|++ |..||.. .........+.... ... ........+.+++.+||+.+|
T Consensus 215 ~~~DiwslG~~l~el~~~g~~p~~~----~~~~~~~~~~~~~~---~~~----------~~~~~~~~l~~li~~cl~~~p 277 (314)
T cd05099 215 HQSDVWSFGILMWEIFTLGGSPYPG----IPVEELFKLLREGH---RMD----------KPSNCTHELYMLMRECWHAVP 277 (314)
T ss_pred ccchhhHHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHcCC---CCC----------CCCCCCHHHHHHHHHHcCCCc
Confidence 999999 9999999999 8888643 22233333332211 100 011222347789999999999
Q ss_pred CCCCCHHHHHHHHhhhh
Q 046907 328 NERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 328 ~~Rpt~~~ll~~L~~l~ 344 (345)
++|||+.++++.|+++.
T Consensus 278 ~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 278 TQRPTFKQLVEALDKVL 294 (314)
T ss_pred ccCcCHHHHHHHHHHHH
Confidence 99999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=275.06 Aligned_cols=237 Identities=23% Similarity=0.313 Sum_probs=180.3
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||+|+||.||+|+.+ .+++.||+|.+...... .......+..|+.+++.++||||
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~------------------------~~~~~~~~~~E~~il~~l~~~~i 55 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLK------------------------KRKGYEGAMVEKRILAKVHSRFI 55 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHh------------------------hhHHHHHHHHHHHHHHhCCCCcE
Confidence 799999999999864 57899999998532111 01234567789999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
+++++++..++ .++++++|++++.+ +++.....++.|++.||.|||+.+ ++||||||+||++
T Consensus 56 ~~~~~~~~~~~--~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili 130 (280)
T cd05608 56 VSLAYAFQTKT--DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLL 130 (280)
T ss_pred eeeeEEEcCCC--eEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 99999887765 68899999987653 456667789999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhh
Q 046907 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~ 281 (345)
+.++.++|+|||++........ ......||..|+|||.+.+..++.++|+| +|+++|||++|..||..........
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~- 207 (280)
T cd05608 131 DNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK- 207 (280)
T ss_pred CCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-
Confidence 9999999999999976544322 22345789999999999998999999999 9999999999999975422111111
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
........... ...+.....+.+++..||+.||++|| +++++++
T Consensus 208 --~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 208 --ELKQRILNDSV-----------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --HHHHhhcccCC-----------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11111111100 01112334577888999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=281.04 Aligned_cols=238 Identities=22% Similarity=0.326 Sum_probs=180.0
Q ss_pred ccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 046907 53 LEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI 130 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 130 (345)
++.||+|+||.||+++.. ..+++.||+|.+...... ........+..|+.+++.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-----------------------~~~~~~~~~~~E~~il~~l 57 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-----------------------RNQKDTAHTKAERNILEAV 57 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-----------------------hhhhhHHHHHHHHHHHHhC
Confidence 368999999999999853 236889999998531100 0122345677899999999
Q ss_pred cCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 046907 131 RHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 131 ~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil 201 (345)
+||||+++++.+..++ .++++++++.++.+. .......++.|++.||.|||+.+ ++||||||+||+
T Consensus 58 ~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil 132 (323)
T cd05584 58 KHPFIVDLIYAFQTGG--KLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENIL 132 (323)
T ss_pred CCCchhceeeEEecCC--eEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeE
Confidence 9999999999988776 688999999887653 34455678899999999999998 999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchh
Q 046907 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~ 280 (345)
++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++||| +|+++|||++|..||... +..
T Consensus 133 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~----~~~ 206 (323)
T cd05584 133 LDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE----NRK 206 (323)
T ss_pred ECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC----CHH
Confidence 99999999999999875422211 22345789999999999988899999999 999999999999997432 222
Q ss_pred hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.....+ ...... ++ +.....+.+++..||+.||++|| ++.++++
T Consensus 207 ~~~~~~---~~~~~~---~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 207 KTIDKI---LKGKLN---LP--------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHH---HcCCCC---CC--------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 222222 111110 01 11123477889999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.34 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=194.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
...+...+.||+|+||.||+|++. .++..||||.+..... ....|+..
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~-------------------------------~~~~~~~~ 736 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNS-------------------------------IPSSEIAD 736 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCcc-------------------------------ccHHHHHH
Confidence 346777889999999999999864 4789999999853211 11235788
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
+++++|||||++++++..++ ..++++||++++.+ ++|..+.+++.|+++|+.|||....++++|||+||+||
T Consensus 737 l~~l~HpnIv~~~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Ni 814 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEK--GAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI 814 (968)
T ss_pred HhhCCCCCcceEEEEEEcCC--CCEEEEeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhE
Confidence 89999999999999998776 57899999998765 56778889999999999999955434599999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccch
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~ 279 (345)
+++.++..++. ||.+..... .....||..|+|||++.+..++.++||| ||+++|||++|+.||...+.. .
T Consensus 815 l~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~ 885 (968)
T PLN00113 815 IIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--H 885 (968)
T ss_pred EECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--C
Confidence 99988887775 555433211 1234678999999999998999999999 999999999999998543332 2
Q ss_pred hhHHHHHHHHhhhcCCCccccccccC--CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVG--NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.....+.+............++.+.. ....++...+.+++.+||+.||++|||+.++++.|+++.
T Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 23444444333222222233333322 234566778899999999999999999999999999873
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=270.81 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=185.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+..+|++.+.||+|+||.||+|+++ ++..+|+|.+...... ...+..|+.
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~~----------------------------~~~~~~e~~ 51 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMS----------------------------EDDFIEEAK 51 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCCC----------------------------HHHHHHHHH
Confidence 3457899999999999999999875 5678999998532211 234677999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+ ..++++++++++.+ +++.....++.|++.|+.|||+.+ ++|+|+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 126 (256)
T cd05059 52 VMMKLSHPNLVQLYGVCTKQR--PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126 (256)
T ss_pred HHHhCCCCCEEEEEEEEcCCC--ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 999999999999999887665 67889999877543 455566789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~ 273 (345)
||+||+++.++.+|++|||+++...+.... ......++..|+|||.+.+..++.++|+| ||+++|++++ |..||...
T Consensus 127 ~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred cHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 999999999999999999998765432211 11122345679999999988899999999 9999999999 79996432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
...+....+........+ ......+.+++.+||+.+|++|||+.++++.|
T Consensus 206 ----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 206 ----SNSEVVESVSAGYRLYRP-------------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ----CHHHHHHHHHcCCcCCCC-------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 222222222221111111 11233578899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=274.53 Aligned_cols=237 Identities=22% Similarity=0.339 Sum_probs=177.8
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||+|+||.||+++.+ .+|+.||+|.+....... ......+..|+.++++++||||
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~------------------------~~~~~~~~~E~~il~~l~hp~i 55 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKK------------------------KSGEKMALLEKEILEKVNSPFI 55 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhc------------------------chhhHHHHHHHHHHHhcCCCcE
Confidence 799999999999864 579999999984311100 1112344568999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~ 204 (345)
+++++.+..++ .++++++|+.++.+ +++.....++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 56 ~~~~~~~~~~~--~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~ 130 (277)
T cd05607 56 VNLAYAFESKT--HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDD 130 (277)
T ss_pred EEEEEEEecCC--eEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcC
Confidence 99999887765 78999999987654 445556778999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHH
Q 046907 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283 (345)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~ 283 (345)
++.++|+|||++........ .....|+..|+|||++.+..++.++|+| +|+++|||++|..||..........
T Consensus 131 ~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--- 204 (277)
T cd05607 131 QGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--- 204 (277)
T ss_pred CCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH---
Confidence 99999999999876644321 2235689999999999988899999999 9999999999999975432211111
Q ss_pred HHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
............. .. ......+.+++..||+.||++||++.++++
T Consensus 205 ~~~~~~~~~~~~~-------~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 205 ELKRRTLEDEVKF-------EH---QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHhhcccccc-------cc---ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 1111111111100 00 012234678889999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=286.81 Aligned_cols=255 Identities=20% Similarity=0.219 Sum_probs=188.4
Q ss_pred cCCcccccccccCcceeeEEEEecC-CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPG-QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+|.+++.||+|+||.||+|...+ .++..||+|.+... ....+|+.
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------------------------------~~~~~E~~ 138 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------------------------------KTPGREID 138 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------------------------------ccHHHHHH
Confidence 4579999999999999999997543 34688999988431 12347999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++++++||||+++++++...+ .++++++++.+ ...+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 139 il~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp 213 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKS--TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKT 213 (392)
T ss_pred HHHhcCCCCccceeeeEeeCC--EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCH
Confidence 999999999999999887665 57777776643 345677788899999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.++|+|||++................||..|+|||++.+..++.++||| +|+++|||++|..||......
T Consensus 214 ~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 214 ENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred HHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 9999999999999999999766543332233356799999999999998999999999 999999999999997543333
Q ss_pred cchhhHHHHHHHHhhhcCCCcc-------------ccccccCCC-cH------HHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRA-------------IDSKLVGNG-CE------EQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~-~~------~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
.....+...+.... ....... +.....+.. .+ .....+.++|.+||+.||++|||+.++
T Consensus 294 ~~~~~l~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~ 372 (392)
T PHA03207 294 SSSSQLRSIIRCMQ-VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDI 372 (392)
T ss_pred CcHHHHHHHHHHhc-cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHH
Confidence 22333333222111 1100000 000000000 00 112346788899999999999999999
Q ss_pred HHH
Q 046907 337 RRM 339 (345)
Q Consensus 337 l~~ 339 (345)
++.
T Consensus 373 l~~ 375 (392)
T PHA03207 373 LSL 375 (392)
T ss_pred hhC
Confidence 863
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=283.65 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=185.8
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++++.||+|+||.||+|... .++..||||.+.....+ ......+.+|+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~ 65 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQS-------------------------LIHARRTYREL 65 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhh-------------------------hHHHHHHHHHH
Confidence 45678999999999999999999854 57889999998532111 12245567899
Q ss_pred HHHhhccCCCccceeEEEecCC----cceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.+++.++||||+++++++.... ....+++++++.+. ..++...+..++.|++.||.|||+.+ ++||
T Consensus 66 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHr 142 (343)
T cd07878 66 RLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHR 142 (343)
T ss_pred HHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 9999999999999999876432 12457777776431 24677778899999999999999999 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||||+||+++.++.+||+|||++...... .....||..|+|||++.+ ..++.++||| +|+++|+|++|..||.
T Consensus 143 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 143 DLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred cCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999865432 234578999999999977 4588999999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCcc--c--------c---ccccCC----CcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRA--I--------D---SKLVGN----GCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~---~~~~~~----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
.. +..+....+......+.+... . . +..... ........+.+++.+||+.||++|||+.
T Consensus 218 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ 293 (343)
T cd07878 218 GN----DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293 (343)
T ss_pred CC----CHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 32 222222222221111110000 0 0 000000 0001112367899999999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
++++
T Consensus 294 ell~ 297 (343)
T cd07878 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=270.71 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=188.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|.+.++||+|+||.||+|++. ++..||+|.+..... ....+.+|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~----------------------------~~~~~~~E 51 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTM----------------------------SPEAFLQE 51 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCcc----------------------------CHHHHHHH
Confidence 345678999999999999999999865 345699999864221 13457789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+.+++.++||||+++++.+... ..++++++++++.+ +++.....++.|++.||.|+|+.+ ++|
T Consensus 52 ~~~l~~l~~~~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H 125 (262)
T cd05071 52 AQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 125 (262)
T ss_pred HHHHHhCCCCCcceEEEEECCC---CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999876433 36789999887654 445566789999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
+||||+||+++.++.++|+|||.+......... ......++..|+|||...+..++.++|+| +|+++|+|++ |..||
T Consensus 126 ~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~ 204 (262)
T cd05071 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204 (262)
T ss_pred cccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999766433221 11234466789999999888899999999 9999999999 88886
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
... ........+.. .... ....+....+.+++..||+.||++|||+.++++.|+..
T Consensus 205 ~~~----~~~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 205 PGM----VNREVLDQVER---GYRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCC----ChHHHHHHHhc---CCCC----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 432 22222222211 1100 01123345578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=268.89 Aligned_cols=248 Identities=19% Similarity=0.308 Sum_probs=188.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|++|.||+|... .++..+|+|.+........ .......+.+|+.++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~----------------------~~~~~~~~~~e~~~l 58 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPE----------------------TKKEVNALECEIQLL 58 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchh----------------------hHHHHHHHHHHHHHH
Confidence 57999999999999999999853 5789999999864322111 022356788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++||||+++++++..++ .+++++++++++.+ ++......++.|++.||.|||+.+ ++|+||+|+
T Consensus 59 ~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~ 133 (263)
T cd06625 59 KNLQHERIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGA 133 (263)
T ss_pred HhCCCCCeeeeEEEEccCC--eEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 9999999999999998776 78999999987654 344556789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCccee-ccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++|+|||++........... .....|+..|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 134 nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--- 210 (263)
T cd06625 134 NILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF--- 210 (263)
T ss_pred HEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc---
Confidence 99999999999999999876543211111 1235678899999999998899999999 999999999999996432
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
....... ........ . .........+.+++..||+.+|++|||+.++++.
T Consensus 211 ~~~~~~~----~~~~~~~~-~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 211 EAMAAIF----KIATQPTN-P--------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred chHHHHH----HHhccCCC-C--------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111111 11111110 0 0111223347788999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=286.31 Aligned_cols=247 Identities=19% Similarity=0.310 Sum_probs=182.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|.+++.||+|+||.||+|+.. .+++.||||.+... +.........+.+|+.++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~------------------------~~~~~~~~~~~~~E~~il 55 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKS------------------------EMFKKDQLAHVKAERDVL 55 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHH------------------------HHHHhHHHHHHHHHHHHH
Confidence 47999999999999999999854 57999999998421 111123456788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ .+++++||++++++. +......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~l~hp~iv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~ 130 (377)
T cd05629 56 AESDSPWVVSLYYSFQDAQ--YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPD 130 (377)
T ss_pred HhCCCCCcceEEEEEEcCC--eeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH
Confidence 9999999999999998776 789999999887653 44455678999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCc-------------c--------------------------------eeccCccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHT-------------H--------------------------------ITTSNVVG 233 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~-------------~--------------------------------~~~~~~~g 233 (345)
|||++.++.++++|||++........ . ......+|
T Consensus 131 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (377)
T cd05629 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVG 210 (377)
T ss_pred HEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCC
Confidence 99999999999999999863211000 0 00012469
Q ss_pred CccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHH
Q 046907 234 TVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQM 312 (345)
Q Consensus 234 t~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (345)
|+.|+|||++.+..++.++||| +||++|||++|..||... ...+....+.... .... . .. .....
T Consensus 211 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~--~~~~--~----p~--~~~~s 276 (377)
T cd05629 211 TPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE----NSHETYRKIINWR--ETLY--F----PD--DIHLS 276 (377)
T ss_pred CccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCC----CHHHHHHHHHccC--CccC--C----CC--CCCCC
Confidence 9999999999998899999999 999999999999997432 2222222111110 0000 0 00 00112
Q ss_pred HHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 046907 313 LLVLKIACFCTLEDPNER---PNSKDVRRM 339 (345)
Q Consensus 313 ~~l~~li~~Cl~~dp~~R---pt~~~ll~~ 339 (345)
..+.+++..|++ +|.+| +|+.++++.
T Consensus 277 ~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 277 VEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred HHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 346778888987 66665 589888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=277.86 Aligned_cols=254 Identities=18% Similarity=0.243 Sum_probs=186.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|.+.+.||+|+||.||+|+.+ .++..||+|.+...... .....+.+|+.+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~E~~~ 57 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEE--------------------------GAPCTAIREVSL 57 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccC--------------------------CcchhHHHHHHH
Confidence 367999999999999999999864 57889999998643211 112345679999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++++||||+++++++..++ ..+++++++.+ +..++......++.|++.||.|||+.+ ++||||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp 132 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDK--SLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKP 132 (309)
T ss_pred HHhCCCCCcceEEEEEeeCC--eEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 99999999999999988776 68888998865 223566677789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++||| +|+++|+|++|..||...
T Consensus 133 ~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~-- 208 (309)
T cd07872 133 QNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS-- 208 (309)
T ss_pred HHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--
Confidence 999999999999999999876433221 1223567899999999865 4578899999 999999999999997532
Q ss_pred ccchhhHHHHHHHHhhhcCCCc---c--------cc-cccc----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKR---A--------ID-SKLV----GNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~---~--------~~-~~~~----~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+..+....+......+.... . .+ +... ....+.....+.+++.+||+.||.+|||+.++++
T Consensus 209 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 209 --TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred --ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 22222222222221111000 0 00 0000 0011122345678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=281.49 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=198.9
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...+.|++.+.||+|.||.||+|+.+ .+|+.+|+|.+....... ......+.+|+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~------------------------~~~~~~v~~Ev 86 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRG------------------------KEDREDVRREV 86 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccc------------------------cccHHHHHHHH
Confidence 35678999999999999999999965 579999999996432211 12456788999
Q ss_pred HHHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 125 NTVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 125 ~~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.+|+.+. |||||.+++++.+++ .+++++|++.||.+ ++..+...++.|++.++.|||+.+ ++|||+
T Consensus 87 ~il~~l~~hpniv~l~~~~e~~~--~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDl 161 (382)
T KOG0032|consen 87 AILQQLSGHPNIVQLKDAFEDPD--SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDL 161 (382)
T ss_pred HHHHhccCCCCEEEEEEEEEcCC--eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccC
Confidence 9999998 999999999999888 79999999998765 455566789999999999999999 999999
Q ss_pred CCCCeeecCC----CCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 196 NPVNVLLDDD----IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 196 k~~nil~~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||+|+|+... +.+|++|||++...... ......+||+.|+|||++.+.+|+..+||| +|+++|.|++|..||
T Consensus 162 KpEN~L~~~~~~~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 162 KPENLLLASKDEGSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPF 238 (382)
T ss_pred CHHHeeeccccCCCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCC
Confidence 9999999732 47999999999987652 234568999999999999999999999999 999999999999996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ........... ... ....+..+.....+.+++..++..||.+|+|+.++++
T Consensus 239 ~~~---~~~~~~~~i~~-~~~----------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 239 WGE---TEFEIFLAILR-GDF----------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred cCC---ChhHHHHHHHc-CCC----------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 432 22222221111 111 1122334455666888999999999999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=270.16 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=191.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+.++|++.+.||+|+||.||+|++... .+..+|+|.+..... .+....+..|
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--------------------------~~~~~~~~~e 55 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--------------------------EKQRRDFLSE 55 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--------------------------HHHHHHHHHH
Confidence 356899999999999999999986422 244799999854321 1224567889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.+++.++||||+++++++..++ .+++++++++++.+ +++.....++.|++.|+.+||+.+ ++|+
T Consensus 56 ~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~ 130 (267)
T cd05066 56 ASIMGQFDHPNIIHLEGVVTKSK--PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHR 130 (267)
T ss_pred HHHHHhCCCCCcceEEEEEecCC--ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeh
Confidence 99999999999999999987665 67889999987543 466667889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCccee-ccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
|+||+|++++.++.++++|||++........... .....++..|+|||.+.+..++.++|+| ||+++||+++ |..||
T Consensus 131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred hhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 9999999999999999999999987654322111 1222335679999999988899999999 9999999886 99996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
... ...+....+......+. .......+.+++.+||+.+|.+||++.++++.|+++
T Consensus 211 ~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 211 WEM----SNQDVIKAIEEGYRLPA-------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ccC----CHHHHHHHHhCCCcCCC-------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 432 22223333322211110 111223477899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=268.06 Aligned_cols=241 Identities=18% Similarity=0.273 Sum_probs=182.5
Q ss_pred ccccCcceeeEEEEecCC-CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 55 KIGSGGCGEVYKAELPGQ-NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
.||+|+||.||+|.++.. ++..||+|.+..... ......+.+|+.++++++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~ 55 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--------------------------KSVRDEMMREAEIMHQLDNP 55 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--------------------------hHHHHHHHHHHHHHHhcCCC
Confidence 489999999999987533 466799999854311 12345688999999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
||+++++++..+ ..++++++++++.+ +++..+.+++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 56 ~ii~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~ 129 (257)
T cd05115 56 YIVRMIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLV 129 (257)
T ss_pred CeEEEEEEEcCC---CeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEc
Confidence 999999987543 47888898877543 456667889999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcce-eccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchh
Q 046907 204 DDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEM 280 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~ 280 (345)
.++.++++|||++.......... ......++..|+|||.+.+..++.++||| ||+++||+++ |..||... ...
T Consensus 130 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~~ 205 (257)
T cd05115 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM----KGP 205 (257)
T ss_pred CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC----CHH
Confidence 99999999999987554332211 11222335789999999888899999999 9999999996 99996542 222
Q ss_pred hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.....+.... .+ ..++.+..++.+++..||+.||++||++.+|.+.|+.++
T Consensus 206 ~~~~~~~~~~---~~----------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 206 EVMSFIEQGK---RL----------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHCCC---CC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 3322222211 11 011122345778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=283.20 Aligned_cols=182 Identities=23% Similarity=0.256 Sum_probs=151.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|.+++.||+|+||.||+|+.+ .++..||+|.... .....|+.
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~---------------------------------~~~~~E~~ 109 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQK---------------------------------GTTLIEAM 109 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCc---------------------------------cccHHHHH
Confidence 4568999999999999999999965 4688999997532 12245899
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++++||||+++++++...+ ..+++++++.+ ...+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlk 184 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGA--ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVK 184 (357)
T ss_pred HHHhCCCCCCcChhheEEeCC--eeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 999999999999999988776 56677776643 234677788899999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|+|||++.++.++|+|||++....... ......||..|+|||++.+..++.++||| +|+++|||+++..|
T Consensus 185 p~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 185 TENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred HHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 999999999999999999987432211 12345789999999999998999999999 99999999986544
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=281.20 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=180.6
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+++ .+++.||+|.+...... .......+..|..++..+ +|
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~------------------------~~~~~~~~~~e~~il~~~~~h 55 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVN------------------------DDEDIDWVQTEKHVFETASNH 55 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hhhHHHHHHHHHHHHHhccCC
Confidence 46899999999999864 57899999999532110 122355677899999888 79
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++..++ .++++++|++++.+ ++...+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 p~Iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~ 130 (329)
T cd05588 56 PFLVGLHSCFQTES--RLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLD 130 (329)
T ss_pred CCCCceEEEEEcCC--EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC
Confidence 99999999988776 78999999988654 556667789999999999999999 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc-chhh
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT-NEMS 281 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~-~~~~ 281 (345)
.++.+||+|||++....... .......||..|+|||++.+..++.++|+| +|+++|+|++|..||....... ....
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05588 131 AEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208 (329)
T ss_pred CCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccccc
Confidence 99999999999986432211 122346789999999999998899999999 9999999999999986322111 1111
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC------HHHHH
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN------SKDVR 337 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt------~~~ll 337 (345)
...++.......... .+.. ....+.+++.+||+.||.+||+ +.+++
T Consensus 209 ~~~~~~~~~~~~~~~------~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 209 TEDYLFQVILEKQIR------IPRS----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred chHHHHHHHHcCCCC------CCCC----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 112222222111110 1111 1234678889999999999997 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=276.96 Aligned_cols=234 Identities=26% Similarity=0.377 Sum_probs=175.9
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+++ .+++.||+|.+..... ........+..|..++... +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~~e~~~l~~~~~h 55 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVV------------------------LEDDDVECTMVERRVLALAWEH 55 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hhhhhHHHHHHHHHHHHhccCC
Confidence 46999999999999865 5788999999853110 0012244455666677654 89
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++..++ .++++++|+.++.+ ++......++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 p~i~~~~~~~~~~~--~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~ 130 (316)
T cd05592 56 PFLTHLFCTFQTKE--HLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLD 130 (316)
T ss_pred CCccceeeEEEcCC--EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEEC
Confidence 99999999988766 78999999988754 445566779999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.+||+|||++....... .......||..|+|||.+.+..++.++||| +|+++|||++|..||... +....
T Consensus 131 ~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~----~~~~~ 204 (316)
T cd05592 131 KDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----DEDEL 204 (316)
T ss_pred CCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC----CHHHH
Confidence 99999999999997643222 122346789999999999998899999999 999999999999997532 22223
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK-DVR 337 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~-~ll 337 (345)
...+.. ..+. ++ . .....+.+++..||+.||.+||++. +++
T Consensus 205 ~~~i~~----~~~~--~~-----~---~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 205 FDSILN----DRPH--FP-----R---WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHc----CCCC--CC-----C---CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222211 1110 00 1 1123467888899999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=274.65 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=184.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCC--ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNG--RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
++|++.+.||+|+||.||+|.... ++ ..+++|.++.... ....+.+.+|+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~~~~--------------------------~~~~~~~~~E~~ 54 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFAS--------------------------ENDHRDFAGELE 54 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEccccCC--------------------------HHHHHHHHHHHH
Confidence 689999999999999999998642 33 3478888753211 122456788999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHHHHHHHHHH
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRIALGLACGL 179 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i~~~i~~~l 179 (345)
++.++ +||||+++++++...+ .+++++++++++++ +++.....++.|++.||
T Consensus 55 ~l~~l~~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 132 (297)
T cd05089 55 VLCKLGHHPNIINLLGACENRG--YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGM 132 (297)
T ss_pred HHHhhcCCCchhheEEEEccCC--cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHH
Confidence 99999 7999999999887765 57888888876543 44556678999999999
Q ss_pred HHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHH
Q 046907 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258 (345)
Q Consensus 180 ~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~ 258 (345)
.|||+.+ ++||||||+||+++.++.+||+|||++...... ........+..|+|||.+.+..++.++||| ||+
T Consensus 133 ~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~ 206 (297)
T cd05089 133 QYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGV 206 (297)
T ss_pred HHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHH
Confidence 9999998 999999999999999999999999998643211 111112335679999999988899999999 999
Q ss_pred HHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 259 LLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 259 vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
++|||++ |..||... ...+....+.... .+. ........+.+++..||+.+|.+|||+++++
T Consensus 207 il~el~t~g~~pf~~~----~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 269 (297)
T cd05089 207 LLWEIVSLGGTPYCGM----TCAELYEKLPQGY---RME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQIS 269 (297)
T ss_pred HHHHHHcCCCCCCCCC----CHHHHHHHHhcCC---CCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 9999997 99997432 2222222221111 000 0111223477899999999999999999999
Q ss_pred HHHhhhh
Q 046907 338 RMLSQIQ 344 (345)
Q Consensus 338 ~~L~~l~ 344 (345)
+.|+.+.
T Consensus 270 ~~l~~~~ 276 (297)
T cd05089 270 VQLSRML 276 (297)
T ss_pred HHHHHHH
Confidence 9998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.08 Aligned_cols=254 Identities=20% Similarity=0.256 Sum_probs=181.9
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|+.+ .+++.||+|.+........ ....+.+|+.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~-------------------------~~~~~~~e~~~l~ 54 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDG-------------------------LPLSTVREVALLK 54 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCC-------------------------CchHHHHHHHHHH
Confidence 5889999999999999999864 5799999999864321110 0122334555555
Q ss_pred h---ccCCCccceeEEEecC---CcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 129 Q---IRHRNLHPLLAHVTRP---DCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 129 ~---l~hpniv~l~~~~~~~---~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
. ++||||+++++++... ....++++++++.+. ..++...+..++.|++.||.|||+.+ ++|
T Consensus 55 ~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH 131 (288)
T cd07863 55 RLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVH 131 (288)
T ss_pred HhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4 4799999999987643 234578888888652 22567777889999999999999999 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|||||+||+++.++.+||+|||++....... ......||..|+|||.+.+..++.++||| +|+++|+|++|.+||.
T Consensus 132 ~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 132 RDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred CCCCHHHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 9999999999999999999999987654321 12335688999999999988899999999 9999999999999974
Q ss_pred ccccccchhhHHHHHHHHhhhcCCC----------cccccc---ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPK----------RAIDSK---LVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. ........+......+... ....+. ......++....+.+++.+||+.||++|||+.++++
T Consensus 209 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 209 GN----SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CC----CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 32 2222222222211111000 000000 000111223445788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=273.68 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=187.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCC----CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ----NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|++.+.||+|+||.||+|.+... ++..||+|.+...... .....+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--------------------------~~~~~~~ 57 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--------------------------QDESDFL 57 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--------------------------HHHHHHH
Confidence 456899999999999999999997531 4678999987532211 1235578
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------------CCHHHHHHHHHHHHHHHHHHhhc
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------------LDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------------l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
.|+.+++.++||||+++++++...+ ..+++++++.++.+ +++..+..++.|++.||.|||+.
T Consensus 58 ~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 135 (277)
T cd05036 58 MEALIMSKFNHQNIVRLIGVSFERL--PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135 (277)
T ss_pred HHHHHHHhCCCCCEeeEEEEEccCC--CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 8999999999999999999887766 46788888876533 45566678999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCC---CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHH
Q 046907 186 HCPRIIHRDLNPVNVLLDDDI---EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLA 261 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~ 261 (345)
+ ++|+||||+||+++.++ .+|++|||+++...............++..|+|||++.+..++.++||| ||+++|
T Consensus 136 ~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 212 (277)
T cd05036 136 H---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212 (277)
T ss_pred C---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHH
Confidence 8 99999999999998654 6999999999876433221122223445689999999988899999999 999999
Q ss_pred HHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 262 GLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 262 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
||++ |..||... ........+.... .+. .+......+.+++.+||+.+|++|||+.+|++.|
T Consensus 213 el~~~g~~pf~~~----~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 213 EIFSLGYMPYPGR----TNQEVMEFVTGGG---RLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred HHHcCCCCCCCCC----CHHHHHHHHHcCC---cCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 9997 99996532 2222322222111 110 0111224578899999999999999999999988
Q ss_pred hh
Q 046907 341 SQ 342 (345)
Q Consensus 341 ~~ 342 (345)
.+
T Consensus 276 ~~ 277 (277)
T cd05036 276 QY 277 (277)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=272.47 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=193.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+++.||+|.-|.||+++.++ ++..+|+|++...... ..++..+...|-+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~------------------------~rkKl~Ra~tE~e 129 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLA------------------------SRKKLKRAQTERE 129 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHHh------------------------hhhHHHHHHHHHH
Confidence 34578899999999999999999764 5699999999543222 2456788889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC-----------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-----------DWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l-----------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
||+.++||.++.+|+.+.++. +++++||||+||++. +...+.-++..++-||+|||-.| ||.||
T Consensus 130 IL~~lDHPFlPTLYa~fet~~--~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRD 204 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDK--YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRD 204 (459)
T ss_pred HHHhcCCCccchhhheeeccc--eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeecc
Confidence 999999999999999999887 899999999998763 44445568999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCC--------------------------------C-c-----------------
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDA--------------------------------H-T----------------- 224 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~--------------------------------~-~----------------- 224 (345)
|||+|||+.++|.+-++||.++...... . .
T Consensus 205 LKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 205 LKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred CCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 9999999999999999999877643210 0 0
Q ss_pred ----ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccc
Q 046907 225 ----HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAI 299 (345)
Q Consensus 225 ----~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (345)
....+.++||-.|.|||++.|...+.+.|+| ||+++|||+.|..||.+. .+..-+.+.+.+....+
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~---~~~~Tl~NIv~~~l~Fp------ 355 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGS---NNKETLRNIVGQPLKFP------ 355 (459)
T ss_pred cCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCC---CchhhHHHHhcCCCcCC------
Confidence 0112457899999999999999999999999 999999999999997543 23333333332222111
Q ss_pred cccccCCCcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 046907 300 DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN----SKDVRR 338 (345)
Q Consensus 300 ~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt----~~~ll~ 338 (345)
..+....++.+||...|..||.+|.. +.||.+
T Consensus 356 -------~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 356 -------EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred -------CCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 11133445789999999999999997 777654
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=269.18 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=187.5
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|.+...||+|+||.||+|.+. .+..+|+|.+..... ....+.+|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~~----------------------------~~~~~~~E 51 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGTM----------------------------MPEAFLQE 51 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCCc----------------------------cHHHHHHH
Confidence 345568999999999999999999864 445699998754221 13457789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+.++++++|||++++++++... ..+++++++.++++ +++..+..++.|++.||.|||+.+ ++|
T Consensus 52 ~~~l~~l~h~~i~~~~~~~~~~---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H 125 (260)
T cd05069 52 AQIMKKLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIH 125 (260)
T ss_pred HHHHHhCCCCCeeeEEEEEcCC---CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eee
Confidence 9999999999999999877532 46788898887654 455566789999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
+||+|+||+++.++.++|+|||++......... ......++..|+|||...+...+.++|+| +|+++|+|++ |..||
T Consensus 126 ~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 204 (260)
T cd05069 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred cccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999765432211 11223456789999999888899999999 9999999999 89996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
... ........+.... .+ .........+.+++.+||+.||++||++.++++.|++
T Consensus 205 ~~~----~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 205 PGM----VNREVLEQVERGY---RM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCC----CHHHHHHHHHcCC---CC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 532 2222222222211 11 0111223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=288.04 Aligned_cols=195 Identities=25% Similarity=0.406 Sum_probs=159.6
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.|.+++.||+|+||.||+|+.. .+++.||+|.+.... .........+.+|+.++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~------------------------~~~~~~~~~~~~E~~il 55 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKD------------------------VLLRNQVAHVKAERDIL 55 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHH------------------------hhhHHHHHHHHHHHHHH
Confidence 36899999999999999999854 578999999984211 11123466788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+..++ .+++++||++++.+. +......++.|++.||.|||+.+ |+||||||+
T Consensus 56 ~~~~h~~iv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~ 130 (382)
T cd05625 56 AEADNEWVVRLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPD 130 (382)
T ss_pred HhCCCCcCCeEEEEEEeCC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 9999999999999998776 789999999887653 44455678999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCC---------------------------------------------cceeccCccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAH---------------------------------------------THITTSNVVG 233 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~---------------------------------------------~~~~~~~~~g 233 (345)
|||++.++.+||+|||++....... ........+|
T Consensus 131 NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 210 (382)
T cd05625 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVG 210 (382)
T ss_pred HEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc
Confidence 9999999999999999975321100 0000123579
Q ss_pred CccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 234 TVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 234 t~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+.|+|||++.+..++.++||| +||++|||++|..||..
T Consensus 211 t~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 211 TPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred CcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 9999999999998999999999 99999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.34 Aligned_cols=235 Identities=20% Similarity=0.301 Sum_probs=179.9
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
+.||+|+||.||+++.+ .+|..||+|.+...... .......+..|+.+++.++||
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~------------------------~~~~~~~~~~e~~~l~~~~hp 55 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIV------------------------AKDEVAHTLTENRVLQNSRHP 55 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hhhHHHHHHHHHHHHHhCCCC
Confidence 46899999999999854 57999999998531100 022345667899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeec
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHM-HHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~-~~~~~iiH~dlk~~nil~~ 203 (345)
||+++++.+..++ .+++++||+.++.+ +++.....++.|++.||.|||+ .+ ++||||||+|||++
T Consensus 56 ~i~~~~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~ 130 (325)
T cd05594 56 FLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLD 130 (325)
T ss_pred CCCceEEEEEcCC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEEC
Confidence 9999999888776 78999999988644 5566677899999999999997 67 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.+||+|||++........ ......||..|+|||++.+..++.++||| +|+++|+|++|..||.. ......
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~----~~~~~~ 204 (325)
T cd05594 131 KDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKL 204 (325)
T ss_pred CCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC----CCHHHH
Confidence 999999999999875322211 22345799999999999988899999999 99999999999999743 222222
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
...+.. .... .... ....+.+++.+||+.||++|+ ++.++++
T Consensus 205 ~~~i~~---~~~~-------~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 205 FELILM---EEIR-------FPRT----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHhc---CCCC-------CCCC----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 222211 1100 0001 122467888999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.62 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=188.1
Q ss_pred cccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 50 LASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
|.+.+.||+|+||.||+|.+.. .++..||||.+.....+ ....+.+.+|+.++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-------------------------~~~~~~~~~E~~~l 55 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-------------------------SSDIEEFLREAACM 55 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-------------------------hHHHHHHHHHHHHH
Confidence 6778899999999999998642 35789999998653322 22356678899999
Q ss_pred hhccCCCccceeEEEecCCc----ceeeeeccccCCCCC---------------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGRRE---------------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~~~---------------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
++++||||+++++++...+. ...++++++..++.+ ++......++.|++.||.|||+.+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-- 133 (273)
T cd05074 56 KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN-- 133 (273)
T ss_pred hcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999998765432 123566666655432 455667889999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++|+||||+||+++.++.++++|||+++...............++..|++||.+.+..++.++||| +|+++|+|++ |
T Consensus 134 -i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g 212 (273)
T cd05074 134 -FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRG 212 (273)
T ss_pred -EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCC
Confidence 999999999999999999999999998865433222222334556789999999888899999999 9999999999 8
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||... ...+....+.... ... ..+.....+.+++.+||+.+|++||++.++++.|+++.
T Consensus 213 ~~p~~~~----~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 213 QTPYAGV----ENSEIYNYLIKGN---RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred CCCCCCC----CHHHHHHHHHcCC---cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 8886432 2223333222111 110 01122346889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=279.27 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=193.6
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecCC------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPGQ------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
..|.....+|++++.||+|+||.||+|++.+. .+..||+|.+..... .
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~ 58 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--------------------------D 58 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--------------------------H
Confidence 35666777899999999999999999975321 234689998753211 1
Q ss_pred HHHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHH
Q 046907 115 KKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLAR 168 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~ 168 (345)
.....+.+|+.+++++ +||||+++++++..++ .++++++|++++.+ +++...
T Consensus 59 ~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (334)
T cd05100 59 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136 (334)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC--ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHH
Confidence 2356788899999999 8999999999988765 57888888877643 344555
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc
Q 046907 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL 248 (345)
Q Consensus 169 ~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~ 248 (345)
..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..+
T Consensus 137 ~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (334)
T cd05100 137 VSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213 (334)
T ss_pred HHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc
Confidence 678999999999999998 99999999999999999999999999986644322222222344567999999998889
Q ss_pred Cccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCC
Q 046907 249 TEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 249 ~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
+.++||| ||+++|||++ |..||.. .........+... .... ........+.+++..||+.+
T Consensus 214 ~~~~Di~slG~il~el~~~g~~p~~~----~~~~~~~~~~~~~---~~~~----------~~~~~~~~l~~li~~cl~~~ 276 (334)
T cd05100 214 THQSDVWSFGVLLWEIFTLGGSPYPG----IPVEELFKLLKEG---HRMD----------KPANCTHELYMIMRECWHAV 276 (334)
T ss_pred CchhhhHHHHHHHHHHHhcCCCCCCC----CCHHHHHHHHHcC---CCCC----------CCCCCCHHHHHHHHHHcccC
Confidence 9999999 9999999998 8888643 2222222222211 1110 11122345788999999999
Q ss_pred CCCCCCHHHHHHHHhhhh
Q 046907 327 PNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 327 p~~Rpt~~~ll~~L~~l~ 344 (345)
|++|||+.++++.|+++.
T Consensus 277 p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 277 PSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred hhhCcCHHHHHHHHHHHh
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.58 Aligned_cols=258 Identities=18% Similarity=0.274 Sum_probs=193.2
Q ss_pred cCCcccccccccCcceeeEEEEec---CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELP---GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..-|++++.||+|+||.||+|++. ..++..||+|.+..... ......+.+|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--------------------------~~~~~~~~~e 56 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------------------------GNHIADLKKE 56 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--------------------------HHHHHHHHHH
Confidence 346799999999999999999853 34688999999864321 1224568899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.+++.++|||++++++++...+....++++|+++++.+ +++..+..++.|++.||.|||+.+ ++||
T Consensus 57 ~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~ 133 (284)
T cd05079 57 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHR 133 (284)
T ss_pred HHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 999999999999999999887755678899999987653 456667789999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||||+||+++.++.++++|||++......... .......++..|+|||.+.+..++.++||| +|+++|||+++..|+.
T Consensus 134 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 134 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 99999999999999999999999866433221 112335567789999999888899999999 9999999999776632
Q ss_pred cccc--------ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 272 KFFQ--------HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 272 ~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.... ..........+.... ..... +........+.+++.+||+.||++|||+.++++.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 214 SPMTLFLKMIGPTHGQMTVTRLVRVLE-EGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccchhhhhcccccccccHHHHHHHHH-cCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1110 001111111111111 11000 01112334688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=266.59 Aligned_cols=243 Identities=20% Similarity=0.307 Sum_probs=185.5
Q ss_pred cccccCcceeeEEEEecCCC--CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 54 EKIGSGGCGEVYKAELPGQN--GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
++||+|+||.||+|.+...+ +..+|+|.+...... .....+.+|+.+++.++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--------------------------~~~~~~~~e~~~l~~l~ 54 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--------------------------AGKKEFLREASVMAQLD 54 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--------------------------HHHHHHHHHHHHHHhcC
Confidence 47999999999999875443 378999998643211 12456788999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
||||+++++++..+ ..+++++++.++.+ +++..+..++.|++.|+.|||+.+ ++|+||||+|+++
T Consensus 55 h~~iv~~~~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili 128 (257)
T cd05060 55 HPCIVRLIGVCKGE---PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLL 128 (257)
T ss_pred CCCeeeEEEEEcCC---ceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEE
Confidence 99999999987643 36788888876543 456667889999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceecCCCCcce-eccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccch
Q 046907 203 DDDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNE 279 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~ 279 (345)
+.++.++++|||++.......... ......++..|+|||.+.+..++.++|+| ||+++|+|++ |..||... ..
T Consensus 129 ~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~----~~ 204 (257)
T cd05060 129 VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM----KG 204 (257)
T ss_pred cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC----CH
Confidence 999999999999998664332211 11222345679999999988899999999 9999999998 99996432 33
Q ss_pred hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhhC
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~~ 345 (345)
......+........ .......+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 205 ~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 257 (257)
T cd05060 205 AEVIAMLESGERLPR-------------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257 (257)
T ss_pred HHHHHHHHcCCcCCC-------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhccC
Confidence 334333332211111 11122357889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=277.68 Aligned_cols=235 Identities=24% Similarity=0.329 Sum_probs=179.8
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+.. .++..||+|.+..... ........+..|..++..+ +|
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~e~~il~~~~~h 55 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVI------------------------LQDDDVDCTMTEKRILALAAKH 55 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHh------------------------hhhhHHHHHHHHHHHHHhccCC
Confidence 46999999999999864 5788999999853110 0122355667788888866 89
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++..++ .+++++||+.++.+ +++.....++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 p~i~~~~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~ 130 (321)
T cd05591 56 PFLTALHCCFQTKD--RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLD 130 (321)
T ss_pred CCccceeeEEEcCC--eEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEEC
Confidence 99999999998776 68999999988654 455566789999999999999999 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.++|+|||++........ ......||+.|+|||++.+..++.++||| +|+++|+|++|..||.. .+....
T Consensus 131 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~----~~~~~~ 204 (321)
T cd05591 131 AEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA----DNEDDL 204 (321)
T ss_pred CCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC----CCHHHH
Confidence 999999999999875432221 22346789999999999998999999999 99999999999999753 233333
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-------NSKDVRR 338 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-------t~~~ll~ 338 (345)
...+.. ..... + .. ....+.+++..||+.||++|| ++.++++
T Consensus 205 ~~~i~~---~~~~~---p-----~~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 205 FESILH---DDVLY---P-----VW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHc---CCCCC---C-----CC---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 322221 11110 0 01 123467888999999999999 6777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=268.32 Aligned_cols=245 Identities=29% Similarity=0.474 Sum_probs=187.1
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|++++.||+|+||.||+++.. .++..+|+|.+....... .......+|+.+++.
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~-------------------------~~~~~~~~e~~~~~~ 54 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEE-------------------------EEREENIREIKILRR 54 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHH-------------------------HHHHHHHHHHHHHHH
T ss_pred CEEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccc-------------------------cccchhhhhhhcccc
Confidence 788999999999999999964 578899999997654332 112233459999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
++||||+++++++...+ .++++++++.++++ ++...+..++.|++.||.+||+.+ ++|+||||+||
T Consensus 55 l~~~~i~~~~~~~~~~~--~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NI 129 (260)
T PF00069_consen 55 LRHPNIVQILDVFQDDN--YLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENI 129 (260)
T ss_dssp HTBTTBCHEEEEEEESS--EEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGE
T ss_pred ccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccc
Confidence 99999999999998865 67799999988543 556667789999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-ccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
+++.++.++|+|||.+...... ........++..|+|||.+. +...+.++|+| +|+++++|++|..||... .
T Consensus 130 l~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~----~ 203 (260)
T PF00069_consen 130 LLDENGEVKLIDFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES----N 203 (260)
T ss_dssp EESTTSEEEESSGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS----S
T ss_pred cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccc----c
Confidence 9999999999999998764221 12344567899999999998 77889999999 999999999999997543 1
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+....+............. ........+.+++..||+.||++|||+.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 204 SDDQLEIIEKILKRPLPSSSQ-------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHHHHTHHHHHTT-------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhhhhhhhhccccccccccc-------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122222222221111000000 00000145889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=276.17 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=186.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCc--eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGR--MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|++.+.||+|+||.||+|+++ .++. .+|+|.+..... ......+.+|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~-~~~~~~~~~ik~~~~~~~--------------------------~~~~~~~~~E 57 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYAS--------------------------KDDHRDFAGE 57 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEc-cCCceeeEEEEEecccCC--------------------------HHHHHHHHHH
Confidence 4568999999999999999999875 3454 457777643211 1235667789
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHHHHHHHH
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRIALGLAC 177 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i~~~i~~ 177 (345)
+.++.++ +||||+++++++...+ .++++++|++++++ ++......++.|++.
T Consensus 58 i~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 135 (303)
T cd05088 58 LEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 135 (303)
T ss_pred HHHHHHhcCCCCcceEEEEECCCC--CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHH
Confidence 9999999 8999999999987766 68888899876543 455567889999999
Q ss_pred HHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-H
Q 046907 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256 (345)
Q Consensus 178 ~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-l 256 (345)
|+.|||+.+ ++||||||+|||++.++.++|+|||++...... .......++..|+|||.+.+..++.++||| |
T Consensus 136 al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 209 (303)
T cd05088 136 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209 (303)
T ss_pred HHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhh
Confidence 999999998 999999999999999999999999998642211 111122346679999999888889999999 9
Q ss_pred HHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 257 GALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 257 G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
|+++|||+| |..||... ...+....+.... .+. ........+.+++.+||+.+|++||++.+
T Consensus 210 G~il~ellt~g~~p~~~~----~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 210 GVLLWEIVSLGGTPYCGM----TCAELYEKLPQGY---RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred hhHHHHHHhcCCCCcccC----ChHHHHHHHhcCC---cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 999999998 99997432 2222222221110 000 00112234788999999999999999999
Q ss_pred HHHHHhhhh
Q 046907 336 VRRMLSQIQ 344 (345)
Q Consensus 336 ll~~L~~l~ 344 (345)
+++.|+++.
T Consensus 273 il~~l~~~~ 281 (303)
T cd05088 273 ILVSLNRML 281 (303)
T ss_pred HHHHHHHHH
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=274.05 Aligned_cols=249 Identities=20% Similarity=0.313 Sum_probs=188.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCc----eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGR----MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|+..+.||+|+||.||+|++. .+|. .+|+|.+..... ......+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~ 57 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWV-PEGETVKIPVAIKILNETTG--------------------------PKANVEFM 57 (303)
T ss_pred chhhceeccccccCCCccEEEEEEe-cCCCcceeeEEEEeccccCC--------------------------HHHHHHHH
Confidence 4568899999999999999999865 2343 578888754321 11234577
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..+. .++++++++++.+ +++.....++.|++.||.|||+.+ ++
T Consensus 58 ~e~~~~~~l~h~niv~~~~~~~~~~---~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iv 131 (303)
T cd05110 58 DEALIMASMDHPHLVRLLGVCLSPT---IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LV 131 (303)
T ss_pred HHHHHHHhCCCCCcccEEEEEcCCC---ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---ee
Confidence 8999999999999999999887653 4567788877643 445566789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||| ||+++||+++ |..|
T Consensus 132 H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999866433222222334457789999999988899999999 9999999997 8899
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ........+......+. .+.+...+.+++..||..+|++||+++++++.|+++.
T Consensus 212 ~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 212 YDGI----PTREIPDLLEKGERLPQ-------------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCC----CHHHHHHHHHCCCCCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 6432 22233333322111110 0112235778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.17 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=188.6
Q ss_pred cCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.++|++.+.||+|+||.||+|++... ++..||+|.+..... ......+..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~e~ 56 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--------------------------EKQRRDFLSEA 56 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--------------------------HHHHHHHHHHH
Confidence 45789999999999999999987532 234799999854211 22356788999
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.+++.++||||+++++++..++ .++++++++.++.+ +++.....++.|++.||.|||+.+ ++|+|
T Consensus 57 ~~l~~l~h~ni~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~d 131 (269)
T cd05065 57 SIMGQFDHPNIIHLEGVVTKSR--PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRD 131 (269)
T ss_pred HHHHhCCCcCcceEEEEECCCC--ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 9999999999999999887665 57888898876533 566677889999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccC-c--ccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSN-V--VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~--~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
+||+|++++.++.++++|||++.............. . ..+..|+|||.+.+..++.++||| +|+++||+++ |..|
T Consensus 132 l~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p 211 (269)
T cd05065 132 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211 (269)
T ss_pred cChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCC
Confidence 999999999999999999999876543221111111 1 124579999999988899999999 9999999886 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
|... ...+....+......+. .++....+.+++..||+.+|++||++.+|++.|+++
T Consensus 212 ~~~~----~~~~~~~~i~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 212 YWDM----SNQDVINAIEQDYRLPP-------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCC----CHHHHHHHHHcCCcCCC-------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 6432 22333333322111110 112233477889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=282.22 Aligned_cols=251 Identities=18% Similarity=0.246 Sum_probs=185.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|++. .+++.+|+|.+.... .........+.+|
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~------------------------~~~~~~~~~~~~e 93 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFE------------------------MIKRSDSAFFWEE 93 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHH------------------------hhhhhhHHHHHHH
Confidence 335679999999999999999999964 578999999984210 0112234557789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC--------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL--------DWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l--------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+.+++.++||||+++++.+..++ .+++++||++++.+. +......++.|++.||.|||+.+ ++||||
T Consensus 94 ~~i~~~~~hp~iv~~~~~~~~~~--~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDL 168 (370)
T cd05621 94 RDIMAFANSPWVVQLFCAFQDDK--YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDV 168 (370)
T ss_pred HHHHHhCCCCCEeeEEEEEEcCC--EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 99999999999999999988766 789999999987653 44556679999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc----cCccchhh-HHHHHHHHHhCCCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT----LTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~----~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||+|||++.++.+||+|||++........ .......||+.|+|||++.+.. ++.++|+| +|+++|||++|..||
T Consensus 169 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 169 KPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred CHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 99999999999999999999987643322 1224567999999999997643 67899999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE--RPNSKDVRRM 339 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--Rpt~~~ll~~ 339 (345)
... +.......+......... . ........+.+++.+|++.++.. |+|+.++++.
T Consensus 248 ~~~----~~~~~~~~i~~~~~~~~~--------p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 248 YAD----SLVGTYSKIMDHKNSLNF--------P--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCC----CHHHHHHHHHhCCcccCC--------C--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 432 222222211111100000 0 00111234667778888755543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=281.44 Aligned_cols=245 Identities=19% Similarity=0.235 Sum_probs=184.8
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+.. .+|+.||+|.+..... ........+..|+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~e~~i~ 55 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVL------------------------LAQETVSFFEEERDIL 55 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hhhhHHHHHHHHHHHH
Confidence 47999999999999999999864 5789999999853211 0123356677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+.++||||+++++.+...+ .++++++|++++.+ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp 130 (330)
T cd05601 56 SISNSPWIPQLQYAFQDKD--NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKP 130 (330)
T ss_pred HhCCCCCCcceeeEEecCC--eEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCch
Confidence 9999999999999887765 78999999988654 444555678999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc------ccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ------MLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~------~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
+||+++.++.+||+|||++......... ......||+.|+|||++. +..++.++||| +|+++|||++|..||
T Consensus 131 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf 209 (330)
T cd05601 131 ENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209 (330)
T ss_pred HheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCC
Confidence 9999999999999999999876543322 223357899999999986 44577899999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ........+... ...... + ..+.....+.+++..||+ +|.+|||+.++++
T Consensus 210 ~~~----~~~~~~~~i~~~---~~~~~~-~------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 210 HEG----TSAKTYNNIMNF---QRFLKF-P------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCC----CHHHHHHHHHcC---CCccCC-C------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 432 111111111111 110000 0 001122346778888997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.84 Aligned_cols=238 Identities=23% Similarity=0.306 Sum_probs=177.4
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+.+ .++..||+|.+....... ......+..|+.++..+ +|
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~------------------------~~~~~~~~~E~~~l~~~~~h 55 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVND------------------------DEDIDWVQTEKHVFEQASNH 55 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcc------------------------hhHHHHHHHHHHHHHhcCCC
Confidence 46999999999999864 578999999996421110 22345677888888776 89
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++..++ .+++++||+.++.+ ++......++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 p~iv~~~~~~~~~~--~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~ 130 (329)
T cd05618 56 PFLVGLHSCFQTES--RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLD 130 (329)
T ss_pred CcCCceeeEEEeCC--EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEC
Confidence 99999999988776 78999999988654 455566789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc-hhh
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN-EMS 281 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~-~~~ 281 (345)
.++.+||+|||++........ ......||..|+|||++.+..++.++|+| +|+++|+|++|..||........ ...
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05618 131 SEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208 (329)
T ss_pred CCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc
Confidence 999999999999875322111 22346789999999999998999999999 99999999999999853221111 111
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
...++.......... . +......+.+++..||+.||++||++
T Consensus 209 ~~~~~~~~i~~~~~~------~----p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 209 TEDYLFQVILEKQIR------I----PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cHHHHHHHHhcCCCC------C----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 112222211111110 0 11122346788899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=277.54 Aligned_cols=235 Identities=23% Similarity=0.270 Sum_probs=179.4
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++++.||+|+||.||+|+.+ .+++.||+|.+..... ........+..|..++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~------------------------~~~~~~~~~~~e~~~l~ 55 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVI------------------------IQDDDVECTMVEKRVLA 55 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hhhhHHHHHHHHHHHHH
Confidence 5889999999999999999864 5688999999853110 01233566778999999
Q ss_pred hccCC-CccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIRHR-NLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~hp-niv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
.++|+ +|+.+++.+...+ .+++++||+.++++ +++.....++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~ 130 (324)
T cd05587 56 LPGKPPFLTQLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLD 130 (324)
T ss_pred hcCCCCceeeeEEEEEcCC--EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHH
Confidence 99665 5788888887766 68999999988765 455666789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.++|+|||++........ ......||..|+|||++.+..++.++||| +|+++|+|++|..||...
T Consensus 131 Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---- 204 (324)
T cd05587 131 NVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---- 204 (324)
T ss_pred HeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC----
Confidence 99999999999999999865322111 12345789999999999998999999999 999999999999997532
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
........+.... .. . .. .....+.+++..||+.||.+|++.
T Consensus 205 ~~~~~~~~i~~~~----~~--~----~~----~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 205 DEDELFQSIMEHN----VS--Y----PK----SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CHHHHHHHHHcCC----CC--C----CC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2222222222111 00 0 00 112346788889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=266.26 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=188.4
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+.+.||+|++|.||+|++. .+++.|++|.+...... ......+.+|+.+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMN-------------------------RREREEAIDEARVLA 54 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCC-------------------------HHHHHHHHHHHHHHH
Confidence 5888999999999999999864 57899999998532211 233567888999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++.+..++ ..+++++++.++.+ ++.....+++.|++.||.|||+.+ ++|+|++|
T Consensus 55 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~ 129 (256)
T cd08529 55 KLDSSYIIRYYESFLDKG--KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKS 129 (256)
T ss_pred hcCCCCeehheeeeccCC--EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCc
Confidence 999999999999988765 68899999887543 445556689999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++........ ......|+..|+|||+..+..++.++|+| ||+++|+|++|..||...
T Consensus 130 ~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--- 204 (256)
T cd08529 130 LNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN--- 204 (256)
T ss_pred ceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC---
Confidence 999999999999999999886654322 12335688999999999988899999999 999999999999996432
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
+.......+.. ...+ .........+.+++.+||+.+|++||++.++++.
T Consensus 205 -~~~~~~~~~~~---~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 205 -NQGALILKIIR---GVFP----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CHHHHHHHHHc---CCCC----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22222222211 1110 0111233458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=288.77 Aligned_cols=246 Identities=22% Similarity=0.363 Sum_probs=190.8
Q ss_pred cCCc-ccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGL-ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 47 ~~~~-~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.++| .+..+||+|+|-+||+|.. ..+|..||=-.++ +..-....+..++|..|+.
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~D-e~~giEVAWnqvk-----------------------~~d~~q~~~~leR~~~Ev~ 93 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFD-EEEGIEVAWNQVK-----------------------IRDVTQSPEELERLYSEVH 93 (632)
T ss_pred CCceeehhhhcccccceeeeeccc-cccchhhHHHHHh-----------------------HHHhhcChHHHHHHHHHHH
Confidence 3444 3446899999999999974 4567776533331 1111122455789999999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHH---------HHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR---------HRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~---------~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|+.|+|||||++|++|.+.....+.+++|++++|.+..+.++ .+++.||++||.|||++. +||+|||||
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLK 172 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLK 172 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccc
Confidence 9999999999999999998887889999999999987655544 579999999999999997 689999999
Q ss_pred CCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
-+||+++ ..|.|||+|+|+|.....++. ....||+.|||||... ..|+...||| ||++++||+|+.+||.+..
T Consensus 173 CDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 173 CDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred cceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 9999999 568999999999998765543 3378999999999998 5899999999 9999999999999976543
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. ..++-+.+..+..+.....+-++ ++.++|..|+.. ..+|||+.|+++
T Consensus 248 n---~AQIYKKV~SGiKP~sl~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 248 N---PAQIYKKVTSGIKPAALSKVKDP------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred C---HHHHHHHHHcCCCHHHhhccCCH------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 2 22222222222222222233333 278999999999 899999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=277.42 Aligned_cols=230 Identities=27% Similarity=0.347 Sum_probs=176.4
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+.+ .+++.||+|.+..... ........+..|..++..+ +|
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~e~~~l~~~~~h 55 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVI------------------------LQDDDVECTMTEKRILSLARNH 55 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHH------------------------hhccHHHHHHHHHHHHHhccCC
Confidence 46899999999999864 5789999999852110 0122355667788888776 79
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++...+ .++++++|++++++ ++......++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 ~~iv~~~~~~~~~~--~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~ 130 (320)
T cd05590 56 PFLTQLYCCFQTPD--RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLD 130 (320)
T ss_pred CchhceeeEEEcCC--EEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEEC
Confidence 99999999988776 68999999988654 455566789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.++|+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||... +....
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~----~~~~~ 204 (320)
T cd05590 131 HEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE----NEDDL 204 (320)
T ss_pred CCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC----CHHHH
Confidence 999999999999875422211 22346799999999999988899999999 999999999999997532 22233
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
...+.. .... .+ ......+.+++.+||+.||++||++
T Consensus 205 ~~~i~~---~~~~---~~--------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 205 FEAILN---DEVV---YP--------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHhc---CCCC---CC--------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 222221 1110 00 1112346788899999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.06 Aligned_cols=241 Identities=27% Similarity=0.406 Sum_probs=190.4
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+.++|++.+.||+|+||.||+|.. .|..||+|.+..... ...++.+|+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~----------------------------~~~~~~~e~ 51 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST----------------------------AAQAFLAEA 51 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh----------------------------HHHHHHHHH
Confidence 3567899999999999999999986 478899999964321 256678899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.+++.++||||+++++++...+ ..++++++++++. .+++.....++.|++.||.|||+.+ ++|+
T Consensus 52 ~~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~ 126 (256)
T cd05039 52 SVMTTLRHPNLVQLLGVVLQGN--PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126 (256)
T ss_pred HHHHhcCCcceeeeEEEEcCCC--CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccch
Confidence 9999999999999999988654 6788999887644 3566777889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~ 271 (345)
||||+||+++.++.++++|||.+....... ....++..|+|||.+.+..++.++|+| +|+++|++++ |..||.
T Consensus 127 di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 201 (256)
T cd05039 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred hcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999997653221 123446789999999888889999999 9999999997 999964
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.. ........+....... ........+.+++.+||+.+|++|||++++++.|+++
T Consensus 202 ~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 202 RI----PLKDVVPHVEKGYRME-------------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CC----CHHHHHHHHhcCCCCC-------------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 32 2223333222211100 0111234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.06 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=192.0
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|....++|.+.+.||+|+||.||+|.++ ++..+|+|.+.....+ ...+..
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~~~----------------------------~~~~~~ 50 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTMS----------------------------PEAFLQ 50 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCccC----------------------------HHHHHH
Confidence 3456789999999999999999999864 5678999998643211 345778
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
|+.++++++||||+++++++.... ..++++++++++.+ +++.....++.+++.|+.|||+.+ ++
T Consensus 51 e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~ 125 (261)
T cd05034 51 EAQIMKKLRHDKLVQLYAVCSEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YI 125 (261)
T ss_pred HHHHHhhCCCCCEeeeeeeeecCC--ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 999999999999999999887655 57888888876543 456667889999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|+|++|+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+| +|+++|++++ |..|
T Consensus 126 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 204 (261)
T cd05034 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204 (261)
T ss_pred cCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998876532211 11223446789999999988899999999 9999999998 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
|.. .........+......+.+ ......+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 205 ~~~----~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 205 YPG----MTNREVLEQVERGYRMPRP-------------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCC----CCHHHHHHHHHcCCCCCCC-------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 643 2222233322221111111 11133578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.11 Aligned_cols=235 Identities=25% Similarity=0.319 Sum_probs=180.6
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+++ .++..||+|.+..... ........+..|..+++.+ +|
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~e~~il~~~~~h 55 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVI------------------------LQDDDVECTMTEKRVLALAGKH 55 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHH------------------------hhhhHHHHHHHHHHHHHhccCC
Confidence 46999999999999864 5688999999852110 0122355667888888877 79
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++...+ .++++++|+.++.+ +++.....++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 ~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~ 130 (318)
T cd05570 56 PFLTQLHSCFQTKD--RLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLD 130 (318)
T ss_pred CCccceeeEEEcCC--EEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEEC
Confidence 99999999988776 78999999987653 566677889999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.++|+|||++........ ......|+..|+|||++.+..++.++|+| +|+++|+|++|..||... .....
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~----~~~~~ 204 (318)
T cd05570 131 SEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD----DEDEL 204 (318)
T ss_pred CCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC----CHHHH
Confidence 999999999999865322111 22345789999999999998999999999 999999999999997432 22222
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS-----KDVRR 338 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~-----~~ll~ 338 (345)
...+... ... . +......+.+++.+||+.||++||++ .++++
T Consensus 205 ~~~i~~~---~~~---~--------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 205 FQSILED---EVR---Y--------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHcC---CCC---C--------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2222111 100 0 01122347789999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=285.52 Aligned_cols=195 Identities=24% Similarity=0.411 Sum_probs=159.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.. .+++.||+|.+.... .........+.+|+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~------------------------~~~~~~~~~~~~E~~il 55 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKAD------------------------VLMRNQAAHVKAERDIL 55 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHH------------------------HHhhhhHHHHHHHHHHH
Confidence 47999999999999999999854 579999999984211 01122356677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+..++ .+++++||++++.+. +......++.|++.||.|||+.+ |+||||||+
T Consensus 56 ~~l~h~~iv~~~~~~~~~~--~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~ 130 (376)
T cd05598 56 AEADNEWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPD 130 (376)
T ss_pred HhCCCCCcceEEEEEEcCC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH
Confidence 9999999999999998776 789999999887653 44455678999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCC-----------------------------------------cceeccCcccCccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAH-----------------------------------------THITTSNVVGTVEY 237 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~~ 237 (345)
|||++.++.++|+|||++....... .........||+.|
T Consensus 131 Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 210 (376)
T cd05598 131 NILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210 (376)
T ss_pred HEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccc
Confidence 9999999999999999975321000 00011235799999
Q ss_pred cccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 238 IAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 238 ~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
+|||++.+..++.++||| +||++|||++|..||..
T Consensus 211 ~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 211 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred cCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCC
Confidence 999999998999999999 99999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=275.39 Aligned_cols=234 Identities=26% Similarity=0.368 Sum_probs=177.1
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+++ .+|+.||+|.+...... ..........|..++... +|
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~------------------------~~~~~~~~~~e~~~l~~~~~~ 55 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVL------------------------IDDDVECTMVEKRVLALAWEN 55 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hcchHHHHHHHHHHHHhccCC
Confidence 46999999999999865 57899999998531100 012244556677787654 89
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++...+ .+++++||+.++.+ ++......++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 ~~i~~~~~~~~~~~--~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~ 130 (316)
T cd05620 56 PFLTHLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLD 130 (316)
T ss_pred CCccCeeEEEEeCC--EEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC
Confidence 99999999988776 78999999988654 455566779999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.++|+|||++........ ......||..|+|||.+.+..++.++||| +|+++|||++|..||.. .+....
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~----~~~~~~ 204 (316)
T cd05620 131 RDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG----DDEDEL 204 (316)
T ss_pred CCCCEEeCccCCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC----CCHHHH
Confidence 999999999999874322111 22346789999999999998999999999 99999999999999743 222333
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK-DVR 337 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~-~ll 337 (345)
...+... .+. .. .. ....+.+++..||+.||++||++. +++
T Consensus 205 ~~~~~~~----~~~------~~-~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 205 FESIRVD----TPH------YP-RW---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHhC----CCC------CC-CC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 3322211 110 00 01 123467888999999999999974 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=277.68 Aligned_cols=235 Identities=23% Similarity=0.274 Sum_probs=180.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+.+.||+|+||.||+|+.+ .++..||+|.+...... .......+..|..++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~~e~~~l~ 55 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVI------------------------QDDDVECTMVEKRVLA 55 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hhhHHHHHHHHHHHHH
Confidence 5889999999999999999864 57889999998532100 0122445667788887
Q ss_pred hc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
.+ +||+|+++++.+...+ .+++++||+.++.+ ++...+..++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 130 (323)
T cd05616 56 LSGKPPFLTQLHSCFQTMD--RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLD 130 (323)
T ss_pred hccCCCeEeeEEEEEecCC--EEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHH
Confidence 77 6899999999888766 78999999988755 455566789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||| +|+++|||++|..||.. .
T Consensus 131 Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~----~ 204 (323)
T cd05616 131 NVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG----E 204 (323)
T ss_pred HeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC----C
Confidence 99999999999999999875432211 22346789999999999999999999999 99999999999999743 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
+.......+.... .. ++ ......+.+++.+||+.||.+|++.
T Consensus 205 ~~~~~~~~i~~~~---~~---~p--------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 205 DEDELFQSIMEHN---VA---YP--------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CHHHHHHHHHhCC---CC---CC--------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 2233332222111 00 00 1112346788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=275.30 Aligned_cols=188 Identities=27% Similarity=0.393 Sum_probs=151.7
Q ss_pred ccccccCcceeeEEEEec-CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 53 LEKIGSGGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
..+||+|+||.||+|+.+ ..++..||+|.+..... ...+.+|+.++++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----------------------------~~~~~~E~~~l~~l~ 56 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----------------------------SMSACREIALLRELK 56 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----------------------------cHHHHHHHHHHHhCC
Confidence 357999999999999864 23578999999854211 224567999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGR-----------------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
||||+++++++.......++++++++.+. ..+++..+..++.|++.||.|||+.+ ++|||
T Consensus 57 h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~D 133 (317)
T cd07867 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRD 133 (317)
T ss_pred CCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCC
Confidence 99999999998776666788999987652 12556667889999999999999998 99999
Q ss_pred CCCCCeee----cCCCCeEEeccccceecCCCCcc-eeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCC
Q 046907 195 LNPVNVLL----DDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 195 lk~~nil~----~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|||+||++ +.++.+||+|||+++........ .......||..|+|||.+.+. .++.++||| +|+++|||++|.
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~ 213 (317)
T cd07867 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCC
Confidence 99999999 45678999999999876443211 122346789999999999774 478999999 999999999999
Q ss_pred CCCcc
Q 046907 268 LPSDK 272 (345)
Q Consensus 268 ~p~~~ 272 (345)
.||..
T Consensus 214 ~~f~~ 218 (317)
T cd07867 214 PIFHC 218 (317)
T ss_pred CCccc
Confidence 99753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=282.08 Aligned_cols=233 Identities=21% Similarity=0.306 Sum_probs=178.9
Q ss_pred ccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 046907 53 LEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI 130 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 130 (345)
++.||+|+||.||+++.. ..+|..||+|.+..... .......+..|+.+++++
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------------------------~~~~~~~~~~E~~~l~~l 55 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-------------------------KVRDRVRTKMERDILAEV 55 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-------------------------hhhhHHHHHHHHHHHHhC
Confidence 367999999999998742 24689999999853110 012244567899999999
Q ss_pred cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 046907 131 RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 131 ~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil 201 (345)
+||||+++++.+..++ .++++++|+.++++ +++.....++.|++.||.|||+.+ ++||||||+||+
T Consensus 56 ~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 130 (318)
T cd05582 56 NHPFIVKLHYAFQTEG--KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENIL 130 (318)
T ss_pred CCCCcccEEEEEEcCC--EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeE
Confidence 9999999999988776 78899999987654 556667889999999999999998 999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchh
Q 046907 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~ 280 (345)
++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||| +|+++|||++|..||... ...
T Consensus 131 ~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~----~~~ 204 (318)
T cd05582 131 LDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK----DRK 204 (318)
T ss_pred ECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC----CHH
Confidence 99999999999999876533211 22346789999999999988889999999 999999999999997532 222
Q ss_pred hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
.....+.... .. + +......+.+++.+||+.||++||++.+
T Consensus 205 ~~~~~i~~~~---~~---~--------p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 205 ETMTMILKAK---LG---M--------PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHcCC---CC---C--------CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2222222111 00 0 0111234678889999999999999654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.84 Aligned_cols=235 Identities=26% Similarity=0.381 Sum_probs=177.5
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh-ccC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ-IRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~h 132 (345)
+.||+|+||.||+|++. .+++.||+|.+...... .......+..|..++.. ++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~~e~~~l~~~~~h 55 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVL------------------------MDDDVECTMVEKRVLSLAWEH 55 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hcchHHHHHHHHHHHHhccCC
Confidence 46999999999999864 57889999998532100 01224455667778776 499
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++..++ .++++++|++++++ +++.....++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 p~iv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~ 130 (316)
T cd05619 56 PFLTHLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLD 130 (316)
T ss_pred CcCcceEEEEEeCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEEC
Confidence 99999999988776 68999999988654 455566789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.++|+|||++........ ......||..|+|||++.+..++.++||| +|+++|||++|..||... +....
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~~~~~ 204 (316)
T cd05619 131 TDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH----DEEEL 204 (316)
T ss_pred CCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC----CHHHH
Confidence 999999999999875322211 22346789999999999998899999999 999999999999997432 22223
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK-DVRR 338 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~-~ll~ 338 (345)
...+... .+. .+ . .....+.+++.+||+.||++||++. ++++
T Consensus 205 ~~~i~~~----~~~--~~-----~---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 205 FQSIRMD----NPC--YP-----R---WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHhC----CCC--CC-----c---cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2222211 110 00 0 1123467888999999999999996 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=260.63 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=195.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-...|...+.||+|..+.|.+|..+ .+|..+|+|++.-........ . -....+...+|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e------------------~-~~~~~EaT~~Ev~ 74 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGE------------------T-PYEMREATRQEIS 74 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCc------------------c-HHHHHHHHHHHHH
Confidence 3457888899999999999999854 689999999986544332110 0 1344677788999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCCCHH---------HHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---------ARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~---------~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
||+++ .||+|+++.+++.++. +++++.++++.|.+++++ ...+++.|+.+|++|||.+. |+||||
T Consensus 75 ILRqv~GHP~II~l~D~yes~s--F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDL 149 (411)
T KOG0599|consen 75 ILRQVMGHPYIIDLQDVYESDA--FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDL 149 (411)
T ss_pred HHHHhcCCCcEEEeeeeccCcc--hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhccc
Confidence 99988 7999999999999886 788899999888876555 55789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc------ccccCccchhh-HHHHHHHHHhCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ------MLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~------~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
||+|||++.+.+++|+|||.+..+.... .....+||++|+|||.+. ...|+...|.| +|+++|.++.|.+
T Consensus 150 KpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 150 KPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred ChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999876543 345689999999999883 33488899999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||= . ...+-.+..+..+... ..++...+......+||.+||+.||.+|.|++++++
T Consensus 227 PFw---H-RkQmlMLR~ImeGkyq----------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 227 PFW---H-RKQMLMLRMIMEGKYQ----------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred chh---H-HHHHHHHHHHHhcccc----------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 952 1 1222222222222111 112233344556788999999999999999999875
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.63 Aligned_cols=240 Identities=18% Similarity=0.274 Sum_probs=187.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||++++. .++..+|+|.+..... ....+.+..|+.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~--------------------------~~~~~~~~~e~~~l~ 53 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKS--------------------------SSAVEDSRKEAVLLA 53 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcc--------------------------hHHHHHHHHHHHHHH
Confidence 5889999999999999999864 5789999999853211 122456678999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++.+..++ .+++++++++++.+ ++......++.|++.||.|||+.+ ++|+||||
T Consensus 54 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p 128 (255)
T cd08219 54 KMKHPNIVAFKESFEADG--HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKS 128 (255)
T ss_pred hCCCCCcceEEEEEEECC--EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCc
Confidence 999999999999988776 78899999987543 445556789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||.+........ ......|+..|+|||++.+..++.++|+| +|+++|+|++|..||..
T Consensus 129 ~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~---- 202 (255)
T cd08219 129 KNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA---- 202 (255)
T ss_pred ceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC----
Confidence 999999999999999999876543221 12345788999999999988899999999 99999999999999743
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.+.......+......+. .......+.+++.+||+.||++|||+.++++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 203 NSWKNLILKVCQGSYKPL-------------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCHHHHHHHHhcCCCCCC-------------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 222222222211111100 11122347789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.16 Aligned_cols=243 Identities=22% Similarity=0.328 Sum_probs=195.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+.+.++..||.|+||.||+|..+ .++...|-|.+.... ......++-|+.
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetks---------------------------eEELEDylVEIe 81 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKS---------------------------EEELEDYLVEIE 81 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccc---------------------------hhHHhhhhhhhh
Confidence 4567899999999999999999854 567777788875432 345778899999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
||..++||+||++++.|..++ .++++-+||+||. .+...++.-+++|++.||.|||++. ||||||
T Consensus 82 ILa~CdHP~ivkLl~ayy~en--kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDL 156 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFEN--KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDL 156 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccC--ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhc
Confidence 999999999999999887777 6899999998863 4677788889999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccc-----cccccCccchhh-HHHHHHHHHhCCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL-----QMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~-----~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|+.|||+.-+|.++++|||++..... .......+.||++|||||+. ...+|+.++||| ||++|.||..+.+|
T Consensus 157 KAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP 234 (1187)
T KOG0579|consen 157 KAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP 234 (1187)
T ss_pred cccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence 99999999999999999999875432 22344679999999999987 567899999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+. +....+.++....+|... .++.-...+.+++..||..||..||+++++++
T Consensus 235 Hhel-------npMRVllKiaKSePPTLl--------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 235 HHEL-------NPMRVLLKIAKSEPPTLL--------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cccc-------chHHHHHHHhhcCCCccc--------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 5432 233333333333333221 22333445677777899999999999999975
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=265.63 Aligned_cols=244 Identities=22% Similarity=0.275 Sum_probs=180.3
Q ss_pred cccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 54 EKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
+.||+|+||.||+|++.. ..+..+|+|.+..... ......+.+|+.+++.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--------------------------~~~~~~~~~e~~~l~~l~ 54 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--------------------------LEEVEQFLKEGIIMKDFS 54 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--------------------------HHHHHHHHHHHHHHccCC
Confidence 468999999999998642 2356899998743210 123567788999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil 201 (345)
||||+++++++...+. ..+++++++.++++ .++.....++.|+++||.|||+.+ ++||||||+||+
T Consensus 55 h~~iv~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nil 130 (262)
T cd05058 55 HPNVLSLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCM 130 (262)
T ss_pred CCCcceEEEEeecCCC-CcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEE
Confidence 9999999997765443 46678888877654 244455678899999999999998 999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC-CCCCccccccc
Q 046907 202 LDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG-KLPSDKFFQHT 277 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg-~~p~~~~~~~~ 277 (345)
++.++.+|++|||+++........ .......++..|+|||.+.+..++.++||| ||+++|||++| .+||.. .
T Consensus 131 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~----~ 206 (262)
T cd05058 131 LDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----V 206 (262)
T ss_pred EcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC----C
Confidence 999999999999998755332111 111234557789999999888899999999 99999999995 556432 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
...+....+.. ...+. ........+.+++..||+.+|++||++.++++.|+++.
T Consensus 207 ~~~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 207 DSFDITVYLLQ---GRRLL----------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CHHHHHHHHhc---CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 22233222221 11110 00111235778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=280.84 Aligned_cols=251 Identities=18% Similarity=0.248 Sum_probs=185.3
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..+.++|++.+.||+|+||.||+|+++ .+++.+|+|.+.... .........+.+|
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~------------------------~~~~~~~~~~~~e 93 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFE------------------------MIKRSDSAFFWEE 93 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHH------------------------hhhhHHHHHHHHH
Confidence 346689999999999999999999864 578999999984210 0112234557789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC--------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL--------DWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l--------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+.+++.++||||+++++.+..++ .++++++|++++.+. +......++.|++.||.|||+.+ ++||||
T Consensus 94 ~~i~~~~~hp~iv~~~~~~~~~~--~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDL 168 (371)
T cd05622 94 RDIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 168 (371)
T ss_pred HHHHHhCCCCCCCeEEEEEEcCC--EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 99999999999999999988765 799999999987653 44455678999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc----cCccchhh-HHHHHHHHHhCCCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT----LTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~----~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||+|||++.++.+||+|||++......... ......||+.|+|||++.+.. ++.++||| +|+++|||++|..||
T Consensus 169 kp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 999999999999999999999876433221 223467999999999997643 77899999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE--RPNSKDVRRM 339 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--Rpt~~~ll~~ 339 (345)
.. .+.......+.. ........ ........+.+++..|++.++.+ ||++.++++.
T Consensus 248 ~~----~~~~~~~~~i~~---~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 248 YA----DSLVGTYSKIMN---HKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CC----CCHHHHHHHHHc---CCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 43 222222222211 11100000 00112234667888899844433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=300.52 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=188.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+.. .+|+.||+|.+....... .....++.+|+.++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~------------------------e~~~~rflrEi~IL 56 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSEN------------------------PLLKKRFLREAKIA 56 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccC------------------------HHHHHHHHHHHHHH
Confidence 58999999999999999999854 578999999986432111 22356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCCCH--------------------HHHHHHHHHHHHHHHHHhhcCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDW--------------------LARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~--------------------~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
++++||||+++++++..++ ..++++++++|+++.++ ....+++.|+++||.|||+.+
T Consensus 57 s~L~HPNIVkl~~v~~d~~--~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G- 133 (932)
T PRK13184 57 ADLIHPGIVPVYSICSDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG- 133 (932)
T ss_pred HhCCCcCcCeEEEEEeeCC--EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999999999988766 68899999988765433 234678999999999999998
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCc----------------ceeccCcccCccccccccccccccCcc
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT----------------HITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
++||||||+||+++.++.++++|||++........ ........||+.|+|||.+.+..++.+
T Consensus 134 --IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k 211 (932)
T PRK13184 134 --VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES 211 (932)
T ss_pred --ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence 99999999999999999999999999986521100 001123579999999999999999999
Q ss_pred chhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCC
Q 046907 252 CDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER 330 (345)
Q Consensus 252 ~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 330 (345)
+||| +|+++|||++|..||.... ....... ... ..+... . ...+....+.+++.+||+.||++|
T Consensus 212 SDIWSLGVILyELLTG~~PF~~~~----~~ki~~~--~~i--~~P~~~-~------p~~~iP~~L~~LI~rcL~~DP~kR 276 (932)
T PRK13184 212 TDIYALGVILYQMLTLSFPYRRKK----GRKISYR--DVI--LSPIEV-A------PYREIPPFLSQIAMKALAVDPAER 276 (932)
T ss_pred hHHHHHHHHHHHHHHCCCCCCCcc----hhhhhhh--hhc--cChhhc-c------ccccCCHHHHHHHHHHccCChhhC
Confidence 9999 9999999999999975421 1111100 000 000000 0 001222347788899999999999
Q ss_pred C-CHHHHHHHHhhh
Q 046907 331 P-NSKDVRRMLSQI 343 (345)
Q Consensus 331 p-t~~~ll~~L~~l 343 (345)
| +++++++.|+..
T Consensus 277 ~ss~eeLl~~Le~~ 290 (932)
T PRK13184 277 YSSVQELKQDLEPH 290 (932)
T ss_pred cCHHHHHHHHHHHH
Confidence 6 567777777654
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.99 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=187.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+++.||+|+||.||+|+.. .++..||+|.+...... ......+..|+.
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~-------------------------e~~~~~~~~EI~ 64 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLK-------------------------EREKSQLVIEVN 64 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccC-------------------------HHHHHHHHHHHH
Confidence 4569999999999999999999865 57889999998643222 223566788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCC----C
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHC----P 188 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~----~ 188 (345)
+++.++|||||++++++.......++++++|+.++++ +++..+..++.||+.||.|||+.+. .
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 9999999999999999877666689999999988654 5566677899999999999998531 2
Q ss_pred CeEecCCCCCCeeecC-----------------CCCeEEeccccceecCCCCcceeccCcccCccccccccccc--cccC
Q 046907 189 RIIHRDLNPVNVLLDD-----------------DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM--LTLT 249 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~--~~~~ 249 (345)
+|+||||||+|||++. ...+||+|||++........ .....||+.|+|||++.+ ..++
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s 221 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYD 221 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCC
Confidence 3999999999999964 23589999999976543221 234578999999999864 3478
Q ss_pred ccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 250 EKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
.++||| |||++|||++|..||... .....+ +......+.. ... .....+.+||..||+.+|.
T Consensus 222 ~KSDVWSLG~ILYELLTGk~PF~~~---~~~~ql---i~~lk~~p~l--------pi~---~~S~eL~dLI~~~L~~dPe 284 (1021)
T PTZ00266 222 DKSDMWALGCIIYELCSGKTPFHKA---NNFSQL---ISELKRGPDL--------PIK---GKSKELNILIKNLLNLSAK 284 (1021)
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcC---CcHHHH---HHHHhcCCCC--------CcC---CCCHHHHHHHHHHhcCChh
Confidence 899999 999999999999997432 111122 2222111111 000 1123477889999999999
Q ss_pred CCCCHHHHHH
Q 046907 329 ERPNSKDVRR 338 (345)
Q Consensus 329 ~Rpt~~~ll~ 338 (345)
+||++.++++
T Consensus 285 eRPSa~QlL~ 294 (1021)
T PTZ00266 285 ERPSALQCLG 294 (1021)
T ss_pred HCcCHHHHhc
Confidence 9999999983
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.83 Aligned_cols=243 Identities=26% Similarity=0.383 Sum_probs=184.5
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|+..+.||+|+||.||+|.++ .+++.||+|.+....... ......+.+|+.+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~------------------------~~~~~~~~~E~~il~ 55 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKK------------------------RKGESMALNEKQILE 55 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccc------------------------hHHHHHHHHHHHHHH
Confidence 3778899999999999999865 578999999985321110 122345678999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++|+|++.+++.+...+ .++++++++.++++ ++......++.|++.||.|||+.+ ++|+||||
T Consensus 56 ~l~~~~i~~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp 130 (285)
T cd05630 56 KVNSRFVVSLAYAYETKD--ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKP 130 (285)
T ss_pred hCCCCCeeeeeEEEecCC--EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCH
Confidence 999999999999888766 78999999887644 455566789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++........ .....|+..|+|||.+.+..++.++|+| +|+++|+|++|..||......
T Consensus 131 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~ 207 (285)
T cd05630 131 ENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207 (285)
T ss_pred HHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999999876533221 1235789999999999998899999999 999999999999997543221
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
.............. .. ........+.+++..||+.||++||| +.++++
T Consensus 208 ~~~~~~~~~~~~~~-~~-------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 208 IKREEVERLVKEVQ-EE-------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred chHHHHHhhhhhhh-hh-------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11111111111110 00 00111234678889999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=267.31 Aligned_cols=244 Identities=20% Similarity=0.308 Sum_probs=176.1
Q ss_pred cccccCcceeeEEEEecC-CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 54 EKIGSGGCGEVYKAELPG-QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
+.||+|+||.||+|++.. .++..+|+|.+...... .....+.+|+.+++.++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h 54 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--------------------------QEQMKFLEEAQPYRSLQH 54 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--------------------------HHHHHHHHHHHHHHhCCC
Confidence 368999999999998642 34678999988643211 123457789999999999
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCCCCHH--------------HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL--------------ARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~--------------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
|||+++++++.... .+++++||++++++.++. ....++.|++.|+.|||+.+ ++|+|+||+
T Consensus 55 ~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~ 129 (269)
T cd05087 55 SNLLQCLGQCTEVT--PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALR 129 (269)
T ss_pred CCEeeEEEEEcCCC--CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcc
Confidence 99999999887665 578899999887654433 33468899999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-------ccCccchhh-HHHHHHHHHh-CCCC
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-------TLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-------~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||+++.++.++++|||++................++..|+|||++.+. .++.++|+| ||+++|||++ |..|
T Consensus 130 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p 209 (269)
T cd05087 130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209 (269)
T ss_pred eEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCC
Confidence 999999999999999998654332222222335678889999998643 357899999 9999999996 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
|..... .+............. ..+... .. ....+.++|..|| .+|++|||+++|+..|+
T Consensus 210 ~~~~~~----~~~~~~~~~~~~~~~----~~~~~~-~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 210 YRHLSD----EQVLTYTVREQQLKL----PKPRLK-LP---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCh----HHHHHHHhhcccCCC----CCCccC-CC---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 754322 222222111111111 111111 11 1223667888899 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=265.71 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=190.5
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|....++|++.+.||+|+||.||++.++ .+..+|+|.+.... .....+.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~~----------------------------~~~~~~~~ 50 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS----------------------------MSVEAFLA 50 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEec--CCccEEEEecCCCh----------------------------hHHHHHHH
Confidence 3456789999999999999999999864 56679999885421 12456788
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
|+.+++.++|+||+++++.+.. . ..++++++++++++ +++..+..++.|++.||.|||+.+ ++
T Consensus 51 e~~~l~~l~~~~i~~~~~~~~~-~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~ 124 (260)
T cd05073 51 EANVMKTLQHDKLVKLHAVVTK-E--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YI 124 (260)
T ss_pred HHHHHHhcCCCCcceEEEEEcC-C--CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 9999999999999999998876 2 57888999887654 345556779999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|+||+|+|++++..+.++++|||.+......... ......++..|+|||.+.+..++.++|+| +|+++|++++ |..|
T Consensus 125 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p 203 (260)
T cd05073 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203 (260)
T ss_pred ccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999765433221 12234456789999999888889999999 9999999999 8999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
|... ........+......+ ........+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 204 ~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 204 YPGM----SNPEVIRALERGYRMP-------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCC----CHHHHHHHHhCCCCCC-------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 6432 2222222222111110 1112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=269.82 Aligned_cols=260 Identities=18% Similarity=0.300 Sum_probs=195.3
Q ss_pred cCCcccccccccCcceeeEEEEec---CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELP---GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
.++|++.+.||+|+||.||+|++. ..+++.+|+|.+...... .....+.+|
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--------------------------~~~~~~~~e 56 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--------------------------QHRSDFERE 56 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--------------------------HHHHHHHHH
Confidence 457899999999999999999864 235789999998643221 125678899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.+++.++||||+++++++...+....+++++++.++++ +++.....++.|++.||.|||+.+ ++|+
T Consensus 57 i~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~ 133 (284)
T cd05038 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHR 133 (284)
T ss_pred HHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 999999999999999999887666678999999987543 566667889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|+||+||+++.++.++++|||.+......... .......++..|+|||.+.+..++.++|+| +|+++|||++|..|+.
T Consensus 134 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 99999999999999999999999876532211 111223456679999999888899999999 9999999999999864
Q ss_pred ccccccch-------hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 272 KFFQHTNE-------MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 272 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
........ ......+.......... .....+...+.+++.+||+.+|++|||+.+|++.|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 214 SPPAEFLRMIGIAQGQMIVTRLLELLKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccchhccccccccccccHHHHHHHHHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 32211100 00011111111111000 011122355888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=267.54 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=190.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCC----ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNG----RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|++.+.||+|+||.||+|.++. +| ..+|+|.+..... ......+.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~~~~aik~~~~~~~--------------------------~~~~~~~~ 57 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIP-EGEKVKIPVAIKVLREETS--------------------------PKANKEIL 57 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEec-CCCCcceEEEEEeccCCCC--------------------------HHHHHHHH
Confidence 45689999999999999999998753 33 3689998754321 12356678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++... ..+++++++.++++ +++.....++.|++.||.|||+.+ ++
T Consensus 58 ~e~~~l~~l~h~~i~~~~~~~~~~---~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~ 131 (279)
T cd05057 58 DEAYVMASVDHPHVVRLLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LV 131 (279)
T ss_pred HHHHHHHhCCCCCcceEEEEEecC---ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 899999999999999999988862 57888888876543 556677889999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|+|+||+||+++.++.++++|||+++...............++..|+|||.+....++.++|+| +|+++||+++ |..|
T Consensus 132 H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 211 (279)
T cd05057 132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred ecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999999999876533222222223345689999999888899999999 9999999998 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ...+....+......+.+ ..+...+.+++..||..||++|||+.++++.|+++.
T Consensus 212 ~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 212 YEGI----PAVEIPDLLEKGERLPQP-------------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCC----CHHHHHHHHhCCCCCCCC-------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 7542 223333333221111110 011234778889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=266.33 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=189.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|+..+.||+|+||.||+|+.... ....+|+|.+..... ....+.+..|
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--------------------------~~~~~~~~~e 56 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--------------------------EKQRQDFLSE 56 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--------------------------HHHHHHHHHH
Confidence 345888999999999999999986421 234799998854211 1224567889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.++++++|||++++.+++...+ ..++++++++++.+ +++.....++.|++.|+.|||+.+ ++|+
T Consensus 57 ~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~ 131 (268)
T cd05063 57 ASIMGQFSHHNIIRLEGVVTKFK--PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHR 131 (268)
T ss_pred HHHHhcCCCCCeeEEEEEEccCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 99999999999999999988766 57889998877543 456677889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCccee-ccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
|+||+||+++.++.++++|||++........... ......+..|+|||.+.+..++.++||| +|+++||+++ |..||
T Consensus 132 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred ccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876643222111 1112234579999999888889999999 9999999997 99996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
... ........+......+. ..+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 212 ~~~----~~~~~~~~i~~~~~~~~-------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 212 WDM----SNHEVMKAINDGFRLPA-------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CcC----CHHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 432 22233333322111100 112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=267.48 Aligned_cols=244 Identities=20% Similarity=0.308 Sum_probs=173.4
Q ss_pred cccccCcceeeEEEEec-CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 54 EKIGSGGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
+.||+|+||.||+|+.. ......+|+|.+..... ......+.+|+.+++.++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--------------------------~~~~~~~~~e~~~~~~l~h 54 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--------------------------PDEQLLFLQEVQPYRELNH 54 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--------------------------hHHHHHHHHHHHHHHhCCC
Confidence 36999999999999753 23456788888753211 1224567889999999999
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCCCCH--------------HHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRELDW--------------LARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~--------------~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
|||+++++.+...+ .+++++++++++++.++ .....++.|++.||.|||+.+ ++||||||+
T Consensus 55 ~nii~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~ 129 (269)
T cd05042 55 PNVLQCLGQCIESI--PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALR 129 (269)
T ss_pred CCcceEEEEECCCC--ceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHh
Confidence 99999999887665 68899999988765332 334678999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-------cccCccchhh-HHHHHHHHHh-CCCC
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-------LTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-------~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||+++.++.+|++|||++................++..|+|||++.. ..++.++||| +|+++|||++ |..|
T Consensus 130 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (269)
T cd05042 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209 (269)
T ss_pred heEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999865432211111223455678999998743 3467899999 9999999999 7888
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
|... ...+.............+ .+. ........+.+++..|| .||++|||+++|++.|.
T Consensus 210 ~~~~----~~~~~~~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 210 YPDL----SDEQVLKQVVREQDIKLP----KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcC----CHHHHHHHHhhccCccCC----CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 6432 222222211111111111 111 11122234556777799 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=275.27 Aligned_cols=231 Identities=26% Similarity=0.345 Sum_probs=173.3
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHhhccC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN-TVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h 132 (345)
+.||+|+||.||+|+.. .+|..||+|.+..... ........+..|.. +++.++|
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~~e~~~~~~~l~h 55 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAI------------------------LKKKEQKHIMAERNVLLKNVKH 55 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHH------------------------hhhhHHHHHHHHHHHHHhhCCC
Confidence 46999999999999864 5799999999842110 00112334455554 4577899
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++.+..++ .++++++|+.++.+ ++......++.|++.||.|||+.+ ++||||||+|||++
T Consensus 56 p~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~ 130 (323)
T cd05575 56 PFLVGLHYSFQTAD--KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLD 130 (323)
T ss_pred CCCCCeeEEEEeCC--EEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEEC
Confidence 99999999888766 78899999988765 445566779999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.+||+|||++....... .......||+.|+|||.+.+..++.++||| +|+++|||++|..||... +..+.
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~ 204 (323)
T cd05575 131 SQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----DTAEM 204 (323)
T ss_pred CCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC----CHHHH
Confidence 99999999999987532211 122346789999999999998999999999 999999999999997432 22222
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
...+ ...... .. +.....+.+++.+||+.||.+||++.
T Consensus 205 ~~~i---~~~~~~-------~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 205 YDNI---LNKPLR-------LK----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHH---HcCCCC-------CC----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2211 111110 01 11123477889999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=268.60 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=185.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .++..||+|.+..... .....+.+|+.
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~---------------------------~~~~~~~~e~~ 58 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPG---------------------------DDFSLIQQEIF 58 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCcc---------------------------chHHHHHHHHH
Confidence 4568999999999999999999864 5789999999854321 12345678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++++||||+++++.+..++ .+++++++++++.+ ++......++.|++.|+.|||+.+ ++|+|++
T Consensus 59 ~l~~~~h~~ii~~~~~~~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~ 133 (267)
T cd06646 59 MVKECKHCNIVAYFGSYLSRE--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIK 133 (267)
T ss_pred HHHhcCCCCeeeeeEEEEeCC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCC
Confidence 999999999999999988765 68889999987654 455566789999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+||+++.++.++++|||++........ ......|+..|+|||.+. ...++.++|+| +|+++|||++|..||..
T Consensus 134 p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 134 GANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred HHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999999999999999986543211 123356889999999884 33467899999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
.... ..... + . .... ..+.. .........+.+++..||+.+|++|||++++++.|
T Consensus 212 ~~~~---~~~~~-~---~-~~~~---~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 212 LHPM---RALFL-M---S-KSNF---QPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cchh---hhhee-e---e-cCCC---CCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 2110 00000 0 0 0000 00000 00112234578899999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=271.36 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=186.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||++++. .++..+|+|.+..... ......+.+|++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~--------------------------~~~~~~~~~E~~~l 53 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIK--------------------------PAIRNQIIRELKVL 53 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccC--------------------------HHHHHHHHHHHHHH
Confidence 47999999999999999999864 5788999999853211 12345678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMH-HCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH~dlk~ 197 (345)
+.++||||+++++.+..++ .+++++||++++.+. +......++.|+++||.|||+. + ++|+|+||
T Consensus 54 ~~l~h~~iv~~~~~~~~~~--~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p 128 (308)
T cd06615 54 HECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKP 128 (308)
T ss_pred HhCCCCCCCeEEEEEeeCC--EEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCCh
Confidence 9999999999999998776 788999999886653 4445678999999999999984 6 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++...... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||....
T Consensus 129 ~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-- 202 (308)
T cd06615 129 SNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-- 202 (308)
T ss_pred HHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--
Confidence 9999999999999999998654322 12346789999999999888889999999 9999999999999974321
Q ss_pred cchhhHHHHHHHHhhhcCCCc---------------------------cccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 277 TNEMSFVKWMRNVMASENPKR---------------------------AIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
................... ...+..... .....+.+++.+||+.||++
T Consensus 203 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~ 277 (308)
T cd06615 203 --AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKE 277 (308)
T ss_pred --hhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhh
Confidence 1111111111000000000 000000000 12335789999999999999
Q ss_pred CCCHHHHHHH
Q 046907 330 RPNSKDVRRM 339 (345)
Q Consensus 330 Rpt~~~ll~~ 339 (345)
|||+.++++.
T Consensus 278 Rpt~~~ll~~ 287 (308)
T cd06615 278 RADLKELTKH 287 (308)
T ss_pred CcCHHHHhcC
Confidence 9999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=268.59 Aligned_cols=243 Identities=25% Similarity=0.342 Sum_probs=183.8
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|+..+.||+|+||.||+|++. .+++.+|+|.+...... .......+.+|+.+++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~~E~~il~ 55 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIK------------------------KRKGESMALNEKQILE 55 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhh------------------------hhhHHHHHHHHHHHHH
Confidence 3677889999999999999865 57899999998532111 0122445678999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++|+||+.+++.+..++ .++++++++.++.+ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 56 ~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp 130 (285)
T cd05632 56 KVNSQFVVNLAYAYETKD--ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKP 130 (285)
T ss_pred HcCCcCceeEEEEEecCC--EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCH
Confidence 999999999999888766 68888888876543 566677889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++....... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 131 ~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~--- 204 (285)
T cd05632 131 ENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR--- 204 (285)
T ss_pred HHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC---
Confidence 99999999999999999987653321 11345789999999999988899999999 999999999999997532
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
........+......... .. .......+.+++..||+.||++||+ +.+++.
T Consensus 205 -~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 205 -KEKVKREEVDRRVLETEE--VY--------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -CHHHHHHHHHHhhhcccc--cc--------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 211111222211111111 00 1112234678888899999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=268.59 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=187.3
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+...+.|++++.||+|+||.||+|+.. .++..+++|.+.... ......+.+|
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~---------------------------~~~~~~~~~e 59 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKS---------------------------EEELEDYMVE 59 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCC---------------------------HHHHHHHHHH
Confidence 445678999999999999999999864 578999999985421 2235667889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.+++.++||||+++++.+..++ ..++++++++++.+ +++..+..++.|++.|+.|||+.+ ++|+
T Consensus 60 ~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~ 134 (292)
T cd06644 60 IEILATCNHPYIVKLLGAFYWDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHR 134 (292)
T ss_pred HHHHHhCCCCcEeeeEEEEEeCC--eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeec
Confidence 99999999999999999887765 68899999987643 466677889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|++|+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+| +|+++|+|++|.
T Consensus 135 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~ 212 (292)
T cd06644 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212 (292)
T ss_pred CCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCC
Confidence 9999999999999999999998875432211 123356788999999985 33467789999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.||.... .... .........+.. .........+.+++.+||+.||++||+++++++
T Consensus 213 ~p~~~~~----~~~~---~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 213 PPHHELN----PMRV---LLKIAKSEPPTL--------SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCcccc----HHHH---HHHHhcCCCccC--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9964321 1111 111111111100 011122334778899999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=264.11 Aligned_cols=243 Identities=21% Similarity=0.338 Sum_probs=187.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+.||+|+||.||+|.+. .+..+|+|.+...... ...+..|++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~~----------------------------~~~~~~e~~ 51 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAMS----------------------------EEDFIEEAQ 51 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCCC----------------------------HHHHHHHHH
Confidence 3468999999999999999999874 5778999998643222 234678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++++++|||++++++++.... ..+++++++.++.+ +++.....++.+++.|+.+||+.+ ++|+|+
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl 126 (256)
T cd05112 52 VMMKLSHPKLVQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126 (256)
T ss_pred HHHhCCCCCeeeEEEEEccCC--ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 999999999999999887665 57888898877543 456667789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~ 273 (345)
||+||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+| +|+++|||++ |..||..
T Consensus 127 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~- 204 (256)
T cd05112 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN- 204 (256)
T ss_pred ccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-
Confidence 999999999999999999998765432211 11223456789999999988899999999 9999999998 8999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
.........+...... ..++ . ....+.+++.+||+.+|++|||+.++++.|.
T Consensus 205 ---~~~~~~~~~~~~~~~~------~~~~----~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 205 ---RSNSEVVETINAGFRL------YKPR----L---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHhCCCCC------CCCC----C---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2222333322211111 0111 1 1245888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=275.81 Aligned_cols=237 Identities=23% Similarity=0.298 Sum_probs=177.6
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+||.||+|+.. .++..||+|.+...... .......+..|+.++.++ +|
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~~e~~~~~~~~~~ 55 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVH------------------------DDEDIDWVQTEKHVFEQASSN 55 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hhhHHHHHHHHHHHHHhhcCC
Confidence 46999999999999864 57899999999532111 123356677899999888 79
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+.+++.+...+ .++++++++.++.+ +++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 ~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~ 130 (327)
T cd05617 56 PFLVGLHSCFQTTS--RLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLD 130 (327)
T ss_pred CCEeeEEEEEEeCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEe
Confidence 99999999888766 68999999988654 556667789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||| +|+++|||++|..||....... ....
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~ 207 (327)
T cd05617 131 ADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNT 207 (327)
T ss_pred CCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc-cccc
Confidence 999999999999875322111 22346799999999999998999999999 9999999999999985322211 1111
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
...+.......... .+ ......+.+++.+||+.||.+|+++
T Consensus 208 ~~~~~~~~~~~~~~------~p----~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 208 EDYLFQVILEKPIR------IP----RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHHhCCCC------CC----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11121111111110 00 0112336788889999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=275.94 Aligned_cols=234 Identities=25% Similarity=0.304 Sum_probs=173.6
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHhhccC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI-NTVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h 132 (345)
+.||+|+||.||+|+.. .++..||+|.+...... .......+..|. .+++.++|
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~~e~~~~l~~~~h 55 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAIL------------------------KKKEEKHIMSERNVLLKNVKH 55 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHH------------------------hhhHHHHHHHHHHHHHHhCCC
Confidence 46999999999999864 57889999998531110 011123334444 35677899
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++++..++ .+++++||+.++.+ ++......++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 ~~Iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~ 130 (325)
T cd05602 56 PFLVGLHFSFQTAD--KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLD 130 (325)
T ss_pred CCCCceeEEEEcCC--eEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEC
Confidence 99999999988776 68899999988755 344455678999999999999999 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||| +|+++|+|++|..||.. .+....
T Consensus 131 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~----~~~~~~ 204 (325)
T cd05602 131 SQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEM 204 (325)
T ss_pred CCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC----CCHHHH
Confidence 999999999999875432211 22346799999999999998999999999 99999999999999743 222222
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
...+.. .+.. .. +.....+.+++..||+.||.+||++.+.+
T Consensus 205 ~~~i~~---~~~~---~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 205 YDNILN---KPLQ---LK--------PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHh---CCcC---CC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 222211 1110 00 11223467888899999999999887433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=264.39 Aligned_cols=248 Identities=18% Similarity=0.291 Sum_probs=185.1
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
.+|+..+.||+|+||.||+|... .++..||+|.+.....+.. ..+....+.+|+.++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~----------------------~~~~~~~~~~e~~~l 58 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPE----------------------TSKEVSALECEIQLL 58 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCch----------------------hHHHHHHHHHHHHHH
Confidence 47899999999999999999854 5789999998864332110 023356788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+.......++++++++.++.+ ++......++.|++.||.|||+.+ ++|+|++|+
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~ 135 (266)
T cd06651 59 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGA 135 (266)
T ss_pred HHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH
Confidence 99999999999998876555578889998876543 456666789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+| +|+++||+++|..||.....
T Consensus 136 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~- 214 (266)
T cd06651 136 NILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA- 214 (266)
T ss_pred HEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-
Confidence 999999999999999998765332111 111234678899999999988899999999 99999999999999753211
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+......... + ..+......+.+++ .||..+|++||++++|++
T Consensus 215 ------~~~~~~~~~~~~~-----~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 ------MAAIFKIATQPTN-----P----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ------HHHHHHHhcCCCC-----C----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111111111100 0 11112223355555 588899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=289.82 Aligned_cols=276 Identities=17% Similarity=0.203 Sum_probs=182.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|.++..++...+.|.+.......... .+... ............+.+|+.+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--k~~~~~~~~~~~~~~Ei~i 216 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKC--------ERLIA--KRVKAGSRAAIQLENEILA 216 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhh--------hhhHh--HHhhcchHHHHHHHHHHHH
Confidence 3689999999999999999998776566666655443221111100 00000 0001112346678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-------------RELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
++.++||||+++++++..++ ..+++++++.+. ..........++.|++.||.|||+.+ |+||
T Consensus 217 l~~l~HpnIv~l~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHr 291 (501)
T PHA03210 217 LGRLNHENILKIEEILRSEA--NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHR 291 (501)
T ss_pred HHhCCCCCcCcEeEEEEECC--eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999998877 456665554321 11123345679999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||||+|||++.++.+||+|||++......... ......||..|+|||++.+..++.++||| +|+++|||++|..++..
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999999999999999876443221 22346799999999999998999999999 99999999998754321
Q ss_pred cccccchhhHHHHHHHHhhh--cCCCc---c---ccc---cccCCCcHH------HHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMAS--ENPKR---A---IDS---KLVGNGCEE------QMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~--~~~~~---~---~~~---~~~~~~~~~------~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
........++...+...... ..+.. . +.. .......+. ....+.+++.+||+.||.+|||+.|
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e 450 (501)
T PHA03210 371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE 450 (501)
T ss_pred CCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH
Confidence 11212222333322211100 00000 0 000 000000011 1124667788999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 451 lL~ 453 (501)
T PHA03210 451 LLA 453 (501)
T ss_pred Hhh
Confidence 986
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=266.35 Aligned_cols=240 Identities=22% Similarity=0.293 Sum_probs=182.9
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
-|++.+.||+|+||.||+|.+. .++..+++|.+.... .+....+.+|+.+++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~---------------------------~~~~~~~~~e~~~l~ 57 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKS---------------------------EEELEDYMVEIDILA 57 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCC---------------------------HHHHHHHHHHHHHHH
Confidence 4788999999999999999864 578899999985432 123556778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
.++|||++++++.+..++ ..+++++|++++.+ +++..+..++.|+++||.|||+.+ ++|+||||+
T Consensus 58 ~l~h~~ii~~~~~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~ 132 (282)
T cd06643 58 SCDHPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAG 132 (282)
T ss_pred HCCCCCeeeEEEEEeeCC--EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcc
Confidence 999999999999988765 67889998876543 456677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||+++.++.++++|||++....... .......|+..|+|||.+. +..++.++|+| +|+++|+|++|..||..
T Consensus 133 nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 133 NILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 9999999999999999987543221 1223457899999999984 34567899999 99999999999999754
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. .......+ .....+... ........+.+++..||+.||++|||+.++++
T Consensus 211 ~~----~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 211 LN----PMRVLLKI---AKSEPPTLA--------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cC----HHHHHHHH---hhcCCCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22 11111111 111111000 01112245788999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=271.15 Aligned_cols=255 Identities=18% Similarity=0.260 Sum_probs=186.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.+ .++..||+|.+...... .....+.+|+.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~E~~ 56 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEE--------------------------GAPCTAIREVS 56 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEeccccc--------------------------CchhHHHHHHH
Confidence 3468999999999999999999864 57889999998543211 11234567999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.+ +..++......++.|++.||.|||+.+ ++|+|||
T Consensus 57 ~l~~l~h~nI~~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlk 131 (301)
T cd07873 57 LLKDLKHANIVTLHDIIHTEK--SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLK 131 (301)
T ss_pred HHHhcCCCCcceEEEEEecCC--eEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCC
Confidence 999999999999999998776 68889998864 223556667789999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.++++|||++........ ......++..|+|||.+.+. .++.++||| +|+++|+|++|..||...
T Consensus 132 p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~- 208 (301)
T cd07873 132 PQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS- 208 (301)
T ss_pred HHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC-
Confidence 9999999999999999999875432211 12234678899999998654 478899999 999999999999997532
Q ss_pred cccchhhHHHHHHHHhhhcCC---Ccccc---------ccccC----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENP---KRAID---------SKLVG----NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~---~~~~~---------~~~~~----~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+......+.. ....+ +.... ...+.....+.+++.+||+.||.+|||+.++++
T Consensus 209 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 209 ---TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ---CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 222222222222211110 00000 00000 001112335678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=264.64 Aligned_cols=239 Identities=26% Similarity=0.392 Sum_probs=185.1
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|.. +++.||+|.+.... ....+.+|
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~-----------------------------~~~~~~~e 49 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV-----------------------------TAQAFLEE 49 (254)
T ss_pred cccHHHceeeeeeccCCCCceEeccc---CCCceEEEeecCcc-----------------------------hHHHHHHH
Confidence 34557899999999999999999974 67889999985321 13467789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+.+++.++|||++++++.+..++ .+++++++.++.+ +++.....++.|++.|+.|||+.+ ++|
T Consensus 50 ~~~l~~~~~~~i~~~~~~~~~~~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H 123 (254)
T cd05083 50 TAVMTKLHHKNLVRLLGVILHNG---LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123 (254)
T ss_pred HHHHHhCCCCCcCeEEEEEcCCC---cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 99999999999999999886554 5788899877543 455666789999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
||+||+||+++.++.++++|||.+...... ......+..|+|||.+.+..++.++|+| +|+++|+|++ |..||
T Consensus 124 ~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 198 (254)
T cd05083 124 RDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198 (254)
T ss_pred cccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998754321 1223346789999999888899999999 9999999998 89996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
... ........+.... .+. ........+.+++.+||+.+|++||++.+++..|++
T Consensus 199 ~~~----~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 199 PKM----SLKEVKECVEKGY---RME----------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ccC----CHHHHHHHHhCCC---CCC----------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 432 2222222222111 110 011123457789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=270.05 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=188.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|++.+.||+|+||.||+|... .++..||+|.+...... ....+.+|+.
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~---------------------------~~~~~~~e~~ 69 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQP---------------------------KKELIINEIL 69 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcc---------------------------hHHHHHHHHH
Confidence 4569999999999999999999853 57889999998543211 2455778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++|||++++++.+..++ ..+++++|+.++.+ ++......++.|++.||.|||+.+ ++|+||||
T Consensus 70 ~l~~~~h~~v~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp 144 (296)
T cd06654 70 VMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKS 144 (296)
T ss_pred HHHhCCCCCEeeEEEEEEeCC--EEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 999999999999999888765 78999999988654 455667789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+| ||+++|+|++|..||.....
T Consensus 145 ~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~- 221 (296)
T cd06654 145 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP- 221 (296)
T ss_pred HHEEEcCCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 999999999999999998875432211 12235688999999999988889999999 99999999999999743211
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........ ....+.. .........+.+++.+||+.+|++|||+.++++
T Consensus 222 --~~~~~~~~----~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 222 --LRALYLIA----TNGTPEL--------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred --HHhHHHHh----cCCCCCC--------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11111111 1111100 011122345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=267.27 Aligned_cols=241 Identities=20% Similarity=0.328 Sum_probs=186.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+++ .++..||+|.+..... ......+.+|+.++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~--------------------------~~~~~~~~~e~~~l 53 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELD--------------------------ESKFNQIIMELDIL 53 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccC--------------------------HHHHHHHHHHHHHH
Confidence 47999999999999999999865 4789999998853211 22356788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC------------CCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR------------ELDWLARHRIALGLACGLEYLHMH-HCPRIIHRD 194 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH~d 194 (345)
++++||||+++++.+..++ .++++++|++++. .+++.....++.|++.||.|||+. + ++|+|
T Consensus 54 ~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~d 128 (286)
T cd06622 54 HKAVSPYIVDFYGAFFIEG--AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRD 128 (286)
T ss_pred HhcCCCcHHhhhhheecCC--eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCC
Confidence 9999999999999888766 6888999998753 456667788999999999999974 6 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc------cCccchhh-HHHHHHHHHhCC
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT------LTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~------~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|||+||+++.++.++++|||++....... .....++..|+|||.+.+.. ++.++|+| +|+++|+|++|.
T Consensus 129 l~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 204 (286)
T cd06622 129 VKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204 (286)
T ss_pred CCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCC
Confidence 99999999999999999999987653321 12346788999999986543 47899999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.||... ........+........+ ...+.....+.+++.+||+.+|++||++.++++
T Consensus 205 ~pf~~~----~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 205 YPYPPE----TYANIFAQLSAIVDGDPP----------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCc----chhhHHHHHHHHhhcCCC----------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 997532 222222222222211111 112223445778999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=286.01 Aligned_cols=251 Identities=19% Similarity=0.259 Sum_probs=176.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .++..||||++..... ....+..|+.
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~~----------------------------~~~~~~~e~~ 177 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVPK----------------------------YTRDAKIEIQ 177 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecchh----------------------------hHHHHHHHHH
Confidence 3578999999999999999999854 5788999999853211 1122334555
Q ss_pred HHhhc------cCCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCe
Q 046907 126 TVGQI------RHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHM-HHCPRI 190 (345)
Q Consensus 126 ~l~~l------~hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~-~~~~~i 190 (345)
+++.+ +|++++++++++..+.. .++++++++.+ ...+++.....++.|++.||.|||+ .+ |
T Consensus 178 ~l~~l~~~~~~~~~~i~~i~~~~~~~~~-~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---I 253 (467)
T PTZ00284 178 FMEKVRQADPADRFPLMKIQRYFQNETG-HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---L 253 (467)
T ss_pred HHHHHhhcCcccCcceeeeEEEEEcCCc-eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 55554 45568889888876543 57777776643 2235666778899999999999998 47 9
Q ss_pred EecCCCCCCeeecCCC----------------CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchh
Q 046907 191 IHRDLNPVNVLLDDDI----------------EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254 (345)
Q Consensus 191 iH~dlk~~nil~~~~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dv 254 (345)
+||||||+|||++.++ .+||+|||.+..... ......||..|+|||++.+..++.++||
T Consensus 254 iHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~Di 328 (467)
T PTZ00284 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDM 328 (467)
T ss_pred ecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHH
Confidence 9999999999998654 499999998754321 1234689999999999999999999999
Q ss_pred h-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcC---------------------CCcccccc----ccCCC-
Q 046907 255 Y-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASEN---------------------PKRAIDSK----LVGNG- 307 (345)
Q Consensus 255 w-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~----~~~~~- 307 (345)
| +||++|||++|..||... +..+....+........ .....++. .....
T Consensus 329 wSlGvil~elltG~~pf~~~----~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (467)
T PTZ00284 329 WSMGCIIYELYTGKLLYDTH----DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARP 404 (467)
T ss_pred HHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccc
Confidence 9 999999999999997542 22333333322211100 00000000 00000
Q ss_pred cH--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 308 CE--EQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 308 ~~--~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. .....+.+||..||+.||++|||+.|+++
T Consensus 405 ~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 405 VREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred hhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00 01245779999999999999999999986
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=263.40 Aligned_cols=249 Identities=22% Similarity=0.355 Sum_probs=187.9
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+...||+|+||.||+|... .++..+|+|.+......... +....+....+.+|+.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~------------------~~~~~~~~~~~~~e~~~l~ 61 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASS------------------KDRKRSMLDALAREIALLK 61 (267)
T ss_pred CccccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccch------------------hHHHHHHHHHHHHHHHHHH
Confidence 4778899999999999999854 56889999988654332211 0011234567889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+++||||+++++++..++ ..++++++++++.+ ++......++.|++.||.|||+.+ ++|+||+|+|
T Consensus 62 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~n 136 (267)
T cd06628 62 ELQHENIVQYLGSSLDAD--HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGAN 136 (267)
T ss_pred hcCCCCeeeEEEEEEeCC--ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHH
Confidence 999999999999988766 67788898877543 455666789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcc----eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTH----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+++.++.++|+|||.+......... .......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||....
T Consensus 137 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 137 ILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred EEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 99999999999999998866432111 111234678899999999988889999999 9999999999999975421
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.... +........+ ..+......+.+++.+||+.||.+||++.++++
T Consensus 217 ----~~~~---~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 217 ----QLQA---IFKIGENASP----------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HHHH---HHHHhccCCC----------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 1111111000 111122345778899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=264.25 Aligned_cols=240 Identities=23% Similarity=0.334 Sum_probs=180.3
Q ss_pred cccccCcceeeEEEEecCCCCc--eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-
Q 046907 54 EKIGSGGCGEVYKAELPGQNGR--MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI- 130 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 130 (345)
+.||+|+||.||+|++.. ++. .+|+|.+..... ......+.+|+.+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~~~--------------------------~~~~~~~~~E~~~l~~l~ 53 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYAS--------------------------KDDHRDFAGELEVLCKLG 53 (270)
T ss_pred CcCCCCCCceEEEEEEcC-CCCeeEEEEEEccccCC--------------------------HHHHHHHHHHHHHHHhhc
Confidence 468999999999998753 443 468888753211 12345678899999999
Q ss_pred cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHHHHHHHHHHHHHhhc
Q 046907 131 RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 131 ~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
+||||+++++++...+ .+++++++++++++ +++.....++.|++.|+.|||+.
T Consensus 54 ~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~ 131 (270)
T cd05047 54 HHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 131 (270)
T ss_pred cCCCeeeEEEEEecCC--CceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 8999999999988766 57888999876543 45566688999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
+ ++|+||||+||+++.++.++++|||++...... ........+..|+|||++.+..++.++|+| ||+++|||+
T Consensus 132 ~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~ 205 (270)
T cd05047 132 Q---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205 (270)
T ss_pred C---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHH
Confidence 8 999999999999999999999999998532211 111112335679999999888899999999 999999999
Q ss_pred h-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 265 M-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 265 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+ |..||... ...+....+.... ... ........+.+++.+||+.||.+|||+.++++.|+++
T Consensus 206 ~~g~~pf~~~----~~~~~~~~~~~~~---~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 206 SLGGTPYCGM----TCAELYEKLPQGY---RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred cCCCCCcccc----CHHHHHHHHhCCC---CCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 7 99997432 2222222221111 000 0111223578999999999999999999999999987
Q ss_pred hC
Q 046907 344 QH 345 (345)
Q Consensus 344 ~~ 345 (345)
.+
T Consensus 269 ~~ 270 (270)
T cd05047 269 LE 270 (270)
T ss_pred hC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.18 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=189.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|.+.+.||+|+||.||+|.+... +...||+|....... .+..+.+.+|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--------------------------~~~~~~~~~e 57 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--------------------------PSVREKFLQE 57 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--------------------------HHHHHHHHHH
Confidence 456799999999999999999986432 235689998854321 1225577889
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.++++++||||+++++++..+. .++++++++++++ +++..+..++.|++.||.|||+.+ ++|+
T Consensus 58 ~~~l~~~~h~~i~~~~~~~~~~~---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~ 131 (270)
T cd05056 58 AYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHR 131 (270)
T ss_pred HHHHHhCCCCchhceeEEEcCCC---cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 99999999999999999887543 5678888876533 566677789999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~ 271 (345)
||||+||+++.++.++++|||++......... ......++..|+|||.+....++.++||| +|+++||+++ |..||.
T Consensus 132 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred ccChheEEEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999998866443221 11223345679999999888899999999 9999999986 999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.. ........+........ .+.....+.+++.+||..+|++|||+.++++.|+++.
T Consensus 211 ~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 211 GV----KNNDVIGRIENGERLPM-------------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CC----CHHHHHHHHHcCCcCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 43 22222222222111110 1122335788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=265.52 Aligned_cols=243 Identities=22% Similarity=0.350 Sum_probs=183.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+.|++.+.||+|+||.||+|.+. .+++.||+|.+..... ....+.+|+.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~----------------------------~~~~~~~e~~ 54 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGD----------------------------EEEEIKQEIN 54 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCCc----------------------------cHHHHHHHHH
Confidence 5678999999999999999999864 5789999999864321 1345667889
Q ss_pred HHhhc-cCCCccceeEEEecCC----cceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPD----CHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+++++ +||||+++++.+...+ ...++++++++.++. .+++.....++.|++.|+.|||+.+
T Consensus 55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--- 131 (272)
T cd06637 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--- 131 (272)
T ss_pred HHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99888 7999999999887543 236789999997753 3556666789999999999999998
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHH
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el 263 (345)
++|+|++|+||+++.++.++|+|||++........ ......|+..|+|||++. +..++.++|+| +|+++|||
T Consensus 132 ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el 209 (272)
T cd06637 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209 (272)
T ss_pred CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999999876533211 223467899999999986 33577899999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++|..||..... ..... ...... . ...... .....+.+++.+||+.||.+|||+.+++.
T Consensus 210 ~~g~~p~~~~~~----~~~~~---~~~~~~-~-----~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 210 AEGAPPLCDMHP----MRALF---LIPRNP-A-----PRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HhCCCCccccCH----HHHHH---HHhcCC-C-----CCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 999999743211 11111 111110 0 000111 12235788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=263.16 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=186.1
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+.+.||+|+||.||+|.. .++..+|+|.+........ ...+....+.+|+.+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~~~---------------------~~~~~~~~~~~e~~~l~ 57 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVL---------------------AAEKEYEKLQEEVDLLK 57 (265)
T ss_pred CccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccchh---------------------hHHHHHHHHHHHHHHHH
Confidence 578899999999999999985 3788999999864332211 01233567889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
.++|+||+++++++...+ .++++++++.++.+ ++......++.|++.||.|||+.+ ++|+||+|+|
T Consensus 58 ~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 132 (265)
T cd06631 58 SLKHVNIVQYLGTCLDDN--TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNN 132 (265)
T ss_pred hcCCCCEeeEeeEeecCC--eEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHh
Confidence 999999999999988765 78899999987643 455566779999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCc----ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHT----HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+++.++.++++|||.+........ ........|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 133 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~- 211 (265)
T cd06631 133 VMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM- 211 (265)
T ss_pred EEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC-
Confidence 9999999999999999876532111 1112345688999999999988889999999 999999999999997432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.. ..... +. ........+.+++.+||+.+|++|||+.++++
T Consensus 212 ---~~~~~~~~~~~---~~~~~----~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 212 ---DRLAAMFYIGA---HRGLM----PR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---ChHHHHHHhhh---ccCCC----CC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111111111 10000 00 11122344678899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=274.28 Aligned_cols=191 Identities=22% Similarity=0.317 Sum_probs=152.1
Q ss_pred ccccccccC--cceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 51 ASLEKIGSG--GCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 51 ~~~~~iG~G--~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+++++||+| +|++||+++.+ .+|+.||+|.+...... ......+..|+.+++
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACT-------------------------NEMVTFLQGELHVSK 54 (327)
T ss_pred ChhhhccccccceEEEEEEeec-ccCcEEEEEEechhhcc-------------------------HHHHHHHHHHHHHHH
Confidence 467899999 67899999854 68999999998532111 223455677999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++++..++ ..+++++|++++.+ +++..+..++.|++.||.|||+.+ ++||||||
T Consensus 55 ~l~hpniv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp 129 (327)
T cd08227 55 LFNHPNIVPYRATFIADN--ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKA 129 (327)
T ss_pred hcCCCCeeeEEEEEEECC--EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCh
Confidence 999999999999998876 68889999886543 556677889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcc-----eeccCcccCccccccccccc--cccCccchhh-HHHHHHHHHhCCCC
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQM--LTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~--~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||+++.++.++++||+........... .......++..|+|||++.+ ..++.++||| +|+++|||++|..|
T Consensus 130 ~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 209 (327)
T cd08227 130 SHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209 (327)
T ss_pred hhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999865443221110 01122356778999999976 3588999999 99999999999999
Q ss_pred Ccc
Q 046907 270 SDK 272 (345)
Q Consensus 270 ~~~ 272 (345)
|..
T Consensus 210 f~~ 212 (327)
T cd08227 210 FKD 212 (327)
T ss_pred CCC
Confidence 754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=263.20 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=189.7
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|.+...++..+|+|.+......... ...........+..|+.++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~-----------------~~~~~~~~~~~~~~e~~~l~ 63 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGK-----------------DKRERDKSIGDIVSEVTIIK 63 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccc-----------------ccccchHHHHHHHHHHHHHh
Confidence 5889999999999999999986546889999998643221110 00011234566778888887
Q ss_pred h-ccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhh-cCCCCeEec
Q 046907 129 Q-IRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHM-HHCPRIIHR 193 (345)
Q Consensus 129 ~-l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~-~~~~~iiH~ 193 (345)
+ ++||||+++++++..++ ..+++++|+.++++ ++......++.|++.||.|||+ .+ ++|+
T Consensus 64 ~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~ 138 (269)
T cd08528 64 EQLRHPNIVRYYKTFLEND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHR 138 (269)
T ss_pred hcCCCCCeeeEEeeEccCC--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeec
Confidence 5 79999999999988766 68899999877544 4455667899999999999996 56 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||+|+||+++.++.++++|||.+....... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||..
T Consensus 139 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 139 DLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred CCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 999999999999999999999998654432 22346788999999999988899999999 99999999999999632
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
.........+......+... ......+.++|.+||+.||++||++.++..+++
T Consensus 216 ----~~~~~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 216 ----TNMLSLATKIVEAVYEPLPE------------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----cCHHHHHHHHhhccCCcCCc------------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 22222222222111111000 011234778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.87 Aligned_cols=237 Identities=24% Similarity=0.323 Sum_probs=181.3
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
+.||+|+||.||+|..+ ++..+|+|.+..... ......+.+|+.++++++||
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~ 52 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLP--------------------------QELKIKFLSEARILKQYDHP 52 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCC--------------------------HHHHHHHHHHHHHHHhCCCC
Confidence 46999999999999854 688999998864321 12234678899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
||+++++++...+ ..++++|+++++.+ +++.....++.|++.||.|+|+.+ ++|+|++|+||+++
T Consensus 53 ~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~ 127 (250)
T cd05085 53 NIVKLIGVCTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVG 127 (250)
T ss_pred CcCeEEEEEecCC--ccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEc
Confidence 9999999987765 57888999876543 455666789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhh
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMS 281 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~ 281 (345)
.++.++++|||++......... ......++..|+|||++.+..++.++|+| +|+++|++++ |..||... ....
T Consensus 128 ~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~----~~~~ 202 (250)
T cd05085 128 ENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM----TNQQ 202 (250)
T ss_pred CCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC----CHHH
Confidence 9999999999998754332211 11223446679999999888889999999 9999999998 99996432 2222
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
....+....... ........+.+++.+||+.+|++||++.++++.|+
T Consensus 203 ~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 203 AREQVEKGYRMS-------------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 222222111100 01112345888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=272.67 Aligned_cols=231 Identities=24% Similarity=0.311 Sum_probs=173.1
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHhhccC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN-TVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h 132 (345)
+.||+|+||.||+|+.. .+++.||+|.+...... .......+..|.. +++.++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~~e~~~~l~~~~h 55 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTIL------------------------KKKEQNHIMAERNVLLKNLKH 55 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHH------------------------HhhHHHHHHHHHHHHHHhCCC
Confidence 46999999999999854 57899999998531100 0122334445554 5788899
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++.+...+ .+++++||+.++.+ ++......++.|++.||.|||+.+ ++||||||+||+++
T Consensus 56 ~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~ 130 (321)
T cd05603 56 PFLVGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLD 130 (321)
T ss_pred CCccceeeEEEcCC--EEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC
Confidence 99999999887766 78999999988754 445556679999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.+||+|||++....... .......||+.|+|||.+.+..++.++||| +|+++|||++|..||.. .+....
T Consensus 131 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~----~~~~~~ 204 (321)
T cd05603 131 SQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS----RDVSQM 204 (321)
T ss_pred CCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC----CCHHHH
Confidence 99999999999987532221 122346789999999999988899999999 99999999999999743 222222
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
...+ ...+.. .++.....+.+++.+||+.||.+||++.
T Consensus 205 ~~~i---~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 205 YDNI---LHKPLQ-----------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHH---hcCCCC-----------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2222 111110 0111223477889999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=270.47 Aligned_cols=235 Identities=23% Similarity=0.279 Sum_probs=179.5
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|+.+ .+|+.||+|.+..... ........+..|..++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~~e~~~l~ 55 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVV------------------------IQDDDVECTMVEKRVLA 55 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hhhhHHHHHHHHHHHHH
Confidence 4788899999999999999864 5789999999852110 01223456677888888
Q ss_pred hcc-CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
.+. |++|+++++.+..++ .+++++||++++.+ +++.....++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~ 130 (323)
T cd05615 56 LQDKPPFLTQLHSCFQTVD--RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLD 130 (323)
T ss_pred hccCCCchhheeeEEecCC--EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 875 677888988887766 68999999988753 566677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.++|+|||++........ ......||..|+|||++.+..++.++|+| +|+++|+|++|..||...
T Consensus 131 Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---- 204 (323)
T cd05615 131 NVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE---- 204 (323)
T ss_pred HeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC----
Confidence 99999999999999999875432211 22345789999999999988899999999 999999999999997542
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
........+... ... . +......+.+++.+||+.+|.+|++.
T Consensus 205 ~~~~~~~~i~~~---~~~---~--------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 205 DEDELFQSIMEH---NVS---Y--------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CHHHHHHHHHhC---CCC---C--------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 222222222211 100 0 01112346788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=266.25 Aligned_cols=243 Identities=23% Similarity=0.376 Sum_probs=186.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||.|+||.||+|+++ .++..+|+|.+.... ......+..|+.+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~---------------------------~~~~~~~~~e~~~ 55 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHK-ETGLFAAAKIIQIES---------------------------EEELEDFMVEIDI 55 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEc-CCCcEEEEEEEeeCC---------------------------HHHHHHHHHHHHH
Confidence 467999999999999999999975 478999999985432 2235668889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++++||||+++++.+..++ .+++++++++++. .++......++.|++.||.|||+.+ ++|+|++
T Consensus 56 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~ 130 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLK 130 (280)
T ss_pred HHhCCCCceeEEEEEEecCC--eEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 99999999999999988765 6889999998753 3566677889999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
|+||+++.++.++++|||++........ ......|+..|+|||.+. ..+++.++|+| +|+++|+|++|..||
T Consensus 131 p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~ 208 (280)
T cd06611 131 AGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208 (280)
T ss_pred hhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCc
Confidence 9999999999999999998865433211 223456899999999985 34467799999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
... ..... +........+... ........+.+++..||+.+|.+||++.++++.
T Consensus 209 ~~~----~~~~~---~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 209 HEL----NPMRV---LLKILKSEPPTLD--------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ccC----CHHHH---HHHHhcCCCCCcC--------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 432 11111 1112111111000 011122346788899999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=278.10 Aligned_cols=195 Identities=24% Similarity=0.391 Sum_probs=161.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+++.||+|.+.... .........+..|+.++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~------------------------~~~~~~~~~~~~e~~~l 55 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKAD------------------------MLEKEQVAHIRAERDIL 55 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHH------------------------HhhhhhHHHHHHHHHHH
Confidence 47999999999999999999864 578999999985211 11123456778899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
..++||||+++++.+..++ .+++++||++++.+ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~l~~~~iv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~ 130 (360)
T cd05627 56 VEADGAWVVKMFYSFQDKR--NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPD 130 (360)
T ss_pred HhCCCCCEeeEEEEEEcCC--EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHH
Confidence 9999999999999988776 78999999988754 455566789999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcc---------------------------------eeccCcccCccccccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTH---------------------------------ITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------~~~~~~~gt~~~~aPE~~~~ 245 (345)
|||++.++.++|+|||++......... ......+||+.|+|||++.+
T Consensus 131 NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 210 (360)
T cd05627 131 NLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ 210 (360)
T ss_pred HEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC
Confidence 999999999999999998754321100 00123579999999999999
Q ss_pred cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 246 LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 246 ~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
..++.++||| +|+++|||++|..||..
T Consensus 211 ~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred CCCCCcceeccccceeeecccCCCCCCC
Confidence 8999999999 99999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=274.29 Aligned_cols=232 Identities=25% Similarity=0.325 Sum_probs=173.7
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHhhccC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN-TVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h 132 (345)
+.||+|+||.||+|+.. .+|..||+|.+...... .......+..|.. +++.++|
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~~e~~~~l~~~~h 55 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVL------------------------NRKEQKHIMAERNVLLKNVKH 55 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hhhHHHHHHHHHHHHHHhCCC
Confidence 46999999999999854 57999999998531100 0122344455554 4677899
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++.+..++ .++++++|+.++.+ ++......++.|++.||.|||+.+ ++||||||+|||++
T Consensus 56 p~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~ 130 (325)
T cd05604 56 PFLVGLHYSFQTTE--KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLD 130 (325)
T ss_pred CCCccEEEEEecCC--EEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEEC
Confidence 99999999888776 78899999988654 456667789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.+||+|||++........ ......||..|+|||.+.+..++.++||| +|+++|+|++|..||... +....
T Consensus 131 ~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~----~~~~~ 204 (325)
T cd05604 131 SQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR----DVAEM 204 (325)
T ss_pred CCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC----CHHHH
Confidence 999999999999875322111 22346789999999999998999999999 999999999999997432 22222
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
.. ........ .. + .....+.+++..|++.+|.+||++.+
T Consensus 205 ~~---~~~~~~~~---~~----~----~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 205 YD---NILHKPLV---LR----P----GASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HH---HHHcCCcc---CC----C----CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 22 11111110 00 1 11234668888999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=260.53 Aligned_cols=241 Identities=24% Similarity=0.398 Sum_probs=184.2
Q ss_pred cccccCcceeeEEEEecCCCC--ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 54 EKIGSGGCGEVYKAELPGQNG--RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
+.||+|++|.||+|.+....+ ..||+|.+...... ...+.+.+|+.++++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~e~~~l~~l~ 54 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--------------------------DIMDDFLKEAAIMHSLD 54 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--------------------------HHHHHHHHHHHHHhhcC
Confidence 468999999999999754333 36999998653221 33677889999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
||||+++++.+.. ...+++++++.++. .+++.....++.|++.||.|||+.+ ++|+||+|+||
T Consensus 55 h~~iv~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~ni 128 (257)
T cd05040 55 HENLIRLYGVVLT---HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNI 128 (257)
T ss_pred CCCccceeEEEcC---CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccE
Confidence 9999999998876 36788888887643 3456677789999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccccccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHT 277 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~ 277 (345)
+++.++.+|++|||++......... .......++..|+|||.+.+..++.++||| +|+++|+|++ |..||...
T Consensus 129 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---- 204 (257)
T cd05040 129 LLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL---- 204 (257)
T ss_pred EEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC----
Confidence 9999999999999999876542221 112234567889999999988899999999 9999999998 99996432
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
...+....+... ..... .....+..+.+++..||+.+|++|||+.++++.|..
T Consensus 205 ~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 205 SGSQILKKIDKE--GERLE----------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CHHHHHHHHHhc--CCcCC----------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 222222222211 00000 011123457889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=273.10 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=190.9
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+..+...|+++++||+|+.+.||++.. .+...||+|.+.-...+ ......+.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~~~~~D-------------------------~qtl~gy~n 408 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLN--SDKQIYALKKVVLLEAD-------------------------NQTLDGYRN 408 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeec--CCCcchhhhHHHHhhcC-------------------------HHHHHHHHH
Confidence 345777999999999999999999974 35667888876432222 456889999
Q ss_pred HHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+..|.+| .|.+||+++++-..++ ++|++||+.+- ....+-..+..+-.|++.++.++|..| |||
T Consensus 409 EI~lL~KLkg~~~IIqL~DYEv~d~--~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVH 483 (677)
T KOG0596|consen 409 EIALLNKLKGHDKIIQLYDYEVTDG--YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVH 483 (677)
T ss_pred HHHHHHHhcCCceEEEEeeeeccCc--eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eee
Confidence 99999999 5999999999988876 89999998653 122221256678899999999999999 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-----------cCccchhh-HHHHH
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-----------LTEKCDIY-FGALL 260 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-----------~~~~~Dvw-lG~vl 260 (345)
.||||.|+|+-. |.+||+|||.|..+............+||+.||+||.+.... .++++||| +||+|
T Consensus 484 SDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCIL 562 (677)
T KOG0596|consen 484 SDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCIL 562 (677)
T ss_pred cCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHH
Confidence 999999998764 489999999999887776666667789999999999984322 46799999 99999
Q ss_pred HHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCC-ccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 261 AGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPK-RAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 261 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|+|+.|+.||.. +.+.+.+......+. .+..+.+.+. . .+.++|..||++||++|||..++++
T Consensus 563 YqMvYgktPf~~---------~~n~~aKl~aI~~P~~~Iefp~~~~~----~--~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 563 YQMVYGKTPFGQ---------IINQIAKLHAITDPNHEIEFPDIPEN----D--ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHhcCCchHH---------HHHHHHHHHhhcCCCccccccCCCCc----h--HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 999999999643 333333333333331 1111111111 1 1889999999999999999999986
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=264.61 Aligned_cols=245 Identities=22% Similarity=0.342 Sum_probs=185.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||+|.+..... .....+.+|+.
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~---------------------------~~~~~~~~e~~ 58 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPG---------------------------EDFAVVQQEII 58 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCch---------------------------hHHHHHHHHHH
Confidence 4568999999999999999999854 5789999999854321 12345668999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++.+...+ .+++++++++++.+ ++......++.|++.|+.|||+.+ ++|+|||
T Consensus 59 ~~~~l~h~~ii~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk 133 (267)
T cd06645 59 MMKDCKHSNIVAYFGSYLRRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIK 133 (267)
T ss_pred HHHhCCCCCeeeEEEEEEeCC--EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 999999999999999988766 68899999987544 456677889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+||+++.++.++++|||++....... .......|+..|+|||.+. ...++.++|+| +|+++|+|++|..||..
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 134 GANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred HHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 999999999999999999987654321 1223457899999999874 44578899999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... .......... ...+.. ... .......+.+++.+||+.+|++|||+++|++
T Consensus 212 ~~~---~~~~~~~~~~---~~~~~~-~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 212 LHP---MRALFLMTKS---NFQPPK-LKD------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc---hhhHHhhhcc---CCCCCc-ccc------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 211 1111111110 000000 000 0011234778899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=266.61 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=182.6
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+.+.||+|++|.||+|+.+ .++..||+|.+.....+ ......+.+|+.+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEE-------------------------EGVPSTAIREISLLK 54 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-CCCcEEEEEEecccccc-------------------------CCchHHHHHHHHHHH
Confidence 5889999999999999999864 57899999998543211 112345677999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++++..++ .++++++++.+. ..++......++.|++.||.|||+.+ ++|+||+|
T Consensus 55 ~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p 129 (285)
T cd07861 55 ELQHPNIVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKP 129 (285)
T ss_pred hcCCCCEeeeEEEEeeCC--eEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCH
Confidence 999999999999988766 678888887641 34677777889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+| +|+++|+|++|..||.....
T Consensus 130 ~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 130 QNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred HHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999999876543211 12234678899999988764 468899999 99999999999999753211
Q ss_pred ccchhhHHHHHHHHhhhcCC------------Cccc---cccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENP------------KRAI---DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
............ .... .... ...............+.+++.+||+.||.+|||+.+|++
T Consensus 208 ---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 208 ---IDQLFRIFRILG-TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred ---HHHHHHHHHHhC-CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 111111111100 0000 0000 000000001112345678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.34 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=190.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++++.||.|+||.||++... .++..+|+|.+...... .....++..|+.+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMT-------------------------EKEKQQLVSEVNILR 54 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCC-------------------------HHHHHHHHHHHHHHH
Confidence 5889999999999999999854 57889999998643222 223566778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHh-----hcCCCCe
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLH-----MHHCPRI 190 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh-----~~~~~~i 190 (345)
+++||||+++++.+.......+++++++++++++ +++.....++.|++.||.||| +.+ +
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i 131 (265)
T cd08217 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---V 131 (265)
T ss_pred hcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---c
Confidence 9999999999998877666678999999987543 455566789999999999999 666 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+|+|++|+||+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++++|++|..|
T Consensus 132 ~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 209 (265)
T cd08217 132 LHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209 (265)
T ss_pred eecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCc
Confidence 9999999999999999999999999987644321 12345789999999999988889999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|... +.......+...... .........+.+++..||+.+|++|||+.+|++
T Consensus 210 ~~~~----~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 210 FTAR----NQLQLASKIKEGKFR-------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ccCc----CHHHHHHHHhcCCCC-------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 7542 222222222211110 111223345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=269.63 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=184.9
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|++. .+|+.+|+|.+...... ......+.+|+.+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~-------------------------~~~~~~~~~ei~~l~ 54 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDD-------------------------EGVPSSALREICLLK 54 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-CCCcEEEEEEeeccccc-------------------------ccCccchhHHHHHHH
Confidence 5889999999999999999964 57899999998643211 111345667999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
.++||||+++++++...+ .++++++|+++ +..+++.....++.|+++||.|||+.+ ++|+||||+|
T Consensus 55 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~n 129 (284)
T cd07839 55 ELKHKNIVRLYDVLHSDK--KLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQN 129 (284)
T ss_pred hcCCCCeeeHHHHhccCC--ceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHH
Confidence 999999999999987665 67888888864 233567777899999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.++||| +|+++|+|++|..|+. ...
T Consensus 130 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~---~~~ 204 (284)
T cd07839 130 LLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF---PGN 204 (284)
T ss_pred EEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc---CCC
Confidence 9999999999999999876543211 122356788999999987654 68899999 9999999999988852 222
Q ss_pred chhhHHHHHHHHhhhcCCC------cccc----cccc-----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPK------RAID----SKLV-----GNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~------~~~~----~~~~-----~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+......+... ...+ +... ....+.....+.+++.+||+.||.+|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 205 DVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 2222222222221111000 0000 0000 0011123356778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.92 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=193.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.+-|.++.+||+|+||.||++.++ .+|..+|||.+.- ..+.+++.+|+.+
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV-----------------------------~sDLQEIIKEISI 81 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPV-----------------------------DTDLQEIIKEISI 81 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCc-----------------------------cchHHHHHHHHHH
Confidence 346889999999999999999865 6899999999843 2457888999999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.+.|++|++||.+.-.. -+|++||||..|+. +....+..++.+.++||+|||... -+|||+|
T Consensus 82 MQQC~S~yVVKYYGSYFK~s--DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIK 156 (502)
T KOG0574|consen 82 MQQCKSKYVVKYYGSYFKHS--DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIK 156 (502)
T ss_pred HHHcCCchhhhhhhhhccCC--ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcc
Confidence 99999999999999766443 49999999987754 455566678899999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+.|||++.+|.+|++|||+|-.+.+.-. ..++..||+.|||||++....|+.++||| +|++..||..|++||.+..+
T Consensus 157 AGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 157 AGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred cccEEEcccchhhhhhccccchhhhhHH--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 9999999999999999999987754322 33568999999999999999999999999 99999999999999765433
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++.-.- + +..+++.+. -++.-..++-+++.+||-.+|++|-|+-++++
T Consensus 235 MRAIFM-------I--PT~PPPTF~------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 235 MRAIFM-------I--PTKPPPTFK------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred cceeEe-------c--cCCCCCCCC------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 221000 0 111111111 12334566888999999999999999988875
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=265.69 Aligned_cols=249 Identities=21% Similarity=0.367 Sum_probs=191.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++++.||+|+||.||++.+. .+|..||+|.+..... ......+.+|+.
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~--------------------------~~~~~~~~~E~~ 55 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAK--------------------------SSVRKQILRELQ 55 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCc--------------------------chHHHHHHHHHH
Confidence 3568999999999999999999864 5789999998853211 122456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMH-HCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH~dl 195 (345)
+++.++||||+++++.+..++ .+++++||++++.+ +++.....++.+++.||.|||+. + ++|+|+
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl 130 (284)
T cd06620 56 IMHECRSPYIVSFYGAFLNEN--NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDI 130 (284)
T ss_pred HHHHcCCCCcceEeeeEecCC--EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCC
Confidence 999999999999999998775 78999999988654 44556678999999999999974 5 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+|+||+++.++.++++|||++...... ......|+..|+|||++.+..++.++|+| +|+++|++++|..||....
T Consensus 131 ~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 131 KPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred CHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999998654322 12235789999999999888889999999 9999999999999986543
Q ss_pred cc----cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 275 QH----TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 275 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.. ..................+. .. .......+.+++..||+.||++|||+.++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 207 IDDDGQDDPMGILDLLQQIVQEPPPR------LP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhhhhhhhhhHHHHHHHHHhhccCCC------CC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 32 11112223332222111110 00 11133457889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=263.47 Aligned_cols=241 Identities=28% Similarity=0.428 Sum_probs=188.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||.|+||.||+|+.. .++..||+|.+..... ......+.+|+.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~--------------------------~~~~~~~~~e~~~l 53 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEA--------------------------EDEIEDIQQEIQFL 53 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeecccc--------------------------chHHHHHHHHHHHH
Confidence 47899999999999999999864 5789999999853211 12245677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+.++||||+++++.+..+. .++++++++.++. .+++.....++.|++.|+.|||+.+ ++|+|++|+|
T Consensus 54 ~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~n 128 (274)
T cd06609 54 SQCRSPYITKYYGSFLKGS--KLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAAN 128 (274)
T ss_pred HHcCCCCeeeeeEEEEECC--eEEEEEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 9999999999999887664 7899999998764 4567777899999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
|+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||....
T Consensus 129 i~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~---- 202 (274)
T cd06609 129 ILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH---- 202 (274)
T ss_pred EEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc----
Confidence 9999999999999999987654321 22345788899999999988899999999 9999999999999975322
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+.... .+ ..... .....+.+++.+||+.+|++|||++++++
T Consensus 203 ~~~~~~~~~~~~---~~------~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 203 PMRVLFLIPKNN---PP------SLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hHHHHHHhhhcC---CC------CCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111111111 10 00001 02334778889999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=259.38 Aligned_cols=241 Identities=23% Similarity=0.337 Sum_probs=186.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++++.||+|++|.||+++.+ .+++.||+|.+...... ......+.+|+.+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNAS-------------------------RRERKAAEQEAQLLS 54 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcC-------------------------HHHHHHHHHHHHHHH
Confidence 5899999999999999999864 56889999998532111 223556788999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++|||++++++.+...+ ..+++++++++++.+ +++.....++.+++.|+.+||+.+ ++|+||+|
T Consensus 55 ~l~~~~i~~~~~~~~~~~-~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p 130 (257)
T cd08223 55 QLKHPNIVAYRESWEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKT 130 (257)
T ss_pred hCCCCCeeeeeeeecCCC-CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCc
Confidence 999999999998775443 368899999876543 456667889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++........ ......|++.|+|||.+.+..++.++|+| +|+++++|++|..||...
T Consensus 131 ~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--- 205 (257)
T cd08223 131 QNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--- 205 (257)
T ss_pred hhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---
Confidence 999999999999999999876643221 22345688999999999988899999999 999999999999996431
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+...... .......+ .........+.+++.+||+.||++|||+.++++
T Consensus 206 -~~~~~~~---~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 206 -DMNSLVY---RIIEGKLP----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CHHHHHH---HHHhcCCC----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2112111 11111111 011223345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=267.38 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=186.8
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+++ .+|+.||+|.+...... ....+.+.+|+.++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~-------------------------~~~~~~~~~e~~~l 54 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDD-------------------------PVIKKIALREIRML 54 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccC-------------------------ccccHHHHHHHHHH
Confidence 47999999999999999999864 56899999988532111 11134567899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++|||++++++++..++ .+++++++++++ ..+++..+..++.|++.||.|||+.+ ++|+||||+
T Consensus 55 ~~~~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~ 129 (286)
T cd07847 55 KQLKHPNLVNLIEVFRRKR--KLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPE 129 (286)
T ss_pred HhCCCCCEeeeeeEEeeCC--EEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChh
Confidence 9999999999999988765 678899998764 23677788899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+| +|+++|+|++|..||.+...
T Consensus 130 nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~- 206 (286)
T cd07847 130 NILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD- 206 (286)
T ss_pred hEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-
Confidence 99999999999999999987644321 1223567889999999876 4478899999 99999999999999754322
Q ss_pred cchhhHHHHHHHHhhhcCC------------Cc--cccccccC---CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENP------------KR--AIDSKLVG---NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~------------~~--~~~~~~~~---~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+....+......... .. ...+.... ...+.....+.+++.+||+.+|++|||+.+++.
T Consensus 207 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 207 ---VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ---HHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 1111111111100000 00 00000000 001122355788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=259.69 Aligned_cols=244 Identities=26% Similarity=0.398 Sum_probs=187.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||.|+||.||+|... .+++.+++|.+..... .....+.+|+.+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~---------------------------~~~~~~~~e~~~ 53 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPG---------------------------DDFEIIQQEISM 53 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCch---------------------------hhHHHHHHHHHH
Confidence 468999999999999999999864 4678899999864321 125667789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++.+...+ .+++++++++++. .++......++.|++.||.|||+.+ ++|+||+
T Consensus 54 l~~~~h~~i~~~~~~~~~~~--~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~ 128 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIK 128 (262)
T ss_pred HHhCCCCChhceEEEEEeCC--EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCC
Confidence 99999999999999887766 6888999987643 3556666789999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc---ccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML---TLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~---~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+| +|+++|+|++|..||..
T Consensus 129 p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 129 GANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred hhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999876543211 12335788899999999776 788899999 99999999999999754
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ............ .+. . ..........+.+++.+||+.+|.+|||+.+++.
T Consensus 207 ~~~---~~~~~~~~~~~~---~~~-----~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 207 LHP---MRALFLISKSNF---PPP-----K--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCH---HHHHHHHHhccC---CCc-----c--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 221 111111111000 000 0 0112233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=263.88 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=181.5
Q ss_pred cccccCcceeeEEEEecC-----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 54 EKIGSGGCGEVYKAELPG-----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+.||+|+||.||+|++.. ..+..+|+|.+..... ......+.+|+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--------------------------~~~~~~~~~e~~~l~ 54 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--------------------------DQEKKEFLKEAHLMS 54 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--------------------------hhhHHHHHHHHHHHH
Confidence 468999999999998642 2236789998743210 123556788999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCCC----------------CHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL----------------DWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l----------------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
.++||||+++++++...+ ..++++++++++.+. ++.....++.|++.||.|||+.+ ++|
T Consensus 55 ~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H 129 (269)
T cd05044 55 NFNHPNIVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIH 129 (269)
T ss_pred hcCCCCeeeEeeeecCCC--CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999887665 578888988775543 44556679999999999999998 999
Q ss_pred cCCCCCCeeecCCC-----CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-
Q 046907 193 RDLNPVNVLLDDDI-----EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM- 265 (345)
Q Consensus 193 ~dlk~~nil~~~~~-----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t- 265 (345)
+|++|+||+++.+. .++++|||++................++..|+|||.+.+..++.++||| ||+++|+|++
T Consensus 130 ~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~ 209 (269)
T cd05044 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209 (269)
T ss_pred CCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHc
Confidence 99999999999877 8999999998765433222222234557889999999988899999999 9999999998
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
|..||... ...+....+.... .. .........+.+++.+||+.+|.+||++.++++.|++
T Consensus 210 g~~p~~~~----~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 210 GQQPYPAL----NNQEVLQHVTAGG---RL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCCCCccc----CHHHHHHHHhcCC---cc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 99996532 2223333222111 00 0111223457889999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.72 Aligned_cols=193 Identities=25% Similarity=0.349 Sum_probs=158.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+++.. .+++.||+|.+... +.........+.+|+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~------------------------~~~~~~~~~~~~~e~~~l 55 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKW------------------------EMLKRAETACFREERDVL 55 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHH------------------------HHhhhhhHHHHHHHHHHH
Confidence 57999999999999999999864 57899999998421 111123356678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCC----------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL----------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l----------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
..++||||+++++.+..++ .+++++||+.++.+. +...+..++.|++.||.|||+.+ ++||||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp 130 (331)
T cd05597 56 VNGDRRWITNLHYAFQDEN--NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKP 130 (331)
T ss_pred HhCCCCCCCceEEEEecCC--eEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCH
Confidence 9999999999999988776 789999999886654 34455678999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----cccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----LTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
+|||++.++.++|+|||++......... ......||+.|+|||++.+ ..++.++||| +|+++|+|++|..||.
T Consensus 131 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 131 DNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred HHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 9999999999999999998765433221 1223568999999999973 3467899999 9999999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=259.67 Aligned_cols=241 Identities=20% Similarity=0.314 Sum_probs=188.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|+.++.||.|+||.||.++.. .++..+++|.+.....+ ......+.+|+.+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLS-------------------------EKERRDALNEIVILS 54 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccc-------------------------hhHHHHHHHHHHHHH
Confidence 5899999999999999999854 57889999998543222 223556789999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++||||+++++++...+ .+++++++++++++ ++......++.|++.|+.|||+.+ ++|+||+|
T Consensus 55 ~~~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p 129 (256)
T cd08221 55 LLQHPNIIAYYNHFMDDN--TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKT 129 (256)
T ss_pred hCCCCCeeEEEeEEecCC--eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCh
Confidence 999999999999998765 68889999987543 455666789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.+|++|||.+........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 130 ~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--- 204 (256)
T cd08221 130 LNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--- 204 (256)
T ss_pred HhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---
Confidence 999999999999999999886644332 22345789999999999888888999999 999999999999996431
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
...+....+ ....... ........+.+++..||+.+|++||++.++++.
T Consensus 205 -~~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 205 -NPLNLVVKI---VQGNYTP----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CHHHHHHHH---HcCCCCC----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 222222222 1111110 011223447788889999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.67 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=187.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
.+|.+.+.||+|+||.||+|... .+|..||+|.+......... ......+.+|+.++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~----------------------~~~~~~~~~E~~~l 58 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPET----------------------SKEVNALECEIQLL 58 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCccc----------------------HHHHHHHHHHHHHH
Confidence 57999999999999999999854 67999999988543221100 12356788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+..+....+++++++++++.+ ++......++.|++.||.|||+.+ ++|+||+|+
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~ 135 (265)
T cd06652 59 KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGA 135 (265)
T ss_pred HhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 99999999999998877655578889999987654 344456789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++|+|||++......... .......|+..|+|||.+.+..++.++|+| ||+++|+|++|..||....
T Consensus 136 nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-- 213 (265)
T cd06652 136 NILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-- 213 (265)
T ss_pred HEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--
Confidence 999999999999999998765332111 112335688899999999888889999999 9999999999999975321
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. ..+........ .+..+......+.+++.+||. +|++||+++++++
T Consensus 214 -~~----~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 214 -AM----AAIFKIATQPT---------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -hH----HHHHHHhcCCC---------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11 11111111110 011222334457788888884 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=264.49 Aligned_cols=265 Identities=17% Similarity=0.173 Sum_probs=177.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCC--CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQN--GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|++.+.||+|+||.||+|++.... +..+|+|.......... . ...............+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~---~-------------e~~~~~~~~~~~~~~~ 73 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIV---M-------------ETLVYNNIYDIDKIAL 73 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchh---h-------------HHHHHHhhhhHHHHHH
Confidence 4579999999999999999999975321 55677775432111100 0 0000001112223345
Q ss_pred HHHHhhccCCCccceeEEEecCCcc--eeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCH--LLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~--~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
...+..++|+|++++++.+...... ..+++++.+.. ....+......++.|++.||.|||+.+ ++||
T Consensus 74 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHr 150 (294)
T PHA02882 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHG 150 (294)
T ss_pred HHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5566778999999999876554422 23444444322 112345566789999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcc-----eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
||||+|||++.++.++|+|||+++........ .......||+.|+|||...+..++.++||| +|+++|||++|.
T Consensus 151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~ 230 (294)
T PHA02882 151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230 (294)
T ss_pred CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999866432111 112235799999999999999999999999 999999999999
Q ss_pred CCCcccccccchhhH--HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 268 LPSDKFFQHTNEMSF--VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
.||............ ..++........ . .+.....+.+++..||+.+|++||++.++++.|+
T Consensus 231 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 231 LPWKGFGHNGNLIHAAKCDFIKRLHEGKI---------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCCCccccchHHHHHhHHHHHHHhhhhhh---------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 998654221111110 111111111100 0 0111244778888899999999999999998763
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.43 Aligned_cols=258 Identities=20% Similarity=0.243 Sum_probs=190.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+.||+|+||.||+|+++ .+++.+|+|.+.....+ ......+.+|+.
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~ 56 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEK-------------------------EGFPITSLREIN 56 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeecccc-------------------------ccchhhHHHHHH
Confidence 3468999999999999999999975 56899999999643222 111334667999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++++||||+++++++..++...++++++++.+ ...+++.....++.|++.||.|||+.+ ++|+||+
T Consensus 57 ~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~ 133 (293)
T cd07843 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLK 133 (293)
T ss_pred HHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCC
Confidence 9999999999999999887755578999999865 123677778899999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.++++|||++........ ......++..|+|||.+.+.. ++.++|+| +|+++|+|++|..||....
T Consensus 134 p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 134 TSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred HHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987654321 123356788999999987654 68899999 9999999999999975432
Q ss_pred cccchhhHHHHHHHHhhhcCC-----------------CccccccccCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENP-----------------KRAIDSKLVGNGCEE-QMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~-~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
. ......+......+.. .......+....... ....+.+++.+||+.||++|||+.|+
T Consensus 212 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el 287 (293)
T cd07843 212 E----IDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287 (293)
T ss_pred h----HHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence 2 2222222111111000 000000000111111 24457789999999999999999999
Q ss_pred HH
Q 046907 337 RR 338 (345)
Q Consensus 337 l~ 338 (345)
++
T Consensus 288 l~ 289 (293)
T cd07843 288 LK 289 (293)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.26 Aligned_cols=241 Identities=21% Similarity=0.379 Sum_probs=178.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT- 126 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~- 126 (345)
++|++.+.||+|+||.||+|++. .+|+.||+|.+....... ....+..|..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~--------------------------~~~~~~~e~~~~ 53 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQ--------------------------EQKRLLMDLDIS 53 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcH--------------------------HHHHHHHHHHHH
Confidence 47999999999999999999864 579999999986432111 11233345554
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEec
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMH-HCPRIIHR 193 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH~ 193 (345)
++..+||||+++++++..++ .++++++++++. ..+++..+..++.|++.||.|||++ + ++||
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~ 128 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREG--DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHR 128 (283)
T ss_pred HHHcCCCCeeeeeEEEecCC--cEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecC
Confidence 55679999999999988766 578888887642 2356777889999999999999997 7 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc----cccCccchhh-HHHHHHHHHhCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM----LTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~----~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
|+||+||+++.++.+||+|||++....... ......|+..|+|||.+.+ ..++.++|+| +|+++|+|++|..
T Consensus 129 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (283)
T cd06617 129 DVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF 205 (283)
T ss_pred CCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCC
Confidence 999999999999999999999987654321 1123467889999998865 3467899999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||..... ..+. +........+ ..... .....+.+++..||+.+|++|||+.++++
T Consensus 206 p~~~~~~---~~~~---~~~~~~~~~~------~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 206 PYDSWKT---PFQQ---LKQVVEEPSP------QLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCcccc---CHHH---HHHHHhcCCC------CCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9743211 1111 1111111111 00001 12345788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.73 Aligned_cols=230 Identities=19% Similarity=0.273 Sum_probs=171.5
Q ss_pred cccccCcceeeEEEEecCC-----------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 54 EKIGSGGCGEVYKAELPGQ-----------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+.||+|+||.||+|++..+ ....|++|.+.... ......+.+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---------------------------~~~~~~~~~ 53 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---------------------------RDISLAFFE 53 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---------------------------hhHHHHHHH
Confidence 4689999999999986422 12358888874321 122456778
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.+++.++||||+++++++..+. ..++++++++++. .+++....+++.|+++|+.|||+.+ ++|
T Consensus 54 ~~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 128 (262)
T cd05077 54 TASMMRQVSHKHIVLLYGVCVRDV--ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVH 128 (262)
T ss_pred HHHHHHhCCCCCEeeEEEEEecCC--CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eEC
Confidence 899999999999999999988765 5678888887653 3566777889999999999999998 999
Q ss_pred cCCCCCCeeecCCCC-------eEEeccccceecCCCCcceeccCcccCcccccccccc-ccccCccchhh-HHHHHHHH
Q 046907 193 RDLNPVNVLLDDDIE-------ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-MLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 193 ~dlk~~nil~~~~~~-------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-~~~~~~~~Dvw-lG~vl~el 263 (345)
|||||+|||++.++. ++++|||++...... ....++..|+|||.+. +..++.++||| ||+++|||
T Consensus 129 ~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el 202 (262)
T cd05077 129 GNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202 (262)
T ss_pred CCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHH
Confidence 999999999986654 899999998654322 2356788999999987 45688899999 99999999
Q ss_pred H-hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 264 V-MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 264 ~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
+ +|..||... ...+...... .... .. ......+.++|..||+.||++||++.+|++.|
T Consensus 203 ~~~~~~p~~~~----~~~~~~~~~~----~~~~-------~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 203 CYNGEIPLKDK----TLAEKERFYE----GQCM-------LV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhCCCCCCCCc----chhHHHHHHh----cCcc-------CC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 8 588885432 1111111110 0000 00 01123578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=271.58 Aligned_cols=257 Identities=23% Similarity=0.335 Sum_probs=188.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|+..+.||+|+||.||+|+.. .+++.||+|.+.....+ ......+.+|+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 67 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQN-------------------------VTHAKRAYRELV 67 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccC-------------------------hhHHHHHHHHHH
Confidence 4568999999999999999999854 57999999998532211 122445668999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGR------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++..++. ..++++++++.+. ..++......++.|++.||.|||+.+ ++||||
T Consensus 68 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dl 144 (353)
T cd07850 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144 (353)
T ss_pred HHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 9999999999999998865432 3578999998652 12566677789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+||+++.++.++++|||++........ .....++..|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 145 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~- 220 (353)
T cd07850 145 KPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT- 220 (353)
T ss_pred CHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC-
Confidence 99999999999999999999986543221 2335678899999999998999999999 999999999999997532
Q ss_pred cccchhhHHHHHHHHhhhcC------------------CC-------cccccccc----CCCcHHHHHHHHHHHhhccCC
Q 046907 275 QHTNEMSFVKWMRNVMASEN------------------PK-------RAIDSKLV----GNGCEEQMLLVLKIACFCTLE 325 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~------------------~~-------~~~~~~~~----~~~~~~~~~~l~~li~~Cl~~ 325 (345)
+.......+......+. +. ........ ..........+.+++.+||+.
T Consensus 221 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 297 (353)
T cd07850 221 ---DHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVI 297 (353)
T ss_pred ---CHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCC
Confidence 11111111111111100 00 00000000 000112345578999999999
Q ss_pred CCCCCCCHHHHHH
Q 046907 326 DPNERPNSKDVRR 338 (345)
Q Consensus 326 dp~~Rpt~~~ll~ 338 (345)
||.+|||+.++++
T Consensus 298 dP~~R~t~~eiL~ 310 (353)
T cd07850 298 DPEKRISVDDALQ 310 (353)
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=266.23 Aligned_cols=243 Identities=25% Similarity=0.351 Sum_probs=187.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|++.+.||.|+||.||+|... .++..||+|.+..... .....+.+|+.
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~---------------------------~~~~~~~~e~~ 68 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQ---------------------------PKKELIINEIL 68 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccC---------------------------chHHHHHHHHH
Confidence 3457999999999999999999853 5789999998853211 12455778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++|||++++++++..++ .++++++++.++.+ +++..+..++.|++.|+.|||+.+ ++|+||+|
T Consensus 69 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p 143 (296)
T cd06655 69 VMKELKNPNIVNFLDSFLVGD--ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKS 143 (296)
T ss_pred HHHhcCCCceeeeeeeEecCc--eEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 999999999999999987765 68899999987644 567778889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| ||+++|+|++|..||....
T Consensus 144 ~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~-- 219 (296)
T cd06655 144 DNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-- 219 (296)
T ss_pred HHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 999999999999999999876543221 12335688899999999988899999999 9999999999999974321
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+.. ...+.. .........+.++|.+||+.||.+|||+.++++
T Consensus 220 --~~~~~~~~~~---~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 220 --PLRALYLIAT---NGTPEL--------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --HHHHHHHHHh---cCCccc--------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1111111111 111000 011112234778899999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=258.00 Aligned_cols=240 Identities=25% Similarity=0.420 Sum_probs=187.2
Q ss_pred cccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 54 EKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
+.||+|+||.||+|.+.. ..+..|++|.+...... .....+..|+..++.++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--------------------------~~~~~~~~e~~~l~~~~ 54 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--------------------------EERKDFLKEARVMKKLG 54 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--------------------------hHHHHHHHHHHHHhhcC
Confidence 469999999999999752 12889999998653221 12567788999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCC------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGR------------------RELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
|||++++++++.... .++++++++.++ ..+++.....++.|++.||.|||+.+ ++|+
T Consensus 55 ~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~ 129 (262)
T cd00192 55 HPNVVRLLGVCTEEE--PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHR 129 (262)
T ss_pred CCChheeeeeecCCC--ceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccC
Confidence 999999999888744 688889988653 34567777899999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~ 271 (345)
||+|+||+++.++.++++|||.+................++..|+|||.+....++.++||| +|+++|+|++ |..||.
T Consensus 130 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~ 209 (262)
T cd00192 130 DLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209 (262)
T ss_pred ccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999876543322223445678899999999888899999999 9999999999 699975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
.. ...+....+....... ........+.+++.+||+.+|.+|||+.++++.|+
T Consensus 210 ~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 210 GL----SNEEVLEYLRKGYRLP-------------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC----CHHHHHHHHHcCCCCC-------------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 43 2333333333211111 11112345788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=282.39 Aligned_cols=234 Identities=26% Similarity=0.381 Sum_probs=186.4
Q ss_pred ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCC
Q 046907 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRN 134 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 134 (345)
+||+|.||+||-|+. ..+...+|||.+.... .+..+-+..|+..-+.++|.|
T Consensus 582 VLGKGTYG~VYA~RD-~~tqvrIaIKEIpekd---------------------------sr~~QPLhEEIaLH~~LrHkN 633 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARD-MDTQVRIAIKEIPEKD---------------------------SREVQPLHEEIALHSTLRHKN 633 (1226)
T ss_pred EeecCceeEEEeecc-ccceeEEEeeeccccc---------------------------chhhccHHHHHHHHHHHhhHh
Confidence 799999999999995 4678889999984321 334566778999999999999
Q ss_pred ccceeEEEecCCcceeeeeccccCCCCCCCHH------------HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 135 LHPLLAHVTRPDCHLLYILNDVSQGRRELDWL------------ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 135 iv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~------------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
||+++|.+..++ ++-+.||-.+||++-+.+ ...-+..||++||.|||++. |+|||||-+|+|+
T Consensus 634 IVrYLGs~senG--f~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLv 708 (1226)
T KOG4279|consen 634 IVRYLGSVSENG--FFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLV 708 (1226)
T ss_pred HHHHhhccCCCC--eEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEE
Confidence 999999977766 677788888888764333 34468999999999999998 9999999999999
Q ss_pred c-CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc--cCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 203 D-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 203 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
+ -.|.+||+|||.++.+-. ....+.++.||..|||||++..++ |+.++||| |||++.||.||++||.+.-...
T Consensus 709 NTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq- 785 (1226)
T KOG4279|consen 709 NTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ- 785 (1226)
T ss_pred eeccceEEecccccchhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-
Confidence 8 578999999999986532 333567799999999999997665 88999999 9999999999999976532211
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
....+-++. +.-++.+++...+...+|.+|+.+||.+||++.++++
T Consensus 786 ----AAMFkVGmy----------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 786 ----AAMFKVGMY----------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----Hhhhhhcce----------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 111111111 1123466777788899999999999999999999875
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=258.98 Aligned_cols=240 Identities=26% Similarity=0.403 Sum_probs=187.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|.++ .++..+++|.+... .....+.+|+.+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~~k~~~~~-----------------------------~~~~~~~~e~~~ 51 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHK-ETGQVVAIKVVPVE-----------------------------EDLQEIIKEISI 51 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEc-CCCcEEEEEEeecH-----------------------------HHHHHHHHHHHH
Confidence 468999999999999999999975 45889999998431 115678889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++.+..+. .+++++++++++. .+++.....++.|++.|+.|||+.+ ++|+|++
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~ 126 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNT--DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIK 126 (256)
T ss_pred HHhCCCCcEeeeeeeeecCC--cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 99999999999999988775 6888999987643 3567777889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||+++.++.++++|||++........ ......|+..|+|||.+.+..++.++||| +|+++|+|++|..||.....
T Consensus 127 ~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 127 AGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred cceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 9999999999999999999886644321 12235578899999999988899999999 99999999999999754222
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+ ...... .. .........+.+++..||+.||++|||+.++++
T Consensus 205 ----~~~~~~~---~~~~~~------~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 205 ----MRAIFMI---PNKPPP------TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ----hhhhhhh---ccCCCC------CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1111100 000000 00 011122345788999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=271.22 Aligned_cols=240 Identities=20% Similarity=0.321 Sum_probs=198.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.+-|.+-+.||+|.|++|-+|++ .-+|+.||||++.....+. -....+.+|++.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArH-VFTGekVAVKviDKTKlD~-------------------------~st~hlfqEVRC 70 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARH-VFTGEKVAVKVIDKTKLDT-------------------------LSTGHLFQEVRC 70 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhh-hcccceeEEEEecccccch-------------------------hhhhHHHHHHHH
Confidence 35688889999999999999984 4689999999997655542 335678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH----------HHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA----------RHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~----------~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
|+.++|||||++|.+..++. .+|++.|+.++|.++++.. ..+++.||+.|+.|||..+ ++|||||
T Consensus 71 MKLVQHpNiVRLYEViDTQT--KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLK 145 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQT--KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLK 145 (864)
T ss_pred HHHhcCcCeeeeeehhcccc--eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCC
Confidence 99999999999999888776 7899999999888766653 4579999999999999999 9999999
Q ss_pred CCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccC-ccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLT-EKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~-~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+|+.+. .-|.+|+.|||++..+... ...++.+|+..|.|||.+.|..|+ ++.||| +|++||-+++|..||.
T Consensus 146 PENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq-- 220 (864)
T KOG4717|consen 146 PENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ-- 220 (864)
T ss_pred cceeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc--
Confidence 9999775 6789999999998765443 245678999999999999999987 479999 9999999999999954
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..++.+.+..|....+. .++....++.+||..||..||.+|.+.++|..
T Consensus 221 --eANDSETLTmImDCKYt--------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 221 --EANDSETLTMIMDCKYT--------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cccchhhhhhhhccccc--------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 44555565555544332 23444556889999999999999999999864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=272.57 Aligned_cols=234 Identities=22% Similarity=0.280 Sum_probs=171.7
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc---cC
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI---RH 132 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~h 132 (345)
||+|+||.||+|+.. .++..||+|.+..... ...........|..++... +|
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~------------------------~~~~~~~~~~~e~~~l~~~~~~~~ 55 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEI------------------------VAKKEVAHTIGERNILVRTLLDES 55 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHH------------------------hhhhHHHHHHHHHHHHHHhccCCC
Confidence 799999999999854 5789999999842100 0012233445566666655 79
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
|||+++++.+..++ .++++++|+.++.+ ++......++.|+++||.|||+.+ ++||||||+|||++
T Consensus 56 p~i~~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~ 130 (330)
T cd05586 56 PFIVGLKFSFQTDS--DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLD 130 (330)
T ss_pred CcCcceEEEEecCC--eEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC
Confidence 99999999988776 68999999988654 556667789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccccchhh
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~ 281 (345)
.++.++|+|||++........ ......||..|+|||.+.+.. ++.++||| +|+++|+|++|..||.. .....
T Consensus 131 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~----~~~~~ 204 (330)
T cd05586 131 ATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA----EDTQQ 204 (330)
T ss_pred CCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC----CCHHH
Confidence 999999999999875422211 223467999999999997654 78999999 99999999999999643 22222
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP----NSKDVRR 338 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp----t~~~ll~ 338 (345)
....+.. .... ..... ....+.+++..||+.||.+|| ++.++++
T Consensus 205 ~~~~i~~---~~~~-------~~~~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 205 MYRNIAF---GKVR-------FPKNV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHc---CCCC-------CCCcc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 2222211 1100 00011 122467888899999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=259.30 Aligned_cols=240 Identities=20% Similarity=0.329 Sum_probs=186.7
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+++.. .+|..||+|.+...... ......+.+|+.+++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMS-------------------------PKEREESRKEVAVLS 54 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCC-------------------------hHHHHHHHHHHHHHH
Confidence 5889999999999999999854 57899999998532111 123457788999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++||||+++++.+...+ ..+++++++.++.+ ++......++.|++.|+.|||+.+ ++|+|++|
T Consensus 55 ~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~ 129 (256)
T cd08218 55 NMKHPNIVQYQESFEENG--NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKS 129 (256)
T ss_pred hCCCCCeeeeEeeecCCC--eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCH
Confidence 999999999999887765 78899999877543 455566789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++........ ......|+..|+|||.+.+...+.++|+| ||+++++|++|..||..
T Consensus 130 ~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~---- 203 (256)
T cd08218 130 QNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---- 203 (256)
T ss_pred HHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC----
Confidence 999999999999999999976544321 11234678899999999988889999999 99999999999999642
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
....+. .........+. ........+.+++.+||+.+|++||++.+|++
T Consensus 204 ~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 204 GNMKNL---VLKIIRGSYPP----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCHHHH---HHHHhcCCCCC----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 122222 11111111110 11122345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=263.63 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=183.6
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++.+.||+|+||.||+|+.. .+++.+|+|.+.... .....+.+|+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~----------------------------~~~~~~~~e~ 65 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIH----------------------------DIDEEIEAEY 65 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEEC-CCCceeEEEeecccc----------------------------chHHHHHHHH
Confidence 36789999999999999999999864 578999999875321 1124566789
Q ss_pred HHHhhc-cCCCccceeEEEec---CCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTR---PDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~---~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
.+++.+ +||||+++++.+.. ++...++++++|++++++ +++..+..++.|++.||.|||+.+
T Consensus 66 ~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~- 144 (286)
T cd06638 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK- 144 (286)
T ss_pred HHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 999998 79999999998753 233478999999987654 344455679999999999999998
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----cccCccchhh-HHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----LTLTEKCDIY-FGALLA 261 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~Dvw-lG~vl~ 261 (345)
++|||+||+||+++.++.++++|||++........ ......|+..|+|||.+.. ..++.++||| +|+++|
T Consensus 145 --i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~ 220 (286)
T cd06638 145 --TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI 220 (286)
T ss_pred --ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHH
Confidence 99999999999999999999999999876543221 1233568999999998853 3478899999 999999
Q ss_pred HHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
||++|..||..... .. .+........+. ...+ . .....+.++|.+||+.||++|||+.++++.
T Consensus 221 el~~g~~p~~~~~~----~~---~~~~~~~~~~~~-~~~~----~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 221 ELGDGDPPLADLHP----MR---ALFKIPRNPPPT-LHQP----E---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHhcCCCCCCCCch----hH---HHhhccccCCCc-ccCC----C---CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 99999999743211 11 111111111010 0000 1 112347889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=262.02 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=189.6
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|...+.||.|++|.||+|... .++..+|+|.+..... .....++.+|++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~--------------------------~~~~~~~~~e~~~l 53 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPN--------------------------PDLQKQILRELEIN 53 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC-CCCeEEEEEEEecCCc--------------------------hHHHHHHHHHHHHH
Confidence 47889999999999999999864 4789999999864321 12245678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.++||||+++++++...+...+++++++++++++ ++......++.|++.||.|||+.+ ++|+|
T Consensus 54 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~d 130 (287)
T cd06621 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRD 130 (287)
T ss_pred HhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 99999999999999877666678999999987654 344455679999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
++|+||+++.++.++++|||++....... .....++..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 131 l~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 131 IKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred CCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999986543221 1234578899999999988899999999 999999999999997643
Q ss_pred ccc-cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQH-TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ....+...++... ..+. ..... .........+.+++.+||+.+|.+|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~---~~~~--~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 207 GEPPLGPIELLSYIVNM---PNPE--LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCCCChHHHHHHHhcC---Cchh--hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 220 1112222222211 1110 00000 000112345789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=261.71 Aligned_cols=249 Identities=19% Similarity=0.335 Sum_probs=188.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCC----CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ----NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|+++..||+|+||.||+|+++.. +...+++|.+..... ......+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--------------------------~~~~~~~~ 56 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--------------------------ENLQSEFR 56 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--------------------------hHHHHHHH
Confidence 346899999999999999999986422 356799998854211 11356688
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC------------------CCCHHHHHHHHHHHHHHHHHHh
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR------------------ELDWLARHRIALGLACGLEYLH 183 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~------------------~l~~~~~~~i~~~i~~~l~~lh 183 (345)
+|+.++++++||||+++++++...+ ..++++++++++. .+++..+..++.|++.||.|||
T Consensus 57 ~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 57 RELDMFRKLSHKNVVRLLGLCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred HHHHHHHhcCCcceeeeEEEECCCC--cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 8999999999999999999887655 5788888887643 3566677889999999999999
Q ss_pred hcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHH
Q 046907 184 MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAG 262 (345)
Q Consensus 184 ~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~e 262 (345)
+.+ ++|+||||+||+++.++.++++|||++........ .......++..|+|||.+.+...+.++||| +|+++|+
T Consensus 135 ~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 210 (275)
T cd05046 135 NAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210 (275)
T ss_pred hcC---cccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHH
Confidence 998 99999999999999999999999999865432211 122334567789999999888888999999 9999999
Q ss_pred HHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 263 LVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 263 l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
+++ |..||... ............. .... ........+.+++.+||+.+|++|||+.++++.|.
T Consensus 211 l~~~~~~p~~~~----~~~~~~~~~~~~~----~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 211 VFTQGELPFYGL----SDEEVLNRLQAGK----LELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHhCCCCCcccc----chHHHHHHHHcCC----cCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 998 78886432 2222222222111 0000 00112235788999999999999999999999886
Q ss_pred h
Q 046907 342 Q 342 (345)
Q Consensus 342 ~ 342 (345)
+
T Consensus 275 ~ 275 (275)
T cd05046 275 E 275 (275)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=267.29 Aligned_cols=243 Identities=24% Similarity=0.327 Sum_probs=187.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~---------------------------~~~~~~~~e~~ 68 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQ---------------------------PKKELIINEIL 68 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCcc---------------------------chHHHHHHHHH
Confidence 4479999999999999999999853 5789999999854221 12345778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++.+..++ ..++++++++++.+ ++......++.|++.||.|||+.+ ++|+||||
T Consensus 69 ~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p 143 (297)
T cd06656 69 VMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKS 143 (297)
T ss_pred HHHhCCCCCEeeEEEEEecCC--EEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 999999999999999988766 68899999988654 455567789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+| +|+++|++++|..||.....
T Consensus 144 ~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~- 220 (297)
T cd06656 144 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP- 220 (297)
T ss_pred HHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-
Confidence 999999999999999999876543221 12335688899999999988889999999 99999999999999743211
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...... + .....+. ..........+.+++.+||+.+|++||++.++++
T Consensus 221 --~~~~~~-~---~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 221 --LRALYL-I---ATNGTPE--------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --chheee-e---ccCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0 0000000 0011122344778889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=250.25 Aligned_cols=244 Identities=21% Similarity=0.399 Sum_probs=184.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++.+++..||.|+.|.||+++++ .+|..+|||.+..... .+..++++..+.+
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~N--------------------------kee~kRILmDldv 143 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGN--------------------------KEENKRILMDLDV 143 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEc-ccceEEEEEeecccCC--------------------------HHHHHHHHHhhhH
Confidence 345667889999999999999986 6899999999965432 3447788888988
Q ss_pred Hhhcc-CCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+.+-+ .|.||+.+|+|..+.. +++-|+.+.. ...+++...-++...+++||.||.+++ .|+|||+|
T Consensus 144 v~~s~dcpyIV~c~GyFi~n~d--V~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvK 219 (391)
T KOG0983|consen 144 VLKSHDCPYIVQCFGYFITNTD--VFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVK 219 (391)
T ss_pred HhhccCCCeeeeeeeEEeeCch--HHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccC
Confidence 87764 9999999999988764 4444444321 233566666678888999999999987 79999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc---ccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML---TLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~---~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|||+|..|++|+||||.+-.+-++..+.. ..|.+.|||||.+.-. .|+-++||| ||++++||.||.+||..
T Consensus 220 PSNILlDe~GniKlCDFGIsGrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 220 PSNILLDERGNIKLCDFGISGRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ccceEEccCCCEEeecccccceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 9999999999999999999987766554433 5789999999999643 478899999 99999999999999754
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. ..+.+.+..+.+ .+.+. ++.. ..++. ++.+++..||+.|+.+||...++++
T Consensus 297 c---~tdFe~ltkvln---~ePP~--L~~~---~gFSp---~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 297 C---KTDFEVLTKVLN---EEPPL--LPGH---MGFSP---DFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred C---CccHHHHHHHHh---cCCCC--CCcc---cCcCH---HHHHHHHHHhhcCcccCcchHHHhc
Confidence 2 223344444433 21111 1111 11223 3566677799999999999998875
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=263.93 Aligned_cols=240 Identities=26% Similarity=0.394 Sum_probs=185.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
...|++.+.||+|+||.||+|+.. .++..||+|.+....... ......+.+|+.+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~------------------------~~~~~~~~~Ei~~ 68 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQS------------------------NEKWQDIIKEVRF 68 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCc------------------------HHHHHHHHHHHHH
Confidence 356999999999999999999864 468999999885332111 2235667889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ ..+++++++.+. ..+++.....++.|++.||.|||+.+ ++|+||+|
T Consensus 69 l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p 143 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKA 143 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCC--eEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCc
Confidence 99999999999999998766 578889888652 34677778889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+++.++.++++|||++...... ....|+..|+|||.+. ...++.++||| ||+++|||++|..||...
T Consensus 144 ~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 144 GNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred ccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 9999999999999999998654322 2356788999999884 34578899999 999999999999996432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.......+ .....+. . ........+.+++.+||+.+|++||++.+|+.
T Consensus 218 ----~~~~~~~~~---~~~~~~~------~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 218 ----NAMSALYHI---AQNDSPT------L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ----cHHHHHHHH---hcCCCCC------C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111111111 1111110 0 11223456889999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.56 Aligned_cols=246 Identities=22% Similarity=0.371 Sum_probs=184.0
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|+..+.||+|+||.||+++.+ .++..+|+|.+..... ......+.+|+.+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~--------------------------~~~~~~~~~e~~~ 55 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVD--------------------------EKEQKRLLMDLDV 55 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccC--------------------------hHHHHHHHHHHHH
Confidence 457888899999999999999865 5789999999853211 1224567789999
Q ss_pred Hhhcc-CCCccceeEEEecCCcceeeeeccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeE
Q 046907 127 VGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQG-------------RRELDWLARHRIALGLACGLEYLHMH-HCPRII 191 (345)
Q Consensus 127 l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~-~~~~ii 191 (345)
+.++. ||||+++++++..++ ..+++++++.. ...+++.....++.+++.||.|||+. + ++
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~--~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~ 130 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREG--DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---II 130 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCC--cEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---ee
Confidence 99995 999999999887765 45666666543 13466777889999999999999975 6 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc---ccCccchhh-HHHHHHHHHhCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML---TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~---~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
||||||+||+++.++.++++|||++........ .....|+..|+|||.+.+. .++.++||| +|+++|+|++|.
T Consensus 131 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 207 (288)
T cd06616 131 HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207 (288)
T ss_pred ccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCC
Confidence 999999999999999999999999876543321 1234678899999999776 588899999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.||.... .....+........+. +...........+.+++.+||+.||++|||+.+|++.
T Consensus 208 ~p~~~~~------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 208 FPYPKWN------SVFDQLTQVVKGDPPI------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCchhcc------hHHHHHhhhcCCCCCc------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9975421 1222222222111111 1111112234457889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=261.59 Aligned_cols=231 Identities=17% Similarity=0.234 Sum_probs=170.9
Q ss_pred cccccCcceeeEEEEecCC-----------------------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHH
Q 046907 54 EKIGSGGCGEVYKAELPGQ-----------------------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~-----------------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (345)
..||+|+||.||+|.+... ....|++|.+....
T Consensus 1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~------------------------ 56 (274)
T cd05076 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH------------------------ 56 (274)
T ss_pred CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH------------------------
Confidence 3699999999999985321 12357888874210
Q ss_pred HHHHHHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHH
Q 046907 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLE 180 (345)
Q Consensus 111 ~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~ 180 (345)
......+.+|+.+++.++||||+++++++..++ ..+++++|++++.+ +++..+..++.|++.||.
T Consensus 57 ---~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 131 (274)
T cd05076 57 ---RDIALAFFETASLMSQVSHIHLAFVHGVCVRGS--ENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALS 131 (274)
T ss_pred ---HHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC--ceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 122456778899999999999999999988776 67889999987643 456667789999999999
Q ss_pred HHhhcCCCCeEecCCCCCCeeecCCC-------CeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccc
Q 046907 181 YLHMHHCPRIIHRDLNPVNVLLDDDI-------EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKC 252 (345)
Q Consensus 181 ~lh~~~~~~iiH~dlk~~nil~~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~ 252 (345)
|||+.+ ++||||||+||+++..+ .++++|||++...... ....++..|+|||.+.+ ..++.++
T Consensus 132 ~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~ 202 (274)
T cd05076 132 YLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAA 202 (274)
T ss_pred HHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHH
Confidence 999998 99999999999997543 3799999987643221 22456788999998875 4578999
Q ss_pred hhh-HHHHHHHHH-hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCC
Q 046907 253 DIY-FGALLAGLV-MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER 330 (345)
Q Consensus 253 Dvw-lG~vl~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 330 (345)
|+| ||+++||++ +|..||..... ........... . ..... ...+.++|..||+.+|++|
T Consensus 203 Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~---~--------~~~~~----~~~~~~li~~cl~~~p~~R 263 (274)
T cd05076 203 DKWSFGTTLLEICFDGEVPLKERTP----SEKERFYEKKH---R--------LPEPS----CKELATLISQCLTYEPTQR 263 (274)
T ss_pred HHHHHHHHHHHHHhCCCCCccccCh----HHHHHHHHhcc---C--------CCCCC----ChHHHHHHHHHcccChhhC
Confidence 999 999999985 68999753221 11111111110 0 00111 1247889999999999999
Q ss_pred CCHHHHHHHHh
Q 046907 331 PNSKDVRRMLS 341 (345)
Q Consensus 331 pt~~~ll~~L~ 341 (345)
||+.+|++.|+
T Consensus 264 ps~~~il~~L~ 274 (274)
T cd05076 264 PSFRTILRDLT 274 (274)
T ss_pred cCHHHHHHhhC
Confidence 99999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=256.47 Aligned_cols=239 Identities=23% Similarity=0.344 Sum_probs=181.4
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
++||+|+||.||+|... .++.||+|.+...... +....+.+|+.+++.++||
T Consensus 1 ~~lg~g~~g~v~~~~~~--~~~~v~~K~~~~~~~~--------------------------~~~~~~~~e~~~l~~l~~~ 52 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPP--------------------------DLKRKFLQEAEILKQYDHP 52 (251)
T ss_pred CccccCCCceEEEEEEe--CCCcEEEEeccccCCH--------------------------HHHHHHHHHHHHHHhCCCC
Confidence 47999999999999864 3899999988543211 1245678899999999999
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
||+++++++...+ ..+++++++.++.+ ++......++.+++.||.|||+.+ ++|+|++|+||+++
T Consensus 53 ~i~~~~~~~~~~~--~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~ 127 (251)
T cd05041 53 NIVKLIGVCVQKQ--PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVG 127 (251)
T ss_pred CeEEEEEEEecCC--CeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEc
Confidence 9999999887765 67888888876543 445556789999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhh
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMS 281 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~ 281 (345)
.++.++++|||.+................++..|+|||.+.+..++.++|+| +|+++|+|++ |..||... ....
T Consensus 128 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~----~~~~ 203 (251)
T cd05041 128 ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM----SNQQ 203 (251)
T ss_pred CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC----CHHH
Confidence 9999999999998765432221111223345679999999888899999999 9999999999 78886432 2222
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
....+....... ........+.+++.+||+.+|++|||+.++++.|++
T Consensus 204 ~~~~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 204 TRERIESGYRMP-------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred HHHHHhcCCCCC-------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 222222111000 111223458889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=271.75 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=188.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|++. .+|..||+|.+..... ......+..|+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~E~~~ 56 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEH--------------------------QTFCQRTLREIKI 56 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEeccccc--------------------------chhHHHHHHHHHH
Confidence 468999999999999999999864 5789999999853111 1224556789999
Q ss_pred HhhccCCCccceeEEEecCCc---ceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++++||||+++++++..... ..++++++++.+. ..+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlk 133 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLK 133 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCC
Confidence 999999999999998765432 3478888888652 24677778889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcce-eccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+||+++.++.++++|||++.......... ......|+..|+|||.+.+ ..++.++||| +|+++|+|++|..||...
T Consensus 134 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 134 PSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred HHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999987654322211 1233578999999998754 4578899999 999999999999997432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCcc---c-------------cccc-cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRA---I-------------DSKL-VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~---~-------------~~~~-~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
........+......+..... . .+.. .....+.....+.+++.+||+.||++|||+.++
T Consensus 214 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 214 ----DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred ----CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 222222222222211111000 0 0000 000011224457899999999999999999999
Q ss_pred HHH
Q 046907 337 RRM 339 (345)
Q Consensus 337 l~~ 339 (345)
++.
T Consensus 290 l~h 292 (336)
T cd07849 290 LAH 292 (336)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=263.50 Aligned_cols=240 Identities=25% Similarity=0.375 Sum_probs=187.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.|+..+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~e~~~l 56 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEA--------------------------EDEIEDIQQEITVL 56 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccc--------------------------hHHHHHHHHHHHHH
Confidence 45778899999999999999864 4688999998853211 12246788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
++++||||+++++.+..++ ..++++|+++++.+ ++......++.|++.|+.|||+.+ ++|+||+|+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~n 131 (277)
T cd06642 57 SQCDSPYITRYYGSYLKGT--KLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAAN 131 (277)
T ss_pred HcCCCCccHhhhcccccCC--ceEEEEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChhe
Confidence 9999999999999887765 68899999987644 456667789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
|+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|||++|..||.....
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--- 206 (277)
T cd06642 132 VLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP--- 206 (277)
T ss_pred EEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch---
Confidence 9999999999999999876543221 22335678899999999988899999999 99999999999999653221
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+... . .+ .........+.+++..||+.+|++|||+.++++
T Consensus 207 -~~~~~~~~~~----~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 207 -MRVLFLIPKN----S-----PP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -hhHHhhhhcC----C-----CC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111111100 0 00 111223345788999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=258.96 Aligned_cols=244 Identities=17% Similarity=0.288 Sum_probs=172.0
Q ss_pred cccccCcceeeEEEEecC-CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 54 EKIGSGGCGEVYKAELPG-QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
..||+|+||.||+|++.. .....+++|.+..... .+....+.+|+.+++.++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--------------------------~~~~~~~~~e~~~~~~l~h 54 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--------------------------SKEQNEFLQQGDPYRILQH 54 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--------------------------hHHHHHHHHHHHHHhccCC
Confidence 369999999999997532 2234566777643211 1225678889999999999
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCCCCHH-------------HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-------------ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~-------------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
|||+++++.+.... ..+++++|+.++++.++. ....++.|++.||.|||+.+ ++||||||+|
T Consensus 55 ~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~n 129 (268)
T cd05086 55 PNILQCLGQCVEAI--PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRN 129 (268)
T ss_pred cchhheEEEecCCC--ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccce
Confidence 99999999988665 688999999887654433 33578899999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-------cccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-------LTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-------~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
||++.++.++++|||++................++..|+|||++.. ..++.++||| ||+++|||++ |..||
T Consensus 130 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 209 (268)
T cd05086 130 CFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209 (268)
T ss_pred EEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999998764322111112234567889999998843 2356789999 9999999997 56675
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
... ........+.... . ....++.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 210 ~~~----~~~~~~~~~~~~~---~-~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 210 SHL----SDREVLNHVIKDQ---Q-VKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCC----CHHHHHHHHHhhc---c-cccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 432 2222222221111 1 11111111111 2234667888899 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=258.60 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=184.4
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+++.+.+++.....||+|+||.||+|+++ .++..||+|.+.... ......+.
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~---------------------------~~~~~~~~ 53 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDL-STQVRIAIKEIPERD---------------------------SRYVQPLH 53 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEec-CCCcEEEEEEecCCC---------------------------HHHHHHHH
Confidence 34556777777789999999999999864 468899999875332 12245678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC------------CHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL------------DWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l------------~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+|+.+++.++||||+++++++..++ ..++++++++++.+. +......++.|++.||.|||+.+
T Consensus 54 ~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 128 (268)
T cd06624 54 EEIALHSYLKHRNIVQYLGSDSENG--FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--- 128 (268)
T ss_pred HHHHHHHhcCCCCeeeeeeeeccCC--EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8999999999999999999988765 688899998876543 33445568899999999999998
Q ss_pred eEecCCCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCccccccccccccc--cCccchhh-HHHHHHHHHh
Q 046907 190 IIHRDLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 190 iiH~dlk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~Dvw-lG~vl~el~t 265 (345)
++|+|+||+||+++. .+.++|+|||++........ ......|+..|+|||.+.+.. ++.++|+| +|+++|+|++
T Consensus 129 i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~ 206 (268)
T cd06624 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206 (268)
T ss_pred EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh
Confidence 999999999999986 67899999999876543221 122346789999999987654 78899999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|..||..... .....+..... .. .+..+......+.+++.+||+.+|.+|||+.++++
T Consensus 207 g~~p~~~~~~----~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 207 GKPPFIELGE----PQAAMFKVGMF-KI----------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCCccccC----hhhhHhhhhhh-cc----------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 9999743211 11111100000 00 00111223345788899999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=266.92 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=189.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+|..||+|.+....... .....+.+|+.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~-------------------------~~~~~~~~E~~ 58 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERD-------------------------GIPISSLREIT 58 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCC-------------------------CCcchhhHHHH
Confidence 4578999999999999999999864 579999999986432111 11223457999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++++||||+++++++.......++++++++.+ ...+++.....++.|++.||.|||+.+ ++|+||+
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~ 135 (309)
T cd07845 59 LLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLK 135 (309)
T ss_pred HHHhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 9999999999999999877655578899998865 133667777889999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||| +|+++|||++|..||..
T Consensus 136 p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~-- 211 (309)
T cd07845 136 VSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG-- 211 (309)
T ss_pred HHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC--
Confidence 9999999999999999999987654321 1122345788999999876 4578999999 99999999999999643
Q ss_pred cccchhhHHHHHHHHhhhcCCCcc-----------c--cccccCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRA-----------I--DSKLVGN---GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~--~~~~~~~---~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+......+..... . ....... ........+.++|..||+.||++|||+.++++
T Consensus 212 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 212 --KSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred --CCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 2333333333332221111000 0 0000000 00112345678999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=260.26 Aligned_cols=241 Identities=25% Similarity=0.384 Sum_probs=189.6
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.|+..+.||.|+||.||+|.+. .++..||+|.+..... ......+.+|+.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~e~~~l 56 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEA--------------------------EDEIEDIQQEITVL 56 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEecccc--------------------------HHHHHHHHHHHHHH
Confidence 57889999999999999999864 4688999999853211 12356788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+.++||||+++++.+..++ ..++++++++++.+ ++......++.|++.|+.|||+.+ ++|+||+|+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~N 131 (277)
T cd06640 57 SQCDSPYVTKYYGSYLKGT--KLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAAN 131 (277)
T ss_pred HhCCCCCEeeEEEEEEECC--EEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhh
Confidence 9999999999999988766 78999999988764 345556689999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
|+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+| ||+++|||++|..||.....
T Consensus 132 il~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--- 206 (277)
T cd06640 132 VLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP--- 206 (277)
T ss_pred EEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh---
Confidence 9999999999999999976643321 12335678899999999988899999999 99999999999999754321
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
......+. ... .+.........+.+++..||+.+|++||++.++++.
T Consensus 207 -~~~~~~~~---~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 207 -MRVLFLIP---KNN----------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -HhHhhhhh---cCC----------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11111110 000 111223445668899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=268.75 Aligned_cols=247 Identities=21% Similarity=0.264 Sum_probs=180.6
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+++.. .+++.||+|.+... +.........+..|..++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~------------------------~~~~~~~~~~~~~e~~~l 55 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKW------------------------EMLKRAETACFREERNVL 55 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHH------------------------HHHhhHHHHHHHHHHHHH
Confidence 58999999999999999999864 57889999998421 011123355677889999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCC----------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL----------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l----------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
..++|+||+++++.+..++ .+++++||+.++.+. +......++.|++.||.|||+.+ ++||||||
T Consensus 56 ~~~~~~~i~~l~~~~~~~~--~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp 130 (331)
T cd05624 56 VNGDCQWITTLHYAFQDEN--YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKP 130 (331)
T ss_pred HhCCCCCEeeEEEEEEcCC--EEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCch
Confidence 9999999999999988776 789999999886553 44455678999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----cccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----LTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
+||+++.++.+||+|||++......... ......||+.|+|||++.+ ..++.++|+| +|+++|+|++|..||.
T Consensus 131 ~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 131 DNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred HHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 9999999999999999999766433221 2233579999999999875 4578899999 9999999999999974
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE--RPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--Rpt~~~ll~ 338 (345)
.. +..+....+ ...... ..++ .........+.+++.+|++.++.. |++++++++
T Consensus 210 ~~----~~~~~~~~i---~~~~~~-~~~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 210 AE----SLVETYGKI---MNHEER-FQFP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CC----CHHHHHHHH---HcCCCc-ccCC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 31 212221111 111100 0000 111122344667777888765543 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=267.47 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=187.8
Q ss_pred CcccccccccCcceeeEEEEecCC-CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQ-NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+|++.+.||+|+||.||+|++... ++..||+|.+....... ......+.+|+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~------------------------~~~~~~~~~e~~~l 56 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY------------------------TGISQSACREIALL 56 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc------------------------cCccHHHHHHHHHH
Confidence 488999999999999999996532 68999999996532110 11234567799999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-------------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
++++||||+++++++...+...+++++|++.+. ..++......++.|++.||.|||+.+ ++|||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~d 133 (316)
T cd07842 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRD 133 (316)
T ss_pred HhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCC
Confidence 999999999999999888556899999998652 13456667789999999999999998 99999
Q ss_pred CCCCCeeecC----CCCeEEeccccceecCCCCc-ceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCC
Q 046907 195 LNPVNVLLDD----DIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 195 lk~~nil~~~----~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|||+||+++. ++.+|++|||++........ ........++..|+|||.+.+. .++.++|+| +|+++|+|++|.
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 213 (316)
T cd07842 134 LKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213 (316)
T ss_pred CCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcC
Confidence 9999999999 89999999999886543322 1122345678899999988764 478899999 999999999999
Q ss_pred CCCcccccccc------hhhHHHHHHHHhhhcCC------------Cc---cccccccC-CCcH-------HHHHHHHHH
Q 046907 268 LPSDKFFQHTN------EMSFVKWMRNVMASENP------------KR---AIDSKLVG-NGCE-------EQMLLVLKI 318 (345)
Q Consensus 268 ~p~~~~~~~~~------~~~~~~~~~~~~~~~~~------------~~---~~~~~~~~-~~~~-------~~~~~l~~l 318 (345)
.||........ .......+ .....+.. .. ........ .... .....+.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 214 PIFKGREAKIKKSNPFQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred CCCcCCcccccccchhHHHHHHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 99864332210 01111111 11100000 00 00000000 0000 223457889
Q ss_pred HhhccCCCCCCCCCHHHHHH
Q 046907 319 ACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 319 i~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.+||+.||++|||+.++++
T Consensus 293 i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 293 LRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhcCCcccCcCHHHHhc
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=264.81 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=183.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|+.++.||.|++|.||+|+.. .+|..||||.+...... ......+.+|+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~E~~~l~ 54 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTET-------------------------EGVPSTAIREISLLK 54 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccc-------------------------cccchHHHHHHHHHH
Confidence 5889999999999999999864 57899999988533211 112356778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQG----------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+++||||+++++++...+ ..+++++++.+ +..+++.....++.|++.||.|||+.+ ++|+|++|+
T Consensus 55 ~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~ 129 (284)
T cd07860 55 ELNHPNIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQ 129 (284)
T ss_pred hcCCCCCcchhhhcccCC--cEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 999999999999987665 67888888754 234677778899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++++|||++........ ......++..|+|||.+.+.. ++.++|+| +|+++|+|+||..||....
T Consensus 130 nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~-- 205 (284)
T cd07860 130 NLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-- 205 (284)
T ss_pred HEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--
Confidence 99999999999999999876543211 122345688999999887654 57889999 9999999999999974311
Q ss_pred cchhhHHHHHHHHhhhcCCC------------cccc---ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPK------------RAID---SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~------------~~~~---~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......... ....+... ..+. ........+.....+.+++.+||+.||.+|||+.++++
T Consensus 206 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 206 -EIDQLFRIFR-TLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred -HHHHHHHHHH-HhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 1111211111 11110000 0000 00000001112234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=267.49 Aligned_cols=193 Identities=24% Similarity=0.354 Sum_probs=157.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+++++ .+++.+|+|.+... +.........+..|+.++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~------------------------~~~~~~~~~~~~~e~~~l 55 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKW------------------------EMLKRAETACFREERDVL 55 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHH------------------------HHHHhhHHHHHHHHHHHH
Confidence 47999999999999999999975 46889999998421 001122345577899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCCCC----------HHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD----------WLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~----------~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
..++|+||+++++.+..++ .+++++||+.++++.+ ......++.|++.||.|||+.+ ++||||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp 130 (332)
T cd05623 56 VNGDNQWITTLHYAFQDEN--NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKP 130 (332)
T ss_pred hhCCCCCEeeEEEEEecCC--EEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCH
Confidence 9999999999999988776 7899999998876544 3445678999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----cccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----LTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
+||+++.++.++|+|||++......... ......||+.|+|||++.+ ..++.++||| +|+++|||++|..||.
T Consensus 131 ~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 131 DNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred HHEEECCCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 9999999999999999998765332221 2234579999999999863 3578899999 9999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=264.39 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=185.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+++.. .+++.||+|.+...... .......+.+|+.++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~------------------------~~~~~~~~~~e~~~l 55 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNLI------------------------LRNQIQQVFVERDIL 55 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhhh------------------------hHHHHHHHHHHHHHH
Confidence 47999999999999999999864 57899999988532110 123356778899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+..++ .+++++++++++.+ +++.....++.|++.|+.|||+.+ ++|+||||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ 130 (305)
T cd05609 56 TFAENPFVVSMFCSFETKR--HLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPD 130 (305)
T ss_pred HhCCCCCeeeeEEEEecCC--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchH
Confidence 9999999999999888765 78999999987654 345556778999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCC-------------cceeccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAH-------------THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
||+++.++.++++|||+++...... .........|+..|+|||.+.+..++.++|+| ||+++|||+
T Consensus 131 NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~ 210 (305)
T cd05609 131 NLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210 (305)
T ss_pred HEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999886321100 00011224678899999999888899999999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
+|..||.. ....+......... ...+. ........+.+++.+||+.||++||++.++.+.|+.
T Consensus 211 ~g~~pf~~----~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 211 VGCVPFFG----DTPEELFGQVISDD-IEWPE----------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hCCCCCCC----CCHHHHHHHHHhcc-cCCCC----------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 99999642 12222222221111 00000 001123347889999999999999997666666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=261.46 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=187.4
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|++. .+|..||+|.+...... ......+.+|+.+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLE-------------------------GGIPNQALREIKALQ 54 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-CCCceEEEEEEEccccc-------------------------chhhHHHHHHHHHHH
Confidence 5889999999999999999864 46899999998643221 122456788999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
.++||||+++++++..++ ..+++++++ ++++ ++...+..++.|+++||.|||+.+ ++|+||+|+
T Consensus 55 ~~~~~~i~~~~~~~~~~~--~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ 128 (286)
T cd07832 55 ACQHPYVVKLLDVFPHGS--GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPA 128 (286)
T ss_pred hCCCCCCcceeeEEecCC--eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHH
Confidence 999999999999988765 688899998 5433 566677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++++|||++........ .......|+..|+|||.+.+.. ++.++||| +|+++++|++|.+||..
T Consensus 129 ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~---- 203 (286)
T cd07832 129 NLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG---- 203 (286)
T ss_pred HEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC----
Confidence 99999999999999999887644321 1123357889999999986544 68899999 99999999999777533
Q ss_pred cchhhHHHHHHHHhhhcCCC------------cccccc----ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPK------------RAIDSK----LVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~----~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+......+... ....+. ...+..++....+.+++.+||+.+|++|||++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 204 ENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 22222222222221111110 000000 000111223467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=258.36 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=187.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+.+.||+|+||.||+|... .+|..+|+|.+......... .+.......+.+..|+.+++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~-----------------~~~~~~~~~~~~~~e~~~l~ 63 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGR-----------------HDSRQKDMVKALRSEIETLK 63 (272)
T ss_pred ceeecceecccCceEEEEEeec-CCCceeeeeeeechhhhhcc-----------------cchHHHHHHHHHHHHHHHHH
Confidence 5778899999999999999853 57899999988543221110 01111233567888999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
.++|||++++++++..++ .+++++|++.++. .++...+..++.|++.||.|||+.+ ++|+|++|+|
T Consensus 64 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~n 138 (272)
T cd06629 64 DLDHLNIVQYLGFETTEE--YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADN 138 (272)
T ss_pred hcCCCCcceEEEEeccCC--ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhh
Confidence 999999999999887765 6788899987764 3566667789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc--cCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
|+++.++.++++|||++................|+..|+|||.+.... ++.++|+| +|+++|++++|..||....
T Consensus 139 il~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-- 216 (272)
T cd06629 139 LLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE-- 216 (272)
T ss_pred EEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--
Confidence 999999999999999987654322222223456889999999987655 78899999 9999999999999974211
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. ..+....... .....+ ..........+.+++..||+.+|++|||+.++++
T Consensus 217 -~~----~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 217 -AI----AAMFKLGNKR-SAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -hH----HHHHHhhccc-cCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11 1111111010 000011 1111223456788899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=255.61 Aligned_cols=239 Identities=22% Similarity=0.286 Sum_probs=185.3
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|... .++..+|+|.+.....+ ......+.+|+.+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMT-------------------------KDERLAAQNECQVLK 54 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccc-------------------------cHHHHHHHHHHHHHh
Confidence 5889999999999999999864 57899999998643221 223567888999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++|||++++++.+...+ .+++++++++++. .+++..+..++.+++.|+.|||+.+ ++|+|++|
T Consensus 55 ~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~ 129 (256)
T cd08220 55 LLSHPNIIEYYENFLEDK--ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKT 129 (256)
T ss_pred hCCCCchhheeeeEecCC--EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 999999999999887665 6889999998753 2566677889999999999999998 99999999
Q ss_pred CCeeecCC-CCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDD-IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.+ +.++++|||.+....... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-- 204 (256)
T cd08220 130 QNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-- 204 (256)
T ss_pred HHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC--
Confidence 99999854 468999999998764432 12235688999999999988889999999 999999999999996432
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.......+......+. .......+.+++.+||+.+|++|||+.++++
T Consensus 205 --~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 205 --NLPALVLKIMSGTFAPI-------------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --chHHHHHHHHhcCCCCC-------------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 22222222211111110 0112334778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=263.96 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=186.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|.++ .+++.||+|.+...... ......+.+|+.++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~-------------------------~~~~~~~~~e~~~l 54 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDD-------------------------KMVKKIAMREIRML 54 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCc-------------------------chhhHHHHHHHHHH
Confidence 47999999999999999999864 46899999987432211 11244567899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ ..+++++|+.++. .+++.....++.|++.||.|||+.+ ++|+|++|+
T Consensus 55 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ 129 (286)
T cd07846 55 KQLRHENLVNLIEVFRRKK--RLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPE 129 (286)
T ss_pred HhcCCcchhhHHHhcccCC--eEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHH
Confidence 9999999999999987665 6889999987642 3677788899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++++|||++........ ......++..|+|||.+.+. .++.++||| ||+++|||++|..||...
T Consensus 130 ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~--- 204 (286)
T cd07846 130 NILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD--- 204 (286)
T ss_pred HEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC---
Confidence 99999999999999999876543321 22335678899999998764 467899999 999999999999986432
Q ss_pred cchhhHHHHHHHHhhhcCC--------C----cccccccc-----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENP--------K----RAIDSKLV-----GNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~--------~----~~~~~~~~-----~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+......... . ....+... ....+.....+.+++.+||+.+|++||++.++++
T Consensus 205 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 205 -SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred -chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 111111111111100000 0 00000000 0011223456888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=262.66 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=190.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|.++ .+++.||+|.+...... ......+.+|++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~-------------------------~~~~~~~~~e~~~l 54 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDD-------------------------EDVKKTALREVKVL 54 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhccc-------------------------ccchhHHHHHHHHH
Confidence 47999999999999999999865 46889999988532111 22356778899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+..++ .+++++++++++. .++......++.|++.|+.|||+.+ ++|+|++|+
T Consensus 55 ~~l~~~~i~~~~~~~~~~~--~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ 129 (288)
T cd07833 55 RQLRHENIVNLKEAFRRKG--RLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPE 129 (288)
T ss_pred HhcCCCCeeehhheEEECC--EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999999999999988765 6889999997642 2556677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++++|||++......... ......++..|+|||.+.+. .++.++|+| +|+++|+|++|..||...
T Consensus 130 ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~--- 205 (288)
T cd07833 130 NILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD--- 205 (288)
T ss_pred HeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 999999999999999998776443221 22345778899999999888 788999999 999999999999997542
Q ss_pred cchhhHHHHHHHHhhhcCCC-----------------ccccccccC-CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPK-----------------RAIDSKLVG-NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~-~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+........+. ....+.... .........+.++|..||+.+|++|||++++++
T Consensus 206 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 206 -SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred -CHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 2222222222211111100 000000000 001112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=259.17 Aligned_cols=247 Identities=24% Similarity=0.403 Sum_probs=187.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||.|+||.||+|.+. .++..+|+|.+...... .....+.+|+.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~--------------------------~~~~~~~~e~~~l 53 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQ--------------------------TSVDELRKEVQAM 53 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcc--------------------------hHHHHHHHHHHHH
Confidence 47999999999999999999864 47889999998532211 1356678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR------------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+.++|||++++++.+..++ ..+++++++.++. .+++.....++.|++.|+.+||+.+ ++|+||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~--~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l 128 (267)
T cd06610 54 SQCNHPNVVKYYTSFVVGD--ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDI 128 (267)
T ss_pred HhcCCCCEEEEEEEEeeCC--EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9999999999999887765 6888999987753 3456667789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcce--eccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHI--TTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
+|+||+++.++.++++|||++.......... ......|+..|+|||.+... .++.++|+| +|+++|+|++|..||.
T Consensus 129 ~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred CHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 9999999999999999999987665432211 12335688999999999877 688899999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..... ........ ...+. .... .........+.+++..||+.||++|||+.+|++
T Consensus 209 ~~~~~---~~~~~~~~----~~~~~--~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 209 KYPPM---KVLMLTLQ----NDPPS--LETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccChh---hhHHHHhc----CCCCC--cCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 43221 11111111 11110 0000 001233355788999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=255.08 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=186.4
Q ss_pred cccccccccCcceeeEEEEecCCC---CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQN---GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
+++.+.||+|+||.||+|++.... +..||+|.+...... .....+..|+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~e~~~ 54 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--------------------------QQIEEFLREARI 54 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--------------------------HHHHHHHHHHHH
Confidence 467899999999999999976322 488999998643211 135667889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++.++||||+++++++...+ ..++++++++++.+ +++.....++.|++.||.+||+.+ ++|+|+
T Consensus 55 l~~l~~~~i~~~~~~~~~~~--~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl 129 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEE--PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDL 129 (258)
T ss_pred HHhcCCCchheEEEEEcCCC--eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeeccc
Confidence 99999999999999988775 68888888876443 566667889999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~ 273 (345)
+|+||+++.++.++++|||++........... ....++..|+|||.+.+..++.++|+| +|+++++|++ |..||..
T Consensus 130 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~- 207 (258)
T smart00219 130 AARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG- 207 (258)
T ss_pred ccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-
Confidence 99999999999999999999987654422211 123467899999999887889999999 9999999998 7888543
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
.........+........ .......+.+++.+||+.||++|||+.++++.|
T Consensus 208 ---~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 208 ---MSNEEVLEYLKKGYRLPK-------------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCHHHHHHHHhcCCCCCC-------------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 233333333322211111 111234577899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=261.61 Aligned_cols=244 Identities=22% Similarity=0.349 Sum_probs=183.9
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...+.|++.+.||+|+||.||+|+.. .++..+|+|.+.... .....+..|+
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~----------------------------~~~~~~~~e~ 63 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTE----------------------------DEEEEIKLEI 63 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecCh----------------------------HHHHHHHHHH
Confidence 46679999999999999999999965 578999999884321 1234567889
Q ss_pred HHHhhc-cCCCccceeEEEecC----CcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTRP----DCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~~----~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
.+++++ +||||+++++++... ....++++++++.++.+ ++......++.|++.|+.|||+.+
T Consensus 64 ~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~-- 141 (282)
T cd06636 64 NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK-- 141 (282)
T ss_pred HHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999888 799999999988542 23478999999987543 444456678999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHH
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAG 262 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~e 262 (345)
++|+|++|+||+++.++.++|+|||++........ ......|+..|+|||.+. +..++.++|+| +|+++||
T Consensus 142 -ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 142 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred -cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence 99999999999999999999999999875432211 123457899999999986 34577899999 9999999
Q ss_pred HHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 263 LVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 263 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|++|..||..... .... ........+ ... .......+.++|.+||+.||.+|||+.+|++
T Consensus 219 l~~g~~p~~~~~~---~~~~----~~~~~~~~~------~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 219 MAEGAPPLCDMHP---MRAL----FLIPRNPPP------KLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHhCCCCccccCH---Hhhh----hhHhhCCCC------CCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 9999999753211 1111 111111110 000 1122345888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=261.86 Aligned_cols=255 Identities=20% Similarity=0.268 Sum_probs=183.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|++|.||+|+.+ .+++.||+|.+....... ....+.+|+.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~--------------------------~~~~~~~E~~~ 56 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEG--------------------------APFTAIREASL 56 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccC--------------------------CchhHHHHHHH
Confidence 468999999999999999999854 578999999985432110 12335679999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ ..++++||+.+ +..++......++.|+++||.|||+.+ ++|+||||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p 131 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKK--TLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKP 131 (291)
T ss_pred HhhCCCcceeeEEEEEecCC--eEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCH
Confidence 99999999999999988665 78899999875 123456677789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.++++|||++........ ......++..|+|||.+.+ ..++.++||| +|+++|+|++|..||.....
T Consensus 132 ~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 209 (291)
T cd07844 132 QNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209 (291)
T ss_pred HHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999999999999865432111 1122356788999999876 4578899999 99999999999999754321
Q ss_pred ccchhhHHHHHHHHhhhcCCCcc----------------ccccccCCCcH--HHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRA----------------IDSKLVGNGCE--EQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~--~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
..+....+......+..... ..++......+ .....+.+++..||+.+|++|||+.+++
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 210 ---VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred ---HHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 11222222222211111000 00000000000 0114567899999999999999999987
Q ss_pred H
Q 046907 338 R 338 (345)
Q Consensus 338 ~ 338 (345)
+
T Consensus 287 ~ 287 (291)
T cd07844 287 K 287 (291)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=268.09 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=190.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|.+. .++..+|+|.+...... ......+.+|+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~-------------------------~~~~~~~~~E~~ 58 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRN-------------------------ATDAQRTFREIM 58 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCc-------------------------chhhhhhhHHHH
Confidence 3468999999999999999999864 56899999988532211 112345667999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQG-------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++++ +||||+++++++...+...++++++++.+ ...+++.....++.|++.||.|||+.+ ++|+||+|
T Consensus 59 ~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p 135 (337)
T cd07852 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKP 135 (337)
T ss_pred HHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 99999 99999999999877766678999999864 124567777889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcc---eeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTH---ITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
+||+++.++.++++|||++......... .......|+..|+|||.+.+ ..++.++|+| +|+++|+|++|..||..
T Consensus 136 ~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 136 SNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred HHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999866433211 12234578999999998865 3478899999 99999999999999754
Q ss_pred cccccchhhHHHHHHHHhhhc---------------CCCccc--cccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASE---------------NPKRAI--DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~--~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
... .+....+....... ...... .........++....+.+++.+||+.||++|||+.+
T Consensus 216 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~ 291 (337)
T cd07852 216 TST----LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291 (337)
T ss_pred CCh----HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHH
Confidence 221 11111111110000 000000 000001111223456788999999999999999999
Q ss_pred HHHH
Q 046907 336 VRRM 339 (345)
Q Consensus 336 ll~~ 339 (345)
+++.
T Consensus 292 il~~ 295 (337)
T cd07852 292 ALEH 295 (337)
T ss_pred HhhC
Confidence 9864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=257.85 Aligned_cols=250 Identities=19% Similarity=0.332 Sum_probs=187.8
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|+..+.||+|+||.||+|+. ..++..||+|.+......... ..+....+.+|+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~alk~~~~~~~~~~~---------------------~~~~~~~~~~e~~~l~ 58 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARD-VKTGTLMAVKQVTYVRNTSSE---------------------QEEVVEALRKEIRLMA 58 (268)
T ss_pred CccccceecCcCceEEEEEEE-cCCCcEEEEEEeecccCCchh---------------------HHHHHHHHHHHHHHHH
Confidence 588899999999999999985 467899999998643221110 0224677889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+++||||+++++++..++ ..+++++++.++.+ +++.....++.|++.||.|||+.+ ++|+||+|+|
T Consensus 59 ~l~h~~iv~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~n 133 (268)
T cd06630 59 RLNHPHIIRMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGAN 133 (268)
T ss_pred HcCCCceehhhceeccCC--eEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999999999987766 67888888877643 455666789999999999999998 9999999999
Q ss_pred eeecCCC-CeEEeccccceecCCCCcc--eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 200 VLLDDDI-EARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 200 il~~~~~-~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+++.++ .++++|||.+......... .......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||.....
T Consensus 134 il~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 134 LLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred EEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 9998765 5999999998766433111 112235678899999999888889999999 99999999999999743211
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+........ .+..+......+.+++.+||+.+|++|||+.++++
T Consensus 214 ----~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 214 ----SNHLALIFKIASATT---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----cchHHHHHHHhccCC---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111111111110000 01122233455888999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.25 Aligned_cols=238 Identities=23% Similarity=0.312 Sum_probs=185.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||++.+. .+++.+|+|.+..... ...+....+.+|+.++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~e~~~l 55 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKI------------------------VKLKQVEHVLNEKRIL 55 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHh------------------------hhhhHHHHHHHHHHHH
Confidence 47999999999999999999865 4789999999853211 1123356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++.+...+ .++++++++.++++ ++......++.|++.||.|||+.+ ++|+||+|+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~ 130 (290)
T cd05580 56 QSIRHPFLVNLYGSFQDDS--NLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPE 130 (290)
T ss_pred HhCCCCCccceeeEEEcCC--eEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH
Confidence 9999999999999988765 78899999977544 556666789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.++|+|||++...... .....|++.|+|||.+.+...+.++|+| +|+++|+|++|..||...
T Consensus 131 nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---- 201 (290)
T cd05580 131 NLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD---- 201 (290)
T ss_pred HEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC----
Confidence 999999999999999998765433 2345688999999999888888999999 999999999999996432
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
........+. ..... . . ......+.+++.+||+.||.+|| +++++++
T Consensus 202 ~~~~~~~~~~---~~~~~---~----~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 202 NPIQIYEKIL---EGKVR---F----P----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CHHHHHHHHh---cCCcc---C----C----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1122212111 11110 0 0 01123477888999999999999 6777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=259.30 Aligned_cols=231 Identities=16% Similarity=0.241 Sum_probs=171.2
Q ss_pred cccccCcceeeEEEEecCC------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 54 EKIGSGGCGEVYKAELPGQ------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.||+|+||.||+|..+.. ....+|+|.+.... ....+.+..|+.++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---------------------------~~~~~~~~~e~~~l 53 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---------------------------RNYSESFFEAASMM 53 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---------------------------HHHHHHHHHHHHHH
Confidence 4799999999999986421 12347777663210 23356778899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+.++|||++++++++..++ ..+++++|+.++.+ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 54 ~~~~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp 128 (258)
T cd05078 54 SQLSHKHLVLNYGVCVCGD--ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCA 128 (258)
T ss_pred HhCCCCChhheeeEEEeCC--CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 9999999999999998765 57788999987643 456667789999999999999998 99999999
Q ss_pred CCeeecCCCC--------eEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCC
Q 046907 198 VNVLLDDDIE--------ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 198 ~nil~~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
+||+++.++. ++++|||.+..... .....++..|+|||++.+. .++.++|+| +|+++|+|++|.
T Consensus 129 ~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 202 (258)
T cd05078 129 KNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG 202 (258)
T ss_pred ceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999987654 68999998865432 1235678899999999874 478899999 999999999984
Q ss_pred -CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 268 -LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 268 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
.|+.. ............ .. .... .....+.+++..||+.||++|||++++++.|+
T Consensus 203 ~~~~~~----~~~~~~~~~~~~-----~~------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 203 DKPLSA----LDSQKKLQFYED-----RH------QLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCChhh----ccHHHHHHHHHc-----cc------cCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 55432 111111111111 00 0000 11134788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=258.76 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=187.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|..+ .++..+|+|.+...... .....+.+|+.++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~--------------------------~~~~~~~~e~~~l 53 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINE--------------------------AIQKQILRELDIL 53 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccCh--------------------------HHHHHHHHHHHHH
Confidence 47899999999999999999864 57899999998643211 2245678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHM-HHCPRIIHRDLN 196 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~-~~~~~iiH~dlk 196 (345)
+.++||||+++++.+..++ .++++++++.+++ .++......++.|++.|+.|+|+ .+ ++|+||+
T Consensus 54 ~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~ 128 (265)
T cd06605 54 HKCNSPYIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVK 128 (265)
T ss_pred HHCCCCchhhhheeeecCC--EEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCC
Confidence 9999999999999988775 7888999998653 34555667899999999999999 87 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||+++.++.++++|||.+........ ....++..|+|||.+.+..++.++|+| +|+++|+|++|..||.....
T Consensus 129 ~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 204 (265)
T cd06605 129 PSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND 204 (265)
T ss_pred HHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999865532211 126788899999999988899999999 99999999999999754321
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+.+........+. .... .....+.++|..||..||++|||+.+++.
T Consensus 205 --~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 205 --PPDGIFELLQYIVNEPPPR------LPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --ccccHHHHHHHHhcCCCCC------CChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1112222333222221111 0000 13344788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=261.01 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=184.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|... .+++.+|+|.+.... .....+..|
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~----------------------------~~~~~~~~e 68 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPIS----------------------------DVDEEIEAE 68 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEecccc----------------------------cHHHHHHHH
Confidence 335789999999999999999999854 578999999985321 113445678
Q ss_pred HHHHhhc-cCCCccceeEEEecCCc---ceeeeeccccCCCC-------------CCCHHHHHHHHHHHHHHHHHHhhcC
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDC---HLLYILNDVSQGRR-------------ELDWLARHRIALGLACGLEYLHMHH 186 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lh~~~ 186 (345)
+.+++++ +|||++++++++...+. ...+++++|+.+++ .+++.....++.|++.||.|||+.+
T Consensus 69 ~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 148 (291)
T cd06639 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR 148 (291)
T ss_pred HHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 8899888 89999999998875542 35789999987654 3456666789999999999999998
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-----cCccchhh-HHHHH
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-----LTEKCDIY-FGALL 260 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-----~~~~~Dvw-lG~vl 260 (345)
++|+||||+||+++.++.++++|||++........ ......|+..|+|||.+.... ++.++|+| +|+++
T Consensus 149 ---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~ 223 (291)
T cd06639 149 ---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITA 223 (291)
T ss_pred ---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHH
Confidence 99999999999999999999999999876543221 112356788999999986432 57899999 99999
Q ss_pred HHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 261 AGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 261 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|||++|..||.... .... +........+. .. ..+.....+.++|.+||+.+|++||++.++++
T Consensus 224 ~el~~g~~p~~~~~----~~~~---~~~~~~~~~~~-~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 224 IELGDGDPPLFDMH----PVKT---LFKIPRNPPPT-LL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHhhCCCCCCCCc----HHHH---HHHHhcCCCCC-CC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999999964321 1111 11111111110 00 01122345888999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=263.64 Aligned_cols=241 Identities=27% Similarity=0.382 Sum_probs=188.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+.|...++||+|+||+|+-|+.+ .+|+.+|.|.+.. ++++. .+--...++|-.
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~K--------------------KRiKk----r~ge~maLnEk~ 237 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVR-ATGKMYACKKLDK--------------------KRIKK----RKGETMALNEKQ 237 (591)
T ss_pred cccceeeeEEEecccccceeEEEEe-cchhhHHHHHHHH--------------------HHHHH----hhhhHHhhHHHH
Confidence 4567888899999999999999865 6899999998832 11111 233556788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+|++++.|.||.+--.|.+++ .+++|+..+.||++ ++.....-++.+|+.||+|||..+ |+.||
T Consensus 238 iL~kV~s~FiVslaYAfeTkd--~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRD 312 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKD--ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRD 312 (591)
T ss_pred HHHHhccCcEEEEeeeecCCC--ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeecc
Confidence 999999999999988888888 68888888877653 788888899999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+|||+|..|+++|+|+|+|..+.....+ ...+||.+|||||+++...|+...|+| +||++|||+.|..||...
T Consensus 313 LKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 313 LKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 9999999999999999999999988766543 346999999999999999999999999 999999999999997543
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
-......++.. .... ++...++..+++...+++. .|+.||++|...
T Consensus 390 KeKvk~eEvdr---r~~~--------~~~ey~~kFS~eakslc~~---LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 390 KEKVKREEVDR---RTLE--------DPEEYSDKFSEEAKSLCEG---LLTKDPEKRLGC 435 (591)
T ss_pred hhhhhHHHHHH---HHhc--------chhhcccccCHHHHHHHHH---HHccCHHHhccC
Confidence 22111111111 1111 1111234445555555554 889999999754
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=263.24 Aligned_cols=243 Identities=21% Similarity=0.361 Sum_probs=185.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.+.|.....||+|+||.||++... .++..||||.+.... ......+.+|+.+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~---------------------------~~~~~~~~~e~~~ 72 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRK---------------------------QQRRELLFNEVVI 72 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEEC-CCCCEEEEEEEecch---------------------------HHHHHHHHHHHHH
Confidence 345566688999999999999853 578899999984321 1234567889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++.++||||+++++.+..++ ..++++++++++.+ +++.....++.|++.|+.|||+.+ ++|+||||+
T Consensus 73 l~~l~h~~ii~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~ 147 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSD 147 (292)
T ss_pred HHhCCCCcHHHHHHheecCC--eEEEEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHH
Confidence 99999999999999887765 68999999987643 456677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|||++|..||...
T Consensus 148 Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~---- 221 (292)
T cd06658 148 SILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---- 221 (292)
T ss_pred HEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----
Confidence 99999999999999999875432211 22335788999999999888899999999 999999999999996431
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
........+......... . .......+.+++..||+.||.+|||+.++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~----~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 222 PPLQAMRRIRDNLPPRVK----D-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHhcCCCccc----c-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 222222222211110000 0 01122346778888999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=263.02 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=188.7
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+...-++|++.+.||+|+||.||+|+.+ .++..||+|.+....... .....+.+
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~-------------------------~~~~~~~~ 60 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKE-------------------------GFPITALR 60 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcC-------------------------CchhHHHH
Confidence 4456678999999999999999999854 579999999985432111 11233457
Q ss_pred HHHHHhhccCCCccceeEEEecCCc------ceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDC------HLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~------~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
|+.++++++||||+++++++...+. ...+++++++.+. ..+++.....++.|++.||.|||+.+
T Consensus 61 e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~- 139 (310)
T cd07865 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK- 139 (310)
T ss_pred HHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999999999999998876542 3568888988652 24677788899999999999999998
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccccc-cCccchhh-HHHHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGL 263 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el 263 (345)
++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+.. ++.++|+| +|+++|+|
T Consensus 140 --i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el 217 (310)
T cd07865 140 --ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217 (310)
T ss_pred --eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHH
Confidence 999999999999999999999999999765432211 1123356788999999887654 68899999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCC---cc-----ccc-cccCCC---------cHHHHHHHHHHHhhccCC
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPK---RA-----IDS-KLVGNG---------CEEQMLLVLKIACFCTLE 325 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~-~~~~~~---------~~~~~~~l~~li~~Cl~~ 325 (345)
++|..||... ........+........+. .. .+. ...... .......+.++|.+||+.
T Consensus 218 ~t~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~ 293 (310)
T cd07865 218 WTRSPIMQGN----TEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293 (310)
T ss_pred HhCCCCCCCC----CHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcC
Confidence 9999996432 2223333333222111100 00 000 000000 000123467899999999
Q ss_pred CCCCCCCHHHHHH
Q 046907 326 DPNERPNSKDVRR 338 (345)
Q Consensus 326 dp~~Rpt~~~ll~ 338 (345)
||++|||++++++
T Consensus 294 ~P~~R~t~~e~l~ 306 (310)
T cd07865 294 DPAKRIDADTALN 306 (310)
T ss_pred ChhhccCHHHHhc
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.68 Aligned_cols=243 Identities=22% Similarity=0.339 Sum_probs=185.3
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|+..+.||+|+||.||+|... .++..|++|.+........ ..+....+.+|+.+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~----------------------~~~~~~~~~~e~~~l~ 57 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQT----------------------GQEAVKQLEQEIALLS 57 (258)
T ss_pred CccccceeeecCCceEEEEEEc-CCCcEEEEEEEEEcccccc----------------------chHHHHHHHHHHHHHH
Confidence 4778899999999999999864 5789999999854321110 1233567888999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
.++||||+++++++..++ .+++++++++++++ +++.....++.|++.|+.|||+.+ ++|+||+|+|
T Consensus 58 ~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~n 132 (258)
T cd06632 58 KLQHPNIVQYLGTEREED--NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGAN 132 (258)
T ss_pred hcCCCCchheeeeEecCC--eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999999887665 67888999987543 456666789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|+++.++.+||+|||++....... ......|+..|+|||.+.... ++.++|+| +|+++|+|++|..||....
T Consensus 133 i~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--- 206 (258)
T cd06632 133 ILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--- 206 (258)
T ss_pred EEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc---
Confidence 999999999999999987654332 123456889999999987766 88999999 9999999999999975432
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+... ...+ .........+.+++.+||+.+|++||++.++++
T Consensus 207 -~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 207 -GVAAVFKIGRS--KELP----------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -HHHHHHHHHhc--ccCC----------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11111111110 0010 011112234678889999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=261.31 Aligned_cols=241 Identities=26% Similarity=0.385 Sum_probs=184.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
..|+..+.||+|+||.||+|++. .++..+|+|.+....... .+....+.+|+.++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~------------------------~~~~~~~~~e~~~l 79 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQS------------------------NEKWQDIIKEVKFL 79 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCc------------------------hHHHHHHHHHHHHH
Confidence 45888999999999999999864 478999999985432111 22356688899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++|||++++++++..++ ..+++++|+.+. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+
T Consensus 80 ~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~ 154 (317)
T cd06635 80 QRIKHPNSIEYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAG 154 (317)
T ss_pred HhCCCCCEEEEEEEEeeCC--eEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcc
Confidence 9999999999999988766 678899988652 33567777889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+++.++.++++|||++..... .....|+..|+|||.+. +..++.++|+| +|+++|+|++|..||...
T Consensus 155 Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~- 227 (317)
T cd06635 155 NILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM- 227 (317)
T ss_pred cEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-
Confidence 99999999999999998865432 22356888999999984 34578899999 999999999999996432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
........+.. ...+. ...+.....+.+++.+||+.+|.+||++.++++..
T Consensus 228 ---~~~~~~~~~~~---~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 228 ---NAMSALYHIAQ---NESPT---------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ---cHHHHHHHHHh---ccCCC---------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 11121111111 11110 01112233578899999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.18 Aligned_cols=256 Identities=21% Similarity=0.244 Sum_probs=182.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|.+.+.||+|+||.||+|... .+|..||+|.+....... ....+.+|+.
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~--------------------------~~~~~~~e~~ 55 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEG--------------------------VPFTAIREAS 55 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCC--------------------------CcHHHHHHHH
Confidence 4578999999999999999999854 468899999985432111 1234567999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++|+||+++++++..++ ..+++++++.+. ..++......++.|++.||.|||+.+ ++|+|||
T Consensus 56 ~l~~l~h~ni~~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlk 130 (291)
T cd07870 56 LLKGLKHANIVLLHDIIHTKE--TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLK 130 (291)
T ss_pred HHHhcCCCCEeEEEEEEecCC--eEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999988765 678888888542 12345566789999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+| +|+++|+|++|..||....
T Consensus 131 p~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 131 PQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred hHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 9999999999999999999875433211 12334578899999998764 478899999 9999999999999975422
Q ss_pred cccchhhHHHHHHHHhhhcC------------CCccccccccCCCc------HHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASEN------------PKRAIDSKLVGNGC------EEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~------~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
. ..+....+......+. .............. ......+.+++.+|++.||.+|||+.++
T Consensus 209 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~ 285 (291)
T cd07870 209 D---VFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285 (291)
T ss_pred h---HHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence 1 1111111111111000 00000000000000 0112456788899999999999999998
Q ss_pred HH
Q 046907 337 RR 338 (345)
Q Consensus 337 l~ 338 (345)
+.
T Consensus 286 l~ 287 (291)
T cd07870 286 LL 287 (291)
T ss_pred hc
Confidence 74
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.07 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCC------CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQN------GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
.|+...++.++.+.||.|.||.|++|...+.. ...||||+++....+ .
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--------------------------~ 343 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--------------------------S 343 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--------------------------H
Confidence 78888889999999999999999999864222 457999999754332 3
Q ss_pred HHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHH
Q 046907 116 KMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARH 169 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~ 169 (345)
..+.+..|+.+++.+ +||||+.++|++...+ .++++.||+..|.+ +...+..
T Consensus 344 ~~~~~~~El~~m~~~g~H~niv~llG~~t~~~--~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLl 421 (609)
T KOG0200|consen 344 EKKDLMSELNVLKELGKHPNIVNLLGACTQDG--PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLL 421 (609)
T ss_pred HHHHHHHHHHHHHHhcCCcchhhheeeeccCC--ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHH
Confidence 467888999999998 7999999999998844 68888888877543 4555667
Q ss_pred HHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcc--cCccccccccccccc
Q 046907 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVV--GTVEYIAPEYLQMLT 247 (345)
Q Consensus 170 ~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--gt~~~~aPE~~~~~~ 247 (345)
+++.||+.|++||++.. ++||||.++|||+..+..+||+|||+|+.......... .... -+..|||||.+....
T Consensus 422 sfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ 497 (609)
T KOG0200|consen 422 SFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRV 497 (609)
T ss_pred HHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCc
Confidence 79999999999999998 99999999999999999999999999986654433321 1112 255699999999999
Q ss_pred cCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCC
Q 046907 248 LTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLE 325 (345)
Q Consensus 248 ~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~ 325 (345)
++.++||| ||+++||++| |..||++. ....++.++++.+.+...|. .+..++.++|..||+.
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~---~~~~~l~~~l~~G~r~~~P~-------------~c~~eiY~iM~~CW~~ 561 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGI---PPTEELLEFLKEGNRMEQPE-------------HCSDEIYDLMKSCWNA 561 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCC---CcHHHHHHHHhcCCCCCCCC-------------CCCHHHHHHHHHHhCC
Confidence 99999999 9999999999 89997541 12444556666666554443 2334577899999999
Q ss_pred CCCCCCCHHHHHHHHhhh
Q 046907 326 DPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 326 dp~~Rpt~~~ll~~L~~l 343 (345)
+|++||++.++.+.|+..
T Consensus 562 ~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 562 DPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcccCCCHHHHHHHHHHH
Confidence 999999999999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=287.81 Aligned_cols=245 Identities=25% Similarity=0.415 Sum_probs=175.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|+.++.||+|+||.||+++ ++-+|..||||++.... + .+....+.+|+..|
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVR-NKlDGr~YAIKKIpl~~-s-------------------------~~~~skI~rEVk~L 531 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVR-NKLDGREYAIKKIPLKA-S-------------------------DKLYSKILREVKLL 531 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEe-ecccchhhhhhhccCch-H-------------------------HHHHHHHHHHHHHH
Confidence 478889999999999999999 55789999999996543 2 34577888999999
Q ss_pred hhccCCCccceeEEEecCCcc-----------------------------------------------------------
Q 046907 128 GQIRHRNLHPLLAHVTRPDCH----------------------------------------------------------- 148 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~----------------------------------------------------------- 148 (345)
++|+|||||+++..|......
T Consensus 532 ArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~ 611 (1351)
T KOG1035|consen 532 ARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKAS 611 (1351)
T ss_pred hhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCcccccccccccc
Confidence 999999999999866432100
Q ss_pred ----------------------------------------------------------eeeeeccccCCC--------CC
Q 046907 149 ----------------------------------------------------------LLYILNDVSQGR--------RE 162 (345)
Q Consensus 149 ----------------------------------------------------------~l~~~~~~~~~~--------~~ 162 (345)
.+|+.|+||+.. +.
T Consensus 612 ~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~ 691 (1351)
T KOG1035|consen 612 YESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH 691 (1351)
T ss_pred ccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc
Confidence 012223333221 01
Q ss_pred C--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecC----C------------CCc
Q 046907 163 L--DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP----D------------AHT 224 (345)
Q Consensus 163 l--~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~----~------------~~~ 224 (345)
+ .....++++.+|++||.|+|++| +|||||||.||+++.+..+||+|||+|.... . ...
T Consensus 692 ~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~ 768 (1351)
T KOG1035|consen 692 FNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSN 768 (1351)
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCC
Confidence 1 12233569999999999999999 9999999999999999999999999998722 0 011
Q ss_pred ceeccCcccCccccccccccccc---cCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcccc
Q 046907 225 HITTSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAID 300 (345)
Q Consensus 225 ~~~~~~~~gt~~~~aPE~~~~~~---~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (345)
....+..+||..|+|||++.+.. |+.|+|+| +|+|++||+. ||. ..++-...+.+......|..
T Consensus 769 ~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~------TsMERa~iL~~LR~g~iP~~--- 836 (1351)
T KOG1035|consen 769 DGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG------TSMERASILTNLRKGSIPEP--- 836 (1351)
T ss_pred CcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC------chHHHHHHHHhcccCCCCCC---
Confidence 11345689999999999997655 89999999 9999999984 332 12223333333322222211
Q ss_pred ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 301 SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 301 ~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++...+....=.++|.++++.||++||||.++++
T Consensus 837 ----~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 837 ----ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ----cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 1111122222357888999999999999999986
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=261.13 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=183.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|++. .+++.||+|.+...... ......+.+|+.++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~-------------------------~~~~~~~~~E~~~l 54 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDE-------------------------EGIPPTALREISLL 54 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccc-------------------------cCCchHHHHHHHHH
Confidence 47999999999999999999864 57899999987532111 11234567899999
Q ss_pred hhc-cCCCccceeEEEecCCc---ceeeeeccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 128 GQI-RHRNLHPLLAHVTRPDC---HLLYILNDVSQGR-------------RELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 128 ~~l-~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+.+ +||||+++++.+...+. ...+++++++++. ..+++.....++.|++.||.|||+.+ +
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i 131 (295)
T cd07837 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---V 131 (295)
T ss_pred HHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 999 56999999998876542 2478899988752 23567778889999999999999998 9
Q ss_pred EecCCCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCC
Q 046907 191 IHRDLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 191 iH~dlk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
+||||+|+||+++. ++.++++|||++........ ......+++.|+|||.+.+. .++.++|+| +|+++|+|++|.
T Consensus 132 ~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 209 (295)
T cd07837 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209 (295)
T ss_pred eecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCC
Confidence 99999999999998 88999999999875532211 11223567889999988654 478899999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCc---cc-----------cccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKR---AI-----------DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----------~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
.||... ........... ....+.... .. .+.......+.....+.++|..||+.||.+||++
T Consensus 210 ~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~ 285 (295)
T cd07837 210 PLFPGD---SELQQLLHIFK-LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285 (295)
T ss_pred CCCCCC---CHHHHHHHHHH-HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence 997432 11112222111 111110000 00 0000000112234557889999999999999999
Q ss_pred HHHHH
Q 046907 334 KDVRR 338 (345)
Q Consensus 334 ~~ll~ 338 (345)
.+++.
T Consensus 286 ~eil~ 290 (295)
T cd07837 286 KAALT 290 (295)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=261.60 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=186.8
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+.. .+++.||+|.+....... ......+..|+.++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~------------------------~~~~~~~~~e~~~l 55 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIK------------------------RNKVKRVLTEQEIL 55 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccch------------------------HHHHHHHHHHHHHH
Confidence 47999999999999999999864 468999999986432221 12356788899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+.++||||+++++.+...+ ..+++++++.++.+ +++.....++.|++.||.|||+.+ ++|+|||
T Consensus 56 ~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 130 (316)
T cd05574 56 ATLDHPFLPTLYASFQTET--YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLK 130 (316)
T ss_pred HhCCCCCchhheeeeecCC--EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999887665 78899999877543 455566778999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcc---------------------------eeccCcccCccccccccccccccC
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTH---------------------------ITTSNVVGTVEYIAPEYLQMLTLT 249 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~---------------------------~~~~~~~gt~~~~aPE~~~~~~~~ 249 (345)
|+||+++.++.++++|||++......... .......|+..|+|||.+.+..++
T Consensus 131 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 210 (316)
T cd05574 131 PENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG 210 (316)
T ss_pred hHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC
Confidence 99999999999999999988754321100 011235788999999999988899
Q ss_pred ccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 250 EKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
.++||| +|+++|+|++|..||.... ....+..... ..... .........+.+++.+||+.||+
T Consensus 211 ~~~Di~slG~ll~~l~~g~~pf~~~~---~~~~~~~~~~----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~ 274 (316)
T cd05574 211 SAVDWWTLGILLYEMLYGTTPFKGSN---RDETFSNILK----KEVTF---------PGSPPVSSSARDLIRKLLVKDPS 274 (316)
T ss_pred chHHHHHHHHHHHHHhhCCCCCCCCc---hHHHHHHHhc----CCccC---------CCccccCHHHHHHHHHHccCCHh
Confidence 999999 9999999999999975322 1112211111 11000 00111344588899999999999
Q ss_pred CCCC----HHHHHH
Q 046907 329 ERPN----SKDVRR 338 (345)
Q Consensus 329 ~Rpt----~~~ll~ 338 (345)
+||| +.++++
T Consensus 275 ~R~s~~~~~~~ll~ 288 (316)
T cd05574 275 KRLGSKRGAAEIKQ 288 (316)
T ss_pred HCCCchhhHHHHHc
Confidence 9999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=256.16 Aligned_cols=244 Identities=23% Similarity=0.367 Sum_probs=186.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|++|.||+|..+ .++..+++|.+.... .....+.+|+.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~----------------------------~~~~~~~~e~~ 54 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIE----------------------------DEEEEIKEEYN 54 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCc----------------------------hhHHHHHHHHH
Confidence 5689999999999999999999864 468899999985432 12356788999
Q ss_pred HHhhc-cCCCccceeEEEecCC----cceeeeeccccCCCC-------------CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPD----CHLLYILNDVSQGRR-------------ELDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
+++++ +||||+++++++...+ ...+++++++++++. .++......++.|++.||.|||+.+
T Consensus 55 ~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~- 133 (275)
T cd06608 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK- 133 (275)
T ss_pred HHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 99999 7999999999987654 346889999998753 3455566679999999999999998
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-----ccCccchhh-HHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-----TLTEKCDIY-FGALLA 261 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-----~~~~~~Dvw-lG~vl~ 261 (345)
++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||.+... .++.++||| +|+++|
T Consensus 134 --i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 209 (275)
T cd06608 134 --VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209 (275)
T ss_pred --cccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHH
Confidence 99999999999999999999999999876543221 22345688999999988542 367789999 999999
Q ss_pred HHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+|++|..||..... ...... ......+ .. .........+.+++.+||..||++|||+.++++
T Consensus 210 ~l~~g~~p~~~~~~---~~~~~~----~~~~~~~------~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 210 ELADGKPPLCDMHP---MRALFK----IPRNPPP------TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHhCCCCccccch---HHHHHH----hhccCCC------CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99999999753211 111111 1111110 00 011223456789999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=263.64 Aligned_cols=259 Identities=23% Similarity=0.288 Sum_probs=186.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|.+.+.||+|+||.||+|+++ .++..+|+|.+....... .....+.+|+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~-------------------------~~~~~~~~e~~~ 60 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKD-------------------------GFPITALREIKI 60 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCC-------------------------CcchhHHHHHHH
Confidence 579999999999999999999964 578899999885432111 012345679999
Q ss_pred HhhccCCCccceeEEEecCCc------ceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC------HLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~------~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
++.++||||+++++.+..... ..++++++|+.+ +..+++..+..++.|+++||.|||+.+ ++
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~ 137 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---IL 137 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999997765432 256788888764 235778888899999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcc---------eeccCcccCcccccccccccc-ccCccchhh-HHHHH
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH---------ITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALL 260 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl 260 (345)
|+||||+||+++.++.++++|||++......... .......|+..|+|||.+.+. .++.++||| +|+++
T Consensus 138 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 217 (311)
T cd07866 138 HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217 (311)
T ss_pred cCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHH
Confidence 9999999999999999999999999765432111 111234668889999988654 478899999 99999
Q ss_pred HHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccc-------------ccccc---CCCcHHHHHHHHHHHhhccC
Q 046907 261 AGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAI-------------DSKLV---GNGCEEQMLLVLKIACFCTL 324 (345)
Q Consensus 261 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~---~~~~~~~~~~l~~li~~Cl~ 324 (345)
|||++|..||... +.......+........+.... ..... ..........+.+++.+||+
T Consensus 218 ~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 293 (311)
T cd07866 218 AEMFTRRPILQGK----SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293 (311)
T ss_pred HHHHhCCCCCCCC----CHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcc
Confidence 9999999997542 2222222222222111110000 00000 00011222467899999999
Q ss_pred CCCCCCCCHHHHHH
Q 046907 325 EDPNERPNSKDVRR 338 (345)
Q Consensus 325 ~dp~~Rpt~~~ll~ 338 (345)
.||++|||+.++++
T Consensus 294 ~~p~~R~t~~ell~ 307 (311)
T cd07866 294 LDPYKRLTASDALE 307 (311)
T ss_pred cCcccCcCHHHHhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=262.28 Aligned_cols=242 Identities=23% Similarity=0.351 Sum_probs=184.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
...|+....||+|+||.||+|+.. .++..||+|.+.... ......+.+|+.+
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~---------------------------~~~~~~~~~e~~~ 71 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRK---------------------------QQRRELLFNEVVI 71 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEc-CCCCEEEEEEEEecc---------------------------cchHHHHHHHHHH
Confidence 345666778999999999999854 578899999984321 1123456789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++.++||||+++++.+..++ ..++++++++++.+ +++.....++.|++.||.|||+.+ ++|+||+|+
T Consensus 72 l~~l~hp~i~~~~~~~~~~~--~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~ 146 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSD 146 (297)
T ss_pred HHhCCCCchhhhhhheeeCC--eEEEEEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 99999999999999888765 68889999987543 566677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|||++|..||.. .
T Consensus 147 Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~----~ 220 (297)
T cd06659 147 SILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS----D 220 (297)
T ss_pred HeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC----C
Confidence 99999999999999999875433221 12345789999999999988899999999 99999999999999642 1
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.. ...... . ........+.+++..||+.+|++||+++++++
T Consensus 221 ~~~~~~~~~~~---~~~~~~----~----~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 221 SPVQAMKRLRD---SPPPKL----K----NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHhc---cCCCCc----c----ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 22222222211 111100 0 01112234778889999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=253.83 Aligned_cols=236 Identities=22% Similarity=0.299 Sum_probs=184.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.-++|+++++||+|.||.|-+|+- +.+|+.+|+|+++..-... .......+.|-+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rE-Kat~k~YAiKIlkKeviia------------------------kdEVAHTlTE~R 220 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCRE-KATGKLYAIKILKKEVIIA------------------------KDEVAHTLTENR 220 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEee-cccCceeehhhhhhhheee------------------------hHHhhhhhhHHH
Confidence 346899999999999999999985 4689999999996422111 334677788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH---------HHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---------ARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~---------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|+..+||.+..+...|.+.+ .++++|+|..||.++-.+ ...-+...|+.||.|||+++ |+.||+|
T Consensus 221 VL~~~~HPFLt~LKYsFQt~d--rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlK 295 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQD--RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLK 295 (516)
T ss_pred HHHhccCcHHHHhhhhhccCc--eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeech
Confidence 999999999999988888877 799999999998774333 34457889999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
.+|+|+|.+|.+||+|||+++..-. ....+.+++||+.|+|||++....|+.+.|+| +|+++|||++|+.|| +
T Consensus 296 LENLlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF---y- 369 (516)
T KOG0690|consen 296 LENLLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF---Y- 369 (516)
T ss_pred hhhheeccCCceEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc---c-
Confidence 9999999999999999999975422 22346779999999999999999999999999 999999999999995 3
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
..+...+.+.|.... -.. +....++ ...|+...|..||.+|.
T Consensus 370 n~dh~kLFeLIl~ed--~kF--------Pr~ls~e----AktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 370 NKDHEKLFELILMED--LKF--------PRTLSPE----AKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ccchhHHHHHHHhhh--ccC--------CccCCHH----HHHHHHHHhhcChHhhc
Confidence 334444444443211 011 1111122 44566667889999996
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=256.56 Aligned_cols=251 Identities=22% Similarity=0.235 Sum_probs=183.2
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|.+.+.||+|+||.||+|+.. .++..||+|.+.....+. ......+|+.++.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~--------------------------~~~~~~~e~~~l~~ 53 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSL--------------------------EQVNNLREIQALRR 53 (282)
T ss_pred CceEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCc--------------------------hhhhHHHHHHHHhh
Confidence 678899999999999999864 578999999985432111 11223468888888
Q ss_pred cc-CCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 130 IR-HRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 130 l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+. |||++++++++.++....++++++++.+. ..+++.....++.|++.||.|||+.+ ++|+||+|+|
T Consensus 54 l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~n 130 (282)
T cd07831 54 LSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPEN 130 (282)
T ss_pred cCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHH
Confidence 84 99999999999877444688899988642 34677788899999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|+++. +.++|+|||++........ .....++..|+|||.+.. ..++.++|+| +|+++|||++|..||...
T Consensus 131 i~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~---- 202 (282)
T cd07831 131 ILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT---- 202 (282)
T ss_pred EEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC----
Confidence 99999 9999999999976543321 123567889999997754 4468899999 999999999999997542
Q ss_pred chhhHHHHHHHHhhhcCC-----------CccccccccC----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENP-----------KRAIDSKLVG----NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~----~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+..+....+......... .....+...+ ...+.....+.+++..||+.+|++|||+.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 203 NELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 222222333222211111 0000000000 011233567899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=253.16 Aligned_cols=248 Identities=19% Similarity=0.287 Sum_probs=187.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
.+|.+.+.||+|+||.||+|+.. .++..||+|.+........ .......+.+|+.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~----------------------~~~~~~~~~~ei~~l 58 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQE----------------------TSKEVNALECEIQLL 58 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccch----------------------hhHHHHHHHHHHHHH
Confidence 58999999999999999999854 5799999998743211100 023356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++||||+++++.+.......+++++++++++.+ ++......++.|++.||.|||+.+ ++|+|++|+
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ 135 (264)
T cd06653 59 KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGA 135 (264)
T ss_pred HHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 99999999999998877665678888899877543 456667789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCc-ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++++|||++........ ........|+..|+|||.+.+..++.++|+| +|+++|++++|..||...
T Consensus 136 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--- 212 (264)
T cd06653 136 NILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY--- 212 (264)
T ss_pred HEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc---
Confidence 99999999999999999976532111 1111235688999999999988889999999 999999999999997532
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ..+......+.. . ..+......+.+++..||+ +|..||++.+++.
T Consensus 213 -~~~---~~~~~~~~~~~~-~--------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 213 -EAM---AAIFKIATQPTK-P--------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CHH---HHHHHHHcCCCC-C--------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111 111111111111 0 1122233457788888999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=255.36 Aligned_cols=241 Identities=26% Similarity=0.398 Sum_probs=186.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+-|+..+.||+|+||.||+|.+. .++..||+|.+..... ......+.+|+.++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~--------------------------~~~~~~~~~e~~~l 56 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEA--------------------------EDEIEDIQQEITVL 56 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccc--------------------------hHHHHHHHHHHHHH
Confidence 35788899999999999999854 4789999998743211 12245678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+.++||||+++++.+..++ ..++++++++++.+ +++.....++.+++.|+.+||+.+ ++|+|++|+|
T Consensus 57 ~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~N 131 (277)
T cd06641 57 SQCDSPYVTKYYGSYLKDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAAN 131 (277)
T ss_pred HhcCCCCEeEEEEEEEeCC--eEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHh
Confidence 9999999999999988765 68899999987543 456667889999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
|+++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||... .
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~----~ 205 (277)
T cd06641 132 VLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL----H 205 (277)
T ss_pred EEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc----c
Confidence 9999999999999999876543221 12335678899999999888889999999 999999999999996432 1
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.......+.. ...+ . ........+.+++..||+.+|++||++.++++.
T Consensus 206 ~~~~~~~~~~---~~~~------~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 206 PMKVLFLIPK---NNPP------T----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHhc---CCCC------C----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1222221111 1110 0 111223446788889999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=252.37 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=186.9
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|... .++..|++|.+...... ......+..|+.+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~~~ 54 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDND-------------------------PKTIKEIADEMKVLE 54 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccc-------------------------hHHHHHHHHHHHHHH
Confidence 5889999999999999999854 47889999998654322 234677889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
.++||||+++++.+...+ .++++++++.++. .+++.....++.+++.|+.|||+.+ ++|+||+|+|
T Consensus 55 ~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~n 129 (264)
T cd06626 55 LLKHPNLVKYYGVEVHRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPAN 129 (264)
T ss_pred hCCCCChhheeeeEecCC--EEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999999877665 6888899987653 3556667789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCccee--ccCcccCccccccccccccc---cCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHIT--TSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~~~gt~~~~aPE~~~~~~---~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+++.++.++|+|||++........... .....++..|+|||.+.+.. .+.++||| ||++++++++|..||...
T Consensus 130 il~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 130 IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred EEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 9999999999999999887644322111 12356788999999998766 78899999 999999999999997532
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. ........+.. ...+. .+. .......+.+++..||+.+|.+|||+.+++.
T Consensus 210 ~---~~~~~~~~~~~---~~~~~--~~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 210 D---NEFQIMFHVGA---GHKPP--IPD------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c---chHHHHHHHhc---CCCCC--CCc------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 11122111111 11110 000 0112334678899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=260.57 Aligned_cols=259 Identities=22% Similarity=0.270 Sum_probs=189.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+++ .+|+.||+|.+...... ......+..|+.
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~-------------------------~~~~~~~~~e~~ 58 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEK-------------------------EGFPITAIREIK 58 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecccc-------------------------cCchHHHHHHHH
Confidence 5678999999999999999999965 57899999998643211 111334567999
Q ss_pred HHhhccCCCccceeEEEecCC--------cceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD--------CHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~--------~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+++.++||||+++++++...+ ...++++++++++. ..+++.....++.|++.||.|||+.+
T Consensus 59 ~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 136 (302)
T cd07864 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136 (302)
T ss_pred HHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999887654 23678899998762 24677788899999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhC
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg 266 (345)
++|+||+|+||+++.++.+||+|||++......... ......++..|+|||.+.+. .++.++||| +|+++|+|++|
T Consensus 137 -i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g 214 (302)
T cd07864 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214 (302)
T ss_pred -eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765433211 11223567889999988654 468899999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccc-----------cccc-----cCCCcHHHHHHHHHHHhhccCCCCCCC
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAI-----------DSKL-----VGNGCEEQMLLVLKIACFCTLEDPNER 330 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~-----~~~~~~~~~~~l~~li~~Cl~~dp~~R 330 (345)
..||.. .+.......+......+.+.... +... ...........+.+++..||+.||.+|
T Consensus 215 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 290 (302)
T cd07864 215 KPIFQA----NQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290 (302)
T ss_pred CCCCCC----CChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhC
Confidence 999643 22233333333322222111000 0000 000011123457899999999999999
Q ss_pred CCHHHHHH
Q 046907 331 PNSKDVRR 338 (345)
Q Consensus 331 pt~~~ll~ 338 (345)
||+.++++
T Consensus 291 p~~~~il~ 298 (302)
T cd07864 291 CTAEEALN 298 (302)
T ss_pred CCHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=256.29 Aligned_cols=240 Identities=24% Similarity=0.380 Sum_probs=183.5
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|++.+.||+|+||.||+|.+. .+++.||+|.+..... ......+.+|+.+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~--------------------------~~~~~~~~~e~~~l~ 54 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTP--------------------------DDDVSDIQREVALLS 54 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCC--------------------------chhHHHHHHHHHHHH
Confidence 5888999999999999999964 5789999999854211 122455678889988
Q ss_pred hcc---CCCccceeEEEecCCcceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIR---HRNLHPLLAHVTRPDCHLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~---hpniv~l~~~~~~~~~~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++ |||++++++.+...+ ..+++++++.++. .+++.....++.|++.||.|||+.+ ++|+||+|
T Consensus 55 ~l~~~~~~~vi~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p 129 (277)
T cd06917 55 QLRQSQPPNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKA 129 (277)
T ss_pred HhccCCCCCeeeEeeeeeeCC--EEEEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCH
Confidence 886 999999999887655 6888999997754 3566677889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.++++|||++........ ......|+..|+|||.+.+. .++.++|+| +|+++|+|++|..||.....
T Consensus 130 ~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 130 ANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred HHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999987654331 22345788999999988654 468899999 99999999999999754211
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ....... . .+.+... .....+.+++..||+.||++||++.++++
T Consensus 208 ----~~~---~~~~~~~-~-----~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 208 ----FRA---MMLIPKS-K-----PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ----hhh---hhccccC-C-----CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 1111100 0 0111111 12345778899999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.77 Aligned_cols=249 Identities=20% Similarity=0.393 Sum_probs=184.6
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.+..+.++|++.+.||+|+||.||+|+++ .++..||||.+...... .....+.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~--------------------------~~~~~~~ 61 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNK--------------------------EENKRIL 61 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCCh--------------------------HHHHHHH
Confidence 34557789999999999999999999975 45899999998643211 1234455
Q ss_pred HHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCe
Q 046907 122 SEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMH-HCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~-~~~~i 190 (345)
.|+.++.+. .||||+++++++...+ .++++++++.+ ...+++..+..++.|++.|+.|||+. + +
T Consensus 62 ~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i 136 (296)
T cd06618 62 MDLDVVLKSHDCPYIVKCYGYFITDS--DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---V 136 (296)
T ss_pred HHHHHHHhccCCCchHhhheeeecCC--eEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---E
Confidence 677766666 5999999999988766 68888888864 23467777789999999999999974 6 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc----cCccchhh-HHHHHHHHHh
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT----LTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~----~~~~~Dvw-lG~vl~el~t 265 (345)
+|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+| ||+++|+|++
T Consensus 137 ~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~ 213 (296)
T cd06618 137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213 (296)
T ss_pred ecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh
Confidence 9999999999999999999999999876543221 12245788999999997654 78899999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
|..||.... ...+... .......+. .. . .......+.+++.+||+.||++||++.++++.
T Consensus 214 g~~p~~~~~---~~~~~~~---~~~~~~~~~--~~----~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 214 GQFPYKNCK---TEFEVLT---KILQEEPPS--LP----P--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCcch---hHHHHHH---HHhcCCCCC--CC----C--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 999975321 1111111 111111110 00 0 00123457889999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=266.57 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=189.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|... .+|..||+|.+...... ......+.+|+.+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~-------------------------~~~~~~~~~e~~~ 57 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDV-------------------------PTLAKRTLRELKI 57 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEecccccc-------------------------ccchHHHHHHHHH
Confidence 378999999999999999999854 57999999998542211 1224566789999
Q ss_pred HhhccCCCccceeEEEecCC--cceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPD--CHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~--~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++++.... ...++++++|+.+ ...++......++.|++.||.|||+.+ ++|+|||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlk 134 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLK 134 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 99999999999999876432 3467889998854 234677888899999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+||+++.++.++|+|||++......... .......|+..|+|||.+.+ ..++.++|+| +|+++|+|++|..||..
T Consensus 135 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 135 PSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred HHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 99999999999999999999765432211 11134578899999999865 3578899999 99999999999999754
Q ss_pred cccccchhhHHHHHHHHhhhcCCCc--------------ccccccc---CCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKR--------------AIDSKLV---GNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~---~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
.. .......+......+.... ....... ....+.....+.+++..||+.+|++|||+++
T Consensus 215 ~~----~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 290 (334)
T cd07855 215 KN----YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQ 290 (334)
T ss_pred CC----hHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 32 1222222222111110000 0000000 0011223456889999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 291 ~l~ 293 (334)
T cd07855 291 ALQ 293 (334)
T ss_pred HHh
Confidence 876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=258.23 Aligned_cols=256 Identities=22% Similarity=0.258 Sum_probs=186.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|..+ .++..||+|.+......... ......+..|+.+++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~----------------------~~~~~~~~~e~~~l~ 57 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAK----------------------DGINFTALREIKLLQ 57 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-CCCcEEEEEEEecccccccc----------------------chhhHHHHHHHHHHh
Confidence 4888999999999999999864 46889999999654322100 112345667999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
.++||||+++++++..++ .++++++++ ++. .+++.....++.|+++||.|||+.+ ++|+||+|+
T Consensus 58 ~~~h~~i~~~~~~~~~~~--~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~ 131 (298)
T cd07841 58 ELKHPNIIGLLDVFGHKS--NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPN 131 (298)
T ss_pred hcCCCCChhhhheeecCC--EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChh
Confidence 999999999999998755 788899988 432 4677778899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+| +|+++|||++|.+||..
T Consensus 132 nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~---- 205 (298)
T cd07841 132 NLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG---- 205 (298)
T ss_pred hEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC----
Confidence 99999999999999999987654322 1223456788999998865 3578899999 99999999999777543
Q ss_pred cchhhHHHHHHHHhhhcCCC---------ccccccccC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPK---------RAIDSKLVG-----NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~-----~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.........+......+... ......... .........+.+++.+||+.||++|||+.++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 206 DSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 22222222222211111000 000000000 0112234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=252.68 Aligned_cols=229 Identities=20% Similarity=0.272 Sum_probs=172.8
Q ss_pred cccccCcceeeEEEEecCCCC---------ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 54 EKIGSGGCGEVYKAELPGQNG---------RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
+.||+|+||.||+|++..... ..+++|.+.... .....+.+|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----------------------------~~~~~~~~e~ 52 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----------------------------RDSLAFFETA 52 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----------------------------hhHHHHHHHH
Confidence 468999999999999753221 357777764221 1156778899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.+++.++||||+++++++.. + ..++++++++++.+ +++..+..++.|++.||.|||+.+ ++|+|
T Consensus 53 ~~l~~l~h~~i~~~~~~~~~-~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 126 (259)
T cd05037 53 SLMSQLSHKHLVKLYGVCVR-D--ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGN 126 (259)
T ss_pred HHHHcCCCcchhheeeEEec-C--CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeccc
Confidence 99999999999999998877 3 46788899887543 566677889999999999999998 99999
Q ss_pred CCCCCeeecCCC-------CeEEeccccceecCCCCcceeccCcccCcccccccccccc--ccCccchhh-HHHHHHHHH
Q 046907 195 LNPVNVLLDDDI-------EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML--TLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 195 lk~~nil~~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~--~~~~~~Dvw-lG~vl~el~ 264 (345)
|||+||+++.++ .++++|||++..... .....++..|+|||++.+. .++.++|+| +|+++|+++
T Consensus 127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred CccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999877 799999999876543 1234567789999999876 688999999 999999999
Q ss_pred h-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 265 M-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 265 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
+ |..||.... ......... ..... .... ...+.+++..||+.+|.+|||+.++++.|+
T Consensus 201 ~~~~~p~~~~~----~~~~~~~~~----~~~~~-------~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 201 SNGEEPLSTLS----SSEKERFYQ----DQHRL-------PMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hCCCCCcccCC----chhHHHHHh----cCCCC-------CCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 9 577754322 111111111 00000 0000 145889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=255.35 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=202.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCC----CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQN----GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.+.+++....+.+|.||.||+|.|+..+ .+.|-+|.++.+ .+ .-....++
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~----------------------AS----~iQv~~~L 335 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH----------------------AS----QIQVNLLL 335 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc----------------------cc----HHHHHHHH
Confidence 5567888899999999999999886322 233444444321 12 23367889
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhh
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-----------------RELDWLARHRIALGLACGLEYLHM 184 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~ 184 (345)
.|...+..+.|||+..+.+.+..+.. ..+++..+..-| ..+...+...++.|++.|+.|||.
T Consensus 336 ~es~lly~~sH~nll~V~~V~ie~~~-~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~ 414 (563)
T KOG1024|consen 336 QESMLLYGASHPNLLSVLGVSIEDYA-TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN 414 (563)
T ss_pred HHHHHHhcCcCCCccceeEEEeeccC-cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999998877553 333333322222 224455667899999999999999
Q ss_pred cCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHH
Q 046907 185 HHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 185 ~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el 263 (345)
.+ ++|.||.++|++||...++|++|-.+++.+...+.++...+...+..||+||.+....|+.++||| ||+++|||
T Consensus 415 ~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWEL 491 (563)
T KOG1024|consen 415 HG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWEL 491 (563)
T ss_pred cC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHH
Confidence 99 999999999999999999999999999999888888887778889999999999999999999999 99999999
Q ss_pred Hh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 264 VM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 264 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
+| |..|+ .+-+..+...+++++.+...|. +|+++++.+|..||...|++||+++++...|.+
T Consensus 492 mtlg~~Py----aeIDPfEm~~ylkdGyRlaQP~-------------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 492 MTLGKLPY----AEIDPFEMEHYLKDGYRLAQPF-------------NCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HhcCCCCc----cccCHHHHHHHHhccceecCCC-------------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 98 99994 4456677778888877766554 344568899999999999999999999999987
Q ss_pred h
Q 046907 343 I 343 (345)
Q Consensus 343 l 343 (345)
+
T Consensus 555 F 555 (563)
T KOG1024|consen 555 F 555 (563)
T ss_pred H
Confidence 6
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=265.74 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=187.9
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++...||+|+||.||+|+.. .+++.||||.+...... ......+.+|+.+
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~~ 57 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDN-------------------------RIDAKRTLREIKL 57 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccc-------------------------cchhHHHHHHHHH
Confidence 357999999999999999999854 57999999998542211 1123456679999
Q ss_pred HhhccCCCccceeEEEecCCc---ceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++.++||||+++++++..... ..++++++++.+ ...++......++.|++.||.|||+.+ ++|+||
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl 134 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDL 134 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 999999999999998765432 247889998864 234667778899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+| +|+++|+|++|..||...
T Consensus 135 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 135 KPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999997654322 12234567889999998865 4588899999 999999999999997532
Q ss_pred ccccchhhHHHHHHHHhhhcCCCcc------------------ccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRA------------------IDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
+.......+......+..... ..... ....+.....+.+++.+||+.+|++|||+.+
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~e 287 (337)
T cd07858 213 ----DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEE 287 (337)
T ss_pred ----ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 222222222221111110000 00000 0011223455789999999999999999999
Q ss_pred HHHH
Q 046907 336 VRRM 339 (345)
Q Consensus 336 ll~~ 339 (345)
+++.
T Consensus 288 ll~h 291 (337)
T cd07858 288 ALAH 291 (337)
T ss_pred HHcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=252.76 Aligned_cols=244 Identities=24% Similarity=0.379 Sum_probs=190.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|++|.||+|+.. .+++.|++|.+...... .....+..|+..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~vk~~~~~~~~--------------------------~~~~~~~~e~~~l 53 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDE--------------------------EFRKQLLRELKTL 53 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeccCcch--------------------------HHHHHHHHHHHHH
Confidence 47899999999999999999865 47999999998643211 2356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHM-HHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~-~~~~~iiH~dlk~ 197 (345)
+.++|||++++++.+..++ .+++++++++++.+ ++......++.|++.|+.|||+ .+ ++|+|++|
T Consensus 54 ~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~ 128 (264)
T cd06623 54 RSCESPYVVKCYGAFYKEG--EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKP 128 (264)
T ss_pred HhcCCCCeeeEEEEEccCC--eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCH
Confidence 9999999999999988775 78889999986544 4555667899999999999999 88 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++++|||.+......... .....++..|+|||.+.+..++.++|+| ||+++|+|++|..||.....
T Consensus 129 ~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~- 205 (264)
T cd06623 129 SNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ- 205 (264)
T ss_pred HHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-
Confidence 9999999999999999998876443221 1235678899999999988889999999 99999999999999754332
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEE-QMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
....+....+ .....+. .... ....+.+++..||+.+|++|||+.++++.
T Consensus 206 ~~~~~~~~~~---~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 206 PSFFELMQAI---CDGPPPS----------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCHHHHHHHH---hcCCCCC----------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122222222 2111111 1111 23457888899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.63 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=186.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|... .++..||+|.+.... ......+.+|+.+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~---------------------------~~~~~~~~~e~~~ 69 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQ---------------------------QPKKELIINEILV 69 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEecccc---------------------------chHHHHHHHHHHH
Confidence 468999999999999999999743 468899999984221 1124567889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++.++|||++++++.+..++ ..+++++++.++.+ ++...+..++.|++.|+.|||+.+ ++|+|++|+
T Consensus 70 l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~ 144 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSD 144 (293)
T ss_pred HhhcCCCCeeehhheeeeCC--cEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHH
Confidence 99999999999999988766 67889999988654 455566789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++|+| ||+++|++++|..||.....
T Consensus 145 Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~-- 220 (293)
T cd06647 145 NILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-- 220 (293)
T ss_pred HEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--
Confidence 99999999999999998876543221 12335688899999999888889999999 99999999999999743211
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
......+ .....+. ..........+.+++..||+.+|++||++.+++..
T Consensus 221 --~~~~~~~---~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 221 --LRALYLI---ATNGTPE--------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --hhheeeh---hcCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110000 0011000 00111223457789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=229.78 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=194.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|+-.++||+|.||+||+|+. ..+++.||+|.+.-..-+. ......++|+.+++
T Consensus 3 ~ydkmekigegtygtvfkarn-~~t~eivalkrvrldddde-------------------------gvpssalreicllk 56 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARN-RETHEIVALKRVRLDDDDE-------------------------GVPSSALREICLLK 56 (292)
T ss_pred chHHHHhhcCCcceeeEeccc-CCccceEEEEEEeccCCCC-------------------------CCcHHHHHHHHHHH
Confidence 577789999999999999984 4689999999997654432 23567789999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
.++|.|||++++...+++ .+.++.++|.. .+.++.....+++.|+++||.++|+.. ++|||+||.|
T Consensus 57 elkhknivrl~dvlhsdk--kltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqn 131 (292)
T KOG0662|consen 57 ELKHKNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQN 131 (292)
T ss_pred HhhhcceeehhhhhccCc--eeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcce
Confidence 999999999999988877 68888888865 234677778899999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
+|++.+|.+|++|||+++.++-... ..+..+-|..|.+|.++-+.. |++..|+| .||++.|+.....| .|++.
T Consensus 132 llin~ngelkladfglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp---lfpg~ 206 (292)
T KOG0662|consen 132 LLINRNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206 (292)
T ss_pred EEeccCCcEEecccchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC---CCCCC
Confidence 9999999999999999998765421 223456689999999998876 89999999 99999999984444 25555
Q ss_pred chhhHHHHHHHHhhhcCCCcc------ccccccCC---------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRA------IDSKLVGN---------GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---------~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+-.+....+....+.+..... .+....+. ..+..-..=.+++...+.-+|..|.++++.++
T Consensus 207 dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 207 DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 555566666666654433221 11111111 11222223445566666779999999998875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=278.22 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=201.4
Q ss_pred CcccccccccCcceeeEEEEecCC---CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQ---NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.....++||+|+||.||+|.|--+ -.-+||+|++..... .+...+++.|+-
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--------------------------~~~s~e~LdeAl 750 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--------------------------PKASIELLDEAL 750 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--------------------------chhhHHHHHHHH
Confidence 455568999999999999998321 145799999854321 334677899999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHH----------HHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR----------HRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~----------~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+|..++|||++++++++.... +.++.++++.|.++++.+. ..++.||++|+.|||++. ++||||
T Consensus 751 ~masldHpnl~RLLgvc~~s~---~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdL 824 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST---LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDL 824 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch---HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhh
Confidence 999999999999999998775 8889999999988777654 469999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~ 273 (345)
.++|+|+..-..+||.|||+++.+.............-.+.|||-|.+....++.++||| ||+++||++| |..|+.+
T Consensus 825 aaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g- 903 (1177)
T KOG1025|consen 825 AARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG- 903 (1177)
T ss_pred hhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-
Confidence 999999999999999999999988766554444444557789999999999999999999 9999999998 9999543
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
....++...++...+.+ .++.+..++..+|.+||..|++.||+++++...+.++.
T Consensus 904 ---i~~~eI~dlle~geRLs-------------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 904 ---IPAEEIPDLLEKGERLS-------------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred ---CCHHHhhHHHhccccCC-------------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 34455555555554432 23445556888999999999999999999999998763
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=257.21 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=184.6
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||.|++|.||+|+.. .+|..||+|.+...... .....+.+|+.+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~--------------------------~~~~~~~~E~~~l~ 53 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEE--------------------------GTPSTAIREISLMK 53 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccc--------------------------cchHHHHHHHHHHH
Confidence 5899999999999999999964 57999999998543211 11345567999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++.+...+ ..+++++++++. ..+++..+..++.|++.||.|||+.+ ++|+|++|
T Consensus 54 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p 128 (284)
T cd07836 54 ELKHENIVRLHDVIHTEN--KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKP 128 (284)
T ss_pred hhcCCCEeeeeeeEeeCC--cEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCH
Confidence 999999999999998776 578888888752 23567777889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.++++|||++........ ......++..|++||.+.+. .++.++|+| +|+++|+|++|..||.....
T Consensus 129 ~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 129 QNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred HHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999875533211 11234578899999998664 468899999 99999999999999754322
Q ss_pred ccchhhHHHHHHHHhhhcCC------------Cccccc---cccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENP------------KRAIDS---KLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~---~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+....+......+.. ...... .......+.....+.+++..||+.||.+||++.++++
T Consensus 207 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 207 ----EDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ----HHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1221211111111100 000000 0000111223455788999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=258.28 Aligned_cols=252 Identities=25% Similarity=0.315 Sum_probs=182.4
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|++.+.||.|++|.||+|.++ .+|..||+|.+...... ......+.+|+.+++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~E~~~l~~ 54 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETED-------------------------EGVPSTAIREISLLKE 54 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-CCCCEEEEEEeeccccc-------------------------ccchhHHHHHHHHHHh
Confidence 678899999999999999864 57999999998643211 1123456779999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
++|||++++++++..++ ..+++++++.+. ..+++.....++.|+++||.|||+.+ ++|+|++|+|
T Consensus 55 l~~~~iv~~~~~~~~~~--~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~n 129 (283)
T cd07835 55 LNHPNIVRLLDVVHSEN--KLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQN 129 (283)
T ss_pred cCCCCccCHhheeccCC--eEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHH
Confidence 99999999999988665 678888887531 14677778899999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|+++.++.++++|||++........ ......++..|+|||.+.+. .++.++|+| +|+++|+|++|..||....
T Consensus 130 il~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--- 204 (283)
T cd07835 130 LLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS--- 204 (283)
T ss_pred EEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 9999999999999999875532211 11223568899999988764 468899999 9999999999999974321
Q ss_pred chhhHHHHHHHHhhhcCCC------------ccc---cccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPK------------RAI---DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~------------~~~---~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
............ ..+... ... .........+.....+.+++.+||+.||.+|||+.++++
T Consensus 205 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 205 EIDQLFRIFRTL-GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHHHHh-CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 111222221111 000000 000 000000111222345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=257.18 Aligned_cols=254 Identities=24% Similarity=0.257 Sum_probs=181.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|++|.||+|+.. .+|+.||+|.+...... ......+.+|+.++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~-------------------------~~~~~~~~~e~~~l 55 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQED-------------------------EGVPSTAIREISLL 55 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhcccc-------------------------ccchHHHHHHHHHH
Confidence 57999999999999999999864 57899999988432111 11245677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+.++||||+++++++..++ ..+++++|+++.. .++......++.|++.||.|||+.+ ++|+||+|
T Consensus 56 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p 130 (294)
T PLN00009 56 KEMQHGNIVRLQDVVHSEK--RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKP 130 (294)
T ss_pred HhccCCCEeeEEEEEecCC--eEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCc
Confidence 9999999999999988765 7888999986421 1344556688999999999999998 99999999
Q ss_pred CCeeecC-CCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 198 VNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 198 ~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+||+++. ++.+|++|||++........ ......++..|+|||.+.+. .++.++||| +|+++|+|++|..||....
T Consensus 131 ~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 131 QNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred ceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999985 55799999999976533211 11234678899999998764 478899999 9999999999999975321
Q ss_pred cccchhhHHHHHHHHhhhcCCCcc-----------ccccccC----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRA-----------IDSKLVG----NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. .....+ +......+..... ..+.... ...+.....+.+++.+|++.+|++||++.++++
T Consensus 209 ~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 209 E---IDELFK-IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred H---HHHHHH-HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111111 1111111100000 0000000 001122344778999999999999999999885
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=256.19 Aligned_cols=237 Identities=26% Similarity=0.410 Sum_probs=181.1
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|...+.||+|+||.||+|+.. .++..|++|.+....... ......+..|+.+++.
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~------------------------~~~~~~~~~E~~~l~~ 77 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQT------------------------NEKWQDIIKEVKFLQQ 77 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCc------------------------hHHHHHHHHHHHHHHh
Confidence 677788999999999999853 578999999985432211 2234567889999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
++|||++++++++...+ ..+++++++.+. ..+++..+..++.|++.|+.|||+.+ ++|+|++|+||
T Consensus 78 l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~ni 152 (313)
T cd06633 78 LKHPNTIEYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNI 152 (313)
T ss_pred CCCCCCccEEEEEEeCC--EEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhE
Confidence 99999999999988775 678888888642 34677778889999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+++.++.++++|||++..... .....|+..|+|||.+. +..++.++|+| +|+++|+|++|..||...
T Consensus 153 li~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~--- 223 (313)
T cd06633 153 LLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--- 223 (313)
T ss_pred EECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 999999999999998754321 23457889999999984 34578899999 999999999999996332
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.. ...+. .. .......+.+++.+||+.+|.+||++.++++
T Consensus 224 -~~~~~~~~~~~---~~~~~------~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 224 -NAMSALYHIAQ---NDSPT------LQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -ChHHHHHHHHh---cCCCC------CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222222211 11110 00 0111234778999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=253.97 Aligned_cols=241 Identities=22% Similarity=0.273 Sum_probs=186.3
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||.|+||.||+|+.. .++..||+|.+...... ..+..+.+.+|+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------------------~~~~~~~~~~e~~~l~ 55 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCV------------------------EKGSVRNVLNERRILQ 55 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhc------------------------chhHHHHHHHHHHHHH
Confidence 5899999999999999999854 57899999998532111 1234667889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+++||||+++++.+..++ .++++++++.++. .++......++.|+++||.|||+.+ ++|+||+|+|
T Consensus 56 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~n 130 (258)
T cd05578 56 ELNHPFLVNLWYSFQDEE--NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDN 130 (258)
T ss_pred hCCCCChHHHHHhhcCCC--eEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 999999999999887665 6889999998754 3566677789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
|+++.++.++++|||.+....... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...... .
T Consensus 131 il~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~ 206 (258)
T cd05578 131 ILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-I 206 (258)
T ss_pred eEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-H
Confidence 999999999999999987654432 12345688899999999888889999999 999999999999997543221 1
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS--KDVR 337 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~--~~ll 337 (345)
...+.. ....... . .++.....+.+++.+||+.||.+||++ .+++
T Consensus 207 ~~~~~~----~~~~~~~--~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 207 RDQIRA----KQETADV--L--------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHH----Hhccccc--c--------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111211 1111111 0 111122557789999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=260.71 Aligned_cols=252 Identities=18% Similarity=0.296 Sum_probs=176.6
Q ss_pred ccccccC--cceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 046907 53 LEKIGSG--GCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI 130 (345)
Q Consensus 53 ~~~iG~G--~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 130 (345)
...||+| +||.||++++ ..+|+.||+|.+...... .+..+.+.+|+.+++.+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~-~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~e~~~~~~l 56 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARH-TPTGTLVTVRITDLENCT-------------------------EEHLKALQNEVVLSHFF 56 (328)
T ss_pred HHHhCCcccCceeEEEEEE-cCCCcEEEEEEeccccCC-------------------------HHHHHHHHHHHHHHHhC
Confidence 3567777 8999999985 357999999998643221 12356778899999999
Q ss_pred cCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 131 RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 131 ~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+||||+++++++..++ .++++++++.++++ ++......++.|++.||.|||+.+ ++||||||+|
T Consensus 57 ~h~niv~~~~~~~~~~--~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~N 131 (328)
T cd08226 57 RHPNIMTSWTVFTTGS--WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASH 131 (328)
T ss_pred CCCCcceEeeeEecCC--ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999999999998776 67888888877554 344455679999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcc-----eeccCcccCcccccccccccc--ccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQML--TLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~--~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|+++.++.++++||+.+......... .......++..|+|||++.+. .++.++||| +|+++|+|++|..||.
T Consensus 132 ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~ 211 (328)
T cd08226 132 ILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211 (328)
T ss_pred EEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999765432211110 001112346679999999764 468899999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcC--------------------------------CCccccccccCCCcHHHHHHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASEN--------------------------------PKRAIDSKLVGNGCEEQMLLVLKIA 319 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~~l~~li 319 (345)
..... ......+......+. ........+...........+.+++
T Consensus 212 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 288 (328)
T cd08226 212 DMLRT---QMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288 (328)
T ss_pred CcChH---HHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence 43221 111111100000000 0000000111111223456789999
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 046907 320 CFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 320 ~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+||+.||++|||++++++
T Consensus 289 ~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 289 ELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred HHHccCCcccCCCHHHHhh
Confidence 9999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.30 Aligned_cols=253 Identities=25% Similarity=0.326 Sum_probs=182.8
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|++.+.||+|+||.||+|+++ .+++.||+|.+...... ......+.+|+.++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~-------------------------~~~~~~~~~e~~~l~~ 54 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLSE-------------------------EGIPLSTLREIALLKQ 54 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-CCCCEEEEEEecccccc-------------------------chhhhhHHHHHHHHHH
Confidence 678899999999999999975 46899999999643211 1112334456666655
Q ss_pred c---cCCCccceeEEEecCCc---ceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 130 I---RHRNLHPLLAHVTRPDC---HLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 130 l---~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+ +|||++++++.+...+. ..++++++++.+. ..+++..+..++.|+++||.|||+.+ ++|+
T Consensus 55 l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~ 131 (287)
T cd07838 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHR 131 (287)
T ss_pred hhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 5 69999999999887652 3477888887541 23677788899999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|++|+||+++.++.++++|||.+........ .....++..|+|||.+.+..++.++|+| +|+++|+|++|..||..
T Consensus 132 ~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 132 DLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred cCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 9999999999999999999999877643321 1234578899999999988899999999 99999999999999653
Q ss_pred cccccchhhHHHHHHHHhhhcC----CC------ccccc---cccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASEN----PK------RAIDS---KLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~----~~------~~~~~---~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. ...+....+........ +. ..... .......++....+.+++.+||+.||.+||++.++++
T Consensus 209 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 209 T----SEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred C----ChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 2 22222222221111100 00 00000 0011112234466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=251.92 Aligned_cols=240 Identities=22% Similarity=0.313 Sum_probs=183.8
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+.+.||+|+||.||+|.++ .+|..+|+|.+.....+ ......+.+|+.+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~E~~~l~ 54 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMP-------------------------VKEKEASKKEVILLA 54 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhcc-------------------------chhhHHHHHHHHHHH
Confidence 5888999999999999999965 46888999998532111 122456678999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++.+...+ .++++++++.++. .+++.....++.|+++||.|||+.+ ++|+|++|
T Consensus 55 ~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~ 129 (257)
T cd08225 55 KMKHPNIVTFFASFQENG--RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKS 129 (257)
T ss_pred hCCCCChhhhhheeccCC--eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCH
Confidence 999999999999887765 7889999987644 3566677889999999999999998 99999999
Q ss_pred CCeeecCCC-CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDI-EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++ .++++|||.+........ ......|+..|+|||.+.+..++.++|+| +|+++++|++|..||...
T Consensus 130 ~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-- 205 (257)
T cd08225 130 QNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-- 205 (257)
T ss_pred HHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--
Confidence 999999775 569999999876543321 11234688999999999888899999999 999999999999996431
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+... .+......... ...+.....+.+++.+||+.+|++|||+.++++
T Consensus 206 --~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 206 --NLHQ---LVLKICQGYFA----------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --cHHH---HHHHHhcccCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111 11111111110 011122235888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=254.93 Aligned_cols=255 Identities=23% Similarity=0.292 Sum_probs=187.4
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|++.+.||+|+||.||+|++. .+++.+|+|.+...... ......+..|+.+++.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~-------------------------~~~~~~~~~e~~~l~~ 54 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEK-------------------------EGFPITAIREIKLLQK 54 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-CCCeEEEEEEEeccccc-------------------------ccchHHHHHHHHHHHh
Confidence 678899999999999999864 46899999999653211 1224567789999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
++|||++++++++........++++++++++ ..+++.....++.|++.||.|||+.+ ++|+||+|+||
T Consensus 55 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~ni 131 (287)
T cd07840 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNI 131 (287)
T ss_pred ccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHe
Confidence 9999999999998877334788888888642 34677778899999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
+++.++.++++|||++......... ......++..|+|||.+.+. .++.++||| ||+++|||++|..||... .
T Consensus 132 l~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~----~ 206 (287)
T cd07840 132 LINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS----T 206 (287)
T ss_pred EEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC----C
Confidence 9999999999999999876543211 12234567889999987653 578899999 999999999999997532 2
Q ss_pred hhhHHHHHHHHhhhcCCCccc---c--------c-----cccCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAI---D--------S-----KLVGNGCEE-QMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~---~--------~-----~~~~~~~~~-~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+......+...... + . ....+.... +...+.+++.+||+.+|.+||++.++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 222222222222111110000 0 0 000000011 2456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=263.76 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=185.0
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|.+...||+|+||.||+|++. .+|..||+|.+...... ......+.+|+.+
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~e~~~ 67 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQS-------------------------EIFAKRAYRELTL 67 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCcccc-------------------------ccchhHHHHHHHH
Confidence 458999999999999999999854 57899999998643211 1123456789999
Q ss_pred HhhccCCCccceeEEEecCCc----ceeeeeccccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQG------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++++..... ...+++++++.. +..++......++.|++.||.|||+.+ ++|||||
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlk 144 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLK 144 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 999999999999998875532 245778887754 224677778889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.++++|||++...... .....++..|+|||.+.+ ..++.++|+| +|+++|||++|..||..
T Consensus 145 p~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~-- 217 (342)
T cd07879 145 PGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-- 217 (342)
T ss_pred HHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC--
Confidence 99999999999999999998754321 223567889999999876 4578899999 99999999999999753
Q ss_pred cccchhhHHHHHHHHhhhcCCC-----------c------cccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPK-----------R------AIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~-----------~------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
.+.......+......+.+. . .....-.....+.....+.+++..||+.||++||++.+++
T Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 218 --KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred --CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 22222222222211111000 0 0000000000112234577899999999999999999998
Q ss_pred HH
Q 046907 338 RM 339 (345)
Q Consensus 338 ~~ 339 (345)
..
T Consensus 296 ~h 297 (342)
T cd07879 296 EH 297 (342)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=260.63 Aligned_cols=260 Identities=22% Similarity=0.324 Sum_probs=185.9
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
.+.....++|++.+.||+|+||.||+|... .++..||+|.+.....+ ......+
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~ 63 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQS-------------------------IIHAKRT 63 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchh-------------------------hHHHHHH
Confidence 344557789999999999999999999853 57899999998542111 1124456
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCc----ceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
.+|+.++++++||||+++++++..... ...+++++++.+. ..+++..+..++.|++.||.|||+.+
T Consensus 64 ~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 140 (345)
T cd07877 64 YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--- 140 (345)
T ss_pred HHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 789999999999999999998764321 2367777776431 23677788889999999999999998
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
++|||+||+||+++.++.++++|||++...... .....|+..|+|||.+.+ ..++.++||| +|+++|+|++|.
T Consensus 141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998764321 233567889999999866 4578899999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCcc--cc-----------ccccC----CCcHHHHHHHHHHHhhccCCCCCCC
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRA--ID-----------SKLVG----NGCEEQMLLVLKIACFCTLEDPNER 330 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----------~~~~~----~~~~~~~~~l~~li~~Cl~~dp~~R 330 (345)
.||.... .......+........+... +. +.... .........+.+++..|++.||.+|
T Consensus 216 ~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 216 TLFPGTD----HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred CCCCCCC----HHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 9974321 11111111111110000000 00 00000 0000112347789999999999999
Q ss_pred CCHHHHHH
Q 046907 331 PNSKDVRR 338 (345)
Q Consensus 331 pt~~~ll~ 338 (345)
|++.++++
T Consensus 292 ~t~~e~l~ 299 (345)
T cd07877 292 ITAAQALA 299 (345)
T ss_pred CCHHHHhc
Confidence 99999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=252.93 Aligned_cols=240 Identities=22% Similarity=0.357 Sum_probs=183.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|.....||+|++|.||++... .++..+++|.+.... ......+.+|+.+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~---------------------------~~~~~~~~~e~~~l~ 71 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK-STGRQVAVKKMDLRK---------------------------QQRRELLFNEVVIMR 71 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC-CCCCEEEEEEEeccc---------------------------hhHHHHHHHHHHHHH
Confidence 5666789999999999999854 478899999874321 122445778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
.++|||++++++++..++ ..+++++++.++.+ ++......++.|++.|+.|||+.+ ++||||+|+||
T Consensus 72 ~~~h~~vv~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Ni 146 (285)
T cd06648 72 DYQHPNIVEMYSSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSI 146 (285)
T ss_pred HcCCCChheEEEEEEcCC--eEEEEEeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhE
Confidence 999999999999888766 67888899887554 455566789999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccch
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~ 279 (345)
+++.++.++++|||.+........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||.. .+.
T Consensus 147 l~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~----~~~ 220 (285)
T cd06648 147 LLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN----EPP 220 (285)
T ss_pred EEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC----CCH
Confidence 999999999999998765433211 11235688999999999988899999999 99999999999999643 111
Q ss_pred hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+.. ...+. .. ........+.+++.+||+.+|++|||+.++++
T Consensus 221 ~~~~~~~~~---~~~~~-~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 221 LQAMKRIRD---NLPPK-LK-------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHh---cCCCC-Cc-------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 222222211 11110 00 00112235888999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=255.46 Aligned_cols=241 Identities=26% Similarity=0.382 Sum_probs=182.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
...|+..+.||+|+||.||+|+.. .++..+|+|.+....... ......+.+|+.+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~------------------------~~~~~~~~~e~~~ 68 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS------------------------NEKWQDIIKEVRF 68 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccC------------------------hHHHHHHHHHHHH
Confidence 345888899999999999999864 578899999885321111 1234567789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++|||++++++++..++ ..+++++++.+. ..++...+..++.|++.|+.|||+.+ ++|+||+|
T Consensus 69 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p 143 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKA 143 (308)
T ss_pred HHhCCCCCcccEEEEEEcCC--eeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCH
Confidence 99999999999999988765 678888887642 23566777889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+++.++.++++|||++...... ....|+..|+|||.+. ...++.++||| +|+++|+|++|..||...
T Consensus 144 ~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 144 GNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred HhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999998754322 2356788999999974 34577899999 999999999999996432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
...+....+.. ...+. . ........+.++|.+||+.+|++||++.++++.
T Consensus 218 ----~~~~~~~~~~~---~~~~~------~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 218 ----NAMSALYHIAQ---NESPA------L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ----cHHHHHHHHhh---cCCCC------c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11111111111 11110 0 011223447889999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=246.94 Aligned_cols=246 Identities=23% Similarity=0.347 Sum_probs=191.4
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|...+.||+|++|.||+|..+ .++..|++|.+...... ....+.+.+|+.+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDS-------------------------EEELEALEREIRILS 54 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccc-------------------------hHHHHHHHHHHHHHH
Confidence 4788899999999999999864 47899999998654321 233667889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+++||||+++++.+.......++++++++.++. .+++..+..++.|++.|+.|||+.+ ++|+|++|+|
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~n 131 (260)
T cd06606 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGAN 131 (260)
T ss_pred HcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 999999999999988773347888899887654 4566677889999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
|+++.++.++|+|||.+................++..|+|||.+.+...+.++|+| +|+++++|++|..||....
T Consensus 132 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---- 207 (260)
T cd06606 132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---- 207 (260)
T ss_pred EEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 99999999999999999876554321112346788999999999888889999999 9999999999999975432
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.....+......... ...+......+.+++.+||+.||++||++.++++
T Consensus 208 --~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 208 --NPMAALYKIGSSGEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --chHHHHHhccccCCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111111111110111 0111222456888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=246.43 Aligned_cols=240 Identities=23% Similarity=0.367 Sum_probs=187.5
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||++.+. .++..|++|.+...... ......+..|+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMS-------------------------EKEREDALNEVKILK 54 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCC-------------------------hHHHHHHHHHHHHHH
Confidence 5889999999999999999964 47899999998653322 223556778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC-------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-------------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.++|||++++++.+...+ ..++++++++++. .++......++.+++.||.+||+.+ ++|+|+
T Consensus 55 ~l~~~~~~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl 129 (258)
T cd08215 55 KLNHPNIIKYYESFEEKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDI 129 (258)
T ss_pred hcCCCChhheEEEEecCC--EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccC
Confidence 999999999999887764 7888899887653 3566677789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+|+||+++.++.++++|||.+....... .......|+..|+|||...+..++.++|+| +|+++++|++|..||...
T Consensus 130 ~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~- 206 (258)
T cd08215 130 KPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE- 206 (258)
T ss_pred ChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-
Confidence 9999999999999999999997664432 122335788899999999888899999999 999999999999996432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+........ ...... . + +......+.+++.+||+.+|++|||+.++++
T Consensus 207 ---~~~~~~~~~---~~~~~~-~-----~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 207 ---NLLELALKI---LKGQYP-P-----I----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ---cHHHHHHHH---hcCCCC-C-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222222221 111110 0 0 1112234778888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=247.47 Aligned_cols=265 Identities=23% Similarity=0.272 Sum_probs=192.4
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCC---CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQN---GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+....|+....||+|.||.||+|.-..++ .+.+|+|.++..... +......-
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-------------------------tGiS~SAc 75 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-------------------------TGISMSAC 75 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-------------------------CCcCHHHH
Confidence 35568999999999999999999533222 347999999764321 11234456
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-------------RELDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+|+.+++.++|||++.+..++... ...++++.||.+.. ..++...+.+++.||+.|+.|||++.
T Consensus 76 REiaL~REl~h~nvi~Lv~Vfl~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW-- 152 (438)
T KOG0666|consen 76 REIALLRELKHPNVISLVKVFLSH-DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW-- 152 (438)
T ss_pred HHHHHHHHhcCCcchhHHHHHhcc-CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--
Confidence 899999999999999999988775 35889999988652 33566667789999999999999999
Q ss_pred CeEecCCCCCCeeecCC----CCeEEeccccceecCCCCcc-eeccCcccCccccccccccccc-cCccchhh-HHHHHH
Q 046907 189 RIIHRDLNPVNVLLDDD----IEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLA 261 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~----~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~ 261 (345)
++||||||.|||+..+ |.+||+|+|+++.+.+.-.- ......+-|..|.|||.+.|.. |+.+.||| .||++.
T Consensus 153 -vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 153 -VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred -eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence 9999999999999876 89999999999988654221 1234456689999999999987 89999999 999999
Q ss_pred HHHhCCCCCcccccccc-----hhhHHHHHHHHhhhcCCCccccccccCCC----------------cHHH-------HH
Q 046907 262 GLVMGKLPSDKFFQHTN-----EMSFVKWMRNVMASENPKRAIDSKLVGNG----------------CEEQ-------ML 313 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~-------~~ 313 (345)
||++-++.|........ ..+.+..|.+.++.+......+-+..++. .... ..
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 99999988753221111 11234455555544433222211111111 0000 01
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 314 LVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 314 ~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..++|+..+|+.||.+|.|+++.++
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhc
Confidence 2567778899999999999998875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=248.55 Aligned_cols=236 Identities=23% Similarity=0.334 Sum_probs=179.6
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||.|+||.||+|+.+ .++..+|+|.+....... ......+.+|+.+++.++||||
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~~i 55 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVE------------------------TGQQEHIFSEKEILEECNHPFI 55 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchh------------------------hhHHHHHHHHHHHHHhCCCCCE
Confidence 799999999999965 468999999985432111 1234568889999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCC
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI 206 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~ 206 (345)
+++++.+..++ .+++++++.+++++ ++...+..++.|+++||.|||+.+ ++|+||+|+||+++.++
T Consensus 56 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~ 130 (262)
T cd05572 56 VKLYRTFKDKK--YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNG 130 (262)
T ss_pred eeeeeeEEcCC--ccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCC
Confidence 99999887665 68889999877544 455566779999999999999998 99999999999999999
Q ss_pred CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHH
Q 046907 207 EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKW 285 (345)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~ 285 (345)
.++++|||++....... ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||..... +.. ..
T Consensus 131 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~---~~ 202 (262)
T cd05572 131 YVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPM---EI 202 (262)
T ss_pred CEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHH---HH
Confidence 99999999998765432 12235678899999999888889999999 99999999999999754321 111 11
Q ss_pred HHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 286 MRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
.......... . ..+......+.+++..||+.+|++||+ +.++++
T Consensus 203 ~~~~~~~~~~-~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 203 YNDILKGNGK-L--------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHhccCCC-C--------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2221110000 0 011111345889999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=248.14 Aligned_cols=238 Identities=21% Similarity=0.277 Sum_probs=187.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+++.+ .++..+|+|.+...... ......+..|+.+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMS-------------------------QKEREDAVNEIRILA 54 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhcc-------------------------HHHHHHHHHHHHHHH
Confidence 5889999999999999999854 57899999998532211 223456678999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.++||||+++++.+...+ ..++++++++++++ +++.....++.|++.||.|||+.+ ++|+|+
T Consensus 55 ~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l 129 (256)
T cd08530 55 SVNHPNIISYKEAFLDGN--KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDL 129 (256)
T ss_pred hCCCCCchhhhhhhccCC--EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 999999999999887764 78889998877543 455566789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+|+||+++.++.++++|||++...... ......++..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 130 ~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~- 204 (256)
T cd08530 130 KSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR- 204 (256)
T ss_pred CcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-
Confidence 999999999999999999999766543 12235678899999999988899999999 999999999999997532
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+... . .+.........+.+++..||+.+|++|||+.++++
T Consensus 205 ---~~~~~~~~~~~~---~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 205 ---SMQDLRYKVQRG---K----------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---CHHHHHHHHhcC---C----------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 222222221111 1 01112234456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=269.99 Aligned_cols=207 Identities=25% Similarity=0.352 Sum_probs=170.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
..+..-+.||+|+||.||+|+. ..+|+.||||.++... ..+..++..+|+++|
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrn-ketG~~vAvK~~~~~~--------------------------~~r~~e~~~~Eieil 65 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRN-KETGRLVAVKTFNKES--------------------------SLRPRERWCREIEIL 65 (732)
T ss_pred cceeehhhhcCCccceeeeecc-cccccchhHHhhhhhc--------------------------ccchHHHHHHHHHHH
Confidence 4556678999999999999984 4789999999986532 123477888999999
Q ss_pred hhccCCCccceeEEEecCC----cceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 128 GQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
++++|||||+++++-.+.. ....+++|+||.||++ ++......++.+++.|+.|||+++ |+
T Consensus 66 kKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---Iv 142 (732)
T KOG4250|consen 66 KKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IV 142 (732)
T ss_pred HHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ce
Confidence 9999999999999776655 3445789999999876 455566789999999999999998 99
Q ss_pred ecCCCCCCeeec--CCC--CeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHh
Q 046907 192 HRDLNPVNVLLD--DDI--EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 192 H~dlk~~nil~~--~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~t 265 (345)
||||||.||++- .+| .-||+|||.|+.+.+.. .....+||..|.+||.... ..|+...|.| ||+++|+++|
T Consensus 143 HRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT 219 (732)
T KOG4250|consen 143 HRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT 219 (732)
T ss_pred eccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc
Confidence 999999999884 223 46999999999887654 4566899999999999985 6789999999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHH
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMR 287 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~ 287 (345)
|..||..+.+..+..+....+.
T Consensus 220 G~lPF~p~~~pk~~~~~~~~~~ 241 (732)
T KOG4250|consen 220 GELPFIPFGGPKNNKEIMWHII 241 (732)
T ss_pred cCCCCCcCCCccccchhhhhhh
Confidence 9999988776655444444443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=259.33 Aligned_cols=258 Identities=25% Similarity=0.327 Sum_probs=191.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|+||.||+|+.. .++..||+|.+.....+ ....+.+..|+.+++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDD-------------------------LIDAKRILREIKLLR 54 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-CCCcEEEEEeecccccc-------------------------chhhhhHHHHHHHHH
Confidence 5889999999999999999864 46899999998643211 123456788999999
Q ss_pred hccCCCccceeEEEecCC---cceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPD---CHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~---~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
.++||||+++++++..++ ...++++++++.+ +..+++.....++.|++.||.+||+.+ ++|+||||
T Consensus 55 ~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp 131 (330)
T cd07834 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKP 131 (330)
T ss_pred hcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 999999999999887654 2357888888764 234677778889999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+||+++.++.++++|||++......... .......++..|+|||.+.+. .++.++|+| +|+++|+|++|..||...
T Consensus 132 ~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~- 210 (330)
T cd07834 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR- 210 (330)
T ss_pred HHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC-
Confidence 9999999999999999999876543210 112345678899999999887 788999999 999999999999997543
Q ss_pred cccchhhHHHHHHHHhhhcCCCccc--c---------------ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAI--D---------------SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~--~---------------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
+..+....+......+...... . ........+.....+.+++..||+.+|++|||+.+++
T Consensus 211 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 211 ---DYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred ---CHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 2223333332222111110000 0 0000001112345578899999999999999999998
Q ss_pred HH
Q 046907 338 RM 339 (345)
Q Consensus 338 ~~ 339 (345)
+.
T Consensus 288 ~~ 289 (330)
T cd07834 288 AH 289 (330)
T ss_pred hC
Confidence 73
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=253.02 Aligned_cols=251 Identities=19% Similarity=0.253 Sum_probs=185.0
Q ss_pred CcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
+|++.+.||+|+||.||+++.. ..+++.||||.+...... ........+.+|+.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~-----------------------~~~~~~~~~~~E~~~ 57 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV-----------------------QKAKTAEHTRTERQV 57 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH-----------------------hhhhHHHHHHHHHHH
Confidence 4889999999999999999853 236789999998532100 012335667889999
Q ss_pred Hhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+.++ +||||+++++.+..++ .++++++|+.++.+ +++.....++.|+++||.|||+.+ ++|+|++
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~ 132 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDT--KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIK 132 (288)
T ss_pred HHhccCCcchhhhheeeecCC--EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999 6999999999887665 68899999987543 455566778999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc--cCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+||+++.++.++++|||++......... ......|+..|+|||.+.+.. .+.++|+| +|+++|+|++|..||...
T Consensus 133 p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 133 LENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred HHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 99999999999999999998765433211 122356889999999987765 67899999 999999999999997431
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
.... ..............+ ........+.+++.+||+.||++|||+.++...|+-
T Consensus 212 ~~~~---~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 212 GEQN---SQSEISRRILKSKPP-----------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cccc---hHHHHHHHHHccCCC-----------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111 111111111111111 001112346788999999999999998888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=257.66 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=184.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||+|.+...... ......+..|+.
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 61 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFST-------------------------PVLAKRTYRELK 61 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccc-------------------------cchhHHHHHHHH
Confidence 5678999999999999999999854 57999999987532111 112455678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+++.++||||+++++++..++. ..+++++++++. ..++......++.|+++||.|||+.+ ++|+|++|+
T Consensus 62 ~l~~l~hpniv~~~~~~~~~~~-~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~ 137 (328)
T cd07856 62 LLKHLRHENIISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPS 137 (328)
T ss_pred HHHhcCCCCeeeEeeeEecCCC-cEEEEeehhccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 9999999999999998876442 567888887541 23455666789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
|++++.++.++++|||.+...... .....++..|+|||.+.+ ..++.++|+| +|+++|+|++|..||....
T Consensus 138 Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-- 210 (328)
T cd07856 138 NILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-- 210 (328)
T ss_pred HEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC--
Confidence 999999999999999998754321 233567889999998866 4688999999 9999999999999975422
Q ss_pred cchhhHHHHHHHHhhhcCC-----------Cccc-cccccC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENP-----------KRAI-DSKLVG-----NGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~-----------~~~~-~~~~~~-----~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.......+.+..+.+.. .... ..+... ...+.....+.++|.+||+.+|++|||+.+++..
T Consensus 211 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 211 --HVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred --HHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111112111111000 0000 000000 0111223568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=258.43 Aligned_cols=257 Identities=22% Similarity=0.314 Sum_probs=182.5
Q ss_pred CcccccccccCcceeeEEEEecCCC--CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQN--GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
+|.+.+.||+|+||.||++++. .+ +..||+|.+...... ......+.+|+.+
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~~~~-------------------------~~~~~~~~~E~~~ 54 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSK-------------------------KILAKRALRELKL 54 (332)
T ss_pred CceEEEEccccCCeEEEEEEeC-CCCcCceEEEEEecccccc-------------------------chhHHHHHHHHHH
Confidence 5888999999999999999965 34 789999998532111 1124556789999
Q ss_pred Hhhc-cCCCccceeEEEecC--CcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQI-RHRNLHPLLAHVTRP--DCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~~--~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++++ +||||+++++..... ....++++++++.+ ...++......++.|++.||.|||+.+ ++||||
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dl 131 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999 599999999875432 22356777777653 344677778889999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||+||+++.++.++|+|||++......... .......|+..|+|||.+.+ ..++.++|+| +|+++|+|++|..||.
T Consensus 132 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred CHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 999999999999999999999866432211 11234578999999998865 4588999999 9999999999999965
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCc-----------------cccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKR-----------------AIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
.. +.......+......+.... ...........+.....+.+++.+||+.||.+|||+.
T Consensus 212 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 287 (332)
T cd07857 212 GK----DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE 287 (332)
T ss_pred CC----CHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 32 22222222222111110000 0000000001111234588999999999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
+++.
T Consensus 288 ~ll~ 291 (332)
T cd07857 288 EALE 291 (332)
T ss_pred HHhc
Confidence 9874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=291.48 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=193.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+++-...||.|.||.||.|. +..+|+..|+|.++.++.. .+....+.+|..+|.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtav-N~~tGellAvKEI~iq~~~-------------------------~k~~~~i~eEm~vlE 1289 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAV-NLDTGELLAVKEIKIQDSD-------------------------HKTFKLIAEEMKVLE 1289 (1509)
T ss_pred eeccccccCCcceeeeEEee-cCCccchhhhhhhhcCccc-------------------------cccCcchHHHHHHHH
Confidence 67778899999999999998 5578999999999776544 233556778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH---------HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA---------RHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~---------~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
.++|||+|++||+-...+ .+++.|+||.+|.+-+... ..-+..|++.|+.|||+.| |||||+||.|
T Consensus 1290 ~lnHpNlV~YyGVEvHRe--kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aN 1364 (1509)
T KOG4645|consen 1290 GLNHPNLVRYYGVEVHRE--KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPAN 1364 (1509)
T ss_pred hccCccccccCceeecHH--HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccc
Confidence 999999999999876655 6889999999987644443 3457889999999999999 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCC--cceeccCcccCccccccccccccc---cCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAH--THITTSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~~~aPE~~~~~~---~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+++.+|.+|.+|||.|..+.... .........||+-|||||++.+.. ...++||| +|||+.||+||+.||..+
T Consensus 1365 I~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1365 ILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred eeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhc
Confidence 999999999999999998876542 112235679999999999997654 45689999 999999999999999654
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++++.+..++-.+-.++.|.. ....-.+++..||+.||+.|-++.|+++
T Consensus 1445 ---dne~aIMy~V~~gh~Pq~P~~-------------ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1445 ---DNEWAIMYHVAAGHKPQIPER-------------LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---cchhHHHhHHhccCCCCCchh-------------hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 344555444443333332221 2233567888899999999999988875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=261.53 Aligned_cols=257 Identities=20% Similarity=0.275 Sum_probs=182.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||.|+||.||+|+.. .+|..||+|.+..... ...+.+.+|+.+
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~---------------------------~~~~~~~~Ei~~ 55 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDP---------------------------QSVKHALREIKI 55 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCC---------------------------chHHHHHHHHHH
Confidence 478999999999999999999854 5799999999854321 124556789999
Q ss_pred HhhccCCCccceeEEEecCCc------------ceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC------------HLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~------------~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
+++++||||+++++.+..... ..++++++++++. ..++......++.|+++||.|||+.+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g- 134 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN- 134 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 999999999999987665432 2468899988752 24667778889999999999999998
Q ss_pred CCeEecCCCCCCeeec-CCCCeEEeccccceecCCCCcce-eccCcccCccccccccccc-cccCccchhh-HHHHHHHH
Q 046907 188 PRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el 263 (345)
++||||||+||+++ .++.++++|||.+.......... ......|+..|+|||.+.+ ..++.++||| +|+++|+|
T Consensus 135 --ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 135 --VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred --cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 99999999999998 45678999999997654321111 1123467889999998754 4578899999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCC-----------Ccc----cccc-ccCCCcHHHHHHHHHHHhhccCCCC
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENP-----------KRA----IDSK-LVGNGCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~----~~~~-~~~~~~~~~~~~l~~li~~Cl~~dp 327 (345)
++|..||..... .......+... ..... ... ...+ ......+.....+.+++.+||+.||
T Consensus 213 ~~g~~pf~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 288 (342)
T cd07854 213 LTGKPLFAGAHE---LEQMQLILESV-PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNP 288 (342)
T ss_pred HhCCCCCCCCCH---HHHHHHHHHhc-CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCc
Confidence 999999754321 11111111100 00000 000 0000 0000011223457789999999999
Q ss_pred CCCCCHHHHHH
Q 046907 328 NERPNSKDVRR 338 (345)
Q Consensus 328 ~~Rpt~~~ll~ 338 (345)
++|||+.++++
T Consensus 289 ~~R~t~~ell~ 299 (342)
T cd07854 289 MDRLTAEEALM 299 (342)
T ss_pred hhccCHHHHhC
Confidence 99999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=244.90 Aligned_cols=240 Identities=25% Similarity=0.419 Sum_probs=187.1
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|++.+.||+|++|.||+++.+ .++..|++|.+...... ......+.+|+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~ 54 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIK-------------------------EEALKSIMQEIDLLK 54 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccC-------------------------HHHHHHHHHHHHHHH
Confidence 5888999999999999999854 56889999999654321 123567889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+++|||++++++++..++ ..++++++++++. .+++.....++.|++.|+.+||+.+ ++|+|++|+|
T Consensus 55 ~l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~n 129 (254)
T cd06627 55 NLKHPNIVKYIGSIETSD--SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAAN 129 (254)
T ss_pred hCCCCCccEEEEEEEeCC--EEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHH
Confidence 999999999999988765 6888889887753 3566677889999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
|+++.++.++|+|||.+......... .....++..|+|||...+...+.++|+| +|+++|+|++|..||....
T Consensus 130 i~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---- 203 (254)
T cd06627 130 ILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN---- 203 (254)
T ss_pred EEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----
Confidence 99999999999999999876543221 2335678899999999887788999999 9999999999999974321
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......... ....+ .. .......+.+++.+||+.+|++|||+.+++.
T Consensus 204 ~~~~~~~~~---~~~~~--~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 204 PMAALFRIV---QDDHP--PL--------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHh---ccCCC--CC--------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111111111 11110 01 1112334778899999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=250.13 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=187.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+.|+....||+|++|.||+|.++ .++..+++|.+..... ....+..|+.
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~----------------------------~~~~~~~e~~ 67 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQ----------------------------NKELIINEIL 67 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecCch----------------------------hHHHHHHHHH
Confidence 5668999999999999999999865 4688999999854321 2556778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.++.++|||++++++.+..++ ..+++++++.+++ .+++..+..++.|++.||.|||+.+ ++|+|+
T Consensus 68 ~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl 142 (286)
T cd06614 68 IMKDCKHPNIVDYYDSYLVGD--ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDI 142 (286)
T ss_pred HHHHCCCCCeeEEEEEEEECC--EEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 999999999999999988775 6888999998643 3566667789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 143 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~- 219 (286)
T cd06614 143 KSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE- 219 (286)
T ss_pred ChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-
Confidence 99999999999999999998865543221 12334678899999999888899999999 999999999999996432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.. ...+. . .........+.+++.+||+.+|.+|||+.++++
T Consensus 220 ---~~~~~~~~~~~---~~~~~-~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 220 ---PPLRALFLITT---KGIPP-L-------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---CHHHHHHHHHh---cCCCC-C-------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11111111111 11110 0 001112345788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=250.83 Aligned_cols=252 Identities=24% Similarity=0.294 Sum_probs=187.4
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|++.+.||+|++|.||+|... .+++.+++|.+...... ......+..|+.+++.
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------------------~~~~~~~~~e~~~l~~ 54 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFES-------------------------EGIPKTALREIKLLKE 54 (283)
T ss_pred CccceeeecCCCceEEEEEcC-CCCcEEEEEEecccccc-------------------------chhHHHHHHHHHHHHH
Confidence 677899999999999999854 57899999998643221 1224567789999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
++||||+++++++..++ .++++++++++. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||
T Consensus 55 l~~~~i~~~~~~~~~~~--~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~ni 129 (283)
T cd05118 55 LNHPNIIKLLDVFRHKG--DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENL 129 (283)
T ss_pred hcCCCcchHHHhhccCC--CEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHE
Confidence 99999999999887765 688888888652 24566677889999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
+++.++.++++|||.+....... .......++..|+|||.+.+. .++.++|+| +|+++|+|++|..||... +
T Consensus 130 li~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~----~ 203 (283)
T cd05118 130 LINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK----S 203 (283)
T ss_pred EECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC----C
Confidence 99999999999999997765432 112235678889999999876 688999999 999999999999996432 2
Q ss_pred hhhHHHHHHHHhhhcCCC---cccc-------------ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPK---RAID-------------SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~---~~~~-------------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+....+......+.+. .... ........+.....+.++|..||+.||.+||++.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 204 EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 222222222111111100 0000 00001112344567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=247.18 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=198.1
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+....+.|.-+.+||+|.||+||+|+.+ .+|+.||+|.+.-. ...........+
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~-n~~kkvalkkvlme-------------------------neKeGfpitalr 65 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSK-NTGKKVALKKVLME-------------------------NEKEGFPITALR 65 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhc-CccchhHHHHHHHh-------------------------ccccCCcHHHHH
Confidence 4567789999999999999999999964 67888998876321 000112445678
Q ss_pred HHHHHhhccCCCccceeEEEecC------CcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRP------DCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~------~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
|+.+|..++|+|++.++..|.+. ....+++++++|+.. -.++...+.+++.++..||.|+|...
T Consensus 66 eikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k- 144 (376)
T KOG0669|consen 66 EIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK- 144 (376)
T ss_pred HHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh-
Confidence 99999999999999998877542 223478898888652 34677788899999999999999998
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCc--ceeccCcccCccccccccccccc-cCccchhh-HHHHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT--HITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGL 263 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el 263 (345)
++|||+||.|+||+.++.+|++|||+++.+..+.. ....++.+-|..|.+||.+.|.. ++++.|+| .||++.||
T Consensus 145 --ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeM 222 (376)
T KOG0669|consen 145 --ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEM 222 (376)
T ss_pred --HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHH
Confidence 99999999999999999999999999987754332 22234566689999999998875 89999999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCC---cccccc---------ccCCCcH---HHHH------HHHHHHhhc
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPK---RAIDSK---------LVGNGCE---EQML------LVLKIACFC 322 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---------~~~~~~~---~~~~------~l~~li~~C 322 (345)
+++.+- ++...+.+.+..|....+...+. ....-+ ++..... +... ..++|+..+
T Consensus 223 wtrspi----mqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l 298 (376)
T KOG0669|consen 223 WTRSPI----MQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL 298 (376)
T ss_pred HccCcc----ccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence 999988 45556666667776665543322 111111 1111111 1111 467788889
Q ss_pred cCCCCCCCCCHHHHHHH
Q 046907 323 TLEDPNERPNSKDVRRM 339 (345)
Q Consensus 323 l~~dp~~Rpt~~~ll~~ 339 (345)
+..||.+|++++++++.
T Consensus 299 l~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 299 LKLDPTKRIDADQALNH 315 (376)
T ss_pred hccCcccCcchHhhhch
Confidence 99999999999998753
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.96 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=176.9
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||+|+||.||+|..+ .+|+.||+|.+...... .......+..|+.+++.++||||
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~~~~i 55 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLK------------------------KRKGEQMALNEKKILEKVSSRFI 55 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhh------------------------hhhhhHHHHHHHHHHHhCCCCCE
Confidence 699999999999854 57999999998532111 01234556789999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~ 204 (345)
+++++.+...+ ..++++++++++. .++......++.|++.||.|||+.+ ++|+||+|+||+++.
T Consensus 56 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~ 130 (277)
T cd05577 56 VSLAYAFETKD--DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDD 130 (277)
T ss_pred eeeeeEEecCC--eEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECC
Confidence 99999887765 6789999987643 3566677789999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHH
Q 046907 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283 (345)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~ 283 (345)
++.++++|||.+....... ......++..|+|||.+.+..++.++|+| +|+++|+|++|..||.............
T Consensus 131 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 207 (277)
T cd05577 131 HGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK 207 (277)
T ss_pred CCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH
Confidence 9999999999987654321 12335678899999999888889999999 9999999999999975432211111111
Q ss_pred HHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.. ...... .........+.+++..||+.||.+|| ++.++++
T Consensus 208 ~~---~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 208 RR---TLEMAV-----------EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred hc---cccccc-----------cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 11 100000 01111233477889999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=243.33 Aligned_cols=239 Identities=29% Similarity=0.429 Sum_probs=186.3
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|...+.||+|++|.||++... .++..+++|.+..... .....+.+|+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~---------------------------~~~~~~~~e~~~l~ 52 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK-RTGKEVAIKVIKLESK---------------------------EKKEKIINEIQILK 52 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC-CCCcEEEEEEecccch---------------------------hHHHHHHHHHHHHH
Confidence 5788999999999999999964 4788999999964321 13567788999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
.++|||++++++.+..++ ..++++++++++. .+++.....++.|++.|+.+||+.+ ++|+|++|+
T Consensus 53 ~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ 127 (253)
T cd05122 53 KCKHPNIVKYYGSYLKKD--ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAA 127 (253)
T ss_pred hCCCCCEeEEEEEEecCC--eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHH
Confidence 999999999999888775 6788888887543 4566777889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.++|+|||.+........ .....|+..|+|||.+.+...+.++|+| +|+++|+|++|..||....
T Consensus 128 ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--- 201 (253)
T cd05122 128 NILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--- 201 (253)
T ss_pred HEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc---
Confidence 99999999999999999876654321 2346788999999999888889999999 9999999999999964321
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......... ...+ .... .......+.+++..||+.||.+|||+.++++
T Consensus 202 -~~~~~~~~~~---~~~~-~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 202 -PMKALFKIAT---NGPP-GLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -hHHHHHHHHh---cCCC-CcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111111 1000 0000 0011345788899999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=250.91 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=183.0
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|+....||+|+||.||++..+ .++..||+|.+.... ......+.+|+.+++.
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~---------------------------~~~~~~~~~e~~~l~~ 73 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRK---------------------------QQRRELLFNEVVIMRD 73 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEc-CCCeEEEEEEecccc---------------------------hhHHHHHHHHHHHHHh
Confidence 344578999999999999864 579999999874221 1224567889999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil 201 (345)
++|||++++++.+..++ ..++++++++++.+ +++.....++.|++.|+.|||+.+ ++|+|++|+||+
T Consensus 74 l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nil 148 (292)
T cd06657 74 YQHENVVEMYNSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSIL 148 (292)
T ss_pred cCCcchhheeeEEEeCC--EEEEEEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence 99999999999988776 78899999987643 566677789999999999999998 999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchh
Q 046907 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~ 280 (345)
++.++.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||.. ....
T Consensus 149 v~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~----~~~~ 222 (292)
T cd06657 149 LTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EPPL 222 (292)
T ss_pred ECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC----CCHH
Confidence 99999999999998876543221 11335688999999999888889999999 99999999999999642 2222
Q ss_pred hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.....+......... ........+.+++.+||+.||.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 223 KAMKMIRDNLPPKLK-----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhhCCcccC-----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 222222221110000 00111224678888999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=264.83 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=191.7
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....+.|.+...||+|.|++|.+|++. .++..||||.+.....+ ....+.+.+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln-------------------------~~~~~k~~re 105 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLN-------------------------PSKRQKLGRE 105 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccC-------------------------hHHHHHHHHH
Confidence 446779999999999999999999975 57999999999655444 3335568899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH---------HHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---------ARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~---------~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.++..++|||||+++.+..++. .+|++++|+.++.+++++ ....++.|+.+|++|||+++ |+|||
T Consensus 106 v~imk~l~HPnIvkl~~v~~t~~--~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrd 180 (596)
T KOG0586|consen 106 VDIMKSLNHPNIVKLFSVIETEA--TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRD 180 (596)
T ss_pred HHHHHhcCCcceeeeeeeeeecc--eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccc
Confidence 99999999999999999998887 799999999998766555 34568999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||++|+|++.+.++||+|||++..+.... ...+.+|++.|.|||+..+..+ ++..|+| +|+++|-|+.|..||++
T Consensus 181 Lk~eNilL~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 181 LKAENILLDENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred cchhhcccccccceeeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999999999999998776433 3456899999999999999886 5789999 99999999999999864
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..- ..+.. +.. -.+..-+. -...+.-++++..+-.+|.+|++++++..
T Consensus 258 ~~l----k~Lr~---rvl---------~gk~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 258 QNL----KELRP---RVL---------RGKYRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccc----ccccc---hhe---------eeeecccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 221 11100 000 00000000 01112456677788899999999998754
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=247.26 Aligned_cols=235 Identities=20% Similarity=0.195 Sum_probs=174.8
Q ss_pred hcCCccccccc--ccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKI--GSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~i--G~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|++.+.+ |+|+||.||+++.+ .++..+|+|.+..... .. .|
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~------------------------------~~--~e 58 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNF------------------------------NA--IE 58 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEc-CCCcEEEEEEEehhhc------------------------------ch--hh
Confidence 34577777776 99999999999854 5789999999853210 00 12
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.....+ +||||+++++.+..++ .+++++||+++++ .+++.....++.|+++||.|||+.+ ++|+
T Consensus 59 ~~~~~~~~~h~~iv~~~~~~~~~~--~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 133 (267)
T PHA03390 59 PMVHQLMKDNPNFIKLYYSVTTLK--GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHN 133 (267)
T ss_pred HHHHHHhhcCCCEEEEEEEEecCC--eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeC
Confidence 2222222 7999999999998876 7899999998754 3566677889999999999999998 9999
Q ss_pred CCCCCCeeecCCC-CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 194 DLNPVNVLLDDDI-EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||+|+||+++.++ .++++|||++...... ....|+..|+|||.+.+..++.++|+| +|+++|+|++|..||.
T Consensus 134 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 134 DIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred CCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999888 9999999998765432 234678999999999988899999999 9999999999999976
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-SKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-~~~ll~ 338 (345)
..... ......+..... .... ........+.+++..||+.+|.+||+ ++++++
T Consensus 208 ~~~~~--~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 208 EDEDE--ELDLESLLKRQQ-KKLP-----------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCCcc--hhhHHHHHHhhc-ccCC-----------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 33221 111112211111 1000 11123334788889999999999996 588874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=248.92 Aligned_cols=236 Identities=23% Similarity=0.294 Sum_probs=171.7
Q ss_pred ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH---HHHhhcc
Q 046907 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI---NTVGQIR 131 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~ 131 (345)
.||+|+||.||+++.. .++..+|+|.+......... ....+.+|. .++...+
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~ 55 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQ------------------------GETLALNERIMLSLVSTGD 55 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccch------------------------HHHHHHHHHHHHHHHhhCC
Confidence 4899999999999864 57899999988643221110 011122333 3344458
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
||||+.+++.+..++ ..+++++|+.++.+ +++.....++.|++.||.|||+.+ ++|+||||+||++
T Consensus 56 ~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~ 130 (279)
T cd05633 56 CPFIVCMTYAFHTPD--KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILL 130 (279)
T ss_pred CCcEeEEEEEEecCC--eEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEE
Confidence 999999999888776 68889999988754 466667789999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccccchh
Q 046907 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~ 280 (345)
+.++.++++|||++....... .....|+..|+|||.+.+ ..++.++|+| +|+++|+|++|..||....... .
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~ 204 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--K 204 (279)
T ss_pred CCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--H
Confidence 999999999999987554322 123568999999999864 5578999999 9999999999999986432211 1
Q ss_pred hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 046907 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRRM 339 (345)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~~ 339 (345)
.. +........ .. .+......+.+++..||+.||.+|| |+.++++.
T Consensus 205 ~~---~~~~~~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 205 HE---IDRMTLTVN------VE----LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HH---HHHHhhcCC------cC----CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 111110000 00 1112234577888999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=245.10 Aligned_cols=237 Identities=22% Similarity=0.271 Sum_probs=173.7
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-hhccC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV-GQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h 132 (345)
+.||+|+||.||+|+.. .+|..||+|.+....... ......+..|..++ ...+|
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~~e~~~~~~~~~~ 56 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIA------------------------KNQVTNVKAERAIMMIQGES 56 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhH------------------------HHHHHHHHHHHHHHhhcCCC
Confidence 57999999999999864 568899999985322111 11122233444443 44589
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
||++++++.+...+ .++++++|+.++.+ ++......++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 57 ~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~ 131 (260)
T cd05611 57 PYVAKLYYSFQSKD--YLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLID 131 (260)
T ss_pred CCeeeeeeeEEcCC--eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC
Confidence 99999999988765 78999999987643 556667889999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
.++.++++|||++..... .....|+..|+|||.+.+..++.++||| +|+++|+|++|..||... .....
T Consensus 132 ~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----~~~~~ 201 (260)
T cd05611 132 QTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE----TPDAV 201 (260)
T ss_pred CCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC----CHHHH
Confidence 999999999998875432 1235678899999999888889999999 999999999999997432 22222
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
...+.... .... ..........+.+++..||+.||++||++.++.+.|
T Consensus 202 ~~~~~~~~--~~~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 202 FDNILSRR--INWP--------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHhcc--cCCC--------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 22211111 0000 001112234578999999999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.09 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=185.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++...||+|++|.||+|++. .++..||+|.+.....+ ......+.+|+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~-------------------------~~~~~~~~~E~~ 66 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPFQS-------------------------AIHAKRTYRELR 66 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEEC-CCCcEEEEEecccccch-------------------------hhHHHHHHHHHH
Confidence 3568999999999999999999864 47889999988542111 122455678999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
++++++|||++++++++..++. ..++++++++++. ..+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~d 143 (343)
T cd07851 67 LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRD 143 (343)
T ss_pred HHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 9999999999999987765442 3478888888541 24677788899999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|+||+++.++.++|+|||++...... .....++..|+|||.+.+. .++.++||| +|+++|++++|..||..
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 144 LKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred CCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998765432 2335678899999998653 578899999 99999999999999753
Q ss_pred cccccchhhHHHHHHHHhhhcCCCcccc---------------cccc---CCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAID---------------SKLV---GNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~---~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
. ........+......+.. .... .... ..........+.+++.+||+.||++|||+.
T Consensus 219 ~----~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 219 S----DHIDQLKRIMNLVGTPDE-ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred C----ChHHHHHHHHHhcCCCCH-HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 2 222222222221111100 0000 0000 000011245688999999999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
+|++
T Consensus 294 ell~ 297 (343)
T cd07851 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=250.85 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=176.5
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
+.+++.+|.|+++.|++++ .+++.||+|.+.....+ ......+.+|+.+++.
T Consensus 4 ~~i~~~~~~~~~v~~~~~~---~~~~~~avK~~~~~~~~-------------------------~~~~~~~~~Ei~~l~~ 55 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHK---PTNTLVAVKKINLDSCS-------------------------KEDLKLLQQEIITSRQ 55 (314)
T ss_pred hhhhHhhcCCceEEEEEec---CCCCEEEEEEEeccccc-------------------------hhHHHHHHHHHHHHHh
Confidence 3444555555665555554 37999999998643211 2346678899999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++||||+++++.+..++ ..++++++++++.+ ++......++.|++.||.|||+.+ ++|+||||+
T Consensus 56 l~h~~i~~~~~~~~~~~--~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~ 130 (314)
T cd08216 56 LQHPNILPYVTSFIVDS--ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKAS 130 (314)
T ss_pred cCCcchhhhhheeecCC--eEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcc
Confidence 99999999999888766 67888999886543 455566789999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCc-----ceeccCcccCcccccccccccc--ccCccchhh-HHHHHHHHHhCCCCC
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHT-----HITTSNVVGTVEYIAPEYLQML--TLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~~~aPE~~~~~--~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||+++.++.++++|||.+........ ........++..|+|||.+.+. .++.++|+| +|+++|||++|..||
T Consensus 131 Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf 210 (314)
T cd08216 131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210 (314)
T ss_pred eEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 99999999999999998875532211 1112335677889999998763 478899999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcC-----C------Cc----cccc----cccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASEN-----P------KR----AIDS----KLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~-----~------~~----~~~~----~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
.... ........+........ + .. ...+ .............+.+++..||+.||++||
T Consensus 211 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 287 (314)
T cd08216 211 KDMP---ATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287 (314)
T ss_pred CCCC---HHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence 5321 11112121111100000 0 00 0000 000011122334678899999999999999
Q ss_pred CHHHHHH
Q 046907 332 NSKDVRR 338 (345)
Q Consensus 332 t~~~ll~ 338 (345)
|+.++++
T Consensus 288 t~~~ll~ 294 (314)
T cd08216 288 SASQLLN 294 (314)
T ss_pred CHHHHhc
Confidence 9999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=255.95 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=184.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|... .+|..||+|.+...... ......+.+|+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~~ 66 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQS-------------------------ELFAKRAYRELR 66 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccc-------------------------hHHHHHHHHHHH
Confidence 4668999999999999999999854 57999999998532111 122456778999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQG-------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++.++||||+++++.+..++. ...+++++++++ ...+++..+..++.|++.||.|||+.+ ++|||
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~d 143 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRD 143 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999999999999998876542 235778888743 134677788899999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|||+||+++.++.++++|||++...... .....++..|+|||.+.+ ..++.++|+| +|+++|++++|..||..
T Consensus 144 lkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 144 LKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred CCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998754322 223567889999999876 3478899999 99999999999999753
Q ss_pred cccccchhhHHHHHHHHhhhcC-----------CCcc------ccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASEN-----------PKRA------IDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~------~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
... .......+. ...... .... ..........+.....+.+++.+|++.||.+|||+.+
T Consensus 219 ~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~ 294 (343)
T cd07880 219 HDH---LDQLMEIMK-VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294 (343)
T ss_pred CCH---HHHHHHHHH-hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHH
Confidence 211 111111111 000000 0000 0000000001122334778999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
++.
T Consensus 295 ~l~ 297 (343)
T cd07880 295 ALA 297 (343)
T ss_pred Hhc
Confidence 883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=246.34 Aligned_cols=239 Identities=24% Similarity=0.337 Sum_probs=179.5
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||.|+||.||+|+++ .+|..+++|.+....... ......+.+|+.+++.++||||
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~------------------------~~~~~~~~~e~~~l~~~~h~~i 55 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIR------------------------KNQVDQVLTERDILSQAQSPYV 55 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhh------------------------hhHHHHHHHHHHHHHhCCCcch
Confidence 699999999999964 568999999985432111 2346678889999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCC
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI 206 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~ 206 (345)
+++++.+...+ ..+++++++.++. .++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 56 ~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~ 130 (265)
T cd05579 56 VKLYYSFQGKK--NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNG 130 (265)
T ss_pred hHHHHheecCc--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCC
Confidence 99999887655 6888999997754 3566677789999999999999998 99999999999999999
Q ss_pred CeEEeccccceecCCCCc------ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccch
Q 046907 207 EARISGFGFARAIPDAHT------HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279 (345)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~ 279 (345)
.++++|||++........ ........++..|+|||...+...+.++|+| +|+++|++++|..||... ..
T Consensus 131 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~----~~ 206 (265)
T cd05579 131 HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE----TP 206 (265)
T ss_pred CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC----CH
Confidence 999999999875432211 0122335678899999999888888999999 999999999999997432 22
Q ss_pred hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
......+.... ...+ . .......+.+++..||+.+|.+|||+..+.+.|
T Consensus 207 ~~~~~~~~~~~-~~~~-~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 207 EEIFQNILNGK-IEWP-E----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHHhcCC-cCCC-c----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 22222221100 0000 0 000134578899999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=255.30 Aligned_cols=269 Identities=22% Similarity=0.250 Sum_probs=185.3
Q ss_pred cCCccc-ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLAS-LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 47 ~~~~~~-~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.++|.. .+.||+|+||.||+|+.. .+++.||+|.+............ .+ ... .......+.+|+.
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~----------~~-~~~--~~~~~~~~~~E~~ 72 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKD----------RQ-LVG--MCGIHFTTLRELK 72 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccc----------hh-hhc--ccccchhHHHHHH
Confidence 456764 567999999999999854 57899999998643322100000 00 000 0001235678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR--------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++ ..+++++++.+. ..++......++.|++.||.|||+.+ ++|+||+|
T Consensus 73 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~ 147 (335)
T PTZ00024 73 IMNEIKHENIMGLVDVYVEGD--FINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSP 147 (335)
T ss_pred HHHhCCCcceeeeeEEEecCC--cEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 999999999999999988766 688888888651 23566677789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCc------------ceeccCcccCccccccccccccc-cCccchhh-HHHHHHHH
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHT------------HITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGL 263 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el 263 (345)
+||+++.++.++++|||.+........ ........++..|+|||.+.+.. ++.++|+| +|+++|+|
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999976642110 01112245678899999997654 68899999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCCccc-----------c---ccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAI-----------D---SKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
++|..||... +.......+......+...... . +.............+.+++..||+.+|++
T Consensus 228 ~tg~~p~~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 303 (335)
T PTZ00024 228 LTGKPLFPGE----NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLE 303 (335)
T ss_pred HhCCCCCCCC----CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchh
Confidence 9999997532 2222222222222111110000 0 00000011122455788999999999999
Q ss_pred CCCHHHHHH
Q 046907 330 RPNSKDVRR 338 (345)
Q Consensus 330 Rpt~~~ll~ 338 (345)
|||+++++.
T Consensus 304 R~s~~~~l~ 312 (335)
T PTZ00024 304 RISAKEALK 312 (335)
T ss_pred ccCHHHHhc
Confidence 999999985
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=248.21 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=181.0
Q ss_pred CcccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
+|++.+.||+|+||.||+|+... .+|..||+|.+....... .......+.+|+.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~-----------------------~~~~~~~~~~e~~~ 57 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ-----------------------KAKTTEHTRTERQV 57 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh-----------------------cchHHHHHHHHHHH
Confidence 58899999999999999998532 368999999985321110 02235667789999
Q ss_pred Hhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.+ +||||+++++.+..++ .+++++++++++.+ ++......++.|++.||.|||+.+ ++|+||+
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~ 132 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDT--KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIK 132 (290)
T ss_pred HHhcccCCChhceeeEeecCC--eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCC
Confidence 9999 6999999999887765 68899999988654 344455678889999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc--ccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML--TLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~--~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+||+++.++.++|+|||++........ .......|+..|+|||.+.+. .++.++||| +|+++|+|++|..||...
T Consensus 133 p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 133 LENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred HHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 9999999999999999999876543221 112235688999999998753 367889999 999999999999997431
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.. ................+ .+......+.+++..||+.||++|| ++.+++.
T Consensus 212 ~~---~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 212 GE---KNSQAEISRRILKSEPP-----------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred Cc---cccHHHHHHHhhccCCC-----------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11 11112222222111111 0111223477899999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=247.82 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=187.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+.+ .+|..||+|.+...... .......+..|+.++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~------------------------~~~~~~~~~~e~~~~ 55 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLI------------------------KEKKVKYVKIEKEVL 55 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhcc------------------------chHHHHHHHHHHHHH
Confidence 47999999999999999999864 57899999998532110 122346678899999
Q ss_pred hhcc-CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++++ ||||+++++++..++ .++++++++.++++ +++.....++.|++.||.+||+.+ ++|+|++|
T Consensus 56 ~~l~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~ 130 (280)
T cd05581 56 TRLNGHPGIIKLYYTFQDEE--NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKP 130 (280)
T ss_pred HhcccCCCchhHHHHhcCCc--eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCH
Confidence 9998 999999999887665 68889999977544 566777889999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcc------------------eeccCcccCccccccccccccccCccchhh-HHH
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTH------------------ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~------------------~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~ 258 (345)
+||+++.++.++++|||++......... .......|+..|+|||...+...+.++|+| +|+
T Consensus 131 ~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~ 210 (280)
T cd05581 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGC 210 (280)
T ss_pred HHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHH
Confidence 9999999999999999998866442210 122345678899999999888889999999 999
Q ss_pred HHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH----H
Q 046907 259 LLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS----K 334 (345)
Q Consensus 259 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~----~ 334 (345)
+++++++|..||... ........+.... .. .+......+.+++..||+.+|++|||+ .
T Consensus 211 ~l~~l~~g~~p~~~~----~~~~~~~~~~~~~--~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 272 (280)
T cd05581 211 IIYQMLTGKPPFRGS----NEYLTFQKILKLE--YS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYD 272 (280)
T ss_pred HHHHHHhCCCCCCCc----cHHHHHHHHHhcC--CC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHH
Confidence 999999999996532 2222222211110 00 011113347889999999999999999 7
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
++++
T Consensus 273 ~ll~ 276 (280)
T cd05581 273 ELKA 276 (280)
T ss_pred HHhc
Confidence 7764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=247.35 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=185.0
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|+..+.||+|.||.||+|+.. .+++.||+|.+...... ......+..|+.+++.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~-------------------------~~~~~~~~~e~~~l~~ 54 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEE-------------------------EGIPSTALREISLLKE 54 (282)
T ss_pred CeeehcccccCcceEEEeeec-CCCcEEEEEEecccccc-------------------------ccccHHHHHHHHHHHh
Confidence 667889999999999999964 56899999998654211 1224556679999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
++|||++++++++...+ .++++++++.+. ..++...+..++.|++.||.+||+.+ ++|+|++|+||
T Consensus 55 ~~~~~i~~~~~~~~~~~--~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni 129 (282)
T cd07829 55 LKHPNIVKLLDVIHTER--KLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNI 129 (282)
T ss_pred cCCCCHHHHHhhhhcCC--ceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheE
Confidence 99999999999888765 688888888642 24667777889999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+| +|+++||+++|..||... .
T Consensus 130 ~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~----~ 203 (282)
T cd07829 130 LINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD----S 203 (282)
T ss_pred EEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc----c
Confidence 999999999999999876543221 12234567789999998776 688899999 999999999999996432 2
Q ss_pred hhhHHHHHHHHhhhcCCC------------ccc---cccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPK------------RAI---DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~------------~~~---~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+......+... ... .........+.....+.+++..||+.||++||++.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 204 EIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 222222222211111100 000 000000111122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=247.85 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=180.3
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|++.+.||+|++|.||+|+.. .+++.|+||.+...... .......+|+..+.+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~--------------------------~~~~~~~~e~~~l~~ 53 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYS--------------------------WEECMNLREVKSLRK 53 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccc--------------------------hhHHHHHHHHHHHHh
Confidence 678899999999999999964 46889999998532211 012233468888999
Q ss_pred cc-CCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 130 IR-HRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 130 l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++ |||++++++.+..++ ..+++++++.+. ..+++.....++.|++.+|.|||+.+ ++|+||+|+
T Consensus 54 ~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ 128 (283)
T cd07830 54 LNEHPNIVKLKEVFREND--ELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPE 128 (283)
T ss_pred ccCCCCchhHHHHhhcCC--cEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChh
Confidence 98 999999999887755 688899988431 24567777889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.++++|||.+........ .....++..|+|||.+.+ ..++.++|+| ||+++++|++|..||.....
T Consensus 129 ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~- 204 (283)
T cd07830 129 NLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE- 204 (283)
T ss_pred hEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh-
Confidence 99999999999999999976543221 123567889999998854 3478899999 99999999999999754321
Q ss_pred cchhhHHHHHHHHhhhcCC-------------Cccccc---cccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENP-------------KRAIDS---KLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~---~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+......+.. ...... .......+.....+.+++..||+.||++|||+.+++.
T Consensus 205 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 205 ---IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ---HHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1111111111111000 000000 0000011112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=244.30 Aligned_cols=242 Identities=21% Similarity=0.305 Sum_probs=180.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+.+.||+|+||.||++++. ..+..+++|.++....... .......+..|+.+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~-~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~e~~~l~ 57 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDK-KAVAEERLKVLKEIPVGEL----------------------NPNETVQANQEAQLLS 57 (260)
T ss_pred CceeeeeecCCCCceEEEEEec-CCCCcceEEEecccccccc----------------------CcchHHHHHHHHHHHH
Confidence 5889999999999999999865 3455666777654322110 0112344667899999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.++||||+++++++..++ ..+++++++.++++ +++.....++.|++.|+.|||+.+ ++|+|+
T Consensus 58 ~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l 132 (260)
T cd08222 58 KLDHPAIVKFHASFLERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDL 132 (260)
T ss_pred hCCCCcHHHHHHHHhcCC--ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 999999999999887665 57888888876543 455666789999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+|+|++++. +.++++|||++........ ......|+..|+|||.+.+..++.++|+| +|+++|+|++|..||...
T Consensus 133 ~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~- 208 (260)
T cd08222 133 KAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ- 208 (260)
T ss_pred ChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-
Confidence 999999985 4699999999876543221 12335678899999999888888999999 999999999999996421
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. ............+ .........+.++|.+||+.+|++||++.++++
T Consensus 209 ---~~---~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 209 ---NF---LSVVLRIVEGPTP----------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---cH---HHHHHHHHcCCCC----------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11 1222222211111 111233346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=243.81 Aligned_cols=238 Identities=23% Similarity=0.301 Sum_probs=171.7
Q ss_pred ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCC
Q 046907 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRN 134 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 134 (345)
.||+|+||.||+|+.. .+++.||+|.+.......... ......-......++...|||
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~ 58 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQG---------------------ETLALNERIMLSLVSTGDCPF 58 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchh---------------------HHHHHHHHHHHHHHHhCCCCc
Confidence 4899999999999854 478999999986432211000 000011112234455568999
Q ss_pred ccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCC
Q 046907 135 LHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD 205 (345)
Q Consensus 135 iv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~ 205 (345)
|+.+++.+..++ .++++++|+.++.+ +++..+..++.|++.|+.|||+.+ ++|+|+||+||+++.+
T Consensus 59 i~~~~~~~~~~~--~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~ 133 (278)
T cd05606 59 IVCMSYAFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH 133 (278)
T ss_pred EeeeeeeeecCC--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCC
Confidence 999999888776 68889999987644 566777889999999999999998 9999999999999999
Q ss_pred CCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHH
Q 046907 206 IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283 (345)
Q Consensus 206 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~ 283 (345)
+.++++|||++....... .....|+..|+|||.+.+. .++.++|+| +|+++|+|++|..||...... ......
T Consensus 134 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-~~~~~~ 208 (278)
T cd05606 134 GHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEID 208 (278)
T ss_pred CCEEEccCcCccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-chHHHH
Confidence 999999999987553321 1235789999999999754 588999999 999999999999997543221 111111
Q ss_pred HHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.. .. ...+ .+. ......+.+++.+||+.+|.+|| ++.++++
T Consensus 209 ~~---~~-~~~~------~~~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 209 RM---TL-TMAV------ELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HH---hh-ccCC------CCC----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 11 0000 011 11123577888899999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=243.28 Aligned_cols=248 Identities=22% Similarity=0.401 Sum_probs=183.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++++-+..||+|+||.|++-.++ ..|+..|||++...-- .++..+++.|..
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~--------------------------~keq~rll~e~d 114 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNI--------------------------EKEQKRLLMEHD 114 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccc--------------------------hHHHHHHHHHHH
Confidence 5567777889999999999999865 6799999999965321 245677888888
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQG-------------RRELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
...+- +.||||++||....++. .|+-||+++- ...+++...-.+..-.+.||.||.... .|+
T Consensus 115 ~~mks~~cp~IVkfyGa~F~EGd--cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiI 190 (361)
T KOG1006|consen 115 TVMKSSNCPNIVKFYGALFSEGD--CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KII 190 (361)
T ss_pred HHHhhcCCcHHHHHhhhhhcCCc--eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhh
Confidence 77665 79999999998887773 5666666643 223344434445555678999998876 699
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc--ccCccchhh-HHHHHHHHHhCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML--TLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~--~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
|||+||+|||+++.|.+|+||||.+-.+.++- ..+.-.|...|||||.+... .|+-++||| +|+++||+.||.+
T Consensus 191 HRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~f 267 (361)
T KOG1006|consen 191 HRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNF 267 (361)
T ss_pred hccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCC
Confidence 99999999999999999999999987664432 22335789999999999543 488899999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|+... .+..+.+........+....+. .+.+....+..+|..|+..|-.+||+..+++.
T Consensus 268 Pyr~w------~svfeql~~Vv~gdpp~l~~~~-----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 268 PYRKW------DSVFEQLCQVVIGDPPILLFDK-----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcchH------HHHHHHHHHHHcCCCCeecCcc-----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 97542 1244555555444433222211 12223344677777799999999999998864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=273.57 Aligned_cols=196 Identities=26% Similarity=0.342 Sum_probs=168.2
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
.-+.++|.++++||+|+||+|..++.+ .+++.||.|++.. .++.......-|..|
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK------------------------~eMlKr~~tA~F~EE 125 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNK------------------------WEMLKRAETACFREE 125 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhH------------------------HHHhhchhHHHHHHH
Confidence 447889999999999999999999975 6899999999842 333334557788899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH---------HHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---------ARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~---------~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
-.+|..-+.+-|+.++-.|.+++ ++|+||+|++||++++.+ .+.-+...++-||.-+|+.| +||||
T Consensus 126 RDimv~~ns~Wiv~LhyAFQD~~--~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRD 200 (1317)
T KOG0612|consen 126 RDIMVFGNSEWIVQLHYAFQDER--YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRD 200 (1317)
T ss_pred hHHHHcCCcHHHHHHHHHhcCcc--ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceecc
Confidence 99999889999999998888776 899999999999765444 34457888999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----cccCccchhh-HHHHHHHHHhCCC
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----LTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
|||+|+|+|..|++|++|||.+..+...+.. .....+|||-|.+||+++. +.|+..+|+| +|+++|||+.|..
T Consensus 201 iKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T 279 (1317)
T KOG0612|consen 201 IKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET 279 (1317)
T ss_pred CCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence 9999999999999999999999887655443 3456899999999999952 4588999999 9999999999999
Q ss_pred CC
Q 046907 269 PS 270 (345)
Q Consensus 269 p~ 270 (345)
||
T Consensus 280 PF 281 (1317)
T KOG0612|consen 280 PF 281 (1317)
T ss_pred cc
Confidence 96
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=244.44 Aligned_cols=248 Identities=18% Similarity=0.256 Sum_probs=191.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|.+.+.+|+|.||.|-.+..+ .++..||||++++. .+..+....|+++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~-~~~~~vAlKIik~V----------------------------~kYreAa~iEi~v 138 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDR-ETKEHVALKIIKNV----------------------------DKYREAALIEIEV 138 (415)
T ss_pred ccceehhhhhcCCcccceEEEeec-CCCceehHHHHHHH----------------------------HHHhhHHHHHHHH
Confidence 678999999999999999999755 45999999999653 3456777889999
Q ss_pred Hhhcc--CC----CccceeEEEecCCcceeeeeccccC--------CC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 127 VGQIR--HR----NLHPLLAHVTRPDCHLLYILNDVSQ--------GR--RELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 127 l~~l~--hp----niv~l~~~~~~~~~~~l~~~~~~~~--------~~--~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
|+++. .| -+|.+.+||...+ .+++++|.++ .. ..++...+..|+.|+++++.+||+.+ +
T Consensus 139 Lqki~~~DP~g~~rcv~m~~wFdyrg--hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l 213 (415)
T KOG0671|consen 139 LQKINESDPNGKFRCVQMRDWFDYRG--HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---L 213 (415)
T ss_pred HHHHHhcCCCCceEEEeeehhhhccC--ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---e
Confidence 99993 33 2778888888777 5677666664 22 23566678899999999999999999 9
Q ss_pred EecCCCCCCeeecC--------------------CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc
Q 046907 191 IHRDLNPVNVLLDD--------------------DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250 (345)
Q Consensus 191 iH~dlk~~nil~~~--------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~ 250 (345)
+|-||||+|||+-. +..++++|||.|....+.+ ...+.|..|.|||++.+.+++.
T Consensus 214 ~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~ 288 (415)
T KOG0671|consen 214 THTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQ 288 (415)
T ss_pred eecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCC
Confidence 99999999999832 2357999999998754433 3467799999999999999999
Q ss_pred cchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcccccc---------------------------
Q 046907 251 KCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSK--------------------------- 302 (345)
Q Consensus 251 ~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------- 302 (345)
++||| +||||.|+.+|...|.+. +..+.++.+..+++ +.|..++...
T Consensus 289 pCDvWSiGCIL~ElytG~~LFqtH----en~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~ 363 (415)
T KOG0671|consen 289 PCDVWSIGCILVELYTGETLFQTH----ENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFE 363 (415)
T ss_pred ccCceeeeeEEEEeeccceecccC----CcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhc
Confidence 99999 999999999999996443 34444567766665 4433222111
Q ss_pred ------ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 303 ------LVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 303 ------~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..-.....+...+++|+..+|..||.+|+|+.|+++
T Consensus 364 ~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 364 PCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 001122345567999999999999999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=235.63 Aligned_cols=244 Identities=18% Similarity=0.253 Sum_probs=186.2
Q ss_pred hcCCccccc-ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLE-KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 46 ~~~~~~~~~-~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
-+++|.+.. +||-|-.|.|..|..+ .+|+.+|+|++.- .....+|+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k-~T~ekfALKvL~D--------------------------------s~KARrEV 105 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHK-RTQEKFALKVLLD--------------------------------SPKARREV 105 (400)
T ss_pred chhhheehhhhhccccCCceEEEEec-cchhhhHHHHHhc--------------------------------CHHHHhHh
Confidence 566777654 7999999999999854 6899999999842 34455677
Q ss_pred HHHhhc-cCCCccceeEEEec--CCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 125 NTVGQI-RHRNLHPLLAHVTR--PDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+.--.. .|||||.+++++.+ .+...+.++||.++||.+ +.+.....|+.||+.|+.|||+.. |
T Consensus 106 eLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---I 182 (400)
T KOG0604|consen 106 ELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---I 182 (400)
T ss_pred hhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---h
Confidence 665444 79999999998864 344578899999999866 445566789999999999999998 9
Q ss_pred EecCCCCCCeeec---CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC
Q 046907 191 IHRDLNPVNVLLD---DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 191 iH~dlk~~nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg 266 (345)
.||||||+|+|.. .+..+|++|||.|+..... ....+.+-|++|.|||++....|+...|+| +|+++|-|++|
T Consensus 183 AHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 183 AHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred hhccCChhheeeecCCCCcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 9999999999996 4567999999999875532 234557889999999999999999999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+|| ++... .-+--.++........ ..+.+..++..+...++|+..|..+|.+|.|+.++.+
T Consensus 260 yPPF---YS~hg-~aispgMk~rI~~gqy------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 260 YPPF---YSNHG-LAISPGMKRRIRTGQY------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCcc---cccCC-ccCChhHHhHhhccCc------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 9996 33221 1111112211111111 1223345566677888999999999999999998864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=236.70 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=183.9
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h 132 (345)
+.||+|+|+.|-.|. +-.+|..||||++.... .....++.+|++++... .|
T Consensus 84 e~LGeGAyasVqtcv-~i~t~~EYAVKiidKq~---------------------------gHsR~RvfREVe~f~~Cqgh 135 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCV-SIQTGKEYAVKIIDKQP---------------------------GHSRSRVFREVETFYQCQGH 135 (463)
T ss_pred HHhcCccceeeeeee-eeccchhhhhhhhhcCC---------------------------chHHHHHHHHHHHHHHhcCC
Confidence 579999999999998 44689999999997653 33478889999999998 59
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCCCCHH---------HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL---------ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~---------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
+||+.+++||.++. ..|+++|-+.||.+++.. ...++..+|+.||.+||.+| |.|||+||+|||..
T Consensus 136 ~nilqLiefFEdd~--~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 136 KNILQLIEFFEDDT--RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCE 210 (463)
T ss_pred ccHHHHHHHhcccc--eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeec
Confidence 99999999998876 689999999999876544 44568999999999999999 99999999999997
Q ss_pred CCC---CeEEeccccceecCCCC-----cceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhCCCC
Q 046907 204 DDI---EARISGFGFARAIPDAH-----THITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 204 ~~~---~~kl~Dfg~a~~~~~~~-----~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
... -+|||||.+........ ......+.+|+..|||||+.. .--|+.+.|.| +|+|+|-|++|.+|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 543 37999998776543221 112234578999999999873 23488999999 99999999999999
Q ss_pred Ccccccccchhh----HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMS----FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|.+..+...+++ ...+.............-.|. ...-.......+++...+-.||.+|.++.++++
T Consensus 291 FvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPd---kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 291 FVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPD---KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCCh---hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 988777665554 222222222111111111111 111122233445566677789999999988775
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=234.91 Aligned_cols=229 Identities=24% Similarity=0.336 Sum_probs=176.0
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||+|+||.||++... .+++.+|+|.+....... ......+..|+.+++.++||||
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~~i 55 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIK------------------------RKEVEHTLTERNILSRINHPFI 55 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcc------------------------hHHHHHHHHHHHHHHHcCCCcH
Confidence 799999999999864 468999999985432111 1235678889999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCC
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI 206 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~ 206 (345)
+++++.+..++ .++++++++.++.+ +++.....++.|+++|+.++|+.+ ++|+||+|+||+++.++
T Consensus 56 ~~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~ 130 (250)
T cd05123 56 VKLHYAFQTEE--KLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADG 130 (250)
T ss_pred HHHHHHeecCC--eeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCC
Confidence 99999887665 78889998866533 566677889999999999999998 99999999999999999
Q ss_pred CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHH
Q 046907 207 EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKW 285 (345)
Q Consensus 207 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~ 285 (345)
.++++|||++........ ......++..|+|||...+...+.++|+| +|+++|++++|..||... ........
T Consensus 131 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~----~~~~~~~~ 204 (250)
T cd05123 131 HIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE----DRKEIYEK 204 (250)
T ss_pred cEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC----CHHHHHHH
Confidence 999999999876543321 22345678899999999888888999999 999999999999996432 22222222
Q ss_pred HHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 286 MRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
+.. . .. .++ ......+.+++.+||+.||++||++.
T Consensus 205 ~~~---~-~~--~~~--------~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 205 ILK---D-PL--RFP--------EFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred Hhc---C-CC--CCC--------CCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 211 1 00 000 11123467889999999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=252.17 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=187.5
Q ss_pred Cccc--ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLAS--LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 49 ~~~~--~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-||+ -++||+|-||.||-|+++ ++|+.||||.+.+-.-. ++.-..+.+|+.|
T Consensus 563 vYQif~devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp-------------------------~kqesqlR~EVaI 616 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFP-------------------------TKQESQLRNEVAI 616 (888)
T ss_pred HHHhhhHhhccCCcceeeecceec-ccCceeeeeeeecccCC-------------------------CchHHHHHHHHHH
Confidence 3444 368999999999999976 68999999999643322 2234667889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG----------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
|+.++||.||.+-..|++++ .++++||-+.| .+.++.....-+..||+.||.|||.++ |+|+|||
T Consensus 617 Lq~l~HPGiV~le~M~ET~e--rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLK 691 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPE--RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLK 691 (888)
T ss_pred HHhcCCCCeeEEEEeecCCc--eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCC
Confidence 99999999999999999988 67888887765 345677777789999999999999998 9999999
Q ss_pred CCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|+|+.. -..+|+||||.|+..++... ....+||+.|+|||+++...|+..-|+| .|+++|--++|..||.+
T Consensus 692 PENVLLas~~~FPQvKlCDFGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 692 PENVLLASASPFPQVKLCDFGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred chheeeccCCCCCceeeccccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 99999974 35799999999999876543 2457999999999999999999999999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
++++-..|.+.... +++ +..++......+||...||..-.+|-+....+
T Consensus 769 ------dEdIndQIQNAaFM------yPp----~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 769 ------DEDINDQIQNAAFM------YPP----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ------ccchhHHhhccccc------cCC----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 22333333332211 111 12233444567888888988988998876554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=244.52 Aligned_cols=239 Identities=24% Similarity=0.266 Sum_probs=183.4
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
.....+|.++.+||+|+||.|.+|. +..+.+.+|||+++..-... ..+.+-.+.|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLae-rkgtdELyAiKiLkKDViiQ------------------------dDDvectm~E 399 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAE-RKGTDELYAIKILKKDVIIQ------------------------DDDVECTMVE 399 (683)
T ss_pred ceeecccceEEEeccCccceeeeec-ccCcchhhhhhhhccceeee------------------------cCcccceehh
Confidence 5566799999999999999999998 55678999999996532211 2234445567
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCCC---------HHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD---------WLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~---------~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
-++|... +-|.+++++..|.+.+ -+|++|||+.||.++= +....-++..|+-||-+||+++ |+.|
T Consensus 400 KrvLAL~~kppFL~qlHScFQTmD--RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYR 474 (683)
T KOG0696|consen 400 KRVLALPGKPPFLVQLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYR 474 (683)
T ss_pred hhheecCCCCchHHHHHHHhhhhh--heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeee
Confidence 7777766 6788999999888887 6999999999987743 2334458999999999999999 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|||.+|+++|.+|.+||+|||+++.---. ...+.+++||+-|+|||.+...+|+.++|+| +|++||||+.|.+||++
T Consensus 475 DLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 475 DLKLDNVMLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred eccccceEeccCCceEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999753222 2245679999999999999999999999999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
+++.++...|..-... .+.....+..++....+...|.+|..
T Consensus 553 ----eDE~elF~aI~ehnvs--------------yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 553 ----EDEDELFQAIMEHNVS--------------YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----CCHHHHHHHHHHccCc--------------CcccccHHHHHHHHHHhhcCCccccC
Confidence 4555554444322211 11111223445555577789999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=255.15 Aligned_cols=232 Identities=22% Similarity=0.275 Sum_probs=181.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+...+|.|+|+.|-++... .++...++|++... .....+|+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~-------------------------------~~~~~~e~~ 367 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKR-------------------------------ADDNQDEIP 367 (612)
T ss_pred cchhhccccccCCCCccceeeeecc-ccccchhheecccc-------------------------------ccccccccc
Confidence 4778999999999999999999854 67889999999543 122335666
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCCCH--------HHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDW--------LARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~--------~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++... +||||+++++.+..+. .++++++.+.++..++- ..+..++.+++.|+.|||++| ++|||+|
T Consensus 368 ~~~~~~~h~niv~~~~v~~~~~--~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLk 442 (612)
T KOG0603|consen 368 ISLLVRDHPNIVKSHDVYEDGK--EIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLK 442 (612)
T ss_pred hhhhhcCCCcceeecceecCCc--eeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCC
Confidence 65555 8999999999887665 79999999998765321 244469999999999999999 9999999
Q ss_pred CCCeee-cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLL-DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+|||+ +..++++|+|||.++..... ..+.+-|..|.|||++...+++.++|+| +|++||+|++|..||...-
T Consensus 443 p~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P 517 (612)
T KOG0603|consen 443 PGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP 517 (612)
T ss_pred hhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence 999999 58889999999999876554 2234568899999999999999999999 9999999999999964322
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++.++.+.+...... ........+|+.+||+.||.+||++.++..
T Consensus 518 ---~~~ei~~~i~~~~~s----------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 518 ---AGIEIHTRIQMPKFS----------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---chHHHHHhhcCCccc----------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 223333333222111 122234678888999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=265.19 Aligned_cols=141 Identities=23% Similarity=0.378 Sum_probs=119.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|.+++.||+|+||.||+|++. .+++.||||.+...... .......+..|+.+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~------------------------~~~~~~~~~~E~~~ 57 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMI------------------------NKNMVHQVQAERDA 57 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhcc------------------------CHHHHHHHHHHHHH
Confidence 468999999999999999999864 57899999998542211 02235667889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+..++||||+++++.+...+ .++++++|+.++.+. +......++.|++.||.|||..+ |+||||||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~--~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP 132 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSAN--NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKP 132 (669)
T ss_pred HHhcCCCCcCeEEEEEEECC--EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccH
Confidence 99999999999998887766 789999999887653 44456789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccce
Q 046907 198 VNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~ 217 (345)
+|||++.++.++|+|||+++
T Consensus 133 ~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 133 DNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=255.48 Aligned_cols=244 Identities=21% Similarity=0.320 Sum_probs=192.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+-|++.++||.|.+|.||+++.+ .++...|+|+...... .-.+++.|.+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~~d----------------------------~deEiE~eyn 67 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPTED----------------------------EEEEIELEYN 67 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCCcc----------------------------ccHHHHHHHH
Confidence 4568999999999999999999854 6889999999865322 2445677899
Q ss_pred HHhhc-cCCCccceeEEEec---CCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 126 TVGQI-RHRNLHPLLAHVTR---PDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~---~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|+.. +|||++.+|+++.- .+...+|+|||||.+|+. +.+..+..|+..++.|+.|||... +
T Consensus 68 il~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---v 144 (953)
T KOG0587|consen 68 MLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---V 144 (953)
T ss_pred HHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---e
Confidence 99887 79999999998853 234579999999998754 566667789999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-----ccCccchhh-HHHHHHHHH
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-----TLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-----~~~~~~Dvw-lG~vl~el~ 264 (345)
+|||+|-.|||++.++.+|++|||++..+.... ...++.+||+.|||||++.-. .|+..+|+| +|++..||.
T Consensus 145 iHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEla 222 (953)
T KOG0587|consen 145 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMA 222 (953)
T ss_pred eeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhc
Confidence 999999999999999999999999998875532 245678999999999999532 367799999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
-|.+|+.++-+. ..+..+.+.++| + ...+..-.+++.++|..||..|.++||++.++++
T Consensus 223 dG~PPl~DmHPm-------raLF~IpRNPPP------k--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 223 EGAPPLCDMHPM-------RALFLIPRNPPP------K--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCccCcchh-------hhhccCCCCCCc------c--ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 999997554331 122222211111 1 1234455667888999999999999999998874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=259.06 Aligned_cols=252 Identities=19% Similarity=0.205 Sum_probs=153.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCC----CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQN----GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|++.+.||+|+||.||+|++. .+ +..||+|.+....... ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~-~~~~~~~~~vAvK~~~~~~~~e-----------------------------~~~ 179 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLV-NKQSKKEGKYVLKKATEYGAVE-----------------------------IWM 179 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEc-CCccccCcEEEEEEecccchhH-----------------------------HHH
Confidence 6789999999999999999999965 45 7899999875321100 000
Q ss_pred HHHHHHhhccCCCccceeEE----EecCCcceeeeeccccCCCCCCCHH-----------------------------HH
Q 046907 122 SEINTVGQIRHRNLHPLLAH----VTRPDCHLLYILNDVSQGRRELDWL-----------------------------AR 168 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~----~~~~~~~~l~~~~~~~~~~~~l~~~-----------------------------~~ 168 (345)
.+ .++...+.++..+... ........++++++|+.++.+.++. .+
T Consensus 180 ~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i 257 (566)
T PLN03225 180 NE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKII 257 (566)
T ss_pred HH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHH
Confidence 00 0111111111111111 1112233567777777765442221 23
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCccccccccccccc
Q 046907 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT 247 (345)
Q Consensus 169 ~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~ 247 (345)
..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++........ ......+++.|+|||.+....
T Consensus 258 ~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 258 QTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccC
Confidence 468999999999999998 999999999999985 679999999999765432221 224568899999999764322
Q ss_pred ----------------------cCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhh-cCCCccccccc
Q 046907 248 ----------------------LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMAS-ENPKRAIDSKL 303 (345)
Q Consensus 248 ----------------------~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 303 (345)
++.++||| +||++|||+++..|++. ....+...+...... ..+.....++.
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~ 408 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRA 408 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhcccc
Confidence 23456999 99999999987776432 111111111110000 00000000000
Q ss_pred cCC------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 304 VGN------GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 304 ~~~------~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+ ..........+|+..||+.||++|||+.++++
T Consensus 409 ~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 409 SPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred chhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 000 00001123457999999999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=230.41 Aligned_cols=210 Identities=21% Similarity=0.199 Sum_probs=159.7
Q ss_pred CcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCccce
Q 046907 59 GGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPL 138 (345)
Q Consensus 59 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 138 (345)
|.+|.||+++. ..+++.||+|.+.... .+.+|...+....||||+++
T Consensus 4 g~~~~v~~~~~-~~~~~~~~~K~i~~~~--------------------------------~~~~~~~~~~~~~~~~i~~~ 50 (237)
T cd05576 4 GVIDKVLLVMD-TRTQQTFILKGLRKSS--------------------------------EYSRERLTIIPHCVPNMVCL 50 (237)
T ss_pred cccceEEEEEE-ccCCcEEEEEeecchh--------------------------------hhhhHHHHHHhcCCCceeeh
Confidence 89999999985 4689999999985321 12234444445579999999
Q ss_pred eEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeE
Q 046907 139 LAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR 209 (345)
Q Consensus 139 ~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~k 209 (345)
++++...+ ..++++|+++++.+ +++.....++.|+++||.|||+.+ ++|||+||+||+++.++.++
T Consensus 51 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 125 (237)
T cd05576 51 HKYIVSED--SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQ 125 (237)
T ss_pred hhheecCC--eEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 99888765 68999999988765 455566789999999999999998 99999999999999999999
Q ss_pred EeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHH
Q 046907 210 ISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRN 288 (345)
Q Consensus 210 l~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 288 (345)
++|||.+...... .....++..|+|||.+.+..++.++|+| +|+++|||++|..|+...... +
T Consensus 126 l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~-- 189 (237)
T cd05576 126 LTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------I-- 189 (237)
T ss_pred Eecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------c--
Confidence 9999987654332 1234557789999999888889999999 999999999999885321100 0
Q ss_pred HhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 289 VMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
. .. . ... .++.....+.+++.+||+.||++||++
T Consensus 190 -~-~~-~----~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 190 -N-TH-T----TLN----IPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -c-cc-c----ccC----CcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 0 00 0 000 111122347788999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=220.04 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=190.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+++|+|.|++||.|. +..+.+.+.||++++ -+.+.+.+|+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~-~~~~~eK~ViKiLKP------------------------------VkkkKIkREik 84 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGI-NITNNEKCVIKILKP------------------------------VKKKKIKREIK 84 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccc-ccCCCceEEEeeech------------------------------HHHHHHHHHHH
Confidence 67899999999999999999997 446788899999963 33566789999
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCCCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRR------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
||+.|. ||||+++++...++......+++|+..+.. .++..++..++.++++||.|||++| |.|||+||.
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPh 161 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPH 161 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcc
Confidence 999996 999999999999998888889999987743 3455567789999999999999999 999999999
Q ss_pred CeeecC-CCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 199 NVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 199 nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+++|. .-.++++|+|+|...-... ..+-.+.+..|-.||.+.... |+.+-|+| |||++..|+..+-|| +.+
T Consensus 162 NvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF--FhG 236 (338)
T KOG0668|consen 162 NVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF--FHG 236 (338)
T ss_pred eeeechhhceeeeeecchHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc--cCC
Confidence 999995 4579999999997654332 223356688889999997655 88899999 999999999999996 234
Q ss_pred ccchhhHHHHHHHHhhhcCCCc-------ccccc---------------ccCCCcHH-HHHHHHHHHhhccCCCCCCCCC
Q 046907 276 HTNEMSFVKWMRNVMASENPKR-------AIDSK---------------LVGNGCEE-QMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---------------~~~~~~~~-~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
..+..+++... +.++...... .++++ ........ ...+.++++...|..|-.+|+|
T Consensus 237 ~dN~DQLVkIa-kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 237 HDNYDQLVKIA-KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred CCCHHHHHHHH-HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 44444544433 3332221110 01111 00000001 1134667777889999999999
Q ss_pred HHHHHH
Q 046907 333 SKDVRR 338 (345)
Q Consensus 333 ~~~ll~ 338 (345)
+.|...
T Consensus 316 akEam~ 321 (338)
T KOG0668|consen 316 AKEAMA 321 (338)
T ss_pred hHHHhc
Confidence 998753
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=245.68 Aligned_cols=241 Identities=24% Similarity=0.434 Sum_probs=183.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.+-|..++.||=|+||+|.+++ +..+...||.|.+... +.+..........|-.
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~-KvDT~~lYAmKTLrKa------------------------DVl~rnQvaHVKAERD 681 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVR-KVDTRALYAMKTLRKA------------------------DVLMRNQVAHVKAERD 681 (1034)
T ss_pred cccceEEEeeecccccceeEEEe-ecchhhHHHHhhhHHH------------------------HHHhhhhhhhhhhhhh
Confidence 56677888999999999999997 5567889999998531 2222344666778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHHH---------HHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH---------RIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~---------~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
||..-+.+.||+||-.|.+.+ .+|+||+|++||+.++.+.+. -+...+..|+++.|..| +||||||
T Consensus 682 ILAEADn~WVVrLyySFQDkd--nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiK 756 (1034)
T KOG0608|consen 682 ILAEADNEWVVRLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIK 756 (1034)
T ss_pred hHhhcCCcceEEEEEEeccCC--ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccC
Confidence 999999999999999888877 799999999999887666443 46678899999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCC----------------------------------------cceeccCcccCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAH----------------------------------------THITTSNVVGTVE 236 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~----------------------------------------~~~~~~~~~gt~~ 236 (345)
|+|||||.+|.+||+|||++.-+...+ ..+.....+||+.
T Consensus 757 PDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~n 836 (1034)
T KOG0608|consen 757 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPN 836 (1034)
T ss_pred ccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCc
Confidence 999999999999999999987543110 0011124689999
Q ss_pred ccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHH
Q 046907 237 YIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLV 315 (345)
Q Consensus 237 ~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 315 (345)
|+|||++....++..+|+| .|++||||+.|..||..-........+.+|- ..++-........++...+
T Consensus 837 yiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~----------~~l~~~~~~~ls~e~~~li 906 (1034)
T KOG0608|consen 837 YIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR----------NFLHIPYQGNLSKEALDLI 906 (1034)
T ss_pred ccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh----------hccccccccccCHHHHHHH
Confidence 9999999999999999999 9999999999999986544433322232222 1222222334456666666
Q ss_pred HHHHhhccCCCCCCCC
Q 046907 316 LKIACFCTLEDPNERP 331 (345)
Q Consensus 316 ~~li~~Cl~~dp~~Rp 331 (345)
.+| |. ++++|.
T Consensus 907 ~kL---c~--sad~RL 917 (1034)
T KOG0608|consen 907 QKL---CC--SADSRL 917 (1034)
T ss_pred HHH---hc--Chhhhh
Confidence 666 54 556665
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=237.52 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=184.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|-+++.||+|+|++||+|-. -...+.||||+-.-+. ++-.+|+ ....+...+|.+|-
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFD-l~EqRYvAvKIHqlNK----------~WrdEKK----------eNYhKHAcREyrIH 521 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFD-LTEQRYVAVKIHQLNK----------NWRDEKK----------ENYHKHACREYRIH 521 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcc-cchhheeeEeeehhcc----------chhhHhh----------hhHHHHHHHHHhhh
Confidence 4678899999999999999973 3567889999874332 2222222 22366778999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.|+||.||++|+++.-+. ...+.|.|||+|..+ ++.....+|..||+.||.||.+.. ++|+|-||||.
T Consensus 522 KeLDHpRIVKlYDyfslDt-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPg 599 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDT-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPG 599 (775)
T ss_pred hccCcceeeeeeeeeeecc-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCc
Confidence 9999999999999998766 367888899988654 566677789999999999999987 67999999999
Q ss_pred Ceeec---CCCCeEEeccccceecCCCCcc-----eeccCcccCcccccccccccc----ccCccchhh-HHHHHHHHHh
Q 046907 199 NVLLD---DDIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQML----TLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 199 nil~~---~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~----~~~~~~Dvw-lG~vl~el~t 265 (345)
|||+- ..|.+||+|||+++.+.+.... ..+....||.+|++||.+.-. .++.+.||| .|+++|.++.
T Consensus 600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 99984 4678999999999988653322 234668899999999988533 368899999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
|+.||..--....-.+.-..+......-++.+.+. . ....+|..||++.-++|.+.-++
T Consensus 680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVs---------s---eAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDILQENTILKATEVQFPPKPVVS---------S---EAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred cCCCCCCchhHHHHHhhhchhcceeccCCCCCccC---------H---HHHHHHHHHHHhhhhhhhhHHHH
Confidence 99996431111111111111111111111111111 1 25577888999999999877665
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=243.07 Aligned_cols=238 Identities=23% Similarity=0.297 Sum_probs=186.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++++.+..||-|+||.|-+++.+. ....+|+|.++. .+...++.-+.+..|-+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~-~~~~fAlKilkK------------------------~hIVdtkQqeHv~sEr~ 472 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNS-QKATFALKILKK------------------------KHIVDTKQQEHVFSERN 472 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecc-cchHHHHHHHhH------------------------hhccchhHHHHHHhHHH
Confidence 45688899999999999999998753 233688888842 11222445667788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH---------HHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA---------RHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~---------~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+|...+.|.||++|..|.++. ++|+++|-|-||.+.+.+. ..-++.-+.+|++|||.++ |+.||||
T Consensus 473 Im~~~~s~fIvrLYrTfrd~k--yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLK 547 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSK--YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLK 547 (732)
T ss_pred HHHhcCchHHHHHHHHhccch--hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCC
Confidence 999999999999999888766 7999999999987754443 3347778999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|++++.+|.+|+.|||.|+.++... .+.+++||+.|.|||.+.....+.++|.| +|+++|||++|.+||....+
T Consensus 548 PENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 548 PENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred hhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 999999999999999999999886653 56789999999999999999999999999 99999999999999665444
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
+ ..-+.|.++...-.. +........+||...+..+|.+|..
T Consensus 625 m----ktYn~ILkGid~i~~------------Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 625 M----KTYNLILKGIDKIEF------------PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred H----HHHHHHHhhhhhhhc------------ccccchhHHHHHHHHHhcCcHhhhc
Confidence 3 333333333321111 1112223566777778889999974
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=246.43 Aligned_cols=197 Identities=27% Similarity=0.395 Sum_probs=165.1
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+..+|..+..+|.|+||.|++|.++ .+...|.||++++ .+.+.......++.-.+..|+
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K-~n~~eVViK~I~K-------------------eRIL~DtWvrDrkLGtVp~EI 617 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHK-ENNYEVVIKMIFK-------------------ERILVDTWVRDRKLGTVPSEI 617 (772)
T ss_pred cccccceeeeeccccccceEEEeeec-ccceEEEeeehhh-------------------hhhhhhhhhcccccCccchhH
Confidence 36678999999999999999999986 4588999999953 233333344455677788899
Q ss_pred HHHhhcc---CCCccceeEEEecCCcceeeeecccc----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 125 NTVGQIR---HRNLHPLLAHVTRPDCHLLYILNDVS----------QGRRELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 125 ~~l~~l~---hpniv~l~~~~~~~~~~~l~~~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+||..++ |+||++++++|++++ ++|+.++.. +-...+++.....|+.|++.|+.|||+.+ |+
T Consensus 618 qIla~l~~~sH~NIlKlLdfFEddd--~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---iv 692 (772)
T KOG1152|consen 618 QILATLNKHSHENILKLLDFFEDDD--YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IV 692 (772)
T ss_pred HHHHHhhhcCccchhhhhheeecCC--eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ce
Confidence 9999997 999999999999888 566655544 33344566677789999999999999999 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|||||-+|+.++.+|-+|++|||.+...++. +...++||..|.|||++.|.+| +...||| +|++||.++..+.|
T Consensus 693 hrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 693 HRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred ecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 9999999999999999999999999877654 3456899999999999999986 6789999 99999999999999
Q ss_pred C
Q 046907 270 S 270 (345)
Q Consensus 270 ~ 270 (345)
|
T Consensus 769 y 769 (772)
T KOG1152|consen 769 Y 769 (772)
T ss_pred C
Confidence 5
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=223.76 Aligned_cols=247 Identities=21% Similarity=0.256 Sum_probs=182.9
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|-....+|.++.+||+|+|+.|..+++. ++...+|+|+++...... .++..-...
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nd------------------------dedidwvqt 299 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVND------------------------DEDIDWVQT 299 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCC------------------------cccchhHHh
Confidence 3345568999999999999999999965 688999999985322111 122333445
Q ss_pred HHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|-.++..- +||.+|.++..|.++. -++++-||..||.+ ++.....-+...|+-||.|||++| |+.
T Consensus 300 ek~vfe~asn~pflvglhscfqtes--rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiy 374 (593)
T KOG0695|consen 300 EKHVFEQASNNPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIY 374 (593)
T ss_pred hHHHHHhccCCCeEEehhhhhcccc--eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eee
Confidence 55666554 8999999999888776 57788888888765 555556668889999999999999 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||||.+|+|+|..|.+|++|+|+++.--. ....+++++||+.|.|||.+++..|+...|+| +|++++||+.|+.||+
T Consensus 375 rdlkldnvlldaeghikltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 375 RDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred eeccccceEEccCCceeecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 99999999999999999999999875322 23356789999999999999999999999999 9999999999999997
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
---....+++...++....-..... -|+ ........++..-+..||.+|.
T Consensus 453 ivgm~n~d~ntedylfqvilekqir---ipr-------slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 453 IVGMDNPDMNTEDYLFQVILEKQIR---IPR-------SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eecCCCcccchhHHHHHHHhhhccc---ccc-------eeehhhHHHHHHhhcCCcHHhc
Confidence 5443334444444444333211110 000 1111234555667788998885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=210.01 Aligned_cols=196 Identities=21% Similarity=0.378 Sum_probs=158.3
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|....+++.-+..||+|+||.|-+-++. .+|...|+|.+...-. .+...+.++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn--------------------------~q~q~r~L~ 93 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVN--------------------------SQEQKRLLM 93 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeec-cCCeEEEEeeehhhcC--------------------------hHHHHHHHH
Confidence 5667777888999999999998877754 5899999999953211 344667788
Q ss_pred HHHHHhhc-cCCCccceeEEEecCCcceeeeeccccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 123 EINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQ------------GRRELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 123 E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
|+.+..+. .+|.+|.+||.....+. +++.||.+. .|...++.-.-+|+..+..||.|||++- .
T Consensus 94 dldi~~r~~~CPf~V~FyGa~~regd--vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~ 169 (282)
T KOG0984|consen 94 DLDIIMRTVDCPFTVHFYGALFREGD--VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--S 169 (282)
T ss_pred hhhhhccCCCCCeEEEeehhhhcccc--EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--h
Confidence 99887665 89999999997776663 566556553 3556677777799999999999999997 6
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc----ccCccchhh-HHHHHHHHH
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML----TLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~----~~~~~~Dvw-lG~vl~el~ 264 (345)
++|||+||+|||++.+|++|+||||.+-.+.++-.. +.-.|.-.|||||.+..+ .|+-++||| +|+++.||.
T Consensus 170 vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA 246 (282)
T KOG0984|consen 170 VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA 246 (282)
T ss_pred hhhccCCcceEEEccCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence 999999999999999999999999999877654321 224678899999998543 578899999 999999999
Q ss_pred hCCCCCcc
Q 046907 265 MGKLPSDK 272 (345)
Q Consensus 265 tg~~p~~~ 272 (345)
++++||+.
T Consensus 247 ~lr~PY~~ 254 (282)
T KOG0984|consen 247 ILRFPYES 254 (282)
T ss_pred hccccccc
Confidence 99999753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=250.04 Aligned_cols=231 Identities=24% Similarity=0.366 Sum_probs=170.8
Q ss_pred ccccccCcce-eeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-
Q 046907 53 LEKIGSGGCG-EVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI- 130 (345)
Q Consensus 53 ~~~iG~G~~g-~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 130 (345)
-+.+|.|+-| .||+|.+ .|+.||||++.. .....+.+|+..|+.-
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~------------------------------e~~~~A~rEi~lL~eSD 560 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY---EGREVAVKRLLE------------------------------EFFDFAQREIQLLQESD 560 (903)
T ss_pred HHHcccCCCCcEEEEEee---CCceehHHHHhh------------------------------HhHHHHHHHHHHHHhcc
Confidence 4678999998 5899998 688999999842 3355677899999988
Q ss_pred cCCCccceeEEEecCCcceeeeeccccC--------CC-C---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 131 RHRNLHPLLAHVTRPDCHLLYILNDVSQ--------GR-R---ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 131 ~hpniv~l~~~~~~~~~~~l~~~~~~~~--------~~-~---~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+|||||++|+.-.+. .++|+.-|.|. .. . .........+..|+++||.|||+.+ |+||||||.
T Consensus 561 ~H~NviRyyc~E~d~--qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQ 635 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDR--QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQ 635 (903)
T ss_pred CCCceEEEEeeccCC--ceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCc
Confidence 799999998765544 47777555543 21 0 1111344678899999999999998 999999999
Q ss_pred CeeecC---C--CCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC-CCCC
Q 046907 199 NVLLDD---D--IEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG-KLPS 270 (345)
Q Consensus 199 nil~~~---~--~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg-~~p~ 270 (345)
||||+. + ..++|+|||+++.+...... ....+..||-+|+|||.+....-+.++||+ +||++|+.++| ..||
T Consensus 636 NILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpF 715 (903)
T KOG1027|consen 636 NILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPF 715 (903)
T ss_pred eEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCC
Confidence 999975 2 47899999999988554332 234668899999999999998888899999 99999999985 9997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.... ..+++........ +. ...++ ...+||.+++.++|..||+|.+|+.
T Consensus 716 Gd~~~R--~~NIl~~~~~L~~-----------L~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 716 GDSLER--QANILTGNYTLVH-----------LE--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred CchHHh--hhhhhcCccceee-----------ec--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 653321 1111111111110 00 00111 5778999999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=220.25 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=187.7
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+.+.-+-||-|+||+||-++.. .+|+.||+|.+.+.... -...+++.+|+..|.
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~-------------------------L~s~krvFre~kmLc 107 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQN-------------------------LASCKRVFREIKMLS 107 (449)
T ss_pred cCCCCCcccccceeEEEeccCC-CCccchhHhhcchHHHH-------------------------HHHHHHHHHHHHHHH
Confidence 5566789999999999999864 58999999998543211 234778899999999
Q ss_pred hccCCCccceeEEEecCCcce---eeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHL---LYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~---l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
-++|.|++..+++...++..+ +|+++|++.+ ...++...+.-+.+||+.||.|||+.+ |+||||||
T Consensus 108 fFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKP 184 (449)
T KOG0664|consen 108 SFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKP 184 (449)
T ss_pred hhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCC
Confidence 999999999999877665322 4667776654 334555666778999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
.|+|++.+..+||||||+++....... ...+..+-|-+|.|||.+.|.. |+.+.||| .||++.|++.++.. |+
T Consensus 185 GNLLVNSNCvLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL----FQ 259 (449)
T KOG0664|consen 185 GNLLVNSNCILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL----FQ 259 (449)
T ss_pred ccEEeccCceEEecccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh----hh
Confidence 999999999999999999987644322 2234456688999999999876 89999999 99999999988877 44
Q ss_pred ccchhhHHHHHHHHhhhcCCCcc---------------cc----ccccCCCc-HHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRA---------------ID----SKLVGNGC-EEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~----~~~~~~~~-~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
..+..+.++.+...++.+....+ .. +.+..-.. ...-.....+.+.++..||++|.+..+
T Consensus 260 Aq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~ 339 (449)
T KOG0664|consen 260 AAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEE 339 (449)
T ss_pred ccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhh
Confidence 45555666666655544432211 00 01110000 011122344555688999999999887
Q ss_pred HHHH
Q 046907 336 VRRM 339 (345)
Q Consensus 336 ll~~ 339 (345)
.+..
T Consensus 340 A~~~ 343 (449)
T KOG0664|consen 340 ALQH 343 (449)
T ss_pred hccc
Confidence 7653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=214.71 Aligned_cols=230 Identities=27% Similarity=0.395 Sum_probs=176.5
Q ss_pred cceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCcccee
Q 046907 60 GCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLL 139 (345)
Q Consensus 60 ~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 139 (345)
+||.||+|++. .+|+.+|+|.+....... ....+.+|+..+++++|+|+++++
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~--------------------------~~~~~~~e~~~~~~l~~~~i~~~~ 53 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKK--------------------------KRERILREISILKKLKHPNIVRLY 53 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEeccccccc--------------------------HHHHHHHHHHHHHhCCCCcHHHHH
Confidence 58999999975 468999999986532210 046778899999999999999999
Q ss_pred EEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 046907 140 AHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210 (345)
Q Consensus 140 ~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl 210 (345)
+.+.... ..++++++..++.+ ++......++.+++.++.+||+.+ ++|+|++|+||+++.++.+++
T Consensus 54 ~~~~~~~--~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l 128 (244)
T smart00220 54 DVFEDED--KLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKL 128 (244)
T ss_pred hheeeCC--EEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEE
Confidence 9888764 67888888877543 455667789999999999999998 999999999999999999999
Q ss_pred eccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHH
Q 046907 211 SGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289 (345)
Q Consensus 211 ~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 289 (345)
+|||.+....... ......++..|++||...+..++.++|+| +|++++++++|..||... .........+...
T Consensus 129 ~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~---~~~~~~~~~~~~~ 202 (244)
T smart00220 129 ADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKP 202 (244)
T ss_pred ccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CcHHHHHHHHhcc
Confidence 9999998765432 22345678899999999888889999999 999999999999996432 2222222222211
Q ss_pred hhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...... ........+.+++.+||..+|++||++.++++
T Consensus 203 ~~~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 203 KPPFPP-----------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCcc-----------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 111000 00002345788999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=229.82 Aligned_cols=267 Identities=18% Similarity=0.182 Sum_probs=165.8
Q ss_pred hcCCcccccccccCcceeeEEEEec---------------CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELP---------------GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 110 (345)
..++|.+.++||+|+||.||+|.+. ...++.||||.+..........+. ...
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl-------------~e~ 209 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFL-------------KTG 209 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHH-------------hhh
Confidence 6789999999999999999999641 123567999998643211110000 000
Q ss_pred HHHHHHHHHHHHHHHHHhhccCCCc-----cceeEEEecC------CcceeeeeccccCCCCCC----------------
Q 046907 111 MLLNKKMRQIQSEINTVGQIRHRNL-----HPLLAHVTRP------DCHLLYILNDVSQGRREL---------------- 163 (345)
Q Consensus 111 ~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~~~~~~~------~~~~l~~~~~~~~~~~~l---------------- 163 (345)
............|+..+.+++|.++ +++++++... .....+++++|++++++.
T Consensus 210 ~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e 289 (507)
T PLN03224 210 TLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEE 289 (507)
T ss_pred hhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHH
Confidence 0001123345567777777766554 6677766542 112468888888775432
Q ss_pred -----------------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcce
Q 046907 164 -----------------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI 226 (345)
Q Consensus 164 -----------------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (345)
++..+..++.|++.||.|+|+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 290 ~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~ 365 (507)
T PLN03224 290 FMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-F 365 (507)
T ss_pred HHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-c
Confidence 23345568999999999999998 99999999999999999999999999975533211 1
Q ss_pred eccCcccCccccccccccccc--------------------c--Cccchhh-HHHHHHHHHhCCC-CCcccccccchhh-
Q 046907 227 TTSNVVGTVEYIAPEYLQMLT--------------------L--TEKCDIY-FGALLAGLVMGKL-PSDKFFQHTNEMS- 281 (345)
Q Consensus 227 ~~~~~~gt~~~~aPE~~~~~~--------------------~--~~~~Dvw-lG~vl~el~tg~~-p~~~~~~~~~~~~- 281 (345)
......+++.|+|||.+.... + ..+.|+| +|+++|+|+++.. |+.....-..+..
T Consensus 366 ~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~ 445 (507)
T PLN03224 366 NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ 445 (507)
T ss_pred CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh
Confidence 111234478999999885432 1 1246999 9999999999875 6532111000000
Q ss_pred ---HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 046907 282 ---FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP---NERPNSKDVRR 338 (345)
Q Consensus 282 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp---~~Rpt~~~ll~ 338 (345)
.....+... ... .+.. ..........+++..++..+| .+|+|+.++++
T Consensus 446 ~~~~~~~~r~~~-~~~----~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 446 YDNDLNRWRMYK-GQK----YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccchHHHHHhhc-ccC----CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000001000 000 0000 011122345677777887655 78999999875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=225.94 Aligned_cols=249 Identities=17% Similarity=0.207 Sum_probs=187.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|.+....|+|-||.|.+|... ..|..||||++.++.. ....-+.|+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE~----------------------------M~KtGl~Elei 481 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNEV----------------------------MHKTGLKELEI 481 (752)
T ss_pred cceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecchH----------------------------HhhhhhHHHHH
Confidence 458888999999999999999854 5678999999987532 35556789999
Q ss_pred Hhhcc------CCCccceeEEEecCCcceeeeeccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 127 VGQIR------HRNLHPLLAHVTRPDCHLLYILNDVSQG-----------RRELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 127 l~~l~------hpniv~l~~~~~~~~~~~l~~~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
|++|+ --++++++..|...+ ++|+|+|.+.. .-.|....+..++.|+.-||.+|-..+
T Consensus 482 LkKL~~AD~Edk~Hclrl~r~F~hkn--HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--- 556 (752)
T KOG0670|consen 482 LKKLNDADPEDKFHCLRLFRHFKHKN--HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--- 556 (752)
T ss_pred HHHhhccCchhhhHHHHHHHHhhhcc--eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---
Confidence 99984 226888888887777 68887776642 122555667789999999999999998
Q ss_pred eEecCCCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 190 IIHRDLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 190 iiH~dlk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|+|.||||+|||++. ...+||||||.|...+.... +.+.-+.+|.|||.+.|.+|+...|+| .||+||||.||+
T Consensus 557 vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGk 632 (752)
T KOG0670|consen 557 VLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGK 632 (752)
T ss_pred eeecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccc
Confidence 999999999999995 45789999999987765432 224457889999999999999999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCcc------------------------------------ccc------cc--
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRA------------------------------------IDS------KL-- 303 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~------~~-- 303 (345)
..|++..+ .+.+.+.....+ ..|..+ +.| .+
T Consensus 633 IlFpG~TN----N~MLrl~me~KG-k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~ 707 (752)
T KOG0670|consen 633 ILFPGRTN----NQMLRLFMELKG-KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA 707 (752)
T ss_pred eecCCCCc----HHHHHHHHHhcC-CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc
Confidence 99765433 222222211111 111000 001 01
Q ss_pred ---cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 304 ---VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 304 ---~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.++..+....++.+|+..|+..||++|.|..++++
T Consensus 708 ~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 708 VQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred cCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 12334566788999999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=234.50 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=189.8
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|+++..+|.|+||.||+++. ..+++..|+|+++-...+ +.+...+|+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd-~~s~elaavkvVkLep~d---------------------------d~~~iqqei 63 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARD-KRSGELAAVKVVKLEPGD---------------------------DFSGIQQEI 63 (829)
T ss_pred CCccchhheeeecCCcccchhhhcc-cccCchhhheeeeccCCc---------------------------cccccccce
Confidence 4677999999999999999999994 468999999999766544 356667899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
-+++..+|||||.+++.+...+ -+++.||||++|++ +++.++...+....+|+.|||+.+ -+|||+
T Consensus 64 ~~~~dc~h~nivay~gsylr~d--klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdi 138 (829)
T KOG0576|consen 64 GMLRDCRHPNIVAYFGSYLRRD--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDI 138 (829)
T ss_pred eeeecCCCcChHHHHhhhhhhc--CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccc
Confidence 9999999999999999887666 58999999999875 667788889999999999999999 899999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccc---cccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL---QMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~---~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|-.||+++..+.+|++|||.+..++..-. ....+.||++|||||+. +...|+..+|+| .|+...|+-.-.+|-
T Consensus 139 KGanilltd~gDvklaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl- 215 (829)
T KOG0576|consen 139 KGANILLTDEGDVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL- 215 (829)
T ss_pred cccceeecccCceeecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc-
Confidence 99999999999999999999987654322 33568999999999988 345688999999 999999998888872
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|.. -.+.....+.+-. ..+...-| .....+. +-+++..|+..+|++||+++-+++
T Consensus 216 --fdl-hpmr~l~LmTkS~--~qpp~lkD----k~kws~~---fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 216 --FDL-HPMRALFLMTKSG--FQPPTLKD----KTKWSEF---FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --ccc-chHHHHHHhhccC--CCCCcccC----CccchHH---HHHHHHHHhcCCCccCCChhhhee
Confidence 221 1112222222111 11111111 1122333 455666699999999999987664
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=209.99 Aligned_cols=126 Identities=29% Similarity=0.403 Sum_probs=103.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|-+.++||=|-|++||+|. +..+.+-||+|+.++. ....+..+-||+
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLaw-Dtq~~r~VAlKVvKSA----------------------------qhYtEaAlDEIk 126 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAW-DTQNKRYVALKVVKSA----------------------------QHYTEAALDEIK 126 (590)
T ss_pred cCceEEEEEeccccccceeEEEe-eccCCeEEEEEEEehh----------------------------hHHHHHHHHHHH
Confidence 55789999999999999999995 5567889999999642 223556677999
Q ss_pred HHhhcc-----CC---CccceeEEEe--cCCcceeeeeccccCC----------CCCCCHHHHHHHHHHHHHHHHHHhhc
Q 046907 126 TVGQIR-----HR---NLHPLLAHVT--RPDCHLLYILNDVSQG----------RRELDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 126 ~l~~l~-----hp---niv~l~~~~~--~~~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
+|+.++ |+ .||+|++.|. .+++.++++|.|++.. -..++...+..|+.|++.||.|||..
T Consensus 127 lL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e 206 (590)
T KOG1290|consen 127 LLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE 206 (590)
T ss_pred HHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh
Confidence 998872 33 5999999885 4677899999999853 22356667789999999999999999
Q ss_pred CCCCeEecCCCCCCeee
Q 046907 186 HCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~ 202 (345)
+ .|||-||||+|||+
T Consensus 207 c--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 207 C--GIIHTDLKPENVLL 221 (590)
T ss_pred c--CccccCCCcceeee
Confidence 7 79999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=204.22 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=184.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
..+|.-+..+|.|+- .|-.+- +.-.+..||+|.+..+... ....++..+|..+
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~-D~v~~~~v~ikk~~~pf~n-------------------------~~~akra~rel~l 68 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAF-DQVLGRPVAIKKLSRPFQN-------------------------QTHAKRAYRELKL 68 (369)
T ss_pred eeeeeeecccCCCCc-eEEecc-hhhccCceehhhhcCcccc-------------------------Cccchhhhhhhhh
Confidence 457888899999988 555554 3346889999988655322 2336677889999
Q ss_pred HhhccCCCccceeEEEecCC----cceeeeeccccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGR------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+..++|+||++++.++.-.. ..-+|+++|++... ..++.....+++.|++.|+.|||+.+ |+|||||
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLk 145 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLK 145 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccC
Confidence 99999999999999886543 12357888888652 23566677899999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||++..++.+||.|||+|+..... -..+.++.|..|.|||++-+-.+.+.+||| .||++.||++|...|.+...
T Consensus 146 Psnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~ 222 (369)
T KOG0665|consen 146 PSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH 222 (369)
T ss_pred cccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH
Confidence 99999999999999999999865433 234557889999999999998899999999 99999999999988653211
Q ss_pred -----------ccchhhHHHHHHHHhh---hcCCC-------ccc-ccc--ccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 276 -----------HTNEMSFVKWMRNVMA---SENPK-------RAI-DSK--LVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 276 -----------~~~~~~~~~~~~~~~~---~~~~~-------~~~-~~~--~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
+..+..+...+....+ ...+. ..+ |.- ...+..+-......+++.++|-.||++|.
T Consensus 223 idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri 302 (369)
T KOG0665|consen 223 IDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI 302 (369)
T ss_pred HHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc
Confidence 1111111111111000 00000 000 000 00111222344577888889999999999
Q ss_pred CHHHHHH
Q 046907 332 NSKDVRR 338 (345)
Q Consensus 332 t~~~ll~ 338 (345)
++.++++
T Consensus 303 sv~daL~ 309 (369)
T KOG0665|consen 303 SVDDALR 309 (369)
T ss_pred cHHHHhc
Confidence 9999885
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=198.05 Aligned_cols=244 Identities=18% Similarity=0.270 Sum_probs=175.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.+.|.+.+.+|+|.||.+-+|+++ .+...+++|.+..+. ...+.|.+|..
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p~----------------------------tt~~dF~rEfh 72 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRPQ----------------------------TTQADFVREFH 72 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcch----------------------------hhHHHHHHHhc
Confidence 4568999999999999999999987 467788899985432 33677888888
Q ss_pred HHhhc-cCCCccceeE-EEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLA-HVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~-~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.--.| .|.||+.-|+ .|.+.+ .+++++|+++.|++ +.+....+++.|+++|+.|+|+.. ++||||
T Consensus 73 Y~~~Ls~H~hIi~tY~vaFqt~d--~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdl 147 (378)
T KOG1345|consen 73 YSFFLSPHQHIIDTYEVAFQTSD--AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDL 147 (378)
T ss_pred cceeeccchhhhHHHHHHhhcCc--eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhccc
Confidence 76666 6999999887 455555 78889999988765 456667899999999999999998 999999
Q ss_pred CCCCeeec--CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-----cCccchhh-HHHHHHHHHhCC
Q 046907 196 NPVNVLLD--DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-----LTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 196 k~~nil~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-----~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|.+|||+- ..-.+|+||||.++..+... ....-+..|.+||.+...+ ..+.+|+| ||++++.++||.
T Consensus 148 K~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~ 222 (378)
T KOG1345|consen 148 KAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGK 222 (378)
T ss_pred ccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCC
Confidence 99999995 33489999999987654322 1123356788999875432 35789999 999999999999
Q ss_pred CCCcccc-cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 268 LPSDKFF-QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 268 ~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
+||.... ....+.++.+|...... .-|+......+. ++.+...-+..+|++|-...++...
T Consensus 223 ~PWQka~~~d~~Y~~~~~w~~rk~~-------~~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 223 FPWQKASIMDKPYWEWEQWLKRKNP-------ALPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred CcchhhhccCchHHHHHHHhcccCc-------cCchhhcccCHH----HHHHHHHhcCCcccccchhHHHHHH
Confidence 9997322 22334444444433221 111112222233 4455556788999998555544443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=190.00 Aligned_cols=201 Identities=31% Similarity=0.519 Sum_probs=167.1
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCc
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNL 135 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 135 (345)
||+|++|.||+++.. .+++.+++|.+....... ....+.+|+..++.++|+++
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~--------------------------~~~~~~~e~~~~~~l~~~~i 53 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDSSS--------------------------LLEELLREIEILKKLNHPNI 53 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccchh--------------------------HHHHHHHHHHHHHhcCCCCe
Confidence 689999999999964 358999999996542210 24678899999999999999
Q ss_pred cceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC-
Q 046907 136 HPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD- 204 (345)
Q Consensus 136 v~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~- 204 (345)
+++++++.... ..+++++++.++. .++......++.+++.++.+||+.+ ++|+|++|.||+++.
T Consensus 54 ~~~~~~~~~~~--~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~ 128 (215)
T cd00180 54 VKLYGVFEDEN--HLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSD 128 (215)
T ss_pred eeEeeeeecCC--eEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCC
Confidence 99999988764 6888888888543 3556667789999999999999998 999999999999998
Q ss_pred CCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccccchhhH
Q 046907 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282 (345)
Q Consensus 205 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~ 282 (345)
++.++++|||.+........ ......+...|++||..... ..+.++|+| +|++++++
T Consensus 129 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------- 187 (215)
T cd00180 129 NGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------- 187 (215)
T ss_pred CCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------
Confidence 89999999999986644321 12235678899999999887 778899999 99999998
Q ss_pred HHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
..+.+++..|++.||++||++.++++.
T Consensus 188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 237788999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-27 Score=205.58 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=186.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
-.+.|...++||.|+|+.||+++.... ..+.||+|.+.. .....++..|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~-----------------------------ts~p~ri~~E 84 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR-----------------------------TSSPSRILNE 84 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc-----------------------------ccCchHHHHH
Confidence 456788999999999999999986532 578999999964 2346778899
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRR------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.|..+ -+.||+++.+.+..++ .+.++++|.+... .++...+..++..+..||.++|..| |+|||+|
T Consensus 85 l~~L~~~gG~~ni~~~~~~~rnnd--~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiK 159 (418)
T KOG1167|consen 85 LEMLYRLGGSDNIIKLNGCFRNND--QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIK 159 (418)
T ss_pred HHHHHHhccchhhhcchhhhccCC--eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCC
Confidence 9999999 6899999999888777 6888888887643 3567778899999999999999999 9999999
Q ss_pred CCCeeec-CCCCeEEeccccceecCC--------C----C----------------------cc--------eeccCccc
Q 046907 197 PVNVLLD-DDIEARISGFGFARAIPD--------A----H----------------------TH--------ITTSNVVG 233 (345)
Q Consensus 197 ~~nil~~-~~~~~kl~Dfg~a~~~~~--------~----~----------------------~~--------~~~~~~~g 233 (345)
|+|+|.+ ..+.-.|.|||+|..... . + .. ....+..|
T Consensus 160 psNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAG 239 (418)
T KOG1167|consen 160 PSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAG 239 (418)
T ss_pred ccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCC
Confidence 9999998 456788999999982110 0 0 00 00124689
Q ss_pred Cccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcC-------------CC--
Q 046907 234 TVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASEN-------------PK-- 296 (345)
Q Consensus 234 t~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~-- 296 (345)
|++|.|||++...+ .+++.||| .|+++..++++.+|| |...++......+....+... +.
T Consensus 240 T~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PF---f~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ks 316 (418)
T KOG1167|consen 240 TPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPF---FKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKS 316 (418)
T ss_pred CCCCCchHHHhhccCcCCccceeeccceeehhhcccccc---ccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccc
Confidence 99999999998776 67899999 999999999999996 333333322222211111110 00
Q ss_pred c------------ccc-c-----c---ccCCCcHHH-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 297 R------------AID-S-----K---LVGNGCEEQ-MLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 297 ~------------~~~-~-----~---~~~~~~~~~-~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. .+. . + .......+. ...+++++.+|++.||.+|.|+++.++
T Consensus 317 n~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 317 NIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 000 0 0 000111122 235788999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-24 Score=182.89 Aligned_cols=189 Identities=30% Similarity=0.439 Sum_probs=154.7
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|.+.+.||.|++|.||+|... .++..+|+|.+...... .....+.+|+..+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~--------------------------~~~~~~~~e~~~~~~ 53 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTE--------------------------KQREEFLREIRILKK 53 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccch--------------------------HHHHHHHHHHHHHHh
Confidence 567889999999999999865 35889999998643211 135677889999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
++|+|++++++++...+ ..++++++++++.+ +++.....++.+++.++.+||+.+ ++|+|++++|
T Consensus 54 ~~~~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~n 128 (225)
T smart00221 54 LKHPNIVKLYGVFEDPE--PLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPEN 128 (225)
T ss_pred CCCCChhhheeeeecCC--ceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 99999999999887665 57778888877432 455667789999999999999998 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccc-cccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL-QMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~-~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
++++.++.++++|||.+......... ......++..|++||.. ....++.++|+| +|+++++|++|..||.
T Consensus 129 i~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 129 ILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred EEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 99999999999999998876543210 12335678889999998 666778899999 9999999999999973
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=226.11 Aligned_cols=188 Identities=13% Similarity=0.151 Sum_probs=124.1
Q ss_pred hccC-CCccceeEEEecCC-----cceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 129 QIRH-RNLHPLLAHVTRPD-----CHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 129 ~l~h-pniv~l~~~~~~~~-----~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.++| +||+++++++.... ...++.++|+..+ ...++...+..++.||++||.|||+++ |+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 3455 57777777662211 1134445555432 234677788899999999999999999 9999
Q ss_pred CCCCCCeeecC-------------------CCCeEEeccccceecCCCCc--------------ceeccCcccCcccccc
Q 046907 194 DLNPVNVLLDD-------------------DIEARISGFGFARAIPDAHT--------------HITTSNVVGTVEYIAP 240 (345)
Q Consensus 194 dlk~~nil~~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~~~aP 240 (345)
||||+|||++. ++.+|++|||+++....... ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 44566777777654211000 0001124688899999
Q ss_pred ccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHH
Q 046907 241 EYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIA 319 (345)
Q Consensus 241 E~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 319 (345)
|++.+..++.++||| |||++|||++|..|+... ......+.... .+ +.. .........++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~------~~~~~~~~~~~---~~-----~~~-----~~~~~~~~~~~ 245 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK------SRTMSSLRHRV---LP-----PQI-----LLNWPKEASFC 245 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH------HHHHHHHHHhh---cC-----hhh-----hhcCHHHHHHH
Confidence 999999999999999 999999999988884321 11111111110 01 000 01112345777
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 046907 320 CFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 320 ~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+||+.+|.+||++.++++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 8899999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=185.82 Aligned_cols=243 Identities=22% Similarity=0.297 Sum_probs=184.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.+++.++.+|.....|+.|+|+|. |..+.+|++.- .....+..+.|..|.-
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwq---gndivakil~v-------------------------r~~t~risrdfneefp 239 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQ---GNDIVAKILNV-------------------------REVTARISRDFNEEFP 239 (448)
T ss_pred chhhhhhhhhhccCCCccccccccc---Ccchhhhhhhh-------------------------hhcchhhcchhhhhCc
Confidence 5567777889999999999999994 55677777742 2333555677888999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCC-----------HHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD-----------WLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~-----------~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.|+.+.||||..+++.|.++. .++++..|++.|++.+ ..+..+++.+++.|+.|||+.. +.+..-.
T Consensus 240 ~lrifshpnilpvlgacnspp--nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~ 316 (448)
T KOG0195|consen 240 ALRIFSHPNILPVLGACNSPP--NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFY 316 (448)
T ss_pred ceeeecCCchhhhhhhccCCC--CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhh
Confidence 999999999999999999885 7888999998877644 3466789999999999999986 3355556
Q ss_pred CCCCCeeecCCCCeEE--eccccceecCCCCcceeccCcccCccccccccccccccC---ccchhh-HHHHHHHHHhCCC
Q 046907 195 LNPVNVLLDDDIEARI--SGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLT---EKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 195 lk~~nil~~~~~~~kl--~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~---~~~Dvw-lG~vl~el~tg~~ 268 (345)
+.+..+++|++.+++| +|--.+.+ ......++.||+||.++..+-+ .++|+| |.+++||+.|.+.
T Consensus 317 lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trev 387 (448)
T KOG0195|consen 317 LNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV 387 (448)
T ss_pred cccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence 8899999999887765 45333322 1223457889999999887643 579999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||.+..+++.++.+ ....++.. .++.....+.+||.-|...||.+||.+..|+-.|++++
T Consensus 388 pfadlspmecgmki---aleglrv~-------------ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 388 PFADLSPMECGMKI---ALEGLRVH-------------IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCchhhhhhh---hhcccccc-------------CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 98776665554433 22222222 22233344677777899999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=175.33 Aligned_cols=156 Identities=21% Similarity=0.211 Sum_probs=115.9
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccc
Q 046907 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIA 239 (345)
Q Consensus 160 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~a 239 (345)
+..+++..+..++.|++.||.|||+.+ ||+||+++.++.+++ ||++...... ...||+.|||
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~g~~~y~a 72 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSRVDPYFMA 72 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-------cCCCcccccC
Confidence 445889999999999999999999884 999999999999999 9998765432 2368999999
Q ss_pred cccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHH--HHHH
Q 046907 240 PEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQM--LLVL 316 (345)
Q Consensus 240 PE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~ 316 (345)
||++.+..++.++||| +|+++|||++|..||..... .......+........+. .+ ....... ..+.
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~ 142 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---LSAILEILLNGMPADDPR----DR---SNLESVSAARSFA 142 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch---hcHHHHHHHHHhccCCcc----cc---ccHHHHHhhhhHH
Confidence 9999999999999999 99999999999999743221 111111111111111000 00 0111122 2588
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 317 KIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 317 ~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+++..||+.||++|||+.++++.+..+
T Consensus 143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 143 DFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=191.80 Aligned_cols=170 Identities=18% Similarity=0.126 Sum_probs=129.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|.+.+.||+|+||.||+|.++..++..+|||.+........ .......+.+|++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~----------------------~~~~~~~~~~E~~ 73 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS----------------------KPLARHLAAREIR 73 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc----------------------cHHHHHHHHHHHH
Confidence 457899999999999999999987655688899998753211000 0122456889999
Q ss_pred HHhhccCCCccc-eeEEEecCCcceeeeeccccCCCCCCCHH--HHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCee
Q 046907 126 TVGQIRHRNLHP-LLAHVTRPDCHLLYILNDVSQGRRELDWL--ARHRIALGLACGLEYLHMHHCPRIIHRDL-NPVNVL 201 (345)
Q Consensus 126 ~l~~l~hpniv~-l~~~~~~~~~~~l~~~~~~~~~~~~l~~~--~~~~i~~~i~~~l~~lh~~~~~~iiH~dl-k~~nil 201 (345)
+++.++|+|++. ++++ + ..+++++|++|+.+.... ....++.++++||.|||+.+ ++|||| ||+|||
T Consensus 74 iL~~L~h~~iv~~l~~~----~--~~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NIL 144 (365)
T PRK09188 74 ALKTVRGIGVVPQLLAT----G--KDGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWL 144 (365)
T ss_pred HHHhccCCCCCcEEEEc----C--CcEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEE
Confidence 999999999985 4432 2 368999999887653111 12578899999999999998 999999 999999
Q ss_pred ecCCCCeEEeccccceecCCCCccee------ccCcccCcccccccccccc
Q 046907 202 LDDDIEARISGFGFARAIPDAHTHIT------TSNVVGTVEYIAPEYLQML 246 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~~~aPE~~~~~ 246 (345)
++.++.++|+|||+|+.......... ..+..++..|+|||.+...
T Consensus 145 v~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 145 MGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99889999999999997754332111 2356788889999999543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=172.16 Aligned_cols=254 Identities=19% Similarity=0.235 Sum_probs=186.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...-+|.++++||+|+||+.+.|+ +--+++.||||.-...+ ...++.-|.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~-Nl~nne~VAIKfEPrkS-----------------------------~APQLrdEY 74 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGK-NLYNNEPVAIKFEPRKS-----------------------------EAPQLRDEY 74 (449)
T ss_pred EecccceeccccccCcceeeeccc-ccccCceEEEEeccccC-----------------------------CcchHHHHH
Confidence 356699999999999999999998 44579999999864321 234455678
Q ss_pred HHHhhc-cCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+..+.| ..+.|..+|-+....- +-.+|+|++.- |..++...+..+|.|++.-++++|++. +|.||
T Consensus 75 r~YKlL~g~~GIP~vYYFGqeG~--~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRD 149 (449)
T KOG1165|consen 75 RTYKLLGGTEGIPQVYYFGQEGK--YNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRD 149 (449)
T ss_pred HHHHHHcCCCCCCceeeeccccc--hhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecc
Confidence 888777 6788888876554433 33444444422 556788888999999999999999998 99999
Q ss_pred CCCCCeeecCC-----CCeEEeccccceecCCCCcce-----eccCcccCccccccccccccccCccchhh-HHHHHHHH
Q 046907 195 LNPVNVLLDDD-----IEARISGFGFARAIPDAHTHI-----TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 195 lk~~nil~~~~-----~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el 263 (345)
|||+|+||... ..+.++|||+|+...+..... .-....||.+||+-..-.|.+.+.+.|+= +|-++++.
T Consensus 150 IKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYF 229 (449)
T KOG1165|consen 150 IKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 229 (449)
T ss_pred cCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhh
Confidence 99999999743 358899999999887654432 22457899999999999999999999999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+-|..||.+....++...+.+.=.... . .+....-...|+++...+..++. .+-++-|+-+-+...+..+
T Consensus 230 LRGsLPWQGLKA~tnK~kYeKIGe~Kr-~------T~i~~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 230 LRGSLPWQGLKADTNKEKYEKIGETKR-S------TPIEVLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred ccCCCccccccCcchHHHHHHhccccc-c------CCHHHHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHH
Confidence 999999998777666555533211111 1 11111112355565555655444 4777888888877776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=169.48 Aligned_cols=257 Identities=20% Similarity=0.242 Sum_probs=185.6
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+.+...+.|.++++||+|+||.+|.|.. -.+|+.||||.-.+... ...+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~-i~~ge~VAiK~Es~~a~-----------------------------hpqL~ 58 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGIS-ITSGEEVAIKLESSKAK-----------------------------HPQLL 58 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeee-ccCCceEEEEeecccCC-----------------------------Ccchh
Confidence 3455678999999999999999999984 46899999999865322 34456
Q ss_pred HHHHHHhhccCCC-ccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRN-LHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpn-iv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
.|..+...+++.. |..+..+..+.+ +-++||+++.- ...++...+.-++-|++..++|+|.++ ++
T Consensus 59 yEskvY~iL~~g~GiP~i~~y~~e~~--ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fi 133 (341)
T KOG1163|consen 59 YESKVYRILQGGVGIPHIRHYGTEKD--YNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FI 133 (341)
T ss_pred HHHHHHHHhccCCCCchhhhhccccc--cceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cc
Confidence 7888888886544 555554444443 55677777643 123555566778999999999999999 99
Q ss_pred ecCCCCCCeeecC---CCCeEEeccccceecCCCCcc-----eeccCcccCccccccccccccccCccchhh-HHHHHHH
Q 046907 192 HRDLNPVNVLLDD---DIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAG 262 (345)
Q Consensus 192 H~dlk~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~e 262 (345)
||||||+|+|..- ...+.++|||+|+...+.... ....+..||.+|.+-....+...+.+.|+- +|.++..
T Consensus 134 HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmY 213 (341)
T KOG1163|consen 134 HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMY 213 (341)
T ss_pred cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeee
Confidence 9999999999963 356889999999877554321 123457899999998888888888999999 9999999
Q ss_pred HHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 263 LVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 263 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
.--|..||.+..+.+....+..........+.. ..|...+.++...+.-|-..--++-|+-..+.+.+.-
T Consensus 214 fnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie----------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 214 FNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE----------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred eecCCCcccccchhhHHHHHHHHHHhhcCCCHH----------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 999999998876655444444433333221111 1112223335555566888888888988887777665
Q ss_pred h
Q 046907 343 I 343 (345)
Q Consensus 343 l 343 (345)
+
T Consensus 284 L 284 (341)
T KOG1163|consen 284 L 284 (341)
T ss_pred H
Confidence 4
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-23 Score=180.93 Aligned_cols=264 Identities=20% Similarity=0.174 Sum_probs=168.0
Q ss_pred CCcccccccccCcceeeEEEEecC---------CC-------------------------CceeEEeeecCCchhhhhhh
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPG---------QN-------------------------GRMISIKKIVGPPMDAAALI 93 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~---------~~-------------------------~~~vavK~~~~~~~~~~~~~ 93 (345)
++|+++..||+|+...||.++... .+ .-+.|||++++-+.+..+..
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~~ 236 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDAH 236 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchHH
Confidence 579999999999999999987541 00 01478888888877766655
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH--Hh-------h-ccCCCccceeEEEecCC-----------------
Q 046907 94 EEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT--VG-------Q-IRHRNLHPLLAHVTRPD----------------- 146 (345)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~-------~-l~hpniv~l~~~~~~~~----------------- 146 (345)
..+.|..+........ ...|... .+ . -+|||||++.++|.+.-
T Consensus 237 iL~sM~~ElvPa~~~a----------~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R 306 (598)
T KOG4158|consen 237 ILKSMGNELVPAPNAA----------KLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPAR 306 (598)
T ss_pred HHHHhhhhccCcchhh----------hhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccce
Confidence 5555555433321110 1112111 11 1 27999999999886532
Q ss_pred --------cceeeeeccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec----CCCC
Q 046907 147 --------CHLLYILNDVSQG-------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD----DDIE 207 (345)
Q Consensus 147 --------~~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~----~~~~ 207 (345)
...+|++|.-.+. ....++....-++.|+++|+.|||.+| +.|||+|++|||+. .-..
T Consensus 307 ~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~ 383 (598)
T KOG4158|consen 307 WYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQ 383 (598)
T ss_pred ecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcE
Confidence 1123444443322 122455556678999999999999999 99999999999994 3346
Q ss_pred eEEeccccceecCCCCcce----eccCcccCcccccccccccccc------Cccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 208 ARISGFGFARAIPDAHTHI----TTSNVVGTVEYIAPEYLQMLTL------TEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 208 ~kl~Dfg~a~~~~~~~~~~----~~~~~~gt~~~~aPE~~~~~~~------~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+.++|||++-.....+... ..-..-|....||||+....+- -.++|.| .|.+.||++....||-.
T Consensus 384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~---- 459 (598)
T KOG4158|consen 384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK---- 459 (598)
T ss_pred EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc----
Confidence 7899999887654422111 1122456778899999865442 2589999 99999999999999632
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
..++.+....+.....+..+ +.+.-.+.+++...++.||++|++..-.-+.|
T Consensus 460 rGem~L~~r~Yqe~qLPalp------------~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 460 RGEMLLDTRTYQESQLPALP------------SRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred cchheechhhhhhhhCCCCc------------ccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 23332222111111111111 11222366777778999999999876555444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-21 Score=174.16 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=176.9
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|.+...||+|+||.||.|.........+|+|......... ...+..|..++.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---------------------------~~~l~~E~~vl~ 71 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---------------------------PSVLKIEIQVLK 71 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---------------------------CccchhHHHHHH
Confidence 89999999999999999998542224578999886432211 114556778887
Q ss_pred hccC----CCccceeEEEe-cCCcceeeeeccccCC----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 129 QIRH----RNLHPLLAHVT-RPDCHLLYILNDVSQG----------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 129 ~l~h----pniv~l~~~~~-~~~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.+.. +++..+++... .++ +-++||+.++. ...++.....+++.|++.+|.++|+.| ++||
T Consensus 72 ~l~~~~~~~~~~~~~~~G~~~~~--~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHR 146 (322)
T KOG1164|consen 72 KLEKKNGPSHFPKLLDHGRSTED--FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHR 146 (322)
T ss_pred HHhhhcCCCCCCEEEEeccCCCc--eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccC
Confidence 7752 57888888774 343 45555665532 256777888899999999999999999 9999
Q ss_pred CCCCCCeeecCC-----CCeEEeccccceecC--CCC----ccee--ccCcccCccccccccccccccCccchhh-HHHH
Q 046907 194 DLNPVNVLLDDD-----IEARISGFGFARAIP--DAH----THIT--TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGAL 259 (345)
Q Consensus 194 dlk~~nil~~~~-----~~~kl~Dfg~a~~~~--~~~----~~~~--~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~v 259 (345)
||||.|+++... -.+.+.|||+++... ... .... .....||..|.++..-.+...+.+.|+| ++.+
T Consensus 147 DiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~ 226 (322)
T KOG1164|consen 147 DIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYM 226 (322)
T ss_pred CcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHH
Confidence 999999999854 358999999998322 111 1111 1346699999999999999999999999 9999
Q ss_pred HHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 260 LAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 260 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
+.|+..|..||...........+........... .....+.....+... +-..+...+|....+...
T Consensus 227 l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 227 LLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR----------FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHhcCCCCCccccccchHHHHHHHhhhhcccc----------ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHH
Confidence 9999999999965443323222222222221111 122344555555555 444789999999999888
Q ss_pred Hhhh
Q 046907 340 LSQI 343 (345)
Q Consensus 340 L~~l 343 (345)
|++.
T Consensus 294 l~~~ 297 (322)
T KOG1164|consen 294 LKDV 297 (322)
T ss_pred HHHH
Confidence 7654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=193.85 Aligned_cols=250 Identities=22% Similarity=0.237 Sum_probs=172.7
Q ss_pred ccccccccCcceeeEEEEecCCCCceeEEeeecCC--chhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGP--PMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.....+|.|++|.|+..... ...+.++.|..... ..+. + .+....+..|..+-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~-~~~~~~~~~~~r~~~~~~~s--------------------~---~~~~~~i~sE~~i~~ 376 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRR-SDLKSFPEKEFRVRVKPTES--------------------E---RKYNYNITSEFCIGS 376 (601)
T ss_pred CccceeeecccCceEEEEec-CCCccchhhhhhcccCCccc--------------------H---HHHhhhhhhheeecc
Confidence 34678999999977776532 34444555544311 0000 0 111122777888889
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
.++|||++..+..+....... -.|||+++ ...+....+..++.|+..|+.|+|+.| +.|||+|++|+
T Consensus 377 ~l~h~~~~e~l~~~~~~~~~~--~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enl 451 (601)
T KOG0590|consen 377 SLSHPNIIETLDIVQEIDGIL--QSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENL 451 (601)
T ss_pred cccCCchhhhHHHHhhcccch--hhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccE
Confidence 999999988776655444222 22788877 123555666789999999999999999 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccccccCc-cchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLTLTE-KCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~~~~-~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
++..++.+||+|||.+....-.... ......+|+..|+|||++.+..|.+ ..||| .|+++..|++|+.||......
T Consensus 452 l~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 452 LVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred EEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 9999999999999998766443332 3456789999999999999999876 69999 999999999999999643332
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+. + ....+. ....... -+.............+|..+|+.||.+|.|+++|++
T Consensus 532 ~~~--~----~~~~~~-~~~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 532 DNS--F----KTNNYS-DQRNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc--h----hhhccc-ccccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 221 1 000000 0000000 000122344556788899999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-19 Score=162.20 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=181.9
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
|.+...||.|+||.||++... ..+++|.+....... ......+.+|+.++..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~------------------------~~~~~~~~~e~~~~~~ 53 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESK------------------------SKEVERFLREIQILAS 53 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccc------------------------hhHHHHHHHHHHHHHH
Confidence 778889999999999999863 778999986432221 1246778899999999
Q ss_pred ccCC-CccceeEEEecCCcceeeeeccccCCCC------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 130 IRHR-NLHPLLAHVTRPDCHLLYILNDVSQGRR------------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 130 l~hp-niv~l~~~~~~~~~~~l~~~~~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+.|+ +++++++.+...+ ..+++++++.++. .+.......+..|++.++.++|+.+ ++|||+|
T Consensus 54 ~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~k 128 (384)
T COG0515 54 LNHPPNIVKLYDFFQDEG--SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIK 128 (384)
T ss_pred ccCCcceeeEEEEEecCC--EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCC
Confidence 9888 7999999985554 3677778777643 3455566789999999999999999 9999999
Q ss_pred CCCeeecCCC-CeEEeccccceecCCCCcce----eccCcccCccccccccccc---cccCccchhh-HHHHHHHHHhCC
Q 046907 197 PVNVLLDDDI-EARISGFGFARAIPDAHTHI----TTSNVVGTVEYIAPEYLQM---LTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 197 ~~nil~~~~~-~~kl~Dfg~a~~~~~~~~~~----~~~~~~gt~~~~aPE~~~~---~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|+|++++... .++++|||.+.......... ......|+..|+|||.+.+ ...+...|+| +|++++++++|.
T Consensus 129 p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~ 208 (384)
T COG0515 129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208 (384)
T ss_pred HHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 9999999888 79999999998654433221 2356789999999999988 5688899999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.||...............+.......... .... .........+.+++..|+..+|..|.+..+...
T Consensus 209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 209 PPFEGEKNSSATSQTLKIILELPTPSLAS-PLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred CCCCCCCccccHHHHHHHHHhcCCccccc-ccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 99543222101223333333222110000 0000 000222345778888899999999998877654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.8e-20 Score=169.08 Aligned_cols=206 Identities=21% Similarity=0.291 Sum_probs=150.2
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCCCC----------HHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD----------WLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~----------~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
|+.+.|.|+.+++|.+..+. ..+++.++|..|++.+ +.-...+..+++.|+.|+|+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~--~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP--EMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCC--ceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 35679999999999998884 6888999998887654 4445678999999999999986 23999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-------cCccchhh-HHHHHHHHHhCCC
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-------LTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-------~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
+.|+++|....+|++|||+.................-...|.|||.+.+.. .+.+.|+| ||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987664311000111122345799999997742 35679999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
||+.........+....+.+ . ... .+-|.+.... +....+..++..||..+|++||+++.+...++.+
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-~-~~~---~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-G-GSN---PFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHh-c-CCC---CcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 98875554444444444444 1 111 1111111010 2233688899999999999999999999988765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-20 Score=154.28 Aligned_cols=181 Identities=13% Similarity=0.063 Sum_probs=130.8
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..-.++|...+.+|.|+||.||+... ++..+|+|.+.......+.... .-.....+.+|
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~------------------~f~~g~~~e~E 85 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLK------------------SFVKGDYYENL 85 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHH------------------hhhhhHHHHHH
Confidence 34577999999999999999999753 4667999999654332211100 01113447899
Q ss_pred HHHHhhccCCCccceeEEEecCCc------ceeeeeccccCCCCCCCHHHH-HHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDC------HLLYILNDVSQGRRELDWLAR-HRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~------~~l~~~~~~~~~~~~l~~~~~-~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+..+.++.||+|....+++..... ...+++|||++|.++.++... .....+++.++..+|+.+ ++|+|++
T Consensus 86 a~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dik 162 (232)
T PRK10359 86 IVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHG---MVSGDPH 162 (232)
T ss_pred HHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcC---CccCCCC
Confidence 999999999999999988664431 246889999999766433211 245679999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHH
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el 263 (345)
|+|++++.++ ++++|||........... ........++.++|+| +|+++.-.
T Consensus 163 p~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred hHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence 9999999888 999999987654221110 1133344566789999 99987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=156.49 Aligned_cols=134 Identities=20% Similarity=0.177 Sum_probs=91.5
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-
Q 046907 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM- 245 (345)
Q Consensus 167 ~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~- 245 (345)
-+..+..|+++.+.+||..| ++|+||+|+|++++.+|.+.++||+.....+... .. ...+..|.+||....
T Consensus 146 arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~--~~~~~~~~PPe~~~~~ 217 (288)
T PF14531_consen 146 ARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC--SEFPVAFTPPELESCA 217 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG--GGS-TTTS-HHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCcee---ec--cCCCcccCChhhhhhh
Confidence 34567789999999999999 9999999999999999999999999877654321 11 234577899997744
Q ss_pred -------cccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHH
Q 046907 246 -------LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLK 317 (345)
Q Consensus 246 -------~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 317 (345)
..++.+.|.| +|+++|.++++..||........... ....+. +.++.+..
T Consensus 218 ~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~ 275 (288)
T PF14531_consen 218 GQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQF 275 (288)
T ss_dssp TSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHH
T ss_pred cccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHH
Confidence 2468899999 99999999999999865433221111 111233 66677889
Q ss_pred HHhhccCCCCCCC
Q 046907 318 IACFCTLEDPNER 330 (345)
Q Consensus 318 li~~Cl~~dp~~R 330 (345)
||...|+.||++|
T Consensus 276 LI~~lL~~~~~~R 288 (288)
T PF14531_consen 276 LIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHT-SSGGGS
T ss_pred HHHHHccCCcccC
Confidence 9999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-19 Score=149.34 Aligned_cols=153 Identities=13% Similarity=0.030 Sum_probs=101.9
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhh---hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIE---EDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
...||+|++|.||+|... +|+.||||.++....+...... ......+... ......-.......|+..+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYC----KSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhcccc----CCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999999864 7999999999865332111000 0000000000 000000112334569999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCC
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYL-HMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~l-h~~~~~~iiH~dlk~~n 199 (345)
+.++++...... ...+ .+++||+++++.. ++......++.|++.+|.++ |+.+ ++|||+||+|
T Consensus 76 l~~~~v~~p~~~-~~~~---~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~N 148 (190)
T cd05147 76 LVTAGIPCPEPI-LLKS---HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYN 148 (190)
T ss_pred HHHCCCCCCcEE-EecC---CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 988776433322 2222 2689999987532 34455678999999999999 6888 9999999999
Q ss_pred eeecCCCCeEEeccccceec
Q 046907 200 VLLDDDIEARISGFGFARAI 219 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~ 219 (345)
|+++ ++.++++|||+|...
T Consensus 149 Ili~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 149 LLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEE-CCcEEEEEccccccC
Confidence 9998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-18 Score=144.02 Aligned_cols=159 Identities=11% Similarity=0.050 Sum_probs=106.4
Q ss_pred cccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 52 SLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
+...||+|++|.||+|+.. +|+.||||.+.....+........... ..............-....+..|...+.++.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 1 INGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGD-PRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CCceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCC-cccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 3578999999999999854 799999999987532211000000000 0000000000000111233457999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCee
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHM-HHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~-~~~~~iiH~dlk~~nil 201 (345)
|+++.....+.... .+++||+++++.. ++......++.|++.++.++|+ .+ ++|||+||+||+
T Consensus 78 ~~~i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 78 EAGVPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred hCCCCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 99875544433322 3789999987632 3334567899999999999999 88 999999999999
Q ss_pred ecCCCCeEEeccccceecCC
Q 046907 202 LDDDIEARISGFGFARAIPD 221 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~ 221 (345)
++ ++.++++|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 78999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-19 Score=173.91 Aligned_cols=243 Identities=19% Similarity=0.225 Sum_probs=161.1
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
++...+.||++.|=+|.+|+.+ .|. |.||++.+..-... -....+-..|++ ..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~s-----------------------L~~~~qrL~~ik-~~ 76 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTIS-----------------------LRPFKQRLEEIK-FA 76 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCC-----------------------chHHHHHHHHHH-HH
Confidence 7888899999999999999864 565 88999876542211 111333344555 55
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
.++|||++.+.-+...+. .-|++..|... +..+......=|+.|++.||..+|..+ |.|+|||.+||
T Consensus 77 l~~~pn~lPfqk~~~t~k--AAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENI 151 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDK--AAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENI 151 (1431)
T ss_pred hhcCCcccchHHHHHhhH--HHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceE
Confidence 569999999977655444 34555554432 222333344559999999999999999 99999999999
Q ss_pred eecCCCCeEEeccccceec--CCCCcc---eeccCcccCccccccccccc----------cc-cCccchhh-HHHHHHHH
Q 046907 201 LLDDDIEARISGFGFARAI--PDAHTH---ITTSNVVGTVEYIAPEYLQM----------LT-LTEKCDIY-FGALLAGL 263 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~--~~~~~~---~~~~~~~gt~~~~aPE~~~~----------~~-~~~~~Dvw-lG~vl~el 263 (345)
|+..=..+.++||..-+.. ...... .-..+...-..|.|||.+.. .+ .+++-||+ +||++.|+
T Consensus 152 LiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaEL 231 (1431)
T KOG1240|consen 152 LITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAEL 231 (1431)
T ss_pred EEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHH
Confidence 9999999999999765533 111111 11111222346999998843 12 46788999 99999999
Q ss_pred Hh-CCCCCcccccccchhhHHHHHHHHhh--hcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 264 VM-GKLPSDKFFQHTNEMSFVKWMRNVMA--SENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 264 ~t-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
++ |.+||.- .++.++-..... ......+.|. .+++++..|++.||++|.++++.++.-
T Consensus 232 f~Eg~PlF~L-------SQL~aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 232 FLEGRPLFTL-------SQLLAYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HhcCCCcccH-------HHHHhHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence 88 6888642 122221111000 0000011111 278899999999999999999999875
Q ss_pred hh
Q 046907 341 SQ 342 (345)
Q Consensus 341 ~~ 342 (345)
++
T Consensus 293 rG 294 (1431)
T KOG1240|consen 293 RG 294 (1431)
T ss_pred hc
Confidence 44
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.3e-18 Score=140.73 Aligned_cols=186 Identities=14% Similarity=0.062 Sum_probs=131.8
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
..+...|++|+||+|+.+. + .+..++.+.+...+.... .-....+.+|+++|++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~-~--~~~k~~~~~l~~~~~~~~-----------------------~~~~~l~~rE~~iL~~ 57 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR-G--GERKFVRRDLSAAPWWLR-----------------------GVAWWLARREALALRQ 57 (218)
T ss_pred cccceeecCCCcceEEEee-c--CCceeeecccccchhhhh-----------------------hHHHHHHHHHHHHHHh
Confidence 3456889999999999775 2 677788777754433211 1123367899999999
Q ss_pred c-cCCCccceeEEEecCCcceeeeeccccCCCCCCCHH--HHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCeeecCC
Q 046907 130 I-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL--ARHRIALGLACGLEYLHMHHCPRIIHRDL-NPVNVLLDDD 205 (345)
Q Consensus 130 l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~--~~~~i~~~i~~~l~~lh~~~~~~iiH~dl-k~~nil~~~~ 205 (345)
+ +|+++++++++ . ..+++++|+.|..+.... ....++.|++.+|.++|+.| ++|||| ||.|||++.+
T Consensus 58 L~~~~~vP~ll~~---~---~~~lvmeyI~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~ 128 (218)
T PRK12274 58 LDGLPRTPRLLHW---D---GRHLDRSYLAGAAMYQRPPRGDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQED 128 (218)
T ss_pred cCCCCCCCEEEEE---c---CEEEEEeeecCccHHhhhhhhhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCC
Confidence 9 45889999886 1 258889998877653221 22457889999999999999 999999 7999999999
Q ss_pred CCeEEeccccceecCCCCcc----e-------eccCcccCcccccccccccc-ccCccchhh--HHHHHHHHHhCCCCC
Q 046907 206 IEARISGFGFARAIPDAHTH----I-------TTSNVVGTVEYIAPEYLQML-TLTEKCDIY--FGALLAGLVMGKLPS 270 (345)
Q Consensus 206 ~~~kl~Dfg~a~~~~~~~~~----~-------~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw--lG~vl~el~tg~~p~ 270 (345)
+.++|+|||++........- . ...-...++.+++|+.-.-. ..+...-+| .|.-+|.++|+..|+
T Consensus 129 g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 129 GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 99999999999865432210 0 00012346667777644332 233334455 999999999998883
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-19 Score=167.50 Aligned_cols=219 Identities=22% Similarity=0.272 Sum_probs=159.6
Q ss_pred ccccCcceeeEEEEe--cCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc-
Q 046907 55 KIGSGGCGEVYKAEL--PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR- 131 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 131 (345)
.+|+|+||.|++++- ....|..+|.|.++....... .......|..++...+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~-------------------------~~~~t~~er~il~~~~~ 55 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR-------------------------DRTHTKQERIILAFVHN 55 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccc-------------------------cccccccHHHHHhhccC
Confidence 479999999998752 122478899999875433211 1114445777787786
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
||.+|++...+.++. .++++.++..++.+ +.+....-+...++-+++++|+.+ +++||+|++||++
T Consensus 56 ~~f~v~lhyafqt~~--kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enill 130 (612)
T KOG0603|consen 56 TPFLVKLHYAFQTDG--KLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLL 130 (612)
T ss_pred CCceeeeeeeecccc--chhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceee
Confidence 999999999888877 57777788877654 345556667778888999999999 9999999999999
Q ss_pred cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhh
Q 046907 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~ 281 (345)
+.+|.+++.|||+++..-... ..+||..|||||++. .....+|.| ||++.+||+||..||.. +
T Consensus 131 d~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~ 194 (612)
T KOG0603|consen 131 LLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------D 194 (612)
T ss_pred cccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------H
Confidence 999999999999987653322 238999999999999 567889999 99999999999999643 2
Q ss_pred HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
....| ...... .+.+......+++...+..+|.+|.-.
T Consensus 195 ~~~~I---l~~~~~-----------~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 195 TMKRI---LKAELE-----------MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHH---hhhccC-----------CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 22222 211111 122233335566666777788888643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.4e-18 Score=167.44 Aligned_cols=194 Identities=19% Similarity=0.183 Sum_probs=143.5
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
...++....+.|.|.+.||+|+||.||+|+.. +|+.||+|.-+......-+-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WEfYI-------------------------- 740 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWEFYI-------------------------- 740 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCceeeee--------------------------
Confidence 34445667789999999999999999999965 59999999987765443221
Q ss_pred HHHHHHHHHhhcc---CCCccceeEEEecCCcceeeeeccccCCCCCCC---------HHHHHHHHHHHHHHHHHHhhcC
Q 046907 119 QIQSEINTVGQIR---HRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD---------WLARHRIALGLACGLEYLHMHH 186 (345)
Q Consensus 119 ~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~---------~~~~~~i~~~i~~~l~~lh~~~ 186 (345)
-.+++.+|+ -+.|..+.......+ --+++++|.+.|++++ +..+..+..|++.-+++||..+
T Consensus 741 ----~~q~~~RLk~~~~~~~~~~~~a~~~~~--~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~ 814 (974)
T KOG1166|consen 741 ----CLQVMERLKPQMLPSIMHISSAHVFQN--ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG 814 (974)
T ss_pred ----hHHHHHhhchhhhcchHHHHHHHccCC--cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc
Confidence 112222222 122334433333333 2456777777766654 4456679999999999999999
Q ss_pred CCCeEecCCCCCCeeec-------CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHH
Q 046907 187 CPRIIHRDLNPVNVLLD-------DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~-------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~ 258 (345)
|||+||||+|+|+. ....++|+|||.+-.+.--.........++|-.+-++|...|.+++...|.| +..
T Consensus 815 ---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa 891 (974)
T KOG1166|consen 815 ---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAA 891 (974)
T ss_pred ---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHH
Confidence 99999999999994 2457899999998755433233344567888899999999999999999999 999
Q ss_pred HHHHHHhCCCC
Q 046907 259 LLAGLVMGKLP 269 (345)
Q Consensus 259 vl~el~tg~~p 269 (345)
+++-|+.|++.
T Consensus 892 ~~h~mLFG~y~ 902 (974)
T KOG1166|consen 892 TVHVMLFGKYM 902 (974)
T ss_pred HHHHHHHHHHH
Confidence 99999988865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.8e-18 Score=166.02 Aligned_cols=211 Identities=23% Similarity=0.315 Sum_probs=141.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|..++.|-.|+||.||.++++ .+...+|+|+-+.+. +++ .
T Consensus 81 ~e~df~~IklisngAygavylvrh~-~trqrfa~kiNkq~l---------------------------------ilR--n 124 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHK-ETRQRFAMKINKQNL---------------------------------ILR--N 124 (1205)
T ss_pred CccccceeEeeccCCCCceeeeecc-ccccchhhcccccch---------------------------------hhh--c
Confidence 4568999999999999999999864 467788885542110 000 0
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD 205 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~ 205 (345)
++.....|.+| .+. ...+.+-..++. +++.+++|+|+.+ |+|||+||+|.+|..-
T Consensus 125 ilt~a~npfvv--------gDc------~tllk~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~m 179 (1205)
T KOG0606|consen 125 ILTFAGNPFVV--------GDC------ATLLKNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSM 179 (1205)
T ss_pred cccccCCccee--------chh------hhhcccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeec
Confidence 22222333333 110 011112122221 2267899999999 9999999999999999
Q ss_pred CCeEEeccccceecCCCC------------cc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 206 IEARISGFGFARAIPDAH------------TH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 206 ~~~kl~Dfg~a~~~~~~~------------~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|.+|++|||+++...... .+ ......+||+.|.|||++....|+...|+| +|+++||.+-|..||
T Consensus 180 GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpf- 258 (1205)
T KOG0606|consen 180 GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF- 258 (1205)
T ss_pred ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeec-
Confidence 999999999887432110 01 112456999999999999999999999999 999999999999996
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
|..+.+.-+-..+......+... +....+..+++...|+.+|..|--
T Consensus 259 --fGdtpeelfg~visd~i~wpE~d------------ea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 259 --FGDTPEELFGQVISDDIEWPEED------------EALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred --cCCCHHHHHhhhhhhhccccccC------------cCCCHHHHHHHHHHHHhChHhhcc
Confidence 55544444544444333222211 111223667777789999999963
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=136.88 Aligned_cols=132 Identities=14% Similarity=0.183 Sum_probs=94.6
Q ss_pred ccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 046907 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI 130 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 130 (345)
.-...||+|+||.||. ++ .++.. +||++..... ...+.+.+|+.+++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp-~~~~k-~IKv~~~~~~---------------------------~~~~~~~rEi~~l~~L 53 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HP-EDAQR-CIKIVYHRGD---------------------------GGDKEIRRELKYYAHL 53 (210)
T ss_pred CCcceecCCCceEEEE--CC-CCcCe-EEEEEecccc---------------------------chHHHHHHHHHHHHHh
Confidence 3457899999999996 44 24433 6898854211 1234578999999999
Q ss_pred -----cCCCccceeEEEecCCc--ceeeeeccccC--CCCCCCHHH------HHHHHHHHHHHH-HHHhhcCCCCeEecC
Q 046907 131 -----RHRNLHPLLAHVTRPDC--HLLYILNDVSQ--GRRELDWLA------RHRIALGLACGL-EYLHMHHCPRIIHRD 194 (345)
Q Consensus 131 -----~hpniv~l~~~~~~~~~--~~l~~~~~~~~--~~~~l~~~~------~~~i~~~i~~~l-~~lh~~~~~~iiH~d 194 (345)
+||||+++++++.++.+ ..+.+++++.+ ++++.+... ...++.+++.++ .|||+.+ |+|||
T Consensus 54 ~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~---IvhrD 130 (210)
T PRK10345 54 SRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNR---IVTME 130 (210)
T ss_pred hccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCC---EeecC
Confidence 57999999999988742 23446899843 444433221 134567778777 9999999 99999
Q ss_pred CCCCCeeecC----CCCeEEeccccc
Q 046907 195 LNPVNVLLDD----DIEARISGFGFA 216 (345)
Q Consensus 195 lk~~nil~~~----~~~~kl~Dfg~a 216 (345)
|||+|||++. +..++|+||+.+
T Consensus 131 lKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 131 LKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9999999974 347999995433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-18 Score=157.13 Aligned_cols=89 Identities=35% Similarity=0.629 Sum_probs=76.9
Q ss_pred HHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC----cceeccCcccCcccccccccccc
Q 046907 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH----THITTSNVVGTVEYIAPEYLQML 246 (345)
Q Consensus 171 i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~~~aPE~~~~~ 246 (345)
++.|++.|+.| ++ .+|+|+||.||....+..+||+|||+........ .....+...||..||+||.+.+.
T Consensus 364 ~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~ 437 (516)
T KOG1033|consen 364 IFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ 437 (516)
T ss_pred HHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhh
Confidence 77888888888 76 9999999999999999899999999987664433 12233457899999999999999
Q ss_pred ccCccchhh-HHHHHHHHHh
Q 046907 247 TLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 247 ~~~~~~Dvw-lG~vl~el~t 265 (345)
.|+.++||| +|++++|++.
T Consensus 438 ~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 438 QYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhcchhhHHHHHHHHHH
Confidence 999999999 9999999986
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.8e-16 Score=132.50 Aligned_cols=156 Identities=17% Similarity=0.132 Sum_probs=108.6
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|.+.+.||+|+||.||+|.+. +|+.||||.+.....+.............. ...............|..++.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDR-----KHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhcc-----ccchhHHHhHHHHHHHHHHHH
Confidence 4888899999999999999864 799999999865432211111000000000 000111223445778999999
Q ss_pred hccCCC--ccceeEEEecCCcceeeeeccccCCCCCCCH---HHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 129 QIRHRN--LHPLLAHVTRPDCHLLYILNDVSQGRRELDW---LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 129 ~l~hpn--iv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~---~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
.+.|++ +...++. + ..++++++++++.+... .....++.+++.++.++|+.+ ++|+|++|+||+++
T Consensus 89 ~l~~~~i~v~~~~~~----~--~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 89 ALYEEGFPVPKPIDW----N--RHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred HHHHcCCCCCceeec----C--CceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 998874 4444432 1 24788999988654322 234578899999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecC
Q 046907 204 DDIEARISGFGFARAIP 220 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~ 220 (345)
.++.++++|||.+....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.6e-16 Score=133.14 Aligned_cols=138 Identities=19% Similarity=0.240 Sum_probs=105.8
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
++.||+|++|.||+|++ +|..+++|.........+.. ........+.+|+.++..++|
T Consensus 1 ~~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~-------------------~~~~~~~~~~~E~~~l~~l~~ 58 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPEL-------------------DERIRRERTRREARIMSRARK 58 (211)
T ss_pred CcccccCceEEEEEEee---CCCceEEEEeCCcCCcChHH-------------------HHHHHHHHHHHHHHHHHHHHH
Confidence 36799999999999986 57789999875432211100 001224567889999999999
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCCCCHH-----HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCC
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-----ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~-----~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~ 207 (345)
+++.....++...+ ..++++++++|+.+.++. ....++.+++.+|.++|+.+ ++|+|++|.|++++ ++.
T Consensus 59 ~~i~~p~~~~~~~~--~~~lv~e~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~ 132 (211)
T PRK14879 59 AGVNVPAVYFVDPE--NFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGK 132 (211)
T ss_pred CCCCCCeEEEEeCC--CCEEEEEEeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCC
Confidence 99877666655444 467889999887765444 23589999999999999998 99999999999999 778
Q ss_pred eEEecccccee
Q 046907 208 ARISGFGFARA 218 (345)
Q Consensus 208 ~kl~Dfg~a~~ 218 (345)
++++|||.+..
T Consensus 133 ~~liDf~~a~~ 143 (211)
T PRK14879 133 IYLIDFGLAEF 143 (211)
T ss_pred EEEEECCcccC
Confidence 99999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.3e-16 Score=134.48 Aligned_cols=167 Identities=12% Similarity=0.029 Sum_probs=109.6
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|......|++.+.||+|++|.||+|+.+..+|..||+|.+........... ....-+.................+.
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRD---RYVDGDFRFKYRKINPRKLVRLWAE 98 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchh---hhcccchhhccCCCCHHHHHHHHHH
Confidence 3455555899999999999999999973335899999999975432211000 0000000000000000011233467
Q ss_pred HHHHHHhhccCCC--ccceeEEEecCCcceeeeeccccCCCCCC---------CHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRN--LHPLLAHVTRPDCHLLYILNDVSQGRREL---------DWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpn--iv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
.|+..+.++.+.. +.+++++ .. .+++++++++..+. .......++.|++.++.+||+.+ .+
T Consensus 99 ~E~~~L~~L~~~~i~~p~~~~~---~~---~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~i 170 (237)
T smart00090 99 KEFRNLQRLYEAGVPVPKPIAW---RR---NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--EL 170 (237)
T ss_pred HHHHHHHHHHhcCCCCCeeeEe---cC---ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CE
Confidence 8999999997532 3344432 22 36888999885432 22234689999999999999986 49
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIP 220 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~ 220 (345)
+|+|+||+||+++ ++.++++|||.+...+
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 7899999999986543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.2e-16 Score=131.53 Aligned_cols=136 Identities=18% Similarity=0.238 Sum_probs=101.7
Q ss_pred ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCC
Q 046907 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRN 134 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 134 (345)
.||+|+||.||+|.+ +|..+++|........... ........++.+|+.++..++|++
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~-------------------~~~~~~~~~~~~E~~~l~~l~~~~ 58 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPE-------------------LDERIRRERTRNEARLLSRARKAG 58 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCch-------------------HHHHHHHHHHHHHHHHHHHHHHCC
Confidence 489999999999986 5778999986543211100 000123567788999999998887
Q ss_pred ccceeEEEecCCcceeeeeccccCCCCCCCHHHHH--HHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEec
Q 046907 135 LHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH--RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISG 212 (345)
Q Consensus 135 iv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~--~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~D 212 (345)
+.....++..++ ..++++++++|+.+.+..... .++.+++.+|.++|+.+ ++|+|++|.|++++ ++.+++.|
T Consensus 59 i~~p~~~~~~~~--~~~lv~e~~~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 59 VNTPVVYDVDPD--NKTIVMEYIEGKPLKDVIEEGNDELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred CCCCEEEEEECC--CCEEEEEEECCccHHHHHhhcHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEE
Confidence 554444444333 357899999988765544332 68999999999999999 99999999999999 78999999
Q ss_pred ccccee
Q 046907 213 FGFARA 218 (345)
Q Consensus 213 fg~a~~ 218 (345)
||++..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.7e-16 Score=150.38 Aligned_cols=142 Identities=20% Similarity=0.225 Sum_probs=106.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|...+.||+|+||.||+|.+. +..+++|.......... ........+++.+|+++++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~-------------------~~~~~~~~~~~~~E~~~l~ 391 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHP-------------------ELDERLRTERTRAEARLLS 391 (535)
T ss_pred ccCccceeccCCcEEEEEEeec---CccceeEEEecccccch-------------------hHHHHHHHHHHHHHHHHHH
Confidence 4456889999999999999874 33455554322110000 0001123467889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH-HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~-~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~ 207 (345)
.++|++++....+...++ ..+++++|++++.+.++. ....++.+++.+|.+||+.+ ++|||+||+||++ .++.
T Consensus 392 ~l~~~~i~~p~~~~~~~~--~~~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~ 465 (535)
T PRK09605 392 EARRAGVPTPVIYDVDPE--EKTIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDR 465 (535)
T ss_pred hhcccCCCeeEEEEEeCC--CCEEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCc
Confidence 999999988776665544 357899999998776554 35678999999999999998 9999999999999 5678
Q ss_pred eEEecccccee
Q 046907 208 ARISGFGFARA 218 (345)
Q Consensus 208 ~kl~Dfg~a~~ 218 (345)
++++|||+++.
T Consensus 466 ~~liDFGla~~ 476 (535)
T PRK09605 466 LYLIDFGLGKY 476 (535)
T ss_pred EEEEeCccccc
Confidence 99999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-16 Score=153.71 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=176.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
...|.+.+.||+|+|+.|-.......+...+|+|.+.....+. ........|..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~-------------------------~~~~~i~~e~~~ 73 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE-------------------------DSSEHIDTETDI 73 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc-------------------------chhhhcCccccc
Confidence 5588899999999999998887544456678888776554221 113333446666
Q ss_pred Hhhcc-CCCccceeEEEecCCcceeeeeccccCCCCCCCH-----------HHHHHHHHHHHHHHHHHh-hcCCCCeEec
Q 046907 127 VGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDW-----------LARHRIALGLACGLEYLH-MHHCPRIIHR 193 (345)
Q Consensus 127 l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~-----------~~~~~i~~~i~~~l~~lh-~~~~~~iiH~ 193 (345)
-..+. |+|++.+++....++ ..++..++..++..+.. .....++.|+..++.|+| ..+ +.|+
T Consensus 74 ~~~~s~h~n~~~~~~~~~~~~--~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~ 148 (601)
T KOG0590|consen 74 QKKLSKHSNTVHMIEPSSSPR--SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHR 148 (601)
T ss_pred cccccccccccccCCccCCCc--ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccC
Confidence 66665 999999999887776 56667777666544332 345679999999999999 887 9999
Q ss_pred CCCCCCeeecCCC-CeEEeccccceecCC-CCcceeccCccc-Cccccccccccccc-cCccchhh-HHHHHHHHHhCCC
Q 046907 194 DLNPVNVLLDDDI-EARISGFGFARAIPD-AHTHITTSNVVG-TVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 194 dlk~~nil~~~~~-~~kl~Dfg~a~~~~~-~~~~~~~~~~~g-t~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
|+||+|.+++..+ ..+++|||+|..... .+........+| ++.|+|||...+.. ..+..|+| .|+++.-+++|..
T Consensus 149 ~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~ 228 (601)
T KOG0590|consen 149 DIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL 228 (601)
T ss_pred CCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC
Confidence 9999999999999 999999999988766 444444556778 99999999998854 46789999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhh-hcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMA-SENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
||....... ..+..++..... ...+ .........++...++..+|+.|.+.+++.
T Consensus 229 p~~~~~~~~--~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 229 PWDFPSRKD--GRYSSWKSNKGRFTQLP------------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred Ccccccccc--ccceeecccccccccCc------------cccCChhhhhcccccccCCchhcccccccc
Confidence 986543322 222222222111 0000 111112355666778889999999887764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.2e-14 Score=118.74 Aligned_cols=153 Identities=14% Similarity=0.029 Sum_probs=96.3
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
.+.||+|+||.||+|+.. +|..||||.+........+...... .. ....................|...+..+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 76 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRT-GD--YRFGRKKSNWRYLSRLWAEKEFRNLKRLYE 76 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhH-HH--HHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence 578999999999999854 7899999998764333211110000 00 000000000000011122345666666643
Q ss_pred C--CccceeEEEecCCcceeeeeccccCCCCCC-----CH---HHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCee
Q 046907 133 R--NLHPLLAHVTRPDCHLLYILNDVSQGRREL-----DW---LARHRIALGLACGLEYLHM-HHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 133 p--niv~l~~~~~~~~~~~l~~~~~~~~~~~~l-----~~---~~~~~i~~~i~~~l~~lh~-~~~~~iiH~dlk~~nil 201 (345)
. .+.+.++. . ..++++++++++... +. .....++.+++.++.++|. .+ ++|+|+||+|++
T Consensus 77 ~~~~~~~~~~~---~---~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 77 AGVPVPKPIDL---N---RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred cCCCCCceEec---C---CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 3 24444432 1 257899999884321 11 3456799999999999999 87 999999999999
Q ss_pred ecCCCCeEEeccccceecC
Q 046907 202 LDDDIEARISGFGFARAIP 220 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~ 220 (345)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.2e-13 Score=108.02 Aligned_cols=133 Identities=21% Similarity=0.168 Sum_probs=105.7
Q ss_pred cccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 52 SLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
+.+.||+|.++.||+++.. +..+++|....... ...+..|+.+++.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~-----------------------------~~~~~~e~~~~~~l~ 49 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK-----------------------------GADREREVAILQLLA 49 (155)
T ss_pred cceecccccccceEEEEec---CCeEEEEecCCCCc-----------------------------hhHHHHHHHHHHHHH
Confidence 4578999999999999863 47899999854321 235677888998887
Q ss_pred C--CCccceeEEEecCCcceeeeeccccCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCC
Q 046907 132 H--RNLHPLLAHVTRPDCHLLYILNDVSQGRREL--DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207 (345)
Q Consensus 132 h--pniv~l~~~~~~~~~~~l~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~ 207 (345)
| +++++++.+...++ ..+++++++.++... +......++.+++.++..+|......++|+|++|.|++++..+.
T Consensus 50 ~~~~~~p~~~~~~~~~~--~~~~v~e~~~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~ 127 (155)
T cd05120 50 RKGLPVPKVLASGESDG--WSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127 (155)
T ss_pred HcCCCCCeEEEEcCCCC--ccEEEEEecCCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE
Confidence 6 58888888776554 678889998876554 34566788999999999999863334999999999999999889
Q ss_pred eEEecccccee
Q 046907 208 ARISGFGFARA 218 (345)
Q Consensus 208 ~kl~Dfg~a~~ 218 (345)
+++.|||.+..
T Consensus 128 ~~l~Df~~~~~ 138 (155)
T cd05120 128 LGIIDWEYAGY 138 (155)
T ss_pred EEEEecccccC
Confidence 99999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.5e-13 Score=115.40 Aligned_cols=144 Identities=17% Similarity=0.189 Sum_probs=97.5
Q ss_pred cccc-cCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhhcc
Q 046907 54 EKIG-SGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE-MLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 54 ~~iG-~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~ 131 (345)
..|| .|+.|.||.++. .+..++||.+.....-.. . ...+ ........++.+|+.++..++
T Consensus 37 ~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~k-------------v--~~~~~~~~~~~~~r~~rE~~ll~~L~ 98 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGK-------------L--SKDRYLFTGLERTRAFAEFRLLAQLY 98 (239)
T ss_pred ceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHh-------------h--hhhcccccchhhhHHHHHHHHHHHHH
Confidence 4576 777888888874 467899998853211000 0 0000 001123567888999999998
Q ss_pred CCCc--cceeEEEecCCcc--eeeeeccccCCCCCC-CHHH----HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 132 HRNL--HPLLAHVTRPDCH--LLYILNDVSQGRREL-DWLA----RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 132 hpni--v~l~~~~~~~~~~--~l~~~~~~~~~~~~l-~~~~----~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
|+++ +..+++....... ..+++++++++...+ .... ....+.+++.++.+||+.| ++|+|+||.|||+
T Consensus 99 ~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv 175 (239)
T PRK01723 99 EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAG---VYHADLNAHNILL 175 (239)
T ss_pred hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCC---CCCCCCCchhEEE
Confidence 8875 6666664443322 235888988874322 2211 1235678999999999999 9999999999999
Q ss_pred cCCCCeEEecccccee
Q 046907 203 DDDIEARISGFGFARA 218 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~ 218 (345)
+.++.++++|||.+..
T Consensus 176 ~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCEEEEECCCccc
Confidence 9888999999998754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-10 Score=109.55 Aligned_cols=160 Identities=15% Similarity=0.117 Sum_probs=98.5
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHH-HHHH-----------HHHHHHHHHHHHH--H
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLN-KKMR-----------QIQSEMLLNKKMR--Q 119 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~--~ 119 (345)
+.||.|++|.||+|+++ +|+.||||+.+..-...-.... .....- .... ....+........ .
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl-~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADI-ALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHH-HHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 57999999999999975 7999999998765322111000 000000 0000 0000111111111 3
Q ss_pred HHHHHHHHhhc----cCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH-------HHHHHHHHHH-HHHHHhhcCC
Q 046907 120 IQSEINTVGQI----RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA-------RHRIALGLAC-GLEYLHMHHC 187 (345)
Q Consensus 120 ~~~E~~~l~~l----~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~-------~~~i~~~i~~-~l~~lh~~~~ 187 (345)
+.+|+..+.++ +|.+-+.+-..+..-. ..-+++|||++|..+.+... ...++..++. .+..+|..|
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~-~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g- 277 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRT-SERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDG- 277 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhc-CCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCC-
Confidence 55666666665 2333333333332111 13589999999987765543 2356666665 467889988
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~ 220 (345)
++|+|++|.|++++.++.++++|||++..++
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.6e-12 Score=118.71 Aligned_cols=244 Identities=19% Similarity=0.223 Sum_probs=165.8
Q ss_pred cCCccccccccc--CcceeeEEEEec-CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGS--GGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 47 ~~~~~~~~~iG~--G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
...+.+...+|. |.+|.||.++.. ..++..+|+|.-+....... ...+-.+|
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-------------------------~~~~k~~~ 167 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-------------------------DSKRKLRE 167 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-------------------------ccccccch
Confidence 335677889999 999999999861 24688899998554433221 12222356
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHH----HHHHHhhcCCCC
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLAC----GLEYLHMHHCPR 189 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~----~l~~lh~~~~~~ 189 (345)
+...+++ .|+|.++.+..+...+ .+++..|.+.+. ..++.........+..+ |+.++|+..
T Consensus 168 ~~s~~~i~~~~~~v~~~~~~e~~~--~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--- 242 (524)
T KOG0601|consen 168 FLSHHKIDSHENPVRDSPAWEGSG--ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--- 242 (524)
T ss_pred hhcccccCccccccccCcccccCC--cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---
Confidence 6666666 5999999888777766 677777777532 11333445567777777 999999998
Q ss_pred eEecCCCCCCeeecCC-CCeEEeccccceecCCCCcce---eccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 190 IIHRDLNPVNVLLDDD-IEARISGFGFARAIPDAHTHI---TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 190 iiH~dlk~~nil~~~~-~~~kl~Dfg~a~~~~~~~~~~---~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
++|-|+||.|+....+ ...+++|||+...+++..... ......|...|++||.+++ .++..+|++ +|.+..+..
T Consensus 243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~ 321 (524)
T KOG0601|consen 243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAI 321 (524)
T ss_pred ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhH
Confidence 9999999999999988 889999999999887654221 1123367889999999987 568899999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++..++..-+. . ....++.. + +..+.+......+...+.++++.+|-.|+++..+..
T Consensus 322 l~~~~~~~g~~--~---~W~~~r~~---------~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 322 LGSHLPSVGKN--S---SWSQLRQG---------Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hhcccccCCCC--C---Cccccccc---------c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 88666322100 0 00000000 0 111222222223444667789999999998877653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.3e-11 Score=97.09 Aligned_cols=129 Identities=16% Similarity=0.137 Sum_probs=92.4
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
++.|+.|.++.||+++. .+..+++|........ ...+..|+.+++.+.+
T Consensus 3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~~----------------------------~~~~~~E~~~l~~l~~ 51 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTEL----------------------------LINRENEAENSKLAAE 51 (170)
T ss_pred eeecCCcccCceEEEEE---CCeEEEEEeCCCCccc----------------------------ccCHHHHHHHHHHHHH
Confidence 45789999999999985 4778999987543210 1234568888888865
Q ss_pred CCcc-ceeEEEecCCcceeeeeccccCCCCCCCH-HHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCeeecCCCCe
Q 046907 133 RNLH-PLLAHVTRPDCHLLYILNDVSQGRRELDW-LARHRIALGLACGLEYLHMHH--CPRIIHRDLNPVNVLLDDDIEA 208 (345)
Q Consensus 133 pniv-~l~~~~~~~~~~~l~~~~~~~~~~~~l~~-~~~~~i~~~i~~~l~~lh~~~--~~~iiH~dlk~~nil~~~~~~~ 208 (345)
.+++ +++.+.. .. -++++++++|...... ......+.+++.++..||..+ ...++|+|++|.|++++ ++.+
T Consensus 52 ~~~~P~~~~~~~-~~---~~lv~e~i~G~~l~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~ 126 (170)
T cd05151 52 AGIGPKLYYFDP-ET---GVLITEFIEGSELLTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRL 126 (170)
T ss_pred hCCCCceEEEeC-CC---CeEEEEecCCCccccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeE
Confidence 5544 4554432 22 3678999998766432 112356778999999999987 12259999999999999 5689
Q ss_pred EEeccccce
Q 046907 209 RISGFGFAR 217 (345)
Q Consensus 209 kl~Dfg~a~ 217 (345)
+++||+.+.
T Consensus 127 ~liDf~~a~ 135 (170)
T cd05151 127 WLIDWEYAG 135 (170)
T ss_pred EEEeccccc
Confidence 999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.9e-11 Score=105.85 Aligned_cols=190 Identities=19% Similarity=0.243 Sum_probs=124.3
Q ss_pred HhhccCCCccceeEEEecCCc---ceeeeeccccCCCCCCCHHHH-------------HHHHHHHHHHHHHHhhcCCCCe
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQGRRELDWLAR-------------HRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~~~l~~~~~-------------~~i~~~i~~~l~~lh~~~~~~i 190 (345)
|-.+-|-|||+++.++.+... .-+.++.+|+..+++-+++++ .+++.||.+||.|||+.. +++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence 344579999999998876432 346778889988776554433 469999999999999986 779
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCC--CCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPD--AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
+|+++.-+.+.+..++-+|++--.-...... ...........+-++|.+||.=..-..+.++||| ||+...||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 9999999999999888888753211110000 0000011223456788999977666667799999 999999998876
Q ss_pred CCCcccccccchhhHHHHH-HHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWM-RNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.-.. ..+.......-+ .......+.. =.+++..|++..|..||+|.+++.
T Consensus 280 iq~t---nseS~~~~ee~ia~~i~~len~l------------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 280 IQST---NSESKVEVEENIANVIIGLENGL------------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccC---CCcceeehhhhhhhheeeccCcc------------------ccCcCcccccCCCCCCcchhhhhc
Confidence 5421 111111111111 1111111111 134666799999999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.6e-10 Score=106.05 Aligned_cols=164 Identities=15% Similarity=0.222 Sum_probs=111.9
Q ss_pred CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCccceeEEEecCCccee
Q 046907 71 GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL 150 (345)
Q Consensus 71 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 150 (345)
..++.+|.|...+.... .......+-++.|+.++||||+++++.+..++ .+
T Consensus 34 k~~~~~vsVF~~~~~~~---------------------------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~--~~ 84 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG---------------------------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEG--TL 84 (690)
T ss_pred eccCCceEEEEEeCCCc---------------------------hhhHHHHHHHHHhhhccCchhhhhhhhhcccC--ce
Confidence 35788888888765432 11334456678899999999999999888877 67
Q ss_pred eeeccccCC-CC---CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcce
Q 046907 151 YILNDVSQG-RR---ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI 226 (345)
Q Consensus 151 ~~~~~~~~~-~~---~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 226 (345)
|+++|-+.- +. .+.-....--+.||+.||.+||+.+ .++|++|..+.|+++..|..||++|-++........
T Consensus 85 ylvTErV~Pl~~~lk~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-- 160 (690)
T KOG1243|consen 85 YLVTERVRPLETVLKELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-- 160 (690)
T ss_pred EEEeeccccHHHHHHHhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--
Confidence 787775522 11 1112223346789999999999776 599999999999999999999999987754322211
Q ss_pred eccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 227 ~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
.......--.|..|+.+.... -..|.| ||++++|++.|..+
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccC
Confidence 001111122345565444222 346999 99999999999443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-10 Score=107.12 Aligned_cols=169 Identities=14% Similarity=0.144 Sum_probs=93.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHH-----HHHH---HHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLL-----NKKM---RQIQSEMLLNKKM 117 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~~~~~ 117 (345)
....|+. ..||+|++|.||+|+++ .+|+.||||+..+.-...-.. +-..+.. ++.. ........-.+..
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~~~I~~-Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLK-DNGREVVVKVLRPDILPVIDA-DLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchHHHHHH-HHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 4556776 78999999999999976 349999999998653221000 0000000 0000 0000000001112
Q ss_pred HH------HHHHHHHHhhc----cCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH-------HHHHHHHHHH-HH
Q 046907 118 RQ------IQSEINTVGQI----RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA-------RHRIALGLAC-GL 179 (345)
Q Consensus 118 ~~------~~~E~~~l~~l----~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~-------~~~i~~~i~~-~l 179 (345)
+. +.+|+.-+.++ .+.+.+.+-..+.+- ...-+++|||+.|+...+... ...++...+. -+
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 22 33344333333 233333333322211 113578999999876643221 1123333322 22
Q ss_pred HHHhhcCCCCeEecCCCCCCeeecCCC----CeEEeccccceecCC
Q 046907 180 EYLHMHHCPRIIHRDLNPVNVLLDDDI----EARISGFGFARAIPD 221 (345)
Q Consensus 180 ~~lh~~~~~~iiH~dlk~~nil~~~~~----~~kl~Dfg~a~~~~~ 221 (345)
..+...| ++|+|++|.||+++.++ .+++.|||+...++.
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3455676 99999999999999887 899999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.4e-10 Score=108.11 Aligned_cols=240 Identities=18% Similarity=0.208 Sum_probs=157.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|..+..||.|.|+.|+.+..+..++..|++|.+.+......+ -..-+.|+-
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-------------------------di~sl~ev~ 317 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-------------------------DIFSLGEVI 317 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-------------------------hhcchhhhh
Confidence 4568899999999999999998755567899999998765544321 122234555
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+...+ .|.+++..+..|...+ ..++-.||+.+++. ++.....++..|++.++.++|+.. ++|+|+
T Consensus 318 l~~~l~~~~~~~g~~~~W~~~r--~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~ 392 (524)
T KOG0601|consen 318 LEAILGSHLPSVGKNSSWSQLR--QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDV 392 (524)
T ss_pred HhhHhhcccccCCCCCCccccc--cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccc
Confidence 55555 5777887776554443 35588888877543 344455678999999999999998 999999
Q ss_pred CCCCeeecCC-CCeEEeccccceecCCCCcceeccCcccCcccc--ccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 196 NPVNVLLDDD-IEARISGFGFARAIPDAHTHITTSNVVGTVEYI--APEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 196 k~~nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~--aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
+|+||++..+ +..+++|||++..+.-. ........+++ +|.......+..++|++ +|..+.+.+++..-..
T Consensus 393 ~psni~i~~~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 393 KPSNILISNDGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred cccceeeccchhhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 9999999876 78899999988642211 11122333444 45555566788999999 9999999998875522
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
.... ... ++. ...+ .......+ +..+.......++..||.+.++....+
T Consensus 468 ~~~~------~~~-i~~---~~~p--------~~~~~~~~---~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 468 SGVQ------SLT-IRS---GDTP--------NLPGLKLQ---LQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cccc------cee-eec---cccc--------CCCchHHh---hhhhhhhhcCCccccchhhhhhcccch
Confidence 1111 000 000 0000 00111233 344444478889999998887765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.1e-09 Score=87.58 Aligned_cols=157 Identities=10% Similarity=-0.035 Sum_probs=98.1
Q ss_pred ccccccCcceeeEEEEecCC-----CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 53 LEKIGSGGCGEVYKAELPGQ-----NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
...||.|-=+.||.|..... .+..+|||+.+....+.........-.. ....+.....+..-...-..+|++.|
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~-rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDY-RFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCc-ccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 45789999999999974311 2579999999876554332111000000 00000000011111233445899999
Q ss_pred hhcc--CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCC
Q 046907 128 GQIR--HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYL-HMHHCPRIIHRDL 195 (345)
Q Consensus 128 ~~l~--hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~l-h~~~~~~iiH~dl 195 (345)
+++. .-++...+++ . --+++|+++++... ++......+..+++.++..+ |..+ ++|+|+
T Consensus 81 ~rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 81 KRMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9884 3456666653 1 24668888876422 12223456778999999988 8888 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIP 220 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~ 220 (345)
++.||+++. +.+.++|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 579999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.6e-08 Score=81.62 Aligned_cols=135 Identities=19% Similarity=0.232 Sum_probs=92.6
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
..+++|+=+.++.+.|. |..+.+|.=-+...-.+...+ .-...+..+|+.++.+++--
T Consensus 2 ~~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~-------------------klrr~Rt~~Earil~~a~~~ 59 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDE-------------------KLRRERTRREARILAKAREA 59 (204)
T ss_pred chhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHH-------------------HHHHHHHHHHHHHHHHHHHc
Confidence 46889999999999873 444556643322221111111 22366778899999988533
Q ss_pred --CccceeEEEecCCcceeeeeccccCCCCCCCHHHHH--HHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeE
Q 046907 134 --NLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH--RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR 209 (345)
Q Consensus 134 --niv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~--~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~k 209 (345)
+...+++ .+++ .-.++|++.+|..+-+.+... .++..+-.-+.-||..+ |+|+||.++|+++.... +.
T Consensus 60 GV~~P~v~d--vD~~--~~~I~me~I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 60 GVPVPIVYD--VDPD--NGLIVMEYIEGELLKDALEEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred CCCCCeEEE--EcCC--CCEEEEEEeCChhHHHHHHhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EE
Confidence 3334433 3333 456788999887654444444 67777878888999999 99999999999998774 99
Q ss_pred Eecccccee
Q 046907 210 ISGFGFARA 218 (345)
Q Consensus 210 l~Dfg~a~~ 218 (345)
++|||++..
T Consensus 132 ~IDfGLg~~ 140 (204)
T COG3642 132 FIDFGLGEF 140 (204)
T ss_pred EEECCcccc
Confidence 999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.3e-07 Score=76.13 Aligned_cols=139 Identities=21% Similarity=0.198 Sum_probs=93.2
Q ss_pred cccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 52 SLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
.+..|-+|+=+.|+++.+ .|+...||.=+....-.++..+ .-...+..+|++.|.++.
T Consensus 11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~-------------------kLtr~Rt~~Ear~l~k~~ 68 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQ-------------------KLTRKRTKQEARLLAKCR 68 (229)
T ss_pred cceeeeccceeeEeeecc---CCceeEEeecccccccchHHHH-------------------HHHHHHHHHHHHHHHHHH
Confidence 678899999999999998 5778788866544333222211 223667788999998875
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
---|.-=.-++.+.+ .-.++|||.+|... ..-.....++..+-+.+.-||..+ ++|+||..+|
T Consensus 69 ~~GI~~P~l~~~D~~--~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSN 143 (229)
T KOG3087|consen 69 ALGIPAPRLIFIDTY--GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSN 143 (229)
T ss_pred HhCCCCceEEEEecC--CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccc
Confidence 333222222233333 23556777766221 111112468888889999999998 9999999999
Q ss_pred eeecCCC---CeEEeccccce
Q 046907 200 VLLDDDI---EARISGFGFAR 217 (345)
Q Consensus 200 il~~~~~---~~kl~Dfg~a~ 217 (345)
+++..++ .+.++|||++.
T Consensus 144 ill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 144 ILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eEEecCCCcCceEEEeecchh
Confidence 9997544 45899999975
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2e-09 Score=106.22 Aligned_cols=246 Identities=21% Similarity=0.204 Sum_probs=155.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....+++.+.+-+-+|+++.++.++ +...|...++|.....+... ....+....+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~-pa~sgh~~~~~v~~~ap~i~------------------------~~~~~s~r~~ 854 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPAS-PAGSGHTRPSKVHGLAPKIR------------------------TNDYESIRSK 854 (1205)
T ss_pred cCCCccceecccccCCCCcccccCC-ccccccccchhhhccchhhc------------------------cccccccCCc
Confidence 3456788888899999999999887 44556666666653322111 1123333444
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH---------HHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA---------RHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~---------~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
-.++-..++|-++...-.+ +....+++++++..++.+.+.+. ...+...+..++++||+.. +.|+|
T Consensus 855 s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~ 929 (1205)
T KOG0606|consen 855 SNILITPRSPAVVRSFPSF--PCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRD 929 (1205)
T ss_pred cCccccCCCCceecccCCC--CCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhccc
Confidence 4444444556555443321 22235788888887765543321 2345566788999999997 89999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCC--------C----------------cc-----eeccCcccCccccccccccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDA--------H----------------TH-----ITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~--------~----------------~~-----~~~~~~~gt~~~~aPE~~~~ 245 (345)
++|.|.++..++..+++|||.....+-. . .. .......||+.|.+||.+.+
T Consensus 930 ~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg 1009 (1205)
T KOG0606|consen 930 LKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG 1009 (1205)
T ss_pred ccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc
Confidence 9999999999999999999844322110 0 00 01124678999999999999
Q ss_pred cccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccC
Q 046907 246 LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTL 324 (345)
Q Consensus 246 ~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~ 324 (345)
......+|+| +|+++.|.++|.+||...... +....+ .....+ .++..........+++...+.
T Consensus 1010 ~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq----~~f~ni---~~~~~~--------~p~g~~~~s~~aq~~~~~ll~ 1074 (1205)
T KOG0606|consen 1010 RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ----QIFENI---LNRDIP--------WPEGPEEGSYEAQDLINRLLT 1074 (1205)
T ss_pred ccCCCcchhhhhhhhhhhhhcCCCCCCCcchh----hhhhcc---ccCCCC--------CCCCccccChhhhhhhhhhhc
Confidence 9999999999 999999999999996543321 111111 111000 011222223335566666778
Q ss_pred CCCCCCCCHH
Q 046907 325 EDPNERPNSK 334 (345)
Q Consensus 325 ~dp~~Rpt~~ 334 (345)
.+|.+|-.+.
T Consensus 1075 ~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1075 EEPTQRLGAK 1084 (1205)
T ss_pred cCchhccCcc
Confidence 8998887664
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.9e-08 Score=79.27 Aligned_cols=145 Identities=17% Similarity=0.113 Sum_probs=82.4
Q ss_pred eeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC--CccceeE
Q 046907 63 EVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR--NLHPLLA 140 (345)
Q Consensus 63 ~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~ 140 (345)
.||.|... +|..+|||..+....+..............+..+ ....+.........+|.+.|.++..- ++.+.++
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~-~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYR-HKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC---G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccc-cccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 48999753 7889999999876554433211111111100000 01112233456778899999999644 5666664
Q ss_pred EEecCCcceeeeeccccC--CCCCCCHH-------HHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCCeeecCCCCeEE
Q 046907 141 HVTRPDCHLLYILNDVSQ--GRRELDWL-------ARHRIALGLACGLEY-LHMHHCPRIIHRDLNPVNVLLDDDIEARI 210 (345)
Q Consensus 141 ~~~~~~~~~l~~~~~~~~--~~~~l~~~-------~~~~i~~~i~~~l~~-lh~~~~~~iiH~dlk~~nil~~~~~~~kl 210 (345)
+. . -+++|||++ |..+-... ....++.++...+.. +|..| ++|+|+.+.||+++.+ .+.+
T Consensus 78 ~~--~----~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 78 YN--R----NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp EE--T----TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred Ee--C----CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 42 2 358889988 42222111 234577777775555 57888 9999999999999988 9999
Q ss_pred eccccceecC
Q 046907 211 SGFGFARAIP 220 (345)
Q Consensus 211 ~Dfg~a~~~~ 220 (345)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.6e-07 Score=80.17 Aligned_cols=136 Identities=18% Similarity=0.226 Sum_probs=97.4
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC-
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH- 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h- 132 (345)
+.||.|..+.||+++.. +|..+++|........ .....+..|+.+++.+.+
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~--------------------------~~~~~~~~E~~~~~~l~~~ 55 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALL--------------------------PSAHDVAREYRVLRALAGT 55 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccC--------------------------cccccHHHHHHHHHHhhCC
Confidence 56899999999999863 4688999997543221 013456788899988865
Q ss_pred -CCccceeEEEecCC-cceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcC----------------
Q 046907 133 -RNLHPLLAHVTRPD-CHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHH---------------- 186 (345)
Q Consensus 133 -pniv~l~~~~~~~~-~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~---------------- 186 (345)
.++.+++.+..... ....++++++++|... ++......++.+++++|..||+..
T Consensus 56 ~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 56 GVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred CCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 34567777655432 1135789999987644 233456678888888888888531
Q ss_pred -------------------------------------CCCeEecCCCCCCeeecC--CCCeEEeccccce
Q 046907 187 -------------------------------------CPRIIHRDLNPVNVLLDD--DIEARISGFGFAR 217 (345)
Q Consensus 187 -------------------------------------~~~iiH~dlk~~nil~~~--~~~~kl~Dfg~a~ 217 (345)
...++|+|+.+.|++++. ++.+.++||+.+.
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 134799999999999998 5668899999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1e-06 Score=81.58 Aligned_cols=159 Identities=19% Similarity=0.222 Sum_probs=113.7
Q ss_pred ceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCccceeE
Q 046907 61 CGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLA 140 (345)
Q Consensus 61 ~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~ 140 (345)
-...|++..+ .+|..|.+|++.....-. ......-++.++++.|+|+|++.+
T Consensus 289 ~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~---------------------------~nk~t~lve~wkkl~h~NvV~fre 340 (655)
T KOG3741|consen 289 SITTYKATSN-VDGNAYVLKRLHGDRDQS---------------------------TNKDTSLVEAWKKLCHTNVVPFRE 340 (655)
T ss_pred cceeEeeeec-cCCceeeeeeeccccccC---------------------------cccchHHHHHHHHhccCceeehhh
Confidence 3467899754 689999999993321100 111223477889999999999999
Q ss_pred EEecC--CcceeeeeccccCCC-------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 141 HVTRP--DCHLLYILNDVSQGR-------------------------RELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 141 ~~~~~--~~~~l~~~~~~~~~~-------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
++.+. +...++++.+|.++. ...++...+.++.|+..||.++|+.| +.-+
T Consensus 341 vf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck 417 (655)
T KOG3741|consen 341 VFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACK 417 (655)
T ss_pred hhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceee
Confidence 88732 234677888887652 23455667889999999999999999 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
-|.+.+|+++.+.+++|+..|....+.... + |-+. .-.+-|.- +|.++.-|.||..-
T Consensus 418 ~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 418 TLDLKKILVTGKMRIRISGCGIMDVLQEDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cccHhHeEeeCcceEEEecccceeeecCCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 999999999999889988877654433221 0 1111 12456887 99999999998544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.9e-07 Score=79.73 Aligned_cols=176 Identities=17% Similarity=0.137 Sum_probs=112.3
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccc
Q 046907 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEY 242 (345)
Q Consensus 163 l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~ 242 (345)
.+|.-..+.+..++.+..-||+.| ..-+|+.++|+|++.++.+.+.|-..-....+... .-..+|...|++||.
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~---~~cpVg~~eftPPEl 187 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTL---HLCPVGVSEFTPPEL 187 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeeccCCce---EecccCccccCCHHH
Confidence 567777899999999999999999 88899999999999999999987432222212211 123688999999998
Q ss_pred cc-----ccccCccchhh-HHHHHHHHHhC-CCCCcccccccchhhH-HHHHHHHhhhcCCCcc--ccccccCCCcHHHH
Q 046907 243 LQ-----MLTLTEKCDIY-FGALLAGLVMG-KLPSDKFFQHTNEMSF-VKWMRNVMASENPKRA--IDSKLVGNGCEEQM 312 (345)
Q Consensus 243 ~~-----~~~~~~~~Dvw-lG~vl~el~tg-~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 312 (345)
.. +..-+...|.+ +|+++++++.| ..||.+.......... ..-|............ ..+...+...+-..
T Consensus 188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lp 267 (637)
T COG4248 188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLP 267 (637)
T ss_pred hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcC
Confidence 75 23346789999 99999999885 9998765432222211 1122222111111100 00000001111222
Q ss_pred HHHHHHHhhccCC--CCCCCCCHHHHHHHHhhhh
Q 046907 313 LLVLKIACFCTLE--DPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 313 ~~l~~li~~Cl~~--dp~~Rpt~~~ll~~L~~l~ 344 (345)
..+..+..+|+.. ++.-|||++.=+..|.++.
T Consensus 268 p~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 268 PDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 3455666678865 3557999998888887764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1e-06 Score=75.58 Aligned_cols=154 Identities=18% Similarity=0.146 Sum_probs=108.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
-..++..||-|.=|.||.|... .|.++|||.-+-...+....-..+.....+ ....|..-......+|.++|+
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~-----~h~sWl~~sRl~A~rEf~~L~ 164 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADK-----EHGSWLYVSRLAAEREFEALQ 164 (304)
T ss_pred HHhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccc-----cCcchhhhHHHHHHHHHHHHH
Confidence 4566789999999999999864 799999999877655544322222211111 111233445777889999999
Q ss_pred hccCC--CccceeEEEecCCcceeeeeccccCCCCCC----CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 129 QIRHR--NLHPLLAHVTRPDCHLLYILNDVSQGRREL----DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 129 ~l~hp--niv~l~~~~~~~~~~~l~~~~~~~~~~~~l----~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
+|... .+.+-+++- --.++|++.+|-.+. +......++..|+.-+...-..| ++|+|+++=||++
T Consensus 165 ~L~~~G~~VP~P~~~n------RHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 165 RLYPEGVKVPKPIAWN------RHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred HhhhcCCCCCCccccc------cceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 98544 566665541 246788888874432 23445567777777777777787 9999999999999
Q ss_pred cCCCCeEEecccccee
Q 046907 203 DDDIEARISGFGFARA 218 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~ 218 (345)
+.+|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=6.7e-06 Score=72.18 Aligned_cols=97 Identities=16% Similarity=0.137 Sum_probs=67.9
Q ss_pred HHHHHHHHHhhccCCC--ccceeEEEecCC---cceeeeeccccCCCCCC------------CHHHHHHHHHHHHHHHHH
Q 046907 119 QIQSEINTVGQIRHRN--LHPLLAHVTRPD---CHLLYILNDVSQGRREL------------DWLARHRIALGLACGLEY 181 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpn--iv~l~~~~~~~~---~~~l~~~~~~~~~~~~l------------~~~~~~~i~~~i~~~l~~ 181 (345)
.+.+|...+.++..-+ ....+++..... ...-+++++++++...+ +......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 4678888887773222 334444443221 22357888888774221 122345788899999999
Q ss_pred HhhcCCCCeEecCCCCCCeeecC-------CCCeEEecccccee
Q 046907 182 LHMHHCPRIIHRDLNPVNVLLDD-------DIEARISGFGFARA 218 (345)
Q Consensus 182 lh~~~~~~iiH~dlk~~nil~~~-------~~~~kl~Dfg~a~~ 218 (345)
||..| ++|+|++++|||++. +..+.++||+.+..
T Consensus 154 LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999 999999999999975 46789999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=2e-05 Score=65.93 Aligned_cols=136 Identities=12% Similarity=0.110 Sum_probs=89.1
Q ss_pred cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCC-
Q 046907 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRN- 134 (345)
Q Consensus 56 iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn- 134 (345)
-|+|+.|-|++-.+ .|..+-+|.-.+.....-.. +--...|.+|...++.|..-+
T Consensus 26 ~~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~---------------------P~g~ptf~rE~~~L~~L~~~Gv 81 (216)
T PRK09902 26 YRRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRY---------------------PFGRPTIVREVAVIKELERAGV 81 (216)
T ss_pred cCCCCcceEEEEEe---CCcEEEEEeccCcccccccC---------------------CCCchHHHHHHHHHHHHHHcCC
Confidence 36799999999876 45578899876332211000 012456888999988884222
Q ss_pred -cccee--EEEecCCcceeeeeccccCCC-CC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 135 -LHPLL--AHVTRPDCHLLYILNDVSQGR-RE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 135 -iv~l~--~~~~~~~~~~l~~~~~~~~~~-~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+.+.. +.-..+....-++|++-+++- ++ .+......+..+++..+.-||+.| +.|+|+.+.|
T Consensus 82 PVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~kh 158 (216)
T PRK09902 82 IVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRH 158 (216)
T ss_pred CCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhh
Confidence 33333 111223333345666655432 11 133344689999999999999999 9999999999
Q ss_pred eeecCCCC--eEEecccccee
Q 046907 200 VLLDDDIE--ARISGFGFARA 218 (345)
Q Consensus 200 il~~~~~~--~kl~Dfg~a~~ 218 (345)
|+++.++. ++++||--++.
T Consensus 159 Ill~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 159 IYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eeecCCCCeeEEEEEhhccch
Confidence 99986666 89999986653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.8e-05 Score=64.57 Aligned_cols=153 Identities=12% Similarity=0.084 Sum_probs=94.6
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..-.++|...+++-......|.+-.. +|..+.+|...+...-.... ...........+....
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~---------------~~sf~kg~~~~~l~~~ 88 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERR---------------FKSFFKGSEYSRLINN 88 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHH---------------HHHHhccHHHHHHHHH
Confidence 44667888888888888877877765 67889999986533221111 1111112222333333
Q ss_pred HHHHhhccCCCccceeEEEecCCc---ceeeeeccccCCCCCCCHHHHH-HHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQGRRELDWLARH-RIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~~~l~~~~~~-~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
...+....--....++....-... ...++++||++|..+.+..... .++..+.+++.-+|..| ++|+|..|.|
T Consensus 89 ~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G---~~HGD~hpgN 165 (229)
T PF06176_consen 89 TDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHG---FYHGDPHPGN 165 (229)
T ss_pred HHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcC---CccCCCCcCc
Confidence 333333222233333333222211 1346799999997765443322 35567788899999999 9999999999
Q ss_pred eeecCCCCeEEecccccee
Q 046907 200 VLLDDDIEARISGFGFARA 218 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~ 218 (345)
++++.+ .+++.||+..+.
T Consensus 166 Flv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 166 FLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred EEEECC-cEEEEECccccc
Confidence 999965 599999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.9e-07 Score=87.07 Aligned_cols=179 Identities=16% Similarity=0.144 Sum_probs=124.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
.-...-+...+..++|+++.+++.+- .. .+...++.+... .....+
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRp-ta-eklL~h~fvs~~--------------------------------l~~rl~ 283 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRP-TA-EKLLQHPFVSQT--------------------------------LSRRLA 283 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCC-Ch-hhheeceeeccc--------------------------------hhhHHH
Confidence 33555667788899999999999873 12 223335655321 223457
Q ss_pred HHHHhhccCCC-ccceeEEEecCCcceeeeeccccCCC-CCC----------CHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 124 INTVGQIRHRN-LHPLLAHVTRPDCHLLYILNDVSQGR-REL----------DWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 124 ~~~l~~l~hpn-iv~l~~~~~~~~~~~l~~~~~~~~~~-~~l----------~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+++|.+++||| .+..++-+..+ ...++.++++.++ +.. ...+...+...-..+++++|+.- -+
T Consensus 284 ~eLLdK~n~P~~~v~~~~d~~~E--~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~ 358 (829)
T KOG0576|consen 284 IELLDKVNNPNPVVRYLEDYDGE--DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KV 358 (829)
T ss_pred HHHHHHccCCCCcccccccCCcc--cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---cc
Confidence 89999999999 55555544433 4788899998776 211 11122234445567888888875 58
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|+| |++... ...+..||+....+.... ......++..|+|||+..+..+....|+| .|.--.++.-|.+|
T Consensus 359 ~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 359 HRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred Ccc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 887 766655 578999999987765432 33557899999999999999999999999 99876777777766
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.2e-05 Score=64.72 Aligned_cols=130 Identities=19% Similarity=0.163 Sum_probs=91.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.....+....||+|.+|.||+|.| .|..+|+|.-+.. .....+..|++
T Consensus 20 ~~~~~~v~~~L~KG~~s~Vyl~~~---~~~~~a~Kvrr~d-----------------------------s~r~~l~kEak 67 (201)
T COG2112 20 GKYELRVEKELAKGTTSVVYLGEW---RGGEVALKVRRRD-----------------------------SPRRNLEKEAK 67 (201)
T ss_pred cchhhhhhhhhhcccccEEEEeec---cCceEEEEEecCC-----------------------------cchhhHHHHHH
Confidence 334555678899999999999998 4668999987643 22566788999
Q ss_pred HHhhccCCCcc-ceeEEEecCCcceeeeeccccCCCCCCCHHHH--HHHHHHHHHHHHHHhhcCCCCeEecCCCC--CCe
Q 046907 126 TVGQIRHRNLH-PLLAHVTRPDCHLLYILNDVSQGRRELDWLAR--HRIALGLACGLEYLHMHHCPRIIHRDLNP--VNV 200 (345)
Q Consensus 126 ~l~~l~hpniv-~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~--~~i~~~i~~~l~~lh~~~~~~iiH~dlk~--~ni 200 (345)
+|..++..++- ++|.+.. .++.|+|+.|..+..+... .+-...+++..--|-..| |-|..+.- .|+
T Consensus 68 iLeil~g~~~~p~vy~yg~------~~i~me~i~G~~L~~~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~v 138 (201)
T COG2112 68 ILEILAGEGVTPEVYFYGE------DFIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNV 138 (201)
T ss_pred HHHHhhhcCCCceEEEech------hhhhhhhhcCcchhhhhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeE
Confidence 99998766654 3433321 2234999998877666552 444555666666667777 88988864 455
Q ss_pred eecCCCCeEEeccccce
Q 046907 201 LLDDDIEARISGFGFAR 217 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~ 217 (345)
++.. ..+.|+||..|+
T Consensus 139 lv~~-~~~~iIDFd~At 154 (201)
T COG2112 139 LVND-RDVYIIDFDSAT 154 (201)
T ss_pred EecC-CcEEEEEccchh
Confidence 5544 489999999876
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=2e-05 Score=65.46 Aligned_cols=150 Identities=19% Similarity=0.209 Sum_probs=96.8
Q ss_pred hcCCcccccccccCcc-eeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGC-GEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~-g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
-..++++++.||.|+- |.||+++. +|..+|+|.+..-....+....+.-..... +.........-|..|.
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~------~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHET------SLSTPAHYADPFNCEC 105 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCcccccccccccc------ccchhhhhcChHHHHH
Confidence 3479999999999999 99999997 688999999433222222111000000000 0000012345677888
Q ss_pred HHHhhc---cCCCc--cceeEEEecCC----------------cceeeeeccccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 046907 125 NTVGQI---RHRNL--HPLLAHVTRPD----------------CHLLYILNDVSQGRRELDWLARHRIALGLACGLEYLH 183 (345)
Q Consensus 125 ~~l~~l---~hpni--v~l~~~~~~~~----------------~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh 183 (345)
+...+| .+.++ |+++||..-.. ....-+|.||......+...+ +.++.+-+..+|
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCccccchhH----HHHHHHHHHHHH
Confidence 887776 45566 89999884331 112245888887766444333 345566678899
Q ss_pred hcCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 046907 184 MHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216 (345)
Q Consensus 184 ~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a 216 (345)
..| |+-+|+++.|.. .-+++|||.+
T Consensus 182 k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCC---eeeccCcccccc-----CCEEEecccC
Confidence 999 999999999987 5699999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.3e-06 Score=83.51 Aligned_cols=93 Identities=23% Similarity=0.459 Sum_probs=70.9
Q ss_pred HHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcce-e------ccCcccCccccccccccccc
Q 046907 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI-T------TSNVVGTVEYIAPEYLQMLT 247 (345)
Q Consensus 175 i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~------~~~~~gt~~~~aPE~~~~~~ 247 (345)
++.|+.++|... .++|+++.|+++.++..+.+|++.|+.+.......... . ..-..-...|.|||++.+.-
T Consensus 108 v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 448999999987 69999999999999999999999998876543311100 0 00112345699999999877
Q ss_pred cCccchhh-HHHHHHHHHhCCCC
Q 046907 248 LTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 248 ~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
.+.++|++ +|+++|-+..|..+
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred ccccccceeeeeEEEEEecCCcc
Confidence 88899999 99999988854433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.2e-05 Score=76.67 Aligned_cols=160 Identities=15% Similarity=0.131 Sum_probs=89.6
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHH-HH-------HHHHHHHHHHHH------H
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKM-RQ-------IQSEMLLNKKMR------Q 119 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~------~ 119 (345)
.-|+.+|-|.||+|+++ +|+.||||+.++.-...-.... ..+..-... ++ ..-...-.+-.+ .
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL-~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADL-KLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHH-HHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 67899999999999986 7999999999876543221111 011000000 00 000000011111 2
Q ss_pred HHHHHHHHhhc----c-CCCccceeEEEecCCcceeeeeccccCCCCCCCHH-------HHHHHHHHHHHH-HHHHhhcC
Q 046907 120 IQSEINTVGQI----R-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL-------ARHRIALGLACG-LEYLHMHH 186 (345)
Q Consensus 120 ~~~E~~~l~~l----~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~-------~~~~i~~~i~~~-l~~lh~~~ 186 (345)
+.+|+.-+.++ + .|+ +.+-..+.+- ..--+++|||+.|-...+.. +...++..++.+ +..+-..|
T Consensus 208 y~~EA~n~~~~~~nf~~~~~-v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 208 YRREAANAERFRENFKDDPD-VYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCC-eEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcC
Confidence 33344444444 2 222 2222222110 00136789999886554432 123444444443 33444456
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~ 221 (345)
+.|.|..|.|++++.++.+.+.|||+...++.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999877654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00013 Score=62.61 Aligned_cols=127 Identities=17% Similarity=0.126 Sum_probs=80.1
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHR 133 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 133 (345)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~-----------------------------~~~~i~~E~~~l~~l~~~ 52 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF-----------------------------DKETIKREFDASRKVFSL 52 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCC-----------------------------CHHHHHHHHHHHHHHHHc
Confidence 67899999999984 23356688875321 123346788888887533
Q ss_pred C--ccceeEEEecCCcceeeeeccccCCCC------CCCHHHHHHHHHHHHHHHHHHhhc--------------------
Q 046907 134 N--LHPLLAHVTRPDCHLLYILNDVSQGRR------ELDWLARHRIALGLACGLEYLHMH-------------------- 185 (345)
Q Consensus 134 n--iv~l~~~~~~~~~~~l~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~-------------------- 185 (345)
. +.+.+++....+ ...+++++++|.. ..+......++.++++.+.-+|+.
T Consensus 53 glpvP~~~~~~~~~~--~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~ 130 (226)
T TIGR02172 53 GIPTPHPFDLVEDGG--RLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEE 130 (226)
T ss_pred CCCCCceEEEEecCC--eeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHh
Confidence 2 456666655444 3556889998863 112222223344444444334431
Q ss_pred --------------------CCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 186 --------------------HCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 186 --------------------~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
....++|+|+.|.|++++.++ +.++||+.+.
T Consensus 131 ~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 131 KDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 013478999999999999887 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.93 E-value=9e-05 Score=62.68 Aligned_cols=99 Identities=24% Similarity=0.242 Sum_probs=70.5
Q ss_pred HHHHHHHHHHHhhcc--CCCccceeEEEecCCc--ceeeeeccccCCCC-C---------CCHHHHHHHHHHHHHHHHHH
Q 046907 117 MRQIQSEINTVGQIR--HRNLHPLLAHVTRPDC--HLLYILNDVSQGRR-E---------LDWLARHRIALGLACGLEYL 182 (345)
Q Consensus 117 ~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~--~~l~~~~~~~~~~~-~---------l~~~~~~~i~~~i~~~l~~l 182 (345)
..+..+|...+..+. .=.....+++...... ...+++++.+++.. + .+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 456677777777663 2224455555544222 23477888887642 2 22334567899999999999
Q ss_pred hhcCCCCeEecCCCCCCeeecCCC---CeEEecccccee
Q 046907 183 HMHHCPRIIHRDLNPVNVLLDDDI---EARISGFGFARA 218 (345)
Q Consensus 183 h~~~~~~iiH~dlk~~nil~~~~~---~~kl~Dfg~a~~ 218 (345)
|+.| ++|+|+++.|||++.+. .+.++||+.++.
T Consensus 135 H~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999999876 789999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00083 Score=57.36 Aligned_cols=156 Identities=17% Similarity=0.134 Sum_probs=89.9
Q ss_pred hcCCcccccc---cccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhh---hhHHHHHHHH-HHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEK---IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIE---EDSMLLNKKM-RQIQSEMLLNKKMR 118 (345)
Q Consensus 46 ~~~~~~~~~~---iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~ 118 (345)
-.++..+... |.+|.-+.||+|.. .++..+|||+++........... .+..+.+-.. .+... ..
T Consensus 43 L~~rg~i~~~~g~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv-------~~ 113 (268)
T COG1718 43 LLSRGVITELVGCISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV-------FA 113 (268)
T ss_pred HhcCCceeeeEeeecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH-------HH
Confidence 3344444444 44566668999974 36899999999876654433111 1111111111 11111 12
Q ss_pred HHHHHHHHHhhcc--CCCccceeEEEecCCcceeeeeccccCCCC-CC--------CHHHHHHHHHHHHHHHHHHhh-cC
Q 046907 119 QIQSEINTVGQIR--HRNLHPLLAHVTRPDCHLLYILNDVSQGRR-EL--------DWLARHRIALGLACGLEYLHM-HH 186 (345)
Q Consensus 119 ~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-~l--------~~~~~~~i~~~i~~~l~~lh~-~~ 186 (345)
=..+|..-|+++. +=.+.+=+.+. .-+++|+|++..+ .- .......+..++++.+.-|-. .+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 2234566666552 11122222211 1367888886542 11 111345667778888877777 55
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~ 220 (345)
++|+||+.=|||+. ++.+.|+|+|-|....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 7799999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00034 Score=59.94 Aligned_cols=76 Identities=18% Similarity=0.295 Sum_probs=48.2
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
++.|+.|..+.||+.+.. + ..+++|..... .....+..|..+++.+..
T Consensus 2 i~~l~~G~~n~~~~v~~~--~-~~~vlK~~~~~-----------------------------~~~~~~~~e~~~~~~l~~ 49 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--D-GRYVLKFYRPP-----------------------------DAAERLRREAAVLRQLAE 49 (239)
T ss_dssp EEEEEESSSSEEEEEEET--T-SEEEEEEESSH-----------------------------HHHHHHHHHHHHHHHHHH
T ss_pred CccCCCCCeeeEEEEEEC--C-cEEEEEEeCCC-----------------------------CCHHHHHHHHHHHHHHHh
Confidence 457899999999999863 3 58889997532 124556678888877743
Q ss_pred C--CccceeEEEecCC-cceeeeeccccCCC
Q 046907 133 R--NLHPLLAHVTRPD-CHLLYILNDVSQGR 160 (345)
Q Consensus 133 p--niv~l~~~~~~~~-~~~l~~~~~~~~~~ 160 (345)
. .+.+++....... ....+.+++++++.
T Consensus 50 ~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 50 HGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp TTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred cCCCCceEEeecccccccccceEEEEEeccc
Confidence 2 3556666443332 22467788887764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00022 Score=59.31 Aligned_cols=91 Identities=20% Similarity=0.175 Sum_probs=72.6
Q ss_pred HHHHHHhhccC-CCccceeEEEecCCcceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 122 SEINTVGQIRH-RNLHPLLAHVTRPDCHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 122 ~E~~~l~~l~h-pniv~l~~~~~~~~~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
.|.-+++.+++ +++.+++|+|-. +++.|+.+.+ ...+|..+.++|.++++.+.++++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47888888865 689999998831 2333444432 2358999999999999999999997666
Q ss_pred CeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
.+.-+|++++|+.++.++.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 699999999999999999999999876644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0015 Score=62.52 Aligned_cols=159 Identities=18% Similarity=0.183 Sum_probs=88.9
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhh--hhhhHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHH--
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAAL--IEEDSMLL--NKKMRQIQSEMLLNKKMRQIQSEINTV-- 127 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~E~~~l-- 127 (345)
+.||..+.|.|++|+.+ +|+.||||+-++.-...-.. ..-+-... ++..........-.+..+.+..|+..+
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 57999999999999986 69999999987654332111 00000000 000000011111122222333333222
Q ss_pred ----h----hccCCC------ccceeEEEecCCcceeeeeccccCCCCCCCHHHH-------HHHHHHHHHHH-HHHhhc
Q 046907 128 ----G----QIRHRN------LHPLLAHVTRPDCHLLYILNDVSQGRRELDWLAR-------HRIALGLACGL-EYLHMH 185 (345)
Q Consensus 128 ----~----~l~hpn------iv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~-------~~i~~~i~~~l-~~lh~~ 185 (345)
. .+.|-+ |.++|..+.+ .-+++|||++|....+.... ..++..+.++. .-+-..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc
Confidence 2 233444 3344433222 24789999999776554432 23444444432 223334
Q ss_pred CCCCeEecCCCCCCeeecC----CCCeEEeccccceecCC
Q 046907 186 HCPRIIHRDLNPVNVLLDD----DIEARISGFGFARAIPD 221 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~----~~~~kl~Dfg~a~~~~~ 221 (345)
| ++|+|-.|-||++.. ++.+.+-|||+......
T Consensus 321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4 999999999999983 66899999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0033 Score=54.51 Aligned_cols=29 Identities=17% Similarity=0.178 Sum_probs=25.4
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.|.|++++.+....|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999987777899998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0012 Score=67.27 Aligned_cols=192 Identities=21% Similarity=0.216 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHhhccCCCccceeEEEecCCcce--eeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHh
Q 046907 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL--LYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLH 183 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~--l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh 183 (345)
+.......|...+.+..|+|++.++.+....-... +.+..+++.... ..+......+..++.+|+.++|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34556667888889999999999998776543222 223445554432 2344455568888999999999
Q ss_pred hcCCCCeEecCCCCC---CeeecCCCCeEEe--ccccceecCCCCcceeccCcccCccccccccccccccCc--cchhh-
Q 046907 184 MHHCPRIIHRDLNPV---NVLLDDDIEARIS--GFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE--KCDIY- 255 (345)
Q Consensus 184 ~~~~~~iiH~dlk~~---nil~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~--~~Dvw- 255 (345)
+.. ..|.-+..+ +-..+..+...++ ||+.+....+.... .....+..+.+||......... ..|+|
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence 986 666666655 4444556666666 88877765443221 1233455677888877666544 47999
Q ss_pred HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 256 FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 256 lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
+|.....+..|..+..... .....+ +. .... .+.+....|+..++++|+.+.+
T Consensus 378 lgll~~~~~~~~~i~~~~~----------~~~~~l---------~~----~~~~----~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA----------VPVSLL---------DV----LSTS----ELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHhhhhhcCccccccc----------chhhhh---------cc----ccch----hhhhhhhhhcchhhhhccchhh
Confidence 9999999988776621100 000000 00 0000 2556667799999999999988
Q ss_pred HHHH
Q 046907 336 VRRM 339 (345)
Q Consensus 336 ll~~ 339 (345)
++..
T Consensus 431 ll~~ 434 (1351)
T KOG1035|consen 431 LLTH 434 (1351)
T ss_pred hhhc
Confidence 8753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.011 Score=60.77 Aligned_cols=83 Identities=11% Similarity=0.207 Sum_probs=53.1
Q ss_pred ccccccCcceeeEEEEecCCC-CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 53 LEKIGSGGCGEVYKAELPGQN-GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
+..++.|.+..+|+.++.... ...+++|+....... .....+.+|+.+++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--------------------------~~~~~~~rE~~~l~~L~ 96 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--------------------------QSAHAVEREYQVLRALG 96 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--------------------------ccHHHHHHHHHHHHHHh
Confidence 577899999999998764211 135667765322110 01235668999999985
Q ss_pred -CCCc--cceeEEEecCC-cceeeeeccccCCCC
Q 046907 132 -HRNL--HPLLAHVTRPD-CHLLYILNDVSQGRR 161 (345)
Q Consensus 132 -hpni--v~l~~~~~~~~-~~~l~~~~~~~~~~~ 161 (345)
|+++ .+++.++.++. ....+++|++++|..
T Consensus 97 ~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 97 EHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred hcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 6664 67777765542 123578899988753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.015 Score=48.66 Aligned_cols=144 Identities=20% Similarity=0.218 Sum_probs=80.9
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc-
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR- 131 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 131 (345)
...||+|+.-.||.- + ......||+........ ........+ .........+..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~H--P--~dp~~cIKV~~~~~~~~--~~~~~~~~k---------~~~~~~~~~~~~~E~~~y~~l~~ 70 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P--DDPNLCIKVMRPDRGER--RRPFKRWLK---------RLRPKSRYRQNRRELRYYKQLSL 70 (199)
T ss_pred CcccccCCCceEEEC--C--CCCCeEEEEEccccccc--cccchhHHH---------hhcccchhHHHHHHHHHHHHHhh
Confidence 467999999999974 3 34446688887654110 000001110 0011223555666666665555
Q ss_pred -----CCCccceeEEEecCCcceeee--eccccCCCCCCCHH-HH-------HHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 132 -----HRNLHPLLAHVTRPDCHLLYI--LNDVSQGRRELDWL-AR-------HRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 132 -----hpniv~l~~~~~~~~~~~l~~--~~~~~~~~~~l~~~-~~-------~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+..|.+++|+..++-+.-+++ +.+. .|..-..+ .. ..+...+-+-..+|-+.+ |+.+|++
T Consensus 71 ~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~--dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~ 145 (199)
T PF10707_consen 71 RRGVDWSHIPRFYGFVETNLGLGLVVELIRDA--DGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLN 145 (199)
T ss_pred ccCCcccccccEeEEEecCCceEEEEEEEECC--CCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCC
Confidence 888999999999887544333 2222 12211111 00 022223333346777777 9999999
Q ss_pred CCCeeecCC--C--CeEEec-cccc
Q 046907 197 PVNVLLDDD--I--EARISG-FGFA 216 (345)
Q Consensus 197 ~~nil~~~~--~--~~kl~D-fg~a 216 (345)
|.||++... + .+.++| ||..
T Consensus 146 ~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cccEEEEecCCCceEEEEEeCCCCc
Confidence 999999632 2 467777 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0085 Score=51.69 Aligned_cols=29 Identities=31% Similarity=0.453 Sum_probs=24.6
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.|++++.....-|.||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 38999999999999876556799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.015 Score=50.00 Aligned_cols=29 Identities=17% Similarity=0.374 Sum_probs=25.5
Q ss_pred CeEecCCCCCCeeecC-CCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDD-DIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~-~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.||+++. ++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4999999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.027 Score=50.43 Aligned_cols=81 Identities=11% Similarity=-0.006 Sum_probs=52.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
...-...||.|..+.||+.... ++ .+.+|..+.. .....+..|+..|+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~-----------------------------~~~~~~~~Ea~~L~ 62 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS--QG-NPMPLMARSF-----------------------------STPGVAQQEAWKLS 62 (297)
T ss_pred hhheeeecCCccceeEEEEEcC--CC-CEEEEEeccc-----------------------------ccchHHHHHHHHHH
Confidence 3444568999999999998642 34 4566775321 01346778899888
Q ss_pred hccC---CCccceeEEEecCC-cceeeeeccccCCCC
Q 046907 129 QIRH---RNLHPLLAHVTRPD-CHLLYILNDVSQGRR 161 (345)
Q Consensus 129 ~l~h---pniv~l~~~~~~~~-~~~l~~~~~~~~~~~ 161 (345)
.+.- -.+.++++++..+. ...-++++++++++.
T Consensus 63 ~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~ 99 (297)
T PRK10593 63 MLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVS 99 (297)
T ss_pred HHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEe
Confidence 8842 35778887765431 123677888877643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0079 Score=52.63 Aligned_cols=28 Identities=14% Similarity=0.339 Sum_probs=24.7
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.|.|++++.++ +.+.||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999999876 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.017 Score=51.70 Aligned_cols=29 Identities=41% Similarity=0.486 Sum_probs=25.6
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.|.|++++.+..+.|.||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 49999999999999987777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.045 Score=49.30 Aligned_cols=29 Identities=45% Similarity=0.587 Sum_probs=25.8
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.|++++.++.+.+.||+.+.
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 49999999999999988767899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.074 Score=49.51 Aligned_cols=30 Identities=20% Similarity=0.413 Sum_probs=25.2
Q ss_pred CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+.+.||++..+ .++++||-.+..
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 359999999999999876 689999986643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.024 Score=50.58 Aligned_cols=152 Identities=14% Similarity=0.091 Sum_probs=96.2
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
-+.++..||=|.=+.||.+-. ..|.+.++|.-.-...+....-+. ..+...+... .|.--..-...+|...|+
T Consensus 93 v~svGnqIGVGKESDIY~v~d--~~G~~~~lK~HRLGRtSFR~Vk~k----RDY~r~r~~~-sWlyLSRlaa~kEfafmk 165 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD--EEGNPLILKLHRLGRTSFRNVKNK----RDYLRKRKSG-SWLYLSRLAATKEFAFMK 165 (465)
T ss_pred hhhhccccccccccceEEEec--CCCCchhHHHHhhhhhhHHHhhhh----hhhHhcCCcc-chhhhHHHHHHHHHHHHH
Confidence 567789999999999999975 378999999765544443221111 0011111111 133445666778999988
Q ss_pred hcc-CCC-ccceeEEEecCCcceeeeeccccCCCCCCC---HHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 129 QIR-HRN-LHPLLAHVTRPDCHLLYILNDVSQGRRELD---WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 129 ~l~-hpn-iv~l~~~~~~~~~~~l~~~~~~~~~~~~l~---~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
.|. |.. +.+-++.. --+++|+++.+-.+.. ......+...+..-+.-|-..| +||+|..-=||+++
T Consensus 166 aL~e~gfpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 166 ALYERGFPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred HHHHcCCCCCCccccc------ceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 883 332 22333221 2467778776644322 1223344555555566777888 99999999999999
Q ss_pred CCCCeEEeccccc
Q 046907 204 DDIEARISGFGFA 216 (345)
Q Consensus 204 ~~~~~kl~Dfg~a 216 (345)
.++.++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.16 Score=45.05 Aligned_cols=29 Identities=28% Similarity=0.579 Sum_probs=24.4
Q ss_pred CeEecCCCCCCeeecCCCC-eEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIE-ARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~-~kl~Dfg~a~ 217 (345)
.++|+|+.+.|++++.++. .-|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997555 4599999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.12 Score=46.82 Aligned_cols=29 Identities=38% Similarity=0.442 Sum_probs=25.1
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.|++++.+...-|.||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 49999999999999976556899999774
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.087 Score=47.22 Aligned_cols=30 Identities=27% Similarity=0.345 Sum_probs=26.1
Q ss_pred CCeEecCCCCCCeeecCC----CCeEEeccccce
Q 046907 188 PRIIHRDLNPVNVLLDDD----IEARISGFGFAR 217 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~----~~~kl~Dfg~a~ 217 (345)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 359999999999999974 789999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.0039 Score=65.64 Aligned_cols=153 Identities=9% Similarity=-0.027 Sum_probs=98.4
Q ss_pred HHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHH----------H---HHHHHHHHHHHHHHH
Q 046907 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL----------A---RHRIALGLACGLEYL 182 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~----------~---~~~i~~~i~~~l~~l 182 (345)
..+....|..-+++..|+++...+.-.......-.+..+.++.+|..++.. . ++....+......-+
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence 345555666667778899888776543322222234444444443322111 1 112222223333333
Q ss_pred hhcC--CCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHH
Q 046907 183 HMHH--CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGAL 259 (345)
Q Consensus 183 h~~~--~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~v 259 (345)
|+.. .+..+|+++|+-|.+|..+..++++++|+.+..... ........+++.|++|+..+...++.++|+| .|+.
T Consensus 1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred hhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 3332 356899999999999999999999999999833221 1123456788899999999998999999999 8999
Q ss_pred HHHHHhCCCCC
Q 046907 260 LAGLVMGKLPS 270 (345)
Q Consensus 260 l~el~tg~~p~ 270 (345)
+|+..-|..+|
T Consensus 1430 ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1430 LYLRSDGNAYF 1440 (2724)
T ss_pred HHHHhcccHHH
Confidence 99887777664
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.078 Score=47.17 Aligned_cols=76 Identities=14% Similarity=0.216 Sum_probs=43.7
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
.+-.+.++.|....+|+.+ .++..+-||.-... ....|..|+.-|+.
T Consensus 19 i~~~~~v~GG~i~~a~~~~---~~~~~~FvK~~~~~------------------------------~~~~f~~Ea~gL~~ 65 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD---TDGGSYFVKVNSES------------------------------GRDMFEGEAEGLKA 65 (288)
T ss_dssp --EEEEE--SSSSEEEEEE---TTS-EEEEEEEEGG------------------------------GCCHHHHHHHHHHH
T ss_pred eeeeEecCCCChhheEEEE---CCCccEEEEecChh------------------------------hHHHHHHHHHHHHH
Confidence 4456679999999999987 36778889987411 13456678888777
Q ss_pred cc---CCCccceeEEEecCCcceeeeeccccCCC
Q 046907 130 IR---HRNLHPLLAHVTRPDCHLLYILNDVSQGR 160 (345)
Q Consensus 130 l~---hpniv~l~~~~~~~~~~~l~~~~~~~~~~ 160 (345)
|. --.+.+.+++....+. -++++|+++.+
T Consensus 66 L~~~~~~~vP~vi~~G~~~~~--~fLlle~l~~~ 97 (288)
T PF03881_consen 66 LAEANPIRVPKVIAWGEYDDD--AFLLLEFLEMG 97 (288)
T ss_dssp HCHTTTSBS--EEEEEE-SSC--CEEEEE-----
T ss_pred HHhcCCCCCCeEEEEEeecCC--ceEEEEeecCC
Confidence 72 3457788887776653 36677776543
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.3 Score=44.74 Aligned_cols=29 Identities=24% Similarity=0.445 Sum_probs=25.4
Q ss_pred CeEecCCCCCCeeecC-CCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDD-DIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~-~~~~kl~Dfg~a~ 217 (345)
.++|+|+++.||+++. ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4999999999999986 4679999998774
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.03 Score=42.73 Aligned_cols=30 Identities=23% Similarity=0.321 Sum_probs=26.4
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVG 84 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~ 84 (345)
-..||.||.|.||+|+++ +|+.||||..++
T Consensus 16 ~~PlasASiaQVh~a~l~--~g~~VaVKV~rP 45 (119)
T PF03109_consen 16 PEPLASASIAQVHRARLK--DGEEVAVKVQRP 45 (119)
T ss_pred cchhhheehhhheeeeec--ccchhhhhhcch
Confidence 367999999999999986 699999999864
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.52 Score=42.41 Aligned_cols=30 Identities=20% Similarity=0.242 Sum_probs=26.8
Q ss_pred CeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
.++|+|+.++|++++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999988899999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.27 Score=44.83 Aligned_cols=68 Identities=18% Similarity=0.171 Sum_probs=49.8
Q ss_pred ceeeeeccccCCC----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 148 HLLYILNDVSQGR----RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 148 ~~l~~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
.+.|+++++..+. ....+.+..+++.+.+.-+.-+...- ++=|||+.-.||||+ +|++-++||.+++.
T Consensus 299 ~y~yl~~kdhgt~is~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDHGTPISIIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecCCceeeeeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 4556666655332 23456677778777666555555543 699999999999999 99999999999984
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.12 Score=49.04 Aligned_cols=164 Identities=16% Similarity=0.189 Sum_probs=86.1
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+++....+++.+.|+|...++++....... ..+|++++.... -+....... -..+++ ..+ +.|.+
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r-~IVV~e~~~~Sl-ed~~~~~~l--~~~s~~----~~~---~~~~~---- 92 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHER-VIVVMEHYTMSL-EDILKTGNL--KDESLL----AHG---VLHLN---- 92 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccce-EEEEehhhccch-HHHHHhccc--chhhhc----ccc---cceeh----
Confidence 455678889999999999999877665544 777888774431 111111110 001111 111 33321
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
..+.+| .++ +. | | .+..+++||| +|.++.++.-|...+.. .
T Consensus 93 --------~~~~td-~~~-----------t~-------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~----~ 134 (725)
T KOG1093|consen 93 --------IIYITD-HFL-----------TK-------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAE----L 134 (725)
T ss_pred --------hhhccc-ccc-----------cc-------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHH----H
Confidence 223333 000 00 0 0 0112499999 99999999988877432 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
...+....+.+....+......... ....-++...++.+...|+-..|..||...++.
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e--~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAME--HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHH--HHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 2233333333333222111000000 012234455678888899999999999766554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.28 Score=41.60 Aligned_cols=85 Identities=12% Similarity=0.014 Sum_probs=55.8
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+..+.+++.+|+. |+++.. ++.+.+-++.|.|-...... ...+.. -.++|...|+.. ...+|+|..|+|
T Consensus 105 y~nky~v~ArmhG--ilrL~N----Dn~~~yGvIlE~Cy~~~i~~---~N~i~a-gi~~L~~fH~~~-~~~lHGD~np~N 173 (308)
T PF07387_consen 105 YFNKYRVFARMHG--ILRLKN----DNNYKYGVILERCYKIKINF---SNFITA-GIKDLMDFHSEN-QHCLHGDCNPDN 173 (308)
T ss_pred hhhhhhHHHHhhh--eeEeec----CCCceeEEEEeeccCcccch---hHHHHH-hHHHHHHhhccC-CCeecCCCChhh
Confidence 4567888888763 666662 34455656666663332221 112221 246778888554 359999999999
Q ss_pred eeecCCCCeEEecccc
Q 046907 200 VLLDDDIEARISGFGF 215 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~ 215 (345)
|+-|..|.+|+.|=+.
T Consensus 174 iM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 174 IMCDKFGYLKLVDPVC 189 (308)
T ss_pred eeecCCCCEEecChhh
Confidence 9999999999999554
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.69 E-value=1.3 Score=40.56 Aligned_cols=28 Identities=21% Similarity=0.462 Sum_probs=23.6
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.||+++.+ .++++|+..+.
T Consensus 193 ~llHGDl~~gNi~~~~~-~~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEH-ETKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCC-CCEEEcCcccc
Confidence 49999999999999776 47799987664
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.85 Score=41.51 Aligned_cols=30 Identities=20% Similarity=0.331 Sum_probs=25.6
Q ss_pred CeEecCCCCCCeeecC-CCCeEEecccccee
Q 046907 189 RIIHRDLNPVNVLLDD-DIEARISGFGFARA 218 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~-~~~~kl~Dfg~a~~ 218 (345)
.+.|+|+.+.||+++. ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4899999999999974 56899999988753
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.22 Score=46.01 Aligned_cols=35 Identities=26% Similarity=0.276 Sum_probs=23.3
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecC
Q 046907 168 RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 168 ~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~ 204 (345)
..+++.-.+.|+.-+-.-. .++|.|+.|.||++.-
T Consensus 346 ~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 346 VKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRF 380 (565)
T ss_pred HHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEe
Confidence 3445555556665443332 3999999999999953
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.78 E-value=3.8 Score=37.01 Aligned_cols=31 Identities=23% Similarity=0.482 Sum_probs=27.5
Q ss_pred CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+.+.|++++...-+-|.||+++..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 4699999999999999887788999998864
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=90.19 E-value=0.4 Score=43.10 Aligned_cols=36 Identities=31% Similarity=0.361 Sum_probs=22.7
Q ss_pred HHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeecCC
Q 046907 170 RIALGLACGLEYLHMH-HCPRIIHRDLNPVNVLLDDD 205 (345)
Q Consensus 170 ~i~~~i~~~l~~lh~~-~~~~iiH~dlk~~nil~~~~ 205 (345)
-++.|++--.-.+.+. +|..++|-||||+|||+-.+
T Consensus 283 fifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 283 FIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 3566664322223233 35669999999999999543
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=89.64 E-value=1.8 Score=37.80 Aligned_cols=31 Identities=13% Similarity=0.016 Sum_probs=24.7
Q ss_pred cccccccCcceeeEEEEecCCCCceeEEeeecC
Q 046907 52 SLEKIGSGGCGEVYKAELPGQNGRMISIKKIVG 84 (345)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~ 84 (345)
....+..|+.+.|+.++. .+|.+.++|....
T Consensus 6 ~~~~~~~g~~s~V~pv~~--~dG~~avLKl~~p 36 (253)
T PF04655_consen 6 PDGPPAHGSSSLVVPVRR--ADGTPAVLKLAPP 36 (253)
T ss_pred cCCCCCCCcceEEEEEEc--CCCCeEEEEecCC
Confidence 345567899999999974 3899999999864
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=89.30 E-value=2.5 Score=38.88 Aligned_cols=151 Identities=15% Similarity=0.100 Sum_probs=84.3
Q ss_pred cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhh-HH--HHHHHHHHHHHHHHHHHHHHH--HHHHHHHHh
Q 046907 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEED-SM--LLNKKMRQIQSEMLLNKKMRQ--IQSEINTVG 128 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~--~~~E~~~l~ 128 (345)
.-|..|-=+-||.++- .+|..+|||+++..-.........- ++ +..--| ..++.++-. ...|++-|.
T Consensus 150 GCiSTGKEANVYHat~--~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyc------k~NPRKMVk~WAEKE~RNLk 221 (520)
T KOG2270|consen 150 GCISTGKEANVYHATE--EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYC------KHNPRKMVKTWAEKEMRNLK 221 (520)
T ss_pred cccccCccceeEeeec--CCCceEEEEEEeeeEEEEechhhhccceeeeecccc------cCCcHHHHHHHHHHHHHHHH
Confidence 3566777778999974 4899999999987554333211100 00 000000 001111111 234666666
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+|+..-| ++-.-..-. .-+++|+|++..+ .++......+-.+++.-+.-|...+ .++|.||.-=|
T Consensus 222 Rl~~aGI-P~PePIlLk---~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN 295 (520)
T KOG2270|consen 222 RLNNAGI-PCPEPILLK---NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFN 295 (520)
T ss_pred HHHhcCC-CCCCceeee---cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhh
Confidence 6643321 111000000 1267888886422 1333345556666677677776665 59999999999
Q ss_pred eeecCCCCeEEeccccceec
Q 046907 200 VLLDDDIEARISGFGFARAI 219 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~ 219 (345)
+|+-. |.+.|+|.+-+...
T Consensus 296 ~Lyhd-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 296 LLYHD-GKLYIIDVSQSVEH 314 (520)
T ss_pred heEEC-CEEEEEEccccccC
Confidence 98765 48899998766543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.87 E-value=4.2 Score=37.82 Aligned_cols=28 Identities=29% Similarity=0.272 Sum_probs=23.2
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.+.|.|+-+.|++.+.+ .+.++||-.|.
T Consensus 228 VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEecCC-CEEEEEecccc
Confidence 48999999999987654 69999998764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=88.10 E-value=0.33 Score=43.86 Aligned_cols=32 Identities=38% Similarity=0.627 Sum_probs=22.1
Q ss_pred HHHHHHHHHHH--Hhhc-CCCCeEecCCCCCCeeecC
Q 046907 171 IALGLACGLEY--LHMH-HCPRIIHRDLNPVNVLLDD 204 (345)
Q Consensus 171 i~~~i~~~l~~--lh~~-~~~~iiH~dlk~~nil~~~ 204 (345)
++.|+ ||.| ..+. +|..++|-||||+|||+-.
T Consensus 280 ifLQi--aLLyikIYelp~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 280 IFLQI--ALLYIKIYELPCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred HHHHH--HHHHeeeecCCCcceeeecccCcCcEEEec
Confidence 45554 4566 3333 3556999999999999953
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.87 E-value=0.44 Score=39.40 Aligned_cols=29 Identities=17% Similarity=0.276 Sum_probs=25.3
Q ss_pred CeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..+|+|+.|.|++++.++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 489999999999998776 88999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=87.31 E-value=10 Score=35.63 Aligned_cols=28 Identities=25% Similarity=0.432 Sum_probs=22.8
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccc
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFA 216 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a 216 (345)
...+|+|+.+.||+++.++ .++.|--.+
T Consensus 230 ~~L~HGDl~~g~i~~~~~~-~~~id~ef~ 257 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS-TQVIDPEFA 257 (418)
T ss_pred cceeecCCCCCcEEEcCCC-ceEecchhh
Confidence 4699999999999999874 788885443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=85.83 E-value=1.7 Score=39.01 Aligned_cols=28 Identities=29% Similarity=0.463 Sum_probs=24.3
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.|++++. +.+.+.||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999987 578899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=85.58 E-value=15 Score=31.74 Aligned_cols=72 Identities=13% Similarity=0.179 Sum_probs=46.1
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
.+.+.-|.--+.|+... ....+-||.-. ......|..|+.-|..|.-
T Consensus 21 r~~v~gG~inea~~v~d---g~~~~FvK~n~------------------------------~~~~~~f~AEa~gL~~la~ 67 (286)
T COG3001 21 REEVSGGDINEAWRLRD---GTDPFFVKCNQ------------------------------REQLSMFTAEADGLELLAR 67 (286)
T ss_pred ccccCCccccceeEeec---CCcceEEEecc------------------------------hhhHHHHHHHHHHHHHHHh
Confidence 44566666666677653 35567788752 3346778889888888754
Q ss_pred CC---ccceeEEEecCCcceeeeeccccCC
Q 046907 133 RN---LHPLLAHVTRPDCHLLYILNDVSQG 159 (345)
Q Consensus 133 pn---iv~l~~~~~~~~~~~l~~~~~~~~~ 159 (345)
.| +.+++.+-.+.+ ..|+|+++++-
T Consensus 68 s~ti~VP~vi~~G~~~~--~sylVle~L~~ 95 (286)
T COG3001 68 SNTITVPKVIAVGASRD--HSYLVLEYLPT 95 (286)
T ss_pred cCCccccceEEecCCCC--eeEEEEeeccC
Confidence 44 555555555444 67888888765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 345 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-28 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-16 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-04 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-71
Identities = 94/299 (31%), Positives = 149/299 (49%), Gaps = 42/299 (14%)
Query: 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114
+G GG G+VYK L +G ++++K+ L ++ Q
Sbjct: 37 ILGRGGFGKVYKGRLA--DGTLVAVKR------------------LKEERTQ-------- 68
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILN--------DVSQGRREL 163
Q Q+E+ + HRNL L P LL Y+ N + + + L
Sbjct: 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
DW R RIALG A GL YLH H P+IIHRD+ N+LLD++ EA + FG A+ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD-KFFQHTNEMS 281
TH+TT V GT+ +IAPEYL +EK D++ +G +L L+ G+ D + +++
Sbjct: 189 THVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340
+ W++ ++ + + +D L GN +E++ ++++A CT P ERP +V RML
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-55
Identities = 74/304 (24%), Positives = 122/304 (40%), Gaps = 47/304 (15%)
Query: 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114
IG G G+VYK L +G +++K+ + Q
Sbjct: 46 LIGHGVFGKVYKGVLR--DGAKVALKR------------------RTPESSQ-------- 77
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI--------LNDVSQGRREL 163
+ + ++EI T+ RH +L L+ + +L Y+ L +
Sbjct: 78 -GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA- 222
W R I +G A GL YL H IIHRD+ +N+LLD++ +I+ FG ++ +
Sbjct: 137 SWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
TH++T V GT+ YI PEY LTEK D+Y FG +L ++ + + ++
Sbjct: 194 QTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-SLPREMVN 251
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
+W + ++ +D L E + A C +RP+ DV L
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
Query: 342 QIQH 345
Sbjct: 312 YALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (463), Expect = 3e-55
Identities = 86/305 (28%), Positives = 137/305 (44%), Gaps = 52/305 (17%)
Query: 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114
K+G GG G VYK + N +++KK+ + +++ +++
Sbjct: 38 KMGEGGFGVVYKGYV---NNTTVAVKKL--------------AAMVDITTEELK------ 74
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILND-------VSQGRRELD 164
+Q EI + + +H NL LL + D L Y+ N G L
Sbjct: 75 ---QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP-DAH 223
W R +IA G A G+ +LH +H IHRD+ N+LLD+ A+IS FG ARA A
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 224 THITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
T +T+ +VGT Y+APE L +T K DIY FG +L ++ G D+ H
Sbjct: 189 TVMTS-RIVGTTAYMAPEA---LRGEITPKSDIYSFGVVLLEIITGLPAVDE---HREPQ 241
Query: 281 SFVKWMRNVMASENP-KRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339
+ + E + ID K+ + + + +A C E N+RP+ K V+++
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
Query: 340 LSQIQ 344
L ++
Sbjct: 301 LQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 67/325 (20%), Positives = 114/325 (35%), Gaps = 61/325 (18%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L LE G G V+KA+L + +++K I++ N+
Sbjct: 26 LQLLEVKARGRFGCVWKAQLLNEY---VAVKIF---------PIQDKQSWQNEY------ 67
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPD---CHLLYILNDVSQG------- 159
E+ ++ ++H N+ + R L I +G
Sbjct: 68 -------------EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHC-------PRIIHRDLNPVNVLLDDDIEARISG 212
+ W IA +A GL YLH P I HRD+ NVLL +++ A I+
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 213 FGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMG 266
FG A + T VGT Y+APE L+ + D+Y G +L L
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLV----GNGC--EEQMLLVLKIAC 320
+D + F + + + E+ + + K + M ++ +
Sbjct: 235 CTAAD-GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 321 FCTLEDPNERPNSKDVRRMLSQIQH 345
C D R ++ V ++Q+Q
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQR 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 65/307 (21%), Positives = 108/307 (35%), Gaps = 67/307 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L K+ GE++K G I +K +
Sbjct: 15 LTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWST----------------------- 48
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDV--SQGRR 161
+K R E + H N+ P+L P + L +V
Sbjct: 49 --RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+D + AL +A G+ +LH P I LN +V++D+D+ ARIS +
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFS--- 162
Query: 222 AHTHITTSNVVGTVEYIAPEYLQM---LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277
+ + ++APE LQ T D++ F LL LV ++P
Sbjct: 163 ----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA------ 212
Query: 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337
++S ++ V A E + I G + ++KI C EDP +RP +
Sbjct: 213 -DLSNMEIGMKV-ALEGLRPTIPP-----GISPHVSKLMKI---CMNEDPAKRPKFDMIV 262
Query: 338 RMLSQIQ 344
+L ++Q
Sbjct: 263 PILEKMQ 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 70/307 (22%), Positives = 128/307 (41%), Gaps = 61/307 (19%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
++IG GG G V+K L + +++IK + + + E +
Sbjct: 25 KQIGKGGFGLVHKGRLVK-DKSVVAIKSL--------------------ILGDSEGETEM 63
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH---------LLYILNDVSQGRRELD 164
+K ++ Q E+ + + H N+ L + P L + L D +
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLD---KAHPIK 120
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE-----ARISGFGFARAI 219
W + R+ L +A G+EY+ + P I+HRDL N+ L E A+++ FG ++
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTL--TEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
+ S ++G +++APE + TEK D Y F +L ++ G+ P D
Sbjct: 180 VH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----- 229
Query: 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336
E S+ K M E R + C ++ V+++ C DP +RP+ +
Sbjct: 230 --EYSYGKIKFINMIREEGLRPT----IPEDCPPRLRNVIEL---CWSGDPKKRPHFSYI 280
Query: 337 RRMLSQI 343
+ LS++
Sbjct: 281 VKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 58/303 (19%), Positives = 113/303 (37%), Gaps = 64/303 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E +G G G V KA+ + ++IK+I
Sbjct: 13 EEVVGRGAFGVVCKAKW---RAKDVAIKQIESESE------------------------- 44
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH---------LLYILNDVSQGRREL 163
+ E+ + ++ H N+ L P C L +L+ ++
Sbjct: 45 ----RKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHG-AEPLPYY 99
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE-ARISGFGFARAIPDA 222
L + G+ YLH +IHRDL P N+LL +I FG A D
Sbjct: 100 TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DI 156
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
TH+T + G+ ++APE + +EKCD++ +G +L ++ + P D E+
Sbjct: 157 QTHMTNN--KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-------EIG 207
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
+ + + + + ++ C +DP++RP+ +++ ++++
Sbjct: 208 GPAFRIMWAVHNGTRPPLIK-----NLPKPIESLMTR---CWSKDPSQRPSMEEIVKIMT 259
Query: 342 QIQ 344
+
Sbjct: 260 HLM 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 70/304 (23%), Positives = 129/304 (42%), Gaps = 62/304 (20%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
EKIG+G G V++AE +G +++K ++ A
Sbjct: 43 EKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHA------------------------ 75
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDV---SQGRR 161
+++ + E+ + ++RH N+ + VT+P L I L + S R
Sbjct: 76 -ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGARE 132
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+LD R +A +A G+ YLH + P I+HR+L N+L+D ++ FG +R
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-- 189
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
A T +++ + GT E++APE L+ EK D+Y FG +L L + P +
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-------NL 242
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340
+ + + V + + I Q+ +++ C +P +RP+ + +L
Sbjct: 243 NPAQVVAAV-GFKCKRLEIPR-----NLNPQVAAIIEG---CWTNEPWKRPSFATIMDLL 293
Query: 341 SQIQ 344
+
Sbjct: 294 RPLI 297
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 67/308 (21%), Positives = 115/308 (37%), Gaps = 67/308 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E IG GG G+VY+A G +++K P + +
Sbjct: 13 EIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDEDIS---------------------- 47
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRRELD 164
+ + ++ E ++H N+ L + L + LN V G+R +
Sbjct: 48 -QTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR-IP 103
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR--------ISGFGFA 216
A+ +A G+ YLH IIHRDL N+L+ +E I+ FG A
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275
R T + G ++APE ++ ++ D++ +G LL L+ G++P
Sbjct: 164 REW----HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR---- 215
Query: 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335
+ + V A I S C E +++ C DP+ RP+ +
Sbjct: 216 ---GIDGLAVAYGV-AMNKLALPIPS-----TCPEPFAKLMED---CWNPDPHSRPSFTN 263
Query: 336 VRRMLSQI 343
+ L+ I
Sbjct: 264 ILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-34
Identities = 63/334 (18%), Positives = 107/334 (32%), Gaps = 76/334 (22%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E IG G G VYK L + R +++K + I E
Sbjct: 19 ELIGRGRYGAVYKGSL---DERPVAVKVF--SFANRQNFINE------------------ 55
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL---LYI---------LNDVSQGRR 161
I V + H N+ + R + L
Sbjct: 56 --------KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LH 106
Query: 162 ELDWLARHRIALGLACGLEYLHM------HHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
DW++ R+A + GL YLH H+ P I HRDLN NVL+ +D IS FG
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166
Query: 216 AR------AIPDAHTHITTSNVVGTVEYIAPEYLQ-------MLTLTEKCDIYFGAL--- 259
+ + + VGT+ Y+APE L+ + ++ D+Y L
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 260 -LAGLVMGKLPSDK-------FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQ 311
+ P + F + M+ +++ E + N
Sbjct: 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN--SLA 284
Query: 312 MLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
+ + + C +D R ++ ++++
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 58/324 (17%), Positives = 107/324 (33%), Gaps = 65/324 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+++IG G GEV+ + G +++K E++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW---RGEKVAVKVF---------FTTEEASWFRET--------- 80
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQG-------RRE 162
EI +RH N+ +A + L I + G
Sbjct: 81 ----------EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT 130
Query: 163 LDWLARHRIALGLACGLEYLHM-----HHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
LD + ++A GL +LH P I HRDL N+L+ + I+ G A
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 218 AIPDA--HTHITTSNVVGTVEYIAPE------YLQMLTLTEKCDIY-FGALLAGLVMGKL 268
I + VGT Y+ PE D+Y FG +L + +
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250
Query: 269 PSDK-------FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACF 321
+ + MR ++ + + + ++ + C QM ++
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE--- 307
Query: 322 CTLEDPNERPNSKDVRRMLSQIQH 345
C +P R + V++ L+++
Sbjct: 308 CWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 65/323 (20%), Positives = 120/323 (37%), Gaps = 67/323 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LE +G G GEV++ G +++K D + E
Sbjct: 13 LECVGKGRYGEVWRGSW---QGENVAVKIF--SSRDEKSWFRE----------------- 50
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPD--CHLLYI---------LNDVSQGRR 161
+E+ +RH N+ +A L++ L D Q
Sbjct: 51 ---------TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LT 100
Query: 162 ELDWLARHRIALGLACGLEYLHM-----HHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
LD ++ RI L +A GL +LH+ P I HRDL N+L+ + + I+ G A
Sbjct: 101 TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160
Query: 217 RAIPDAHTHITTSN--VVGTVEYIAPE------YLQMLTLTEKCDIY-FGALLAGLVMGK 267
+ + N VGT Y+APE + ++ DI+ FG +L +
Sbjct: 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220
Query: 268 LPSDK-------FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIAC 320
+ + F+ + MR V+ + + I ++ + + ++K
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE-- 278
Query: 321 FCTLEDPNERPNSKDVRRMLSQI 343
C ++P+ R + +++ L++I
Sbjct: 279 -CWYQNPSARLTALRIKKTLTKI 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 64/308 (20%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++IGSG G VYK + G +++K +
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP----------------------- 61
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRRE- 162
++++ ++E+ + + RH N+ + + T P L I L
Sbjct: 62 --QQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETK 116
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ IA A G++YLH IIHRDL N+ L +D +I FG A
Sbjct: 117 FEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278
+ G++ ++APE ++M + + D+Y FG +L L+ G+LP + + N
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP----YSNIN 229
Query: 279 EMSFVKWM--RNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336
+ M R ++ + K V + C ++M ++ C + +ERP+ +
Sbjct: 230 NRDQIIEMVGRGSLSPDLSK-------VRSNCPKRMKRLMA---ECLKKKRDERPSFPRI 279
Query: 337 RRMLSQIQ 344
+ ++
Sbjct: 280 LAEIEELA 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-31
Identities = 64/325 (19%), Positives = 111/325 (34%), Gaps = 67/325 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E IG G GEV++ + G +++K E+ +
Sbjct: 47 QESIGKGRFGEVWRGKW---RGEEVAVKIF---------SSREERSWFREA--------- 85
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPD--CHLLYI---------LNDVSQGRR 161
EI +RH N+ +A + + L++ L D R
Sbjct: 86 ----------EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RY 134
Query: 162 ELDWLARHRIALGLACGLEYLHM-----HHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+ ++AL A GL +LHM P I HRDL N+L+ + I+ G A
Sbjct: 135 TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
Query: 217 RAIPDAHTHITTSN--VVGTVEYIAPEYL------QMLTLTEKCDIY-FGALLAGLVMGK 267
A I + VGT Y+APE L + ++ DIY G + +
Sbjct: 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 254
Query: 268 LPSDK-------FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIAC 320
++ V+ MR V+ + + I ++ M +++
Sbjct: 255 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE-- 312
Query: 321 FCTLEDPNERPNSKDVRRMLSQIQH 345
C + R + +++ LSQ+
Sbjct: 313 -CWYANGAARLTALRIKKTLSQLSQ 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 62/315 (19%), Positives = 104/315 (33%), Gaps = 73/315 (23%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E +G G G+ K M+ +K+ LI D
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMV-MKE----------LIRFDEET-------------- 50
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH-----------LLYILNDVSQGRRE 162
R E+ + + H N+ + + + L I+ +
Sbjct: 51 ---QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQ 104
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
W R A +A G+ YLH + IIHRDLN N L+ ++ ++ FG AR + D
Sbjct: 105 YPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161
Query: 223 HTHITTSN------------VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
T VVG ++APE + + EK D++ FG +L ++
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
Query: 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329
+ R + N + +D + C I C DP +
Sbjct: 222 DPDYL-----------PRTMDFGLNVRGFLD-RYCPPNCPPS---FFPITVRCCDLDPEK 266
Query: 330 RPNSKDVRRMLSQIQ 344
RP+ + L ++
Sbjct: 267 RPSFVKLEHWLETLR 281
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 60/315 (19%), Positives = 105/315 (33%), Gaps = 74/315 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E IG G G+VY G+ ++I+ I + L
Sbjct: 38 GELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQL-------------------- 73
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRRE- 162
+ + E+ Q RH N+ + P L I L V + +
Sbjct: 74 -----KAFKREVMAYRQTRHENVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIV 126
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR---AI 219
LD +IA + G+ YLH I+H+DL NV D+ I+ FG +
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGK-VVITDFGLFSISGVL 182
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTL---------TEKCDIY-FGALLAGLVMGKLP 269
G + ++APE ++ L+ ++ D++ G + L + P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329
F+ + + W K + G +++ +L FC + E
Sbjct: 243 ----FKTQPAEA-IIW----QMGTGMKPNLSQ----IGMGKEISDILL---FCWAFEQEE 286
Query: 330 RPNSKDVRRMLSQIQ 344
RP + ML ++
Sbjct: 287 RPTFTKLMDMLEKLP 301
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-25
Identities = 36/259 (13%), Positives = 76/259 (29%), Gaps = 33/259 (12%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIE--EDSMLLNKKMRQI 107
L +G +A + G + + I+ ++ +L + +R I
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 108 QSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI--------------- 152
+++ +R + V + + + + +
Sbjct: 139 KNQKQAKVHLR-FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 153 LNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISG 212
L S + L AR ++ L + L LH + ++H L PV+++LD ++G
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 213 FGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----LTLTEKCDIY-FGALLAGLVMG 266
F + E A L +T D + G + +
Sbjct: 255 FEHLVRDGASAVSPIGR-GFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 267 KLPSDKFFQHTNEMSFVKW 285
LP + +W
Sbjct: 314 DLP----NTDDAALGGSEW 328
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-24
Identities = 57/310 (18%), Positives = 117/310 (37%), Gaps = 74/310 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L++IGSGG +V++ + ++ +IK + N +
Sbjct: 14 LKQIGSGGSSKVFQVL--NEKKQIYAIKYV------------------NLEEAD------ 47
Query: 113 LNKKMRQIQSEINTVGQIRHRNLH--PLLAHVTRPDCHLLYI--------LNDVSQGRRE 162
N+ + ++EI + +++ + L + +Y+ LN + ++
Sbjct: 48 -NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKS 104
Query: 163 LD-WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+D W + + + +H H I+H DL P N L+ D + ++ FG A +
Sbjct: 105 IDPWERKS-YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQP 159
Query: 222 AHTHITTSNVVGTVEYIAPEYLQ-----------MLTLTEKCDIY-FGALLAGLVMGKLP 269
T + + VGTV Y+ PE ++ ++ K D++ G +L + GK P
Sbjct: 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
Query: 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAID-SKLVGNGCEEQMLLVLKIACFCTLEDPN 328
FQ + + A +P I+ + ++ + LK DP
Sbjct: 220 ----FQQIINQ-----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR-------DPK 263
Query: 329 ERPNSKDVRR 338
+R + ++
Sbjct: 264 QRISIPELLA 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 38/303 (12%), Positives = 71/303 (23%), Gaps = 36/303 (11%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIV----GPPMDAAALIEEDSMLLNKKMRQIQ- 108
E + G V+ + ++K + L E +
Sbjct: 68 EPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 109 ----------SEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQ 158
S+ + + N L+ + L L+ V
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
R + LA H + L L ++H P N+ + D +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQ--MLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275
+ V Y E+L T T + + G + + LP F
Sbjct: 244 VGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FG 294
Query: 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335
W R + ++ + L+ + F D R +
Sbjct: 295 LVTPGIKGSWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIGRFLNF----DRRRRLLPLE 349
Query: 336 VRR 338
Sbjct: 350 AME 352
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 56/313 (17%), Positives = 115/313 (36%), Gaps = 80/313 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L++IGSGG +V++ + ++ +IK + N +
Sbjct: 33 LKQIGSGGSSKVFQVL--NEKKQIYAIKYV------------------NLEEAD------ 66
Query: 113 LNKKMRQIQSEINTVGQIRHRNLH--PLLAHVTRPDCHLLYI--------LNDVSQGRRE 162
N+ + ++EI + +++ + L + +Y+ LN + ++
Sbjct: 67 -NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKS 123
Query: 163 LD-WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+D W + + + +H H I+H DL P N L+ D + ++ FG A +
Sbjct: 124 IDPWERKS-YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQP 178
Query: 222 AHTHITTSNVVGTVEYIAPEYLQ-----------MLTLTEKCDIY-FGALLAGLVMGKLP 269
T + + VGTV Y+ PE ++ ++ K D++ G +L + GK P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDS-KLVGNGCEE---QMLLVLKIACFCTLE 325
FQ + + A +P I+ + ++ L
Sbjct: 239 ----FQQIINQ-----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR---------- 279
Query: 326 DPNERPNSKDVRR 338
DP +R + ++
Sbjct: 280 DPKQRISIPELLA 292
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 56/310 (18%), Positives = 116/310 (37%), Gaps = 74/310 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L++IGSGG +V++ + ++ +IK + N +
Sbjct: 61 LKQIGSGGSSKVFQVL--NEKKQIYAIKYV------------------NLEEAD------ 94
Query: 113 LNKKMRQIQSEINTVGQIRHRNLH--PLLAHVTRPDCHLLYI--------LNDVSQGRRE 162
N+ + ++EI + +++ + L + +Y+ LN + ++
Sbjct: 95 -NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKS 151
Query: 163 LD-WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+D W + + + +H H I+H DL P N L+ D + ++ FG A +
Sbjct: 152 IDPWERKS-YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQP 206
Query: 222 AHTHITTSNVVGTVEYIAPEYLQ-----------MLTLTEKCDIY-FGALLAGLVMGKLP 269
T + + VG V Y+ PE ++ ++ K D++ G +L + GK P
Sbjct: 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
Query: 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAID-SKLVGNGCEEQMLLVLKIACFCTLEDPN 328
FQ + + A +P I+ + ++ + LK DP
Sbjct: 267 ----FQQIINQ-----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR-------DPK 310
Query: 329 ERPNSKDVRR 338
+R + ++
Sbjct: 311 QRISIPELLA 320
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 1e-21
Identities = 34/261 (13%), Positives = 75/261 (28%), Gaps = 44/261 (16%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEE--DSMLLNKKMRQIQSEM 111
+G +A + G + + I++ + +L + +R I+++
Sbjct: 79 TVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG------------ 159
+R + V + + + + + L Q
Sbjct: 138 QAKVHLR-FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 196
Query: 160 ---RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+ L AR ++ L + L LH + ++H L PV+++LD ++GF
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-----------TEKCDIY-FGALLAGLV 264
+ + PE T D + G ++ +
Sbjct: 254 VRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 265 MGKLPSDKFFQHTNEMSFVKW 285
LP + +W
Sbjct: 308 CADLP----ITKDAALGGSEW 324
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 51/295 (17%), Positives = 100/295 (33%), Gaps = 60/295 (20%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+IG G VYK L + ++ ++Q L
Sbjct: 32 IEIGRGSFKTVYKG-LDTETTVEVAWC-------------------------ELQDRKLT 65
Query: 114 NKKMRQIQSEINTVGQIRHRNL---HPLLAHVTRPDCHLLYILNDVSQGR--------RE 162
+ ++ + E + ++H N+ + + ++ + ++ G +
Sbjct: 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV 125
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI-EARISGFGFARAIPD 221
+ + GL++LH P IIHRDL N+ + +I G A
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
+ V+GT E++APE + E D+Y FG + + + P ++
Sbjct: 185 SFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP------YSECQ 233
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335
+ + R V S + D + E ++ C + +ER + KD
Sbjct: 234 NAAQIYRRVT-SGVKPASFDKVAI----PEVKEIIEG--CIRQ--NKDERYSIKD 279
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 49/314 (15%), Positives = 98/314 (31%), Gaps = 68/314 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +G G V++ + G + +IK N
Sbjct: 15 DILGQGATANVFRGRHK-KTGDLFAIKVF------------------NNI--------SF 47
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILND-VSQGRREL-DWLARHRI 171
+ + E + ++ H+N+ L A ++ + G L L
Sbjct: 48 LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG--SLYTVLEEPSN 105
Query: 172 ALGL------------ACGLEYLHMHHCPRIIHRDLNPVNVLL----DDDIEARISGFGF 215
A GL G+ +L + I+HR++ P N++ D +++ FG
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL--------TEKCDIY-FGALLAGLVMG 266
AR + D ++ + GT EY+ P+ + L D++ G G
Sbjct: 163 ARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326
LP F + M ++ + + NG + + C+L
Sbjct: 220 SLP---FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID---WSGDMPVSCSLSR 273
Query: 327 PNERPNSKDVRRML 340
+ + + +L
Sbjct: 274 GLQVLLTPVLANIL 287
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 57/321 (17%), Positives = 105/321 (32%), Gaps = 83/321 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V KA + R +IKKI
Sbjct: 11 IAVLGQGAFGQVVKAR-NALDSRYYAIKKI------------------RHT--------- 42
Query: 113 LNKKMRQIQSEINTVGQIRHRNL-----------HPLLAHVTRPDCHLLYI--------- 152
+K+ I SE+ + + H+ + + + L+I
Sbjct: 43 -EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT 101
Query: 153 LND-VSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARIS 211
L D + R+ + L Y+H IIHRDL P+N+ +D+ +I
Sbjct: 102 LYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158
Query: 212 GFGFARAIPDAHTHITTSN------------VVGTVEYIAPEYLQ-MLTLTEKCDIY-FG 257
FG A+ + + + + +GT Y+A E L EK D+Y G
Sbjct: 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG 218
Query: 258 ALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLK 317
+ ++ F ++ +K +R + N + + ++
Sbjct: 219 IIFFEMIYP------FSTGMERVNILKKLR------SVSIEFPPDFDDNKMKVEKKIIRL 266
Query: 318 IACFCTLEDPNERPNSKDVRR 338
DPN+RP ++ +
Sbjct: 267 --LIDH--DPNKRPGARTLLN 283
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-20
Identities = 52/333 (15%), Positives = 97/333 (29%), Gaps = 79/333 (23%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +G G V++ + G + +IK N
Sbjct: 15 DILGQGATANVFRGRHK-KTGDLFAIKVF------------------NNI--------SF 47
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILND-VSQGRREL-DWLARHRI 171
+ + E + ++ H+N+ L A ++ + G L L
Sbjct: 48 LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG--SLYTVLEEPSN 105
Query: 172 ALGL------------ACGLEYLHMHHCPRIIHRDLNPVNVLL----DDDIEARISGFGF 215
A GL G+ +L + I+HR++ P N++ D +++ FG
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL--------TEKCDIY-FGALLAGLVMG 266
AR + D ++ + GT EY+ P+ + L D++ G G
Sbjct: 163 ARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCT--- 323
LP F + M ++ + + NG + +
Sbjct: 220 SLP---FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQ 276
Query: 324 ----------LE-DPNERPNSKDVRRMLSQIQH 345
LE D + S I H
Sbjct: 277 VLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 55/237 (23%)
Query: 53 LEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
E +G GG EV+ A R +++K ++ + D + R+ Q+
Sbjct: 17 GEILGFGGMSEVHLARDLRD----HRDVAVK-VLRADL------ARDPSFYLRFRREAQN 65
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHV------TRPDCHLLYI---------LN 154
LN HP + V P L YI L
Sbjct: 66 AAALN---------------------HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 104
Query: 155 DVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
D+ + + L + H + IIHRD+ P N+++ ++ FG
Sbjct: 105 DIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG 161
Query: 215 FARAIPDAHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
ARAI D+ +T T+ V+GT +Y++PE + ++ + D+Y G +L ++ G+ P
Sbjct: 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 60/318 (18%), Positives = 114/318 (35%), Gaps = 87/318 (27%)
Query: 53 LEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
++K+G GG VY AE L ++IK + P E L + R++ +
Sbjct: 16 VDKLGGGGMSTVYLAEDTIL----NIKVAIK-AIFIPP------REKEETLKRFEREVHN 64
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHV--TRPDCHLLYI---------LNDVSQ 158
L+ H + + + Y+ L++ +
Sbjct: 65 SSQLS---------------------HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE 103
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
L + G+++ H I+HRD+ P N+L+D + +I FG A+A
Sbjct: 104 SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF---- 273
+ + T++V+GTV+Y +PE + E DIY G +L +++G+ P F
Sbjct: 161 L-SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP---FNGET 216
Query: 274 -----FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328
+H + + N + + ++L+ T +D
Sbjct: 217 AVSIAIKHIQD-----------SVPNVTTDVRKD-IPQSLSN---VILR----ATEKDKA 257
Query: 329 ERPNS-----KDVRRMLS 341
R + D+ +L
Sbjct: 258 NRYKTIQEMKDDLSSVLH 275
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 49/231 (21%)
Query: 53 LEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+G GG G+VY+AE R++++K L++ + S
Sbjct: 39 RRLVGRGGMGDVYEAEDTVR----ERIVALK------------------LMS---ETLSS 73
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGR 160
+ + +M++ E T G+++ ++ P+ H LY+ L + + +
Sbjct: 74 DPVFRTRMQR---EARTAGRLQEPHVVPI--HDFGEIDGQLYVDMRLINGVDLAAMLRRQ 128
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L I + L+ H HRD+ P N+L+ D A + FG A A
Sbjct: 129 GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185
Query: 221 DAHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
D +T N VGT+ Y+APE T + DIY +L + G P
Sbjct: 186 D--EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 46/231 (19%), Positives = 75/231 (32%), Gaps = 54/231 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
I GG G +Y A NGR + +K + DA A
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQ-------------------- 123
Query: 113 LNKKMRQIQSEINTVGQIRHRNL---HPLLAHVTRPDCHLLYI---------LNDVSQGR 160
+E + ++ H ++ + H R + YI L +
Sbjct: 124 -----AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK 178
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
+ L + L YLH +++ DL P N++L ++ + ++ G I
Sbjct: 179 LPVAEAIA--YLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLP 269
+ GT + APE + T T DIY G LA L +
Sbjct: 233 S------FGYLYGTPGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 55/252 (21%), Positives = 92/252 (36%), Gaps = 56/252 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L IG+G G K +G+++ K++ D + + +Q
Sbjct: 11 LYTIGTGSYGRCQKIRRK-SDGKILVWKEL-------------DYGSMTEAEKQ------ 50
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------------LNDVSQG 159
+ SE+N + +++H N+ + LYI + ++
Sbjct: 51 ------MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 160 RRELD----WLARHRIALGLACGLEYLHMHHCP--RIIHRDLNPVNVLLDDDIEARISGF 213
R+ LD R+ L L+ H ++HRDL P NV LD ++ F
Sbjct: 105 RQYLDEEFVL----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272
G AR + H VGT Y++PE + ++ EK DI+ G LL L P
Sbjct: 161 GLARIL--NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--- 215
Query: 273 FFQHTNEMSFVK 284
F ++
Sbjct: 216 -FTAFSQKELAG 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 56/255 (21%), Positives = 91/255 (35%), Gaps = 59/255 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E++G+GG G V + G ++IK+ ++ L
Sbjct: 19 KERLGTGGFGYVLRWIHQ-DTGEQVAIKQC------------------RQE--------L 51
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLA------HVTRPDCHLLYILNDVSQGRREL-DW 165
K + EI + ++ H N+ + D LL + G +L +
Sbjct: 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL-AMEYCEGG--DLRKY 108
Query: 166 LARHRIALGL------------ACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR---I 210
L + GL + L YLH + IIHRDL P N++L + I
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKI 165
Query: 211 SGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
G+A+ + VGT++Y+APE L+ T D + FG L + G P
Sbjct: 166 IDLGYAKELDQGELCTE---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
Query: 270 SDKFFQHTNEMSFVK 284
+Q V+
Sbjct: 223 FLPNWQPVQWHGKVR 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 58/322 (18%), Positives = 110/322 (34%), Gaps = 78/322 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++K+G GG V E +G ++K+I + ++ R+
Sbjct: 34 IQKLGEGGFSYVDLVE-GLHDGHFYALKRI---------------LCHEQQDRE------ 71
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAH--VTRPDCHLLYILNDVSQGRRELDWLARH- 169
+ Q E + H N+ L+A+ R H ++L + + + R
Sbjct: 72 ------EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125
Query: 170 ------------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ LG+ GLE +H HRDL P N+LL D+ + + G
Sbjct: 126 DKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182
Query: 218 AIPDAHTHITTSNVV-------GTVEYIAPEYLQM---LTLTEKCDIY-FGALLAGLVMG 266
+ + T+ Y APE + + E+ D++ G +L ++ G
Sbjct: 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEE---QMLLVLKIACFCT 323
+ P + + +A +N S + + M+ V
Sbjct: 243 EGP----YDMVFQKGDSV----ALAVQNQLSIPQSPRHSSALWQLLNSMMTV-------- 286
Query: 324 LEDPNERPNSKDVRRMLSQIQH 345
DP++RP+ + L +Q
Sbjct: 287 --DPHQRPHIPLLLSQLEALQP 306
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-18
Identities = 51/237 (21%), Positives = 91/237 (38%), Gaps = 50/237 (21%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G G VY A Q+ ++++K +L K ++
Sbjct: 17 LGKGKFGNVYLAREK-QSKFILALK------------------VLFKA------QLEKAG 51
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL----------NDVSQGRRELDW 165
Q++ E+ +RH N+ L + D +Y++ ++ + + +
Sbjct: 52 VEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFDEQ 109
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
I LA L Y H +IHRD+ P N+LL E +I+ FG++ P
Sbjct: 110 RTATYITE-LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRR 164
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
GT++Y+ PE ++ EK D++ G L ++GK P F+
Sbjct: 165 TDL---CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQE 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-18
Identities = 51/284 (17%), Positives = 89/284 (31%), Gaps = 80/284 (28%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++ +G GG G V++A+ + +IK+I P +
Sbjct: 10 IQCLGRGGFGVVFEAKN-KVDDCNYAIKRIRLPNRE------------------------ 44
Query: 113 LNKKMRQIQSEINTVGQIRHRNL----------HPLLAHVTRPDCHLLYI---------L 153
++ E+ + ++ H + + LYI L
Sbjct: 45 --LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL 102
Query: 154 NDV---SQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210
D E + I L +A +E+LH ++HRDL P N+ D ++
Sbjct: 103 KDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159
Query: 211 SGFGFARAIPDAHTHITTSNV----------VGTVEYIAPEYLQMLTLTEKCDIY----- 255
FG A+ T VGT Y++PE + + + K DI+
Sbjct: 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLI 219
Query: 256 -------FGA------LLAGLVMGKLPSDKFFQHTNEMSFVKWM 286
F L + K P ++ E V+ M
Sbjct: 220 LFELLYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDM 263
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 52/303 (17%), Positives = 92/303 (30%), Gaps = 73/303 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAA---ALIE--------------- 94
++ +G GG G V++A+ + +IK+I P + A + E
Sbjct: 11 IQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 95 -----EDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLA------HVT 143
E ++ + ++ R + P
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 144 RPDCHLLYI---------LNDVSQGRR---ELDWLARHRIALGLACGLEYLHMHHCPRII 191
LYI L D R + + I + +A +E+LH ++
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLM 186
Query: 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNV----------VGTVEYIAPE 241
HRDL P N+ D ++ FG A+ T VGT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 242 YLQMLTLTEKCDIY------------FGA------LLAGLVMGKLPSDKFFQHTNEMSFV 283
+ + K DI+ F ++ + K P ++ E V
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMV 306
Query: 284 KWM 286
+ M
Sbjct: 307 QDM 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 50/250 (20%), Positives = 90/250 (36%), Gaps = 61/250 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+KIG G G+ + ++GR IK+I + ++ K R+
Sbjct: 29 LQKIGEGSFGKAILVK-STEDGRQYVIKEI-------------NISRMSSKERE------ 68
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRRE- 162
+ + E+ + ++H N+ LYI L ++
Sbjct: 69 ------ESRREVAVLANMKHPNIVQYRESFEENGS--LYIVMDYCEGGDLFKRINAQKGV 120
Query: 163 -------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
LDW + + L+++H +I+HRD+ N+ L D ++ FG
Sbjct: 121 LFQEDQILDWFVQ------ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274
AR + +GT Y++PE + K DI+ G +L L K F
Sbjct: 172 ARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----F 225
Query: 275 QHTNEMSFVK 284
+ + + V
Sbjct: 226 EAGSMKNLVL 235
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 52/238 (21%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G G VY A QN ++++K +L K S++
Sbjct: 22 LGKGKFGNVYLAREK-QNKFIMALK------------------VLFK------SQLEKEG 56
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY-ILNDVSQGRREL-DWLARH---- 169
Q++ EI +RH N+ + + D +Y +L +G EL L +H
Sbjct: 57 VEHQLRREIEIQSHLRHPNILRMYNYFH--DRKRIYLMLEFAPRG--ELYKELQKHGRFD 112
Query: 170 -----RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
LA L Y H +IHRD+ P N+L+ E +I+ FG++ P
Sbjct: 113 EQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
T GT++Y+ PE ++ T EK D++ G L ++G P F +
Sbjct: 170 R-TM---CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP----FDSPSHTE 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ LEYLH IIHRDL P N+LL++D+ +I+ FG A+ + ++ VGT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
+Y++PE L + + D++ G ++ LV G P F+ NE
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEY 238
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 58/333 (17%), Positives = 113/333 (33%), Gaps = 93/333 (27%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+ ++G+G G V+K +G +++ K I +E
Sbjct: 35 FEKISELGAGNGGVVFKVSHK-PSGLVMARKLI---------HLEIKP------------ 72
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH-------LLYI---------L 153
QI E+ Q+ H P ++ + + I L
Sbjct: 73 -----AIRNQIIREL----QVLHECNSP---YIVG--FYGAFYSDGEISICMEHMDGGSL 118
Query: 154 NDVSQ--GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARIS 211
+ V + GR L + +++ + GL YL H +I+HRD+ P N+L++ E ++
Sbjct: 119 DQVLKKAGRIPEQILGK--VSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLC 174
Query: 212 GFGFARAIPD--AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK- 267
FG + + D A++ VGT Y++PE LQ + + DI+ G L + +G+
Sbjct: 175 DFGVSGQLIDSMANSF------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 268 -LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACF----- 321
+P + P+ + + ++ +
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288
Query: 322 -------------------CTLEDPNERPNSKD 335
C +++P ER + K
Sbjct: 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 64/313 (20%), Positives = 108/313 (34%), Gaps = 91/313 (29%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +G G G + + + R +++K+I L
Sbjct: 30 DVLGHGAEGTIVYRGM--FDNRDVAVKRI------------------------------L 57
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTR-----PDCHLLYI--------LND--VSQ 158
+ E+ +R + HP +V R D YI L + +
Sbjct: 58 PECFSFADREVQL---LRESDEHP---NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQK 111
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL-----DDDIEARISGF 213
L + GL +LH I+HRDL P N+L+ I+A IS F
Sbjct: 112 DFAHLGLEPIT-LLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDF 167
Query: 214 GFARAI-PDAHTHITTSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FGALLAG-LVMGK 267
G + + H+ S V GT +IAPE L T DI+ G + + G
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227
Query: 268 LPSDKFFQHTNEM-SFVKWMRNVMASENPKRAIDSK---LVGNGCEEQMLLVLKIACFCT 323
P F + + + + + +P++ D L+ E+M+ +
Sbjct: 228 HP----FGKSLQRQANILLGACSLDCLHPEKHEDVIARELI-----EKMIAM-------- 270
Query: 324 LEDPNERPNSKDV 336
DP +RP++K V
Sbjct: 271 --DPQKRPSAKHV 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 46/217 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +GSG CGEV A + + ++I+ I K +
Sbjct: 141 KTLGSGACGEVKLAFER-KTCKKVAIRII-------------------SKRKFAIGSARE 180
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH--- 169
+++EI + ++ H + + D ++ +L + G EL D + +
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYI--VLELMEGG--ELFDKVVGNKRL 236
Query: 170 ------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIP 220
+ ++YLH + IIHRDL P NVLL ++D +I+ FG ++ +
Sbjct: 237 KEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDI 254
+ T + GT Y+APE L + D
Sbjct: 294 ETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDC 327
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 50/242 (20%), Positives = 92/242 (38%), Gaps = 58/242 (23%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G GG + ++ + + K ++ K + LL
Sbjct: 49 LGKGGFAKCFEISDA-DTKEVFAGK------------------IVPKSL-------LLKP 82
Query: 116 KMR-QIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYI---------LNDVSQGRRE 162
R ++ EI+ + H++ H +++ L ++ + R+
Sbjct: 83 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKA 137
Query: 163 LD-WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI-P 220
L AR + G +YLH + +IHRDL N+ L++D+E +I FG A +
Sbjct: 138 LTEPEAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
D GT YIAPE L + + D++ G ++ L++GK P F+ +
Sbjct: 194 DGERKKVL---CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETSCL 246
Query: 280 MS 281
Sbjct: 247 KE 248
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 50/242 (20%), Positives = 92/242 (38%), Gaps = 58/242 (23%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G GG + ++ + + K ++ K + LL
Sbjct: 23 LGKGGFAKCFEISDA-DTKEVFAGK------------------IVPKSL-------LLKP 56
Query: 116 KMR-QIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYI---------LNDVSQGRRE 162
R ++ EI+ + H++ H +++ L ++ + R+
Sbjct: 57 HQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKA 111
Query: 163 LD-WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI-P 220
L AR + G +YLH + +IHRDL N+ L++D+E +I FG A +
Sbjct: 112 LTEPEAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
D GT YIAPE L + + D++ G ++ L++GK P F+ +
Sbjct: 168 DGERKKVL---CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETSCL 220
Query: 280 MS 281
Sbjct: 221 KE 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 36/242 (14%), Positives = 82/242 (33%), Gaps = 51/242 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ + G ++ E ++ + ++KK + + L ++ + +
Sbjct: 36 IRTLNQGKFNKIILCE---KDNKFYALKKY-----EKSLLEKKRDFTKSNNDKISIKSK- 86
Query: 113 LNKKMRQIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYILND-VSQGRREL-DWLA 167
++E+ + I++ ++ + +YI+ + + + +
Sbjct: 87 ----YDDFKNELQIITDIKNEYCLTCEGIITNYDE-----VYIIYEYMEND--SILKFDE 135
Query: 168 RH-----------------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210
I + Y+H I HRD+ P N+L+D + ++
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKL 193
Query: 211 SGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ--MLTLTEKCDIY-FGALLAGLVMGK 267
S FG + + D S GT E++ PE+ K DI+ G L +
Sbjct: 194 SDFGESEYMVDKKIK--GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 268 LP 269
+P
Sbjct: 250 VP 251
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 38/222 (17%), Positives = 78/222 (35%), Gaps = 42/222 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V + A K ++
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGD---------NTGEQVAV----------KSLKPESGGN- 65
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGRRE 162
+ ++ EI + + H N+ T + + + L + + + + +
Sbjct: 66 ---HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
++ + + A+ + G++YL +HRDL NVL++ + + +I FG +AI
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179
Query: 223 HTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ T + V + APE L D++ FG L
Sbjct: 180 KEYYTVKD--DRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 42/228 (18%), Positives = 84/228 (36%), Gaps = 63/228 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+E IGSGG G+V+KA+ +G+ IK++
Sbjct: 16 IELIGSGGFGQVFKAKHR-IDGKTYVIKRV------------------------------ 44
Query: 113 LNKKMRQIQSEINTVGQIRHRN--------------LHPLLAHVTRPDCHLLYILNDVSQ 158
+ + E+ + ++ H N + +R L+I +
Sbjct: 45 -KYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD 103
Query: 159 GRRELDWLARHR-----------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207
W+ + R + + G++Y+H ++I+RDL P N+ L D +
Sbjct: 104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160
Query: 208 ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255
+I FG ++ + + GT+ Y++PE + ++ D+Y
Sbjct: 161 VKIGDFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLY 205
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 41/225 (18%), Positives = 81/225 (36%), Gaps = 49/225 (21%)
Query: 53 LEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L+++G G G V L G ++++KK+ + +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----------QHSTE----------- 52
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQG 159
+ +R + EI + ++H N+ L + L D + +
Sbjct: 53 -----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 107
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+ +D + + + G+EYL IHRDL N+L++++ +I FG + +
Sbjct: 108 KERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVL 164
Query: 220 PDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
P + + APE L + D++ FG +L
Sbjct: 165 PQDKEFFKVKE--PGESPIFWYAPESLTESKFSVASDVWSFGVVL 207
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 47/263 (17%), Positives = 83/263 (31%), Gaps = 65/263 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L ++G G GEV+K ++GR+ ++K+ + P K + +E+
Sbjct: 62 LSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGP------------KDRARKLAEVG 108
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-- 170
++K+ Q H L LY+ ++ L
Sbjct: 109 SHEKVGQ------------HPCCVRLEQAWEEGGI--LYLQTELCGP--SLQQHCEAWGA 152
Query: 171 ---------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
L +LH ++H D+ P N+ L ++ FG +
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI-----------------YFGALLAGLV 264
A G Y+APE LQ + D+ + G L
Sbjct: 210 AGAGEV---QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR 265
Query: 265 MGKLPSDKFFQHTNEM-SFVKWM 286
G LP + ++E+ S + M
Sbjct: 266 QGYLPPEFTAGLSSELRSVLVMM 288
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 55/322 (17%), Positives = 105/322 (32%), Gaps = 75/322 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ GG VY+A+ +GR ++K+++ + ++++
Sbjct: 33 RRVLAEGGFAFVYEAQ-DVGSGREYALKRLLSNEEEK----------NRAIIQEVCF--- 78
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELD 164
M+++ N V + + +L ++ +G
Sbjct: 79 ----MKKLSGHPNIVQFCSA---ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 165 WLARH---RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
L+ +I ++++H P IIHRDL N+LL + ++ FG A I
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190
Query: 222 AHTHITTSNVVGTVE----------YIAPEYLQM---LTLTEKCDI-YFGALLAGLVMGK 267
+ ++ VE Y PE + + + EK DI G +L L +
Sbjct: 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
Query: 268 LPSDKFFQHTNEMSFV----KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCT 323
P F+ ++ V + I + ML V
Sbjct: 251 HP----FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRA----------MLQV-------- 288
Query: 324 LEDPNERPNSKDVRRMLSQIQH 345
+P ER + +V L +I
Sbjct: 289 --NPEERLSIAEVVHQLQEIAA 308
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 42/189 (22%), Positives = 78/189 (41%), Gaps = 33/189 (17%)
Query: 110 EMLLNKKMR-QIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYI---------LND- 155
+ + M ++Q+E+ Q++H + L+ +Y+ +N
Sbjct: 47 KAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY-----VYLVLEMCHNGEMNRY 101
Query: 156 -VSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
++ + + ARH + + G+ YLH H I+HRDL N+LL ++ +I+ FG
Sbjct: 102 LKNRVKPFSENEARHFMH-QIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFG 157
Query: 215 FA-RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272
A + H T GT YI+PE + D++ G + L++G+ P
Sbjct: 158 LATQLKMPHEKHYTL---CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP--- 211
Query: 273 FFQHTNEMS 281
F +
Sbjct: 212 -FDTDTVKN 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 41/225 (18%), Positives = 82/225 (36%), Gaps = 49/225 (21%)
Query: 53 LEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L+++G G G V L G ++++KK+ + +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----------QHSTE----------- 83
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQG 159
+ +R + EI + ++H N+ L + L D + +
Sbjct: 84 -----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 138
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+ +D + + + G+EYL IHRDL N+L++++ +I FG + +
Sbjct: 139 KERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVL 195
Query: 220 PDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
P + + + APE L + D++ FG +L
Sbjct: 196 PQDKEYYKVKE--PGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 58/312 (18%), Positives = 112/312 (35%), Gaps = 72/312 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+KIG G EVY+A +G +++KK+ ++ +
Sbjct: 37 EKKIGRGQFSEVYRA-ACLLDGVPVALKKV--------------------QIFDLMDA-- 73
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRRE- 162
K EI+ + Q+ H N+ A + L I L+ + + ++
Sbjct: 74 --KARADCIKEIDLLKQLNHPNVIKYYASFIEDNE--LNIVLELADAGDLSRMIKHFKKQ 129
Query: 163 ---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
+ + L LE++H R++HRD+ P NV + ++
Sbjct: 130 KRLIPERTVWKYFVQ------LCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDL 180
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272
G R T + +VGT Y++PE + K DI+ G LL + + P
Sbjct: 181 GLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--- 235
Query: 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332
F+ + + + + + P L + E++ ++ C DP +RP+
Sbjct: 236 FYGDKMNLYSL--CKKIEQCDYP------PLPSDHYSEELRQLVN-MCINP--DPEKRPD 284
Query: 333 SKDVRRMLSQIQ 344
V + ++
Sbjct: 285 VTYVYDVAKRMH 296
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 50/233 (21%), Positives = 92/233 (39%), Gaps = 48/233 (20%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+ K+G G GEVY+ + +++K + M+ ++E +++
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVEEFLKEAAVM---------- 270
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND--VSQ 158
+I+H NL LL TR YI L D
Sbjct: 271 ------------------KEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLREC 310
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
R+E+ + +A ++ +EYL + IHR+L N L+ ++ +++ FG +R
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
+ T+ + +++ APE L + K D++ FG LL + G P
Sbjct: 368 MTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 56/245 (22%), Positives = 87/245 (35%), Gaps = 47/245 (19%)
Query: 32 SPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMIS--IK--KIVGPPM 87
S L+ + KD+ ++ S IG G G VY E Q I IK +
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 88 DAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDC 147
A + E ++ + H N+ L+ + P+
Sbjct: 65 QVEAFLREGLLM----------------------------RGLNHPNVLALIGIMLPPEG 96
Query: 148 HLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198
+L + G +R L +A G+EYL +HRDL
Sbjct: 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF---VHRDLAAR 153
Query: 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT--VEYIAPEYLQMLTLTEKCDIY- 255
N +LD+ +++ FG AR I D + + V++ A E LQ T K D++
Sbjct: 154 NCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWS 213
Query: 256 FGALL 260
FG LL
Sbjct: 214 FGVLL 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 65/326 (19%), Positives = 114/326 (34%), Gaps = 63/326 (19%)
Query: 34 LIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALI 93
L++ + + + E IG G G VY L +G+ I A+
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC-----------AV- 58
Query: 94 EEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL 153
K + +I ++ Q +E + H N+ LL R + L +L
Sbjct: 59 --------KSLNRITDIG----EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106
Query: 154 NDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204
+ G L +A G++YL +HRDL N +LD+
Sbjct: 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF---VHRDLAARNCMLDE 163
Query: 205 DIEARISGFGFARAIPDAHTHITTSNVVGT--VEYIAPEYLQMLTLTEKCDIY-FGALLA 261
+++ FG AR + D + + V+++A E LQ T K D++ FG LL
Sbjct: 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 223
Query: 262 GLVM-GKLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQM-LLVLK 317
L+ G P + ++ + P+ C + + ++LK
Sbjct: 224 ELMTRGAPP---YPDVNTFDITVYLL-QGRRL--LQPE----------YCPDPLYEVMLK 267
Query: 318 IACFCTLEDPNERPNSKDVRRMLSQI 343
C RP+ ++ +S I
Sbjct: 268 ----CWHPKAEMRPSFSELVSRISAI 289
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 31/113 (27%), Positives = 45/113 (39%), Gaps = 21/113 (18%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
L L+YL IIHRD+ P N+LLD+ I+ F A +P T + GT
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGT 177
Query: 235 VEYIAPEYLQMLTLTEKCDIY--------FGALLAGLVMGKLPSDKFFQHTNE 279
Y+APE + K Y G L+ G+ P + ++
Sbjct: 178 KPYMAPEMFS----SRKGAGYSFAVDWWSLGVTAYELLRGRRP---YHIRSST 223
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 45/215 (20%), Positives = 72/215 (33%), Gaps = 53/215 (24%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
++G G GEV++ Q G ++KK+ +++
Sbjct: 64 PRVGRGSFGEVHRM-KDKQTGFQCAVKKV-----------------------RLEV---- 95
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGRREL 163
E+ + + PL V + I L + Q
Sbjct: 96 -----FRVEELVACAGLSSPRIVPLYGAVREGPW--VNIFMELLEGGSLGQLIKQMGCLP 148
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD-IEARISGFGFARAIPD- 221
+ A + GLEYLH RI+H D+ NVLL D A + FG A +
Sbjct: 149 EDRALY-YLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 222 --AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ +T + GT ++APE + K DI
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 61/250 (24%), Positives = 98/250 (39%), Gaps = 48/250 (19%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
IG GG GEVY G+M ++K +D + + + LN+
Sbjct: 197 IGRGGFGEVYGCRKAD-TGKMYAMKC-----LDKKRIKMKQ-----------GETLALNE 239
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDW-LARHRI--- 171
R + S ++T + + PD L +IL+ ++ G +L + L++H +
Sbjct: 240 --RIMLSLVSTG---DCPFIVCMSYAFHTPD-KLSFILDLMNGG--DLHYHLSQHGVFSE 291
Query: 172 ------ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
A + GLE++H +++RDL P N+LLD+ RIS G A
Sbjct: 292 ADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 345
Query: 226 ITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
VGT Y+APE LQ D + G +L L+ G P F+
Sbjct: 346 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKH 400
Query: 284 KWMRNVMASE 293
+ R +
Sbjct: 401 EIDRMTLTMA 410
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 51/221 (23%), Positives = 80/221 (36%), Gaps = 47/221 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E+IG G GEV+ L N +++K ++++ L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTL-VAVK-----------------SCRETLPPDLKAKFL 160
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR--PDCHLLYI----------LNDVSQGR 160
E + Q H N+ L+ T+ P +YI L +
Sbjct: 161 ---------QEARILKQYSHPNIVRLIGVCTQKQP----IYIVMELVQGGDFLTFLRTEG 207
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L ++ A G+EYL C IHRDL N L+ + +IS FG +R
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEA 264
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
D + V++ APE L + + D++ FG LL
Sbjct: 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 50/218 (22%), Positives = 78/218 (35%), Gaps = 36/218 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V N G A K ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTND---------GTGEMVAV----------KALKADAGPQ- 75
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRI- 171
+ EI+ + + H ++ L ++ + D+L RH I
Sbjct: 76 ---HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG 132
Query: 172 -------ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
A + G+ YLH H IHRDL NVLLD+D +I FG A+A+P+ H
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
Query: 225 H-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + V + APE L+ D++ FG L
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 37/225 (16%), Positives = 77/225 (34%), Gaps = 46/225 (20%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRM---ISIKKIVGPPMDAAALIEEDSMLLNKKMRQ 106
++ +GSG G VYK + ++ ++IK L +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-----------------ELREATSPK 59
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----------LNDV 156
E+L E + + + ++ LL + + L+ V
Sbjct: 60 ANKEIL---------DEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYV 107
Query: 157 SQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+ + + + +A G+ YL +HRDL NVL+ +I+ FG A
Sbjct: 108 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + ++++A E + T + D++ +G +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 41/106 (38%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ CGLE LH RI++RDL P N+LLDD RIS G A +P+ T VGT
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGT 348
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
V Y+APE ++ T D + G LL ++ G+ P FQ +
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP----FQQRKK 390
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 46/217 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +GSG CGEV A + + ++IK I K +
Sbjct: 16 KTLGSGACGEVKLAFE-RKTCKKVAIKII-------------------SKRKFAIGSARE 55
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH--- 169
+++EI + ++ H + + D ++ +L + G EL D + +
Sbjct: 56 ADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYI--VLELMEGG--ELFDKVVGNKRL 111
Query: 170 ------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIP 220
+ ++YLH + IIHRDL P NVLL ++D +I+ FG ++ +
Sbjct: 112 KEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDI 254
+ T + GT Y+APE L + D
Sbjct: 169 ETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDC 202
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 52/241 (21%), Positives = 87/241 (36%), Gaps = 39/241 (16%)
Query: 32 SPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAA 91
L++ + + + E IG G G VY L +G+ I A
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC-----------A 121
Query: 92 LIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY 151
+ K + +I ++ Q +E + H N+ LL R + L
Sbjct: 122 V---------KSLNRITDIG----EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168
Query: 152 ILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202
+L + G L +A G+++L +HRDL N +L
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCML 225
Query: 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGT--VEYIAPEYLQMLTLTEKCDIY-FGAL 259
D+ +++ FG AR + D + V+++A E LQ T K D++ FG L
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 260 L 260
L
Sbjct: 286 L 286
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 36/109 (33%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ GLE+LH II+RDL P NVLLDDD RIS G A + T T GT
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGT 352
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP--SDKFFQHTNEM 280
++APE L D + G L ++ + P + E+
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 5e-15
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 52/234 (22%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L K+G G GEV+ G ++IK + M A ++E ++
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPEAFLQEAQVM---------- 316
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR-PDCHLLYI---------LNDV--S 157
++RH L L A V+ P +YI L D
Sbjct: 317 ------------------KKLRHEKLVQLYAVVSEEP----IYIVTEYMSKGSLLDFLKG 354
Query: 158 QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ + L +A +A G+ Y+ + +HRDL N+L+ +++ +++ FG AR
Sbjct: 355 ETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLAR 411
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
I D + + +++ APE T K D++ FG LL L G++P
Sbjct: 412 LIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 41/238 (17%), Positives = 89/238 (37%), Gaps = 49/238 (20%)
Query: 38 AKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRM-ISIKKIVGPPMDAAALIEED 96
FL++ L + ++G G G V + + ++ ++IK
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK---------------- 369
Query: 97 SMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---- 152
+L + EM+ E + Q+ + + L+ L +
Sbjct: 370 -VLKQGTEKADTEEMM---------REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEM 416
Query: 153 -----LND-VSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI 206
L+ + R E+ + ++ G++YL + +HR+L NVLL +
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRH 473
Query: 207 EARISGFGFARAIPDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
A+IS FG ++A+ ++ T +++ APE + + + D++ +G +
Sbjct: 474 YAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 55/216 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
EKIG G G VY A + G+ ++I+++ + E
Sbjct: 25 FEKIGQGASGTVYTA-MDVATGQEVAIRQM---NLQQQPKKEL----------------- 63
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI---------LND-VSQ 158
I +EI + + ++ N+ V D +L L++ L D V++
Sbjct: 64 -------IINEILVMRENKNPNI------VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+ +A + LE+LH + +IHRD+ N+LL D +++ FGF
Sbjct: 111 TCMDEGQIAA--VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
I + +T +VGT ++APE + K DI
Sbjct: 166 ITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDI 199
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 59/226 (26%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L L+ IG G G+V + G +++K I + D+ +
Sbjct: 195 LKLLQTIGKGEFGDVMLGDY---RGNKVAVKCI-----------KNDAT----------A 230
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND--VSQ 158
+ L +E + + Q+RH NL LL + + LYI L D S+
Sbjct: 231 QAFL--------AEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSR 281
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
GR L + +L + +EYL ++ +HRDL NVL+ +D A++S FG +
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKE 338
Query: 219 IPDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
V++ APE L+ + K D++ FG LL
Sbjct: 339 ASSTQD--------TGKLPVKWTAPEALREKKFSTKSDVWSFGILL 376
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 66/326 (20%), Positives = 110/326 (33%), Gaps = 92/326 (28%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +G G G V GR +++K++ L E+ L
Sbjct: 21 KILGYGSSGTVVFQGS--FQGRPVAVKRM-----------------LIDFCDIALMEIKL 61
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI--------LNDVSQGRRELDW 165
+ + H N+ T LYI L D+ + + D
Sbjct: 62 ---LTES---------DDHPNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDE 107
Query: 166 LARH-------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-------------DD 205
+ + +A G+ +LH +IIHRDL P N+L+ ++
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
Query: 206 IEARISGFGFARAIPDAHT--HITTSNVVGTVEYIAPEYLQMLT-------LTEKCDIY- 255
+ IS FG + + + +N GT + APE L+ LT DI+
Sbjct: 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 256 FGALL-AGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCE--EQM 312
G + L GK P F + S + +R + + + K D L+ + QM
Sbjct: 225 MGCVFYYILSKGKHP---FGDKYSRESNI--IRGIFSLDEMKCLHDRSLIAEATDLISQM 279
Query: 313 LLVLKIACFCTLEDPNERPNSKDVRR 338
+ DP +RP + V R
Sbjct: 280 IDH----------DPLKRPTAMKVLR 295
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 52/234 (22%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L K+G G GEV+ G ++IK + M A ++E ++
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPEAFLQEAQVM---------- 233
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR-PDCHLLYI---------LNDV--S 157
++RH L L A V+ P +YI L D
Sbjct: 234 ------------------KKLRHEKLVQLYAVVSEEP----IYIVTEYMSKGSLLDFLKG 271
Query: 158 QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ + L +A +A G+ Y+ + +HRDL N+L+ +++ +++ FG AR
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLAR 328
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
I D + + +++ APE T K D++ FG LL L G++P
Sbjct: 329 LIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 42/220 (19%), Positives = 83/220 (37%), Gaps = 47/220 (21%)
Query: 55 KIGSGGCGEVYKAELPGQNGRM-ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
++GSG G V K + +++K + + ++ ++ E+L
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----------KNEAN-----DPALKDELL- 66
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRRELD 164
+E N + Q+ + + ++ + LN Q R +
Sbjct: 67 --------AEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVK 115
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ ++ G++YL + +HRDL NVLL A+IS FG ++A+
Sbjct: 116 DKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 225 HITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ V++ APE + + K D++ FG L+
Sbjct: 173 YYKAQ--THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 51/223 (22%), Positives = 80/223 (35%), Gaps = 48/223 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEM 111
EK+G G G V + E +G+ +S +K + + +++
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD---------------- 67
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGRR 161
E+N + + HRNL L V P + + L D + + +
Sbjct: 68 --------FIREVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQG 116
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
R A+ +A G+ YL IHRDL N+LL +I FG RA+P
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 222 AHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
H + APE L+ T + D + FG L
Sbjct: 174 NDDHYVMQ--EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 48/216 (22%), Positives = 79/216 (36%), Gaps = 55/216 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
KIG G G V A +GR +++K + + E
Sbjct: 50 YVKIGEGSTGIVCLA-REKHSGRQVAVKMM---DLRKQQRREL----------------- 88
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI---------LND-VSQ 158
+ +E+ + +H N+ V +L L++ L D VSQ
Sbjct: 89 -------LFNEVVIMRDYQHFNV------VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ 135
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
R + +A + + L YLH +IHRD+ ++LL D ++S FGF
Sbjct: 136 VRLNEEQIAT--VCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQ 190
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
I + +VGT ++APE + + DI
Sbjct: 191 ISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDI 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 43/225 (19%), Positives = 78/225 (34%), Gaps = 49/225 (21%)
Query: 53 LEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
+ ++G G G V L G ++++K+ L
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ----------LQHSGPD----------- 66
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQG 159
+ R Q EI + + + P L + L D + +
Sbjct: 67 ------QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
R LD + + G+EYL C +HRDL N+L++ + +I+ FG A+ +
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLL 177
Query: 220 PDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
P + + + APE L + + D++ FG +L
Sbjct: 178 PLDKDYYVVRE--PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 37/225 (16%), Positives = 77/225 (34%), Gaps = 46/225 (20%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRM---ISIKKIVGPPMDAAALIEEDSMLLNKKMRQ 106
++ +GSG G VYK + ++ ++IK L +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-----------------ELREATSPK 59
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----------LNDV 156
E+L E + + + ++ LL + + L+ V
Sbjct: 60 ANKEIL---------DEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYV 107
Query: 157 SQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
+ + + + +A G+ YL +HRDL NVL+ +I+ FG A
Sbjct: 108 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLA 164
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + ++++A E + T + D++ +G +
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 48/224 (21%), Positives = 79/224 (35%), Gaps = 54/224 (24%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L L +IG G G V K +G+++++K+I D K+ +Q+
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRI---------RSTVDE----KEQKQLLM 69
Query: 110 EMLLNKKMRQIQSEINTV---GQIRHRNLHPLLAHVTRPDC------------HLLYILN 154
+ L+ MR V G A DC +
Sbjct: 70 D--LDVVMRSSDCP-YIVQFYG-----------ALFREGDCWICMELMSTSFDKFYKYVY 115
Query: 155 DVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
V + L + I L L +L + +IIHRD+ P N+LLD ++ FG
Sbjct: 116 SVLDDVIPEEILGK--ITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171
Query: 215 FARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL----TEKCDI 254
+ + D+ I + G Y+APE + + D+
Sbjct: 172 ISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDV 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 52/238 (21%), Positives = 88/238 (36%), Gaps = 48/238 (20%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G G+V + + ++K +L KK +
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVK------------------ILKKKKLRRIPNGE--- 50
Query: 116 KMRQIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARHRI 171
++ EI + ++RH+N L +L + + ++ ++ G +E+ D + R
Sbjct: 51 --ANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM--VMEYCVCGMQEMLDSVPEKRF 106
Query: 172 ALGLAC--------GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ A GLEYLH I+H+D+ P N+LL +IS G A A+
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTE--KCDIY-FGALLAGLVMGKLPSDKFFQHTN 278
T G+ + PE L K DI+ G L + G P F+ N
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDN 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 59/218 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEK+G G G VYKA + G++++IK+ +
Sbjct: 34 LEKLGEGSYGSVYKAI-HKETGQIVAIKQ-----------------------------VP 63
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI---------LNDVSQG 159
+ +++I EI+ + Q ++ V + L+I ++D+ +
Sbjct: 64 VESDLQEIIKEISIMQQCDSPHV------VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL 117
Query: 160 RREL---DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
R + D +A I GLEYLH IHRD+ N+LL+ + A+++ FG A
Sbjct: 118 RNKTLTEDEIAT--ILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ D T V+GT ++APE +Q + DI
Sbjct: 173 GQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADI 208
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 39/221 (17%), Positives = 83/221 (37%), Gaps = 49/221 (22%)
Query: 55 KIGSGGCGEVYKAELPGQNGRM-ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
++G G G V + + ++ ++IK +L + EM+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIK-----------------VLKQGTEKADTEEMM- 58
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGRREL 163
E + Q+ + + L+ L + L+ + R E+
Sbjct: 59 --------REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEI 107
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ ++ G++YL + +HRDL NVLL + A+IS FG ++A+
Sbjct: 108 PVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 224 THITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
++ T +++ APE + + + D++ +G +
Sbjct: 165 SYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 35/246 (14%)
Query: 54 EKIGSGGCGEVYKA--ELPGQNGRM--ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
++IG G G V A E M +S KK++ + Q +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----------LNDVSQG 159
+ Q+ EI + ++ H N+ L+ + P+ LY+ + +
Sbjct: 79 ------PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
D AR L G+EYLH +IIHRD+ P N+L+ +D +I+ FG +
Sbjct: 133 PLSED-QAR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLT---EKCDIY-FGALLAGLVMGKLPSDKFFQ 275
+ ++ + VGT ++APE L + D++ G L V G+ P F
Sbjct: 188 KGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----FM 241
Query: 276 HTNEMS 281
M
Sbjct: 242 DERIMC 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-14
Identities = 47/223 (21%), Positives = 82/223 (36%), Gaps = 53/223 (23%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L + ++G G G V K +G+++++K+I +S ++ +++
Sbjct: 9 LEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRI---------RATVNS----QEQKRLLM 54
Query: 110 EMLLNKKMRQIQSEINTV---GQIRHRNLHPLLAHVTRPDCHL-----------LYILND 155
+ L+ MR + TV G A D + Y
Sbjct: 55 D--LDISMRTVDCP-FTVTFYG-----------ALFREGDVWICMELMDTSLDKFYKQVI 100
Query: 156 VSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
D L + IA+ + LE+LH +IHRD+ P NVL++ + ++ FG
Sbjct: 101 DKGQTIPEDILGK--IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGI 156
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPE----YLQMLTLTEKCDI 254
+ + D G Y+APE L + K DI
Sbjct: 157 SGYLVDDVAKDI---DAGCKPYMAPERINPELNQKGYSVKSDI 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 50/239 (20%), Positives = 86/239 (35%), Gaps = 66/239 (27%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E +G G V + + ++K I + S +
Sbjct: 23 EILGRGVSSVVRRCIHKP-TCKEYAVKII------------------DVTGGGSFSAEEV 63
Query: 114 NKKMRQIQSEINTVGQI-RHRNLHPLLAHVTR-----PDCHLLYILND-VSQGRREL-DW 165
+ E+ I R + HP ++ + +++ D + +G EL D+
Sbjct: 64 QELREATLKEV----DILRKVSGHP---NIIQLKDTYETNTFFFLVFDLMKKG--ELFDY 114
Query: 166 LARH---------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
L +I L + LH + I+HRDL P N+LLDDD+ +++ FGF+
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL------TEKCDI-------YFGALLAG 262
+ V GT Y+APE ++ ++ D+ Y LLAG
Sbjct: 172 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT--LLAG 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 51/224 (22%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L +K+G+G GEV+ A +++K + M A + E +++
Sbjct: 190 LKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLAEANVM---------- 237
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR-PDCHLLYI---------LND--VS 157
++H L L A VT+ P +YI L D S
Sbjct: 238 ------------------KTLQHDKLVKLHAVVTKEP----IYIITEFMAKGSLLDFLKS 275
Query: 158 QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ + +A G+ ++ + IHRDL N+L+ + +I+ FG AR
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLAR 332
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
I D + + +++ APE + + T K D++ FG LL
Sbjct: 333 VIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 8e-14
Identities = 30/283 (10%), Positives = 67/283 (23%), Gaps = 56/283 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+G G +VY+A N K ++ K +
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVL------------------KVQKPANP--- 108
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIA 172
+ + + + + ++ ++ L+ + ++
Sbjct: 109 --WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG--SVLVGELYSYGTLLNAINLYKNT 164
Query: 173 LG--------------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA---------- 208
+ +E +H IIH D+ P N +L +
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 209 -RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG 266
+ G + + + T + E L + D + A + ++ G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCE 309
K E R + + L C
Sbjct: 282 TYM--KVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 62/316 (19%), Positives = 109/316 (34%), Gaps = 72/316 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
+G G G V +A+L ++G + +K ML + E
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVK-----------------MLKADIIASSDIE 70
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPD----CHLLYI---------LNDVS 157
L E + + H ++ L+ R + + L+
Sbjct: 71 EFL--------REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
Query: 158 QGRR------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARIS 211
R L R + +ACG+EYL + IHRDL N +L +D+ ++
Sbjct: 123 LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVA 179
Query: 212 GFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269
FG +R I + V+++A E L T D++ FG + ++ G+ P
Sbjct: 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 270 SDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327
+ N +++ N + + P C E+ V + C DP
Sbjct: 240 ---YAGIENAEIYNYLI-GGNRL--KQPP----------ECMEE---VYDLMYQCWSADP 280
Query: 328 NERPNSKDVRRMLSQI 343
+RP+ +R L I
Sbjct: 281 KQRPSFTCLRMELENI 296
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 21/70 (30%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ L+ +H IHRD+ P N+LLD +++ FG + + VGT
Sbjct: 177 VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGT 232
Query: 235 VEYIAPEYLQ 244
+YI+PE L+
Sbjct: 233 PDYISPEVLK 242
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 47/235 (20%), Positives = 88/235 (37%), Gaps = 54/235 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L ++GSG CG+V+K + G +I++K++ ++ ++I +
Sbjct: 30 LGEMGSGTCGQVWKMRF-RKTGHVIAVKQM---RRSGN----------KEENKRILMD-- 73
Query: 113 LNKKMRQIQSEINTV---GQIRHRNLHPLLAHVTRPDCH---------LLYILNDVSQGR 160
L+ ++ V G +T D + +
Sbjct: 74 LDVVLKSHDCP-YIVQCFG-----------TFITNTDVFIAMELMGTCAEKLKKRMQGPI 121
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
E L + + + + L YL H +IHRD+ P N+LLD+ + ++ FG + +
Sbjct: 122 PE-RILGK--MTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTE-----KCDIY-FGALLAGLVMGKLP 269
D G Y+APE + T+ + D++ G L L G+ P
Sbjct: 177 DD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 9e-14
Identities = 30/70 (42%), Positives = 41/70 (58%), Gaps = 8/70 (11%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ LEYLH II+RDL P N+LLD + +I+ FGFA+ +PD T + GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 166
Query: 235 VEYIAPEYLQ 244
+YIAPE +
Sbjct: 167 PDYIAPEVVS 176
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 10/101 (9%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ ++ +H H +HRD+ P N+L+D + R++ FG + + T + +S VGT
Sbjct: 184 MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGT 239
Query: 235 VEYIAPEYLQMLTLTEK-----CDIY-FGALLAGLVMGKLP 269
+YI+PE LQ + + CD + G + ++ G+ P
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 25/103 (24%), Positives = 43/103 (41%), Gaps = 12/103 (11%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ ++ +H +HRD+ P N+LLD R++ FG + A + + VGT
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGT 226
Query: 235 VEYIAPEYLQMLTLTEKCDIY--------FGALLAGLVMGKLP 269
+Y++PE LQ + Y G + G+ P
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 44/222 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ IG+G GEVYK L +G+ + A K ++ +E
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGK---------KEVPVAI----------KTLKAGYTE-- 87
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGRRE 162
K+ E +GQ H N+ L +++ + I L+ + + E
Sbjct: 88 --KQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGE 143
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
L + G+A G++YL + +HRDL N+L++ ++ ++S FG +R + D
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200
Query: 223 HTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
T++ G + + APE + T D++ FG ++
Sbjct: 201 PEATYTTS--GGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 61/340 (17%), Positives = 114/340 (33%), Gaps = 73/340 (21%)
Query: 28 PAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGP 85
P L K +D+ L + +G G G V + L ++G + +K
Sbjct: 16 PRGSEELQNKLEDVVIDRNL--LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK----- 68
Query: 86 PMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRP 145
+ Q + E L SE + H N+ LL
Sbjct: 69 ------------TMKLDNSSQREIEEFL--------SEAACMKDFSHPNVIRLLGVCIEM 108
Query: 146 D---CHLLYIL---------------NDVSQGRRELDWLARHRIALGLACGLEYLHMHHC 187
++ + + G + + + + +A G+EYL +
Sbjct: 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF 168
Query: 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT 247
+HRDL N +L DD+ ++ FG ++ I + V++IA E L
Sbjct: 169 ---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 225
Query: 248 LTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKL 303
T K D++ FG + + G P + N ++ + + + P+
Sbjct: 226 YTSKSDVWAFGVTMWEIATRGMTP---YPGVQNHEMYDYLL-HGHRL--KQPE------- 272
Query: 304 VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
C ++ + +I C DP +RP +R L ++
Sbjct: 273 ---DCLDE---LYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 43/216 (19%), Positives = 79/216 (36%), Gaps = 50/216 (23%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+G G G VY N I+IK+I
Sbjct: 28 VVLGKGTYGIVYAG-RDLSNQVRIAIKEI---------------------------PERD 59
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQ---GRR 161
++ + + EI ++H+N+ L + + I L+ + + G
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF--IKIFMEQVPGGSLSALLRSKWGPL 117
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI-EARISGFGFARAIP 220
+ + + GL+YLH + +I+HRD+ NVL++ +IS FG ++ +
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTL--TEKCDI 254
+ T GT++Y+APE + + DI
Sbjct: 175 GINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADI 208
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 41/221 (18%), Positives = 80/221 (36%), Gaps = 46/221 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
IG G G+V++ ++ IK N ++ +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK-----------------TCKNCTSDSVREK 437
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGR 160
L E T+ Q H ++ L+ +T ++I L + +
Sbjct: 438 FL---------QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRK 485
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
LD + A L+ L YL +HRD+ NVL+ + ++ FG +R +
Sbjct: 486 FSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 542
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
D+ + + + ++++APE + T D++ FG +
Sbjct: 543 DSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCM 582
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 56/218 (25%), Positives = 85/218 (38%), Gaps = 58/218 (26%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEKIG G GEV+K + + ++++IK I ++ A ED
Sbjct: 27 LEKIGKGSFGEVFKG-IDNRTQKVVAIKII---DLEEAEDEIED---------------- 66
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI---------LNDVSQG 159
IQ EI + Q + +L L+I D+ +
Sbjct: 67 -------IQQEITVLSQCDSPYV------TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP 113
Query: 160 RRELDWLARHRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
L +IA + GL+YLH + IHRD+ NVLL + E +++ FG A
Sbjct: 114 GP----LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ D T VGT ++APE ++ K DI
Sbjct: 167 GQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADI 202
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 59/226 (26%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L L+ IG G G+V + G +++K I+ D+
Sbjct: 23 LKLLQTIGKGEFGDVMLGDY---RGNKVAVKC-----------IKNDAT----------- 57
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDV--SQ 158
+ +E + + Q+RH NL LL + + LYI L D S+
Sbjct: 58 -------AQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSR 109
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
GR L + +L + +EYL ++ +HRDL NVL+ +D A++S FG +
Sbjct: 110 GRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKE 166
Query: 219 IPDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
V++ APE L+ + K D++ FG LL
Sbjct: 167 ASSTQD--------TGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 46/222 (20%), Positives = 85/222 (38%), Gaps = 45/222 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
+ +G+G GEV L + + IS IK + +
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----------KVGYT------------ 86
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGR 160
K+ R E + +GQ H N+ L VT+ + I L+ + +
Sbjct: 87 ---EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHD 141
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
+ + + G+A G++YL +HRDL N+L++ ++ ++S FG R +
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 221 D-AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
D TT + + +PE + T D++ +G +L
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 21/177 (11%)
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DW 165
I L ++++ E+ + + H N+ L V + L I+ S G E+ D+
Sbjct: 48 IDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF-EVIETEKTLYLIMEYASGG--EVFDY 104
Query: 166 LARH---------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
L H + ++Y H I+HRDL N+LLD D+ +I+ FGF+
Sbjct: 105 LVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS 161
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGKLPSD 271
+ G Y APE Q + D++ G +L LV G LP D
Sbjct: 162 NEFTVGG-KLDAF--CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 40/224 (17%), Positives = 79/224 (35%), Gaps = 52/224 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
IG G G+V++ ++ IK N ++ +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIK-----------------TCKNCTSDSVREK 62
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----------LNDVSQGR 160
L E T+ Q H ++ L+ +T ++I + + +
Sbjct: 63 FL---------QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRK 110
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
LD + A L+ L YL +HRD+ NVL+ + ++ FG +R +
Sbjct: 111 YSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME 167
Query: 221 DAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
D+ + + ++++APE + T D++ FG +
Sbjct: 168 DSTYYKAS----KGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 39/218 (17%), Positives = 75/218 (34%), Gaps = 40/218 (18%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +GSG G V+K + + K +
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGE---------SIKIPVCI----------KVIEDKSGRQ-- 57
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----------LNDVSQGRREL 163
+ + + +G + H ++ LL L + L+ V Q R L
Sbjct: 58 --SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGAL 112
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ +A G+ YL H +HR+L NVLL + +++ FG A +P
Sbjct: 113 GPQLLLNWGVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ S ++++A E + T + D++ +G +
Sbjct: 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 23/70 (32%), Positives = 36/70 (51%), Gaps = 8/70 (11%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ EYLH +I+RDL P N+L+D +++ FGFA+ + T + GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGT 201
Query: 235 VEYIAPEYLQ 244
E +APE +
Sbjct: 202 PEALAPEIIL 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 7e-13
Identities = 43/225 (19%), Positives = 76/225 (33%), Gaps = 55/225 (24%)
Query: 53 LEKIGSGGC--GEVYKA-ELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L IG G V A P G +++++I +E S
Sbjct: 30 LTVIGKGFEDLMTVNLARYKP--TGEYVTVRRI---------NLEACS------------ 66
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGR 160
N+ + +Q E++ H N+ P A + L++ D+
Sbjct: 67 ----NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTH 120
Query: 161 RELDWLARHRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
D + IA G+ L+Y+H +HR + ++L+ D + +SG
Sbjct: 121 FM-DGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNL 176
Query: 218 AIPDAHT-----HITTSNVVGTVEYIAPEYLQMLTL--TEKCDIY 255
++ H V + +++PE LQ K DIY
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 49/224 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
+ IGSG GEV L R + IK L + + +
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK-----------------ALKAGYTERQRRD 96
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGR 160
L SE + +GQ H N+ L VTR L I L+ +
Sbjct: 97 FL---------SEASIMGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHD 145
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
+ + + G+ G+ YL +HRDL NVL+D ++ ++S FG +R +
Sbjct: 146 GQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202
Query: 221 DAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
D T+ G + + APE + T + D++ FG ++
Sbjct: 203 DDPDAAYTTT--GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 53/316 (16%), Positives = 111/316 (35%), Gaps = 69/316 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++G G G VY+ G P A K + + S
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKD--------EPETRVAI----------KTVNEAASM-- 69
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRR-- 161
++ + +E + + + ++ LL V++ + L + R
Sbjct: 70 --RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPA 125
Query: 162 -----ELDWLARHR---IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
L + + +A +A G+ YL+ + +HRDL N ++ +D +I F
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDF 182
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSD 271
G R I + + + V +++PE L+ T D++ FG +L + + P
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-- 240
Query: 272 KFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329
+ +NE + FV ++ + P C + + ++ C +P
Sbjct: 241 -YQGLSNEQVLRFVM-EGGLL--DKPD----------NCPDML---FELMRMCWQYNPKM 283
Query: 330 RPNSKDVRRMLSQIQH 345
RP+ ++ + +
Sbjct: 284 RPSFLEIISSIKEEME 299
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-13
Identities = 48/232 (20%), Positives = 90/232 (38%), Gaps = 38/232 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +GSG G V+ A + + + +K I KK + ++ +
Sbjct: 29 MSPLGSGAFGFVWTAVDK-EKNKEVVVKFI-------------------KKEKVLEDCWI 68
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH--- 169
+ K+ ++ EI + ++ H N+ +L + ++ G ++ RH
Sbjct: 69 EDPKLGKVTLEIAILSRVEHANIIKVL-DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127
Query: 170 ------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
I L + YL + IIHRD+ N+++ +D ++ FG A A +
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERG 183
Query: 224 THITTSNVVGTVEYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273
T GT+EY APE L + +++ G L LV + P +
Sbjct: 184 KLFYTF--CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 60/220 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +IG G G VY A +N +++IKK+ E+
Sbjct: 59 LREIGHGSFGAVYFA-RDVRNSEVVAIKKM---SYSGKQSNEKWQ--------------- 99
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI--------LNDVSQGR 160
I E+ + ++RH N + C+L ++ +D+ +
Sbjct: 100 ------DIIKEVRFLQKLRHPNT------IQYRGCYLREHTAWLVMEYCLGSASDLLEVH 147
Query: 161 RELDWLARHRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
++ L IA G GL YLH H+ +IHRD+ N+LL + ++ FG A
Sbjct: 148 KKP--LQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS 202
Query: 218 AIPDAHTHITTSNVVGTVEYIAPE---YLQMLTLTEKCDI 254
+ A++ VGT ++APE + K D+
Sbjct: 203 IMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDV 236
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 55/226 (24%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L +E++G+G GEV+ G +++K + M A + E +++
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGH--TKVAVKSLKQGSMSPDAFLAEANLM---------- 62
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR-PDCHLLYI---------LNDV--S 157
Q++H+ L L A VT+ P +YI L D +
Sbjct: 63 ------------------KQLQHQRLVRLYAVVTQEP----IYIITEYMENGSLVDFLKT 100
Query: 158 QGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+L +A +A G+ ++ + IHRDL N+L+ D + +I+ FG AR
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 218 AIPDAHTHITTSNVVGT--VEYIAPEYLQMLTLTEKCDIY-FGALL 260
I D + T+ +++ APE + T T K D++ FG LL
Sbjct: 158 LIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 41/224 (18%), Positives = 82/224 (36%), Gaps = 52/224 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMIS--IKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
+G G GEVY+ G I+ +K ++D L NK+ +
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKT-----------CKKDCTLDNKE------K 59
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGR 160
+ SE + + H ++ L+ + +I L + + +
Sbjct: 60 FM---------SEAVIMKNLDHPHIVKLIGIIEE---EPTWIIMELYPYGELGHYLERNK 107
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L L +L + + YL +C +HRD+ N+L+ ++ FG +R I
Sbjct: 108 NSLKVLTLVLYSLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIE 164
Query: 221 DAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
D + + T +++++PE + T D++ F +
Sbjct: 165 DEDYYKAS----VTRLPIKWMSPESINFRRFTTASDVWMFAVCM 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 55/224 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
K+G G GEVY+ + +++K + M+ ++E +++
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVEEFLKEAAVM------------- 63
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR--PDCHLLYI---------LND--VSQG 159
+I+H NL LL TR P YI L D
Sbjct: 64 ---------------KEIKHPNLVQLLGVCTREPP----FYIITEFMTYGNLLDYLRECN 104
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
R+E+ + +A ++ +EYL + IHRDL N L+ ++ +++ FG +R +
Sbjct: 105 RQEVSAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLM 161
Query: 220 PDAHTHITTSNVVGT--VEYIAPEYLQMLTLTEKCDIY-FGALL 260
T++ +++ APE L + K D++ FG LL
Sbjct: 162 TG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 50/223 (22%), Positives = 81/223 (36%), Gaps = 53/223 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E IGSG V A ++IK+I ++
Sbjct: 20 QEVIGSGATAVVQAA-YCAPKKEKVAIKRI---NLEKC---------------------- 53
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDV-----SQ 158
M ++ EI + Q H N+ + + + L++ + D+ ++
Sbjct: 54 -QTSMDELLKEIQAMSQCHHPNI--VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAK 110
Query: 159 GRRELDWLARHRIALGLA---CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
G + L IA L GLEYLH + IHRD+ N+LL +D +I+ FG
Sbjct: 111 GEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167
Query: 216 ARAIPDAHTHITTSN---VVGTVEYIAPEYL-QMLTLTEKCDI 254
+ + VGT ++APE + Q+ K DI
Sbjct: 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADI 210
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 48/215 (22%), Positives = 82/215 (38%), Gaps = 53/215 (24%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E +GSG EV+ + G++ ++K I KK + L
Sbjct: 15 EVLGSGAFSEVFLVK-QRLTGKLFALKCI-------------------KKSPAFRDSSLE 54
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWL------ 166
N EI + +I+H N+ L Y++ + G EL D +
Sbjct: 55 N--------EIAVLKKIKHENIVTLEDIYESTTH--YYLVMQLVSGG-ELFDRILERGVY 103
Query: 167 ----ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAI 219
A + + ++YLH + I+HRDL P N+L +++ + I+ FG ++
Sbjct: 104 TEKDASL-VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ S GT Y+APE L ++ D
Sbjct: 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDC 190
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 41/219 (18%), Positives = 77/219 (35%), Gaps = 47/219 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+++IGSG G V+ ++ ++IK I M IEE ++
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKD--KVAIKTIREGAMSEEDFIEEAEVM------------- 57
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----------LNDVSQGRRE 162
++ H L L + + + + R
Sbjct: 58 ---------------MKLSHPKLVQLYGVCLEQA--PICLVTEFMEHGCLSDYLRTQRGL 100
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ L + G+ YL IHRDL N L+ ++ ++S FG R + D
Sbjct: 101 FAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLD- 156
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ +++ V++ +PE + K D++ FG L+
Sbjct: 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 23/80 (28%), Positives = 39/80 (48%), Gaps = 8/80 (10%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
L Y H ++ IIHRD+ P VLL ++ ++ GFG A + ++ VGT
Sbjct: 142 ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGT 196
Query: 235 VEYIAPEYLQMLTLTEKCDI 254
++APE ++ + D+
Sbjct: 197 PHFMAPEVVKREPYGKPVDV 216
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 29/99 (29%), Positives = 41/99 (41%), Gaps = 10/99 (10%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR--ISGFGFARAIPDAHTH--ITTSNVVG 233
L YLH I HRD+ P N L + + FG ++ + + G
Sbjct: 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 234 TVEYIAPEYLQMLTL--TEKCDIY-FGALLAGLVMGKLP 269
T ++APE L KCD + G LL L+MG +P
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 52/225 (23%), Positives = 83/225 (36%), Gaps = 53/225 (23%)
Query: 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L L+++G+G G V + GQ ++IK I M IEE ++
Sbjct: 26 LTFLKELGTGQFGVVKYGKWRGQ--YDVAIKMIKEGSMSEDEFIEEAKVM---------- 73
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI----------LNDVSQG 159
+ H L L T+ ++I LN + +
Sbjct: 74 ------------------MNLSHEKLVQLYGVCTKQR--PIFIITEYMANGCLLNYLREM 113
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
R + + +EYL +HRDL N L++D ++S FG +R +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYV 170
Query: 220 PDAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
D T+S VG+ V + PE L + K DI+ FG L+
Sbjct: 171 LD--DEYTSS--VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 51/217 (23%), Positives = 78/217 (35%), Gaps = 52/217 (23%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
K+GSG G+V+ E +G IK I NK Q+ E +
Sbjct: 28 RKLGSGAFGDVHLVEERS-SGLERVIKTI------------------NKDRSQVPMEQIE 68
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIAL 173
EI + + H N+ + D H +YI+ + +G L+ + +
Sbjct: 69 A--------EIEVLKSLDHPNIIKI--FEVFEDYHNMYIVMETCEGGELLERIVSAQARG 118
Query: 174 G-------------LACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFAR 217
+ L Y H H ++H+DL P N+L +I FG A
Sbjct: 119 KALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+N GT Y+APE + +T KCDI
Sbjct: 176 LFKSDEHS---TNAAGTALYMAPEVFKR-DVTFKCDI 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 21/98 (21%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEY 237
+ +LH ++ I+HRDL P N+LLDD+++ R+S FGF+ + + GT Y
Sbjct: 212 AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGY 265
Query: 238 IAPEYLQMLTL------TEKCDI-------YFGALLAG 262
+APE L+ ++ D+ + LLAG
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFT--LLAG 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 43/223 (19%), Positives = 77/223 (34%), Gaps = 62/223 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ ++G G G+VYKA + G + + K I E+
Sbjct: 24 VGELGDGAFGKVYKA-KNKETGALAAAKVI--------ETKSEE---------------- 58
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI---------LNDVSQG 159
++ EI + H + V + L+I ++ +
Sbjct: 59 ---ELEDYIVEIEILATCDHPYI------VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE 109
Query: 160 RRELDWLARHRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA 216
L +I + + L +LH IIHRDL NVL+ + + R++ FG +
Sbjct: 110 LDRG--LTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164
Query: 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE-----KCDI 254
+ +GT ++APE + T+ + K DI
Sbjct: 165 AKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADI 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 59/225 (26%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+E +G+G G+VYK + G++ +IK + + D
Sbjct: 29 VELVGNGTYGQVYKG-RHVKTGQLAAIKVM---------DVTGD---------------- 62
Query: 113 LNKKMRQIQSEINTVGQI-RHRNLHP-----LLAHVTRPDCHL------------LYILN 154
+ +I+ EIN + + HRN+ + + D L ++
Sbjct: 63 ---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 155 DVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFG 214
+ + +W+A I + GL +LH H +IHRD+ NVLL ++ E ++ FG
Sbjct: 120 NTKGNTLKEEWIAY--ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 215 FARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE-----KCDI 254
+ + T +GT ++APE + + K D+
Sbjct: 175 VSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDL 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ IGSG G V A R ++IKK+ P ++ + R++ +L
Sbjct: 67 LKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRP--------FQNQTHAKRAYREL---VL 114
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL-----LYI--------LNDVSQG 159
+ + H+N+ LL +V P L +Y+ L V
Sbjct: 115 MK--------------CVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-- 157
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+ ELD + + CG+++LH IIHRDL P N+++ D +I FG AR
Sbjct: 158 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
+ + T VV T Y APE + + E DI+ G ++ +V K
Sbjct: 215 GT--SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 10/106 (9%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
LA L++LH II+RDL P N+LLD++ +++ FG ++ + GT
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGT 189
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
VEY+APE + T+ D + FG L+ ++ G LP FQ +
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP----FQGKDR 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 9/106 (8%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ L+YLH +++RDL N++LD D +I+ FG + T GT
Sbjct: 257 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 312
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
EY+APE L+ D + G ++ ++ G+LP F + +
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDH 354
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 51/234 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V +A+ G + + + V A +++E + + + R + SE+
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKT--ATCRTV-----AVKMLKEGAT--HSEHRALMSELK 82
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-- 170
+ + I H N+ LL T+P L+ I+ G +L R
Sbjct: 83 I---LIHIG---------HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNE 129
Query: 171 -----------------------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207
+ +A G+E+L C IHRDL N+LL +
Sbjct: 130 FVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNV 186
Query: 208 ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+I FG AR I ++ + ++++APE + T + D++ FG LL
Sbjct: 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 21/71 (29%), Positives = 37/71 (52%), Gaps = 6/71 (8%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFA-RAIPDAHTHITTSNVVG 233
+ LE+LH II+RD+ N+LLD + ++ FG + + D + G
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE--RAYDFCG 222
Query: 234 TVEYIAPEYLQ 244
T+EY+AP+ ++
Sbjct: 223 TIEYMAPDIVR 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 44/240 (18%), Positives = 73/240 (30%), Gaps = 79/240 (32%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEKIGSG G V+K + +G + +IK+ P + + E+
Sbjct: 16 LEKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGS------------VDEQNALREVY 62
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR-----PDCHLLYILN------DVSQGRR 161
+ + Q H HV R + + I N ++
Sbjct: 63 AHAVLGQ----------------HS---HVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS 103
Query: 162 ELDWLARH-------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD--------- 205
E + + + L + GL Y+H ++H D+ P N+ +
Sbjct: 104 ENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEE 160
Query: 206 ----------IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDI 254
+ +I G I G ++A E LQ T K DI
Sbjct: 161 GDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADI 214
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 31/106 (29%), Positives = 48/106 (45%), Gaps = 10/106 (9%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
++ L +LH II+RDL P N++L+ +++ FG + H T GT
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGT 184
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
+EY+APE L D + GAL+ ++ G P F N
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTGENR 226
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 54/213 (25%), Positives = 82/213 (38%), Gaps = 47/213 (22%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+G G GEV K + + ++K I NK
Sbjct: 28 CMLGKGSFGEVLKCK-DRITQQEYAVKVI------------------NKAS-------AK 61
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH---- 169
NK I E+ + ++ H N+ L D YI+ ++ G D + +
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKL--FEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 170 -----RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPD 221
RI + G+ Y+H H+ I+HRDL P N+LL + D + +I FG +
Sbjct: 120 EHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+GT YIAPE L+ T EKCD+
Sbjct: 177 NTKMKD---RIGTAYYIAPEVLRG-TYDEKCDV 205
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 17/98 (17%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNV 231
L + ++H ++HRDL P N+L +D++E +I FGFAR P + + T
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--P 169
Query: 232 VGTVEYIAPEYLQMLTLTEKCDI-------YFGALLAG 262
T+ Y APE L E CD+ Y +L+G
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYT--MLSG 205
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 54/244 (22%), Positives = 83/244 (34%), Gaps = 50/244 (20%)
Query: 27 GPAIFSPLIKKAKDLAFLEKKGGLASL----EKIGSGGCGEVYKAELPGQNGRMISIKKI 82
GP + + + +G G GEV + G+ ++K I
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVI 59
Query: 83 VGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHV 142
K + Q + E+ + Q+ H N+ L +
Sbjct: 60 -------------------SKRQVKQKT-----DKESLLREVQLLKQLDHPNIMKL--YE 93
Query: 143 TRPDCHLLYILNDVSQGRRELDWLARH---------RIALGLACGLEYLHMHHCPRIIHR 193
D Y++ +V G D + RI + G+ Y+H + I+HR
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHR 150
Query: 194 DLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250
DL P N+LL D RI FG + + +GT YIAPE L T E
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIAPEVLHG-TYDE 206
Query: 251 KCDI 254
KCD+
Sbjct: 207 KCDV 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 57/224 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+++GSG G V + GQ +++K I M +E +
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ--YDVAVKMIKEGSMSEDEFFQEAQTM------------- 57
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR--PDCHLLYI----------LNDVSQGR 160
++ H L ++ P +YI LN +
Sbjct: 58 ---------------MKLSHPKLVKFYGVCSKEYP----IYIVTEYISNGCLLNYLRSHG 98
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
+ L+ + + G+ +L H IHRDL N L+D D+ ++S FG R +
Sbjct: 99 KGLEPSQLLEMCYDVCEGMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155
Query: 221 DAHTHITTSNVVGT---VEYIAPEYLQMLTLTEKCDIY-FGALL 260
D + GT V++ APE + K D++ FG L+
Sbjct: 156 DDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 58/317 (18%), Positives = 102/317 (32%), Gaps = 71/317 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++G G G+V+ AE M A K + SE
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPE--------QDKMLVAV-----------KALKEASE-- 84
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTR--PDC--------------------HLL 150
+ Q E + ++H+++ T P
Sbjct: 85 --SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAK 142
Query: 151 YILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210
+ L +A +A G+ YL H +HRDL N L+ + +I
Sbjct: 143 LLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKI 199
Query: 211 SGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKL 268
FG +R I + + + ++ PE + T + D++ FG +L + GK
Sbjct: 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259
Query: 269 PSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326
P ++Q +N + + + E P+ C + V I C +
Sbjct: 260 P---WYQLSNTEAIDCIT-QGREL--ERPR----------ACPPE---VYAIMRGCWQRE 300
Query: 327 PNERPNSKDVRRMLSQI 343
P +R + KDV L +
Sbjct: 301 PQQRHSIKDVHARLQAL 317
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 37/213 (17%), Positives = 71/213 (33%), Gaps = 48/213 (22%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E++G+G G V++ G + K + + E +
Sbjct: 163 EELGTGAFGVVHRVTERA-TGNNFAAKFV-------------------MTPHESDKETVR 202
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIAL 173
EI T+ +RH L L H D + + ++ + G + +A +
Sbjct: 203 K--------EIQTMSVLRHPTLVNL--HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 252
Query: 174 G----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI--SGFGFARAIPD 221
+ GL ++H ++ +H DL P N++ + FG + D
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-D 308
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ GT E+ APE + + D+
Sbjct: 309 PKQSVKV--TTGTAEFAAPEVAEGKPVGYYTDM 339
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 9/80 (11%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ Y H + I+HR+L P N+LL +++ FG A + D+ GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGT 193
Query: 235 VEYIAPEYLQMLTLTEKCDI 254
Y++PE L+ ++ DI
Sbjct: 194 PGYLSPEVLKKDPYSKPVDI 213
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 9/80 (11%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ Y H + I+HR+L P N+LL +++ FG A + D+ GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
Query: 235 VEYIAPEYLQMLTLTEKCDI 254
Y++PE L+ ++ DI
Sbjct: 171 PGYLSPEVLKKDPYSKPVDI 190
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 52/205 (25%), Positives = 77/205 (37%), Gaps = 52/205 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +G G G V K GR+++IKK + ++D M+ MR
Sbjct: 30 LGLVGEGSYGMVMKCR-NKDTGRIVAIKKFL--------ESDDDKMVKKIAMR------- 73
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL----YILNDVSQGRRELDWLAR 168
EI + Q+RH NL LL V + ++ + + LD L
Sbjct: 74 ----------EIKLLKQLRHENLVNLL-EVCKKKKRWYLVFEFVDHTI------LDDLEL 116
Query: 169 HRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
L + G+ + H H IIHRD+ P N+L+ ++ FGFAR
Sbjct: 117 FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFART 173
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYL 243
+ + V T Y APE L
Sbjct: 174 LAAPGEVYD--DEVATRWYRAPELL 196
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 50/213 (23%), Positives = 78/213 (36%), Gaps = 47/213 (22%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+K+GSG GEV +IK I K +
Sbjct: 43 KKLGSGAYGEVLLCRDK-VTHVERAIKII------------------RKTS-------VS 76
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH---- 169
++ E+ + + H N+ L + D Y++ + +G D +
Sbjct: 77 TSSNSKLLEEVAVLKLLDHPNIMKL--YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 170 -----RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPD 221
I + G+ YLH H+ I+HRDL P N+LL + D +I FG + +
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+GT YIAPE L+ EKCD+
Sbjct: 192 QKKMKE---RLGTAYYIAPEVLRK-KYDEKCDV 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 4e-11
Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 47/216 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E++GSG V K G+ + K I KK R S +
Sbjct: 11 EELGSGQFAIVRKCR-QKGTGKEYAAKFI-------------------KKRRLSSSRRGV 50
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQGRREL-DWLARH-- 169
+++ I+ E+N + +IRH N+ L + D L IL VS G EL D+LA
Sbjct: 51 SREE--IEREVNILREIRHPNIITLHDIFENKTDVVL--ILELVSGG--ELFDFLAEKES 104
Query: 170 ---RIALGLAC----GLEYLHMHHCPRIIHRDLNPVNVLL----DDDIEARISGFGFARA 218
A G+ YLH I H DL P N++L + ++ FG A
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
I + N+ GT E++APE + L + D+
Sbjct: 162 IEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADM 194
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 57/322 (17%), Positives = 113/322 (35%), Gaps = 76/322 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAA-LIEEDSMLLNKKMRQIQSEM 111
++G G G+V+ AE + M A +++ ++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPT--------KDKMLVAVKALKDPTL------------- 58
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------RPDC 147
+ Q E + ++H ++ PD
Sbjct: 59 ---AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115
Query: 148 HLLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207
+ + Q + EL IA +A G+ YL H +HRDL N L+ ++
Sbjct: 116 MI-LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLL 171
Query: 208 ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-M 265
+I FG +R + + + + + ++ PE + T + D++ FG +L +
Sbjct: 172 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 266 GKLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCT 323
GK P +FQ +N + + V+ E P+ C ++ V + C
Sbjct: 232 GKQP---WFQLSNTEVIECIT-QGRVL--ERPR----------VCPKE---VYDVMLGCW 272
Query: 324 LEDPNERPNSKDVRRMLSQIQH 345
+P +R N K++ ++L +
Sbjct: 273 QREPQQRLNIKEIYKILHALGK 294
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 40/214 (18%), Positives = 75/214 (35%), Gaps = 52/214 (24%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
++G G VY+ + + ++K + K
Sbjct: 59 SELGRGATSIVYRCK-QKGTQKPYALKVL------------------KKT---------- 89
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH--- 169
+ +++EI + ++ H N+ L + ++ ++ G EL D +
Sbjct: 90 -VDKKIVRTEIGVLLRLSHPNIIKL--KEIFETPTEISLVLELVTGG-ELFDRIVEKGYY 145
Query: 170 ------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIP 220
+ + YLH + I+HRDL P N+L D +I+ FG ++ +
Sbjct: 146 SERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
T V GT Y APE L+ + D+
Sbjct: 203 HQVLMKT---VCGTPGYCAPEILRGCAYGPEVDM 233
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 18/99 (18%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA----RISGFGFARAIPDAHTHITTSN 230
+ +EYLH ++HRDL P N+L D+ RI FGFA+ + + + T
Sbjct: 125 ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-- 179
Query: 231 VVGTVEYIAPEYLQMLTLTEKCDI-------YFGALLAG 262
T ++APE L+ CDI Y +L G
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYT--MLTG 216
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 67/329 (20%), Positives = 118/329 (35%), Gaps = 89/329 (27%)
Query: 53 LEKIGSGGCGEVYKAEL----PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
+E++G G+VYK L PG+ + ++IK L +K ++
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-----------------TLKDKAEGPLR 56
Query: 109 SEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------R 144
E E +++H N+ LL VT
Sbjct: 57 EEFR---------HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRS 107
Query: 145 PDCHLLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD 204
P + +D + L+ + +A G+EYL HH +H+DL NVL+ D
Sbjct: 108 PHSDVGSTDDDRTVKS-ALEPPDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYD 163
Query: 205 DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263
+ +IS G R + A + N + + ++APE + + DI+ +G +L +
Sbjct: 164 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223
Query: 264 VM-GKLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQ----MLLVL 316
G P + ++N+ + ++ R V+ P C M+
Sbjct: 224 FSYGLQP---YCGYSNQDVVEMIR-NRQVL--PCPD----------DCPAWVYALMIE-- 265
Query: 317 KIACFCTLEDPNERPNSKDVRRMLSQIQH 345
C E P+ RP KD+ L +
Sbjct: 266 -----CWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 5e-11
Identities = 49/199 (24%), Positives = 77/199 (38%), Gaps = 40/199 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ KIG G G V+K G++++IKK + E+D ++ +R
Sbjct: 8 IGKIGEGSYGVVFKCR-NRDTGQIVAIKKFL--------ESEDDPVIKKIALR------- 51
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL----YILNDVSQ----GRRELD 164
EI + Q++H NL LL V R L Y + V +R +
Sbjct: 52 ----------EIRMLKQLKHPNLVNLL-EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVP 100
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
I + + H H IHRD+ P N+L+ ++ FGFAR +
Sbjct: 101 EHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157
Query: 225 HITTSNVVGTVEYIAPEYL 243
+ + V T Y +PE L
Sbjct: 158 YYD--DEVATRWYRSPELL 174
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 70/319 (21%), Positives = 119/319 (37%), Gaps = 70/319 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V AE G + V A ++++D+ K + + SEM
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV-----AVKMLKDDAT--EKDLSDLVSEME 138
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------RPDCH 148
+ M+ I +H+N+ LL T RP
Sbjct: 139 M---MKMIG---------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 149 LLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
+ ++ + LA G+EYL C IHRDL NVL+ ++
Sbjct: 187 EYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVM 242
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MG 266
+I+ FG AR I + + T+N V+++APE L T + D++ FG L+ + +G
Sbjct: 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 267 KLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTL 324
P + E +K + M + P C ++ + C
Sbjct: 303 GSP---YPGIPVEELFKLLK-EGHRM--DKPA----------NCTNEL---YMMMRDCWH 343
Query: 325 EDPNERPNSKDVRRMLSQI 343
P++RP K + L +I
Sbjct: 344 AVPSQRPTFKQLVEDLDRI 362
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 36/213 (16%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
K+GSG GEV + +IK I + ++ + K + E +
Sbjct: 42 RKLGSGAYGEVLLCKEK-NGHSEKAIKVI------KKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH---- 169
N EI+ + + H N+ L D Y++ + +G + +
Sbjct: 95 N--------EISLLKSLDHPNIIKLFD--VFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 170 -----RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPD 221
I + G+ YLH H+ I+HRD+ P N+LL + + +I FG +
Sbjct: 145 ECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ + +GT YIAPE L+ EKCD+
Sbjct: 202 DYKL---RDRLGTAYYIAPEVLKK-KYNEKCDV 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 35/106 (33%), Positives = 50/106 (47%), Gaps = 10/106 (9%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A L YLH + I++RDL P N+LLD ++ FG + + + TTS GT
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGT 202
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
EY+APE L D + GA+L ++ G P F N
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP----FYSRNT 244
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 18/80 (22%), Positives = 33/80 (41%), Gaps = 8/80 (10%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ + H ++HR+L P N+LL +++ FG A + GT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGT 176
Query: 235 VEYIAPEYLQMLTLTEKCDI 254
Y++PE L+ + D+
Sbjct: 177 PGYLSPEVLRKDPYGKPVDL 196
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 8e-11
Identities = 43/233 (18%), Positives = 80/233 (34%), Gaps = 44/233 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+GSGG G VY + ++IK + K +I
Sbjct: 48 GPLLGSGGFGSVYSGI-RVSDNLPVAIKHV------------------EKD--RISDWGE 86
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPL-LAHVTRPDCHLLYILNDVSQGRREL-DWLARH- 169
L R + E+ + ++ + L + IL ++L D++
Sbjct: 87 LPNGTR-VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE-PVQDLFDFITERG 144
Query: 170 --------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIP 220
+ + + H ++HRD+ N+L+D + E ++ FG +
Sbjct: 145 ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK 201
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLT-EKCDIY-FGALLAGLVMGKLPSD 271
D T T GT Y PE+++ ++ G LL +V G +P +
Sbjct: 202 D--TVYTDF--DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 57/216 (26%), Positives = 85/216 (39%), Gaps = 47/216 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E++GSG V K G + K I KK + S +
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAKFI-------------------KKRQSRASRRGV 57
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQGRREL-DWLARH-- 169
+++ I+ E++ + Q+ H N+ L + R D L IL VS G EL D+LA+
Sbjct: 58 SREE--IEREVSILRQVLHHNVITLHDVYENRTDVVL--ILELVSGG--ELFDFLAQKES 111
Query: 170 ---RIALGLAC----GLEYLHMHHCPRIIHRDLNPVNVLL----DDDIEARISGFGFARA 218
A G+ YLH I H DL P N++L ++ FG A
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
I D N+ GT E++APE + L + D+
Sbjct: 169 IEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 57/216 (26%), Positives = 84/216 (38%), Gaps = 47/216 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E++GSG V K G + K I KK + S +
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAKFI-------------------KKRQSRASRRGV 57
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQGRREL-DWLARH-- 169
++ I+ E++ + Q+ H N+ L + R D L IL VS G EL D+LA+
Sbjct: 58 CREE--IEREVSILRQVLHPNIITLHDVYENRTDVVL--ILELVSGG--ELFDFLAQKES 111
Query: 170 ---RIALGLAC----GLEYLHMHHCPRIIHRDLNPVNVLL----DDDIEARISGFGFARA 218
A G+ YLH I H DL P N++L ++ FG A
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
I D N+ GT E++APE + L + D+
Sbjct: 169 IEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADM 201
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 39/235 (16%), Positives = 78/235 (33%), Gaps = 46/235 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+G GG G V+ + ++IK I + ++
Sbjct: 36 GPLLGKGGFGTVFAGHRL-TDRLQVAIKVI------------------PRN--RVLGWSP 74
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHP----LLAHVTRPDCHLLYILNDVSQGRRELDWLAR 168
L+ + E+ + ++ HP LL + + +L + D++
Sbjct: 75 LSDSVT-CPLEVALLWKVGAGGGHPGVIRLLDWFETQE-GFMLVLERPLPAQDLFDYITE 132
Query: 169 H---------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI-EARISGFGFARA 218
+ +++ H ++HRD+ N+L+D A++ FG
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL 189
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGKLPSD 271
+ D T GT Y PE++ ++ G LL +V G +P +
Sbjct: 190 LHD--EPYTDF--DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 68/311 (21%), Positives = 108/311 (34%), Gaps = 69/311 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G GEVY+ ++ G P+ A K + ++ SE
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPND--------PSPLQVAV----------KTLPEVCSEQD 76
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LNDVSQGRR-- 161
E + + H+N+ + + +I L + R
Sbjct: 77 ELD----FLMEALIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPR 130
Query: 162 -----ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR---ISGF 213
L L +A +ACG +YL +H IHRD+ N LL R I F
Sbjct: 131 PSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSD 271
G AR I A + + V+++ PE T K D + FG LL + +G +P
Sbjct: 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-- 245
Query: 272 KFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329
+ +N+ + FV M + PK C V +I C P +
Sbjct: 246 -YPSKSNQEVLEFVT-SGGRM--DPPK----------NCPGP---VYRIMTQCWQHQPED 288
Query: 330 RPNSKDVRRML 340
RPN + +
Sbjct: 289 RPNFAIILERI 299
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 23/70 (32%), Positives = 35/70 (50%), Gaps = 5/70 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ LEYLH +++RD+ N++LD D +I+ FG + T GT
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 168
Query: 235 VEYIAPEYLQ 244
EY+APE L+
Sbjct: 169 PEYLAPEVLE 178
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ IGSG G V A R ++IKK+ P ++ + R++ +L
Sbjct: 30 LKPIGSGAQGIVCAA-YDAILERNVAIKKLSRP--------FQNQTHAKRAYREL---VL 77
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL-----LYI--------LNDVSQG 159
+ + H+N+ LL +V P L +YI L V
Sbjct: 78 MK--------------CVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELMDANLCQVI-- 120
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+ ELD + + CG+++LH IIHRDL P N+++ D +I FG AR
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
+ + T VV T Y APE + + E DI+ G ++ ++ G
Sbjct: 178 GT--SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 56/214 (26%), Positives = 85/214 (39%), Gaps = 49/214 (22%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+G G GEV K + + ++K I NK
Sbjct: 28 CMLGKGSFGEVLKCKDR-ITQQEYAVKVI------------------NKAS-------AK 61
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH--- 169
NK I E+ + ++ H N+ L D YI+ ++ G EL D + +
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFE--ILEDSSSFYIVGELYTGG-ELFDEIIKRKRF 118
Query: 170 ------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIP 220
RI + G+ Y+H H+ I+HRDL P N+LL + D + +I FG +
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 221 DAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ +GT YIAPE L+ T EKCD+
Sbjct: 176 QNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDV 205
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 44/213 (20%), Positives = 70/213 (32%), Gaps = 49/213 (23%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
IG G GEV A G + KKI + +
Sbjct: 15 NTIGRGSWGEVKIAVQKG-TRIRRAAKKI-----------------PKYFVEDVDR---- 52
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH---- 169
+ EI + + H N+ L + T D +Y++ ++ G + +
Sbjct: 53 ------FKQEIEIMKSLDHPNIIRL--YETFEDNTDIYLVMELCTGGELFERVVHKRVFR 104
Query: 170 -----RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPD 221
RI + + Y H + + HRDL P N L D ++ FG A
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
T VGT Y++P+ L+ +CD
Sbjct: 162 GKMMRT---KVGTPYYVSPQVLEG-LYGPECDE 190
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 47/216 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E++GSG V K G + K I KK R S +
Sbjct: 17 EELGSGQFAVVKKCR-EKSTGLQYAAKFI-------------------KKRRTKSSRRGV 56
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQGRREL-DWLARH-- 169
+++ I+ E++ + +I+H N+ L + + D L IL V+ G EL D+LA
Sbjct: 57 SRE--DIEREVSILKEIQHPNVITLHEVYENKTDVIL--ILELVAGG--ELFDFLAEKES 110
Query: 170 ---RIALGLAC----GLEYLHMHHCPRIIHRDLNPVNVLL----DDDIEARISGFGFARA 218
A G+ YLH I H DL P N++L +I FG A
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
I + N+ GT E++APE + L + D+
Sbjct: 168 IDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADM 200
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 9/80 (11%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
G+ YLH ++ I+H DL P N+LL + +I FG +R I A ++GT
Sbjct: 143 GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGT 196
Query: 235 VEYIAPEYLQMLTLTEKCDI 254
EY+APE L +T D+
Sbjct: 197 PEYLAPEILNYDPITTATDM 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 47/261 (18%), Positives = 89/261 (34%), Gaps = 57/261 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNG----RMISIKKIVGPPM--DAAALIEEDSML-------- 99
+ +G G G+V +A+ G + R +++K + + AL+ E +L
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 100 ------------------------------LNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129
L K + + RQ + + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 130 IRHRNLHPLLAHVT---------RPDCHLLYILNDVSQGRRELDWLARHRIALGLACGLE 180
R L + + + + + + L + +A G+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 181 YLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAP 240
+L C IHRDL N+LL + +I FG AR I ++ + ++++AP
Sbjct: 208 FLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 241 EYLQMLTLTEKCDIY-FGALL 260
E + T + D++ FG LL
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLL 285
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 47/215 (21%), Positives = 81/215 (37%), Gaps = 59/215 (27%)
Query: 54 EKIGSGGCGEVYKA-ELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
K+G G G VYKA G++ + ++K+I E + ++ R E+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQI-----------EGTGISMSA-CR----EIA 70
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL-----NDVSQGRRELDWLA 167
L ++++ H N+ L +++L +D+ +
Sbjct: 71 LLRELK-------------HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK 117
Query: 168 RHRIALGLA------------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR----IS 211
++ + L G+ YLH + ++HRDL P N+L+ + R I+
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 212 GFGFARA--IPD-AHTHITTSNVVGTVEYIAPEYL 243
GFAR P + VV T Y APE L
Sbjct: 175 DMGFARLFNSPLKPLADLD--PVVVTFWYRAPELL 207
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 46/215 (21%), Positives = 77/215 (35%), Gaps = 52/215 (24%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
E++GSG G V++ GR+ K I + +
Sbjct: 57 EELGSGAFGVVHRCVEK-ATGRVFVAKFI-------------------NTPYPLDKYTVK 96
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQGRREL-DWLARHRI 171
N EI+ + Q+ H L L A + + L IL +S G EL D +A
Sbjct: 97 N--------EISIMNQLHHPKLINLHDAFEDKYEMVL--ILEFLSGG--ELFDRIAAEDY 144
Query: 172 ALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR--ISGFGFARAI 219
+ GL+++H H I+H D+ P N++ + + I FG A +
Sbjct: 145 KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDI 254
+ + T E+ APE + + D+
Sbjct: 202 -NPDEIVKV--TTATAEFAAPEIVDREPVGFYTDM 233
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 16/93 (17%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSN- 230
+A L++LH I HRDL P N+L + +I F I S
Sbjct: 120 VASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 231 ----VVGTVEYIAPEYLQMLTLT-----EKCDI 254
G+ EY+APE ++ + ++CD+
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 50/210 (23%), Positives = 84/210 (40%), Gaps = 58/210 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV-----GPPMDAAALIEEDSMLLNKKMRQI 107
LEK+G+G VYK L G +++K++ G P A
Sbjct: 10 LEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPSTA------------------ 50
Query: 108 QSEMLLNKKMRQIQSEINTVGQIRHRN---LHPLLAHVTRP-------DCHLLYILNDVS 157
+R EI+ + +++H N L+ ++ + D L ++ +
Sbjct: 51 ---------IR----EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRT 97
Query: 158 QGRRELDWLARH--RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
G L GL + H + +I+HRDL P N+L++ + ++ FG
Sbjct: 98 VGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154
Query: 216 ARA--IPDAHTHITTSNVVGTVEYIAPEYL 243
ARA IP + +S VV T+ Y AP+ L
Sbjct: 155 ARAFGIP---VNTFSSEVV-TLWYRAPDVL 180
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 55/207 (26%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV------GPPMDAAALIEEDSMLLNKKMRQ 106
+EKIG G G VYKA G ++++KKI G P A
Sbjct: 8 VEKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTA----------------- 49
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDV-----SQ 158
+R EI+ + ++ H N+ LL + + L ++ D+ +
Sbjct: 50 ----------IR----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS 95
Query: 159 GRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+ L GL + H H R++HRDL P N+L++ + +++ FG ARA
Sbjct: 96 ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARA 152
Query: 219 --IPDAHTHITTSNVVGTVEYIAPEYL 243
+P T VV T+ Y APE L
Sbjct: 153 FGVP---VRTYTHEVV-TLWYRAPEIL 175
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ GL++LH I++RDL N+LLD D +I+ FG + + T+ GT
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGT 181
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
+YIAPE L D + FG LL +++G+ P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 70/321 (21%), Positives = 119/321 (37%), Gaps = 70/321 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V AE G + V A ++++D+ K + + SEM
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV-----AVKMLKDDAT--EKDLSDLVSEME 92
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------RPDCH 148
+ M+ I +H+N+ LL T RP
Sbjct: 93 M---MKMIG---------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 149 LLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
+ ++ + LA G+EYL C IHRDL NVL+ ++
Sbjct: 141 EYSYDINRVPEE-QMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVM 196
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MG 266
+I+ FG AR I + + T+N V+++APE L T + D++ FG L+ + +G
Sbjct: 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 267 KLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTL 324
P + E +K + M + P C ++ + C
Sbjct: 257 GSP---YPGIPVEELFKLLK-EGHRM--DKPA----------NCTNEL---YMMMRDCWH 297
Query: 325 EDPNERPNSKDVRRMLSQIQH 345
P++RP K + L +I
Sbjct: 298 AVPSQRPTFKQLVEDLDRILT 318
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 23/83 (27%), Positives = 39/83 (46%), Gaps = 9/83 (10%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNV 231
+ ++YLH + I HRD+ P N+L + +++ FGFA+ ++ T
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---P 223
Query: 232 VGTVEYIAPEYLQMLTLTEKCDI 254
T Y+APE L + CD+
Sbjct: 224 CYTPYYVAPEVLGPEKYDKSCDM 246
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 49/232 (21%), Positives = 80/232 (34%), Gaps = 56/232 (24%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ IG G G+V KA + G MDAA K+M++ S+
Sbjct: 31 DVIGEGNFGQVLKARIKKD-----------GLRMDAAI----------KRMKEYASK--- 66
Query: 114 NKKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLL---------------------- 150
R E+ + ++ H N+ LL L
Sbjct: 67 -DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 151 -YILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR 209
+ L A +A G++YL IHRDL N+L+ ++ A+
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAK 182
Query: 210 ISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
I+ FG +R ++ + V ++A E L T D++ +G LL
Sbjct: 183 IADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 59/254 (23%), Positives = 91/254 (35%), Gaps = 59/254 (23%)
Query: 18 AVRRVGRDPGPAIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMI 77
+ V PA F I AK A ++ E +G G G+V+K E G +
Sbjct: 60 SALAVDIPAPPAPFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEET-ATGLKL 117
Query: 78 SIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHP 137
+ K I K E + N EI+ + Q+ H NL
Sbjct: 118 AAKII-------------------KTRGMKDKEEVKN--------EISVMNQLDHANLIQ 150
Query: 138 LL-AHVTRPDCHLL--YI----LND--VSQGRR--ELDWLARH--RIALGLACGLEYLHM 184
L A ++ D L+ Y+ L D + + ELD + G+ ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD--TILFMKQICE---GIRHMHQ 205
Query: 185 HHCPRIIHRDLNPVNVLL----DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAP 240
+ I+H DL P N+L I +I FG AR GT E++AP
Sbjct: 206 MY---ILHLDLKPENILCVNRDAKQI--KIIDFGLARRYKPREKLKV---NFGTPEFLAP 257
Query: 241 EYLQMLTLTEKCDI 254
E + ++ D+
Sbjct: 258 EVVNYDFVSFPTDM 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 50/242 (20%), Positives = 85/242 (35%), Gaps = 66/242 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIK---KIVGP---PMDAAALIEEDSMLLNKKMRQ 106
+ +G+G G+V +A G ++ K++ P + AL+ E +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV-------- 79
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL 166
+ + H N+ LL T L I G L++L
Sbjct: 80 ----------LSYLG---------NHMNIVNLLGACTIGG-PTLVITEYCCYGDL-LNFL 118
Query: 167 ARHR---------------------------IALGLACGLEYLHMHHCPRIIHRDLNPVN 199
R R + +A G+ +L +C IHRDL N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARN 175
Query: 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGA 258
+LL +I FG AR I + ++ N V+++APE + T + D++ +G
Sbjct: 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 259 LL 260
L
Sbjct: 236 FL 237
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 62/233 (26%), Positives = 93/233 (39%), Gaps = 48/233 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V AE G + + V A +++ D+ K + + SEM
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-----AVKMLKSDATE--KDLSDLISEME 126
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------RPDCH 148
+ M+ I +H+N+ LL T RP
Sbjct: 127 M---MKMIG---------KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP-G 173
Query: 149 LLYILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
L Y N +L A +A G+EYL C IHRDL NVL+ +D
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVM 230
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+I+ FG AR I + T+N V+++APE L T + D++ FG LL
Sbjct: 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 26/70 (37%), Positives = 37/70 (52%), Gaps = 5/70 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ L +LH II+RDL NVLLD + +++ FG + +TT+ GT
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGT 187
Query: 235 VEYIAPEYLQ 244
+YIAPE LQ
Sbjct: 188 PDYIAPEILQ 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 66/315 (20%), Positives = 108/315 (34%), Gaps = 77/315 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G GEVY+ ++ G P+ A K + ++ SE
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPND--------PSPLQVAV----------KTLPEVCSEQD 117
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-- 170
E + + H+N+ + + + +L ++ G +L R
Sbjct: 118 ELD----FLMEALIISKFNHQNIVRCIGVSLQSLPRFI-LLELMAGGDL-KSFLRETRPR 171
Query: 171 --------------IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR---ISGF 213
+A +ACG +YL +H IHRD+ N LL R I F
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDF 228
Query: 214 GFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSD 271
G AR I A + + V+++ PE T K D + FG LL + +G +P
Sbjct: 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-- 286
Query: 272 KFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQ----MLLVLKIACFCTLE 325
+ +N+ + FV M + PK C M C
Sbjct: 287 -YPSKSNQEVLEFVT-SGGRM--DPPK----------NCPGPVYRIMTQ-------CWQH 325
Query: 326 DPNERPNSKDVRRML 340
P +RPN + +
Sbjct: 326 QPEDRPNFAIILERI 340
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 26/70 (37%), Positives = 36/70 (51%), Gaps = 5/70 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
++ L YLH II+RDL NVLLD + +++ +G + TTS GT
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 173
Query: 235 VEYIAPEYLQ 244
YIAPE L+
Sbjct: 174 PNYIAPEILR 183
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 26/70 (37%), Positives = 36/70 (51%), Gaps = 5/70 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
++ L YLH II+RDL NVLLD + +++ +G + TTS GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGT 216
Query: 235 VEYIAPEYLQ 244
YIAPE L+
Sbjct: 217 PNYIAPEILR 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 25/70 (35%), Positives = 37/70 (52%), Gaps = 5/70 (7%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A GL +L II+RDL NV+LD + +I+ FG + + +TT GT
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGT 184
Query: 235 VEYIAPEYLQ 244
+YIAPE +
Sbjct: 185 PDYIAPEIIA 194
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 8e-10
Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 66/212 (31%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV------GPPMDAAALIEEDSMLLNKKMRQ 106
LEKIG G G V+KA + ++++K++ G P A +R
Sbjct: 7 LEKIGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVPSSA--------------LR- 50
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQGRREL 163
EI + +++H+N+ L + L + D+ +
Sbjct: 51 ----------------EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK----- 89
Query: 164 DWLARHRIALGLA----------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
+ L GL + H ++HRDL P N+L++ + E +++ F
Sbjct: 90 -YFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANF 145
Query: 214 GFARA--IPDAHTHITTSNVVGTVEYIAPEYL 243
G ARA IP ++ VV T+ Y P+ L
Sbjct: 146 GLARAFGIP---VRCYSAEVV-TLWYRPPDVL 173
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 67/212 (31%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV------GPPMDAAALIEEDSMLLNKKMRQ 106
LEK+G G G VYKA+ GR++++K+I G P A +R
Sbjct: 26 LEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGIPSTA--------------IR- 68
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQGRREL 163
EI+ + ++ H N+ L+ + C L ++ D+ +
Sbjct: 69 ----------------EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKK----- 107
Query: 164 DWLARHRIALGLA----------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
L ++ L + G+ + H H RI+HRDL P N+L++ D +++ F
Sbjct: 108 -VLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADF 163
Query: 214 GFARA--IPDAHTHITTSNVVGTVEYIAPEYL 243
G ARA IP T VV T+ Y AP+ L
Sbjct: 164 GLARAFGIP---VRSYTHEVV-TLWYRAPDVL 191
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 10/106 (9%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+A GL +L II+RDL NV+LD + +I+ FG + + +TT GT
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGT 505
Query: 235 VEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
+YIAPE + + D + FG LL ++ G+ P F+ +E
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGEDE 547
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 10/83 (12%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHTHITTSNV 231
+ +++LH H+ I HRD+ P N+L + D +++ FGFA+ + T
Sbjct: 137 IGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQT--P 189
Query: 232 VGTVEYIAPEYLQMLTLTEKCDI 254
T Y+APE L + CD+
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDM 212
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 45/217 (20%), Positives = 82/217 (37%), Gaps = 51/217 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
IG+G G V +A R+++IKKI + ED + + +R+I +
Sbjct: 58 RHLIGTGSYGHVCEA-YDKLEKRVVAIKKI--------LRVFEDLIDCKRILREI---AI 105
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYILNDVSQGRRELDWLAR 168
LN ++ H ++ +L + P LY++ +++ + L R
Sbjct: 106 LN--------------RLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIAD--SDFKKLFR 148
Query: 169 HRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+ L L G++Y+H I+HRDL P N L++ D ++ FG AR
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205
Query: 219 I-----PDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250
+ ++ I+ + LT
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 46/228 (20%)
Query: 56 IGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115
+G G G+V E G +++K +LN++ +I+S ++ K
Sbjct: 19 LGVGTFGKVKIGE-HQLTGHKVAVK------------------ILNRQ--KIRSLDVVGK 57
Query: 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH----- 169
I+ EI + RH ++ L V ++ VS G EL D++ +H
Sbjct: 58 ----IKREIQNLKLFRHPHIIKLY-QVISTPTDFFMVMEYVSGG--ELFDYICKHGRVEE 110
Query: 170 ----RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
R+ + ++Y H H ++HRDL P NVLLD + A+I+ FG + +
Sbjct: 111 MEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEF 166
Query: 226 ITTSNVVGTVEYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGKLPSD 271
+ TS G+ Y APE + L + DI+ G +L L+ G LP D
Sbjct: 167 LRTS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 45/236 (19%), Positives = 88/236 (37%), Gaps = 56/236 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ K+G G EV++A + N + +K + +++ K R+I +
Sbjct: 41 VRKLGRGKYSEVFEA-INITNNEKVVVKIL--------KPVKKK-----KIKREI---KI 83
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH--LLYILNDVSQG--RRELDWLAR 168
L + +R N+ L + + + V+ ++ L
Sbjct: 84 L-ENLRG------------GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD 129
Query: 169 HRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHT 224
+ I + L+Y H I+HRD+ P NV++D + + R+ +G A
Sbjct: 130 YDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 225 HITTSNV-VGTVEYIAPEYLQMLTLTE---KCDIY-FGALLAGLVMGKLPSDKFFQ 275
+ NV V + + PE ++ D++ G +LA ++ K P FF
Sbjct: 187 Y----NVRVASRYFKGPEL--LVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFH 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 42/141 (29%), Positives = 56/141 (39%), Gaps = 27/141 (19%)
Query: 119 QIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH-RIAL 173
+Q EI +RH N ++ T HL I+ S G EL + + R +
Sbjct: 62 NVQREIINHRSLRHPNIVRFKEVILTPT----HLAIIMEYASGG--ELYERICNAGRFSE 115
Query: 174 GLA--------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR--ISGFGFARAIPDAH 223
A G+ Y H I HRDL N LLD R I FG++ H
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLH 171
Query: 224 THITTSNVVGTVEYIAPEYLQ 244
+ ++ VGT YIAPE L
Sbjct: 172 SQPKST--VGTPAYIAPEVLL 190
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 38/142 (26%), Positives = 55/142 (38%), Gaps = 16/142 (11%)
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH-R 170
I+ EI + H N+ H + L S G EL D +
Sbjct: 45 AVDCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLFLEYCSGG--ELFDRIEPDIG 101
Query: 171 IALGLA--------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ A G+ YLH I HRD+ P N+LLD+ +IS FG A
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 HTHITTSNVVGTVEYIAPEYLQ 244
+ + + GT+ Y+APE L+
Sbjct: 159 NRERLLNKMCGTLPYVAPELLK 180
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 49/230 (21%), Positives = 86/230 (37%), Gaps = 46/230 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G+G G+V +A G +K V A +++ + + + SE+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLK--V-----AVKMLKSTAHA--DEKEALMSELK 101
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT---------------------RPDCHLLY 151
+ M + +H N+ LL T R +L
Sbjct: 102 I---MSHLG---------QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLE 149
Query: 152 ILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARIS 211
+ + +A G+ +L +C IHRD+ NVLL + A+I
Sbjct: 150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIG 206
Query: 212 GFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
FG AR I + +I N V+++APE + T + D++ +G LL
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 38/142 (26%), Positives = 55/142 (38%), Gaps = 16/142 (11%)
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARH-R 170
I+ EI + H N+ H + L S G EL D +
Sbjct: 45 AVDCPENIKKEICINKMLNHENVVKFYGHRREGN-IQYLFLEYCSGG--ELFDRIEPDIG 101
Query: 171 IALGLA--------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ A G+ YLH I HRD+ P N+LLD+ +IS FG A
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158
Query: 223 HTHITTSNVVGTVEYIAPEYLQ 244
+ + + GT+ Y+APE L+
Sbjct: 159 NRERLLNKMCGTLPYVAPELLK 180
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 21/79 (26%), Positives = 34/79 (43%), Gaps = 8/79 (10%)
Query: 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA--RISGFGFARAIPDAHTHITTSNVVGTV 235
L++LH H+ I H D+ P N++ + +I FG AR + +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAP 167
Query: 236 EYIAPEYLQMLTLTEKCDI 254
EY APE Q ++ D+
Sbjct: 168 EYYAPEVHQHDVVSTATDM 186
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 54/212 (25%), Positives = 82/212 (38%), Gaps = 67/212 (31%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV------GPPMDAAALIEEDSMLLNKKMRQ 106
LEKIG G G VYKA+ G ++KKI G P +R
Sbjct: 7 LEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTT--------------IR- 49
Query: 107 IQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQGRREL 163
EI+ + +++H N+ L + +L ++ D+ +
Sbjct: 50 ----------------EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK----- 88
Query: 164 DWLARHRIALGLA----------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
L L G+ Y H R++HRDL P N+L++ + E +I+ F
Sbjct: 89 -LLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF 144
Query: 214 GFARA--IPDAHTHITTSNVVGTVEYIAPEYL 243
G ARA IP T +V T+ Y AP+ L
Sbjct: 145 GLARAFGIP---VRKYTHEIV-TLWYRAPDVL 172
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 51/206 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEE--DSMLLNKKMRQIQSE 110
L+ +G G VYKA ++++IKKI + + ++ + L
Sbjct: 15 LDFLGEGQFATVYKARDK-NTNQIVAIKKI---KLGHRSEAKDGINRTAL---------- 60
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQGRRELDWLA 167
R EI + ++ H N+ LL L ++ D+ +
Sbjct: 61 -------R----EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV------IIK 103
Query: 168 RHRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ + L GLEYLH H I+HRDL P N+LLD++ +++ FG A+
Sbjct: 104 DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYL 243
+ T VV T Y APE L
Sbjct: 161 SFGS-PNRAYTHQVV-TRWYRAPELL 184
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 3e-09
Identities = 26/71 (36%), Positives = 36/71 (50%), Gaps = 10/71 (14%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTSNVV 232
GL++LH + I+HRDL P N+L+ +++ FG AR A T VV
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP----VVV 181
Query: 233 GTVEYIAPEYL 243
T+ Y APE L
Sbjct: 182 -TLWYRAPEVL 191
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 20/149 (13%)
Query: 107 IQSEMLLNKKMR-QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-D 164
+ + + + + +I+ EI + RH ++ L V + ++ VS G EL D
Sbjct: 49 LNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY-QVISTPSDIFMVMEYVSGG--ELFD 105
Query: 165 WLARH-RIALGLA--------CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGF 215
++ ++ R+ + G++Y H H ++HRDL P NVLLD + A+I+ FG
Sbjct: 106 YICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGL 162
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAPEYLQ 244
+ + D T+ G+ Y APE +
Sbjct: 163 SNMMSDGEFLRTS---CGSPNYAAPEVIS 188
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 55/232 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +GSG G V A + G +++KK+ P + + + R++ L
Sbjct: 34 LSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRP--------FQSIIHAKRTYREL---RL 81
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL-----LYI--------LNDVSQG 159
L ++H N+ LL V P L +Y+ LN++ +
Sbjct: 82 LK--------------HMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 126
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
++ D + + + GL+Y+H IIHRDL P N+ +++D E +I FG AR
Sbjct: 127 QKLTDDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDIY-FGALLAGLVMGK 267
D T V T Y APE ML + DI+ G ++A L+ G+
Sbjct: 183 ADEMT-----GYVATRWYRAPEI--MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 59/326 (18%), Positives = 111/326 (34%), Gaps = 79/326 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ IG G G V++A PG P A K +++ S
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPY--------EPFTMVAV----------KMLKEEASA-- 91
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------RPDCH 148
Q E + + + N+ LL P
Sbjct: 92 --DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 149
Query: 149 LLYILNDVSQGRRELDWLARH-------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201
+D+S R IA +A G+ YL +HRDL N L
Sbjct: 150 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCL 206
Query: 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ +++ +I+ FG +R I A + N + ++ PE + T + D++ +G +L
Sbjct: 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
Query: 261 AGLV-MGKLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLK 317
+ G P ++ +E + +V+ N++ P+ C + +
Sbjct: 267 WEIFSYGLQP---YYGMAHEEVIYYVR-DGNIL--ACPE----------NCPLE---LYN 307
Query: 318 IACFCTLEDPNERPNSKDVRRMLSQI 343
+ C + P +RP+ + R+L ++
Sbjct: 308 LMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 49/212 (23%), Positives = 73/212 (34%), Gaps = 46/212 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
IG G G VY A + ++IKK+ ED + + +R+I +
Sbjct: 31 KHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRM--------FEDLIDCKRILREI---TI 78
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL----LYI--------LNDVSQGR 160
LN +++ + L + PD L LYI L + +
Sbjct: 79 LN--------------RLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIADSDLKKLFKTP 123
Query: 161 RELDWLARHR--IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
L H I L G ++H IIHRDL P N LL+ D ++ FG AR
Sbjct: 124 IFLT--EEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250
I +++ E LT
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 62/232 (26%), Positives = 95/232 (40%), Gaps = 55/232 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ +GSG G V A + G+ G ++IKK+ P + + + R++ L
Sbjct: 30 LQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRP--------FQSELFAKRAYREL---RL 77
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL-----LYI--------LNDVSQG 159
L +RH N+ LL V PD L Y+ L + +
Sbjct: 78 LK--------------HMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFMGTDLGKLMK- 121
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+L + + GL Y+H IIHRDL P N+ +++D E +I FG AR
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDIY-FGALLAGLVMGK 267
T V T Y APE +L T+ DI+ G ++A ++ GK
Sbjct: 179 DSEMT-----GYVVTRWYRAPEV--ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 55/206 (26%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+K+G G VYK + +V AL K++R E
Sbjct: 7 LDKLGEGTYATVYKG-------KSKLTDNLV-------AL---------KEIRLEHEEGA 43
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILNDVSQGRRELDWLARH 169
+R E++ + ++H N+ L + L Y+ D+ Q +L
Sbjct: 44 PCTAIR----EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQ------YLDDC 93
Query: 170 RIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA- 218
+ L GL Y H +++HRDL P N+L+++ E +++ FG ARA
Sbjct: 94 GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK 150
Query: 219 -IPDAHTHITTSNVVGTVEYIAPEYL 243
IP T + VV T+ Y P+ L
Sbjct: 151 SIP---TKTYDNEVV-TLWYRPPDIL 172
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 28/71 (39%), Positives = 39/71 (54%), Gaps = 10/71 (14%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA--IPDAHTHITTSNVV 232
L GL++LH H R++HRDL P N+L+ + +++ FG AR A T VV
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS----VVV 181
Query: 233 GTVEYIAPEYL 243
T+ Y APE L
Sbjct: 182 -TLWYRAPEVL 191
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 7e-09
Identities = 37/220 (16%), Positives = 63/220 (28%), Gaps = 51/220 (23%)
Query: 36 KKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEE 95
K + L EKIG G GEV++ + ++IK I ++ L+
Sbjct: 8 KGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKII---AIEGPDLVNG 61
Query: 96 DSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLL-AHVTRPDCHLLYI-- 152
K +I E++++K++ + E R L H + L +
Sbjct: 62 SHQ---KTFEEILPEIIISKELSLLSGE----VCNRTEGFIGLNSVHCVQGSYPPLLLKA 114
Query: 153 ----------LNDVSQGRRE-----------------------LDWLARHRIALGLACGL 179
ND ++ I L L
Sbjct: 115 WDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174
Query: 180 EYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
R HRDL+ NVLL ++ ++
Sbjct: 175 --AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 9e-09
Identities = 63/326 (19%), Positives = 116/326 (35%), Gaps = 79/326 (24%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V KA GR A K +++ S
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGR--------AGYTTVAV----------KMLKENASP-- 67
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------RPDCH 148
++R + SE N + Q+ H ++ L + R
Sbjct: 68 --SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 149 LLYILNDVSQGRRELDWLARH-------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201
R A ++ G++YL +HRDL N+L
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNIL 182
Query: 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ + + +IS FG +R + + +++ S V+++A E L T + D++ FG LL
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 261 AGLV-MGKLPSDKFFQHTNE--MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLK 317
+V +G P + E + +K + M E P C E+M +
Sbjct: 243 WEIVTLGGNP---YPGIPPERLFNLLK-TGHRM--ERPD----------NCSEEM---YR 283
Query: 318 IACFCTLEDPNERPNSKDVRRMLSQI 343
+ C ++P++RP D+ + L ++
Sbjct: 284 LMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 60/234 (25%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+GSG G V A + ++G ++IKK+ P + + + R++ +L
Sbjct: 29 PTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRP--------FQSEIFAKRAYREL---LL 76
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL-----LYI--------LNDVSQG 159
L ++H N+ LL V P L Y+ L +
Sbjct: 77 LK--------------HMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121
Query: 160 RRELDWLARHR--IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ + + + GL+Y+H ++HRDL P N+ +++D E +I FG AR
Sbjct: 122 KFSEE----KIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDIY-FGALLAGLVMGK 267
T V T Y APE +L+ + DI+ G ++A ++ GK
Sbjct: 175 HADAEMT-----GYVVTRWYRAPEV--ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 54/240 (22%), Positives = 86/240 (35%), Gaps = 57/240 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAA-LIEEDSMLLNKKMRQIQSEM 111
+ +GSG G+V A G + G + A +++E + + + SE+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKT--------GVSIQVAVKMLKEKADS--SEREALMSEL 99
Query: 112 LLNKKMRQIQSEINTVGQIRHRNLHPLLAHVT------------------------RPDC 147
+ M Q+ H N+ LL T R
Sbjct: 100 KM---MTQLG---------SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 148 HLLYILNDVSQGRRELDWLAR------HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201
I + + E + L A +A G+E+L C +HRDL NVL
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVL 204
Query: 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ +I FG AR I ++ N V+++APE L T K D++ +G LL
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 47/205 (22%), Positives = 74/205 (36%), Gaps = 40/205 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
I SG G V G ++IK++ +++ + + + L
Sbjct: 27 QRFISSGSYGAVCAGV--DSEGIPVAIKRV------------FNTVSDGRTVNILSDSFL 72
Query: 113 LNKKMRQIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYI--------LNDVSQGRR 161
+ +R EI + H N L + H P H LY+ L V +R
Sbjct: 73 CKRVLR----EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR 128
Query: 162 ELDWLARHRIAL---GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARA 218
+ ++ I + GL LH ++HRDL+P N+LL D+ + I F AR
Sbjct: 129 IV--ISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 219 IPDAHTHITTSNVVGTVEYIAPEYL 243
T V Y APE +
Sbjct: 184 DTA--DANKTHYVT-HRWYRAPELV 205
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 35/99 (35%), Positives = 57/99 (57%), Gaps = 8/99 (8%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGT 234
+ C +EY H H I+HRDL P N+LLDD++ +I+ FG + + D + + TS G+
Sbjct: 117 IICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGS 170
Query: 235 VEYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGKLPSD 271
Y APE + L + D++ G +L +++G+LP D
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 52/216 (24%), Positives = 80/216 (37%), Gaps = 62/216 (28%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L KIG G GEV+KA R + V AL KK+ +
Sbjct: 22 LAKIGQGTFGEVFKA-------RHRKTGQKV-------AL---------KKVL------M 52
Query: 113 LNKK-------MRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDV--------- 156
N+K +R EI + ++H N+ L+ +
Sbjct: 53 ENEKEGFPITALR----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108
Query: 157 ------SQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI 210
S + R+ L GL Y+H + +I+HRD+ NVL+ D ++
Sbjct: 109 DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 165
Query: 211 SGFGFARAI---PDAHTHITTSNVVGTVEYIAPEYL 243
+ FG ARA ++ + T+ VV T+ Y PE L
Sbjct: 166 ADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELL 200
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 21/187 (11%), Positives = 59/187 (31%), Gaps = 44/187 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E +G G +++K + V ++++ ++
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEV-----LLKVLDKAHRNYSESF-------- 59
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------LND-VSQGRRE 162
+ + ++ H++L D + L+ + + +
Sbjct: 60 --------FEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNC 109
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR--------ISGFG 214
++ L + +A LA + +L + IH ++ N+LL + + + +S G
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 215 FARAIPD 221
+ +
Sbjct: 167 ISITVLP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 30/228 (13%), Positives = 60/228 (26%), Gaps = 73/228 (32%)
Query: 53 LEKIGSGGCGEVYKAE---LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQS 109
L G + ++A L R +++ + + +++E
Sbjct: 36 LIFHGGVPPLQFWQALDTAL----DRQVALTFVDPQGVLPDDVLQE-------------- 77
Query: 110 EMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LNDVSQGRRE 162
S + +I + +L V L+ +I L +V+
Sbjct: 78 ----------TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-- 125
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ R LA + H + +P V + D G
Sbjct: 126 PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSID--------GDV------ 168
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269
V+ + + DI GA L L++ + P
Sbjct: 169 --------VLAYPATMPDA-------NPQDDIRGIGASLYALLVNRWP 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 26/76 (34%), Positives = 34/76 (44%), Gaps = 14/76 (18%)
Query: 175 LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR-----ISGFGFARA--IPDAHTHIT 227
L G+ + H R +HRDL P N+LL + I FG ARA IP
Sbjct: 141 LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP---IRQF 194
Query: 228 TSNVVGTVEYIAPEYL 243
T ++ T+ Y PE L
Sbjct: 195 THEII-TLWYRPPEIL 209
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 33/96 (34%), Positives = 48/96 (50%), Gaps = 10/96 (10%)
Query: 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI-PDAHTHITTSNVVGTV 235
GL+Y+H ++HRDL P N+LL+ + +I FG AR PD + V T
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 236 EYIAPEYLQMLTL---TEKCDIY-FGALLAGLVMGK 267
Y APE ML T+ DI+ G +LA ++ +
Sbjct: 196 WYRAPEI--MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 37/210 (17%), Positives = 71/210 (33%), Gaps = 47/210 (22%)
Query: 54 EKIGSGGCGEVYKAE-------LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQ 106
G +Y+A G + S+K D E++ K Q
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQNFFQRAAKPLQ 104
Query: 107 IQSEMLLNKKMRQIQSEINTVG----------QIRHRNL-HPLLAHVTRPDCHLLYILND 155
+ L + Q ++R L P L L L+
Sbjct: 105 VNKWKKLYS--------TPLLAIPTCMGFGVHQDKYRFLVLPSLG----RS--LQSALDV 150
Query: 156 VSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI--SGF 213
+ L + ++A L LE+LH + +H ++ N+ +D + ++++ +G+
Sbjct: 151 --SPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 214 GFARAIPDAHTHI-----TTSNVVGTVEYI 238
GFA + H+ + S G +E+I
Sbjct: 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 61/209 (29%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ IG+G G VY+A+L +G +++IKK+ L +K+
Sbjct: 59 TKVIGNGSFGVVYQAKL-CDSGELVAIKKV----------------LQDKRF-------- 93
Query: 113 LNKKMRQIQSEINTVGQIRHRN----LHPLLAHVTRPDCHLLYIL-----NDVSQGRREL 163
K R E+ + ++ H N + + + D L ++ V R
Sbjct: 94 ---KNR----ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY---RVA 143
Query: 164 DWLARHRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA-RISG 212
+R + L L L Y+H I HRD+ P N+LLD D ++
Sbjct: 144 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 200
Query: 213 FGFARAIPDAHTHITTSNVVGTVEYIAPE 241
FG A+ + S + + Y APE
Sbjct: 201 FGSAKQL--VRGEPNVSYIC-SRYYRAPE 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTV- 235
++ LH + +IHRDL P N+L++ + + ++ FG AR I ++ + +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 236 -EYI------APEYLQMLTL---TEKCDIY-FGALLAGLVMGK 267
E++ APE MLT + D++ G +LA L + +
Sbjct: 180 VEFVATRWYRAPE--VMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 39/211 (18%), Positives = 69/211 (32%), Gaps = 59/211 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
G G G V + G ++IKK++ P
Sbjct: 28 ERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDPRF------------------------ 62
Query: 113 LNKKMRQIQSEINTVGQIRHRN---LHPLLAHVTRPDCHLLYILN--------DVSQGRR 161
+ R++Q + + + H N L + D +Y LN + R
Sbjct: 63 ---RNRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY-LNVVMEYVPDTLH---R 114
Query: 162 ELDWLARHRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARI 210
R ++A L + LH + HRD+ P NVL++ D ++
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKL 173
Query: 211 SGFGFARAIPDAHTHITTSNVVGTVEYIAPE 241
FG A+ + + + + + + Y APE
Sbjct: 174 CDFGSAKKL--SPSEPNVAYIC-SRYYRAPE 201
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 46/255 (18%), Positives = 87/255 (34%), Gaps = 67/255 (26%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQI----- 107
+ +G+G G V + ++G+ ++KK+ D E ++ K + +
Sbjct: 12 GKTLGTGSFGIVCEVFD-IESGKRFALKKV---LQDPRYKNRELDIM--KVLDHVNIIKL 65
Query: 108 -----QSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL-----NDVS 157
+ K + G+ N H V L ++ + +
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 158 QGRRELDWLARHRIALG--------------LACGLEYLHMHHCPRIIHRDLNPVNVLLD 203
+ + + I G L + ++H I HRD+ P N+L++
Sbjct: 126 K-------VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVN 175
Query: 204 -DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYI------APEYLQMLTLTE---KCD 253
D ++ FG A+ + + V YI APE ML TE D
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPS---------VAYICSRFYRAPEL--MLGATEYTPSID 224
Query: 254 IY-FGALLAGLVMGK 267
++ G + L++GK
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 50/245 (20%), Positives = 93/245 (37%), Gaps = 68/245 (27%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ +G GG G V+ A + + ++IKKIV D + +R+I +
Sbjct: 16 LKPLGCGGNGLVFSA-VDNDCDKRVAIKKIVL----------TDPQSVKHALREI---KI 61
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL--------- 163
+ ++ H N+ + + P L +
Sbjct: 62 IR--------------RLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMET 106
Query: 164 DWLARHRI----ALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEA 208
D + L L GL+Y+H + ++HRDL P N+ ++ +D+
Sbjct: 107 DL---ANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160
Query: 209 RISGFGFARAI--PDAHTHITTSNVVGTVEYIAPEYLQMLTL---TEKCDIY-FGALLAG 262
+I FG AR + +H + +V T Y +P +L+ T+ D++ G + A
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRL--LLSPNNYTKAIDMWAAGCIFAE 217
Query: 263 LVMGK 267
++ GK
Sbjct: 218 MLTGK 222
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 34/200 (17%), Positives = 65/200 (32%), Gaps = 30/200 (15%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+KIGSGG G +Y A P + + + L E K +++ + +
Sbjct: 43 KKIGSGGFGLIYLAF-PTNKPEKDARHVVKVEYQENGPLFSE-----LKFYQRVAKKDCI 96
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTR--------PDCHLLYILNDVSQGRRELDW 165
K + + Q + + L R D L +S
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID------LQKISGQNGTFKK 150
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI--SGFGFARAIPDAH 223
++ + + LEY+H + +H D+ N+LL ++ + +G +
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 224 THI-----TTSNVVGTVEYI 238
H GT+E+
Sbjct: 208 NHKQYQENPRKGHNGTIEFT 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 15/74 (20%), Positives = 32/74 (43%), Gaps = 4/74 (5%)
Query: 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVE 236
++YLH ++HRD+ P N+LL+ + +++ FG +R+ + +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 237 YIAPEYLQMLTLTE 250
+ LT+
Sbjct: 177 TENFDD-DQPILTD 189
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 5e-06
Identities = 42/315 (13%), Positives = 87/315 (27%), Gaps = 88/315 (27%)
Query: 13 KLFLAAVRRVGRDPGPAIFSPL-IKKAKDLAFLEKKGGLASLEKI------GSGGCG--- 62
++++ R+ D F+ + + + L + L L G G G
Sbjct: 110 RMYIEQRDRLYNDNQV--FAKYNVSRLQPYLKLRQA--LLELRPAKNVLIDGVLGSGKTW 165
Query: 63 ---EVYKAE--LPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117
+V + + ++ + + ++E ML + + +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLN--LKNCNSPETVLE---MLQKLLYQIDPNWTSRSDHS 220
Query: 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIALGLAC 177
I+ I+ I+ L LL +C LL +L +V A+ A L+C
Sbjct: 221 SNIKLRIH---SIQAE-LRRLLKSKPYENC-LL-VLLNV--------QNAKAWNAFNLSC 266
Query: 178 GLEYLHMHHCPRII--HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTV 235
+I+ R + L THI+ + T+
Sbjct: 267 -----------KILLTTRFKQVTDFL-----------------SAATTTHISLDHHSMTL 298
Query: 236 EYIAPEYLQMLTL----------TEKCDIYFGALLAGLVMGKLPSD-----KFFQHTNEM 280
E +L E ++ + D ++H N
Sbjct: 299 T--PDEVKSLLLKYLDCRPQDLPREVLTT--NPRRLSII-AESIRDGLATWDNWKHVNCD 353
Query: 281 SFVKWMRNVMASENP 295
+ + + P
Sbjct: 354 KLTTIIESSLNVLEP 368
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 43/211 (20%), Positives = 74/211 (35%), Gaps = 62/211 (29%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ IG+G G V++A+L ++IKK++ K R++Q
Sbjct: 45 CKVIGNGSFGVVFQAKL--VESDEVAIKKVLQDKRF--------------KNRELQI--- 85
Query: 113 LNKKMRQIQSEINTVGQIRHRN----LHPLLAHVTRPDCHLLYIL-----NDVSQGRREL 163
MR + +H N ++ + D L ++ V R
Sbjct: 86 ----MRIV----------KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVY---RAS 128
Query: 164 DWLARHRIALG----------LACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI-EARISG 212
A+ + + L L Y+H I HRD+ P N+LLD ++
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLID 185
Query: 213 FGFARAIPDAHTHITTSNVVGTVEYIAPEYL 243
FG A+ + S + + Y APE +
Sbjct: 186 FGSAKIL--IAGEPNVSYIC-SRYYRAPELI 213
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 36/208 (17%), Positives = 67/208 (32%), Gaps = 43/208 (20%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVG---PPMDAAALIEEDSMLLNKKMRQIQSE 110
IG GG G +Y A++ + + P D L E K ++
Sbjct: 41 LPIGQGGFGCIYLADM--NSSESVGSDAPCVVKVEPSDNGPLFTE-----LKFYQRAAKP 93
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI------LNDVSQGRRELD 164
+ K +R + + V + LH + + L + +
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLH----DKNGKSYRFMIMDRFGSDLQKI------YE 143
Query: 165 WLARH-------RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARI--SGFGF 215
A+ +++L + LEY+H H +H D+ N+LL+ ++ +G
Sbjct: 144 ANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGL 200
Query: 216 AR--AIPDAHTHITT---SNVVGTVEYI 238
A H GT+E+
Sbjct: 201 AYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 14/106 (13%)
Query: 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD------DIEARISGFGFARAIPDA 222
+I+ L GL+Y+H IIH D+ P NVL++ I+ +I+ G A
Sbjct: 134 KQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WY 188
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
H T + T EY +PE L DI+ L+ L+ G
Sbjct: 189 DEHYTN--SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 22/76 (28%), Positives = 32/76 (42%), Gaps = 11/76 (14%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR---ISGFGFARAIPDAHT-- 224
+A + +E++H +HRD+ P N L+ A I FG A+ D T
Sbjct: 107 MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 225 HI---TTSNVVGTVEY 237
HI N+ GT Y
Sbjct: 164 HIPYRENKNLTGTARY 179
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 9/102 (8%)
Query: 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL--DDDIEARISGFGFARAIPDAHTHI 226
+ A + L +L IIH DL P N+LL +I FG +
Sbjct: 160 RKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS-----CQLGQ 213
Query: 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
+ + Y +PE L + D++ G +L + G+
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 27/102 (26%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL--DDDIEARISGFGFARAIPDAHTHI 226
+ A + L+ LH + RIIH DL P N+LL ++ FG + + H
Sbjct: 203 RKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQ 254
Query: 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
+ + Y APE + D++ G +LA L+ G
Sbjct: 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 24/76 (31%), Positives = 33/76 (43%), Gaps = 11/76 (14%)
Query: 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL---DDDIEARISGFGFARAIPDAHT-- 224
+A + +EY+H + IHRD+ P N L+ I FG A+ DA T
Sbjct: 109 LLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 225 HI---TTSNVVGTVEY 237
HI N+ GT Y
Sbjct: 166 HIPYRENKNLTGTARY 181
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 345 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.52 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.77 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.37 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.19 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.5 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.96 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.92 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.82 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.08 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.64 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.2 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 93.48 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.35 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=398.00 Aligned_cols=262 Identities=22% Similarity=0.360 Sum_probs=199.4
Q ss_pred hhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHH
Q 046907 37 KAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKK 116 (345)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (345)
+...-.|+++.+++++.++||+|+||+||+|+++ ..||||.++....+ ...
T Consensus 25 ~~~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~-------------------------~~~ 75 (307)
T 3omv_A 25 RDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPT-------------------------PEQ 75 (307)
T ss_dssp ----CCCBCCTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCC-------------------------HHH
T ss_pred CCCCcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCC-------------------------HHH
Confidence 3444468889999999999999999999999974 24999998754333 233
Q ss_pred HHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcC
Q 046907 117 MRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHH 186 (345)
Q Consensus 117 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~ 186 (345)
.+.|.+|+.++++++|||||++++++..+ .+++++||+++|++ +++..+..++.|++.||.|||+++
T Consensus 76 ~~~f~~E~~il~~l~HpNIV~l~g~~~~~---~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 152 (307)
T 3omv_A 76 FQAFRNEVAVLRKTRHVNILLFMGYMTKD---NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN 152 (307)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSS---SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEECC---eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 67799999999999999999999987654 37899999998754 677788899999999999999998
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc---cccCccchhh-HHHHHHH
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM---LTLTEKCDIY-FGALLAG 262 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~---~~~~~~~Dvw-lG~vl~e 262 (345)
|+||||||+|||++.++.+||+|||+|+..............+||+.|||||++.+ .+++.++||| ||+++||
T Consensus 153 ---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~E 229 (307)
T 3omv_A 153 ---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYE 229 (307)
T ss_dssp ---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHH
T ss_pred ---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHH
Confidence 99999999999999999999999999987654333333456789999999999964 3589999999 9999999
Q ss_pred HHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 263 LVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 263 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
|+||..||.+.. +.......+......+.. ....+++...+.++|..||+.||++|||+.+|++.|+.
T Consensus 230 lltg~~Pf~~~~---~~~~~~~~~~~~~~~p~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 230 LMTGELPYSHIN---NRDQIIFMVGRGYASPDL---------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp HHHSSCTTTTCC---CHHHHHHHHHTTCCCCCS---------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred HHHCCCCCCCCC---hHHHHHHHHhcCCCCCCc---------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 999999975422 222233333222211111 11122334457788999999999999999999999998
Q ss_pred hhC
Q 046907 343 IQH 345 (345)
Q Consensus 343 l~~ 345 (345)
|++
T Consensus 298 l~~ 300 (307)
T 3omv_A 298 LQH 300 (307)
T ss_dssp HHT
T ss_pred Hhc
Confidence 864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-56 Score=395.42 Aligned_cols=251 Identities=19% Similarity=0.348 Sum_probs=202.9
Q ss_pred hhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
++.++|.+.+.||+|+||.||+|++.. .++..||||.+.... ....++|
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------------------------~~~~~~f 62 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---------------------------DNARKDF 62 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---------------------------HHHHHHH
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---------------------------hHHHHHH
Confidence 356789999999999999999998752 357899999996432 2235678
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------------------CCHHHHHHHHHHHHHH
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------------------LDWLARHRIALGLACG 178 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------------------l~~~~~~~i~~~i~~~ 178 (345)
.+|++++++++|||||++++++.+++ .+++++||+++|++ +++..+..++.|++.|
T Consensus 63 ~~E~~il~~l~HpnIV~l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 140 (299)
T 4asz_A 63 HREAELLTNLQHEHIVKFYGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140 (299)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEECSSS--SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCccEEEEEeeCC--EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999998776 68999999998765 5666778999999999
Q ss_pred HHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HH
Q 046907 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FG 257 (345)
Q Consensus 179 l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG 257 (345)
|.|||+++ |+||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++||| ||
T Consensus 141 l~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~G 217 (299)
T 4asz_A 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217 (299)
T ss_dssp HHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHH
Confidence 99999998 999999999999999999999999999876544433344456799999999999999999999999 99
Q ss_pred HHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 258 ALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 258 ~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+++|||+| |..||.. .+..+....+......+.+ +.+...+.+||.+||+.||++|||+.+|
T Consensus 218 vvl~Ellt~G~~Pf~~----~~~~~~~~~i~~~~~~~~p-------------~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 218 VVLWEIFTYGKQPWYQ----LSNNEVIECITQGRVLQRP-------------RTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HHHHHHHTTTCCTTTT----SCHHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCCCCCC----CCHHHHHHHHHcCCCCCCC-------------ccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999 8999754 2344454444433222111 1223357789999999999999999999
Q ss_pred HHHHhhhh
Q 046907 337 RRMLSQIQ 344 (345)
Q Consensus 337 l~~L~~l~ 344 (345)
.+.|+++.
T Consensus 281 ~~~L~~~~ 288 (299)
T 4asz_A 281 HTLLQNLA 288 (299)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=396.95 Aligned_cols=251 Identities=21% Similarity=0.326 Sum_probs=196.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
.+.++|.+.++||+|+||.||+|++++ .++..||||.+.... ....+.|
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---------------------------~~~~~~f 90 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---------------------------ESARQDF 90 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---------------------------HHHHHHH
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---------------------------HHHHHHH
Confidence 356788999999999999999999753 358899999996432 2235678
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC------------------------CCHHHHHHHHHHHH
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------------------LDWLARHRIALGLA 176 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------------------l~~~~~~~i~~~i~ 176 (345)
.+|+.++++++|||||++++++..++ .+++++||+++|++ +++..+.+++.|++
T Consensus 91 ~~E~~il~~l~HpnIV~l~g~~~~~~--~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 168 (329)
T 4aoj_A 91 QREAELLTMLQHQHIVRFFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168 (329)
T ss_dssp HHHHHHHTTCCCTTBCCEEEEECSSS--SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECC--EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHH
Confidence 99999999999999999999998776 68999999998765 56677889999999
Q ss_pred HHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-
Q 046907 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY- 255 (345)
Q Consensus 177 ~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw- 255 (345)
.||.|||+.+ |+||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||
T Consensus 169 ~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS 245 (329)
T 4aoj_A 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245 (329)
T ss_dssp HHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccc
Confidence 9999999998 999999999999999999999999999876544333334457899999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 256 FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 256 lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
||+++|||+| |..||.. ....+....+......+.+ +.+...+.+||.+||+.||++|||+.
T Consensus 246 ~Gvvl~Ellt~G~~Pf~~----~~~~~~~~~i~~g~~~~~p-------------~~~~~~~~~li~~cl~~dP~~RPs~~ 308 (329)
T 4aoj_A 246 FGVVLWEIFTYGKQPWYQ----LSNTEAIDCITQGRELERP-------------RACPPEVYAIMRGCWQREPQQRHSIK 308 (329)
T ss_dssp HHHHHHHHHTTSCCTTCS----SCHHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHCCSSTTTSCCHH
T ss_pred hHHHHHHHHcCCCCCCCC----CCHHHHHHHHHcCCCCCCc-------------ccccHHHHHHHHHHcCcChhHCcCHH
Confidence 9999999999 8999654 2344444444433222111 11223477899999999999999999
Q ss_pred HHHHHHhhhh
Q 046907 335 DVRRMLSQIQ 344 (345)
Q Consensus 335 ~ll~~L~~l~ 344 (345)
+|++.|+.+.
T Consensus 309 ei~~~L~~l~ 318 (329)
T 4aoj_A 309 DVHARLQALA 318 (329)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=394.96 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=202.4
Q ss_pred hhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
...++++++++||+|+||.||+|++.+ .++..||||.+...... ...+.|
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--------------------------~~~~~f 76 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--------------------------PLREEF 76 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------------------------CHHHH
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--------------------------HHHHHH
Confidence 355678999999999999999999843 35789999999643211 124678
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHHHHHH
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRIALGL 175 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i~~~i 175 (345)
.+|+.++++++|||||+++|++..++ .+++++||+++|++ +++..+.+++.|+
T Consensus 77 ~~E~~il~~l~HpNIV~l~g~~~~~~--~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 154 (308)
T 4gt4_A 77 RHEAMLRARLQHPNVVCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 154 (308)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCcceEEEECC--EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHH
Confidence 89999999999999999999998776 58899999998765 4556778999999
Q ss_pred HHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh
Q 046907 176 ACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255 (345)
Q Consensus 176 ~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw 255 (345)
+.||.|||+.+ ++||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||
T Consensus 155 a~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVw 231 (308)
T 4gt4_A 155 AAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 231 (308)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhh
Confidence 99999999998 999999999999999999999999999876544333334557899999999999999999999999
Q ss_pred -HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 256 -FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 256 -lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
||+++|||+| |..||.+ .+..++...+......+. +++++..+.+||.+||+.||++|||+
T Consensus 232 SfGvvl~El~t~g~~Pf~~----~~~~~~~~~i~~~~~~~~-------------p~~~~~~~~~li~~C~~~dP~~RPs~ 294 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCG----YSNQDVVEMIRNRQVLPC-------------PDDCPAWVYALMIECWNEFPSRRPRF 294 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTT----CCHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHcCCCCCC-------------cccchHHHHHHHHHHcCCChhHCcCH
Confidence 9999999998 8999654 344455554443322111 11233457789999999999999999
Q ss_pred HHHHHHHhhh
Q 046907 334 KDVRRMLSQI 343 (345)
Q Consensus 334 ~~ll~~L~~l 343 (345)
.+|++.|+++
T Consensus 295 ~ei~~~L~a~ 304 (308)
T 4gt4_A 295 KDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHHHhc
Confidence 9999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=386.48 Aligned_cols=242 Identities=21% Similarity=0.313 Sum_probs=190.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|++++.||+|+||+||+|+++ .+|+.||||.+.....+ .+..+.+.+|+.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~-------------------------~~~~~~~~~E~~i 76 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMS-------------------------SKEREESRREVAV 76 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSC-------------------------HHHHHHHHHHHHH
T ss_pred ccceEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCC-------------------------HHHHHHHHHHHHH
Confidence 468999999999999999999864 57999999999754332 2336678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++++|||||++++++.+++ .+|++|||++||++ +++.....++.|++.||.|||+++ |+||||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~--~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDl 151 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENG--SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDI 151 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTC
T ss_pred HHHCCCCCCCcEEEEEEECC--EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccC
Confidence 99999999999999998876 79999999998765 345566789999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+|||++.++.+||+|||+|+...... ....+.+||+.|||||++.+..|+.++||| +||++|||++|..||..
T Consensus 152 Kp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-- 227 (350)
T 4b9d_A 152 KSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-- 227 (350)
T ss_dssp CGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--
T ss_pred CHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--
Confidence 9999999999999999999998654321 123456899999999999999999999999 99999999999999743
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+..+....+... ..+. . .......+.+||.+||+.||++|||+.++++
T Consensus 228 --~~~~~~~~~i~~~---~~~~------~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 228 --GSMKNLVLKIISG---SFPP------V----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --SSHHHHHHHHHHT---CCCC------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --cCHHHHHHHHHcC---CCCC------C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2333343333322 2111 0 0111234778899999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=388.58 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=206.9
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCC----CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQ----NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
.|+...++|++++.||+|+||.||+|++.+. +++.||||.+...... ...
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--------------------------~~~ 111 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--------------------------SEH 111 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--------------------------HHH
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--------------------------HHH
Confidence 4788899999999999999999999997532 3578999999653221 235
Q ss_pred HHHHHHHHHHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHH
Q 046907 118 RQIQSEINTVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRI 171 (345)
Q Consensus 118 ~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i 171 (345)
+.+.+|+.+|.+++ |||||+++++|..++ ..+++++||+++|++ +++..+..+
T Consensus 112 ~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 190 (353)
T 4ase_A 112 RALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190 (353)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCcEEEEEEEEEecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHH
Confidence 67899999999995 599999999987654 257899999998765 455667789
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 172 ~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.+
T Consensus 191 ~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k 267 (353)
T 4ase_A 191 SFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 267 (353)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc
Confidence 999999999999998 99999999999999999999999999987755544445566789999999999999999999
Q ss_pred chhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 252 CDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 252 ~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
+||| ||+++|||+| |..||.+.. ....+...+......+.+. .+...+.++|..||+.||++
T Consensus 268 sDVwS~Gv~l~El~t~G~~Pf~~~~---~~~~~~~~i~~g~~~~~p~-------------~~~~~~~~li~~c~~~dP~~ 331 (353)
T 4ase_A 268 SDVWSFGVLLWEIFSLGASPYPGVK---IDEEFCRRLKEGTRMRAPD-------------YTTPEMYQTMLDCWHGEPSQ 331 (353)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCC---CSHHHHHHHHHTCCCCCCT-------------TCCHHHHHHHHHHTCSSGGG
T ss_pred ccEeehHHHHHHHHhCCCCCCCCCC---HHHHHHHHHHcCCCCCCCc-------------cCCHHHHHHHHHHcCcChhH
Confidence 9999 9999999998 899975432 2233444444333222211 11234778889999999999
Q ss_pred CCCHHHHHHHHhhh
Q 046907 330 RPNSKDVRRMLSQI 343 (345)
Q Consensus 330 Rpt~~~ll~~L~~l 343 (345)
|||+.+|++.|+++
T Consensus 332 RPt~~eil~~L~~l 345 (353)
T 4ase_A 332 RPTFSELVEHLGNL 345 (353)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999999886
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=382.11 Aligned_cols=241 Identities=21% Similarity=0.360 Sum_probs=196.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.|+++++||+|+||.||+|+++ .+|+.||||.+...... ..+.+.+|+.+|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~---------------------------~~~~~~~Ei~il 125 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQ---------------------------RRELLFNEVVIM 125 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCS---------------------------SGGGGHHHHHHH
T ss_pred HhcEEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchh---------------------------HHHHHHHHHHHH
Confidence 56999999999999999999964 68999999999532111 134467899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+.++|||||++++++.+++ .+|++|||+++|++ +++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 126 ~~l~HpnIV~l~~~~~~~~--~~~ivmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~N 200 (346)
T 4fih_A 126 RDYQHENVVEMYNSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDS 200 (346)
T ss_dssp HHCCCTTBCCEEEEEEETT--EEEEEECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred HhCCCCCCCcEEEEEEECC--EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHH
Confidence 9999999999999999887 79999999999754 667777899999999999999999 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
||++.++.+||+|||+|+....... ...+.+||+.|||||++.+..|+.++||| +||++|||++|..||.. .+
T Consensus 201 ILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~~ 274 (346)
T 4fih_A 201 ILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----EP 274 (346)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----SC
T ss_pred EEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----cC
Confidence 9999999999999999987654322 23567999999999999999999999999 99999999999999643 33
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+....+.... .+.. .........+.+||.+||+.||++|||+.|+++
T Consensus 275 ~~~~~~~i~~~~---~~~~--------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 275 PLKAMKMIRDNL---PPRL--------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHHHHSS---CCCC--------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHcCC---CCCC--------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 444444443321 1110 011122234778999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=375.84 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=197.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||+||+|+.+ .+|+.||||.+..... ......+.+.+|+++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~------------------------~~~~~~~~~~~E~~i 85 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHI------------------------IKENKVPYVTRERDV 85 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHHH
T ss_pred ccccEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHC------------------------CCHHHHHHHHHHHHH
Confidence 357999999999999999999964 6899999999952110 112235678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++++|||||++++++.+++ .+|++|||++||++ +++.....++.|++.||.|||+++ |+||||||
T Consensus 86 l~~l~HpnIv~l~~~~~~~~--~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKP 160 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKP 160 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSS--EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred HHhCCCCCCCeEEEEEEeCC--EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCH
Confidence 99999999999999998876 79999999999765 555666789999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.+||+|||+|+.+..........+.+||+.|||||++.+..++.++||| +||++|||++|..||..
T Consensus 161 eNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---- 236 (311)
T 4aw0_A 161 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---- 236 (311)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC----
T ss_pred HHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC----
Confidence 9999999999999999999987544433345668999999999999999999999999 99999999999999643
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
.+.......+.... .. + +... ...+.+|+.+||+.||++|||+.|++
T Consensus 237 ~~~~~~~~~i~~~~---~~---~----p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 237 GNEGLIFAKIIKLE---YD---F----PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp SSHHHHHHHHHHTC---CC---C----CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCHHHHHHHHHcCC---CC---C----Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 33444444433221 10 0 1111 22467899999999999999998863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=370.73 Aligned_cols=244 Identities=20% Similarity=0.316 Sum_probs=188.8
Q ss_pred CCc-ccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGL-ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 48 ~~~-~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
++| ++.++||+|+||.||+|+++ .++..||+|.+.....+ ....++|.+|+.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~-------------------------~~~~~~~~~E~~i 78 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLT-------------------------KSERQRFKEEAEM 78 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSC-------------------------HHHHHHHHHHHHH
T ss_pred CceEEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCC-------------------------HHHHHHHHHHHHH
Confidence 344 67788999999999999965 57999999999643222 2235678999999
Q ss_pred HhhccCCCccceeEEEec--CCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTR--PDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++++|||||++++++.+ .+...++++|||+++|++ +++..+..++.|++.||.|||+++ ++|+||||
T Consensus 79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDl 157 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDL 157 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCC
T ss_pred HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEeccc
Confidence 999999999999999865 334578999999999875 455666789999999999999986 35999999
Q ss_pred CCCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+|||++ .++.+||+|||+|+..... ...+.+||+.|||||++.+ .++.++||| +||++|||+||..||.+.
T Consensus 158 Kp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 158 KCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999998 4789999999999754332 2245789999999999876 699999999 999999999999997432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+...+...+. ....+. ..+ .... ..+.++|.+||+.||++|||+.++++
T Consensus 233 ---~~~~~~~~~i~---~~~~~~-~~~----~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 233 ---QNAAQIYRRVT---SGVKPA-SFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---SSHHHHHHHHT---TTCCCG-GGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CcHHHHHHHHH---cCCCCC-CCC----ccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222322222 111111 111 1111 23678899999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=377.93 Aligned_cols=248 Identities=22% Similarity=0.265 Sum_probs=193.7
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+....+.|++.++||+|+||.||+|+++ .+|+.||||.+.... ...+
T Consensus 53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~--------------------------------~~~~ 99 (336)
T 4g3f_A 53 YREEVHWMTHQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEV--------------------------------FRVE 99 (336)
T ss_dssp CCBTTTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTT--------------------------------CCTH
T ss_pred hhcchhheEeCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHH--------------------------------hHHH
Confidence 3445667899999999999999999964 679999999995321 1136
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
|+.+++.++|||||++++++.+++ .+|++|||++||++ +++.....++.|++.||.|||+++ |+||
T Consensus 100 E~~il~~l~HpnIV~l~~~~~~~~--~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHR 174 (336)
T 4g3f_A 100 ELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHG 174 (336)
T ss_dssp HHHTTTTCCCTTBCCEEEEEEETT--EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECS
T ss_pred HHHHHHhCCCCCCCcEEEEEEECC--EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 999999999999999999998876 78999999999765 566677789999999999999998 9999
Q ss_pred CCCCCCeeecCCC-CeEEeccccceecCCCCcc---eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 194 DLNPVNVLLDDDI-EARISGFGFARAIPDAHTH---ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 194 dlk~~nil~~~~~-~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
||||+|||++.++ .+||+|||+|+........ ......+||+.|||||++.+.+++.++||| +||++|||++|..
T Consensus 175 DlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp CCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 9999999999887 6999999999877543221 122346899999999999999999999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
||...... .....+.. ...+.. . .++.....+.++|.+||+.||++|||+.|+++.|...
T Consensus 255 Pf~~~~~~----~~~~~i~~---~~~~~~----~----~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 255 PWTQYFRG----PLCLKIAS---EPPPIR----E----IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp SSTTTCCS----CCHHHHHH---SCCGGG----G----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCHH----HHHHHHHc---CCCCch----h----cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 98653322 22222221 111110 1 1112233467888999999999999999999887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=372.63 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=191.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
.+|.+.+.||+|+||.||+|++ +|+.||||++.... .....+..|+..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~----------------------------~~~~~~e~Ei~~~ 51 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE----------------------------ERSWFREAEIYQT 51 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGG----------------------------HHHHHHHHHHHTS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc----------------------------hhhHHHHHHHHHH
Confidence 3688899999999999999997 58899999985311 0112234577777
Q ss_pred hhccCCCccceeEEEecCCc--ceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEe
Q 046907 128 GQIRHRNLHPLLAHVTRPDC--HLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHH-----CPRIIH 192 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~--~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~-----~~~iiH 192 (345)
.+++|||||++++++..++. ..+++++||+++|++ +++..+.+++.|++.||.|||+.+ .++|+|
T Consensus 52 ~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiH 131 (303)
T 3hmm_A 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131 (303)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEEC
T ss_pred hcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEee
Confidence 88999999999999987653 357999999999875 456677899999999999999871 123999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCcccccccccccc------ccCccchhh-HHHHHHHH
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQML------TLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~------~~~~~~Dvw-lG~vl~el 263 (345)
|||||+|||++.++.+||+|||+|+........ ......+||+.|||||++.+. .++.++||| ||+++|||
T Consensus 132 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence 999999999999999999999999876543322 123346899999999999764 467899999 99999999
Q ss_pred HhCCCCCccccccc-------chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 264 VMGKLPSDKFFQHT-------NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 264 ~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+||..||....... ........+............++... ...++...+.+||.+||+.||++||||.+|
T Consensus 212 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99987754221110 00011112222221221111111111 123566778999999999999999999999
Q ss_pred HHHHhhhh
Q 046907 337 RRMLSQIQ 344 (345)
Q Consensus 337 l~~L~~l~ 344 (345)
++.|++|.
T Consensus 289 ~~~L~~l~ 296 (303)
T 3hmm_A 289 KKTLSQLS 296 (303)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999884
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=361.76 Aligned_cols=240 Identities=21% Similarity=0.353 Sum_probs=179.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+|+.||||.+....... .....++.+|+.++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~------------------------~~~~~~~~~Ei~il 67 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKVLAK------------------------SDMQGRIEREISYL 67 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC------------------------------CHHHHHHHHHHH
T ss_pred eCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHHcCC------------------------HHHHHHHHHHHHHH
Confidence 68999999999999999999854 689999999996543221 12356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+.++|||||++++++.+++ .++++|||++| ...+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 68 ~~l~HpnIv~~~~~~~~~~--~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~N 142 (275)
T 3hyh_A 68 RLLRHPHIIKLYDVIKSKD--EIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPEN 142 (275)
T ss_dssp HHCCCTTBCCEEEEEECSS--EEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTT
T ss_pred HHCCCCCCCeEEEEEEECC--EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHH
Confidence 9999999999999998876 78999999954 234677778899999999999999999 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||++.++.+||+|||+|+...... ...+.+||+.|||||++.+..+ +.++||| +||++|+|++|..||.. .
T Consensus 143 ILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~----~ 215 (275)
T 3hyh_A 143 LLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD----E 215 (275)
T ss_dssp EEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC----S
T ss_pred eEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC----C
Confidence 999999999999999998654432 2345789999999999998886 5799999 99999999999999743 3
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.......+.... .. ++ .. ....+.+++.+||+.||++|||+.|+++
T Consensus 216 ~~~~~~~~i~~~~---~~---~p-----~~---~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 216 SIPVLFKNISNGV---YT---LP-----KF---LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SHHHHHHHHHHTC---CC---CC-----TT---SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHcCC---CC---CC-----CC---CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3333433333221 11 00 11 1234678899999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=383.31 Aligned_cols=242 Identities=21% Similarity=0.361 Sum_probs=196.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.+.|+++++||+|+||.||+|+++ .+|+.||||.+...... ..+.+.+|+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~---------------------------~~~~~~~Ei~i 201 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQ---------------------------RRELLFNEVVI 201 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCS---------------------------SGGGHHHHHHH
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchh---------------------------HHHHHHHHHHH
Confidence 357999999999999999999965 68999999999643221 13456789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
|+.++|||||++++++.+++ .+|++|||++||++ +++..+..++.|++.||.|||+++ |+||||||+
T Consensus 202 l~~l~HpnIV~l~~~~~~~~--~~~iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~ 276 (423)
T 4fie_A 202 MRDYQHENVVEMYNSYLVGD--ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSD 276 (423)
T ss_dssp HHHCCCTTBCCEEEEEEETT--EEEEEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTT
T ss_pred HHhCCCCCCCceEEEEEECC--EEEEEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHH
Confidence 99999999999999999887 79999999999764 566677899999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.+||+|||+|+....... ...+.+||+.|||||++.+..|+.++||| +||++|||++|..||.. .
T Consensus 277 NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~----~ 350 (423)
T 4fie_A 277 SILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN----E 350 (423)
T ss_dssp TEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT----S
T ss_pred HEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC----c
Confidence 99999999999999999987654322 33567999999999999999999999999 99999999999999643 3
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.......+.... .+... ........+.+||.+||+.||++|||+.|+++
T Consensus 351 ~~~~~~~~i~~~~---~~~~~--------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 351 PPLKAMKMIRDNL---PPRLK--------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSC---CCCCS--------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHcCC---CCCCc--------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3444444443321 11100 00111234678899999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=365.33 Aligned_cols=243 Identities=21% Similarity=0.315 Sum_probs=186.8
Q ss_pred hcCCcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+.++|++++.||+|+||+||+|+.. ..+++.||||.+........ ...++.+|
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-------------------------~~~~~~~E 76 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-------------------------DRVRTKME 76 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-------------------------ECC-----
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-------------------------HHHHHHHH
Confidence 4468999999999999999999853 34688999999965433211 12346789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.++++++|||||++++++.+++ .+|++|||++||++ +++..+..++.|++.||.|||+++ |+|||
T Consensus 77 ~~il~~l~HpnIv~l~~~~~~~~--~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 151 (304)
T 3ubd_A 77 RDILVEVNHPFIVKLHYAFQTEG--KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRD 151 (304)
T ss_dssp -CCCCCCCCTTEECEEEEEEETT--EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHHHHHCCCCCCCeEEEEEEECC--EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 99999999999999999999876 79999999999865 556667789999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+|||++.++.+||+|||+|+....... ...+.+||+.|||||++.+..++.++||| +||++|||++|..||..
T Consensus 152 lKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~- 228 (304)
T 3ubd_A 152 LKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG- 228 (304)
T ss_dssp CCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred CCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-
Confidence 999999999999999999999986543221 23457899999999999999999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS-----KDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~-----~~ll~ 338 (345)
.+..+....+.... .. + +.. ....+.+++.+||+.||++|||+ +|+++
T Consensus 229 ---~~~~~~~~~i~~~~---~~---~----p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 229 ---KDRKETMTMILKAK---LG---M----PQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---SSHHHHHHHHHHCC---CC---C----CTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---cCHHHHHHHHHcCC---CC---C----CCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 33344444333221 11 0 111 12346788999999999999985 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=361.06 Aligned_cols=242 Identities=22% Similarity=0.375 Sum_probs=178.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||+||+|+++ .+|+.||||.+..... ....+++.+|+.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~--------------------------~~~~~~~~~E~~il 57 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNR--------------------------ELAREKVMREVKAL 57 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSS--------------------------HHHHHHHHHHHHHH
T ss_pred hhCEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCC--------------------------HHHHHHHHHHHHHH
Confidence 36999999999999999999964 5799999999864321 12356788999999
Q ss_pred hhccCCCccceeEEEecCCc----------ceeeeeccccCCCCCCCH------------HHHHHHHHHHHHHHHHHhhc
Q 046907 128 GQIRHRNLHPLLAHVTRPDC----------HLLYILNDVSQGRRELDW------------LARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~----------~~l~~~~~~~~~~~~l~~------------~~~~~i~~~i~~~l~~lh~~ 185 (345)
++++|||||++++++...+. ..+|+++||+.++++.++ ..+..++.|+++||.|||++
T Consensus 58 ~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~ 137 (299)
T 4g31_A 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK 137 (299)
T ss_dssp TTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999999876542 247899999998865433 33567999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcc----------eeccCcccCccccccccccccccCccchhh
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH----------ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw 255 (345)
+ |+||||||+|||++.++.+||+|||+|+........ ....+.+||+.|||||++.+..++.++|||
T Consensus 138 ~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw 214 (299)
T 4g31_A 138 G---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIF 214 (299)
T ss_dssp T---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHH
T ss_pred c---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHH
Confidence 9 999999999999999999999999999876543211 112346899999999999999999999999
Q ss_pred -HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 256 -FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 256 -lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
+||++|||++ ||.. ..+....+........+. ..+.......+++.+||+.||++|||+.
T Consensus 215 SlGvilyell~---Pf~~------~~~~~~~~~~~~~~~~p~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ 275 (299)
T 4g31_A 215 SLGLILFELLY---PFST------QMERVRTLTDVRNLKFPP----------LFTQKYPCEYVMVQDMLSPSPMERPEAI 275 (299)
T ss_dssp HHHHHHHHHHS---CCSS------HHHHHHHHHHHHTTCCCH----------HHHHHCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHcc---CCCC------ccHHHHHHHHHhcCCCCC----------CCcccCHHHHHHHHHHcCCChhHCcCHH
Confidence 9999999995 7532 112222222222111110 1122233466799999999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
++++
T Consensus 276 eil~ 279 (299)
T 4g31_A 276 NIIE 279 (299)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=362.98 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=198.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+++ .+|+.||||++...... .....++.+|+.+|
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~-------------------------~~~~~~~~~Ei~il 107 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDV-------------------------VTNAKRTLRELKIL 107 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSS-------------------------HHHHHHHHHHHHHH
T ss_pred CCeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccc-------------------------hHHHHHHHHHHHHH
Confidence 57999999999999999999864 68999999999654322 22356778999999
Q ss_pred hhccCCCccceeEEEecC----CcceeeeeccccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 128 GQIRHRNLHPLLAHVTRP----DCHLLYILNDVSQGR--------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~----~~~~l~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+.++|||||++++++... +...+|++|||++|+ ..+++..+..++.|++.||.|||+++ |+||||
T Consensus 108 ~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDl 184 (398)
T 4b99_A 108 KHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDL 184 (398)
T ss_dssp HHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCc
Confidence 999999999999988654 234689999999752 34778888999999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCC--cceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAH--THITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||+|||++.++.+||+|||+|+.+.... ......+.+||+.|||||++.+.. ++.++||| +||++|||++|.+||.
T Consensus 185 KP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 185 KPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 9999999999999999999998764322 122345679999999999988764 68999999 9999999999999964
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccc--------------cccccC---CCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAI--------------DSKLVG---NGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~---~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
..+..+....+......+...... .+.... ...+.....+.+|+.+||+.||++|||+.
T Consensus 265 ----g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 340 (398)
T 4b99_A 265 ----GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAA 340 (398)
T ss_dssp ----CSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred ----CCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 345555555555554333221100 000000 00011234577899999999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
|+++
T Consensus 341 e~L~ 344 (398)
T 4b99_A 341 AALR 344 (398)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=349.94 Aligned_cols=255 Identities=19% Similarity=0.262 Sum_probs=191.7
Q ss_pred cCCcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.++|++.+.||+|+||.||+|+.+ ..+++.||+|.+.... ...++.+|+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----------------------------~~~~~~~E~ 70 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----------------------------HPIRIAAEL 70 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----------------------------CHHHHHHHH
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----------------------------CHHHHHHHH
Confidence 468999999999999999999854 2467899999985431 133467899
Q ss_pred HHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++|+.+ +|||||++++++..++ .+++++||++++++ +++..+..++.|++.||.|||+++ |+||||||
T Consensus 71 ~~l~~~~~h~nIv~l~~~~~~~~--~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKP 145 (361)
T 4f9c_A 71 QCLTVAGGQDNVMGVKYCFRKND--HVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKP 145 (361)
T ss_dssp HHHHHTCSBTTBCCCSEEEEETT--EEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred HHHHHhcCCCCCceEEEEEEECC--EEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCH
Confidence 999988 7999999999998876 79999999998754 677788899999999999999999 99999999
Q ss_pred CCeeecCC-CCeEEeccccceecCCCCcc--------------------------eeccCcccCccccccccccccc-cC
Q 046907 198 VNVLLDDD-IEARISGFGFARAIPDAHTH--------------------------ITTSNVVGTVEYIAPEYLQMLT-LT 249 (345)
Q Consensus 198 ~nil~~~~-~~~kl~Dfg~a~~~~~~~~~--------------------------~~~~~~~gt~~~~aPE~~~~~~-~~ 249 (345)
+|||++.+ +.+||+|||+|+...+.... ......+||+.|||||++.+.+ ++
T Consensus 146 eNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~ 225 (361)
T 4f9c_A 146 SNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQT 225 (361)
T ss_dssp GGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCC
T ss_pred HHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC
Confidence 99999876 79999999999865432210 1123468999999999998765 89
Q ss_pred ccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCC------------------Ccc------------
Q 046907 250 EKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENP------------------KRA------------ 298 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~------------ 298 (345)
.++||| +||++|||++|..|| +...++.+....+....+.+.. ...
T Consensus 226 ~~~DiWSlG~il~ell~G~~Pf---~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 302 (361)
T 4f9c_A 226 TAIDMWSAGVIFLSLLSGRYPF---YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMD 302 (361)
T ss_dssp THHHHHHHHHHHHHHHHTCSSS---SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC---
T ss_pred CccchhhhHHHHHHHHHCCCCC---CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccc
Confidence 999999 999999999999996 4444444444444333221100 000
Q ss_pred -cccccc---------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 299 -IDSKLV---------GNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 299 -~~~~~~---------~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+... .........++.+|+.+||+.||++|||++|+++
T Consensus 303 ~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 303 SSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0001112245678999999999999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=359.42 Aligned_cols=241 Identities=19% Similarity=0.245 Sum_probs=194.1
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+|+.||+|.+..... ...+.+.+|+.+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~~---------------------------~~~~~~~~Ei~il 208 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHE---------------------------SDKETVRKEIQTM 208 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSH---------------------------HHHHHHHHHHHHH
T ss_pred cccEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccch---------------------------hhHHHHHHHHHHH
Confidence 58999999999999999999864 6899999999965321 1245677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+.++|||||++++++.+++ .+++++||+.||++ +++..+..++.||+.||.|||+++ |+||||||
T Consensus 209 ~~l~hpnIv~l~~~~~~~~--~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp 283 (573)
T 3uto_A 209 SVLRHPTLVNLHDAFEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 283 (573)
T ss_dssp HHTCCTTBCCEEEEEECSS--EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred HhCCCCCCCeEEEEEEECC--EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCh
Confidence 9999999999999998776 79999999998764 445567889999999999999999 99999999
Q ss_pred CCeeecC--CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 198 VNVLLDD--DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 198 ~nil~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+|||++. .+.+||+|||+|+.+..... ....+||+.|||||++.+.+++.++||| +||++|||++|..||.+
T Consensus 284 ~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-- 358 (573)
T 3uto_A 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-- 358 (573)
T ss_dssp GGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC--
T ss_pred hhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--
Confidence 9999985 47999999999998754432 3346899999999999999999999999 99999999999999643
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+..+....+...... . +.... +.....+.+||..||+.||++|||+.|+++
T Consensus 359 --~~~~~~~~~i~~~~~~--~----~~~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 359 --ENDDETLRNVKSCDWN--M----DDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --SSHHHHHHHHHTTCCC--C----CSGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --cCHHHHHHHHHhCCCC--C----Ccccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3334444433322111 0 01111 111234678899999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=358.20 Aligned_cols=246 Identities=23% Similarity=0.283 Sum_probs=187.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|++++.||+|+||.||+|+.+ .+|+.||||.+......... ..........++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~---------------------~~~~~~~E~~~l~l 245 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQ---------------------GETLALNERIMLSL 245 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTT---------------------CHHHHHHHHHHHHH
T ss_pred hHHeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhh---------------------hHHHHHHHHHHHHH
Confidence 468999999999999999999964 68999999999531110000 00112222345677
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++|||||++++++.+++ .+|++|||+.||++ +++..+..++.||+.||.|||+++ |+||||||
T Consensus 246 l~~~~HP~IV~l~~~f~~~~--~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKP 320 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKP 320 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSG
T ss_pred HhhCCCCCEeEEEEEEEECC--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCch
Confidence 78889999999999999887 79999999999865 566667789999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+|||++.+|.+||+|||+|+...... ..+.+||+.|||||++.+ ..|+.++|+| +||++|||++|.+||.....
T Consensus 321 eNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 321 ANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred HHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999998765432 345799999999999964 5799999999 99999999999999854322
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
. +.............. .+.. ....+.+||..||+.||.+|++ +.+|++
T Consensus 397 ~----~~~~i~~~i~~~~~~-------~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 397 K----DKHEIDRMTLTMAVE-------LPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C----CHHHHHHHHHHCCCC-------CCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred H----HHHHHHHhhcCCCCC-------CCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1 112222222211111 0111 1234678899999999999998 577653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=325.08 Aligned_cols=266 Identities=26% Similarity=0.431 Sum_probs=215.6
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|+++ +|..||||.+...... ..+.+.+|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---------------------------~~~~~~~E 85 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQ---------------------------GIEEFETE 85 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSS---------------------------HHHHHHHH
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccChH---------------------------HHHHHHHH
Confidence 447789999999999999999999864 6899999988654221 25567899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+.+++.++||||+++++++..++ .++++++++.++++ +++..+..++.|++.||.|||+.+ +
T Consensus 86 ~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 160 (321)
T 2qkw_B 86 IETLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---I 160 (321)
T ss_dssp HHGGGSCCCTTBCCEEEECCCTT--CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHhCCCCCEeeEEEEEcCCC--eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---e
Confidence 99999999999999999987765 67888999877543 677788999999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||| +|+++|||++|..|
T Consensus 161 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p 240 (321)
T 2qkw_B 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240 (321)
T ss_dssp ECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred ecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCc
Confidence 99999999999999999999999999875433222223445789999999999988999999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|....... ......+..............++.......++....+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 241 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 241 IVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCcHH-HHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 86543322 223333333333333444445555556677888999999999999999999999999999999763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=329.98 Aligned_cols=270 Identities=23% Similarity=0.285 Sum_probs=204.5
Q ss_pred hhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHH
Q 046907 37 KAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKK 116 (345)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (345)
..+...+..+.++|++.+.||+|+||.||+|++ .++.||||.+.... ..
T Consensus 13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~----------------------------~~ 61 (322)
T 3soc_A 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQD----------------------------KQ 61 (322)
T ss_dssp -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGGG----------------------------HH
T ss_pred ccCccccccchhhchhhheecccCceEEEEEEE---CCCEEEEEEeecCc----------------------------hH
Confidence 344555667888999999999999999999986 47899999985321 11
Q ss_pred HHHHHHHHHHHhhccCCCccceeEEEecCC--cceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhc-
Q 046907 117 MRQIQSEINTVGQIRHRNLHPLLAHVTRPD--CHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMH- 185 (345)
Q Consensus 117 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~- 185 (345)
......|+.+++.++||||+++++++..++ ...+++++++++++++ +++..+..++.|++.||.|||+.
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~ 141 (322)
T 3soc_A 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDI 141 (322)
T ss_dssp HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCE
T ss_pred HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhc
Confidence 334456899999999999999999988755 3357899999988755 56677789999999999999998
Q ss_pred ---------CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----cccCcc
Q 046907 186 ---------HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----LTLTEK 251 (345)
Q Consensus 186 ---------~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----~~~~~~ 251 (345)
+ ++||||||+|||++.++.+||+|||++................||+.|+|||.+.+ ..++.+
T Consensus 142 ~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 218 (322)
T 3soc_A 142 PGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218 (322)
T ss_dssp EEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHH
T ss_pred cccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCcc
Confidence 8 99999999999999999999999999987755443333445689999999999987 356678
Q ss_pred chhh-HHHHHHHHHhCCCCCcccccccchh---------hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhh
Q 046907 252 CDIY-FGALLAGLVMGKLPSDKFFQHTNEM---------SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACF 321 (345)
Q Consensus 252 ~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 321 (345)
+||| +|+++|||++|..||.......... ...... ................ ........+.++|.+
T Consensus 219 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~ 294 (322)
T 3soc_A 219 IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ-EVVVHKKKRPVLRDYW---QKHAGMAMLCETIEE 294 (322)
T ss_dssp HHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH-HHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh-hhhhcccCCCCccccc---cccchHHHHHHHHHH
Confidence 9999 9999999999999986532211000 111111 1111111111111111 112445668899999
Q ss_pred ccCCCCCCCCCHHHHHHHHhhhh
Q 046907 322 CTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 322 Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||+.||++|||+.+|++.|++|+
T Consensus 295 cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 295 CWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=327.88 Aligned_cols=275 Identities=32% Similarity=0.550 Sum_probs=222.1
Q ss_pred hhhhhhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 35 IKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 35 ~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
....+..++....++|++.+.||+|+||.||+|+++ +|..||||.+......
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-------------------------- 68 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQ-------------------------- 68 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC------------------------------
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCc--------------------------
Confidence 344455567778999999999999999999999854 7899999999653211
Q ss_pred HHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHH
Q 046907 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEY 181 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~ 181 (345)
.....+.+|+.+++.++||||+++++++..++ ..+++++++.++++ +++..+..++.|++.||.|
T Consensus 69 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 146 (326)
T 3uim_A 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT--ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146 (326)
T ss_dssp -CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS--CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhccCCCccceEEEEecCC--ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 11235788999999999999999999998776 56788999887543 6777888999999999999
Q ss_pred Hhhc---CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HH
Q 046907 182 LHMH---HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FG 257 (345)
Q Consensus 182 lh~~---~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG 257 (345)
||+. + ++||||||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||| +|
T Consensus 147 lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 222 (326)
T 3uim_A 147 LHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG 222 (326)
T ss_dssp HHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHH
T ss_pred HHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHH
Confidence 9999 7 999999999999999999999999999876543322 23446699999999999988899999999 99
Q ss_pred HHHHHHHhCCCCCcccc-cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 258 ALLAGLVMGKLPSDKFF-QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 258 ~vl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+++|+|++|..||.... ..........++.............+........++....+.+++..||+.||.+|||+.+|
T Consensus 223 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 302 (326)
T 3uim_A 223 VMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302 (326)
T ss_dssp HHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred HHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence 99999999999985322 22233345555555555555555556666667788889999999999999999999999999
Q ss_pred HHHHhhh
Q 046907 337 RRMLSQI 343 (345)
Q Consensus 337 l~~L~~l 343 (345)
++.|++.
T Consensus 303 l~~L~~~ 309 (326)
T 3uim_A 303 VRMLEGD 309 (326)
T ss_dssp HHHHHTS
T ss_pred HHHhcCc
Confidence 9999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=328.33 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=201.6
Q ss_pred HhhcCCcccccccccCcceeeEEEEecC------CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPG------QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
....++|++.+.||+|+||.||+|++.+ .++..||||.+..... ....
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~ 130 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--------------------------EKDL 130 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--------------------------HHHH
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--------------------------HHHH
Confidence 3456789999999999999999998632 3467899999965321 2235
Q ss_pred HHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHH
Q 046907 118 RQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRI 171 (345)
Q Consensus 118 ~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i 171 (345)
..+.+|+.+++.+ +||||+++++++..++ .++++++|+.++++ +++.....+
T Consensus 131 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 208 (370)
T 2psq_A 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208 (370)
T ss_dssp HHHHHHHHHHHHSCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEccCC--CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHH
Confidence 6788999999999 8999999999988766 68889999988654 455667789
Q ss_pred HHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 172 ALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 172 ~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.+
T Consensus 209 ~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 285 (370)
T 2psq_A 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 285 (370)
T ss_dssp HHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH
T ss_pred HHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH
Confidence 999999999999999 99999999999999999999999999987655433333344567889999999999899999
Q ss_pred chhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 252 CDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 252 ~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
+||| ||+++|||++ |..||... ...+....+........ +..+...+.++|..||+.||++
T Consensus 286 ~DvwslG~il~ellt~g~~p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dP~~ 348 (370)
T 2psq_A 286 SDVWSFGVLMWEIFTLGGSPYPGI----PVEELFKLLKEGHRMDK-------------PANCTNELYMMMRDCWHAVPSQ 348 (370)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHHHHTTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHcCCChhh
Confidence 9999 9999999999 99997542 33334433332221111 1122335788999999999999
Q ss_pred CCCHHHHHHHHhhhh
Q 046907 330 RPNSKDVRRMLSQIQ 344 (345)
Q Consensus 330 Rpt~~~ll~~L~~l~ 344 (345)
|||+.++++.|+++.
T Consensus 349 Rpt~~ell~~L~~il 363 (370)
T 2psq_A 349 RPTFKQLVEDLDRIL 363 (370)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999999873
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=320.27 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=192.0
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+....++|++.+.||+|+||.||+|++ +|..||||.+...... ....+.+.+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~-------------------------~~~~~~~~~ 83 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFH-------------------------AERVNEFLR 83 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCS-------------------------HHHHHHHHH
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCC-------------------------HHHHHHHHH
Confidence 345678999999999999999999986 5888999999765433 223567889
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
|+.++++++||||+++++++..++ .++++++++.++++ +++..+..++.|++.||.|||+.+ .++
T Consensus 84 E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~i 160 (309)
T 3p86_A 84 EVAIMKRLRHPNIVLFMGAVTQPP--NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPI 160 (309)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSTT--CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHHHHhCCCCCEeeEEEEEEECC--ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCE
Confidence 999999999999999999998766 58899999988654 566677889999999999999986 349
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..|
T Consensus 161 vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~P 238 (309)
T 3p86_A 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238 (309)
T ss_dssp CCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCT
T ss_pred ECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999975433221 22346789999999999999999999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ...+....+........ .+......+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 239 f~~~----~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 239 WGNL----NPAQVVAAVGFKCKRLE------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp TTTS----CHHHHHHHHHHSCCCCC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHhcCCCCC------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7542 22222222211111110 11112234778999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=332.09 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=201.9
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|..+.++|.+.+.||+|+||.||+|+++ .++..||||.+..... ......+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~ 160 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLP--------------------------PDLKAKFL 160 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSC--------------------------HHHHTTTT
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCC--------------------------HHHHHHHH
Confidence 57778899999999999999999999975 4789999999864321 12245678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..++ .+++++|+++++++ +++.....++.|++.||.|||+.+ ++
T Consensus 161 ~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---iv 235 (377)
T 3cbl_A 161 QEARILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235 (377)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCEEEEEEEEecCC--CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cC
Confidence 8999999999999999999997765 68899999988654 556667789999999999999999 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++||| ||+++|||++ |..|
T Consensus 236 HrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p 315 (377)
T 3cbl_A 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315 (377)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999865433221111223457789999999988899999999 9999999998 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ...+....+......+.+ ..+...+.++|..||+.||++|||+.++++.|+++.
T Consensus 316 ~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 316 YPNL----SNQQTREFVEKGGRLPCP-------------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp STTS----CHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHcCCCCCCC-------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 6542 333333333322211111 112234778899999999999999999999999885
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=324.15 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=204.9
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
...+|....++|++.+.||+|+||.||+|++. ..+++.||||.+..... .
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~ 66 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------------------------H 66 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------------------------H
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--------------------------H
Confidence 34567788999999999999999999999853 34678999999964321 1
Q ss_pred HHHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------------
Q 046907 115 KKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------------------------- 162 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------------------------- 162 (345)
.....+.+|+.++..+ +||||+++++++..++. .++++++|+.++++
T Consensus 67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (359)
T 3vhe_A 67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS-CCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------
T ss_pred HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC-ceEEEEEecCCCcHHHHHHhccccccccccccchhhccccccccc
Confidence 2356788999999999 89999999999887653 57888899887543
Q ss_pred --------------------------------------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 163 --------------------------------------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 163 --------------------------------------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+++.....++.|++.||.|||+.+ ++||||||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~ 222 (359)
T 3vhe_A 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 222 (359)
T ss_dssp --------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred chhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChh
Confidence 667778889999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~ 276 (345)
||+++.++.+||+|||++................||+.|+|||++.+..++.++||| +|+++|||++ |..||....
T Consensus 223 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-- 300 (359)
T 3vhe_A 223 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK-- 300 (359)
T ss_dssp GEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC--
T ss_pred hEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc--
Confidence 999999999999999999876544333344556789999999999998999999999 9999999998 999975422
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
........+........+ ......+.+++..||+.||.+|||+.++++.|+++.
T Consensus 301 -~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 301 -IDEEFCRRLKEGTRMRAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -CSHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hhHHHHHHHHcCCCCCCC-------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 122333333322211111 111234778889999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=314.33 Aligned_cols=249 Identities=23% Similarity=0.428 Sum_probs=197.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+.+.||+|+||.||+|++. .+++.||+|.+.... ....+.+.+|+.
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~---------------------------~~~~~~~~~E~~ 59 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFD---------------------------EETQRTFLKEVK 59 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCC---------------------------HHHHHHHHHHHH
T ss_pred ChhHeeccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCC---------------------------HHHHHHHHHHHH
Confidence 5679999999999999999999964 579999999985432 233567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++..++ .++++++++.+++ .+++..+..++.|++.||.|||+.+ ++||||
T Consensus 60 ~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dl 134 (310)
T 3s95_A 60 VMRCLEHPNVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDL 134 (310)
T ss_dssp HHTTCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHhCCCcCcccEEEEEecCC--eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 999999999999999998776 6889999998854 3667778899999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcce------------eccCcccCccccccccccccccCccchhh-HHHHHHH
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHI------------TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAG 262 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~------------~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~e 262 (345)
||+||+++.++.+||+|||++.......... ......||+.|+|||.+.+..++.++||| +|+++||
T Consensus 135 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~e 214 (310)
T 3s95_A 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCE 214 (310)
T ss_dssp STTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred CcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999999999998764432211 11246799999999999999999999999 9999999
Q ss_pred HHhCCCCCcccccccchh--hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 263 LVMGKLPSDKFFQHTNEM--SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 263 l~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
|++|..||.......... ........ ..+. .....+.+++..||+.||++|||+.++++.|
T Consensus 215 l~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-------------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 215 IIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPP-------------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp HHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCT-------------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhcCCCCCcchhhhHHHHhhhhhccccc----cCCC-------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999976543322111 11111111 1110 1112378899999999999999999999999
Q ss_pred hhhh
Q 046907 341 SQIQ 344 (345)
Q Consensus 341 ~~l~ 344 (345)
++++
T Consensus 278 ~~l~ 281 (310)
T 3s95_A 278 ETLR 281 (310)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=312.43 Aligned_cols=243 Identities=24% Similarity=0.340 Sum_probs=193.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+. ..+|+.||+|.+...... ..+.+.+|+.
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~---------------------------~~~~~~~E~~ 69 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQP---------------------------KKELIINEIL 69 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEB-TTTCCEEEEEEEEGGGCS---------------------------CHHHHHHHHH
T ss_pred hhhceeeeeeeccCCCeEEEEEEE-CCCCcEEEEEEeeccccc---------------------------HHHHHHHHHH
Confidence 456899999999999999999985 357999999998532211 1345778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++ .+++++|++.++++ ++......++.|++.||.|||+.+ ++||||||
T Consensus 70 ~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp 144 (297)
T 3fxz_A 70 VMRENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKS 144 (297)
T ss_dssp HHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HHhcCCCCCCCeEeEEEEECC--EEEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCH
Confidence 999999999999999998776 68999999988765 566677899999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 145 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--- 219 (297)
T 3fxz_A 145 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--- 219 (297)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS---
T ss_pred HHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---
Confidence 999999999999999999987654332 23456899999999999999999999999 999999999999997432
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.......+... ..+... ........+.+++..||+.||++|||+.++++
T Consensus 220 -~~~~~~~~~~~~---~~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 220 -NPLRALYLIATN---GTPELQ--------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CHHHHHHHHHHH---CSCCCS--------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CHHHHHHHHHhC---CCCCCC--------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 222222222211 111100 11122344788999999999999999999976
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=312.52 Aligned_cols=265 Identities=15% Similarity=0.198 Sum_probs=205.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++. .+++.||||.+...... ...+.+.+|+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~E~~ 59 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFL--------------------------RPVDVQMREFE 59 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGG--------------------------SCHHHHHHHHH
T ss_pred CCCCEEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEecccccc--------------------------chHHHHHHHHH
Confidence 3468999999999999999999965 57999999998642211 11455678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
++++++||||+++++++...+...++++++++.++++ +++..+..++.|++.||.|||+.+ ++||
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 136 (319)
T 4euu_A 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHR 136 (319)
T ss_dssp HHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 9999999999999999988776788999999987643 677888899999999999999999 9999
Q ss_pred CCCCCCeee----cCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc--------ccccCccchhh-HHHHH
Q 046907 194 DLNPVNVLL----DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ--------MLTLTEKCDIY-FGALL 260 (345)
Q Consensus 194 dlk~~nil~----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~--------~~~~~~~~Dvw-lG~vl 260 (345)
||||+||++ +.++.+||+|||++........ .....||..|+|||.+. +..++.++||| +|+++
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp CCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred CCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 999999999 7778899999999987654332 23467999999999986 46788999999 99999
Q ss_pred HHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcc---------ccc--cccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 261 AGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRA---------IDS--KLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 261 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
|||++|..||...............+........+... ... +............+.+++..||+.||++
T Consensus 214 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 293 (319)
T 4euu_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293 (319)
T ss_dssp HHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred HHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhh
Confidence 99999999986544433333333333322211111100 000 1112344667778999999999999999
Q ss_pred CCCHHHHHHHHhhh
Q 046907 330 RPNSKDVRRMLSQI 343 (345)
Q Consensus 330 Rpt~~~ll~~L~~l 343 (345)
|||+.|+++...+-
T Consensus 294 R~s~~ell~h~~d~ 307 (319)
T 4euu_A 294 CWGFDQFFAETSDI 307 (319)
T ss_dssp SCCHHHHHHHHHHH
T ss_pred hccHHHhhhccHHH
Confidence 99999999887653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=315.98 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=193.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|++. .+|+.||||.+.....+ .....++.+|+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 66 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLN-------------------------PTSLQKLFREVR 66 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSC-------------------------HHHHHHHHHHHH
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCC-------------------------HHHHHHHHHHHH
Confidence 4679999999999999999999864 57999999998643221 233567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .+++++++++++++ ++......++.|++.||.|||+.+ ++|||||
T Consensus 67 ~l~~l~hpnIv~l~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlk 141 (328)
T 3fe3_A 67 IMKILNHPNIVKLFEVIETEK--TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLK 141 (328)
T ss_dssp HHHHCCCTTBCCEEEEEECSS--EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred HHHhCCCCCEeeEEEEEEECC--EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCC
Confidence 999999999999999998776 78999999988654 556667789999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccC-ccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLT-EKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~-~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++....... ......||+.|+|||.+.+..+. .++||| +|+++|+|++|..||..
T Consensus 142 p~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-- 216 (328)
T 3fe3_A 142 AENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-- 216 (328)
T ss_dssp GGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred HHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--
Confidence 999999999999999999997654432 23457899999999999988865 799999 99999999999999753
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.......+.... .. .+ ......+.+++..||+.||.+|||+.++++
T Consensus 217 --~~~~~~~~~i~~~~---~~-------~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 217 --QNLKELRERVLRGK---YR-------IP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --SSHHHHHHHHHHCC---CC-------CC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCHHHHHHHHHhCC---CC-------CC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 23333333332221 11 00 011234678889999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=314.37 Aligned_cols=259 Identities=19% Similarity=0.302 Sum_probs=196.2
Q ss_pred hcCCcccccccccCcceeeEEEEe---cCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAEL---PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
..++|++++.||+|+||.||+|++ +..+++.||||.+.... ....+.+.+
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~ 60 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---------------------------EEHLRDFER 60 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---------------------------HHHHHHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---------------------------HHHHHHHHH
Confidence 467999999999999999999985 34578999999996532 223567889
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.+++.++||||+++++++...+...+++++++++++++ +++.....++.|++.||.|||+.+ ++|
T Consensus 61 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 137 (295)
T 3ugc_A 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 137 (295)
T ss_dssp HHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---ccc
Confidence 9999999999999999999877665578999999987654 666777889999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
|||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||| +|+++|+|++|..||
T Consensus 138 ~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~ 217 (295)
T 3ugc_A 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 217 (295)
T ss_dssp SCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred CCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccccc
Confidence 999999999999999999999999876443221 122335677889999999999999999999 999999999999997
Q ss_pred cccccc---------cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 271 DKFFQH---------TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 271 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
...... ................... ..+......+.+++..||+.||++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 218 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL----------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp CSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCChHHHHhhhcCccccchhHHHHHHHHhccCcC----------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 532210 0001111111111111111 111222345788999999999999999999999999
Q ss_pred hhh
Q 046907 342 QIQ 344 (345)
Q Consensus 342 ~l~ 344 (345)
++.
T Consensus 288 ~l~ 290 (295)
T 3ugc_A 288 QIR 290 (295)
T ss_dssp HHH
T ss_pred HHH
Confidence 885
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.96 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=198.1
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++.+.||+|+||.||+|+++ ++..||+|.+...... ...+.+|+
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~----------------------------~~~~~~E~ 54 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMS----------------------------EDEFFQEA 54 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTBC----------------------------HHHHHHHH
T ss_pred echhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCCc----------------------------HHHHHHHH
Confidence 45679999999999999999999875 6778999999654322 34577899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.+++.++||||+++++++..++ .+++++++++++++ +++..+..++.|++.||.|||+.+ ++|||
T Consensus 55 ~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 129 (268)
T 3sxs_A 55 QTMMKLSHPKLVKFYGVCSKEY--PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRD 129 (268)
T ss_dssp HHHHHCCCTTBCCEEEEECSSS--SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESS
T ss_pred HHHHhCCCCCEeeEEEEEccCC--ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 9999999999999999987665 68899999987643 667777899999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~ 272 (345)
|||+||+++.++.++|+|||++......... ......+|+.|+|||.+.+..++.++||| +|+++|+|++ |..||..
T Consensus 130 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp CSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876544322 22345667889999999998899999999 9999999999 9999753
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhhC
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~~ 345 (345)
. ........+........+ .. ....+.+++..||+.||++|||+.++++.|+++.+
T Consensus 209 ~----~~~~~~~~~~~~~~~~~~----------~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 209 Y----TNSEVVLKVSQGHRLYRP----------HL---ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp S----CHHHHHHHHHTTCCCCCC----------TT---SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred c----ChHHHHHHHHcCCCCCCC----------Cc---ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2 222222222221111111 11 12347788999999999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=322.82 Aligned_cols=256 Identities=26% Similarity=0.348 Sum_probs=204.5
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecC------CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPG------QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
..|....++|++.+.||+|+||.||+|++.+ ..+..||||.+..... .
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~ 115 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--------------------------E 115 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--------------------------H
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--------------------------H
Confidence 3456677899999999999999999998642 2346899999965421 2
Q ss_pred HHHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHH
Q 046907 115 KKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLAR 168 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~ 168 (345)
.....+.+|+.+++.+ +||||+++++++..++ .++++++++.++++ +++..+
T Consensus 116 ~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 193 (382)
T 3tt0_A 116 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193 (382)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCchhhhheeeeccCC--ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH
Confidence 2356788999999999 9999999999998766 57889999987543 677788
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc
Q 046907 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL 248 (345)
Q Consensus 169 ~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~ 248 (345)
..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++................||+.|+|||.+.+..+
T Consensus 194 ~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 270 (382)
T 3tt0_A 194 VSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270 (382)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence 899999999999999998 99999999999999999999999999987655433333445677889999999999899
Q ss_pred Cccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCC
Q 046907 249 TEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 249 ~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
+.++||| +|+++|+|++ |..||.. ....+....+........+ ......+.+++..||+.|
T Consensus 271 ~~~~DiwslG~il~ellt~g~~p~~~----~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~d 333 (382)
T 3tt0_A 271 THQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGHRMDKP-------------SNCTNELYMMMRDCWHAV 333 (382)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHHHHHHTTCCCCCC-------------SSCCHHHHHHHHHHTCSS
T ss_pred CchhHHHHHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHcCCCCCCC-------------ccCCHHHHHHHHHHcCCC
Confidence 9999999 9999999999 9999643 2333444433332211111 112234778899999999
Q ss_pred CCCCCCHHHHHHHHhhhh
Q 046907 327 PNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 327 p~~Rpt~~~ll~~L~~l~ 344 (345)
|++|||+.+|++.|+++.
T Consensus 334 P~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 334 PSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=309.46 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=199.6
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|..+.++|++.+.||+|+||.||+|++. ++..||+|.+...... .+.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~----------------------------~~~~~ 53 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS----------------------------EEDFI 53 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTSBC----------------------------HHHHH
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec--CCCeEEEEEecccccC----------------------------HHHHH
Confidence 46667889999999999999999999975 6788999999754322 24577
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.++++++||||+++++++..++ .+++++++++++++ ++......++.|++.||.|||+.+ ++
T Consensus 54 ~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~ 128 (269)
T 4hcu_A 54 EEAEVMMKLSHPKLVQLYGVCLEQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128 (269)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSS--SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCEeeEEEEEecCC--ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 8999999999999999999988766 58899999987543 567778899999999999999999 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+||+++.++.++|+|||++........ .......+|..|+|||.+.+..++.++||| +|+++|+|++ |..|
T Consensus 129 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p 207 (269)
T 4hcu_A 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 207 (269)
T ss_dssp CSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999999976543221 122345667889999999988999999999 9999999999 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|.. .........+........+ ......+.+++..||+.||++|||+.++++.|+++.
T Consensus 208 ~~~----~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 208 YEN----RSNSEVVEDISTGFRLYKP-------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp TTT----CCHHHHHHHHHTTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHhcCccCCCC-------------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 643 2333333333322111111 111234778899999999999999999999999885
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=313.57 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=204.8
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
.+..|....++|.+.+.||+|+||.||+|++. ..++..||+|.+..... .
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~ 67 (314)
T 2ivs_A 14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--------------------------P 67 (314)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--------------------------H
T ss_pred CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--------------------------H
Confidence 34456667889999999999999999999863 23568999999964321 2
Q ss_pred HHHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------------------------------
Q 046907 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------------- 162 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------------- 162 (345)
...+.+.+|+.+++.++||||+++++++..++ .++++++++.++++
T Consensus 68 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (314)
T 2ivs_A 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145 (314)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC--ceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence 23567889999999999999999999987766 58889999987543
Q ss_pred -CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccc
Q 046907 163 -LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPE 241 (345)
Q Consensus 163 -l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE 241 (345)
+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++................+|+.|+|||
T Consensus 146 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 222 (314)
T 2ivs_A 146 ALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence 566677889999999999999998 9999999999999999999999999998775544333334456788999999
Q ss_pred cccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHH
Q 046907 242 YLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIA 319 (345)
Q Consensus 242 ~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 319 (345)
.+.+..++.++||| +|+++|+|++ |..||... ........+........+ ......+.+++
T Consensus 223 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li 285 (314)
T 2ivs_A 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI----PPERLFNLLKTGHRMERP-------------DNCSEEMYRLM 285 (314)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC----CGGGHHHHHHTTCCCCCC-------------TTCCHHHHHHH
T ss_pred hhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHhhcCCcCCCC-------------ccCCHHHHHHH
Confidence 99998899999999 9999999999 99997542 333333333322211111 11223477899
Q ss_pred hhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 320 CFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 320 ~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||+.||++|||+.++++.|+++.
T Consensus 286 ~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 286 LQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=322.99 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=196.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
...++|++++.||+|+||.||+|++.+ .++..||||.+..... ......+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~ 121 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--------------------------EQDELDF 121 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC--------------------------HHHHHHH
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC--------------------------hhhHHHH
Confidence 345789999999999999999999642 3577899999864321 1224567
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------------CCHHHHHHHHHHHHHHHHHHhh
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------------LDWLARHRIALGLACGLEYLHM 184 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------------l~~~~~~~i~~~i~~~l~~lh~ 184 (345)
.+|+.+++.++||||+++++++...+ ..+++++++.++++ +++..+..++.|++.||.|||+
T Consensus 122 ~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 199 (367)
T 3l9p_A 122 LMEALIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199 (367)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCeEEEEEecCC--CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh
Confidence 88999999999999999999988766 56889999987543 5666677899999999999999
Q ss_pred cCCCCeEecCCCCCCeeecCCC---CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHH
Q 046907 185 HHCPRIIHRDLNPVNVLLDDDI---EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260 (345)
Q Consensus 185 ~~~~~iiH~dlk~~nil~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl 260 (345)
.+ ++||||||+|||++.++ .+||+|||+++...............||+.|+|||.+.+..++.++||| +|+++
T Consensus 200 ~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 200 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp TT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 99 99999999999999554 5999999999755332222223346779999999999998999999999 99999
Q ss_pred HHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 261 AGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 261 ~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
|||++ |..||.. .........+........+ ......+.+++..||+.||++|||+.+|++.
T Consensus 277 ~ellt~g~~pf~~----~~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 339 (367)
T 3l9p_A 277 WEIFSLGYMPYPS----KSNQEVLEFVTSGGRMDPP-------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339 (367)
T ss_dssp HHHHTTSCCSSTT----CCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCC----CCHHHHHHHHHcCCCCCCC-------------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99998 9999643 3334444444332211111 1112347789999999999999999999999
Q ss_pred Hhhhh
Q 046907 340 LSQIQ 344 (345)
Q Consensus 340 L~~l~ 344 (345)
|+.+.
T Consensus 340 l~~~~ 344 (367)
T 3l9p_A 340 IEYCT 344 (367)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=307.66 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=198.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+++.||+|.+....... .....+.+|+.++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------------------~~~~~~~~E~~~l 55 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDE-------------------------GVPSSALREICLL 55 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSST-------------------------THHHHHHHHHHHH
T ss_pred CCceeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcC-------------------------CcchHHHHHHHHH
Confidence 58999999999999999999864 579999999997543321 2245677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ .+++++++++++ ..++...+..++.|++.||.|||+.+ ++||||||+
T Consensus 56 ~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~ 130 (292)
T 3o0g_A 56 KELKHKNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQ 130 (292)
T ss_dssp TTCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred hcCCCCCEeeEEeEEEeCC--EEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 9999999999999998776 788999998752 45778888999999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||| +|+++|+|++|..|| +..
T Consensus 131 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~---~~~ 205 (292)
T 3o0g_A 131 NLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL---FPG 205 (292)
T ss_dssp GEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS---CCC
T ss_pred HEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC---cCC
Confidence 99999999999999999987643322 224467899999999998766 79999999 999999999988884 344
Q ss_pred cchhhHHHHHHHHhhhcCCCcccc---------------ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAID---------------SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+......+....... ........+.....+.+++..||+.||++|||++++++
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 444445454444433222211000 00011112233455778999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.46 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=196.8
Q ss_pred HhhcCCcccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
....++|++.+.||+|+||.||+|++.. ..+..||||.+..... ......+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~ 98 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--------------------------ERQRRDFL 98 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC--------------------------HHHHHHHH
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC--------------------------HHHHHHHH
Confidence 3456789999999999999999999742 2345699999964321 22356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..++ .++++++++.+++ .+++..+..++.|++.||.|||+.+ ++
T Consensus 99 ~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---iv 173 (325)
T 3kul_A 99 SEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YV 173 (325)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECGGG--CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCCCcEEEEEEeCC--ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 9999999999999999999987665 6889999998754 3667778899999999999999999 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCc-ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
||||||+||+++.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||| +|+++|||++ |..
T Consensus 174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999987654322 1222334567889999999988999999999 9999999999 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||.. .........+......+.+ ......+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 254 p~~~----~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 254 PYWN----MTNRDVISSVEEGYRLPAP-------------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp TTTT----SCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cccc----CCHHHHHHHHHcCCCCCCC-------------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9643 2333333333322211111 122235778999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=329.46 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=200.7
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
...|....++|++.+.||+|+||.||+|+++ ++..||||.+...... .+.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~----------------------------~~~ 229 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSMS----------------------------VEA 229 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTSBC----------------------------HHH
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCCcc----------------------------HHH
Confidence 3457888899999999999999999999975 5788999999753221 456
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+.+|+.+++.++||||+++++++..+ .++++++++.++++ +++.....++.|++.||.|||+.+
T Consensus 230 ~~~E~~~l~~l~h~~iv~l~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-- 304 (454)
T 1qcf_A 230 FLAEANVMKTLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304 (454)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEECSS---SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEeCC---ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 88999999999999999999988633 47899999988765 344456679999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++||||||+|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||| ||+++|||++ |
T Consensus 305 -ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g 382 (454)
T 1qcf_A 305 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382 (454)
T ss_dssp -CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCC
Confidence 99999999999999999999999999986643211 112334567889999999988999999999 9999999999 9
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||... ...+....+......+.+ ..+...+.++|..||+.||++|||+.+|++.|+++.
T Consensus 383 ~~P~~~~----~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 383 RIPYPGM----SNPEVIRALERGYRMPRP-------------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCSSTTC----CHHHHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCC----CHHHHHHHHHcCCCCCCC-------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 9997542 333444434332221111 122345788999999999999999999999999873
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=314.63 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=203.9
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEecC------CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELPG------QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 112 (345)
....|....++|++.+.||+|+||.||+|++.+ .++..||+|.+.....
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------------- 80 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT------------------------- 80 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-------------------------
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-------------------------
Confidence 445567788999999999999999999998642 3577899999964321
Q ss_pred HHHHHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHH
Q 046907 113 LNKKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWL 166 (345)
Q Consensus 113 ~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~ 166 (345)
......+.+|+.+++.+ +||||+++++++..++ .++++++++.++++ +++.
T Consensus 81 -~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (334)
T 2pvf_A 81 -EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157 (334)
T ss_dssp -HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHH
T ss_pred -HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC--ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHH
Confidence 22356788999999999 9999999999988766 67889999987543 5667
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc
Q 046907 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML 246 (345)
Q Consensus 167 ~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~ 246 (345)
.+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++................+|+.|+|||.+.+.
T Consensus 158 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 234 (334)
T 2pvf_A 158 DLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234 (334)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC
Confidence 77889999999999999998 999999999999999999999999999877654433333445678899999999988
Q ss_pred ccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccC
Q 046907 247 TLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTL 324 (345)
Q Consensus 247 ~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~ 324 (345)
.++.++||| +|+++|+|++ |..||.. ....+....+........+ ......+.+++..||+
T Consensus 235 ~~~~~~Di~slG~il~ellt~g~~p~~~----~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~ 297 (334)
T 2pvf_A 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPG----IPVEELFKLLKEGHRMDKP-------------ANCTNELYMMMRDCWH 297 (334)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTC
T ss_pred CcChHHHHHHHHHHHHHHHhCCCCCcCc----CCHHHHHHHHhcCCCCCCC-------------ccCCHHHHHHHHHHcc
Confidence 899999999 9999999999 9999643 2333333333332211111 1122347788999999
Q ss_pred CCCCCCCCHHHHHHHHhhhh
Q 046907 325 EDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 325 ~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||.+|||+.++++.|+++.
T Consensus 298 ~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 298 AVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=308.29 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=192.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++ +++.||||.+... ....+..|.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~------------------------------~~~~~~~e~~ 52 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR------------------------------DEKSWFRETE 52 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG------------------------------GHHHHHHHHH
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc------------------------------cchhhHHHHH
Confidence 356899999999999999999986 6889999998531 1223344555
Q ss_pred HHhh--ccCCCccceeEEEecC--CcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHh--------hc
Q 046907 126 TVGQ--IRHRNLHPLLAHVTRP--DCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLH--------MH 185 (345)
Q Consensus 126 ~l~~--l~hpniv~l~~~~~~~--~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh--------~~ 185 (345)
++.. ++||||+++++++... ....++++++++.++++ +++.....++.|++.||.||| +.
T Consensus 53 ~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp HHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred HHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 5555 7999999999986543 33468899999988654 677788899999999999999 77
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcce--eccCcccCcccccccccccc------ccCccchhh-H
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI--TTSNVVGTVEYIAPEYLQML------TLTEKCDIY-F 256 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~~~aPE~~~~~------~~~~~~Dvw-l 256 (345)
+ ++||||||+|||++.++.+||+|||++.......... ......||+.|+|||.+.+. .++.++||| +
T Consensus 133 ~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 133 A---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp E---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred C---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 7 9999999999999999999999999998765433221 12345899999999999876 556799999 9
Q ss_pred HHHHHHHHhC----------CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCC
Q 046907 257 GALLAGLVMG----------KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 257 G~vl~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
|+++|||++| ..||............. .............+.. .........+.+++..||+.|
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~d 283 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM---RKVVCVDQQRPNIPNR---WFSDPTLTSLAKLMKECWYQN 283 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH---HHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHCCSS
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcchhhh---hHHHhccCCCCCCChh---hccCccHHHHHHHHHHHhhcC
Confidence 9999999999 78875543332222221 1111111111111111 112345667889999999999
Q ss_pred CCCCCCHHHHHHHHhhh
Q 046907 327 PNERPNSKDVRRMLSQI 343 (345)
Q Consensus 327 p~~Rpt~~~ll~~L~~l 343 (345)
|++|||+.+|++.|+++
T Consensus 284 P~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 284 PSARLTALRIKKTLTKI 300 (301)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHhcc
Confidence 99999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=306.52 Aligned_cols=270 Identities=20% Similarity=0.254 Sum_probs=191.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||||.+...................... ............+.+.+|+.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP-APGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC--------------------------------CHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccc-cccccccccchHHHHHHHHH
Confidence 5679999999999999999999854 579999999997654322110000000000000 00000011223567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++...+++++|+++++.+ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999999988666689999999987543 677788999999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc---cCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~---~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++||| +|+++|+|++|..||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987654322 234468999999999998765 37789999 999999999999997432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+... ...... .+.....+.+++.+||+.||++|||+.++++
T Consensus 244 ----~~~~~~~~~~~~----~~~~~~--------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 ----RIMCLHSKIKSQ----ALEFPD--------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ----SHHHHHHHHHHC----CCCCCS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cHHHHHHHHhcc----cCCCCC--------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 222222222211 110000 0111234778899999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=311.93 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=192.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++++.||+|+||.||+|+.. +|+.||+|.+.....+ ......+.+|+.
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~~ 71 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAED-------------------------EGIPSTAIREIS 71 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC-------------------------------CHHHHHHHHHH
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEeccccc-------------------------chhhHHHHHHHH
Confidence 3468999999999999999999864 6899999999643211 123566788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .+++++++++++ ..++...+..++.|++.||.|||+.+ ++|||||
T Consensus 72 ~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dik 146 (311)
T 3niz_A 72 LLKELHHPNIVSLIDVIHSER--CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLK 146 (311)
T ss_dssp HHHHCCCTTBCCEEEEECCSS--CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHHHcCCCCEeeeeeEEccCC--EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCc
Confidence 999999999999999988765 688999998752 33778888899999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++........ ......||+.|+|||.+.+ ..++.++||| +|+++|+|++|..||....
T Consensus 147 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 224 (311)
T 3niz_A 147 PQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVT 224 (311)
T ss_dssp GGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987653322 2234678999999999976 4589999999 9999999999999975432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccc-----------cccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDS-----------KLVGN-----GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~-----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+....+......+.+...... ..... ..+.....+.+++..||+.||++|||+.++++
T Consensus 225 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 225 ----DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp ----TTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ----hHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 33333444443333322111000 00000 01112245778999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=317.21 Aligned_cols=254 Identities=21% Similarity=0.334 Sum_probs=199.8
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
+....++|++.+.||+|+||.||+|++.+ .++..||||.+..... .....
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~ 95 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------------------------ADMQA 95 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------------------------HHHHH
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--------------------------HHHHH
Confidence 45577899999999999999999999753 3568999999964321 12356
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------------------------------CCH
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------------------------------LDW 165 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------------------------------l~~ 165 (345)
.+.+|+.+++.++||||+++++++..++ .++++++++.++++ +++
T Consensus 96 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 173 (343)
T 1luf_A 96 DFQREAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173 (343)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEccCC--ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCH
Confidence 7889999999999999999999988765 68889999987543 556
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc
Q 046907 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 166 ~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~ 245 (345)
..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++................||+.|+|||.+.+
T Consensus 174 ~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 174 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 667789999999999999998 99999999999999999999999999976643322223344678899999999998
Q ss_pred cccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhcc
Q 046907 246 LTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCT 323 (345)
Q Consensus 246 ~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl 323 (345)
..++.++||| +|+++|+|++ |..||.. ....+....+........ +......+.+++..||
T Consensus 251 ~~~~~~~Di~slG~il~el~t~g~~p~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l 313 (343)
T 1luf_A 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYG----MAHEEVIYYVRDGNILAC-------------PENCPLELYNLMRLCW 313 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTT----SCHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHT
T ss_pred CCcCcccccHHHHHHHHHHHhcCCCcCCC----CChHHHHHHHhCCCcCCC-------------CCCCCHHHHHHHHHHc
Confidence 8999999999 9999999999 9999643 233333333322211110 1112234778899999
Q ss_pred CCCCCCCCCHHHHHHHHhhhh
Q 046907 324 LEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 324 ~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
+.||.+|||+.++++.|+++.
T Consensus 314 ~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 314 SKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp CSSGGGSCCHHHHHHHHHHTT
T ss_pred ccCcccCCCHHHHHHHHHHHH
Confidence 999999999999999999885
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=305.90 Aligned_cols=258 Identities=31% Similarity=0.495 Sum_probs=199.9
Q ss_pred ccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 046907 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI 130 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 130 (345)
...+.||+|+||.||+|++ ++..||+|.+........ ....+.+.+|+.+++.+
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITT-----------------------EELKQQFDQEIKVMAKC 87 (307)
T ss_dssp TTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCT-----------------------TTHHHHHHHHHHHHHHC
T ss_pred ccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcch-----------------------HHHHHHHHHHHHHHHhc
Confidence 3348999999999999985 578999999865322110 12256788999999999
Q ss_pred cCCCccceeEEEecCCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 131 RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 131 ~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+||||+++++++..++ ..++++++++++++ +++..+..++.|++.||.|||+.+ ++|+||||+
T Consensus 88 ~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~ 162 (307)
T 2nru_A 88 QHENLVELLGFSSDGD--DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSA 162 (307)
T ss_dssp CCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred CCCCeEEEEEEEecCC--ceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHH
Confidence 9999999999988766 57888899877543 667778899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
||+++.++.+||+|||++................||+.|+|||.+.+ .++.++||| +|+++|+|++|..||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999987654433333445689999999999876 578899999 9999999999999976543332
Q ss_pred chhhHHHHHHHHhhhcCC-CccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 278 NEMSFVKWMRNVMASENP-KRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
........+ ...... ....+. ............+.+++..||+.||.+|||+.++++.|+++.
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 LLLDIKEEI---EDEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BTTHHHHHH---HTTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHh---hhhhhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 222222221 111111 111111 223456677788999999999999999999999999999885
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=321.41 Aligned_cols=261 Identities=20% Similarity=0.307 Sum_probs=187.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++++.||+|+||.||+|+.. .+|+.||||.+...... .....++.+|+.
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~-------------------------~~~~~~~~~E~~ 60 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQN-------------------------STDAQRTFREIM 60 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEET-TTCCEEEEEEECC--CC-------------------------HHHHHHHHHHHH
T ss_pred ccCceEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccC-------------------------hHHHHHHHHHHH
Confidence 3568999999999999999999854 57999999998643222 233566788999
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.+. ||||+++++++..++...++++++++.+. ..++......++.|++.||.|||+.+ ++||||||
T Consensus 61 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp 137 (388)
T 3oz6_A 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKP 137 (388)
T ss_dssp HHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred HHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCH
Confidence 999997 99999999999887767899999999752 34667777889999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCC-------------------cceeccCcccCccccccccccc-cccCccchhh-H
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAH-------------------THITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-F 256 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-l 256 (345)
+|||++.++.+||+|||+++...... ........+||+.|+|||++.+ ..++.++||| +
T Consensus 138 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 217 (388)
T 3oz6_A 138 SNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217 (388)
T ss_dssp GGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred HHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHH
Confidence 99999999999999999998653311 0112244689999999999987 5689999999 9
Q ss_pred HHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcccc--------------------ccccCCCcH-------
Q 046907 257 GALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAID--------------------SKLVGNGCE------- 309 (345)
Q Consensus 257 G~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~------- 309 (345)
|+++|||++|..||.+ .+.......+......+....... ........+
T Consensus 218 G~il~ell~g~~pf~~----~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (388)
T 3oz6_A 218 GCILGEILCGKPIFPG----SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL 293 (388)
T ss_dssp HHHHHHHHHSSCSCCC----SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCC----CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcc
Confidence 9999999999999653 333444444433332221100000 000000000
Q ss_pred ------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 310 ------EQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 310 ------~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.....+.+|+.+||+.||++|||++++++.
T Consensus 294 ~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 123457889999999999999999999763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=306.95 Aligned_cols=253 Identities=21% Similarity=0.313 Sum_probs=198.7
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
....|..+.++|++++.||+|+||.||+|+++ ++..||+|.+...... .+
T Consensus 15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~----------------------------~~ 64 (283)
T 3gen_A 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS----------------------------ED 64 (283)
T ss_dssp -CCTTBCCGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSBC----------------------------HH
T ss_pred CCCCccCCHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCCC----------------------------HH
Confidence 34567778899999999999999999999875 6788999999754322 34
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
.+.+|+.+++.++||||+++++++..++ .++++++++.+++ .+++.....++.|++.||.|||+.+
T Consensus 65 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 140 (283)
T 3gen_A 65 EFIEEAKVMMNLSHEKLVQLYGVCTKQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140 (283)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhcCCCCCEeeEEEEEecCC--CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5778999999999999999999987765 6889999998753 3677788899999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++|+||||+||+++.++.++|+|||++........ .......+|+.|+|||.+.+..++.++||| +|+++|+|++ |
T Consensus 141 -i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp -CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred -ccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999976543221 122335567889999999988999999999 9999999998 9
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||... ........+........+ .. ....+.+++..||+.||++|||+.++++.|+++.
T Consensus 219 ~~p~~~~----~~~~~~~~~~~~~~~~~~----------~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 219 KMPYERF----TNSETAEHIAQGLRLYRP----------HL---ASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCTTTTS----CHHHHHHHHHTTCCCCCC----------TT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccc----ChhHHHHHHhcccCCCCC----------Cc---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 9997542 333333333322211111 01 1234778999999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=322.92 Aligned_cols=246 Identities=15% Similarity=0.224 Sum_probs=194.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|... .+|..+|+|.+.....+ ....+.+.+|+.
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~-------------------------~~~~~~~~~E~~ 62 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLS-------------------------ARDHQKLEREAR 62 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCH-------------------------HHHHHHHHHHHH
T ss_pred ccCCeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCC-------------------------HHHHHHHHHHHH
Confidence 3468999999999999999999854 68999999999765433 223567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.++++ ++......++.|++.||.|||+.+ ++|||||
T Consensus 63 il~~l~hpnIv~l~~~~~~~~--~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlK 137 (444)
T 3soa_A 63 ICRLLKHPNIVRLHDSISEEG--HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLK 137 (444)
T ss_dssp HHHHCCBTTBCCEEEEEECSS--EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCS
T ss_pred HHHhCCCcCCCeEEEEEEECC--EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCC
Confidence 999999999999999998776 78999999988754 566777899999999999999999 9999999
Q ss_pred CCCeeec---CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLD---DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|||++ .++.+||+|||++........ ......||+.|+|||++.+..++.++||| +|+++|+|++|..||..
T Consensus 138 p~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp STTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 9999998 467899999999976654322 22346899999999999998999999999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.......+......... ...+.....+.+++..||+.||++|||+.++++
T Consensus 216 ----~~~~~~~~~i~~~~~~~~~----------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 216 ----EDQHRLYQQIKAGAYDFPS----------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----SSHHHHHHHHHHTCCCCCT----------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----ccHHHHHHHHHhCCCCCCc----------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2333444433332211110 011112234778889999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=311.83 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=190.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|+.. .+++.||+|.+...... ...+.+.+|+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~E~~ 57 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAV--------------------------DCPENIKKEIC 57 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC---------------------------------CHHHHHH
T ss_pred HhhhceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccc--------------------------chHHHHHHHHH
Confidence 3478999999999999999999864 57999999998643211 12355778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ ..++++|++.++++ +++.....++.|++.||.|||+.+ ++|||||
T Consensus 58 ~l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlk 132 (323)
T 3tki_A 58 INKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIK 132 (323)
T ss_dssp HHHHCCCTTBCCEEEEEECSS--EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhCCCCCCCeEEEEEecCC--eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccc
Confidence 999999999999999998776 78899999987543 677788999999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++................||+.|+|||++.+..+ +.++||| +|+++|+|++|..||....
T Consensus 133 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 212 (323)
T 3tki_A 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212 (323)
T ss_dssp GGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSC
T ss_pred hHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999999999999999986643333333345789999999999988775 7789999 9999999999999986432
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. ......+..... ...+ .......+.+++..||+.||++|||+.++++
T Consensus 213 ~~--~~~~~~~~~~~~-~~~~------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 213 DS--CQEYSDWKEKKT-YLNP------------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TT--SHHHHHHHTTCT-TSTT------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hH--HHHHHHHhcccc-cCCc------------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 21 111211111110 0000 1112234678999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.93 Aligned_cols=258 Identities=24% Similarity=0.310 Sum_probs=202.9
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
+..|....++|++.+.||+|+||.||+|++. ..++..||+|.+..... ..
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~ 90 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------------------------SS 90 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------------------
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--------------------------HH
Confidence 4456778899999999999999999999862 23577899999964211 12
Q ss_pred HHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC--------------------------------
Q 046907 116 KMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------------- 162 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------------- 162 (345)
....+.+|+.+++++ +||||+++++++..++ .+++++++++++++
T Consensus 91 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (344)
T 1rjb_A 91 EREALMSELKMMTQLGSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168 (344)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC--ccEEEEecCCCCcHHHHHhhccccccccccchhhhccccccccccc
Confidence 356788999999999 9999999999988766 58889999987543
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccc
Q 046907 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEY 242 (345)
Q Consensus 163 l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~ 242 (345)
+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++................||+.|+|||.
T Consensus 169 l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~ 245 (344)
T 1rjb_A 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 245 (344)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence 466677889999999999999998 99999999999999999999999999987654433333445677889999999
Q ss_pred ccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHh
Q 046907 243 LQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIAC 320 (345)
Q Consensus 243 ~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 320 (345)
+.+..++.++||| +|+++|+|++ |..||..... .......+........+ ......+.+++.
T Consensus 246 ~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~ 309 (344)
T 1rjb_A 246 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV---DANFYKLIQNGFKMDQP-------------FYATEEIYIIMQ 309 (344)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHH
T ss_pred hccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc---HHHHHHHHhcCCCCCCC-------------CCCCHHHHHHHH
Confidence 9988999999999 9999999998 9999754322 22233333222111111 112234788999
Q ss_pred hccCCCCCCCCCHHHHHHHHhhhh
Q 046907 321 FCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 321 ~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||+.||.+|||+.++++.|+.+.
T Consensus 310 ~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 310 SCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHcCCCchhCcCHHHHHHHHHHHH
Confidence 999999999999999999998873
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.55 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=185.6
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCC--ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNG--RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
++....++|++.+.||+|+||.||+|++....+ ..||||.+...... ....+.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~ 71 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-------------------------SSDIEE 71 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------------------------CHHHHH
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-------------------------HHHHHH
Confidence 345567899999999999999999998653222 37999998543211 233677
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcc----eeeeeccccCCCCC---------------CCHHHHHHHHHHHHHHHH
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCH----LLYILNDVSQGRRE---------------LDWLARHRIALGLACGLE 180 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~----~l~~~~~~~~~~~~---------------l~~~~~~~i~~~i~~~l~ 180 (345)
+.+|+.+++.++||||+++++++...+.. ..+++++++.++++ +++..+..++.|++.||.
T Consensus 72 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 151 (323)
T 3qup_A 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151 (323)
T ss_dssp HHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH
Confidence 88999999999999999999998776532 34889999988643 666778899999999999
Q ss_pred HHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHH
Q 046907 181 YLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGAL 259 (345)
Q Consensus 181 ~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~v 259 (345)
|||+.+ ++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||| +|++
T Consensus 152 ~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 228 (323)
T 3qup_A 152 YLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228 (323)
T ss_dssp HHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHH
Confidence 999999 999999999999999999999999999876544332233345678899999999998999999999 9999
Q ss_pred HHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 260 LAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 260 l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+|+|++ |..||... ........+........ .+.....+.+++..||+.||++|||+.++++
T Consensus 229 l~ell~~g~~p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 229 MWEIMTRGQTPYAGI----ENAEIYNYLIGGNRLKQ-------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp HHHHHTTSCCTTTTC----CGGGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCcccc----ChHHHHHHHhcCCCCCC-------------CCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999 89997542 23333333322211111 1122235788999999999999999999999
Q ss_pred HHhhhh
Q 046907 339 MLSQIQ 344 (345)
Q Consensus 339 ~L~~l~ 344 (345)
.|+++.
T Consensus 292 ~l~~~l 297 (323)
T 3qup_A 292 ELENIL 297 (323)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=309.90 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=204.0
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEe----cCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAEL----PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKK 116 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (345)
..|....++|++.+.||+|+||.||+|++ +..++..||+|.+...... ..
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~ 69 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--------------------------TE 69 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--------------------------HH
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--------------------------HH
Confidence 34566778999999999999999999986 3356889999999643211 22
Q ss_pred HHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------------------------CCHHHH
Q 046907 117 MRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------------------------LDWLAR 168 (345)
Q Consensus 117 ~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------------------------l~~~~~ 168 (345)
.+.+.+|+.+++++ +||||+++++++..++ ..+++++++.++++ +++...
T Consensus 70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 70 REALMSELKVLSYLGNHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHhhcccCCCeeeEEEEEecCC--CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 56788999999999 9999999999998766 57888999877433 667778
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc
Q 046907 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL 248 (345)
Q Consensus 169 ~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~ 248 (345)
..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++................||+.|+|||.+.+..+
T Consensus 148 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 899999999999999998 99999999999999999999999999987755443333445677889999999998899
Q ss_pred Cccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCC
Q 046907 249 TEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 249 ~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
+.++||| +|+++|+|++ |..||..... .......+........+ ......+.+++..||+.|
T Consensus 225 ~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~d 288 (313)
T 1t46_A 225 TFESDVWSYGIFLWELFSLGSSPYPGMPV---DSKFYKMIKEGFRMLSP-------------EHAPAEMYDIMKTCWDAD 288 (313)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SHHHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCSS
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCcccc---hhHHHHHhccCCCCCCc-------------ccCCHHHHHHHHHHcCCC
Confidence 9999999 9999999999 9999754322 22232333222111111 112234788899999999
Q ss_pred CCCCCCHHHHHHHHhhhh
Q 046907 327 PNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 327 p~~Rpt~~~ll~~L~~l~ 344 (345)
|.+|||+.++++.|+++.
T Consensus 289 p~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 289 PLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred chhCcCHHHHHHHHHHHH
Confidence 999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.81 Aligned_cols=249 Identities=19% Similarity=0.305 Sum_probs=188.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCce----eEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRM----ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|++.+.||+|+||.||+|++. .++.. ||+|.+.... .......+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~~vaiK~~~~~~--------------------------~~~~~~~~~ 65 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREAT--------------------------SPKANKEIL 65 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEC-C----CCEEEEEEEC---------------------------------CHHHHH
T ss_pred CHHHcccceEEeeCCCeEEEEEEEc-CCCceEEEEEEEeeccccc--------------------------CHHHHHHHH
Confidence 4568999999999999999999864 34444 5888774321 022356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..++ .+++++++.++++ +++..+..++.|++.||.|||+.+ ++
T Consensus 66 ~E~~~l~~l~h~~iv~~~~~~~~~~---~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---iv 139 (327)
T 3poz_A 66 DEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LV 139 (327)
T ss_dssp HHHHHHHHCCBTTBCCEEEEEESSS---EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCEeEEEEEEecCC---eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---ee
Confidence 9999999999999999999998765 5667777776543 566677889999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+|||++.++.+||+|||+++...............||..|+|||.+.+..++.++||| +|+++|||++ |..|
T Consensus 140 H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 9999999999999999999999999877554433333445678899999999999999999999 9999999999 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ........+......+.+ +.....+.+++..||+.||++|||+.++++.|+++.
T Consensus 220 ~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 220 YDGI----PASEISSILEKGERLPQP-------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTTC----CGGGHHHHHHTTCCCCCC-------------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ccCC----CHHHHHHHHHcCCCCCCC-------------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 7542 333343433332211111 112234778899999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=331.26 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=201.8
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|....++|++.+.||+|+||.||+|+++ .++..||||.+...... .+.+.
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~ 264 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTME----------------------------VEEFL 264 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSSSC----------------------------HHHHH
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcccc----------------------------hHHHH
Confidence 46677889999999999999999999975 45889999999653221 45678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|+.++++++||||+++++++..++ .+++++|++.++++ +++.....++.|++.||.|||+.+ +
T Consensus 265 ~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i 339 (495)
T 1opk_A 265 KEAAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339 (495)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhcCCCCEeeEEEEEecCC--cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 8999999999999999999998765 68899999987654 556667789999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
+||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||| ||+++|||++ |..
T Consensus 340 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~ 418 (495)
T 1opk_A 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418 (495)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987644322 122345567899999999988999999999 9999999999 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||... ...+....+........ +..+...+.++|.+||+.||++|||+.+|++.|+.+.
T Consensus 419 p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 419 PYPGI----DLSQVYELLEKDYRMER-------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp SSTTC----CGGGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCC----CHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 97543 23334343332221111 1122345778899999999999999999999999873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.57 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=187.4
Q ss_pred HhhcCCcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..+.++|++.+.||+|+||.||+|++. ..++..||||.+..... ....+.+.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~ 94 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--------------------------EKQRRDFL 94 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--------------------------HHHHHHHH
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--------------------------HHHHHHHH
Confidence 446779999999999999999999864 23577899999964321 12356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.++++++||||+++++++..++ .+++++|++++++ .+++..+..++.|++.||.|||+.+ ++
T Consensus 95 ~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 169 (373)
T 2qol_A 95 GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YV 169 (373)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCCCeEEEEEeeCC--ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 9999999999999999999988765 6888999998754 3667778899999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
||||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||| ||+++|||++ |..
T Consensus 170 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp CSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred CCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876443211 112223457789999999998999999999 9999999998 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
||... ........+......+.+ ......+.+++..||+.||++||++.+|++.|+++
T Consensus 250 P~~~~----~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 250 PYWEM----SNQDVIKAVDEGYRLPPP-------------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp TTTTC----CHHHHHHHHHTTEECCCC-------------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHcCCCCCCC-------------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 96432 333333333322211111 12234578899999999999999999999999887
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=307.11 Aligned_cols=255 Identities=23% Similarity=0.379 Sum_probs=187.9
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
++...++|++.+.||+|+||.||+|+++ ..||+|.+.....+ ....+.+.+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~-------------------------~~~~~~~~~ 69 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPT-------------------------PQQLQAFKN 69 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCC-------------------------HHHHHHHHH
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCC-------------------------HHHHHHHHH
Confidence 3557789999999999999999999853 24999999754433 233567889
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.+++.++||||++++++...+ ..+++++++.+++ .+++..+..++.|++.||.|||+.+ ++|
T Consensus 70 E~~~l~~l~h~~iv~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H 143 (289)
T 3og7_A 70 EVGVLRKTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 143 (289)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSS---SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHhCCCCcEEEEEeeccCC---ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 99999999999999999976443 3778888887643 3667778899999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
|||||+||+++.++.++|+|||++................||+.|+|||.+. +..++.++||| +|+++|+|++|..
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 223 (289)
T 3og7_A 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223 (289)
T ss_dssp SCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCC
Confidence 9999999999999999999999997654322222334567899999999986 55688899999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||.... ........+......+... .........+.+++..||+.||.+|||+.++++.|+++.
T Consensus 224 p~~~~~---~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 224 PYSNIN---NRDQIIEMVGRGSLSPDLS---------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TTSSCC---CHHHHHHHHHHTSCCCCTT---------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Cccccc---hHHHHHHHhcccccCcchh---------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 975432 2233333333222111111 111223345788999999999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.89 Aligned_cols=242 Identities=21% Similarity=0.299 Sum_probs=191.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.+ .+|+.||+|.+..... ........+.+|+.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~~E~~~ 58 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI------------------------IAKDEVAHTVTESRV 58 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHHH
T ss_pred hHHeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHh------------------------hhhhHHHHHHHHHHH
Confidence 468999999999999999999864 5799999999952110 012235667889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ .+++++||+.++.+ ++......++.|++.||.|||+.+ ++||||||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp 133 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKL 133 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCG
T ss_pred HHhCCCCcCcceEEEEEeCC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCH
Confidence 99999999999999998776 78999999998765 566667789999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|+| +|+++|||++|..||..
T Consensus 134 ~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~---- 207 (337)
T 1o6l_A 134 ENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---- 207 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC----
T ss_pred HHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC----
Confidence 999999999999999999975432221 23457899999999999999999999999 99999999999999643
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.+.......+... ... .+. .....+.+++..||+.||++|| ++.++++
T Consensus 208 ~~~~~~~~~i~~~---~~~-------~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 208 QDHERLFELILME---EIR-------FPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSHHHHHHHHHHC---CCC-------CCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHHHHHHcC---CCC-------CCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 2333333322211 110 001 1123467888999999999999 8888875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.99 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=197.4
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
..|..+.++|++.+.||+|+||.||+|++ .|..||||.++... ..+.+
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~~-----------------------------~~~~~ 233 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA-----------------------------TAQAF 233 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSCT-----------------------------TSHHH
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCch-----------------------------HHHHH
Confidence 44667889999999999999999999997 47799999996532 14567
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
.+|+.++++++||||+++++++...+ ..+++++|++.++++ ++......++.|++.||.|||+.+
T Consensus 234 ~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--- 309 (450)
T 1k9a_A 234 LAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 309 (450)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECTT-SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHhccCCCEEEEEEEEEcCC-CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 88999999999999999999887654 258899999988654 456667789999999999999998
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GK 267 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~ 267 (345)
++||||||+|||++.++.+||+|||+++..... .....++..|+|||.+.+..++.++||| ||+++|||++ |.
T Consensus 310 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 384 (450)
T 1k9a_A 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384 (450)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999854322 1223678899999999999999999999 9999999998 99
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||... ...+....+........+ ..+...+.++|..||+.||++|||+.++++.|+.+.
T Consensus 385 ~P~~~~----~~~~~~~~i~~~~~~~~p-------------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 385 VPYPRI----PLKDVVPRVEKGYKMDAP-------------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CSSTTS----CTTTHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC----CHHHHHHHHHcCCCCCCC-------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 997543 223333333322211111 122345778999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=309.71 Aligned_cols=259 Identities=19% Similarity=0.277 Sum_probs=191.4
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
..+..+.++|.+.+.||+|+||.||+|++... ++..||+|.+...... ....+
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~ 81 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-------------------------QREIE 81 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-------------------------HHHHH
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-------------------------hhHHH
Confidence 33466888999999999999999999987533 4668999998643222 23356
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcc---eeeeeccccCCCC---------------CCCHHHHHHHHHHHHHHHH
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCH---LLYILNDVSQGRR---------------ELDWLARHRIALGLACGLE 180 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---~l~~~~~~~~~~~---------------~l~~~~~~~i~~~i~~~l~ 180 (345)
.+.+|+.++++++||||+++++++...+.. ..+++++++.+++ .+++..+..++.|++.||.
T Consensus 82 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 161 (313)
T 3brb_A 82 EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161 (313)
T ss_dssp HHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHH
Confidence 788999999999999999999998876533 4588889887653 3677788899999999999
Q ss_pred HHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHH
Q 046907 181 YLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGAL 259 (345)
Q Consensus 181 ~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~v 259 (345)
|||+.+ ++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||| +|++
T Consensus 162 ~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 238 (313)
T 3brb_A 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238 (313)
T ss_dssp HHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHH
T ss_pred HHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHH
Confidence 999998 999999999999999999999999999866443322223345678899999999998999999999 9999
Q ss_pred HHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 260 LAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 260 l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+|+|++ |..||... ........+........ .......+.+++..||+.||.+|||+.++++
T Consensus 239 l~el~~~g~~p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 239 MWEIATRGMTPYPGV----QNHEMYDYLLHGHRLKQ-------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp HHHHHTTSCCSSTTC----CGGGHHHHHHTTCCCCC-------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCccC----CHHHHHHHHHcCCCCCC-------------CccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999 88996542 23333333322211111 1112235788999999999999999999999
Q ss_pred HHhhhh
Q 046907 339 MLSQIQ 344 (345)
Q Consensus 339 ~L~~l~ 344 (345)
.|+++.
T Consensus 302 ~L~~l~ 307 (313)
T 3brb_A 302 QLEKLL 307 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=310.25 Aligned_cols=241 Identities=20% Similarity=0.240 Sum_probs=192.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .++..||+|.+.... .....+.+|+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~----------------------------~~~~~~~~E~~~ 54 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKG----------------------------TDQVLVKKEISI 54 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCT----------------------------HHHHHHHHHHHH
T ss_pred hhceEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecCc----------------------------ccHHHHHHHHHH
Confidence 468999999999999999999864 579999999986432 123457789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++++...+ .+++++|++++++ .+++.....++.|++.||.|||+.+ ++|||||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlk 129 (321)
T 1tki_A 55 LNIARHRNILHLHESFESME--ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIR 129 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETT--EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHhCCCCCCCeEeEEEecCC--EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 99999999999999998776 7899999998754 3677788899999999999999999 9999999
Q ss_pred CCCeeecC--CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLDD--DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+||+++. ++.+||+|||++........ .....||+.|+|||++.+..++.++||| +|+++|+|++|..||..
T Consensus 130 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~- 205 (321)
T 1tki_A 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA- 205 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-
T ss_pred HHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-
Confidence 99999986 78999999999987654332 2346789999999999998899999999 99999999999999743
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+.... ... +... .+.....+.+++..||+.||.+|||+.++++
T Consensus 206 ---~~~~~~~~~i~~~~---~~~---~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 206 ---ETNQQIIENIMNAE---YTF---DEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---SSHHHHHHHHHHTC---CCC---CHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHcCC---CCC---Chhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23333333332221 110 0000 0112235788999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=317.84 Aligned_cols=265 Identities=15% Similarity=0.195 Sum_probs=205.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|++. .+|+.||||.+...... ...+.+.+|+.+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~E~~~ 60 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFL--------------------------RPVDVQMREFEV 60 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGG--------------------------SCHHHHHHHHHH
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEecccccc--------------------------chHHHHHHHHHH
Confidence 468999999999999999999964 57999999998632211 114556789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++++||||+++++++...+....+++++++.++++ +++.....++.|++.||.|||+.+ ++|||
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 137 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRN 137 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECC
Confidence 999999999999999988776678999999987532 778888999999999999999999 99999
Q ss_pred CCCCCeee----cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc--------cccCccchhh-HHHHHH
Q 046907 195 LNPVNVLL----DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM--------LTLTEKCDIY-FGALLA 261 (345)
Q Consensus 195 lk~~nil~----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~--------~~~~~~~Dvw-lG~vl~ 261 (345)
|||+||++ +.++.+||+|||++....... ......||..|+|||.+.+ ..++.++||| +|+++|
T Consensus 138 lkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~ 214 (396)
T 4eut_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFY 214 (396)
T ss_dssp CCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHH
T ss_pred cCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHH
Confidence 99999999 777789999999998765432 2234679999999999875 4678899999 999999
Q ss_pred HHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcc---------ccc--cccCCCcHHHHHHHHHHHhhccCCCCCCC
Q 046907 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRA---------IDS--KLVGNGCEEQMLLVLKIACFCTLEDPNER 330 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--~~~~~~~~~~~~~l~~li~~Cl~~dp~~R 330 (345)
||++|..||...............+............ ... +............+.+++..||+.||++|
T Consensus 215 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R 294 (396)
T 4eut_A 215 HAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294 (396)
T ss_dssp HHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTS
T ss_pred HHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhh
Confidence 9999999986544433333333322222111111000 000 11123346677888999999999999999
Q ss_pred CCHHHHHHHHhhhh
Q 046907 331 PNSKDVRRMLSQIQ 344 (345)
Q Consensus 331 pt~~~ll~~L~~l~ 344 (345)
||+.++++.++++.
T Consensus 295 ~s~~e~l~~l~~il 308 (396)
T 4eut_A 295 WGFDQFFAETSDIL 308 (396)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHh
Confidence 99999999998763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=305.67 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=193.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .++..||+|.+....... ......+.+|+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~~e~~~ 64 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREK------------------------EETLKRFEREVHN 64 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCC------------------------HHHHHHHHHHHHH
T ss_pred hccEEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCcccc------------------------HHHHHHHHHHHHH
Confidence 468999999999999999999854 578999999986543322 2336678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ .+++++++++++++ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp 139 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKP 139 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred HhcCCCCCCceEEEeeeeCC--eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 99999999999999988766 78999999988654 567777889999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++.++||| +|+++|+|++|..||....
T Consensus 140 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-- 216 (294)
T 4eqm_A 140 QNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-- 216 (294)
T ss_dssp GGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--
T ss_pred HHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 999999999999999999976543321 122346799999999999998999999999 9999999999999975421
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhh
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-NSKDVRRMLSQI 343 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-t~~~ll~~L~~l 343 (345)
.... .........+.. ... ..+.....+.+++.+||+.||.+|| ++.++.+.|+++
T Consensus 217 --~~~~---~~~~~~~~~~~~--~~~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 217 --AVSI---AIKHIQDSVPNV--TTD----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --HHHH---HHHHHSSCCCCH--HHH----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --hHHH---HHHHhhccCCCc--chh----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 1111 111111111110 001 1112234577889999999999999 899999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=311.37 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=191.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCce----eEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRM----ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|++.+.||+|+||.||+|++. .++.. ||+|.+...... .....+.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~kv~~K~~~~~~~~--------------------------~~~~~~~ 63 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWI-PEGESIKIPVCIKVIEDKSGR--------------------------QSFQAVT 63 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEEC-CTTCSCCEEEEEEEECCTTSC--------------------------SCBCSCC
T ss_pred CHhHceeeeeeeecCCceEEEEEEc-CCCceEEEEEEEEeccccccH--------------------------HHHHHHH
Confidence 4578999999999999999999975 34554 778877533211 1123456
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..+ ..+++++++.++++ +++..+..++.|++.||.|||+.+ ++
T Consensus 64 ~e~~~l~~l~h~~iv~~~~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 137 (325)
T 3kex_A 64 DHMLAIGSLDHAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MV 137 (325)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECBS---SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHhcCCCCCcCeEEEEEcCC---ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CC
Confidence 789999999999999999988644 47788899887654 455567789999999999999999 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+|||++.++.+||+|||++................||..|+|||.+.+..++.++||| +|+++|+|++ |..|
T Consensus 138 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp CSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 9999999999999999999999999877554433333456788899999999988999999999 9999999999 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ........+........+.. . ...+.+++..||+.||.+|||+.++++.|+++.
T Consensus 218 ~~~~----~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 218 YAGL----RLAEVPDLLEKGERLAQPQI-C------------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TTTS----CTTHHHHHHHTTCBCCCCTT-B------------CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred cccc----CHHHHHHHHHcCCCCCCCCc-C------------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 7542 33334344433222111111 1 112678899999999999999999999998874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=313.23 Aligned_cols=244 Identities=18% Similarity=0.293 Sum_probs=193.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.+ .+|..||+|.+.....+ ....+.+.+|+.+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~-------------------------~~~~~~~~~E~~i 81 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLS-------------------------ARDFQKLEREARI 81 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCC-------------------------HHHHHHHHHHHHH
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCC-------------------------HHHHHHHHHHHHH
Confidence 458999999999999999999864 57999999999754332 2235678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ ..+++++++.++.+ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp 156 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKP 156 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSG
T ss_pred HHhCCCCCCCeEEEEEEeCC--EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCch
Confidence 99999999999999998776 78899999988654 567788899999999999999999 99999999
Q ss_pred CCeeecCC---CCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDD---IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+|||++.+ +.+||+|||++....... ......||+.|+|||++.+..++.++||| +|+++|+|++|..||..
T Consensus 157 ~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~- 232 (362)
T 2bdw_A 157 ENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD- 232 (362)
T ss_dssp GGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred HHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-
Confidence 99999864 459999999998765432 22346899999999999998999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.......+....... +.. ........+.+++..||+.||++|||+.++++
T Consensus 233 ---~~~~~~~~~i~~~~~~~-~~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 233 ---EDQHRLYAQIKAGAYDY-PSP---------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ---SSHHHHHHHHHHTCCCC-CTT---------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CCHHHHHHHHHhCCCCC-Ccc---------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23333333333222111 100 01112234778999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.84 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=179.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.+ .+|..||+|.+...... .....+.+|+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~E~~ 55 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEE--------------------------GTPSTAIREIS 55 (317)
T ss_dssp ----------------CEEEEEECS-SSCCEEEEEEEECCSTT--------------------------CSCHHHHHHHH
T ss_pred cccceeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeeccccc--------------------------ccHHHHHHHHH
Confidence 4579999999999999999999854 57999999999654311 11345678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR--------------RELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+++.++||||+++++++..++ .+++++|++++. ..++...+..++.|++.||.|||+.+ ++
T Consensus 56 ~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---iv 130 (317)
T 2pmi_A 56 LMKELKHENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---IL 130 (317)
T ss_dssp HHTTCCBTTBCCEEEEECCTT--EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHhcCCCCcceEEEEEEECC--eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 999999999999999998776 688999999752 23666777889999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+. .++.++||| +|+++|||++|..|
T Consensus 131 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 208 (317)
T 2pmi_A 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPL 208 (317)
T ss_dssp CCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987643221 22346789999999999764 589999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccc--------cccc------------cCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAI--------DSKL------------VGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~------------~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
|.. .+.......+......+...... .+.. ...........+.+++.+||+.||++
T Consensus 209 f~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 284 (317)
T 2pmi_A 209 FPG----TNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284 (317)
T ss_dssp CCC----SSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGG
T ss_pred CCC----CChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCccc
Confidence 653 33344444444433222111000 0000 00000112345788999999999999
Q ss_pred CCCHHHHHH
Q 046907 330 RPNSKDVRR 338 (345)
Q Consensus 330 Rpt~~~ll~ 338 (345)
|||+.++++
T Consensus 285 Rpt~~e~l~ 293 (317)
T 2pmi_A 285 RLSAKQALH 293 (317)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhC
Confidence 999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.37 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=193.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+|+.||||.+...... .....++.+|+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~-------------------------~~~~~~~~~E~~ 113 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQN-------------------------QTHAKRAYRELV 113 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGS-------------------------HHHHHHHHHHHH
T ss_pred ecCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccC-------------------------hHHHHHHHHHHH
Confidence 3578999999999999999999854 57999999999643211 233567889999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGR------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+. ..+++++|+++++ ..+++..+..++.|++.||.|||+.+ ++||||
T Consensus 114 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDl 190 (464)
T 3ttj_A 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 190 (464)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 9999999999999999876542 4679999999874 23677888899999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+|||++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||| +|+++|||++|..||.+
T Consensus 191 kp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g-- 265 (464)
T 3ttj_A 191 KPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-- 265 (464)
T ss_dssp CGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred ChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC--
Confidence 9999999999999999999998664432 23457899999999999999999999999 99999999999999754
Q ss_pred cccchhhHHHHHHHHhhhcCCCc-------------------------cccccccCCC---cHHHHHHHHHHHhhccCCC
Q 046907 275 QHTNEMSFVKWMRNVMASENPKR-------------------------AIDSKLVGNG---CEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~---~~~~~~~l~~li~~Cl~~d 326 (345)
.+..+....+....+.+.+.. .+.....+.. .......+.+|+.+||+.|
T Consensus 266 --~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 343 (464)
T 3ttj_A 266 --RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343 (464)
T ss_dssp --SSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred --CCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCC
Confidence 333333333333322221100 0000000000 1112456889999999999
Q ss_pred CCCCCCHHHHHH
Q 046907 327 PNERPNSKDVRR 338 (345)
Q Consensus 327 p~~Rpt~~~ll~ 338 (345)
|++|||++|+++
T Consensus 344 P~~R~ta~e~L~ 355 (464)
T 3ttj_A 344 PAKRISVDDALQ 355 (464)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=304.69 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=188.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+. .+|+.||+|.+.....+. .....+.+|+.++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~-------------------------~~~~~~~~E~~~l 54 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDE-------------------------GIPSTTIREISIL 54 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGG-------------------------CCCHHHHHHHHGG
T ss_pred ccchhhhhcccCCCEEEEEEEc--CCCCEEEEEEEecccccc-------------------------ccchhHHHHHHHH
Confidence 5899999999999999999986 478999999996543221 1134567899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ .++++++++.+ ...++......++.|++.||.|||+.+ ++||||||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 129 (288)
T 1ob3_A 55 KELKHSNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQ 129 (288)
T ss_dssp GGCCCTTBCCEEEEEECSS--CEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred HhcCCCCEeeeeeEEccCC--eEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999999999999998776 68888888865 234677888899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.+||+|||++........ ......||+.|+|||.+.+. .++.++||| +|+++|+|++|..||...
T Consensus 130 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--- 204 (288)
T 1ob3_A 130 NLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV--- 204 (288)
T ss_dssp GEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS---
T ss_pred HEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---
Confidence 99999999999999999976543221 22345789999999999764 489999999 999999999999997542
Q ss_pred cchhhHHHHHHHHhhhcCCCcc--------ccccc-------cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRA--------IDSKL-------VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~-------~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+......+..... .++.. ...........+.+++.+||+.||++|||+.++++
T Consensus 205 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 205 -SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp -SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 333333333332222111100 00000 00011122345778999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=314.87 Aligned_cols=272 Identities=16% Similarity=0.190 Sum_probs=197.7
Q ss_pred hhcCCcccccccccCcceeeEEEEecCC----CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQ----NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
...++|++.+.||+|+||.||+|+++.. .++.||||.+........ .+ .+.........+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~e-------------~~~~~~~~~~~~ 95 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF---TE-------------LKFYQRAAKPEQ 95 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHH---HH-------------HHHHHHHCCHHH
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHH---HH-------------HHHHHhhhhhHH
Confidence 3567999999999999999999987532 368899999865432110 00 011112223456
Q ss_pred HHHHHHHhhccCCCccceeEEEecCC--cceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPD--CHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~--~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
..|+..++.++||||+++++++.... ...++++++++ ++ ..+++..+..++.|++.||.|||+.+
T Consensus 96 ~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~-- 172 (364)
T 3op5_A 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE-- 172 (364)
T ss_dssp HHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 67888899999999999999887642 35688999998 53 34778888999999999999999998
Q ss_pred CeEecCCCCCCeeec--CCCCeEEeccccceecCCCCcce-----eccCcccCccccccccccccccCccchhh-HHHHH
Q 046907 189 RIIHRDLNPVNVLLD--DDIEARISGFGFARAIPDAHTHI-----TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260 (345)
Q Consensus 189 ~iiH~dlk~~nil~~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl 260 (345)
++||||||+|||++ .++.+||+|||+++......... ......||+.|+|||.+.+..++.++||| ||+++
T Consensus 173 -iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 251 (364)
T 3op5_A 173 -YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM 251 (364)
T ss_dssp -EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHH
Confidence 99999999999999 88999999999998764322111 11345699999999999999999999999 99999
Q ss_pred HHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 261 AGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 261 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
|||++|..||..... .............. ......+..+..... ...+.+++..||+.||++||++.+|++.|
T Consensus 252 ~el~~g~~Pf~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 252 IQWLTGHLPWEDNLK---DPKYVRDSKIRYRE-NIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp HHHHHSCCTTGGGTT---CHHHHHHHHHHHHH-CHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHhCCCCcccccc---CHHHHHHHHHHhhh-hHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 999999999864322 12222222211111 111111111111111 23477888889999999999999999999
Q ss_pred hhh
Q 046907 341 SQI 343 (345)
Q Consensus 341 ~~l 343 (345)
+++
T Consensus 325 ~~~ 327 (364)
T 3op5_A 325 LQG 327 (364)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=300.25 Aligned_cols=249 Identities=23% Similarity=0.295 Sum_probs=196.1
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+.++|++.+.||+|+||.||+|++ ++..||+|.+.....+ ....+.+.+|+
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~-------------------------~~~~~~~~~E~ 58 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWS-------------------------TRKSRDFNEEC 58 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCC-------------------------HHHHHHHHHHG
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccC-------------------------HHHHHHHHHHH
Confidence 3567999999999999999999997 4889999999764333 22356788999
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.+++.++||||+++++++..++...+++++++++++++ +++..+..++.|++.||.|||+.+ ++++||
T Consensus 59 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~ 137 (271)
T 3kmu_A 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRH 137 (271)
T ss_dssp GGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTC
T ss_pred HHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecC
Confidence 99999999999999999988755678999999987543 678888999999999999999975 359999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc---cchhh-HHHHHHHHHhCCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE---KCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~---~~Dvw-lG~vl~el~tg~~p 269 (345)
||||+||+++.++.++++|||++..... ....||+.|+|||.+.+..++. ++||| +|+++|||++|..|
T Consensus 138 dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 210 (271)
T 3kmu_A 138 ALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210 (271)
T ss_dssp CCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCT
T ss_pred CCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999887654322 2357899999999998766544 79999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhhC
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~~ 345 (345)
|... ........+.. ..... . .+......+.+++..||+.||++|||+.++++.|+++.+
T Consensus 211 ~~~~----~~~~~~~~~~~---~~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 211 FADL----SNMEIGMKVAL---EGLRP-----T----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TTTS----CHHHHHHHHHH---SCCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cccc----ChHHHHHHHHh---cCCCC-----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 7542 22222111111 11110 0 111122347788899999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=305.34 Aligned_cols=261 Identities=17% Similarity=0.266 Sum_probs=198.1
Q ss_pred hcCCcccccccccCcceeeEEEEe---cCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAEL---PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
....|++.+.||+|+||.||+|++ +..+++.||+|.+..... ......+.+
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~~ 72 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--------------------------GNHIADLKK 72 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------------------------CCHHHHHH
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--------------------------chhHHHHHH
Confidence 345799999999999999999985 335789999999964321 112466788
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.+++.++||||+++++++..++...+++++++++++++ +++..+..++.|++.||.|||+.+ ++|
T Consensus 73 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H 149 (302)
T 4e5w_A 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVH 149 (302)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---ccc
Confidence 9999999999999999999988766678999999988654 566667789999999999999999 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
+||||+||+++.++.++|+|||++......... .......||..|+|||.+.+..++.++||| +|+++|+|++|..|+
T Consensus 150 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 150 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999877544322 223446788899999999998899999999 999999999999985
Q ss_pred ccccc--------ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 271 DKFFQ--------HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 271 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
..... .................... ..++.....+.+++..||+.||.+|||+.++++.|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 230 SSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp GSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhhHHhhccCCcccccCHHHHHHHHhccCCC----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 43211 01111111112111111111 1111223457889999999999999999999999998
Q ss_pred hhC
Q 046907 343 IQH 345 (345)
Q Consensus 343 l~~ 345 (345)
+.+
T Consensus 300 ll~ 302 (302)
T 4e5w_A 300 LLK 302 (302)
T ss_dssp HHC
T ss_pred HhC
Confidence 753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=324.83 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=194.9
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
...|....++|++.+.||+|+||.||+|+++ .+..||||.+...... .+.
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~----------------------------~~~ 225 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS----------------------------PEA 225 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC----------------------------HHH
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCCCC----------------------------HHH
Confidence 3457778899999999999999999999985 4567999999754321 345
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+.+|+.++++++||||+++++++..+ .++++++++.++++ +++.....++.|++.||.|||+.+
T Consensus 226 ~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-- 300 (452)
T 1fmk_A 226 FLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300 (452)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcCC---ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 78899999999999999999988653 47899999988654 556667789999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++||||||+|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||| ||+++|||++ |
T Consensus 301 -ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 378 (452)
T 1fmk_A 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378 (452)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred -eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCC
Confidence 999999999999999999999999999876433211 12334568899999999988999999999 9999999999 9
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||... ...+....+......+. ++.+...+.++|..||+.||++|||+.+|++.|+++.
T Consensus 379 ~~P~~~~----~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 379 RVPYPGM----VNREVLDQVERGYRMPC-------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCSSTTC----CHHHHHHHHHTTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCC----CHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 9996542 33333333332221111 1122345778999999999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.53 Aligned_cols=260 Identities=22% Similarity=0.320 Sum_probs=204.3
Q ss_pred hhhhHHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHH
Q 046907 39 KDLAFLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114 (345)
Q Consensus 39 ~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (345)
....|....++|++.+.||+|+||.||+|++. ..+++.||||.+..... .
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~ 71 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------------------------H 71 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------------------------H
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--------------------------c
Confidence 34456678889999999999999999999853 24678999999965321 1
Q ss_pred HHHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHH
Q 046907 115 KKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLAR 168 (345)
Q Consensus 115 ~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~ 168 (345)
.....+.+|+.++.++ +||||+++++++..++ ..++++++++.++++ +++..+
T Consensus 72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (316)
T 2xir_A 72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150 (316)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHH
T ss_pred HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHH
Confidence 2356788999999999 7999999999987655 357888899887433 566778
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc
Q 046907 169 HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL 248 (345)
Q Consensus 169 ~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~ 248 (345)
..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++................||+.|+|||.+.+..+
T Consensus 151 ~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 889999999999999998 99999999999999999999999999987654433334445678899999999999899
Q ss_pred Cccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCC
Q 046907 249 TEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 249 ~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
+.++||| +|+++|+|++ |..||..... .......+........+ ......+.+++..||+.|
T Consensus 228 ~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~d 291 (316)
T 2xir_A 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCRRLKEGTRMRAP-------------DYTTPEMYQTMLDCWHGE 291 (316)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCC---SHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSS
T ss_pred cchhHHHHHHHHHHHHHhCCCCCCcccch---hHHHHHHhccCccCCCC-------------CCCCHHHHHHHHHHcCCC
Confidence 9999999 9999999998 9999754321 22233333222111111 011234778899999999
Q ss_pred CCCCCCHHHHHHHHhhhh
Q 046907 327 PNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 327 p~~Rpt~~~ll~~L~~l~ 344 (345)
|.+|||+.++++.|+++.
T Consensus 292 p~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 292 PSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999999873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.76 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=182.2
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++++.||+|+||.||+|+.. .+++.||||.+...... ...+.+|
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~~~E 66 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGAAI----------------------------DENVQRE 66 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESSTTS----------------------------CHHHHHH
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCccc----------------------------cHHHHHH
Confidence 346789999999999999999999864 57999999999653221 2346689
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.+++.++||||+++++++..++ .++++++|+.++++ ++......++.|++.||.|||+.+ ++|||
T Consensus 67 ~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~D 141 (361)
T 3uc3_A 67 IINHRSLRHPNIVRFKEVILTPT--HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRD 141 (361)
T ss_dssp HHHHHHCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCC
T ss_pred HHHHHhCCCCCCCcEEEEEeeCC--EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 99999999999999999998776 68999999988654 566677889999999999999999 99999
Q ss_pred CCCCCeeecCCCC--eEEeccccceecCCCCcceeccCcccCccccccccccccccCcc-chhh-HHHHHHHHHhCCCCC
Q 046907 195 LNPVNVLLDDDIE--ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK-CDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 195 lk~~nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~-~Dvw-lG~vl~el~tg~~p~ 270 (345)
|||+||+++.++. +||+|||+++...... ......||+.|+|||++.+..++.+ +||| +|+++|+|++|..||
T Consensus 142 lkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf 218 (361)
T 3uc3_A 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218 (361)
T ss_dssp CCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCC
Confidence 9999999987665 9999999987432221 2234679999999999988887655 8999 999999999999998
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........ ....+........... .. ......+.+++.+||+.||++|||+.++++
T Consensus 219 ~~~~~~~~---~~~~~~~~~~~~~~~~-~~--------~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 219 EDPEEPRD---YRKTIQRILSVKYSIP-DD--------IRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp C----CCC---HHHHHHHHHTTCCCCC-TT--------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCccHHH---HHHHHHHHhcCCCCCC-Cc--------CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 65433222 2233333222111100 00 011234678999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=311.63 Aligned_cols=249 Identities=21% Similarity=0.261 Sum_probs=194.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++++.||+|+||.||+|+.+ .+|..||+|.+.......... ....+.+.+|+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~---------------------~~~~~~~~~E~~ 67 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRR---------------------GVCREEIEREVS 67 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSS---------------------SBCHHHHHHHHH
T ss_pred hhhceEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccc---------------------hhHHHHHHHHHH
Confidence 3468999999999999999999864 579999999997543321100 001456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.++++ +++.....++.|++.||.|||+.+ ++|||||
T Consensus 68 il~~l~hpnIv~l~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlk 142 (361)
T 2yab_A 68 ILRQVLHPNIITLHDVYENRT--DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLK 142 (361)
T ss_dssp HHTTCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred HHHhCCCcCCCcEEEEEEeCC--EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 999999999999999998766 78999999987654 567778899999999999999998 9999999
Q ss_pred CCCeeecCCC----CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 197 PVNVLLDDDI----EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 197 ~~nil~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||| +|+++|+|++|..||.
T Consensus 143 p~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp GGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred HHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999998776 79999999998765432 23456899999999999998999999999 9999999999999964
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. .........+..... . +++... +.....+.+++..||+.||.+|||+.++++
T Consensus 220 ~----~~~~~~~~~i~~~~~---~---~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 220 G----DTKQETLANITAVSY---D---FDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C----SSHHHHHHHHHTTCC---C---CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C----CCHHHHHHHHHhcCC---C---CCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3 233333333322111 0 011100 111234778999999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=309.13 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=190.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.+ .+|+.||||.+........ .....+.+.+|+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~~E~~~ 79 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSS----------------------PGLSTEDLKREASI 79 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTS----------------------SSCCHHHHHHHHHH
T ss_pred ccceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccc----------------------ccchHHHHHHHHHH
Confidence 357999999999999999999864 5799999999842110000 00024568899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
++.++||||+++++++..++ .+++++|++.++++ +++.....++.|++.||.|||+.+ ++||
T Consensus 80 l~~l~hpnIv~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHr 154 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDG--MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHR 154 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETT--EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCCCCCcEEEEEEeCC--EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 99999999999999998776 78999999998654 566677789999999999999998 9999
Q ss_pred CCCCCCeeecCCCC---eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 194 DLNPVNVLLDDDIE---ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 194 dlk~~nil~~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
||||+|||++.++. +||+|||++........ ......||+.|+|||++.+..++.++||| +|+++|+|++|..|
T Consensus 155 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp CCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 99999999986544 99999999987654322 23446899999999999998999999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|... . ......+.... .. ..+... +.....+.+++..||+.||++|||+.++++
T Consensus 233 f~~~----~-~~~~~~i~~~~---~~---~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 233 FYGT----K-ERLFEGIIKGK---YK---MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SCSS----H-HHHHHHHHHTC---CC---CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCc----H-HHHHHHHHcCC---CC---CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 7541 1 22222222111 10 000000 111235778999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.01 Aligned_cols=262 Identities=18% Similarity=0.253 Sum_probs=202.3
Q ss_pred HhhcCCcccccccccCcceeeEEEEe---cCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAEL---PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
..+.++|++.+.||+|+||.||+|++ +..++..||||.+.... ....+.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~ 71 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---------------------------PDQQRDF 71 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---------------------------HHHHHHH
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---------------------------HHHHHHH
Confidence 34677999999999999999999986 34578999999996542 2234668
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
.+|+.+++.++||||+++++++..++...+++++++++++++ +++..+..++.|++.||.|||+.+ +
T Consensus 72 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i 148 (327)
T 3lxl_A 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---C 148 (327)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 899999999999999999999987776789999999987654 566777889999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
+|+||||+||+++.++.+||+|||++......... .......||..|+|||.+.+..++.++||| +|+++|+|++|..
T Consensus 149 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp ECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999876543322 223345688899999999998899999999 9999999999999
Q ss_pred CCccccccc-------chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 269 PSDKFFQHT-------NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 269 p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
||....... ........+......... ..........+.+++..||+.||.+|||+.++++.|+
T Consensus 229 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 229 KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp GGGSHHHHHHHHCC----CCHHHHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCccccchhhhhcccccccccHHHHHHHhhcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 964322100 000001111111111110 0111223345788899999999999999999999999
Q ss_pred hhh
Q 046907 342 QIQ 344 (345)
Q Consensus 342 ~l~ 344 (345)
.+.
T Consensus 300 ~~~ 302 (327)
T 3lxl_A 300 MLW 302 (327)
T ss_dssp HC-
T ss_pred HHH
Confidence 874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.44 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=184.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+.||+|+||.||+|++ ++..||||.+....... .....+.+.+|+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~~e~~ 58 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDED-----------------------ISQTIENVRQEAK 58 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC---------------------------------CHHHHHHHHH
T ss_pred chhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCccc-----------------------HHHHHHHHHHHHH
Confidence 567999999999999999999986 58899999986432111 0223567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++ .++++++++.++. .+++.....++.|++.||.|||+.+..+++||||||
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp 136 (271)
T 3dtc_A 59 LFAMLKHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136 (271)
T ss_dssp HHHHCCCTTBCCEEEEECCC----CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG
T ss_pred HHHhcCCCCEeeEEEEEecCC--ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch
Confidence 999999999999999988766 6788999997753 467778889999999999999999744488999999
Q ss_pred CCeeecC--------CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 198 VNVLLDD--------DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 198 ~nil~~~--------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
+||+++. ++.++|+|||++....... .....||+.|+|||.+.+..++.++||| +|+++|+|++|..
T Consensus 137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (271)
T 3dtc_A 137 SNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212 (271)
T ss_dssp GGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCC
T ss_pred HHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999985 6789999999997654332 1245789999999999998899999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
||... ........+.. .... . .........+.+++.+||+.||.+|||+.++++.|++|
T Consensus 213 p~~~~----~~~~~~~~~~~---~~~~-~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 213 PFRGI----DGLAVAYGVAM---NKLA-L--------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TTTTS----CHHHHHHHHHT---SCCC-C--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCC----CHHHHHHhhhc---CCCC-C--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 97542 22222111111 1110 0 01112234578899999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=303.87 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=187.4
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
++....++|++.+.||+|+||.||+|++.. ..+..||+|.+..... ....+.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~ 62 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------------------------DSVREK 62 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------------------------HHHHHH
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--------------------------HHHHHH
Confidence 345567899999999999999999998753 2356799999864321 123567
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+.+|+.+++.++||||+++++++..+ ..+++++++.+++ .+++.....++.|++.||.|||+.+
T Consensus 63 ~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 136 (281)
T 1mp8_A 63 FLQEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--- 136 (281)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSS---SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhCCCCccceEEEEEccC---ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 88999999999999999999987543 4778899998754 3667778889999999999999998
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GK 267 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~ 267 (345)
++||||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||| +|+++|||++ |.
T Consensus 137 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 215 (281)
T 1mp8_A 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215 (281)
T ss_dssp CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC
Confidence 999999999999999999999999999876443221 22334567899999999988999999999 9999999997 99
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||... ...+....+......+. .+.....+.+++..||+.||++|||+.++++.|+++.
T Consensus 216 ~pf~~~----~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 216 KPFQGV----KNNDVIGRIENGERLPM-------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CTTTTC----CGGGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcC----CHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 997543 22333333332211111 1122234778899999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=311.13 Aligned_cols=244 Identities=24% Similarity=0.317 Sum_probs=187.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++++.||+|+||.||+|+.+ .+|+.||+|.+.... .........+..|.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~------------------------~~~~~~~~~~~~E~ 74 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDV------------------------ILQDDDVECTMTEK 74 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHH------------------------HHHHTTHHHHHHHH
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHH------------------------hcchhHHHHHHHHH
Confidence 35679999999999999999999865 579999999995211 01123356678899
Q ss_pred HHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.+++.+ +||||+++++++..++ .+++++||+.++++ +++..+..++.|++.||.|||+.+ ++|||
T Consensus 75 ~il~~~~~hp~Iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 149 (353)
T 3txo_A 75 RILSLARNHPFLTQLFCCFQTPD--RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRD 149 (353)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHHhccCCCceeeEEEEEEeCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccC
Confidence 999988 7999999999998776 78999999998754 566677789999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++||| +|+++|||++|..||..
T Consensus 150 lkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~- 226 (353)
T 3txo_A 150 LKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA- 226 (353)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred CCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-
Confidence 99999999999999999999997543221 133457899999999999998999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS------KDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~------~~ll~ 338 (345)
.+..+....+... ... ++ . .....+.+++..||+.||.+||++ .++++
T Consensus 227 ---~~~~~~~~~i~~~---~~~---~p-----~---~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 227 ---ENEDDLFEAILND---EVV---YP-----T---WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---SSHHHHHHHHHHC---CCC---CC-----T---TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCHHHHHHHHHcC---CCC---CC-----C---CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 2333333333221 111 00 0 112347788899999999999998 66654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=298.30 Aligned_cols=253 Identities=24% Similarity=0.447 Sum_probs=192.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++. .+++.||+|.+........... ....+.+.+|+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~--------------------~~~~~~~~~E~~ 75 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEM--------------------IEKFQEFQREVF 75 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHH--------------------HCCSHHHHHHHH
T ss_pred hhccceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhH--------------------HHHHHHHHHHHH
Confidence 5679999999999999999999864 5799999999865443221100 111367889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++..+. +++++++.+++ .+++.....++.|++.||.|||+.+ .+++||||
T Consensus 76 ~l~~l~h~~i~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~di 150 (287)
T 4f0f_A 76 IMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDL 150 (287)
T ss_dssp HHTTCCCTTBCCEEEEETTTT----EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCC
T ss_pred HHHhCCCCCchhhheeecCCC----eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCC
Confidence 999999999999999986654 47888887654 3677788899999999999999986 34999999
Q ss_pred CCCCeeecCCCC-----eEEeccccceecCCCCcceeccCcccCcccccccccc--ccccCccchhh-HHHHHHHHHhCC
Q 046907 196 NPVNVLLDDDIE-----ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ--MLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 196 k~~nil~~~~~~-----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~--~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
||+||+++.++. +||+|||++...... .....||+.|+|||.+. ...++.++||| +|+++|+|++|.
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999987766 999999999754332 23467899999999994 44578899999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.||..... ........+.... .. . .........+.+++..||+.||++|||+.++++.|++|
T Consensus 226 ~pf~~~~~--~~~~~~~~~~~~~---~~-~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 226 GPFDEYSY--GKIKFINMIREEG---LR-P--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CTTTTCCC--CHHHHHHHHHHSC---CC-C--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCccccc--cHHHHHHHHhccC---CC-C--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 99864322 1112222222111 11 0 01112234578899999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=315.68 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=187.5
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++++.||+|+||.||+|+.+ .+++.||+|.+....... ......+..|.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~------------------------~~~~~~~~~E~ 103 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVND------------------------DEDIDWVQTEK 103 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----------------------------CCHHHHHH
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccC------------------------HHHHHHHHHHH
Confidence 35678999999999999999999965 579999999996432211 12245567889
Q ss_pred HHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.++.++ +||||+++++++..++ .+++++||+.++.+ +++..+..++.|++.||.|||+.+ |+|||
T Consensus 104 ~il~~~~~hp~Iv~l~~~~~~~~--~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 178 (396)
T 4dc2_A 104 HVFEQASNHPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRD 178 (396)
T ss_dssp HHHHHHTTCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHHhcCCCCCcCeeEEEEEECC--EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecc
Confidence 999887 8999999999998776 78999999998754 566677789999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++||| +|+++|||++|..||...
T Consensus 179 LKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 179 LKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999997532221 234557899999999999999999999999 999999999999998542
Q ss_pred ccccch-hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 274 FQHTNE-MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 274 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
...... ......+.......... .+ ......+.+++..||+.||.+||++
T Consensus 257 ~~~~~~~~~~~~~~~~~i~~~~~~------~p----~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 257 GSSDNPDQNTEDYLFQVILEKQIR------IP----RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp TC------CCHHHHHHHHHHCCCC------CC----TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccccccchhhHHHHHHHHhccccC------CC----CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 211110 11111111111111110 00 1112347788999999999999996
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.68 Aligned_cols=256 Identities=16% Similarity=0.287 Sum_probs=201.3
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
..+|....++|++.+.||+|+||.||+|++.+ .++..||+|.+..... ..
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--------------------------~~ 70 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--------------------------MR 70 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--------------------------HH
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--------------------------HH
Confidence 44667788899999999999999999998652 3578899999864321 12
Q ss_pred HHHHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC-------------------CHHHHHHHHHHHH
Q 046907 116 KMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-------------------DWLARHRIALGLA 176 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l-------------------~~~~~~~i~~~i~ 176 (345)
....+.+|+.+++.++||||+++++++..++ ..+++++++.++++. ++..+..++.|++
T Consensus 71 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 148 (322)
T 1p4o_A 71 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148 (322)
T ss_dssp HHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeEEEEccCC--ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHH
Confidence 3456889999999999999999999987765 678899999886543 4556677999999
Q ss_pred HHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-
Q 046907 177 CGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY- 255 (345)
Q Consensus 177 ~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw- 255 (345)
.||.|||+.+ ++||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++|||
T Consensus 149 ~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 225 (322)
T 1p4o_A 149 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 225 (322)
T ss_dssp HHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHH
Confidence 9999999999 999999999999999999999999999865443322233445678899999999988899999999
Q ss_pred HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 256 FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 256 lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
+|+++|+|++ |..||... ...+....+........ .......+.+++..||+.||.+|||+.
T Consensus 226 lG~il~el~~~g~~p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ 288 (322)
T 1p4o_A 226 FGVVLWEIATLAEQPYQGL----SNEQVLRFVMEGGLLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFL 288 (322)
T ss_dssp HHHHHHHHHHTSCCTTTTS----CHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHhcCCCccccC----CHHHHHHHHHcCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 9999999999 89996432 23333333322111110 112223477889999999999999999
Q ss_pred HHHHHHhhh
Q 046907 335 DVRRMLSQI 343 (345)
Q Consensus 335 ~ll~~L~~l 343 (345)
++++.|+++
T Consensus 289 e~l~~L~~~ 297 (322)
T 1p4o_A 289 EIISSIKEE 297 (322)
T ss_dssp HHHHHHGGG
T ss_pred HHHHHHHHh
Confidence 999999886
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=300.96 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=198.2
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|..+.++|++.+.||+|+||.||+|++. ++..||+|.+...... .+.+.+
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~----------------------------~~~~~~ 52 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS----------------------------EEDFIE 52 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTBC----------------------------HHHHHH
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCCC----------------------------HHHHHH
Confidence 4567789999999999999999999975 6788999999754322 245778
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.+++.++||||+++++++..++ .+++++++++++++ +++.....++.|++.||.|||+.+ ++|
T Consensus 53 e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H 127 (267)
T 3t9t_A 53 EAEVMMKLSHPKLVQLYGVCLEQA--PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127 (267)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSS--SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHhCCCCCEeeEEEEEccCC--CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 999999999999999999988765 58889999987543 567777889999999999999999 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||| +|+++|+|++ |..||
T Consensus 128 ~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp SSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCC
Confidence 99999999999999999999999976543211 122335677889999999988899999999 9999999999 89996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.. .........+........+ ......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 207 ~~----~~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 207 EN----RSNSEVVEDISTGFRLYKP-------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp TT----CCHHHHHHHHHTTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----CCHHHHHHHHhcCCcCCCC-------------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 43 2333333333222111111 111234778899999999999999999999999885
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=310.73 Aligned_cols=253 Identities=16% Similarity=0.190 Sum_probs=195.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+|+.||||.+..... ...+.+|+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-----------------------------~~~~~~E~~ 56 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKSR-----------------------------APQLHLEYR 56 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTCS-----------------------------SCCHHHHHH
T ss_pred EcCCeEEEEEeeccCCceEEEEEEC-CCCcEEEEEEeccccc-----------------------------hHHHHHHHH
Confidence 3578999999999999999999853 5799999999864321 234668999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.+ +||||+++++++..++ ..+++++++.+ +..+++..+..++.|++.||.|||+.+ ++||||
T Consensus 57 ~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDl 131 (330)
T 2izr_A 57 FYKQLGSGDGIPQVYYFGPCGK--YNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDV 131 (330)
T ss_dssp HHHHHCSCTTSCCEEEEEEETT--EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHHhhCCCCCCEEEEEEecCC--ccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 99999 9999999999988866 78899999932 234677788899999999999999998 999999
Q ss_pred CCCCeeecCCCC-----eEEeccccceecCCCCcce-----eccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 196 NPVNVLLDDDIE-----ARISGFGFARAIPDAHTHI-----TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 196 k~~nil~~~~~~-----~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
||+|||++.++. +||+|||++.......... ......||+.|+|||.+.+..++.++||| +|+++|||+
T Consensus 132 kp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 211 (330)
T 2izr_A 132 KPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL 211 (330)
T ss_dssp CGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHh
Confidence 999999998876 9999999998765432211 12457899999999999999999999999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
+|..||...... ........+......... . ......+ .+.+++..||+.||.+||++.+|++.|+++.
T Consensus 212 ~g~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~-~-----~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 212 RGSLPWQGLKAD-TLKERYQKIGDTKRATPI-E-----VLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HSSCTTTTCCCS-SHHHHHHHHHHHHHHSCH-H-----HHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCCCccccccc-cHHHHHHHHHhhhccCCH-H-----HHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 999998654322 222222222222111110 0 0011122 5888999999999999999999999998763
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=310.45 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=198.0
Q ss_pred CcccccccccCcceeeEEEEec---CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 49 GLASLEKIGSGGCGEVYKAELP---GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.|++++.||+|+||.||+|+++ ..+++.||||.+..... ......+.+|+.
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~~E~~ 85 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--------------------------PQHRSGWKQEID 85 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--------------------------HHHHHHHHHHHH
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--------------------------hHHHHHHHHHHH
Confidence 4599999999999999998764 23688999999965321 123567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++...+...+++++++++++++ +++.....++.|++.||.|||+.+ ++|+||||
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp 162 (318)
T 3lxp_A 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAA 162 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred HHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCch
Confidence 9999999999999999998776789999999987643 677788899999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.+||+|||++......... .......||..|+|||.+.+..++.++||| +|+++|+|++|..||.....
T Consensus 163 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 163 RNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp GGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred heEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch
Confidence 9999999999999999999877554322 123345688899999999998899999999 99999999999999753221
Q ss_pred c--------cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 276 H--------TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 276 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
. ................... .........+.+++..||+.||++|||+.++++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGERL----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhcccccchhHHHHHHHHhcccCC----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0 0011111111111111110 111222345788999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.30 Aligned_cols=249 Identities=19% Similarity=0.303 Sum_probs=186.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCce----eEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRM----ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..++|++++.||+|+||.||+|++. .++.. ||+|.+...... .....+.
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~kv~iK~~~~~~~~--------------------------~~~~~~~ 65 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATSP--------------------------KANKEIL 65 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEEC-CTTCSCCEEEEEEEECCCSSC--------------------------CCHHHHH
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEc-CCCceEEEEEEEEeeccccCH--------------------------HHHHHHH
Confidence 5679999999999999999999865 34554 477776532211 1245678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..++ .+++++++.++++ ++......++.|++.||.|||+.+ ++
T Consensus 66 ~E~~~l~~l~hp~iv~~~~~~~~~~---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 139 (327)
T 3lzb_A 66 DEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LV 139 (327)
T ss_dssp HHHHHHTTCCBTTBCCCCEEEESSS---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCeeEEEEEEecCC---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---Cc
Confidence 8999999999999999999998765 5666777766543 566677889999999999999999 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+||+++.++.+||+|||++................||..|+|||.+.+..++.++||| +|+++|+|++ |..|
T Consensus 140 H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 219 (327)
T 3lzb_A 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999876544333333445678899999999999999999999 9999999999 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ........+......+.+ +.....+.+++..||+.||.+|||+.++++.|+++.
T Consensus 220 ~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 220 YDGI----PASEISSILEKGERLPQP-------------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTTC----CGGGHHHHHHTTCCCCCC-------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHcCCCCCCC-------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 7543 333344433332211111 112234778999999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=299.29 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=197.8
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+|....++|++.+.||+|+||.||+|+++ ++..||+|.+...... .+.+.
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~----------------------------~~~~~ 56 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS----------------------------PDAFL 56 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC----------------------------HHHHH
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCccc----------------------------HHHHH
Confidence 56677889999999999999999999864 6778999999654322 34577
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|+.+++.++||||+++++++..+ ..+++++++.++++ +++.....++.|++.||.|||+.+ +
T Consensus 57 ~E~~~l~~l~h~~i~~~~~~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 130 (279)
T 1qpc_A 57 AEANLMKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130 (279)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSS---SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhCCCcCcceEEEEEcCC---CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 899999999999999999988644 37889999977543 566777899999999999999999 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
+|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||| +|+++|+|++ |..
T Consensus 131 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 209 (279)
T 1qpc_A 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (279)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred eccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543221 22345667899999999988899999999 9999999999 899
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||... ...+....+........ .......+.+++..||+.||++|||+.++++.|+++.
T Consensus 210 p~~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 210 PYPGM----TNPEVIQNLERGYRMVR-------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp SSTTC----CHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccc----CHHHHHHHHhcccCCCC-------------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 96532 22333333322211110 1112235778889999999999999999999999873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=309.61 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=188.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+.+.||+|+||.||+|++. .+++.||+|.+...... .......+.+|+.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~~E~~ 61 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLK------------------------KSDMHMRVEREIS 61 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHH------------------------HTTCSHHHHHHHH
T ss_pred ccCCEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHcc------------------------chhHHHHHHHHHH
Confidence 3478999999999999999999964 57999999998521100 0112456789999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR--------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++ .+++++|++.+. ..+++.....++.|++.||.|||+.+ ++||||||
T Consensus 62 ~l~~l~hpnIv~l~~~~~~~~--~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp 136 (336)
T 3h4j_B 62 YLKLLRHPHIIKLYDVITTPT--DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKP 136 (336)
T ss_dssp HHTTCCCTTBCCEEEEEECSS--EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCST
T ss_pred HHHhCCCCCCCeEEEEEEeCC--EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCch
Confidence 999999999999999998876 688999999432 23567778899999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.+||+|||++....... ......||+.|+|||.+.+..+ +.++||| +|+++|+|++|..||.....
T Consensus 137 ~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 137 ENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp TTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred hhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 99999999999999999998654432 2244689999999999998776 6899999 99999999999999864322
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..- ........ ...+......+.+++..||+.||.+|||+.++++
T Consensus 214 ~~~----------------~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 214 PNL----------------FKKVNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp TTC----------------BCCCCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHH----------------HHHHHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 110 00000000 0011112234678999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=306.93 Aligned_cols=242 Identities=22% Similarity=0.360 Sum_probs=186.6
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+++ .+|+.||||.+...... ...+.+.+|+.++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~E~~~l 58 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRE--------------------------LAREKVMREVKAL 58 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTT--------------------------THHHHHHHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCch--------------------------hHHHHHHHHHHHH
Confidence 57999999999999999999964 57999999999643211 1256688999999
Q ss_pred hhccCCCccceeEEEecCCc-------------------------------------------------------ceeee
Q 046907 128 GQIRHRNLHPLLAHVTRPDC-------------------------------------------------------HLLYI 152 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~-------------------------------------------------------~~l~~ 152 (345)
++++||||+++++++...+. ..+++
T Consensus 59 ~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 138 (332)
T 3qd2_B 59 AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYI 138 (332)
T ss_dssp TSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEE
T ss_pred HhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEE
Confidence 99999999999998865432 24789
Q ss_pred eccccCCCCCCCHH------------HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 046907 153 LNDVSQGRRELDWL------------ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220 (345)
Q Consensus 153 ~~~~~~~~~~l~~~------------~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~ 220 (345)
+++++.++++.++. .+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 139 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 215 (332)
T 3qd2_B 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215 (332)
T ss_dssp EEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccc
Confidence 99999987654333 36789999999999999998 9999999999999999999999999998775
Q ss_pred CCCcc----------eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHH
Q 046907 221 DAHTH----------ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNV 289 (345)
Q Consensus 221 ~~~~~----------~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 289 (345)
..... .......||+.|+|||.+.+..++.++||| +|+++|||++|..|+.. ....+...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---------~~~~~~~~ 286 (332)
T 3qd2_B 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---------RVRIITDV 286 (332)
T ss_dssp CC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---------HHHHHHHH
T ss_pred cchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---------HHHHHHHh
Confidence 43211 122346799999999999998999999999 99999999998877311 11111111
Q ss_pred hhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 290 MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.....+ .........+.+++..||+.||++|||+.++++
T Consensus 287 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 287 RNLKFP----------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HTTCCC----------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hccCCC----------cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 111111 111233345788999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.63 Aligned_cols=265 Identities=19% Similarity=0.279 Sum_probs=194.4
Q ss_pred hhhHHhhcCCcccccccccC--cceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSG--GCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G--~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
+.++..+.++|++++.||+| +||.||+|+.+ .+|+.||||.+.....+ ....
T Consensus 17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~ 70 (389)
T 3gni_B 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACS-------------------------NEMV 70 (389)
T ss_dssp -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSC-------------------------HHHH
T ss_pred hhcccCCCCcEEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccC-------------------------hHHH
Confidence 33455588899999999999 99999999964 57999999999643211 2335
Q ss_pred HHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcC
Q 046907 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHH 186 (345)
Q Consensus 118 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~ 186 (345)
..+.+|+.+++.++||||+++++++..++ .++++++++.++++ ++...+..++.|++.||.|||+.+
T Consensus 71 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 148 (389)
T 3gni_B 71 TFLQGELHVSKLFNHPNIVPYRATFIADN--ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG 148 (389)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCCcEeEEEEECC--EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 67888999999999999999999998876 78999999987543 566777899999999999999999
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCc-----ceeccCcccCccccccccccc--cccCccchhh-HHH
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT-----HITTSNVVGTVEYIAPEYLQM--LTLTEKCDIY-FGA 258 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~~~aPE~~~~--~~~~~~~Dvw-lG~ 258 (345)
++||||||+|||++.++.+||+|||.+........ ........||+.|+|||++.+ ..++.++||| +|+
T Consensus 149 ---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 225 (389)
T 3gni_B 149 ---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225 (389)
T ss_dssp ---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHH
T ss_pred ---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHH
Confidence 99999999999999999999999998865432211 111233578999999999987 5689999999 999
Q ss_pred HHHHHHhCCCCCcccccccchhhHHHHHHHHhhhc----C-CCcc-----------------c---c-----c-cccCCC
Q 046907 259 LLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASE----N-PKRA-----------------I---D-----S-KLVGNG 307 (345)
Q Consensus 259 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~-----------------~---~-----~-~~~~~~ 307 (345)
++|||++|..||....... .....+....... . +... . . . ......
T Consensus 226 il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (389)
T 3gni_B 226 TACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302 (389)
T ss_dssp HHHHHHHSSCTTTTCCSTT---HHHHC-----------------------------------------------------
T ss_pred HHHHHHHCCCCCCCCCHHH---HHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcc
Confidence 9999999999986432211 1111111000000 0 0000 0 0 0 000011
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 308 CEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 308 ~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+.+++.+||+.||++|||+.++++
T Consensus 303 ~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1223456888999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=310.87 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=191.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.+ .+++.||+|.+..... ........+.+|+.
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~------------------------~~~~~~~~~~~E~~ 67 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKC------------------------VERNEVRNVFKELQ 67 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHH
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhc------------------------ccHHHHHHHHHHHH
Confidence 4578999999999999999999864 5799999999852110 01223567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.++++ ++...+..++.|++.||.|||+.+ ++|||||
T Consensus 68 il~~l~hp~Iv~l~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlk 142 (384)
T 4fr4_A 68 IMQGLEHPFLVNLWYSFQDEE--DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMK 142 (384)
T ss_dssp HHHTCCCTTBCCEEEEEECSS--EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred HHHhCCCCCCCcEEEEEEeCC--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCc
Confidence 999999999999999998776 68999999988643 677778899999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc---cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM---LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~---~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||| +|+++|||++|..||..
T Consensus 143 p~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 143 PDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 999999999999999999998765432 2345789999999999974 4588999999 99999999999999754
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-SKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-~~~ll~ 338 (345)
.... . .............. .+......+.+++..||+.||.+||+ +.++++
T Consensus 220 ~~~~-~---~~~~~~~~~~~~~~-----------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 220 RSST-S---SKEIVHTFETTVVT-----------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CTTS-C---HHHHHHHHHHCCCC-----------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCc-c---HHHHHHHHhhcccC-----------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 3221 1 22222222111111 01112234788899999999999998 666653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=297.51 Aligned_cols=244 Identities=18% Similarity=0.283 Sum_probs=193.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.+ .+|..||+|.+.....+ ......+.+|+.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~e~~~ 58 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLS-------------------------ARDFQKLEREARI 58 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCC-------------------------HHHHHHHHHHHHH
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCC-------------------------HHHHHHHHHHHHH
Confidence 478999999999999999999864 57999999998643222 2235678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++++||||+++++++..++ ..+++++++.++.+ ++......++.|++.||.|||+.+ ++||||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp 133 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEES--FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKP 133 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred HHHcCCCCcCeEEEEEEcCC--EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCH
Confidence 99999999999999998766 68899999988765 677778899999999999999999 99999999
Q ss_pred CCeeecCCCC---eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDDIE---ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+++.++. +||+|||++........ .....||+.|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 134 ~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~- 209 (284)
T 3kk8_A 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD- 209 (284)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred HHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-
Confidence 9999986554 99999999987654322 2346789999999999999999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+......... .........+.+++..||+.||++|||+.++++
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 210 ---EDQHRLYAQIKAGAYDYPS----------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---SSHHHHHHHHHHTCCCCCT----------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhHHHHHHHhccccCCc----------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2333333333222111110 001112234778899999999999999999976
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=307.23 Aligned_cols=245 Identities=20% Similarity=0.361 Sum_probs=181.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|... ++..||||.+.....+ ......+.+|+.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~~ 59 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEAD-------------------------NQTLDSYRNEIA 59 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCC-------------------------HHHHHHHHHHHH
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccc-------------------------hHHHHHHHHHHH
Confidence 5678999999999999999999863 6899999998654322 233567889999
Q ss_pred HHhhccC--CCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRH--RNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~h--pniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++| |||+++++++..++ .+++++++..+ ...+++..+..++.|++.||.|||+.+ ++||||
T Consensus 60 ~l~~l~~~~~~iv~~~~~~~~~~--~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDi 134 (343)
T 3dbq_A 60 YLNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDL 134 (343)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSS--EEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHHhhhhcCCceEEEeeeEeeCC--EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 9999976 99999999998776 68888885432 234677788899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----------cccCccchhh-HHHHHHHH
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----------LTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----------~~~~~~~Dvw-lG~vl~el 263 (345)
||+|||++ ++.+||+|||++................||+.|+|||++.+ ..++.++||| +|+++|+|
T Consensus 135 kp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el 213 (343)
T 3dbq_A 135 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213 (343)
T ss_dssp CGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred CcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence 99999997 56899999999987654333223345689999999999965 5688899999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++|..||..... . ...+.......... .. +... ...+.+++..||+.||.+|||+.++++
T Consensus 214 l~g~~pf~~~~~---~---~~~~~~~~~~~~~~-~~-----~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 214 TYGKTPFQQIIN---Q---ISKLHAIIDPNHEI-EF-----PDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHSSCTTTTCCS---H---HHHHHHHHCTTSCC-CC-----CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCcchhhhh---H---HHHHHHHhcCCccc-CC-----cccC---CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 999999754222 1 11111111111110 00 0111 234778889999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=306.52 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=200.8
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCC----CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQ----NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
.|....++|++.+.||+|+||.||+|++... .+..||+|.+..... ....
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~ 93 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--------------------------ADEK 93 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--------------------------HHHH
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--------------------------hHHH
Confidence 4667788999999999999999999986532 134799999965421 1235
Q ss_pred HHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-----------------------CCHHHHHHHHH
Q 046907 118 RQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------------------LDWLARHRIAL 173 (345)
Q Consensus 118 ~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------------------l~~~~~~~i~~ 173 (345)
..+.+|+.+++.+ +||||+++++++..++ .+++++++++++++ +++.....++.
T Consensus 94 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (333)
T 2i1m_A 94 EALMSELKIMSHLGQHENIVNLLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171 (333)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEecCC--ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHH
Confidence 6788999999999 8999999999988766 58889999987544 35556678999
Q ss_pred HHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccch
Q 046907 174 GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCD 253 (345)
Q Consensus 174 ~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~D 253 (345)
|++.||.|||+.+ ++||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++|
T Consensus 172 qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 248 (333)
T 2i1m_A 172 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248 (333)
T ss_dssp HHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHH
Confidence 9999999999998 9999999999999999999999999998664433333334566788999999999889999999
Q ss_pred hh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 254 IY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 254 vw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
|| +|+++|+|++ |..||..... .......+........+ ......+.+++..||+.||.+||
T Consensus 249 i~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rp 312 (333)
T 2i1m_A 249 VWSYGILLWEIFSLGLNPYPGILV---NSKFYKLVKDGYQMAQP-------------AFAPKNIYSIMQACWALEPTHRP 312 (333)
T ss_dssp HHHHHHHHHHHTTTSCCSSTTCCS---SHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHcCCCCCCcccch---hHHHHHHHhcCCCCCCC-------------CCCCHHHHHHHHHHhccChhhCc
Confidence 99 9999999998 9999754322 22222222222111111 11123477899999999999999
Q ss_pred CHHHHHHHHhhhh
Q 046907 332 NSKDVRRMLSQIQ 344 (345)
Q Consensus 332 t~~~ll~~L~~l~ 344 (345)
|+.++++.|+++.
T Consensus 313 s~~~l~~~L~~~~ 325 (333)
T 2i1m_A 313 TFQQICSFLQEQA 325 (333)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=301.63 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=201.5
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|....++|++.+.||+|+||.||+|+++ .++..||+|.+..... ..+.+.
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~----------------------------~~~~~~ 57 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM----------------------------EVEEFL 57 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSCST----------------------------HHHHHH
T ss_pred cccccccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcCHH----------------------------HHHHHH
Confidence 34557889999999999999999999975 4689999999965322 245678
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|+.+++.++||||+++++++..++ .++++++++.++++ +++..+..++.|++.||.|||+.+ +
T Consensus 58 ~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 132 (288)
T 3kfa_A 58 KEAAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 132 (288)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSS--SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---C
T ss_pred HHHHHHHhCCCCCEeeEEEEEccCC--CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---c
Confidence 8999999999999999999987765 58889999986533 667777899999999999999999 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
+|+||||+||+++.++.++|+|||++........ .......+|+.|+|||.+.+..++.++||| +|+++|+|++ |..
T Consensus 133 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~ 211 (288)
T 3kfa_A 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211 (288)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999986654332 223445678899999999988999999999 9999999999 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||... ........+........+ ......+.+++..||+.||.+|||+.++++.|+++.
T Consensus 212 p~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 212 PYPGI----DLSQVYELLEKDYRMERP-------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp SSTTC----CGGGHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHhccCCCCCC-------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 96542 333343333332211111 112235788899999999999999999999998873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.94 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=191.0
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|+..+.||+|+||.||+|+.. .+|+.||||.+...... ..+.+.+|+.+++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~---------------------------~~~~~~~E~~~l~ 97 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQ---------------------------RRELLFNEVVIMR 97 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCC---------------------------SHHHHHHHHHHHT
T ss_pred hhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchh---------------------------HHHHHHHHHHHHH
Confidence 3777889999999999999864 57999999998643211 1455778999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
.++||||+++++++...+ .+++++|++.++. .+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 98 ~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI 172 (321)
T 2c30_A 98 DYQHFNVVEMYKSYLVGE--ELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSI 172 (321)
T ss_dssp TCCCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred hCCCCCcceEEEEEEECC--EEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHE
Confidence 999999999999998876 6889999998864 3677888899999999999999998 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccch
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~ 279 (345)
+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||... ..
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~----~~ 246 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD----SP 246 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS----CH
T ss_pred EECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CH
Confidence 999999999999999987654322 22456899999999999998999999999 999999999999997432 22
Q ss_pred hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+.. ...+... ........+.+++..||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~---~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 247 VQAMKRLRD---SPPPKLK--------NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHHHH---SSCCCCT--------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhc---CCCCCcC--------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 233332222 1111100 01112234778899999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=306.76 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=187.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.+ .+++.||+|.+....... ......+.+|..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~------------------------~~~~~~~~~E~~ 61 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVND------------------------DEDIDWVQTEKH 61 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCS------------------------HHHHHHHHHHHH
T ss_pred chhheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcc------------------------hHHHHHHHHHHH
Confidence 3468999999999999999999964 579999999996432211 223566778999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++++ +||||+++++++..++ .++++++++.++.+ ++...+..++.|++.||.|||+.+ ++||||
T Consensus 62 ~l~~~~~hp~iv~l~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 136 (345)
T 3a8x_A 62 VFEQASNHPFLVGLHSCFQTES--RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDL 136 (345)
T ss_dssp HHHHTTTCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHHhcCCCCccCeEEEEEEeCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 99887 8999999999998776 78999999988754 566667789999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|+| +|+++|||++|..||....
T Consensus 137 kp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 137 KLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp CGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred CHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 9999999999999999999997543222 123457899999999999999999999999 9999999999999985422
Q ss_pred cccch-hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 275 QHTNE-MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 275 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
..... ......+.......... .+ ......+.+++..||+.||.+||++
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~~~~------~p----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVILEKQIR------IP----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C-------CHHHHHHHHHHCCCC------CC----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cccccccccHHHHHHHHHcCCCC------CC----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11110 01111111111111110 01 1112347788899999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=317.94 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=180.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.+ .+++.||||.+.....+ .....++.+|+.+
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~-------------------------~~~~~~~~~E~~~ 105 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFED-------------------------LIDCKRILREIAI 105 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-C--CEEEEEEECSTTSS-------------------------HHHHHHHHHHHHH
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcC-------------------------HHHHHHHHHHHHH
Confidence 468999999999999999999854 57999999999653322 2235678899999
Q ss_pred HhhccCCCccceeEEEecCC---cceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPD---CHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~---~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++.++||||+++++++...+ ...++++++++.+ ...++...+..++.|++.||.|||+.+ |+||||
T Consensus 106 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDl 182 (458)
T 3rp9_A 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDL 182 (458)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCC
Confidence 99999999999999986543 2468899998864 234788888999999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcc-------------------------eeccCcccCccccccccc-cccccC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTH-------------------------ITTSNVVGTVEYIAPEYL-QMLTLT 249 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~~~aPE~~-~~~~~~ 249 (345)
||+|||++.++.+||+|||+++........ ......+||+.|+|||++ .+..++
T Consensus 183 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 262 (458)
T 3rp9_A 183 KPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262 (458)
T ss_dssp CGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCC
T ss_pred ChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCC
Confidence 999999999999999999999876432110 123456889999999986 455699
Q ss_pred ccchhh-HHHHHHHHHh-----------CCCCCccccc----------------ccchhhHHHHHHHHhhhcCCCcc---
Q 046907 250 EKCDIY-FGALLAGLVM-----------GKLPSDKFFQ----------------HTNEMSFVKWMRNVMASENPKRA--- 298 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~t-----------g~~p~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~--- 298 (345)
.++||| +||++|||++ |.++|.+... .....+....+....+.+.....
T Consensus 263 ~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~ 342 (458)
T 3rp9_A 263 EAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342 (458)
T ss_dssp THHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTS
T ss_pred cHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhc
Confidence 999999 9999999999 5555433110 01112233333333322211000
Q ss_pred -----------cc---ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 299 -----------ID---SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 299 -----------~~---~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+. ........+.....+.+|+.+||+.||++|||++|+++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 343 EKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp SCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000111222445778999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.99 Aligned_cols=253 Identities=16% Similarity=0.172 Sum_probs=196.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+|+.||||.+..... ...+.+|+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-----------------------------~~~~~~e~~ 57 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD-----------------------------APQLRDEYR 57 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT-----------------------------SCCHHHHHH
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCCc-----------------------------cHHHHHHHH
Confidence 3568999999999999999999853 5799999999854321 234567899
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++.+ +|+|++++++++...+ ..+++++++ ++ ..+++..+..++.|++.||.|||+.+ ++|||
T Consensus 58 ~~~~l~~~~~i~~~~~~~~~~~--~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 131 (298)
T 1csn_A 58 TYKLLAGCTGIPNVYYFGQEGL--HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 131 (298)
T ss_dssp HHHHTTTCTTCCCEEEEEEETT--EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHHHhcCCCCCeEEeecCCCc--eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 99999 8999999999987665 688899998 43 24677788899999999999999998 99999
Q ss_pred CCCCCeeecCCCC-----eEEeccccceecCCCCcc-----eeccCcccCccccccccccccccCccchhh-HHHHHHHH
Q 046907 195 LNPVNVLLDDDIE-----ARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 195 lk~~nil~~~~~~-----~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el 263 (345)
|||+||+++.++. +||+|||++......... .......||+.|+|||.+.+..++.++||| +|+++|||
T Consensus 132 lkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 211 (298)
T 1csn_A 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 211 (298)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 9999999987765 999999999877543221 123456799999999999998999999999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
++|..||.......... ....+........... .. ......+.+++..||+.||++|||+.+|++.|+++
T Consensus 212 ~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 212 LRGSLPWQGLKAATNKQ-KYERIGEKKQSTPLRE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHSSCTTSSCCSCCHHH-HHHHHHHHHHHSCHHH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HcCCCCcchhhccccHH-HHHHHHhhccCccHHH-----HH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 99999986643322222 2222222221111100 00 11223577889999999999999999999999987
Q ss_pred h
Q 046907 344 Q 344 (345)
Q Consensus 344 ~ 344 (345)
.
T Consensus 282 ~ 282 (298)
T 1csn_A 282 L 282 (298)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=300.79 Aligned_cols=256 Identities=18% Similarity=0.242 Sum_probs=196.6
Q ss_pred hhHHhhcCCccccc-ccccCcceeeEEEEec-CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLE-KIGSGGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 41 ~~~~~~~~~~~~~~-~iG~G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
.++..+.++|++.+ .||+|+||.||+|.+. ..++..||||.+.....+ ....+
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~ 63 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------------------------PALKD 63 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------------------------CHHHH
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-------------------------HHHHH
Confidence 34455778999999 9999999999999653 345789999999643211 22356
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
.+.+|+.+++.++||||+++++++..+ ..+++++++.++++ ++......++.|++.||.|||+.+
T Consensus 64 ~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--- 137 (291)
T 1xbb_A 64 ELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--- 137 (291)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEESS---SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEECCC---CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 788999999999999999999998433 47889999987543 667778899999999999999998
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcce-eccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++|+||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++||| +|+++|+|++ |
T Consensus 138 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 217 (291)
T 1xbb_A 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 217 (291)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999998765433221 22234567889999999988899999999 9999999999 9
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||... ........+....... .+......+.+++..||+.||++|||+.++++.|+++.
T Consensus 218 ~~p~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 218 QKPYRGM----KGSEVTAMLEKGERMG-------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp CCSSTTC----CHHHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCC----CHHHHHHHHHcCCCCC-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9996542 3333333333221111 11122335788999999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=310.02 Aligned_cols=242 Identities=19% Similarity=0.244 Sum_probs=192.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.+ .+|+.||+|.+..... .....+.+|+.+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~---------------------------~~~~~~~~E~~i 101 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYP---------------------------LDKYTVKNEISI 101 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSH---------------------------HHHHHHHHHHHH
T ss_pred ccceEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccch---------------------------hhHHHHHHHHHH
Confidence 468999999999999999999864 5799999999865421 123467789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++++..++ .+++++|++.+++ .+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 102 l~~l~hpnIv~~~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlk 176 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIK 176 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSS--EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHhCCCcCCCeEEEEEEeCC--EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccc
Confidence 99999999999999998765 7899999998754 3677788899999999999999998 9999999
Q ss_pred CCCeeecC--CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLDD--DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+|||++. .+.+||+|||++........ .....||+.|+|||++.+..++.++||| +|+++|+|++|..||..
T Consensus 177 p~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~- 252 (387)
T 1kob_A 177 PENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG- 252 (387)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-
T ss_pred hHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-
Confidence 99999974 56899999999987654332 2235789999999999998999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.......+....... +. .........+.+++..||+.||++|||+.++++
T Consensus 253 ---~~~~~~~~~i~~~~~~~------~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 253 ---EDDLETLQNVKRCDWEF------DE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ---SSHHHHHHHHHHCCCCC------CS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---CCHHHHHHHHHhCCCCC------Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 23333333332221110 00 111122335788999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=304.05 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=190.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|++ +++.||||.+.... ...+..|..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~------------------------------~~~~~~e~~ 81 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE------------------------------EASWFRETE 81 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG------------------------------HHHHHHHHH
T ss_pred cccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc------------------------------cchhhhHHH
Confidence 346899999999999999999986 48899999985321 122334445
Q ss_pred HHhh--ccCCCccceeEEEecCCc--ceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhc--------
Q 046907 126 TVGQ--IRHRNLHPLLAHVTRPDC--HLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMH-------- 185 (345)
Q Consensus 126 ~l~~--l~hpniv~l~~~~~~~~~--~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~-------- 185 (345)
++.. ++||||+++++++..... ..++++++++.++++ +++.....++.|++.||.|||+.
T Consensus 82 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 161 (337)
T 3mdy_A 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161 (337)
T ss_dssp HHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred HHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 5444 599999999999887643 478999999998765 56667788999999999999998
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccccccCcc------chhh-H
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLTLTEK------CDIY-F 256 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~~~~~------~Dvw-l 256 (345)
+ ++||||||+||+++.++.+||+|||++......... .......||+.|+|||.+.+...+.. +||| +
T Consensus 162 ~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 162 A---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp C---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred C---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 7 999999999999999999999999999766443221 12235689999999999987766554 9999 9
Q ss_pred HHHHHHHHhC----------CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCC
Q 046907 257 GALLAGLVMG----------KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 257 G~vl~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
|+++|||++| ..||............. .............+... ...++...+.+++.+||+.|
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~d 312 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM---REIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHN 312 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH---HHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCCchhhh---HHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhC
Confidence 9999999999 66665443322222221 11111111111111111 12356677899999999999
Q ss_pred CCCCCCHHHHHHHHhhhh
Q 046907 327 PNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 327 p~~Rpt~~~ll~~L~~l~ 344 (345)
|.+|||+.++++.|+++.
T Consensus 313 P~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 313 PASRLTALRVKKTLAKMS 330 (337)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHH
Confidence 999999999999999884
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=300.77 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=186.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+|..||+|.+....... ......+.+|+.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~~E~~ 84 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMD------------------------AKARADCIKEID 84 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCC------------------------HHHHHHHHHHHH
T ss_pred cccceEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccC------------------------HHHHHHHHHHHH
Confidence 5568999999999999999999864 578999999996532211 223567888999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+++.++||||+++++++..++ .++++++++.++++ ++......++.|++.||.|||+.+ ++|
T Consensus 85 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H 159 (310)
T 2wqm_A 85 LLKQLNHPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMH 159 (310)
T ss_dssp HHHTCCCTTBCCEEEEEEETT--EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHhCCCCCEeeEEEEEEcCC--cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeC
Confidence 999999999999999998776 68899999987543 556667789999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
+||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+..++.++||| +|+++|+|++|..||.
T Consensus 160 ~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp CCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999876543221 22345789999999999998999999999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
... .........+... ..+. .... .....+.+++..||+.||++|||+.++++.|+++.
T Consensus 238 ~~~--~~~~~~~~~~~~~---~~~~------~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 238 GDK--MNLYSLCKKIEQC---DYPP------LPSD---HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp -----CCHHHHHHHHHTT---CSCC------CCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccc--hhHHHHHHHhhcc---cCCC------Cccc---ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 321 1222222222211 1110 0001 11234778889999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=313.94 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=192.2
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++++.||+|+||.||+|+++ .+++.||+|.+..... ........+.+|
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~------------------------~~~~~~~~~~~E 124 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEM------------------------LKRAETACFREE 124 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHH------------------------HHTTTTCCHHHH
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHh------------------------hhHHHHHHHHHH
Confidence 446789999999999999999999965 5789999999952100 001123347789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
..++..++||||+++++++..++ .+++++||+.++++ +++.....++.|++.||.|||+.+ ++||
T Consensus 125 ~~il~~~~hp~Iv~l~~~~~~~~--~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHr 199 (437)
T 4aw2_A 125 RDVLVNGDSKWITTLHYAFQDDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHR 199 (437)
T ss_dssp HHHHHHSCTTTBCCEEEEEECSS--EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHHHhCCCCCEEEEEEEEeeCC--EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEec
Confidence 99999999999999999998776 78999999987643 566677889999999999999999 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
||||+|||++.++.+||+|||+++........ .....+||+.|+|||++. ...++.++||| +|+++|||++|.
T Consensus 200 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred ccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 99999999999999999999999876543322 234468999999999997 45689999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHh-hhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVM-ASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE--RPNSKDVRR 338 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--Rpt~~~ll~ 338 (345)
.||.. .+..+....+.... ....+.. .......+.++|..||+.+|++ ||+++++++
T Consensus 279 ~Pf~~----~~~~~~~~~i~~~~~~~~~p~~----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 279 TPFYA----ESLVETYGKIMNHKERFQFPTQ----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CTTCC----SSHHHHHHHHHTHHHHCCCCSS----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCCCC----CChhHHHHhhhhccccccCCcc----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 99743 23333333332221 1111110 0111234678888899888888 999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=306.16 Aligned_cols=240 Identities=26% Similarity=0.387 Sum_probs=188.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.+.|+.++.||+|+||.||+|+.. .+|..||||.+....... ....+.+.+|+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~~E~~~ 107 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS------------------------NEKWQDIIKEVRF 107 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCH------------------------HHHHHHHHHHHHH
T ss_pred hhheeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccc------------------------hHHHHHHHHHHHH
Confidence 346999999999999999999853 579999999986543221 2335678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ ..+++++++.++ ..+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 108 l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 182 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKA 182 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSG
T ss_pred HHhCCCCCEeeEEEEEEECC--eEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCH
Confidence 99999999999999998776 788999998752 34677788899999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+++.++.+||+|||++...... ....||+.|+|||++. +..++.++||| +|+++|||++|..||...
T Consensus 183 ~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 183 GNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp GGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999765432 3467999999999985 45688999999 999999999999996432
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.......+ .....+. ...... ...+.+++..||+.||++|||+.++++
T Consensus 257 ----~~~~~~~~~---~~~~~~~------~~~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 257 ----NAMSALYHI---AQNESPA------LQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----CHHHHHHHH---HHSCCCC------CCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----ChHHHHHHH---HhcCCCC------CCCCCC---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 222222222 1111111 011111 234678888999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=313.84 Aligned_cols=249 Identities=19% Similarity=0.270 Sum_probs=193.6
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++++.||+|+||.||+|+.+ .+++.||+|.+..... ........+.+|
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~------------------------~~~~~~~~~~~E 119 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEM------------------------IKRSDSAFFWEE 119 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTCCCSTHHHH
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhh------------------------hhhHHHHHHHHH
Confidence 346789999999999999999999965 5799999999852100 001123447789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+.+++.++||||+++++++.+++ .+++++||+.++++ ++......++.|++.||.|||+.+ ++||||
T Consensus 120 ~~il~~l~hp~Iv~l~~~~~~~~--~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDL 194 (410)
T 3v8s_A 120 RDIMAFANSPWVVQLFYAFQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 194 (410)
T ss_dssp HHHHHHCCCTTBCCEEEEEECSS--EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHHHhCCCCCCCeEEEEEEECC--EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 99999999999999999998766 79999999988765 556667789999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc----cCccchhh-HHHHHHHHHhCCCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT----LTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~----~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||+|||++.++.+||+|||+++....... ......+||+.|+|||++.+.. ++.++||| +|+++|||++|..||
T Consensus 195 Kp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 99999999999999999999987654332 2334678999999999998765 78899999 999999999999996
Q ss_pred cccccccchhhHHHHHHHHhhh-cCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMAS-ENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE--RPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~--Rpt~~~ll~ 338 (345)
.. .+.......+...... ..+.. ......+.++|..||+.+|.+ ||++.+|++
T Consensus 274 ~~----~~~~~~~~~i~~~~~~~~~p~~-----------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 274 YA----DSLVGTYSKIMNHKNSLTFPDD-----------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CC----SSHHHHHHHHHTHHHHCCCCTT-----------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CC----CChhhHHHHHHhccccccCCCc-----------ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 43 2333333333322111 11110 011234778888999999988 999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=296.96 Aligned_cols=251 Identities=18% Similarity=0.257 Sum_probs=193.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
....++|.+.+.||+|+||.||+|++... ++..||+|.+..... ....+.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~ 61 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--------------------------LDNKEKFM 61 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC--------------------------HHHHHHHH
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC--------------------------chHHHHHH
Confidence 34678999999999999999999987533 345699999865321 12356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..+. .+++++++.++++ ++......++.|++.||.|||+.+ ++
T Consensus 62 ~E~~~l~~l~h~~i~~~~~~~~~~~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 135 (281)
T 3cc6_A 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CV 135 (281)
T ss_dssp HHHHHHHHHCCTTBCCEEEEECSSS---CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCcceEEEEEcCCC---CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999886543 5788899887543 666777889999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||| +|+++|+|++ |..|
T Consensus 136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p 214 (281)
T 3cc6_A 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214 (281)
T ss_dssp CCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999866443221 22335678899999999988899999999 9999999998 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ........+......+.+ ......+.+++..||+.||++|||+.++++.|+++.
T Consensus 215 ~~~~----~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 215 FFWL----ENKDVIGVLEKGDRLPKP-------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTTS----CGGGHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccC----ChHHHHHHHhcCCCCCCC-------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 7432 223333333322211111 111234778899999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=304.45 Aligned_cols=240 Identities=19% Similarity=0.253 Sum_probs=191.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.+ .+|+.||+|.+..... ........+.+|+.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~------------------------~~~~~~~~~~~E~~ 93 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKV------------------------VKLKQIEHTLNEKR 93 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHH
T ss_pred CHHHCEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHh------------------------ccHHHHHHHHHHHH
Confidence 3468999999999999999999964 5799999999842110 01123567888999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.++++ ++......++.|++.||.|||+.+ ++|||||
T Consensus 94 ~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlk 168 (350)
T 1rdq_E 94 ILQAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLK 168 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred HHHhCCCCCCCeEEEEEEcCC--EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCc
Confidence 999999999999999998766 78999999988754 456667789999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++||| +|+++|||++|..||..
T Consensus 169 p~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~--- 240 (350)
T 1rdq_E 169 PENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA--- 240 (350)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC---
T ss_pred cceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC---
Confidence 99999999999999999999876432 2346899999999999998999999999 99999999999999643
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
.+.......+... ... + + ......+.+++..||+.||.+||+ +.+|++
T Consensus 241 -~~~~~~~~~i~~~---~~~---~----p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 241 -DQPIQIYEKIVSG---KVR---F----P----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -SSHHHHHHHHHHC---CCC---C----C----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCHHHHHHHHHcC---CCC---C----C----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2333333333221 110 0 0 111234778899999999999998 777764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=306.67 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=189.9
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++.+.||+|+||.||+|+++ .+|+.||+|.+..... ........+..|.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~~E~ 68 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVV------------------------LMDDDVECTMVEK 68 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHH------------------------HHTTCHHHHHHHH
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHh------------------------hhhhhHHHHHHHH
Confidence 46689999999999999999999965 5799999999952110 0012345677888
Q ss_pred HHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.++..+ +||||+++++++..++ .+++++||+.++++ +++.....++.|++.||.|||+.+ ++|||
T Consensus 69 ~il~~~~~hp~iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 143 (345)
T 1xjd_A 69 RVLSLAWEHPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRD 143 (345)
T ss_dssp HHHHHHTTCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHHhcCCCCCCCcEEEEEEeCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 999877 9999999999998776 78999999988755 556667789999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|+| +|+++|||++|..||..
T Consensus 144 lkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~- 220 (345)
T 1xjd_A 144 LKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG- 220 (345)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred CChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-
Confidence 999999999999999999999975432211 23457899999999999999999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK-DVR 337 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~-~ll 337 (345)
.+.......+.... +. ++ .. ....+.+++..||+.||.+||++. +++
T Consensus 221 ---~~~~~~~~~i~~~~----~~--~p-----~~---~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 221 ---QDEEELFHSIRMDN----PF--YP-----RW---LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---SSHHHHHHHHHHCC----CC--CC-----TT---SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCHHHHHHHHHhCC----CC--CC-----cc---cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 23333333332211 10 00 11 123477888999999999999987 554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.88 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=189.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.+ .+|+.||+|.+...... ..+....+.+|..+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~------------------------~~~~~~~~~~E~~~ 59 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVV------------------------RLKQVEHTNDERLM 59 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHH------------------------HTTCHHHHHHHHHH
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhh------------------------hhhHHHHHHHHHHH
Confidence 468999999999999999999864 57999999998521100 01235567789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++.+.+ .+++++|++.++++ ++......++.|++.||.|||+.+ ++||||||
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp 134 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQ--QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKP 134 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCG
T ss_pred HhhCCCCCCceEeEEEEeCC--EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCh
Confidence 99999999999999998766 78999999988654 556667789999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.+||+|||++...... .....||+.|+|||++.+..++.++|+| +|+++|||++|..||..
T Consensus 135 ~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~---- 205 (318)
T 1fot_A 135 ENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---- 205 (318)
T ss_dssp GGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC----
T ss_pred heEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC----
Confidence 9999999999999999999875432 2346899999999999999999999999 99999999999999743
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.+.......+.. .... .+ +.....+.+++..||+.||.+|| +++++++
T Consensus 206 ~~~~~~~~~i~~---~~~~-------~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 206 SNTMKTYEKILN---AELR-------FP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp SSHHHHHHHHHH---CCCC-------CC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHh---CCCC-------CC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 222222222221 1110 00 11123477888999999999999 8888874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=297.97 Aligned_cols=252 Identities=18% Similarity=0.292 Sum_probs=198.0
Q ss_pred HhhcCCccccc-ccccCcceeeEEEEec-CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLE-KIGSGGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~-~iG~G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
....++|.+.+ .||+|+||.||+|+++ ..++..||+|.+..... ....+.+.
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~ 58 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------------------------KADTEEMM 58 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------------------------HHHHHHHH
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--------------------------hhHHHHHH
Confidence 44667888888 9999999999999864 23578899999975321 22356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..+ .++++++++.++ ..+++..+..++.|++.||.|||+.+ ++
T Consensus 59 ~E~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~ 132 (287)
T 1u59_A 59 REAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 132 (287)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEESS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCEeEEEEEecCC---CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---Ee
Confidence 999999999999999999998543 478888988764 33677888999999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
|+||||+||+++.++.++|+|||++......... .......||+.|+|||.+.+..++.++||| +|+++|+|++ |..
T Consensus 133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999877543321 122334668899999999988899999999 9999999998 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||... ...+....+........ ++.....+.+++..||+.||++|||+.++++.|+++.
T Consensus 213 p~~~~----~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 213 PYKKM----KGPEVMAFIEQGKRMEC-------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TTTTC----CTHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccC----CHHHHHHHHhcCCcCCC-------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 97542 23333333332211111 1122335778999999999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=303.42 Aligned_cols=248 Identities=21% Similarity=0.261 Sum_probs=192.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+|..||+|.+.......... ....+.+.+|+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~---------------------~~~~~~~~~E~~~ 67 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRR---------------------GVSREDIEREVSI 67 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSS---------------------SBCHHHHHHHHHH
T ss_pred ccceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccc---------------------hhhHHHHHHHHHH
Confidence 357999999999999999999864 579999999987543321100 0014567889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ .++++++++.++++ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 68 l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp 142 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKP 142 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred HHhCCCCCCCcEEEEEEeCC--EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCH
Confidence 99999999999999998766 68899999987543 567778899999999999999998 99999999
Q ss_pred CCeeecCCC----CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 198 VNVLLDDDI----EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 198 ~nil~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
+||+++.++ .+||+|||++....... ......||+.|+|||++.+..++.++||| +|+++|+|++|..||..
T Consensus 143 ~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 143 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred HHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 999998877 79999999998764332 22346799999999999988999999999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+...... . ..... +.....+.+++..||+.||++|||+.++++
T Consensus 220 ----~~~~~~~~~~~~~~~~--~----~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 220 ----DTKQETLANVSAVNYE--F----EDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----SSHHHHHHHHHHTCCC--C----CHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCHHHHHHHHHhcCCC--c----Ccccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2223333322221100 0 00000 111234778899999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=302.25 Aligned_cols=240 Identities=23% Similarity=0.395 Sum_probs=183.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+.||+|+||.||+|++ .++.||+|.+... ...+.+.+|+.
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~E~~ 53 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESE-----------------------------SERKAFIVELR 53 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSST-----------------------------THHHHHHHHHH
T ss_pred CHhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecCh-----------------------------hHHHHHHHHHH
Confidence 567899999999999999999987 4788999998532 12456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhh---cCCCCe
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHM---HHCPRI 190 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~---~~~~~i 190 (345)
++++++||||+++++++... .++++++++++++ ++......++.|+++||.|||+ .+ +
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---i 126 (307)
T 2eva_A 54 QLSRVNHPNIVKLYGACLNP----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---L 126 (307)
T ss_dssp HHHHCCCTTBCCEEEBCTTT----TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---C
T ss_pred HHhcCCCCCcCeEEEEEcCC----cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---e
Confidence 99999999999999987632 6789999987654 4556678899999999999999 66 9
Q ss_pred EecCCCCCCeeecCCCC-eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 191 IHRDLNPVNVLLDDDIE-ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~-~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
+||||||+||+++.++. +||+|||++...... .....||+.|+|||.+.+..++.++||| +|+++|||++|..
T Consensus 127 vH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 201 (307)
T 2eva_A 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201 (307)
T ss_dssp CCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred ecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999998876 799999999755332 2235689999999999998999999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||..... ........+ .....+. ........+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 202 p~~~~~~--~~~~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 202 PFDEIGG--PAFRIMWAV---HNGTRPP----------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TTTTTCS--SHHHHHHHH---HTTCCCC----------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred CchhhCc--cHHHHHHHH---hcCCCCC----------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 9754322 111111111 1111110 01112234778899999999999999999999998874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=299.66 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=194.7
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecCCC--CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPGQN--GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
..+-....+|++.+.||+|+||.||+|++...+ +..+|+|.+..... ....+
T Consensus 18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--------------------------~~~~~ 71 (298)
T 3f66_A 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------------------------IGEVS 71 (298)
T ss_dssp GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--------------------------HHHHH
T ss_pred eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--------------------------HHHHH
Confidence 334456678999999999999999999864322 34689999864321 22356
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
.+.+|+.++++++||||+++++++...+ ...+++++++.++++ ++......++.|++.||.|||+.+
T Consensus 72 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-- 148 (298)
T 3f66_A 72 QFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-- 148 (298)
T ss_dssp HHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCEeeeeeEEEcCC-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 7889999999999999999999876544 357788999987543 566777889999999999999999
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCc--ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT--HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t 265 (345)
++||||||+||+++.++.+||+|||++........ ........||+.|+|||.+.+..++.++||| +|+++|+|++
T Consensus 149 -i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 227 (298)
T 3f66_A 149 -FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227 (298)
T ss_dssp -CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred -ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999986644321 1122345678899999999998999999999 9999999999
Q ss_pred -CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 266 -GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 266 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|.+||.. ....+....+........+ .. ....+.+++..||+.||++|||+.++++.|+++.
T Consensus 228 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~----------~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 228 RGAPPYPD----VNTFDITVYLLQGRRLLQP----------EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp TSCCSSTT----SCTTTHHHHHHTTCCCCCC----------TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcc----CCHHHHHHHHhcCCCCCCC----------cc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 5556433 3333333333322211111 11 1234788899999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=301.53 Aligned_cols=237 Identities=17% Similarity=0.267 Sum_probs=180.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.++||+|+||.||+|++. .+|+.||||++....... ........|+..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~-------------------------~~~~~~~~e~~~~ 110 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGP-------------------------KDRARKLAEVGSH 110 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSH-------------------------HHHHHHHHHHHHH
T ss_pred hheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccCh-------------------------HHHHHHHHHHHHH
Confidence 57999999999999999999864 579999999986543331 1233445566665
Q ss_pred hhc-cCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
..+ +||||+++++++...+ .++++++++.+. ..+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 111 ~~~~~h~~iv~l~~~~~~~~--~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 185 (311)
T 3p1a_A 111 EKVGQHPCCVRLEQAWEEGG--ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKP 185 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETT--EEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HHhcCCCcEEEEEEEEEeCC--EEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCH
Confidence 555 9999999999998776 788999999552 34788888999999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.+||+|||++....... ......||+.|+|||++.+ .++.++||| +|+++|||++|..|+.. .
T Consensus 186 ~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~---~ 258 (311)
T 3p1a_A 186 ANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG---G 258 (311)
T ss_dssp GGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS---H
T ss_pred HHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC---c
Confidence 99999999999999999998765432 2234579999999999987 789999999 99999999999766421 1
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. ...+ . ..... +... ......+.+++..||+.||++|||+.++++
T Consensus 259 ---~~-~~~~---~-~~~~~----~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 ---EG-WQQL---R-QGYLP----PEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HH-HHHH---T-TTCCC----HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cH-HHHH---h-ccCCC----cccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 1111 1 11111 1111 112245788999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=307.68 Aligned_cols=242 Identities=19% Similarity=0.267 Sum_probs=177.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|++. .+++.||||.+... ...+.+.+|+.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~E~~ 100 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKT-----------------------------VDKKIVRTEIG 100 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC---------------------------------------CH
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccc-----------------------------hhHHHHHHHHH
Confidence 3467999999999999999999965 57889999999642 12345678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++++||||+++++++..++ .++++++++.++++ +++.....++.|++.||.|||+.+ ++|||||
T Consensus 101 ~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik 175 (349)
T 2w4o_A 101 VLLRLSHPNIIKLKEIFETPT--EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLK 175 (349)
T ss_dssp HHHHCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred HHHhCCCCCCcceeeeEecCC--eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCC
Confidence 999999999999999998776 68899999987654 577788899999999999999998 9999999
Q ss_pred CCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+||+++. ++.+||+|||++....... ......||+.|+|||.+.+..++.++||| +|+++|||++|..||..
T Consensus 176 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 176 PENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp GGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99999975 8899999999998654322 22346789999999999998999999999 99999999999999743
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. .........+... .... ...........+.+++.+||+.||++|||+.++++
T Consensus 253 ~---~~~~~~~~~i~~~---~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 253 E---RGDQFMFRRILNC---EYYF-------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp T---TCHHHHHHHHHTT---CCCC-------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---cccHHHHHHHHhC---CCcc-------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2 2222222222211 1100 00111122345778999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=303.95 Aligned_cols=260 Identities=19% Similarity=0.244 Sum_probs=188.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||+|.+......... ......+.+|+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~~e~~ 63 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGG----------------------GGLPISTVREVA 63 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTTS----------------------SCCCHHHHHHHH
T ss_pred cccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEecccccccc----------------------cccchhHHHHHH
Confidence 3579999999999999999999853 57999999998643211100 000123345666
Q ss_pred HHhhc---cCCCccceeEEEecCCc---ceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 126 TVGQI---RHRNLHPLLAHVTRPDC---HLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 126 ~l~~l---~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+++.+ +||||+++++++..... ..++++++++.+. ..+++..+..++.|++.||.|||+.+
T Consensus 64 ~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--- 140 (308)
T 3g33_A 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--- 140 (308)
T ss_dssp HHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 66555 59999999999876542 3578899988752 12788888999999999999999999
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
++||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+..++.++||| +|+++|+|++|..
T Consensus 141 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 217 (308)
T 3g33_A 141 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217 (308)
T ss_dssp CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSC
T ss_pred cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999997654332 22446889999999999998999999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCcccc------cccc-------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAID------SKLV-------GNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-------~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
||.. .........+......+....... .... ....++....+.+++.+||+.||++|||+.+
T Consensus 218 pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 293 (308)
T 3g33_A 218 LFCG----NSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293 (308)
T ss_dssp SCCC----SSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCC----CCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH
Confidence 9643 333444444443332221111000 0000 0001122345778999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 294 ~l~ 296 (308)
T 3g33_A 294 ALQ 296 (308)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.96 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=189.0
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
...|..+.++|++.+.||+|+||.||+|++ +|..||+|.+.... ..+.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------------------------~~~~ 60 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA-----------------------------TAQA 60 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC-------------------------------HH
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecchh-----------------------------HHHH
Confidence 334556788999999999999999999986 58899999986431 2456
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+.+|+.+++.++||||+++++++..++ ..+++++++++++++ +++.....++.|++.||.|||+.+
T Consensus 61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-- 137 (278)
T 1byg_A 61 FLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 137 (278)
T ss_dssp HHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEEcCC-CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 788999999999999999999876543 367899999988654 455566789999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++|+||||+||+++.++.++|+|||++....... ....++..|+|||.+.+..++.++||| +|+++|+|++ |
T Consensus 138 -i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 211 (278)
T 1byg_A 138 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 211 (278)
T ss_dssp -CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987554321 234678899999999988899999999 9999999998 9
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||... ...+....+....... ........+.+++..||+.||++|||+.++++.|++++
T Consensus 212 ~~p~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 212 RVPYPRI----PLKDVVPRVEKGYKMD-------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCSCTTS----CGGGHHHHHTTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC----CHHHHHHHHhcCCCCC-------------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 9997542 2233333222111110 11112234778889999999999999999999999885
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.91 Aligned_cols=244 Identities=20% Similarity=0.355 Sum_probs=181.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|++++.||+|+||.||+|... ++..||||.+.....+ ......+.+|+.
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~Ei~ 106 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEAD-------------------------NQTLDSYRNEIA 106 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCC-------------------------HHHHHHHHHHHH
T ss_pred cCCceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEeccccc-------------------------HHHHHHHHHHHH
Confidence 3456999999999999999999864 5899999999654322 233567889999
Q ss_pred HHhhcc--CCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIR--HRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~--hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++.++ ||||+++++++..++ .+++++++ .++ ..+++..+..++.|++.||.|||+.+ |+|||
T Consensus 107 ~l~~l~~~~~~iv~~~~~~~~~~--~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrD 180 (390)
T 2zmd_A 107 YLNKLQQHSDKIIRLYDYEITDQ--YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSD 180 (390)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSS--EEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCC
T ss_pred HHHHcccCCCeEEEEEEEEecCC--EEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 999996 599999999998776 58888884 343 23566678899999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----------cccCccchhh-HHHHHHH
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----------LTLTEKCDIY-FGALLAG 262 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----------~~~~~~~Dvw-lG~vl~e 262 (345)
|||+|||++ ++.+||+|||++................||+.|+|||++.+ ..++.++||| +|+++||
T Consensus 181 lkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e 259 (390)
T 2zmd_A 181 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259 (390)
T ss_dssp CCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence 999999996 57899999999987654333223345689999999999975 3588899999 9999999
Q ss_pred HHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 263 LVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 263 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|++|..||..... .. ..+........... . +... ...+.+++..||+.||.+|||+.++++
T Consensus 260 ll~G~~Pf~~~~~---~~---~~~~~~~~~~~~~~-~-----~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 260 MTYGKTPFQQIIN---QI---SKLHAIIDPNHEIE-F-----PDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHSSCTTTTCCC---HH---HHHHHHHCTTSCCC-C-----CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCcchhhhH---HH---HHHHHHhCccccCC-C-----Cccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 9999999754221 11 11222221111100 0 0111 234778889999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.84 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=187.8
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|++. .+|+.||+|.+.....+ ......+.+|+.++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~~~l 56 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDD-------------------------PVIKKIALREIRML 56 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC--------------------------HHHHHHHHHHHHHH
T ss_pred ccceEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccc-------------------------hHHHHHHHHHHHHH
Confidence 68999999999999999999964 57999999998654322 22356678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++||||+++++++..++ .+++++++++++ ..++......++.|++.||.|||+.+ ++||||||+
T Consensus 57 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~ 131 (311)
T 4agu_A 57 KQLKHPNLVNLLEVFRRKR--RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPE 131 (311)
T ss_dssp HHCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred HhCCCCCccchhheeecCC--eEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChh
Confidence 9999999999999998776 688899998864 33677788899999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.+||+|||++........ ......||..|+|||.+.+ ..++.++||| +|+++|+|++|..||...
T Consensus 132 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--- 206 (311)
T 4agu_A 132 NILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK--- 206 (311)
T ss_dssp GEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---
T ss_pred hEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---
Confidence 99999999999999999987653322 2234678999999999976 5679999999 999999999999997542
Q ss_pred cchhhHHHHHHHHhhhcCCC--------------ccccccccCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPK--------------RAIDSKLVGN---GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~---~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+........+. ...++..... ..+.....+.+++..||+.||++|||++++++
T Consensus 207 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 207 -SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp -SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred -CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 2333333333222111000 0000000000 00122345778999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=302.78 Aligned_cols=260 Identities=19% Similarity=0.300 Sum_probs=197.0
Q ss_pred hcCCcccccccccCcceeeEEEEe---cCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAEL---PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
..++|++++.||+|+||.||+|++ ...++..||||.+.... ....+.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---------------------------~~~~~~~~~ 91 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---------------------------EEHLRDFER 91 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---------------------------SHHHHHHHH
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---------------------------HHHHHHHHH
Confidence 456899999999999999999985 23578999999996532 123567889
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.+++.++||||+++++++...+...+++++++++++++ +++.....++.|++.||.|||+.+ ++|
T Consensus 92 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 168 (326)
T 2w1i_A 92 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 168 (326)
T ss_dssp HHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 9999999999999999999887765678899999987543 667777889999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcce-eccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
+||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++||| +|+++|+|++|..||
T Consensus 169 ~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~ 248 (326)
T 2w1i_A 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 248 (326)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred cCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999998765433221 12335677889999999988899999999 999999999999986
Q ss_pred ccccc--------ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhh
Q 046907 271 DKFFQ--------HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342 (345)
Q Consensus 271 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~ 342 (345)
..... ..........+.......... ..+......+.++|..||+.||++|||+.++++.|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp GSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 43210 000011111111111111000 0111223457889999999999999999999999998
Q ss_pred hh
Q 046907 343 IQ 344 (345)
Q Consensus 343 l~ 344 (345)
++
T Consensus 320 l~ 321 (326)
T 2w1i_A 320 IR 321 (326)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.16 Aligned_cols=255 Identities=20% Similarity=0.261 Sum_probs=193.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||||.+.... ....+.+|+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-----------------------------~~~~~~~e~~ 56 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT-----------------------------KHPQLHIESK 56 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC--------------------------------CCCHHHHHH
T ss_pred cCCceEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc-----------------------------cchHHHHHHH
Confidence 4578999999999999999999854 579999999875421 2334678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++|++++..+..+...+ ...+++++++.+ ...+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 132 (296)
T 4hgt_A 57 IYKMMQGGVGIPTIRWCGAEG-DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVK 132 (296)
T ss_dssp HHHHHTTSTTCCCEEEEEEET-TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHHhcCCCCCCeeeeecCCC-CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 999999998888877665443 367889999832 234677788899999999999999999 9999999
Q ss_pred CCCeee---cCCCCeEEeccccceecCCCCcc-----eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 197 PVNVLL---DDDIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 197 ~~nil~---~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|+||++ +.++.+||+|||++......... .......||+.|+|||.+.+..++.++||| +|+++|+|++|.
T Consensus 133 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 212 (296)
T 4hgt_A 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 999999 78889999999999876543321 122356899999999999999999999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||......................+. .... ......+.+++..||+.||++|||+.++++.|+++.
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 213 LPWQGLKAATKRQKYERISEKKMSTPI--EVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CTTSSCCCSSSSSHHHHHHHHHHHSCH--HHHT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCcccchhhhhhhhhhhhcccccchh--hhhh--------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 998764443333333332222221110 0000 011234788999999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=297.76 Aligned_cols=253 Identities=25% Similarity=0.317 Sum_probs=194.3
Q ss_pred hcCCcccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..-.|.+.+.||+|+||.||+|++.. .++..||+|.+..... ....+.+.+|
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--------------------------~~~~~~~~~E 72 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--------------------------MQQVEAFLRE 72 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--------------------------HHHHHHHHHH
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--------------------------HHHHHHHHHH
Confidence 44467778999999999999998642 2344799999864321 1235678899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.+++.++||||+++++++..++. ..+++++++.+++ .+++.....++.|++.||.|||+.+ ++||
T Consensus 73 ~~~l~~l~h~~iv~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~ 148 (298)
T 3pls_A 73 GLLMRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHR 148 (298)
T ss_dssp HHHHHTCCCTTBCCCCEEECCSSS-CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHhCCCCCeeeEEEEEecCCC-CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999877653 3467778876654 3566677889999999999999999 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCc--ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHT--HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||||+||+++.++.+||+|||++........ ........+|..|+|||.+.+..++.++||| +|+++|+|++|..|+
T Consensus 149 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp CCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 9999999999999999999999976543221 1122345778899999999999999999999 999999999965553
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
+...........+........+ ......+.+++..||+.||.+|||+.++++.|+++.
T Consensus 229 ---~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 229 ---YRHIDPFDLTHFLAQGRRLPQP-------------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ---TTTSCGGGHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHhhcCCCCCCC-------------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3333444444444433221111 111234788999999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.46 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=199.6
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
.-.|....++|++.+.||+|+||.||+|+++ .+..||||.+...... .+.
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~----------------------------~~~ 308 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS----------------------------PEA 308 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTSSC----------------------------HHH
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCCCC----------------------------HHH
Confidence 3457788899999999999999999999985 4567999999754321 345
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+.+|+.++++++||||+++++++..+ .+++++|++.++++ +++.....++.|++.||.|||+.+
T Consensus 309 ~~~E~~~l~~l~hpniv~~~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-- 383 (535)
T 2h8h_A 309 FLQEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383 (535)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSS---SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEeec---cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 78899999999999999999988653 47899999988644 556667789999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-C
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-G 266 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g 266 (345)
++||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||| ||+++|||++ |
T Consensus 384 -ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g 461 (535)
T 2h8h_A 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461 (535)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTT
T ss_pred -eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999976543211 112234567899999999988999999999 9999999999 8
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
..||... ...+....+......+. ...+...+.++|..||+.||++|||+.+|++.|+.+.
T Consensus 462 ~~P~~~~----~~~~~~~~i~~~~~~~~-------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 462 RVPYPGM----VNREVLDQVERGYRMPC-------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCSSTTC----CHHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCC----CHHHHHHHHHcCCCCCC-------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 9996542 33334333332221111 1122345778999999999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=311.22 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=190.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++++.||+|+||.||+|++. .+++.||||.+.....+ .....++.+|+.
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~-------------------------~~~~~~~~~E~~ 77 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFED-------------------------LIDCKRILREIT 77 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTS-------------------------HHHHHHHHHHHH
T ss_pred ecCCEEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcC-------------------------hHHHHHHHHHHH
Confidence 4679999999999999999999864 57999999999653322 233567889999
Q ss_pred HHhhccCCCccceeEEEecCCc---ceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++.++||||+++++++...+. ..++++++++++ ...++...+..++.|++.||.|||+.+ ++|||
T Consensus 78 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrD 154 (432)
T 3n9x_A 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRD 154 (432)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCC
Confidence 9999999999999999876642 458899998875 234788888999999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcc--------------------eeccCcccCccccccccc-cccccCccch
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTH--------------------ITTSNVVGTVEYIAPEYL-QMLTLTEKCD 253 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~~~aPE~~-~~~~~~~~~D 253 (345)
|||+|||++.++.+||+|||+++........ ......+||+.|+|||++ .+..++.++|
T Consensus 155 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~D 234 (432)
T 3n9x_A 155 LKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSID 234 (432)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHH
T ss_pred CCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccc
Confidence 9999999999999999999999876443211 123567899999999986 5556899999
Q ss_pred hh-HHHHHHHHHhCCCCCcc-------cccccc-----------------hhhHHHHHHHHhhhcCCCcc----------
Q 046907 254 IY-FGALLAGLVMGKLPSDK-------FFQHTN-----------------EMSFVKWMRNVMASENPKRA---------- 298 (345)
Q Consensus 254 vw-lG~vl~el~tg~~p~~~-------~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~---------- 298 (345)
|| +||++|||++|..||.. .+...+ ..+....+....+.+.....
T Consensus 235 iwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~ 314 (432)
T 3n9x_A 235 IWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK 314 (432)
T ss_dssp HHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHH
Confidence 99 99999999986555431 111111 12223333333322211000
Q ss_pred ----cccccc---CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 299 ----IDSKLV---GNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 299 ----~~~~~~---~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...... ....+.....+.+|+.+||+.||++|||+.++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 315 YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 0000122345778999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=303.36 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=191.0
Q ss_pred hhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
...++|++.+.||+|+||.||+|++. ..++..||||.+..... ......+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~ 80 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS--------------------------EQDELDF 80 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC--------------------------HHHHHHH
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc--------------------------hhhHHHH
Confidence 35679999999999999999999853 24578999999964321 1224567
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------------CCHHHHHHHHHHHHHHHHHHhh
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------------LDWLARHRIALGLACGLEYLHM 184 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------------l~~~~~~~i~~~i~~~l~~lh~ 184 (345)
.+|+.++++++||||+++++++..++ ..+++++++.++++ +++..+..++.|++.||.|||+
T Consensus 81 ~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~ 158 (327)
T 2yfx_A 81 LMEALIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158 (327)
T ss_dssp HHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhCCCCCCCeEEEEEcCCC--CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 88999999999999999999988766 56888999876433 5666778899999999999999
Q ss_pred cCCCCeEecCCCCCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHH
Q 046907 185 HHCPRIIHRDLNPVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260 (345)
Q Consensus 185 ~~~~~iiH~dlk~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl 260 (345)
.+ ++||||||+||+++. +..++|+|||++................||+.|+|||.+.+..++.++||| +|+++
T Consensus 159 ~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 159 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235 (327)
T ss_dssp TT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHH
Confidence 98 999999999999984 446999999999765443322233345778999999999988999999999 99999
Q ss_pred HHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 261 AGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 261 ~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
|+|++ |..||.. .........+........+ ......+.+++..||+.||.+|||+.++++.
T Consensus 236 ~ellt~g~~p~~~----~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 298 (327)
T 2yfx_A 236 WEIFSLGYMPYPS----KSNQEVLEFVTSGGRMDPP-------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298 (327)
T ss_dssp HHHHTTSCCSSTT----CCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCC----cCHHHHHHHHhcCCCCCCC-------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99998 9999643 2333333333322111111 1122347789999999999999999999999
Q ss_pred Hhhhh
Q 046907 340 LSQIQ 344 (345)
Q Consensus 340 L~~l~ 344 (345)
|+.+.
T Consensus 299 l~~~~ 303 (327)
T 2yfx_A 299 IEYCT 303 (327)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.28 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=190.3
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCC---CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQN---GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
....++|.+.+.||+|+||.||+|+++..+ +..||||.+..... ......+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~ 93 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--------------------------EKQRVDF 93 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--------------------------HHHHHHH
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC--------------------------HHHHHHH
Confidence 446779999999999999999999875332 34699999964321 1224568
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
.+|+.+++.++||||+++++++...+ .++++++++.+++ .+++..+..++.|++.||.|||+.+ +
T Consensus 94 ~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 168 (333)
T 1mqb_A 94 LGEAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---Y 168 (333)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHhCCCCCCCcEEEEEecCC--CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 89999999999999999999987665 6889999998753 3667778899999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCc-ceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GK 267 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~ 267 (345)
+||||||+||+++.++.+||+|||++........ ........+|..|+|||.+.+..++.++||| +|+++|||++ |.
T Consensus 169 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999987644321 1122234567889999999988999999999 9999999999 99
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.||... ...+....+......+. .......+.+++..||+.||++||++.++++.|+++
T Consensus 249 ~pf~~~----~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 249 RPYWEL----SNHEVMKAINDGFRLPT-------------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp CTTTTC----CHHHHHHHHHTTCCCCC-------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcccC----CHHHHHHHHHCCCcCCC-------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 997432 22333333322211111 111223477889999999999999999999999886
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=305.33 Aligned_cols=255 Identities=23% Similarity=0.327 Sum_probs=187.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+|+.||||.+.....+ .....++.+|+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 76 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQS-------------------------ELFAKRAYRELR 76 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSS-------------------------HHHHHHHHHHHH
T ss_pred ecceEEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccC-------------------------HHHHHHHHHHHH
Confidence 3578999999999999999999854 57999999998653222 223567889999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQG-------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++.++||||+++++++..++. ..++++++++.+ ...++......++.|++.||.|||+.+ ++|||
T Consensus 77 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~D 153 (367)
T 1cm8_A 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRD 153 (367)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 9999999999999999876542 346889998832 123677778899999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|||+||+++.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||| +|+++|||++|..||.+
T Consensus 154 lkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 154 LKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999875432 234688999999999987 6789999999 99999999999999653
Q ss_pred cccccchhhHHHHHHHHhhhcCCCc-----------------cccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKR-----------------AIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
.+..+....+......+.... ...........+.....+.+++.+||+.||.+|||+.+
T Consensus 229 ----~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 229 ----SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304 (367)
T ss_dssp ----SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ----CCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence 233333333333222111000 00000001111223345778999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 305 ~l~ 307 (367)
T 1cm8_A 305 ALA 307 (367)
T ss_dssp HHH
T ss_pred Hhc
Confidence 987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=302.84 Aligned_cols=248 Identities=21% Similarity=0.322 Sum_probs=190.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++++.||+|+||.||+|++. .+++.||||.+... ......+..|+.
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~~e~~ 83 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI----------------------------KKYTRSAKIEAD 83 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC----------------------------HHHHHHHHHHHH
T ss_pred ecCEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc----------------------------hhhhhhhHHHHH
Confidence 4679999999999999999999964 57899999999642 122445667888
Q ss_pred HHhhcc-----CCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 126 TVGQIR-----HRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 126 ~l~~l~-----hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+++.++ ||||+++++++...+ .++++++++ +++ .++...+..++.|++.||.|||+.+
T Consensus 84 ~l~~l~~~~~~h~~iv~~~~~~~~~~--~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--- 157 (360)
T 3llt_A 84 ILKKIQNDDINNNNIVKYHGKFMYYD--HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--- 157 (360)
T ss_dssp HHHHTCCCSTTGGGBCCEEEEEEETT--EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHhcccCCCCCCeecccceeeECC--eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 988886 999999999998876 688999998 433 2677778899999999999999999
Q ss_pred eEecCCCCCCeeecC-------------------------CCCeEEeccccceecCCCCcceeccCcccCcccccccccc
Q 046907 190 IIHRDLNPVNVLLDD-------------------------DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ 244 (345)
Q Consensus 190 iiH~dlk~~nil~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~ 244 (345)
++||||||+|||++. ++.+||+|||++...... .....||+.|+|||++.
T Consensus 158 ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~ 232 (360)
T 3llt_A 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVIL 232 (360)
T ss_dssp EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHT
T ss_pred eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHc
Confidence 999999999999975 788999999999865432 23467899999999999
Q ss_pred ccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccc-----------------cccccCC
Q 046907 245 MLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAI-----------------DSKLVGN 306 (345)
Q Consensus 245 ~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~ 306 (345)
+..++.++||| +|+++|+|++|..||.. ....+....+........ .... .......
T Consensus 233 ~~~~~~~~DiwslG~il~ell~g~~pf~~----~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 307 (360)
T 3llt_A 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRT----HEHMEHLAMMESIIQPIP-KNMLYEATKTNGSKYVNKDELKLAWPEN 307 (360)
T ss_dssp TCCCCTTHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHHTCCCC-HHHHHHHTTSGGGGGEETTTTEECTTTT
T ss_pred CCCCCCccchHHHHHHHHHHHHCCCCCCC----CcHHHHHHHHHHhcCCCC-HHHHhhhhhccCccccCcccceecCccc
Confidence 99999999999 99999999999999754 233344444433322111 0000 0000000
Q ss_pred Cc-HH---------------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 307 GC-EE---------------QMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 307 ~~-~~---------------~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. .. ....+.+++..||+.||++|||+.++++
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 308 ASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00 0145779999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=302.91 Aligned_cols=243 Identities=22% Similarity=0.290 Sum_probs=189.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.+ .+|+.||+|.+..... ........+..|..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~------------------------~~~~~~~~~~~E~~ 72 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVV------------------------IQDDDVECTMVEKR 72 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHH------------------------HHTTCHHHHHHHHH
T ss_pred chHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh------------------------hcchHHHHHHHHHH
Confidence 5679999999999999999999964 5789999999952110 01123566778999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++..+ +||||+++++++...+ .+++++|++.++++ +++.....++.|++.||.|||+.+ ++||||
T Consensus 73 ~l~~~~~hp~iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDl 147 (353)
T 2i0e_A 73 VLALPGKPPFLTQLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDL 147 (353)
T ss_dssp HHTCTTCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHHhcCCCCEEeeEEEEEEcCC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccC
Confidence 99887 8999999999998776 78999999988754 556667789999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+|||++.++.+||+|||++....... ......+||+.|+|||++.+..++.++|+| +|+++|||++|..||..
T Consensus 148 kp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-- 223 (353)
T 2i0e_A 148 KLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-- 223 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred CHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC--
Confidence 9999999999999999999997543222 123457899999999999999999999999 99999999999999743
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
.+.......+... ... ++ ......+.+++..||+.||.+||+ +.++++
T Consensus 224 --~~~~~~~~~i~~~---~~~---~p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 224 --EDEDELFQSIMEH---NVA---YP--------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --SSHHHHHHHHHHC---CCC---CC--------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCHHHHHHHHHhC---CCC---CC--------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2333333333221 110 00 111234778889999999999995 466653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=297.23 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=188.5
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCc--eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGR--MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
....++|++.+.||+|+||.||+|++...++. .||+|.+....... ....+.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~ 69 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------------------------PEAMDDFI 69 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------------------------CHHHHHHH
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC------------------------HHHHHHHH
Confidence 34667999999999999999999987544443 68999986432111 23367788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..++ .+++++++.++++ +++.....++.|++.||.|||+.+ ++
T Consensus 70 ~e~~~l~~l~h~~i~~~~~~~~~~~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~ 143 (291)
T 1u46_A 70 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FI 143 (291)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSS---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCcccEEEEEccCC---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 9999999999999999999988765 6788899887643 566677789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
|+||||+||+++.++.+||+|||++......... .......+|..|+|||.+.+..++.++||| +|+++|+|++ |..
T Consensus 144 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 223 (291)
T 1u46_A 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223 (291)
T ss_dssp CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543322 122345678889999999988899999999 9999999999 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||... ........+.. ..... .........+.+++..||+.||++|||+.++++.|++++
T Consensus 224 p~~~~----~~~~~~~~~~~---~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 224 PWIGL----NGSQILHKIDK---EGERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TTTTC----CHHHHHHHHHT---SCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcccC----CHHHHHHHHHc---cCCCC---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 97542 22233222221 11110 011122345788999999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=327.02 Aligned_cols=252 Identities=18% Similarity=0.289 Sum_probs=193.3
Q ss_pred HhhcCCccccc-ccccCcceeeEEEEecC-CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLE-KIGSGGCGEVYKAELPG-QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~-~iG~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
....+++.+.+ .||+|+||.||+|.++. .++..||||.++..... ...+.+.
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--------------------------~~~~~~~ 384 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--------------------------ADTEEMM 384 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--------------------------TTHHHHH
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--------------------------HHHHHHH
Confidence 44556666666 89999999999998753 24678999999754211 1256788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..+ .+++++|++.++++ +++..+..++.|++.||.|||+.+ ++
T Consensus 385 ~E~~il~~l~hpniv~l~~~~~~~---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ii 458 (613)
T 2ozo_A 385 REAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 458 (613)
T ss_dssp HHHHHHTTCCCTTBCCEEEEEESS---SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCEeeEEEEeccC---CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 999999999999999999998764 38899999988643 567778899999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
||||||+|||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||| ||+++|||++ |..
T Consensus 459 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999866432211 112234557899999999988999999999 9999999998 999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||... ...+....+........+ ..+...+.++|..||+.||++|||+.+|++.|+.+.
T Consensus 539 Pf~~~----~~~~~~~~i~~~~~~~~p-------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 539 PYKKM----KGPEVMAFIEQGKRMECP-------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTTTC----CSHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHcCCCCCCC-------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 97543 333444444332211111 122345778999999999999999999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=302.54 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=184.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+++.||||.+....... ......+.+|+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~~E~~~ 65 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARD------------------------PSFYLRFRREAQN 65 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTS------------------------HHHHHHHHHHHTT
T ss_pred cCcEEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCC------------------------HHHHHHHHHHHHH
Confidence 468999999999999999999854 579999999997543221 2235678899999
Q ss_pred HhhccCCCccceeEEEecCCc--ceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC--HLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~--~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++.++||||+++++++...+. ...++++|+++++++ +++.....++.|++.||.|||+.+ ++||||
T Consensus 66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 142 (311)
T 3ork_A 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDV 142 (311)
T ss_dssp CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 999999999999998876543 256899999987543 566777899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+||+++.++.+||+|||++......... .......||+.|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 143 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp CGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999866443221 223346789999999999998999999999 999999999999997532
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH-HHHHhh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV-RRMLSQ 342 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l-l~~L~~ 342 (345)
....... .......... .... ......+.+++..||+.||++||++.++ ...+.+
T Consensus 223 ----~~~~~~~---~~~~~~~~~~----~~~~---~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 223 ----SPVSVAY---QHVREDPIPP----SARH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp ----SHHHHHH---HHHHCCCCCH----HHHS---TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----ChHHHHH---HHhcCCCCCc----cccc---CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 2222211 1111111100 0000 1122347788999999999999975554 444443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=301.48 Aligned_cols=253 Identities=18% Similarity=0.240 Sum_probs=193.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+.||+|+||.||+|+.. .+++.||+|.+.... ...+.+|+.
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~------------------------------~~~~~~E~~ 82 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK------------------------------KKKIKREIK 82 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSCC------------------------------HHHHHHHHH
T ss_pred CCCceEEEEEecccCCeEEEEEEEC-CCCcEEEEEEecccc------------------------------hHHHHHHHH
Confidence 5678999999999999999999854 579999999996421 345778999
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCC------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+++.++ ||||+++++++..+.....+++++++.++.+ ++......++.|++.||.|||+.+ ++||||||+
T Consensus 83 ~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~ 159 (330)
T 3nsz_A 83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPH 159 (330)
T ss_dssp HHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred HHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHH
Confidence 999996 9999999999998766688999999988653 667778899999999999999999 999999999
Q ss_pred CeeecCCC-CeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 199 NVLLDDDI-EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 199 nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|||++.++ .+||+|||++........ .....||..|+|||.+.+ ..++.++||| +|+++|+|++|..||..
T Consensus 160 Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~--- 233 (330)
T 3nsz_A 160 NVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH--- 233 (330)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC---
T ss_pred HEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc---
Confidence 99999766 899999999987644322 234678999999999987 5689999999 99999999999999732
Q ss_pred ccchhhHHHHHHHHhhhcCC-----------------------CccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 046907 276 HTNEMSFVKWMRNVMASENP-----------------------KRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
..........+......+.. ...................+.+++..||+.||.+|||
T Consensus 234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 313 (330)
T 3nsz_A 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313 (330)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC
Confidence 22222222222221111000 0000000011111123456889999999999999999
Q ss_pred HHHHHH
Q 046907 333 SKDVRR 338 (345)
Q Consensus 333 ~~~ll~ 338 (345)
++++++
T Consensus 314 a~e~l~ 319 (330)
T 3nsz_A 314 AREAME 319 (330)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.86 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=166.6
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc-
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR- 131 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 131 (345)
.+.||+|+||.||+|+++ .+++.||||.+... ....+.+|+.+++.+.
T Consensus 16 ~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~------------------------------~~~~~~~e~~~l~~l~~ 64 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHK-KSNQAFAVKIISKR------------------------------MEANTQKEITALKLCEG 64 (325)
T ss_dssp SCCSEEETTEEEEEEEET-TTCCEEEEEEEEGG------------------------------GHHHHHHHHHHHHHTTT
T ss_pred CCccccCCCeEEEEEEEC-CCCCEEEEEEEChh------------------------------hhhhHHHHHHHHHHhcC
Confidence 378999999999999864 57999999998521 1344567999999996
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
||||+++++++..++ .+++++|++.++++ +++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 65 h~niv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll 139 (325)
T 3kn6_A 65 HPNIVKLHEVFHDQL--HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLF 139 (325)
T ss_dssp CTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCCeeEEEEEEEcCC--EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEE
Confidence 999999999998766 78999999988654 567778899999999999999998 9999999999999
Q ss_pred cCCC---CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 203 DDDI---EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 203 ~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
+.++ .+||+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||........
T Consensus 140 ~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 217 (325)
T 3kn6_A 140 TDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT 217 (325)
T ss_dssp EC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------
T ss_pred ecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc
Confidence 7655 799999999986543322 22346789999999999999999999999 99999999999999865433222
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+.......... . ..........+.+++..||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~i~~~~~~~---~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 218 CTSAVEIMKKIKKGDFSF---E----GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCCHHHHHHHHTTTCCCC---C----SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccHHHHHHHHHcCCCCC---C----cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 222233333332221110 0 0011122345788999999999999999998763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=310.31 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=184.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCC--CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQN--GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....|++.+.||+|+||.||+|++...+ +..||+|.+..... ....+.+.+|
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~~E 140 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------------------------IGEVSQFLTE 140 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--------------------------SHHHHHHHHH
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--------------------------HHHHHHHHHH
Confidence 3446788899999999999999875333 35689999864221 1235678899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.++++++||||+++++++...+ ...+++++++.++++ +++.....++.|++.||.|||+.+ ++||
T Consensus 141 ~~il~~l~hpnIv~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 216 (373)
T 3c1x_A 141 GIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHR 216 (373)
T ss_dssp HTTSTTCCCTTBCCCCEEECCCS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHHHhCCCCCcceEEEEEEcCC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 99999999999999999876543 256789999987654 456667889999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||+||+++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||| +|+++|||++ |.+|
T Consensus 217 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 99999999999999999999999865432211 122335678899999999998999999999 9999999999 6777
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ...+....+........+ . .....+.++|..||+.||++|||+.++++.|+++.
T Consensus 297 ~~~~----~~~~~~~~~~~~~~~~~p----------~---~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 297 YPDV----NTFDITVYLLQGRRLLQP----------E---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CTTS----CSSCHHHHHHTTCCCCCC----------T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHcCCCCCCC----------C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 6442 223333333222111111 1 12234778899999999999999999999999873
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.98 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=194.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.+ .+|+.||+|.+..... ........+.+|+.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~------------------------~~~~~~~~~~~E~~ 236 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRI------------------------KKRKGEAMALNEKQ 236 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHH
T ss_pred cccceEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhh------------------------hhhHHHHHHHHHHH
Confidence 5578999999999999999999964 5799999999942110 00122456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++.++||||+++++++.+.+ .++++++|+.++++ +++..+..++.|++.||.|||+.+ |+|||
T Consensus 237 iL~~l~hp~Iv~l~~~~~~~~--~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrD 311 (576)
T 2acx_A 237 ILEKVNSRFVVSLAYAYETKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRD 311 (576)
T ss_dssp HHHHCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCCEeeEEEEEeeCC--EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccC
Confidence 999999999999999998776 79999999987654 677788899999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+|||++.++.+||+|||++........ ....+||+.|+|||++.+..++.++||| +|+++|||++|..||...
T Consensus 312 LKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 312 LKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred CchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999987654322 2346899999999999998999999999 999999999999998653
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
............+... +.. + +......+.+++..||+.||.+|| ++.+|++
T Consensus 389 ~~~~~~~~i~~~i~~~---~~~---~--------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 389 KKKIKREEVERLVKEV---PEE---Y--------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SSCCCHHHHHHHHHHC---CCC---C--------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccchhHHHHHHHhhcc---ccc---C--------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 3322223333322211 110 0 011123477888999999999999 6788764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.28 Aligned_cols=257 Identities=23% Similarity=0.310 Sum_probs=186.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+++.||||.+...... ......+.+|+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~~ 76 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQN-------------------------QTHAKRAYRELV 76 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSS-------------------------HHHHHHHHHHHH
T ss_pred hhhheeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCC-------------------------hHHHHHHHHHHH
Confidence 3579999999999999999999854 57999999999653222 223566788999
Q ss_pred HHhhccCCCccceeEEEecCCc----ceeeeeccccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQGR------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+. ..++++++++.++ ..++......++.|++.||.|||+.+ ++||||
T Consensus 77 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dl 153 (371)
T 2xrw_A 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 153 (371)
T ss_dssp HHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 9999999999999999876542 3689999999763 23677778899999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+||+++.++.+||+|||++....... ......||+.|+|||++.+..++.++||| +|+++|+|++|..||...
T Consensus 154 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~- 229 (371)
T 2xrw_A 154 KPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT- 229 (371)
T ss_dssp CGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred CHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC-
Confidence 9999999999999999999997654322 22346789999999999998999999999 999999999999997542
Q ss_pred cccchhhHHHHHHHHhhhcCC------------------C--c-----cccccccCCC---cHHHHHHHHHHHhhccCCC
Q 046907 275 QHTNEMSFVKWMRNVMASENP------------------K--R-----AIDSKLVGNG---CEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~------------------~--~-----~~~~~~~~~~---~~~~~~~l~~li~~Cl~~d 326 (345)
+.......+......+.+ . . .......+.. .......+.+++.+||+.|
T Consensus 230 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 306 (371)
T 2xrw_A 230 ---DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306 (371)
T ss_dssp ---SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred ---CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCC
Confidence 222222222211111000 0 0 0000000011 1223567899999999999
Q ss_pred CCCCCCHHHHHH
Q 046907 327 PNERPNSKDVRR 338 (345)
Q Consensus 327 p~~Rpt~~~ll~ 338 (345)
|++|||+.++++
T Consensus 307 P~~R~t~~e~l~ 318 (371)
T 2xrw_A 307 ASKRISVDEALQ 318 (371)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHhC
Confidence 999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=302.81 Aligned_cols=236 Identities=21% Similarity=0.273 Sum_probs=181.9
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
.+.||+|+||.||+|+.. .+|..||+|.+..... ...+.+.+|+.++++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~---------------------------~~~~~~~~E~~~l~~l~h 145 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGM---------------------------KDKEEVKNEISVMNQLDH 145 (373)
T ss_dssp EEECC-----CEEEEEET-TTCCEEEEEEEECCSH---------------------------HHHHHHHHHHHHHTTCCC
T ss_pred ceEEecCcCEEEEEEEEc-CCCcEEEEEEEccccc---------------------------ccHHHHHHHHHHHHhCCC
Confidence 568999999999999864 5799999999975321 224567899999999999
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
|||+++++++...+ .+++++||++++++ +++.....++.|++.||.|||+.+ ++||||||+|||+
T Consensus 146 pnIv~~~~~~~~~~--~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 220 (373)
T 2x4f_A 146 ANLIQLYDAFESKN--DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILC 220 (373)
T ss_dssp TTBCCEEEEEECSS--EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred CCCCeEEEEEEECC--EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEE
Confidence 99999999998776 68999999988654 566677889999999999999999 9999999999999
Q ss_pred --cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccch
Q 046907 203 --DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279 (345)
Q Consensus 203 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~ 279 (345)
+.++.+||+|||++........ .....||+.|+|||++.+..++.++||| +|+++|||++|..||.. .+.
T Consensus 221 ~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~----~~~ 293 (373)
T 2x4f_A 221 VNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG----DND 293 (373)
T ss_dssp EETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC----SSH
T ss_pred ecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC----CCH
Confidence 5677899999999987654322 2345799999999999988899999999 99999999999999643 233
Q ss_pred hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
......+........ .. ........+.+++.+||+.||.+|||+.++++
T Consensus 294 ~~~~~~i~~~~~~~~------~~----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 294 AETLNNILACRWDLE------DE----EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHHHTCCCSC------SG----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCCCC------hh----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 333333322211100 00 01112235788999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=300.37 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=182.2
Q ss_pred hcCCcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|++.+.||+|+||.||+|+.. ..+|+.||+|.+........ ......+.+|
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------------------~~~~~~~~~E 71 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-----------------------AKDTAHTKAE 71 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------------------------H
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh-----------------------hhHHHHHHHH
Confidence 5679999999999999999999863 24789999999975422110 1235567789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.+++.++||||+++++++..++ .++++++++.++.+ ++......++.|++.||.|||+.+ ++|||
T Consensus 72 ~~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~D 146 (327)
T 3a62_A 72 RNILEEVKHPFIVDLIYAFQTGG--KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRD 146 (327)
T ss_dssp HHHHHHCCCTTBCCEEEEEECSS--CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHHHhCCCCCccceeEEEEcCC--EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEccc
Confidence 99999999999999999998766 68999999988654 455667789999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 147 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 147 LKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp CCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999875432211 23446899999999999998899999999 999999999999997532
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
+.......+.... .. . ++.....+.+++.+||+.||.+|| ++.++++
T Consensus 225 ----~~~~~~~~i~~~~---~~---~--------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 225 ----NRKKTIDKILKCK---LN---L--------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----SHHHHHHHHHHTC---CC---C--------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CHHHHHHHHHhCC---CC---C--------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 2233322222211 10 0 011123477889999999999999 6777765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=301.48 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=188.4
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+.++|++.+.||+|+||.||+|++ +++.||||.+..... .......|+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~----------------------------~~~~~e~~~ 58 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANR----------------------------QNFINEKNI 58 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGH----------------------------HHHHHHHHH
T ss_pred cChHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccch----------------------------hhHHHHHHH
Confidence 3678999999999999999999986 689999999853210 011112344
Q ss_pred HHHhhccCCCccceeEEEe---cCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhc--------
Q 046907 125 NTVGQIRHRNLHPLLAHVT---RPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMH-------- 185 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~---~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~-------- 185 (345)
..+..++||||+++++.+. ..+...+++++||++++++ .++.....++.|++.||.|||+.
T Consensus 59 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp HTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred HHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 4456689999999998553 3334467899999988765 35556778999999999999999
Q ss_pred -CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCc------ceeccCcccCccccccccccc-------cccCcc
Q 046907 186 -HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT------HITTSNVVGTVEYIAPEYLQM-------LTLTEK 251 (345)
Q Consensus 186 -~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~~~aPE~~~~-------~~~~~~ 251 (345)
+ ++||||||+|||++.++.+||+|||++........ ........||+.|+|||++.+ ..++.+
T Consensus 139 ~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 215 (336)
T 3g2f_A 139 PA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215 (336)
T ss_dssp CC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred cc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence 8 99999999999999999999999999987654321 112234679999999999987 456789
Q ss_pred chhh-HHHHHHHHHhCCCCCcccccccchh-h---------HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHh
Q 046907 252 CDIY-FGALLAGLVMGKLPSDKFFQHTNEM-S---------FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIAC 320 (345)
Q Consensus 252 ~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 320 (345)
+||| +|+++|||++|..||.......... . ....+............++... ...+.....+.++|.
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~ 293 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIE 293 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHH
Confidence 9999 9999999999977743211111000 0 0011111111111111111111 122345667899999
Q ss_pred hccCCCCCCCCCHHHHHHHHhhhh
Q 046907 321 FCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 321 ~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
+||+.||++|||+.++++.|+++.
T Consensus 294 ~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 294 DCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp HHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCChhhCcchHHHHHHHHHHH
Confidence 999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.26 Aligned_cols=243 Identities=17% Similarity=0.218 Sum_probs=180.5
Q ss_pred cCCcccc-cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASL-EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 47 ~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.++|.+. +.||+|+||.||+|+.. .+|+.||||.+... ..+.+|+.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~--------------------------------~~~~~E~~ 106 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC--------------------------------PKARREVE 106 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECS--------------------------------HHHHHHHH
T ss_pred cccceeccceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc--------------------------------hhHHHHHH
Confidence 4567776 68999999999999854 67999999998531 23456777
Q ss_pred HHhh-ccCCCccceeEEEec--CCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 126 TVGQ-IRHRNLHPLLAHVTR--PDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 126 ~l~~-l~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
++.+ .+||||+++++++.. .+...+++++||+.++++ +++..+..++.|++.||.|||+.+ ++
T Consensus 107 ~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 183 (400)
T 1nxk_A 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IA 183 (400)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 7644 589999999998864 334578999999988543 677778899999999999999998 99
Q ss_pred ecCCCCCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 192 HRDLNPVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 192 H~dlk~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
||||||+|||++. ++.+||+|||+++...... .....+||+.|+|||++.+..++.++||| +|+++|||++|.
T Consensus 184 HrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 260 (400)
T 1nxk_A 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCC
Confidence 9999999999997 7899999999998654322 22456889999999999998999999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.||...............+...... .+ ..........+.++|..||+.||++|||+.++++
T Consensus 261 ~pf~~~~~~~~~~~~~~~i~~~~~~-~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 261 PPFYSNHGLAISPGMKTRIRMGQYE-FP---------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CSCCCCTTCSSCCSHHHHHHHTCCC-CC---------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCCccccccHHHHHHHHcCccc-CC---------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9986533322212222222221110 00 0011122345788999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=308.46 Aligned_cols=249 Identities=19% Similarity=0.235 Sum_probs=190.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++++.||+|+||.||+|+.+ .+|+.||+|.+.... .........+.+|.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~------------------------~~~~~~~~~~~~E~ 112 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWD------------------------MLKRGEVSCFREER 112 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHH------------------------HHHHGGGCCHHHHH
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHH------------------------hhhHHHHHHHHHHH
Confidence 46789999999999999999999964 579999999995210 00122345577899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.++..++||||+++++++.+++ .+++++||+.++++ +++..+..++.|++.||.|||+.+ ++|||
T Consensus 113 ~il~~~~hp~Iv~l~~~~~~~~--~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrD 187 (412)
T 2vd5_A 113 DVLVNGDRRWITQLHFAFQDEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRD 187 (412)
T ss_dssp HHHHHSCTTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHhcCCCCeeeEEEEEeeCC--EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 9999999999999999998776 79999999988654 555566789999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-------ccccCccchhh-HHHHHHHHHhC
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-------MLTLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-------~~~~~~~~Dvw-lG~vl~el~tg 266 (345)
|||+|||++.++.+||+|||++........ ......+||+.|+|||++. +..++.++||| +|+++|||++|
T Consensus 188 LKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 188 IKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred cCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence 999999999999999999999987654322 1233468999999999997 35689999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER---PNSKDVRR 338 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~R---pt~~~ll~ 338 (345)
..||.. .+.......+........... ........+.++|..||+ +|.+| |+++++++
T Consensus 267 ~~Pf~~----~~~~~~~~~i~~~~~~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 267 QTPFYA----DSTAETYGKIVHYKEHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp SCTTCC----SSHHHHHHHHHTHHHHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCCCC----CCHHHHHHHHHhcccCcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 999743 233333333322111111100 001112347789999999 99998 58888864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=312.01 Aligned_cols=242 Identities=25% Similarity=0.390 Sum_probs=192.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+++.||+|+||.||+|++. .+|+.||||.+...... .......+.+|+.
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~------------------------~~~~~~~~~~Ei~ 68 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIR------------------------SLDVVGKIRREIQ 68 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHH------------------------HTTTHHHHHHHHH
T ss_pred eecCEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhcc------------------------CHHHHHHHHHHHH
Confidence 4568999999999999999999864 57999999998521100 0122567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .+++++|++.+++ .++......++.|++.||.|||+.+ ++|||||
T Consensus 69 ~l~~l~HpnIv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLk 143 (476)
T 2y94_A 69 NLKLFRHPHIIKLYQVISTPS--DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLK 143 (476)
T ss_dssp HHTTCCCTTBCCEEEEEECSS--EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCS
T ss_pred HHHhCCCCCCCcEEEEEEECC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCccccc
Confidence 999999999999999998776 6899999997753 3677888999999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++....... .....+||+.|+|||.+.+..+ +.++||| +|+++|+|++|..||...
T Consensus 144 p~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~- 219 (476)
T 2y94_A 144 PENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD- 219 (476)
T ss_dssp GGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred HHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC-
Confidence 999999999999999999998765432 2344689999999999998775 6899999 999999999999997532
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.... ... + .. ....+.+++..||+.||++|||+.++++
T Consensus 220 ---~~~~~~~~i~~~~---~~~-------p-~~---~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 220 ---HVPTLFKKICDGI---FYT-------P-QY---LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---SSHHHHHHHHTTC---CCC-------C-TT---CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CHHHHHHHHhcCC---cCC-------C-cc---CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 2233333332211 100 0 01 1124778899999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=295.21 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=185.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||+|.+....... ......+.+|+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~~e~~ 86 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSD------------------------PVFRTRMQREAR 86 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGS------------------------HHHHHHHHHHHH
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccC------------------------HHHHHHHHHHHH
Confidence 4679999999999999999999854 578999999985432211 223567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.++++ +++.....++.|++.||.|||+.+ ++|+|||
T Consensus 87 ~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlk 161 (309)
T 2h34_A 87 TAGRLQEPHVVPIHDFGEIDG--QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVK 161 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETT--EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred HHhhcCCCCeeEEEEEEeeCC--eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCC
Confidence 999999999999999998776 68899999987543 566777899999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||+++.++.+||+|||++......... ......|++.|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-- 238 (309)
T 2h34_A 162 PENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-- 238 (309)
T ss_dssp GGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC--
T ss_pred hHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc--
Confidence 99999999999999999998765443211 22346789999999999998899999999 999999999999997532
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhh
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-NSKDVRRMLSQIQ 344 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-t~~~ll~~L~~l~ 344 (345)
........+. ...+... . ..+.....+.+++..||+.||++|| |+.++++.|+++.
T Consensus 239 --~~~~~~~~~~----~~~~~~~---~----~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 239 --QLSVMGAHIN----QAIPRPS---T----VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp --HHHHHHHHHH----SCCCCGG---G----TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred --hHHHHHHHhc----cCCCCcc---c----cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 2222222221 1111100 0 0111222477889999999999999 9999999998763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=309.35 Aligned_cols=253 Identities=18% Similarity=0.248 Sum_probs=187.7
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|+.. .+|+.||||.+..... ...+|
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~-------------------------------~~~~E 50 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPR-------------------------------YKNRE 50 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCTT-------------------------------SCCHH
T ss_pred ccccceEEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCcc-------------------------------hHHHH
Confidence 346779999999999999999999854 5899999999864321 12369
Q ss_pred HHHHhhccCCCccceeEEEecC------------------------------------CcceeeeeccccCCC-------
Q 046907 124 INTVGQIRHRNLHPLLAHVTRP------------------------------------DCHLLYILNDVSQGR------- 160 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~------------------------------------~~~~l~~~~~~~~~~------- 160 (345)
+.+++.++||||+++++++... +...+++++++++++
T Consensus 51 ~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~ 130 (383)
T 3eb0_A 51 LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130 (383)
T ss_dssp HHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHH
T ss_pred HHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHH
Confidence 9999999999999999988553 233578999999753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec-CCCCeEEeccccceecCCCCcceeccCcccC
Q 046907 161 -----RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGT 234 (345)
Q Consensus 161 -----~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 234 (345)
..+++..+..++.|++.||.|||+.+ ++||||||+||+++ .++.+||+|||++........ .....||
T Consensus 131 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t 204 (383)
T 3eb0_A 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICS 204 (383)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCC
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccC
Confidence 45777788899999999999999998 99999999999998 688999999999987644332 2346789
Q ss_pred ccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcc----------cccc
Q 046907 235 VEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRA----------IDSK 302 (345)
Q Consensus 235 ~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 302 (345)
+.|+|||.+.+.. ++.++||| +|+++|||++|..||.. ....+....+......+..... ..+.
T Consensus 205 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~----~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 280 (383)
T 3eb0_A 205 RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG----ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280 (383)
T ss_dssp SSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCC
T ss_pred CCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC----CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCc
Confidence 9999999988754 89999999 99999999999999653 2333333333332222111000 0000
Q ss_pred ccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 303 LVGN-----GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 303 ~~~~-----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.... ........+.+++..||+.||.+|||+.++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 11112345788999999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=291.11 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=190.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+++.||+|.+...... .....+.+|+.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~e~~~ 58 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAV--------------------------DCPENIKKEICI 58 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCT--------------------------THHHHHHHHHHH
T ss_pred ecceEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccch--------------------------hhhHHHHHHHHH
Confidence 468999999999999999999864 57899999998532111 124567789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ ..+++++++++++ .++......++.|++.||.|||+.+ ++|+||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p 133 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKP 133 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETT--EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred HHhcCCCCceeeeeEEEcCC--EEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCh
Confidence 99999999999999998766 6788899987753 3667788899999999999999998 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+||+++.++.++|+|||.+................||..|+|||.+.+..+ +.++||| +|+++|+|++|..||.....
T Consensus 134 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred HHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 999999999999999999986543322222345678999999999988775 7789999 99999999999999865322
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
. ......+... ..... ........+.+++..||+.||++|||+.++++
T Consensus 214 ~--~~~~~~~~~~----~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 214 S--CQEYSDWKEK----KTYLN---------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp T--SHHHHHHHTT----CTTST---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred H--HHHHHHhhhc----ccccC---------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1 1112111111 00000 00112234778999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.01 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=184.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+++.||||.+...... ......+.+|+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 85 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEE-------------------------EGVPGTAIREVS 85 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC---------------------------------CHHHHH
T ss_pred chhhEEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEcccccc-------------------------cccchhHHHHHH
Confidence 5568999999999999999999854 57999999999654322 223556778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR--------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++ .++++++++.+. ..+++..+..++.|++.||.|||+.+ ++||||||
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp 160 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNH--RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKP 160 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred HHHHcCCCCcceEEEEEecCC--EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCH
Confidence 999999999999999998776 688999998752 23677778899999999999999999 99999999
Q ss_pred CCeeec-----CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCC
Q 046907 198 VNVLLD-----DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 198 ~nil~~-----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
+|||++ ..+.+||+|||++........ ......||..|+|||++.+.. ++.++||| +|+++|+|++|..||
T Consensus 161 ~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 238 (329)
T 3gbz_A 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238 (329)
T ss_dssp GGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999994 445699999999986643221 223457899999999998754 89999999 999999999999996
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCcccc-----------ccccCCCcH-----HHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAID-----------SKLVGNGCE-----EQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~-----~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
.. ....+....+......+....... +........ .....+.+++..||+.||++|||+.
T Consensus 239 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 314 (329)
T 3gbz_A 239 PG----DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314 (329)
T ss_dssp CC----SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CC----CCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHH
Confidence 43 233333333333322221110000 000000000 0224578899999999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
++++
T Consensus 315 e~l~ 318 (329)
T 3gbz_A 315 NALE 318 (329)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=301.75 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=195.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|++ +|+.||||.+... ....+.+|..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~------------------------------~~~~~~~e~~ 86 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR------------------------------EERSWFREAE 86 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG------------------------------GHHHHHHHHH
T ss_pred ccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCch------------------------------hHHHHHHHHH
Confidence 346899999999999999999986 5889999998521 1334567788
Q ss_pred HHhh--ccCCCccceeEEEecCCcc--eeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHh--------hc
Q 046907 126 TVGQ--IRHRNLHPLLAHVTRPDCH--LLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLH--------MH 185 (345)
Q Consensus 126 ~l~~--l~hpniv~l~~~~~~~~~~--~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh--------~~ 185 (345)
++.. ++||||+++++++..++.. .++++++++.++++ +++.....++.|++.||.||| +.
T Consensus 87 ~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 166 (342)
T 1b6c_B 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166 (342)
T ss_dssp HHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred HHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC
Confidence 8876 7999999999998876532 68899999988765 556677889999999999999 77
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcce--eccCcccCcccccccccccc------ccCccchhh-H
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI--TTSNVVGTVEYIAPEYLQML------TLTEKCDIY-F 256 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~~~aPE~~~~~------~~~~~~Dvw-l 256 (345)
+ ++||||||+||+++.++.+||+|||++.......... ......||+.|+|||.+.+. .++.++||| +
T Consensus 167 ~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 167 A---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp E---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred C---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 7 9999999999999999999999999998765433221 23456899999999999875 334789999 9
Q ss_pred HHHHHHHHhC----------CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCC
Q 046907 257 GALLAGLVMG----------KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLED 326 (345)
Q Consensus 257 G~vl~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~d 326 (345)
|+++|||++| ..||.......... ........ ..........+. ...++...+.+++.+||+.|
T Consensus 244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~d 317 (342)
T 1b6c_B 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV--EEMRKVVC-EQKLRPNIPNRW---QSCEALRVMAKIMRECWYAN 317 (342)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH--HHHHHHHT-TSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSS
T ss_pred HHHHHHHHhccCcCCcccccccCccccCcCcccH--HHHHHHHH-HHHhCCCCcccc---cchhHHHHHHHHHHHHhccC
Confidence 9999999999 77865433322111 11111111 111111111111 12356677899999999999
Q ss_pred CCCCCCHHHHHHHHhhhh
Q 046907 327 PNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 327 p~~Rpt~~~ll~~L~~l~ 344 (345)
|++|||+.+|++.|+++.
T Consensus 318 p~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 318 GAARLTALRIKKTLSQLS 335 (342)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHH
Confidence 999999999999999884
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=295.34 Aligned_cols=255 Identities=19% Similarity=0.260 Sum_probs=195.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+|+.||||.+..... ...+.+|+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-----------------------------~~~~~~e~~ 56 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK-----------------------------HPQLHIESK 56 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCSS-----------------------------CCHHHHHHH
T ss_pred eccEEEEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCcc-----------------------------hhHHHHHHH
Confidence 4579999999999999999999854 5799999999864321 234678999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++|++++..+..+...+ ...+++++++.+ ...+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 57 ~l~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlk 132 (296)
T 3uzp_A 57 IYKMMQGGVGIPTIRWCGAEG-DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVK 132 (296)
T ss_dssp HHHHHTTSTTCCCEEEEEEET-TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred HHHHhhcCCCCCccccccCCC-CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCC
Confidence 999999998887777665443 367889999832 224677778899999999999999999 9999999
Q ss_pred CCCeee---cCCCCeEEeccccceecCCCCcce-----eccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 197 PVNVLL---DDDIEARISGFGFARAIPDAHTHI-----TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 197 ~~nil~---~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|+||++ +.++.+||+|||++.......... ......||+.|+|||.+.+..++.++||| +|+++|+|++|.
T Consensus 133 p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 212 (296)
T 3uzp_A 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred HHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 999999 478899999999998765543211 12456899999999999999999999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||......................+. ... . ......+.+++..||+.||++|||+.++++.|+++.
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 213 LPWQGLKAATKRQKYERISEKKMSTPI--EVL----C----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp CTTSSCCCSSSSSHHHHHHHHHHHSCH--HHH----T----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCcCchhhhhhhhhhcccccCCch--HHH----H----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 998764433333333332222221110 000 0 011234778899999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.94 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=194.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||+|.+.....+ ....+.+.+|+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~e~~ 57 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMT-------------------------EAEKQMLVSEVN 57 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCC-------------------------HHHHHHHHHHHH
T ss_pred chhheeeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCC-------------------------HHHHHHHHHHHH
Confidence 4578999999999999999999864 57999999999754322 223567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcC--CCCe
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHH--CPRI 190 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~--~~~i 190 (345)
+++.++||||+++++++.......+++++++++++++ +++.....++.|++.||.|||+.+ ..++
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i 137 (279)
T 2w5a_A 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 137 (279)
T ss_dssp HHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------
T ss_pred HHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCee
Confidence 9999999999999998876555689999999987543 667778899999999999999986 1239
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+|+||||+||+++.++.+||+|||++........ ......|+..|+|||.+.+..++.++||| +|+++|+|++|..|
T Consensus 138 vH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 138 LHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999976543221 12235789999999999998899999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
|... ...+....+........+ ......+.+++.+||+.||.+|||+.+|++.+.
T Consensus 216 ~~~~----~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 216 FTAF----SQKELAGKIREGKFRRIP-------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SCCS----SHHHHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred Cccc----CHHHHHHHHhhcccccCC-------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 7542 333333333332211111 112234778899999999999999999997654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.15 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=188.3
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..-.++|++.+.||+|+||.||+|+.. .++..||+|.+...... .......+.+.+|
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~----------------------~~~~~~~~~~~~E 78 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIR----------------------QINPKDVERIKTE 78 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHH----------------------C---CHHHHHHHH
T ss_pred hhhhhheeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhc----------------------ccCHHHHHHHHHH
Confidence 446678999999999999999999854 67899999998521100 0012346778899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC----------------------------------------
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL---------------------------------------- 163 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l---------------------------------------- 163 (345)
+.+++.++||||+++++++...+ .+++++++++++++.
T Consensus 79 ~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (345)
T 3hko_A 79 VRLMKKLHHPNIARLYEVYEDEQ--YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156 (345)
T ss_dssp HHHHHHCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--
T ss_pred HHHHHhCCCCCcceeehhhccCC--eEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccc
Confidence 99999999999999999998766 789999999886542
Q ss_pred ---------CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCC--CeEEeccccceecCCCCc--ceeccC
Q 046907 164 ---------DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI--EARISGFGFARAIPDAHT--HITTSN 230 (345)
Q Consensus 164 ---------~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~ 230 (345)
+......++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++........ ......
T Consensus 157 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 233 (345)
T 3hko_A 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233 (345)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccc
Confidence 23345679999999999999998 99999999999998666 899999999986643211 112345
Q ss_pred cccCccccccccccc--cccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCC
Q 046907 231 VVGTVEYIAPEYLQM--LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNG 307 (345)
Q Consensus 231 ~~gt~~~~aPE~~~~--~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (345)
..||+.|+|||.+.+ ..++.++||| +|+++|||++|..||... ........+.. ....... ..
T Consensus 234 ~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----~~~~~~~~~~~---~~~~~~~-------~~ 299 (345)
T 3hko_A 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV----NDADTISQVLN---KKLCFEN-------PN 299 (345)
T ss_dssp -CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHH---CCCCTTS-------GG
T ss_pred cCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----ChHHHHHHHHh---cccccCC-------cc
Confidence 679999999999975 5688999999 999999999999997432 22222222221 1111000 00
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 308 CEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 308 ~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+.+++..||+.||.+|||+.++++
T Consensus 300 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1112234778999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=302.74 Aligned_cols=259 Identities=23% Similarity=0.260 Sum_probs=187.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++. .+|+.||||.+........ .......+.+|+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~~E~~ 64 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEA----------------------KDGINRTALREIK 64 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC----------------------------------CTHHHHHHH
T ss_pred HhcccEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchh----------------------hhhhhHHHHHHHH
Confidence 5679999999999999999999864 5789999999964321110 0112346778999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++...+ .++++++++.++ ..+++..+..++.|++.||.|||+.+ ++|||||
T Consensus 65 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 139 (346)
T 1ua2_A 65 LLQELSHPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLK 139 (346)
T ss_dssp HHHHCCCTTBCCEEEEECCTT--CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred HHhhCCCCCCCeEEEEEeeCC--ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCC
Confidence 999999999999999987765 577888888652 24667778899999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++........ ......||+.|+|||.+.+. .++.++||| +|+++|+|++|.+||..
T Consensus 140 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~-- 215 (346)
T 1ua2_A 140 PNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG-- 215 (346)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred HHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC--
Confidence 9999999999999999999986643321 22346789999999999764 478999999 99999999999999643
Q ss_pred cccchhhHHHHHHHHhhhcCCCcccc---------ccccCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAID---------SKLVGNGC-----EEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~-----~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
....+....+......+......+ ....+... ......+.+++..||+.||++|||+.++++
T Consensus 216 --~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 216 --DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp --SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred --CCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 233333333333332221111000 00000111 122356888999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=290.38 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=187.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|++.+.||+|+||.||+|++. .++..||+|.+...... .......+.+|+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~e~~ 61 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLE------------------------KAGVEHQLRREVE 61 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHH------------------------HHTCHHHHHHHHH
T ss_pred ecccEEEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccc------------------------hhhHHHHHHHHHH
Confidence 4578999999999999999999864 57889999998421100 0122456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++...+ ..++++++++++.+ ++......++.|++.||.|||+.+ ++|+|||
T Consensus 62 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlk 136 (279)
T 3fdn_A 62 IQSHLRHPNILRLYGYFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIK 136 (279)
T ss_dssp HHTTCCCTTBCCEEEEEECSS--EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCC
T ss_pred HHHcCCCCCCcchhheEecCC--EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCC
Confidence 999999999999999998775 68899999987644 566677889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||+++.++.++|+|||++...... ......|++.|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 137 p~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~--- 209 (279)
T 3fdn_A 137 PENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA--- 209 (279)
T ss_dssp GGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC---
T ss_pred hHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC---
Confidence 99999999999999999988654332 12346789999999999998899999999 99999999999999753
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+.... .. .+......+.+++..||+.||.+|||+.++++
T Consensus 210 -~~~~~~~~~~~~~~---~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 210 -NTYQETYKRISRVE---FT-----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -SSHHHHHHHHHHTC---CC-----------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CcHHHHHHHHHhCC---CC-----------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 22223333222211 11 00111234678899999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=297.04 Aligned_cols=242 Identities=15% Similarity=0.235 Sum_probs=187.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCC-------ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNG-------RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
..++|++.+.||+|+||.||+|+++. ++ ..||+|.+.... ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~~va~K~~~~~~---------------------------~~~~~ 57 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRRE-VGDYGQLHETEVLLKVLDKAH---------------------------RNYSE 57 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEE-ECGGGCEEEEEEEEEEECGGG---------------------------GGGHH
T ss_pred chhHeeeeeeeccCCCceEEEEEEec-ccccccccchhhhhhhccccc---------------------------HHHHH
Confidence 46789999999999999999998652 33 579999985321 11245
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
.+.+|+.+++.++||||+++++++..++ ..+++++++.++++ ++...+..++.|++.||.|||+.+
T Consensus 58 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-- 133 (289)
T 4fvq_A 58 SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133 (289)
T ss_dssp HHHHHHHHHHTSCCTTBCCEEEEECCTT--CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCEeEEEEEEEeCC--CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 6789999999999999999999998766 56889999987654 666677889999999999999999
Q ss_pred CeEecCCCCCCeeecCCCC--------eEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHH
Q 046907 189 RIIHRDLNPVNVLLDDDIE--------ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGA 258 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~--------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~ 258 (345)
++||||||+||+++.++. +||+|||++...... ....||..|+|||.+.+ ..++.++||| +|+
T Consensus 134 -ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 206 (289)
T 4fvq_A 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGT 206 (289)
T ss_dssp -CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred -eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence 999999999999998776 999999998654321 23567899999999987 6689999999 999
Q ss_pred HHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 259 LLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 259 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
++|+|++|..|+ +.............. ........+ ..+.+++..||+.||++|||+.++++
T Consensus 207 il~el~~g~~~~---~~~~~~~~~~~~~~~---~~~~~~~~~------------~~l~~li~~~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 207 TLWEICSGGDKP---LSALDSQRKLQFYED---RHQLPAPKA------------AELANLINNCMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp HHHHHHTTTCCT---TTTSCHHHHHHHHHT---TCCCCCCSS------------CTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCC---ccccchHHHHHHhhc---cCCCCCCCC------------HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999965442 222222222222211 111111111 12778999999999999999999999
Q ss_pred HHhhhh
Q 046907 339 MLSQIQ 344 (345)
Q Consensus 339 ~L~~l~ 344 (345)
.|+++.
T Consensus 269 ~l~~l~ 274 (289)
T 4fvq_A 269 DLNSLF 274 (289)
T ss_dssp HHHTCC
T ss_pred HHHHhc
Confidence 999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=305.12 Aligned_cols=253 Identities=18% Similarity=0.254 Sum_probs=186.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.. .+++.||+|.+...... .....+.+|+.++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~~E~~~l 54 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEE--------------------------GAPCTAIREVSLL 54 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC--------------------------------CCCCCCCHHHH
T ss_pred CceEEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEeccccc--------------------------ccchhHHHHHHHH
Confidence 58999999999999999999864 57899999998643211 1122345799999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ .++++++++++ +..++...+..++.|++.||.|||+.+ ++||||||+
T Consensus 55 ~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~ 129 (324)
T 3mtl_A 55 KDLKHANIVTLHDIIHTEK--SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQ 129 (324)
T ss_dssp SCCCCTTBCCEEEEEECSS--CEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGG
T ss_pred HhcCCCCCCeeeeEEeeCC--EEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHH
Confidence 9999999999999998776 68899999875 234677788899999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
||+++.++.+||+|||++........ ......||+.|+|||.+.+ ..++.++||| +|+++|+|++|..||..
T Consensus 130 NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~---- 203 (324)
T 3mtl_A 130 NLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG---- 203 (324)
T ss_dssp GEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred HEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC----
Confidence 99999999999999999976543221 2234578999999999976 4589999999 99999999999999643
Q ss_pred cchhhHHHHHHHHhhhcCCCccc---cc---------cccCC----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAI---DS---------KLVGN----GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~---~~---------~~~~~----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
....+....+......+...... .. ..... ..+.....+.+++..||+.||.+|||+.++++
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 34444445554444332221110 00 00000 00112345778999999999999999999976
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=301.14 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=196.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+|+.||+|.+........ ....+.+|+.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-------------------------~~~~~~~E~~ 68 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEG-------------------------FPITALREIK 68 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSS-------------------------SCHHHHHHHH
T ss_pred cccceeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEeccccccc-------------------------chHHHHHHHH
Confidence 4579999999999999999999964 5799999999865433211 1345668999
Q ss_pred HHhhccCCCccceeEEEecCC------cceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD------CHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~------~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+++.++||||+++++++.... ...++++++++.+ ...+++..+..++.|++.||.|||+.+ +
T Consensus 69 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i 145 (351)
T 3mi9_A 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---I 145 (351)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 999999999999999988754 2368899999875 234788889999999999999999999 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCc--ceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT--HITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg 266 (345)
+||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+. .++.++||| +|+++|+|++|
T Consensus 146 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred eCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987653221 1223456789999999999764 579999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCcccc---ccc------c---CCCcHHH------HHHHHHHHhhccCCCCC
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAID---SKL------V---GNGCEEQ------MLLVLKIACFCTLEDPN 328 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------~---~~~~~~~------~~~l~~li~~Cl~~dp~ 328 (345)
..||.. .........+........+..... ... . .....+. ...+.+++.+||+.||+
T Consensus 226 ~~pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 301 (351)
T 3mi9_A 226 SPIMQG----NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301 (351)
T ss_dssp SCSCCC----SSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG
T ss_pred CCCCCC----CChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh
Confidence 999653 344444444444433222211000 000 0 0001111 23478899999999999
Q ss_pred CCCCHHHHHH
Q 046907 329 ERPNSKDVRR 338 (345)
Q Consensus 329 ~Rpt~~~ll~ 338 (345)
+|||+.++++
T Consensus 302 ~R~t~~e~l~ 311 (351)
T 3mi9_A 302 QRIDSDDALN 311 (351)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhC
Confidence 9999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=303.15 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=190.6
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++++.||+|+||.||+|+.. .+|+.||+|.+.....+ ......+.+|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E 74 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDD-------------------------KMVKKIAMRE 74 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSC-------------------------HHHHHHHHHH
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCc-------------------------hHHHHHHHHH
Confidence 446779999999999999999999864 57999999998654322 2235567789
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.+++.++||||+++++++...+ .+++++++++++ ..+++.....++.|++.||.|||+.+ ++|||
T Consensus 75 ~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~d 149 (331)
T 4aaa_A 75 IKLLKQLRHENLVNLLEVCKKKK--RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRD 149 (331)
T ss_dssp HHHHHHCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHHhhCCCCCEeeEEEEeecCC--EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccC
Confidence 99999999999999999998776 688999998764 34677888899999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|||+||+++.++.+||+|||++........ ......||..|+|||.+.+. .++.++||| +|+++|+|++|..||..
T Consensus 150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 150 IKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp CCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999976543322 22346789999999999875 688999999 99999999999999754
Q ss_pred cccccchhhHHHHHHHHhhhcCC------------CccccccccCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENP------------KRAIDSKLVGN-----GCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~-----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
. ...+....+........+ .....+..... ..+.....+.+++..||+.||++|||+.+
T Consensus 228 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 303 (331)
T 4aaa_A 228 D----SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303 (331)
T ss_dssp S----SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred C----CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence 2 222222222211111000 00000000000 01123456889999999999999999998
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 304 ll~ 306 (331)
T 4aaa_A 304 LLH 306 (331)
T ss_dssp GGG
T ss_pred Hhc
Confidence 875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=315.34 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=192.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+.+.||+|+||.||+|+.+ .+|+.||+|.+..... ........+.+|+.
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~------------------------~~~~~~~~~~~E~~ 237 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRL------------------------KKRKGYQGAMVEKK 237 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHH
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHh------------------------hhhHHHHHHHHHHH
Confidence 3478999999999999999999964 5799999999852110 00123567788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+++.++||||+++++++...+ .++++++|+.++++ +++.....++.|++.||.|||+.+ ++|
T Consensus 238 iL~~l~hp~Iv~l~~~~~~~~--~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvH 312 (543)
T 3c4z_A 238 ILAKVHSRFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIY 312 (543)
T ss_dssp HHHHCCCTTBCCEEEEEECSS--EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCEeeEEEEEeeCC--EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---Ccc
Confidence 999999999999999988776 68999999987643 666777889999999999999999 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|||||+|||++.++.+||+|||++........ .....+||+.|+|||++.+..++.++||| +|+++|||++|..||.
T Consensus 313 rDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~ 390 (543)
T 3c4z_A 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390 (543)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654322 22346899999999999999999999999 9999999999999986
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS-----KDVR 337 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~-----~~ll 337 (345)
..............+.. .... + ++.....+.+++..||+.||.+||++ .+|+
T Consensus 391 ~~~~~~~~~~~~~~i~~---~~~~---~--------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 391 ARGEKVENKELKQRVLE---QAVT---Y--------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp CTTCCCCHHHHHHHHHH---CCCC---C--------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred CCccchhHHHHHHHHhh---cccC---C--------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 53322222233222221 1110 0 01112346788899999999999975 5555
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=327.10 Aligned_cols=250 Identities=19% Similarity=0.266 Sum_probs=190.1
Q ss_pred cCCccccc-ccccCcceeeEEEEec-CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLE-KIGSGGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 47 ~~~~~~~~-~iG~G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+.+.+.. .||+|+||.||+|.+. ..+++.||||.++....+ ....+.+.+|+
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------------------------~~~~~~~~~E~ 421 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------------------------PALKDELLAEA 421 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-------------------------GGGHHHHHHHH
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-------------------------HHHHHHHHHHH
Confidence 33344433 7999999999999764 235789999999643222 11256788999
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
.++++++|||||++++++..+. ++++++++.++++ +++..+..++.|++.||.|||+.+ ++||||
T Consensus 422 ~il~~l~hpnIv~l~~~~~~~~---~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDL 495 (635)
T 4fl3_A 422 NVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDL 495 (635)
T ss_dssp HHHHHCCCTTBCCEEEEEESSS---EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHHHhCCCCCEeeEEEEEecCC---EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCC
Confidence 9999999999999999987543 7789999988654 566677899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDK 272 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~ 272 (345)
||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||| ||+++|||++ |..||..
T Consensus 496 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp SGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876543221 122334568899999999998999999999 9999999998 9999644
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.........+........+ ..+...+.++|..||+.||++|||+.+|++.|+++.
T Consensus 576 ----~~~~~~~~~i~~~~~~~~p-------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 576 ----MKGSEVTAMLEKGERMGCP-------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp ----CCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHcCCCCCCC-------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2333444444333221111 122345778999999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=313.37 Aligned_cols=243 Identities=20% Similarity=0.296 Sum_probs=183.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+|..||||.+..... ........+.+|+.
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~------------------------~~~~~~~~~~~e~~ 200 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVI------------------------VAKDEVAHTLTENR 200 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH------------------------C-------------
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhh------------------------hhhHHHHHHHHHHH
Confidence 4578999999999999999999854 5799999999852110 01233566788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHM-HHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~-~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+ .+++++||+.++++ ++......++.|++.||.|||+ .+ ++||||
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDl 275 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHD--RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDL 275 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETT--EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCC
T ss_pred HHHhCCCCeEeeEEEEEeeCC--EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCC
Confidence 999999999999999998876 68999999998754 5666778899999999999998 87 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||| +|+++|||++|..||..
T Consensus 276 kp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-- 351 (446)
T 4ejn_A 276 KLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-- 351 (446)
T ss_dssp CGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred CHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC--
Confidence 99999999999999999999975432221 23457899999999999999999999999 99999999999999643
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.+.......+... ... .+ ......+.+++..||+.||.+|| |+.++++
T Consensus 352 --~~~~~~~~~i~~~---~~~-------~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 352 --QDHEKLFELILME---EIR-------FP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --SSHHHHHHHHHHC---CCC-------CC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCHHHHHHHHHhC---CCC-------CC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 2333333333221 110 00 01123477889999999999999 9999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.43 Aligned_cols=246 Identities=20% Similarity=0.310 Sum_probs=176.5
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|+.. .+|+.||+|.+...... ......+..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~~ 56 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNS-------------------------QEQKRLLMDL 56 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CH-------------------------HHHHHHHHHH
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCc-------------------------HHHHHHHHHH
Confidence 345689999999999999999999864 57999999999643221 1123334455
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhc-CCCCe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMH-HCPRI 190 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~-~~~~i 190 (345)
...++.++||||+++++++..++ ..++++++++++ ..+++..+..++.|++.||.|||+. + +
T Consensus 57 ~~~~~~~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i 131 (290)
T 3fme_A 57 DISMRTVDCPFTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---V 131 (290)
T ss_dssp HHHHTTCCCTTBCCEEEEEECSS--SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---C
T ss_pred HHHHHhCCCCeEEEEeeeeeccC--CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---e
Confidence 56678889999999999998766 578888988752 3477788889999999999999998 8 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccc----cccccCccchhh-HHHHHHHHHh
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL----QMLTLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~----~~~~~~~~~Dvw-lG~vl~el~t 265 (345)
+||||||+||+++.++.+||+|||++........ .....||+.|+|||.+ .+..++.++||| +|+++|+|++
T Consensus 132 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (290)
T 3fme_A 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208 (290)
T ss_dssp CCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999976544322 2335789999999996 455688999999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|..||..... ....... ......+.. ... .....+.+++..||+.||++|||+.++++
T Consensus 209 g~~p~~~~~~--~~~~~~~----~~~~~~~~~------~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 209 LRFPYDSWGT--PFQQLKQ----VVEEPSPQL------PAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp TSCSSCCCSC--HHHHHHH----HHHSCCCCC------CTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCccccCc--hHHHHHH----HhccCCCCc------ccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 9999753211 1111111 111111110 001 11234778899999999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=317.56 Aligned_cols=243 Identities=25% Similarity=0.361 Sum_probs=189.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.+ .++..||||.+...... ......+.+|+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E~~~ 74 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAK-------------------------NKDTSTILREVEL 74 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHB-------------------------CSCHHHHHHHHHH
T ss_pred hcceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEeccccc-------------------------chHHHHHHHHHHH
Confidence 358999999999999999999864 57999999998521110 1125667899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ .++++++++.++.+ ++...+..++.|++.||.|||+.+ ++||||||
T Consensus 75 l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp 149 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILEDSS--SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKP 149 (486)
T ss_dssp HHHCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred HHhCCCCCcCeEEEEEEcCC--EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCch
Confidence 99999999999999998766 78999999988754 566677889999999999999999 99999999
Q ss_pred CCeeec---CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLD---DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+|||++ .++.+||+|||++....... ......||+.|+|||++.+ .++.++||| +|+++|+|++|..||..
T Consensus 150 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~- 224 (486)
T 3mwu_A 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG- 224 (486)
T ss_dssp GGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred HHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC-
Confidence 999995 45679999999997654432 2344679999999999986 589999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+.......... ........+.+++..||+.||.+|||+.++++
T Consensus 225 ---~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 225 ---KNEYDILKRVETGKYAFDLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ---SSHHHHHHHHHHTCCCSCSG----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---CCHHHHHHHHHhCCCCCCCc----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23334433333322111110 01112234778999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.88 Aligned_cols=240 Identities=26% Similarity=0.324 Sum_probs=180.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.+ .++..||+|.+....... ......+..|..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~------------------------~~~~~~~~~e~~ 90 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILK------------------------KKEEKHIMSERN 90 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------------------------------
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhh------------------------hHHHHHHHHHHH
Confidence 5578999999999999999999964 578999999996432211 122445566777
Q ss_pred H-HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 T-VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~-l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+ ++.++||||+++++++...+ .+++++||+.++.+ ++......++.|++.||.|||+.+ ++||||
T Consensus 91 ~ll~~~~hp~Iv~l~~~~~~~~--~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDl 165 (373)
T 2r5t_A 91 VLLKNVKHPFLVGLHFSFQTAD--KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDL 165 (373)
T ss_dssp CCBCCCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHHHhCCCCCCCCEEEEEEeCC--EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 6 46789999999999998776 78999999998765 455566779999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|+| +|+++|||++|..||..
T Consensus 166 kp~NIll~~~g~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-- 241 (373)
T 2r5t_A 166 KPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-- 241 (373)
T ss_dssp CGGGEEECTTSCEEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC--
T ss_pred CHHHEEECCCCCEEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC--
Confidence 99999999999999999999975432211 23457899999999999999999999999 99999999999999743
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
.+.......+.. .... +. .. ....+.+++..||+.||.+||++.+
T Consensus 242 --~~~~~~~~~i~~---~~~~---~~----~~----~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 242 --RNTAEMYDNILN---KPLQ---LK----PN----ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --SBHHHHHHHHHH---SCCC---CC----SS----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --CCHHHHHHHHHh---cccC---CC----CC----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 233333332222 1110 00 11 1234778889999999999999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=305.31 Aligned_cols=242 Identities=21% Similarity=0.294 Sum_probs=186.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.+ .+|+.||+|.+..... ...+|+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~-------------------------------~~~~E~~~ 68 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR-------------------------------DPTEEIEI 68 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC-------------------------------CCHHHHHH
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC-------------------------------ChHHHHHH
Confidence 468999999999999999999864 5799999999964321 12357788
Q ss_pred Hhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+.++ +||||+++++++..++ .+++++|++.++++ +++.....++.|++.||.|||+.+ ++|||||
T Consensus 69 l~~~~~hp~iv~~~~~~~~~~--~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlk 143 (342)
T 2qr7_A 69 LLRYGQHPNIITLKDVYDDGK--YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLK 143 (342)
T ss_dssp HHHHTTSTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred HHHhcCCCCcCeEEEEEEcCC--EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCC
Confidence 8777 7999999999998765 78999999988654 566777899999999999999999 9999999
Q ss_pred CCCeeecCC----CCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 197 PVNVLLDDD----IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 197 ~~nil~~~~----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|+||++... +.+||+|||++........ ......||+.|+|||++.+..++.++||| +|+++|+|++|..||.
T Consensus 144 p~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 144 PSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp GGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 999998532 3599999999987644322 23456889999999999988899999999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.... .........+.... ... ...........+.+++..||+.||++|||+.++++
T Consensus 222 ~~~~-~~~~~~~~~i~~~~---~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 222 NGPD-DTPEEILARIGSGK---FSL-------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp SSTT-SCHHHHHHHHHHCC---CCC-------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCc-CCHHHHHHHHccCC---ccc-------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4211 22223333332211 110 00111122345778899999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=292.83 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=190.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .++..||+|.+...... ........+.+|+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~-----------------------~~~~~~~~~~~E~~~ 59 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKLR-----------------------RIPNGEANVKKEIQL 59 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHHH-----------------------HSTTHHHHHHHHHHH
T ss_pred ccceeEeeEEecCCCeEEEEEEEC-CCCcEEEEEEecccccc-----------------------ccchhHHHHHHHHHH
Confidence 368999999999999999999854 57899999998521100 001235678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++++..++...+++++|++.++ ..+++.....++.|++.||.|||+.+ ++|||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlk 136 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIK 136 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCC
Confidence 9999999999999998766656789999998764 34677788899999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc--cCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+||+++.++.++|+|||++................||..|+|||.+.+.. .+.++||| +|+++|+|++|..||..
T Consensus 137 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~- 215 (305)
T 2wtk_C 137 PGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG- 215 (305)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-
Confidence 999999999999999999998765433333334567999999999998654 47799999 99999999999999753
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+.... .. .. ......+.+++.+||+.||.+|||+.++++
T Consensus 216 ---~~~~~~~~~i~~~~---~~-------~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 216 ---DNIYKLFENIGKGS---YA-------IP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ---SSHHHHHHHHHHCC---CC-------CC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---chHHHHHHHHhcCC---CC-------CC----CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22233333222211 10 00 111234778899999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=300.48 Aligned_cols=259 Identities=22% Similarity=0.284 Sum_probs=193.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .++..||||.+..... ......+.+|+.
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~E~~ 77 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEH--------------------------QTYCQRTLREIK 77 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTC--------------------------HHHHHHHHHHHH
T ss_pred ccccEEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccC--------------------------cHHHHHHHHHHH
Confidence 4569999999999999999999854 5789999999964221 123567889999
Q ss_pred HHhhccCCCccceeEEEecCC---cceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD---CHLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~---~~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++++++||||+++++++..++ ...++++++++.+. ..++...+..++.|++.||.|||+.+ ++||||
T Consensus 78 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 154 (364)
T 3qyz_A 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDL 154 (364)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 999999999999999987653 23578899998752 23677788899999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcce-eccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||+||+++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++||| +|+++|+|++|..||..
T Consensus 155 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998764332211 12446899999999987654 489999999 99999999999999654
Q ss_pred cccccchhhHHHHHHHHhhhcCCCcc--------------cc-cc-c-cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRA--------------ID-SK-L-VGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~-~~-~-~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
. ...+....+......+..... .. .. . .....+.....+.+++.+||+.||++|||+.+
T Consensus 235 ~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 310 (364)
T 3qyz_A 235 K----HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310 (364)
T ss_dssp S----SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred C----ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 2 333333333332222111000 00 00 0 00000112345788999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 311 ~l~ 313 (364)
T 3qyz_A 311 ALA 313 (364)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=303.66 Aligned_cols=242 Identities=19% Similarity=0.270 Sum_probs=188.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|+.. .+++.||||.+............ ......+.+|+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~-------------------~~~~~~~~~E~~ 81 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIE-------------------DPKLGKVTLEIA 81 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEE-------------------ETTTEEEEHHHH
T ss_pred cccceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccc-------------------hHHHHHHHHHHH
Confidence 3468999999999999999999854 57999999999765322110000 001334567999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC-C---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-R---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+ .++++++++.++ . .+++..+..++.|++.||.|||+.+ ++||||
T Consensus 82 ~l~~l~h~~Iv~~~~~~~~~~--~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 156 (335)
T 3dls_A 82 ILSRVEHANIIKVLDIFENQG--FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDI 156 (335)
T ss_dssp HHTTCCCTTBCCEEEEEECSS--EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHhCCCCCEeeEEEEEeeCC--EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEecc
Confidence 999999999999999998766 678888887654 2 4677788899999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+||+++.++.+||+|||++........ .....||+.|+|||.+.+..+ +.++||| +|+++|+|++|..||...
T Consensus 157 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 157 KDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 99999999999999999999987654432 234678999999999998876 7899999 999999999999997542
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
... ...... .+.. ....+.+++..||+.||++|||+.++++.
T Consensus 234 ~~~-------------~~~~~~--------~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 234 EET-------------VEAAIH--------PPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp GGG-------------TTTCCC--------CSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHH-------------HhhccC--------CCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 000000 0001 12347788899999999999999999873
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=308.14 Aligned_cols=250 Identities=21% Similarity=0.231 Sum_probs=188.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+++.||||.+.... .....+.+|+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~~----------------------------~~~~~~~~E~~ 145 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNEK----------------------------RFHRQAAEEIR 145 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSCH----------------------------HHHHHHHHHHH
T ss_pred ccCcEEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCcc----------------------------chHHHHHHHHH
Confidence 3457999999999999999999854 579999999996531 12345556777
Q ss_pred HHhhc------cCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 126 TVGQI------RHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 126 ~l~~l------~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+++.+ +|+||+++++++...+ .++++++++.+. ..+++..+..++.|++.||.|||+.+
T Consensus 146 ~l~~l~~~~~~~~~~iv~~~~~~~~~~--~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--- 220 (429)
T 3kvw_A 146 ILEHLRKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--- 220 (429)
T ss_dssp HHHHHHTTCTTSCSCBCCEEEEEEETT--EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHhhccccCCcCEEEEEeecccCC--eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 77666 6789999999998776 688899998652 22677788899999999999999998
Q ss_pred eEecCCCCCCeeecCCCC--eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC
Q 046907 190 IIHRDLNPVNVLLDDDIE--ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg 266 (345)
++||||||+|||++.++. +||+|||++...... .....||+.|+|||++.+..++.++||| +|+++|||++|
T Consensus 221 ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG 295 (429)
T 3kvw_A 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295 (429)
T ss_dssp EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHS
T ss_pred eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhC
Confidence 999999999999998877 999999999765432 2346889999999999999999999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCc---------cccc---------------------------c----ccCC
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKR---------AIDS---------------------------K----LVGN 306 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~---------------------------~----~~~~ 306 (345)
..||.. .+..+....+......+.... .++. + ....
T Consensus 296 ~~pf~~----~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (429)
T 3kvw_A 296 YPLLPG----EDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR 371 (429)
T ss_dssp SCSSCC----SSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCS
T ss_pred CCCCCC----CCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccch
Confidence 999643 233344443333322111000 0000 0 0000
Q ss_pred CcH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 307 GCE-----EQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 307 ~~~-----~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... .....+.+++..||+.||++|||+.++++
T Consensus 372 ~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 372 EWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408 (429)
T ss_dssp CHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence 000 11345788999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=299.08 Aligned_cols=271 Identities=15% Similarity=0.193 Sum_probs=192.9
Q ss_pred hcCCcccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|++.+.||+|+||.||+|++.. .++..+|+|.+........ .+ ...........+.+|
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~---~e-------------~~~~~~~~~~~~~~e 98 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SE-------------LKFYQRVAKKDCIKK 98 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHH---HH-------------HHHHHHHCCHHHHHH
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchH---HH-------------HHHHHHHhhhHHHHH
Confidence 46799999999999999999999752 2678999999875432211 00 001112224557789
Q ss_pred HHHHhhccCCCccceeEEEecC--CcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 124 INTVGQIRHRNLHPLLAHVTRP--DCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~--~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+..++.++||||+++++++... +...++++++++ +++ .+++..+..++.|++.||.|||+.+ ++|
T Consensus 99 ~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 174 (345)
T 2v62_A 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVH 174 (345)
T ss_dssp HHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeC
Confidence 9999999999999999998772 245789999998 533 4688889999999999999999998 999
Q ss_pred cCCCCCCeeecCCC--CeEEeccccceecCCCCcc-----eeccCcccCccccccccccccccCccchhh-HHHHHHHHH
Q 046907 193 RDLNPVNVLLDDDI--EARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV 264 (345)
Q Consensus 193 ~dlk~~nil~~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~ 264 (345)
|||||+||+++.++ .+||+|||+++........ .......||..|+|||.+.+..++.++||| +|+++|||+
T Consensus 175 ~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 254 (345)
T 2v62_A 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254 (345)
T ss_dssp SCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999777 9999999999876432111 112446899999999999998899999999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+|..||..... ..... ...........+... ....... .....+.+++..||+.||++|||+.+|++.|+++
T Consensus 255 ~g~~pf~~~~~--~~~~~-~~~~~~~~~~~~~~~-~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 255 CGKLPWEQNLK--DPVAV-QTAKTNLLDELPQSV-LKWAPSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HSSCTTGGGTT--CHHHH-HHHHHHHHHTTTHHH-HHHSCTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred hCCCCcccccc--ccHHH-HHHHHhhcccccHHH-Hhhcccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 99999854222 11112 222222222221110 0000000 1223477888899999999999999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=298.49 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=193.5
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..+.++|++.+.||+|+||.||+|+.. .+++.||||.+.... ......+.+|
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------~~~~~~~~~E 76 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHE---------------------------QQDREEAQRE 76 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESS---------------------------HHHHHHHHHH
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCC---------------------------HHHHHHHHHH
Confidence 456789999999999999999999854 579999999885422 2235677899
Q ss_pred HHHHhhccCCCccceeEEEecC--CcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 124 INTVGQIRHRNLHPLLAHVTRP--DCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~--~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+.+++.++||||+++++++... .....+++++++.++++ +++..+..++.|++.||.|||+.+
T Consensus 77 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-- 154 (317)
T 2buj_A 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-- 154 (317)
T ss_dssp HHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 9999999999999999988642 33468899999988543 667777889999999999999998
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCcc-------eeccCcccCccccccccccccc---cCccchhh-HH
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-------ITTSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FG 257 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~gt~~~~aPE~~~~~~---~~~~~Dvw-lG 257 (345)
++||||||+||+++.++.++|+|||++......... .......||+.|+|||.+.+.. ++.++||| +|
T Consensus 155 -ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 233 (317)
T 2buj_A 155 -YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233 (317)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHH
T ss_pred -cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHH
Confidence 999999999999999999999999988754321100 0112346799999999997654 68899999 99
Q ss_pred HHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 258 ALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 258 ~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
+++|+|++|..||........ .....+......+ ..+.....+.+++..||+.||.+|||+.+++
T Consensus 234 ~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 298 (317)
T 2buj_A 234 CVLYAMMFGEGPYDMVFQKGD--SVALAVQNQLSIP-------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298 (317)
T ss_dssp HHHHHHHHSSCTTHHHHHTTS--CHHHHHHCC--CC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHhCCCChhhhhcccc--hhhHHhhccCCCC-------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 999999999999854322111 1111111111000 0111223478899999999999999999999
Q ss_pred HHHhhhh
Q 046907 338 RMLSQIQ 344 (345)
Q Consensus 338 ~~L~~l~ 344 (345)
+.|++++
T Consensus 299 ~~L~~~~ 305 (317)
T 2buj_A 299 SQLEALQ 305 (317)
T ss_dssp HHHHHTC
T ss_pred HHhhhcC
Confidence 9999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=304.91 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=179.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+.. .+|..||||.+.....+ .....++.+|+.
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 80 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQS-------------------------IIHAKRTYRELR 80 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEET-TTTEEEEEEECSSTTSS-------------------------HHHHHHHHHHHH
T ss_pred CCCceEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccC-------------------------HHHHHHHHHHHH
Confidence 3479999999999999999999854 57999999998653222 223567789999
Q ss_pred HHhhccCCCccceeEEEecCC----cceeeeeccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQG-------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++.++||||+++++++.... ...++++++++.+ ...++...+..++.|++.||.|||+.+ ++|||
T Consensus 81 ~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~D 157 (367)
T 2fst_X 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRD 157 (367)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCC
Confidence 999999999999999987542 2346788888743 124677788899999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|||+||+++.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||| +|+++|||++|..||.+
T Consensus 158 lkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 158 LKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp CCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999765432 234688999999999987 5689999999 99999999999999654
Q ss_pred cccccchhhHHHHHHHHhhhcCCCcc---cc----------ccccCCC----cHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRA---ID----------SKLVGNG----CEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----------~~~~~~~----~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
.+.......+......+..... .. +...... .+.....+.+|+.+||+.||++|||+.+
T Consensus 233 ----~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e 308 (367)
T 2fst_X 233 ----TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308 (367)
T ss_dssp ----SSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ----CCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence 3334444444433322211000 00 0000000 0112345788999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 309 ~L~ 311 (367)
T 2fst_X 309 ALA 311 (367)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=290.55 Aligned_cols=238 Identities=22% Similarity=0.364 Sum_probs=190.0
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|++. .+++.||+|.+.... ..+.+|+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-------------------------------~~~~~e~~~ 57 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN-------------------------------EKAEREVKA 57 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS-------------------------------GGGHHHHHH
T ss_pred ccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc-------------------------------HHHHHHHHH
Confidence 457999999999999999999864 578999999996432 234579999
Q ss_pred HhhccCCCccceeEEEec--------------CCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHH
Q 046907 127 VGQIRHRNLHPLLAHVTR--------------PDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEY 181 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~--------------~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~ 181 (345)
++.++||||+++++++.. .....+++++++++++++ +++.....++.|++.||.|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 137 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999999999998764 123457899999988543 5666778899999999999
Q ss_pred HhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHH
Q 046907 182 LHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260 (345)
Q Consensus 182 lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl 260 (345)
||+.+ ++|+||||+||+++.++.+||+|||++........ .....||+.|+|||.+.+..++.++||| +|+++
T Consensus 138 lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (284)
T 2a19_B 138 IHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211 (284)
T ss_dssp HHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHH
T ss_pred HHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHH
Confidence 99998 99999999999999999999999999987654332 2345789999999999998899999999 99999
Q ss_pred HHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 046907 261 AGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340 (345)
Q Consensus 261 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L 340 (345)
|+|++|..|+.. .... ..... ...... .. ...+.+++.+||+.||.+|||+.++++.|
T Consensus 212 ~~l~~~~~~~~~------~~~~---~~~~~-~~~~~~---------~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 212 AELLHVCDTAFE------TSKF---FTDLR-DGIISD---------IF---DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp HHHHSCCSSHHH------HHHH---HHHHH-TTCCCT---------TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcCCcchh------HHHH---HHHhh-cccccc---------cC---CHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999999988421 1111 11111 111111 11 12367888999999999999999999999
Q ss_pred hhhh
Q 046907 341 SQIQ 344 (345)
Q Consensus 341 ~~l~ 344 (345)
+.+.
T Consensus 270 ~~~~ 273 (284)
T 2a19_B 270 TVWK 273 (284)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.23 Aligned_cols=250 Identities=11% Similarity=0.053 Sum_probs=173.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|++.+.||+|+||.||+|++. .+|+.||||.+....... ......+.+|+.
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~~E~~ 114 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENS------------------------RSELERLHEATF 114 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTH------------------------HHHHHHHHHHHH
T ss_pred CceeeeeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEeccccc------------------------ccHHHHHHHHHH
Confidence 3446999999999999999999964 579999999998754321 223556677755
Q ss_pred HHhhc--cCCCcccee-------EEEecCCc---------------ceeeeeccccCCCCCCCHHH----------H---
Q 046907 126 TVGQI--RHRNLHPLL-------AHVTRPDC---------------HLLYILNDVSQGRRELDWLA----------R--- 168 (345)
Q Consensus 126 ~l~~l--~hpniv~l~-------~~~~~~~~---------------~~l~~~~~~~~~~~~l~~~~----------~--- 168 (345)
+++.+ +||||++++ +++..++. ..+++++||++ +++.++.. +
T Consensus 115 ~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~ 193 (371)
T 3q60_A 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGI 193 (371)
T ss_dssp HHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHH
T ss_pred HHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhh
Confidence 55555 699988755 44443332 34789999998 55544443 2
Q ss_pred ---HHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc
Q 046907 169 ---HRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 169 ---~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~ 245 (345)
..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++...+.. .....+|+.|+|||.+.+
T Consensus 194 ~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 194 LALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTC
T ss_pred hhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccC
Confidence 467799999999999999 999999999999999999999999999876432 113567799999999987
Q ss_pred --cccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhc
Q 046907 246 --LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFC 322 (345)
Q Consensus 246 --~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~C 322 (345)
..++.++||| +|+++|||++|..||.......... ...................+.....+.++|.+|
T Consensus 266 ~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 336 (371)
T 3q60_A 266 STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336 (371)
T ss_dssp SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHH
T ss_pred CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHH
Confidence 6799999999 9999999999999986543211000 000000000000111111122334577899999
Q ss_pred cCCCCCCCCCHHHHHH
Q 046907 323 TLEDPNERPNSKDVRR 338 (345)
Q Consensus 323 l~~dp~~Rpt~~~ll~ 338 (345)
|+.||++|||+.++++
T Consensus 337 L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 337 LNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCSSTTTCCCHHHHTT
T ss_pred cCCChhhCCCHHHHhc
Confidence 9999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=302.41 Aligned_cols=255 Identities=18% Similarity=0.210 Sum_probs=194.9
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+++.||||.+... ......+.+|+.+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~~E~~~ 86 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA----------------------------EHYTETALDEIRL 86 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC----------------------------HHHHHHHHHHHHH
T ss_pred CCeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC----------------------------CcchHHHHHHHHH
Confidence 368999999999999999999854 57999999999643 1224567789999
Q ss_pred Hhhcc--------CCCccceeEEEecC--CcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhc-
Q 046907 127 VGQIR--------HRNLHPLLAHVTRP--DCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMH- 185 (345)
Q Consensus 127 l~~l~--------hpniv~l~~~~~~~--~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~- 185 (345)
++.++ ||||+++++++... +...++++++++.++ ..+++..+..++.|++.||.|||++
T Consensus 87 l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ 166 (397)
T 1wak_A 87 LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC 166 (397)
T ss_dssp HHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 98885 88899999988732 345789999999652 2377888899999999999999998
Q ss_pred CCCCeEecCCCCCCeeecCCC-------------------------------------------------CeEEeccccc
Q 046907 186 HCPRIIHRDLNPVNVLLDDDI-------------------------------------------------EARISGFGFA 216 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~-------------------------------------------------~~kl~Dfg~a 216 (345)
+ ++||||||+|||++.++ .+||+|||++
T Consensus 167 g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a 243 (397)
T 1wak_A 167 R---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243 (397)
T ss_dssp C---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGC
T ss_pred C---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccc
Confidence 8 99999999999998765 7999999999
Q ss_pred eecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc--hhhHHHHHHHHhhhc
Q 046907 217 RAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN--EMSFVKWMRNVMASE 293 (345)
Q Consensus 217 ~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 293 (345)
...... .....||+.|+|||++.+..++.++||| +|+++|||++|..||........ .......+.......
T Consensus 244 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (397)
T 1wak_A 244 CWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV 318 (397)
T ss_dssp EETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSC
T ss_pred cccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCC
Confidence 876432 2346789999999999999999999999 99999999999999865433221 222223333222211
Q ss_pred CCCc---------cccc--------c-----------ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 294 NPKR---------AIDS--------K-----------LVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 294 ~~~~---------~~~~--------~-----------~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.... .+.. . ............+.+|+.+||+.||++|||+.++++
T Consensus 319 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 319 PRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 1000 0000 0 001234566778999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.46 Aligned_cols=247 Identities=19% Similarity=0.305 Sum_probs=189.4
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+...|.+.+.||+|+||.||+|.+. .++..||+|.+.....+ ....+.+.+|+
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~-------------------------~~~~~~~~~e~ 76 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLT-------------------------KSERQRFKEEA 76 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSC-------------------------HHHHHHHHHHH
T ss_pred cCceeEEeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhC-------------------------HHHHHHHHHHH
Confidence 35566899999999999999999864 57899999998643222 23366788999
Q ss_pred HHHhhccCCCccceeEEEecC--CcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTRP--DCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~--~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
.+++.++||||+++++++... +...+++++++++++++ ++......++.|++.||.|||+.+ .+++|+
T Consensus 77 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~ 155 (290)
T 1t4h_A 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHR 155 (290)
T ss_dssp HHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCS
T ss_pred HHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEEC
Confidence 999999999999999988653 34578999999988654 566667789999999999999985 349999
Q ss_pred CCCCCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCc
Q 046907 194 DLNPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 194 dlk~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
||||+||+++ .++.+||+|||++....... .....||+.|+|||.+.+ .++.++||| +|+++|+|++|..||.
T Consensus 156 dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 156 DLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 9999999998 78899999999997544332 233578999999998875 589999999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ........+ .....+ ...+. . ....+.+++..||+.||.+|||+.++++
T Consensus 231 ~~~---~~~~~~~~~---~~~~~~-~~~~~----~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 231 ECQ---NAAQIYRRV---TSGVKP-ASFDK----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TCS---SHHHHHHHH---TTTCCC-GGGGG----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcC---cHHHHHHHH---hccCCc-cccCC----C----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 422 222222222 111111 11111 1 1124788999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=298.33 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=190.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCce--eEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRM--ISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+.++|++.+.||+|+||.||+|++. .++.. +|+|.+..... ......+.+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~v~iK~~~~~~~--------------------------~~~~~~~~~E 75 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYAS--------------------------KDDHRDFAGE 75 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC--------------------------------CHHHHH
T ss_pred cHHHccceeeeecCCCceEEEEEEc-cCCcccceeeeeeccccc--------------------------hHHHHHHHHH
Confidence 5679999999999999999999865 35654 49999864211 1235667889
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCC-------------------------CCCHHHHHHHHHHHHH
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-------------------------ELDWLARHRIALGLAC 177 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-------------------------~l~~~~~~~i~~~i~~ 177 (345)
+.+++++ +||||+++++++..++ .++++++++++++ .+++..+..++.|++.
T Consensus 76 ~~~l~~l~~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 153 (327)
T 1fvr_A 76 LEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153 (327)
T ss_dssp HHHHTTCCCCTTBCCEEEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCchhhhceeeeeCC--ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHH
Confidence 9999999 9999999999998776 6889999997754 3567777899999999
Q ss_pred HHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-H
Q 046907 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256 (345)
Q Consensus 178 ~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-l 256 (345)
||.|||+.+ ++||||||+||+++.++.+||+|||++...... .......++..|+|||.+.+..++.++||| +
T Consensus 154 aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 227 (327)
T 1fvr_A 154 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 227 (327)
T ss_dssp HHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHH
Confidence 999999998 999999999999999999999999998743221 112234668899999999988899999999 9
Q ss_pred HHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 257 GALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 257 G~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
|+++|+|++ |..||... ........+... .... ........+.+++.+||+.||.+|||+.+
T Consensus 228 G~il~ellt~g~~pf~~~----~~~~~~~~~~~~---~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 290 (327)
T 1fvr_A 228 GVLLWEIVSLGGTPYCGM----TCAELYEKLPQG---YRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQ 290 (327)
T ss_dssp HHHHHHHHTTSCCTTTTC----CHHHHHHHGGGT---CCCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCCCCC----cHHHHHHHhhcC---CCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999998 99997432 222222222111 1110 01112234788999999999999999999
Q ss_pred HHHHHhhhh
Q 046907 336 VRRMLSQIQ 344 (345)
Q Consensus 336 ll~~L~~l~ 344 (345)
+++.|+++.
T Consensus 291 ll~~L~~~~ 299 (327)
T 1fvr_A 291 ILVSLNRML 299 (327)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998873
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=295.88 Aligned_cols=248 Identities=21% Similarity=0.268 Sum_probs=192.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+|..||+|.+.......... ......+.+|+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~---------------------~~~~~~~~~E~~~ 68 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRR---------------------GVSREEIEREVSI 68 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSS---------------------SBCHHHHHHHHHH
T ss_pred hccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEeccccccccc---------------------chhHHHHHHHHHH
Confidence 457999999999999999999864 579999999997543321100 0014567889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++...+ .++++++++.++++ ++......++.|++.||.|||+.+ ++||||||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp 143 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRT--DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKP 143 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HHhCCCCCcceEEEEEecCC--EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCh
Confidence 99999999999999998765 68899999987654 456677899999999999999998 99999999
Q ss_pred CCeeecCCC----CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 198 VNVLLDDDI----EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 198 ~nil~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
+||+++.++ .++|+|||++........ .....||+.|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 144 ~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp GGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred HHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 999999877 799999999987654322 2346789999999999998999999999 99999999999999743
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+..... . .++... ......+.+++..||+.||++|||+.++++
T Consensus 221 ----~~~~~~~~~i~~~~~---~---~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 221 ----DTKQETLANITSVSY---D---FDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----SSHHHHHHHHHTTCC---C---CCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----CCHHHHHHHHHhccc---c---cChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222333332222110 0 011000 111234788999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.52 Aligned_cols=259 Identities=17% Similarity=0.211 Sum_probs=182.5
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
.......++|++.+.||+|+||.||+|++. .+|..||||.+...... ....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~----------------------------~~~~ 66 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDPRF----------------------------RNRE 66 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEET-TTCCEEEEEEEECCTTC----------------------------CCHH
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCccc----------------------------cHHH
Confidence 344567789999999999999999999864 57999999998653221 2234
Q ss_pred HHHHHHHhhccCCCccceeEEEecCC-----cceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHh
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPD-----CHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLH 183 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh 183 (345)
.+++..+..++||||+++++++...+ ..+++++++++.++ ..++......++.|++.||.|||
T Consensus 67 ~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 146 (360)
T 3e3p_A 67 LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146 (360)
T ss_dssp HHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence 56777788889999999999986533 23478899998764 23566677889999999999999
Q ss_pred --hcCCCCeEecCCCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHH
Q 046907 184 --MHHCPRIIHRDLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGA 258 (345)
Q Consensus 184 --~~~~~~iiH~dlk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~ 258 (345)
+.+ ++||||||+|||++. ++.+||+|||++........ .....||+.|+|||++.+.. ++.++||| +|+
T Consensus 147 ~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 220 (360)
T 3e3p_A 147 LPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC 220 (360)
T ss_dssp STTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred CCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence 888 999999999999996 88999999999987654332 23467899999999997655 89999999 999
Q ss_pred HHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCC---------cccc---------ccccCCCcHHHHHHHHHHHh
Q 046907 259 LLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPK---------RAID---------SKLVGNGCEEQMLLVLKIAC 320 (345)
Q Consensus 259 vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~---------~~~~~~~~~~~~~~l~~li~ 320 (345)
++|+|++|..||.. .........+......+... ...+ ..............+.+++.
T Consensus 221 il~ell~g~~pf~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 296 (360)
T 3e3p_A 221 IFAEMMLGEPIFRG----DNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296 (360)
T ss_dssp HHHHHHHSSCSSCC----SSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHH
T ss_pred HHHHHHhCCCCcCC----CChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHH
Confidence 99999999999754 23333333332222111100 0000 00111112224556889999
Q ss_pred hccCCCCCCCCCHHHHHH
Q 046907 321 FCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 321 ~Cl~~dp~~Rpt~~~ll~ 338 (345)
.||+.||.+|||+.++++
T Consensus 297 ~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 297 ALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHhccCccccCCHHHHhc
Confidence 999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=288.85 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=189.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.+ .++..+|+|.+...... ..+.+.+|+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~---------------------------~~~~~~~E~~~ 59 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVE---------------------------DVDRFKQEIEI 59 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCS---------------------------CHHHHHHHHHH
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccc---------------------------hHHHHHHHHHH
Confidence 357999999999999999999864 57889999998542211 14567789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ .++++++++.++++ +++.....++.|++.||.|||+.+ ++|+||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp 134 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNT--DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKP 134 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HHhCCCCCEeeEEEEEecCC--eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCH
Confidence 99999999999999998765 68899999988654 567778899999999999999999 99999999
Q ss_pred CCeee---cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||++ +.++.++|+|||++........ .....||+.|+|||.+.+. ++.++||| +|+++|+|++|..||...
T Consensus 135 ~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 99999 7888999999999987654332 2346789999999998764 89999999 999999999999997542
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+...... .+. ... ......+.+++..||+.||++|||+.++++
T Consensus 211 ----~~~~~~~~~~~~~~~-~~~-----~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 211 ----TDSEVMLKIREGTFT-FPE-----KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----SHHHHHHHHHHCCCC-CCH-----HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CHHHHHHHHHhCCCC-CCc-----hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222332222221110 000 000 011235788999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=301.68 Aligned_cols=191 Identities=23% Similarity=0.376 Sum_probs=162.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++. .++..||+|.+..... ......+.+|+.
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~--------------------------~~~~~~~~~E~~ 83 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIK--------------------------PAIRNQIIRELQ 83 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCC--------------------------HHHHHHHHHHHG
T ss_pred ccccceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccC--------------------------HHHHHHHHHHHH
Confidence 4568999999999999999999964 5799999999965421 223567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMH-HCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH~dl 195 (345)
+++.++||||+++++++..++ .+++++++++++++ ++......++.|++.||.|||+. + ++||||
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dl 158 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDV 158 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETT--EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCC
T ss_pred HHHHCCCCCEEEEeEEEEECC--EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCc
Confidence 999999999999999998776 68999999988654 45556678999999999999996 7 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||+||+++.++.++|+|||++...... ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 159 kp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 159 KPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred cHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998654321 12346789999999999998999999999 99999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.96 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=182.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|.+.+.||+|+||.||+|+.+ .++..+|+|.+...... ...+.+.+|+.++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~--------------------------~~~~~~~~E~~~l 74 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQ--------------------------VPMEQIEAEIEVL 74 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCC--------------------------SCHHHHHHHHHHH
T ss_pred hheeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccc--------------------------hhHHHHHHHHHHH
Confidence 58999999999999999999864 57899999998643211 1245678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+.++||||+++++++...+ .++++++++.++++ +++..+..++.|++.||.|||+.+ ++|||
T Consensus 75 ~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~d 149 (285)
T 3is5_A 75 KSLDHPNIIKIFEVFEDYH--NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKD 149 (285)
T ss_dssp HTCCCTTBCCEEEEEECSS--EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HhCCCchHHhHHHheecCC--eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECC
Confidence 9999999999999998765 68999999988654 566667789999999999999998 99999
Q ss_pred CCCCCeeec---CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 195 LNPVNVLLD---DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 195 lk~~nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
|||+||+++ .++.+||+|||++....... ......||+.|+|||.+.+ .++.++||| +|+++|+|++|..||
T Consensus 150 ikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf 225 (285)
T 3is5_A 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPF 225 (285)
T ss_dssp CSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCC
Confidence 999999994 56789999999997654332 2234678999999999864 678999999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
... ........... ...... ... .. ....+.+++..||+.||++|||+.++++
T Consensus 226 ~~~----~~~~~~~~~~~---~~~~~~-~~~---~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 226 TGT----SLEEVQQKATY---KEPNYA-VEC---RP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCS----SHHHHHHHHHH---CCCCCC-C-----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCC----CHHHHHhhhcc---CCcccc-ccc---Cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 542 22222222211 111100 000 00 1234678899999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=290.64 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=193.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..+.|++++.||+|+||.||+|+.. .+++.||+|.+...... .....+.+|+.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~--------------------------~~~~~~~~e~~ 72 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAE--------------------------DEIEDIQQEIT 72 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCS--------------------------TTHHHHHHHHH
T ss_pred hHHHHHHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccH--------------------------HHHHHHHHHHH
Confidence 4467999999999999999999854 57899999998654321 12456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++.++||||+++++++..++ .+++++++++++. .+++.....++.|++.||.|||+.+ ++|+||||
T Consensus 73 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p 147 (303)
T 3a7i_A 73 VLSQCDSPYVTKYYGSYLKDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKA 147 (303)
T ss_dssp HHHHCCCTTBCCEEEEEEETT--EEEEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HHHhCCCCCEeEEEEEEecCC--eEEEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCh
Confidence 999999999999999998766 6889999998753 3677788899999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+||+++.++.++|+|||++........ ......||..|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 148 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--- 222 (303)
T 3a7i_A 148 ANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL--- 222 (303)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---
T ss_pred heEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc---
Confidence 999999999999999999987654322 22446789999999999998999999999 999999999999997532
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
........+.... .+ .... .....+.+++..||+.||.+|||+.++++.
T Consensus 223 -~~~~~~~~~~~~~---~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 223 -HPMKVLFLIPKNN---PP------TLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -CHHHHHHHHHHSC---CC------CCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -CHHHHHHHhhcCC---CC------CCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2222322222211 11 0011 112347788999999999999999999763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=311.89 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=186.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .++..||+|.+....... .....+.+|+.++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~-------------------------~~~~~~~~E~~~l 90 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVST-------------------------SSNSKLLEEVAVL 90 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC------------------------------CTTHHHHHHHHHH
T ss_pred cCeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCc-------------------------hHHHHHHHHHHHH
Confidence 36999999999999999999964 578999999996543221 1245677899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ .++++++++.++.+ +++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 91 ~~l~hpniv~~~~~~~~~~--~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~ 165 (494)
T 3lij_A 91 KLLDHPNIMKLYDFFEDKR--NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPE 165 (494)
T ss_dssp TTCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred HhCCCCCCCeEEEEEEeCC--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChh
Confidence 9999999999999998766 78999999998765 556677889999999999999999 999999999
Q ss_pred CeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 199 NVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 199 nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|||++. ++.+||+|||++....... ......||+.|+|||++.+ .++.++||| +|+++|+|++|..||..
T Consensus 166 Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~-- 239 (494)
T 3lij_A 166 NLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGG-- 239 (494)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred hEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCC--
Confidence 999975 4559999999998765432 2344679999999999874 689999999 99999999999999643
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+.......... ........+.+++..||+.||.+|||+.++++
T Consensus 240 --~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 240 --QTDQEILRKVEKGKYTFDSP----------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --SSHHHHHHHHHHTCCCCCSG----------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCHHHHHHHHHhCCCCCCch----------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 23334444333322111100 00112234778899999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=307.15 Aligned_cols=259 Identities=23% Similarity=0.269 Sum_probs=178.5
Q ss_pred CCccc-ccccccCcceeeEEEEecC-CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLAS-LEKIGSGGCGEVYKAELPG-QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 48 ~~~~~-~~~iG~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.|++ .++||+|+||.||+|+++. .++..||||.+..... ...+.+|+.
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----------------------------~~~~~~E~~ 70 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----------------------------SMSACREIA 70 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----------------------------CHHHHHHHH
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----------------------------CHHHHHHHH
Confidence 45666 4589999999999998642 3688999999964321 234668999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------------ELDWLARHRIALGLACGLEYLHMHHCP 188 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~lh~~~~~ 188 (345)
+++.++||||+++++++.......++++++|+.++. .+++..+..++.|++.||.|||+.+
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-- 148 (405)
T 3rgf_A 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148 (405)
T ss_dssp HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999998766668999999987531 2677778899999999999999999
Q ss_pred CeEecCCCCCCeee----cCCCCeEEeccccceecCCCCc-ceeccCcccCccccccccccccc-cCccchhh-HHHHHH
Q 046907 189 RIIHRDLNPVNVLL----DDDIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLA 261 (345)
Q Consensus 189 ~iiH~dlk~~nil~----~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~ 261 (345)
++||||||+|||+ +.++.+||+|||++........ ........||+.|+|||++.+.. ++.++||| +|+++|
T Consensus 149 -ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 149 -VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp -CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred -EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 9999999999999 6778999999999987643211 12234568899999999998754 89999999 999999
Q ss_pred HHHhCCCCCcccccc-----cchhhHHHHHHHHhhhcCCCcccccc---------------ccCCCcH---------HHH
Q 046907 262 GLVMGKLPSDKFFQH-----TNEMSFVKWMRNVMASENPKRAIDSK---------------LVGNGCE---------EQM 312 (345)
Q Consensus 262 el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~---------~~~ 312 (345)
+|++|..||...... ....+....+......+......... ....... ...
T Consensus 228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (405)
T 3rgf_A 228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307 (405)
T ss_dssp HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence 999999998542211 11122333333333222211100000 0000000 002
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 313 LLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 313 ~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..+.+|+..||+.||.+|||+.++++
T Consensus 308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 308 SKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp SHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 35778999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=309.37 Aligned_cols=250 Identities=21% Similarity=0.269 Sum_probs=185.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
..+|++.+.||+|+||.||+|++. .+|+.||||.+.... ....+|+.+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~-------------------------------~~~~~E~~i 100 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK-------------------------------RFKNRELQI 100 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT-------------------------------TSCCHHHHH
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc-------------------------------hhHHHHHHH
Confidence 347999999999999999999965 579999999986431 112368999
Q ss_pred HhhccCCCccceeEEEecC----CcceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 127 VGQIRHRNLHPLLAHVTRP----DCHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~----~~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
++.++||||+++++++... +..+++++++|++++ ..+++..+..++.|++.||.|||+.+ |
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---i 177 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---I 177 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 9999999999999988542 334577899998752 34677778899999999999999998 9
Q ss_pred EecCCCCCCeeecCC-CCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCC
Q 046907 191 IHRDLNPVNVLLDDD-IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 191 iH~dlk~~nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++||| +|+++|||++|.
T Consensus 178 vHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~ 254 (420)
T 1j1b_A 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254 (420)
T ss_dssp ECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence 999999999999965 5689999999987644322 2346789999999999765 689999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCC----------CccccccccCC-----CcHHHHHHHHHHHhhccCCCCCCCCC
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENP----------KRAIDSKLVGN-----GCEEQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-----~~~~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
.||... ...+....+......+.. .....+..... ..+.....+.+|+.+||+.||.+|||
T Consensus 255 ~pf~~~----~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 255 PIFPGD----SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp CSSCCS----SHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCC----CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 997542 222222222222111100 00000000000 01122345788999999999999999
Q ss_pred HHHHHH
Q 046907 333 SKDVRR 338 (345)
Q Consensus 333 ~~~ll~ 338 (345)
+.++++
T Consensus 331 ~~e~l~ 336 (420)
T 1j1b_A 331 PLEACA 336 (420)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=310.23 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=181.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|.+.+.||+|+||.||+|+.+ .+++.||||.+.......... ........+.+|+.
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~-------------------~~~~~~~~~~~E~~ 192 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSA-------------------READPALNVETEIE 192 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC---------------------------CCHHHHHH
T ss_pred hhccEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhccccc-------------------ccchhHHHHHHHHH
Confidence 4678999999999999999999864 578999999986432211000 00122345788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++++++||||+++++++..++ .+++++++.++++ +++.....++.|++.||.|||+.+ ++|||||
T Consensus 193 ~l~~l~hpniv~l~~~~~~~~---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlk 266 (419)
T 3i6u_A 193 ILKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLK 266 (419)
T ss_dssp HHHHCCCTTBCCCCEEEESSE---EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred HHHhCCCCCEeeEEEEEecCc---eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCC
Confidence 999999999999999986543 6889999987654 567788899999999999999998 9999999
Q ss_pred CCCeeecCC---CCeEEeccccceecCCCCcceeccCcccCccccccccccc---cccCccchhh-HHHHHHHHHhCCCC
Q 046907 197 PVNVLLDDD---IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM---LTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 197 ~~nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~---~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|+|||++.+ ..+||+|||++....... ......||+.|+|||++.+ ..++.++||| +|+++|+|++|..|
T Consensus 267 p~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 267 PENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp GGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred hHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999754 459999999998764432 2234689999999999864 5678899999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|..... .......+........ +.. .......+.+++.+||+.||++|||+.++++
T Consensus 344 f~~~~~---~~~~~~~i~~~~~~~~------~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 344 FSEHRT---QVSLKDQITSGKYNFI------PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCCCSS---SCCHHHHHHTTCCCCC------HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCcc---hHHHHHHHhcCCCCCC------chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 864322 2223333322111100 000 0112345788999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.60 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=177.5
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
.....+|++.+.||+|+||.||+|++. .+++.||+|.+.... ......+.+|
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------------------~~~~~~~~~e 75 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNE---------------------------EEKNRAIIQE 75 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESS---------------------------HHHHHHHHHH
T ss_pred eccCceEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCc---------------------------hHHHHHHHHH
Confidence 345668999999999999999999964 578999999985432 2235567889
Q ss_pred HHHHhhcc-CCCccceeEEEec------CCcceeeeeccccCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhc
Q 046907 124 INTVGQIR-HRNLHPLLAHVTR------PDCHLLYILNDVSQGR-----------RELDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 124 ~~~l~~l~-hpniv~l~~~~~~------~~~~~l~~~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
+.+++++. ||||+++++++.. .+...++++++++.+. ..+++..+..++.|++.||.|||+.
T Consensus 76 ~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 155 (337)
T 3ll6_A 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155 (337)
T ss_dssp HHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99999995 9999999998853 2334578899998652 2367778889999999999999998
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcc----------eeccCcccCccccccccc---cccccCccc
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH----------ITTSNVVGTVEYIAPEYL---QMLTLTEKC 252 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~~~aPE~~---~~~~~~~~~ 252 (345)
+ ++++||||||+||+++.++.+||+|||++......... .......||+.|+|||.+ .+..++.++
T Consensus 156 ~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~ 234 (337)
T 3ll6_A 156 K-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234 (337)
T ss_dssp S-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHH
T ss_pred C-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHH
Confidence 5 34999999999999999999999999999876543211 011245689999999998 566788999
Q ss_pred hhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 253 DIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 253 Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
||| +|+++|+|++|..||..... . ..+......+ ... .....+.+++..||+.||++||
T Consensus 235 Dv~slG~il~el~~g~~p~~~~~~----~---~~~~~~~~~~-~~~------------~~~~~~~~li~~~l~~~p~~Rp 294 (337)
T 3ll6_A 235 DIWALGCILYLLCFRQHPFEDGAK----L---RIVNGKYSIP-PHD------------TQYTVFHSLIRAMLQVNPEERL 294 (337)
T ss_dssp HHHHHHHHHHHHHHSSCCC-------------------CCCC-TTC------------CSSGGGHHHHHHHSCSSGGGSC
T ss_pred hHHHHHHHHHHHHhCCCCCcchhH----H---HhhcCcccCC-ccc------------ccchHHHHHHHHHccCChhhCc
Confidence 999 99999999999999753211 1 1111111100 000 0112267889999999999999
Q ss_pred CHHHHHHHHhhhh
Q 046907 332 NSKDVRRMLSQIQ 344 (345)
Q Consensus 332 t~~~ll~~L~~l~ 344 (345)
|+.++++.|+.+.
T Consensus 295 s~~e~l~~l~~~~ 307 (337)
T 3ll6_A 295 SIAEVVHQLQEIA 307 (337)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHH
Confidence 9999999998873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=297.45 Aligned_cols=244 Identities=12% Similarity=0.073 Sum_probs=188.0
Q ss_pred HHhhcCCcccccccccCcceeeEEEEe----cCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAEL----PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
+....++|.+.+.||+|+||.||+|++ ...+++.||||.+.... ..
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------------------------~~ 109 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------------------------------PW 109 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------------------------------HH
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------------------------------hh
Confidence 344677899999999999999999953 23478999999996432 23
Q ss_pred HHHHHHHHHhhcc---CCCccceeEEEecCCcceeeeeccccCCCCC--------------CCHHHHHHHHHHHHHHHHH
Q 046907 119 QIQSEINTVGQIR---HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------------LDWLARHRIALGLACGLEY 181 (345)
Q Consensus 119 ~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------------l~~~~~~~i~~~i~~~l~~ 181 (345)
.+..|+.+++.++ |+||+.+++++..++ ..++++||+.++++ +++..+..++.|++.||.|
T Consensus 110 ~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~ 187 (365)
T 3e7e_A 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187 (365)
T ss_dssp HHHHHHHHHHHSCGGGGGGBCCEEEEEECSS--CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhheeeecCC--CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 4556667766665 999999999998776 57899999987644 5566678899999999999
Q ss_pred HhhcCCCCeEecCCCCCCeeecC-----------CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc
Q 046907 182 LHMHHCPRIIHRDLNPVNVLLDD-----------DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250 (345)
Q Consensus 182 lh~~~~~~iiH~dlk~~nil~~~-----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~ 250 (345)
||+.+ |+||||||+|||++. ++.+||+|||++................||+.|+|||++.+..++.
T Consensus 188 lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 264 (365)
T 3e7e_A 188 VHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY 264 (365)
T ss_dssp HHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST
T ss_pred HhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc
Confidence 99998 999999999999988 8999999999998664333333445678999999999999999999
Q ss_pred cchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 251 KCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 251 ~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
++||| +|+++|||++|..||........ ........... ...+.+++..|++.+|.+
T Consensus 265 ~~DiwslG~il~elltg~~pf~~~~~~~~-------------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~ 322 (365)
T 3e7e_A 265 QIDYFGVAATVYCMLFGTYMKVKNEGGEC-------------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCH 322 (365)
T ss_dssp HHHHHHHHHHHHHHHHSSCCCEEEETTEE-------------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTT
T ss_pred cccHHHHHHHHHHHHhCCCccccCCCCce-------------------eechhccccCc---HHHHHHHHHHHcCCCCCC
Confidence 99999 99999999999999753222100 00000000111 233566777799999999
Q ss_pred C-CCHHHHHHHHhhh
Q 046907 330 R-PNSKDVRRMLSQI 343 (345)
Q Consensus 330 R-pt~~~ll~~L~~l 343 (345)
| |++.++.+.|+++
T Consensus 323 r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 323 HLPSLDLLRQKLKKV 337 (365)
T ss_dssp CCCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHH
Confidence 9 5788888888765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=293.78 Aligned_cols=259 Identities=25% Similarity=0.350 Sum_probs=172.9
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQ 119 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (345)
...|....++|++.+.||+|+||.||+|+.. .+++.||||.+..... ......
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~ 59 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKC--------------------------QTSMDE 59 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC------------------------------------
T ss_pred ccccccchhhhhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhc--------------------------chhHHH
Confidence 3456778899999999999999999999853 5788999999853211 122556
Q ss_pred HHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------------CCHHHHHHHHHHHHHHHHHH
Q 046907 120 IQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------------LDWLARHRIALGLACGLEYL 182 (345)
Q Consensus 120 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------------l~~~~~~~i~~~i~~~l~~l 182 (345)
+.+|+.+++.++||||+++++++..++ ..+++++++.++++ +++..+..++.|++.||.||
T Consensus 60 ~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 137 (303)
T 2vwi_A 60 LLKEIQAMSQCHHPNIVSYYTSFVVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137 (303)
T ss_dssp ------CCCCCCCTTBCCEEEEEESSS--CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCCEeeEEEEEeecC--CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 788999999999999999999998776 58889999987543 56777788999999999999
Q ss_pred hhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCc---ceeccCcccCccccccccccc-cccCccchhh-HH
Q 046907 183 HMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT---HITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FG 257 (345)
Q Consensus 183 h~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG 257 (345)
|+.+ ++|+||||+||+++.++.++|+|||++........ ........||+.|+|||.+.+ ..++.++||| +|
T Consensus 138 H~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 214 (303)
T 2vwi_A 138 HKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214 (303)
T ss_dssp HHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred HhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence 9998 99999999999999999999999999876543211 111234678999999999976 4688999999 99
Q ss_pred HHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 258 ALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 258 ~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
+++|+|++|..||..... ....................+.... ......+.+++..||+.||.+|||+.+++
T Consensus 215 ~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 215 ITAIELATGAAPYHKYPP----MKVLMLTLQNDPPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp HHHHHHHHSSCTTTTSCG----GGHHHHHHTSSCCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHHHhCCCCCccCch----hhHHHHHhccCCCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 999999999999754322 2221111111100000001111111 11223577888999999999999999998
Q ss_pred H
Q 046907 338 R 338 (345)
Q Consensus 338 ~ 338 (345)
+
T Consensus 287 ~ 287 (303)
T 2vwi_A 287 R 287 (303)
T ss_dssp T
T ss_pred h
Confidence 6
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.11 Aligned_cols=243 Identities=19% Similarity=0.292 Sum_probs=192.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+.+.||+|+||.||+|+.. .+++.||+|.+....... ....+.+.+|+.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~------------------------~~~~~~~~~E~~ 93 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLK------------------------PHQREKMSMEIS 93 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCS------------------------HHHHHHHHHHHH
T ss_pred cCCceEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcC------------------------HHHHHHHHHHHH
Confidence 5678999999999999999999864 578999999985322111 223567788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++...+ .++++++++.++.+ +++.....++.|++.||.|||+.+ ++|+|||
T Consensus 94 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlk 168 (335)
T 2owb_A 94 IHRSLAHQHVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 168 (335)
T ss_dssp HHHTCCCTTBCCEEEEEECSS--EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred HHHhCCCCCCCeEEEEEecCC--eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCC
Confidence 999999999999999998766 78999999987643 566777889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||+++.++.+||+|||++........ ......||..|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 169 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-- 244 (335)
T 2owb_A 169 LGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-- 244 (335)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--
T ss_pred chhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC--
Confidence 9999999999999999999987643322 22346789999999999998899999999 999999999999997532
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+.... .... . .....+.+++.+||+.||++|||+.++++
T Consensus 245 --~~~~~~~~~~~~~--~~~~--------~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 245 --CLKETYLRIKKNE--YSIP--------K----HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --SHHHHHHHHHHTC--CCCC--------T----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CHHHHHHHHhcCC--CCCC--------c----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222222222111 0000 0 11124678899999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=302.15 Aligned_cols=255 Identities=16% Similarity=0.159 Sum_probs=190.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCC-------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQ-------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
..++|++.+.||+|+||.||+|++... .+..||+|.+... .
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------------------------~ 87 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------------------------G 87 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------------------------S
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------------------------c
Confidence 357999999999999999999997532 4889999998532 2
Q ss_pred HHHHHHHHHhhccCCCccc---------------eeEEEecCCcceeeeeccccCCC-----------CCCCHHHHHHHH
Q 046907 119 QIQSEINTVGQIRHRNLHP---------------LLAHVTRPDCHLLYILNDVSQGR-----------RELDWLARHRIA 172 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~---------------l~~~~~~~~~~~l~~~~~~~~~~-----------~~l~~~~~~~i~ 172 (345)
.+.+|+.++++++||||++ +++++...+ ..++++++++ ++ ..+++..+..++
T Consensus 88 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 88 RLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQD-KYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp THHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETT-TEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred hHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCC-cEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 4567888999999988887 566666533 3788899998 53 346778888999
Q ss_pred HHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCC--CeEEeccccceecCCCCcc-----eeccCcccCccccccccccc
Q 046907 173 LGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI--EARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 173 ~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~ 245 (345)
.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||++......... .......||+.|+|||.+.+
T Consensus 166 ~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 99999999999998 99999999999999988 8999999999766432211 11234589999999999999
Q ss_pred cccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccC
Q 046907 246 LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTL 324 (345)
Q Consensus 246 ~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~ 324 (345)
..++.++||| +|+++|||++|..||..... ................ . ......... ......+.+++..||+
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~-~-~~~~~~~~~---~~~~~~l~~li~~~l~ 315 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP--NTEDIMKQKQKFVDKP-G-PFVGPCGHW---IRPSETLQKYLKVVMA 315 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--CHHHHHHHHHHHHHSC-C-CEECTTSCE---ECCCHHHHHHHHHHHT
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCCc--CHHHHHHHHHhccCCh-h-hhhhhcccc---CCCcHHHHHHHHHHHh
Confidence 8999999999 99999999999999865332 2222333332222111 1 111110000 0112347788889999
Q ss_pred CCCCCCCCHHHHHHHHhhhh
Q 046907 325 EDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 325 ~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||++|||+.+|++.|+++.
T Consensus 316 ~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 316 LTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp CCTTCCCCHHHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.34 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=192.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.+ .+|+.||||.+....... ......+.+|+.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~------------------------~~~~~~~~~E~~~ 79 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQ------------------------KTDKESLLREVQL 79 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCB------------------------SSCHHHHHHHHHH
T ss_pred cCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhccc------------------------chHHHHHHHHHHH
Confidence 458999999999999999999864 579999999986432211 1125567889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++...+ .++++++++.++.+ +++..+..++.|++.||.|||+.+ ++||||||
T Consensus 80 l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp 154 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKG--YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKP 154 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred HHhCCCCCCCcEEEEEEeCC--EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCH
Confidence 99999999999999998766 78999999987654 566778899999999999999999 99999999
Q ss_pred CCeee---cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||| +|+++|+|++|..||..
T Consensus 155 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~- 229 (484)
T 3nyv_A 155 ENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG- 229 (484)
T ss_dssp GGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred HHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC-
Confidence 99999 4678999999999987654322 234579999999999977 689999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.......+.......... ........+.+++..||+.||.+|||+.++++
T Consensus 230 ---~~~~~~~~~i~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 230 ---ANEYDILKKVEKGKYTFELP----------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---SSHHHHHHHHHHCCCCCCSG----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCHHHHHHHHHcCCCCCCCc----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 33344444433322111100 01122334778999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.84 Aligned_cols=243 Identities=22% Similarity=0.351 Sum_probs=168.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+|+.||+|.+...... .....+.+.+|+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~------------------------~~~~~~~~~~e~~ 63 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMY------------------------KAGMVQRVQNEVK 63 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHH------------------------HTTCHHHHHHHHH
T ss_pred ccccceeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhh------------------------hhhHHHHHHHHHH
Confidence 4468999999999999999999854 57899999998421100 0122467889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+ .+++++++++++ ..++......++.|++.||.|||+.+ ++|+||
T Consensus 64 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 138 (278)
T 3cok_A 64 IHCQLKHPSILELYNYFEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDL 138 (278)
T ss_dssp HHTTBCCTTBCCEEEEEECSS--EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSC
T ss_pred HHHhCCCCCeEeEEEEEccCC--eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 999999999999999998765 788999999764 34677788899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
||+||+++.++.++|+|||++........ ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||....
T Consensus 139 ~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 139 TLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 99999999999999999999987643221 12345789999999999988899999999 9999999999999975422
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. ... ...... +... +......+.+++.+||+.||++|||+.++++
T Consensus 217 ~~----~~~---~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 217 VK----NTL---NKVVLA-------DYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC------------CCSS-------CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HH----HHH---HHHhhc-------ccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11 111 000000 0001 1112234778999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=290.96 Aligned_cols=252 Identities=19% Similarity=0.264 Sum_probs=182.7
Q ss_pred cCCcccc-cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASL-EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 47 ~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.+.|++. +.||+|+||.||+|+.. .+++.||||.+...... ....+.+|+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~~E~~ 62 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGH---------------------------IRSRVFREVE 62 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS-SSCCEEEEEEEECCSSC---------------------------CHHHHHHHHH
T ss_pred ceeEEecCceecCCceEEEEEEEEc-CCCcEEEEEEEeeCcch---------------------------hHHHHHHHHH
Confidence 4578885 78999999999999853 57999999999654321 1456778999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++.++ +||||+++++++..++ .+++++|++.++++ ++......++.|++.||.|||+.+ ++||||
T Consensus 63 ~l~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dl 137 (316)
T 2ac3_A 63 MLYQCQGHRNVLELIEFFEEED--RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDL 137 (316)
T ss_dssp HHHHTCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHHHhcCCCCeeeEEEEEeeCC--EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCC
Confidence 99885 7999999999998776 78999999987654 566677789999999999999998 999999
Q ss_pred CCCCeeecCCCC---eEEeccccceecCCCCc-----ceeccCcccCccccccccccc-----cccCccchhh-HHHHHH
Q 046907 196 NPVNVLLDDDIE---ARISGFGFARAIPDAHT-----HITTSNVVGTVEYIAPEYLQM-----LTLTEKCDIY-FGALLA 261 (345)
Q Consensus 196 k~~nil~~~~~~---~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~~~aPE~~~~-----~~~~~~~Dvw-lG~vl~ 261 (345)
||+||+++.++. +||+|||++........ ........||+.|+|||.+.+ ..++.++||| +|+++|
T Consensus 138 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~ 217 (316)
T 2ac3_A 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217 (316)
T ss_dssp CGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHH
T ss_pred CHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHH
Confidence 999999997765 99999999876532211 111223569999999999975 4578999999 999999
Q ss_pred HHHhCCCCCcccccccchhh--------HHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 046907 262 GLVMGKLPSDKFFQHTNEMS--------FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~ 333 (345)
+|++|..||........... ......... ..... .+.... ......+.+++.+||+.||++|||+
T Consensus 218 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~ 290 (316)
T 2ac3_A 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ-EGKYE--FPDKDW----AHISCAAKDLISKLLVRDAKQRLSA 290 (316)
T ss_dssp HHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH-HCCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHCCCCCcccccccccccccccchhHHHHHHHHHh-ccCcc--cCchhc----ccCCHHHHHHHHHHhhCChhhCCCH
Confidence 99999999865432211110 011111111 11110 000000 0112357889999999999999999
Q ss_pred HHHHH
Q 046907 334 KDVRR 338 (345)
Q Consensus 334 ~~ll~ 338 (345)
.++++
T Consensus 291 ~e~l~ 295 (316)
T 2ac3_A 291 AQVLQ 295 (316)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 99986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.83 Aligned_cols=243 Identities=19% Similarity=0.313 Sum_probs=191.9
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.+.+.||+|+||.||+|+.. .+++.||+|.+....... ....+.+.+|+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~------------------------~~~~~~~~~e~~ 67 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLK------------------------PHQREKMSMEIS 67 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCS------------------------HHHHHHHHHHHH
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccC------------------------HHHHHHHHHHHH
Confidence 4568999999999999999999864 578999999985422111 223567788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.++.+ +++.....++.|++.||.|||+.+ ++|+|||
T Consensus 68 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~ 142 (294)
T 2rku_A 68 IHRSLAHQHVVGFHGFFEDND--FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 142 (294)
T ss_dssp HHHTCCCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHHhCCCCCEeeeeeeeccCC--EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCC
Confidence 999999999999999998766 78999999987643 566777889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||+++.++.+||+|||++........ ......||..|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 143 p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-- 218 (294)
T 2rku_A 143 LGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-- 218 (294)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--
T ss_pred hHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--
Confidence 9999999999999999999987643222 22346789999999999998899999999 999999999999997542
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+.. .... .. . .....+.+++.+||+.||++|||+.++++
T Consensus 219 --~~~~~~~~~~~---~~~~-------~~-~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 219 --CLKETYLRIKK---NEYS-------IP-K---HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --SHHHHHHHHHT---TCCC-------CC-T---TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CHHHHHHHHhh---ccCC-------Cc-c---ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 22222221111 1110 00 0 11234778899999999999999999876
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=309.49 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=190.0
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++++.||+|+||.||+|+.+ .++..||+|.+............. ........+.+.+|+.
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~E~~ 98 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDD--------------NKNIEKFHEEIYNEIS 98 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC------------------------------CTHHHHHHHHH
T ss_pred cccceEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhccccccccc--------------chhhHHHHHHHHHHHH
Confidence 3568999999999999999999864 578999999997643321110000 0000123567889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ .++++++++.++++ +++..+..++.|++.||.|||+.+ ++|||||
T Consensus 99 ~l~~l~hpniv~~~~~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlk 173 (504)
T 3q5i_A 99 LLKSLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIK 173 (504)
T ss_dssp HHHTCCCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhCCCCCCCeEEEEEEcCC--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCc
Confidence 999999999999999998766 78999999988754 567778899999999999999999 9999999
Q ss_pred CCCeeecCCC---CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 197 PVNVLLDDDI---EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 197 ~~nil~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|+|||++.++ .+||+|||++....... ......||+.|+|||++.+ .++.++||| +|+++|+|++|..||..
T Consensus 174 p~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 174 PENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp GGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999998765 69999999998765432 2244679999999999875 689999999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+.... ... +.... ......+.+++..||+.||.+|||+.++++
T Consensus 250 ----~~~~~~~~~i~~~~---~~~---~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 250 ----QNDQDIIKKVEKGK---YYF---DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ----SSHHHHHHHHHHCC---CCC---CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCHHHHHHHHHcCC---CCC---Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 33344444333221 110 00000 011234778999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=286.69 Aligned_cols=241 Identities=22% Similarity=0.312 Sum_probs=190.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .++..||+|.+...... .......+.+|+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~~e~~ 66 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLE------------------------KEGVEHQLRREIE 66 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHH------------------------HTTCHHHHHHHHH
T ss_pred hhhhceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccc------------------------hHHHHHHHHHHHH
Confidence 4568999999999999999999864 57889999998521100 0112456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++...+ .++++++++.++++ ++......++.|++.||.|||+.+ ++|+|||
T Consensus 67 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~ 141 (284)
T 2vgo_A 67 IQSHLRHPNILRMYNYFHDRK--RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIK 141 (284)
T ss_dssp HHHTCCCTTBCCEEEEEECSS--EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCS
T ss_pred HHhcCCCCCEeeEEEEEEcCC--EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCC
Confidence 999999999999999998765 78899999987644 566677889999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+||+++.++.++|+|||++....... .....|+..|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-- 215 (284)
T 2vgo_A 142 PENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-- 215 (284)
T ss_dssp GGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--
T ss_pred HHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC--
Confidence 999999999999999999987654322 2346789999999999998899999999 999999999999997532
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.. .... .. +.....+.+++..||+.||.+|||+.++++
T Consensus 216 --~~~~~~~~~~~---~~~~-------~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 216 --SHTETHRRIVN---VDLK-------FP----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --SHHHHHHHHHT---TCCC-------CC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CHhHHHHHHhc---cccC-------CC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 22222222211 1100 00 111234778899999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.74 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=189.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|.+.+.||+|+||.||+|+.. .+|+.||||.+.....+ ......+.+|+.
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~ 93 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQS-------------------------EIFAKRAYRELL 93 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSS-------------------------HHHHHHHHHHHH
T ss_pred ccccEEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccc-------------------------hhHHHHHHHHHH
Confidence 3469999999999999999999854 57999999999654322 223567789999
Q ss_pred HHhhccCCCccceeEEEecCCcc----eeeeeccccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCH----LLYILNDVSQG------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~----~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++...+.. ..+++++++.+ +..++...+..++.|++.||.|||+.+ ++||||
T Consensus 94 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 170 (371)
T 4exu_A 94 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDL 170 (371)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCc
Confidence 99999999999999999876532 24788888875 234788889999999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+||+++.++.+||+|||++...... .....||+.|+|||.+.+ ..++.++||| +|+++|+|++|..||...
T Consensus 171 kp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 171 KPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp CGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999765332 234678999999999987 6789999999 999999999999997532
Q ss_pred ccccchhhHHHHHHHHhhhcCCCcccc--------------ccccCC----CcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAID--------------SKLVGN----GCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
+..+....+......+... ... +..... ..+.....+.+++..||+.||++|||+.+
T Consensus 246 ----~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 320 (371)
T 4exu_A 246 ----DYLDQLTQILKVTGVPGTE-FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 320 (371)
T ss_dssp ----SHHHHHHHHHHHHCCCCHH-HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred ----ChHHHHHHHHHHhCCCcHH-HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHH
Confidence 3333333332222111000 000 000000 01122345788999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 321 ll~ 323 (371)
T 4exu_A 321 ALT 323 (371)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.39 Aligned_cols=241 Identities=22% Similarity=0.351 Sum_probs=188.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|.+.+.||+|+||.||+|+.. .+|+.||+|.+..... .....+.+|+.+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---------------------------~~~~~~~~e~~~ 59 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPA---------------------------FRDSSLENEIAV 59 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC---------------------------------HHHHHHHH
T ss_pred hccceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccc---------------------------cchHHHHHHHHH
Confidence 458999999999999999999864 5799999999964321 113457789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++...+ .+++++++++++++ ++......++.|++.||.|||+.+ ++|+||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp 134 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTT--HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKP 134 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCG
T ss_pred HHhCCCCCeeehhhhcccCC--EEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCH
Confidence 99999999999999988766 78999999987654 456667789999999999999998 99999999
Q ss_pred CCeee---cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLL---DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||++ +.++.++|+|||++...... ......||+.|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 135 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~- 209 (304)
T 2jam_A 135 ENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE- 209 (304)
T ss_dssp GGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-
T ss_pred HHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-
Confidence 99999 77889999999998754332 12335689999999999998999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.........+....... .. .........+.+++..||+.||++|||+.++++
T Consensus 210 ---~~~~~~~~~i~~~~~~~------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 210 ---ETESKLFEKIKEGYYEF------ES----PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---SCHHHHHHHHHHCCCCC------CT----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---CCHHHHHHHHHcCCCCC------Cc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22333333333221110 00 111122345778999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=294.61 Aligned_cols=251 Identities=20% Similarity=0.315 Sum_probs=192.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|+++ .+|+.||||.+......... .......+.+.+|+.
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~-------------------~~~~~~~~~~~~E~~ 151 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSP-------------------EQLEEVREATRRETH 151 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCH-------------------HHHHHHHHHHHHHHH
T ss_pred hhhhcccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCH-------------------HHHHHHHHHHHHHHH
Confidence 3467999999999999999999864 47999999998654321100 001233567889999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.+ +||||+++++++...+ ..+++++++.++.+ +++.....++.|++.||.|||+.+ ++|+||
T Consensus 152 ~l~~l~~hp~iv~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dl 226 (365)
T 2y7j_A 152 ILRQVAGHPHIITLIDSYESSS--FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDL 226 (365)
T ss_dssp HHHHHTTCTTBCCEEEEEEBSS--EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHhcCCCCEeEEEEEEeeCC--EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999 8999999999988765 78999999988654 566677889999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc------ccCccchhh-HHHHHHHHHhCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML------TLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~------~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
||+||+++.++.++|+|||++....... ......||+.|+|||++.+. .++.++||| +|+++|+|++|..
T Consensus 227 kp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 227 KPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 9999999999999999999998765432 22446899999999998643 578899999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||.. .........+.... .... .+. .. .....+.+++..||+.||++|||+.++++
T Consensus 304 pf~~----~~~~~~~~~i~~~~---~~~~--~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 304 PFWH----RRQILMLRMIMEGQ---YQFS--SPE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSCC----SSHHHHHHHHHHTC---CCCC--HHH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC----CCHHHHHHHHHhCC---CCCC--Ccc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9643 22223333222211 1000 000 00 11234778999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=319.20 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=193.5
Q ss_pred HhhcCCcccccccccCcceeeEEEEecC--CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
....++|++.+.||+|+||.||+|++.. ..+..||+|.+..... ....+.+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~ 439 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--------------------------DSVREKFL 439 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--------------------------HHHHHHHH
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--------------------------HHHHHHHH
Confidence 4456789999999999999999998753 2367899999864321 12356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.+++.++||||+++++++..+ .++++++++.++++ +++.....++.|++.||.|||+.+ ++
T Consensus 440 ~E~~~l~~l~HpnIv~l~~~~~~~---~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iv 513 (656)
T 2j0j_A 440 QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FV 513 (656)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSS---SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCCCeEEEEEecC---ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 999999999999999999988543 47889999987654 556667789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||| +|+++|||++ |..|
T Consensus 514 HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~P 592 (656)
T 2j0j_A 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592 (656)
T ss_dssp CSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999876443221 22335667899999999988999999999 9999999997 9999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|... ...+....+......+.+ +.....+.++|..||+.||++|||+.++++.|+++.
T Consensus 593 f~~~----~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 593 FQGV----KNNDVIGRIENGERLPMP-------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp TTTC----CHHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHcCCCCCCC-------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 6532 333343333332211111 112235778999999999999999999999999873
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=309.48 Aligned_cols=252 Identities=20% Similarity=0.257 Sum_probs=191.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|++. .+++.||||.+..... ...+..|+.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~-----------------------------~~~~~~E~~i 55 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK-----------------------------HPQLLYESKI 55 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCS-----------------------------SCCHHHHHHH
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEeccccc-----------------------------cHHHHHHHHH
Confidence 478999999999999999999864 5799999998754321 2235679999
Q ss_pred HhhccCCCcccee-EEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLL-AHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~-~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++|++.+..+ .++...+ ..+++++++.+ ...+++..+..++.|++.||.|||+.+ |+|||||
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~--~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIK 130 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGD--YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIK 130 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETT--EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHHhcCCCCCCeEEEEEeeCC--EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccC
Confidence 9999875555444 4444433 67889999833 234677788899999999999999999 9999999
Q ss_pred CCCeee---cCCCCeEEeccccceecCCCCcce-----eccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 197 PVNVLL---DDDIEARISGFGFARAIPDAHTHI-----TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 197 ~~nil~---~~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
|+|||+ +.++.+||+|||+++......... ......||..|+|||.+.+..++.++||| ||+++|||++|.
T Consensus 131 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~ 210 (483)
T 3sv0_A 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210 (483)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 999999 578899999999998775433211 12357899999999999999999999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.||...........+......... ..... +. ......+.+++..||+.||++||++.+|++.|+++
T Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~~-----l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 211 LPWQGLKAGTKKQKYEKISEKKVA-TSIEA-----LC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CTTSSCCCSSHHHHHHHHHHHHHH-SCHHH-----HH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCCccccchhHHHHHHHHhhcccc-ccHHH-----Hh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 998764443333333222222211 11000 00 01123578899999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=298.34 Aligned_cols=269 Identities=18% Similarity=0.214 Sum_probs=189.8
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+.....++|++.+.||+|+||.||+|+.. +|..||||.+............. ......+.+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~----------------~~~~~~~~~~ 77 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNIL----------------SDSFLCKRVL 77 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGG----------------GSHHHHHHHH
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhh----------------hhhhHHHHHH
Confidence 34557789999999999999999999854 59999999986543321110000 0023357788
Q ss_pred HHHHHHhhccCCCccceeEEEecC---CcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRP---DCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~---~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+|+.+++.++||||+++++++... ....++++++++.++ ..+++..+..++.|++.||.|||+.+
T Consensus 78 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 154 (362)
T 3pg1_A 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--- 154 (362)
T ss_dssp HHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---
Confidence 999999999999999999988653 334688999998752 24778888999999999999999999
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
++||||||+||+++.++.+||+|||++....... ......||+.|+|||.+.+ ..++.++||| +|+++|+|++|.
T Consensus 155 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCC
Confidence 9999999999999999999999999997543322 2234678999999999977 5689999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCcc------------------ccccccCCCcHHHHHHHHHHHhhccCCCCCC
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRA------------------IDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~ 329 (345)
.||... ........+......+..... ..........+.....+.+++..||+.||.+
T Consensus 232 ~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 232 ALFRGS----TFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp CSCCCS----SHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCC----CHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 997542 333333333322211111000 0000000001122345788999999999999
Q ss_pred CCCHHHHHH
Q 046907 330 RPNSKDVRR 338 (345)
Q Consensus 330 Rpt~~~ll~ 338 (345)
|||+.++++
T Consensus 308 Rpt~~ell~ 316 (362)
T 3pg1_A 308 RISTEQALR 316 (362)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHHc
Confidence 999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=316.94 Aligned_cols=244 Identities=22% Similarity=0.281 Sum_probs=191.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++++.||+|+||.||+|+.+ .+++.||||.+..... ........+..|.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~------------------------~~~~~~~~~~~E~ 392 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVV------------------------IQDDDVECTMVEK 392 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHH------------------------HHTTTTHHHHHHH
T ss_pred ccccceEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEecccc------------------------ccHHHHHHHHHHH
Confidence 35678999999999999999999965 5789999999952110 0122356677899
Q ss_pred HHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.++..+ +||||+++++++...+ .+++++||+.++++ +++..+..++.|++.||.|||+.+ |+|||
T Consensus 393 ~~l~~~~~~~~i~~l~~~~~~~~--~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrD 467 (674)
T 3pfq_A 393 RVLALPGKPPFLTQLHSCFQTMD--RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 467 (674)
T ss_dssp HHHTCTTCCTTBCCEEEECBCSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCC
T ss_pred HHHHhccCCCeEEEEEEEEEeCC--EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 999887 7999999999988766 78999999998755 566667789999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||| +|+++|||++|..||..
T Consensus 468 LKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~- 544 (674)
T 3pfq_A 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG- 544 (674)
T ss_dssp CCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred CChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-
Confidence 999999999999999999999986433222 24557899999999999999999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS-----KDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~-----~~ll~ 338 (345)
.+..+....+.. .... + +......+.+|+..||+.||++||++ .+|++
T Consensus 545 ---~~~~~~~~~i~~---~~~~---~--------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 545 ---EDEDELFQSIME---HNVA---Y--------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---SSHHHHHHHHHS---SCCC---C--------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCHHHHHHHHHh---CCCC---C--------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 233333333322 1111 0 01122347788899999999999997 66653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.95 Aligned_cols=247 Identities=22% Similarity=0.284 Sum_probs=188.8
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|+.. .+|+.||+|.+.......... ....+.+.+|+.++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~---------------------~~~~~~~~~E~~~l 62 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRR---------------------GVSREEIEREVNIL 62 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSS---------------------SBCHHHHHHHHHHH
T ss_pred hhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhcccccccc---------------------chHHHHHHHHHHHH
Confidence 57999999999999999999864 578999999987643321110 01145678899999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++||||+++++++..++ ..+++++++.++++ +++.....++.|++.||.|||+.+ ++|+||||+
T Consensus 63 ~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ 137 (283)
T 3bhy_A 63 REIRHPNIITLHDIFENKT--DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPE 137 (283)
T ss_dssp HHCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred HhCCCCCeeehhheecCCC--eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChH
Confidence 9999999999999998765 68899999987654 566677899999999999999998 999999999
Q ss_pred CeeecCCC----CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 199 NVLLDDDI----EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 199 nil~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+++.++ .++|+|||++........ .....|++.|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 138 Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred HEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 99998776 799999999987644321 2345789999999999988999999999 999999999999997542
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.... .. .+.... +.....+.+++.+||+.||++|||+.++++
T Consensus 215 ----~~~~~~~~~~~~~---~~---~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 215 ----TKQETLTNISAVN---YD---FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ----SHHHHHHHHHTTC---CC---CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----chHHHHHHhHhcc---cC---Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2222222222111 00 000000 111234788999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=287.86 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=185.2
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
...++|++.+.||+|+||.||+|++. .+|..||+|.+.... ....+.+|+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~-----------------------------~~~~~~~e~ 75 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVES-----------------------------DLQEIIKEI 75 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET-TTCCEEEEEEEETTS-----------------------------CCHHHHHHH
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCchH-----------------------------HHHHHHHHH
Confidence 45678999999999999999999864 579999999986421 134567899
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.+++.++||||+++++++..++ .++++++++++++ .++......++.|++.||.|||+.+ ++|+|
T Consensus 76 ~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~d 150 (314)
T 3com_A 76 SIMQQCDSPHVVKYYGSYFKNT--DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRD 150 (314)
T ss_dssp HHHHTCCCTTBCCEEEEEEETT--EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHhCCCCCCccEEEEEEeCC--EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCC
Confidence 9999999999999999998766 6889999998743 3566777889999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||+||+++.++.++|+|||++........ ......||..|+|||.+.+..++.++||| +|+++|+|++|..||...
T Consensus 151 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 228 (314)
T 3com_A 151 IKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228 (314)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654322 22346789999999999998899999999 999999999999997542
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+. ....+.. . ........+.+++..||+.||.+|||+.++++
T Consensus 229 ----~~~~~~~~~~---~~~~~~~-~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 229 ----HPMRAIFMIP---TNPPPTF-R-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----CHHHHHHHHH---HSCCCCC-S-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----ChHHHHHHHh---cCCCccc-C-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 2222211111 1111100 0 01111235788999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=294.15 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=189.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|.+.+.||+|+||.||+|+.. .+|+.||||.+.....+ ......+.+|+.+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~~E~~~ 76 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQS-------------------------EIFAKRAYRELLL 76 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSS-------------------------HHHHHHHHHHHHH
T ss_pred CceEEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccc-------------------------hHHHHHHHHHHHH
Confidence 468999999999999999999864 57999999999653322 2235677899999
Q ss_pred HhhccCCCccceeEEEecCCcc----eeeeeccccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCH----LLYILNDVSQG------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~----~l~~~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++||||+++++++...+.. .++++++++.+ +..++...+..++.|++.||.|||+.+ ++|||||
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlk 153 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLK 153 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCC
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 9999999999999998876532 35788888864 224678888999999999999999998 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.+||+|||++...... .....||+.|+|||.+.+ ..++.++||| +|+++|+|++|..||...
T Consensus 154 p~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~- 227 (353)
T 3coi_A 154 PGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK- 227 (353)
T ss_dssp GGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS-
T ss_pred HHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC-
Confidence 99999999999999999999764322 234678999999999987 5688999999 999999999999997542
Q ss_pred cccchhhHHHHHHHHhhhcCC------------------CccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENP------------------KRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+..+....+......+.. ..... .......+.....+.+++.+||+.||++|||+.++
T Consensus 228 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 303 (353)
T 3coi_A 228 ---DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR-KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303 (353)
T ss_dssp ---CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSS-CCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred ---CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCC-ccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 223333333222111100 00000 00111122334567889999999999999999999
Q ss_pred HH
Q 046907 337 RR 338 (345)
Q Consensus 337 l~ 338 (345)
++
T Consensus 304 l~ 305 (353)
T 3coi_A 304 LT 305 (353)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=296.18 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=189.5
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
.+|....++|++.+.||+|+||.||+|+++ ..+|+|.+........ ..+.+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~-------------------------~~~~~ 76 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNED-------------------------QLKAF 76 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCC-------------------------CCCCC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHH-------------------------HHHHH
Confidence 456678899999999999999999999864 2499999875432211 13345
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
.+|+.+++.++||||+++++++..++ .++++++++.+++ .+++.....++.|++.||.|||+.+ +
T Consensus 77 ~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i 151 (319)
T 2y4i_B 77 KREVMAYRQTRHENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151 (319)
T ss_dssp CTTGGGGTTCCCTTBCCCCEEEECSS--CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHhcCCCCCEeEEEEEEecCC--ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 67899999999999999999998776 5888999987642 4677888999999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCc---ceeccCcccCccccccccccc---------cccCccchhh-HH
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT---HITTSNVVGTVEYIAPEYLQM---------LTLTEKCDIY-FG 257 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~~~aPE~~~~---------~~~~~~~Dvw-lG 257 (345)
+|+||||+||+++ ++.++|+|||++........ ........|+..|+|||.+.+ ..++.++||| +|
T Consensus 152 ~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG 230 (319)
T 2y4i_B 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230 (319)
T ss_dssp CCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH
T ss_pred cccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH
Confidence 9999999999998 67999999999875432111 112234568999999999975 3478899999 99
Q ss_pred HHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 258 ALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 258 ~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
+++|+|++|..||... ........+.......... .. ....+.+++..||+.||++|||+.+++
T Consensus 231 ~il~el~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~----~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~ 294 (319)
T 2y4i_B 231 TIWYELHAREWPFKTQ----PAEAIIWQMGTGMKPNLSQ----IG--------MGKEISDILLFCWAFEQEERPTFTKLM 294 (319)
T ss_dssp HHHHHHHHSSCSSSSC----CHHHHHHHHHTTCCCCCCC----SS--------CCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCC----CHHHHHHHhccCCCCCCCc----CC--------CCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 9999999999997532 2233332222221111111 01 112378899999999999999999999
Q ss_pred HHHhhhh
Q 046907 338 RMLSQIQ 344 (345)
Q Consensus 338 ~~L~~l~ 344 (345)
+.|+++.
T Consensus 295 ~~l~~l~ 301 (319)
T 2y4i_B 295 DMLEKLP 301 (319)
T ss_dssp HHHTTC-
T ss_pred HHHHHHH
Confidence 9999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=295.14 Aligned_cols=259 Identities=19% Similarity=0.251 Sum_probs=191.1
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|++. .+|+.||||.+..... ......+.+|+.
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~E~~ 61 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDK--------------------------PLFALRTLREIK 61 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSS--------------------------HHHHHHHHHHHH
T ss_pred cccceEEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeeccccc--------------------------chHHHHHHHHHH
Confidence 3579999999999999999999864 5799999999964321 123556778999
Q ss_pred HHhhccCCCccceeEEEecCC---cceeeeeccccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD---CHLLYILNDVSQGR-------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~---~~~l~~~~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++..+. ....+++++++.+. ..++...+..++.|++.||.|||+.+ ++||||
T Consensus 62 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dl 138 (353)
T 2b9h_A 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDL 138 (353)
T ss_dssp HHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 999999999999999876542 24678899998752 34677788899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcc--------eeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHh
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTH--------ITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--------~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~t 265 (345)
||+||+++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++||| +|+++|+|++
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 218 (353)
T 2b9h_A 139 KPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218 (353)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh
Confidence 999999999999999999999876532211 01233578999999998765 5689999999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCCccccc-------------cccCC-----CcHHHHHHHHHHHhhccCCCC
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDS-------------KLVGN-----GCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~-----~~~~~~~~l~~li~~Cl~~dp 327 (345)
|..||... +.......+......+........ ...+. ..+.....+.+++..||+.||
T Consensus 219 g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 219 RRPIFPGR----DYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp SSCSCCCS----SHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred CCCCCCCC----CcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 99997542 333333333332222111000000 00000 011223457789999999999
Q ss_pred CCCCCHHHHHH
Q 046907 328 NERPNSKDVRR 338 (345)
Q Consensus 328 ~~Rpt~~~ll~ 338 (345)
++|||+.++++
T Consensus 295 ~~Rpt~~ell~ 305 (353)
T 2b9h_A 295 AKRITAKEALE 305 (353)
T ss_dssp GGSCCHHHHHT
T ss_pred ccCCCHHHHhc
Confidence 99999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=288.76 Aligned_cols=249 Identities=18% Similarity=0.296 Sum_probs=191.2
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|.....++..||||.+... ......+.+|+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~~e~~~ 64 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----------------------------DRYCEAARSEIQV 64 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----------------------------HHHHHHHHHHHHH
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----------------------------CchhHHHHHHHHH
Confidence 469999999999999999999865567899999999642 1224566788888
Q ss_pred HhhccCCC------ccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 127 VGQIRHRN------LHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 127 l~~l~hpn------iv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
++.++|+| ++++++++...+ .++++++++.+. ..++...+..++.|++.||.|||+.+ +
T Consensus 65 l~~l~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 139 (339)
T 1z57_A 65 LEHLNTTDPNSTFRCVQMLEWFEHHG--HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---L 139 (339)
T ss_dssp HHHHHHHCTTCTTCBCCEEEEEEETT--EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHhhhcCCCCceeeEeeecccccCC--cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 88887665 999999998776 788999998431 13567778899999999999999998 9
Q ss_pred EecCCCCCCeeecC-------------------CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 191 IHRDLNPVNVLLDD-------------------DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 191 iH~dlk~~nil~~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+||||||+||+++. ++.+||+|||++...... .....||+.|+|||.+.+..++.+
T Consensus 140 vH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 214 (339)
T 1z57_A 140 THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQP 214 (339)
T ss_dssp ECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTH
T ss_pred cCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcc
Confidence 99999999999987 668999999999865432 234678999999999999899999
Q ss_pred chhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCcccc------------------------------
Q 046907 252 CDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAID------------------------------ 300 (345)
Q Consensus 252 ~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------------ 300 (345)
+||| +|+++|||++|..||... +..+....+....... +.....
T Consensus 215 ~Di~slG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (339)
T 1z57_A 215 CDVWSIGCILIEYYLGFTVFPTH----DSKEHLAMMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289 (339)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCS----CHHHHHHHHHHHHCSC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred hhhHHHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHHhCCC-CHHHHhhccchhHHhhccccccccccccchhhhcCc
Confidence 9999 999999999999997542 3333333333332211 100000
Q ss_pred -ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 301 -SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 301 -~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..............+.+++..||+.||.+|||+.++++
T Consensus 290 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 00001112345567889999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=285.78 Aligned_cols=235 Identities=20% Similarity=0.298 Sum_probs=183.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|++. .+++.||+|.+....... .....+.+|+..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~-------------------------~~~~~~~~e~~~ 63 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGS-------------------------VDEQNALREVYA 63 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTS-------------------------HHHHHHHHHHHH
T ss_pred cchhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEeccccccc-------------------------HHHHHHHHHHHH
Confidence 468999999999999999999864 579999999997543331 124567789999
Q ss_pred Hhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 127 VGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+..+ +||||+++++++..++ .+++++++++++++ +++..+..++.|++.||.|||+.+ ++|
T Consensus 64 ~~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH 138 (289)
T 1x8b_A 64 HAVLGQHSHVVRYFSAWAEDD--HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVH 138 (289)
T ss_dssp HHHSCSCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhCCCCCeeeeeeeeecCC--eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---Eee
Confidence 9998 9999999999998776 78899999988654 566677789999999999999998 999
Q ss_pred cCCCCCCeeecC-------------------CCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccc
Q 046907 193 RDLNPVNVLLDD-------------------DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKC 252 (345)
Q Consensus 193 ~dlk~~nil~~~-------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~ 252 (345)
|||||+||+++. ...++++|||.+....... ...||..|+|||.+.+. .++.++
T Consensus 139 ~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~ 212 (289)
T 1x8b_A 139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKA 212 (289)
T ss_dssp SCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHH
T ss_pred cCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchh
Confidence 999999999984 4479999999998765432 24689999999999876 466899
Q ss_pred hhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 253 DIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 253 Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
||| +|+++|+|++|..|+... .....+... ..+ ... ......+.+++..||+.||++||
T Consensus 213 Di~slG~il~~l~~~~~~~~~~-------~~~~~~~~~---~~~------~~~----~~~~~~~~~li~~~l~~dp~~Rp 272 (289)
T 1x8b_A 213 DIFALALTVVCAAGAEPLPRNG-------DQWHEIRQG---RLP------RIP----QVLSQEFTELLKVMIHPDPERRP 272 (289)
T ss_dssp HHHHHHHHHHHHTTCCCCCSSS-------HHHHHHHTT---CCC------CCS----SCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHHHHHHHhcCCCCCcch-------hHHHHHHcC---CCC------CCC----cccCHHHHHHHHHHhCCCcccCC
Confidence 999 999999999998774221 111111111 111 001 11123477888999999999999
Q ss_pred CHHHHHH
Q 046907 332 NSKDVRR 338 (345)
Q Consensus 332 t~~~ll~ 338 (345)
|+.++++
T Consensus 273 s~~~ll~ 279 (289)
T 1x8b_A 273 SAMALVK 279 (289)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=302.89 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=185.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...+|.+.+.||+|+||.||+|++. .+..+|+|.+..... ...+|+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~-------------------------------~~~~E~~ 84 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKR-------------------------------FKNRELQ 84 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTT-------------------------------SCCHHHH
T ss_pred ccceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcc-------------------------------hHHHHHH
Confidence 3457999999999999999999865 344589998854321 1125899
Q ss_pred HHhhccCCCccceeEEEecCC----cceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+++.++||||+++++++...+ ..+++++++|++++ ..++...+..++.|++.||.|||+.+
T Consensus 85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--- 161 (394)
T 4e7w_A 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--- 161 (394)
T ss_dssp HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 999999999999999886533 34578999999763 35677788899999999999999999
Q ss_pred eEecCCCCCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhC
Q 046907 190 IIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 190 iiH~dlk~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg 266 (345)
++||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||| +|+++|||++|
T Consensus 162 ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 238 (394)
T 4e7w_A 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238 (394)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999 789999999999987644322 2346789999999999765 489999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCc-------ccc---ccccCC-----CcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKR-------AID---SKLVGN-----GCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~---~~~~~~-----~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
..||.+. +..+....+......+.... ... +..... ..+.....+.+++.+||+.||.+||
T Consensus 239 ~~pf~~~----~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (394)
T 4e7w_A 239 QPLFPGE----SGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314 (394)
T ss_dssp SCSSCCS----SHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCC----CHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC
Confidence 9997542 33333222222221111000 000 000000 0111234578899999999999999
Q ss_pred CHHHHHH
Q 046907 332 NSKDVRR 338 (345)
Q Consensus 332 t~~~ll~ 338 (345)
|+.++++
T Consensus 315 t~~e~l~ 321 (394)
T 4e7w_A 315 TAIEALC 321 (394)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=286.11 Aligned_cols=243 Identities=22% Similarity=0.305 Sum_probs=183.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|.....||+|+||.||+|++. .++..||+|.+..... ...+.+.+|+.
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~---------------------------~~~~~~~~e~~ 71 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDS---------------------------RYSQPLHEEIA 71 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC------------------------------HHHHHHHH
T ss_pred cccCCCCcEEEeecCcEEEEEEEEC-CCCeEEEEEEccCCch---------------------------HHHHHHHHHHH
Confidence 4556666679999999999999864 5789999999865421 12456788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+++.++||||+++++++...+ .++++++++.++.+ ++......++.|++.||.|||+.+ ++|+
T Consensus 72 ~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 146 (295)
T 2clq_A 72 LHKHLKHKNIVQYLGSFSENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHR 146 (295)
T ss_dssp HHHTCCCTTBCCEEEEEEETT--EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHHhCCCCCEeeEeeEEEeCC--cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEcc
Confidence 999999999999999998776 68889999876533 345566778999999999999998 9999
Q ss_pred CCCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCccccccccccccc--cCccchhh-HHHHHHHHHhCCCC
Q 046907 194 DLNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 194 dlk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
||||+||+++. ++.++|+|||++........ ......|+..|+|||.+.+.. ++.++||| +|+++|+|++|..|
T Consensus 147 dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 224 (295)
T 2clq_A 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224 (295)
T ss_dssp CCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred CCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999987 88999999999987643221 223467899999999997654 78899999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|..... ... ...........+ . .+......+.+++..||+.||++|||+.++++
T Consensus 225 f~~~~~----~~~-~~~~~~~~~~~~------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 225 FYELGE----PQA-AMFKVGMFKVHP------E----IPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TGGGSS----HHH-HHHHHHHHCCCC------C----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCCc----hhH-HHHhhccccccc------c----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 754211 111 111111111110 0 11112234778889999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=290.98 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=183.1
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++.+.||+|+||.||+|++. .+|..||||.+...... ...+.+|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~----------------------------~~~~~~e 70 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGDE----------------------------EEEIKQE 70 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSST----------------------------THHHHHH
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCccc----------------------------HHHHHHH
Confidence 346789999999999999999999864 57899999998653221 3456789
Q ss_pred HHHHhhc-cCCCccceeEEEecCC----cceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPD----CHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
+.+++++ +||||+++++++...+ ...++++++++.+++ .++......++.|++.||.|||+.+
T Consensus 71 ~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~- 149 (326)
T 2x7f_A 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149 (326)
T ss_dssp HHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999998 8999999999998743 347899999998754 3566667889999999999999998
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLA 261 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~ 261 (345)
++|+||||+||+++.++.+||+|||++........ ......||+.|+|||.+. +..++.++||| +|+++|
T Consensus 150 --ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~ 225 (326)
T 2x7f_A 150 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 225 (326)
T ss_dssp --CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHH
T ss_pred --ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHH
Confidence 99999999999999999999999999876543211 223457899999999997 45688999999 999999
Q ss_pred HHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+|++|..||... ........+ .....+. ...... ...+.+++..||+.||.+|||+.++++
T Consensus 226 ~l~~g~~p~~~~----~~~~~~~~~---~~~~~~~------~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 226 EMAEGAPPLCDM----HPMRALFLI---PRNPAPR------LKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHSSCTTTTS----CHHHHHHHH---HHSCCCC------CSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCC----cHHHHHHHh---hcCcccc------CCcccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 999999997432 222222211 1111111 011111 234778889999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.60 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=184.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++. .++..||+|.+.... ......+.+|+.
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~---------------------------~~~~~~~~~e~~ 68 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKS---------------------------EEELEDYIVEIE 68 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC-------------------------------CCHHHHHHHHH
T ss_pred CccceeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCC---------------------------HHHHHHHHHHHH
Confidence 5678999999999999999999964 578999999985431 112566788999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++.++||||+++++++..++ .+++++++++++. .++......++.|++.||.|||+.+ ++|+||
T Consensus 69 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 143 (302)
T 2j7t_A 69 ILATCDHPYIVKLLGAYYHDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDL 143 (302)
T ss_dssp HHHHCCCTTBCCEEEEEECC---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhcCCCCCEeeeeeeeeeCC--eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCC
Confidence 999999999999999998765 6888999998753 3677778899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhCCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
||+||+++.++.+||+|||++....... .......||..|+|||.+. +..++.++||| +|+++|+|++|..|
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 144 KAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp SGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999875432110 1123357899999999983 56688999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|... ....... .......+.... .......+.+++..||+.||++|||+.++++
T Consensus 222 ~~~~----~~~~~~~---~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 222 HHEL----NPMRVLL---KIAKSDPPTLLT--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp TTTS----CHHHHHH---HHHHSCCCCCSS--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccC----CHHHHHH---HHhccCCcccCC--------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 7542 2222222 121111111100 1112234778999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=292.66 Aligned_cols=244 Identities=19% Similarity=0.230 Sum_probs=186.9
Q ss_pred cCCcccc-cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASL-EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 47 ~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
.+.|.+. +.||+|+||.||+|+.. .+++.||+|.+....... .....+.+|+.
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------------------~~~~~~~~e~~ 80 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQ-------------------------DCRAEILHEIA 80 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTE-------------------------ECHHHHHHHHH
T ss_pred hhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcch-------------------------HHHHHHHHHHH
Confidence 4467776 78999999999999864 579999999987543221 11456778999
Q ss_pred HHhhc-cCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 126 TVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 126 ~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+++.+ +||||+++++++..++ .++++++++.++. .+++..+..++.|++.||.|||+.+ ++||
T Consensus 81 ~l~~l~~~~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~ 155 (327)
T 3lm5_A 81 VLELAKSCPRVINLHEVYENTS--EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHL 155 (327)
T ss_dssp HHHHTTTCTTBCCEEEEEECSS--EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhccCCCCEEEEEEEEEeCC--eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 99998 5799999999998766 6889999998753 3677788899999999999999999 9999
Q ss_pred CCCCCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 194 DLNPVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 194 dlk~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
||||+||+++. ++.+||+|||++........ .....||+.|+|||.+.+..++.++||| +|+++|+|++|..|
T Consensus 156 Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (327)
T 3lm5_A 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232 (327)
T ss_dssp CCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999997 78999999999987654321 2346799999999999999999999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|... ........+........ ..........+.+++..||+.||++|||+.++++
T Consensus 233 f~~~----~~~~~~~~i~~~~~~~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 233 FVGE----DNQETYLNISQVNVDYS----------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp SCCS----SHHHHHHHHHHTCCCCC----------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCC----CchHHHHHHHhcccccC----------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 7432 22222222222211110 0111122344778899999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.36 Aligned_cols=252 Identities=19% Similarity=0.263 Sum_probs=193.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
-.++|++.+.||+|+||.||+|+.+ .+|+.||||.+.......... .......+.+.+|+.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~------------------~~~~~~~~~~~~e~~ 75 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSA------------------EEVQELREATLKEVD 75 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCH------------------HHHHHHHHHHHHHHH
T ss_pred hhhccceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCH------------------HHHHHHHHHHHHHHH
Confidence 4579999999999999999999864 578999999996543211000 001234567889999
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++++. ||||+++++++..++ ..+++++++.++++ ++......++.|++.||.|||+.+ ++|+||
T Consensus 76 ~l~~l~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 150 (298)
T 1phk_A 76 ILRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDL 150 (298)
T ss_dssp HHHHHTTCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHHhcCCCCEeeeeeeeccCC--eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 999995 999999999998765 78999999987654 566677889999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc------ccccCccchhh-HHHHHHHHHhCCC
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ------MLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~------~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
||+||+++.++.++|+|||++....... ......|++.|+|||.+. ...++.++||| +|+++|+|++|..
T Consensus 151 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 227 (298)
T 1phk_A 151 KPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227 (298)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence 9999999999999999999998765432 223467899999999985 34578899999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||.. .........+........ ..........+.+++.+||+.||.+|||+.++++
T Consensus 228 p~~~----~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 228 PFWH----RKQMLMLRMIMSGNYQFG----------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SSCC----SSHHHHHHHHHHTCCCCC----------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcC----ccHHHHHHHHhcCCcccC----------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 9643 222333222222111100 0111222345788999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=283.39 Aligned_cols=242 Identities=25% Similarity=0.393 Sum_probs=182.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++. .+|+.||||.+...... .......+.+|+.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~~e~~ 63 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIR------------------------SLDVVGKIKREIQ 63 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHH------------------------HTTCHHHHHHHHH
T ss_pred eeccEEEEeeecCCCCeEEEEEEEC-CCCceEEEEEecccccc------------------------chhHHHHHHHHHH
Confidence 4579999999999999999999864 57899999998521100 0122557888999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++.++||||+++++++..++ ..+++++++.++++ ++......++.|++.||.|||+.+ ++|+|||
T Consensus 64 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~ 138 (276)
T 2h6d_A 64 NLKLFRHPHIIKLYQVISTPT--DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLK 138 (276)
T ss_dssp HHHTCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCC
T ss_pred HHhcCCCCCEeEEEEEEecCC--eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCC
Confidence 999999999999999988765 78899999987654 566677889999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
|+||+++.++.++|+|||++........ .....|++.|+|||.+.+..+ +.++||| +|+++|+|++|..||...
T Consensus 139 p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~- 214 (276)
T 2h6d_A 139 PENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE- 214 (276)
T ss_dssp GGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred hhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC-
Confidence 9999999999999999999976644321 234578999999999988765 6899999 999999999999997532
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.... .. . . . .....+.+++..||+.||++|||+.++++
T Consensus 215 ---~~~~~~~~~~~~~---~~---~----~-~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 215 ---HVPTLFKKIRGGV---FY---I----P-E---YLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---SHHHHHHHHHHCC---CC---C----C-T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cHHHHHHHhhcCc---cc---C----c-h---hcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 2223333222211 00 0 0 1 11234778899999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=287.58 Aligned_cols=247 Identities=20% Similarity=0.350 Sum_probs=181.1
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
....++|++++.||+|+||.||+|+.. ++..||||.+.....+ ......+.+|
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-------------------------~~~~~~~~~E 76 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEAD-------------------------NQTLDSYRNE 76 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCC-------------------------HHHHHHHHHH
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEecccccc-------------------------ccchHHHHHH
Confidence 346678999999999999999999864 6889999999654322 2235678899
Q ss_pred HHHHhhcc--CCCccceeEEEecCCcceeeeeccccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQIR--HRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l~--hpniv~l~~~~~~~~~~~l~~~~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.++++++ ||||+++++++..++ .+++++++..+ ...++...+..++.|++.||.|||+.+ ++||
T Consensus 77 ~~~l~~l~~~~~~iv~~~~~~~~~~--~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 151 (313)
T 3cek_A 77 IAYLNKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 151 (313)
T ss_dssp HHHHHHHGGGCTTBCCEEEEEECSS--EEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHhccccCCceEEEEEEeecCC--EEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 99999996 599999999998776 67888884432 234677788899999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-----------cccCccchhh-HHHHHH
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-----------LTLTEKCDIY-FGALLA 261 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-----------~~~~~~~Dvw-lG~vl~ 261 (345)
||||+||+++. +.+||+|||++................||+.|+|||.+.+ ..++.++||| +|+++|
T Consensus 152 dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 152 DLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp CCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred CCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 99999999975 7899999999987654332222344678999999999975 4678899999 999999
Q ss_pred HHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+|++|..||..... .. ..+.......... .. +... ...+.+++..||+.||.+|||+.++++
T Consensus 231 el~~g~~pf~~~~~---~~---~~~~~~~~~~~~~-~~-----~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 231 YMTYGKTPFQQIIN---QI---SKLHAIIDPNHEI-EF-----PDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHSSCTTTTCCS---HH---HHHHHHHCTTSCC-CC-----CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCchhhHHH---HH---HHHHHHHhccccc-CC-----cccc---hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 99999999754322 11 1111111111100 00 0111 234778889999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.37 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=184.9
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+++.||||.+.......... ........+.+|+.+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~-------------------~~~~~~~~~~~E~~~ 68 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSA-------------------READPALNVETEIEI 68 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC----------------------------------CHHHHHHH
T ss_pred hhceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhccc-------------------ccchhhhhHHHHHHH
Confidence 358999999999999999999864 578999999996532211000 001224567889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++||||+++++++..++ .+++++++.++++ ++......++.|++.||.|||+.+ ++||||||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp 142 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKP 142 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSS---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HHhCCCCCCceEeeEEcCCc---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 99999999999999987654 7888999987543 567778899999999999999998 99999999
Q ss_pred CCeeecCCCC---eEEeccccceecCCCCcceeccCcccCcccccccccc---ccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 198 VNVLLDDDIE---ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ---MLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 198 ~nil~~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~---~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
+||+++.++. +||+|||++....... ......||+.|+|||.+. ...++.++||| +|+++|+|++|..||
T Consensus 143 ~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (322)
T 2ycf_A 143 ENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219 (322)
T ss_dssp GGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999986554 9999999998765432 123357899999999974 45688999999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...... ......+....... .+... ......+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~~~---~~~~~~~~~~~~~~------~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 220 SEHRTQ---VSLKDQITSGKYNF------IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CSTTCS---SCHHHHHHHTCCCC------CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccchH---HHHHHHHHhCcccc------Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 543221 22333332211100 00000 112245788999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=289.16 Aligned_cols=249 Identities=18% Similarity=0.250 Sum_probs=190.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.....+..||+|.+... ......+.+|+.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~~E~~~ 69 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----------------------------GKYREAARLEINV 69 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----------------------------HHHHHHHHHHHHH
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----------------------------ccchhHHHHHHHH
Confidence 469999999999999999999875444579999999642 1224566788999
Q ss_pred HhhccCCC------ccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 127 VGQIRHRN------LHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 127 l~~l~hpn------iv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
++.++|++ ++.+++++...+ .++++++++.++ ..+++..+..++.|++.||.|||+.+ +
T Consensus 70 l~~l~~~~~~~~~~~~~~~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i 144 (355)
T 2eu9_A 70 LKKIKEKDKENKFLCVLMSDWFNFHG--HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---L 144 (355)
T ss_dssp HHHHHHHCTTSCSCBCCEEEEEEETT--EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---E
T ss_pred HHHHhhcCCCCceeEEEeeeeeeeCC--eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 98887766 889999888776 788999998652 24677888899999999999999998 9
Q ss_pred EecCCCCCCeee-------------------cCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCcc
Q 046907 191 IHRDLNPVNVLL-------------------DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEK 251 (345)
Q Consensus 191 iH~dlk~~nil~-------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~ 251 (345)
+||||||+|||+ +.++.+||+|||++...... .....||+.|+|||++.+..++.+
T Consensus 145 vH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 219 (355)
T 2eu9_A 145 THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQP 219 (355)
T ss_dssp ECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred ccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCc
Confidence 999999999999 56789999999999864432 234678999999999999899999
Q ss_pred chhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccc----------c--------------------
Q 046907 252 CDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAI----------D-------------------- 300 (345)
Q Consensus 252 ~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~-------------------- 300 (345)
+||| +|+++|||++|..||.. .........+...... .+.... .
T Consensus 220 ~Di~slG~il~el~~g~~pf~~----~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (355)
T 2eu9_A 220 CDVWSIGCILFEYYRGFTLFQT----HENREHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294 (355)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred cchHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCC
Confidence 9999 99999999999999753 2333333333333221 111000 0
Q ss_pred -ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 301 -SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 301 -~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..............+.+++..||+.||++|||+.++++
T Consensus 295 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000112234557889999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=292.17 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=169.6
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|....++|++++.||+|+||.||+|+.. .+|+.||||.+...... .....+.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~--------------------------~~~~~~~ 68 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDE--------------------------KEQKQLL 68 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCH--------------------------HHHHHHH
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCc--------------------------hHHHHHH
Confidence 34556789999999999999999999864 57999999999754221 1133444
Q ss_pred HHHH-HHhhccCCCccceeEEEecCCcceeeeeccccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhc-C
Q 046907 122 SEIN-TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR-------------RELDWLARHRIALGLACGLEYLHMH-H 186 (345)
Q Consensus 122 ~E~~-~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~-~ 186 (345)
.|+. +++.++||||+++++++..++ ..+++++++.++ ..+++.....++.|++.||.|||+. +
T Consensus 69 ~e~~~~~~~~~h~niv~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 146 (327)
T 3aln_A 69 MDLDVVMRSSDCPYIVQFYGALFREG--DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146 (327)
T ss_dssp HHHHHHHSSCCCTTBCCEEEEEECSS--EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCcEeeeeeEEEeCC--ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence 5555 677789999999999998776 688899998762 3467777889999999999999998 8
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccc----cccccCccchhh-HHHHHH
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL----QMLTLTEKCDIY-FGALLA 261 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~----~~~~~~~~~Dvw-lG~vl~ 261 (345)
++||||||+||+++.++.+||+|||++....... ......||..|+|||.+ .+..++.++||| +|+++|
T Consensus 147 ---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 220 (327)
T 3aln_A 147 ---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220 (327)
T ss_dssp ---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHH
T ss_pred ---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999997654332 12234789999999999 455688999999 999999
Q ss_pred HHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 262 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+|++|..||...... ...+........ +.+...........+.+++..||+.||++|||+.++++
T Consensus 221 ~l~~g~~pf~~~~~~------~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 221 ELATGRFPYPKWNSV------FDQLTQVVKGDP------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHSCCCSSCC-------------CCCCCSCC------CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchH------HHHHHHHhcCCC------CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 999999997542110 011111111100 11111111122345778889999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.91 Aligned_cols=235 Identities=16% Similarity=0.140 Sum_probs=176.0
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH--
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI-- 124 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-- 124 (345)
.++|++.+.||+|+||.||+|++. .+|+.||||.+....... ....+.+.+|+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~~E~~~ 126 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPP------------------------SNAIKQMKEEVLR 126 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CC------------------------TTHHHHHHHHHHG
T ss_pred CceEEEcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccc------------------------hHHHHHHHHHHHH
Confidence 578999999999999999999864 579999999996432211 12356678899
Q ss_pred -HHHhhccCCCcccee-------EEEecCCc------------c---eeeeeccccCCCCCCCH----------------
Q 046907 125 -NTVGQIRHRNLHPLL-------AHVTRPDC------------H---LLYILNDVSQGRRELDW---------------- 165 (345)
Q Consensus 125 -~~l~~l~hpniv~l~-------~~~~~~~~------------~---~l~~~~~~~~~~~~l~~---------------- 165 (345)
.+++.++||||++++ +++..++. . ..++++|++. |++.++
T Consensus 127 l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~l~~ 205 (377)
T 3byv_A 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVH 205 (377)
T ss_dssp GGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTHHHHH
T ss_pred HHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccccccH
Confidence 455556899999998 66554431 1 2678899994 444332
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc
Q 046907 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 166 ~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~ 245 (345)
..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+
T Consensus 206 ~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 206 HARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcc
Confidence 445579999999999999999 99999999999999999999999999986432 2234677 99999999998
Q ss_pred c-----------ccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHH
Q 046907 246 L-----------TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQML 313 (345)
Q Consensus 246 ~-----------~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (345)
. .++.++||| ||+++|||++|..||........ ...... ..+....
T Consensus 277 ~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~------~~~~~~~ 334 (377)
T 3byv_A 277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG----------------SEWIFR------SCKNIPQ 334 (377)
T ss_dssp HTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC----------------SGGGGS------SCCCCCH
T ss_pred cccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc----------------hhhhhh------hccCCCH
Confidence 7 799999999 99999999999999754221110 000000 0011123
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 314 LVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 314 ~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.++|..||+.||++|||+.++++
T Consensus 335 ~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 335 PVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHcCCCchhCCCHHHHhh
Confidence 4778899999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=298.91 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=188.3
Q ss_pred hcCCcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..++|++.+.||+|+||.||+|+.. ..+++.||||.+........ ......+.+|
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~~E 108 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-----------------------AKTTEHTRTE 108 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-----------------------ESSGGGCCCH
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh-----------------------hhHHHHHHHH
Confidence 3468999999999999999999863 24789999999864321100 0012345568
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHR 193 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~ 193 (345)
+.+++.+ +||||+++++++..++ .++++++|+.++++ ++......++.|++.||.|||+.+ ++||
T Consensus 109 ~~~l~~l~~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~ 183 (355)
T 1vzo_A 109 RQVLEHIRQSPFLVTLHYAFQTET--KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYR 183 (355)
T ss_dssp HHHHHHHHTCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHHHHHccCCCceeEEEEEEeeCc--eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccC
Confidence 9999999 6999999999998776 68899999988654 556667789999999999999998 9999
Q ss_pred CCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc--ccCccchhh-HHHHHHHHHhCCCCC
Q 046907 194 DLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML--TLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 194 dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~--~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+. .++.++||| +|+++|||++|..||
T Consensus 184 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 184 DIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp CCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999986543222 122346799999999999863 478899999 999999999999998
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRRM 339 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~~ 339 (345)
............. ......... .+......+.+++..||+.||.+|| |+.++++.
T Consensus 263 ~~~~~~~~~~~~~---~~~~~~~~~-----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 263 TVDGEKNSQAEIS---RRILKSEPP-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp SCTTSCCCHHHHH---HHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCCccchHHHHH---HHHhccCCC-----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 6433222222222 222211111 1111223477889999999999999 89988763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=291.51 Aligned_cols=258 Identities=19% Similarity=0.279 Sum_probs=189.8
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++...+|+.||+|.+......... ...+.+|+.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------~~~~~~e~~ 63 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------------------------PLSTIREVA 63 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------------------------BCTHHHHHH
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC-------------------------CchhhHHHH
Confidence 5579999999999999999999975467899999998643322110 122345666
Q ss_pred HHhhc---cCCCccceeEEEec---CCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 126 TVGQI---RHRNLHPLLAHVTR---PDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 126 ~l~~l---~hpniv~l~~~~~~---~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+++.+ +||||+++++++.. +....++++++++.+. ..+++..+..++.|++.||.|||+.+
T Consensus 64 ~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--- 140 (326)
T 1blx_A 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--- 140 (326)
T ss_dssp HHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 66555 89999999998862 2345788999998752 22677788899999999999999999
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
++|+||||+||+++.++.+||+|||++....... ......||..|+|||.+.+..++.++||| +|+++|+|++|..
T Consensus 141 i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999997654221 23446789999999999998999999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCcc----------cc---ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRA----------ID---SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
||... ........+......+..... .. ........+.....+.+++.+||+.||.+|||+.+
T Consensus 218 pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 293 (326)
T 1blx_A 218 LFRGS----SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293 (326)
T ss_dssp SCCCS----SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCC----CHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 96532 333333333332221110000 00 00000111223345778999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 294 ~l~ 296 (326)
T 1blx_A 294 ALS 296 (326)
T ss_dssp HHT
T ss_pred Hhc
Confidence 984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=290.94 Aligned_cols=249 Identities=19% Similarity=0.203 Sum_probs=188.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+++.||||.+.... .....+..|+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~----------------------------~~~~~~~~e~~~ 103 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNKK----------------------------AFLNQAQIEVRL 103 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSSH----------------------------HHHHHHHHHHHH
T ss_pred eeeEEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEeccH----------------------------HHHHHHHHHHHH
Confidence 468999999999999999999854 578999999996421 124456677888
Q ss_pred Hhhcc-CC-----CccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhh--cCCC
Q 046907 127 VGQIR-HR-----NLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHM--HHCP 188 (345)
Q Consensus 127 l~~l~-hp-----niv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~--~~~~ 188 (345)
++.++ |+ +|+++++++...+ .++++++++++. ..+++.....++.|++.||.|||+ .+
T Consensus 104 l~~l~~~~~~~~~~iv~~~~~~~~~~--~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~-- 179 (382)
T 2vx3_A 104 LELMNKHDTEMKYYIVHLKRHFMFRN--HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS-- 179 (382)
T ss_dssp HHHHHHCSSGGGGGBCCEEEEEEETT--EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC--
T ss_pred HHHHHhcccccceeEEEeeeeeccCC--ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC--
Confidence 87774 44 4999999988776 788999998752 236777888999999999999995 55
Q ss_pred CeEecCCCCCCeeec--CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh
Q 046907 189 RIIHRDLNPVNVLLD--DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 189 ~iiH~dlk~~nil~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t 265 (345)
|+||||||+|||++ .++.+||+|||++...... .....||+.|+|||++.+..++.++||| +|+++|||++
T Consensus 180 -ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 253 (382)
T 2vx3_A 180 -IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253 (382)
T ss_dssp -EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999995 5778999999999876432 2346789999999999999999999999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCC-----------------ccc------------ccc--------------
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPK-----------------RAI------------DSK-------------- 302 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~------------~~~-------------- 302 (345)
|..||.. .+..+....+......+... ... .+.
T Consensus 254 g~~pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 329 (382)
T 2vx3_A 254 GEPLFSG----ANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329 (382)
T ss_dssp SSCSSCC----SSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTT
T ss_pred CCCCCCC----CCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhcccc
Confidence 9999653 23333333333332211100 000 000
Q ss_pred -------ccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 303 -------LVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 303 -------~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
-.......+...+.+|+.+||+.||++|||+.++++
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp SGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence 000112344567899999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=287.95 Aligned_cols=267 Identities=17% Similarity=0.265 Sum_probs=190.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|++ +|+.||+|.+............... ............+.+|+.
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~E~~ 95 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSN----------NDKISIKSKYDDFKNELQ 95 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCS----------SSSCCEEEHHHHHHHHHH
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhcccc----------chhhhHHhHHHHHHHHHH
Confidence 357999999999999999999986 7999999998532111000000000 000000001267889999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------------CCHHHHHHHHHHHHHHHHHHhh-cCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------------LDWLARHRIALGLACGLEYLHM-HHC 187 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------------l~~~~~~~i~~~i~~~l~~lh~-~~~ 187 (345)
+++.++||||+++++++..++ .+++++++++++++ +++..+..++.|++.||.|||+ .+
T Consensus 96 ~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~- 172 (348)
T 2pml_X 96 IITDIKNEYCLTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN- 172 (348)
T ss_dssp HHTTCCCTTBCCCSEEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC-
T ss_pred HHHhCCCCCcceEEEEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC-
Confidence 999999999999999998776 68889999877433 5567788999999999999999 88
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCc-cchhh-HHHHHHHHH
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTE-KCDIY-FGALLAGLV 264 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~-~~Dvw-lG~vl~el~ 264 (345)
++|+||||+||+++.++.++|+|||.+...... ......|+..|+|||.+.+. .++. ++||| +|+++|+|+
T Consensus 173 --i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~ 246 (348)
T 2pml_X 173 --ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246 (348)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred --EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999876443 23456789999999999887 5666 99999 999999999
Q ss_pred hCCCCCcccccccchhhHHHHHHHHhhhcCCC--cccccccc----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 265 MGKLPSDKFFQHTNEMSFVKWMRNVMASENPK--RAIDSKLV----GNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 265 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+|..||..... .......+..... ..+. ........ ..........+.+++..||+.||.+|||+.++++
T Consensus 247 ~g~~pf~~~~~---~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 247 YNVVPFSLKIS---LVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HSSCSSCCSSC---SHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCc---HHHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999754222 1233322221110 0000 00000000 0001223345788999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=284.44 Aligned_cols=248 Identities=19% Similarity=0.323 Sum_probs=172.3
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+....++|++++.||+|+||.||+|+++ .+|+.||||.+....... ...+.+..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------------------~~~~~~~~ 73 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKE-------------------------ENKRILMD 73 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEET-TTCCEEEEEEEETTSCHH-------------------------HHHHHHHH
T ss_pred hhhhhccccccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccch-------------------------HHHHHHHH
Confidence 3446679999999999999999999864 578999999996543221 11233344
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMH-HCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH 192 (345)
+..+++.++||||+++++++..++ .++++++++.+ ...++......++.|++.||.|||+. + ++|
T Consensus 74 ~~~~~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H 148 (318)
T 2dyl_A 74 LDVVLKSHDCPYIVQCFGTFITNT--DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIH 148 (318)
T ss_dssp HHHHHHTTTCTTBCCEEEEEECSS--EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCC
T ss_pred HHHHHHhcCCCceeeEEEEEecCC--cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEe
Confidence 556678889999999999998776 68889998843 23467778889999999999999995 8 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg 266 (345)
+||||+||+++.++.+||+|||++........ .....||+.|+|||.+. +..++.++||| +|+++|+|++|
T Consensus 149 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 225 (318)
T 2dyl_A 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhC
Confidence 99999999999999999999999976543321 23457899999999994 45678899999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..||.... ........+.. ...+.... .......+.+++..||+.||.+|||+.++++
T Consensus 226 ~~pf~~~~---~~~~~~~~~~~---~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 226 QFPYKNCK---TDFEVLTKVLQ---EEPPLLPG--------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCTTTTCC---SHHHHHHHHHH---SCCCCCCS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCCC---ccHHHHHHHhc---cCCCCCCc--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 99975421 22222222221 11111000 0011234778889999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=290.66 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=188.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++.+.||+|+||.||+|+.. .+++.||||.+.... .....+.+|+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~----------------------------~~~~~~~~e~~ 67 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK----------------------------VYTEAAEDEIK 67 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH----------------------------HHHHHHHHHHH
T ss_pred cCCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCCc----------------------------cchhhhhHHHH
Confidence 4579999999999999999999854 579999999996431 12345667888
Q ss_pred HHhhcc-----------CCCccceeEEEecC--CcceeeeeccccCC----------CCCCCHHHHHHHHHHHHHHHHHH
Q 046907 126 TVGQIR-----------HRNLHPLLAHVTRP--DCHLLYILNDVSQG----------RRELDWLARHRIALGLACGLEYL 182 (345)
Q Consensus 126 ~l~~l~-----------hpniv~l~~~~~~~--~~~~l~~~~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~l 182 (345)
++++++ ||||+++++++... +...++++++++.+ ...++...+..++.|++.||.||
T Consensus 68 ~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l 147 (373)
T 1q8y_A 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 147 (373)
T ss_dssp HHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH
Confidence 887775 89999999988754 34467888988832 12367777889999999999999
Q ss_pred hhc-CCCCeEecCCCCCCeeec------CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh
Q 046907 183 HMH-HCPRIIHRDLNPVNVLLD------DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY 255 (345)
Q Consensus 183 h~~-~~~~iiH~dlk~~nil~~------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw 255 (345)
|+. + ++||||||+|||++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||
T Consensus 148 H~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 219 (373)
T 1q8y_A 148 HRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIW 219 (373)
T ss_dssp HHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHH
T ss_pred HhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHH
Confidence 998 8 99999999999994 3447999999999876432 2345789999999999999999999999
Q ss_pred -HHHHHHHHHhCCCCCccccccc--chhhHHHHHHHHhhhcCCCccc--------------------cc---------cc
Q 046907 256 -FGALLAGLVMGKLPSDKFFQHT--NEMSFVKWMRNVMASENPKRAI--------------------DS---------KL 303 (345)
Q Consensus 256 -lG~vl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--------------------~~---------~~ 303 (345)
+|+++|||++|..||....... ........+....... +.... .. ..
T Consensus 220 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (373)
T 1q8y_A 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 298 (373)
T ss_dssp HHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSC-CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCC-CHHHHhccchhhhhcCCcchhcccccccccchhhhhhh
Confidence 9999999999999986433211 1112222222222111 00000 00 00
Q ss_pred cCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 304 VGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 304 ~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...........+.+++..||+.||++|||+.++++
T Consensus 299 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 299 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 11234567788999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=283.70 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=181.9
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.. .+++.||+|.+.... ....+.+.+|+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------------------~~~~~~~~~e~~~ 61 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTD---------------------------PQSVKHALREIKI 61 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET-TTTEEEEEEEEECCS---------------------------HHHHHHHHHHHHH
T ss_pred CCceeEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCC---------------------------hHHHHHHHHHHHH
Confidence 568999999999999999999864 579999999986432 2235677899999
Q ss_pred HhhccCCCccceeEEEecC------------CcceeeeeccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046907 127 VGQIRHRNLHPLLAHVTRP------------DCHLLYILNDVSQG-------RRELDWLARHRIALGLACGLEYLHMHHC 187 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~------------~~~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~ 187 (345)
++.++||||+++++++..+ ....++++++++.+ ...++......++.|++.||.|||+.+
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 140 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN- 140 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 9999999999999987543 22467889999874 234677778899999999999999999
Q ss_pred CCeEecCCCCCCeeec-CCCCeEEeccccceecCCCCc-ceeccCcccCccccccccccc-cccCccchhh-HHHHHHHH
Q 046907 188 PRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGL 263 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~-~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el 263 (345)
++||||||+||+++ .++.+||+|||++........ ........+|..|+|||.+.+ ..++.++||| +|+++|||
T Consensus 141 --i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el 218 (320)
T 2i6l_A 141 --VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218 (320)
T ss_dssp --CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHH
T ss_pred --EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHH
Confidence 99999999999997 567899999999986543211 112234567899999998865 5689999999 99999999
Q ss_pred HhCCCCCcccccccchhhHHHHHHHHhhhcCC----------Ccccccccc-C-----CCcHHHHHHHHHHHhhccCCCC
Q 046907 264 VMGKLPSDKFFQHTNEMSFVKWMRNVMASENP----------KRAIDSKLV-G-----NGCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 264 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~-~-----~~~~~~~~~l~~li~~Cl~~dp 327 (345)
++|..||... ........+......... ......... + ...+.....+.+++.+||+.||
T Consensus 219 ~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (320)
T 2i6l_A 219 LTGKTLFAGA----HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294 (320)
T ss_dssp HHSSCSSCCS----SHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSG
T ss_pred HhCCCCCCCC----CHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCc
Confidence 9999997542 222222222211100000 000000000 0 0011223457889999999999
Q ss_pred CCCCCHHHHHH
Q 046907 328 NERPNSKDVRR 338 (345)
Q Consensus 328 ~~Rpt~~~ll~ 338 (345)
++|||+.++++
T Consensus 295 ~~Rpt~~ell~ 305 (320)
T 2i6l_A 295 MDRLTAEEALS 305 (320)
T ss_dssp GGSCCHHHHHT
T ss_pred cccCCHHHHhC
Confidence 99999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=284.18 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=179.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.. .+++.||||.+... ......+.+|+.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~----------------------------~~~~~~~~~E~~~ 55 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT----------------------------EEKLSTILSEVML 55 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE----------------------------HHHHHHHHHHHHH
T ss_pred cccchhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc----------------------------HHHHHHHHHHHHH
Confidence 458999999999999999999854 57899999998431 1235678899999
Q ss_pred HhhccCCCccceeEEEecCC-----------cceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhc
Q 046907 127 VGQIRHRNLHPLLAHVTRPD-----------CHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMH 185 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~-----------~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~ 185 (345)
++.++||||+++++++.... ...+++++++++++++ ++......++.|++.||.|||+.
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 135 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC
Confidence 99999999999999886532 3467899999987654 34456678999999999999999
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCc------------ceeccCcccCcccccccccccc-ccCccc
Q 046907 186 HCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT------------HITTSNVVGTVEYIAPEYLQML-TLTEKC 252 (345)
Q Consensus 186 ~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~~~aPE~~~~~-~~~~~~ 252 (345)
+ ++|+||||+||+++.++.+||+|||++........ ........||..|+|||.+.+. .++.++
T Consensus 136 ~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 212 (303)
T 1zy4_A 136 G---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212 (303)
T ss_dssp T---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHH
T ss_pred C---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchh
Confidence 8 99999999999999999999999999976543210 1122346789999999999865 588999
Q ss_pred hhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 046907 253 DIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP 331 (345)
Q Consensus 253 Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp 331 (345)
||| +|+++|+|++ ||.. ..........+.... . .............+.+++..||+.||.+||
T Consensus 213 Di~slG~il~~l~~---p~~~---~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (303)
T 1zy4_A 213 DMYSLGIIFFEMIY---PFST---GMERVNILKKLRSVS---I-------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276 (303)
T ss_dssp HHHHHHHHHHHHHS---CCSS---HHHHHHHHHHHHSTT---C-------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHHHHHHHHh---ccCC---chhHHHHHHhccccc---c-------ccCccccccchHHHHHHHHHHHhcCcccCc
Confidence 999 9999999998 5321 111122222222111 0 011112223334577889999999999999
Q ss_pred CHHHHHH
Q 046907 332 NSKDVRR 338 (345)
Q Consensus 332 t~~~ll~ 338 (345)
|+.++++
T Consensus 277 s~~~ll~ 283 (303)
T 1zy4_A 277 GARTLLN 283 (303)
T ss_dssp CHHHHHH
T ss_pred CHHHHhC
Confidence 9999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=282.00 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=188.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+++.||+|.+...... ......+.+|+.+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~-------------------------~~~~~~~~~e~~~ 74 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAK-------------------------NKDTSTILREVEL 74 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBS-------------------------SSCHHHHHHHHHH
T ss_pred hhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccc-------------------------hHHHHHHHHHHHH
Confidence 458999999999999999999864 57899999998543221 1124567889999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++++||||+++++++...+ .++++++++.++.+ ++......++.|++.||.|||+.+ ++|+||||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p 149 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSS--SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKP 149 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred HHhccCCCccEEEEEEeCCC--eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCh
Confidence 99999999999999988765 68899999987654 566677899999999999999998 99999999
Q ss_pred CCeeecCC---CCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLDDD---IEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||+++.+ +.+||+|||++........ .....||+.|+|||.+.+ .++.++||| +|+++|+|++|..||..
T Consensus 150 ~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~- 224 (287)
T 2wei_A 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG- 224 (287)
T ss_dssp GGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred hhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC-
Confidence 99999754 4799999999976544321 233568899999999876 488999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
....+....+.......... ........+.+++..||+.||++|||+.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 225 ---KNEYDILKRVETGKYAFDLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---SSHHHHHHHHHHCCCCCCSG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHcCCCCCCch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 23333333332221110000 00111234778999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=288.41 Aligned_cols=244 Identities=18% Similarity=0.239 Sum_probs=160.4
Q ss_pred hcCCccccc-ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLE-KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 46 ~~~~~~~~~-~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
-.++|++.+ .||+|+||.||+|+.+ .+|+.||||.+..... ... ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------------------~~~---e~~ 73 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALKLLYDSPK----------------------------ARQ---EVD 73 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESSHH----------------------------HHH---HHH
T ss_pred ccceeEecceeeeeCCCeEEEEEEEC-CCCCEEEEEEecCcHH----------------------------HHH---HHH
Confidence 456899965 6999999999999864 5799999999854210 011 122
Q ss_pred HHHhhccCCCccceeEEEec--CCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 125 NTVGQIRHRNLHPLLAHVTR--PDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
..++.++||||+++++++.. .+...++++++++.+++ .+++..+..++.|++.||.|||+.+ ++
T Consensus 74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---iv 150 (336)
T 3fhr_A 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IA 150 (336)
T ss_dssp HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 33556799999999998865 22346899999998753 3677788899999999999999999 99
Q ss_pred ecCCCCCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCC
Q 046907 192 HRDLNPVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 192 H~dlk~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
||||||+||+++. ++.+||+|||++....... .....||+.|+|||.+.+..++.++||| +|+++|+|++|.
T Consensus 151 H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (336)
T 3fhr_A 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF 226 (336)
T ss_dssp CSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 9999999999985 4569999999998654322 2345789999999999888899999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.||...............+...... ............+.+++..||+.||++|||+.++++
T Consensus 227 ~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 227 PPFYSNTGQAISPGMKRRIRLGQYG----------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CCC---------------------C----------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCccchhhhhhHHHhhhccccc----------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9975432211111111111111000 000111122345778899999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=293.31 Aligned_cols=239 Identities=23% Similarity=0.330 Sum_probs=172.6
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|.+.+.||+|+||.||.+.. .+|+.||||.+... ..+.+.+|+.+++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~------------------------------~~~~~~~E~~~l~ 63 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLID------------------------------FCDIALMEIKLLT 63 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG------------------------------GHHHHHHHHHHHH
T ss_pred eeeccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH------------------------------HHHHHHHHHHHHH
Confidence 445567899999999976543 37999999998521 1234568999998
Q ss_pred hc-cCCCccceeEEEecCCcceeeeeccccCCCCCCCHH----------------HHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 129 QI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWL----------------ARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 129 ~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~----------------~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
++ +||||+++++++..++ .+++++|++.+ ++.++. ....++.|++.||.|||+.+ ++
T Consensus 64 ~l~~HpnIv~~~~~~~~~~--~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 137 (434)
T 2rio_A 64 ESDDHPNVIRYYCSETTDR--FLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---II 137 (434)
T ss_dssp HHTTSTTBCCEEEEEECSS--EEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hccCCCCcCeEEEEEecCC--eEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---cc
Confidence 76 8999999999987765 78999999864 332211 23469999999999999998 99
Q ss_pred ecCCCCCCeeecCC-------------CCeEEeccccceecCCCCcc--eeccCcccCccccccccccc-------cccC
Q 046907 192 HRDLNPVNVLLDDD-------------IEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQM-------LTLT 249 (345)
Q Consensus 192 H~dlk~~nil~~~~-------------~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~-------~~~~ 249 (345)
||||||+|||++.+ +.+||+|||++......... .......||+.|+|||++.+ ..++
T Consensus 138 HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 217 (434)
T 2rio_A 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217 (434)
T ss_dssp CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC
T ss_pred ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc
Confidence 99999999999754 47999999999876543221 12234689999999999976 5688
Q ss_pred ccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCC
Q 046907 250 EKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp 327 (345)
.++||| +|+++|||++ |..||...... ....+......+. ............+.+++.+||+.||
T Consensus 218 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~i~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP 284 (434)
T 2rio_A 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSR-----ESNIIRGIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDP 284 (434)
T ss_dssp THHHHHHHHHHHHHHHTTSCCTTCSTTTH-----HHHHHHTCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSG
T ss_pred hhhhhHhHHHHHHHHHhCCCCCCCCchhh-----HHHHhcCCCCccc--------ccccccccchHHHHHHHHHHhhCCh
Confidence 999999 9999999999 99997543221 1111111111100 1111234556678899999999999
Q ss_pred CCCCCHHHHHH
Q 046907 328 NERPNSKDVRR 338 (345)
Q Consensus 328 ~~Rpt~~~ll~ 338 (345)
.+|||+.++++
T Consensus 285 ~~Rps~~eil~ 295 (434)
T 2rio_A 285 LKRPTAMKVLR 295 (434)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHHh
Confidence 99999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=283.97 Aligned_cols=240 Identities=18% Similarity=0.287 Sum_probs=183.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..-.++|++.+.||+|+||.||+|+.. .++..||||.+........... .....+.+|
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~---------------------~~~~~~~~E 96 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGEL---------------------PNGTRVPME 96 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEEC---------------------TTCCEEEHH
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhh---------------------hhhhHHHHH
Confidence 345678999999999999999999854 5799999999864322110000 012345578
Q ss_pred HHHHhhcc--CCCccceeEEEecCCcceeeeeccccCC-C---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 124 INTVGQIR--HRNLHPLLAHVTRPDCHLLYILNDVSQG-R---------RELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 124 ~~~l~~l~--hpniv~l~~~~~~~~~~~l~~~~~~~~~-~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+.++++++ ||||+++++++..++ ..+++++++.+ + ..++......++.|++.||.|||+.+ ++
T Consensus 97 ~~~l~~l~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iv 171 (320)
T 3a99_A 97 VVLLKKVSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VL 171 (320)
T ss_dssp HHHHHHHCSSSCSBCCEEEEEECSS--EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHhhccCCCCceEEEEEEecCC--cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cE
Confidence 99999995 599999999998776 67778888764 2 34667777889999999999999998 99
Q ss_pred ecCCCCCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCC
Q 046907 192 HRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 192 H~dlk~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~ 268 (345)
||||||+||+++ .++.+||+|||++....... .....||+.|+|||.+.+..+ +.++||| +|+++|||++|..
T Consensus 172 H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 247 (320)
T 3a99_A 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred eCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence 999999999999 77899999999998765432 234678999999999987775 6789999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||.... . . ...... .. .. ....+.+++.+||+.||++|||+.++++
T Consensus 248 pf~~~~------~---~----~~~~~~---~~----~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 248 PFEHDE------E---I----IRGQVF---FR----QR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp SCCSHH------H---H----HHCCCC---CS----SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCChh------h---h----hccccc---cc----cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 974311 0 0 101100 00 01 1234778899999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=280.85 Aligned_cols=240 Identities=17% Similarity=0.208 Sum_probs=175.8
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
..-.++|++.+.||+|+||.||+|+.. .++..||||.+.......... ......+.+|
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~---------------------~~~~~~~~~e 84 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSP---------------------LSDSVTCPLE 84 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC-----------------------------CCCCHH
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEeccccccccc---------------------chhhHHHHHH
Confidence 334678999999999999999999854 578999999996543221100 0123445678
Q ss_pred HHHHhhc----cCCCccceeEEEecCCcceeeeeccc-cCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 124 INTVGQI----RHRNLHPLLAHVTRPDCHLLYILNDV-SQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 124 ~~~l~~l----~hpniv~l~~~~~~~~~~~l~~~~~~-~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+.++.++ +||||+++++++...+ ..++++++ +.+++ .+++..+..++.|++.||.|||+.+
T Consensus 85 ~~~l~~l~~~~~h~~i~~~~~~~~~~~--~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 159 (312)
T 2iwi_A 85 VALLWKVGAGGGHPGVIRLLDWFETQE--GFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--- 159 (312)
T ss_dssp HHHHHHHHSSCCCSSBCCEEEEC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred HHHHHhhcccCCCCCeeeEEEEEecCC--eEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 8998888 8999999999987765 45666666 45433 3677778899999999999999999
Q ss_pred eEecCCCCCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccC-ccchhh-HHHHHHHHHhC
Q 046907 190 IIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLT-EKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 190 iiH~dlk~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~-~~~Dvw-lG~vl~el~tg 266 (345)
++||||||+||+++ .++.+||+|||++....... .....|+..|+|||.+.+..+. .++||| +|+++|+|++|
T Consensus 160 i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 235 (312)
T 2iwi_A 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235 (312)
T ss_dssp EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHC
Confidence 99999999999999 78899999999998765432 2346789999999999877664 589999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..||.... . ... .... ........+.+++.+||+.||++|||+.++++
T Consensus 236 ~~pf~~~~------~---~~~----~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 236 DIPFERDQ------E---ILE----AELH-----------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp SCSCCSHH------H---HHH----TCCC-----------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCChH------H---Hhh----hccC-----------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99975311 1 110 0000 00111234778899999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=295.54 Aligned_cols=241 Identities=22% Similarity=0.333 Sum_probs=172.8
Q ss_pred HhhcCCcccccccccCcceeeE-EEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVY-KAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~-~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
.....+|++.+.||+|+||.|+ ++.. +|+.||||.+..... ..+.+
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~---~~~~vAvK~~~~~~~------------------------------~~~~~ 66 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMF---DNRDVAVKRILPECF------------------------------SFADR 66 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEES---SSSEEEEEEECTTTE------------------------------EECHH
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEe---CCeEEEEEEECHHHH------------------------------HHHHH
Confidence 4455689999999999999854 4442 789999999964321 12346
Q ss_pred HHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 123 EINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 123 E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
|+.+++.+ +||||+++++++...+ .++++++++.+ ++ ........++.|++.||.|||+.+ ++
T Consensus 67 E~~~l~~l~~HpnIv~l~~~~~~~~--~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 140 (432)
T 3p23_A 67 EVQLLRESDEHPNVIRYFCTEKDRQ--FQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IV 140 (432)
T ss_dssp HHHHHHHSCCCTTBCCEEEEEEETT--EEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHhccCCCCcCeEEEEEecCC--EEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CE
Confidence 89999999 8999999999988766 78999999864 22 223345689999999999999999 99
Q ss_pred ecCCCCCCeeecC-----CCCeEEeccccceecCCCCc-ceeccCcccCccccccccccc---cccCccchhh-HHHHHH
Q 046907 192 HRDLNPVNVLLDD-----DIEARISGFGFARAIPDAHT-HITTSNVVGTVEYIAPEYLQM---LTLTEKCDIY-FGALLA 261 (345)
Q Consensus 192 H~dlk~~nil~~~-----~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~~~aPE~~~~---~~~~~~~Dvw-lG~vl~ 261 (345)
||||||+|||++. ...+||+|||++........ ........||+.|+|||++.+ ..++.++||| +|+++|
T Consensus 141 HrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ 220 (432)
T 3p23_A 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY 220 (432)
T ss_dssp CCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHH
T ss_pred eCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHH
Confidence 9999999999953 34688999999987653321 122345679999999999974 4577899999 999999
Q ss_pred HHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 262 GLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 262 el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||++ |..||..... ... ..+ ....... ... ........+.+++.+||+.||.+|||+.++++
T Consensus 221 ellt~g~~pf~~~~~----~~~-~~~---~~~~~~~-~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 221 YVISEGSHPFGKSLQ----RQA-NIL---LGACSLD-CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHTTSCBTTBSTTT----HHH-HHH---TTCCCCT-TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCCcchhhH----HHH-HHH---hccCCcc-ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9999 8999743211 111 111 1111110 000 11123344778999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=301.66 Aligned_cols=236 Identities=21% Similarity=0.286 Sum_probs=187.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|++...+|+.||||.+..... ......+.+|+.+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~E~~~ 132 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--------------------------AEAQAMAMAERQF 132 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--------------------------HHHHHHHHHHHGG
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--------------------------HHHHHHHHHHHHH
Confidence 37899999999999999999997644789999999864321 1235567889999
Q ss_pred HhhccCCCccceeEEEecCCc---ceeeeeccccCCCCC-------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQGRRE-------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~~~-------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++++||||+++++++...+. ...++++||++++++ +++..+..++.|++.||.|||+.+ |+|||||
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlk 209 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLK 209 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccC
Confidence 999999999999999887653 236899999987654 667788899999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|+|||++.+ .+||+|||++...... ....||+.|+|||++.+.. +.++||| +|+++|+|++|..||...+.
T Consensus 210 p~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~ 281 (681)
T 2pzi_A 210 PENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV 281 (681)
T ss_dssp GGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC
T ss_pred hHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc
Confidence 999999986 8999999999876543 3467999999999997754 8899999 99999999999888643221
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhhh
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-SKDVRRMLSQI 343 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-~~~ll~~L~~l 343 (345)
.. .+. ..........+.+++.+||+.||++||+ ++++...|..+
T Consensus 282 ~~----------------~~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 282 DG----------------LPE--------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp SS----------------CCT--------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cc----------------ccc--------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 10 000 0001122345889999999999999995 66676666554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=298.23 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=183.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|.+. .+|..||||.+..... ......+.+|+.+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~--------------------------~~~~~~~~~Ei~i 65 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELS--------------------------PKNRERWCLEIQI 65 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCC--------------------------HHHHHHHHHHHHH
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCC--------------------------HHHHHHHHHHHHH
Confidence 478999999999999999999854 5799999999865321 2235678899999
Q ss_pred HhhccCCCccceeEEEec----CCcceeeeeccccCCCCC------------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 127 VGQIRHRNLHPLLAHVTR----PDCHLLYILNDVSQGRRE------------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~----~~~~~l~~~~~~~~~~~~------------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+++++||||+++++++.. ......+++++++.++++ +++..+..++.|++.||.|||+.+ +
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---I 142 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---I 142 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---B
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 999999999999998755 123467899999987543 556677889999999999999998 9
Q ss_pred EecCCCCCCeeecCCCC---eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC
Q 046907 191 IHRDLNPVNVLLDDDIE---ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg 266 (345)
+||||||+||+++.++. ++|+|||++........ .....||+.|+|||.+.+..++.++||| +|+++|+|++|
T Consensus 143 VHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG 219 (676)
T 3qa8_A 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219 (676)
T ss_dssp CCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSS
T ss_pred ccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHC
Confidence 99999999999996654 89999999987654322 2346899999999999999999999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHH--------hhhcCCCcc--ccc--cccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNV--------MASENPKRA--IDS--KLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~~~--~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
..||..... ...+.... ......... ... .......+.....+.+++..||+.||++|||+.
T Consensus 220 ~~Pf~~~~~------~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~ 293 (676)
T 3qa8_A 220 FRPFLPNWQ------PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293 (676)
T ss_dssp CSSCCSSCH------HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred CCCCCcccc------hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence 999754211 00000000 000000000 000 111223344567788999999999999999997
Q ss_pred HH
Q 046907 335 DV 336 (345)
Q Consensus 335 ~l 336 (345)
++
T Consensus 294 el 295 (676)
T 3qa8_A 294 QN 295 (676)
T ss_dssp TC
T ss_pred HH
Confidence 73
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=281.94 Aligned_cols=236 Identities=16% Similarity=0.121 Sum_probs=165.0
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
..+|...+.||+|+||.||+|++. .+|+.||||++....... ....+.+.+|+.+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~------------------------~~~~~~~~~E~~~ 131 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPP------------------------SNAIKQMKEEVLR 131 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----------------------------CCHHHHHHHHG
T ss_pred ceeEEEecccccCCCEEEEEEEec-CCCCceEEEEEecCCCcc------------------------HHHHHHHHHHHHH
Confidence 345888899999999999999964 579999999987432221 1225567789999
Q ss_pred HhhccC-CCcc---------ceeEEEec------------CC---cceeeeeccccCC---------------CCCCCHH
Q 046907 127 VGQIRH-RNLH---------PLLAHVTR------------PD---CHLLYILNDVSQG---------------RRELDWL 166 (345)
Q Consensus 127 l~~l~h-pniv---------~l~~~~~~------------~~---~~~l~~~~~~~~~---------------~~~l~~~ 166 (345)
++.++| +|.. ...+.... .. ...++++++...+ +..+++.
T Consensus 132 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~ 211 (413)
T 3dzo_A 132 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 211 (413)
T ss_dssp GGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHH
T ss_pred HHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHH
Confidence 988876 2211 11111111 11 1123444443321 2224455
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccc---
Q 046907 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYL--- 243 (345)
Q Consensus 167 ~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~--- 243 (345)
.+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..... .....| +.|+|||++
T Consensus 212 ~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~ 282 (413)
T 3dzo_A 212 ARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAER 282 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhcc
Confidence 66788999999999999999 999999999999999999999999998765432 344677 999999999
Q ss_pred -------cccccCccchhh-HHHHHHHHHhCCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHH
Q 046907 244 -------QMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLV 315 (345)
Q Consensus 244 -------~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 315 (345)
.+..++.++||| +|+++|||++|..||........ ....+... . .....+
T Consensus 283 ~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~~--~----~~~~~~ 340 (413)
T 3dzo_A 283 MLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG----------------SEWIFRSC--K----NIPQPV 340 (413)
T ss_dssp TSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSSC--C----CCCHHH
T ss_pred ccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhhc--c----cCCHHH
Confidence 555688899999 99999999999999754322110 00000000 0 112457
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 046907 316 LKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 316 ~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.++|..||+.||++|||+.++++
T Consensus 341 ~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 341 RALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHccCChhhCcCHHHHHh
Confidence 88999999999999999877754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=267.23 Aligned_cols=226 Identities=13% Similarity=0.060 Sum_probs=171.5
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++.+.||+|+||.||+|++. .+++.||||.+....... ......+.+|+.++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~~e~~~l 85 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLP------------------------DDVLQETLSRTLRL 85 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSC------------------------HHHHHHHHHHHHHH
T ss_pred CcEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccC------------------------HHHHHHHHHHHHHH
Confidence 68999999999999999999864 579999999997654321 12356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC-------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNV 200 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ni 200 (345)
..++||||+++++++..++ ..++++||+.++++ .......+++.|++.||.|||+.+ ++||||||+||
T Consensus 86 ~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NI 160 (286)
T 3uqc_A 86 SRIDKPGVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRV 160 (286)
T ss_dssp HTCCCTTBCCEEEEEEETT--EEEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGE
T ss_pred hcCCCCCcceeeEEEEECC--cEEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccE
Confidence 9999999999999998876 68999999987543 234466789999999999999999 99999999999
Q ss_pred eecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccch
Q 046907 201 LLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279 (345)
Q Consensus 201 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~ 279 (345)
|++.++.+||++++. ++ +++.++||| +|+++|||++|..||.........
T Consensus 161 ll~~~g~~kl~~~~~----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~ 211 (286)
T 3uqc_A 161 RVSIDGDVVLAYPAT----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL 211 (286)
T ss_dssp EEETTSCEEECSCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS
T ss_pred EEcCCCCEEEEeccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh
Confidence 999999999975432 22 368899999 999999999999998653221100
Q ss_pred hhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.... ...... ...+.. ..+.....+.+++.+||+.||++| |+.++++.|+++.
T Consensus 212 ~~~~----~~~~~~----~~~~~~---~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 212 APAE----RDTAGQ----PIEPAD---IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp EECC----BCTTSC----BCCHHH---HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred HHHH----HHhccC----CCChhh---cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0000 000000 000000 011122347889999999999999 9999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=261.83 Aligned_cols=221 Identities=16% Similarity=0.208 Sum_probs=164.4
Q ss_pred hcCCcccc-cccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASL-EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 46 ~~~~~~~~-~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
-.++|.+. +.||+|+||.||+|+.. .+++.||+|.+.. ...+.+|+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~--------------------------------~~~~~~e~ 61 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD--------------------------------CPKARREV 61 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEC--------------------------------SHHHHHHH
T ss_pred cccchhhcCcccccCCCeEEEEEEEc-CCCcEEEEEEecc--------------------------------cHHHHHHH
Confidence 34578888 77999999999999854 5799999999953 12345678
Q ss_pred HHH-hhccCCCccceeEEEec--CCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 125 NTV-GQIRHRNLHPLLAHVTR--PDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 125 ~~l-~~l~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
.++ +..+||||+++++++.. .+...++++++++.++++ +++.....++.|++.||.|||+.+ +
T Consensus 62 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 138 (299)
T 3m2w_A 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---I 138 (299)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 777 55599999999998865 334578999999987543 667778899999999999999999 9
Q ss_pred EecCCCCCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC
Q 046907 191 IHRDLNPVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 191 iH~dlk~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg 266 (345)
+||||||+||+++. ++.++|+|||++.... +..++.++||| +|+++|+|++|
T Consensus 139 ~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg 194 (299)
T 3m2w_A 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCG 194 (299)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHS
T ss_pred ccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHC
Confidence 99999999999997 7889999999986432 23567899999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccc--cccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDS--KLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
..||....... .. .......... .............+.+++..||+.||++|||+.++++
T Consensus 195 ~~pf~~~~~~~----~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 195 YPPFYSNHGLA----IS--------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCSCCC-------------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCcchh----hh--------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99975422110 00 0000000000 0000000112345788999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=263.95 Aligned_cols=243 Identities=18% Similarity=0.131 Sum_probs=175.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|++ +|+.||||.+............ ....+.+.+|+.
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~-------------------~~~~~~~~~E~~ 75 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSH-------------------QKTFEEILPEII 75 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBC-------------------CBCHHHHHHHHH
T ss_pred ccccchheeeecccCceEEEEEEe---CCceEEEEEEecCCcccccccc-------------------chhHHHHHHHHH
Confidence 457899999999999999999986 6899999999754321000000 011355677888
Q ss_pred HHhhcc---------CCCccceeEEEecC----------------------------CcceeeeeccccCCCC-------
Q 046907 126 TVGQIR---------HRNLHPLLAHVTRP----------------------------DCHLLYILNDVSQGRR------- 161 (345)
Q Consensus 126 ~l~~l~---------hpniv~l~~~~~~~----------------------------~~~~l~~~~~~~~~~~------- 161 (345)
+++.++ ||||+++.+.+... +...+++++||+.+|.
T Consensus 76 ~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~ 155 (336)
T 2vuw_A 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT 155 (336)
T ss_dssp HHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT
T ss_pred HHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh
Confidence 887775 77777777654311 1347899999998764
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCCeeecCCC--------------------CeEEeccccceec
Q 046907 162 -ELDWLARHRIALGLACGLEYLH-MHHCPRIIHRDLNPVNVLLDDDI--------------------EARISGFGFARAI 219 (345)
Q Consensus 162 -~l~~~~~~~i~~~i~~~l~~lh-~~~~~~iiH~dlk~~nil~~~~~--------------------~~kl~Dfg~a~~~ 219 (345)
.++...+..++.|++.||.||| +.+ |+||||||+|||++.++ .+||+|||+|+..
T Consensus 156 ~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 232 (336)
T 2vuw_A 156 KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232 (336)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence 3567788999999999999999 898 99999999999999876 8999999999876
Q ss_pred CCCCcceeccCcccCccccccccccccccCccchhh-HHHH-HHHHHhCCCCCcccccccchhhHHHHH-HHHhhhcCCC
Q 046907 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGAL-LAGLVMGKLPSDKFFQHTNEMSFVKWM-RNVMASENPK 296 (345)
Q Consensus 220 ~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~v-l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 296 (345)
... ...||+.|+|||++.+.. +.++||| ++++ .+++++|..||... .....+ ..........
T Consensus 233 ~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~~~ 297 (336)
T 2vuw_A 233 RDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMTFK 297 (336)
T ss_dssp ETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCCCS
T ss_pred CCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhccC
Confidence 432 357999999999999876 8899999 8776 77788899995321 110111 1111111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 046907 297 RAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337 (345)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll 337 (345)
........+.....+.+|+.+||+.| |+.+++
T Consensus 298 ----~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 298 ----TKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp ----SCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ----cccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 00111123456677999999999976 999887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-29 Score=244.12 Aligned_cols=189 Identities=18% Similarity=0.084 Sum_probs=124.8
Q ss_pred ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-cCC
Q 046907 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-RHR 133 (345)
Q Consensus 55 ~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp 133 (345)
..+.|+.|.+..++ +.-.|+.+|+|.+......... .........+++.+|+++|+++ +|+
T Consensus 241 ~~~~~~~~~h~~~r-r~~fg~~~~~K~~~~~~~~~~~-----------------~~~~~~~~~~~~~~E~~~l~~~~~~~ 302 (569)
T 4azs_A 241 QPYAGAGLAHKRSR-RYFFGEDYVCKFFYYDMPHGIL-----------------TAEESQRNKYELHNEIKFLTQPPAGF 302 (569)
T ss_dssp C-C--------CCE-EEEECSSEEEEEEESSCSTTCS-----------------CHHHHHHHHHHHHHHHHHHHSCCTTC
T ss_pred ccccCCcccccccc-cccccceeEEEEEecccccccc-----------------hhhhhHHHHHHHHHHHHHHHhcCCCC
Confidence 34556665555443 2236889999999754322110 0111134577899999999999 799
Q ss_pred CccceeEEEecCCcceeeeeccccCCCCCCCHHH------HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCC
Q 046907 134 NLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA------RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207 (345)
Q Consensus 134 niv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~------~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~ 207 (345)
||+++++++.+++ .+|+||||++|+++.+.+. ..+|+.||+.||.|+|++| |+||||||+|||++.++.
T Consensus 303 ~i~~~~~~~ed~~--~~yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~ 377 (569)
T 4azs_A 303 DAPAVLAHGENAQ--SGWLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQH 377 (569)
T ss_dssp CCCCEEEEEECSS--EEEEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSC
T ss_pred CeeEEEEEEEECC--EEEEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCC
Confidence 9999999998776 7999999999976644332 2469999999999999999 999999999999999999
Q ss_pred eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 208 ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 208 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||+|||+|+....... ...+.+||+.|||||++.+. +..++|+| +|++++++.++..+
T Consensus 378 vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 378 ARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EEEeecccCeeCCCCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 99999999987654322 23457899999999999874 56789999 99988776554433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-27 Score=225.20 Aligned_cols=191 Identities=17% Similarity=0.123 Sum_probs=140.6
Q ss_pred ccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 046907 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI 130 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 130 (345)
...+.||+|+||.||+|++ .+..+++|............ ......+++.+|+.+++++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~-------------------~~~~~~~~~~~E~~il~~l 396 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERL-------------------DENIRKSRTAREARYLALV 396 (540)
T ss_dssp ---------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHH-------------------HHHHHHHHHHHHHHHHHHG
T ss_pred CCCCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhh-------------------hhHHHHHHHHHHHHHHHhc
Confidence 3467899999999999975 57889999876533221110 1122367789999999999
Q ss_pred cCCCccceeEEEecCCcceeeeeccccCCCCCCCHHH-HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeE
Q 046907 131 RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLA-RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEAR 209 (345)
Q Consensus 131 ~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~-~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~k 209 (345)
+||||+++..++..++ ..++++||++++++.++.. ...++.|+++||.|||+.+ ++||||||+|||++. .+|
T Consensus 397 ~h~nIv~~~~~~~~~~--~~~lVmE~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~k 469 (540)
T 3en9_A 397 KDFGIPAPYIFDVDLD--NKRIMMSYINGKLAKDVIEDNLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLY 469 (540)
T ss_dssp GGGTCCCCCEEEEETT--TTEEEEECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEE
T ss_pred CCCCcCceEEEEEeCC--ccEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEE
Confidence 9999995554444444 4589999999887644433 4689999999999999999 999999999999999 999
Q ss_pred EeccccceecCCCCcce-----eccCcccCccccccccccc--cccCccchhh-HHHHHHHHHhCCCCC
Q 046907 210 ISGFGFARAIPDAHTHI-----TTSNVVGTVEYIAPEYLQM--LTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 210 l~Dfg~a~~~~~~~~~~-----~~~~~~gt~~~~aPE~~~~--~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
|+|||+++......... ......||+.|||||++.+ ..|+..+|+| ..+-..+.+.++.+|
T Consensus 470 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 470 IIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999998875432211 1235789999999999987 5678889999 888888877777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-23 Score=182.85 Aligned_cols=166 Identities=13% Similarity=0.017 Sum_probs=118.9
Q ss_pred HhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 44 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
......|++.+.||+|+||.||+|++ .+|..||+|.+.....+........... ...+.......+.+|
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~---------~~~w~~~~~~~~~~E 154 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYG---------DLHFSVLAIRSARNE 154 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC----------------CHHHHHHHHHHHH
T ss_pred HhCCeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhc---------chhhHHHHHHHHHHH
Confidence 34555667779999999999999997 4799999999965432211100000000 111112346778899
Q ss_pred HHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCCC--HHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 046907 124 INTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD--WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201 (345)
Q Consensus 124 ~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~--~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil 201 (345)
+.++++++ | +++++.+..+ ..++++++++++++.+ ......++.|++.||.|||+.+ ++||||||+|||
T Consensus 155 ~~~l~~l~--~-~~v~~~~~~~---~~~lvmE~~~g~~L~~l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 155 FRALQKLQ--G-LAVPKVYAWE---GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp HHHHHHTT--T-SSSCCEEEEE---TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred HHHHHhcc--C-CCcCeEEecc---ceEEEEEecCCCcHHHcchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 99999998 4 5666555433 3689999998876643 2234579999999999999999 999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc
Q 046907 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 202 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~ 245 (345)
++ ++.+||+|||++.. +..++|||.+.+
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99 99999999999863 334678888754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.7e-18 Score=149.66 Aligned_cols=156 Identities=15% Similarity=0.078 Sum_probs=103.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCce--eEEeeecCCchhhhhhhh---hhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRM--ISIKKIVGPPMDAAALIE---EDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
...-|++.+.||+|+||.||+|++. .+|.. ||||.+............ .+....... ..........+
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 117 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRR------ISPKEKVFIWT 117 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----------CHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhc------cChHHHHHHHH
Confidence 3334788999999999999999862 36888 999998654222110000 000000000 00001224567
Q ss_pred HHHHHHHhhccCCCc--cceeEEEecCCcceeeeeccccCC-CCCCC----------HHHHHHHHHHHHHHHHHHh-hcC
Q 046907 121 QSEINTVGQIRHRNL--HPLLAHVTRPDCHLLYILNDVSQG-RRELD----------WLARHRIALGLACGLEYLH-MHH 186 (345)
Q Consensus 121 ~~E~~~l~~l~hpni--v~l~~~~~~~~~~~l~~~~~~~~~-~~~l~----------~~~~~~i~~~i~~~l~~lh-~~~ 186 (345)
.+|+.++..++|+++ ...++. . ..+++|+|+++ |...+ ......++.|++.||.||| +.+
T Consensus 118 ~~E~~~l~~l~~~~i~~p~~~~~---~---~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 118 EKEFRNLERAKEAGVSVPQPYTY---M---KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHHHHHHHHHHHTTCCCCCEEEE---E---TTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HHHHHHHHHHHhCCCCCCeEEEc---C---CCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC
Confidence 889999999988864 344432 1 35788999942 21111 1245679999999999999 888
Q ss_pred CCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 046907 187 CPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219 (345)
Q Consensus 187 ~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~ 219 (345)
++||||||+|||++. .++|+|||+|...
T Consensus 192 ---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 ---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.2e-15 Score=138.76 Aligned_cols=160 Identities=13% Similarity=0.082 Sum_probs=102.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...-|+++..||+|++|.||+|... +|+.||||+++....+............. .....+.....-...+|..
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~-----~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRN-----RSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTT-----SCHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHh-----hccccHHHHHHHHHHHHHH
Confidence 4446999999999999999999853 79999999987543332111000000000 0000000111222346777
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
.|.++.+..+....-+.. .. .+++|+|++|..+ .+......++.|++.+|.+||..| ++||||||.|||+
T Consensus 166 nL~rL~~~gv~vp~p~~~-~~---~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ-SR---HTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE-ET---TEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred HHHHHHhcCCCCCeeeec-cC---ceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 787775554322111111 11 2689999987543 223345678999999999999998 9999999999999
Q ss_pred cCCC----------CeEEeccccceec
Q 046907 203 DDDI----------EARISGFGFARAI 219 (345)
Q Consensus 203 ~~~~----------~~kl~Dfg~a~~~ 219 (345)
+.++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8765 3889999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.8e-10 Score=100.06 Aligned_cols=139 Identities=12% Similarity=0.053 Sum_probs=104.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|.+...+|.|+.+.||++.. .+..+++|........ ....+.+|+.+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~---------------------------~~~~~~~E~~~ 62 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKG---------------------------TTYDVEREKDM 62 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTT---------------------------STTCHHHHHHH
T ss_pred hccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCC---------------------------CHHHHHHHHHH
Confidence 35799999999999999999974 4678999998532111 02246678999
Q ss_pred Hhhc-cCCCccceeEEEecCCcceeeeeccccCCCCCCC----HHHHHHHHHHHHHHHHHHhhcC---------------
Q 046907 127 VGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD----WLARHRIALGLACGLEYLHMHH--------------- 186 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~----~~~~~~i~~~i~~~l~~lh~~~--------------- 186 (345)
++.+ ++..+.+++++....+ ..++++++++|..+.+ ......++.+++.++..||+..
T Consensus 63 l~~l~~~~~vP~v~~~~~~~~--~~~lv~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 63 MLWLEGKLPVPKVLHFERHDG--WSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp HHHHTTTSCCCCEEEEEEETT--EEEEEEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred HHHHhcCCCCCeEEEEEecCC--ceEEEEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 8888 4677889998887654 6889999999865422 1233478889999999999811
Q ss_pred -----------------------------------------CCCeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 187 -----------------------------------------CPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 187 -----------------------------------------~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
...++|+|+++.||+++....+.|+||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0239999999999999876556799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=1.3e-09 Score=94.10 Aligned_cols=138 Identities=15% Similarity=0.130 Sum_probs=98.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...++.+....+.|+.+.||++.. .+|..+++|...... ...+..|+.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~~------------------------------~~~~~~E~~ 65 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA--QGRPVLFVKTDLSGA------------------------------LNELQDEAA 65 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC--TTSCCEEEEEECSCT------------------------------TSCHHHHHH
T ss_pred hcCCCceEecccCCCCceEEEEec--CCCCeEEEEeCCccc------------------------------chhhhHHHH
Confidence 445677655555777799999974 367789999975421 123457888
Q ss_pred HHhhccCCC--ccceeEEEecCCcceeeeeccccCCCCCC-CHHHHHHHHHHHHHHHHHHhhcC----------------
Q 046907 126 TVGQIRHRN--LHPLLAHVTRPDCHLLYILNDVSQGRREL-DWLARHRIALGLACGLEYLHMHH---------------- 186 (345)
Q Consensus 126 ~l~~l~hpn--iv~l~~~~~~~~~~~l~~~~~~~~~~~~l-~~~~~~~i~~~i~~~l~~lh~~~---------------- 186 (345)
+++.+.+.+ +.+++++...++ ..++++++++|..+. +......++.+++..+..||+..
T Consensus 66 ~l~~l~~~~~~vP~~~~~~~~~~--~~~~v~e~i~G~~l~~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~ 143 (264)
T 1nd4_A 66 RLSWLATTGVPCAAVLDVVTEAG--RDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIER 143 (264)
T ss_dssp HHHHHHTTTCCBCCEEEEEECSS--CEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHH
T ss_pred HHHHHHhCCCCCCeEEEeccCCC--CCEEEEEecCCcccCcCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Confidence 888885434 456888776554 478899999887653 11123467788888899998753
Q ss_pred ---------------------------------------CCCeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 187 ---------------------------------------CPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 187 ---------------------------------------~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
...++|+|++|.||+++.+..+.++||+.+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 144 ARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877666799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=3.4e-08 Score=89.75 Aligned_cols=140 Identities=12% Similarity=0.154 Sum_probs=99.6
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeec--CCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIV--GPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
..-++.|+.|.++.||+.+. .+..+++|... .... ......+.+|+.++
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~~--------------------------~~~~~~~~~E~~~l 90 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSKL--------------------------LPSAHAIEREYRVM 90 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC---SSCEEEEECCCC------------------------------------CHHHHHHHH
T ss_pred CceEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCCC--------------------------CCcHHHHHHHHHHH
Confidence 34467899999999999985 34578888874 2110 01134567799999
Q ss_pred hhcc--CCCccceeEEEecCCc-ceeeeeccccCCCCC-------CCHHHHHHHHHHHHHHHHHHhhcC-----------
Q 046907 128 GQIR--HRNLHPLLAHVTRPDC-HLLYILNDVSQGRRE-------LDWLARHRIALGLACGLEYLHMHH----------- 186 (345)
Q Consensus 128 ~~l~--hpniv~l~~~~~~~~~-~~l~~~~~~~~~~~~-------l~~~~~~~i~~~i~~~l~~lh~~~----------- 186 (345)
+.+. +..+.+++.++...+. ...++++++++|... ++......++.+++..|..||...
T Consensus 91 ~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~ 170 (359)
T 3dxp_A 91 DALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK 170 (359)
T ss_dssp HHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred HHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence 8886 4567888887765531 246789999988654 245566788999999999999731
Q ss_pred --------------------------------------------CCCeEecCCCCCCeeecCCCC--eEEecccccee
Q 046907 187 --------------------------------------------CPRIIHRDLNPVNVLLDDDIE--ARISGFGFARA 218 (345)
Q Consensus 187 --------------------------------------------~~~iiH~dlk~~nil~~~~~~--~kl~Dfg~a~~ 218 (345)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.52 E-value=2e-07 Score=82.57 Aligned_cols=181 Identities=19% Similarity=0.203 Sum_probs=110.7
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc-c
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI-R 131 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 131 (345)
++.++.|....||+.. ..+++|.... ......+.+|+.+++.+ .
T Consensus 25 i~~~~~G~~n~v~~v~------~~~vlR~~~~-----------------------------~~~~~~~~~E~~~l~~l~~ 69 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN------RDFIFKFPKH-----------------------------SRGSTNLFNEVNILKRIHN 69 (304)
T ss_dssp CCEEEECSSEEEEEST------TSEEEEEESS-----------------------------HHHHHHHHHHHHHHHHHTT
T ss_pred eEecCCCCcceEEEEC------CEEEEEecCC-----------------------------cchHHHHHHHHHHHHHHHh
Confidence 4568999999999863 3588898642 11245677899999887 3
Q ss_pred CCC--ccceeEEEecCCc-ceeeeeccccCCCCCC-------CHHHHHHHHHHHHHHHHHHhhcC---------------
Q 046907 132 HRN--LHPLLAHVTRPDC-HLLYILNDVSQGRREL-------DWLARHRIALGLACGLEYLHMHH--------------- 186 (345)
Q Consensus 132 hpn--iv~l~~~~~~~~~-~~l~~~~~~~~~~~~l-------~~~~~~~i~~~i~~~l~~lh~~~--------------- 186 (345)
+.. +.+++......+. ...++++++++|..+. +......++.+++..+..||+..
T Consensus 70 ~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~ 149 (304)
T 3sg8_A 70 KLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREK 149 (304)
T ss_dssp SSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHH
T ss_pred cCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHH
Confidence 332 3344444333221 2347789999886553 33345678888888888888621
Q ss_pred ----------------------------------------CCCeEecCCCCCCeeecC--CCCeEEeccccceecCCCCc
Q 046907 187 ----------------------------------------CPRIIHRDLNPVNVLLDD--DIEARISGFGFARAIPDAHT 224 (345)
Q Consensus 187 ----------------------------------------~~~iiH~dlk~~nil~~~--~~~~kl~Dfg~a~~~~~~~~ 224 (345)
...++|+|+++.|++++. ...+.++||+.+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D 229 (304)
T 3sg8_A 150 INEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND 229 (304)
T ss_dssp HHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH
T ss_pred HHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH
Confidence 134899999999999997 45678999998865322100
Q ss_pred ceeccCc---ccC---------ccccc-cccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 225 HITTSNV---VGT---------VEYIA-PEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 225 ~~~~~~~---~gt---------~~~~a-PE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
....... .+. .+... |+.... ...-.+.| +|.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000000 000 00111 222111 11225788 999999999999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=0.00021 Score=63.04 Aligned_cols=130 Identities=22% Similarity=0.188 Sum_probs=86.2
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
...++.|....||+. |..+++|.... ......+..|+.+|+.+.+
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~~-----------------------------~~~~~~~~~E~~~L~~L~~ 68 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPKS-----------------------------QQGADELNKEIQLLPLLVG 68 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEESS-----------------------------HHHHHHHHHHHHHHHHHTT
T ss_pred eeecCCCcceeEEEE------CCEEEEEecCC-----------------------------chHHHHHHHHHHHHHHHHh
Confidence 456888999999987 34577888532 1224567889999999864
Q ss_pred C---CccceeEEEecCCcceeeeeccccCCCCCC-------CHHHHHHHHHHHHHHHHHHhhcC----------------
Q 046907 133 R---NLHPLLAHVTRPDCHLLYILNDVSQGRREL-------DWLARHRIALGLACGLEYLHMHH---------------- 186 (345)
Q Consensus 133 p---niv~l~~~~~~~~~~~l~~~~~~~~~~~~l-------~~~~~~~i~~~i~~~l~~lh~~~---------------- 186 (345)
. .+.+.+.+....+ ...++++++++|..+. +......++.++...|..||+..
T Consensus 69 ~~~v~VP~~~~~~~~~~-g~~~~v~e~i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~ 147 (306)
T 3tdw_A 69 CVKVNIPQYVYIGKRSD-GNPFVGYRKVQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKN 147 (306)
T ss_dssp TCSSBCCCEEEEEECTT-SCEEEEEECCCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHH
T ss_pred cCCCCCCCeEeecccCC-CceEEEEeccCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHH
Confidence 2 2556666654222 2456899999886442 22334455555655555555432
Q ss_pred -----------------------------------------CCCeEecCCCCCCeeecC---CCC-eEEecccccee
Q 046907 187 -----------------------------------------CPRIIHRDLNPVNVLLDD---DIE-ARISGFGFARA 218 (345)
Q Consensus 187 -----------------------------------------~~~iiH~dlk~~nil~~~---~~~-~kl~Dfg~a~~ 218 (345)
...++|+|+.+.|++++. ++. +.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 148 KILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 124799999999999987 455 47999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=0.0003 Score=60.66 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=88.9
Q ss_pred cCCcccccccccCcce-eeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCG-EVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g-~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
...|.. +.+..|..| .||+.... ..+..+.+|.-.. .....+..|..
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~------------------------------~~~~~~~~E~~ 71 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGK-PNAPELFLKHGKG------------------------------SVANDVTDEMV 71 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECC-TTCCCEEEEEEET------------------------------HHHHHHHHHHH
T ss_pred ccCCeE-EEccCCCcCCeEEEEEec-CCCeEEEEEECCC------------------------------CCHhHHHHHHH
Confidence 334544 334445544 68987643 3566788998642 11344667888
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCCCCCCCH-----HHHHHHHHHHHHHHHHHhhcCC------------
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDW-----LARHRIALGLACGLEYLHMHHC------------ 187 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~-----~~~~~i~~~i~~~l~~lh~~~~------------ 187 (345)
.|+.+. +--+.++++++..++ ..+++|++++|....+. .....+..++...|.-||....
T Consensus 72 ~l~~l~~~vPVP~v~~~~~~~~--~~~lvme~l~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~ 149 (272)
T 4gkh_A 72 RLNWLTAFMPLPTIKHFIRTPD--DAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFR 149 (272)
T ss_dssp HHHHHTTTSCCCCEEEEEEETT--EEEEEEECCCSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHH
T ss_pred HHHHhccCCCcCeEEEEEEECC--eEEEEEEeeCCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccc
Confidence 888773 323667888777665 57889999988543211 1223456666666666665321
Q ss_pred -------------------------------------------CCeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 188 -------------------------------------------PRIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 188 -------------------------------------------~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
..++|+|+.+.|++++..+.+-|.||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 150 LAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 238999999999999987667799999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0006 Score=62.38 Aligned_cols=30 Identities=23% Similarity=0.378 Sum_probs=25.3
Q ss_pred CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+.+.|++++.+ .+.+.||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 359999999999999876 489999987754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00054 Score=61.62 Aligned_cols=31 Identities=19% Similarity=0.218 Sum_probs=25.5
Q ss_pred CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+.+.||+++....+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 3599999999999999644578999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0039 Score=55.00 Aligned_cols=75 Identities=12% Similarity=0.096 Sum_probs=52.7
Q ss_pred ccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhc
Q 046907 51 ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQI 130 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 130 (345)
.-.+.|+.|....+|+.+. ++..+.+|..... ....+..|+..|+.+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~------------------------------~~~~~~~E~~~L~~L 85 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND---EVQTVFVKINERS------------------------------YRSMFRAEADQLALL 85 (312)
T ss_dssp CEEEEECCSSSSEEEEEES---SSCEEEEEEEEGG------------------------------GHHHHHHHHHHHHHH
T ss_pred eeeEEeCCccceeeeEEEE---CCCeEEEEeCCcc------------------------------cHHHHHHHHHHHHHH
Confidence 3356789999999999874 4667888986421 134567788888877
Q ss_pred c---CCCccceeEEEecCCcceeeeeccccCCC
Q 046907 131 R---HRNLHPLLAHVTRPDCHLLYILNDVSQGR 160 (345)
Q Consensus 131 ~---hpniv~l~~~~~~~~~~~l~~~~~~~~~~ 160 (345)
. ...+.+++.+...++ ..+++++++++.
T Consensus 86 ~~~~~v~VP~vl~~~~~~g--~~~lvme~l~G~ 116 (312)
T 3jr1_A 86 AKTNSINVPLVYGIGNSQG--HSFLLLEALNKS 116 (312)
T ss_dssp HHTTSSBCCCEEEEEECSS--EEEEEEECCCCC
T ss_pred HhhCCCCcceEEEEeecCC--ceEEEEEeccCC
Confidence 3 356778888776554 567777777663
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0076 Score=53.45 Aligned_cols=30 Identities=20% Similarity=0.375 Sum_probs=26.6
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
..++|+|+.+.|++++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 359999999999999877889999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0023 Score=55.72 Aligned_cols=36 Identities=19% Similarity=0.336 Sum_probs=29.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecC
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVG 84 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~ 84 (345)
.....-.+.+|.|..+.||+.+.. +|+.|.+|....
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~ 49 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPD 49 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCT
T ss_pred CCCeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCC
Confidence 345666788999999999999874 789999998654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0099 Score=51.95 Aligned_cols=126 Identities=11% Similarity=-0.020 Sum_probs=76.8
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc-
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR- 131 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~- 131 (345)
++.|+.|....+|+. ..+.+|........ .-....|+.+++.+.
T Consensus 23 i~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~----------------------------~~~r~~E~~~l~~l~~ 67 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-------GDLCLRIPGKGTEE----------------------------YINRANEAVAAREAAK 67 (301)
T ss_dssp CEEEESCSSEEEEEE-------TTEEEEEECC--------------------------------CCCHHHHHHHHHHHHH
T ss_pred eeEcCCcccccccee-------eeEEEECCCCCccc----------------------------eeCHHHHHHHHHHHHH
Confidence 678899999999998 34778887532100 011134666666663
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCCCCCCHHHHH---HHHHHHHHHHHHHhhcCC---------------------
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH---RIALGLACGLEYLHMHHC--------------------- 187 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~---~i~~~i~~~l~~lh~~~~--------------------- 187 (345)
+.-..++++..... -+++++++.+|..++..... .++.++++.|.-+|+...
T Consensus 68 ~g~~P~~~~~~~~~----~~~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (301)
T 3dxq_A 68 AGVSPEVLHVDPAT----GVMVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLST 143 (301)
T ss_dssp TTSSCCEEEECTTT----CCEEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC-
T ss_pred cCCCCceEEEECCC----CEEEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhh
Confidence 22224666543222 24667888444444433222 255666666666776431
Q ss_pred -----------------------------CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 -----------------------------PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 -----------------------------~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+.+.|++ ..++.+.++||..+..
T Consensus 144 ~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 144 KNVTLPAGYHDVVREAGGVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp -CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred cCCCchhhHHHHHHHHHHHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 23799999999999 5566789999987764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.012 Score=54.20 Aligned_cols=30 Identities=23% Similarity=0.357 Sum_probs=26.3
Q ss_pred CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+++.||+++.++ +.+.||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 3599999999999998776 99999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.04 E-value=0.031 Score=51.56 Aligned_cols=31 Identities=10% Similarity=0.225 Sum_probs=22.9
Q ss_pred ccccccCcceeeEEEEecCC------CCceeEEeeec
Q 046907 53 LEKIGSGGCGEVYKAELPGQ------NGRMISIKKIV 83 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~------~~~~vavK~~~ 83 (345)
+..|+.|....||++..... ++..+.+|+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~ 114 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF 114 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeC
Confidence 46788899999999986421 24678899874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.96 E-value=0.02 Score=50.34 Aligned_cols=29 Identities=34% Similarity=0.368 Sum_probs=25.0
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.|++++.+..+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 49999999999999987556799998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.036 Score=50.18 Aligned_cols=30 Identities=20% Similarity=0.318 Sum_probs=25.8
Q ss_pred CCeEecCCCCCCeeecCC----CCeEEeccccce
Q 046907 188 PRIIHRDLNPVNVLLDDD----IEARISGFGFAR 217 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~----~~~kl~Dfg~a~ 217 (345)
..++|+|+.+.|++++.+ +.+.++||..+.
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 359999999999999876 688999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.82 E-value=0.052 Score=47.76 Aligned_cols=28 Identities=25% Similarity=0.258 Sum_probs=24.4
Q ss_pred CeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
.++|+|+++.||+++ + .+.+.||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 489999999999999 4 899999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.047 Score=48.25 Aligned_cols=32 Identities=22% Similarity=0.262 Sum_probs=27.0
Q ss_pred CCeEecCCCCCCeeecCC----CCeEEeccccceec
Q 046907 188 PRIIHRDLNPVNVLLDDD----IEARISGFGFARAI 219 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~----~~~kl~Dfg~a~~~ 219 (345)
..++|+|+.+.|++++.+ ..+.+.||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 359999999999999874 67899999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.08 E-value=0.11 Score=48.15 Aligned_cols=30 Identities=13% Similarity=0.012 Sum_probs=20.5
Q ss_pred ccccccCcceeeEEEEecCCCCceeEEeeec
Q 046907 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIV 83 (345)
Q Consensus 53 ~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~ 83 (345)
+..|+.|....+|++.... .+..+.+|+..
T Consensus 113 i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g 142 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-KQAKYLIRLYG 142 (458)
T ss_dssp EEEECC--CEEEEEEEETT-TTEEEEEEEEC
T ss_pred EEEcCCCeEeEEEEEEECC-CCceEEEEECC
Confidence 4568888899999998641 24678888874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.64 E-value=0.099 Score=46.93 Aligned_cols=28 Identities=21% Similarity=0.420 Sum_probs=23.6
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.+.||+++.+. +.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 499999999999998654 8999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.20 E-value=0.15 Score=45.31 Aligned_cols=31 Identities=19% Similarity=0.222 Sum_probs=26.9
Q ss_pred CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+.+.|++++.++.+.+.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999877899999987654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=93.48 E-value=0.015 Score=54.29 Aligned_cols=65 Identities=5% Similarity=-0.005 Sum_probs=19.7
Q ss_pred ccccccccCcceeeEEEEecCCCCceeEE------eeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 51 ASLEKIGSGGCGEVYKAELPGQNGRMISI------KKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+.+.|| ||+||+|.++. ...+||+ |...... ...+....+.+|.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~-~~~~Vav~~~~~~K~~~~~~-------------------------~~~e~~~~~~rea 195 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYK-KHMPVLKETHDERDSTGQDG-------------------------VSEKRLTSLVRRA 195 (463)
T ss_dssp CSTTTSS---BCCC----------CCBGGGC-------------------------------------------------
T ss_pred cccccCC---chhhhcccccc-cCCchhhhhccCcccccccc-------------------------ccccccccccccc
Confidence 5667787 99999999863 2457888 5443211 1123356678899
Q ss_pred HHHhhccCCCccceeEEEec
Q 046907 125 NTVGQIRHRNLHPLLAHVTR 144 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~ 144 (345)
.+.+.++|||+++.+++...
T Consensus 196 ~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 196 TLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp -----------CBCCCEEEE
T ss_pred cccccccccccCCCcceEEe
Confidence 99999999999999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.40 E-value=1.3 Score=36.39 Aligned_cols=88 Identities=10% Similarity=0.006 Sum_probs=54.1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccc
Q 046907 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIA 239 (345)
Q Consensus 160 ~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~a 239 (345)
+..++..+++.++.|.+.+|.-+-.+. .+ ..+=..|..+++..+|.+.+.+ +.+. .....+.|
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~ 105 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVA 105 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------------------
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc--------------ccccCCCC
Confidence 567889999999999999887663211 01 1223346888899998888764 1110 11234567
Q ss_pred cccccccccCccchhh-HHHHHHHHHh
Q 046907 240 PEYLQMLTLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 240 PE~~~~~~~~~~~Dvw-lG~vl~el~t 265 (345)
||... ...+.+.=|| +|+++|.-+-
T Consensus 106 pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 106 GKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred hhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 88764 2445677899 9999998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 345 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-38 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-36 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-35 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-35 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-34 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-32 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-28 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-28 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-26 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-26 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-26 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-44
Identities = 60/303 (19%), Positives = 120/303 (39%), Gaps = 55/303 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++IGSG G VYK + G +++K +
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD----VAVKML-------------------------NVTAP 43
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY-------ILNDVSQGRRELDW 165
++++ ++E+ + + RH N+ + + T P ++ + + + + +
Sbjct: 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEM 103
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
+ IA A G++YLH IIHRDL N+ L +D+ +I FG A
Sbjct: 104 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160
Query: 226 ITTSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
+ G++ ++APE ++M + + D+Y FG +L L+ G+LP + + N
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRD 216
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
+ +M + D V + C + M ++ C + +ERP + +
Sbjct: 217 QIIFMVG-----RGYLSPDLSKVRSNCPKAM---KRLMAECLKKKRDERPLFPQILASIE 268
Query: 342 QIQ 344
+
Sbjct: 269 LLA 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 61/329 (18%), Positives = 108/329 (32%), Gaps = 55/329 (16%)
Query: 29 AIFSPLIKKAKDLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMD 88
A+ L++ + + + E IG G G VY L +G+ I
Sbjct: 8 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV------- 60
Query: 89 AAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH 148
K + +I ++ Q +E + H N+ LL R +
Sbjct: 61 -------------KSLNRITDI----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103
Query: 149 LLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199
L +L + G L +A G+ + +HRDL N
Sbjct: 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARN 160
Query: 200 VLLDDDIEARISGFGFARAIPD--AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256
+LD+ +++ FG AR + D + + V+++A E LQ T K D++ F
Sbjct: 161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 220
Query: 257 GALLAGLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVL 316
G LL L+ P + N ++ P+ D +
Sbjct: 221 GVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRLLQPEYCPDP-------------LY 264
Query: 317 KIACFCTLEDPNERPNSKDVRRMLSQIQH 345
++ C RP+ ++ +S I
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-39
Identities = 66/323 (20%), Positives = 115/323 (35%), Gaps = 65/323 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E IG G GEV++ + G +++K R+ +S
Sbjct: 8 QESIGKGRFGEVWRGKW---RGEEVAVKIF--------------------SSREERSWF- 43
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHL--LYILNDVSQG--------RRE 162
++EI +RH N+ +A + + L++++D + R
Sbjct: 44 -------REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT 96
Query: 163 LDWLARHRIALGLACGLEYLHMH-----HCPRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
+ ++AL A GL +LHM P I HRDL N+L+ + I+ G A
Sbjct: 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 218 AIPDA--HTHITTSNVVGTVEYIAPEYLQM------LTLTEKCDIY-FGALLAGLVMGKL 268
A I ++ VGT Y+APE L ++ DIY G + +
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 269 PSDK-------FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACF 321
++ V+ MR V+ + + I ++ M KI
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM---AKIMRE 273
Query: 322 CTLEDPNERPNSKDVRRMLSQIQ 344
C + R + +++ LSQ+
Sbjct: 274 CWYANGAARLTALRIKKTLSQLS 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-38
Identities = 59/300 (19%), Positives = 110/300 (36%), Gaps = 59/300 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+E++G+G GEV+ G +++K + K+
Sbjct: 18 VERLGAGQFGEVWMGYYNG--HTKVAVKSL-------------------KQGSMSP---- 52
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILND--------VSQGRRELD 164
+E N + Q++H+ L L A VT+ +++ + + +L
Sbjct: 53 -----DAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLT 107
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+A +A G+ ++ + IHRDL N+L+ D + +I+ FG AR I D
Sbjct: 108 INKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+++ APE + T T K D++ FG LL +V + +
Sbjct: 165 TAREG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVI 220
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
+ + P C E++ ++ C E P +RP +R +L
Sbjct: 221 QNLERGYRMVRPD----------NCPEEL---YQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 7e-38
Identities = 49/301 (16%), Positives = 100/301 (33%), Gaps = 50/301 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++ +GSG G VYK G + I + K++R+ S
Sbjct: 14 IKVLGSGAFGTVYKGLWI-PEGEKVKIPVAI------------------KELREATSP-- 52
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY-------ILNDVSQGRRELDW 165
K ++I E + + + ++ LL L+ +L+ V + + +
Sbjct: 53 --KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGS 110
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
+ +A G+ YL ++HRDL NVL+ +I+ FG A+ +
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
++++A E + T + D++ +G + L+ +
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISS 224
Query: 285 WMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344
+ P V I C + D + RP +++ S++
Sbjct: 225 ILEKGERLPQPPICTID-------------VYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
Query: 345 H 345
Sbjct: 272 R 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 56/300 (18%), Positives = 101/300 (33%), Gaps = 59/300 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
K+G G GEV+ G ++IK + K + E
Sbjct: 22 EVKLGQGCFGEVWMGTWNG--TTRVAIKTL--------------------KPGTMSPEAF 59
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILND--------VSQGRRELD 164
L E + ++RH L L A V+ +++ + + L
Sbjct: 60 LQ--------EAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR 111
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+A +A G+ Y+ + +HRDL N+L+ +++ +++ FG AR I D
Sbjct: 112 LPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+++ APE T K D++ FG LL L + +
Sbjct: 169 TARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVL 224
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
+ P +S + + C C ++P ERP + ++ L
Sbjct: 225 DQVERGYRMPCPPECPES-------------LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-37
Identities = 59/313 (18%), Positives = 109/313 (34%), Gaps = 59/313 (18%)
Query: 43 FLEKKGGLASLE--KIGSGGCGEVYKAELP-GQNGRMISIKKIVGPPMDAAALIEEDSML 99
+L++K L +LE ++GSG G V K + + +++K +
Sbjct: 2 YLDRK--LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL----------------- 42
Query: 100 LNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY------IL 153
++E ++ +E N + Q+ + + ++ L+ L
Sbjct: 43 --------KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPL 94
Query: 154 NDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGF 213
N Q R + + ++ G++YL + +HRDL NVLL A+IS F
Sbjct: 95 NKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDF 151
Query: 214 GFARAIPDAHTHITTSN-VVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270
G ++A+ + V++ APE + + K D++ FG L+ G+ P
Sbjct: 152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP- 210
Query: 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER 330
++ + P GC +M + C D R
Sbjct: 211 ---YRGMKGSEVTAMLEKGERMGCPA----------GCPREM---YDLMNLCWTYDVENR 254
Query: 331 PNSKDVRRMLSQI 343
P V L
Sbjct: 255 PGFAAVELRLRNY 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 131 bits (329), Expect = 3e-36
Identities = 53/301 (17%), Positives = 107/301 (35%), Gaps = 29/301 (9%)
Query: 53 LEKIGSGGCGEVYKAELPG----QNGRMISIKKI--VGPPMDAAALIEEDSML--LNKKM 104
+ IG G G V++A PG + M+++K + A E +++ +
Sbjct: 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 77
Query: 105 RQIQSEMLLNKKMRQIQSEINTVGQIRHR-NLHPLLAHVTRPDCHLLYILNDVSQGRREL 163
+ K + E G + + L S G L
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 164 DWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAH 223
+ IA +A G+ YL + +HRDL N L+ +++ +I+ FG +R I A
Sbjct: 138 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 224 THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
+ N + ++ PE + T + D++ +G +L + L +
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---PYYGMAHEEV 251
Query: 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342
+ ++R+ P+ + + C + P +RP+ + R+L +
Sbjct: 252 IYYVRDGNILACPENCPLE-------------LYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 343 I 343
+
Sbjct: 299 M 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-36
Identities = 50/304 (16%), Positives = 116/304 (38%), Gaps = 46/304 (15%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ ++G+G G V+K +G +++ K I + +++
Sbjct: 11 ISELGAGNGGVVFKVSHK-PSGLVMARKLI------------------HLEIKP------ 45
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LNDVSQGRRELDW 165
QI E+ + + + + ++ L+ V + +
Sbjct: 46 --AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 103
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
++++ + GL YL +I+HRD+ P N+L++ E ++ FG + + D+
Sbjct: 104 QILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
++ VGT Y++PE LQ + + DI+ G L + +G+ P E+ F
Sbjct: 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 285 WMRNVMASENPKRAIDSKLVG--NGCEEQMLLVLKIACFCTLEDPNERPN---SKDVRRM 339
+ A P+ + + + + ++ + E P + P+ S + +
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
Query: 340 LSQI 343
+++
Sbjct: 278 VNKC 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 4e-36
Identities = 60/302 (19%), Positives = 105/302 (34%), Gaps = 61/302 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L IG+G G K +G+++ K++ ++E
Sbjct: 9 LYTIGTGSYGRCQKIRRK-SDGKILVWKEL-------------------DYGSMTEAEK- 47
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------------LNDVSQG 159
+ + SE+N + +++H N+ + LYI + ++
Sbjct: 48 -----QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 102
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHC--PRIIHRDLNPVNVLLDDDIEARISGFGFAR 217
R+ LD R+ L L+ H ++HRDL P NV LD ++ FG AR
Sbjct: 103 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
+ + VGT Y++PE + ++ EK DI+ G LL L P F
Sbjct: 163 ILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTA 216
Query: 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336
++ +R P R D + +I RP+ +++
Sbjct: 217 FSQKELAGKIREGKFRRIPYRYSDE-------------LNEIITRMLNLKDYHRPSVEEI 263
Query: 337 RR 338
Sbjct: 264 LE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 1e-35
Identities = 56/303 (18%), Positives = 111/303 (36%), Gaps = 63/303 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
K+G G GEVY+ +++K + +ED+M
Sbjct: 22 KHKLGGGQYGEVYEGVWKK-YSLTVAVKTL-----------KEDTM-------------- 55
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH-----------LLYILNDVSQGRR 161
++ + E + +I+H NL LL TR LL L + R+
Sbjct: 56 ---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQ 110
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
E+ + +A ++ +EYL + IHRDL N L+ ++ +++ FG +R +
Sbjct: 111 EVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
+++ APE L + K D++ FG LL + + + +
Sbjct: 168 DTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLS 223
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRML 340
+ + E P+ + V ++ C +P++RP+ ++ +
Sbjct: 224 QVYELLEKDYRMERPEGCPEK-------------VYELMRACWQWNPSDRPSFAEIHQAF 270
Query: 341 SQI 343
+
Sbjct: 271 ETM 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 1e-35
Identities = 58/306 (18%), Positives = 117/306 (38%), Gaps = 61/306 (19%)
Query: 53 LEKIGSGGCGEVYKAEL--PGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
+ IG+G GEV L PG+ ++IK +
Sbjct: 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--------------------------KS 64
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILND-----VSQGRRE 162
K+ R SE + +GQ H N+ L VT+ ++ ++ N + Q +
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
+ + G+A G++YL + +HRDL N+L++ ++ ++S FG +R + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 223 HTHITTSNVVG---TVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHT 277
+ T ++ +G + + APE +Q T D++ +G ++ ++ G+ P +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDM 237
Query: 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337
+ + P + + ++ C +D N RP +
Sbjct: 238 TNQDVINAIEQDYRLPPPMDCPSA-------------LHQLMLDCWQKDRNHRPKFGQIV 284
Query: 338 RMLSQI 343
L ++
Sbjct: 285 NTLDKM 290
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-35
Identities = 56/301 (18%), Positives = 102/301 (33%), Gaps = 61/301 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+++G+G G V + G ++IK I K+ +
Sbjct: 9 LKELGTGQFGVVKYGKWRG--QYDVAIKMI-------------------KEGSMSE---- 43
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY--------ILNDVSQGRRELD 164
+ E + + H L L T+ + +LN + + R
Sbjct: 44 -----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 98
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ + +EYL +HRDL N L++D ++S FG +R + D
Sbjct: 99 TQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLV-MGKLPSDKFFQHTNEMSF 282
++ V + PE L + K DI+ FG L+ + +GK+P ++
Sbjct: 156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFTNSET 210
Query: 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342
+ + + P A + V I C E +ERP K + +
Sbjct: 211 AEHIAQGLRLYRPHLASEK-------------VYTIMYSCWHEKADERPTFKILLSNILD 257
Query: 343 I 343
+
Sbjct: 258 V 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-35
Identities = 60/297 (20%), Positives = 106/297 (35%), Gaps = 64/297 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+G G G VY A Q+ ++++K + Q++
Sbjct: 11 GRPLGKGKFGNVYLAREK-QSKFILALKVL--------------------FKAQLEKA-- 47
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDW 165
Q++ E+ +RH N+ L + L + + Q + D
Sbjct: 48 --GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 105
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
LA L Y H R+IHRD+ P N+LL E +I+ FG++ P +
Sbjct: 106 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
+ GT++Y+ PE ++ EK D++ G L ++GK P F+ K
Sbjct: 163 ----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYK 214
Query: 285 WMRNV---MASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ V + A D L+ + +P++RP ++V
Sbjct: 215 RISRVEFTFPDFVTEGARD-------------LISR----LLKHNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-35
Identities = 63/295 (21%), Positives = 109/295 (36%), Gaps = 54/295 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++ +G G GEV A +++K + + K
Sbjct: 10 VQTLGEGAYGEVQLAVNR-VTEEAVAVKIV------------------DMKRAV------ 44
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDW 165
I+ EI + H N+ H + L++ L D + +
Sbjct: 45 --DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE 102
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
R L G+ YLH I HRD+ P N+LLD+ +IS FG A +
Sbjct: 103 PDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 226 ITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+ + GT+ Y+APE L+ E D++ G +L ++ G+LP + Q ++
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEY 216
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ NP + IDS + L+ K +E+P+ R D+++
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLA--------LLHK----ILVENPSARITIPDIKK 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 8e-35
Identities = 54/300 (18%), Positives = 110/300 (36%), Gaps = 52/300 (17%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ IG+G GEVYK L +G+ I K ++ +E
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAI-------------------KTLKAGYTE--- 50
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY--------ILNDVSQGRRELDW 165
K+ E +GQ H N+ L +++ ++ + + + E
Sbjct: 51 -KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV 109
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
L + G+A G++Y +HRDL N+L++ ++ ++S FG +R + D
Sbjct: 110 LQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166
Query: 226 I-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
TTS + + APE + T D++ FG ++ ++ + + +
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVM 223
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
K + + P + + ++ C ++ RP D+ +L ++
Sbjct: 224 KAINDGFRLPTPMDCPSA-------------IYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 8e-35
Identities = 66/297 (22%), Positives = 112/297 (37%), Gaps = 61/297 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +IG G G VY A +N +++IKK+ QS
Sbjct: 20 LREIGHGSFGAVYFARDV-RNSEVVAIKKM--------------------SYSGKQS--- 55
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDW 165
N+K + I E+ + ++RH N R L + + + ++ L
Sbjct: 56 -NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
+ + G GL YLH H+ +IHRD+ N+LL + ++ FG A + A++
Sbjct: 115 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS- 170
Query: 226 ITTSNVVGTVEYIAPEYLQMLT---LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
VGT ++APE + + K D++ G L K P + N MS
Sbjct: 171 -----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMS 221
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ ++ +N A+ S V C + P +RP S+ + +
Sbjct: 222 ---ALYHIA--QNESPALQSGHWSEYFRN---FVDS----CLQKIPQDRPTSEVLLK 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 9e-35
Identities = 60/303 (19%), Positives = 104/303 (34%), Gaps = 67/303 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ IG G G+V + G +++K I K
Sbjct: 12 LQTIGKGEFGDVMLGDY---RGNKVAVKCI-------------------KN--------- 40
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDV----------SQGRRE 162
+ + +E + + Q+RH NL LL + L + + S+GR
Sbjct: 41 -DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 99
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
L + +L + +EYL ++ +HRDL NVL+ +D A++S FG +
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
V++ APE L+ + K D++ FG LL + +
Sbjct: 157 QDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKD 208
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLS 341
V + + P + V ++ C D RP+ +R L
Sbjct: 209 VVPRVEKGYKMDAPDGCPPA-------------VYEVMKNCWHLDAAMRPSFLQLREQLE 255
Query: 342 QIQ 344
I+
Sbjct: 256 HIK 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-34
Identities = 54/300 (18%), Positives = 102/300 (34%), Gaps = 62/300 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ ++G G G+VYKA+ + + + K I + K +
Sbjct: 17 IGELGDGAFGKVYKAQNK-ETSVLAAAKVI------------------DTKSEE------ 51
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY--------ILNDVSQGRRELD 164
++ EI+ + H N+ LL + + + + + R L
Sbjct: 52 ---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT 108
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ L YLH + IIHRDL N+L D + +++ FG +
Sbjct: 109 ESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165
Query: 225 HITTSNVVGTVEYIAPEYLQMLTL-----TEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278
+ +GT ++APE + T K D++ G L + + P N
Sbjct: 166 RRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELN 219
Query: 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
M + + + SE P A S+ + K C ++ + R + + +
Sbjct: 220 PM---RVLLKIAKSEPPTLAQPSRW----SSNFKDFLKK----CLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-34
Identities = 48/298 (16%), Positives = 98/298 (32%), Gaps = 60/298 (20%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+IG G VYK + ++ ++ Q L
Sbjct: 15 IEIGRGSFKTVYKGLDT-ETTVEVAWCEL-------------------------QDRKLT 48
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLA--HVTRPDCHLLYI---------LNDVSQGRRE 162
+ ++ + E + ++H N+ T + + L + +
Sbjct: 49 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV 108
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDD-DIEARISGFGFARAIPD 221
+ + GL++LH P IIHRDL N+ + +I G A
Sbjct: 109 MKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
+ V+GT E++APE + E D+Y FG + + + P + + N
Sbjct: 168 SFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP---YSECQNAA 219
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ + + + + + ++ +I C ++ +ER + KD+
Sbjct: 220 QIYRRVTSGVKPASFDKVAIPEVK------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-34
Identities = 57/301 (18%), Positives = 103/301 (34%), Gaps = 59/301 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+++IGSG G V+ N ++IK I ++ +
Sbjct: 10 VQEIGSGQFGLVHLGYWL--NKDKVAIKTI-------------------REGAMSE---- 44
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRREL-D 164
E + ++ H L L L L+D + +R L
Sbjct: 45 -----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA 99
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ L + G+ YL +IHRDL N L+ ++ ++S FG R + D
Sbjct: 100 AETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+T V++ +PE + K D++ FG L+ + +++ + V
Sbjct: 157 TSSTG-TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVV 212
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
+ + P+ A V +I C E P +RP + R L++I
Sbjct: 213 EDISTGFRLYKPRLASTH-------------VYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
Query: 344 Q 344
Sbjct: 260 A 260
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-34
Identities = 63/302 (20%), Positives = 104/302 (34%), Gaps = 51/302 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEK+G G G V + E +G+ +S+ K ++ +
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAV--------------------KCLKP--DVLS 50
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY-------ILNDVSQGRRELDW 165
+ M E+N + + HRNL L V P ++ +L+ + + +
Sbjct: 51 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL 110
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
R A+ +A G+ YL IHRDL N+LL +I FG RA+P H
Sbjct: 111 GTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 226 IT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSF 282
+ + APE L+ T + D + FG L + G+ P +
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQIL 224
Query: 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQ 342
K + P+ + + C P +RP +R L +
Sbjct: 225 HKIDKEGERLPRPEDCPQD-------------IYNVMVQCWAHKPEDRPTFVALRDFLLE 271
Query: 343 IQ 344
Q
Sbjct: 272 AQ 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-33
Identities = 46/299 (15%), Positives = 103/299 (34%), Gaps = 55/299 (18%)
Query: 55 KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLN 114
++G G G V + + ++ K+ L + + +E ++
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKV-----------------LKQGTEKADTEEMMR 58
Query: 115 KKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY-------ILNDVSQGRRELDWLA 167
E + Q+ + + L+ L+ + + R E+
Sbjct: 59 --------EAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN 110
Query: 168 RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI-PDAHTHI 226
+ ++ G++YL + +HRDL NVLL + A+IS FG ++A+ D +
Sbjct: 111 VAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167
Query: 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAG-LVMGKLPSDKFFQHTNEMSFVK 284
S +++ APE + + + D++ +G + L G+ P ++ +
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEVMA 223
Query: 285 WMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
++ E P + + C + +RP+ V + +
Sbjct: 224 FIEQGKRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-32
Identities = 59/300 (19%), Positives = 106/300 (35%), Gaps = 52/300 (17%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G V A R +IK + + R I E
Sbjct: 13 GKILGEGSFSTVVLAREL-ATSREYAIKIL--------------------EKRHIIKE-- 49
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHR-- 170
K+ + E + + ++ H L + LY ++ L ++ +
Sbjct: 50 --NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSF 105
Query: 171 ----IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI 226
A + L H IIHRDL P N+LL++D+ +I+ FG A+ +
Sbjct: 106 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKW 285
++ VGT +Y++PE L + + D++ G ++ LV G P F+ NE
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLI--- 218
Query: 286 MRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345
+ ++ E K + LV K + D +R +++ H
Sbjct: 219 FQKIIKLEYD---FPEKF----FPKARDLVEK----LLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-32
Identities = 59/295 (20%), Positives = 116/295 (39%), Gaps = 59/295 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
EKIG G G VY A G+ ++I+++ +Q + E++
Sbjct: 25 FEKIGQGASGTVYTAMDV-ATGQEVAIRQM-------------------NLQQQPKKELI 64
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------RRELD 164
+N EI + + ++ N+ L D L+++ + G +D
Sbjct: 65 IN--------EILVMRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMD 114
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+ LE+LH + +IHRD+ N+LL D +++ FGF I +
Sbjct: 115 EGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 225 HITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+T +VGT ++APE + K DI+ G + ++ G+ P + + N +
Sbjct: 172 KRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPL--- 222
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ + + + P+ KL + + C D +R ++K++ +
Sbjct: 223 RALYLIATNGTPELQNPEKL----SAIFRDFLNR----CLDMDVEKRGSAKELLQ 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-32
Identities = 67/321 (20%), Positives = 114/321 (35%), Gaps = 74/321 (23%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +GSG G+V A G + +SI+ V K +++
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAV------------------KMLKEKADS-- 81
Query: 113 LNKKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRE-- 162
+ + SE+ + Q+ H N+ LL T L L + + +RE
Sbjct: 82 --SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKF 139
Query: 163 ---------------------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL 201
L + A +A G+E+L +HRDL NVL
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVL 196
Query: 202 LDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALL 260
+ +I FG AR I ++ N V+++APE L T K D++ +G LL
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256
Query: 261 AGLV-MGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIA 319
+ +G P + + +F K ++N + P A + + I
Sbjct: 257 WEIFSLGVNP---YPGIPVDANFYKLIQNGFKMDQPFYATEE-------------IYIIM 300
Query: 320 CFCTLEDPNERPNSKDVRRML 340
C D +RP+ ++ L
Sbjct: 301 QSCWAFDSRKRPSFPNLTSFL 321
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-32
Identities = 51/321 (15%), Positives = 102/321 (31%), Gaps = 74/321 (23%)
Query: 53 LEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
+ +G G G+V +A+ G R +++K +
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-------------------------- 51
Query: 109 SEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG--------- 159
E + + R + SE+ + I H L L ++ + +
Sbjct: 52 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 111
Query: 160 ----------------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203
+ L + +A G+E+L IHRDL N+LL
Sbjct: 112 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168
Query: 204 DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAG 262
+ +I FG AR I ++ + ++++APE + T + D++ FG LL
Sbjct: 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228
Query: 263 LVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFC 322
+ + + F + ++ P + + C
Sbjct: 229 IFSLGASP--YPGVKIDEEFCRRLKEGTRMRAPDYTTPE-------------MYQTMLDC 273
Query: 323 TLEDPNERPNSKDVRRMLSQI 343
+P++RP ++ L +
Sbjct: 274 WHGEPSQRPTFSELVEHLGNL 294
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-31
Identities = 61/316 (19%), Positives = 104/316 (32%), Gaps = 72/316 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ IG G G+V KA + RM AA+ K+M++ S+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRM------------DAAI---------KRMKEYASK-- 51
Query: 113 LNKKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYI------------------- 152
R E+ + ++ H N+ LL L I
Sbjct: 52 --DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 109
Query: 153 ----LNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
+ L A +A G++YL + IHRDL N+L+ ++ A
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
+I+ FG +R ++ + V ++A E L T D++ +G LL +V
Sbjct: 167 KIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
Query: 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327
+ + + E P D V + C E P
Sbjct: 224 GT---PYCGMTCAELYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKP 267
Query: 328 NERPNSKDVRRMLSQI 343
ERP+ + L+++
Sbjct: 268 YERPSFAQILVSLNRM 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-31
Identities = 56/322 (17%), Positives = 105/322 (32%), Gaps = 75/322 (23%)
Query: 53 LEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
+ +G+G G+V +A G +++K + +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML------------------KPSAHLTE 69
Query: 109 SEMLLNKKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLL----------------- 150
E L++ E+ + + H N+ LL T L+
Sbjct: 70 REALMS--------ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 151 --------YILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202
+ LD + +A G+ +L + IHRDL N+LL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178
Query: 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLA 261
+I FG AR I + ++ N V+++APE + T + D++ +G L
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 262 GLVMGKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACF 321
L + + F K ++ +P+ A + I
Sbjct: 239 ELFSLGSS--PYPGMPVDSKFYKMIKEGFRMLSPEHAPAE-------------MYDIMKT 283
Query: 322 CTLEDPNERPNSKDVRRMLSQI 343
C DP +RP K + +++ +
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-31
Identities = 66/316 (20%), Positives = 111/316 (35%), Gaps = 64/316 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V AE G + + V A+ K ++ +E
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AV---------KMLKSDATE-- 59
Query: 113 LNKKMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLL--------------------- 150
K + + SE+ + I +H+N+ LL T+ +
Sbjct: 60 --KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 151 --YILNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEA 208
Y N +L A +A G+EYL IHRDL NVL+ +D
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 174
Query: 209 RISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGK 267
+I+ FG AR I + T+N V+++APE L T + D++ FG LL +
Sbjct: 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 234
Query: 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327
+ K ++ + P + + + C P
Sbjct: 235 GS---PYPGVPVEELFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVP 278
Query: 328 NERPNSKDVRRMLSQI 343
++RP K + L +I
Sbjct: 279 SQRPTFKQLVEDLDRI 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-31
Identities = 46/315 (14%), Positives = 106/315 (33%), Gaps = 67/315 (21%)
Query: 53 LEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQ 108
++G G G VY+ G + ++IK +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------------------------- 58
Query: 109 SEMLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI---------------- 152
+E ++ + +E + + + ++ LL V++ L+ +
Sbjct: 59 NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118
Query: 153 -LNDVSQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARIS 211
+ ++A +A G+ YL+ + +HRDL N ++ +D +I
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175
Query: 212 GFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270
FG R I + + + V +++PE L+ T D++ FG +L +
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ- 234
Query: 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNER 330
+Q + ++++ + P D + ++ C +P R
Sbjct: 235 --PYQGLSNEQVLRFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMR 279
Query: 331 PNSKDVRRMLSQIQH 345
P+ ++ + +
Sbjct: 280 PSFLEIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 8e-31
Identities = 49/299 (16%), Positives = 102/299 (34%), Gaps = 52/299 (17%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
IG G G+V++ +++ K + S+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAI--------------------KTCKNCTSD-- 49
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY-------ILNDVSQGRRELDW 165
+ E T+ Q H ++ L+ +T ++ + + + + LD
Sbjct: 50 --SVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDL 107
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
+ A L+ L R +HRD+ NVL+ + ++ FG +R + D+ +
Sbjct: 108 ASLILYAYQLSTAL---AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
+ ++++APE + T D++ FG + ++M + FQ +
Sbjct: 165 KASK-GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK---PFQGVKNNDVIG 220
Query: 285 WMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343
+ N P + + + C DP+ RP +++ LS I
Sbjct: 221 RIENGERLPMPPNCPPT-------------LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 2e-30
Identities = 51/308 (16%), Positives = 96/308 (31%), Gaps = 60/308 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
KIGSG G++Y G ++IK
Sbjct: 12 GRKIGSGSFGDIYLGTDI-AAGEEVAIKLE-----------------------------C 41
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI--------LNDVSQGRRELD 164
+ K Q+ E ++ P + + + + + + R+
Sbjct: 42 VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS 101
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVL---LDDDIEARISGFGFARAIPD 221
+A + +EY+H + IHRD+ P N L I FG A+ D
Sbjct: 102 LKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158
Query: 222 AHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275
A TH N+ GT Y + + + + D+ G +L +G LP
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218
Query: 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335
T + + K + +++ G + L C +++P+
Sbjct: 219 ATKRQKYERISE-------KKMSTPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSY 268
Query: 336 VRRMLSQI 343
+R++ +
Sbjct: 269 LRQLFRNL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 4e-29
Identities = 40/310 (12%), Positives = 94/310 (30%), Gaps = 62/310 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+IG G G +++ N + ++IK
Sbjct: 10 GRRIGEGSFGVIFEGTNL-LNNQQVAIKFE-----------------------------P 39
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL--------NDVSQGRRELD 164
Q++ E T + P + + + H + ++ + + R+
Sbjct: 40 RRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS 99
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDI-----EARISGFGFARAI 219
A + ++ +H +++RD+ P N L+ + FG +
Sbjct: 100 VKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
Query: 220 PDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273
D T N+ GT Y++ + + D+ G + + G LP
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
Query: 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333
TN+ + + K++ + + G E+ + + P+
Sbjct: 217 KAATNKQKYERIGEK-------KQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDY 266
Query: 334 KDVRRMLSQI 343
++ + S++
Sbjct: 267 DYLQGLFSKV 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 109 bits (273), Expect = 2e-28
Identities = 60/307 (19%), Positives = 115/307 (37%), Gaps = 56/307 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E +G GG EV+ A + R +++K + + +
Sbjct: 12 GEILGFGGMSEVHLARDL-RLHRDVAVKVL--------------------RADLARDP-- 48
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVT--RPDCHLLYI---------LNDVSQGRR 161
+ + E + H + + P L YI L D+
Sbjct: 49 --SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG 106
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+ + L + H + IIHRD+ P N+++ ++ FG ARAI D
Sbjct: 107 PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 163
Query: 222 AHTHIT-TSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
+ +T T+ V+GT +Y++PE + ++ + D+Y G +L ++ G+ P F +
Sbjct: 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSP 219
Query: 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS-KDVRR 338
+S ++V P A L + +VLK ++P R + ++R
Sbjct: 220 VSV--AYQHVREDPIPPSARHEGL----SADLDAVVLK----ALAKNPENRYQTAAEMRA 269
Query: 339 MLSQIQH 345
L ++ +
Sbjct: 270 DLVRVHN 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-28
Identities = 59/294 (20%), Positives = 101/294 (34%), Gaps = 61/294 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G G G+V+ AE + + +IK + ++D +L++ + E
Sbjct: 7 HKMLGKGSFGKVFLAEFK-KTNQFFAIKAL-----------KKDVVLMDDDVECTMVEKR 54
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDW 165
+ H L + + + L Q + D
Sbjct: 55 VLSL------------AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL 102
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
A + GL++LH I++RDL N+LLD D +I+ FG +
Sbjct: 103 SRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
T GT +YIAPE L D + FG LL +++G+ P F +E
Sbjct: 160 TNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFH 213
Query: 285 WMRN---VMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335
+R K A D L++K + +P +R +
Sbjct: 214 SIRMDNPFYPRWLEKEAKD-------------LLVK----LFVREPEKRLGVRG 250
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 109 bits (274), Expect = 5e-28
Identities = 50/297 (16%), Positives = 97/297 (32%), Gaps = 59/297 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E++G+G G V++ G + K ++ P
Sbjct: 31 HEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHE------------------------- 64
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YILND-----VSQGRRELD 164
++ EI T+ +RH L L + ++ ++ V+ ++
Sbjct: 65 --SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS 122
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL--DDDIEARISGFGFARAIPDA 222
+ GL ++H ++ +H DL P N++ E ++ FG +
Sbjct: 123 EDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
+ T GT E+ APE + + D++ G L L+ G P F N+
Sbjct: 180 QSVKVT---TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDE 232
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
++ +++ +D E+ + K L DPN R
Sbjct: 233 TLRNVKSC------DWNMDDSAFSGISEDGKDFIRK----LLLADPNTRMTIHQALE 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 5e-28
Identities = 55/251 (21%), Positives = 92/251 (36%), Gaps = 48/251 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +G+G G V+ NGR ++K + K +
Sbjct: 9 LRTLGTGSFGRVHLIRSR-HNGRYYAMKVL--------------------KKEIVVRL-- 45
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL-------YILNDVSQGRRELDW 165
K++ E + + H + + + L + + +
Sbjct: 46 --KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN 103
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
A + LEYLH II+RDL P N+LLD + +I+ FGFA+ +PD
Sbjct: 104 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY- 159
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
+ GT +YIAPE + + D + FG L+ ++ G P F +N M K
Sbjct: 160 ----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTM---K 208
Query: 285 WMRNVMASENP 295
++ +E
Sbjct: 209 TYEKILNAELR 219
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 106 bits (266), Expect = 2e-27
Identities = 52/301 (17%), Positives = 104/301 (34%), Gaps = 54/301 (17%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E +G G V + + ++K I + S
Sbjct: 8 KEILGRGVSSVVRRCIHK-PTCKEYAVKII------------------DVTGGGSFSAEE 48
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI--------LNDVSQGRRELD 164
+ + E++ + ++ L + + L D + L
Sbjct: 49 VQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS 108
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
+I L + LH + I+HRDL P N+LLDDD+ +++ FGF+ +
Sbjct: 109 EKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE- 164
Query: 225 HITTSNVVGTVEYIAPEYLQMLTL------TEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277
V GT Y+APE ++ ++ D++ G ++ L+ G P F H
Sbjct: 165 --KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHR 218
Query: 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVR 337
+M +R +M+ + + + ++ LV + + P +R +++
Sbjct: 219 KQM---LMLRMIMSGNYQFGSPEWDDYSDTVKD---LVSR----FLVVQPQKRYTAEEAL 268
Query: 338 R 338
Sbjct: 269 A 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 8e-27
Identities = 61/310 (19%), Positives = 112/310 (36%), Gaps = 55/310 (17%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ +G G VYKA ++++IKKI K + +++
Sbjct: 3 LDFLGEGQFATVYKARDK-NTNQIVAIKKI-------------------KLGHRSEAKDG 42
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL-------YILNDVSQGRRELDW 165
+N R EI + ++ H N+ LL L + + L
Sbjct: 43 IN---RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP 99
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
L GLEYLH H I+HRDL P N+LLD++ +++ FG A++ +
Sbjct: 100 SHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156
Query: 226 ITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
T + V T Y APE L + D++ G +LA L++ +++ +
Sbjct: 157 YT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQL 210
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACF--------------CTLEDPNE 329
+ + + ++ D + + + + + L +P
Sbjct: 211 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 270
Query: 330 RPNSKDVRRM 339
R + +M
Sbjct: 271 RITATQALKM 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-26
Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 64/314 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L IG G G V A N ++IKKI S
Sbjct: 13 LSYIGEGAYGMVCSAYDN-VNKVRVAIKKI--------------------------SPFE 45
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH---LLYILNDVSQG-------RRE 162
++ EI + + RH N+ + + P +Y++ + +
Sbjct: 46 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH 105
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
L + GL+Y+H + ++HRDL P N+LL+ + +I FG AR
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162
Query: 223 HTHITT-SNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLP---------- 269
H H + V T Y APE + T+ DI+ G +LA ++ +
Sbjct: 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222
Query: 270 -------SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFC 322
+ N + +K +++ + + ++L N + + L+ K+ F
Sbjct: 223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF- 281
Query: 323 TLEDPNERPNSKDV 336
+P++R +
Sbjct: 282 ---NPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 55/307 (17%), Positives = 104/307 (33%), Gaps = 51/307 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +IG G G+V+KA GR +++K++ Q E +
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRV---------------------RVQTGEEGM 50
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH---LLYILNDVSQG---------- 159
+R++ + + H N+ L T L ++ +
Sbjct: 51 PLSTIREVA-VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP 109
Query: 160 RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+ + L GL++LH H ++HRDL P N+L+ + +++ FG AR
Sbjct: 110 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 166
Query: 220 PDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSD------- 271
+ VV T+ Y APE L + D++ G + A + K
Sbjct: 167 SFQMALTS---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223
Query: 272 --KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNE 329
K W R+V + ++ + + L + C +P +
Sbjct: 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
Query: 330 RPNSKDV 336
R ++
Sbjct: 284 RISAYSA 290
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-26
Identities = 52/297 (17%), Positives = 96/297 (32%), Gaps = 60/297 (20%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E +G G G V++ + + K + K
Sbjct: 10 AEDLGRGEFGIVHRCVET-SSKKTYMAKFV------------------KVK--------- 41
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY--------ILNDVSQGRRELD 164
++ EI+ + RHRN+ L + ++ I ++ EL+
Sbjct: 42 -GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN 100
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD--DDIEARISGFGFARAIPDA 222
+ L++LH H+ I H D+ P N++ +I FG AR +
Sbjct: 101 EREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
EY APE Q ++ D++ G L+ L+ G P F
Sbjct: 158 DNFRLL---FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQ- 209
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ + N+M N + D + E M V + +++ R + + +
Sbjct: 210 --QIIENIM---NAEYTFDEEAFKEISIEAMDFVDR----LLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (261), Expect = 2e-26
Identities = 52/294 (17%), Positives = 101/294 (34%), Gaps = 52/294 (17%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ +G+G EV AE + ++++IK I ++
Sbjct: 14 RDVLGTGAFSEVILAEDK-RTQKLVAIKCI--------------------------AKKA 46
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL---YI----LNDVSQGRRELDW 165
L K +++EI + +I+H N+ L L + L D +
Sbjct: 47 LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTE 106
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
R+ + ++YLH + N + LD+D + IS FG ++
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
S GT Y+APE L ++ D + G + L+ G P F N+ K
Sbjct: 165 -VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDA---K 216
Query: 285 WMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
++ +E + + + ++ + +DP +R + +
Sbjct: 217 LFEQILKAEYEFDSPYWDDISDSAKD---FIRH----LMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 105 bits (262), Expect = 3e-26
Identities = 50/297 (16%), Positives = 95/297 (31%), Gaps = 59/297 (19%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LE++GSG G V++ GR+ K I + +
Sbjct: 34 LEELGSGAFGVVHRCVEK-ATGRVFVAKFI-------------------NTPYPLDKYTV 73
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLY--------ILNDVSQGRRELD 164
N EI+ + Q+ H L L +L + + ++ ++
Sbjct: 74 KN--------EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 125
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD--DDIEARISGFGFARAIPDA 222
GL+++H H I+H D+ P N++ + +I FG A +
Sbjct: 126 EAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
T T E+ APE + + D++ G L L+ G P F +++
Sbjct: 183 EIVKVT---TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLE 235
Query: 282 FVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
++ ++ D + E + ++P +R D
Sbjct: 236 TLQNVKRC------DWEFDEDAFSSVSPEAKDFIKN----LLQKEPRKRLTVHDALE 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 7e-26
Identities = 47/243 (19%), Positives = 86/243 (35%), Gaps = 40/243 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ +G G G+V GR ++K + + I ++
Sbjct: 10 LKLLGKGTFGKVILVREK-ATGRYYAMKIL--------------------RKEVIIAK-- 46
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH--- 169
++ +E + RH L L D L + + + G L+R
Sbjct: 47 --DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVF 102
Query: 170 ---RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI 226
R A + L H +++RD+ N++LD D +I+ FG +
Sbjct: 103 TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 160
Query: 227 TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKW 285
T GT EY+APE L+ D + G ++ ++ G+LP F + + +
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFEL 216
Query: 286 MRN 288
+
Sbjct: 217 ILM 219
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 7e-26
Identities = 60/298 (20%), Positives = 105/298 (35%), Gaps = 54/298 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
E++GSG V K G + K I KK R S
Sbjct: 15 GEELGSGQFAVVKKCREK-STGLQYAAKFI-------------------KKRRTKSSRRG 54
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLL-------YILNDVSQGRRELDW 165
++++ I+ E++ + +I+H N+ L +L L D + L
Sbjct: 55 VSRE--DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE 112
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD----IEARISGFGFARAIPD 221
+ G+ + H +I H DL P N++L D +I FG A I
Sbjct: 113 EEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
+ N+ GT E++APE + L + D++ G + L+ G P F T +
Sbjct: 170 GN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQE 223
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ E+ + S L + + + ++DP +R +D +
Sbjct: 224 TLANVSAVNYEFEDEYFSNTSALAKD-------FIRR----LLVKDPKKRMTIQDSLQ 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (250), Expect = 1e-24
Identities = 39/244 (15%), Positives = 82/244 (33%), Gaps = 45/244 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
++ +G+G G V + ++G ++K + +++
Sbjct: 46 IKTLGTGSFGRVMLVKHK-ESGNHYAMKIL--------------------DKQKVVKL-- 82
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDW 165
K++ +E + + L L + + + +
Sbjct: 83 --KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
A + EYLH +I+RDL P N+L+D +++ FGFA+ +
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
+ GT E +APE + + D + G L+ + G P F + +
Sbjct: 198 LC-----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYE 248
Query: 285 WMRN 288
+ +
Sbjct: 249 KIVS 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 6e-24
Identities = 54/308 (17%), Positives = 107/308 (34%), Gaps = 65/308 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ IG+G G VY+A+L +G +++IKK+
Sbjct: 25 TKVIGNGSFGVVYQAKLC-DSGELVAIKKV------------------------------ 53
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRP----------------DCHLLYILNDV 156
+ R E+ + ++ H N+ L + +
Sbjct: 54 -LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY 112
Query: 157 SQGRRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDD-IEARISGFGF 215
S+ ++ L + L L Y+H I HRD+ P N+LLD D ++ FG
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 216 ARAIPDAHTHITTSNVVGTVEYIAP-EYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273
A+ + +++ + + Y AP T D++ G +LA L++G+
Sbjct: 170 AKQLVRGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI---- 222
Query: 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333
F + + + + V+ + ++ + E +K + + P P +
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMN---PNYTEFKFPQIKAHPWTKVFRPRTPPEA 279
Query: 334 KD-VRRML 340
R+L
Sbjct: 280 IALCSRLL 287
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 3e-23
Identities = 54/299 (18%), Positives = 99/299 (33%), Gaps = 66/299 (22%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+GSGG G VY + ++IK + +K R L
Sbjct: 9 GPLLGSGGFGSVYSGIRV-SDNLPVAIKHV-------------------EKDRISDWGEL 48
Query: 113 LNKKMRQIQSEINTVGQIR--HRNLHPLLAHVTRPDCHLLYI--------LNDVSQGRRE 162
++ E+ + ++ + LL RPD +L + L D R
Sbjct: 49 --PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 106
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPD 221
L + + + H ++HRD+ N+L+D + E ++ FG + D
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQHTNE 279
+ GT Y PE+++ ++ G LL +V G +P F+H E
Sbjct: 164 TVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEE 215
Query: 280 MSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338
+ + S + I C P++RP ++++
Sbjct: 216 IIRGQVFFRQRVSSECQHLIRW--------------------CLALRPSDRPTFEEIQN 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.3 bits (239), Expect = 4e-23
Identities = 60/290 (20%), Positives = 94/290 (32%), Gaps = 53/290 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
IG GG GEVY G+M ++K + K+++ Q E L
Sbjct: 9 HRIIGRGGFGEVYGCRKA-DTGKMYAMKCL-----------------DKKRIKMKQGETL 50
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDW 165
+ ++ V + + PD + L+
Sbjct: 51 A----LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 106
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
A + GLE++H +++RDL P N+LLD+ RIS G A H
Sbjct: 107 ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 163
Query: 226 ITTSNVVGTVEYIAPEYLQ-MLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+ GT Y+APE LQ + D + G +L L+ G P F QH +
Sbjct: 164 ASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKHE 216
Query: 284 KWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333
+ + + +L L+ D N R
Sbjct: 217 IDRMTLTMAVELPDSFSPELRS--------LLEG----LLQRDVNRRLGC 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 5e-23
Identities = 59/305 (19%), Positives = 105/305 (34%), Gaps = 47/305 (15%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L KIG G GEV+KA + G+ +++KK+ E
Sbjct: 15 LAKIGQGTFGEVFKARHR-KTGQKVALKKV-------------------------LMENE 48
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDC------HLLYILNDVSQG------R 160
EI + ++H N+ L+ +Y++ D +
Sbjct: 49 KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 108
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIP 220
L I + L L+ H +I+HRD+ NVL+ D +++ FG ARA
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168
Query: 221 DAHTHITT--SNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
A +N V T+ Y PE L D++ G ++A + Q
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQG 224
Query: 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD- 335
E + + + S P+ + + +++ K L+ P + D
Sbjct: 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
Query: 336 VRRML 340
+ ++L
Sbjct: 285 IDKLL 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (226), Expect = 8e-22
Identities = 53/295 (17%), Positives = 102/295 (34%), Gaps = 41/295 (13%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEKIG G G V+KA+ + ++++K++ D
Sbjct: 7 LEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDD------------------------ 41
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARH--- 169
EI + +++H+N+ L + L ++ D
Sbjct: 42 -EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP 100
Query: 170 -RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITT 228
+ L L+ L H ++HRDL P N+L++ + E +++ FG ARA
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--Y 158
Query: 229 SNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVKWM 286
S V T+ Y P+ L + D++ G + A L P F + +K +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRI 215
Query: 287 RNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD-VRRML 340
++ + ++ + + M P +D ++ +L
Sbjct: 216 FRLLGTPTEEQWPSMTKLPDYKPYPM---YPATTSLVNVVPKLNATGRDLLQNLL 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 2e-21
Identities = 64/315 (20%), Positives = 112/315 (35%), Gaps = 68/315 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+EKIG G G VYKA G ++++KKI + +
Sbjct: 7 VEKIGEGTYGVVYKARNK-LTGEVVALKKI-------------------------RLDTE 40
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI--------LNDVSQGRRELD 164
EI+ + ++ H N+ LL + + L + +
Sbjct: 41 TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP 100
Query: 165 WLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHT 224
L GL + H H ++HRDL P N+L++ + +++ FG ARA
Sbjct: 101 LPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157
Query: 225 HITTSNVVGTVEYIAPE-YLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
T V T+ Y APE L + DI+ G + A +V + F +E+
Sbjct: 158 TYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQ 211
Query: 283 VKWMRNVMASENP-------------------KRAIDSKLVGNGCEEQMLLVLKIACFCT 323
+ + + + + R SK+V E+ L+ ++ +
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY-- 269
Query: 324 LEDPNERPNSKDVRR 338
DPN+R ++K
Sbjct: 270 --DPNKRISAKAALA 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 3e-21
Identities = 61/301 (20%), Positives = 109/301 (36%), Gaps = 51/301 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ +GSG G V A + G ++IKK+ R QSE+
Sbjct: 23 LQPVGSGAYGAVCSAVDG-RTGAKVAIKKL---------------------YRPFQSELF 60
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCH-----------LLYILNDVSQGRR 161
++ E+ + +RH N+ LL T + +
Sbjct: 61 A----KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE 116
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+L + + GL Y+H HRDL P N+ +++D E +I FG AR
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
T VV L + T+ DI+ G ++A ++ GK F+ ++ +
Sbjct: 174 EM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHL 225
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD-VRRM 339
+K + V + + + + L L+ F ++ N P + + + +M
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKM 284
Query: 340 L 340
L
Sbjct: 285 L 285
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 4e-21
Identities = 46/302 (15%), Positives = 98/302 (32%), Gaps = 65/302 (21%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +G G G+V + + ++K + + + + E+ L
Sbjct: 18 QVLGLGINGKVLQIFNK-RTQEKFALKML-------------------QDCPKARREVEL 57
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLA--HVTRPDCHLLYI---------LNDV--SQGR 160
+ + + ++ ++ L I L +G
Sbjct: 58 HWRA------------SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 105
Query: 161 RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE---ARISGFGFAR 217
+ I + ++YLH + I HRD+ P N+L +++ FGFA+
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162
Query: 218 AIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276
++ T T Y+APE L + CD++ G ++ L+ G P F
Sbjct: 163 ETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYS 215
Query: 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336
+ ++ M+ + + + EE +L+ +P +R +
Sbjct: 216 NHGLAISPGMKTRIRMGQYE--FPNPEWSEVSEEVKMLIRN----LLKTEPTQRMTITEF 269
Query: 337 RR 338
Sbjct: 270 MN 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 89.2 bits (220), Expect = 6e-21
Identities = 62/313 (19%), Positives = 105/313 (33%), Gaps = 66/313 (21%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
LEKIG G G VYKA+ G ++KKI + E
Sbjct: 7 LEKIGEGTYGVVYKAQN--NYGETFALKKI-------------------------RLEKE 39
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYI-------LNDVSQGRRELDW 165
EI+ + +++H N+ L + +L + L+
Sbjct: 40 DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES 99
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
+ L L G+ Y H ++HRDL P N+L++ + E +I+ FG ARA
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF-GIPVR 155
Query: 226 ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFVK 284
T +V + + DI+ G + A +V G F +E +
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLM 211
Query: 285 WMRNVMASENPKRAID-------------------SKLVGNGCEEQMLLVLKIACFCTLE 325
+ ++ + N K + + E + L+ K+
Sbjct: 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL---- 267
Query: 326 DPNERPNSKDVRR 338
DPN+R +K
Sbjct: 268 DPNQRITAKQALE 280
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 8e-21
Identities = 56/291 (19%), Positives = 109/291 (37%), Gaps = 48/291 (16%)
Query: 53 LEKIGSGGCGEVYKAELPG--QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSE 110
L+ +G+G G+V+ G++ ++K + KK +Q
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL-------------------KKATIVQKA 69
Query: 111 MLLNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL-----NDVSQGRRELDW 165
K ++E + IR L + + + L IL ++ + +
Sbjct: 70 ----KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER 125
Query: 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH 225
H + + + + L H II+RD+ N+LLD + ++ FG ++ T
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
Query: 226 ITTSNVVGTVEYIAPEYLQML--TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSF 282
+ GT+EY+AP+ ++ + D + G L+ L+ G P F + S
Sbjct: 186 RAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQ 241
Query: 283 VKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNS 333
+ R ++ SE P S L + L+ + ++DP +R
Sbjct: 242 AEISRRILKSEPPYPQEMSALAKD-------LIQR----LLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 89.1 bits (220), Expect = 9e-21
Identities = 48/257 (18%), Positives = 92/257 (35%), Gaps = 48/257 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ K+G G EV++A N + +K + K ++I+ E+
Sbjct: 40 VRKLGRGKYSEVFEAINI-TNNEKVVVKIL-----------------KPVKKKKIKREIK 81
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYIL------NDVSQGRRELDWL 166
+ + +R N+ L V P ++ D Q + L
Sbjct: 82 ILENLRG------------GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY 129
Query: 167 ARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTH 225
+ L+Y H I+HRD+ P NV++D + + R+ +G A +
Sbjct: 130 DIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 226 ITTSNVVGTVEYIAPE-YLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMSFV 283
+ V + + PE + D++ G +LA ++ K P FF + +
Sbjct: 187 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQL 240
Query: 284 KWMRNVMASENPKRAID 300
+ V+ +E+ ID
Sbjct: 241 VRIAKVLGTEDLYDYID 257
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.3 bits (220), Expect = 1e-20
Identities = 47/254 (18%), Positives = 93/254 (36%), Gaps = 12/254 (4%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
+ K+G G V+ A+ N +++K + G + A +E +L +++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDKVYTEAAEDEIKLL--QRVNDADNTKE 74
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIA 172
+ I ++ +H ++ + L I R + + +I+
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK---YEHRGIPLIYVKQIS 131
Query: 173 LGLACGLEYLHMHHCPRIIHRDLNPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNV 231
L GL+Y+H IIH D+ P NVL++ D + A +N
Sbjct: 132 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 232 VGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP--SDKFFQHTNEMSFVKWMRN 288
+ T EY +PE L DI+ L+ L+ G D+ +T + + +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 289 VMASENPKRAIDSK 302
++ + K
Sbjct: 250 LLGELPSYLLRNGK 263
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.3 bits (202), Expect = 3e-18
Identities = 55/255 (21%), Positives = 96/255 (37%), Gaps = 47/255 (18%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L+ IGSG G V A R ++IKK+ P +
Sbjct: 22 LKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQN------------------------ 56
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQG------RRE 162
++ E+ + + H+N+ LL T +Y++ ++ + E
Sbjct: 57 -QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME 115
Query: 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDA 222
LD + + CG+++LH IHRDL P N+++ D +I FG AR
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTA--- 169
Query: 223 HTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEMS 281
T + V T Y APE + + E DI+ G ++ +V K+ F + +
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYID 225
Query: 282 FVKWMRNVMASENPK 296
+ + + P+
Sbjct: 226 QWNKVIEQLGTPCPE 240
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 2e-17
Identities = 55/301 (18%), Positives = 107/301 (35%), Gaps = 51/301 (16%)
Query: 53 LEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEML 112
L +GSG G V A + G +++KK+ ++ + I
Sbjct: 23 LSPVGSGAYGSVCAAFDT-KTGLRVAVKKL------------------SRPFQSI----- 58
Query: 113 LNKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQG-------RR 161
++ E+ + ++H N+ LL T + +Y++ + +
Sbjct: 59 --IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116
Query: 162 ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPD 221
+L + + GL+Y+H HRDL P N+ +++D E +I FG AR
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHT-- 171
Query: 222 AHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280
T V L + + DI+ G ++A L+ G+ F T+ +
Sbjct: 172 --DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHI 225
Query: 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD-VRRM 339
+K + ++ + + Q L + F + P + D + +M
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKM 284
Query: 340 L 340
L
Sbjct: 285 L 285
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 62.1 bits (150), Expect = 4e-12
Identities = 19/166 (11%), Positives = 52/166 (31%), Gaps = 19/166 (11%)
Query: 54 EKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLL 113
+ +G G V+ +K + S K+ R
Sbjct: 6 KLMGEGKESAVFNCYSE--KFGECVVKFH---------KVGHTSFKKVKEKRDYGDLHFS 54
Query: 114 NKKMRQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRELDWLARHRIAL 173
+R ++E + +++ + + A + + + + ++ + +
Sbjct: 55 VLAIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRVRVENPDEVLD 110
Query: 174 GLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAI 219
+ + + I+H DL+ NVL+ ++ I F + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 345 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.76 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.72 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.42 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=372.83 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=195.9
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+|+.+.++|++.+.||+|+||.||+|+++ ..||||.+.....+. ...+.|.
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~-------------------------~~~~~~~ 52 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTP-------------------------QQLQAFK 52 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCT-------------------------THHHHHH
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCH-------------------------HHHHHHH
Confidence 46678899999999999999999999864 249999997543332 2356788
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.++++++|||||++++++..+ .+++++||+++|+ .+++..+..++.|+++||.|||+++ |+
T Consensus 53 ~E~~~l~~l~HpnIv~~~~~~~~~---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iv 126 (276)
T d1uwha_ 53 NEVGVLRKTRHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---II 126 (276)
T ss_dssp HHHHHHTTCCCTTBCCEEEEECSS---SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHHhCCCCCEeeeeEEEecc---EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---Ee
Confidence 999999999999999999987654 3788999998754 3677788899999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc---ccCccchhh-HHHHHHHHHhCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML---TLTEKCDIY-FGALLAGLVMGK 267 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~---~~~~~~Dvw-lG~vl~el~tg~ 267 (345)
||||||+|||++.++.+||+|||+|+...............||+.|||||++.+. +++.++||| ||+++|||+||.
T Consensus 127 HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~ 206 (276)
T d1uwha_ 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206 (276)
T ss_dssp CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence 9999999999999999999999999876544333344567899999999999643 478999999 999999999999
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.||.+.. ........+......+... .....+...+.++|.+||+.||++|||+.+|++.|+.|+
T Consensus 207 ~Pf~~~~---~~~~~~~~~~~~~~~p~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 207 LPYSNIN---NRDQIIFMVGRGYLSPDLS---------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CTTTTCC---CHHHHHHHHHHTSCCCCGG---------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC---hHHHHHHHHhcCCCCCcch---------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 9975432 2222333333222111110 111222345778999999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-53 Score=369.30 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=201.7
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+|+.+.++|++++.||+|+||.||+|+++ ++..||||.+...... .+.+.
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~----------------------------~~~~~ 56 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS----------------------------PDAFL 56 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC----------------------------HHHHH
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCcCC----------------------------HHHHH
Confidence 57778899999999999999999999975 6788999999653222 34688
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|+.++++++|||||++++++..++ +++++||+++|++ +++..+.+++.|+++||.|||+.+ +
T Consensus 57 ~E~~~l~~l~HpnIv~~~g~~~~~~---~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---i 130 (272)
T d1qpca_ 57 AEANLMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130 (272)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSS---CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHhCCCCCEeEEEeeeccCC---eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 9999999999999999999876543 6889999998764 677788899999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||||||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++||| ||+++|||+||..|
T Consensus 131 vHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~ 209 (272)
T d1qpca_ 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209 (272)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCC
Confidence 99999999999999999999999999887654322 23456789999999999998999999999 99999999996555
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+ +......+....+........+ + .....+.++|.+||+.||++|||+++|++.|+.+
T Consensus 210 ~---~~~~~~~~~~~~i~~~~~~~~p----------~---~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 210 P---YPGMTNPEVIQNLERGYRMVRP----------D---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp S---STTCCHHHHHHHHHTTCCCCCC----------T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---CCCCCHHHHHHHHHhcCCCCCc----------c---cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 3 3333344444444332222111 1 1223477889999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-53 Score=373.39 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=204.3
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
.|+.+.++|++.+.||+|+||.||+|+++ .+|..||||.+...... .+++.
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~----------------------------~~~~~ 61 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTME----------------------------VEEFL 61 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTCSC----------------------------HHHHH
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCccch----------------------------HHHHH
Confidence 47788899999999999999999999975 46899999998643221 45688
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|+.++++++|||||++++++..++ .+++++||+++|++ +++..+..++.|++.||.|||+++ |
T Consensus 62 ~E~~il~~l~HpnIv~~~~~~~~~~--~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---i 136 (287)
T d1opja_ 62 KEAAVMKEIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 136 (287)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHhCCCCCEecCCccEeeCC--eeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 9999999999999999999998776 67889999988654 566677889999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||||||+|||++.++.+||+|||+|+........ ......|++.|+|||++.+..++.++||| ||+++|||++|..|
T Consensus 137 iHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p 215 (287)
T d1opja_ 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215 (287)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543322 23445689999999999999999999999 99999999997776
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
| +...+.......+......+.+ ......+.++|..||+.||++|||+++|++.|+.+.
T Consensus 216 ~---~~~~~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 216 P---YPGIDLSQVYELLEKDYRMERP-------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp S---STTCCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred C---CCcchHHHHHHHHhcCCCCCCC-------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4 3333444444444332221111 112234778999999999999999999999998874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-53 Score=367.47 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=191.1
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
.+.++|++++.||+|+||.||+|+++ ++..||||.+...... .+.+.+|+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~----------------------------~~~~~~E~ 51 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS----------------------------EEDFIEEA 51 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSSSC----------------------------HHHHHHHH
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCcCc----------------------------HHHHHHHH
Confidence 35679999999999999999999975 6788999999653222 34578999
Q ss_pred HHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.++++++|||||++++++..++ .+++++||+.+|++ +++..+..++.|++.||.|||+.+ ++|||
T Consensus 52 ~~l~~l~HpnIv~~~g~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrD 126 (263)
T d1sm2a_ 52 EVMMKLSHPKLVQLYGVCLEQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 126 (263)
T ss_dssp HHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTT
T ss_pred HHHHhcCCCCcccccceeccCC--ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecc
Confidence 9999999999999999998776 57889999988654 566677889999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhC-CCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMG-KLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg-~~p~~~ 272 (345)
|||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||| ||+++|||+|+ .+||
T Consensus 127 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~-- 203 (263)
T d1sm2a_ 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY-- 203 (263)
T ss_dssp CSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT--
T ss_pred cchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC--
Confidence 9999999999999999999999876543322 22346789999999999999999999999 99999999995 5553
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhhC
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQH 345 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~~ 345 (345)
......+....+........+. .+...+.++|..||+.||++|||+++|++.|++|.|
T Consensus 204 --~~~~~~~~~~~i~~~~~~~~p~-------------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 204 --ENRSNSEVVEDISTGFRLYKPR-------------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp --CSCCHHHHHHHHHHTCCCCCCT-------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCHHHHHHHHHhcCCCCCcc-------------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 3334445555554433222111 112347789999999999999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=365.35 Aligned_cols=245 Identities=23% Similarity=0.335 Sum_probs=191.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|++++.||+|+||+||+|+++ .+|+.||||.+..... .+..+.+.+|+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~--------------------------~~~~~~~~~Ei~~ 56 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRA--------------------------VDCPENIKKEICI 56 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC---------------------------------CHHHHHHH
T ss_pred CcceEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhc--------------------------chHHHHHHHHHHH
Confidence 358999999999999999999965 5799999999864321 1124567899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+++++|||||++++++.+++ .++++|||+++|++ +++..+..++.|+++||.|||+++ |+||||||
T Consensus 57 l~~l~HpnIv~~~~~~~~~~--~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp 131 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGN--IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKP 131 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETT--EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred HHhCCCCCEeeEeeeeccCc--eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccH
Confidence 99999999999999999877 78999999988654 567778899999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+|||++.++.+||+|||+|+..............+||+.|||||++.+.++ +.++||| +|+++|||++|..||.....
T Consensus 132 ~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp GGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred HHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999987654433333456789999999999998876 5789999 99999999999999754322
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+........+ .......+.+++.+||+.||++|||++|+++
T Consensus 212 ---~~~~~~~~~~~~~~~~~------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 212 ---SCQEYSDWKEKKTYLNP------------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TSHHHHHHHTTCTTSTT------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---HHHHHHHHhcCCCCCCc------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111111100000 0111234678899999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=365.57 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=185.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.+ .+|+.||||.+.....+ ....+.+.+|+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~-------------------------~~~~~~~~~E~~i 56 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMT-------------------------EAEKQMLVSEVNL 56 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSC-------------------------HHHHHHHHHHHHH
T ss_pred chhCEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCC-------------------------HHHHHHHHHHHHH
Confidence 468999999999999999999864 67999999999764433 2235678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC-------------CCHHHHHHHHHHHHHHHHHHhhcCC--CCeE
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------LDWLARHRIALGLACGLEYLHMHHC--PRII 191 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------l~~~~~~~i~~~i~~~l~~lh~~~~--~~ii 191 (345)
+++++|||||++++++.+.....+++++||+++|++ +++..+..++.|++.||.|||+.+. ++|+
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii 136 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence 999999999999999876655578999999998765 5566678899999999999998752 3499
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
||||||+|||++.++.+||+|||+++....... ......||+.|||||++.+..++.++||| +|+++|||++|..||
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 999999999999999999999999987654322 23457899999999999999999999999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. .+..+....+........+ . .....+.+++.+||+.||++|||++|+++
T Consensus 215 ~~----~~~~~~~~~i~~~~~~~~~----------~---~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 215 TA----FSQKELAGKIREGKFRRIP----------Y---RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC----SSHHHHHHHHHHTCCCCCC----------T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CCHHHHHHHHHcCCCCCCC----------c---ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 53 2334444433332211111 1 11234778889999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=357.22 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=200.6
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|+++++||+|+||+||+|+++ ++..||||.++..... .+.+.+|+.
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~----------------------------~~~~~~Ev~ 51 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS----------------------------EDEFIEEAK 51 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSC----------------------------HHHHHHHHH
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCC----------------------------HHHHHHHHH
Confidence 4579999999999999999999985 7889999999754322 345789999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++++++||||+++++++..++ .+++++||+.+|. .+++..+.+++.|+++||.|||+.+ ++||||
T Consensus 52 ~~~~l~HpnIv~~~g~~~~~~--~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dl 126 (258)
T d1k2pa_ 52 VMMNLSHEKLVQLYGVCTKQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 126 (258)
T ss_dssp HHHTCCCTTBCCEEEEECCSS--SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCC
T ss_pred HHHhcCCCceeeEEEEEeeCC--ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccc
Confidence 999999999999999998766 5899999998764 3667778899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~ 273 (345)
||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||| ||+++|||+| |..||...
T Consensus 127 k~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp SGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 999999999999999999999876544322 23346789999999999999999999999 9999999998 89996443
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
...+....+........+ .. ....+.++|..||+.||++|||+++|++.|.+|
T Consensus 206 ----~~~~~~~~i~~~~~~~~p----------~~---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 206 ----TNSETAEHIAQGLRLYRP----------HL---ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----CHHHHHHHHHTTCCCCCC----------TT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----CHHHHHHHHHhCCCCCCc----------cc---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 344444444433222211 11 123578899999999999999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=361.74 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=194.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+|+.||||.+..... ...+.+.+|+.++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~---------------------------~~~~~~~~E~~il 71 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQ---------------------------PKKELIINEILVM 71 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGC---------------------------SCHHHHHHHHHHH
T ss_pred cccEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccC---------------------------hHHHHHHHHHHHH
Confidence 47999999999999999999854 6799999999853211 1145678999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
++++|||||++++++..++ .+++++||++++++ ++...+..++.|++.||.|||+++ |+||||||+|
T Consensus 72 ~~l~HpnIv~~~~~~~~~~--~~~ivmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~N 146 (293)
T d1yhwa1 72 RENKNPNIVNYLDSYLVGD--ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDN 146 (293)
T ss_dssp HHCCCTTBCCEEEEEEETT--EEEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred HhCCCCCEeeEeEEEEECC--EEEEEEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHH
Confidence 9999999999999999887 68999999998765 566677889999999999999999 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTN 278 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~ 278 (345)
||++.++.+||+|||+|+....... ......||+.|+|||++.+.+++.++||| +|+++|+|++|..||... +
T Consensus 147 ILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----~ 220 (293)
T d1yhwa1 147 ILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE----N 220 (293)
T ss_dssp EEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS----C
T ss_pred eEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC----C
Confidence 9999999999999999987654322 23457899999999999999999999999 999999999999997432 2
Q ss_pred hhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 279 EMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.......+... ..+.... ++.....+.++|.+||+.||++|||+.|+++
T Consensus 221 ~~~~~~~~~~~---~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 221 PLRALYLIATN---GTPELQN--------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHHHH---CSCCCSS--------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHhC---CCCCCCC--------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222222221 1111111 1112234778999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-51 Score=365.30 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=189.8
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCC--CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQN--GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
.+.++|++.+.||+|+||.||+|+++... ...||||.+..... ....+.|.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~~ 76 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--------------------------EKQRRDFLS 76 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--------------------------HHHHHHHHH
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--------------------------HHHHHHHHH
Confidence 45678999999999999999999975322 34689998864322 123567899
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.+|++++|||||++++++..++ .+++++||+++|+ .+++..+..++.|+++||.|||+.+ ++|
T Consensus 77 E~~~l~~l~HpnIv~l~g~~~~~~--~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiH 151 (299)
T d1jpaa_ 77 EASIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVH 151 (299)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHhCCCCCCccEEEEEeeCC--EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---Ccc
Confidence 999999999999999999998776 6889999998864 3678888899999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcc---eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTH---ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GK 267 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~ 267 (345)
|||||+|||++.++.+||+|||+++........ .......||+.|||||.+.+..++.++||| ||+++|||+| |.
T Consensus 152 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~ 231 (299)
T d1jpaa_ 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231 (299)
T ss_dssp SCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence 999999999999999999999999876543221 112235678999999999999999999999 9999999998 89
Q ss_pred CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 268 LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 268 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.||.+ ....+....+......+.+ .+....+.++|.+||+.||++|||+.+|++.|+++
T Consensus 232 ~Pf~~----~~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 232 RPYWD----MTNQDVINAIEQDYRLPPP-------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CTTTT----CCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCC----CCHHHHHHHHHcCCCCCCC-------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 99643 2334444444332221111 12234577899999999999999999999999886
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=362.34 Aligned_cols=251 Identities=18% Similarity=0.293 Sum_probs=200.4
Q ss_pred HhhcCCcccccc-cccCcceeeEEEEecCC-CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 44 LEKKGGLASLEK-IGSGGCGEVYKAELPGQ-NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 44 ~~~~~~~~~~~~-iG~G~~g~V~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
..+.++|.+.+. ||+|+||.||+|+++.. ++..||||.+..... ....++|.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--------------------------~~~~~~~~ 57 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--------------------------KADTEEMM 57 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--------------------------HHHHHHHH
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--------------------------HHHHHHHH
Confidence 345678888885 99999999999987533 456899999964321 22356789
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
+|+.++++++|||||++++++..+. +++++||+++|++ +++..+.+++.|+++||.|||+++ ++
T Consensus 58 ~E~~il~~l~HpnIv~l~g~~~~~~---~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---ii 131 (285)
T d1u59a_ 58 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FV 131 (285)
T ss_dssp HHHHHHHHCCCTTBCCEEEEEESSS---EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHhCCCCCEeeEeeeeccCe---EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999987653 7899999988643 677788899999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||| ||+++|||+| |..
T Consensus 132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~ 211 (285)
T d1u59a_ 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211 (285)
T ss_dssp CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence 9999999999999999999999999987654322 223446789999999999998999999999 9999999998 899
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
||... ...+....+......+.+ +.....+.++|.+||+.||++|||+.+|.+.|+.+
T Consensus 212 Pf~~~----~~~~~~~~i~~~~~~~~p-------------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 212 PYKKM----KGPEVMAFIEQGKRMECP-------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TTTTC----CTHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHcCCCCCCC-------------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 97543 334444444433222111 11223577899999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=360.39 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=191.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCC---ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNG---RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
+.++|+..++||+|+||.||+|+++..++ ..||||.+..... .+....|.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--------------------------~~~~~~~~~ 58 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--------------------------EKQRVDFLG 58 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--------------------------HHHHHHHHH
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--------------------------hHHHHHHHH
Confidence 45689999999999999999999864332 4799999864321 123556889
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.++++++|||||++++++..++ .++++++++.++ ..+++..+.+++.|++.||.|||+.+ |+|
T Consensus 59 E~~il~~l~H~nIv~~~g~~~~~~--~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiH 133 (283)
T d1mqba_ 59 EAGIMGQFSHHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVH 133 (283)
T ss_dssp HHHHHHTCCCTTBCCEEEEECSSS--SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHhcCCCCEeeeeEEEecCC--ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---ccc
Confidence 999999999999999999998776 578888988774 34778888999999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
|||||+|||++.++.+||+|||+++........ .......||+.|||||++.+..++.++||| ||+++|||+++..|+
T Consensus 134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 999999999999999999999999876443221 122345789999999999999999999999 999999999976664
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
+......+....+......+.+ .+....+.++|.+||+.||++|||+.+|++.|+++.
T Consensus 214 ---~~~~~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 214 ---YWELSNHEVMKAINDGFRLPTP-------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ---TTTCCHHHHHHHHHTTCCCCCC-------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---cccCCHHHHHHHHhccCCCCCc-------------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 2333344444444433222111 112245788999999999999999999999998763
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=355.50 Aligned_cols=239 Identities=22% Similarity=0.354 Sum_probs=193.0
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+++.||+|.+...... .......+.+|+.++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~------------------------~~~~~~~~~~E~~il 60 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLE------------------------KAGVEHQLRREVEIQ 60 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHH------------------------HTTCHHHHHHHHHHH
T ss_pred hHeEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHcc------------------------ChHHHHHHHHHHHHH
Confidence 57999999999999999999964 57999999998521110 012356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++|||||++++++.+++ .+++++||+++|++ +++..+..++.|++.||.|||+++ |+||||||+
T Consensus 61 ~~l~hpnIv~~~~~~~~~~--~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~ 135 (263)
T d2j4za1 61 SHLRHPNILRLYGYFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPE 135 (263)
T ss_dssp HTCCCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred HhcCCCCCCeEEEEEEECC--EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccc
Confidence 9999999999999999776 78999999998764 566677889999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.+||+|||+|....... .....||+.|||||++.+..++.++||| +|+++|||++|..||.. .
T Consensus 136 Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~----~ 207 (263)
T d2j4za1 136 NLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA----N 207 (263)
T ss_dssp GEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC----S
T ss_pred cceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC----C
Confidence 9999999999999999997664432 2346899999999999999999999999 99999999999999743 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+..+....+.. .... + + +. ....+.+++.+||+.||++|||+.|+++
T Consensus 208 ~~~~~~~~i~~---~~~~---~----p-~~---~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 TYQETYKRISR---VEFT---F----P-DF---VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SHHHHHHHHHT---TCCC---C----C-TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHc---CCCC---C----C-cc---CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 33333333322 1111 0 0 11 1234678889999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=367.86 Aligned_cols=255 Identities=25% Similarity=0.333 Sum_probs=202.3
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEecCCC----CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELPGQN----GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
+..|+.+.++|++++.||+|+||+||+|++++.+ ...||+|.+..... ..
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~ 82 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--------------------------SS 82 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------------------
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--------------------------HH
Confidence 4567788899999999999999999999976322 24699999854211 22
Q ss_pred HHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC--------------------------------
Q 046907 116 KMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------------- 162 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------------- 162 (345)
....+.+|+.++.++ +|||||++++++..++ .+++++||+++|++
T Consensus 83 ~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (325)
T d1rjba_ 83 EREALMSELKMMTQLGSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160 (325)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHTTTTCC---------------------
T ss_pred HHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC--eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCC
Confidence 356788999999998 8999999999998876 68899999998754
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccc
Q 046907 163 LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEY 242 (345)
Q Consensus 163 l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~ 242 (345)
+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+|+............+..||+.|||||.
T Consensus 161 l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 237 (325)
T d1rjba_ 161 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237 (325)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHH
Confidence 455667789999999999999998 99999999999999999999999999987655444444456778999999999
Q ss_pred ccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHh
Q 046907 243 LQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIAC 320 (345)
Q Consensus 243 ~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 320 (345)
+.+..++.++||| ||+++|||+| |..||.+.. ....+...+......+.+ ......+.+||.
T Consensus 238 l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~---~~~~~~~~~~~~~~~~~p-------------~~~~~~l~~li~ 301 (325)
T d1rjba_ 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---VDANFYKLIQNGFKMDQP-------------FYATEEIYIIMQ 301 (325)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC---CSHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHH
T ss_pred HcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC---HHHHHHHHHhcCCCCCCC-------------CcCCHHHHHHHH
Confidence 9999999999999 9999999998 899975432 222333333332211111 112235788999
Q ss_pred hccCCCCCCCCCHHHHHHHHh
Q 046907 321 FCTLEDPNERPNSKDVRRMLS 341 (345)
Q Consensus 321 ~Cl~~dp~~Rpt~~~ll~~L~ 341 (345)
+||+.||++|||+++|++.|.
T Consensus 302 ~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 302 SCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHTCSSGGGSCCHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHh
Confidence 999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=355.49 Aligned_cols=242 Identities=19% Similarity=0.276 Sum_probs=190.2
Q ss_pred cccccCcceeeEEEEecC-CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Q 046907 54 EKIGSGGCGEVYKAELPG-QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIRH 132 (345)
Q Consensus 54 ~~iG~G~~g~V~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 132 (345)
++||+|+||.||+|.++. .+++.||||.+.....+ ....+++.+|+.++++++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------------------------~~~~~~~~~E~~il~~l~H 67 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-------------------------PALKDELLAEANVMQQLDN 67 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------------------------CHHHHHHHHHHHHHHTCCC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-------------------------HHHHHHHHHHHHHHHhCCC
Confidence 369999999999998753 35688999999643221 2235678999999999999
Q ss_pred CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeec
Q 046907 133 RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLD 203 (345)
Q Consensus 133 pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~ 203 (345)
||||++++++..++ .++++||+++|++ +++..+.+++.|++.||.|||+.+ ++||||||+|||++
T Consensus 68 pnIv~~~g~~~~~~---~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~ 141 (277)
T d1xbba_ 68 PYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLV 141 (277)
T ss_dssp TTBCCEEEEEESSS---EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred CCCceEEEEeccCC---EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhccc
Confidence 99999999987654 6789999998654 677778899999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCCcccccccchh
Q 046907 204 DDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEM 280 (345)
Q Consensus 204 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~ 280 (345)
.++.+|++|||+++........ .......||+.|||||.+.+..++.++||| ||+++|||+| |..||.+ ....
T Consensus 142 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~----~~~~ 217 (277)
T d1xbba_ 142 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG----MKGS 217 (277)
T ss_dssp ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT----CCHH
T ss_pred ccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC----CCHH
Confidence 9999999999999877544332 223446789999999999999999999999 9999999998 8999754 2334
Q ss_pred hHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 281 SFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+....+......+.+ ..+...+.++|.+||+.||++|||+++|.+.|+..
T Consensus 218 ~~~~~i~~~~~~~~p-------------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 218 EVTAMLEKGERMGCP-------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCC-------------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 444444432211111 11223577899999999999999999999988865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=352.78 Aligned_cols=244 Identities=20% Similarity=0.319 Sum_probs=187.8
Q ss_pred CCc-ccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGL-ASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 48 ~~~-~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
++| ++.++||+|+||+||+|+++ .++..||+|.+.....+ ....+.+.+|+++
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~-------------------------~~~~~~~~~E~~i 61 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLT-------------------------KSERQRFKEEAEM 61 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSC-------------------------HHHHHHHHHHHHH
T ss_pred CCEEEeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCC-------------------------HHHHHHHHHHHHH
Confidence 345 67778999999999999864 57899999998643222 2235678899999
Q ss_pred HhhccCCCccceeEEEec--CCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTR--PDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
+++++|||||++++++.. .+...++++|||++++++ +++..+..++.|+++||.|||+++ .+|+||||
T Consensus 62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDi 140 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDL 140 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCC
T ss_pred HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCc
Confidence 999999999999999865 334578999999999765 455566789999999999999986 34999999
Q ss_pred CCCCeeec-CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLD-DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+|||++ .++.+||+|||+|+...... .....||+.|||||++.+ .++.++||| +|+++|||++|..||.+.
T Consensus 141 Kp~NILl~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 141 KCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ChhhceeeCCCCCEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 99999997 57899999999997644332 234689999999999876 699999999 999999999999997532
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+.......+.. ...+. ..+ .... ..+.++|.+||+.||++|||+.|+++
T Consensus 216 ---~~~~~~~~~i~~---~~~~~-~~~----~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 216 ---QNAAQIYRRVTS---GVKPA-SFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---SSHHHHHHHHTT---TCCCG-GGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccHHHHHHHHHc---CCCCc-ccC----ccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 222223222221 11111 111 1111 23678899999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-51 Score=363.79 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=202.5
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMR 118 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (345)
++..+++|++++.||+|+||.||+|++++ .++..||||++..... .....
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------------------------~~~~~ 61 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--------------------------ADMQA 61 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--------------------------HHHHH
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--------------------------hHHHH
Confidence 44567899999999999999999999753 3568999999864321 12356
Q ss_pred HHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------------------------------CCH
Q 046907 119 QIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------------------------------LDW 165 (345)
Q Consensus 119 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------------------------------l~~ 165 (345)
++.+|+.+++.++||||+++++++...+ .++++++++.++++ +++
T Consensus 62 ~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 139 (301)
T d1lufa_ 62 DFQREAALMAEFDNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139 (301)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred HHHHHHHHHHhcCCCCcccceeeeccCC--ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCH
Confidence 7889999999999999999999998766 57788888877543 456
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc
Q 046907 166 LARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM 245 (345)
Q Consensus 166 ~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~ 245 (345)
..+.+++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+|+...+........+..||+.|+|||.+.+
T Consensus 140 ~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 140 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 678889999999999999998 99999999999999999999999999986654433334455678999999999999
Q ss_pred cccCccchhh-HHHHHHHHHhCC-CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhcc
Q 046907 246 LTLTEKCDIY-FGALLAGLVMGK-LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCT 323 (345)
Q Consensus 246 ~~~~~~~Dvw-lG~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl 323 (345)
..++.++||| ||+++|||++|. +|| ......+....+......+.+ .....++.+||..||
T Consensus 217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~----~~~~~~e~~~~v~~~~~~~~p-------------~~~~~~~~~li~~cl 279 (301)
T d1lufa_ 217 NRYTTESDVWAYGVVLWEIFSYGLQPY----YGMAHEEVIYYVRDGNILACP-------------ENCPLELYNLMRLCW 279 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTT----TTSCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHT
T ss_pred CCCChhhhhccchhhHHHHHccCCCCC----CCCCHHHHHHHHHcCCCCCCC-------------ccchHHHHHHHHHHc
Confidence 9999999999 999999999985 564 333444554444433221111 112234778999999
Q ss_pred CCCCCCCCCHHHHHHHHhhhhC
Q 046907 324 LEDPNERPNSKDVRRMLSQIQH 345 (345)
Q Consensus 324 ~~dp~~Rpt~~~ll~~L~~l~~ 345 (345)
+.||++||||.+|++.|++|.|
T Consensus 280 ~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 280 SKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp CSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCChhHCcCHHHHHHHHHHhcC
Confidence 9999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=365.20 Aligned_cols=191 Identities=23% Similarity=0.376 Sum_probs=164.5
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|+++ .+|+.||+|.+...... ....++.+|+.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~--------------------------~~~~~~~~Ei~ 56 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKP--------------------------AIRNQIIRELQ 56 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCT--------------------------THHHHHHHHGG
T ss_pred CccCCEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCH--------------------------HHHHHHHHHHH
Confidence 4678999999999999999999864 68999999998653211 12456789999
Q ss_pred HHhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCC
Q 046907 126 TVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMH-HCPRIIHRDL 195 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~-~~~~iiH~dl 195 (345)
+|+.++|||||++++++.+++ .+++++||+.++++ +++..+..++.|++.||.|||++ + |+||||
T Consensus 57 il~~l~HpnIv~l~~~~~~~~--~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDi 131 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDV 131 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSS--EEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCC
T ss_pred HHHhCCCCCCCcEEEEEEECC--EEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcccc
Confidence 999999999999999999876 68999999998654 56667788999999999999985 7 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||+|||++.++.+||+|||+|....+. ...+.+||+.|+|||++.+..++.++||| +||++|||++|..||..
T Consensus 132 KP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 132 KPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp SGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999865432 12357899999999999999999999999 99999999999999854
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-50 Score=358.35 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=190.6
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.|+.++.||+|+||.||+|++. .+|+.||||.+....... ....+.+.+|+.+++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~------------------------~~~~~~~~~Ei~il~ 70 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS------------------------NEKWQDIIKEVRFLQ 70 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCH------------------------HHHHHHHHHHHHHHT
T ss_pred hcEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccC------------------------HHHHHHHHHHHHHHH
Confidence 5999999999999999999864 579999999986543221 233667889999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVN 199 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~n 199 (345)
+++|||||++++++.+++ .+++++||+.++. .+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 71 ~l~HpnIv~~~~~~~~~~--~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~N 145 (309)
T d1u5ra_ 71 KLRHPNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGN 145 (309)
T ss_dssp TCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGG
T ss_pred HCCCCCEeeEEEEEEECC--EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcce
Confidence 999999999999998876 7899999998753 4678888899999999999999999 9999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc---cccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 200 VLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM---LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 200 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~---~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
||++.++.+||+|||+|...... ....||+.|||||++.+ ..++.++||| +|+++|||++|..||...
T Consensus 146 ILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-- 217 (309)
T d1u5ra_ 146 ILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-- 217 (309)
T ss_dssp EEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--
T ss_pred EEECCCCCEEEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--
Confidence 99999999999999999765432 34689999999999864 3588999999 999999999999997432
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
...+....+ .....+. ...... ...+.++|.+||+.||++|||++++++
T Consensus 218 --~~~~~~~~i---~~~~~~~------~~~~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 218 --NAMSALYHI---AQNESPA------LQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CHHHHHHHH---HHSCCCC------CSCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CHHHHHHHH---HhCCCCC------CCCCCC---CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 222222222 2221111 011111 234778889999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=358.17 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=192.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.+.|++++.||+|+||.||+|+++ .+|..||||.+...... ..+.+.+|+++
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~---------------------------~~~~~~~E~~i 62 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEE---------------------------ELEDYMVEIDI 62 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSG---------------------------GGGGTHHHHHH
T ss_pred ccCeEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHH---------------------------HHHHHHHHHHH
Confidence 357999999999999999999964 57999999999654221 14457789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++++|||||++++++.+++ .++++|||+++|++ +++..+..++.|++.||.|||+++ |+|||||
T Consensus 63 l~~l~HpnIv~l~~~~~~~~--~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiK 137 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLK 137 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETT--EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred HHhCCCCCCCeEEEEEeeCC--eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecC
Confidence 99999999999999998877 78899999988643 667777889999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccc-----ccccCccchhh-HHHHHHHHHhCCCCC
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQ-----MLTLTEKCDIY-FGALLAGLVMGKLPS 270 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~-----~~~~~~~~Dvw-lG~vl~el~tg~~p~ 270 (345)
|+|||++.++.+||+|||+|....... .......||+.|+|||++. +.+++.++||| +||++|||++|..||
T Consensus 138 p~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf 215 (288)
T d2jfla1 138 AGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 215 (288)
T ss_dssp GGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred hhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC
Confidence 999999999999999999997653221 1234578999999999984 45578999999 999999999999997
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+. +..+....+.. ...+... .++.....+.++|.+||+.||++|||++|+++
T Consensus 216 ~~~----~~~~~~~~i~~---~~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 216 HEL----NPMRVLLKIAK---SEPPTLA--------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp TTS----CGGGHHHHHHH---SCCCCCS--------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC----CHHHHHHHHHc---CCCCCCC--------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 543 33333332222 1111111 11122235778999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=354.32 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=190.5
Q ss_pred hhcCCcccccccccCcceeeEEEEecCCCC--ceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 45 EKKGGLASLEKIGSGGCGEVYKAELPGQNG--RMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 45 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
++.++|++++.||+|+||.||+|+++..++ ..||||.+....... .+..+.|.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~------------------------~~~~~~~~~ 60 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ------------------------PEAMDDFIR 60 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------------------------CHHHHHHHH
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC------------------------HHHHHHHHH
Confidence 356789999999999999999999765443 478999985432211 223567899
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.++++++|||||++++++..+ .++++++|+.+++ .+++..+..++.|++.||.|||+++ ++|
T Consensus 61 Ei~~l~~l~H~nIv~~~g~~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiH 134 (273)
T d1u46a_ 61 EVNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIH 134 (273)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHhCCCCCEEEEEEEEeec---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---Eee
Confidence 99999999999999999999765 3678899998764 3677788899999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcce-eccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHI-TTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
|||||+||+++.++.+|++|||+++......... ......|+..|+|||.+.+..++.++||| ||+++|||+| |..|
T Consensus 135 rDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~P 214 (273)
T d1u46a_ 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214 (273)
T ss_dssp SCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred eeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCC
Confidence 9999999999999999999999999875543322 23345678899999999999999999999 9999999998 8999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|.. .+..+....+.... ..+. ..+.....+.++|.+||+.||++|||+.+|++.|++.+
T Consensus 215 f~~----~~~~~~~~~i~~~~--~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 215 WIG----LNGSQILHKIDKEG--ERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp TTT----CCHHHHHHHHHTSC--CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC----cCHHHHHHHHHhCC--CCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 643 34444443332211 1110 11112234778999999999999999999999998864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=356.03 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=190.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+|+.||||.+..... ........+.+|+.++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~------------------------~~~~~~~~~~~E~~il 62 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHI------------------------IKENKVPYVTRERDVM 62 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHHHH
T ss_pred CCCEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHc------------------------cCHHHHHHHHHHHHHH
Confidence 57999999999999999999864 5799999999852110 0122356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++||||+++++++.+++ .+++++||+++|++ +++..+..++.|++.||.|||+.+ |+||||||+
T Consensus 63 ~~l~HpnIv~l~~~~~~~~--~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~ 137 (288)
T d1uu3a_ 63 SRLDHPFFVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPE 137 (288)
T ss_dssp HHCCSTTBCCEEEEEECSS--EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred HHcCCCCeeEEEEEEEECC--EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCcc
Confidence 9999999999999998776 78999999998754 566677789999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++||| +||++|||++|..||.. .
T Consensus 138 NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~ 213 (288)
T d1uu3a_ 138 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----G 213 (288)
T ss_dssp GEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC----S
T ss_pred ccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC----c
Confidence 999999999999999999877544333344557899999999999999999999999 99999999999999743 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+.......+... ... + +.. ....+.+||.+||+.||++|||++|+++
T Consensus 214 ~~~~~~~~i~~~---~~~---~----p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 214 NEYLIFQKIIKL---EYD---F----PEK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp SHHHHHHHHHTT---CCC---C----CTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CHHHHHHHHHcC---CCC---C----Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 333333333221 110 1 111 1234778999999999999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=356.21 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=195.1
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
+|+.+.++|++.+.||+|+||.||+|+++ ++..||||.+.....+ .+.|.
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~~~----------------------------~~~~~ 60 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS----------------------------PEAFL 60 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC----------------------------HHHHH
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcccCC----------------------------HHHHH
Confidence 46667889999999999999999999975 5567999999644222 35688
Q ss_pred HHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC-----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 122 SEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR-----------ELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 122 ~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|+.++++++|||||++++++..++ +++++||+.+|+ .+++..+..++.|++.||.|||+.+ +
T Consensus 61 ~E~~~l~~l~h~nIv~~~g~~~~~~---~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---i 134 (285)
T d1fmka3 61 QEAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 134 (285)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSS---CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHhcccCCEeEEEEEEecCC---eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---e
Confidence 9999999999999999999886543 678999999864 3678888999999999999999998 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||| ||+++|||++|..|
T Consensus 135 vH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCC
Confidence 99999999999999999999999999876543322 22346789999999999999999999999 99999999997666
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
+ +......+....+......+.+ +.....+.++|.+||+.||++|||+++|++.|+..
T Consensus 214 ~---~~~~~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 214 P---YPGMVNREVLDQVERGYRMPCP-------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp S---STTCCHHHHHHHHHTTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred C---CCCCCHHHHHHHHHhcCCCCCC-------------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 4 3334445555554433221111 12223577899999999999999999999998865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=355.35 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=191.2
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCC--CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQ--NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQI 120 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (345)
|+.+.++|++++.||+|+||.||+|++... .+..||||.+..... ......+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--------------------------~~~~~~~ 55 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------------------------DSVREKF 55 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--------------------------HHHHHHH
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--------------------------HHHHHHH
Confidence 667788999999999999999999987533 356799998854321 2235678
Q ss_pred HHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 121 QSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 121 ~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
.+|+.++++++|||||++++++..+ .+++++|++.+|.+ +++..+..++.|+++||.|||+.+ +
T Consensus 56 ~~E~~~l~~l~HpnIv~l~~~~~~~---~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---i 129 (273)
T d1mp8a_ 56 LQEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---F 129 (273)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEECSS---SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHHHHHHhCCCCCEeeEEEEEecC---eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---e
Confidence 8999999999999999999998643 47899999987643 577778899999999999999999 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKL 268 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~ 268 (345)
+||||||+||+++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++||| ||+++|||++ |.+
T Consensus 130 iHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~ 208 (273)
T d1mp8a_ 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208 (273)
T ss_dssp CCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCC
T ss_pred eccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCC
Confidence 99999999999999999999999999876443222 23446789999999999999999999999 9999999998 899
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
||... ...+....+......+.+ +.....+.++|..||+.||++|||+.+|++.|+++.
T Consensus 209 P~~~~----~~~~~~~~i~~~~~~~~~-------------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 209 PFQGV----KNNDVIGRIENGERLPMP-------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TTTTC----CGGGHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHcCCCCCCC-------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 96543 344444444433222111 122245788999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=357.02 Aligned_cols=247 Identities=19% Similarity=0.306 Sum_probs=190.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCc----eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGR----MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
.++|++++.||+|+||.||+|++. .+|+ .||+|.+..... .+..+.+.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~-~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~~ 60 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATS--------------------------PKANKEILD 60 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEEC-C----CCEEEEEEEECC------------------------------CTHHHHHH
T ss_pred HHHCEEeeEEecCCCeEEEEEEEc-CCCCEEEEEEEEEEeccccC--------------------------HHHHHHHHH
Confidence 357999999999999999999975 3443 588888853211 123567889
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
|+.++++++|||||++++++.+++ .+++++++.+++ .+++..+.+++.|++.||.|||+++ ++|
T Consensus 61 E~~~l~~l~HpnIv~l~g~~~~~~---~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiH 134 (317)
T d1xkka_ 61 EAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVH 134 (317)
T ss_dssp HHHHHHHCCCTTBCCEEEEEESSS---EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHHHHHhCCCCCEeeEEEEEecCC---eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---ccc
Confidence 999999999999999999998765 445556665543 4677778899999999999999998 999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCCC
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLPS 270 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p~ 270 (345)
|||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||| ||+++|||+| |..||
T Consensus 135 rDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 135 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp SCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999999877554443344456789999999999999999999999 9999999998 78886
Q ss_pred cccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 271 DKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
.. ....++...+......+.+ +.+...+.++|.+||+.||++|||+.+|++.|+.+
T Consensus 215 ~~----~~~~~~~~~i~~~~~~~~p-------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 215 DG----IPASEISSILEKGERLPQP-------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp TT----SCGGGHHHHHHHTCCCCCC-------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCHHHHHHHHHcCCCCCCC-------------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 43 3344455555443322221 11223477899999999999999999999998876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=354.01 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=195.2
Q ss_pred hhHHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHH
Q 046907 41 LAFLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKK 116 (345)
Q Consensus 41 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (345)
..|+...++|++++.||+|+||.||+|++.. .+++.||||.+..... ...
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------------------------~~~ 59 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--------------------------HSE 59 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--------------------------HHH
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--------------------------cHH
Confidence 4577788999999999999999999999753 2457899999853211 223
Q ss_pred HHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHH
Q 046907 117 MRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHR 170 (345)
Q Consensus 117 ~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~ 170 (345)
.+.+.+|..++.++ +||||+.+++++..++ ..+++++||+++|++ +++..+..
T Consensus 60 ~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 138 (299)
T d1ywna1 60 HRALMSELKILIHIGHHLNVVNLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138 (299)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHH
Confidence 55677788888777 7999999999877655 368899999988754 45566788
Q ss_pred HHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCc
Q 046907 171 IALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTE 250 (345)
Q Consensus 171 i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~ 250 (345)
++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.
T Consensus 139 ~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 215 (299)
T d1ywna1 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 215 (299)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc
Confidence 9999999999999998 9999999999999999999999999998765544444445678999999999999999999
Q ss_pred cchhh-HHHHHHHHHhC-CCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCC
Q 046907 251 KCDIY-FGALLAGLVMG-KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 251 ~~Dvw-lG~vl~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
++||| ||+++|||++| ..||... .....+...+........+ ......+.++|.+||+.||+
T Consensus 216 ~sDiwS~Gvil~ellt~~~~p~~~~---~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~cl~~dP~ 279 (299)
T d1ywna1 216 QSDVWSFGVLLWEIFSLGASPYPGV---KIDEEFCRRLKEGTRMRAP-------------DYTTPEMYQTMLDCWHGEPS 279 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTC---CCSHHHHHHHHHTCCCCCC-------------TTCCHHHHHHHHHHTCSSGG
T ss_pred ccceeehHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhcCCCCCCC-------------ccCCHHHHHHHHHHcCCChh
Confidence 99999 99999999996 5675432 2223343444333222111 11123477899999999999
Q ss_pred CCCCHHHHHHHHhhh
Q 046907 329 ERPNSKDVRRMLSQI 343 (345)
Q Consensus 329 ~Rpt~~~ll~~L~~l 343 (345)
+|||+++|++.|+++
T Consensus 280 ~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 280 QRPTFSELVEHLGNL 294 (299)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=348.61 Aligned_cols=244 Identities=25% Similarity=0.380 Sum_probs=191.2
Q ss_pred HHhhcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQS 122 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 122 (345)
|+.+.++|++++.||+|+||.||+|++ .|..||||+++... ..+.+.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~~-----------------------------~~~~~~~ 49 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDA-----------------------------TAQAFLA 49 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC-------------------------------HHHHH
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcHH-----------------------------HHHHHHH
Confidence 667788999999999999999999997 47789999996421 2456789
Q ss_pred HHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeE
Q 046907 123 EINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRII 191 (345)
Q Consensus 123 E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~ii 191 (345)
|+.++++++||||+++++++..++ ..+++++||+++|++ +++..+.+++.|++.||.|||+.+ ++
T Consensus 50 E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---iv 125 (262)
T d1byga_ 50 EASVMTQLRHSNLVQLLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 125 (262)
T ss_dssp THHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred HHHHHHhCCCCCEeeEEEEEEecC-CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---ee
Confidence 999999999999999999886543 257999999999765 455566789999999999999998 99
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHh-CCCC
Q 046907 192 HRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM-GKLP 269 (345)
Q Consensus 192 H~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t-g~~p 269 (345)
||||||+||+++.++.+|++|||+++..... .....+|..|+|||++.+..++.++||| ||+++|||+| |..|
T Consensus 126 H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p 200 (262)
T d1byga_ 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 200 (262)
T ss_dssp CSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999865432 2335678999999999999999999999 9999999998 6887
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
|.. ....+....+......+.+ ......+.+++.+||+.||++|||+.+|++.|++++
T Consensus 201 ~~~----~~~~~~~~~i~~~~~~~~~-------------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 201 YPR----IPLKDVVPRVEKGYKMDAP-------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CTT----SCGGGHHHHHTTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHcCCCCCCC-------------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 543 3344454444332222211 112234778999999999999999999999999885
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-49 Score=354.19 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=178.7
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.+.|++++.||+|+||.||+|+.+ .+|+.||||.+...... .....+.+|+.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~--------------------------~~~~~~~~Ei~i 60 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALE--------------------------GKEGSMENEIAV 60 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC------------------------------------CHHHHH
T ss_pred ccceEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhh--------------------------hHHHHHHHHHHH
Confidence 356999999999999999999864 57999999999643211 123457789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++|||||++++++.+++ .+++++||++|+++ +++.....++.|++.||.|||+.+ ++||||||
T Consensus 61 l~~l~HpnIv~l~~~~~~~~--~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp 135 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGG--HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKP 135 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred HHhCCCCCCCcEEEEEEECC--EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecc
Confidence 99999999999999998776 78999999998754 667778899999999999999999 99999999
Q ss_pred CCeeec---CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 198 VNVLLD---DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 198 ~nil~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
+||++. .++.+||+|||+|+...... ...+.+||+.|||||++.+..++.++||| +|+++|||++|..||..
T Consensus 136 ~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~- 211 (307)
T d1a06a_ 136 ENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD- 211 (307)
T ss_dssp GGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred cceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-
Confidence 999995 57899999999998654432 22446899999999999999999999999 99999999999999743
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
....+....+.... ... +. +..+.....+.+++..||+.||++|||++|+++
T Consensus 212 ---~~~~~~~~~i~~~~---~~~---~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 212 ---ENDAKLFEQILKAE---YEF---DS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ---SSHHHHHHHHHTTC---CCC---CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHhccC---CCC---CC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 23333333332221 110 00 111122234778899999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.9e-49 Score=356.53 Aligned_cols=241 Identities=19% Similarity=0.241 Sum_probs=194.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+|+.||||.+..... ...+.+.+|+.++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~---------------------------~~~~~~~~E~~il 77 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHE---------------------------SDKETVRKEIQTM 77 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSH---------------------------HHHHHHHHHHHHH
T ss_pred cCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccch---------------------------hhHHHHHHHHHHH
Confidence 58999999999999999999864 5799999999965321 1245678999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++++|||||++++++.+++ .+++++||+++|++ +++..+..++.|++.||.|||+.+ ++||||||
T Consensus 78 ~~l~HpnIv~~~~~~~~~~--~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp 152 (350)
T d1koaa2 78 SVLRHPTLVNLHDAFEDDN--EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKP 152 (350)
T ss_dssp HHTCCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred HhCCCCCCCcEEEEEEECC--EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---Ceeeeech
Confidence 9999999999999998876 78999999988653 667778899999999999999999 99999999
Q ss_pred CCeeec--CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccc
Q 046907 198 VNVLLD--DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFF 274 (345)
Q Consensus 198 ~nil~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~ 274 (345)
+|||++ .++.+||+|||+++....... .....||+.|||||++.+.+++.++||| +||++|||++|..||..
T Consensus 153 ~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-- 227 (350)
T d1koaa2 153 ENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-- 227 (350)
T ss_dssp GGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC--
T ss_pred hHeeeccCCCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC--
Confidence 999996 467899999999987755432 2346899999999999999999999999 99999999999999643
Q ss_pred cccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 275 QHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+..+....+......... . ..+.....+.++|.+||+.||++|||++|+++
T Consensus 228 --~~~~~~~~~i~~~~~~~~~------~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 228 --ENDDETLRNVKSCDWNMDD------S----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp --SSHHHHHHHHHHTCCCSCC------G----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHhCCCCCCc------c----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2333443333322211110 0 11112234778999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-49 Score=355.23 Aligned_cols=242 Identities=19% Similarity=0.231 Sum_probs=195.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.+ .+|+.||||.+..... .....+.+|+.+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~---------------------------~~~~~~~~Ei~i 79 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYP---------------------------LDKYTVKNEISI 79 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSH---------------------------HHHHHHHHHHHH
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcch---------------------------hHHHHHHHHHHH
Confidence 468999999999999999999864 5799999999865321 124567789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++++|||||++++++..++ .++++|||++++++ +++..+..++.|++.||.|||+.+ |+|||||
T Consensus 80 l~~l~HpnIv~~~~~~~~~~--~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiK 154 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKY--EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIK 154 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSS--EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHhCCCCCCCcEEEEEEECC--EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccc
Confidence 99999999999999998776 78999999998643 677788899999999999999999 9999999
Q ss_pred CCCeeec--CCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLD--DDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+|||++ .++.+||+|||+|........ .....||+.|+|||++.+..++.++||| +||++|||++|..||.+
T Consensus 155 p~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~- 230 (352)
T d1koba_ 155 PENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG- 230 (352)
T ss_dssp GGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-
T ss_pred cccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-
Confidence 9999998 578999999999988765432 2346789999999999999999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
....+....+....... + ....+.....+.+||..||+.||.+|||+.|+++
T Consensus 231 ---~~~~~~~~~i~~~~~~~-~---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 231 ---EDDLETLQNVKRCDWEF-D---------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---SSHHHHHHHHHHCCCCC-C---------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---CCHHHHHHHHHhCCCCC-C---------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23333433333222110 0 0111122234778999999999999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=350.29 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=200.3
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecCC------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPGQ------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
.|..+.++|++++.||+|+||.||+|+..+. ++..||||.+...... +
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--------------------------~ 60 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--------------------------K 60 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--------------------------H
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--------------------------H
Confidence 3777889999999999999999999986432 2457999999653321 2
Q ss_pred HHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHH
Q 046907 116 KMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARH 169 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~ 169 (345)
....+.+|...+.++ +|||||++++++..++ .+++++||+.+|.+ +++..+.
T Consensus 61 ~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~--~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 138 (299)
T d1fgka_ 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138 (299)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCeEEecccccccCC--eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHH
Confidence 356678899999888 8999999999998765 68899999988643 5777788
Q ss_pred HHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccC
Q 046907 170 RIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLT 249 (345)
Q Consensus 170 ~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~ 249 (345)
.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++
T Consensus 139 ~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence 99999999999999999 999999999999999999999999999877655444444567889999999999999999
Q ss_pred ccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCC
Q 046907 250 EKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDP 327 (345)
Q Consensus 250 ~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp 327 (345)
.++||| ||+++|||++ |..||.. .........+......+.+. . ....+.++|.+||+.||
T Consensus 216 ~k~DiwS~Gvvl~ell~~g~~p~~~----~~~~~~~~~i~~~~~~~~p~---------~----~~~~l~~li~~cl~~dP 278 (299)
T d1fgka_ 216 HQSDVWSFGVLLWEIFTLGGSPYPG----VPVEELFKLLKEGHRMDKPS---------N----CTNELYMMMRDCWHAVP 278 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHHHHHHTTCCCCCCS---------S----CCHHHHHHHHHHTCSSG
T ss_pred chhhhHHhHHHHHHhccCCCCCCCC----CCHHHHHHHHHcCCCCCCCc---------c----chHHHHHHHHHHccCCH
Confidence 999999 9999999998 6888543 33344444443332221111 1 12347889999999999
Q ss_pred CCCCCHHHHHHHHhhh
Q 046907 328 NERPNSKDVRRMLSQI 343 (345)
Q Consensus 328 ~~Rpt~~~ll~~L~~l 343 (345)
++|||+.+|++.|++|
T Consensus 279 ~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 279 SQRPTFKQLVEDLDRI 294 (299)
T ss_dssp GGSCCHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHH
Confidence 9999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=351.51 Aligned_cols=255 Identities=17% Similarity=0.296 Sum_probs=205.4
Q ss_pred hHHhhcCCcccccccccCcceeeEEEEecC----CCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHH
Q 046907 42 AFLEKKGGLASLEKIGSGGCGEVYKAELPG----QNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKM 117 (345)
Q Consensus 42 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (345)
+|+.+.++|++++.||+|+||.||+|++++ .++..||||++..... .+..
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~--------------------------~~~~ 67 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--------------------------MRER 67 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--------------------------HHHH
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC--------------------------hHHH
Confidence 578888999999999999999999998752 2367899999864321 1235
Q ss_pred HHHHHHHHHHhhccCCCccceeEEEecCCcceeeeeccccCCCCCC-------------------CHHHHHHHHHHHHHH
Q 046907 118 RQIQSEINTVGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRREL-------------------DWLARHRIALGLACG 178 (345)
Q Consensus 118 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l-------------------~~~~~~~i~~~i~~~ 178 (345)
..+.+|+.++++++|||||++++++..++ .++++++++.+|++. ++..+.+++.|+++|
T Consensus 68 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~g 145 (308)
T d1p4oa_ 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145 (308)
T ss_dssp HHHHHHHHHGGGCCCTTBCCEEEEECSSS--SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCEeeeeeEEecCC--ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHH
Confidence 67889999999999999999999997766 688999999987653 445567899999999
Q ss_pred HHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HH
Q 046907 179 LEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FG 257 (345)
Q Consensus 179 l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG 257 (345)
|.|||+.+ ++||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||| ||
T Consensus 146 l~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G 222 (308)
T d1p4oa_ 146 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 222 (308)
T ss_dssp HHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHH
Confidence 99999998 999999999999999999999999999877554444445556889999999999999999999999 99
Q ss_pred HHHHHHHhCC-CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 258 ALLAGLVMGK-LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 258 ~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+++|||+||. .|| ...+..+....+.+....+.+ +.....+.++|.+||+.||++|||+.+|
T Consensus 223 ~il~El~t~~~~p~----~~~~~~~~~~~i~~~~~~~~p-------------~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 223 VVLWEIATLAEQPY----QGLSNEQVLRFVMEGGLLDKP-------------DNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp HHHHHHHHTSCCTT----TTSCHHHHHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhCCCCCC----CCCCHHHHHHHHHhCCCCCCc-------------ccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9999999984 664 333444444444332221111 1122357889999999999999999999
Q ss_pred HHHHhhhh
Q 046907 337 RRMLSQIQ 344 (345)
Q Consensus 337 l~~L~~l~ 344 (345)
++.|++..
T Consensus 286 l~~L~~~~ 293 (308)
T d1p4oa_ 286 ISSIKEEM 293 (308)
T ss_dssp HHHHGGGS
T ss_pred HHHHHHhc
Confidence 99998763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=348.44 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=194.8
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
+.|++++.||+|+||+||+|+++ .+|+.||||.+.......... ....+.+.+|+.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~---------------------~~~~~~~~~E~~il 67 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRR---------------------GVSREDIEREVSIL 67 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSS---------------------SBCHHHHHHHHHHH
T ss_pred cCEEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhh---------------------hHHHHHHHHHHHHH
Confidence 57999999999999999999964 589999999986543322110 11256788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++|||||++++++.+++ .+++++||++++++ +++..+..++.|++.||.|||+.+ ++||||||+
T Consensus 68 ~~l~HpnIv~~~~~~~~~~--~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~ 142 (293)
T d1jksa_ 68 KEIQHPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPE 142 (293)
T ss_dssp HHCCCTTBCCEEEEEECSS--EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred HhCCCCCCCcEEEEEEECC--EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccc
Confidence 9999999999999998876 78999999998765 566667789999999999999999 999999999
Q ss_pred CeeecCCC----CeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 199 NVLLDDDI----EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 199 nil~~~~~----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|||++.++ .+|++|||++........ .....||+.|+|||++.+..++.++||| +|+++|||++|..||.+
T Consensus 143 Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~- 218 (293)
T d1jksa_ 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG- 218 (293)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-
T ss_pred eEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-
Confidence 99998765 599999999987654332 3446889999999999998999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+..+....+..... ... .... +.....+.++|.+||+.||++|||++++++
T Consensus 219 ---~~~~~~~~~i~~~~~--~~~----~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 219 ---DTKQETLANVSAVNY--EFE----DEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---SSHHHHHHHHHTTCC--CCC----HHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHhcCC--CCC----chhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233333333322211 000 0000 112234778999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=348.77 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=206.0
Q ss_pred hhhHHhhcCCcccccccccCcceeeEEEEec----CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHH
Q 046907 40 DLAFLEKKGGLASLEKIGSGGCGEVYKAELP----GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNK 115 (345)
Q Consensus 40 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 115 (345)
+..|+...++|++.+.||+|+||.||+|+++ ..+++.||||++..... ..
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--------------------------~~ 68 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--------------------------LT 68 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--------------------------HH
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--------------------------HH
Confidence 3467778899999999999999999999874 34678999999964322 12
Q ss_pred HHHHHHHHHHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC---------------------------CCHHH
Q 046907 116 KMRQIQSEINTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------------------------LDWLA 167 (345)
Q Consensus 116 ~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------------------------l~~~~ 167 (345)
....+.+|+.+++++ +|||||++++++..++ .+++++||++++++ +++..
T Consensus 69 ~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~--~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (311)
T d1t46a_ 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred HHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC--EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence 356788999999999 7999999999998776 68899999988653 56667
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc
Q 046907 168 RHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT 247 (345)
Q Consensus 168 ~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~ 247 (345)
+..++.|++.||.|||+++ ++||||||+||+++.++.+|++|||+++...............||+.|+|||.+.+..
T Consensus 147 ~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence 8889999999999999999 9999999999999999999999999998876554444556678999999999999989
Q ss_pred cCccchhh-HHHHHHHHHh-CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCC
Q 046907 248 LTEKCDIY-FGALLAGLVM-GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLE 325 (345)
Q Consensus 248 ~~~~~Dvw-lG~vl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~ 325 (345)
++.++||| ||+++|||+| |.+||... .....+...+........+ +.....+.+||.+||+.
T Consensus 224 ~~~~~DIwS~G~~l~ellt~g~p~~~~~---~~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~Li~~cl~~ 287 (311)
T d1t46a_ 224 YTFESDVWSYGIFLWELFSLGSSPYPGM---PVDSKFYKMIKEGFRMLSP-------------EHAPAEMYDIMKTCWDA 287 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTC---CSSHHHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCS
T ss_pred CCCcccccchHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhcCCCCCCc-------------ccccHHHHHHHHHHcCC
Confidence 99999999 9999999999 55554321 1222333344333222111 11223478899999999
Q ss_pred CCCCCCCHHHHHHHHhhh
Q 046907 326 DPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 326 dp~~Rpt~~~ll~~L~~l 343 (345)
||++|||+++|++.|+++
T Consensus 288 dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 288 DPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHHh
Confidence 999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=348.14 Aligned_cols=242 Identities=20% Similarity=0.286 Sum_probs=193.8
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|++++.||+|+||.||+|+.+ .+|+.||||.+..... ........+.+|+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~------------------------~~~~~~~~~~~E~~i 58 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI------------------------IAKDEVAHTVTESRV 58 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHHH
T ss_pred hHhcEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhc------------------------cCHHHHHHHHHHHHH
Confidence 468999999999999999999954 6899999999952110 012235678899999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
|++++||||+++++++.+++ .+++++||+++|.+ ++...+..++.|++.||.|||+++ ++||||||
T Consensus 59 l~~l~hp~Iv~l~~~~~~~~--~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP 133 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKL 133 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCG
T ss_pred HHhCCCCCEEEEEeeecccc--ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCH
Confidence 99999999999999999876 79999999999765 566667789999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.+||+|||+|+....... .....+||+.|+|||++.+.+++.++||| +||++|||++|.+||..
T Consensus 134 ~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~---- 207 (337)
T d1o6la_ 134 ENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---- 207 (337)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC----
T ss_pred HHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC----
Confidence 999999999999999999986543222 33457899999999999999999999999 99999999999999643
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
.+.......+.... .. .+... ...+.+||.+||+.||.+||+ +.++++
T Consensus 208 ~~~~~~~~~i~~~~---~~-------~p~~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 208 QDHERLFELILMEE---IR-------FPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSHHHHHHHHHHCC---CC-------CCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCHHHHHHHHhcCC---CC-------CCccC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 33333333332211 10 01111 223678899999999999995 777765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-48 Score=341.40 Aligned_cols=255 Identities=20% Similarity=0.297 Sum_probs=193.0
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+|+.||||.+....... .....++.+|+.+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~------------------------~~~~~~~~~E~~~ 60 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARD------------------------PSFYLRFRREAQN 60 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTC------------------------HHHHHHHHHHHHH
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccC------------------------HHHHHHHHHHHHH
Confidence 357999999999999999999854 579999999997543321 2335678899999
Q ss_pred HhhccCCCccceeEEEecCCc--ceeeeeccccCCCC---------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC--HLLYILNDVSQGRR---------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~--~~l~~~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
++.++|||||++++++..++. ..++++|||++++. .+++..+..++.|++.||.|||+.+ ++||||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDi 137 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDV 137 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccc
Confidence 999999999999998876543 45889999999864 3677778899999999999999998 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCC-cceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAH-THITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+|||++.++..+++|||.+....... .........||+.|+|||++.+..++.++||| +|+++|||+||..||...
T Consensus 138 KP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 217 (277)
T d1o6ya_ 138 KPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217 (277)
T ss_dssp SGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc
Confidence 9999999999999999999987654322 22233457899999999999999999999999 999999999999997532
Q ss_pred ccccchhhHHHHHHHHhhhc-CCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhhhh
Q 046907 274 FQHTNEMSFVKWMRNVMASE-NPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-NSKDVRRMLSQIQ 344 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-t~~~ll~~L~~l~ 344 (345)
+..+... ...... .+..... +.....+.+++.+||+.||++|| |++++++.|.+++
T Consensus 218 ----~~~~~~~---~~~~~~~~~~~~~~--------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 218 ----SPVSVAY---QHVREDPIPPSARH--------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----SHHHHHH---HHHHCCCCCGGGTS--------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CHHHHHH---HHHhcCCCCCchhc--------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 2222221 112111 1111111 11223477888999999999999 8999999998875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-48 Score=344.29 Aligned_cols=238 Identities=25% Similarity=0.357 Sum_probs=191.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+.+ .+|+.||||++...... .....+.+.+|+.++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~------------------------~~~~~~~~~~E~~il 58 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVV------------------------RLKQVEHTNDERLML 58 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHH------------------------HTTCHHHHHHHHHHH
T ss_pred hHeEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHcc------------------------CHHHHHHHHHHHHHH
Confidence 57999999999999999999964 57999999998521110 122356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++|||||++++++.+++ .+++++||+.|+.+ ++......++.|++.||.|||+++ |+||||||+
T Consensus 59 ~~l~HpnIv~~~~~~~~~~--~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~ 133 (316)
T d1fota_ 59 SIVTHPFIIRMWGTFQDAQ--QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPE 133 (316)
T ss_dssp HSCCBTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGG
T ss_pred HhccCcChhheeeeEeeCC--eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCch
Confidence 9999999999999998776 79999999998753 455566789999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.+||+|||+|+...+. ..+.+||+.|||||++.+..++.++||| +|+++|||++|..||.. .
T Consensus 134 NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~----~ 204 (316)
T d1fota_ 134 NILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD----S 204 (316)
T ss_dssp GEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC----S
T ss_pred heeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC----c
Confidence 999999999999999999876543 2347899999999999999999999999 99999999999999743 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
+.......+... ... . ++. ....+.+++.+||+.||.+|| |++++++
T Consensus 205 ~~~~~~~~i~~~---~~~---~----p~~----~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 205 NTMKTYEKILNA---ELR---F----PPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SHHHHHHHHHHC---CCC---C----CTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHcC---CCC---C----CCC----CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 333333333221 111 0 011 123477888999999999996 8999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=344.91 Aligned_cols=248 Identities=22% Similarity=0.269 Sum_probs=191.5
Q ss_pred ccccccccCcceeeEEEEecCCC--CceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 51 ASLEKIGSGGCGEVYKAELPGQN--GRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 51 ~~~~~iG~G~~g~V~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
.+.++||+|+||+||+|++...+ ...||||.+..... ....++|.+|+++++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~--------------------------~~~~~~~~~E~~~l~ 83 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--------------------------IGEVSQFLTEGIIMK 83 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC--------------------------HHHHHHHHHHHHHHH
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC--------------------------HHHHHHHHHHHHHHH
Confidence 34678999999999999976433 34689999853211 234678999999999
Q ss_pred hccCCCccceeEEEecCCcceeeeeccccCCCCC----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 129 QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+++|||||++++++...+ ..+++++||+.++++ .++..+.+++.|++.||.|+|+.+ ++||||||+
T Consensus 84 ~l~HpnIv~~~g~~~~~~-~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~ 159 (311)
T d1r0pa_ 84 DFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAAR 159 (311)
T ss_dssp TCCCTTBCCCCEEEEETT-TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred hCCCCCEeEEeEEEEecC-CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHH
Confidence 999999999999887544 268899999988754 445667899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|||++.++.+||+|||+++........ .......||..|+|||.+.+..++.++||| ||+++|||++|..||..
T Consensus 160 NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~--- 236 (311)
T d1r0pa_ 160 NCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--- 236 (311)
T ss_dssp GEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred hEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC---
Confidence 999999999999999999876543322 122346789999999999999999999999 99999999998777533
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhhh
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQIQ 344 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l~ 344 (345)
.....+....+........+ +.+...+.++|.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~~~~~~~~i~~g~~~~~p-------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 237 DVNTFDITVYLLQGRRLLQP-------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ------CHHHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCc-------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22223333333332221111 112234778999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=346.50 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=192.7
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCc--eeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGR--MISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSE 123 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 123 (345)
+.++|++.+.||+|+||+||+|+++. +|. .||||.+..... .+..+.+.+|
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~~E 60 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYAS--------------------------KDDHRDFAGE 60 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC--------------------------------CHHHHH
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccC--------------------------hHHHHHHHHH
Confidence 56899999999999999999999863 444 578888753211 2235678999
Q ss_pred HHHHhhc-cCCCccceeEEEecCCcceeeeeccccCCCCC-------------------------CCHHHHHHHHHHHHH
Q 046907 124 INTVGQI-RHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE-------------------------LDWLARHRIALGLAC 177 (345)
Q Consensus 124 ~~~l~~l-~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~-------------------------l~~~~~~~i~~~i~~ 177 (345)
+.+++++ +|||||++++++..++ .++++++|+++|++ +++..+.+++.|++.
T Consensus 61 ~~~l~~l~~HpnIv~~~~~~~~~~--~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~ 138 (309)
T d1fvra_ 61 LEVLCKLGHHPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 138 (309)
T ss_dssp HHHHTTCCCCTTBCCEEEEEEETT--EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCEeeEEEEEecCC--eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHH
Confidence 9999998 7999999999998876 78999999998654 566678899999999
Q ss_pred HHHHHhhcCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-H
Q 046907 178 GLEYLHMHHCPRIIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256 (345)
Q Consensus 178 ~l~~lh~~~~~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-l 256 (345)
||.|+|+.+ ++||||||+|||++.++.+||+|||+++...... ......||..|+|||.+.+..++.++||| |
T Consensus 139 gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSf 212 (309)
T d1fvra_ 139 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 212 (309)
T ss_dssp HHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHH
T ss_pred HHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehh
Confidence 999999998 9999999999999999999999999997653322 22345789999999999999999999999 9
Q ss_pred HHHHHHHHhCC-CCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 257 GALLAGLVMGK-LPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 257 G~vl~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
|+++|||++|. +||. ..+...+...+......+.+ ......+.+||.+||+.||++|||+.+
T Consensus 213 Gvil~ell~~~~~p~~----~~~~~~~~~~i~~~~~~~~~-------------~~~~~~~~~li~~cl~~dP~~RPs~~e 275 (309)
T d1fvra_ 213 GVLLWEIVSLGGTPYC----GMTCAELYEKLPQGYRLEKP-------------LNCDDEVYDLMRQCWREKPYERPSFAQ 275 (309)
T ss_dssp HHHHHHHHTTSCCTTT----TCCHHHHHHHGGGTCCCCCC-------------TTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhcCCCCCC----CCCHHHHHHHHHhcCCCCCC-------------ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 99999999975 4543 33444444333322211111 112235788999999999999999999
Q ss_pred HHHHHhhhh
Q 046907 336 VRRMLSQIQ 344 (345)
Q Consensus 336 ll~~L~~l~ 344 (345)
|++.|+++.
T Consensus 276 il~~L~~i~ 284 (309)
T d1fvra_ 276 ILVSLNRML 284 (309)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999998873
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-47 Score=335.05 Aligned_cols=251 Identities=19% Similarity=0.266 Sum_probs=196.6
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.. .+|+.||||++.....+..... ......+.+.+|+.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~~------------------~~~~~~~~~~~E~~~ 62 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAE------------------EVQELREATLKEVDI 62 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHH------------------HHHHHHHHHHHHHHH
T ss_pred cccCEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhHH------------------HHHHHHHHHHHHHHH
Confidence 368999999999999999999854 6899999999976543321110 012346778899999
Q ss_pred Hhhcc-CCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
+++++ ||||+++++++.+++ .++++|||++++++ +++..+..++.|++.||.|||+.+ ++|||||
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~--~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlk 137 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLK 137 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHhcCCCCeEEEEeecccCc--ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---Ccccccc
Confidence 99996 999999999998776 79999999998754 567778899999999999999999 9999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc------ccCccchhh-HHHHHHHHHhCCCC
Q 046907 197 PVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML------TLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 197 ~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~------~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|+|||++.++.+||+|||+++....... .....||..|+|||.+.+. .++.++||| +|+++|||++|..|
T Consensus 138 p~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P 214 (277)
T d1phka_ 138 PENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214 (277)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCC
Confidence 9999999999999999999988754332 2446899999999999642 367899999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
|.. .+.......+...... +.. ...+....++.+++.+||+.||.+|||++||++
T Consensus 215 f~~----~~~~~~~~~i~~~~~~--~~~--------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 215 FWH----RKQMLMLRMIMSGNYQ--FGS--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp SCC----SSHHHHHHHHHHTCCC--CCT--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC----CCHHHHHHHHHhCCCC--CCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 643 3333333333322111 100 111122235778999999999999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-47 Score=344.75 Aligned_cols=238 Identities=19% Similarity=0.247 Sum_probs=191.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|+++ .+|+.||||.+..... ......+.+.+|+.++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~------------------------~~~~~~~~~~~E~~il 95 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKV------------------------VKLKQIEHTLNEKRIL 95 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH------------------------HHTTCHHHHHHHHHHH
T ss_pred cCeEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHc------------------------cCHHHHHHHHHHHHHH
Confidence 57999999999999999999964 5799999999842110 0122356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++|||||++++++...+ .++++++++.++.+ ++...+..++.|++.||.|||+.+ |+||||||+
T Consensus 96 ~~l~hpnIv~~~~~~~~~~--~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~ 170 (350)
T d1rdqe_ 96 QAVNFPFLVKLEFSFKDNS--NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPE 170 (350)
T ss_dssp TTCCCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred HHcCCCcEeeccccccccc--ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHH
Confidence 9999999999999998776 68899999988754 566677889999999999999999 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQHT 277 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~ 277 (345)
|||++.++.+||+|||+|+..... .....||+.|||||++.+..++.++||| +||++|||++|..||.. .
T Consensus 171 NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~----~ 241 (350)
T d1rdqe_ 171 NLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA----D 241 (350)
T ss_dssp GEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----S
T ss_pred HcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC----c
Confidence 999999999999999999876543 2347899999999999999999999999 99999999999999743 2
Q ss_pred chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 278 NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
+.......+.... ... .. .....+.+++.+||+.||.+|+ |++++++
T Consensus 242 ~~~~~~~~i~~~~---~~~-------p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 QPIQIYEKIVSGK---VRF-------PS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SHHHHHHHHHHCC---CCC-------CT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHhcCC---CCC-------Cc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 3333333332221 110 01 1123477889999999999994 8999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=340.22 Aligned_cols=253 Identities=24% Similarity=0.267 Sum_probs=190.4
Q ss_pred cccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcc
Q 046907 52 SLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQIR 131 (345)
Q Consensus 52 ~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 131 (345)
.+++||+|+||+||+|+.+ .+|+.||||++........ .......+.+|+.++++++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~----------------------~~~~~~~~~~Ei~il~~l~ 58 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEA----------------------KDGINRTALREIKLLQELS 58 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-SCCSEEEEEEC----------------------------------CTHHHHHHHHHHHCC
T ss_pred cceEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhh----------------------hHHHHHHHHHHHHHHHhCC
Confidence 4688999999999999854 5799999999854321110 0122456889999999999
Q ss_pred CCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 046907 132 HRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLL 202 (345)
Q Consensus 132 hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~ 202 (345)
|||||++++++..++ .+++++||+.++ ..++...+..++.|++.||.|||+++ ++||||||+|||+
T Consensus 59 hpnIv~~~~~~~~~~--~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli 133 (299)
T d1ua2a_ 59 HPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLL 133 (299)
T ss_dssp CTTBCCEEEEECCTT--CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCCEeEEEeeeccCC--ceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEe
Confidence 999999999998877 588899998763 34677788899999999999999999 9999999999999
Q ss_pred cCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCcccccccchh
Q 046907 203 DDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKFFQHTNEM 280 (345)
Q Consensus 203 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~~~~~ 280 (345)
+.++.+||+|||+++....... .....+||+.|+|||++.+. .++.++||| +||++|||++|..||. ..+..
T Consensus 134 ~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~----~~~~~ 207 (299)
T d1ua2a_ 134 DENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP----GDSDL 207 (299)
T ss_dssp CTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC----CSSHH
T ss_pred cCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC----CCCHH
Confidence 9999999999999986644322 23346899999999998755 579999999 9999999999999964 33455
Q ss_pred hHHHHHHHHhhhcCCCccccc---------cccCCCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 281 SFVKWMRNVMASENPKRAIDS---------KLVGNGC-----EEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-----~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
+....+......+......+. ...+... +.....+.+|+.+||+.||++|||++|+++
T Consensus 208 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 555555554433222111000 0000111 122345788999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=339.16 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=191.6
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
.+|.+.+.||+|+||.||+|++ +|..||||++.... ........|+..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~----------------------------~~~~~~e~ei~~~ 51 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE----------------------------ERSWFREAEIYQT 51 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGG----------------------------HHHHHHHHHHHTS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc----------------------------hhHHHHHHHHHHH
Confidence 3678889999999999999996 68899999985311 0112223466677
Q ss_pred hhccCCCccceeEEEecCCc--ceeeeeccccCCCCC--------CCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEe
Q 046907 128 GQIRHRNLHPLLAHVTRPDC--HLLYILNDVSQGRRE--------LDWLARHRIALGLACGLEYLHMHH-----CPRIIH 192 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~--~~l~~~~~~~~~~~~--------l~~~~~~~i~~~i~~~l~~lh~~~-----~~~iiH 192 (345)
..++|||||++++++..++. ..+++++||+++|++ +++..+.+++.|++.||.|+|+.. .++|+|
T Consensus 52 ~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH 131 (303)
T d1vjya_ 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 131 (303)
T ss_dssp TTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred hhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec
Confidence 78899999999999986543 368899999998765 566677899999999999999741 123999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCccccccccccccc------cCccchhh-HHHHHHHH
Q 046907 193 RDLNPVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQMLT------LTEKCDIY-FGALLAGL 263 (345)
Q Consensus 193 ~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~~------~~~~~Dvw-lG~vl~el 263 (345)
|||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+.. ++.++||| ||+++|||
T Consensus 132 rDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el 211 (303)
T d1vjya_ 132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred cccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence 999999999999999999999999877543322 2234578999999999987643 57789999 99999999
Q ss_pred HhCCCCCccccccc-------chhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 264 VMGKLPSDKFFQHT-------NEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 264 ~tg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+||..||....... ........+..........+.++.. ....+....+.++|.+||+.||++|||+.+|
T Consensus 212 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 212 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred hhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99988764211110 0001122222222222221111111 1123456678999999999999999999999
Q ss_pred HHHHhhhh
Q 046907 337 RRMLSQIQ 344 (345)
Q Consensus 337 l~~L~~l~ 344 (345)
++.|+++.
T Consensus 289 ~~~L~~i~ 296 (303)
T d1vjya_ 289 KKTLSQLS 296 (303)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99999884
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.5e-47 Score=343.40 Aligned_cols=246 Identities=23% Similarity=0.278 Sum_probs=186.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-++|++++.||+|+||.||+|+.. .+|+.||||.+........ ...........|+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~~---------------------~~~~~~~~e~~~~~~ 60 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMK---------------------QGETLALNERIMLSL 60 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHH---------------------TCHHHHHHHHHHHHH
T ss_pred HHhCeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcchh---------------------hHHHHHHHHHHHHHH
Confidence 368999999999999999999864 5799999999852111100 001112223345778
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++|||||++++++..++ .+++++||++++++ +++..+..++.|++.||.|||+.+ ++||||||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~--~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP 135 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKP 135 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSS--EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred HhcCCCCcEEEEEEEEEECC--EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeecc
Confidence 88889999999999998876 68999999998765 455566789999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+|||++.++.+||+|||+|+...... .....||+.|+|||++.+ ..++.++||| +||++|||++|..||.....
T Consensus 136 ~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 136 ANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp GGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999998765432 245689999999999975 5689999999 99999999999999764322
Q ss_pred ccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN-----SKDVRR 338 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt-----~~~ll~ 338 (345)
.+.............. .... ....+.++|..||+.||++||| ++++++
T Consensus 212 ----~~~~~~~~~~~~~~~~-------~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 212 ----KDKHEIDRMTLTMAVE-------LPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----SCHHHHHHHSSSCCCC-------CCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----HHHHHHHHhcccCCCC-------CCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2222222222211111 0111 1234678899999999999999 678764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=335.14 Aligned_cols=255 Identities=23% Similarity=0.299 Sum_probs=194.3
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||.||+|++. .+|+.||||.+...... .....++.+|+.++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~-------------------------~~~~~~~~~Ei~il 55 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTET-------------------------EGVPSTAIREISLL 55 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC--------------------------------CCHHHHHHHHHH
T ss_pred CCCEeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcC-------------------------hHHHHHHHHHHHHH
Confidence 58999999999999999999964 57999999999543211 12356788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++++|||||++++++.+++ .+++++|++.++ ..+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 56 ~~l~Hp~Iv~~~~~~~~~~--~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKp 130 (298)
T d1gz8a_ 56 KELNHPNIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKP 130 (298)
T ss_dssp TTCCCTTBCCEEEEEEETT--EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred HhCCCCcEEEecccccccc--ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCc
Confidence 9999999999999999877 789999998753 34788899999999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
+|||++.++.+|++|||.|+....... ......||+.|+|||.+.... ++.++|+| +|+++|+|++|..||..
T Consensus 131 eNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~--- 205 (298)
T d1gz8a_ 131 QNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG--- 205 (298)
T ss_dssp GGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred hheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC---
Confidence 999999999999999999987654322 334568999999999987766 47899999 99999999999999753
Q ss_pred ccchhhHHHHHHHHhhhcCCCcccc-----------ccccCCC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 046907 276 HTNEMSFVKWMRNVMASENPKRAID-----------SKLVGNG----CEEQMLLVLKIACFCTLEDPNERPNSKDVRRM 339 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~ 339 (345)
.+..+....+......+....... +...... .+.....+.+++.+||+.||++|||+.|+++.
T Consensus 206 -~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 206 -DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp -SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 233333333333222211110000 0000000 11222457889999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=337.25 Aligned_cols=241 Identities=20% Similarity=0.243 Sum_probs=192.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|.+++.||+|+||.||+|+++ .+|+.||||.+..... ....+.+|+.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~~----------------------------~~~~~~~Ei~i 54 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGT----------------------------DQVLVKKEISI 54 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCTH----------------------------HHHHHHHHHHH
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCcc----------------------------cHHHHHHHHHH
Confidence 468999999999999999999864 5799999999965321 13456789999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
|+.++|||||++++++.+++ .+|+++||++|++ .+++..+..++.|++.||.|||+.+ |+|||||
T Consensus 55 l~~l~HpnIv~~~~~~~~~~--~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlK 129 (321)
T d1tkia_ 55 LNIARHRNILHLHESFESME--ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIR 129 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETT--EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHhCCCCCCCeEEEEEEECC--EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCccccc
Confidence 99999999999999998876 7999999998754 3677788899999999999999999 9999999
Q ss_pred CCCeeecC--CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 197 PVNVLLDD--DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 197 ~~nil~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
|+|||++. ...+|++|||++........ .....||+.|+|||.+.+..++.++||| +|+++|+|++|..||..
T Consensus 130 p~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~- 205 (321)
T d1tkia_ 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA- 205 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-
T ss_pred ccceeecCCCceEEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-
Confidence 99999984 45899999999987654332 2346789999999999999999999999 99999999999999643
Q ss_pred ccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+..+....+.... .. ++..... .....+.+++..||+.||++|||+.|+++
T Consensus 206 ---~~~~~~~~~i~~~~---~~---~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 206 ---ETNQQIIENIMNAE---YT---FDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---SSHHHHHHHHHHTC---CC---CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHhCC---CC---CChhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23333333333221 11 0000000 11234678999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=337.82 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=190.2
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|.+++.||+|+||+||+|+.+ .+|+.||||.+..... ........+..|..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~------------------------~~~~~~~~~~~e~~~l 56 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVV------------------------LMDDDVECTMVEKRVL 56 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHH------------------------HHTTCHHHHHHHHHHH
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhc------------------------cChHHHHHHHHHHHHH
Confidence 58999999999999999999964 6899999999952110 0112345666777776
Q ss_pred h-hccCCCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 G-QIRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~-~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
. .++|||||++++++.+++ .+++++||+++|++ ++...+..++.|++.||.|||+++ ++||||||
T Consensus 57 ~~~~~hp~Iv~~~~~~~~~~--~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp 131 (320)
T d1xjda_ 57 SLAWEHPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKL 131 (320)
T ss_dssp HHHTTCTTBCCEEEEEECSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCG
T ss_pred HHhCCCCcEEEEEEEEccCC--ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcc
Confidence 5 579999999999999887 79999999998754 566667889999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.+|++|||+++....... ......||+.|+|||++.+..++.++||| +||++|||++|..||.+
T Consensus 132 ~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~---- 205 (320)
T d1xjda_ 132 DNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---- 205 (320)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----
T ss_pred cceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC----
Confidence 999999999999999999986543322 23456899999999999999999999999 99999999999999643
Q ss_pred cchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK-DVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~-~ll~ 338 (345)
.+..+....+.... .... .. ....+.+|+.+||+.||++|||+. ++++
T Consensus 206 ~~~~~~~~~i~~~~--~~~p---------~~---~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 206 QDEEELFHSIRMDN--PFYP---------RW---LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SSHHHHHHHHHHCC--CCCC---------TT---SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCHHHHHHHHHcCC--CCCC---------cc---CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 33344444333211 1111 11 123377889999999999999985 6653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=339.83 Aligned_cols=242 Identities=17% Similarity=0.235 Sum_probs=185.7
Q ss_pred CCccccc-ccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLE-KIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 48 ~~~~~~~-~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
++|+++. .||+|+||.||+|+.. .+++.||||.+.. ...+.+|+.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~--------------------------------~~~~~~E~~~ 57 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD--------------------------------CPKARREVEL 57 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEC--------------------------------SHHHHHHHHH
T ss_pred cCEEEeeEEeeeccCeEEEEEEEC-CCCCEEEEEEECC--------------------------------cHHHHHHHHH
Confidence 5899886 5999999999999864 5799999999853 2234578888
Q ss_pred Hhhc-cCCCccceeEEEec--CCcceeeeeccccCCCCC-----------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 127 VGQI-RHRNLHPLLAHVTR--PDCHLLYILNDVSQGRRE-----------LDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 127 l~~l-~hpniv~l~~~~~~--~~~~~l~~~~~~~~~~~~-----------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+.++ +|||||++++++.+ .+...+++++||++||++ +++..+..++.|++.||.|||+.+ ++|
T Consensus 58 ~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiH 134 (335)
T d2ozaa1 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 134 (335)
T ss_dssp HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccc
Confidence 7655 89999999998865 334578999999988643 566678899999999999999999 999
Q ss_pred cCCCCCCeeecC---CCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 193 RDLNPVNVLLDD---DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 193 ~dlk~~nil~~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
|||||+|||++. .+.+||+|||+|+....... .....||+.|||||++.+..++.++||| +||++|+|+||..
T Consensus 135 RDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred ccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 999999999985 55799999999987654332 3457899999999999999999999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
||..... ......+......... ..+....+.....+.+|+.+||+.||++|||+.++++
T Consensus 212 Pf~~~~~----~~~~~~~~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 212 PFYSNHG----LAISPGMKTRIRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCEETTC----C--------CCCSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCH----HHHHHHHHHHHhcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 9754322 1111111111110000 0111112233456889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=337.29 Aligned_cols=258 Identities=19% Similarity=0.289 Sum_probs=192.4
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
..++|++++.||+|+||.||+|++...+++.||||.+......... ...+.+|+.
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-------------------------~~~~~~E~~ 59 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-------------------------PLSTIREVA 59 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-------------------------BCTHHHHHH
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-------------------------HHHHHHHHH
Confidence 4579999999999999999999975555788999998653322111 223446777
Q ss_pred HHhhc---cCCCccceeEEEecC---CcceeeeeccccCCCC----------CCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046907 126 TVGQI---RHRNLHPLLAHVTRP---DCHLLYILNDVSQGRR----------ELDWLARHRIALGLACGLEYLHMHHCPR 189 (345)
Q Consensus 126 ~l~~l---~hpniv~l~~~~~~~---~~~~l~~~~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~~~~ 189 (345)
+++.+ +||||+++++++... ....++++++++.++. .+++.....++.|++.||.|||+.+
T Consensus 60 ~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--- 136 (305)
T d1blxa_ 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--- 136 (305)
T ss_dssp HHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 76655 799999999988642 3346889999998752 3677788899999999999999999
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 190 IIHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 190 iiH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
|+||||||+|||++.++.+||+|||++...... .......||+.|+|||++.+.+++.++||| +||++|||++|..
T Consensus 137 ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~ 213 (305)
T d1blxa_ 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213 (305)
T ss_dssp CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCC
Confidence 999999999999999999999999998754322 233567899999999999999999999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCcc----------cc---ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRA----------ID---SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
||.. .+..+....+......+..... .. ........+.....+.+|+.+||+.||++|||+.|
T Consensus 214 pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 214 LFRG----SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp SCCC----SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCC----CCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 9743 2334444444333322111100 00 00000111122345678899999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 290 ~L~ 292 (305)
T d1blxa_ 290 ALS 292 (305)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-46 Score=330.64 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=190.9
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|+++++||+|+||.||+|+++ +|+.||||.+.....+. ....++.+|+.++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~-------------------------~~~~~~~~E~~il 54 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDE-------------------------GIPSTTIREISIL 54 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGG-------------------------CCCHHHHHHHHGG
T ss_pred CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcCh-------------------------HHHHHHHHHHHHH
Confidence 68999999999999999999874 78999999996543221 1245688999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
++++|||||++++++..++ ..+++++++.+ ...++...+..++.|++.||.|||+.+ |+||||||+
T Consensus 55 ~~l~hpnIv~~~~~~~~~~--~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~ 129 (286)
T d1ob3a_ 55 KELKHSNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQ 129 (286)
T ss_dssp GGCCCTTBCCEEEEEECSS--CEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred HhCCCCcEEeeeeecccCC--ceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCc
Confidence 9999999999999999887 57777777765 345788899999999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
|||++.++.+|++|||.+........ ......|++.|+|||.+.+.. ++.++||| +|+++|||++|..||..
T Consensus 130 NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~---- 203 (286)
T d1ob3a_ 130 NLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG---- 203 (286)
T ss_dssp GEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred eeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC----
Confidence 99999999999999999987654322 233457899999999997654 68999999 99999999999999753
Q ss_pred cchhhHHHHHHHHhhhcCCCcccc---------------ccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAID---------------SKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+..+....+......+....... +.......+.....+.+++.+||+.||++|||++|+++
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233334343333332222111100 00000111122345778999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=331.03 Aligned_cols=237 Identities=18% Similarity=0.287 Sum_probs=183.9
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++.+.||+|+||.||+|+.. .+|..||||.+.....+.... .....++.+|+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~---------------------~~~~~~~~~E~~i 60 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGE---------------------LPNGTRVPMEVVL 60 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEE---------------------CTTCCEEEHHHHH
T ss_pred CCeEEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhh---------------------hhHHHHHHHHHHH
Confidence 368999999999999999999864 579999999986432221100 0012335679999
Q ss_pred Hhhcc--CCCccceeEEEecCCcceeeeeccccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 127 VGQIR--HRNLHPLLAHVTRPDCHLLYILNDVSQGR----------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 127 l~~l~--hpniv~l~~~~~~~~~~~l~~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
+++++ |||||++++++..++ .++++++++.++ ..+++..+..++.|++.||.|||+.+ ++|||
T Consensus 61 l~~l~~~h~nIv~~~~~~~~~~--~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrD 135 (273)
T d1xwsa_ 61 LKKVSSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRD 135 (273)
T ss_dssp HHHHCSSSCSBCCEEEEEECSS--EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhccCCCCccEEEEEEeeCC--eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 99986 999999999998877 678888888653 23677778899999999999999999 99999
Q ss_pred CCCCCeeecC-CCCeEEeccccceecCCCCcceeccCcccCcccccccccccccc-Cccchhh-HHHHHHHHHhCCCCCc
Q 046907 195 LNPVNVLLDD-DIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTL-TEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 195 lk~~nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~-~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|||+|||++. .+.+||+|||+|...... ...+..||+.|+|||++.+..+ +.++||| +|+++|||++|..||.
T Consensus 136 iKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 136 IKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 9999999985 478999999999865433 2345789999999999987775 5679999 9999999999999975
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.. .+ + ...... ..+ .. ...+.+++.+||+.||++|||++|+++
T Consensus 212 ~~------~~----i---~~~~~~---~~~----~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 212 HD------EE----I---IRGQVF---FRQ----RV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp SH------HH----H---HHCCCC---CSS----CC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc------hH----H---hhcccC---CCC----CC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 31 11 1 111110 111 11 234778899999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-45 Score=330.48 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=188.5
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||.||+|+.+ .+|+.||||.+.....+ ....+.+.+|+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~-------------------------~~~~~~~~~Ei~i 70 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQS-------------------------ELFAKRAYRELRL 70 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSS-------------------------HHHHHHHHHHHHH
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcC-------------------------hHHHHHHHHHHHH
Confidence 579999999999999999999854 57999999999643322 2335678899999
Q ss_pred HhhccCCCccceeEEEecCCc----ceeeeeccccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC----HLLYILNDVSQG-------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~----~~l~~~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
|+.++|||||++++++...+. ..+++++++++. ...++...+..++.|++.||.|||+++ |+||||
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDi 147 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDL 147 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---Cccccc
Confidence 999999999999999976642 257899999954 235788888999999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCCCccc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLPSDKF 273 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p~~~~ 273 (345)
||+|||++.++.+|++|||+|...... .+...||+.|+|||.+.+. .++.++||| +||++|+|++|.+||...
T Consensus 148 Kp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 148 KPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 999999999999999999999876442 2457899999999999765 468899999 999999999999997542
Q ss_pred ccccchhhHHHHHHHHhhhcCCCc-----------------cccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 046907 274 FQHTNEMSFVKWMRNVMASENPKR-----------------AIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDV 336 (345)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~l 336 (345)
+.......+........... ...........+.....+.+|+.+||+.||.+|||+.|+
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei 298 (346)
T d1cm8a_ 223 ----DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298 (346)
T ss_dssp ----SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ----ChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 22333222222221110000 000000001111222346789999999999999999999
Q ss_pred HHH
Q 046907 337 RRM 339 (345)
Q Consensus 337 l~~ 339 (345)
++.
T Consensus 299 L~H 301 (346)
T d1cm8a_ 299 LAH 301 (346)
T ss_dssp HHS
T ss_pred hcC
Confidence 873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=328.80 Aligned_cols=253 Identities=20% Similarity=0.263 Sum_probs=189.1
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||+||+|++. .+|+.||||.+..... ..++..|+++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~-----------------------------~~~~~~E~~i 55 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK-----------------------------HPQLHIESKI 55 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCTT-----------------------------SCCHHHHHHH
T ss_pred CCEEEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhcc-----------------------------CHHHHHHHHH
Confidence 467999999999999999999864 5789999999864321 2235679999
Q ss_pred HhhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
++.++|+|++..+..+...+ ...++++++++++ ..++...+..++.|++.||.|||+++ |+||||||
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~-~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp 131 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEG-DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKP 131 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEET-TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred HHHccCCCcccEEEEEEecC-CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCH
Confidence 99998877666655544333 2677888998663 35788888999999999999999999 99999999
Q ss_pred CCeeec---CCCCeEEeccccceecCCCCcc-----eeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCC
Q 046907 198 VNVLLD---DDIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKL 268 (345)
Q Consensus 198 ~nil~~---~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~ 268 (345)
+|||++ .+..++++|||+|+........ .......||+.|||||.+.+.+++.++||| ||+++|||++|..
T Consensus 132 ~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 132 DNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp GGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred hhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCC
Confidence 999986 3557999999999987553321 123456899999999999999999999999 9999999999999
Q ss_pred CCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 269 PSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 269 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
||......................+ .. .... ..+..+.++|..||+.||++||+++++.+.|+.+
T Consensus 212 P~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 212 PWQGLKAATKRQKYERISEKKMSTP--IE----VLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp TTCCCC-------HHHHHHHHHHSC--HH----HHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHhhcccCCCC--hh----Hhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 9876444333333322222221111 00 0001 1123467888889999999999999999988876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=324.78 Aligned_cols=253 Identities=18% Similarity=0.234 Sum_probs=193.3
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+.++|+++++||+|+||+||+|+.. .+|+.||||++.... .+++.+|+.
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~------------------------------~~~~~~Ei~ 81 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK------------------------------KKKIKREIK 81 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSSC------------------------------HHHHHHHHH
T ss_pred CCcCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHHH------------------------------HHHHHHHHH
Confidence 5578999999999999999999954 589999999986421 345678999
Q ss_pred HHhhcc-CCCccceeEEEecCCcceeeeeccccCCCC------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 126 TVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRR------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 126 ~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+|+.++ ||||+++++++..+....++++++++.++. .++...+..++.|++.||.|||+++ |+||||||+
T Consensus 82 il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~ 158 (328)
T d3bqca1 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPH 158 (328)
T ss_dssp HHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred HHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---ccccccccc
Confidence 999995 999999999998776668899999998875 4678888999999999999999999 999999999
Q ss_pred CeeecCCC-CeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCccccc
Q 046907 199 NVLLDDDI-EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQ 275 (345)
Q Consensus 199 nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~ 275 (345)
|||++.++ .+|++|||+|....... ......||+.|+|||.+.+.. ++.++||| +|+++|||++|..||...
T Consensus 159 NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~-- 233 (328)
T d3bqca1 159 NVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG-- 233 (328)
T ss_dssp GEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC--
T ss_pred ceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC--
Confidence 99998655 68999999998765432 234568899999999987765 78999999 999999999999997432
Q ss_pred ccchhhHHHHHHHHhhhc-----------CCCcc------------ccccccCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 046907 276 HTNEMSFVKWMRNVMASE-----------NPKRA------------IDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPN 332 (345)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~-----------~~~~~------------~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt 332 (345)
.........+......+ ..... ................+.+||.+||+.||++|||
T Consensus 234 -~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 312 (328)
T d3bqca1 234 -HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312 (328)
T ss_dssp -SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC
T ss_pred -chhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC
Confidence 22222222222211110 00000 0000011111122345778999999999999999
Q ss_pred HHHHHH
Q 046907 333 SKDVRR 338 (345)
Q Consensus 333 ~~~ll~ 338 (345)
++|+++
T Consensus 313 a~e~L~ 318 (328)
T d3bqca1 313 AREAME 318 (328)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=323.73 Aligned_cols=260 Identities=23% Similarity=0.290 Sum_probs=193.2
Q ss_pred hcCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 46 KKGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEIN 125 (345)
Q Consensus 46 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 125 (345)
+-++|++++.||+|+||.||+|+++ .+|+.||||++...... .....++.+|+.
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~-------------------------~~~~~~~~~E~~ 61 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEK-------------------------EGFPITALREIK 61 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CT-------------------------TSSCHHHHHHHH
T ss_pred ccCCEEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcc-------------------------hHHHHHHHHHHH
Confidence 4579999999999999999999864 58999999998543221 112456778999
Q ss_pred HHhhccCCCccceeEEEecCC------cceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046907 126 TVGQIRHRNLHPLLAHVTRPD------CHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRI 190 (345)
Q Consensus 126 ~l~~l~hpniv~l~~~~~~~~------~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~i 190 (345)
+|++++||||+++++++.... ...++++++++.++ ..++......++.|++.||.|||+.+ |
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---i 138 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---I 138 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---E
Confidence 999999999999999886643 23578899988653 34677788899999999999999999 9
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCcc--eeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhC
Q 046907 191 IHRDLNPVNVLLDDDIEARISGFGFARAIPDAHTH--ITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMG 266 (345)
Q Consensus 191 iH~dlk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg 266 (345)
+||||||+|||++.++.+|++|||++......... .......||+.|+|||.+.+. .++.++||| +|+++|||++|
T Consensus 139 vHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g 218 (318)
T d3blha1 139 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218 (318)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred EecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhC
Confidence 99999999999999999999999999876543221 123446799999999999765 589999999 99999999999
Q ss_pred CCCCcccccccchhhHHHHHHHHhhhcCCCccccc-----------ccc-CCCcHHH------HHHHHHHHhhccCCCCC
Q 046907 267 KLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDS-----------KLV-GNGCEEQ------MLLVLKIACFCTLEDPN 328 (345)
Q Consensus 267 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~~------~~~l~~li~~Cl~~dp~ 328 (345)
..||.+ .........+............... ... .....+. ...+.+|+.+||+.||+
T Consensus 219 ~~pf~~----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 219 SPIMQG----NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp SCSCCC----SSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred CCCCCC----CCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence 999643 3444555555554433222111000 000 0011111 23467899999999999
Q ss_pred CCCCHHHHHH
Q 046907 329 ERPNSKDVRR 338 (345)
Q Consensus 329 ~Rpt~~~ll~ 338 (345)
+|||++|+++
T Consensus 295 ~R~sa~elL~ 304 (318)
T d3blha1 295 QRIDSDDALN 304 (318)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHHc
Confidence 9999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=316.76 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=197.4
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|++++.||+|+||+||+|++. .+|+.||||+++..... .....++.+|+.++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~-------------------------~~~~~~~~~E~~il 55 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDD-------------------------EGVPSSALREICLL 55 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSS-------------------------TTHHHHHHHHHHHH
T ss_pred CCCEeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCC-------------------------hHHHHHHHHHHHHH
Confidence 58999999999999999999964 68999999999654322 12366788999999
Q ss_pred hhccCCCccceeEEEecCCcceeeeeccccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPDCHLLYILNDVSQGR---------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPV 198 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~ 198 (345)
+.++||||+++++++..++ ..+++++++.++ ..+++..+..++.|++.||.|||+++ |+||||||+
T Consensus 56 ~~l~h~niv~~~~~~~~~~--~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~ 130 (292)
T d1unla_ 56 KELKHKNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQ 130 (292)
T ss_dssp TTCCCTTBCCEEEEEECSS--EEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred HhcCcCCEEeecccccccc--ceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCc
Confidence 9999999999999998877 567777777653 34677788899999999999999998 999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 199 NVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 199 nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
|||++.++.+|++|||.+........ ......++..|+|||.+.+.. ++.++||| +|+++|||++|..|| +..
T Consensus 131 NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~---~~~ 205 (292)
T d1unla_ 131 NLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL---FPG 205 (292)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS---CCC
T ss_pred ccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC---CCC
Confidence 99999999999999999987654332 223356788899999987765 68999999 999999999999996 444
Q ss_pred cchhhHHHHHHHHhhhcCCCccc---------------cccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 277 TNEMSFVKWMRNVMASENPKRAI---------------DSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
.+..+....+......+...... .........+.....+.+|+.+||+.||.+|||++|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 55555555555444332211100 000011112223345778899999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=328.49 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=187.3
Q ss_pred CcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 046907 49 GLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVG 128 (345)
Q Consensus 49 ~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 128 (345)
+|+.+++||+|+||+||+|++. .+|+.||||.+..... ...+|+.+++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~-------------------------------~~~~Ei~il~ 68 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR-------------------------------FKNRELQIMR 68 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS-------------------------------SCCHHHHHHH
T ss_pred CcEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch-------------------------------HHHHHHHHHH
Confidence 7999999999999999999965 5799999999965321 1236999999
Q ss_pred hccCCCccceeEEEecC----CcceeeeeccccCCC------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046907 129 QIRHRNLHPLLAHVTRP----DCHLLYILNDVSQGR------------RELDWLARHRIALGLACGLEYLHMHHCPRIIH 192 (345)
Q Consensus 129 ~l~hpniv~l~~~~~~~----~~~~l~~~~~~~~~~------------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH 192 (345)
+++||||+++++++... +..++++++||++++ ..+++..+..++.|++.||.|||+.+ |+|
T Consensus 69 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiH 145 (350)
T d1q5ka_ 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICH 145 (350)
T ss_dssp HCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EEC
T ss_pred hcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---Ccc
Confidence 99999999999988543 445788999999764 23777888899999999999999998 999
Q ss_pred cCCCCCCeeecCCC-CeEEeccccceecCCCCcceeccCcccCcccccccccccc-ccCccchhh-HHHHHHHHHhCCCC
Q 046907 193 RDLNPVNVLLDDDI-EARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQML-TLTEKCDIY-FGALLAGLVMGKLP 269 (345)
Q Consensus 193 ~dlk~~nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~-~~~~~~Dvw-lG~vl~el~tg~~p 269 (345)
|||||+|||++.++ .+||+|||++........ ..+..||..|+|||.+.+. .++.++||| +||++|||++|..|
T Consensus 146 rDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~p 222 (350)
T d1q5ka_ 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222 (350)
T ss_dssp CCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred cCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCC
Confidence 99999999999765 899999999987654332 2446899999999988754 689999999 99999999999999
Q ss_pred CcccccccchhhHHHHHHHHhhhcCC---------------CccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 046907 270 SDKFFQHTNEMSFVKWMRNVMASENP---------------KRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSK 334 (345)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~ 334 (345)
|... +..+....+......+.. .............+.....+.+|+.+||+.||++|||+.
T Consensus 223 f~~~----~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 223 FPGD----SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp SCCS----SHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCC----CHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 7432 233333323222211110 000000000011112233477889999999999999999
Q ss_pred HHHH
Q 046907 335 DVRR 338 (345)
Q Consensus 335 ~ll~ 338 (345)
|+++
T Consensus 299 e~L~ 302 (350)
T d1q5ka_ 299 EACA 302 (350)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=324.36 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=187.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|+++++||+|+||+||+|++. .+|..||||++.....+ .....++.+|+.++
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~-------------------------~~~~~~~~~Ei~il 70 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQN-------------------------QTHAKRAYRELVLM 70 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSS-------------------------HHHHHHHHHHHHHH
T ss_pred CCeEEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcC-------------------------HHHHHHHHHHHHHH
Confidence 58999999999999999999864 57999999999754332 23356788999999
Q ss_pred hhccCCCccceeEEEecCC----cceeeeeccccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 046907 128 GQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGR------RELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNP 197 (345)
Q Consensus 128 ~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~ 197 (345)
+.++|||||++++++...+ ...+|+++||+.++ ..+++..+..++.|++.||.|||+.| |+||||||
T Consensus 71 ~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP 147 (355)
T d2b1pa1 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147 (355)
T ss_dssp HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred HhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCc
Confidence 9999999999999997653 35789999999774 34778888999999999999999999 99999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-HHHHHHHHHhCCCCCcccccc
Q 046907 198 VNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVMGKLPSDKFFQH 276 (345)
Q Consensus 198 ~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~tg~~p~~~~~~~ 276 (345)
+|||++.++.++++|||+++...... ......||+.|+|||++.+..++.++||| +||++|+|++|..||...
T Consensus 148 ~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~--- 221 (355)
T d2b1pa1 148 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR--- 221 (355)
T ss_dssp GGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred cccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC---
Confidence 99999999999999999987654432 23456789999999999999999999999 999999999999997432
Q ss_pred cchhhHHHHHHHHhhhcCCC-------------------c------cccccccCC---CcHHHHHHHHHHHhhccCCCCC
Q 046907 277 TNEMSFVKWMRNVMASENPK-------------------R------AIDSKLVGN---GCEEQMLLVLKIACFCTLEDPN 328 (345)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~-------------------~------~~~~~~~~~---~~~~~~~~l~~li~~Cl~~dp~ 328 (345)
+.......+......+.+. . ......... ........+.+|+.+||+.||+
T Consensus 222 -~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 222 -DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp -SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred -CHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 2222222222211111000 0 000001111 1123456688999999999999
Q ss_pred CCCCHHHHHH
Q 046907 329 ERPNSKDVRR 338 (345)
Q Consensus 329 ~Rpt~~~ll~ 338 (345)
+|||++|+++
T Consensus 301 ~R~ta~elL~ 310 (355)
T d2b1pa1 301 KRISVDDALQ 310 (355)
T ss_dssp TSCCHHHHHT
T ss_pred HCcCHHHHhc
Confidence 9999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-44 Score=317.86 Aligned_cols=252 Identities=15% Similarity=0.175 Sum_probs=192.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||+||+|++. .+|+.||||.+..... ...+.+|++.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~-----------------------------~~~~~~e~~~ 53 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD-----------------------------APQLRDEYRT 53 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT-----------------------------SCCHHHHHHH
T ss_pred CCceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEccccC-----------------------------cHHHHHHHHH
Confidence 468999999999999999999964 5799999998854321 1234568888
Q ss_pred HhhccC-CCccceeEEEecCCcceeeeeccccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046907 127 VGQIRH-RNLHPLLAHVTRPDCHLLYILNDVSQG---------RRELDWLARHRIALGLACGLEYLHMHHCPRIIHRDLN 196 (345)
Q Consensus 127 l~~l~h-pniv~l~~~~~~~~~~~l~~~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk 196 (345)
++.++| +|++.+++++..++ ..+++++++.+ +..++......++.|++.||.|||+.+ ++|||||
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~--~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiK 128 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGL--HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIK 128 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETT--EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCC
T ss_pred HHHhcCCCCCCEEEEEeecCC--ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCC
Confidence 888854 89999999888766 67888899854 234777788899999999999999999 9999999
Q ss_pred CCCeeecC-----CCCeEEeccccceecCCCCcc-----eeccCcccCccccccccccccccCccchhh-HHHHHHHHHh
Q 046907 197 PVNVLLDD-----DIEARISGFGFARAIPDAHTH-----ITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-FGALLAGLVM 265 (345)
Q Consensus 197 ~~nil~~~-----~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-lG~vl~el~t 265 (345)
|+|||++. .+.+|++|||+|+........ .......||+.|||||.+.+..++.++||| +|+++|||++
T Consensus 129 p~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt 208 (293)
T d1csna_ 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 208 (293)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh
Confidence 99999974 568999999999876543221 123456899999999999999999999999 9999999999
Q ss_pred CCCCCcccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhhh
Q 046907 266 GKLPSDKFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERPNSKDVRRMLSQI 343 (345)
Q Consensus 266 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~~L~~l 343 (345)
|..||............ ..+........+. .+.... +.++.+++..||+.+|++||+...+.+.|+++
T Consensus 209 g~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~-----~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 209 GSLPWQGLKAATNKQKY-ERIGEKKQSTPLR-----ELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SSCTTSSCCSCCHHHHH-HHHHHHHHHSCHH-----HHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCCcCCCccchhHHHHH-HHHHhccCCCChH-----HhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 99998654333222222 2222221111111 111111 23467788889999999999999999988875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=320.59 Aligned_cols=258 Identities=22% Similarity=0.257 Sum_probs=185.3
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
+++|++++.||+|+||.||+|+.+ .+|+.||||.+..... .....++.+|+.+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~--------------------------~~~~~~~~~Ei~i 59 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEH--------------------------QTYCQRTLREIKI 59 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTC--------------------------HHHHHHHHHHHHH
T ss_pred CCCeEEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcC--------------------------hHHHHHHHHHHHH
Confidence 457999999999999999999854 6899999999964321 2235678899999
Q ss_pred HhhccCCCccceeEEEecCCc---ceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046907 127 VGQIRHRNLHPLLAHVTRPDC---HLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRDL 195 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~~---~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dl 195 (345)
|+.++||||+++++++..+.. ..++++++++ +++ .+++..+..++.|++.||.|||+++ |+||||
T Consensus 60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~-~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDI 135 (345)
T d1pmea_ 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDL 135 (345)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC-CEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHcCCCCCCcEEEEEeeccccccceEEEEEeec-CCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 999999999999999876542 2355555544 543 4677778899999999999999999 999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCcc-eeccCcccCccccccccccc-cccCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 196 NPVNVLLDDDIEARISGFGFARAIPDAHTH-ITTSNVVGTVEYIAPEYLQM-LTLTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 196 k~~nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~~~aPE~~~~-~~~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
||+|||++.++.+||+|||++......... .......||+.|+|||.+.. ..++.++||| +|+++|||++|..||..
T Consensus 136 Kp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 136 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 999999999999999999999876443221 12345789999999999854 4578899999 99999999999999753
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccc-------------cccccCC----CcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAI-------------DSKLVGN----GCEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~----~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
. ...+...........+...... .+..... ..+.....+.+++.+||+.||.+|||+.+
T Consensus 216 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 216 K----HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp S----SHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred C----CHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 2 2222222222221111100000 0000000 00111234778999999999999999999
Q ss_pred HHHH
Q 046907 336 VRRM 339 (345)
Q Consensus 336 ll~~ 339 (345)
+++.
T Consensus 292 ~L~h 295 (345)
T d1pmea_ 292 ALAH 295 (345)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=320.95 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=188.8
Q ss_pred cCCcccccccccCcceeeEEEEec--CCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELP--GQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEI 124 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 124 (345)
-++|++++.||+|+||.||+|+.. ..+|+.||||.+........ ....+.+.+|+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-----------------------~~~~~~~~~E~ 79 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-----------------------AKTTEHTRTER 79 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-----------------------ESSGGGCCCHH
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-----------------------hHHHHHHHHHH
Confidence 367999999999999999999852 34689999999864322110 01134567899
Q ss_pred HHHhhccC-CCccceeEEEecCCcceeeeeccccCCCCC---------CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 125 NTVGQIRH-RNLHPLLAHVTRPDCHLLYILNDVSQGRRE---------LDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 125 ~~l~~l~h-pniv~l~~~~~~~~~~~l~~~~~~~~~~~~---------l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
.++++++| |||+++++++..++ .++++++++.++++ ++......++.|++.||.|+|+.+ ++|||
T Consensus 80 ~il~~l~h~pnIv~~~~~~~~~~--~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrD 154 (322)
T d1vzoa_ 80 QVLEHIRQSPFLVTLHYAFQTET--KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 154 (322)
T ss_dssp HHHHHHHTCTTBCCEEEEEEETT--EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHHhccCCCeEEEeeeeeccCC--ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEecc
Confidence 99999966 89999999998887 78899999988765 344556679999999999999998 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc--cCccchhh-HHHHHHHHHhCCCCCc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT--LTEKCDIY-FGALLAGLVMGKLPSD 271 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~--~~~~~Dvw-lG~vl~el~tg~~p~~ 271 (345)
|||+|||++.++.+||+|||+++........ ......|++.|+|||.+.+.. ++.++||| +||++|||++|..||.
T Consensus 155 iKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 155 IKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999876443222 234568999999999997654 67899999 9999999999999986
Q ss_pred ccccccchhhHHHHHHHHhhhcCCCccccccccCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 046907 272 KFFQHTNEMSFVKWMRNVMASENPKRAIDSKLVGNGCEEQMLLVLKIACFCTLEDPNERP-----NSKDVRR 338 (345)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~dp~~Rp-----t~~~ll~ 338 (345)
.............. .. ...+. .+......+.+++.+||++||++|| |++|+++
T Consensus 234 ~~~~~~~~~~i~~~---~~-~~~~~----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 234 VDGEKNSQAEISRR---IL-KSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CTTSCCCHHHHHHH---HH-HCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCHHHHHHHHHHh---cc-cCCCC----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 54333322222221 11 11111 1112233577889999999999999 4788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=313.93 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=185.4
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
.++|++++.||+|+||+||+|+.. .+|+.||||++.....+ .....++.+|+.+
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~-------------------------~~~~~~~~~Ei~i 70 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQS-------------------------IIHAKRTYRELRL 70 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSS-------------------------HHHHHHHHHHHHH
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcC-------------------------hHHHHHHHHHHHH
Confidence 578999999999999999999854 68999999999754333 2235678899999
Q ss_pred HhhccCCCccceeEEEecCC----cceeeeeccccCCCC--------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046907 127 VGQIRHRNLHPLLAHVTRPD----CHLLYILNDVSQGRR--------ELDWLARHRIALGLACGLEYLHMHHCPRIIHRD 194 (345)
Q Consensus 127 l~~l~hpniv~l~~~~~~~~----~~~l~~~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~d 194 (345)
|+.++|||||++++++...+ ...+++++ ++.+++ .++...+..++.|++.||.|||+++ |+|||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~-~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrD 146 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRD 146 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE-ECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEE-eecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---Ccccc
Confidence 99999999999999986542 22344444 444543 4777888999999999999999999 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCcceeccCcccCccccccccccccc-cCccchhh-HHHHHHHHHhCCCCCcc
Q 046907 195 LNPVNVLLDDDIEARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLT-LTEKCDIY-FGALLAGLVMGKLPSDK 272 (345)
Q Consensus 195 lk~~nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~-~~~~~Dvw-lG~vl~el~tg~~p~~~ 272 (345)
|||+|||++.++.+|++|||.+..... ...+..||+.|+|||.+.+.. ++.++||| +|+++|+|++|..||..
T Consensus 147 iKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 147 LKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp CCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence 999999999999999999999875432 234578899999999877765 68899999 99999999999999643
Q ss_pred cccccchhhHHHHHHHHhhhcCCCccc-------------cccccCCC----cHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 046907 273 FFQHTNEMSFVKWMRNVMASENPKRAI-------------DSKLVGNG----CEEQMLLVLKIACFCTLEDPNERPNSKD 335 (345)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~----~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ 335 (345)
.+.......+............. ........ .......+.+||.+||+.||++|||+.|
T Consensus 222 ----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 222 ----TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp ----SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ----CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 33334444443332221110000 00000000 0112234678999999999999999999
Q ss_pred HHH
Q 046907 336 VRR 338 (345)
Q Consensus 336 ll~ 338 (345)
+++
T Consensus 298 lL~ 300 (348)
T d2gfsa1 298 ALA 300 (348)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-39 Score=293.79 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=180.7
Q ss_pred CCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTV 127 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 127 (345)
++|+++++||+|+||.||+|+.. .+|+.||||+++... ...+.+.+|+.++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~----------------------------~~~~~~~~Ei~~l 63 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDK----------------------------VYTEAAEDEIKLL 63 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH----------------------------HHHHHHHHHHHHH
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeccc----------------------------cchHHHHHHHHHH
Confidence 46999999999999999999853 589999999996431 1134456677777
Q ss_pred hhcc-----------CCCccceeEEEecCCcceeeeeccccCC------------CCCCCHHHHHHHHHHHHHHHHHHhh
Q 046907 128 GQIR-----------HRNLHPLLAHVTRPDCHLLYILNDVSQG------------RRELDWLARHRIALGLACGLEYLHM 184 (345)
Q Consensus 128 ~~l~-----------hpniv~l~~~~~~~~~~~l~~~~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~lh~ 184 (345)
+.++ ||||+++++++...+....+.++.+... ...++...+..++.|++.||.|||+
T Consensus 64 ~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~ 143 (362)
T d1q8ya_ 64 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 143 (362)
T ss_dssp HHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh
Confidence 6654 6889999998876554444444443322 2346777888999999999999998
Q ss_pred -cCCCCeEecCCCCCCeeecCCCC------eEEeccccceecCCCCcceeccCcccCccccccccccccccCccchhh-H
Q 046907 185 -HHCPRIIHRDLNPVNVLLDDDIE------ARISGFGFARAIPDAHTHITTSNVVGTVEYIAPEYLQMLTLTEKCDIY-F 256 (345)
Q Consensus 185 -~~~~~iiH~dlk~~nil~~~~~~------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~~~aPE~~~~~~~~~~~Dvw-l 256 (345)
.+ |+||||||+|||++.++. ++++|||.+...... .....||+.|+|||++.+..++.++|+| +
T Consensus 144 ~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 215 (362)
T d1q8ya_ 144 RCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWST 215 (362)
T ss_dssp TTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHH
T ss_pred hcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccch
Confidence 76 999999999999986543 899999998765432 2346799999999999999999999999 9
Q ss_pred HHHHHHHHhCCCCCcccccccc--hhhHHHHHHHHhhhcCCC------------------ccccc----------cccCC
Q 046907 257 GALLAGLVMGKLPSDKFFQHTN--EMSFVKWMRNVMASENPK------------------RAIDS----------KLVGN 306 (345)
Q Consensus 257 G~vl~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~------------------~~~~~----------~~~~~ 306 (345)
|+++++|++|..||........ ............+..... ..... .....
T Consensus 216 G~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (362)
T d1q8ya_ 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 295 (362)
T ss_dssp HHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC
T ss_pred HHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccc
Confidence 9999999999999864322111 111111111111110000 00000 01122
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 046907 307 GCEEQMLLVLKIACFCTLEDPNERPNSKDVRR 338 (345)
Q Consensus 307 ~~~~~~~~l~~li~~Cl~~dp~~Rpt~~~ll~ 338 (345)
........+.+|+.+||+.||.+|||++|+++
T Consensus 296 ~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 296 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp CCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 34566778999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.7e-23 Score=171.15 Aligned_cols=150 Identities=13% Similarity=0.067 Sum_probs=106.9
Q ss_pred cccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Q 046907 50 LASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINTVGQ 129 (345)
Q Consensus 50 ~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 129 (345)
+.+.++||+|+||.||+|+.. +|+.||||.++....+....... ... ............+.+|...+.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~e~~~l~~ 70 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEK-RDY--------GDLHFSVLAIRSARNEFRALQK 70 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC----------------CHHHHHHHHHHHHHHHHHH
T ss_pred chhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhh-hhh--------ccHHHHHHHHHHHHHHHHHHHH
Confidence 457899999999999999864 78999999986543321110000 000 0000112234456678999999
Q ss_pred ccCCCccceeEEEecCCcceeeeeccccCCCCC--CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeecCCCC
Q 046907 130 IRHRNLHPLLAHVTRPDCHLLYILNDVSQGRRE--LDWLARHRIALGLACGLEYLHMHHCPRIIHRDLNPVNVLLDDDIE 207 (345)
Q Consensus 130 l~hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~--l~~~~~~~i~~~i~~~l~~lh~~~~~~iiH~dlk~~nil~~~~~~ 207 (345)
+.|++++..+++.. -+++++++++... ++......++.|++.++.|||+.+ ++||||||+|||++.+ .
T Consensus 71 l~~~~v~~~~~~~~------~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 71 LQGLAVPKVYAWEG------NAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp TTTSSSCCEEEEET------TEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-E
T ss_pred ccCCCcceEEEecC------CEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-C
Confidence 99999999876531 2578888877543 445556789999999999999999 9999999999999965 5
Q ss_pred eEEeccccceecC
Q 046907 208 ARISGFGFARAIP 220 (345)
Q Consensus 208 ~kl~Dfg~a~~~~ 220 (345)
++++|||.|....
T Consensus 141 ~~liDFG~a~~~~ 153 (191)
T d1zara2 141 IWIIDFPQSVEVG 153 (191)
T ss_dssp EEECCCTTCEETT
T ss_pred EEEEECCCcccCC
Confidence 8999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.93 E-value=2.4e-05 Score=65.19 Aligned_cols=139 Identities=13% Similarity=0.065 Sum_probs=89.0
Q ss_pred cCCcccccccccCcceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 47 KGGLASLEKIGSGGCGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQSEINT 126 (345)
Q Consensus 47 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 126 (345)
-+.|+..+..+.++.+.||+... ++..+.+|......... ...+.+|...
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~~~~---------------------------~~~~~~E~~~ 62 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGT---------------------------TYDVEREKDM 62 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGGTTS---------------------------TTCHHHHHHH
T ss_pred hhceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCcccc---------------------------hhhHHHHHHH
Confidence 35777777766666789999863 45567788774322111 2234567777
Q ss_pred Hhhcc-CCCccceeEEEecCCcceeeeeccccCCCCC----CCHHHHHHHHHHHHHHHHHHhhcCC--------------
Q 046907 127 VGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQGRRE----LDWLARHRIALGLACGLEYLHMHHC-------------- 187 (345)
Q Consensus 127 l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~----l~~~~~~~i~~~i~~~l~~lh~~~~-------------- 187 (345)
+..+. +--+.+++.+...++ ..++++++++|... .+......++.+++..+..||+...
T Consensus 63 l~~l~~~vpvP~vl~~~~~~~--~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~ 140 (263)
T d1j7la_ 63 MLWLEGKLPVPKVLHFERHDG--WSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp HHHHTTTSCCCCEEEEEEETT--EEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHH
T ss_pred HHHHhccCCCCcEEEEEecCC--ceEEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhh
Confidence 76663 333567777766665 56788888877532 1111223455556666666664321
Q ss_pred ------------------------------------------CCeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 188 ------------------------------------------PRIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 188 ------------------------------------------~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
..++|+|+.+.|++++.+...-+.||+.+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 238999999999999987666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.76 E-value=5.7e-05 Score=62.48 Aligned_cols=140 Identities=16% Similarity=0.143 Sum_probs=82.5
Q ss_pred HHhhcCCcccccccccCc-ceeeEEEEecCCCCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 43 FLEKKGGLASLEKIGSGG-CGEVYKAELPGQNGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 43 ~~~~~~~~~~~~~iG~G~-~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
|......+.+. .+..|. -+.||+.+.+ .+..+.+|....... ..+.
T Consensus 6 ~~~~l~g~~~~-~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~~------------------------------~~l~ 52 (255)
T d1nd4a_ 6 WVERLFGYDWA-QQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGAL------------------------------NELQ 52 (255)
T ss_dssp GTTTTTTCEEE-ECSCTTSSCEEEEEECT--TSCCEEEEEECSCTT------------------------------SCHH
T ss_pred HHHhccCCceE-EcCCcccCCeEEEEEeC--CCCEEEEEeCCccCH------------------------------hHHH
Confidence 33344445543 334444 4678998753 566788898654321 1234
Q ss_pred HHHHHHhhcc--CCCccceeEEEecCCcceeeeeccccCCCCCCC-HHHHHHHHHHHHHHHHHHhhcCC-----------
Q 046907 122 SEINTVGQIR--HRNLHPLLAHVTRPDCHLLYILNDVSQGRRELD-WLARHRIALGLACGLEYLHMHHC----------- 187 (345)
Q Consensus 122 ~E~~~l~~l~--hpniv~l~~~~~~~~~~~l~~~~~~~~~~~~l~-~~~~~~i~~~i~~~l~~lh~~~~----------- 187 (345)
.|+..++.+. .--+.+++.+...++ ..++++++++|....+ .......+.++...+.-||+...
T Consensus 53 ~E~~~l~~L~~~gvpvP~v~~~~~~~~--~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~ 130 (255)
T d1nd4a_ 53 DEAARLSWLATTGVPCAAVLDVVTEAG--RDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKH 130 (255)
T ss_dssp HHHHHHHHHHTTTCCBCCEEEEEECSS--CEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHH
T ss_pred HHHHHHHHHHhcCCCCCceeeeccccc--ceEEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchh
Confidence 5666666653 223566777666554 5678888887744321 11112233344444444443210
Q ss_pred --------------------------------------------CCeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 188 --------------------------------------------PRIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 188 --------------------------------------------~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
..++|+|+.|.|++++.+..+-|+||+.+.
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 131 RIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 238999999999999987667799998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.14 E-value=0.025 Score=49.35 Aligned_cols=29 Identities=24% Similarity=0.397 Sum_probs=25.1
Q ss_pred CeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
.++|+|+.+.|||++.+ .++|.||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence 49999999999999876 489999987754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.52 E-value=0.049 Score=46.00 Aligned_cols=29 Identities=24% Similarity=0.239 Sum_probs=23.2
Q ss_pred CCeEecCCCCCCeeecCCCCeEEecccccee
Q 046907 188 PRIIHRDLNPVNVLLDDDIEARISGFGFARA 218 (345)
Q Consensus 188 ~~iiH~dlk~~nil~~~~~~~kl~Dfg~a~~ 218 (345)
..++|+|+.+.|+|++.+ ..+.||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 348999999999999743 45889987653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.72 E-value=0.058 Score=45.14 Aligned_cols=29 Identities=34% Similarity=0.368 Sum_probs=25.8
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccce
Q 046907 189 RIIHRDLNPVNVLLDDDIEARISGFGFAR 217 (345)
Q Consensus 189 ~iiH~dlk~~nil~~~~~~~kl~Dfg~a~ 217 (345)
.++|+|+.++|++++.+...-+.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999988777899999774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.42 E-value=0.073 Score=46.19 Aligned_cols=76 Identities=11% Similarity=0.103 Sum_probs=43.4
Q ss_pred CCcccccccccCcceeeEEEEecCC------CCceeEEeeecCCchhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 046907 48 GGLASLEKIGSGGCGEVYKAELPGQ------NGRMISIKKIVGPPMDAAALIEEDSMLLNKKMRQIQSEMLLNKKMRQIQ 121 (345)
Q Consensus 48 ~~~~~~~~iG~G~~g~V~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (345)
++++ ++.|+.|-.-.+|+++.... ..+.|.+++.-. ... .-...
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~----------------------------~idr~ 92 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET----------------------------ESHLV 92 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC----------------------------HHHHH
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch----------------------------hhHHH
Confidence 3454 46788888999999986421 234566666532 111 01123
Q ss_pred HHHHHHhhcc-CCCccceeEEEecCCcceeeeeccccCC
Q 046907 122 SEINTVGQIR-HRNLHPLLAHVTRPDCHLLYILNDVSQG 159 (345)
Q Consensus 122 ~E~~~l~~l~-hpniv~l~~~~~~~~~~~l~~~~~~~~~ 159 (345)
+|..+++.+. +.-..++++++. + ..+++|+.|
T Consensus 93 ~E~~i~~~ls~~gl~Pkll~~~~--~----g~I~efi~g 125 (395)
T d1nw1a_ 93 AESVIFTLLSERHLGPKLYGIFS--G----GRLEEYIPS 125 (395)
T ss_dssp HHHHHHHHHHHTTSSSCEEEEET--T----EEEECCCCE
T ss_pred HHHHHHHHHHhCCCCCeEEEEcC--C----ceEEEEecc
Confidence 5777777773 444457777653 2 345666665
|